
PMID- 12377809
OWN - NLM
STAT- MEDLINE
DCOM- 20021203
LR  - 20190501
IS  - 0017-5749 (Print)
IS  - 1458-3288 (Electronic)
IS  - 0017-5749 (Linking)
VI  - 51
IP  - 5
DP  - 2002 Nov
TI  - Is anorectal endosonography valuable in dyschesia?
PG  - 695-700
AB  - AIMS: Dyschesia can be provoked by inappropriate defecation movements. The aim of 
      this prospective study was to demonstrate dysfunction of the anal sphincter 
      and/or the musculus (m.) puborectalis in patients with dyschesia using anorectal 
      endosonography. METHODS: Twenty consecutive patients with a medical history of 
      dyschesia and a control group of 20 healthy subjects underwent linear anorectal 
      endosonography (Toshiba models IUV 5060 and PVL-625 RT). In both groups, the 
      dimensions of the anal sphincter and the m. puborectalis were measured at rest, 
      and during voluntary squeezing and straining. Statistical analysis was performed 
      within and between the two groups. RESULTS: The anal sphincter became 
      paradoxically shorter and/or thicker during straining (versus the resting state) 
      in 85% of patients but in only 35% of control subjects. Changes in sphincter 
      length were statistically significantly different (p<0.01, chi(2) test) in 
      patients compared with control subjects. The m. puborectalis became paradoxically 
      shorter and/or thicker during straining in 80% of patients but in only 30% of 
      controls. Both the changes in length and thickness of the m. puborectalis were 
      significantly different (p<0.01, chi(2) test) in patients versus control 
      subjects. CONCLUSIONS: Linear anorectal endosonography demonstrated incomplete or 
      even absent relaxation of the anal sphincter and the m. puborectalis during a 
      defecation movement in the majority of our patients with dyschesia. This study 
      highlights the value of this elegant ultrasonographic technique in the diagnosis 
      of "pelvic floor dyssynergia" or "anismus".
FAU - Van Outryve, S M
AU  - Van Outryve SM
AD  - Department of Gastroenterology and Hepatology, University Hospital of Antwerp, 
      University of Antwerp, Belgium.
FAU - Van Outryve, M J
AU  - Van Outryve MJ
FAU - De Winter, B Y
AU  - De Winter BY
FAU - Pelckmans, P A
AU  - Pelckmans PA
LA  - eng
PT  - Journal Article
PL  - England
TA  - Gut
JT  - Gut
JID - 2985108R
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Anal Canal/*diagnostic imaging/physiopathology
MH  - Case-Control Studies
MH  - Chi-Square Distribution
MH  - Constipation/*diagnostic imaging/physiopathology
MH  - Defecation
MH  - *Endosonography
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Pelvic Floor/physiopathology
MH  - Rectum/diagnostic imaging/physiopathology
PMC - PMC1773419
EDAT- 2002/10/16 04:00
MHDA- 2002/12/04 04:00
PMCR- 2005/11/01
CRDT- 2002/10/16 04:00
PHST- 2002/10/16 04:00 [pubmed]
PHST- 2002/12/04 04:00 [medline]
PHST- 2002/10/16 04:00 [entrez]
PHST- 2005/11/01 00:00 [pmc-release]
AID - 0510695 [pii]
AID - 10.1136/gut.51.5.695 [doi]
PST - ppublish
SO  - Gut. 2002 Nov;51(5):695-700. doi: 10.1136/gut.51.5.695.

PMID- 26163474
OWN - NLM
STAT- MEDLINE
DCOM- 20161213
LR  - 20240323
IS  - 1472-6831 (Electronic)
IS  - 1472-6831 (Linking)
VI  - 15
DP  - 2015 Jul 11
TI  - Is there a connection between sublingual varices and hypertension?
PG  - 78
LID - 10.1186/s12903-015-0054-2 [doi]
LID - 78
AB  - BACKGROUND: Sublingual varices have earlier been related to ageing, smoking and 
      cardiovascular disease. The aim of this study was to investigate whether 
      sublingual varices are related to presence of hypertension. METHODS: In an 
      observational clinical study among 431 dental patients tongue status and blood 
      pressure were documented. Digital photographs of the lateral borders of the 
      tongue for grading of sublingual varices were taken, and blood pressure was 
      measured. Those patients without previous diagnosis of hypertension and with a 
      noted blood pressure >/= 140 mmHg and/or >/= 90 mmHg at the dental clinic performed 
      complementary home blood pressure during one week. Those with an average home 
      blood pressure >/= 135 mmHg and/or >/= 85 mmHg were referred to the primary health 
      care centre, where three office blood pressure measurements were taken with one 
      week intervals. Two independent blinded observers studied the photographs of the 
      tongues. Each photograph was graded as none/few (grade 0) or medium/severe (grade 
      1) presence of sublingual varices. Pearson's Chi-square test, Student's t-test, 
      and multiple regression analysis were applied. Power calculation stipulated a 
      study population of 323 patients. RESULTS: An association between sublingual 
      varices and hypertension was found (OR = 2.25, p < 0.002). Mean systolic blood 
      pressure was 123 and 132 mmHg in patients with grade 0 and grade 1 sublingual 
      varices, respectively (p < 0.0001, CI 95 %). Mean diastolic blood pressure was 80 
      and 83 mmHg in patients with grade 0 and grade 1 sublingual varices, respectively 
      (p < 0.005, CI 95 %). Sublingual varices indicate hypertension with a positive 
      predictive value of 0.5 and a negative predictive value of 0.80. CONCLUSIONS: An 
      association was found between sublingual varices and hypertension. Examining the 
      lateral borders of the tongue is easily done, causes no harm and could be a 
      valuable method for the dental profession to take active part in preventive 
      healthcare.
FAU - Hedstrom, Lennart
AU  - Hedstrom L
AD  - Public Dental Services, Box 1254, S-43218, Varberg, Sweden. 
      lennart.hedstrom@regionhalland.se.
FAU - Albrektsson, Margit
AU  - Albrektsson M
AD  - Public Dental Services, Box 1254, S-43218, Varberg, Sweden. 
      margit.albrektsson@regionhalland.se.
FAU - Bergh, Hakan
AU  - Bergh H
AD  - Research & Development Unit, County of Halland, 30185, Halmstad, Sweden. 
      hakan.bergh@regionhalland.se.
LA  - eng
PT  - Journal Article
PT  - Observational Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20150711
PL  - England
TA  - BMC Oral Health
JT  - BMC oral health
JID - 101088684
SB  - IM
MH  - Adult
MH  - Aged
MH  - Angina Pectoris/complications
MH  - Atrial Fibrillation/complications
MH  - Blood Pressure/physiology
MH  - Female
MH  - Humans
MH  - Hypertension/*complications
MH  - Image Processing, Computer-Assisted/methods
MH  - Male
MH  - Middle Aged
MH  - Myocardial Infarction/complications
MH  - Myocardial Ischemia/complications
MH  - Photography/methods
MH  - Predictive Value of Tests
MH  - Sensitivity and Specificity
MH  - Smoking
MH  - Stroke/complications
MH  - Tongue/*blood supply
MH  - Varicose Veins/*complications
PMC - PMC4499223
EDAT- 2015/07/15 06:00
MHDA- 2016/12/15 06:00
PMCR- 2015/07/11
CRDT- 2015/07/12 06:00
PHST- 2014/10/26 00:00 [received]
PHST- 2015/06/03 00:00 [accepted]
PHST- 2015/07/12 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/12/15 06:00 [medline]
PHST- 2015/07/11 00:00 [pmc-release]
AID - 10.1186/s12903-015-0054-2 [pii]
AID - 54 [pii]
AID - 10.1186/s12903-015-0054-2 [doi]
PST - epublish
SO  - BMC Oral Health. 2015 Jul 11;15:78. doi: 10.1186/s12903-015-0054-2.

PMID- 19100463
OWN - NLM
STAT- MEDLINE
DCOM- 20090225
LR  - 20131121
IS  - 0041-1345 (Print)
IS  - 0041-1345 (Linking)
VI  - 40
IP  - 10
DP  - 2008 Dec
TI  - Is the affinity column-mediated immunoassay method suitable as an alternative to 
      the microparticle enzyme immunoassay method as a blood tacrolimus assay?
PG  - 3673-8
LID - 10.1016/j.transproceed.2008.04.019 [doi]
AB  - BACKGROUND: Tacrolimus is a potent immunosuppressive drug used in organ 
      transplantation. Because of its substantial toxic effects, narrow therapeutic 
      index, and interindividual pharmacokinetic variability, therapeutic drug 
      monitoring of whole-blood tacrolimus concentrations has been recommended. We 
      investigated the comparability of the results of 2 immunoassay systems, affinity 
      column-mediated immunoassay (ACMIA) and microparticle enzyme immunoassay (MEIA), 
      comparing differences in the tacrolimus concentrations measured by the 2 methods 
      in relation to the hematologic and biochemical values of hepatic and renal 
      functions. METHODS: A total of 154 samples from kidney or liver transplant 
      recipients were subjected to Dimension RxL HM with a tacrolimus Flex reagent 
      cartilage for the ACMIA method and IMx tacrolimus II for the MEIA method. 
      RESULTS: Tacrolimus concentrations measured by the ACMIA method (n = 154) closely 
      correlated with those measured by the MEIA method (r = 0.84). The Bland-Altman 
      plot using concentration differences between the 2 methods and the average of the 
      2 methods showed no specific trends. The tacrolimus levels determined by both the 
      MEIA method and the ACMIA method were not influenced by hematocrit levels, but 
      the difference between the 2 methods (ACMIA - MEIA) tended to be larger in low 
      hematocrit samples (P < .001). CONCLUSION: The ACMIA method used for a tacrolimus 
      assay is precise and has advantages, including the lack of a required 
      pretreatment procedure. Furthermore, it is only slightly influenced by the 
      hematologic or biochemical status of the samples.
FAU - Ju, M K
AU  - Ju MK
AD  - Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of 
      Korea. ysms91@yuhs.ac
FAU - Chang, H K
AU  - Chang HK
FAU - Kim, H J
AU  - Kim HJ
FAU - Huh, K H
AU  - Huh KH
FAU - Ahn, H J
AU  - Ahn HJ
FAU - Kim, M S
AU  - Kim MS
FAU - Kim, S I
AU  - Kim SI
FAU - Kim, Y S
AU  - Kim YS
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Transplant Proc
JT  - Transplantation proceedings
JID - 0243532
RN  - 0 (Immunosuppressive Agents)
RN  - 0 (Serum Albumin)
RN  - AYI8EX34EU (Creatinine)
RN  - RFM9X3LJ49 (Bilirubin)
RN  - WM0HAQ4WNM (Tacrolimus)
SB  - IM
MH  - Bilirubin/blood
MH  - Chromatography, Affinity/methods
MH  - Creatinine/blood
MH  - Hematocrit
MH  - Humans
MH  - Immunoassay/methods
MH  - Immunoenzyme Techniques
MH  - Immunosuppressive Agents/*blood/therapeutic use
MH  - Kidney Transplantation/immunology
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - Serum Albumin/analysis
MH  - Tacrolimus/*blood/*therapeutic use
EDAT- 2008/12/23 09:00
MHDA- 2009/02/26 09:00
CRDT- 2008/12/23 09:00
PHST- 2007/10/01 00:00 [received]
PHST- 2008/04/10 00:00 [accepted]
PHST- 2008/12/23 09:00 [entrez]
PHST- 2008/12/23 09:00 [pubmed]
PHST- 2009/02/26 09:00 [medline]
AID - S0041-1345(08)00983-4 [pii]
AID - 10.1016/j.transproceed.2008.04.019 [doi]
PST - ppublish
SO  - Transplant Proc. 2008 Dec;40(10):3673-8. doi: 10.1016/j.transproceed.2008.04.019.

PMID- 18537964
OWN - NLM
STAT- MEDLINE
DCOM- 20080924
LR  - 20211020
IS  - 1365-2125 (Electronic)
IS  - 0306-5251 (Print)
IS  - 0306-5251 (Linking)
VI  - 66
IP  - 2
DP  - 2008 Aug
TI  - Does a physician's specialty influence the recording of medication history in 
      patients' case notes?
PG  - 308-12
LID - 10.1111/j.1365-2125.2008.03202.x [doi]
AB  - AIMS: To determine the impact of a physician's specialty on the frequency and 
      depth of medication history documented in patient medical records. METHODS: A 
      cross-sectional assessment of the frequency and depth of medication history 
      information documented by 123 physicians for 900 randomly selected patients 
      stratified across Cardiology, Chest, Dermatology, Endocrine, Gastroenterology, 
      Haematology, Neurology, Psychiatry and Renal specialties was carried out at a 
      900-bed teaching hospital located in Ibadan, Nigeria. RESULTS: Four hundred and 
      forty-three (49.2%) of the cohort were males and 457 (50.8%) were females; with 
      mean ages 43.2 +/- 18.6 and 43.1 +/- 17.9 years respectively. Physicians' 
      specialties significantly influenced the depth of documentation of the medication 
      history information across the nine specialties (P < 0.0001). Post hoc pair-wise 
      comparisons with Tukey's HSD test showed that the mean scores for adverse drug 
      reactions and adherence to medicines was highest in the Cardiology specialty; 
      while the Chest specialty had the highest mean scores for allergy to drugs, food, 
      chemicals and cigarette smoking. Mean scores for the use of alcohol; illicit 
      drugs; dietary restrictions was highest for Gastroenterology, Psychiatry and 
      Endocrine specialties respectively. Physicians' specialties also significantly 
      influenced the frequency of documentation of the medication history across the 
      nine specialties (P < 0.0001). CONCLUSIONS: Physicians appear to document more 
      frequently and in greater depth medication history information that may aid the 
      diagnostic tasks in their specific specialty. Researchers and other users of 
      medication history data documented in patients' medical records by physicians may 
      want to take special cognizance of this phenomenon.
FAU - Yusuff, Kazeem B
AU  - Yusuff KB
AD  - Department of Clinical Pharmacy and Pharmacy Administration, Faculty of Pharmacy, 
      University of Ibadan, Ibadan, Nigeria. yusuffkby@yahoo.co.uk
FAU - Tayo, Fola
AU  - Tayo F
LA  - eng
PT  - Journal Article
DEP - 20080411
PL  - England
TA  - Br J Clin Pharmacol
JT  - British journal of clinical pharmacology
JID - 7503323
SB  - IM
MH  - Adult
MH  - *Attitude of Health Personnel
MH  - Clinical Protocols/standards
MH  - Cross-Sectional Studies
MH  - Female
MH  - Humans
MH  - Male
MH  - Medical History Taking/*standards
MH  - Medical Records/standards
MH  - *Medicine
MH  - Middle Aged
MH  - Nigeria
MH  - Physicians/*standards
MH  - Practice Patterns, Physicians'/*standards
MH  - Random Allocation
MH  - *Specialization
PMC - PMC2492926
EDAT- 2008/06/10 09:00
MHDA- 2008/09/25 09:00
PMCR- 2009/08/01
CRDT- 2008/06/10 09:00
PHST- 2008/06/10 09:00 [pubmed]
PHST- 2008/09/25 09:00 [medline]
PHST- 2008/06/10 09:00 [entrez]
PHST- 2009/08/01 00:00 [pmc-release]
AID - BCP3202 [pii]
AID - 10.1111/j.1365-2125.2008.03202.x [doi]
PST - ppublish
SO  - Br J Clin Pharmacol. 2008 Aug;66(2):308-12. doi: 
      10.1111/j.1365-2125.2008.03202.x. Epub 2008 Apr 11.

PMID- 12913878
OWN - NLM
STAT- MEDLINE
DCOM- 20040129
LR  - 20151119
IS  - 0196-8092 (Print)
IS  - 0196-8092 (Linking)
VI  - 33
IP  - 2
DP  - 2003
TI  - Locoregional opening of the rodent blood-brain barrier for paclitaxel using 
      Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy?
PG  - 75-80
AB  - BACKGROUND AND OBJECTIVES: Nd:YAG laser-induced thermo therapy (LITT) of rat 
      brains is associated with blood-brain barrier (BBB) permeability changes. We 
      address the question of whether LITT-induced locoregional disruption of the BBB 
      could possibly allow a locoregional passage of chemotherapeutic agents into brain 
      tissue to treat malignant glioma. STUDY DESIGN/MATERIALS AND METHODS: CD Fischer 
      rats were subject to LITT of the left forebrain. Disruption of the BBB was 
      analyzed using Evans blue and immunohistochemistry (IH). Animals were perfused 
      with paclitaxel, and high-pressure liquid chromatography (HPLC) was employed to 
      analyze the content of paclitaxel in brain and plasma samples. RESULTS: LITT 
      induces an opening of the BBB as demonstrated by locoregional extravasation of 
      Evans blue, C3C, fibrinogen, and IgM. HPLC proved the passage of paclitaxel 
      across the disrupted BBB. CONCLUSIONS: LITT induces a locoregional passage of 
      chemotherapeutic agents into the brain tissue. This is of potential interest for 
      the treatment of brain tumors.
CI  - Copyright 2003 Wiley-Liss, Inc.
FAU - Sabel, Michael
AU  - Sabel M
AD  - Neurochirurgische Klinik, Heinrich-Heine-Universitat, Moorenstrasse 5, D-40225 
      Dusseldorf, Germany. sabel@uni-duesseldorf.de
FAU - Rommel, Frank
AU  - Rommel F
FAU - Kondakci, Mustafa
AU  - Kondakci M
FAU - Gorol, Marion
AU  - Gorol M
FAU - Willers, Reinhard
AU  - Willers R
FAU - Bilzer, Thomas
AU  - Bilzer T
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Lasers Surg Med
JT  - Lasers in surgery and medicine
JID - 8007168
RN  - 0 (Antineoplastic Agents, Phytogenic)
RN  - P88XT4IS4D (Paclitaxel)
SB  - IM
MH  - Administration, Topical
MH  - Animals
MH  - Antineoplastic Agents, Phytogenic/*administration & dosage
MH  - Blood-Brain Barrier/physiopathology/*surgery
MH  - Brain Neoplasms/*drug therapy
MH  - Chemotherapy, Adjuvant/methods
MH  - Glioma/*drug therapy
MH  - Hyperthermia, Induced/methods
MH  - Laser Therapy/*methods
MH  - Neurosurgical Procedures/*methods
MH  - Paclitaxel/*administration & dosage
MH  - Permeability/radiation effects
MH  - Rats
MH  - Rats, Inbred F344
EDAT- 2003/08/13 05:00
MHDA- 2004/01/30 05:00
CRDT- 2003/08/13 05:00
PHST- 2003/08/13 05:00 [pubmed]
PHST- 2004/01/30 05:00 [medline]
PHST- 2003/08/13 05:00 [entrez]
AID - 10.1002/lsm.10181 [doi]
PST - ppublish
SO  - Lasers Surg Med. 2003;33(2):75-80. doi: 10.1002/lsm.10181.

PMID- 12765819
OWN - NLM
STAT- MEDLINE
DCOM- 20030610
LR  - 20190823
IS  - 0090-3019 (Print)
IS  - 0090-3019 (Linking)
VI  - 59
IP  - 5
DP  - 2003 May
TI  - Spinal subdural hematoma: a sequela of a ruptured intracranial aneurysm?
PG  - 408-12; discussion 412
AB  - BACKGROUND: A case of spinal subdural hematoma (SSDH) following subarachnoid 
      hemorrhage (SAH) because of a ruptured internal carotid aneurysm is described. 
      Such a case has never been reported. CASE DESCRIPTION: A 52-year-old woman 
      underwent a craniotomy for a ruptured internal carotid aneurysm. A computed 
      tomography scan showed that SAH existed predominantly in the posterior fossa and 
      subdural hematoma beneath the cerebellar tentorium. Intrathecal administration of 
      urokinase, IV administration of fasudil hydrochloride, and continuous 
      cerebrospinal fluid (CSF) evacuation via cisternal drainage were performed as 
      prophylactic treatments for vasospasm. On the sixth postoperative day, the 
      patient complained of severe lower back and buttock pain. Magnetic resonance 
      imaging showed a subdural hematoma in the lumbosacral region. Although the mass 
      effect was extensive, the patient showed no neurologic symptoms other than the 
      sciatica. She was treated conservatively. The hematoma dissolved gradually and 
      had diminished completely 15 weeks later. Her pain gradually subsided, and she 
      was discharged 7 weeks later without any neurologic deficit. CONCLUSION: Although 
      the exact mechanism of SSDH in this case is unclear, we speculate that this SSDH 
      was a hematoma that migrated from the intracranial subdural space. Low CSF 
      pressure because of continuous drainage and intrathecal thrombolytic therapy may 
      have played an important role in the migration of the hematoma through the spinal 
      canal. It is important to recognize the SSDH as a possible complication of the 
      SAH accompanied with intracranial subdural hematoma.
FAU - Yamaguchi, Satoshi
AU  - Yamaguchi S
AD  - Department of Neurosurgery, Hokkaido University Graduate School of Medicine, 
      Sapporo, Japan.
FAU - Hida, Kazutoshi
AU  - Hida K
FAU - Akino, Minoru
AU  - Akino M
FAU - Yano, Shunsuke
AU  - Yano S
FAU - Iwasaki, Yoshinobu
AU  - Iwasaki Y
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - Surg Neurol
JT  - Surgical neurology
JID - 0367070
SB  - IM
MH  - Aneurysm, Ruptured/*complications/surgery
MH  - Carotid Artery, Internal/*pathology
MH  - Craniotomy
MH  - Female
MH  - Hematoma, Subdural/*etiology/pathology
MH  - Humans
MH  - Intracranial Aneurysm/*complications/surgery
MH  - Magnetic Resonance Imaging
MH  - Middle Aged
MH  - Rupture, Spontaneous
MH  - Subarachnoid Hemorrhage/*complications/etiology
MH  - Tomography, X-Ray Computed
EDAT- 2003/05/27 05:00
MHDA- 2003/06/11 05:00
CRDT- 2003/05/27 05:00
PHST- 2003/05/27 05:00 [pubmed]
PHST- 2003/06/11 05:00 [medline]
PHST- 2003/05/27 05:00 [entrez]
AID - S0090301903000168 [pii]
AID - 10.1016/s0090-3019(03)00016-8 [doi]
PST - ppublish
SO  - Surg Neurol. 2003 May;59(5):408-12; discussion 412. doi: 
      10.1016/s0090-3019(03)00016-8.

PMID- 25475395
OWN - NLM
STAT- MEDLINE
DCOM- 20150706
LR  - 20181202
IS  - 1743-6109 (Electronic)
IS  - 1743-6095 (Linking)
VI  - 12
IP  - 2
DP  - 2015 Feb
TI  - Is there a correlation between androgens and sexual desire in women?
PG  - 358-73
LID - 10.1111/jsm.12774 [doi]
AB  - INTRODUCTION: For women, the correlation between circulating androgens and sexual 
      desire is inconclusive. Substitution with androgens at physiological levels 
      improves sexual function in women who experience decreased sexual desire and 
      androgen deficiency from surgical menopause, pituitary disease, and age-related 
      decline in androgen production in the ovaries. Measuring bioactive testosterone 
      is difficult and new methods have been proposed, including measuring the primary 
      androgen metabolite androsterone glucuronide (ADT-G). AIM: The aim of this study 
      was to investigate a possible correlation between serum levels of androgens and 
      sexual desire in women and whether the level of ADT-G is better correlated than 
      the level of circulating androgens with sexual desire. METHODS: This was a 
      cross-sectional study including 560 healthy women aged 19-65 years divided into 
      three age groups. Correlations were considered to be statistically significant at 
      P<0.05. MAIN OUTCOME MEASURE: Sexual desire was determined as the total score of 
      the sexual desire domain of the Female Sexual Function Index. Total testosterone 
      (TT), calculated free testosterone (FT), androstenedione, dehydroepiandrosterone 
      sulfate (DHEAS), and ADT-G were analyzed using mass spectrometry. RESULTS: Sexual 
      desire correlated overall with FT and androstenedione in the total cohort of 
      women. In a subgroup of women aged 25-44 years with no use of systemic hormonal 
      contraception, sexual desire correlated with TT, FT, androstenedione, and DHEAS. 
      In women aged 45-65 years, androstenedione correlated with sexual desire. No 
      correlations between ADT-G and sexual desire were identified. CONCLUSIONS: In the 
      present study, FT and androstenedione were statistically significantly correlated 
      with sexual desire in the total cohort of women. ADT-G did not correlate more 
      strongly than circulating androgens with sexual desire and is therefore not 
      superior to measuring circulating androgens by mass spectrometry.
CI  - (c) 2014 International Society for Sexual Medicine.
FAU - Wahlin-Jacobsen, Sarah
AU  - Wahlin-Jacobsen S
AD  - Department of Sexological Research, Psychiatric Center Copenhagen, Copenhagen, 
      Denmark.
FAU - Pedersen, Anette Tonnes
AU  - Pedersen AT
FAU - Kristensen, Ellids
AU  - Kristensen E
FAU - Laessoe, Nanna Cassandra
AU  - Laessoe NC
FAU - Lundqvist, Marika
AU  - Lundqvist M
FAU - Cohen, Arieh S
AU  - Cohen AS
FAU - Hougaard, David M
AU  - Hougaard DM
FAU - Giraldi, Annamaria
AU  - Giraldi A
LA  - eng
SI  - GENBANK/CD004509
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20141205
PL  - Netherlands
TA  - J Sex Med
JT  - The journal of sexual medicine
JID - 101230693
RN  - 0 (Androgens)
RN  - 0 (Androstenols)
RN  - 1852-43-3 (androsterone glucuronide)
RN  - 3XMK78S47O (Testosterone)
RN  - 409J2J96VR (Androstenedione)
RN  - 57B09Q7FJR (Dehydroepiandrosterone Sulfate)
RN  - C24W7J5D5R (Androsterone)
SB  - IM
CIN - J Sex Med. 2015 Jul;12(7):1654-5. doi: 10.1111/jsm.12892. PMID: 25929781
CIN - J Sex Med. 2015 Aug;12(8):1851-2. doi: 10.1111/jsm.12945. PMID: 26211464
MH  - Adult
MH  - Age Factors
MH  - Aged
MH  - Androgens/*blood
MH  - Androstenedione/blood
MH  - Androstenols/*blood
MH  - Androsterone/analogs & derivatives/blood
MH  - Cross-Sectional Studies
MH  - Dehydroepiandrosterone Sulfate/blood
MH  - Female
MH  - Humans
MH  - Libido/*physiology
MH  - Middle Aged
MH  - Molecular Sequence Data
MH  - Socioeconomic Factors
MH  - Testosterone/blood
MH  - Women's Health
OTO - NOTNLM
OT  - 17b-Hydroxysteroid Dehydrogenase
OT  - Androgen
OT  - Androgen Metabolites
OT  - Androstenedione
OT  - Androsterone Glucuronide
OT  - DHEAS
OT  - FSFI
OT  - Sexual Desire
OT  - Testosterone
OT  - Woman
EDAT- 2014/12/06 06:00
MHDA- 2015/07/07 06:00
CRDT- 2014/12/06 06:00
PHST- 2014/12/06 06:00 [entrez]
PHST- 2014/12/06 06:00 [pubmed]
PHST- 2015/07/07 06:00 [medline]
AID - S1743-6095(15)30917-6 [pii]
AID - 10.1111/jsm.12774 [doi]
PST - ppublish
SO  - J Sex Med. 2015 Feb;12(2):358-73. doi: 10.1111/jsm.12774. Epub 2014 Dec 5.

PMID- 19130332
OWN - NLM
STAT- MEDLINE
DCOM- 20090505
LR  - 20090108
IS  - 1306-696X (Print)
IS  - 1306-696X (Linking)
VI  - 15
IP  - 1
DP  - 2009 Jan
TI  - Is the zeolite hemostatic agent beneficial in reducing blood loss during arterial 
      injury?
PG  - 7-11
AB  - BACKGROUND: Uncontrolled hemorrhage is the leading cause of fatality. The aim of 
      this study was to evaluate the effect of zeolite mineral (QuikClot - Advanced 
      Clotting Sponge [QC-ACS]) on blood loss and physiological variables in a swine 
      extremity arterial injury model. METHODS: Sixteen swine were used. Oblique groin 
      incision was created and a 5 mm incision was made. The animals were allocated to: 
      control group (n: 6): Pressure dressing was applied with manual pressure over 
      gauze sponge; or QC group (n: 10): QC was directly applied over lacerated femoral 
      artery. Mean arterial pressure, blood loss and physiological parameters were 
      measured during the study period. RESULTS: Application of QC led to a slower drop 
      in blood pressure. The control group had a significantly higher increase in 
      lactate within 60 minutes. The mean prothrombin time in the control group was 
      significantly increased at 60 minutes. The application of QC led to decreased 
      total blood loss. The QC group had significantly higher hematocrit levels. QC 
      application generated a significant heat production. There were mild edematous 
      and vacuolar changes in nerve samples. CONCLUSION: According to the physiological 
      parameters, we observed that zeolite tends to reduce blood loss, however could 
      not stop bleeding completely. We believe that further clinical trials are needed 
      to conclude that zeolite could be used in the routine practice.
FAU - Eryilmaz, Mehmet
AU  - Eryilmaz M
AD  - Department of Emergency Medicine, Gulhane Military Medical Academy, Ankara, 
      Turkey. mehmeteryilmaz@hotmail.com
FAU - Ozer, Tahir
AU  - Ozer T
FAU - Mentes, Oner
AU  - Mentes O
FAU - Torer, Nurkan
AU  - Torer N
FAU - Durusu, Murat
AU  - Durusu M
FAU - Gunal, Armagan
AU  - Gunal A
FAU - Uzar, Ali Ihsan
AU  - Uzar AI
LA  - eng
PT  - Journal Article
PL  - Turkey
TA  - Ulus Travma Acil Cerrahi Derg
JT  - Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency 
      surgery : TJTES
JID - 101274231
RN  - 0 (Hemostatics)
RN  - 1318-02-1 (Zeolites)
SB  - IM
MH  - Administration, Topical
MH  - Animals
MH  - Bandages
MH  - Blood Pressure/drug effects
MH  - *Disease Models, Animal
MH  - Femoral Artery/injuries
MH  - Hematocrit
MH  - Hemorrhage/*drug therapy/therapy
MH  - Hemostatics/*therapeutic use
MH  - Random Allocation
MH  - Specific Pathogen-Free Organisms
MH  - Survival Rate
MH  - Swine
MH  - Zeolites/*therapeutic use
EDAT- 2009/01/09 09:00
MHDA- 2009/05/06 09:00
CRDT- 2009/01/09 09:00
PHST- 2009/01/09 09:00 [entrez]
PHST- 2009/01/09 09:00 [pubmed]
PHST- 2009/05/06 09:00 [medline]
PST - ppublish
SO  - Ulus Travma Acil Cerrahi Derg. 2009 Jan;15(1):7-11.

PMID- 9427037
OWN - NLM
STAT- MEDLINE
DCOM- 19980305
LR  - 20071114
IS  - 0258-851X (Print)
IS  - 0258-851X (Linking)
VI  - 11
IP  - 5
DP  - 1997 Sep-Oct
TI  - Are endothelial cell patterns of astrocytomas indicative of grade?
PG  - 371-5
AB  - BACKGROUND: The most common primary brain tumors in children and adults are of 
      astrocytic origin. Classic histologic grading schemes for astrocytomas have 
      included evaluating the presence or absence of nuclear abnormalities, mitoses, 
      vascular endothelial proliferation, and tumor necrosis. MATERIALS AND METHODS: We 
      evaluated the vascular pattern of 17 astrocytoma surgical specimens (seven from 
      children and 10 from adults), and four normal brains obtained at autopsy, 
      utilizing antibody to glial fibrillary acidic protein (GFAP) and von Willebrand 
      factor (vWF) utilizing confocal microscopy. A modified WHO classification was 
      used. RESULTS: All tumor cases showed cells positive for GFAP. Control tissues 
      showed a few, widely separated vessels. Pilocytic astrocytomas (four cases) 
      showed lacy clusters of small-to-medium sized vessels, with intact vessel wall 
      integrity. Diffuse, low grade astrocytoma (three cases) showed a staining pattern 
      similar to control tissue; intermediate grade (one case), anaplastic astrocytoma 
      (three cases) and gliobastoma multiforme (six cases) showed an increased vessel 
      density with multiple small vessels (glomeruloid clusters), some with prominent 
      intimal hyperplasia, loss of vessel wall integrity, and with numerous 
      vWF-positive single cells/microvessels within the tumor substance. CONCLUSIONS: 
      Evaluation of astrocytomas utilizing antibody to vWF and confocal microscopy aids 
      in the grading of these neoplasms.
FAU - Selby, D M
AU  - Selby DM
AD  - Department of Pathology, Children's National Medical Center, Washington, DC 
      20010, USA.
FAU - Woodard, C A
AU  - Woodard CA
FAU - Henry, M L
AU  - Henry ML
FAU - Bernstein, J J
AU  - Bernstein JJ
LA  - eng
GR  - CA48956/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - Greece
TA  - In Vivo
JT  - In vivo (Athens, Greece)
JID - 8806809
RN  - 0 (Glial Fibrillary Acidic Protein)
RN  - 0 (von Willebrand Factor)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Astrocytoma/*blood supply/classification/metabolism/*pathology
MH  - Child, Preschool
MH  - Endothelium, Vascular/*pathology
MH  - Female
MH  - Fluorescent Antibody Technique, Indirect
MH  - Glial Fibrillary Acidic Protein/metabolism
MH  - Humans
MH  - Infant
MH  - Male
MH  - von Willebrand Factor/metabolism
EDAT- 1998/01/14 00:00
MHDA- 1998/01/14 00:01
CRDT- 1998/01/14 00:00
PHST- 1998/01/14 00:00 [pubmed]
PHST- 1998/01/14 00:01 [medline]
PHST- 1998/01/14 00:00 [entrez]
PST - ppublish
SO  - In Vivo. 1997 Sep-Oct;11(5):371-5.

PMID- 24481006
OWN - NLM
STAT- MEDLINE
DCOM- 20150115
LR  - 20161125
IS  - 1421-976X (Electronic)
IS  - 0008-6568 (Linking)
VI  - 48
IP  - 3
DP  - 2014
TI  - Should cavitation in proximal surfaces be reported in cone beam computed 
      tomography examination?
PG  - 208-13
LID - 10.1159/000354838 [doi]
AB  - AIM: A clinical study was done to assess the clinical diagnostic accuracy of cone 
      beam computed tomography (CBCT) in detecting proximal cavitated carious lesions 
      in order to determine whether cavitation should be reported when a CBCT 
      examination is available. MATERIALS AND METHODS: 79 adjacent proximal surfaces 
      without restorations in permanent teeth were examined. Patients suspected to have 
      carious lesions after a visual clinical and a bitewing examination participated 
      in a CBCT examination (Kodak 9000 3D, 5 x 3.7 cm field of view, voxel size 0.07 
      mm). Ethical approval and informed consent were obtained according to the 
      Helsinki Declaration. Radiographic assessment recording lesions with or without 
      cavitation was performed by two observers in bitewings and CBCT sections. 
      Orthodontic separators were placed interdentally between two lesion-suspected 
      surfaces. The separator was removed after 3 days and the surfaces recorded as 
      cavitated (yes/no), i.e. validated clinically. Differences between the two 
      radiographic modalities (sensitivity, specificity and overall accuracy) were 
      estimated by analyzing the binary data in a generalized linear model. RESULTS: 
      For both observers, sensitivity was significantly higher for CBCT than for 
      bitewings (average difference 33%, p < 0.001) while specificity was not 
      significantly different between the methods (p = 0.19). The overall accuracy was 
      also significantly higher for CBCT (p < 0.001). CONCLUSION: CBCT was more 
      accurate in detecting cavitation in proximal surfaces than bitewing radiographs; 
      therefore a CBCT examination performed for other clinical applications should 
      also be assessed for proximal surface cavities in teeth without restorations, and 
      when detected, this pathology must be part of the dentist's report.
FAU - Sansare, K
AU  - Sansare K
AD  - Oral Medicine and Radiology, Nair Hospital Dental College, Mumbai, India.
FAU - Singh, D
AU  - Singh D
FAU - Sontakke, S
AU  - Sontakke S
FAU - Karjodkar, F
AU  - Karjodkar F
FAU - Saxena, V
AU  - Saxena V
FAU - Frydenberg, M
AU  - Frydenberg M
FAU - Wenzel, A
AU  - Wenzel A
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20140129
PL  - Switzerland
TA  - Caries Res
JT  - Caries research
JID - 0103374
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Bicuspid/diagnostic imaging/pathology
MH  - Cone-Beam Computed Tomography/*standards
MH  - Dental Caries/diagnosis/*diagnostic imaging
MH  - Female
MH  - Humans
MH  - Image Processing, Computer-Assisted/standards
MH  - Linear Models
MH  - Male
MH  - Middle Aged
MH  - Molar/diagnostic imaging/pathology
MH  - Observer Variation
MH  - Physical Examination
MH  - Radiography, Bitewing/methods
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - Tooth Crown/*diagnostic imaging/pathology
MH  - Tooth Discoloration/diagnosis
MH  - Young Adult
EDAT- 2014/02/01 06:00
MHDA- 2015/01/16 06:00
CRDT- 2014/02/01 06:00
PHST- 2013/03/12 00:00 [received]
PHST- 2013/08/02 00:00 [accepted]
PHST- 2014/02/01 06:00 [entrez]
PHST- 2014/02/01 06:00 [pubmed]
PHST- 2015/01/16 06:00 [medline]
AID - 000354838 [pii]
AID - 10.1159/000354838 [doi]
PST - ppublish
SO  - Caries Res. 2014;48(3):208-13. doi: 10.1159/000354838. Epub 2014 Jan 29.

PMID- 8165771
OWN - NLM
STAT- MEDLINE
DCOM- 19940526
LR  - 20190714
IS  - 0090-4295 (Print)
IS  - 0090-4295 (Linking)
VI  - 43
IP  - 5
DP  - 1994 May
TI  - Ultrasound in squamous cell carcinoma of the penis; a useful addition to clinical 
      staging? A comparison of ultrasound with histopathology.
PG  - 702-7
AB  - OBJECTIVE: As part of the staging procedure in squamous cell carcinoma of the 
      penis, we assessed the role of ultrasound examination, in particular its role in 
      assessing the extent and the invasion into the corpora. METHODS: From 1988 until 
      1992, all patients referred for primary treatment underwent ultrasound assessment 
      with a 7.5 MHz linear array small parts transducer as part of the clinical 
      workup. All ultrasound images were reviewed by one radiologist, without knowledge 
      of the clinical outcome and were compared with the results obtained at 
      histopathologic examination. RESULTS: In 16 patients the primary tumor and in 1 
      patient a recurrent cancer after primary therapy were examined. All tumors were 
      identified as hypoechoic lesions. Ultrasound examination in the region of the 
      glans was not able to differentiate between invasion of the subepithelial tissue 
      and invasion into the corpus spongiosum, but absence or presence of invasion into 
      the tunica albuginea of the corpus cavernosum was clearly demonstrated. Accurate 
      measurement by ultrasound of maximum tumor thickness was seen in seven of sixteen 
      examinations. CONCLUSIONS: While ultrasound examination is inexpensive and easily 
      done, it is not accurate enough for staging small penile cancers located at the 
      glans penis. However, for larger tumors ultrasound can be a useful addition to 
      physical examination by delineating reliably the anatomic relations of the tumor 
      to structures such as the tunica albuginea, corpus cavernosum, and urethra.
FAU - Horenblas, S
AU  - Horenblas S
AD  - Department of Urology, Netherlands Cancer Institute, Antoni van Leeuwenhoekhuis, 
      Amsterdam.
FAU - Kroger, R
AU  - Kroger R
FAU - Gallee, M P
AU  - Gallee MP
FAU - Newling, D W
AU  - Newling DW
FAU - van Tinteren, H
AU  - van Tinteren H
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - United States
TA  - Urology
JT  - Urology
JID - 0366151
SB  - IM
MH  - Carcinoma, Squamous Cell/*diagnostic imaging/pathology
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Invasiveness
MH  - Neoplasm Staging
MH  - Penile Neoplasms/*diagnostic imaging/pathology
MH  - Penis/*pathology
MH  - Ultrasonography
EDAT- 1994/05/01 00:00
MHDA- 1994/05/01 00:01
CRDT- 1994/05/01 00:00
PHST- 1994/05/01 00:00 [pubmed]
PHST- 1994/05/01 00:01 [medline]
PHST- 1994/05/01 00:00 [entrez]
AID - 0090-4295(94)90189-9 [pii]
AID - 10.1016/0090-4295(94)90189-9 [doi]
PST - ppublish
SO  - Urology. 1994 May;43(5):702-7. doi: 10.1016/0090-4295(94)90189-9.

PMID- 22680064
OWN - NLM
STAT- MEDLINE
DCOM- 20130430
LR  - 20191210
IS  - 1476-4954 (Electronic)
IS  - 1476-4954 (Linking)
VI  - 25
IP  - 11
DP  - 2012 Nov
TI  - Can third trimester ultrasound predict the presentation of the first twin at 
      delivery?
PG  - 2432-4
LID - 10.3109/14767058.2012.700344 [doi]
AB  - OBJECTIVE: To determine the ability of early sonogram to predict the presentation 
      of twin A at birth. METHODS: A retrospective cohort study was conducted on all 
      twin pregnancies evaluated at our Fetal Evaluation Unit from 2007 to 2009. 
      Sonogram records were reviewed for the presentation of twin A at seven 
      gestational age intervals and inpatient medical records were reviewed for the 
      presentation of twin A at delivery. The positive predictive value, sensitivity, 
      and specificity of presentation as determined by ultrasound, at each gestational 
      age interval, for the same presentation at delivery were calculated. RESULTS: Two 
      hundred and thirty-eight twin pregnancies met inclusion criteria. A total of 896 
      ultrasounds were reviewed. The positive predictive value of cephalic presentation 
      of twin A as determined by ultrasound for the persistence of cephalic 
      presentation at delivery reached 95% after 28 weeks gestation. The positive 
      predictive value for noncephalic presentation as established by sonogram for 
      noncephalic at delivery was >90% after 32 weeks gestation. CONCLUSIONS: The 
      presentation of the first twin at delivery can be determined by sonogram by the 
      32nd week of gestation in over 90% of twin pregnancies.
FAU - Schwartz, Rachelle
AU  - Schwartz R
AD  - Department of Obstetrics and Gynecology, St. Luke's-Roosevelt Hospital Center, 
      New York, NY 10019, USA. raschwartz@chpnet.org
FAU - Fuchs, Anna
AU  - Fuchs A
FAU - Rosenn, Barak
AU  - Rosenn B
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
DEP - 20120628
PL  - England
TA  - J Matern Fetal Neonatal Med
JT  - The journal of maternal-fetal & neonatal medicine : the official journal of the 
      European Association of Perinatal Medicine, the Federation of Asia and Oceania 
      Perinatal Societies, the International Society of Perinatal Obstetricians
JID - 101136916
SB  - IM
MH  - Adult
MH  - Birth Order
MH  - Birth Weight/physiology
MH  - Cohort Studies
MH  - Delivery, Obstetric/methods
MH  - Female
MH  - Humans
MH  - Infant, Newborn
MH  - *Labor Presentation
MH  - Predictive Value of Tests
MH  - Pregnancy
MH  - *Pregnancy Trimester, Third
MH  - *Pregnancy, Twin/physiology
MH  - Retrospective Studies
MH  - *Twins
MH  - Ultrasonography, Prenatal/*methods
EDAT- 2012/06/12 06:00
MHDA- 2013/05/01 06:00
CRDT- 2012/06/12 06:00
PHST- 2012/06/12 06:00 [entrez]
PHST- 2012/06/12 06:00 [pubmed]
PHST- 2013/05/01 06:00 [medline]
AID - 10.3109/14767058.2012.700344 [doi]
PST - ppublish
SO  - J Matern Fetal Neonatal Med. 2012 Nov;25(11):2432-4. doi: 
      10.3109/14767058.2012.700344. Epub 2012 Jun 28.

PMID- 22540518
OWN - NLM
STAT- MEDLINE
DCOM- 20140520
LR  - 20220331
IS  - 1600-0501 (Electronic)
IS  - 0905-7161 (Linking)
VI  - 24
IP  - 7
DP  - 2013 Jul
TI  - Is micro-computed tomography reliable to determine the microstructure of the 
      maxillary alveolar bone?
PG  - 730-7
LID - 10.1111/j.1600-0501.2012.02478.x [doi]
AB  - OBJECTIVES: To analyze the reliability of micro-computed tomography (micro-CT) to 
      assess bone density and the microstructure of the maxillary bones at the alveolar 
      process in human clinics by direct comparison with conventional stereologic-based 
      histomorphometry. MATERIALS AND METHODS: Analysis of osseous microstructural 
      variables including bone volumetric density (BV/TV) of 39 biopsies from the 
      maxillary alveolar bone was performed by micro-CT. Conventional stereologic-based 
      histomorphometry of 10 bone biopsies was performed by optic microscopy (OM) and 
      low-vacuum surface electronic microscopy (SEM). Percentages of bone between 
      micro-CT and conventional stereologic-based histomorphometry were compared. 
      RESULTS: Significant positive correlations were observed between BV/TV and the 
      percentage of bone (%Bone) analyzed by SEM (r = 0.933, P < 0.001), by toluidine 
      blue staining OM (r = 0.950, P < 0.001) and by dark field OM (r = 0.667, 
      P = 0.05). The high positive correlation coefficient between BV/TV and trabecular 
      thickness illustrates that a value of BV/TV upper than 50% squares with a bone 
      presenting most of their trabecules thicker than 0.2 mm. The high negative 
      correlation between BV/TV and trabecular separation shows that values of BV/TV 
      upper than 50% squares with a bone presenting most of their trabecules separated 
      less than 0.3 mm each other. CONCLUSION: BV/TV assessed by micro-CT correlates 
      with the percentage of bone assessed by conventional stereologic-based 
      histomorphometry. Micro-CT is a reliable technique to determine the bone density 
      and the microstructure of the maxillary alveolar bone at the site of dental 
      implant insertion.
CI  - (c) 2012 John Wiley & Sons A/S.
FAU - Gonzalez-Garcia, Raul
AU  - Gonzalez-Garcia R
AD  - Department of Oral and Maxillofacial-Head and Neck Surgery, University Hospital 
      Infanta Cristina, Badajoz, Spain. raulmaxilo@gmail.com
FAU - Monje, Florencio
AU  - Monje F
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20120430
PL  - Denmark
TA  - Clin Oral Implants Res
JT  - Clinical oral implants research
JID - 9105713
RN  - 0 (Coloring Agents)
RN  - 15XUH0X66N (Tolonium Chloride)
MH  - Adult
MH  - Aged
MH  - Alveolar Process/*diagnostic imaging/ultrastructure
MH  - Biopsy/methods
MH  - Bone Density/physiology
MH  - Coloring Agents
MH  - Dental Implantation, Endosseous/instrumentation
MH  - Female
MH  - Humans
MH  - Image Processing, Computer-Assisted/methods
MH  - Male
MH  - Maxilla/*diagnostic imaging/ultrastructure
MH  - Microscopy
MH  - Microscopy, Electron
MH  - Middle Aged
MH  - Reproducibility of Results
MH  - Spectrometry, X-Ray Emission
MH  - Tolonium Chloride
MH  - X-Ray Microtomography/methods/*statistics & numerical data
MH  - Young Adult
EDAT- 2012/05/01 06:00
MHDA- 2014/05/21 06:00
CRDT- 2012/05/01 06:00
PHST- 2012/03/12 00:00 [accepted]
PHST- 2012/05/01 06:00 [entrez]
PHST- 2012/05/01 06:00 [pubmed]
PHST- 2014/05/21 06:00 [medline]
AID - 10.1111/j.1600-0501.2012.02478.x [doi]
PST - ppublish
SO  - Clin Oral Implants Res. 2013 Jul;24(7):730-7. doi: 
      10.1111/j.1600-0501.2012.02478.x. Epub 2012 Apr 30.

PMID- 20629769
OWN - NLM
STAT- MEDLINE
DCOM- 20110328
LR  - 20240531
IS  - 1369-7625 (Electronic)
IS  - 1369-6513 (Print)
IS  - 1369-6513 (Linking)
VI  - 13
IP  - 4
DP  - 2010 Dec
TI  - Is primary angioplasty an acceptable alternative to thrombolysis? Quantitative 
      and qualitative study of patient and carer satisfaction.
PG  - 350-8
LID - 10.1111/j.1369-7625.2009.00589.x [doi]
AB  - OBJECTIVE: The National Infarct Angioplasty Project assessed the feasibility of 
      establishing a comprehensive primary angioplasty service. We aimed to compare 
      satisfaction at intervention hospitals offering angioplasty-based care and 
      control hospitals offering thrombolysis-based care. DESIGN: Mixed methods, with 
      postal survey of patients and their carers, supported by semi-structured 
      interviews. SETTING AND PARTICIPANTS: Survey of 682 patients and 486 carers, and 
      interviews with 33 patients and carers, in eight English hospitals. 
      INTERVENTIONS: Primary angioplasty or thrombolysis. MAIN OUTCOME MEASURES: 
      Satisfaction with treatment. RESULTS: Responses were received from 595/682 
      patients (87%) and 418/486 carers (86%). Satisfaction with overall care was high 
      at both intervention and control sites (78% vs. 71% patients rated their care as 
      'excellent', P = 0.074). Patient satisfaction was higher at intervention sites 
      for some aspects of care such as speed of treatment (80% vs. 67%'excellent', P = 
      0.001). Convenience of visiting was rated lower at intervention sites by carers 
      (12% vs. 1%'poor', P = 0.001). During interviews, carers reported that they 
      accepted the added inconvenience of visiting primary angioplasty sites in the 
      context of this life-saving treatment. Patient satisfaction with discharge and 
      aftercare was lower in both treatment groups than for other aspects of care. 
      CONCLUSIONS: Reorganization of care to offer a primary angioplasty service was 
      acceptable to patients and their carers. Satisfaction levels were high regardless 
      of the type of care received, with the exception of discharge and aftercare.
CI  - (c) 2010 The Authors. Health Expectations (c) 2010 Blackwell Publishing Ltd.
FAU - Sampson, Fiona C
AU  - Sampson FC
AD  - University of Sheffield, Sheffield, UK. f.c.sampson@sheffield.ac.uk
FAU - O'Cathain, Alicia
AU  - O'Cathain A
FAU - Goodacre, Steve
AU  - Goodacre S
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - England
TA  - Health Expect
JT  - Health expectations : an international journal of public participation in health 
      care and health policy
JID - 9815926
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - *Angioplasty
MH  - Caregivers/*psychology
MH  - England
MH  - Health Care Surveys
MH  - Humans
MH  - Interviews as Topic
MH  - Male
MH  - Middle Aged
MH  - Myocardial Infarction/*drug therapy/*surgery
MH  - *Patient Satisfaction
MH  - *Thrombolytic Therapy
MH  - Young Adult
PMC - PMC5060554
EDAT- 2010/07/16 06:00
MHDA- 2011/03/29 06:00
PMCR- 2010/12/01
CRDT- 2010/07/16 06:00
PHST- 2010/07/16 06:00 [entrez]
PHST- 2010/07/16 06:00 [pubmed]
PHST- 2011/03/29 06:00 [medline]
PHST- 2010/12/01 00:00 [pmc-release]
AID - HEX589 [pii]
AID - 10.1111/j.1369-7625.2009.00589.x [doi]
PST - ppublish
SO  - Health Expect. 2010 Dec;13(4):350-8. doi: 10.1111/j.1369-7625.2009.00589.x.

PMID- 21726930
OWN - NLM
STAT- MEDLINE
DCOM- 20120328
LR  - 20220316
IS  - 1872-7654 (Electronic)
IS  - 0301-2115 (Linking)
VI  - 159
IP  - 1
DP  - 2011 Nov
TI  - Is endometrial polyp formation associated with increased expression of vascular 
      endothelial growth factor and transforming growth factor-beta1?
PG  - 198-203
LID - 10.1016/j.ejogrb.2011.06.036 [doi]
AB  - OBJECTIVE: Endometrial polyp is a common cause of abnormal uterine bleeding, but 
      the etiology and pathogenesis remain unclear. Vascular endothelial growth factor 
      (VEGF) is angiogenic, related to thick walled vessels and transforming growth 
      factor-beta1 (TGF-beta1) is related to fibrotic tissue, which are characteristics of 
      endometrial polyps. The primary objective of this study was to find out if 
      endometrial polyp formation is associated with increased expression of VEGF or 
      TGF-beta1, or both. A secondary objective is to determine if the changes are related 
      to steroid receptor expression. STUDY DESIGN: This prospective study compared 
      VEGF and TGF-beta1 expression of endometrial polyps and adjacent endometrial tissue 
      in 70 premenopausal women. The comparison of results was separately made for 
      endometrium specimens obtained in the proliferative and secretory phases. The 
      results were correlated with the steroid receptors (estrogen receptor and 
      progesterone receptor) expression. RESULTS: The score of VEGF in glandular cells 
      of endometrial polyps was significantly higher than the score in adjacent 
      endometrium, both in the proliferative phase (P<0.001) and the secretory phase 
      (P=0.03); the score of VEGF in stromal cells of endometrial polyps was 
      significantly higher than the score in adjacent endometrium only in proliferative 
      phase (P=0.006). The score of TGF-beta1 in glandular cells of endometrial polyps was 
      significantly higher than the score in adjacent endometrium in proliferative 
      phase (P=0.02); whereas the score of TGF-beta1 in stromal cells of endometrial 
      polyps was significantly higher than the score in adjacent endometrium, both in 
      the proliferative phase (P=0.006) and the secretory phase (P=0.008). There was a 
      significant correlation between the expression of steroid receptors and VEGF and 
      TGF-beta1 (Spearman's correlation P<0.001 and P<0.05, respectively). CONCLUSIONS: 
      There was increased expression of TGF-beta1 and VEGF in polyps compared to adjacent 
      normal endometrial tissue. It suggested that these cytokines might play a role in 
      endometrial polyp formation. In addition, there was a significant correlation 
      between steroid receptor expression and VEGF and TGF-beta1 expression.
CI  - Copyright (c) 2011 Elsevier Ireland Ltd. All rights reserved.
FAU - Xuebing, Peng
AU  - Xuebing P
AD  - Hysterosopic Center, Fuxing Hospital, Capital Medical University, Beijing, 
      100038, People's Republic of China. peng_xue_bing@hotmail.com
FAU - TinChiu, Li
AU  - TinChiu L
FAU - Enlan, Xia
AU  - Enlan X
FAU - Jing, Luo
AU  - Jing L
FAU - Xiaowu, Huang
AU  - Xiaowu H
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20110702
PL  - Ireland
TA  - Eur J Obstet Gynecol Reprod Biol
JT  - European journal of obstetrics, gynecology, and reproductive biology
JID - 0375672
RN  - 0 (Receptors, Estrogen)
RN  - 0 (Receptors, Progesterone)
RN  - 0 (TGFB1 protein, human)
RN  - 0 (Transforming Growth Factor beta1)
RN  - 0 (VEGFA protein, human)
RN  - 0 (Vascular Endothelial Growth Factor A)
SB  - IM
MH  - Adult
MH  - Biopsy
MH  - Endometrium/immunology/*metabolism/pathology
MH  - Female
MH  - Follicular Phase/metabolism
MH  - Humans
MH  - Hysteroscopy
MH  - Immunohistochemistry
MH  - Luteal Phase/metabolism
MH  - Middle Aged
MH  - Polyps/immunology/*metabolism/pathology
MH  - Prospective Studies
MH  - Receptors, Estrogen/metabolism
MH  - Receptors, Progesterone/metabolism
MH  - Stromal Cells
MH  - Transforming Growth Factor beta1/*metabolism
MH  - *Up-Regulation
MH  - Uterine Diseases/immunology/*metabolism/pathology
MH  - Vascular Endothelial Growth Factor A/*metabolism
MH  - Young Adult
EDAT- 2011/07/06 06:00
MHDA- 2012/03/29 06:00
CRDT- 2011/07/06 06:00
PHST- 2010/09/23 00:00 [received]
PHST- 2011/03/06 00:00 [revised]
PHST- 2011/06/09 00:00 [accepted]
PHST- 2011/07/06 06:00 [entrez]
PHST- 2011/07/06 06:00 [pubmed]
PHST- 2012/03/29 06:00 [medline]
AID - S0301-2115(11)00394-0 [pii]
AID - 10.1016/j.ejogrb.2011.06.036 [doi]
PST - ppublish
SO  - Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):198-203. doi: 
      10.1016/j.ejogrb.2011.06.036. Epub 2011 Jul 2.

PMID- 21481154
OWN - NLM
STAT- MEDLINE
DCOM- 20120202
LR  - 20120517
IS  - 1471-0528 (Electronic)
IS  - 1470-0328 (Linking)
VI  - 119
IP  - 2
DP  - 2012 Jan
TI  - Improvements in survival of gynaecological cancer in the Anglia region of 
      England: are these an effect of centralisation of care and use of 
      multidisciplinary management?
PG  - 160-5
LID - 10.1111/j.1471-0528.2011.02961.x [doi]
AB  - OBJECTIVE: Our hypothesis is that the adoption of Department of Health (DH) 
      guidance has led to an improvement in outcome in gynaecological cancer survival. 
      SETTING: In 1999 the DH in England introduced the Improving Outcomes in 
      Gynaecological Cancer guidance, advising case management by multidisciplinary 
      teams with surgical concentration in specialist hospitals. This guidance was 
      rapidly adopted in the East of England, with a population of 2.5 million. 
      POPULATION: The population of the Anglia Cancer Network was approximately 2.3 
      million. METHODS: From 1996 to 2003, details of 3406 cases of gynaecological 
      cancer were identified in the Anglia region of England. Survival analysis was 
      performed by Cox proportional hazards regression, relative to cases diagnosed in 
      1996. MAIN OUTCOME MEASURE: Primary endpoint was survival. RESULTS: The survival 
      rates for cases diagnosed between 1996 and 1999 were broadly the same across the 
      time period, with a marked improvement taking place in 2000, and continuing to 
      2003 (HR 0.71, 95% CI 0.64-0.79, comparing 2000-03 with 1996-99 diagnoses), for 
      all gynaecological sites combined. Adjustment for treatments or method of case 
      follow-up did not attenuate these improvements. There was a concurrent change 
      towards major surgery being performed in specialist centres from 2000. 
      CONCLUSIONS: The adoption of the 1999 guidance on gynaecological cancer, which 
      included multidisciplinary case management and centralisation of surgery, 
      resulted in a marked step-change improvement in survival of gynaecological cancer 
      in an area of eastern England in 2000.
CI  - (c) 2011 The Authors BJOG An International Journal of Obstetrics and Gynaecology (c) 
      2011 RCOG.
FAU - Crawford, R
AU  - Crawford R
AD  - Addenbrookes Hospital, Cambridge, UK. robin.crawford@addenbrookes.nhs.uk
FAU - Greenberg, D
AU  - Greenberg D
LA  - eng
PT  - Journal Article
DEP - 20110412
PL  - England
TA  - BJOG
JT  - BJOG : an international journal of obstetrics and gynaecology
JID - 100935741
SB  - IM
CIN - BJOG. 2012 May;119(6):768-9; author reply 769. doi: 
      10.1111/j.1471-0528.2012.03299.x. PMID: 22489764
MH  - England/epidemiology
MH  - Female
MH  - Genital Neoplasms, Female/*mortality/therapy
MH  - Health Services Accessibility/organization & administration
MH  - Humans
MH  - Patient Care Team
MH  - Regional Medical Programs/*organization & administration
MH  - Survival Rate
EDAT- 2011/04/13 06:00
MHDA- 2012/02/03 06:00
CRDT- 2011/04/13 06:00
PHST- 2011/04/13 06:00 [entrez]
PHST- 2011/04/13 06:00 [pubmed]
PHST- 2012/02/03 06:00 [medline]
AID - 10.1111/j.1471-0528.2011.02961.x [doi]
PST - ppublish
SO  - BJOG. 2012 Jan;119(2):160-5. doi: 10.1111/j.1471-0528.2011.02961.x. Epub 2011 Apr 
      12.

PMID- 22902073
OWN - NLM
STAT- MEDLINE
DCOM- 20121213
LR  - 20220309
IS  - 1097-6868 (Electronic)
IS  - 0002-9378 (Linking)
VI  - 207
IP  - 4
DP  - 2012 Oct
TI  - Estimated fetal weight by ultrasound: a modifiable risk factor for cesarean 
      delivery?
PG  - 309.e1-6
LID - S0002-9378(12)00719-3 [pii]
LID - 10.1016/j.ajog.2012.06.065 [doi]
AB  - OBJECTIVE: The purpose of this study was to investigate whether knowledge of 
      ultrasound-obtained estimated fetal weight (US-EFW) is a risk factor for cesarean 
      delivery (CD). STUDY DESIGN: Retrospective cohort from a single center in 
      2009-2010 of singleton, term live births. CD rates were compared for women with 
      and without US-EFW within 1 month of delivery and adjusted for potential 
      confounders. RESULTS: Of the 2329 women in our cohort, 50.2% had US-EFW within 1 
      month of delivery. CD was significantly more common for women with US-EFW (15.7% 
      vs 10.2%; P < .001); after we controlled for confounders, US-EFW remained an 
      independent risk factor for CD (odds ratio, 1.44; 95% confidence interval, 
      1.1-1.9). The risk increased when US-EFW was >3500 g (odds ratio, 1.8; 95% 
      confidence interval, 1.3-2.7). CONCLUSION: Knowledge of US-EFW, above and beyond 
      the impact of fetal size itself, increases the risk of CD. Acquisition of US-EFW 
      near term appears to be an independent and potentially modifiable risk factor for 
      CD.
CI  - Copyright (c) 2012 Mosby, Inc. All rights reserved.
FAU - Little, Sarah E
AU  - Little SE
AD  - Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, 
      Brigham and Women's Hospital, Boston, MA, USA.
FAU - Edlow, Andrea G
AU  - Edlow AG
FAU - Thomas, Ann M
AU  - Thomas AM
FAU - Smith, Nicole A
AU  - Smith NA
LA  - eng
PT  - Journal Article
DEP - 20120709
PL  - United States
TA  - Am J Obstet Gynecol
JT  - American journal of obstetrics and gynecology
JID - 0370476
SB  - IM
MH  - Birth Weight/*physiology
MH  - *Cesarean Section
MH  - Female
MH  - Fetal Weight/*physiology
MH  - Gestational Age
MH  - Humans
MH  - Predictive Value of Tests
MH  - Pregnancy
MH  - Retrospective Studies
MH  - Risk Factors
MH  - *Ultrasonography, Prenatal
EDAT- 2012/08/21 06:00
MHDA- 2012/12/14 06:00
CRDT- 2012/08/21 06:00
PHST- 2012/03/12 00:00 [received]
PHST- 2012/05/05 00:00 [revised]
PHST- 2012/06/29 00:00 [accepted]
PHST- 2012/08/21 06:00 [entrez]
PHST- 2012/08/21 06:00 [pubmed]
PHST- 2012/12/14 06:00 [medline]
AID - S0002-9378(12)00719-3 [pii]
AID - 10.1016/j.ajog.2012.06.065 [doi]
PST - ppublish
SO  - Am J Obstet Gynecol. 2012 Oct;207(4):309.e1-6. doi: 10.1016/j.ajog.2012.06.065. 
      Epub 2012 Jul 9.

PMID- 26370095
OWN - NLM
STAT- MEDLINE
DCOM- 20170117
LR  - 20220129
IS  - 1360-0443 (Electronic)
IS  - 0965-2140 (Linking)
VI  - 111
IP  - 2
DP  - 2016 Feb
TI  - Are financial incentives cost-effective to support smoking cessation during 
      pregnancy?
PG  - 360-70
LID - 10.1111/add.13160 [doi]
AB  - AIMS: To investigate the cost-effectiveness of up to  pound400 worth of financial 
      incentives for smoking cessation in pregnancy as an adjunct to routine health 
      care. DESIGN: Cost-effectiveness analysis based on a Phase II randomized 
      controlled trial (RCT) and a cost-utility analysis using a life-time Markov 
      model. SETTING: The RCT was undertaken in Glasgow, Scotland. The economic 
      analysis was undertaken from the UK National Health Service (NHS) perspective. 
      PARTICIPANTS: A total of 612 pregnant women randomized to receive usual cessation 
      support plus or minus financial incentives of up to  pound400 vouchers (US $609), 
      contingent upon smoking cessation. MEASUREMENTS: Comparison of usual support and 
      incentive interventions in terms of cotinine-validated quitters, quality-adjusted 
      life years (QALYs) and direct costs to the NHS. FINDINGS: The incremental cost 
      per quitter at 34-38 weeks pregnant was  pound1127 ($1716).This is similar to the 
      standard look-up value derived from Stapleton & West's published ICER tables, 
       pound1390 per quitter, by looking up the Cessation in Pregnancy Incentives Trial 
      (CIPT) incremental cost ( pound157) and incremental 6-month quit outcome (0.14). The 
      life-time model resulted in an incremental cost of  pound17 [95% confidence interval 
      (CI) = - pound93,  pound107] and a gain of 0.04 QALYs (95% CI = -0.058, 0.145), giving an 
      ICER of  pound482/QALY ($734/QALY). Probabilistic sensitivity analysis indicates 
      uncertainty in these results, particularly regarding relapse after birth. The 
      expected value of perfect information was  pound30 million (at a willingness to pay of 
       pound30 000/QALY), so given current uncertainty, additional research is potentially 
      worthwhile. CONCLUSION: Financial incentives for smoking cessation in pregnancy 
      are highly cost-effective, with an incremental cost per quality-adjusted life 
      years of  pound482, which is well below recommended decision thresholds.
CI  - (c) 2015 Society for the Study of Addiction.
FAU - Boyd, Kathleen A
AU  - Boyd KA
AD  - Health Economics and Health Technology Assessment, University of Glasgow, 
      Glasgow, UK.
FAU - Briggs, Andrew H
AU  - Briggs AH
AD  - Health Economics and Health Technology Assessment, University of Glasgow, 
      Glasgow, UK.
FAU - Bauld, Linda
AU  - Bauld L
AD  - Institute for Social Marketing, University of Stirling and UK Centre for Tobacco 
      and Alcohol Studies, Stirling, UK.
FAU - Sinclair, Lesley
AU  - Sinclair L
AD  - Institute for Social Marketing, University of Stirling and UK Centre for Tobacco 
      and Alcohol Studies, Stirling, UK.
FAU - Tappin, David
AU  - Tappin D
AD  - Paediatric Epidemiology and Community Health Unit, University of Glasgow, 
      Glasgow, UK.
LA  - eng
GR  - CZH/4/594/CSO_/Chief Scientist Office/United Kingdom
GR  - MC_UU_12017/14/MRC_/Medical Research Council/United Kingdom
GR  - MR/K023195/1/MRC_/Medical Research Council/United Kingdom
GR  - SPHSU14/CSO_/Chief Scientist Office/United Kingdom
PT  - Clinical Trial, Phase II
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20151111
PL  - England
TA  - Addiction
JT  - Addiction (Abingdon, England)
JID - 9304118
SB  - IM
CIN - Addiction. 2016 Jun;111(6):115-7. doi: 10.1111/add.13374. PMID: 27157899
CIN - Addiction. 2016 Jun;111(6):1114-5. doi: 10.1111/add.13307. PMID: 27157908
MH  - Cost-Benefit Analysis
MH  - Female
MH  - Health Promotion/economics/methods
MH  - Humans
MH  - Markov Chains
MH  - *Motivation
MH  - Pregnancy
MH  - Pregnancy Complications/economics/*prevention & control
MH  - Prenatal Care/*economics/methods
MH  - Quality-Adjusted Life Years
MH  - Scotland
MH  - Smoking/economics
MH  - Smoking Cessation/*economics
MH  - *Smoking Prevention
OTO - NOTNLM
OT  - Cost-effectiveness
OT  - financial incentives
OT  - pregnancy
OT  - smoking cessation
EDAT- 2015/09/16 06:00
MHDA- 2017/01/18 06:00
CRDT- 2015/09/16 06:00
PHST- 2015/02/09 00:00 [received]
PHST- 2015/03/03 00:00 [revised]
PHST- 2015/09/07 00:00 [accepted]
PHST- 2015/09/16 06:00 [entrez]
PHST- 2015/09/16 06:00 [pubmed]
PHST- 2017/01/18 06:00 [medline]
AID - 10.1111/add.13160 [doi]
PST - ppublish
SO  - Addiction. 2016 Feb;111(2):360-70. doi: 10.1111/add.13160. Epub 2015 Nov 11.

PMID- 18041059
OWN - NLM
STAT- MEDLINE
DCOM- 20080221
LR  - 20220331
IS  - 0008-543X (Print)
IS  - 0008-543X (Linking)
VI  - 112
IP  - 2
DP  - 2008 Jan 15
TI  - Do adjuvant aromatase inhibitors increase the cardiovascular risk in 
      postmenopausal women with early breast cancer? Meta-analysis of randomized 
      trials.
PG  - 260-7
AB  - BACKGROUND: Despite the advantages from using aromatase inhibitors (AIs) compared 
      with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 
      and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of 
      Canada-Common Toxicity Criteria [version 2.0] was demonstrated. METHODS: Phase 3 
      randomized clinical trials (RCTs) comparing AI with tamoxifen in early breast 
      cancer were considered eligible for this review. The event-based risk ratios 
      (RRs) with 95% confidence intervals (95% CIs) were derived, and a test of 
      heterogeneity was applied. Finally, absolute differences (ADs) in event rates and 
      the number of patients needed to harm 1 patient (NNH) were determined. RESULTS: 
      Seven eligible RCTs (19,818 patients) reported CVAE results. When considering all 
      RCTs, the AD of the primary endpoint (CVAE) between the 2 arms (0.52%), tamoxifen 
      versus AI, was statistically significant (RR, 1.31; 95% CI, 1.07-1.60; P= .007). 
      This translated into an NNH value of 189 patients; when only third-generation AIs 
      were considered, the difference (0.57%) remained significant (RR, 1.34; 95% CI, 
      1.09-1.63; P= .0038). Thromboembolic events were significantly more frequent in 
      the tamoxifen arm, regardless of the strategy adopted (RR, 0.53; 95% CI, 
      0.42-0.65; P< .0001), without significant heterogeneity (P= .21). An AD of 1.17% 
      and an NNH value of 85 patients were observed. CONCLUSIONS: According to the 
      results from this meta-analysis, the risk of grade 3 and 4 CVAEs in patients who 
      were receiving AIs was higher compared with the risk in patients who were 
      receiving tamoxifen, and the difference reached statistical significance. 
      However, the AD was relatively low, and from 160 to 180 patients had to be 
      treated to produce 1 event.
FAU - Cuppone, Federica
AU  - Cuppone F
AD  - Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, 
      Italy.
FAU - Bria, Emilio
AU  - Bria E
FAU - Verma, Sunil
AU  - Verma S
FAU - Pritchard, Kathleen I
AU  - Pritchard KI
FAU - Gandhi, Sonal
AU  - Gandhi S
FAU - Carlini, Paolo
AU  - Carlini P
FAU - Milella, Michele
AU  - Milella M
FAU - Nistico, Cecilia
AU  - Nistico C
FAU - Terzoli, Edmondo
AU  - Terzoli E
FAU - Cognetti, Francesco
AU  - Cognetti F
FAU - Giannarelli, Diana
AU  - Giannarelli D
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Cancer
JT  - Cancer
JID - 0374236
RN  - 0 (Aromatase Inhibitors)
RN  - 094ZI81Y45 (Tamoxifen)
SB  - IM
MH  - Aromatase Inhibitors/*adverse effects
MH  - Breast Neoplasms/*drug therapy
MH  - Cardiovascular Diseases/*chemically induced
MH  - Female
MH  - Humans
MH  - Middle Aged
MH  - Postmenopause
MH  - Randomized Controlled Trials as Topic
MH  - Tamoxifen/adverse effects
EDAT- 2007/11/28 09:00
MHDA- 2008/02/22 09:00
CRDT- 2007/11/28 09:00
PHST- 2007/11/28 09:00 [pubmed]
PHST- 2008/02/22 09:00 [medline]
PHST- 2007/11/28 09:00 [entrez]
AID - 10.1002/cncr.23171 [doi]
PST - ppublish
SO  - Cancer. 2008 Jan 15;112(2):260-7. doi: 10.1002/cncr.23171.

PMID- 15041506
OWN - NLM
STAT- MEDLINE
DCOM- 20040505
LR  - 20220408
IS  - 0002-9610 (Print)
IS  - 0002-9610 (Linking)
VI  - 187
IP  - 4
DP  - 2004 Apr
TI  - Is fear of anaphylactic shock discouraging surgeons from more widely adopting 
      percutaneous and laparoscopic techniques in the treatment of liver hydatid cyst?
PG  - 533-7
AB  - BACKGROUND: Sources of reports about laparoscopic and percutaneous treatment of 
      liver hydatid cysts are limited to just a few countries. To address the reason 
      behind this, we carried out a survey of 30 surgeons in northern Jordan. METHODS: 
      A questionnaire was distributed to collect data regarding the surgical technique 
      preferred by each surgeon. Further information was collected from those not 
      adopting minimal-access techniques to determine their reasons for not doing so. 
      RESULTS: Only 3 surgeons (10%) considered laparoscopy as the first line of 
      treatment. Of the 27 surgeons who did not consider percutaneous or laparoscopic 
      treatment, fear of anaphylaxis and/or dissemination was the main reason given by 
      21 surgeons (78%) for not using minimal access techniques. CONCLUSIONS: The 
      seemingly exaggerated traditional fear of anaphylaxis seems to discourage 
      surgeons from more widely adopting minimal access techniques for the treatment of 
      hydatid cyst.
FAU - Yaghan, Rami
AU  - Yaghan R
AD  - Department of Surgery, Jordan University of Science and Technology, P.O. Box 
      3030, Irbid, Jordan. lamees32@yahoo.com
FAU - Heis, Hussein
AU  - Heis H
FAU - Bani-Hani, Kamal
AU  - Bani-Hani K
FAU - Matalka, Ismail
AU  - Matalka I
FAU - Shatanawi, Nawaf
AU  - Shatanawi N
FAU - Gharaibeh, Kamal
AU  - Gharaibeh K
FAU - Bani-Hani, Amjad
AU  - Bani-Hani A
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Am J Surg
JT  - American journal of surgery
JID - 0370473
SB  - IM
MH  - Adult
MH  - Anaphylaxis/*etiology
MH  - Echinococcosis, Hepatic/*surgery
MH  - General Surgery
MH  - Humans
MH  - Laparoscopy/*statistics & numerical data
MH  - Middle Aged
MH  - Postoperative Complications/*etiology
MH  - Practice Patterns, Physicians'
MH  - *Surveys and Questionnaires
EDAT- 2004/03/26 05:00
MHDA- 2004/05/07 05:00
CRDT- 2004/03/26 05:00
PHST- 2003/04/30 00:00 [received]
PHST- 2003/10/31 00:00 [revised]
PHST- 2004/03/26 05:00 [pubmed]
PHST- 2004/05/07 05:00 [medline]
PHST- 2004/03/26 05:00 [entrez]
AID - S0002961003006408 [pii]
AID - 10.1016/j.amjsurg.2003.12.046 [doi]
PST - ppublish
SO  - Am J Surg. 2004 Apr;187(4):533-7. doi: 10.1016/j.amjsurg.2003.12.046.

PMID- 11146778
OWN - NLM
STAT- MEDLINE
DCOM- 20010215
LR  - 20190704
IS  - 0004-0010 (Print)
IS  - 0004-0010 (Linking)
VI  - 136
IP  - 1
DP  - 2001 Jan
TI  - Risk stratification in emergency surgical patients: is the APACHE II score a 
      reliable marker of physiological impairment?
PG  - 55-9
AB  - HYPOTHESES: The APACHE II (Acute Physiology and Chronic Health Evaluation II) 
      score used as an intensive care unit (ICU) admission score in emergency surgical 
      patients is not independent of the effects of treatment and might lead to 
      considerable bias in the comparability of defined groups of patients and in the 
      evaluation of treatment policies. Postoperative monitoring with the APACHE II 
      score is clinically irrelevant. DESIGN: Inception cohort study. SETTING: 
      Secondary referral center. PATIENTS: Eighty-five consecutive emergency surgical 
      patients admitted to the surgical ICU in 1999. The APACHE II score was calculated 
      before surgery; after admission to the ICU; and on postoperative days 3, 7, and 
      10. MAIN OUTCOME MEASURES: APACHE II scores and predicted and observed mortality 
      rates. RESULTS: The mean +/- SD APACHE II score of 24.2 +/- 8.3 at admission to 
      the ICU was approximately 36% greater than the initial APACHE II score of 17.8 
      +/- 7.7, a difference that was highly statistically significant (P<.001). The 
      overall mortality of 32% favorably corresponds with the predicted mortality of 
      34% according to the initial APACHE II score. However, the predicted mortality of 
      50% according to the APACHE II score at admission to the ICU was significantly 
      different from the observed mortality rate (P =.02). In 40 long-term patients 
      (>/=10 days in the ICU), the difference between the APACHE II scores of survivors 
      and patients who died was statistically significant on day 10 (P =.04). 
      CONCLUSIONS: For risk stratification in emergency surgical patients, it is 
      essential to measure the APACHE II score before surgical treatment. Longitudinal 
      APACHE II scoring reveals continuous improvement of the score in surviving 
      patients but has no therapeutic relevance in the individual patient.
FAU - Koperna, T
AU  - Koperna T
AD  - Department of Surgery, Hospital Mistelbach, Liechtensteinstrasse 67, A-2130 
      Mistelbach, Austria.
FAU - Semmler, D
AU  - Semmler D
FAU - Marian, F
AU  - Marian F
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Arch Surg
JT  - Archives of surgery (Chicago, Ill. : 1960)
JID - 9716528
SB  - IM
CIN - Arch Surg. 2001 Mar;136(3):353. doi: 10.1001/archsurg.136.3.353. PMID: 11231861
MH  - *APACHE
MH  - Aged
MH  - Cohort Studies
MH  - *Emergency Treatment/mortality
MH  - Female
MH  - Humans
MH  - Intensive Care Units
MH  - Male
MH  - Preoperative Care
MH  - Risk Assessment
MH  - Surgical Procedures, Operative/*statistics & numerical data
MH  - Survival Rate
MH  - Time Factors
EDAT- 2001/01/13 11:00
MHDA- 2001/03/03 10:01
CRDT- 2001/01/13 11:00
PHST- 2001/01/13 11:00 [pubmed]
PHST- 2001/03/03 10:01 [medline]
PHST- 2001/01/13 11:00 [entrez]
AID - soa0125 [pii]
AID - 10.1001/archsurg.136.1.55 [doi]
PST - ppublish
SO  - Arch Surg. 2001 Jan;136(1):55-9. doi: 10.1001/archsurg.136.1.55.

PMID- 27281318
OWN - NLM
STAT- MEDLINE
DCOM- 20170309
LR  - 20170309
IS  - 2328-5273 (Electronic)
IS  - 2328-4633 (Linking)
VI  - 74
IP  - 2
DP  - 2016 Jun
TI  - Can Flexible Instruments Create Adequate Femoral Tunnel Lengths at 90 degrees  of Knee 
      Flexion in Anterior Cruciate Ligament Reconstruction?
PG  - 135-40
AB  - PURPOSE: This study aims to study femoral tunnel lengths drilled with a flexible 
      reamer and the distance to important lateral structures obtained by flexing the 
      knee at various angles and by drilling the guide pins arthroscopically to 
      resemble clinical practice. The purpose of this cadaveric study was twofold: 1. 
      to determine whether femoral tunnel lengths of greater than 20 mm can be created 
      with a flexible reamer system at 90  degrees  of knee flexion and 2. to determine whether 
      the lateral structures of the knee are safe with this technique. METHODS: Ten 
      fresh cadaveric knees were utilized. The intra-osseous length can be measured 
      with a specially de - signed flexible guide pin. Flexible pins were inserted with 
      the knee at 70 degrees , 90 degrees , and 120 degrees  of flexion. The intra-osseous length was measured 
      with the measuring device. Each speci - men was dissected around the lateral 
      aspect of the knee to identify the critical structures, the common peroneal 
      nerve, and the LCL. The distance from the guide pins to the com - mon peroneal 
      nerve and femoral attachment of the LCL were measured with a standard flexible 
      paper ruler to the nearest millimeter. RESULTS: There is a trend for 
      progressively increasing mean intra-osseous length associated with increased 
      flexion of the knee. The mean intra-osseous length for 70 degrees  flexion was 25.2 mm 
      (20 mm to 32 mm), which was statistically significant when compared to mean 
      intra-osseous lengths of 32.1 mm (22 mm to 45 mm) and 38.0 mm (34 mm to 45 mm) in 
      the 90 degrees  and 120 degrees  flexion groups, respectively (p < 0.05). There were no 
      significant differences among the groups with respect to distance to the LCL. 
      There is a trend toward longer distances to the common peroneal nerve with 
      increased flexion. There was a statistically significant dif - ference when 
      comparing 120 degrees  versus 70 degrees  (p < 0.05). CONCLUSIONS: This study that shows that 
      adequate femoral tunnel lengths can be safely created without knee hyperflex - 
      ion using flexible instruments via an anteromedial portal.
FAU - Kalra, Kunal
AU  - Kalra K
FAU - Tang, Edward
AU  - Tang E
FAU - Atanda, Abiola
AU  - Atanda A
FAU - Khatib, Omar
AU  - Khatib O
FAU - Shamah, Steven
AU  - Shamah S
FAU - Meislin, Robert
AU  - Meislin R
FAU - Jazrawi, Laith
AU  - Jazrawi L
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Bull Hosp Jt Dis (2013)
JT  - Bulletin of the Hospital for Joint Disease (2013)
JID - 101614130
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Anatomic Landmarks
MH  - Anterior Cruciate Ligament/diagnostic imaging/innervation/*surgery
MH  - Anterior Cruciate Ligament Reconstruction/*instrumentation
MH  - Biomechanical Phenomena
MH  - Cadaver
MH  - Equipment Design
MH  - Femur/diagnostic imaging/innervation/*surgery
MH  - Humans
MH  - Knee Joint/diagnostic imaging/innervation/*surgery
MH  - Middle Aged
MH  - Pliability
MH  - Range of Motion, Articular
MH  - *Surgical Instruments
EDAT- 2016/06/10 06:00
MHDA- 2017/03/10 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/03/10 06:00 [medline]
PST - ppublish
SO  - Bull Hosp Jt Dis (2013). 2016 Jun;74(2):135-40.

PMID- 21645374
OWN - NLM
STAT- MEDLINE
DCOM- 20110829
LR  - 20220310
IS  - 1471-2229 (Electronic)
IS  - 1471-2229 (Linking)
VI  - 11
IP  - 1
DP  - 2011 Jun 6
TI  - Do mitochondria play a role in remodelling lace plant leaves during programmed 
      cell death?
PG  - 102
LID - 10.1186/1471-2229-11-102 [doi]
AB  - BACKGROUND: Programmed cell death (PCD) is the regulated death of cells within an 
      organism. The lace plant (Aponogeton madagascariensis) produces perforations in 
      its leaves through PCD. The leaves of the plant consist of a latticework of 
      longitudinal and transverse veins enclosing areoles. PCD occurs in the cells at 
      the center of these areoles and progresses outwards, stopping approximately five 
      cells from the vasculature. The role of mitochondria during PCD has been 
      recognized in animals; however, it has been less studied during PCD in plants. 
      RESULTS: The following paper elucidates the role of mitochondrial dynamics during 
      developmentally regulated PCD in vivo in A. madagascariensis. A single areole 
      within a window stage leaf (PCD is occurring) was divided into three areas based 
      on the progression of PCD; cells that will not undergo PCD (NPCD), cells in early 
      stages of PCD (EPCD), and cells in late stages of PCD (LPCD). Window stage leaves 
      were stained with the mitochondrial dye MitoTracker Red CMXRos and examined. 
      Mitochondrial dynamics were delineated into four categories (M1-M4) based on 
      characteristics including distribution, motility, and membrane potential (DeltaPsim). A 
      TUNEL assay showed fragmented nDNA in a gradient over these mitochondrial stages. 
      Chloroplasts and transvacuolar strands were also examined using live cell 
      imaging. The possible importance of mitochondrial permeability transition pore 
      (PTP) formation during PCD was indirectly examined via in vivo cyclosporine A 
      (CsA) treatment. This treatment resulted in lace plant leaves with a 
      significantly lower number of perforations compared to controls, and that 
      displayed mitochondrial dynamics similar to that of non-PCD cells. CONCLUSIONS: 
      Results depicted mitochondrial dynamics in vivo as PCD progresses within the lace 
      plant, and highlight the correlation of this organelle with other organelles 
      during developmental PCD. To the best of our knowledge, this is the first report 
      of mitochondria and chloroplasts moving on transvacuolar strands to form a ring 
      structure surrounding the nucleus during developmental PCD. Also, for the first 
      time, we have shown the feasibility for the use of CsA in a whole plant system. 
      Overall, our findings implicate the mitochondria as playing a critical and early 
      role in developmentally regulated PCD in the lace plant.
FAU - Lord, Christina E N
AU  - Lord CE
AD  - Department of Biology, Dalhousie University, 1355 Oxford Street, Halifax, B3H 
      4R2, Canada.
FAU - Wertman, Jaime N
AU  - Wertman JN
FAU - Lane, Stephanie
AU  - Lane S
FAU - Gunawardena, Arunika H L A N
AU  - Gunawardena AH
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20110606
PL  - England
TA  - BMC Plant Biol
JT  - BMC plant biology
JID - 100967807
SB  - IM
EIN - BMC Plant Biol. 2013;13:58
MH  - Alismataceae/cytology/growth & development/*physiology
MH  - Apoptosis/*physiology
MH  - Cell Differentiation/physiology
MH  - Mitochondria/*physiology
MH  - Plant Leaves/cytology/growth & development/physiology
PMC - PMC3118178
EDAT- 2011/06/08 06:00
MHDA- 2011/08/30 06:00
PMCR- 2011/06/06
CRDT- 2011/06/08 06:00
PHST- 2011/03/01 00:00 [received]
PHST- 2011/06/06 00:00 [accepted]
PHST- 2011/06/08 06:00 [entrez]
PHST- 2011/06/08 06:00 [pubmed]
PHST- 2011/08/30 06:00 [medline]
PHST- 2011/06/06 00:00 [pmc-release]
AID - 1471-2229-11-102 [pii]
AID - 10.1186/1471-2229-11-102 [doi]
PST - epublish
SO  - BMC Plant Biol. 2011 Jun 6;11(1):102. doi: 10.1186/1471-2229-11-102.

PMID- 9465206
OWN - NLM
STAT- MEDLINE
DCOM- 19980304
LR  - 20161124
IS  - 0033-8362 (Print)
IS  - 0033-8362 (Linking)
VI  - 94
IP  - 5
DP  - 1997 Nov
TI  - ["Occult" posttraumatic lesions of the knee: can magnetic resonance substitute 
      for diagnostic arthroscopy?].
PG  - 433-9
AB  - PURPOSE: We investigated the actual role of MRI versus arthroscopy in the 
      detection and characterization of occult bone and/or cartilage injuries in 
      patients with previous musculoskeletal trauma of the knee, pain and severe 
      functional impairment. Occult post-traumatic osteochondral injuries of the knee 
      are trauma-related bone and/or cartilage damage missed at plain radiography. 
      MATERIAL AND METHODS: We retrospectively selected 70 patients (men:women = 7:3; 
      age range: 35 +/- 7 years) with a history of acute musculoskeletal trauma, 
      negative conventional radiographs, pain and limited joint movements. All patients 
      were submitted to conventional radiography, arthroscopy and MRI, the latter with 
      0.5 T units and T1-weighted SE. T2-weighted GE and FIR sequences with fat 
      suppression. RESULTS AND DISCUSSION: We identified three types of occult 
      post-traumatic injuries by morpho-topographic and signal intensity patterns: bone 
      bruises (no. 25), subchondral (no. 33) and osteochondral (no. 35) injuries. 
      Arthroscopy depicted 45 osteochondral and 19 chondral injuries. A bone bruise was 
      defined as a typical subcortical area of signal loss, with various shapes, on 
      T1-weighted images and of increased signal intensity on T2-weighted and FIR 
      images. The cortical bone and articular cartilage were normal in all cases, while 
      osteochondral injuries exhibited associated bone and cartilage damage with the 
      same abnormal MR signal intensity. Sprain was the mechanism of injury in 52 
      cases, bruise in 12 and stress in 6. In 52 sprains (30 in valgus), the injury 
      site was the lateral compartment in 92.3% of cases (100% in valgus), associated 
      with meniscal damage in 73% of cases (90% in valgus) and with ligament injury in 
      90.4% (100% in valgus). In 12 bruises, the injury site was the lateral 
      compartment in 58.3% of cases, the knee cap in 25% and the medial compartment in 
      16.7%; meniscal damage was associated in 25% of cases and ligament damage in 
      8.3%. In 6 stress injuries, the injury site was localized in the medial tibial 
      condyle in 80% of cases, while meniscal and ligament tears were absent. 
      CONCLUSIONS: After comparing MR with arthroscopic findings and reviewing the 
      available literature, we conclude that arthroscopy permits the direct 
      visualization of even fine articular surface changes but does not depict the 
      subchondral bone, the most frequent site of injury detected with MRI. MRI was a 
      very useful tool in the detection and characterization of the different types of 
      occult bone and/or cartilage injuries and showed a statistically significant 
      correlation between site and distribution of bone and cartilage injuries and 
      between internal damage and trauma mechanisms. Therefore, we believe that MRI can 
      help avoid diagnostic arthroscopy in the patients with a history of 
      post-traumatic pain, acute articular blocks and negative radiographic findings.
FAU - Tamburrini, O
AU  - Tamburrini O
AD  - Dipartimento di Medicina Sperimentale e Clinica, Universita degli Studi di Reggio 
      Calabria.
FAU - Bianchi, D
AU  - Bianchi D
FAU - Capparelli, G
AU  - Capparelli G
FAU - Barresi, D
AU  - Barresi D
FAU - Arcuri, P P
AU  - Arcuri PP
FAU - Barbalace, G
AU  - Barbalace G
FAU - Stana, C
AU  - Stana C
LA  - ita
PT  - Comparative Study
PT  - Journal Article
TT  - Lesioni "occulte" post-traumatiche del ginocchio: puo la Risonanza Magnetica 
      sostituire l'artroscopia diagnostica?
PL  - Italy
TA  - Radiol Med
JT  - La Radiologia medica
JID - 0177625
SB  - IM
MH  - Adult
MH  - *Arthroscopy
MH  - Cartilage, Articular/injuries/pathology
MH  - Contusions/diagnosis
MH  - Female
MH  - Fractures, Bone/diagnosis
MH  - Humans
MH  - Knee Injuries/*diagnosis
MH  - Knee Joint/diagnostic imaging/pathology
MH  - Ligaments, Articular/injuries/pathology
MH  - *Magnetic Resonance Imaging/instrumentation/methods
MH  - Male
MH  - Menisci, Tibial/pathology
MH  - Radiography
MH  - Retrospective Studies
MH  - Sensitivity and Specificity
MH  - Tibial Meniscus Injuries
EDAT- 1998/02/18 00:00
MHDA- 1998/02/18 00:01
CRDT- 1998/02/18 00:00
PHST- 1998/02/18 00:00 [pubmed]
PHST- 1998/02/18 00:01 [medline]
PHST- 1998/02/18 00:00 [entrez]
PST - ppublish
SO  - Radiol Med. 1997 Nov;94(5):433-9.

PMID- 25887165
OWN - NLM
STAT- MEDLINE
DCOM- 20150901
LR  - 20150619
IS  - 1531-5053 (Electronic)
IS  - 0278-2391 (Linking)
VI  - 73
IP  - 7
DP  - 2015 Jul
TI  - Does Sensation Return to the Nasal Tip After Microfat Grafting?
PG  - 1396.e1-6
LID - S0278-2391(15)00340-7 [pii]
LID - 10.1016/j.joms.2015.03.048 [doi]
AB  - PURPOSE: Patients usually complain about numbness in the nasal tip after microfat 
      injections. The present study evaluated the severity of the numbness in the nasal 
      tip after the procedure. PATIENTS AND METHODS: To address the research question, 
      a prospective study of young women was designed and performed at the Beijing 
      Anzhen Hospital. Time was the primary predictor variable. The nasal tip 
      sensation, which was evaluated using objective and subjective assessments, was 
      used as the primary outcome variable. The McNemar-Bowker test (time vs nasal tip 
      sensation) was used to detect statistical significance. RESULTS: A total of 30 
      young women (age 20.04 +/- 3.63 years) were recruited for the present study. The 
      preoperative mean touch threshold value was 3.60 units. One week after the 
      injection, the women experienced a decrease in the touch threshold value by 2.50 
      units. However, the sensation recovered gradually during the follow-up period 
      (1.51 units at week 2, 2.39 units at week 4, 3.01 units at week 8, and 3.35 units 
      at week 12). Significant differences were detected between multiple different 
      measurement points (P < .05). The percentage of those experiencing paresthesia 
      after the microfat injections also gradually diminished to none. CONCLUSION: 
      Postoperative numbness occurs in most patients receiving nasal microfat 
      injections. Partial to complete recovery of nasal tip sensation can be expected 
      to occur over a 3-month period.
CI  - Copyright (c) 2015 American Association of Oral and Maxillofacial Surgeons. 
      Published by Elsevier Inc. All rights reserved.
FAU - Huang, Lin
AU  - Huang L
AD  - Professor, Department of Plastic and Reconstructive Surgery, Beijing Anzhen 
      Hospital, Capital Medical University, Beijing, China. Electronic address: 
      cc.ll.80811@163.com.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20150325
PL  - United States
TA  - J Oral Maxillofac Surg
JT  - Journal of oral and maxillofacial surgery : official journal of the American 
      Association of Oral and Maxillofacial Surgeons
JID - 8206428
SB  - IM
MH  - Abdominal Fat/surgery
MH  - Adipose Tissue/*transplantation
MH  - Adult
MH  - Cohort Studies
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Hypesthesia/etiology/physiopathology
MH  - Middle Aged
MH  - Nose/*physiology/surgery
MH  - Postoperative Complications
MH  - Prospective Studies
MH  - Recovery of Function/*physiology
MH  - Rhinoplasty/*methods
MH  - Sensory Thresholds/physiology
MH  - Touch/*physiology
MH  - Transplant Donor Site/surgery
MH  - Young Adult
EDAT- 2015/04/19 06:00
MHDA- 2015/09/02 06:00
CRDT- 2015/04/19 06:00
PHST- 2014/07/30 00:00 [received]
PHST- 2015/03/18 00:00 [revised]
PHST- 2015/03/19 00:00 [accepted]
PHST- 2015/04/19 06:00 [entrez]
PHST- 2015/04/19 06:00 [pubmed]
PHST- 2015/09/02 06:00 [medline]
AID - S0278-2391(15)00340-7 [pii]
AID - 10.1016/j.joms.2015.03.048 [doi]
PST - ppublish
SO  - J Oral Maxillofac Surg. 2015 Jul;73(7):1396.e1-6. doi: 
      10.1016/j.joms.2015.03.048. Epub 2015 Mar 25.

PMID- 15995461
OWN - NLM
STAT- MEDLINE
DCOM- 20050804
LR  - 20190711
IS  - 0022-5282 (Print)
IS  - 0022-5282 (Linking)
VI  - 58
IP  - 6
DP  - 2005 Jun
TI  - Do some U.S. states have higher/lower injury mortality rates than others?
PG  - 1144-9
AB  - BACKGROUND: This article examines the hypothesis that the six U.S. states with 
      the highest rates of road traffic deaths (group 1 states) also had above-average 
      rates of other forms of injury such as falling, poisoning, drowning, fire, 
      suffocation, homicide, and suicide, and also for the retail trade and 
      construction industries. The converse, second hypothesis, for the six states with 
      the lowest rates of road traffic deaths (group 2 states) is also examined. 
      RESULTS: Data for these 12 states for the period 1983 to 1995 included nine 
      categories of unintentional and four categories of intentional injury. 
      Seventy-four percent of the group 1 states conformed to the first hypothesis, and 
      85% of the group 2 states conformed to the second hypothesis. CONCLUSION: Group 1 
      states are likely to exhibit above-average rates for most other categories of 
      injury death, whereas group 2 states are even more likely to exhibit 
      below-average rates for most other categories of injury death.
FAU - Wigglesworth, Eric C
AU  - Wigglesworth EC
AD  - Accident Research Centre, Monash University, Melbourne, Victoria 3800, Australia. 
      eric.wigglesworth@general.monash.edu.au
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Trauma
JT  - The Journal of trauma
JID - 0376373
SB  - IM
MH  - Accidental Falls/mortality
MH  - Accidents, Traffic/mortality
MH  - Asphyxia/mortality
MH  - Drowning/mortality
MH  - Female
MH  - Fires/statistics & numerical data
MH  - Humans
MH  - Male
MH  - Poisoning/mortality
MH  - United States/epidemiology
MH  - Wounds and Injuries/*mortality
MH  - Wounds, Gunshot/mortality
EDAT- 2005/07/05 09:00
MHDA- 2005/08/05 09:00
CRDT- 2005/07/05 09:00
PHST- 2005/07/05 09:00 [pubmed]
PHST- 2005/08/05 09:00 [medline]
PHST- 2005/07/05 09:00 [entrez]
AID - 00005373-200506000-00008 [pii]
AID - 10.1097/01.ta.0000170103.26177.3e [doi]
PST - ppublish
SO  - J Trauma. 2005 Jun;58(6):1144-9. doi: 10.1097/01.ta.0000170103.26177.3e.

PMID- 21850494
OWN - NLM
STAT- MEDLINE
DCOM- 20120228
LR  - 20211020
IS  - 1573-2568 (Electronic)
IS  - 0163-2116 (Linking)
VI  - 57
IP  - 1
DP  - 2012 Jan
TI  - Hepatorenal syndrome: are we missing some prognostic factors?
PG  - 210-4
LID - 10.1007/s10620-011-1861-1 [doi]
AB  - BACKGROUND: Hepatorenal syndrome (HRS) is the functional renal failure associated 
      with advanced cirrhosis and has also been described in fulminant hepatic failure. 
      Without liver transplantation its prognosis is dismal. Our study included 
      patients with type 1 HRS associated with cirrhosis, who were not liver transplant 
      candidates. AIM: To identify variables associated with improved survival. 
      METHODS: Sixty-eight patients fulfilled the revised Ascites Club Criteria for 
      type 1 HRS. None of them was suitable for liver transplantation. All the patients 
      were treated with combinations of: albumin, midodrine and octreotide, pressors, 
      and hemodialysis. RESULTS: Median survival was 13 days for the whole group. 
      Survival varied with the end-stage liver disease (ESLD) etiology: autoimmune, 49 
      days, cardiac cirrhosis, 22 days, idiopathic, 15.5 days, viral, 15 days, 
      hepatitis C and alcohol, 14.5 days, alcohol 8 days, and neoplasia 4 days (p = 
      0.048). Survival of HRS associated with alcoholic liver disease versus other 
      etiologies was not statistically significant (p = 0.1). Increased serum 
      creatinine (p = 0.02) and urinary sodium 6-10 mEq/l (p = 0.027) at the initiation 
      of therapy were prognostic factors for mortality. HRS treatment modalities (p = 
      0.73), use of dialysis (p = 0.56), dialysis modality (p = 0.35), use of 
      vasopressors (p = 0.26), pre-existing renal disease (p = 0.49), gender (p = 
      0.90), and age (p = 0.57) were not associated with survival. CONCLUSIONS: We 
      report for the first time ESLD etiology as a prognostic factor for survival. The 
      renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the 
      time of diagnosis were found to be associated with survival, suggesting that 
      early treatment might increase survival.
FAU - Olivera-Martinez, Marco
AU  - Olivera-Martinez M
AD  - Section of Gastroenterology and Hepatology, University of Nebraska Medical 
      Center, 983040 Nebraska Medical Center, Omaha, NE 69198-3040, USA. 
      molivera@unmc.edu
FAU - Sayles, Harlan
AU  - Sayles H
FAU - Vivekanandan, Renuga
AU  - Vivekanandan R
FAU - D' Souza, Sharlene
AU  - D' Souza S
FAU - Florescu, Marius C
AU  - Florescu MC
LA  - eng
PT  - Journal Article
DEP - 20110818
PL  - United States
TA  - Dig Dis Sci
JT  - Digestive diseases and sciences
JID - 7902782
RN  - 0 (Albumins)
RN  - 6YE7PBM15H (Midodrine)
RN  - 9NEZ333N27 (Sodium)
RN  - AYI8EX34EU (Creatinine)
RN  - RWM8CCW8GP (Octreotide)
SB  - IM
EIN - Dig Dis Sci. 2012 Feb;57(2):587. Martinez, Marco Olivera [corrected to 
      Olivera-Martinez, Marco]
MH  - Albumins/therapeutic use
MH  - Alcoholism/*complications
MH  - Autoimmune Diseases/*complications
MH  - Creatinine/blood
MH  - End Stage Liver Disease/*etiology/therapy
MH  - Female
MH  - Hepatitis C/*complications
MH  - Hepatorenal Syndrome/*diagnosis/metabolism/*mortality
MH  - Humans
MH  - Liver Cirrhosis/*complications
MH  - Male
MH  - Middle Aged
MH  - Midodrine/therapeutic use
MH  - Octreotide/therapeutic use
MH  - Prognosis
MH  - Renal Dialysis
MH  - Retrospective Studies
MH  - Sodium/urine
MH  - Survival Rate
EDAT- 2011/08/19 06:00
MHDA- 2012/03/01 06:00
CRDT- 2011/08/19 06:00
PHST- 2011/02/25 00:00 [received]
PHST- 2011/08/03 00:00 [accepted]
PHST- 2011/08/19 06:00 [entrez]
PHST- 2011/08/19 06:00 [pubmed]
PHST- 2012/03/01 06:00 [medline]
AID - 10.1007/s10620-011-1861-1 [doi]
PST - ppublish
SO  - Dig Dis Sci. 2012 Jan;57(1):210-4. doi: 10.1007/s10620-011-1861-1. Epub 2011 Aug 
      18.

PMID- 19106867
OWN - NLM
STAT- MEDLINE
DCOM- 20090217
LR  - 20220321
IS  - 0021-7697 (Print)
IS  - 0021-7697 (Linking)
VI  - 145
IP  - 5
DP  - 2008 Sep-Oct
TI  - [The Main Gate Syndrome: a new format in mass-casualty victim "surge" 
      management?].
PG  - 459-65
AB  - INTRODUCTION: Recent suicide bombings pose the novel problem for Trauma Centers 
      of the massive simultaneous arrival of many gravely wounded patients. METHODS: We 
      report the experience of the French-German Military Trauma Group, a Level 2 
      Trauma Center, in Afghanistan during the wave of suicide bombings in February 
      2007. RESULTS: Fourteen casualties were received. A first triage was carried out 
      by the U S Army Level I group prior to evacuation. A second surgical triage was 
      carried out with systematic ultrasound exam. Four cases (ISS>25) were 
      re-categorized and underwent emergency surgical procedures. CONCLUSION: Suicide 
      bombing in crowded locations near an evacuation hospital may overwhelm the 
      medical resources of the receiving center. It has been referred to as "The Main 
      Gate Syndrome." We introduced the novel concept of a semi-evacuation hospital or 
      receiving center where a second surgical triage was carried out. These 
      exceptional circumstances require open-minded flexibility, a tailored approach, 
      and close cooperation between surgeons and anesthetists to share experience, 
      opinions, and ideas. In the setting of mass casualties, emergency ultrasound exam 
      was shown to be a valuable and effective tool by virtue of its mobility, 
      reproducibility, and immediate results.
FAU - Sockeel, P
AU  - Sockeel P
AD  - Service de chirurgie digestive, HIA Legouest - Metz-armees. phsockeel@hotmail.com
FAU - De Saint Roman, C
AU  - De Saint Roman C
FAU - Massoure, M-P
AU  - Massoure MP
FAU - Nadaud, J
AU  - Nadaud J
FAU - Cinquetti, G
AU  - Cinquetti G
FAU - Chatelain, E
AU  - Chatelain E
LA  - fre
PT  - English Abstract
PT  - Journal Article
TT  - Le Main Gate Syndrom ou faut-il redefinir notre conception du triage chirurgical?
PL  - France
TA  - J Chir (Paris)
JT  - Journal de chirurgie
JID - 0374754
SB  - IM
MH  - Abdominal Injuries/surgery
MH  - Adult
MH  - Afghanistan
MH  - Blast Injuries/diagnosis/*surgery
MH  - *Bombs
MH  - Emergency Medical Services/*organization & administration
MH  - Extremities/injuries/surgery
MH  - Humans
MH  - Male
MH  - *Mass Casualty Incidents
MH  - Middle Aged
MH  - Reproducibility of Results
MH  - Rescue Work/organization & administration
MH  - Retrospective Studies
MH  - Syndrome
MH  - Thoracic Injuries/surgery
MH  - Trauma Severity Indices
MH  - Treatment Outcome
MH  - Wounds, Penetrating/surgery
MH  - Young Adult
EDAT- 2008/12/25 09:00
MHDA- 2009/02/20 09:00
CRDT- 2008/12/25 09:00
PHST- 2008/12/25 09:00 [entrez]
PHST- 2008/12/25 09:00 [pubmed]
PHST- 2009/02/20 09:00 [medline]
AID - S0021-7697(08)74656-8 [pii]
AID - 10.1016/s0021-7697(08)74656-8 [doi]
PST - ppublish
SO  - J Chir (Paris). 2008 Sep-Oct;145(5):459-65. doi: 10.1016/s0021-7697(08)74656-8.

PMID- 21342862
OWN - NLM
STAT- MEDLINE
DCOM- 20120105
LR  - 20191210
IS  - 1308-0032 (Electronic)
IS  - 1302-8723 (Linking)
VI  - 11
IP  - 2
DP  - 2011 Mar
TI  - Is EQ-5D a valid quality of life instrument in patients with acute coronary 
      syndrome?
PG  - 156-62
LID - 10.5152/akd.2011.037 [doi]
AB  - OBJECTIVE: To evaluate the construct validity of the Turkish version of the EQ-5D 
      in patients with acute coronary syndrome. METHODS: The study was conducted as a 
      cross-sectional study at the Trakya University Hospital between February and May 
      2008. All patients completed the Turkish version of the EQ-5D and MacNew 
      heart-related quality of life scale. Construct validity of the EQ-5D was assessed 
      according to relationships with MacNew subscales by using Spearman rank 
      correlation and multiple linear regression analyses. RESULTS: One hundred and 
      twenty-two patients responded to the instruments. Mean age was 62.9+/-9.3 years and 
      male gender (88 or 72.1%) was dominant. Mean score of the EQ-5D index was 
      0.79+/-0.32, while the global score of MacNew was 5.01+/-1.16. The correlation 
      coefficients of the EQ-5D index score with the MacNew subscales ranged from 0.557 
      to 0.721, with EQ-5D VAS score ranging from 0.297 to 0.484 (p<0.001 for all of 
      them). According to the stepwise regression model MacNew global score was found 
      to be significantly effective factor on EQ-5D index score (beta =0.188; 95% CI: 
      0.152-0.224; p<0.001). CONCLUSION: The Turkish version of the EQ-5D-based utility 
      score seems to be a valid instrument in the assessment of quality of life studies 
      in patients with acute coronary syndrome.
FAU - Kahyaoglu Sut, Hatice
AU  - Kahyaoglu Sut H
AD  - Department of Nursing, Health Sciences Institute, Faculty of Health Sciences, 
      Trakya University, Edirne, Turkey. haticesut@yahoo.com
FAU - Unsar, Serap
AU  - Unsar S
LA  - eng
PT  - Journal Article
PT  - Validation Study
DEP - 20110223
PL  - Turkey
TA  - Anadolu Kardiyol Derg
JT  - Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology
JID - 101095069
SB  - IM
MH  - Acute Coronary Syndrome/*psychology
MH  - Cross-Sectional Studies
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Quality of Life
MH  - Surveys and Questionnaires/*standards
MH  - Turkey
EDAT- 2011/02/24 06:00
MHDA- 2012/01/06 06:00
CRDT- 2011/02/24 06:00
PHST- 2011/02/24 06:00 [entrez]
PHST- 2011/02/24 06:00 [pubmed]
PHST- 2012/01/06 06:00 [medline]
AID - 10.5152/akd.2011.037 [doi]
PST - ppublish
SO  - Anadolu Kardiyol Derg. 2011 Mar;11(2):156-62. doi: 10.5152/akd.2011.037. Epub 
      2011 Feb 23.

PMID- 24352924
OWN - NLM
STAT- MEDLINE
DCOM- 20140128
LR  - 20161128
IS  - 1932-149X (Print)
IS  - 1932-149X (Linking)
VI  - 8
IP  - 2
DP  - 2013 Spring
TI  - Is portable ultrasonography accurate in the evaluation of Schanz pin placement 
      during extremity fracture fixation in austere environments?
PG  - 91-6
LID - ajdm.2013.0115 [pii]
LID - 10.5055/ajdm.2013.0115 [doi]
AB  - OBJECTIVE: The purpose of this study was to investigate the efficacy of 
      ultrasonography to confirm Schanz pin placement in a cadaveric model, and the 
      interobserver repeatability of the ultrasound methodology. DESIGN: This 
      investigation is a repeated measures cadaveric study with multiple examiners. 
      PARTICIPANTS: Cadaveric preparation and observations were done by an orthopaedic 
      traumatologist and resident, and two general surgery traumatologists. 
      INTERVENTIONS: A total of 16 Schanz pins were equally placed in bilateral femora 
      and tibiae. Four examiners took measurements of pin protrusion beyond the distal 
      cortices using first ultrasonography and then by direct measurement after gross 
      dissection. MAIN OUTCOME MEASURE(S): Distal Schanz pin protrusion length 
      measurements from both ultrasonography and direct measurement post dissection. 
      RESULTS: Schanz pin protrusion measurements are underestimated by ultrasonography 
      (p < 0.01) by an average of 10 percent over the range of 5 to 18 mm, and they 
      display a proportional bias that increases the under reporting as the magnitude 
      of pin protrusion increases. Ultrasound data demonstrate good linear correlation 
      and closely represent actual protrusion values in the 5 to 12 mm range. 
      Interobserver repeatability analysis demonstrated that all examiners were not 
      statistically different in their measurements despite minimal familiarity with 
      the ultrasound methodology (p > 0.8). CONCLUSIONS: Despite the statistical 
      imparity of pin protrusion measurement via ultrasound compared to that of gross 
      dissection, a consideration of the clinical relevance of ultrasound measurement 
      bias during an austere operating theatre leads to the conclusion that 
      ultrasonography is an adequate methodology for Schanz pin protrusion measurement.
FAU - Dahl, Brian P
AU  - Dahl BP
AD  - Department of Surgery, Division of Orthopaedics and Rehabilitation, Southern 
      Illinois University School of Medicine, Springfield, Illinois.
FAU - Pemberton, Aaron J
AU  - Pemberton AJ
AD  - Department of Surgery, Division of Orthopaedics and Rehabilitation, Southern 
      Illinois University School of Medicine, Springfield, Illinois.
FAU - Beck, Ryan T
AU  - Beck RT
AD  - Department of Surgery, Division of Orthopaedics and Rehabilitation, Southern 
      Illinois University School of Medicine, Springfield, Illinois.
FAU - Cetindag, Bulent
AU  - Cetindag B
AD  - Department of Surgery, Division of General Surgery, Southern Illinois University 
      School of Medicine, Springfield, Illinois.
FAU - Wohltmann, Christopher D
AU  - Wohltmann CD
AD  - Department of Surgery, Division of General Surgery, Southern Illinois University 
      School of Medicine, Springfield, Illinois.
FAU - McAndrew, Mark
AU  - McAndrew M
AD  - Department of Surgery, Division of Orthopaedics and Rehabilitation, Southern 
      Illinois University School of Medicine, Springfield, Illinois.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Am J Disaster Med
JT  - American journal of disaster medicine
JID - 101291100
SB  - IM
MH  - *Bone Nails
MH  - Cadaver
MH  - External Fixators
MH  - Femoral Fractures/*diagnostic imaging/surgery
MH  - *Fracture Fixation
MH  - Humans
MH  - *Point-of-Care Systems
MH  - Reproducibility of Results
MH  - Tibial Fractures/*diagnostic imaging/surgery
MH  - Ultrasonography/*instrumentation
EDAT- 2013/12/20 06:00
MHDA- 2014/01/29 06:00
CRDT- 2013/12/20 06:00
PHST- 2013/12/20 06:00 [entrez]
PHST- 2013/12/20 06:00 [pubmed]
PHST- 2014/01/29 06:00 [medline]
AID - ajdm.2013.0115 [pii]
AID - 10.5055/ajdm.2013.0115 [doi]
PST - ppublish
SO  - Am J Disaster Med. 2013 Spring;8(2):91-6. doi: 10.5055/ajdm.2013.0115.

PMID- 16147837
OWN - NLM
STAT- MEDLINE
DCOM- 20051221
LR  - 20050908
IS  - 1476-7058 (Print)
IS  - 1476-4954 (Linking)
VI  - 17
IP  - 4
DP  - 2005 Apr
TI  - Is grandmultiparity an independent risk factor for adverse perinatal outcomes?
PG  - 277-80
AB  - OBJECTIVE: To compare maternal and neonatal outcomes among grandmultiparous women 
      to those of multiparous women 30 years or older. METHODS: A database of the vast 
      majority of maternal and newborn hospital discharge records linked to birth/death 
      certificates was queried to obtain information on all multiparous women with a 
      singleton delivery in the state of California from January 1, 1997 through 
      December 31, 1998. Maternal and neonatal pregnancy outcomes of grandmultiparous 
      women were compared to multiparous women who were 30 years or older at the time 
      of their last birth. RESULTS: The study population included 25,512 
      grandmultiparous and 265,060 multiparous women 30 years or older as controls. 
      Grandmultiparous women were predominantly Hispanic (56%). After controlling for 
      potential confounding factors, grandmultiparous women were at significantly 
      higher risk for abruptio placentae (odds ratio OR: 1.3; 95% confidence intervals 
      CI: 1.2-1.5), preterm delivery (OR: 1.3; 95% CI: 1.2-1.4), fetal macrosomia (OR: 
      1.5; 95% CI: 1.4-1.6), neonatal death (OR: 1.5; 95% CI: 1.3-1.8), postpartum 
      hemorrhage (OR: 1.2; 95% CI: 1.1-1.3) and blood transfusion (OR: 1.5; 95% CI: 
      1.3-1.8). CONCLUSION: Grandmultiparous women had increased maternal and neonatal 
      morbidity, and neonatal mortality even after controlling for confounders, 
      suggesting a need for closer observation than regular multiparous patients during 
      labor and delivery.
FAU - Yasmeen, Shagufta
AU  - Yasmeen S
AD  - Department of Obstetrics & Gynecology, University of California Davis, USA. 
      shagufta.yasmeen@ucdmc.ucdavis.edu
FAU - Danielsen, Beate
AU  - Danielsen B
FAU - Moshesh, Malana
AU  - Moshesh M
FAU - Gilbert, William M
AU  - Gilbert WM
LA  - eng
PT  - Journal Article
PL  - England
TA  - J Matern Fetal Neonatal Med
JT  - The journal of maternal-fetal & neonatal medicine : the official journal of the 
      European Association of Perinatal Medicine, the Federation of Asia and Oceania 
      Perinatal Societies, the International Society of Perinatal Obstetricians
JID - 101136916
SB  - IM
MH  - Female
MH  - Humans
MH  - *Parity
MH  - Pregnancy
MH  - Pregnancy Complications/*etiology
MH  - *Pregnancy Outcome
MH  - Retrospective Studies
MH  - Risk Factors
EDAT- 2005/09/09 09:00
MHDA- 2005/12/22 09:00
CRDT- 2005/09/09 09:00
PHST- 2005/09/09 09:00 [pubmed]
PHST- 2005/12/22 09:00 [medline]
PHST- 2005/09/09 09:00 [entrez]
AID - R1106075L7W9073R [pii]
AID - 10.1080/14767050500123798 [doi]
PST - ppublish
SO  - J Matern Fetal Neonatal Med. 2005 Apr;17(4):277-80. doi: 
      10.1080/14767050500123798.

PMID- 26879871
OWN - NLM
STAT- MEDLINE
DCOM- 20161220
LR  - 20221207
IS  - 1469-8978 (Electronic)
IS  - 0033-2917 (Print)
IS  - 0033-2917 (Linking)
VI  - 46
IP  - 6
DP  - 2016 Apr
TI  - Does depression diagnosis and antidepressant prescribing vary by location? 
      Analysis of ethnic density associations using a large primary-care dataset.
PG  - 1321-9
LID - 10.1017/S0033291715002913 [doi]
AB  - BACKGROUND: Studies have linked ethnic differences in depression rates with 
      neighbourhood ethnic density although results have not been conclusive. We looked 
      at this using a novel approach analysing whole population data covering just over 
      one million GP patients in four London boroughs. METHOD: Using a dataset of GP 
      records for all patients registered in Lambeth, Hackney, Tower Hamlets and Newham 
      in 2013 we investigated new diagnoses of depression and antidepressant use for: 
      Indian, Pakistani, Bangladeshi, black Caribbean and black African patients. 
      Neighbourhood effects were assessed independently of GP practice using a 
      cross-classified multilevel model. RESULTS: Black and minority ethnic groups are 
      up to four times less likely to be newly diagnosed with depression or prescribed 
      antidepressants compared to white British patients. We found an inverse 
      relationship between neighbourhood ethnic density and new depression diagnosis 
      for some groups, where an increase of 10% own-ethnic density was associated with 
      a statistically significant (p < 0.05) reduced odds of depression for Pakistani 
      [odds ratio (OR) 0.81, 95% confidence interval (CI) 0.70-0.93], Indian (OR 0.88, 
      CI 0.81-0.95), African (OR 0.88, CI 0.78-0.99) and Bangladeshi (OR 0.94, CI 
      0.90-0.99) patients. Black Caribbean patients, however, showed the opposite 
      effect (OR 1.26, CI 1.09-1.46). The results for antidepressant use were very 
      similar although the corresponding effect for black Caribbeans was no longer 
      statistically significant (p = 0.07). CONCLUSION: New depression diagnosis and 
      antidepressant use was shown to be less likely in areas of higher own-ethnic 
      density for some, but not all, ethnic groups.
FAU - Schofield, P
AU  - Schofield P
AD  - Division of Health & Social Care Research,Faculty of Life Sciences & 
      Medicine,King's College London,Addison House,Guy's Campus,London,UK.
FAU - Das-Munshi, J
AU  - Das-Munshi J
AD  - Institute of Psychiatry, Psychology & Neuroscience,King's College London,UK.
FAU - Mathur, R
AU  - Mathur R
AD  - Centre for Primary Care and Public Health,Queen Mary University of London,UK.
FAU - Congdon, P
AU  - Congdon P
AD  - Centre for Primary Care and Public Health,Queen Mary University of London,UK.
FAU - Hull, S
AU  - Hull S
AD  - Centre for Primary Care and Public Health,Queen Mary University of London,UK.
LA  - eng
GR  - MR/K021494/1/MRC_/Medical Research Council/United Kingdom
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160216
PL  - England
TA  - Psychol Med
JT  - Psychological medicine
JID - 1254142
RN  - 0 (Antidepressive Agents)
SB  - IM
MH  - Adult
MH  - Antidepressive Agents/*therapeutic use
MH  - Black People
MH  - Datasets as Topic
MH  - Depressive Disorder/*drug therapy/*ethnology
MH  - Drug Prescriptions/*statistics & numerical data
MH  - Ethnicity/*statistics & numerical data
MH  - Female
MH  - Humans
MH  - London/ethnology
MH  - Male
MH  - Middle Aged
MH  - Primary Health Care
MH  - Regression Analysis
MH  - Residence Characteristics
MH  - White People
MH  - Young Adult
PMC - PMC4828938
OTO - NOTNLM
OT  - Antidepressants
OT  - depression
OT  - ethnicity
EDAT- 2016/02/18 06:00
MHDA- 2016/12/21 06:00
PMCR- 2016/04/12
CRDT- 2016/02/17 06:00
PHST- 2016/02/17 06:00 [entrez]
PHST- 2016/02/18 06:00 [pubmed]
PHST- 2016/12/21 06:00 [medline]
PHST- 2016/04/12 00:00 [pmc-release]
AID - S0033291715002913 [pii]
AID - 00291 [pii]
AID - 10.1017/S0033291715002913 [doi]
PST - ppublish
SO  - Psychol Med. 2016 Apr;46(6):1321-9. doi: 10.1017/S0033291715002913. Epub 2016 Feb 
      16.

PMID- 15918864
OWN - NLM
STAT- MEDLINE
DCOM- 20050830
LR  - 20151119
IS  - 0730-7659 (Print)
IS  - 0730-7659 (Linking)
VI  - 32
IP  - 2
DP  - 2005 Jun
TI  - Learning needs of postpartum women: does socioeconomic status matter?
PG  - 86-92
AB  - BACKGROUND: Little is known about how information needs change over time in the 
      early postpartum period or about how these needs might differ given socioeconomic 
      circumstances. This study's aim was to examine women's concerns at the time of 
      hospital discharge and unmet learning needs as self-identified at 4 weeks after 
      discharge. METHODS: Data were collected as part of a cross-sectional survey of 
      postpartum health outcomes, service use, and costs of care in the first 4 weeks 
      after postpartum hospital discharge. Recruitment of 250 women was conducted from 
      each of 5 hospitals in Ontario, Canada (n = 1,250). Women who had given vaginal 
      birth to a single live infant, and who were being discharged at the same time as 
      their infant, assuming care of their infant, competent to give consent, and able 
      to communicate in one of the study languages were eligible. Participants 
      completed a self-report questionnaire in hospital; 890 (71.2%) took part in a 
      structured telephone interview 4 weeks after hospital discharge. RESULTS: 
      Approximately 17 percent of participants were of low socioeconomic status. 
      Breastfeeding and signs of infant illness were the most frequently identified 
      concerns by women, regardless of their socioeconomic status. Signs of infant 
      illness and infant care/behavior were the main unmet learning needs. Although few 
      differences in identified concerns were evident, women of low socioeconomic 
      status were significantly more likely to report unmet learning needs related to 9 
      of 10 topics compared with women of higher socioeconomic status. For most topics, 
      significantly more women of both groups identified learning needs 4 weeks after 
      discharge compared with the number who identified corresponding concerns while in 
      hospital. CONCLUSIONS: It is important to ensure that new mothers are adequately 
      informed about topics important to them while in hospital. The findings highlight 
      the need for accessible and appropriate community-based information resources for 
      women in the postpartum period, especially for those of low socioeconomic status.
FAU - Sword, Wendy
AU  - Sword W
AD  - School of Nursing, McMaster University, Hamilton, Ontario, Canada.
FAU - Watt, Susan
AU  - Watt S
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Birth
JT  - Birth (Berkeley, Calif.)
JID - 8302042
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - *Attitude to Health
MH  - *Breast Feeding
MH  - Female
MH  - Humans
MH  - Ontario
MH  - *Patient Education as Topic
MH  - *Postpartum Period
MH  - *Socioeconomic Factors
MH  - Surveys and Questionnaires
MH  - Time Factors
EDAT- 2005/05/28 09:00
MHDA- 2005/09/01 09:00
CRDT- 2005/05/28 09:00
PHST- 2005/05/28 09:00 [pubmed]
PHST- 2005/09/01 09:00 [medline]
PHST- 2005/05/28 09:00 [entrez]
AID - BIR350 [pii]
AID - 10.1111/j.0730-7659.2005.00350.x [doi]
PST - ppublish
SO  - Birth. 2005 Jun;32(2):86-92. doi: 10.1111/j.0730-7659.2005.00350.x.

PMID- 22075911
OWN - NLM
STAT- MEDLINE
DCOM- 20120327
LR  - 20161125
IS  - 1476-5373 (Electronic)
IS  - 0007-0610 (Linking)
VI  - 211
IP  - 9
DP  - 2011 Nov 11
TI  - Is there a differential in the dental health of new recruits to the British Armed 
      Forces? A pilot study.
PG  - E18
LID - 10.1038/sj.bdj.2011.937 [doi]
AB  - BACKGROUND AND AIM: Figures from the British Defence Dental Services reveal that 
      serving personnel in the British Army have a persistently lower level of dental 
      fitness than those in the Royal Navy or the Royal Air Force. No research had been 
      undertaken to ascertain if this reflects the oral health of recruits joining each 
      Service. This study aimed to pilot a process for collecting dental and 
      sociodemographic data from new recruits to each Service and examine the null 
      hypothesis that no differences in dental health existed. METHOD: Diagnostic 
      criteria were developed, a sample size calculated and data collected at the 
      initial training establishments of each Service. RESULTS: Data for 432 
      participants were entered into the analysis. Recruits in the Army sample had a 
      significantly greater prevalence of dental decay and greater treatment resource 
      need than either of the other two Services. Army recruits had a mean number of 
      2.59 (2.08, 3.09) decayed teeth per recruit, compared to 1.93 (1.49, 2.39 p 
      <0.01) in Royal Navy recruits and 1.26 (0.98, 1.53 p <0.001) in Royal Air Force 
      recruits. Among Army recruits 62.7% were from the two most deprived quintiles of 
      the Index of Multiple Deprivation compared to 42.5% of Royal Naval recruits and 
      36.6% of Royal Air Force recruits. CONCLUSION: A significant difference in dental 
      health between recruits to each Service does exist and is a likely to be a 
      reflection of the sociodemographic background from which they are drawn.
FAU - Elmer, T B
AU  - Elmer TB
AD  - West Midlands Strategic Health Authority, St Chad's Court, 213 Hagley Road, 
      Birmingham, B16 9RG. tim.elmer@southstaffspct.nhs.uk
FAU - Langford, J
AU  - Langford J
FAU - McCormick, R
AU  - McCormick R
FAU - Morris, A J
AU  - Morris AJ
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20111111
PL  - England
TA  - Br Dent J
JT  - British dental journal
JID - 7513219
SB  - IM
CIN - Br Dent J. 2011 Nov 11;211(9):424-5. doi: 10.1038/sj.bdj.2011.910. PMID: 22075887
MH  - Adolescent
MH  - Cross-Sectional Studies
MH  - DMF Index
MH  - Dental Caries/*epidemiology
MH  - Female
MH  - *Health Status Disparities
MH  - Humans
MH  - Male
MH  - Military Dentistry/*statistics & numerical data
MH  - *Military Personnel/statistics & numerical data
MH  - *Oral Health
MH  - Pilot Projects
MH  - Prevalence
MH  - Smoking/epidemiology
MH  - Statistics, Nonparametric
MH  - United Kingdom/epidemiology
MH  - Young Adult
EDAT- 2011/11/15 06:00
MHDA- 2012/03/28 06:00
CRDT- 2011/11/15 06:00
PHST- 2011/08/24 00:00 [accepted]
PHST- 2011/11/15 06:00 [entrez]
PHST- 2011/11/15 06:00 [pubmed]
PHST- 2012/03/28 06:00 [medline]
AID - sj.bdj.2011.937 [pii]
AID - 10.1038/sj.bdj.2011.937 [doi]
PST - epublish
SO  - Br Dent J. 2011 Nov 11;211(9):E18. doi: 10.1038/sj.bdj.2011.937.

PMID- 11035130
OWN - NLM
STAT- MEDLINE
DCOM- 20001130
LR  - 20190513
IS  - 1462-0324 (Print)
IS  - 1462-0324 (Linking)
VI  - 39
IP  - 10
DP  - 2000 Oct
TI  - Do patients with rheumatoid arthritis established on methotrexate and folic acid 
      5 mg daily need to continue folic acid supplements long term?
PG  - 1102-9
AB  - BACKGROUND: It is postulated that some aspects of methotrexate toxicity may be 
      related to its action as an anti-folate. Folic acid (FA) is often given as an 
      adjunct to methotrexate therapy, but there is no conclusive proof that it 
      decreases the toxicity of methotrexate and there is a theoretical risk that it 
      may decrease the efficacy of methotrexate. OBJECTIVES: To look at the effect of 
      stopping FA supplementation in UK rheumatoid arthritis (RA) patients established 
      on methotrexate <20 mg weekly and FA 5 mg daily, to report all toxicity 
      (including absolute changes in haematological and liver enzyme indices) and to 
      report changes in the efficacy of methotrexate. METHODS: In a prospective, 
      randomized, double-blind, placebo-controlled study, 75 patients who were 
      established on methotrexate <20 mg weekly and FA 5 mg daily were asked to stop 
      their FA and were randomized to one of two groups: placebo or FA 5 mg daily. 
      Patients were evaluated for treatment toxicity and efficacy before entry and then 
      at intervals of 3 months for 1 yr. RESULTS: Overall, 25 (33%) patients concluded 
      the study early, eight (21%) in the group remaining on FA and 17 (46%) in the 
      placebo group (P = 0.02). Two patients in the placebo group discontinued because 
      of neutropenia. At 9 months there was an increased incidence of nausea in the 
      placebo group (45 vs. 7%, P = 0.001). The placebo group had significantly lower 
      disease activity on a few of the variables measured, but these were probably not 
      of clinical significance. CONCLUSIONS: It is important to continue FA 
      supplementation over the long term in patients on methotrexate and FA in order to 
      prevent them discontinuing treatment because of mouth ulcers or nausea and 
      vomiting. Our data suggest that FA supplementation is also helpful in preventing 
      neutropenia, with very little loss of efficacy of methotrexate.
FAU - Griffith, S M
AU  - Griffith SM
AD  - Department of Rheumatology, East Surrey Hospital, Surrey, UK.
FAU - Fisher, J
AU  - Fisher J
FAU - Clarke, S
AU  - Clarke S
FAU - Montgomery, B
AU  - Montgomery B
FAU - Jones, P W
AU  - Jones PW
FAU - Saklatvala, J
AU  - Saklatvala J
FAU - Dawes, P T
AU  - Dawes PT
FAU - Shadforth, M F
AU  - Shadforth MF
FAU - Hothersall, T E
AU  - Hothersall TE
FAU - Hassell, A B
AU  - Hassell AB
FAU - Hay, E M
AU  - Hay EM
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
PT  - Randomized Controlled Trial
PL  - England
TA  - Rheumatology (Oxford)
JT  - Rheumatology (Oxford, England)
JID - 100883501
RN  - 0 (Antirheumatic Agents)
RN  - 935E97BOY8 (Folic Acid)
RN  - YL5FZ2Y5U1 (Methotrexate)
SB  - IM
CIN - Rheumatology (Oxford). 2001 Jun;40(6):715-6. doi: 10.1093/rheumatology/40.6.715. 
      PMID: 11426040
MH  - Aged
MH  - Antirheumatic Agents/adverse effects/*therapeutic use
MH  - Arthritis, Rheumatoid/*drug therapy
MH  - Double-Blind Method
MH  - Drug Administration Schedule
MH  - Female
MH  - Folic Acid/*administration & dosage/adverse effects/therapeutic use
MH  - Humans
MH  - Male
MH  - Methotrexate/adverse effects/*therapeutic use
MH  - Middle Aged
MH  - Prospective Studies
MH  - Treatment Outcome
EDAT- 2000/10/18 11:00
MHDA- 2001/02/28 10:01
CRDT- 2000/10/18 11:00
PHST- 2000/10/18 11:00 [pubmed]
PHST- 2001/02/28 10:01 [medline]
PHST- 2000/10/18 11:00 [entrez]
AID - 10.1093/rheumatology/39.10.1102 [doi]
PST - ppublish
SO  - Rheumatology (Oxford). 2000 Oct;39(10):1102-9. doi: 
      10.1093/rheumatology/39.10.1102.

PMID- 21228436
OWN - NLM
STAT- MEDLINE
DCOM- 20110725
LR  - 20191210
IS  - 2044-5423 (Electronic)
IS  - 2044-5415 (Linking)
VI  - 20
IP  - 4
DP  - 2011 Apr
TI  - Can teaching medical students to investigate medication errors change their 
      attitudes towards patient safety?
PG  - 319-25
LID - 10.1136/bmjqs.2010.041376 [doi]
AB  - BACKGROUND: The purpose of this study was to evaluate the impact of a 
      patient-safety curriculum administered during a paediatric clerkship on medical 
      students' attitudes towards patient safety. METHODS: Medical students viewed an 
      online video introducing them to systems-based analyses of medical errors. 
      Faculty presented an example of a medication administration error and 
      demonstrated use of the Learning From Defects tool to investigate the defect. 
      Student groups identified and then analysed medication errors during their 
      clinical rotation using the Learning From Defects framework to organise and 
      present their findings. Outcomes included patient safety attitudinal changes, as 
      measured by questions derived from the Safety Attitudes Questionnaire. RESULTS: 
      108 students completed the curriculum between July 2008 and July 2009. All 
      student groups (25 total) identified, analysed and presented patient safety 
      concerns. Curriculum effectiveness was demonstrated by significant changes on 
      questionnaire items related to patient safety attitudes. The majority of students 
      felt that the curriculum was relevant to their clinical rotation and should 
      remain part of the clerkship. CONCLUSIONS: An active learning curriculum 
      integrated into a clinical clerkship can change learners' attitudes towards 
      patient safety. Students found the curriculum relevant and recommended its 
      continuation.
FAU - Dudas, Robert A
AU  - Dudas RA
AD  - Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA. 
      rdudas@jhmi.edu
FAU - Bundy, David G
AU  - Bundy DG
FAU - Miller, Marlene R
AU  - Miller MR
FAU - Barone, Michael
AU  - Barone M
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
DEP - 20110112
PL  - England
TA  - BMJ Qual Saf
JT  - BMJ quality & safety
JID - 101546984
MH  - *Attitude of Health Personnel
MH  - *Clinical Clerkship
MH  - *Curriculum
MH  - Humans
MH  - Medication Errors/*prevention & control
MH  - Pediatrics/*education
MH  - Program Evaluation
MH  - Safety Management
MH  - Students, Medical/*psychology
MH  - Surveys and Questionnaires
EDAT- 2011/01/14 06:00
MHDA- 2011/07/26 06:00
CRDT- 2011/01/14 06:00
PHST- 2011/01/14 06:00 [entrez]
PHST- 2011/01/14 06:00 [pubmed]
PHST- 2011/07/26 06:00 [medline]
AID - bmjqs.2010.041376 [pii]
AID - 10.1136/bmjqs.2010.041376 [doi]
PST - ppublish
SO  - BMJ Qual Saf. 2011 Apr;20(4):319-25. doi: 10.1136/bmjqs.2010.041376. Epub 2011 
      Jan 12.

PMID- 11833948
OWN - NLM
STAT- MEDLINE
DCOM- 20020301
LR  - 20181130
IS  - 0028-8446 (Print)
IS  - 0028-8446 (Linking)
VI  - 114
IP  - 1145
DP  - 2001 Dec 14
TI  - Does a delay in transfer to a rehabilitation unit for older people affect outcome 
      after fracture of the proximal femur?
PG  - 547-9
AB  - AIMS: To detemine the relationship between delay in transfer to rehabilitation 
      wards and outcome for patients aged over 75 years with fracture of the proximal 
      femur. METHODS: An observational study in a district general hospital of all 
      patients admitted to hospital aged over 75 years with fracture of the proximal 
      femur over 3 1/2 years. Outcome data collected included the number of patients 
      discharged back to their usual residence and total hospital length of stay 
      related to age, gender, usual residence and delay in transfer to a rehabilitation 
      ward. RESULTS: 58% of 455 patients were transferred to a rehabilitation ward. For 
      those patients who were transferred to a rehabilitation ward only age predicted 
      discharge to a more dependent residence. The relative risk for discharge to a 
      more dependent residence for people aged over 85 years compared to younger people 
      was 1.47 (95% CI 1.15-1.88). Delay in transfer to rehabilitation was associated 
      with a longer total hospital length of stay of 0.64 (95% CI 0.23-1.05) days per 
      day of delay in transfer. CONCLUSIONS: Delay in transfer to a rehabilitation ward 
      was associated with a disproportionate increase in total hospital length of stay 
      for patients aged over 75 with fracture of the proximal femur.
FAU - Weatherall, M
AU  - Weatherall M
AD  - Department of Medicine, Wellington School of Medicine, Wellington South. 
      markw@wnmeds.ac.nz
LA  - eng
PT  - Journal Article
PL  - New Zealand
TA  - N Z Med J
JT  - The New Zealand medical journal
JID - 0401067
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Female
MH  - Femoral Neck Fractures/*rehabilitation
MH  - Hospital Units/*statistics & numerical data
MH  - Humans
MH  - Length of Stay/*statistics & numerical data
MH  - Logistic Models
MH  - Male
MH  - *Patient Transfer
MH  - Rehabilitation Centers/*statistics & numerical data
MH  - Risk Factors
MH  - Time Factors
EDAT- 2002/02/09 10:00
MHDA- 2002/03/02 10:01
CRDT- 2002/02/09 10:00
PHST- 2002/02/09 10:00 [pubmed]
PHST- 2002/03/02 10:01 [medline]
PHST- 2002/02/09 10:00 [entrez]
PST - ppublish
SO  - N Z Med J. 2001 Dec 14;114(1145):547-9.

PMID- 17682349
OWN - NLM
STAT- MEDLINE
DCOM- 20071108
LR  - 20221207
IS  - 1049-510X (Print)
IS  - 1049-510X (Linking)
VI  - 17
IP  - 2
DP  - 2007 Spring
TI  - Are there gender differences in the reasons why African Americans delay in 
      seeking medical help for symptoms of an acute myocardial infarction?
PG  - 221-7
AB  - OBJECTIVES: To identify gender differences in delay time and the reasons why 
      African Americans delay in seeking medical care for symptoms of acute myocardial 
      infarction (AMI). DESIGN: Cross-sectional. SETTING: Five hospitals in the San 
      Francisco and East Bay areas. PATIENTS: Sixty-one African American men and women 
      diagnosed with an AMI. MAIN OUTCOME MEASURES: Prehospital delay time. RESULTS: 
      Median delay time was longer for women compared to men (4.4 hours vs 3.5 hours), 
      although the difference was not significant. Single women delayed longer than 
      single men (P = .03), and women who were alone when symptoms began delayed longer 
      than women with someone (P = .03). Women who received advice to seek help or call 
      911 upon symptom onset had shorter delays compared to women who were not advised 
      to call 911 (P = .01). Men at home delayed longer than men who experienced their 
      symptoms outside the home (P = .01). Men with emergency room insurance delayed 
      longer than men without emergency room insurance (P = .03), and men who took an 
      ambulance to the hospital had shorter delay times than men who took other means 
      of transportation (P = .04). CONCLUSION: Women compared to men often delay 
      seeking treatment for an AMI, which further increases their risks. Our findings 
      suggest specific characteristics that can serve as a profile to those African 
      Americans most likely to delay seeking treatment for AMI.
FAU - Banks, Angela D
AU  - Banks AD
AD  - University of San Francisco, Department of Adult Health, San Francisco, 
      California, USA. adbanks@usfca.edu
FAU - Dracup, Kathleen
AU  - Dracup K
LA  - eng
GR  - 1 R25 GM56847/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Ethn Dis
JT  - Ethnicity & disease
JID - 9109034
SB  - IM
MH  - Acute Disease
MH  - Adult
MH  - *Black or African American
MH  - Aged
MH  - Aged, 80 and over
MH  - Female
MH  - Health Services Needs and Demand
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Myocardial Infarction/physiopathology
MH  - *Patient Acceptance of Health Care
MH  - San Francisco
MH  - Surveys and Questionnaires
MH  - Time Factors
EDAT- 2007/08/09 09:00
MHDA- 2007/11/09 09:00
CRDT- 2007/08/09 09:00
PHST- 2007/08/09 09:00 [pubmed]
PHST- 2007/11/09 09:00 [medline]
PHST- 2007/08/09 09:00 [entrez]
PST - ppublish
SO  - Ethn Dis. 2007 Spring;17(2):221-7.

PMID- 17355582
OWN - NLM
STAT- MEDLINE
DCOM- 20070405
LR  - 20220311
IS  - 0017-9124 (Print)
IS  - 0017-9124 (Linking)
VI  - 42
IP  - 1 Pt 1
DP  - 2007 Feb
TI  - Does ambulatory process of care predict health-related quality of life outcomes 
      for patients with chronic disease?
PG  - 63-83
AB  - OBJECTIVE: The validity of quality of care measurement has important implications 
      for practicing clinicians, their patients, and all involved with health care 
      delivery. We used empirical data from managed care patients enrolled in west 
      coast physician organizations to test the hypothesis that observed changes in 
      health-related quality of life across a 2.5-year window reflecting process of 
      care. DATA SOURCES/STUDY SETTING: Patient self-report data as well as clinically 
      detailed medical record review regarding 963 patients with chronic disease 
      associated with managed care from three west coast states. STUDY DESIGN: 
      Prospective cohort study of change in health-related quality of life scores 
      across 30 months as measured by change in SF-12 physical component scores. DATA 
      COLLECTION/EXTRACTION METHODS: Patient self-report and medical record 
      abstraction. PRINCIPAL FINDINGS: We found a positive relationship between better 
      process scores and higher burden of illness (p<.05). After adjustment for burden 
      of illness, using an instrumental variables approach revealed better process is 
      associated with smaller declines in SF-12 scores across a 30-month observation 
      window (p=.014). The application of the best quartile of process of care to 
      patients currently receiving poor process is associated with a 4.24 increment in 
      delta SF-12-physical component summary scores. CONCLUSIONS: The use of 
      instrumental variables allowed us to demonstrate a significant relationship 
      between better ambulatory process of care and better health-related quality of 
      life. This finding underscores the importance of efforts to improve the process 
      of care.
FAU - Kahn, Katherine L
AU  - Kahn KL
AD  - Department of Medicine, University of California at Los Angeles, Division of 
      General Internal Medicine and Health Services Research, 911 Broxton Plaza, Box 
      951736, Los Angeles, CA 90095-1736, USA.
FAU - Tisnado, Diana M
AU  - Tisnado DM
FAU - Adams, John L
AU  - Adams JL
FAU - Liu, Honghu
AU  - Liu H
FAU - Chen, Wen-Pin
AU  - Chen WP
FAU - Hu, Fang Ashlee
AU  - Hu FA
FAU - Mangione, Carol M
AU  - Mangione CM
FAU - Hays, Ronald D
AU  - Hays RD
FAU - Damberg, Cheryl L
AU  - Damberg CL
LA  - eng
GR  - T32 HS000046/HS/AHRQ HHS/United States
GR  - T32-HS00046/HS/AHRQ HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - Health Serv Res
JT  - Health services research
JID - 0053006
SB  - IM
MH  - Aged
MH  - Chronic Disease/*therapy
MH  - Female
MH  - Health Status
MH  - Humans
MH  - Male
MH  - Managed Care Programs/organization & administration
MH  - Middle Aged
MH  - Outcome and Process Assessment, Health Care/*organization & administration
MH  - Prospective Studies
MH  - Quality of Health Care/*organization & administration
MH  - *Quality of Life
PMC - PMC1955244
EDAT- 2007/03/16 09:00
MHDA- 2007/04/06 09:00
PMCR- 2009/02/01
CRDT- 2007/03/16 09:00
PHST- 2007/03/16 09:00 [pubmed]
PHST- 2007/04/06 09:00 [medline]
PHST- 2007/03/16 09:00 [entrez]
PHST- 2009/02/01 00:00 [pmc-release]
AID - HESR604 [pii]
AID - 10.1111/j.1475-6773.2006.00604.x [doi]
PST - ppublish
SO  - Health Serv Res. 2007 Feb;42(1 Pt 1):63-83. doi: 
      10.1111/j.1475-6773.2006.00604.x.

PMID- 15597845
OWN - NLM
STAT- MEDLINE
DCOM- 20050310
LR  - 20200929
IS  - 0392-2936 (Print)
IS  - 0392-2936 (Linking)
VI  - 25
IP  - 6
DP  - 2004
TI  - Is the combination with 2-methoxyestradiol able to reduce the dosages of 
      chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro 
      investigations.
PG  - 699-701
AB  - PURPOSE OF INVESTIGATION: The endogenous estradiol metabolite, 2-methoxyestradiol 
      (2ME), has been shown to be a potent inhibitor of cell growth and a strong 
      anti-angiogenic substance. We investigated for the first time whether in vitro 
      combinations of 2ME with various chemotherapeutic compounds may result in an 
      additive inhibitory effect on the proliferation of human ovary cancer cells. 
      METHOD: As a model two different human ovary cancer cell lines were used. All 
      cell lines were incubated with equimolar concentrations of 2ME (0.8-25 microM) 
      and the chemotherapeutics epirubicine, doxorubicine, paclitaxel, docetaxel, 
      carboplatin, vinorelbine, 5-fluorouracil and mafosfamide. Proliferation was 
      measured after four days using the ATP-chemosensitivity test. RESULTS: For both 
      ovary cancer cell lines a significant additive effect of 2ME with epirubicine and 
      carboplatin was observed at the lower concentration range of these 
      chemotherapeutic substances. CONCLUSION: 2ME is able to enhance the 
      antiproliferative activity of certain chemotherapeutics at pharmacological 
      relevant concentrations. This estradiol metabolite is currently in a phase II 
      trial in patients with refractary metastatic breast cancer and the tolerability 
      has been shown to be very good. The combination of 2ME with chemotherapeutics may 
      therefore offer a new clinically relevant treatment regimen for hormone-dependent 
      cancer.
FAU - Mueck, A O
AU  - Mueck AO
AD  - Section of Endocrinology and Menopause, University Women's Hospital, Tuebingen, 
      Germany.
FAU - Seeger, H
AU  - Seeger H
FAU - Wallwiener, D
AU  - Wallwiener D
FAU - Huober, J
AU  - Huober J
LA  - eng
PT  - Journal Article
PL  - Singapore
TA  - Eur J Gynaecol Oncol
JT  - European journal of gynaecological oncology
JID - 8100357
RN  - 0 (Taxoids)
RN  - 15H5577CQD (Docetaxel)
RN  - 3Z8479ZZ5X (Epirubicin)
RN  - 4TI98Z838E (Estradiol)
RN  - 5970HH9923 (mafosfamide)
RN  - 5V9KLZ54CY (Vinblastine)
RN  - 6I2QW73SR5 (2-Methoxyestradiol)
RN  - 80168379AG (Doxorubicin)
RN  - 8N3DW7272P (Cyclophosphamide)
RN  - BG3F62OND5 (Carboplatin)
RN  - P88XT4IS4D (Paclitaxel)
RN  - Q6C979R91Y (Vinorelbine)
RN  - U3P01618RT (Fluorouracil)
SB  - IM
MH  - 2-Methoxyestradiol
MH  - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
MH  - Carboplatin/administration & dosage/pharmacology
MH  - Cell Line, Tumor/drug effects
MH  - Cell Proliferation/drug effects
MH  - Cyclophosphamide/administration & dosage/*analogs & derivatives/pharmacology
MH  - Docetaxel
MH  - Dose-Response Relationship, Drug
MH  - Doxorubicin/administration & dosage/pharmacology
MH  - Drug Administration Schedule
MH  - Epirubicin/administration & dosage/pharmacology
MH  - Estradiol/administration & dosage/*analogs & 
      derivatives/*pharmacology/therapeutic use
MH  - Female
MH  - Fluorouracil/administration & dosage/pharmacology
MH  - Humans
MH  - Ovarian Neoplasms/drug therapy/pathology
MH  - Paclitaxel/administration & dosage/pharmacology
MH  - Taxoids/administration & dosage/pharmacology
MH  - Vinblastine/administration & dosage/*analogs & derivatives/pharmacology
MH  - Vinorelbine
EDAT- 2004/12/16 09:00
MHDA- 2005/03/11 09:00
CRDT- 2004/12/16 09:00
PHST- 2004/12/16 09:00 [pubmed]
PHST- 2005/03/11 09:00 [medline]
PHST- 2004/12/16 09:00 [entrez]
PST - ppublish
SO  - Eur J Gynaecol Oncol. 2004;25(6):699-701.

PMID- 10158597
OWN - NLM
STAT- MEDLINE
DCOM- 19960815
LR  - 20241219
IS  - 0963-8172 (Print)
IS  - 0963-8172 (Linking)
VI  - 5
IP  - 2
DP  - 1996 Jun
TI  - Does a dedicated discharge coordinator improve the quality of hospital discharge?
PG  - 89-96
AB  - OBJECTIVE: To evaluate the effectiveness of the role of a discharge coordinator 
      whose sole responsibility was to plan and coordinate the discharge of patients 
      from medical wards. DESIGN: An intervention study in which the quality of 
      discharge planning was assessed before and after the introduction of a discharge 
      coordinator. Patients were interviewed on the ward before discharge and seven to 
      10 days after being discharged home. SETTING: The three medical wards at the 
      Homerton Hospital in Hackney, East London. PATIENTS: 600 randomly sampled adult 
      patients admitted to the medical wards of the study hospital, who were resident 
      in the district (but not in institutions), were under the care of physicians 
      (excluding psychiatry), and were discharged home from one of the medical wards. 
      The sampling was conducted in three study phases, over 18 months. INTERVENTIONS: 
      Phase I comprised base line data collection; in phase II data were collected 
      after the introduction of the district discharge planning policy and a discharge 
      form (checklist) for all patients; in phase III data were collected after the 
      introduction of the discharge coordinator. MAIN MEASURES: The quality and out 
      come of discharge planning. Readmission rates, duration of stay, appropriateness 
      of days of care, patients' health and satisfaction, problems after discharge, and 
      receipt of services. RESULTS: The discharge coordinator resulted in an improved 
      discharge planning process, and there was a reduction in problems experienced by 
      patients after discharge, and in perceived need for medical and healthcare 
      services. There was no evidence that the discharge coordinator resulted in a more 
      timely or effective provision of community services after discharge, or that the 
      appropriateness or efficiency of bed use was improved. CONCLUSIONS: The 
      introduction of a discharge coordinator improved the quality of discharge 
      planning, but at additional cost.
FAU - Houghton, A
AU  - Houghton A
AD  - Research Unit, Royal College of Physicians, London, UK.
FAU - Bowling, A
AU  - Bowling A
FAU - Clarke, K D
AU  - Clarke KD
FAU - Hopkins, A P
AU  - Hopkins AP
FAU - Jones, I
AU  - Jones I
LA  - eng
GR  - Wellcome Trust/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - Qual Health Care
JT  - Quality in health care : QHC
JID - 9209948
MH  - Activities of Daily Living
MH  - Health Status Indicators
MH  - Humans
MH  - Length of Stay
MH  - London
MH  - Patient Discharge/*standards
MH  - Patient Readmission
MH  - Patient Satisfaction/*statistics & numerical data
MH  - Program Evaluation
MH  - Quality Assurance, Health Care/*organization & administration/statistics & 
      numerical data
MH  - Social Work/*organization & administration
MH  - State Medicine/organization & administration/standards
PMC - PMC1055371
EDAT- 1996/05/07 00:00
MHDA- 1996/05/07 00:01
PMCR- 1996/06/01
CRDT- 1996/05/07 00:00
PHST- 1996/05/07 00:00 [pubmed]
PHST- 1996/05/07 00:01 [medline]
PHST- 1996/05/07 00:00 [entrez]
PHST- 1996/06/01 00:00 [pmc-release]
AID - 10.1136/qshc.5.2.89 [doi]
PST - ppublish
SO  - Qual Health Care. 1996 Jun;5(2):89-96. doi: 10.1136/qshc.5.2.89.

PMID- 27549226
OWN - NLM
STAT- MEDLINE
DCOM- 20171018
LR  - 20240325
IS  - 1478-4491 (Electronic)
IS  - 1478-4491 (Linking)
VI  - 14
IP  - 1
DP  - 2016 Aug 22
TI  - Impact of MPH programs: contributing to health system strengthening in low- and 
      middle-income countries?
PG  - 52
LID - 10.1186/s12960-016-0150-7 [doi]
LID - 52
AB  - BACKGROUND: The "health workforce" crisis has led to an increased interest in 
      health professional education, including MPH programs. Recently, it was 
      questioned whether training of mid- to higher level cadres in public health 
      prepared graduates with competencies to strengthen health systems in low- and 
      middle-income countries. Measuring educational impact has been notoriously 
      difficult; therefore, innovative methods for measuring the outcome and impact of 
      MPH programs were sought. Impact was conceptualized as "impact on workplace" and 
      "impact on society," which entailed studying how these competencies were enacted 
      and to what effect within the context of the graduates' workplaces, as well as on 
      societal health. METHODS: This is part of a larger six-country mixed method 
      study; in this paper, the focus is on the qualitative findings of two English 
      language programs, one a distance MPH program offered from South Africa, the 
      other a residential program in the Netherlands. Both offer MPH training to 
      students from a diversity of countries. In-depth interviews were conducted with 
      10 graduates (per program), working in low- and middle-income health systems, 
      their peers, and their supervisors. RESULTS: Impact on the workplace was reported 
      as considerable by graduates and peers as well as supervisors and included 
      changes in management and leadership: promotion to a leadership position as well 
      as expanded or revitalized management roles were reported by many participants. 
      The development of leadership capacity was highly valued amongst many graduates, 
      and this capacity was cited by a number of supervisors and peers. Wider impact in 
      the workplace took the form of introducing workplace innovations such as setting 
      up an AIDS and addiction research center and research involvement; teaching and 
      training, advocacy, and community engagement were other ways in which graduates' 
      influence reached a wider target grouping. Beyond the workplace, an intersectoral 
      approach, national reach through policy advisory roles to Ministries of Health, 
      policy development, and capacity building, was reported. Work conditions and 
      context influenced conduciveness for innovation and the extent to which graduates 
      were able to have effect. Self-selection of graduates and their role in selecting 
      peers and supervisors may have resulted in some bias, some graduates could not be 
      traced, and social acceptability bias may have influenced findings. CONCLUSIONS: 
      There was considerable impact at many levels; graduates were perceived to be able 
      to contribute significantly to their workplaces and often had influence at the 
      national level. Much of the impact described was in line with public health 
      educational aims. The qualitative method study revealed more in-depth 
      understanding of graduates' impact as well as their career pathways.
FAU - Zwanikken, Prisca A C
AU  - Zwanikken PA
AD  - Royal Tropical Institute, Mauritskade 63, Amsterdam, The Netherlands. 
      P.Zwanikken@kit.nl.
FAU - Alexander, Lucy
AU  - Alexander L
AD  - School of Public Health, University of the Western Cape, Cape Town, South Africa.
FAU - Scherpbier, Albert
AU  - Scherpbier A
AD  - Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, 
      The Netherlands.
LA  - eng
PT  - Journal Article
DEP - 20160822
PL  - England
TA  - Hum Resour Health
JT  - Human resources for health
JID - 101170535
SB  - IM
MH  - *Attitude of Health Personnel
MH  - *Delivery of Health Care/standards
MH  - *Developing Countries
MH  - Education, Distance
MH  - *Education, Graduate
MH  - *Education, Public Health Professional
MH  - Humans
MH  - Income
MH  - Internet
MH  - Leadership
MH  - Netherlands
MH  - Professional Role
MH  - Public Health/*education
MH  - Public Health Practice
MH  - Qualitative Research
MH  - South Africa
MH  - Workforce
MH  - Workplace
PMC - PMC4994422
OTO - NOTNLM
OT  - Evaluation
OT  - Graduate
OT  - Impact
OT  - Low- and middle-income countries
OT  - Master of public health
EDAT- 2016/08/24 06:00
MHDA- 2017/10/19 06:00
PMCR- 2016/08/22
CRDT- 2016/08/24 06:00
PHST- 2015/12/14 00:00 [received]
PHST- 2016/08/08 00:00 [accepted]
PHST- 2016/08/24 06:00 [entrez]
PHST- 2016/08/24 06:00 [pubmed]
PHST- 2017/10/19 06:00 [medline]
PHST- 2016/08/22 00:00 [pmc-release]
AID - 10.1186/s12960-016-0150-7 [pii]
AID - 150 [pii]
AID - 10.1186/s12960-016-0150-7 [doi]
PST - epublish
SO  - Hum Resour Health. 2016 Aug 22;14(1):52. doi: 10.1186/s12960-016-0150-7.

PMID- 26348845
OWN - NLM
STAT- MEDLINE
DCOM- 20160418
LR  - 20151216
IS  - 1934-6638 (Electronic)
IS  - 1934-662X (Linking)
VI  - 123
IP  - 12
DP  - 2015 Dec
TI  - Pap smears with glandular cell abnormalities: Are they detected by rapid 
      prescreening?
PG  - 739-44
LID - 10.1002/cncy.21601 [doi]
AB  - BACKGROUND: Rapid prescreening (RPS) is one of the quality assurance (QA) methods 
      used in gynecologic cytology. The efficacy of RPS has been previously studied but 
      mostly with respect to squamous lesions; in fact, there has been no study so far 
      specifically looking at the sensitivity of RPS for detecting glandular cell 
      abnormalities. METHODS: A total of 80,565 Papanicolaou (Pap) smears underwent RPS 
      during a 25-month period. A sample was designated as "review for abnormality" (R) 
      if any abnormal cells (at the threshold of atypical squamous cells of 
      undetermined significance/atypical glandular cells [AGC]) were thought to be 
      present or was designated as negative (N) if none were detected. Each sample then 
      underwent full screening (FS) and was designated as either R or N and also given 
      a cytologic interpretation. RESULTS: The final cytologic interpretation was a 
      glandular cell abnormality (>/=AGC) in 107 samples (0.13%); 39 of these (36.4%) 
      were flagged as R on RPS. Twenty-four patients (33.8%) out of 71 who had 
      histologic follow-up were found to harbor a high-grade squamous intraepithelial 
      lesion or carcinoma; 13 of those 24 Pap smears (54.2%) had been flagged as R on 
      RPS. Notably, 11 AGC cases were picked up by RPS only and not by FS and 
      represented false-negative cases; 2 of these showed endometrial adenocarcinoma on 
      histologic follow-up. CONCLUSIONS: Pap smears with glandular cell abnormalities 
      are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% 
      (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap 
      smears by RPS only, and this demonstrates that RPS is a valuable QA method.
CI  - (c) 2015 American Cancer Society.
FAU - Kanber, Yonca
AU  - Kanber Y
AD  - Department of Pathology, McGill University, Montreal, Canada.
AD  - Department of Pathology, McGill University Health Center, Montreal, Canada.
FAU - Charbonneau, Michele
AU  - Charbonneau M
AD  - Department of Pathology, McGill University Health Center, Montreal, Canada.
FAU - Auger, Manon
AU  - Auger M
AD  - Department of Pathology, McGill University, Montreal, Canada.
AD  - Department of Pathology, McGill University Health Center, Montreal, Canada.
LA  - eng
PT  - Journal Article
DEP - 20150908
PL  - United States
TA  - Cancer Cytopathol
JT  - Cancer cytopathology
JID - 101499453
SB  - IM
MH  - Adenocarcinoma/*diagnosis
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Female
MH  - Humans
MH  - Mass Screening/methods/standards
MH  - Middle Aged
MH  - Papanicolaou Test/methods/standards
MH  - Sensitivity and Specificity
MH  - Uterine Cervical Neoplasms/*diagnosis
MH  - Vaginal Smears/*methods/*standards
MH  - Young Adult
OTO - NOTNLM
OT  - atypical glandular cells (AGC)
OT  - glandular cell abnormalities
OT  - rapid prescreening
OT  - rescreening
EDAT- 2015/09/09 06:00
MHDA- 2016/04/19 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/04/16 00:00 [received]
PHST- 2015/07/01 00:00 [revised]
PHST- 2015/07/07 00:00 [accepted]
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/04/19 06:00 [medline]
AID - 10.1002/cncy.21601 [doi]
PST - ppublish
SO  - Cancer Cytopathol. 2015 Dec;123(12):739-44. doi: 10.1002/cncy.21601. Epub 2015 
      Sep 8.

PMID- 25588461
OWN - NLM
STAT- MEDLINE
DCOM- 20151120
LR  - 20220409
IS  - 1878-3627 (Electronic)
IS  - 0922-6028 (Linking)
VI  - 33
IP  - 2
DP  - 2015
TI  - Can transcranial direct current stimulation be useful in differentiating 
      unresponsive wakefulness syndrome from minimally conscious state patients?
PG  - 159-76
LID - 10.3233/RNN-140448 [doi]
AB  - PURPOSE: Disorders of consciousness (DOC) diagnosis relies on the presence or 
      absence of purposeful motor responsiveness, which characterizes the minimally 
      conscious state (MCS) and the unresponsive wakefulness syndrome (UWS), 
      respectively. Functional neuroimaging studies have raised the question of 
      possible residual conscious awareness also in clinically-defined UWS patients. 
      The aim of our study was to identify electrophysiological parameters, by means of 
      a transcranial magnetic stimulation approach, which might potentially express the 
      presence of residual networks sustaining fragmentary behavioral patterns, even 
      when no conscious behavior can be observed. METHODS: We enrolled 25 severe DOC 
      patients, following post-anoxic or traumatic brain injury and 20 healthy 
      individuals (HC) as control group. Baseline electrophysiological evaluation 
      evidenced, in comparison to HC, a partial preservation of cortical effective 
      connectivity and excitability in clinically defined MCS, whereas these components 
      were absent in clinically defined UWS. Then, we applied an anodal transcranial 
      direct current stimulation (a-tDCS) protocol over the orbitofrontal cortex. 
      RESULT: a-tDCS was able to boost cortical connectivity and excitability in all 
      HC, MCS, and to unmask such excitability/connectivity in some UWS patients. 
      CONCLUSION: a-tDCS could be useful in identifying residual connectivity markers 
      in clinically-defined UWS, who may lack of purposeful behavior as a result of a 
      motor-output failure.
FAU - Naro, Antonino
AU  - Naro A
AD  - IRCCS Centro Neurolesi Bonino-Pulejo Messina, Italy.
FAU - Calabro, Rocco Salvatore
AU  - Calabro RS
AD  - IRCCS Centro Neurolesi Bonino-Pulejo Messina, Italy.
FAU - Russo, Margherita
AU  - Russo M
AD  - IRCCS Centro Neurolesi Bonino-Pulejo Messina, Italy.
FAU - Leo, Antonino
AU  - Leo A
AD  - IRCCS Centro Neurolesi Bonino-Pulejo Messina, Italy.
FAU - Pollicino, Patrizia
AU  - Pollicino P
AD  - IRCCS Centro Neurolesi Bonino-Pulejo Messina, Italy.
FAU - Quartarone, Angelo
AU  - Quartarone A
AD  - Department of Neurosciences, University of Messina, Italy.
FAU - Bramanti, Placido
AU  - Bramanti P
AD  - IRCCS Centro Neurolesi Bonino-Pulejo Messina, Italy.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Restor Neurol Neurosci
JT  - Restorative neurology and neuroscience
JID - 9005499
SB  - IM
MH  - Adult
MH  - Aged
MH  - Consciousness Disorders/*diagnosis/physiopathology
MH  - Diagnosis, Differential
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Neural Pathways/physiopathology
MH  - Persistent Vegetative State/*diagnosis/physiopathology
MH  - Prefrontal Cortex/physiopathology
MH  - Transcranial Direct Current Stimulation/*methods
OTO - NOTNLM
OT  - Disorders of consciousness
OT  - cortical connectivity
OT  - cortical excitability
OT  - minimally conscious state
OT  - transcranial direct current stimulation
OT  - transcranial magnetic stimulation
OT  - unresponsive wakefulness syndrome
EDAT- 2015/01/16 06:00
MHDA- 2015/12/15 06:00
CRDT- 2015/01/16 06:00
PHST- 2015/01/16 06:00 [entrez]
PHST- 2015/01/16 06:00 [pubmed]
PHST- 2015/12/15 06:00 [medline]
AID - 251G823226543056 [pii]
AID - 10.3233/RNN-140448 [doi]
PST - ppublish
SO  - Restor Neurol Neurosci. 2015;33(2):159-76. doi: 10.3233/RNN-140448.

PMID- 23359100
OWN - NLM
STAT- MEDLINE
DCOM- 20131018
LR  - 20211021
IS  - 1432-5195 (Electronic)
IS  - 0341-2695 (Print)
IS  - 0341-2695 (Linking)
VI  - 37
IP  - 4
DP  - 2013 Apr
TI  - Is etoricoxib effective in preventing heterotopic ossification after primary 
      total hip arthroplasty?
PG  - 583-7
LID - 10.1007/s00264-013-1781-0 [doi]
AB  - PURPOSE: Heterotopic ossification is a common complication after total hip 
      arthroplasty. Non-steroidal anti-inflammatory drugs (NSAIDs) are known to prevent 
      heterotopic ossifications effectively, however gastrointestinal complaints are 
      reported frequently. In this study, we investigated whether etoricoxib, a 
      selective cyclo-oxygenase-2 (COX-2) inhibitor that produces fewer 
      gastrointestinal side effects, is an effective alternative for the prevention of 
      heterotopic ossification. METHODS: We investigated the effectiveness of oral 
      etoricoxib 90 mg for seven days in a prospective two-stage study design for 
      phase-2 clinical trials in a small sample of patients (n = 42). A cemented 
      primary total hip arthroplasty was implanted for osteoarthritis. Six months after 
      surgery, heterotopic ossification was determined on anteroposterior pelvic 
      radiographs using the Brooker classification. RESULTS: No heterotopic 
      ossification was found in 62 % of the patients that took etoricoxib; 31 % of the 
      patients had Brooker grade 1 and 7 % Brooker grade 2 ossification. CONCLUSIONS: 
      Etoricoxib seems effective in preventing heterotopic ossification after total hip 
      arthroplasty. This finding further supports the use of COX-2 inhibitors for the 
      prevention of heterotopic ossification following total hip arthroplasty.
FAU - Brunnekreef, Jaap J
AU  - Brunnekreef JJ
AD  - Department of Orthopaedics, Radboud University Nijmegen Medical Centre, P.O. Box 
      9101, 6500, HB, Nijmegen, The Netherlands.
FAU - Hoogervorst, Paul
AU  - Hoogervorst P
FAU - Ploegmakers, Marieke J
AU  - Ploegmakers MJ
FAU - Rijnen, Wim H
AU  - Rijnen WH
FAU - Schreurs, Berend W
AU  - Schreurs BW
LA  - eng
PT  - Clinical Trial, Phase II
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20130129
PL  - Germany
TA  - Int Orthop
JT  - International orthopaedics
JID - 7705431
RN  - 0 (Cyclooxygenase 2 Inhibitors)
RN  - 0 (Pyridines)
RN  - 0 (Sulfones)
RN  - WRX4NFY03R (Etoricoxib)
SB  - IM
CIN - Int Orthop. 2013 Aug;37(8):1629. doi: 10.1007/s00264-013-1943-0. PMID: 23736968
CIN - Int Orthop. 2013 Aug;37(8):1631. doi: 10.1007/s00264-013-1948-8. PMID: 23778642
MH  - Administration, Oral
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Arthroplasty, Replacement, Hip/*adverse effects
MH  - Cyclooxygenase 2 Inhibitors/administration & dosage/adverse effects/*therapeutic 
      use
MH  - Dose-Response Relationship, Drug
MH  - Etoricoxib
MH  - Female
MH  - Hip Joint/diagnostic imaging/surgery
MH  - Hip Prosthesis
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Ossification, Heterotopic/*etiology/*prevention & control
MH  - Osteoarthritis, Hip/*surgery
MH  - Prospective Studies
MH  - Pyridines/administration & dosage/adverse effects/*therapeutic use
MH  - Radiography
MH  - Severity of Illness Index
MH  - Sulfones/administration & dosage/adverse effects/*therapeutic use
MH  - Treatment Outcome
PMC - PMC3609973
EDAT- 2013/01/30 06:00
MHDA- 2013/10/19 06:00
PMCR- 2014/04/01
CRDT- 2013/01/30 06:00
PHST- 2012/10/19 00:00 [received]
PHST- 2013/01/06 00:00 [accepted]
PHST- 2013/01/30 06:00 [entrez]
PHST- 2013/01/30 06:00 [pubmed]
PHST- 2013/10/19 06:00 [medline]
PHST- 2014/04/01 00:00 [pmc-release]
AID - 1781 [pii]
AID - 10.1007/s00264-013-1781-0 [doi]
PST - ppublish
SO  - Int Orthop. 2013 Apr;37(4):583-7. doi: 10.1007/s00264-013-1781-0. Epub 2013 Jan 
      29.

PMID- 26548832
OWN - NLM
STAT- MEDLINE
DCOM- 20160719
LR  - 20160311
IS  - 1878-8769 (Electronic)
IS  - 1878-8750 (Linking)
VI  - 87
DP  - 2016 Mar
TI  - Assessing Patient Reported Outcomes Measures via Phone Interviews Versus Patient 
      Self-Survey in the Clinic: Are We Measuring the Same Thing?
PG  - 230-4
LID - S1878-8750(15)01510-7 [pii]
LID - 10.1016/j.wneu.2015.10.092 [doi]
AB  - BACKGROUND: Longitudinally following patients requires a full-time employee 
      (FTE)-dependent data inflow infrastructure. There are efforts to capture 
      patient-reported outcomes (PROs) by the use of non-FTE-dependent methodologies. 
      In this study, we set out to assess the reliability of PRO data captured via 
      FTE-dependent compared with non-FTE-dependent methodologies. METHODS: A total of 
      119 adult patients (65 men) who underwent 1-and 2-level lumbar fusions at Duke 
      University Medical Center were enrolled in this prospective study. Enrollment 
      criteria included available demographic, clinical, and PRO data. All patients 
      completed 2 sets of questionnaires--the first a phone interviews and the second a 
      self-survey. There was at least a 2-week period between the phone interviews and 
      self-survey. Questionnaires included the Oswestry Disability Index (ODI), the 
      visual analog scale for back pain (VAS-BP), and the visual analog scale for leg 
      pain (VAS-LP). Repeated-measures analysis of variance was used to compare the 
      reliability of baseline PRO data captured. RESULTS: A total of 39.49% of patients 
      were smokers, 21.00% had diabetes, and 11.76% had coronary artery disease; 26.89% 
      reported history of anxiety disorder, and 28.57% reported history of depression. 
      A total of 97.47% of patients had a high-school diploma or General Education 
      Development, and 49.57% attained a 4-year college degree or postgraduate degree. 
      We observed a high correlation between baseline PRO data captured between 
      FTE-dependent versus non-FTE dependent methodologies (ODI: r = -0.89, VAS-BP: r = 
      0.74, VAS-LP: r = 0.70). There was no difference in PROs of baseline pain and 
      functional disability between FTE-dependent and non-FTE-dependent methodologies: 
      baseline ODI (FTE-dependent: 47.73 +/- 16.77 [mean +/- SD] vs. non-FTE-dependent: 
      45.81 +/- 12.11, P = 0.39), VAS-LP (FTE-dependent: 6.13 +/- 2.78 vs. 
      non-FTE-dependent: 6.46 +/- 2.79, P = 0.36) and VAS-BP (FTE-dependent: 6.33 +/- 2.90 
      vs. non-FTE-dependent: 6.53 +/- 2.48, P = 0.57). CONCLUSION: Our study suggests 
      that there is great reliability between PRO data captured between FTE-dependent 
      and non-FTE-dependent methodologies.
CI  - Copyright (c) 2016 Elsevier Inc. All rights reserved.
FAU - Adogwa, Owoicho
AU  - Adogwa O
AD  - Division of Neurosurgery, Duke University Medical Center, Durham, North Carolina, 
      USA. Electronic address: owoicho.adogwa@gmail.com.
FAU - Elsamadicy, Aladine A
AU  - Elsamadicy AA
AD  - Division of Neurosurgery, Duke University Medical Center, Durham, North Carolina, 
      USA.
FAU - Cheng, Joseph
AU  - Cheng J
AD  - Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, 
      Tennessee, USA.
FAU - Bagley, Carlos
AU  - Bagley C
AD  - Department of Neurosurgery, University of Texas Southwestern Medical Center, 
      Dallas, Texas, USA.
LA  - eng
PT  - Journal Article
DEP - 20151105
PL  - United States
TA  - World Neurosurg
JT  - World neurosurgery
JID - 101528275
SB  - IM
MH  - Adult
MH  - Aged
MH  - Disability Evaluation
MH  - Female
MH  - Health Personnel
MH  - Humans
MH  - Lumbosacral Region
MH  - Male
MH  - Middle Aged
MH  - Pain/etiology
MH  - Pain Measurement
MH  - *Patient Outcome Assessment
MH  - Prospective Studies
MH  - Reproducibility of Results
MH  - Risk Factors
MH  - Socioeconomic Factors
MH  - Spinal Fusion
MH  - *Surveys and Questionnaires
MH  - Telephone
OTO - NOTNLM
OT  - Clinic surveys
OT  - FTE-dependent
OT  - Non-FTE dependent
OT  - Oswestry Disability Index
OT  - PROs
OT  - Patient-reported outcomes
OT  - Phone interviews
OT  - Visual analog score
EDAT- 2015/11/10 06:00
MHDA- 2016/07/20 06:00
CRDT- 2015/11/10 06:00
PHST- 2015/09/16 00:00 [received]
PHST- 2015/10/25 00:00 [revised]
PHST- 2015/10/26 00:00 [accepted]
PHST- 2015/11/10 06:00 [entrez]
PHST- 2015/11/10 06:00 [pubmed]
PHST- 2016/07/20 06:00 [medline]
AID - S1878-8750(15)01510-7 [pii]
AID - 10.1016/j.wneu.2015.10.092 [doi]
PST - ppublish
SO  - World Neurosurg. 2016 Mar;87:230-4. doi: 10.1016/j.wneu.2015.10.092. Epub 2015 
      Nov 5.

PMID- 25756710
OWN - NLM
STAT- MEDLINE
DCOM- 20160210
LR  - 20220310
IS  - 1742-6723 (Electronic)
IS  - 1742-6723 (Linking)
VI  - 27
IP  - 2
DP  - 2015 Apr
TI  - Can emergency physicians accurately and reliably assess acute vertigo in the 
      emergency department?
PG  - 126-31
LID - 10.1111/1742-6723.12372 [doi]
AB  - OBJECTIVE: To validate a clinical diagnostic tool, used by emergency physicians 
      (EPs), to diagnose the central cause of patients presenting with vertigo, and to 
      determine interrater reliability of this tool. METHODS: A convenience sample of 
      adult patients presenting to a single academic ED with isolated vertigo (i.e. 
      vertigo without other neurological deficits) was prospectively evaluated with 
      STANDING (SponTAneousNystagmus, Direction, head Impulse test, standiNG) by five 
      trained EPs. The first step focused on the presence of spontaneous nystagmus, the 
      second on the direction of nystagmus, the third on head impulse test and the 
      fourth on gait. The local standard practice, senior audiologist evaluation 
      corroborated by neuroimaging when deemed appropriate, was considered the 
      reference standard. Sensitivity and specificity of STANDING were calculated. On 
      the first 30 patients, inter-observer agreement among EPs was also assessed. 
      RESULTS: Five EPs with limited experience in nystagmus assessment volunteered to 
      participate in the present study enrolling 98 patients. Their average evaluation 
      time was 9.9 +/- 2.8 min (range 6-17). Central acute vertigo was suspected in 16 
      (16.3%) patients. There were 13 true positives, three false positives, 81 true 
      negatives and one false negative, with a high sensitivity (92.9%, 95% CI 70-100%) 
      and specificity (96.4%, 95% CI 93-38%) for central acute vertigo according to 
      senior audiologist evaluation. The Cohen's kappas of the first, second, third and 
      fourth steps of the STANDING were 0.86, 0.93, 0.73 and 0.78, respectively. The 
      whole test showed a good inter-observer agreement (k = 0.76, 95% CI 0.45-1). 
      CONCLUSIONS: In the hands of EPs, STANDING showed a good inter-observer agreement 
      and accuracy validated against the local standard of care.
CI  - (c) 2015 Australasian College for Emergency Medicine and Australasian Society for 
      Emergency Medicine.
FAU - Vanni, Simone
AU  - Vanni S
AD  - Department of Emergency Medicine, Careggi University Hospital, Firenze, Italy.
FAU - Nazerian, Peiman
AU  - Nazerian P
FAU - Casati, Carlotta
AU  - Casati C
FAU - Moroni, Federico
AU  - Moroni F
FAU - Risso, Michele
AU  - Risso M
FAU - Ottaviani, Maddalena
AU  - Ottaviani M
FAU - Pecci, Rudi
AU  - Pecci R
FAU - Pepe, Giuseppe
AU  - Pepe G
FAU - Vannucchi, Paolo
AU  - Vannucchi P
FAU - Grifoni, Stefano
AU  - Grifoni S
LA  - eng
PT  - Journal Article
DEP - 20150310
PL  - Australia
TA  - Emerg Med Australas
JT  - Emergency medicine Australasia : EMA
JID - 101199824
SB  - IM
MH  - Acute Disease
MH  - *Algorithms
MH  - Clinical Competence
MH  - *Decision Support Systems, Clinical
MH  - Emergency Medicine
MH  - *Emergency Service, Hospital
MH  - Humans
MH  - Prospective Studies
MH  - Vertigo/*diagnosis
OTO - NOTNLM
OT  - emergency physician
OT  - head impulse test
OT  - nystagmus
OT  - stroke
OT  - vertigo
EDAT- 2015/03/11 06:00
MHDA- 2016/02/11 06:00
CRDT- 2015/03/11 06:00
PHST- 2015/01/22 00:00 [accepted]
PHST- 2015/03/11 06:00 [entrez]
PHST- 2015/03/11 06:00 [pubmed]
PHST- 2016/02/11 06:00 [medline]
AID - 10.1111/1742-6723.12372 [doi]
PST - ppublish
SO  - Emerg Med Australas. 2015 Apr;27(2):126-31. doi: 10.1111/1742-6723.12372. Epub 
      2015 Mar 10.

PMID- 20297950
OWN - NLM
STAT- MEDLINE
DCOM- 20100730
LR  - 20131121
IS  - 1473-4877 (Electronic)
IS  - 0300-7995 (Linking)
VI  - 26
IP  - 5
DP  - 2010 May
TI  - Proof of concept study: does fenofibrate have a role in sleep apnoea syndrome?
PG  - 1185-92
LID - 10.1185/03007991003693581 [doi]
AB  - OBJECTIVE: To investigate the effect of fenofibrate on sleep apnoea indices. 
      METHODS: Proof-of-concept study comprising a placebo run-in period (1 week, 5 
      weeks if fibrate washout was required) and a 4-week randomized, double-blind 
      treatment period. Thirty-four subjects (mean age 55 years, body mass index 34 
      kg/m 2 , fasting triglycerides 3.5 mmol/L) with diagnosed sleep apnoea syndrome 
      not treated with continuous positive airways pressure were enrolled and 
      randomized to once daily treatment with fenofibrate (145 mg NanoCrystal(R) 
      tablet) or placebo. Overnight polysomnography, computerized attention/vigilance 
      tests and blood sampling for measurement of lipids, insulin, fasting plasma 
      glucose and fibrinogen were performed at the end of each study period. CLINICAL 
      TRIAL REGISTRATION: NCT00816829. MAIN OUTCOME MEASURES: As this was an 
      exploratory study, a range of sleep variables were evaluated. The 
      apnoea/hypopnoea index (AHI) and percentage of time spent with arterial oxygen 
      saturation (SpO(2)) <90% were relevant as they have been evaluated in other 
      clinical trials. Other variables included total apnoeas, hypopnoeas and oxygen 
      desaturations, and non-cortical micro-awakenings related to respiratory events 
      per hour. RESULTS: Fenofibrate treatment significantly reduced the percentage of 
      time with SpO(2) <90% (from 9.0% to 3.5% vs. 10.0% to 11.5% with placebo, p = 
      0.007), although there was no significant change in the AHI (reduction vs. 
      control 14% (95%CI -47 to 40%, p = 0.533). Treatment reduced obstructive apnoeas 
      (by 44%, from 18.5 at baseline to 15.0 at end of treatment vs. 29.0 to 30.5 on 
      placebo, p = 0.048), and non-cortical micro-awakenings per hour (from 23.5 to 
      18.0 vs. 24.0 to 25.0 with placebo, p = 0.004). Other sleep variables were not 
      significantly influenced by fenofibrate. KEY LIMITATIONS: Exploratory study in 
      patients with mild to moderate sleep apnoea, limited treatment duration; 
      concomitant hypnotic treatment (35%); lack of correction for multiplicity of 
      testing. CONCLUSIONS: The consistent direction of change in sleep indices in this 
      proof-of-concept study may support further investigation of fenofibrate in 
      moderate to severe sleep apnoea syndrome.
FAU - Bruckert, Eric
AU  - Bruckert E
AD  - Service d'Endocrinologie et Metabolisme, Assistance Publique - Hopitaux de Paris, 
      Hopital de la Pitie-Salpetriere, 75013 Paris, France. eric.bruckert@psl.aphp.fr
FAU - Duchene, Emilie
AU  - Duchene E
FAU - Bonnefont-Rousselot, Dominique
AU  - Bonnefont-Rousselot D
FAU - Hansel, Boris
AU  - Hansel B
FAU - Ansquer, Jean-Claude
AU  - Ansquer JC
FAU - Dubois, Andre
AU  - Dubois A
FAU - Gaymard, Bertrand
AU  - Gaymard B
LA  - eng
SI  - ClinicalTrials.gov/NCT00816829
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - Curr Med Res Opin
JT  - Current medical research and opinion
JID - 0351014
RN  - 0 (Hypolipidemic Agents)
RN  - 0 (Lipids)
RN  - 0 (Placebos)
RN  - U202363UOS (Fenofibrate)
SB  - IM
MH  - Attention
MH  - Double-Blind Method
MH  - Female
MH  - Fenofibrate/adverse effects/*therapeutic use
MH  - Humans
MH  - Hypolipidemic Agents/adverse effects/*therapeutic use
MH  - Lipids/blood
MH  - Male
MH  - Middle Aged
MH  - Placebos
MH  - Sleep
MH  - Sleep Apnea Syndromes/*drug therapy/physiopathology
EDAT- 2010/03/20 06:00
MHDA- 2010/07/31 06:00
CRDT- 2010/03/20 06:00
PHST- 2010/03/20 06:00 [entrez]
PHST- 2010/03/20 06:00 [pubmed]
PHST- 2010/07/31 06:00 [medline]
AID - 10.1185/03007991003693581 [doi]
PST - ppublish
SO  - Curr Med Res Opin. 2010 May;26(5):1185-92. doi: 10.1185/03007991003693581.

PMID- 24622801
OWN - NLM
STAT- MEDLINE
DCOM- 20150320
LR  - 20220408
IS  - 1528-1132 (Electronic)
IS  - 0009-921X (Print)
IS  - 0009-921X (Linking)
VI  - 472
IP  - 11
DP  - 2014 Nov
TI  - Does implant coating with antibacterial-loaded hydrogel reduce bacterial 
      colonization and biofilm formation in vitro?
PG  - 3311-23
LID - 10.1007/s11999-014-3558-1 [doi]
AB  - BACKGROUND: Implant-related infections represent one of the most severe 
      complications in orthopaedics. A fast-resorbable, antibacterial-loaded hydrogel 
      may reduce or prevent bacterial colonization and biofilm formation of implanted 
      biomaterials. QUESTIONS/PURPOSES: We asked: (1) Is a fast-resorbable hydrogel 
      able to deliver antibacterial compounds in vitro? (2) Can a hydrogel (alone or 
      antibacterial-loaded) coating on implants reduce bacterial colonization? And (3) 
      is intraoperative coating feasible and resistant to press-fit implant insertion? 
      METHODS: We tested the ability of Disposable Antibacterial Coating (DAC) hydrogel 
      (Novagenit Srl, Mezzolombardo, Italy) to deliver antibacterial agents using 
      spectrophotometry and a microbiologic assay. Antibacterial and antibiofilm 
      activity were determined by broth microdilution and a crystal violet assay, 
      respectively. Coating resistance to press-fit insertion was tested in rabbit 
      tibias and human femurs. RESULTS: Complete release of all tested antibacterial 
      compounds was observed in less than 96 hours. Bactericidal and antibiofilm effect 
      of DAC hydrogel in combination with various antibacterials was shown in vitro. 
      Approximately 80% of the hydrogel coating was retrieved on the implant after 
      press-fit insertion. CONCLUSIONS: Implant coating with an antibacterial-loaded 
      hydrogel reduces bacterial colonization and biofilm formation in vitro. CLINICAL 
      RELEVANCE: A fast-resorbable, antibacterial-loaded hydrogel coating may help 
      prevent implant-related infections in orthopaedics. However, further validation 
      in animal models and properly controlled human studies is required.
FAU - Drago, Lorenzo
AU  - Drago L
AD  - Dipartimento di Chirurgia Ricostruttiva e delle Infezioni Osteo-articolari, 
      Istituto Ortopedico IRCCS Galeazzi, Via Riccardo Galeazzi, 4, Milano, 20161, 
      Italy.
FAU - Boot, Willemijn
AU  - Boot W
FAU - Dimas, Kostantinos
AU  - Dimas K
FAU - Malizos, Kostantinos
AU  - Malizos K
FAU - Hansch, Gertrud M
AU  - Hansch GM
FAU - Stuyck, Jos
AU  - Stuyck J
FAU - Gawlitta, Debby
AU  - Gawlitta D
FAU - Romano, Carlo L
AU  - Romano CL
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
PL  - United States
TA  - Clin Orthop Relat Res
JT  - Clinical orthopaedics and related research
JID - 0075674
RN  - 0 (Anti-Bacterial Agents)
RN  - 0 (Coated Materials, Biocompatible)
RN  - 0 (Drug Carriers)
RN  - 25852-47-5 (Hydrogel, Polyethylene Glycol Dimethacrylate)
SB  - IM
MH  - Absorbable Implants
MH  - Animals
MH  - Anti-Bacterial Agents/*administration & dosage
MH  - Biofilms/*drug effects
MH  - Coated Materials, Biocompatible/*pharmacology
MH  - Drug Carriers
MH  - Drug Delivery Systems/*methods
MH  - Feasibility Studies
MH  - Femur/microbiology/surgery
MH  - Humans
MH  - Hydrogel, Polyethylene Glycol Dimethacrylate
MH  - In Vitro Techniques
MH  - Microbial Sensitivity Tests
MH  - Prosthesis-Related Infections/*microbiology/*prevention & control
MH  - Rabbits
MH  - Staphylococcus aureus/drug effects
MH  - Staphylococcus epidermidis/drug effects
MH  - Tibia/microbiology/surgery
PMC - PMC4182393
EDAT- 2014/03/14 06:00
MHDA- 2015/03/21 06:00
PMCR- 2014/03/13
CRDT- 2014/03/14 06:00
PHST- 2014/03/14 06:00 [entrez]
PHST- 2014/03/14 06:00 [pubmed]
PHST- 2015/03/21 06:00 [medline]
PHST- 2014/03/13 00:00 [pmc-release]
AID - 3558 [pii]
AID - 10.1007/s11999-014-3558-1 [doi]
PST - ppublish
SO  - Clin Orthop Relat Res. 2014 Nov;472(11):3311-23. doi: 10.1007/s11999-014-3558-1.

PMID- 9722752
OWN - NLM
STAT- MEDLINE
DCOM- 19980908
LR  - 20190719
IS  - 0007-1331 (Print)
IS  - 0007-1331 (Linking)
VI  - 82
IP  - 2
DP  - 1998 Aug
TI  - Does bone anchor fixation improve the outcome of percutaneous bladder neck 
      suspension in female stress urinary incontinence?
PG  - 192-5
AB  - OBJECTIVE: To evaluate the outcome of a new modification of percutaneous needle 
      suspension, using a bone anchor system for fixing the suture at the public bone, 
      and to compare the results with those published previously. PATIENTS AND METHODS: 
      From March 1996, 37 patients with stress urinary incontinence (> 2 years) were 
      treated using a bone anchor system. On each side the suture was attached to the 
      pubocervical fascia and the vaginal wall via a broad 'Z'-stitch. A urodynamic 
      investigation performed preoperatively in all patients confirmed stress 
      incontinence and excluded detrusor instability. The outcome was assessed by 
      either by a clinical follow-up investigation or using a standardized 
      questionnaire, over a mean follow-up of 11 months (range 6-18). RESULTS: In the 
      37 patients, the procedure was successful in 25 (68%), with 16 (43%) of the 
      patients completely dry and nine (24%) significantly improved. Removal of the 
      bone anchor and suture was necessary in two patients, because of unilateral 
      bacterial infection in one and a bilateral soft tissue granuloma in the other. 
      One bone anchor became dislocated in a third patient. In two cases where the 
      treatment failed, new detrusor instability was documented urodynamically. Minor 
      complications were prolonged wound pain in 10 (26%) and transient urinary 
      retention or residual urine in 12 patients (32%). CONCLUSION: The poor success 
      rate in the study corresponds with the long-term results of conventional or 
      modified needle suspension procedures and does not reinforce the optimistic 
      results of bone anchoring published recently. Because of the poorer long-term 
      results from percutaneous needle suspension than from other techniques of open 
      retropubic bladder neck suspension, it remains questionable whether percutaneous 
      needle suspension should be considered a first-line procedure for the treatment 
      of female stress urinary incontinence.
FAU - Schultheiss, D
AU  - Schultheiss D
AD  - Department of Urology, Medizinische Hochschule Hannover, Germany.
FAU - Hofner, K
AU  - Hofner K
FAU - Oelke, M
AU  - Oelke M
FAU - Grunewald, V
AU  - Grunewald V
FAU - Jonas, U
AU  - Jonas U
LA  - eng
PT  - Journal Article
PL  - England
TA  - Br J Urol
JT  - British journal of urology
JID - 15740090R
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - *Bone Nails
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Middle Aged
MH  - *Suture Techniques
MH  - Treatment Outcome
MH  - Urinary Bladder Diseases/physiopathology/*surgery
MH  - Urinary Incontinence, Stress/physiopathology/*surgery
MH  - Urodynamics
MH  - Urologic Surgical Procedures/*methods
EDAT- 1998/09/02 00:00
MHDA- 1998/09/02 00:01
CRDT- 1998/09/02 00:00
PHST- 1998/09/02 00:00 [pubmed]
PHST- 1998/09/02 00:01 [medline]
PHST- 1998/09/02 00:00 [entrez]
AID - 10.1046/j.1464-410x.1998.00691.x [doi]
PST - ppublish
SO  - Br J Urol. 1998 Aug;82(2):192-5. doi: 10.1046/j.1464-410x.1998.00691.x.

PMID- 20577124
OWN - NLM
STAT- MEDLINE
DCOM- 20101207
LR  - 20171116
IS  - 1473-5598 (Electronic)
IS  - 0263-6352 (Linking)
VI  - 28
IP  - 9
DP  - 2010 Sep
TI  - Is leptin involved in phagocytic NADPH oxidase overactivity in obesity? Potential 
      clinical implications.
PG  - 1944-50
LID - 10.1097/HJH.0b013e32833c21af [doi]
AB  - OBJECTIVES: Hyperleptinemia and oxidative stress play a major role in the 
      development of cardiovascular diseases in obesity. This study aimed to 
      investigate whether there is a relationship between plasma levels of leptin and 
      phagocytic nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, 
      and its potential relevance in the vascular remodeling in obese patients. 
      METHODS: The study was performed in 164 obese and 94 normal-weight individuals 
      (controls). NADPH oxidase activity was evaluated by luminescence in phagocytic 
      cells. Levels of leptin were quantified by ELISA in plasma samples. Carotid 
      intima-media thickness (cIMT) was measured by ultrasonography. In addition, we 
      performed in-vitro experiments in human peripheral blood mononuclear cells and 
      murine macrophages. RESULTS: Phagocytic NADPH oxidase activity and leptin levels 
      were enhanced (P < 0.05) in obese patients compared with controls. NADPH oxidase 
      activity positively correlated with leptin in obese patients. This association 
      remained significant in a multivariate analysis. cIMT was higher (P < 0.05) in 
      obese patients compared with controls. In addition, cIMT also correlated 
      positively with leptin and NADPH oxidase activity in obese patients. In-vitro 
      studies showed that leptin induced NADPH oxidase activation. Inhibition of the 
      leptin-induced NADPH oxidase activity by wortmannin and bisindolyl maleimide 
      suggested a direct involvement of the phosphatidylinositol 3-kinase and protein 
      kinase C pathways, respectively. Finally, leptin-induced NADPH oxidase activation 
      promoted macrophage proliferation. CONCLUSIONS: These findings show that 
      phagocytic NADPH oxidase activity is increased in obesity and is related to 
      preclinical atherosclerosis in this condition. We also suggest that 
      hyperleptinemia may contribute to phagocytic NADPH oxidase overactivity in 
      obesity.
FAU - Fortuno, Ana
AU  - Fortuno A
AD  - Division of Cardiovascular Sciences, Centre for Applied Medical Research, 
      Pamplona, Spain. afortuno@unav.es
FAU - Bidegain, Julen
AU  - Bidegain J
FAU - Baltanas, Ana
AU  - Baltanas A
FAU - Moreno, Maria U
AU  - Moreno MU
FAU - Montero, Laura
AU  - Montero L
FAU - Landecho, Manuel F
AU  - Landecho MF
FAU - Beloqui, Oscar
AU  - Beloqui O
FAU - Diez, Javier
AU  - Diez J
FAU - Zalba, Guillermo
AU  - Zalba G
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Netherlands
TA  - J Hypertens
JT  - Journal of hypertension
JID - 8306882
RN  - 0 (Leptin)
RN  - 11062-77-4 (Superoxides)
RN  - EC 1.6.3.- (NADPH Oxidases)
SB  - IM
MH  - Animals
MH  - Atherosclerosis/etiology/pathology
MH  - Carotid Arteries/pathology
MH  - Case-Control Studies
MH  - Cell Line
MH  - Cell Proliferation/drug effects
MH  - Female
MH  - Humans
MH  - In Vitro Techniques
MH  - Leptin/*blood/pharmacology
MH  - Macrophages/cytology/drug effects
MH  - Male
MH  - Mice
MH  - Middle Aged
MH  - NADPH Oxidases/*blood
MH  - Obesity/*blood/complications/*enzymology/pathology
MH  - Oxidative Stress
MH  - Phagocytes/enzymology
MH  - Superoxides/blood
MH  - Tunica Intima/pathology
EDAT- 2010/06/26 06:00
MHDA- 2010/12/14 06:00
CRDT- 2010/06/26 06:00
PHST- 2010/06/26 06:00 [entrez]
PHST- 2010/06/26 06:00 [pubmed]
PHST- 2010/12/14 06:00 [medline]
AID - 10.1097/HJH.0b013e32833c21af [doi]
PST - ppublish
SO  - J Hypertens. 2010 Sep;28(9):1944-50. doi: 10.1097/HJH.0b013e32833c21af.

PMID- 19027440
OWN - NLM
STAT- MEDLINE
DCOM- 20090603
LR  - 20220410
IS  - 0022-3999 (Print)
IS  - 0022-3999 (Linking)
VI  - 65
IP  - 6
DP  - 2008 Dec
TI  - Can we predict which head and neck cancer survivors develop fears of recurrence?
PG  - 525-32
LID - 10.1016/j.jpsychores.2008.03.014 [doi]
AB  - OBJECTIVES: The objectives of this study were to investigate longitudinal 
      predictors of fear of recurrence in survivors of head and neck cancer (HNC) using 
      Leventhal's Common Sense Model (CSM) as a framework. The research questions were 
      as follows: (a) to what extent do HNC patients report fear of cancer recurrence? 
      (b) To what extent are fears of recurrence manifestations of illness-related 
      anxiety? (c) Are fears of recurrence closely related to current symptoms, 
      disease, and treatment-related factors, or psychological/socio-demographic 
      factors? (d) What factors are predictive of long-term fears of recurrence? 
      METHODS: A prospective repeat measures design was employed whereby a sample of 82 
      newly diagnosed HNC patients (54 males, 28 females, mean age 60 years) completed 
      measures of fears of recurrence, illness perceptions, coping, and anxiety and 
      depression, prior to treatment and 6-8 months after treatment (fears of 
      recurrence only). RESULTS: A third of HNC patients at diagnosis reported 
      relatively high levels of fears of recurrence, with 12% still reporting similar 
      levels of fear 6-8 months after treatment. Fears of recurrence were not related 
      to any socio-demographic factor (age, gender, ethnicity, marital status, and 
      educational attainment) or disease, treatment, or symptom-related factors. Path 
      analyses demonstrated that fears of cancer recurrence after treatment were 
      directly predicted by pre-treatment fears and optimism. CONCLUSION: Although 
      components of the CSM (cognitive and emotional representations, coping 
      strategies) were associated with fears of recurrence, optimism was found to be 
      the strongest predictor of fear, independent of anxiety and level of fear 
      reported prior to treatment.
FAU - Llewellyn, Carrie D
AU  - Llewellyn CD
AD  - Division of Primary Care and Public Health, Brighton and Sussex Medical School, 
      Brighton, UK. c.d.llewellyn@bsms.ac.uk
FAU - Weinman, John
AU  - Weinman J
FAU - McGurk, Mark
AU  - McGurk M
FAU - Humphris, Gerry
AU  - Humphris G
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20080924
PL  - England
TA  - J Psychosom Res
JT  - Journal of psychosomatic research
JID - 0376333
SB  - IM
MH  - Adaptation, Psychological
MH  - Attitude to Health
MH  - Breast Neoplasms/psychology
MH  - *Fear
MH  - Female
MH  - Head and Neck Neoplasms/diagnosis/*psychology
MH  - Humans
MH  - Male
MH  - Personality Inventory
MH  - Prognosis
MH  - Recurrence
MH  - Stress, Psychological/diagnosis/psychology
MH  - Surveys and Questionnaires
MH  - Survivors/*psychology
EDAT- 2008/11/26 09:00
MHDA- 2009/06/06 09:00
CRDT- 2008/11/26 09:00
PHST- 2007/10/11 00:00 [received]
PHST- 2008/03/11 00:00 [revised]
PHST- 2008/03/20 00:00 [accepted]
PHST- 2008/11/26 09:00 [pubmed]
PHST- 2009/06/06 09:00 [medline]
PHST- 2008/11/26 09:00 [entrez]
AID - S0022-3999(08)00158-X [pii]
AID - 10.1016/j.jpsychores.2008.03.014 [doi]
PST - ppublish
SO  - J Psychosom Res. 2008 Dec;65(6):525-32. doi: 10.1016/j.jpsychores.2008.03.014. 
      Epub 2008 Sep 24.

PMID- 18239988
OWN - NLM
STAT- MEDLINE
DCOM- 20080718
LR  - 20211020
IS  - 0043-5325 (Print)
IS  - 0043-5325 (Linking)
VI  - 120
IP  - 1-2
DP  - 2008
TI  - Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine 
      laboratory markers useful?
PG  - 25-30
LID - 10.1007/s00508-007-0921-1 [doi]
AB  - BACKGROUND/AIMS: Specific markers for differentiation of nonalcoholic (NASH) from 
      alcoholic steatohepatitis (ASH) are lacking. We investigated the role of routine 
      laboratory parameters in distinguishing NASH from ASH. METHODS: Liver biopsies 
      performed at our hospital over a 10-year period were reviewed, 95 patients with 
      steatohepatitis identified and their data prior to biopsy reevaluated. The 
      diagnosis NASH or ASH was assigned (other liver diseases excluded) on the basis 
      of the biopsy and history of alcohol consumption (< 140 g/week). Logistic 
      regression models were used for analysis. RESULTS: NASH was diagnosed in 58 
      patients (61%; 30 f) and ASH in 37 (39%; 9 f). High-grade fibrosis (59% vs. 19%, 
      P < 0.0001) and an AST/ALT ratio > 1 (54.1% vs 20.7%, P = 0.0008) were more 
      common in ASH. The MCV was elevated in 53% of ASH patients and normal in all NASH 
      patients (P < 0.0001). Multivariate analysis identified the MCV (P = 0.0013), the 
      AST/ALT ratio (P = 0.011) and sex (P = 0.0029) as relevant regressors (aROC = 
      0.92). The AST/ALT ratio (P < 0.0001) and age (P = 0.00049) were independent 
      predictors of high-grade fibrosis. Differences in MCV were more marked in 
      high-grade fibrosis. CONCLUSIONS: Higher MCVs and AST/ALT ratios in ASH reflect 
      the severity of underlying liver disease and do not differentiate NASH from ASH. 
      Instead, these biomarkers might prove useful in guiding selection of patients for 
      liver biopsy and in targeting therapy.
FAU - Kazemi-Shirazi, Lili
AU  - Kazemi-Shirazi L
AD  - Department of Internal Medicine III, Division of Gastroenterology and Hepatology, 
      Medical University of Vienna, Vienna, Austria.
FAU - Veloso, Moema Pinheiro
AU  - Veloso MP
FAU - Frommlet, Florian
AU  - Frommlet F
FAU - Steindl-Munda, Petra
AU  - Steindl-Munda P
FAU - Wrba, Fritz
AU  - Wrba F
FAU - Zehetmayer, Sonja
AU  - Zehetmayer S
FAU - Marsik, Claudia
AU  - Marsik C
FAU - Ferenci, Peter
AU  - Ferenci P
LA  - eng
PT  - Journal Article
PL  - Austria
TA  - Wien Klin Wochenschr
JT  - Wiener klinische Wochenschrift
JID - 21620870R
RN  - 0 (Biomarkers)
RN  - EC 2.6.1.1 (Aspartate Aminotransferases)
RN  - EC 2.6.1.2 (Alanine Transaminase)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Alanine Transaminase/blood
MH  - Aspartate Aminotransferases/blood
MH  - Biomarkers/blood
MH  - Biopsy
MH  - Diagnosis, Differential
MH  - Erythrocyte Indices
MH  - Fatty Liver/blood/*diagnosis/pathology
MH  - Fatty Liver, Alcoholic/blood/*diagnosis/pathology
MH  - Female
MH  - Humans
MH  - Liver/pathology
MH  - Liver Cirrhosis/blood/diagnosis/pathology
MH  - Liver Cirrhosis, Alcoholic/blood/diagnosis/pathology
MH  - *Liver Function Tests
MH  - Male
MH  - Middle Aged
MH  - Predictive Value of Tests
MH  - Retrospective Studies
EDAT- 2008/02/02 09:00
MHDA- 2008/07/19 09:00
CRDT- 2008/02/02 09:00
PHST- 2007/09/20 00:00 [received]
PHST- 2007/11/28 00:00 [accepted]
PHST- 2008/02/02 09:00 [pubmed]
PHST- 2008/07/19 09:00 [medline]
PHST- 2008/02/02 09:00 [entrez]
AID - 10.1007/s00508-007-0921-1 [doi]
PST - ppublish
SO  - Wien Klin Wochenschr. 2008;120(1-2):25-30. doi: 10.1007/s00508-007-0921-1.

PMID- 27858166
OWN - NLM
STAT- MEDLINE
DCOM- 20170316
LR  - 20181113
IS  - 1436-2813 (Electronic)
IS  - 0941-1291 (Print)
IS  - 0941-1291 (Linking)
VI  - 47
IP  - 3
DP  - 2017 Mar
TI  - Traumatic aortic injury: does the anatomy of the aortic arch influence aortic 
      trauma severity?
PG  - 328-334
LID - 10.1007/s00595-016-1443-0 [doi]
AB  - PURPOSE: Traumatic aortic injury (TAI) is a rare but life-threatening type of 
      injury. We investigate whether the anatomy of the aortic arch influences the 
      severity of aortic injury. METHODS: This is a retrospective study of twenty-two 
      cases treated with TEVAR for TAI in our department from 2009 to 2014. Aortic 
      injury was assessed in accordance with the recommendations of the Society of 
      Vascular Surgery. We measured the aortic arch angle and the aortic arch index, 
      based on the initial angio-CT scan, in each of the analyzed cases. RESULTS: The 
      mean aortic arch index and mean aortic arch angle were 6.8 cm and 58.3 degrees , 
      respectively, in the type I injury group; 4.4 cm and 45.9 degrees  in the type III group; 
      3.3 cm and 37 degrees  in the type IV group. There were substantial differences in both 
      the aortic arch index and the aortic arch angle of the type III and IV groups. A 
      multivariate analysis confirmed that the aortic arch angle was significantly 
      associated with the occurrence of type III damage (OR 1.5; 95% CI 1.03-2.2). 
      CONCLUSIONS: The severity of TAI is influenced by the sharpness of the aortic 
      arch. There is an inverse relationship between the severity of aortic injury and 
      the aortic arch index.
FAU - Wojciechowski, Jacek
AU  - Wojciechowski J
AD  - Department of Cardiac and Vascular Surgery, Medical University of Gdansk, ul. 
      Debinki 7, 80-923, Gdansk, Poland.
FAU - Znaniecki, Lukasz
AU  - Znaniecki L
AD  - Department of Cardiac and Vascular Surgery, Medical University of Gdansk, ul. 
      Debinki 7, 80-923, Gdansk, Poland. l.znaniecki@gmail.com.
FAU - Bury, Kamil
AU  - Bury K
AD  - Department of Cardiac and Vascular Surgery, Medical University of Gdansk, ul. 
      Debinki 7, 80-923, Gdansk, Poland.
FAU - Chwojnicki, Kamil
AU  - Chwojnicki K
AD  - Department of Neurology, Medical University of Gdansk, Gdansk, Poland.
FAU - Rogowski, Jan
AU  - Rogowski J
AD  - Department of Cardiac and Vascular Surgery, Medical University of Gdansk, ul. 
      Debinki 7, 80-923, Gdansk, Poland.
LA  - eng
PT  - Journal Article
DEP - 20161117
PL  - Japan
TA  - Surg Today
JT  - Surgery today
JID - 9204360
SB  - IM
MH  - Adult
MH  - Aorta/diagnostic imaging/*injuries/surgery
MH  - Aorta, Thoracic/*anatomy & histology/diagnostic imaging
MH  - Endovascular Procedures/methods
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Multivariate Analysis
MH  - Retrospective Studies
MH  - Stents
MH  - Thoracic Injuries/classification/*diagnosis/*pathology/surgery
MH  - Tomography, X-Ray Computed
MH  - *Trauma Severity Indices
MH  - Treatment Outcome
MH  - Young Adult
PMC - PMC5288446
OTO - NOTNLM
OT  - Aorta
OT  - Injury
OT  - Stent-graft
OT  - Thoracic trauma
OT  - Trauma
COIS- The authors declare no conflicts of interest in association with the present 
      study.
EDAT- 2016/11/20 06:00
MHDA- 2017/03/17 06:00
PMCR- 2016/11/17
CRDT- 2016/11/19 06:00
PHST- 2015/06/17 00:00 [received]
PHST- 2016/06/14 00:00 [accepted]
PHST- 2016/11/20 06:00 [pubmed]
PHST- 2017/03/17 06:00 [medline]
PHST- 2016/11/19 06:00 [entrez]
PHST- 2016/11/17 00:00 [pmc-release]
AID - 10.1007/s00595-016-1443-0 [pii]
AID - 1443 [pii]
AID - 10.1007/s00595-016-1443-0 [doi]
PST - ppublish
SO  - Surg Today. 2017 Mar;47(3):328-334. doi: 10.1007/s00595-016-1443-0. Epub 2016 Nov 
      17.

PMID- 27050489
OWN - NLM
STAT- MEDLINE
DCOM- 20170131
LR  - 20190722
IS  - 1488-2361 (Electronic)
IS  - 0846-5371 (Linking)
VI  - 67
IP  - 3
DP  - 2016 Aug
TI  - The Prevalence of Incidentally Detected Idiopathic Misty Mesentery 
      on Multidetector Computed Tomography: Can Obesity Be the Triggering Cause?
PG  - 212-7
LID - S0846-5371(15)00087-X [pii]
LID - 10.1016/j.carj.2015.06.004 [doi]
AB  - PURPOSE: Misty mesentery appearance is commonly reported in daily practice, 
      usually as a secondary finding of various pathological entities, but sometimes it 
      is encountered as an isolated finding that cannot be attributed to any other 
      disease entity. We aimed to assess the prevalence of cases with incidentally 
      detected idiopathic misty mesentery on computed tomography (CT) and to summarize 
      the pathologies leading to this appearance. METHODS: Medical records and initial 
      and follow-up CT features of patients with misty mesentery appearance between 
      January 2011 and January 2013 were analysed. The study included cases with no 
      known cause of misty mesentery according to associated CT findings, clinical 
      history, or biochemical manifestations, and excluded patients with diseases known 
      to cause misty mesentery, lymph nodes greater than a short-axis diameter of 5 mm, 
      discrete mesenteric masses, or bowel wall thickening. RESULTS: There were a total 
      of 561 patients in whom misty mesentery appearance was depicted on abdominopelvic 
      CT scans. A total of 80 cases were found to have isolated incidental idiopathic 
      misty mesentery, giving a prevalence of 7%. The common indication for CT 
      examination was abdominal pain. There was a slight female predominance (51.3%). 
      67.5% of all patients were classified as obese and 17.5% as overweight. 
      CONCLUSIONS: The results of the present study show that idiopathic incidental 
      misty mesentery appearance has a significant prevalence. Also, the high body mass 
      index of these patients and the growing evidence of obesity-induced inflammatory 
      changes in adipose tissue are suggestive of an association between obesity and 
      misty mesentery appearance on CT.
CI  - Copyright (c) 2016 Canadian Association of Radiologists. Published by Elsevier Inc. 
      All rights reserved.
FAU - Unlu, Ebru
AU  - Unlu E
AD  - Department of Radiology, Afyon Kocatepe University Faculty of Medicine, 
      Afyonkarahisar, Turkey. Electronic address: edunlu@yahoo.com.
FAU - Okur, Nazan
AU  - Okur N
AD  - Department of Radiology, Afyon Kocatepe University Faculty of Medicine, 
      Afyonkarahisar, Turkey.
FAU - Acay, Mehtap Beker
AU  - Acay MB
AD  - Department of Radiology, Afyon Kocatepe University Faculty of Medicine, 
      Afyonkarahisar, Turkey.
FAU - Kacar, Emre
AU  - Kacar E
AD  - Department of Radiology, Afyon Kocatepe University Faculty of Medicine, 
      Afyonkarahisar, Turkey.
FAU - Ozdinc, Serife
AU  - Ozdinc S
AD  - Department of Emergency Medicine, Afyon Kocatepe University Faculty of Medicine, 
      Afyonkarahisar, Turkey.
FAU - Balcik, Cinar
AU  - Balcik C
AD  - Department of Radiology, Afyon Kocatepe University Faculty of Medicine, 
      Afyonkarahisar, Turkey.
FAU - Tokgoz, Ozlem Turksoy
AU  - Tokgoz OT
AD  - Department of Radiology, Antalya Training and Research Hospital, Antalya, Turkey.
LA  - eng
PT  - Journal Article
DEP - 20160401
PL  - United States
TA  - Can Assoc Radiol J
JT  - Canadian Association of Radiologists journal = Journal l'Association canadienne 
      des radiologistes
JID - 8812910
SB  - IM
MH  - Adult
MH  - Body Mass Index
MH  - Female
MH  - Humans
MH  - Incidental Findings
MH  - Male
MH  - Mesentery/*diagnostic imaging
MH  - Middle Aged
MH  - *Multidetector Computed Tomography
MH  - Obesity/*epidemiology
MH  - Prevalence
OTO - NOTNLM
OT  - Misty mesentery
OT  - Multidetector computed tomography
OT  - Obesity
OT  - Prevalence
EDAT- 2016/04/07 06:00
MHDA- 2017/02/01 06:00
CRDT- 2016/04/07 06:00
PHST- 2014/11/30 00:00 [received]
PHST- 2015/04/25 00:00 [revised]
PHST- 2015/06/03 00:00 [accepted]
PHST- 2016/04/07 06:00 [entrez]
PHST- 2016/04/07 06:00 [pubmed]
PHST- 2017/02/01 06:00 [medline]
AID - S0846-5371(15)00087-X [pii]
AID - 10.1016/j.carj.2015.06.004 [doi]
PST - ppublish
SO  - Can Assoc Radiol J. 2016 Aug;67(3):212-7. doi: 10.1016/j.carj.2015.06.004. Epub 
      2016 Apr 1.

PMID- 16266387
OWN - NLM
STAT- MEDLINE
DCOM- 20060126
LR  - 20220321
IS  - 0105-4538 (Print)
IS  - 0105-4538 (Linking)
VI  - 60
IP  - 12
DP  - 2005 Dec
TI  - Fast foods - are they a risk factor for asthma?
PG  - 1537-41
AB  - BACKGROUND: Lifestyle changes over the last 30 years are the most likely 
      explanation for the increase in allergic disease over this period. AIM: This 
      study tests the hypothesis that the consumption of fast food is related to the 
      prevalence of asthma and allergy. METHODS: As part of the International Study of 
      Asthma and Allergies in Childhood (ISAAC) a cross-sectional prevalence study of 
      1321 children (mean age = 11.4 years, range: 10.1-12.5) was conducted in 
      Hastings, New Zealand. Using standard questions we collected data on the 
      prevalence of asthma and asthma symptoms, as well as food frequency data. Skin 
      prick tests were performed to common environmental allergens and exercise-induced 
      bronchial hyperresponsiveness (BHR) was assessed according to a standard 
      protocol. Body mass index (BMI) was calculated as weight/height2 (kg/m2) and 
      classified into overweight and obese according to a standard international 
      definition. RESULTS: After adjusting for lifestyle factors, including other diet 
      and BMI variables, compared with children who never ate hamburgers, we found an 
      independent risk of hamburger consumption on having a history of wheeze 
      [consumption less than once a week (OR = 1.44, 95% CI: 1.06-1.96) and 1+ times a 
      week (OR = 1.65, 95% CI: 1.07-2.52)] and on current wheeze [consumption less than 
      once a week (OR = 1.17, 95% CI: 0.80-1.70) and 1+ times a week (OR = 1.81, 95% 
      CI: 1.10-2.98)]. Takeaway consumption 1+ times a week was marginally 
      significantly related to BHR (OR = 2.41, 95% CI: 0.99-5.91). There was no effect 
      on atopy. CONCLUSIONS: Frequent consumption of hamburgers showed a dose-dependent 
      association with asthma symptoms, and frequent takeaway consumption showed a 
      similar association with BHR.
FAU - Wickens, K
AU  - Wickens K
AD  - Wellington Asthma Research Group, Wellington School of Medicine and Health 
      Sciences, Wellington, New Zealand.
FAU - Barry, D
AU  - Barry D
FAU - Friezema, A
AU  - Friezema A
FAU - Rhodius, R
AU  - Rhodius R
FAU - Bone, N
AU  - Bone N
FAU - Purdie, G
AU  - Purdie G
FAU - Crane, J
AU  - Crane J
LA  - eng
PT  - Journal Article
PL  - Denmark
TA  - Allergy
JT  - Allergy
JID - 7804028
SB  - IM
MH  - Adult
MH  - Animals
MH  - Asthma/*epidemiology/*etiology
MH  - Beverages/*adverse effects
MH  - Bronchial Hyperreactivity/epidemiology/etiology
MH  - Cattle
MH  - Child
MH  - Cross-Sectional Studies
MH  - Diet/*adverse effects
MH  - Female
MH  - Humans
MH  - Male
MH  - Meat Products/*adverse effects
MH  - Prevalence
MH  - Respiratory Sounds/etiology
MH  - Risk Factors
MH  - Skin Tests
EDAT- 2005/11/04 09:00
MHDA- 2006/01/27 09:00
CRDT- 2005/11/04 09:00
PHST- 2005/11/04 09:00 [pubmed]
PHST- 2006/01/27 09:00 [medline]
PHST- 2005/11/04 09:00 [entrez]
AID - ALL945 [pii]
AID - 10.1111/j.1398-9995.2005.00945.x [doi]
PST - ppublish
SO  - Allergy. 2005 Dec;60(12):1537-41. doi: 10.1111/j.1398-9995.2005.00945.x.

PMID- 27287237
OWN - NLM
STAT- MEDLINE
DCOM- 20170808
LR  - 20171211
IS  - 1460-2091 (Electronic)
IS  - 0305-7453 (Linking)
VI  - 71
IP  - 10
DP  - 2016 Oct
TI  - Assessment of appropriate antimicrobial prescribing: do experts agree?
PG  - 2980-7
LID - 10.1093/jac/dkw207 [doi]
AB  - OBJECTIVES: Little is known about the validity and reliability of expert 
      assessments of the quality of antimicrobial prescribing, despite their importance 
      in antimicrobial stewardship. We investigated how infectious disease doctors' 
      assessments compared with a reference standard (modal expert opinion) and with 
      the assessments of their colleagues. METHODS: Twenty-four doctors specialized in 
      infectious diseases or clinical microbiology (16 specialists and 8 residents) 
      from five hospitals were asked to assess the appropriateness of antimicrobial 
      agents prescribed for a broad spectrum of indications in 56 paper cases. They 
      were instructed how to handle guideline applicability and deviations. We created 
      a reference standard of antimicrobial appropriateness using the modal assessment 
      of 16 specialists. We calculated criterion validity and interrater and intrarater 
      overall and specific agreement with an index expert (senior infectious disease 
      physician) and analysed the influence of doctor characteristics on validity. 
      RESULTS: Specialists agreed with the reference standard in 80% of cases (range 
      75%-86%), with a sensitivity and specificity of 75% and 84%, respectively. This 
      did not differ by clinical specialty, hospital or years of experience, and 
      residents had similar results. Specialists agreed with the index expert in 76% of 
      cases and the index expert agreed with his previous assessments in 71% of cases. 
      CONCLUSIONS: Doctors specialized in infectious diseases and clinical microbiology 
      assess the appropriateness of antimicrobials prescribed for a broad spectrum of 
      indications with acceptable agreement and validity, regardless of their 
      experience or hospital of employment. However, there is room for improvement, 
      which merits attention in multidisciplinary discussions and education.
CI  - (c) The Author 2016. Published by Oxford University Press on behalf of the British 
      Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, 
      please e-mail: journals.permissions@oup.com.
FAU - Sikkens, Jonne J
AU  - Sikkens JJ
AD  - Department of Internal Medicine, VU University Medical Centre, Amsterdam, The 
      Netherlands EMGO Institute for Health and Care Research, Amsterdam, The 
      Netherlands Research and Expertise Centre in Pharmacotherapy Education (RECIPE), 
      Amsterdam, The Netherlands j.sikkens@vumc.nl.
FAU - van Agtmael, Michiel A
AU  - van Agtmael MA
AD  - Department of Internal Medicine, VU University Medical Centre, Amsterdam, The 
      Netherlands Research and Expertise Centre in Pharmacotherapy Education (RECIPE), 
      Amsterdam, The Netherlands.
FAU - Peters, Edgar J G
AU  - Peters EJ
AD  - Department of Internal Medicine, VU University Medical Centre, Amsterdam, The 
      Netherlands.
FAU - Vandenbroucke-Grauls, Christina M J E
AU  - Vandenbroucke-Grauls CM
AD  - Department of Medical Microbiology and Infection Control, VU University Medical 
      Centre, Amsterdam, The Netherlands.
FAU - Kramer, Mark H H
AU  - Kramer MH
AD  - Department of Internal Medicine, VU University Medical Centre, Amsterdam, The 
      Netherlands.
FAU - de Vet, Henrica C W
AU  - de Vet HC
AD  - EMGO Institute for Health and Care Research, Amsterdam, The Netherlands 
      Department of Epidemiology and Biostatistics, VU University Medical Centre, 
      Amsterdam, The Netherlands.
LA  - eng
PT  - Journal Article
DEP - 20160610
PL  - England
TA  - J Antimicrob Chemother
JT  - The Journal of antimicrobial chemotherapy
JID - 7513617
RN  - 0 (Anti-Bacterial Agents)
SB  - IM
MH  - Anti-Bacterial Agents/administration & dosage/*therapeutic use
MH  - Communicable Diseases/*drug therapy
MH  - *Drug Prescriptions/standards/statistics & numerical data
MH  - Hospitals
MH  - Humans
MH  - Physicians
MH  - Practice Patterns, Physicians'
EDAT- 2016/06/12 06:00
MHDA- 2017/08/09 06:00
CRDT- 2016/06/12 06:00
PHST- 2016/02/08 00:00 [received]
PHST- 2016/05/03 00:00 [accepted]
PHST- 2016/06/12 06:00 [entrez]
PHST- 2016/06/12 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - dkw207 [pii]
AID - 10.1093/jac/dkw207 [doi]
PST - ppublish
SO  - J Antimicrob Chemother. 2016 Oct;71(10):2980-7. doi: 10.1093/jac/dkw207. Epub 
      2016 Jun 10.

PMID- 11079675
OWN - NLM
STAT- MEDLINE
DCOM- 20010102
LR  - 20220316
IS  - 0735-1097 (Print)
IS  - 0735-1097 (Linking)
VI  - 36
IP  - 5
DP  - 2000 Nov 1
TI  - Pulmonary valve replacement in adults late after repair of tetralogy of fallot: 
      are we operating too late?
PG  - 1670-5
AB  - OBJECTIVES: The purpose of this study is to evaluate right ventricular (RV) 
      volume and function after pulmonary valve replacement (PVR) and to address the 
      issue of optimal surgical timing in these patients. BACKGROUND: Chronic pulmonary 
      regurgitation (PR) following repair of tetralogy of Fallot (TOF) leads to RV 
      dilation and an increased incidence of sudden cardiac death in adult patients. 
      METHODS: We studied 25 consecutive adult patients who underwent PVR for 
      significant PR late after repair of TOF. Radionuclide angiography was performed 
      in all at a mean of 8.2 months (+/- 8 months) before PVR and repeated at a mean 
      of 28.0 months (+/- 22.8 months) after the operation. Right ventricular (RV) 
      end-systolic volume (RVESV), RV end-diastolic volume (RVEDV) and RV ejection 
      fraction (RVEF) were measured. RESULTS: Mean RVEDV, RVESV and RVEF remained 
      unchanged after PVR (227.1 ml versus 214.9 ml, p = 0.74; 157.4 ml versus 155.4 
      ml, p = 0.94; 35.6% versus 34.7%, p = 0.78, respectively). Of the 10 patients 
      with RVEF > or = 0.40 before PVR, 5 patients (50%) maintained a RVEF > or = 0.40 
      following PVR, whereas only 2 out of 15 patients (13%) with pre-operative values 
      <0.40 reached an RVEF > or = 0.40 postoperatively (p < 0.001). CONCLUSIONS: Right 
      ventricular recovery following PVR for chronic significant pulmonary 
      regurgitation after repair of TOF may be compromised in the adult population. In 
      order to maintain adequate RV contractility, pulmonary valve implant in these 
      patients should be considered before RV function deteriorates.
FAU - Therrien, J
AU  - Therrien J
AD  - University of Toronto Congenital Cardiac Center for Adults, Ontario, Canada.
FAU - Siu, S C
AU  - Siu SC
FAU - McLaughlin, P R
AU  - McLaughlin PR
FAU - Liu, P P
AU  - Liu PP
FAU - Williams, W G
AU  - Williams WG
FAU - Webb, G D
AU  - Webb GD
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - J Am Coll Cardiol
JT  - Journal of the American College of Cardiology
JID - 8301365
SB  - IM
CIN - J Am Coll Cardiol. 2001 Jun 1;37(7):2008-9. doi: 10.1016/s0735-1097(01)01256-6. 
      PMID: 11401149
MH  - Adolescent
MH  - Adult
MH  - Child
MH  - Child, Preschool
MH  - Female
MH  - *Heart Valve Prosthesis
MH  - Humans
MH  - Male
MH  - Pulmonary Valve
MH  - Pulmonary Valve Insufficiency/etiology/mortality/physiopathology/*surgery
MH  - Radionuclide Angiography
MH  - Survival Rate
MH  - Tetralogy of Fallot/*complications/mortality/physiopathology
MH  - Time Factors
MH  - Ventricular Function, Right
EDAT- 2000/11/18 11:00
MHDA- 2001/02/28 10:01
CRDT- 2000/11/18 11:00
PHST- 2000/11/18 11:00 [pubmed]
PHST- 2001/02/28 10:01 [medline]
PHST- 2000/11/18 11:00 [entrez]
AID - S0735-1097(00)00930-X [pii]
AID - 10.1016/s0735-1097(00)00930-x [doi]
PST - ppublish
SO  - J Am Coll Cardiol. 2000 Nov 1;36(5):1670-5. doi: 10.1016/s0735-1097(00)00930-x.

PMID- 10331115
OWN - NLM
STAT- MEDLINE
DCOM- 20000105
LR  - 20190815
IS  - 0006-3223 (Print)
IS  - 0006-3223 (Linking)
VI  - 45
IP  - 9
DP  - 1999 May 1
TI  - Is amoxapine an atypical antipsychotic? Positron-emission tomography 
      investigation of its dopamine2 and serotonin2 occupancy.
PG  - 1217-20
AB  - BACKGROUND: All currently available atypical antipsychotics have, at clinically 
      relevant doses: i) high serotonin (5-HT)2 occupancy; ii) greater 5-HT2 than 
      dopamine (D)2 occupancy; and iii) a higher incidence of extrapyramidal side 
      effects when their D2 occupancy exceeds 80%. A review of pharmacologic and 
      behavioral data suggested that amoxapine should also conform to this profile; 
      therefore, we undertook a positron-emission tomography (PET) study of its 5-HT2 
      and D2 occupancy. METHODS: Seven healthy volunteers received 50-250 mg/day of 
      amoxapine for 5 days and then had [11C]-raclopride and [18F]-setoperone PET 
      scans. RESULTS: 5-HT2 receptors showed near saturation at doses of 100 mg/day and 
      above. The D2 receptor occupancies showed a dose-dependent increase, never 
      exceeding 80%; at all doses 5-HT2 occupancy exceeded D2 occupancy. CONCLUSIONS: 
      PET data show that amoxapine's profile is very similar to that of the established 
      atypical antipsychotics. These data, together with amoxapine's in vitro 
      pharmacologic profile, effectiveness in animal models, and efficacy in psychotic 
      depression raise the possibility of amoxapine as an "atypical" antipsychotic 
      agent in the treatment of schizophrenia.
FAU - Kapur, S
AU  - Kapur S
AD  - Clarke Institute of Psychiatry, Center for Addictions and Mental Health, Toronto, 
      Ontario, Canada.
FAU - Cho, R
AU  - Cho R
FAU - Jones, C
AU  - Jones C
FAU - McKay, G
AU  - McKay G
FAU - Zipursky, R B
AU  - Zipursky RB
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Biol Psychiatry
JT  - Biological psychiatry
JID - 0213264
RN  - 0 (Receptors, Dopamine D2)
RN  - 0 (Receptors, Serotonin)
RN  - R63VQ857OT (Amoxapine)
SB  - IM
MH  - Adult
MH  - Amoxapine/*metabolism/*therapeutic use
MH  - Brain/*diagnostic imaging
MH  - Female
MH  - Humans
MH  - Male
MH  - Psychotic Disorders/*diagnostic imaging/*drug therapy
MH  - Receptors, Dopamine D2/*metabolism
MH  - Receptors, Serotonin/*metabolism
MH  - Tomography, Emission-Computed
EDAT- 1999/05/20 00:00
MHDA- 1999/05/20 00:01
CRDT- 1999/05/20 00:00
PHST- 1999/05/20 00:00 [pubmed]
PHST- 1999/05/20 00:01 [medline]
PHST- 1999/05/20 00:00 [entrez]
AID - S0006-3223(98)00204-2 [pii]
AID - 10.1016/s0006-3223(98)00204-2 [doi]
PST - ppublish
SO  - Biol Psychiatry. 1999 May 1;45(9):1217-20. doi: 10.1016/s0006-3223(98)00204-2.

PMID- 18594195
OWN - NLM
STAT- MEDLINE
DCOM- 20080916
LR  - 20191110
IS  - 1594-0667 (Print)
IS  - 1594-0667 (Linking)
VI  - 20
IP  - 3
DP  - 2008 Jun
TI  - Do older patients who refuse to participate in a self-management intervention in 
      the Netherlands differ from older patients who agree to participate?
PG  - 266-71
AB  - BACKGROUND AND AIMS: Refusal of patients to participate in intervention programs 
      is an important problem in clinical trials but, in general, researchers devote 
      relatively little attention to it. In this article, a comparison is made between 
      patients who, after having been invited, agreed to participate in a 
      self-management intervention (participants) and those who refused (refusers). 
      Compared with other studies of refusers, relatively more information could be 
      gathered with regard to both their characteristics and reasons for refusing, 
      because all potential participants were invited personally. METHODS: Older 
      patients from a Dutch outpatient clinic were invited to participate in a 
      self-management intervention, and their characteristics were assessed. 
      Demographic data were collected, as well as data on physical functioning and lack 
      of emotional support. People who refused to participate were asked to give their 
      reasons for refusing. RESULTS: Of the 361 patients invited, 267 (74%) refused 
      participation. These refusers were more restricted in their mobility, lived 
      further away from the location of the intervention, and had a partner more often 
      than did the participants. No differences were found in level of education, age 
      or gender. The main reasons given by respondents for refusing to participate were 
      lack of time, travel distance, and transport problems. CONCLUSIONS: As in many 
      studies, the refusal rate in this study is high, and seems to be related to 
      physical mobility restrictions, travel distance and, partly, to availability of 
      emotional support. These findings may be used to make the recruitment process 
      more effective - for example, by offering transport to the location of the 
      intervention.
FAU - Elzen, Henrike
AU  - Elzen H
AD  - Department of Internal Medicine and Geriatrics, University Medical Center 
      Groningen, University of Groningen, 9700 RB Groningen, The Netherlands. 
      h.a.elzen@int.umcg.nl
FAU - Slaets, Joris P
AU  - Slaets JP
FAU - Snijders, Tom A
AU  - Snijders TA
FAU - Steverink, Nardi
AU  - Steverink N
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Germany
TA  - Aging Clin Exp Res
JT  - Aging clinical and experimental research
JID - 101132995
SB  - IM
MH  - Aged
MH  - Female
MH  - Humans
MH  - Logistic Models
MH  - Male
MH  - Motor Activity
MH  - Netherlands
MH  - Patients/*statistics & numerical data
MH  - Refusal to Participate/*statistics & numerical data
MH  - Self Care/*statistics & numerical data
MH  - Surveys and Questionnaires
EDAT- 2008/07/03 09:00
MHDA- 2008/09/17 09:00
CRDT- 2008/07/03 09:00
PHST- 2008/07/03 09:00 [pubmed]
PHST- 2008/09/17 09:00 [medline]
PHST- 2008/07/03 09:00 [entrez]
AID - 4667 [pii]
AID - 10.1007/BF03324777 [doi]
PST - ppublish
SO  - Aging Clin Exp Res. 2008 Jun;20(3):266-71. doi: 10.1007/BF03324777.

PMID- 22497340
OWN - NLM
STAT- MEDLINE
DCOM- 20130211
LR  - 20120619
IS  - 1651-2251 (Electronic)
IS  - 0001-6489 (Linking)
VI  - 132
IP  - 7
DP  - 2012 Jul
TI  - Is horizontal semicircular canal ocular reflex influenced by otolith organs 
      input?
PG  - 715-9
LID - 10.3109/00016489.2012.656286 [doi]
AB  - CONCLUSION: Otolith organs input influences the axis of horizontal semicircular 
      canal ocular reflex; therefore, the plane of compensatory eye movements induced 
      by the horizontal canal stimulation is not always parallel to the canal. 
      OBJECTIVE: To clarify whether horizontal canal ocular reflex is influenced by 
      otolith organs input. METHODS: The subjects were seven healthy humans. The right 
      ear was stimulated using ice-water. Each subject was kept in a left-ear-down 
      position for 20 s and then repositioned to a prone position, a right-ear-down 
      position and a supine position with 20 s intervals. Nystagmus was analysed using 
      three-dimensional video-oculography. RESULTS: Eye movements in the supine 
      position and the prone position were not in a symmetric fashion. Nystagmus in the 
      left-ear-down position and the right-ear-down position were not symmetric either. 
      These phenomena indicate that the axis of the eyeball rotation was affected by 
      the shift of the direction of gravity exerted on the head.
FAU - Ichijo, Hiroaki
AU  - Ichijo H
AD  - Ichijo Ear, Nose and Throat Clinic, Ekimae, Hirosaki, Japan. 
      hiro3387@mvj.biglobe.ne.jp
LA  - eng
PT  - Journal Article
DEP - 20120412
PL  - England
TA  - Acta Otolaryngol
JT  - Acta oto-laryngologica
JID - 0370354
SB  - IM
MH  - Adult
MH  - Head Movements
MH  - Humans
MH  - Male
MH  - Nystagmus, Physiologic/physiology
MH  - Otolithic Membrane/*physiology
MH  - Physical Stimulation
MH  - Prone Position
MH  - Reference Values
MH  - Reflex, Vestibulo-Ocular/*physiology
MH  - Semicircular Canals/physiology
MH  - Supine Position
MH  - Young Adult
EDAT- 2012/04/14 06:00
MHDA- 2013/02/12 06:00
CRDT- 2012/04/14 06:00
PHST- 2012/04/14 06:00 [entrez]
PHST- 2012/04/14 06:00 [pubmed]
PHST- 2013/02/12 06:00 [medline]
AID - 10.3109/00016489.2012.656286 [doi]
PST - ppublish
SO  - Acta Otolaryngol. 2012 Jul;132(7):715-9. doi: 10.3109/00016489.2012.656286. Epub 
      2012 Apr 12.

PMID- 16769333
OWN - NLM
STAT- MEDLINE
DCOM- 20061002
LR  - 20220311
IS  - 1531-5037 (Electronic)
IS  - 0022-3468 (Linking)
VI  - 41
IP  - 6
DP  - 2006 Jun
TI  - Preoperative tracheobronchoscopy in newborns with esophageal atresia: does it 
      matter?
PG  - 1054-7
AB  - BACKGROUND/PURPOSE: Despite surgical refinements, perioperative use of 
      tracheobronchoscopy (TBS) as part of surgical approach to esophageal atresia (EA) 
      is still controversial. The purpose of this study was to evaluate the influence 
      of preoperative TBS in newborns with EA in preventing complications and improving 
      diagnosis and surgical treatment. METHODS: In the period ranging from 1997 to 
      2003, 62 patients with EA underwent preoperative TBS. The procedure was carried 
      out with flexible bronchoscope maintaining spontaneous breathing. When a wide 
      carinal fistula was found, this was mechanically occluded by Fogarty catheter and 
      cannulated with rigid bronchoscopy. Type of EA, surgical procedure variations 
      caused by TBS, and associated anomalies not easily detectable were recorded. 
      RESULTS: Before TBS, the Gross classification of the 62 patients was as follows: 
      type A, 9 patients; type B, none; type C, 51 patients. At TBS, however, 3 of 9 
      type A patients had an unsuspected proximal fistula (type B). These 3 patients, 
      plus the 2 with H-type fistula, were repaired through a cervical approach. In 4 
      patients, previously undetected malformations of the respiratory tree (2 aberrant 
      right upper bronchus and 2 hypoplastic bronchi) were found at TBS. Carinal 
      fistulas in 14 type C patients were occluded by Fogarty catheter to improve 
      ventilation during repair. No complications were observed. Overall, TBS was 
      clinically useful in 28 (45.2%) of 62 patients, including 15 (24.2%) of 62 
      infants in whom it was crucial in modifying the surgical approach. CONCLUSION: 
      Tracheobronchoscopy is a useful and safe procedure and should be recommended in 
      tertiary centers for babies with EA before surgical repair.
FAU - Atzori, Pietro
AU  - Atzori P
AD  - Neonatal Surgery Unit-Department of Medical and Surgical Neonatology, Bambino 
      Gesu Childrens' Hospital, Rome-00165 Italy. pietroatzori@tiscali.it
FAU - Iacobelli, Barbara D
AU  - Iacobelli BD
FAU - Bottero, Sergio
AU  - Bottero S
FAU - Spirydakis, Joannis
AU  - Spirydakis J
FAU - Laviani, Raoul
AU  - Laviani R
FAU - Trucchi, Alessandro
AU  - Trucchi A
FAU - Braguglia, Annabella
AU  - Braguglia A
FAU - Bagolan, Pietro
AU  - Bagolan P
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
PL  - United States
TA  - J Pediatr Surg
JT  - Journal of pediatric surgery
JID - 0052631
SB  - IM
MH  - *Bronchoscopy/standards
MH  - *Digestive System Surgical Procedures
MH  - Endoscopy/standards
MH  - Esophageal Atresia/*pathology/*surgery
MH  - Female
MH  - Humans
MH  - Infant, Newborn
MH  - Male
MH  - Postoperative Complications/prevention & control
MH  - Preoperative Care
MH  - Respiratory Tract Fistula/pathology/surgery
MH  - Retrospective Studies
MH  - Trachea/*pathology
EDAT- 2006/06/14 09:00
MHDA- 2006/10/03 09:00
CRDT- 2006/06/14 09:00
PHST- 2006/06/14 09:00 [pubmed]
PHST- 2006/10/03 09:00 [medline]
PHST- 2006/06/14 09:00 [entrez]
AID - S0022-3468(06)00088-1 [pii]
AID - 10.1016/j.jpedsurg.2006.01.074 [doi]
PST - ppublish
SO  - J Pediatr Surg. 2006 Jun;41(6):1054-7. doi: 10.1016/j.jpedsurg.2006.01.074.

PMID- 20571467
OWN - NLM
STAT- MEDLINE
DCOM- 20100903
LR  - 20151119
IS  - 1534-6080 (Electronic)
IS  - 0041-1337 (Linking)
VI  - 90
IP  - 3
DP  - 2010 Aug 15
TI  - Is it appropriate to implant kidneys from elderly donors in young recipients?
PG  - 286-91
LID - 10.1097/TP.0b013e3181e36dee [doi]
AB  - BACKGROUND: Kidneys from elderly donors tend to be implanted in recipients who 
      are also elderly. We present the results obtained after 10 years of evolution on 
      transplanting elderly kidneys into young recipients. METHODS: Ninety-one 
      consecutive transplants are studied, carried out in our center with kidneys from 
      cadaver donors older than 60 years implanted in recipients younger than 60 years. 
      The control group is made up of 91 transplants, matched with those from the study 
      group, whose donor and recipient were younger than 60 years. RESULTS: There were 
      no differences between groups with regard to recipient age, sex, cause of death 
      and renal function of the donor, hepatitis C and cytomegalovirus serologies, cold 
      ischemia time, tubular necrosis, immediate diuresis, need for dialysis, human 
      leukocyte antigen incompatibilities, hypersensitized patients, acute rejection, 
      waiting time on dialysis, and days of admission. Survival in both groups at 1, 5, 
      and 10 years was 97.6%, 87.2%, and 76.6% vs. 98.8%, 87.5%, and 69.5% for the 
      patient (P=0.642), 92.9%, 81.3%, and 64.2% vs. 93.9%, 76.4%, and 69.5% for the 
      graft (P=0.980), and 94.4%, 92.6%, and 77.4% vs. 94.3%, 86.7%, and 84.4% for the 
      graft with death censured (P=0.747), respectively. Creatininaemias at 1, 5, and 
      10 years were 172, 175, and 210 vs. 139, 134, and 155 (P<0.05). CONCLUSIONS: We 
      conclude that patient and graft survival on transplanting kidneys from elderly 
      donors to young recipients is superimposable on that obtained with young donors. 
      However, renal function is better in the group of young donors.
FAU - Sola, Ricard
AU  - Sola R
AD  - CIBER of Epidemiology and Public Health, Barcelona, Spain. 
      rsola@fundacio-puigvert.es
FAU - Guirado, Lluis
AU  - Guirado L
FAU - Lopez-Navidad, Antonio
AU  - Lopez-Navidad A
FAU - Bonfill, Xavier
AU  - Bonfill X
FAU - Diaz, Joan-Manuel
AU  - Diaz JM
FAU - Puig, Teresa
AU  - Puig T
FAU - Facundo, Carmen
AU  - Facundo C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Transplantation
JT  - Transplantation
JID - 0132144
RN  - 0 (Biomarkers)
RN  - AYI8EX34EU (Creatinine)
SB  - IM
CIN - Transplantation. 2010 Aug 15;90(3):246-7. doi: 10.1097/TP.0b013e3181e46a54. PMID: 
      20526236
MH  - Adult
MH  - Age Factors
MH  - Aged
MH  - Biomarkers/blood
MH  - Case-Control Studies
MH  - Chi-Square Distribution
MH  - Creatinine/blood
MH  - *Donor Selection
MH  - Female
MH  - Glomerular Filtration Rate
MH  - *Graft Survival
MH  - Humans
MH  - Kaplan-Meier Estimate
MH  - *Kidney Transplantation/adverse effects/mortality
MH  - Male
MH  - Middle Aged
MH  - Prospective Studies
MH  - *Resource Allocation
MH  - Risk Assessment
MH  - Risk Factors
MH  - Time Factors
MH  - Tissue Donors/*supply & distribution
MH  - Treatment Outcome
MH  - Young Adult
EDAT- 2010/06/24 06:00
MHDA- 2010/09/04 06:00
CRDT- 2010/06/24 06:00
PHST- 2010/06/24 06:00 [entrez]
PHST- 2010/06/24 06:00 [pubmed]
PHST- 2010/09/04 06:00 [medline]
AID - 10.1097/TP.0b013e3181e36dee [doi]
PST - ppublish
SO  - Transplantation. 2010 Aug 15;90(3):286-91. doi: 10.1097/TP.0b013e3181e36dee.

PMID- 12094116
OWN - NLM
STAT- MEDLINE
DCOM- 20021209
LR  - 20220409
IS  - 0022-4707 (Print)
IS  - 0022-4707 (Linking)
VI  - 42
IP  - 3
DP  - 2002 Sep
TI  - Is muscle power related to running speed with changes of direction?
PG  - 282-8
AB  - BACKGROUND: The purpose of this study was to identify the relationships between 
      leg muscle power and sprinting speed with changes of direction. EXPERIMENTAL 
      DESIGN: the study was designed to describe relationships between physical 
      qualities and a component of sports performance. SETTING: testing was conducted 
      in an indoor sports hall and a biomechanics laboratory. PARTICIPANTS: 15 male 
      participants were required to be free of injury and have recent experience 
      competing in sports involving sprints with changes of direction. MEASURES: 
      subjects were timed in 8 m sprints in a straight line and with various changes of 
      direction. They were also tested for bilateral and unilateral leg extensor muscle 
      concentric power output by an isokinetic squat and reactive strength by a drop 
      jump. RESULTS: The correlations between concentric power and straight sprinting 
      speed were non-significant whereas the relationships between reactive strength 
      and straight speed were statistically significant. Correlations between muscle 
      power and speed while changing direction were generally low and non-significant 
      for concentric leg power with some moderate and significant (p<0.05) coefficients 
      found for reactive strength. The participants who turned faster to one side 
      tended to have a reactive strength dominance in the leg responsible for the 
      push-off action. CONCLUSIONS: The relationships between leg muscle power and 
      change-of-direction speed were not consistent. Reactive strength as measured by 
      the drop jump appears to have some importance for lateral change-of-direction 
      speed, possibly because of similar push-off actions. It was concluded that 
      reactive strength of the leg extensor muscles has some importance in 
      change-of-direction performance but the other technical and perceptual factors 
      than influence agility performance should also be considered.
FAU - Young, W B
AU  - Young WB
AD  - School of Human Movement and Sport Sciences, University of Ballarat, Ballarat, 
      Victoria, Australia. w.young@ballarat.edu.au
FAU - James, R
AU  - James R
FAU - Montgomery, I
AU  - Montgomery I
LA  - eng
PT  - Journal Article
PL  - Italy
TA  - J Sports Med Phys Fitness
JT  - The Journal of sports medicine and physical fitness
JID - 0376337
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Humans
MH  - Kinesis/*physiology
MH  - Leg/physiology
MH  - Male
MH  - Muscle Contraction/physiology
MH  - Muscle, Skeletal/*physiology
MH  - Reaction Time/physiology
MH  - Running/*physiology
EDAT- 2002/07/03 10:00
MHDA- 2002/12/10 04:00
CRDT- 2002/07/03 10:00
PHST- 2002/07/03 10:00 [pubmed]
PHST- 2002/12/10 04:00 [medline]
PHST- 2002/07/03 10:00 [entrez]
PST - ppublish
SO  - J Sports Med Phys Fitness. 2002 Sep;42(3):282-8.

PMID- 17276182
OWN - NLM
STAT- MEDLINE
DCOM- 20070403
LR  - 20070205
IS  - 1558-3597 (Electronic)
IS  - 0735-1097 (Linking)
VI  - 49
IP  - 5
DP  - 2007 Feb 6
TI  - Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors 
      in the pathogenesis of atrial fibrillation?
PG  - 578-86
AB  - OBJECTIVES: This study sought to evaluate mutations in genes encoding the slow 
      component of the cardiac delayed rectifier K+ current (I(Ks)) channel in familial 
      atrial fibrillation (AF). BACKGROUND: Although AF can have a genetic etiology, 
      links between inherited gene defects and acquired factors such as atrial stretch 
      have not been explored. METHODS: Mutation screening of the KCNQ1, KCNE1, KCNE2, 
      and KCNE3 genes was performed in 50 families with AF. The effects of mutant 
      protein on cardiac I(Ks) activation were evaluated using electrophysiological 
      studies and human atrial action potential modeling. RESULTS: One missense KCNQ1 
      mutation, R14C, was identified in 1 family with a high prevalence of 
      hypertension. Atrial fibrillation was present only in older individuals who had 
      developed atrial dilation and who were genotype positive. Patch-clamp studies of 
      wild-type or R14C KCNQ1 expressed with KCNE1 in CHO cells showed no statistically 
      significant differences between wild-type and mutant channel kinetics at 
      baseline, or after activation of adenylate cyclase with forskolin. After exposure 
      to hypotonic solution to elicit cell swelling/stretch, mutant channels showed a 
      marked increase in current, a leftward shift in the voltage dependence of 
      activation, altered channel kinetics, and shortening of the modeled atrial action 
      potential duration. CONCLUSIONS: These data suggest that the R14C KCNQ1 mutation 
      alone is insufficient to cause AF. Rather, we suggest a model in which a "second 
      hit", such as an environmental factor like hypertension, which promotes atrial 
      stretch and thereby unmasks an inherited defect in ion channel kinetics (the 
      "first hit"), is required for AF to be manifested. Such a model would also 
      account for the age-related increase in AF development.
FAU - Otway, Robyn
AU  - Otway R
AD  - Sr. Bernice Research Program in Inherited Heart Diseases, Darlinghurst, New South 
      Wales, Australia.
FAU - Vandenberg, Jamie I
AU  - Vandenberg JI
FAU - Guo, Guanglan
AU  - Guo G
FAU - Varghese, Anthony
AU  - Varghese A
FAU - Castro, M Leticia
AU  - Castro ML
FAU - Liu, Jian
AU  - Liu J
FAU - Zhao, JingTing
AU  - Zhao J
FAU - Bursill, Jane A
AU  - Bursill JA
FAU - Wyse, Ken R
AU  - Wyse KR
FAU - Crotty, Haley
AU  - Crotty H
FAU - Baddeley, Olivia
AU  - Baddeley O
FAU - Walker, Bruce
AU  - Walker B
FAU - Kuchar, Dennis
AU  - Kuchar D
FAU - Thorburn, Charles
AU  - Thorburn C
FAU - Fatkin, Diane
AU  - Fatkin D
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20070122
PL  - United States
TA  - J Am Coll Cardiol
JT  - Journal of the American College of Cardiology
JID - 8301365
RN  - 0 (KCNQ1 Potassium Channel)
RN  - 0 (KCNQ1 protein, human)
RN  - 0 (Potassium Channels, Voltage-Gated)
SB  - IM
MH  - Action Potentials/physiology
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Atrial Fibrillation/*genetics/physiopathology
MH  - Cohort Studies
MH  - Female
MH  - Heart Atria/physiopathology
MH  - Humans
MH  - KCNQ1 Potassium Channel/*genetics
MH  - Male
MH  - Middle Aged
MH  - Mutation, Missense/*genetics
MH  - Pedigree
MH  - Potassium Channels, Voltage-Gated/*physiology
EDAT- 2007/02/06 09:00
MHDA- 2007/04/04 09:00
CRDT- 2007/02/06 09:00
PHST- 2006/07/14 00:00 [received]
PHST- 2006/09/05 00:00 [revised]
PHST- 2006/09/27 00:00 [accepted]
PHST- 2007/02/06 09:00 [pubmed]
PHST- 2007/04/04 09:00 [medline]
PHST- 2007/02/06 09:00 [entrez]
AID - S0735-1097(06)02864-6 [pii]
AID - 10.1016/j.jacc.2006.09.044 [doi]
PST - ppublish
SO  - J Am Coll Cardiol. 2007 Feb 6;49(5):578-86. doi: 10.1016/j.jacc.2006.09.044. Epub 
      2007 Jan 22.

PMID- 26419377
OWN - NLM
STAT- MEDLINE
DCOM- 20170502
LR  - 20181202
IS  - 1433-7347 (Electronic)
IS  - 0942-2056 (Linking)
VI  - 25
IP  - 1
DP  - 2017 Jan
TI  - Are pelvic anatomical structures in danger during arthroscopic acetabular labral 
      repair? Definition of safe bone depth.
PG  - 45-49
LID - 10.1007/s00167-015-3797-z [doi]
AB  - PURPOSE: The purpose of this study was to evaluate safe depth for suture anchor 
      insertion during acetabular labral repair and to determine the neighbouring 
      structures at risk during drilling and anchor insertion. METHODS: Ten human 
      cadaveric hips (six males and four females) were obtained. Acetabular labral 
      surface was prepared and marked for right hips as 12, 1 and 3 o'clock positions, 
      for left hips 12, 11 and 9 o'clock positions. Those were defined as anterior, 
      anterior-superior and superior zones, respectively. These labral positions were 
      drilled at defined zones. After measurements, depth of the bone at 10 degrees  and 20 degrees  
      drill angles on zones was compared statistically. RESULTS: Acetabular bone widths 
      at investigated labral insertion points did not statistically differ. A total of 
      14 injuries in 60 penetrations occurred (23.3 %) with free drill penetrations, 
      and no injuries occurred with stopped drill penetrations. The bone depth was 
      gradually decreasing from 10 degrees  to 20 degrees  drill angles and from anterior to superior 
      inserting zones without significant importance. The risk of perforation to the 
      pelvic cavity started with 20 mm drill depth, and the mean depth for all 
      insertions was calculated as 31.7 mm (SD 2.6). CONCLUSIONS: It is anatomically 
      possible that some pelvic structures sustain iatrogenic injury during acetabular 
      drilling for anchor placement. Being aware of mean pelvic vault is important in 
      which drilling after excessive pincer rim trimming could easily decrease the 
      depth of acetabular bone without a standard. Careful drilling by using stopped 
      drill bit is crucial to prevent iatrogenic injury.
FAU - Gereli, Arel
AU  - Gereli A
AD  - Department of Orthopaedics and Traumatology, Faculty of Medicine, Acibadem 
      University, Soyak Evreka, A Blok, D:43, Soganlik, Kartal, Istanbul, Turkey.
FAU - Kocaoglu, Baris
AU  - Kocaoglu B
AD  - Department of Orthopaedics and Traumatology, Faculty of Medicine, Acibadem 
      University, Soyak Evreka, A Blok, D:43, Soganlik, Kartal, Istanbul, Turkey. 
      bariskocaoglu@gmail.com.
FAU - Ulku, Kerem Tekin
AU  - Ulku KT
AD  - Department of Orthopaedics and Traumatology, Faculty of Medicine, Acibadem 
      University, Soyak Evreka, A Blok, D:43, Soganlik, Kartal, Istanbul, Turkey.
FAU - Veli Ismailoglu, Abdul
AU  - Veli Ismailoglu A
AD  - Department of Anatomy, Faculty of Medicine, Acibadem University, Istanbul, 
      Turkey.
FAU - Silay, Sena
AU  - Silay S
AD  - Department of Anatomy, Faculty of Medicine, Acibadem University, Istanbul, 
      Turkey.
FAU - Karahan, Mustafa
AU  - Karahan M
AD  - Department of Orthopaedics and Traumatology, Faculty of Medicine, Acibadem 
      University, Soyak Evreka, A Blok, D:43, Soganlik, Kartal, Istanbul, Turkey.
LA  - eng
PT  - Journal Article
DEP - 20150929
PL  - Germany
TA  - Knee Surg Sports Traumatol Arthrosc
JT  - Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA
JID - 9314730
SB  - IM
MH  - Acetabulum/*surgery
MH  - Arthroscopy/adverse effects
MH  - Cadaver
MH  - Cartilage, Articular/surgery
MH  - Female
MH  - Hip Joint/*surgery
MH  - Humans
MH  - Male
MH  - Pelvis/*injuries
MH  - Postoperative Complications/etiology/prevention & control
MH  - Safety
MH  - Suture Anchors/*adverse effects
OTO - NOTNLM
OT  - Acetabulum
OT  - Arthroscopy
OT  - Drilling
OT  - Injury
OT  - Labrum
OT  - Pelvic structures
EDAT- 2015/10/01 06:00
MHDA- 2017/05/04 06:00
CRDT- 2015/10/01 06:00
PHST- 2015/05/30 00:00 [received]
PHST- 2015/09/15 00:00 [accepted]
PHST- 2015/10/01 06:00 [pubmed]
PHST- 2017/05/04 06:00 [medline]
PHST- 2015/10/01 06:00 [entrez]
AID - 10.1007/s00167-015-3797-z [pii]
AID - 10.1007/s00167-015-3797-z [doi]
PST - ppublish
SO  - Knee Surg Sports Traumatol Arthrosc. 2017 Jan;25(1):45-49. doi: 
      10.1007/s00167-015-3797-z. Epub 2015 Sep 29.

PMID- 23810330
OWN - NLM
STAT- MEDLINE
DCOM- 20131031
LR  - 20220331
IS  - 1532-2157 (Electronic)
IS  - 0748-7983 (Linking)
VI  - 39
IP  - 9
DP  - 2013 Sep
TI  - Is intraoperative neuromonitoring associated with better functional outcome in 
      patients undergoing open TME? Results of a case-control study.
PG  - 994-9
LID - S0748-7983(13)00414-9 [pii]
LID - 10.1016/j.ejso.2013.06.004 [doi]
AB  - AIMS: Intraoperative neuromonitoring (IONM) aims to control nerve-sparing total 
      mesorectal excision (TME) for rectal cancer in order to improve patients' 
      functional outcome. This study was designed to compare the urogenital and 
      anorectal functional outcome of TME with and without IONM of innervation to the 
      bladder and the internal anal sphincter. METHODS: A consecutive series of 150 
      patients with primary rectal cancer were analysed. Fifteen match pairs with open 
      TME and combined urogenital and anorectal functional assessment at follow up were 
      established identical regarding gender, tumour site, tumour stage, neoadjuvant 
      radiotherapy and type of surgery. Urogenital and anorectal function was evaluated 
      prospectively on the basis of self-administered standardized questionnaires, 
      measurement of residual urine volume and longterm-catheterization rate. RESULTS: 
      Newly developed urinary dysfunction after surgery was reported by 1 of 15 
      patients in the IONM group and by 6 of 15 in the control group (p = 0.031). 
      Postoperative residual urine volume was significantly higher in the control 
      group. At follow up impaired anorectal function was present in 1 of 15 patients 
      undergoing TME with IONM and in 6 of 15 without IONM (p = 0.031). The IONM group 
      showed a trend towards a lower rate of sexual dysfunction after surgery. 
      CONCLUSIONS: In this study TME with IONM was associated with significant lower 
      rates of urinary and anorectal dysfunction. Prospective randomized trials are 
      mandatory to evaluate the definite role of IONM in rectal cancer surgery.
CI  - Copyright (c) 2013. Published by Elsevier Ltd.
FAU - Kneist, W
AU  - Kneist W
AD  - Department of General, Visceral and Transplant Surgery, University Medicine of 
      the Johannes Gutenberg-University Mainz, Langenbeckstrasse 1, 55131 Mainz, 
      Germany. Electronic address: werner.kneist@unimedizin-mainz.de.
FAU - Kauff, D W
AU  - Kauff DW
FAU - Juhre, V
AU  - Juhre V
FAU - Hoffmann, K P
AU  - Hoffmann KP
FAU - Lang, H
AU  - Lang H
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20130628
PL  - England
TA  - Eur J Surg Oncol
JT  - European journal of surgical oncology : the journal of the European Society of 
      Surgical Oncology and the British Association of Surgical Oncology
JID - 8504356
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Anal Canal/*innervation
MH  - *Autonomic Pathways
MH  - Case-Control Studies
MH  - Cohort Studies
MH  - Fecal Incontinence/prevention & control
MH  - Female
MH  - Humans
MH  - Lower Urinary Tract Symptoms/prevention & control
MH  - Male
MH  - Middle Aged
MH  - Monitoring, Intraoperative
MH  - Organ Sparing Treatments
MH  - Peripheral Nerve Injuries/*prevention & control
MH  - Prospective Studies
MH  - Rectal Neoplasms/*surgery
MH  - Rectum/*surgery
MH  - Sexual Dysfunction, Physiological/prevention & control
MH  - Treatment Outcome
MH  - Urinary Bladder/*innervation
OTO - NOTNLM
OT  - Anal sphincter
OT  - Autonomic nerves
OT  - Electric stimulation
OT  - Electromyography
OT  - Intraoperative monitoring
OT  - Rectal cancer
EDAT- 2013/07/03 06:00
MHDA- 2013/11/01 06:00
CRDT- 2013/07/02 06:00
PHST- 2013/01/24 00:00 [received]
PHST- 2013/03/28 00:00 [revised]
PHST- 2013/06/06 00:00 [accepted]
PHST- 2013/07/02 06:00 [entrez]
PHST- 2013/07/03 06:00 [pubmed]
PHST- 2013/11/01 06:00 [medline]
AID - S0748-7983(13)00414-9 [pii]
AID - 10.1016/j.ejso.2013.06.004 [doi]
PST - ppublish
SO  - Eur J Surg Oncol. 2013 Sep;39(9):994-9. doi: 10.1016/j.ejso.2013.06.004. Epub 
      2013 Jun 28.

PMID- 15151701
OWN - NLM
STAT- MEDLINE
DCOM- 20040819
LR  - 20191210
IS  - 1472-6963 (Electronic)
IS  - 1472-6963 (Linking)
VI  - 4
IP  - 1
DP  - 2004 May 19
TI  - Profiling quality of care: Is there a role for peer review?
PG  - 9
AB  - BACKGROUND: We sought to develop a more reliable structured implicit chart review 
      instrument for use in assessing the quality of care for chronic disease and to 
      examine if ratings are more reliable for conditions in which the evidence base 
      for practice is more developed. METHODS: We conducted a reliability study in a 
      cohort with patient records including both outpatient and inpatient care as the 
      objects of measurement. We developed a structured implicit review instrument to 
      assess the quality of care over one year of treatment. 12 reviewers conducted a 
      total of 496 reviews of 70 patient records selected from 26 VA clinical sites in 
      two regions of the country. Each patient had between one and four conditions 
      specified as having a highly developed evidence base (diabetes and hypertension) 
      or a less developed evidence base (chronic obstructive pulmonary disease or a 
      collection of acute conditions). Multilevel analysis that accounts for the nested 
      and cross-classified structure of the data was used to estimate the signal and 
      noise components of the measurement of quality and the reliability of implicit 
      review. RESULTS: For COPD and a collection of acute conditions the reliability of 
      a single physician review was quite low (intra-class correlation = 0.16-0.26) but 
      comparable to most previously published estimates for the use of this method in 
      inpatient settings. However, for diabetes and hypertension the reliability is 
      significantly higher at 0.46. The higher reliability is a result of the reviewers 
      collectively being able to distinguish more differences in the quality of care 
      between patients (p < 0.007) and not due to less random noise or individual 
      reviewer bias in the measurement. For these conditions the level of true quality 
      (i.e. the rating of quality of care that would result from the full population of 
      physician reviewers reviewing a record) varied from poor to good across patients. 
      CONCLUSIONS: For conditions with a well-developed quality of care evidence base, 
      such as hypertension and diabetes, a single structured implicit review to assess 
      the quality of care over a period of time is moderately reliable. This method 
      could be a reasonable complement or alternative to explicit indicator approaches 
      for assessing and comparing quality of care. Structured implicit review, like 
      explicit quality measures, must be used more cautiously for illnesses for which 
      the evidence base is less well developed, such as COPD and acute, short-course 
      illnesses.
FAU - Hofer, Timothy P
AU  - Hofer TP
AD  - Veterans Affairs Health Services Research and Development Center of Excellence, 
      Veterans Affairs Ann Arbor Healthcare System, Michigan, USA. thofer@umich.edu
FAU - Asch, Steven M
AU  - Asch SM
FAU - Hayward, Rodney A
AU  - Hayward RA
FAU - Rubenstein, Lisa V
AU  - Rubenstein LV
FAU - Hogan, Mary M
AU  - Hogan MM
FAU - Adams, John
AU  - Adams J
FAU - Kerr, Eve A
AU  - Kerr EA
LA  - eng
GR  - P60-972573/PHS HHS/United States
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, U.S. Gov't, P.H.S.
PT  - Validation Study
DEP - 20040519
PL  - England
TA  - BMC Health Serv Res
JT  - BMC health services research
JID - 101088677
SB  - IM
MH  - Acute Disease/therapy
MH  - Chronic Disease/classification/therapy
MH  - Cohort Studies
MH  - Continuity of Patient Care
MH  - Diabetes Mellitus/*therapy
MH  - Disease Management
MH  - Evidence-Based Medicine
MH  - Health Services Misuse
MH  - Humans
MH  - Hypertension/*therapy
MH  - Internal Medicine/*standards
MH  - Los Angeles
MH  - Medical Records
MH  - Michigan
MH  - Observer Variation
MH  - Outcome and Process Assessment, Health Care
MH  - Peer Review, Health Care/*methods
MH  - Primary Health Care/*standards
MH  - Pulmonary Disease, Chronic Obstructive/*therapy
MH  - Quality Assurance, Health Care/*methods
MH  - Veterans
PMC - PMC434524
EDAT- 2004/05/21 05:00
MHDA- 2004/08/20 05:00
PMCR- 2004/05/19
CRDT- 2004/05/21 05:00
PHST- 2004/02/05 00:00 [received]
PHST- 2004/05/19 00:00 [accepted]
PHST- 2004/05/21 05:00 [pubmed]
PHST- 2004/08/20 05:00 [medline]
PHST- 2004/05/21 05:00 [entrez]
PHST- 2004/05/19 00:00 [pmc-release]
AID - 1472-6963-4-9 [pii]
AID - 10.1186/1472-6963-4-9 [doi]
PST - epublish
SO  - BMC Health Serv Res. 2004 May 19;4(1):9. doi: 10.1186/1472-6963-4-9.

PMID- 23736032
OWN - NLM
STAT- MEDLINE
DCOM- 20130910
LR  - 20240210
IS  - 1532-1827 (Electronic)
IS  - 0007-0920 (Print)
IS  - 0007-0920 (Linking)
VI  - 108
IP  - 12
DP  - 2013 Jun 25
TI  - Multidisciplinary decisions in breast cancer: does the patient receive what the 
      team has recommended?
PG  - 2442-7
LID - 10.1038/bjc.2013.267 [doi]
AB  - BACKGROUND: A multidisciplinary team (MDT) approach to breast cancer management 
      is the gold standard. The aim is to evaluate MDT decision making in a modern 
      breast unit. METHODS: All referrals to the breast MDT where breast cancer was 
      diagnosed from 1 July 2009 to 30 June 2011 were included. Multidisciplinary team 
      decisions were compared with subsequent patient management and classified as 
      concordant or discordant. RESULTS: Over the study period, there were 3230 MDT 
      decisions relating to 705 patients. Overall, 91.5% (2956 out of 3230) of 
      decisions were concordant, 4.5% (146 out of 3230), were discordant and 4% (128 
      out of 3230) had no MDT decision. Of 146 discordant decisions, 26 (17.8%) were 
      considered 'unjustifiable' as there was no additional information available after 
      the MDT to account for the change in management. The remaining 120 discordant MDT 
      decisions were considered 'justifiable', as management was altered due to patient 
      choice (n=61), additional information available after MDT (n=54) or MDT error 
      (n=5). CONCLUSION: The vast majority of MDT decisions are implemented. Management 
      alteration was most often due to patient choice or additional information 
      available after the MDT. A minority of management alterations were 
      'unjustifiable' and the authors recommend that any patient whose treatment is 
      subsequently changed should have MDT rediscussion prior to treatment.
FAU - Rajan, S
AU  - Rajan S
AD  - Cambridge Breast Unit, Box 97, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 
      0QQ, UK. sabrinarajan@gmail.com
FAU - Foreman, J
AU  - Foreman J
FAU - Wallis, M G
AU  - Wallis MG
FAU - Caldas, C
AU  - Caldas C
FAU - Britton, P
AU  - Britton P
LA  - eng
GR  - 16942/CRUK_/Cancer Research UK/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20130604
PL  - England
TA  - Br J Cancer
JT  - British journal of cancer
JID - 0370635
SB  - IM
MH  - Breast Neoplasms/epidemiology/*therapy
MH  - Carcinoma/epidemiology/*therapy
MH  - Choice Behavior
MH  - *Decision Making/physiology
MH  - Female
MH  - Guideline Adherence/statistics & numerical data
MH  - Humans
MH  - *Interdisciplinary Communication
MH  - Medical Errors/statistics & numerical data
MH  - Patient Access to Records/statistics & numerical data
MH  - Patient Care Team/*organization & administration
MH  - Patient Compliance/statistics & numerical data
MH  - Patient Education as Topic/organization & administration
MH  - *Physician-Patient Relations
MH  - Referral and Consultation/statistics & numerical data
MH  - Retrospective Studies
PMC - PMC3694248
EDAT- 2013/06/06 06:00
MHDA- 2013/09/11 06:00
PMCR- 2014/06/25
CRDT- 2013/06/06 06:00
PHST- 2013/06/06 06:00 [entrez]
PHST- 2013/06/06 06:00 [pubmed]
PHST- 2013/09/11 06:00 [medline]
PHST- 2014/06/25 00:00 [pmc-release]
AID - bjc2013267 [pii]
AID - 10.1038/bjc.2013.267 [doi]
PST - ppublish
SO  - Br J Cancer. 2013 Jun 25;108(12):2442-7. doi: 10.1038/bjc.2013.267. Epub 2013 Jun 
      4.

PMID- 28143468
OWN - NLM
STAT- MEDLINE
DCOM- 20170830
LR  - 20231104
IS  - 1472-6963 (Electronic)
IS  - 1472-6963 (Linking)
VI  - 17
IP  - 1
DP  - 2017 Jan 31
TI  - Are performance measurement systems useful? Perceptions from health care.
PG  - 96
LID - 10.1186/s12913-017-2022-9 [doi]
LID - 96
AB  - BACKGROUND: Prior literature identified the use of Performance Measurement 
      Systems (PMS) as crucial in addressing improved processes of care. Moreover, a 
      strategic use of PMS has been found to enhance quality, compared to non-strategic 
      use, although a clear understanding of this linkage is still to be achieved. This 
      paper deals with the test of direct and indirect models related to the link 
      between the strategic use of PMS and the level of improved processes in health 
      care organizations. Indirect models were mediated by the degree of perceived 
      managerial discretion. METHODS: A PLS analysis on a survey of 97 Italian managers 
      working for health care organizations in the Lombardy region was conducted. The 
      response rate was 77.6%. RESULTS: The strategic use of PMS in health care 
      organizations directly and significantly (p < 0.001) enhances performance in 
      terms of improved processes. Perceived managerial discretion is positively and 
      significantly (p < 0.001) affected by the strategic use of PMS, whereas the 
      mediation effect is non-significant. CONCLUSIONS: This study contributes to the 
      literature investigating the design and implementation of a non-financial 
      measurement tool, such as the non-financial information included into a balanced 
      scorecard (BSC), in health care organizations. Managers in health care 
      organizations can benefit from the strategic use of PMS to effectively allocate 
      their time to strategic opportunities and threats, which might arise and affect 
      organizational, output-related performance, such as improving processes.
FAU - Demartini, Chiara
AU  - Demartini C
AD  - Department of Economics and Management, University of Pavia, Via S. Felice, 5/7, 
      27100, Pavia, Italy.
FAU - Trucco, Sara
AU  - Trucco S
AD  - Faculty of Economics, Rome University of International Studies, Via Cristoforo 
      Colombo, 200, 00147, Rome, Italy. sara.trucco@unint.eu.
LA  - eng
PT  - Journal Article
DEP - 20170131
PL  - England
TA  - BMC Health Serv Res
JT  - BMC health services research
JID - 101088677
SB  - IM
MH  - Administrative Personnel/*psychology
MH  - Female
MH  - *Health Knowledge, Attitudes, Practice
MH  - Humans
MH  - Italy
MH  - Male
MH  - *Quality Indicators, Health Care
MH  - Surveys and Questionnaires
PMC - PMC5282789
OTO - NOTNLM
OT  - Health care
OT  - PLS-SEM
OT  - Perceived managerial discretion
OT  - Performance measures
OT  - Process improvement
EDAT- 2017/02/02 06:00
MHDA- 2017/08/31 06:00
PMCR- 2017/01/31
CRDT- 2017/02/02 06:00
PHST- 2016/09/07 00:00 [received]
PHST- 2017/01/16 00:00 [accepted]
PHST- 2017/02/02 06:00 [entrez]
PHST- 2017/02/02 06:00 [pubmed]
PHST- 2017/08/31 06:00 [medline]
PHST- 2017/01/31 00:00 [pmc-release]
AID - 10.1186/s12913-017-2022-9 [pii]
AID - 2022 [pii]
AID - 10.1186/s12913-017-2022-9 [doi]
PST - epublish
SO  - BMC Health Serv Res. 2017 Jan 31;17(1):96. doi: 10.1186/s12913-017-2022-9.

PMID- 23495128
OWN - NLM
STAT- MEDLINE
DCOM- 20141024
LR  - 20140304
IS  - 1557-0681 (Electronic)
IS  - 1478-2189 (Linking)
VI  - 12
IP  - 1
DP  - 2014 Mar
TI  - The colour of pain: can patients use colour to describe osteoarthritis pain?
PG  - 34-46
LID - 10.1002/msc.1048 [doi]
AB  - OBJECTIVE: The aim of the present study was to explore patients' views on the 
      acceptability and feasibility of using colour to describe osteoarthritis (OA) 
      pain, and whether colour could be used to communicate pain to healthcare 
      professionals. METHODS: Six group interviews were conducted with 17 patients with 
      knee OA. Discussion topics included first impressions about using colour to 
      describe pain, whether participants could associate their pain with colour, how 
      colours related to changes to intensity and different pain qualities, and whether 
      they could envisage using colour to describe pain to healthcare professionals. 
      RESULTS: The group interviews indicated that, although the idea of using colour 
      was generally acceptable, it did not suit all participants as a way of describing 
      their pain. The majority of participants chose red to describe high-intensity 
      pain; the reasons given were because red symbolized inflammation, fire, anger and 
      the stop signal in a traffic light system. Colours used to describe the absence 
      of pain were chosen because of their association with positive emotional 
      feelings, such as purity, calmness and happiness. A range of colours was chosen 
      to represent changes in pain intensity. Aching pain was consistently identified 
      as being associated with colours such as grey or black, whereas sharp pain was 
      described using a wider selection of colours. The majority of participants 
      thought that they would be able to use colour to describe their pain to 
      healthcare professionals, although issues around the interpretability and 
      standardization of colour were raised. CONCLUSIONS: For some patients, using 
      colour to describe their pain experience may be a useful tool to improve 
      doctor-patient communication.
CI  - Copyright (c) 2013 John Wiley & Sons, Ltd.
FAU - Wylde, Vikki
AU  - Wylde V
AD  - Musculoskeletal Research Unit, School of Clinical Sciences, University of 
      Bristol, Southmead Hospital, Bristol, UK.
FAU - Wells, Victoria
AU  - Wells V
FAU - Dixon, Samantha
AU  - Dixon S
FAU - Gooberman-Hill, Rachael
AU  - Gooberman-Hill R
LA  - eng
PT  - Journal Article
DEP - 20130313
PL  - England
TA  - Musculoskeletal Care
JT  - Musculoskeletal care
JID - 101181344
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - *Color
MH  - *Communication
MH  - Feasibility Studies
MH  - Female
MH  - Humans
MH  - Interviews as Topic
MH  - Male
MH  - Middle Aged
MH  - Nurse-Patient Relations
MH  - Osteoarthritis, Knee/*psychology
MH  - Pain Measurement/*methods
MH  - Physician-Patient Relations
OTO - NOTNLM
OT  - Pain
OT  - colour
OT  - communication
OT  - osteoarthritis
EDAT- 2013/03/16 06:00
MHDA- 2014/10/25 06:00
CRDT- 2013/03/16 06:00
PHST- 2013/03/16 06:00 [entrez]
PHST- 2013/03/16 06:00 [pubmed]
PHST- 2014/10/25 06:00 [medline]
AID - 10.1002/msc.1048 [doi]
PST - ppublish
SO  - Musculoskeletal Care. 2014 Mar;12(1):34-46. doi: 10.1002/msc.1048. Epub 2013 Mar 
      13.

PMID- 12121321
OWN - NLM
STAT- MEDLINE
DCOM- 20020906
LR  - 20190813
IS  - 0013-9580 (Print)
IS  - 0013-9580 (Linking)
VI  - 43 Suppl 5
DP  - 2002
TI  - Do mossy fibers release GABA?
PG  - 196-202
AB  - PURPOSE: Mossy fibers are the sole excitatory projection from dentate gyrus 
      granule cells to the hippocampus, forming part of the trisynaptic hippocampal 
      circuit. They undergo significant plasticity during epileptogenesis and have been 
      implicated in seizure generation. Mossy fibers are a highly unusual projection in 
      the mammalian brain; in addition to glutamate, they release adenosine, dynorphin, 
      zinc, and possibly other peptides. Mossy fiber terminals also show intense 
      immunoreactivity for the inhibitory neurotransmitter gamma-aminobutyric acid 
      (GABA), and immunoreactivity for GAD67. The purpose of this review is to present 
      physiologic evidence of GABA release by mossy fibers and its modulation by 
      epileptic activity. METHODS: We used hippocampal slices from 3- to 5-week-old 
      guinea pigs and made whole-cell voltage clamp recordings from CA3 pyramidal 
      cells. We placed stimulating electrodes in stratum granulosum and adjusted their 
      position in order to recruit mossy fiber to CA3 projections. RESULTS: We have 
      shown that electrical stimuli that recruit dentate granule cells elicit 
      monosynaptic GABAA receptor-mediated synaptic signals in CA3 pyramidal neurons. 
      These inhibitory signals satisfy the criteria that distinguish mossy fiber-CA3 
      synapses: high sensitivity to metabotropic glutamate-receptor agonists, 
      facilitation during repetitive stimulation, and N-methyl-D-aspartate (NMDA) 
      receptor-independent long-term potentiation. CONCLUSIONS: We have thus provided 
      compelling evidence that there is a mossy fiber GABAergic signal. The physiologic 
      role of this mossy fiber GABAergic signal is uncertain, but may be of 
      developmental importance. Other evidence suggests that this GABAergic signal is 
      transiently upregulated after seizures. This could have an inhibitory or 
      disinhibitory effect, and further work is needed to elucidate its actual role.
FAU - Walker, Matthew C
AU  - Walker MC
AD  - Department of Clinical and Experimental Epilepsy, Institute of Neurology, Queen 
      Square, London WC1N 3BG, UK. m.walker@ion.ucl.ac.uk
FAU - Ruiz, Arnaud
AU  - Ruiz A
FAU - Kullmann, Dimitri M
AU  - Kullmann DM
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Epilepsia
JT  - Epilepsia
JID - 2983306R
RN  - 0 (Receptors, GABA-A)
RN  - 3KX376GY7L (Glutamic Acid)
RN  - 56-12-2 (gamma-Aminobutyric Acid)
SB  - IM
MH  - Animals
MH  - Excitatory Postsynaptic Potentials/physiology
MH  - Glutamic Acid/metabolism
MH  - Guinea Pigs
MH  - In Vitro Techniques
MH  - Mossy Fibers, Hippocampal/*metabolism
MH  - Neural Inhibition/physiology
MH  - Patch-Clamp Techniques
MH  - Pyramidal Cells/metabolism
MH  - Receptors, GABA-A/physiology
MH  - Signal Transduction
MH  - Synapses/metabolism
MH  - Synaptic Transmission/physiology
MH  - gamma-Aminobutyric Acid/*metabolism
EDAT- 2002/07/18 10:00
MHDA- 2002/09/07 10:01
CRDT- 2002/07/18 10:00
PHST- 2002/07/18 10:00 [pubmed]
PHST- 2002/09/07 10:01 [medline]
PHST- 2002/07/18 10:00 [entrez]
AID - epis60041 [pii]
AID - 10.1046/j.1528-1157.43.s.5.6.x [doi]
PST - ppublish
SO  - Epilepsia. 2002;43 Suppl 5:196-202. doi: 10.1046/j.1528-1157.43.s.5.6.x.

PMID- 18570208
OWN - NLM
STAT- MEDLINE
DCOM- 20090611
LR  - 20161124
IS  - 1469-0705 (Electronic)
IS  - 0960-7692 (Linking)
VI  - 32
IP  - 6
DP  - 2008 Nov
TI  - Is severe macrosomia manifested at 11-14 weeks of gestation?
PG  - 740-3
LID - 10.1002/uog.5310 [doi]
AB  - OBJECTIVE: To determine the association between fetal biometry in the first or 
      early second trimester and severe macrosomia at delivery. METHODS: This 
      case-control study included 30 term severely macrosomic neonates; 90 
      appropriate-for-gestational age (AGA) neonates served as controls. All 
      pregnancies underwent nuchal translucency (NT) screening at 11-14 weeks' 
      gestation. Pregnancies were dated by accurate last menstrual period consistent 
      with crown-rump length (CRL) measurements at the time of screening, early 
      pregnancy CRL or date of fertilization. The association between birth weight and 
      the difference between the measured and the expected CRL at the time of NT 
      screening was analyzed. RESULTS: The difference between measured and expected 
      CRL, expressed both in mm and in days of gestation, was statistically greater in 
      the severely macrosomic neonates compared with controls (mean, 6.66 +/- 4.78 mm 
      vs. 1.17 +/- 4.6 mm, P < 0.0001 and 3 +/- 2.2 days vs. 0.5 +/- 2.3 days, P < 
      0.0001, respectively). Furthermore, there were significant correlations between 
      the extent of macrosomia and the discrepancy between expected and measured fetal 
      size at the time of NT screening (r = 0.47, P < 0.01 and r = 0.48, P < 0.01, 
      respectively). CONCLUSION: Severe macrosomia apparently manifests as early as 
      11-14 weeks' gestation.
CI  - (c) 2008 ISUOG. Published by John Wiley & Sons, Ltd.
FAU - Hackmon, R
AU  - Hackmon R
AD  - Lenox Hill Hospital, Department of Obstetrics and Gynecology, New York, NY, USA. 
      rhackmon@fhcrc.org
FAU - Le Scale, K B
AU  - Le Scale KB
FAU - Horani, J
AU  - Horani J
FAU - Ferber, A
AU  - Ferber A
FAU - Divon, M Y
AU  - Divon MY
LA  - eng
PT  - Journal Article
PL  - England
TA  - Ultrasound Obstet Gynecol
JT  - Ultrasound in obstetrics & gynecology : the official journal of the International 
      Society of Ultrasound in Obstetrics and Gynecology
JID - 9108340
SB  - IM
MH  - Biometry
MH  - Case-Control Studies
MH  - Crown-Rump Length
MH  - Female
MH  - Fetal Macrosomia/*diagnostic imaging/physiopathology
MH  - Humans
MH  - Infant, Newborn
MH  - Nuchal Translucency Measurement/*methods
MH  - Pregnancy
MH  - Pregnancy Trimester, First
MH  - Pregnancy Trimester, Second
MH  - Retrospective Studies
MH  - Severity of Illness Index
EDAT- 2008/06/24 09:00
MHDA- 2009/06/12 09:00
CRDT- 2008/06/24 09:00
PHST- 2008/06/24 09:00 [pubmed]
PHST- 2009/06/12 09:00 [medline]
PHST- 2008/06/24 09:00 [entrez]
AID - 10.1002/uog.5310 [doi]
PST - ppublish
SO  - Ultrasound Obstet Gynecol. 2008 Nov;32(6):740-3. doi: 10.1002/uog.5310.

PMID- 28707539
OWN - NLM
STAT- MEDLINE
DCOM- 20170901
LR  - 20240330
IS  - 1748-880X (Electronic)
IS  - 0007-1285 (Print)
IS  - 0007-1285 (Linking)
VI  - 90
IP  - 1077
DP  - 2017 Aug
TI  - Visceral adipose tissue area measurement at a single level: can it represent 
      visceral adipose tissue volume?
PG  - 20170253
LID - 10.1259/bjr.20170253 [doi]
LID - 20170253
AB  - OBJECTIVE: Measurement of visceral adipose tissue (VAT) needs to be accurate and 
      sensitive to change for risk monitoring. The purpose of this study is to 
      determine the CT slice location where VAT area can best reflect changes in VAT 
      volume and body weight. METHODS: 60 plain abdominal CT images from 30 males [mean 
      age (range) 51 (41-68) years, mean body weight (range) 71.1 (101.9-50.9) kg] who 
      underwent workplace screenings twice within a 1-year interval were evaluated. 
      Automatically calculated and manually corrected areas of the VAT of various scan 
      levels using "freeform curve" region of interest on CT were recorded and compared 
      with body weight changes. RESULTS: The strongest correlations of VAT area with 
      VAT volume and body weight changes were shown in a slice 3 cm above the lower 
      margin of L3 with r values of 0.853 and 0.902, respectively. CONCLUSION: VAT area 
      measurement at a single level 3 cm above the lower margin of the L3 vertebra is 
      feasible and can reflect changes in VAT volume and body weight. Advances in 
      knowledge: As VAT area at a CT slice 3cm above the lower margin of L3 can best 
      reflect interval changes in VAT volume and body weight, VAT area measurement 
      should be selected at this location.
FAU - Noumura, Yusuke
AU  - Noumura Y
AD  - 1 Department of Health Sciences, Hokkaido University , Sapporo , Japan.
FAU - Kamishima, Tamotsu
AU  - Kamishima T
AD  - 2 Department of Biomedical Science and Engineering, Faculty of Health Sciences, 
      Hokkaido University , Sapporo , Japan.
FAU - Sutherland, Kenneth
AU  - Sutherland K
AD  - 3 Division of Photonic Bioimaging, Faculty of Medicine Research Center for 
      Cooperative Projects, Hokkaido University , Sapporo , Japan.
FAU - Nishimura, Hideho
AU  - Nishimura H
AD  - 4 Sapporo Ryokuai Hospital , Sapporo , Japan.
LA  - eng
PT  - Journal Article
DEP - 20170714
PL  - England
TA  - Br J Radiol
JT  - The British journal of radiology
JID - 0373125
SB  - IM
MH  - Abdomen/anatomy & histology
MH  - Adult
MH  - Aged
MH  - Humans
MH  - Intra-Abdominal Fat/*anatomy & histology
MH  - Male
MH  - Middle Aged
MH  - *Multidetector Computed Tomography
MH  - Reproducibility of Results
MH  - Retrospective Studies
PMC - PMC5858805
EDAT- 2017/07/15 06:00
MHDA- 2017/09/02 06:00
PMCR- 2018/08/01
CRDT- 2017/07/15 06:00
PHST- 2017/07/15 06:00 [pubmed]
PHST- 2017/09/02 06:00 [medline]
PHST- 2017/07/15 06:00 [entrez]
PHST- 2018/08/01 00:00 [pmc-release]
AID - 10.1259/bjr.20170253 [doi]
PST - ppublish
SO  - Br J Radiol. 2017 Aug;90(1077):20170253. doi: 10.1259/bjr.20170253. Epub 2017 Jul 
      14.

PMID- 22117569
OWN - NLM
STAT- MEDLINE
DCOM- 20130517
LR  - 20191210
IS  - 1365-2648 (Electronic)
IS  - 0309-2402 (Linking)
VI  - 68
IP  - 9
DP  - 2012 Sep
TI  - Is an advance care planning model feasible in community palliative care? A 
      multi-site action research approach.
PG  - 2021-33
LID - 10.1111/j.1365-2648.2011.05892.x [doi]
AB  - AIM: This article reports a study to determine the feasibility of an advance care 
      planning model developed with Australian community palliative care services. 
      BACKGROUND: An effective advance care planning programme involves an 
      organizational wide commitment and preparedness for health service reform to 
      embed advance care planning into routine practice. Internationally, such 
      programmes have been implemented predominantly in aged and acute care with more 
      recent work in primary care. METHODS: A multi-site action research was conducted 
      over a 16-month period in 2007-2009 with three Victorian community palliative 
      care services. Using mixed method data collection strategies to assess 
      feasibility, we conducted a baseline audit of staff and clients; analysed 
      relevant documents (client records, policies, procedures and quality improvement 
      strategies) pre-implementation and post-implementation and conducted key 
      informant interviews (n = 9). SETTINGS AND PARTICIPANTS: Three community 
      palliative care services: one regional and two metropolitan services in Victoria, 
      Australia. RESULTS: The services demonstrated that it was feasible to embed the 
      Model into their organizational structures. Advance care planning conversations 
      and involvement of family was an important outcome measure rather than completion 
      rate of advance care planning documents in community settings. Services adapted 
      and applied their own concept of community, which widened the impact of the 
      model. Changes to quality audit processes were essential to consolidate the model 
      into routine palliative care practice. CONCLUSION: An advance care planning model 
      is feasible for community palliative care services. Quality audit processes are 
      an essential component of the Model with documentation of advance care planning 
      discussion established as an important outcome measure.
CI  - (c) 2011 Blackwell Publishing Ltd.
FAU - Blackford, Jeanine
AU  - Blackford J
AD  - School of Nursing & Midwifery La Trobe University, Bundoora Victoria, Australia. 
      j.blackford@latrobe.edu.au
FAU - Street, Annette
AU  - Street A
LA  - eng
PT  - Comparative Study
PT  - Evaluation Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20111127
PL  - England
TA  - J Adv Nurs
JT  - Journal of advanced nursing
JID - 7609811
SB  - IM
MH  - Adult
MH  - Advance Care Planning/*organization & administration
MH  - Advance Directives
MH  - Aged
MH  - Aged, 80 and over
MH  - Community Health Services/*organization & administration
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Models, Organizational
MH  - Palliative Care/*organization & administration
MH  - Program Evaluation
MH  - Rural Population
MH  - Terminal Care/*organization & administration
MH  - Urban Population
MH  - Victoria
EDAT- 2011/11/29 06:00
MHDA- 2013/05/18 06:00
CRDT- 2011/11/29 06:00
PHST- 2011/11/29 06:00 [entrez]
PHST- 2011/11/29 06:00 [pubmed]
PHST- 2013/05/18 06:00 [medline]
AID - 10.1111/j.1365-2648.2011.05892.x [doi]
PST - ppublish
SO  - J Adv Nurs. 2012 Sep;68(9):2021-33. doi: 10.1111/j.1365-2648.2011.05892.x. Epub 
      2011 Nov 27.

PMID- 18783922
OWN - NLM
STAT- MEDLINE
DCOM- 20090511
LR  - 20161124
IS  - 1872-6844 (Electronic)
IS  - 0920-1211 (Linking)
VI  - 82
IP  - 2-3
DP  - 2008 Dec
TI  - Do cytokines have any role in epilepsy?
PG  - 171-6
LID - 10.1016/j.eplepsyres.2008.07.018 [doi]
AB  - OBJECTIVE: We analyzed cytokines levels in patients with epilepsy and new onset 
      seizure and correlated it with various parameters. MATERIALS AND METHODS: After 
      obtaining consent, serum samples from 100 patients with epilepsy or new onset 
      seizure were prospectively collected in the immediate post-ictal phase. In 16 
      patients, a second sample was collected during the seizure-free period. The serum 
      cytokine levels [TNF-alpha, IFN-gamma, IL-1beta, IL-2, IL-4, and IL-6] were 
      assessed (ELISA) in these patients and 100 matched healthy controls. CSF analysis 
      was carried out in 9 patients of this cohort, when clinically indicated. RESULTS: 
      The type of seizures (n=100) was major (45), partial (41) and status epilepticus 
      (SE=14), while the epilepsy syndromes were idiopathic generalized (53) and 
      localization related (47). The detectable serum cytokines in the patient group 
      (n=100) were: IL-6 (42), TNF-alpha (36), IL-2 (22), IL-4 (22), IFN-gamma (20) and 
      IL-1 (11) compared to the controls. CSF IL-6 and IL-1 was detectable in 4/9 and 
      2/9 patients, respectively while, IL-2, IL-4, IFN-gamma was detectable 1 in each 
      patient. Correlations were noted between male gender and IL-1beta (p=0.04), 
      positive family history and IL-1beta (p=0.001), "no alcohol use" and TNF-alpha 
      (p=0.05), more than one year history of epilepsy and IL-1beta (p=0.02), status 
      epilepticus (SE) and IL-6 (p=0.04). There was no difference between the new onset 
      seizures vs. epilepsy group. Serial analysis during the seizure-free period 
      revealed a decrease in cytokine levels: TNF-alpha (25% to 12.5%), IFN-gamma 
      (12.5% to 0%), IL-1 (25% to 0) and IL-2 (6.2% to 6.2%), IL-4 (18.8% to 0%) and 
      IL-6 (18.8% to 6.2%). CONCLUSIONS: We found increased post-ictal serum cytokine 
      levels in patients with several epilepsy syndromes.
FAU - Sinha, S
AU  - Sinha S
AD  - Department of Neurology, NIMHANS, Bangalore, India. sanjib_sinha2004@yahoo.co.in
FAU - Patil, S A
AU  - Patil SA
FAU - Jayalekshmy, V
AU  - Jayalekshmy V
FAU - Satishchandra, P
AU  - Satishchandra P
LA  - eng
PT  - Journal Article
DEP - 20080909
PL  - Netherlands
TA  - Epilepsy Res
JT  - Epilepsy research
JID - 8703089
RN  - 0 (Cytokines)
RN  - 0 (Interleukins)
RN  - 0 (Tumor Necrosis Factor-alpha)
RN  - 82115-62-6 (Interferon-gamma)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Age of Onset
MH  - Aged
MH  - Alcoholism/epidemiology
MH  - Child
MH  - Child, Preschool
MH  - Cytokines/blood/cerebrospinal fluid/*physiology
MH  - Epilepsies, Partial/blood/cerebrospinal fluid/diagnostic 
      imaging/epidemiology/physiopathology
MH  - Epilepsy/blood/cerebrospinal fluid/diagnostic 
      imaging/epidemiology/*physiopathology
MH  - Female
MH  - Humans
MH  - Infant
MH  - Inflammation/blood/epidemiology
MH  - Interferon-gamma/blood/cerebrospinal fluid
MH  - Interleukins/blood/cerebrospinal fluid
MH  - Male
MH  - Middle Aged
MH  - Prospective Studies
MH  - Status Epilepticus/blood/cerebrospinal fluid/diagnostic 
      imaging/epidemiology/physiopathology
MH  - Tomography, X-Ray Computed
MH  - Tumor Necrosis Factor-alpha/analysis/cerebrospinal fluid
MH  - Young Adult
EDAT- 2008/09/12 09:00
MHDA- 2009/05/12 09:00
CRDT- 2008/09/12 09:00
PHST- 2008/03/13 00:00 [received]
PHST- 2008/07/28 00:00 [revised]
PHST- 2008/07/28 00:00 [accepted]
PHST- 2008/09/12 09:00 [pubmed]
PHST- 2009/05/12 09:00 [medline]
PHST- 2008/09/12 09:00 [entrez]
AID - S0920-1211(08)00220-9 [pii]
AID - 10.1016/j.eplepsyres.2008.07.018 [doi]
PST - ppublish
SO  - Epilepsy Res. 2008 Dec;82(2-3):171-6. doi: 10.1016/j.eplepsyres.2008.07.018. Epub 
      2008 Sep 9.

PMID- 15528969
OWN - NLM
STAT- MEDLINE
DCOM- 20050222
LR  - 20220408
IS  - 0167-6806 (Print)
IS  - 0167-6806 (Linking)
VI  - 87
IP  - 3
DP  - 2004 Oct
TI  - Is expert breast pathology assessment necessary for the management of ductal 
      carcinoma in situ ?
PG  - 265-72
AB  - BACKGROUND: Current guidelines include a recommendation that a pathologist with 
      expertise in breast disease review all ductal carcinoma in situ (DCIS) specimens 
      due to the presence of significant variability in pathologic reporting of DCIS. 
      The objective of this study was to evaluate the completeness and accuracy of 
      pathologic reporting of DCIS over the past decade and to determine the current 
      impact of expert breast pathology assessment on the management of DCIS. METHODS: 
      All patients with a diagnosis of DCIS referred to a single regional cancer centre 
      between 1982 and 2000 have been reviewed. Inter-observer variability between 
      initial and secondary reports has been evaluated using kappa statistics. For each 
      case, the Van Nuys Prognostic Index (VNPI) using pathologic data obtained from 
      the initial and reviewed pathology reports were compared. The impact of expert 
      breast pathology on risk assessment and treatment was determined. RESULTS: 481 
      individuals with DCIS were referred and pathology review was performed on 350 
      patients (73%). Inter-observer agreement was high for the main pathologic 
      features of DCIS. From 1996 to 2000, secondary pathology assessments lead to a 
      change in the assessment of local recurrence risk in 100 cases (29%) and 
      contributed to a change in treatment recommendation in 93 (43%) cases. 
      CONCLUSION: Expert breast pathology assessments continue to be necessary in the 
      management of DCIS.
FAU - Rakovitch, Eileen
AU  - Rakovitch E
AD  - Department of Radiation Oncology, Toronto-Sunnybrook Regional Cancer Centre, 
      Sunnybrook and Women's College Health Sciences Centre, 2075 Bayview Avenue, 
      Ontario, Canada. eileen.rakovitch@sw.ca
FAU - Mihai, Alina
AU  - Mihai A
FAU - Pignol, Jean-Philippe
AU  - Pignol JP
FAU - Hanna, Wedad
AU  - Hanna W
FAU - Kwinter, Jennifer
AU  - Kwinter J
FAU - Chartier, Carole
AU  - Chartier C
FAU - Ackerman, Ida
AU  - Ackerman I
FAU - Kim, John
AU  - Kim J
FAU - Pritchard, Kathleen
AU  - Pritchard K
FAU - Paszat, Lawrence
AU  - Paszat L
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
PL  - Netherlands
TA  - Breast Cancer Res Treat
JT  - Breast cancer research and treatment
JID - 8111104
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Biopsy/*methods
MH  - Breast Neoplasms/epidemiology/etiology/*pathology
MH  - Carcinoma, Intraductal, Noninfiltrating/epidemiology/etiology/*pathology
MH  - Decision Support Techniques
MH  - Female
MH  - Humans
MH  - Medical Records
MH  - Middle Aged
MH  - Observer Variation
MH  - Ontario/epidemiology
MH  - Predictive Value of Tests
MH  - Retrospective Studies
EDAT- 2004/11/06 09:00
MHDA- 2005/02/23 09:00
CRDT- 2004/11/06 09:00
PHST- 2004/11/06 09:00 [pubmed]
PHST- 2005/02/23 09:00 [medline]
PHST- 2004/11/06 09:00 [entrez]
AID - 5379454 [pii]
AID - 10.1007/s10549-004-9454-8 [doi]
PST - ppublish
SO  - Breast Cancer Res Treat. 2004 Oct;87(3):265-72. doi: 10.1007/s10549-004-9454-8.

PMID- 19482903
OWN - NLM
STAT- MEDLINE
DCOM- 20090714
LR  - 20091111
IS  - 1538-6724 (Electronic)
IS  - 0031-9023 (Linking)
VI  - 89
IP  - 7
DP  - 2009 Jul
TI  - Treadmill testing of children who have spina bifida and are ambulatory: does peak 
      oxygen uptake reflect maximum oxygen uptake?
PG  - 679-87
LID - 10.2522/ptj.20080328 [doi]
AB  - BACKGROUND: Earlier studies have demonstrated low peak oxygen uptake 
      ((.)Vo(2)peak) in children with spina bifida. Low peak heart rate and low peak 
      respiratory exchange ratio in these studies raised questions regarding the true 
      maximal character of (.)Vo(2)peak values obtained with treadmill testing. 
      OBJECTIVE: The aim of this study was to determine whether the Vo(2)peak measured 
      during an incremental treadmill test is a true reflection of the maximum oxygen 
      uptake ((.)Vo(2)max) in children who have spina bifida and are ambulatory. 
      DESIGN: A cross-sectional design was used for this study. METHODS: Twenty 
      children who had spina bifida and were ambulatory participated. The (.)Vo(2)peak 
      was measured during a graded treadmill exercise test. The validity of 
      (.)Vo(2)peak measurements was evaluated by use of previously described guidelines 
      for maximum exercise testing in children who are healthy, as well as differences 
      between Vo(2)peak and (.)Vo(2) during a supramaximal protocol 
      ((.)Vo(2)supramaximal). RESULTS: The average values for (.)Vo(2)peak and 
      normalized (.)Vo(2)peak were, respectively, 1.23 L/min (SD=0.6) and 34.1 
      mL/kg/min (SD=8.3). Fifteen children met at least 2 of the 3 previously described 
      criteria; one child failed to meet any criteria. Although there were no 
      significant differences between (.)Vo(2)peak and Vo(2)supramaximal, 5 children 
      did show improvement during supramaximal testing. LIMITATIONS: These results 
      apply to children who have spina bifida and are at least community ambulatory. 
      CONCLUSIONS: The (.)Vo(2)peak measured during an incremental treadmill test seems 
      to reflect the true (.)Vo(2)max in children who have spina bifida and are 
      ambulatory, validating the use of a treadmill test for these children. When 
      confirmation of maximal effort is needed, the addition of supramaximal testing of 
      children with disability is an easy and well-tolerated method.
FAU - de Groot, Janke Frederike
AU  - de Groot JF
AD  - Research Group Lifestyle and Health, University of Applied Sciences, Utrecht, the 
      Netherlands. J.F.deGroot-16@umcutrecht.nl
FAU - Takken, Tim
AU  - Takken T
FAU - de Graaff, Sanna
AU  - de Graaff S
FAU - Gooskens, Rob H J M
AU  - Gooskens RH
FAU - Helders, Paul J M
AU  - Helders PJ
FAU - Vanhees, Luc
AU  - Vanhees L
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20090529
PL  - United States
TA  - Phys Ther
JT  - Physical therapy
JID - 0022623
SB  - IM
MH  - Child
MH  - Cross-Sectional Studies
MH  - Exercise Test/methods
MH  - Female
MH  - Heart Rate/physiology
MH  - Humans
MH  - Locomotion/physiology
MH  - Male
MH  - Mobility Limitation
MH  - Oxygen Consumption/*physiology
MH  - Physical Endurance/physiology
MH  - Pulmonary Ventilation/physiology
MH  - Spinal Dysraphism/*physiopathology
MH  - Walking/*physiology
EDAT- 2009/06/02 09:00
MHDA- 2009/07/15 09:00
CRDT- 2009/06/02 09:00
PHST- 2009/06/02 09:00 [entrez]
PHST- 2009/06/02 09:00 [pubmed]
PHST- 2009/07/15 09:00 [medline]
AID - ptj.20080328 [pii]
AID - 10.2522/ptj.20080328 [doi]
PST - ppublish
SO  - Phys Ther. 2009 Jul;89(7):679-87. doi: 10.2522/ptj.20080328. Epub 2009 May 29.

PMID- 11977907
OWN - NLM
STAT- MEDLINE
DCOM- 20020612
LR  - 20191105
IS  - 1051-2284 (Print)
IS  - 1051-2284 (Linking)
VI  - 12
IP  - 2
DP  - 2002 Apr
TI  - Subclavian steal syndrome: can the blood pressure difference between arms predict 
      the severity of steal?
PG  - 131-5
AB  - BACKGROUND AND PURPOSE: A side-to-side difference in systolic brachial arterial 
      blood pressure is a common finding in subclavian artery stenosis and is 
      frequently used as a screening tool for subclavian steal syndrome (SSS). It was 
      the goal of this retrospective study to investigate the relationship between 
      different vertebral artery waveform types and the side-to-side difference in 
      systolic blood pressure in patients with sonographically proven SSS. METHODS: The 
      records of 1860 patients from the Neuroultrasound Laboratory between January 2000 
      and December 2000 were screened for the diagnosis of SSS in the final ultrasound 
      report. In all patients, bilateral brachial arterial blood pressure was measured 
      in a sitting position prior to the ultrasound examination. Vertebral artery 
      waveforms were classified as (1) systolic deceleration, (2) alternating flow, and 
      (3) complete reversal at rest. Blood pressure difference as calculated by 
      normal-side blood pressure minus lesion-side blood pressure was compared with the 
      3 Doppler waveform types. RESULTS: SSS was found in 51 of 1860 (2.7%) 
      ultrasonography studies of 49 patients (17 men, 32 women; mean age 65.3 +/- 10.5 
      years). Two patients (4%) had bilateral SSS. In 3 patients (6%), SSS was related 
      to an innominate artery stenosis. Waveform analysis showed a completely reversed 
      flow in 16 (31%), an alternating flow in 24 (47%), and a systolic deceleration in 
      11 (22%) cases. Systolic blood pressure difference was significantly higher in 
      the complete reversal and alternating groups than in the systolic deceleration 
      group (P < .001). CONCLUSION: Brachial systolic blood pressure difference is 
      related to the severity of SSS and can be used as a screening tool for SSS. 
      However, it performed better in severe steal than milder steal phenomena.
FAU - Tan, Teng-Yeow
AU  - Tan TY
AD  - Department of Neurology (I), Chang Gung Memorial Hospital, 123 Ta-Pei Road, 
      Niao-Sung Hsiang, Kaohsiung Hsien 833, Taiwan. tengyeowtan@yahoo.com
FAU - Schminke, Ulf
AU  - Schminke U
FAU - Lien, Li-Ming
AU  - Lien LM
FAU - Tegeler, Charles H
AU  - Tegeler CH
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Neuroimaging
JT  - Journal of neuroimaging : official journal of the American Society of 
      Neuroimaging
JID - 9102705
SB  - IM
MH  - Aged
MH  - Analysis of Variance
MH  - Arm/blood supply
MH  - Blood Flow Velocity/physiology
MH  - Blood Pressure/*physiology
MH  - Female
MH  - Hemodynamics
MH  - Humans
MH  - Male
MH  - Retrospective Studies
MH  - Risk Factors
MH  - Subclavian Steal Syndrome/*diagnostic imaging/*physiopathology
MH  - Ultrasonography, Doppler
MH  - Vertebral Artery/diagnostic imaging/physiopathology
EDAT- 2002/04/30 10:00
MHDA- 2002/06/13 10:01
CRDT- 2002/04/30 10:00
PHST- 2002/04/30 10:00 [pubmed]
PHST- 2002/06/13 10:01 [medline]
PHST- 2002/04/30 10:00 [entrez]
AID - 10.1111/j.1552-6569.2002.tb00109.x [doi]
PST - ppublish
SO  - J Neuroimaging. 2002 Apr;12(2):131-5. doi: 10.1111/j.1552-6569.2002.tb00109.x.

PMID- 17306983
OWN - NLM
STAT- MEDLINE
DCOM- 20070628
LR  - 20080214
IS  - 1010-7940 (Print)
IS  - 1010-7940 (Linking)
VI  - 31
IP  - 4
DP  - 2007 Apr
TI  - Is size-reducing ascending aortoplasty with external reinforcement an option in 
      modern aortic surgery?
PG  - 614-7
AB  - OBJECTIVE: Enlargement of the ascending aorta is often combined with valvular, 
      coronary, or other cardiac diseases. Reduction aortoplasty can be an optional 
      therapy; however, indications regarding the diameter of aorta, the history of 
      dilatation (poststenosis, bicuspid aortic valve), or the intraoperative 
      management (wall excision, reduction suture, external reinforcement) are not 
      established. METHODS: In a retrospective study between 1997 and 2005, we 
      investigated 531 patients operated for aneurysm or ectasia of the ascending aorta 
      (diameter: 45-76mm). Of these, in 50 patients, size-reducing ascending 
      aortoplasty was performed. External reinforcement with a non-coated dacron 
      prosthesis was added in order to stabilize the aortic wall. RESULTS: Aortoplasty 
      was associated with aortic valve replacement in 47 cases (35 mechanical vs 12 
      biological), subvalvular myectomy in 29 cases, and CABG in 13 cases. The 
      procedure was performed with low hospital mortality (2%) and a low postoperative 
      morbidity. Computertomographic and echocardiographic diameters were significantly 
      smaller after reduction (55.8+/-9mm down to 40.51+/-6.2mm (CT), p<0.002; 
      54.1+/-6.7mm preoperatively down to 38.7+/-7.1mm (echocardiography), p<0.002), 
      with stable performance in long-term follow-up (mean follow-up time: 70 months). 
      CONCLUSIONS: As demonstrated in this study, size reduction of the ascending aorta 
      using aortoplasty with external reinforcement is a safe procedure with excellent 
      long-term results. It is a therapeutic option in modern aortic surgery in 
      patients with poststenotic dilatation of the aorta without impairment of the 
      sinotubular junction of the aortic valve and root.
FAU - Feindt, Peter
AU  - Feindt P
AD  - Department of Thoracic and Cardiovascular Surgery, Heinrich-Heine-University 
      Hospital, Dusseldorf, Germany.
FAU - Litmathe, Jens
AU  - Litmathe J
FAU - Borgens, Adina
AU  - Borgens A
FAU - Boeken, Udo
AU  - Boeken U
FAU - Kurt, Muhammed
AU  - Kurt M
FAU - Gams, Emmeran
AU  - Gams E
LA  - eng
PT  - Journal Article
DEP - 20070216
PL  - Germany
TA  - Eur J Cardiothorac Surg
JT  - European journal of cardio-thoracic surgery : official journal of the European 
      Association for Cardio-thoracic Surgery
JID - 8804069
SB  - IM
CIN - Eur J Cardiothorac Surg. 2007 Sep;32(3):554-5; author reply 555. doi: 
      10.1016/j.ejcts.2007.05.023. PMID: 17588766
CIN - Eur J Cardiothorac Surg. 2007 Oct;32(4):683-4; author reply 684. doi: 
      10.1016/j.ejcts.2007.06.019. PMID: 17689089
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Aorta/pathology/*surgery
MH  - Aortic Aneurysm/surgery
MH  - Aortic Diseases/pathology/*surgery
MH  - Cardiac Surgical Procedures/*methods
MH  - Coronary Artery Bypass/methods
MH  - Dilatation, Pathologic/surgery
MH  - Female
MH  - Heart Valve Prosthesis Implantation/methods
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Postoperative Care/methods
MH  - Retrospective Studies
MH  - Treatment Outcome
EDAT- 2007/02/20 09:00
MHDA- 2007/06/29 09:00
CRDT- 2007/02/20 09:00
PHST- 2006/10/12 00:00 [received]
PHST- 2006/12/31 00:00 [revised]
PHST- 2007/01/04 00:00 [accepted]
PHST- 2007/02/20 09:00 [pubmed]
PHST- 2007/06/29 09:00 [medline]
PHST- 2007/02/20 09:00 [entrez]
AID - S1010-7940(07)00068-1 [pii]
AID - 10.1016/j.ejcts.2007.01.028 [doi]
PST - ppublish
SO  - Eur J Cardiothorac Surg. 2007 Apr;31(4):614-7. doi: 10.1016/j.ejcts.2007.01.028. 
      Epub 2007 Feb 16.

PMID- 24318956
OWN - NLM
STAT- MEDLINE
DCOM- 20140203
LR  - 20211021
IS  - 1097-0045 (Electronic)
IS  - 0270-4137 (Print)
IS  - 0270-4137 (Linking)
VI  - 74
IP  - 1
DP  - 2014 Jan
TI  - Is digoxin use for cardiovascular disease associated with risk of prostate 
      cancer?
PG  - 97-102
LID - 10.1002/pros.22733 [doi]
AB  - PURPOSE: Digoxin is a commonly used medication for heart failure and cardiac 
      arrhythmias that has recently been suggested as a novel chemotherapeutic agent. 
      Preclinical studies of prostate cancer (PCa) have shown anti-tumor activity with 
      digoxin. We explore the relationship between use of digoxin and PCa risk. 
      METHODS: Data from a population-based case-control study of incident cases aged 
      35-74 years at PCa diagnosis in 2002-2005 in King County, Washington were 
      available. Controls were identified by random digit dialing and frequency matched 
      by age. Use of digoxin was determined from in-person questionnaires regarding 
      medical and prescription history. The relationship of digoxin use with PCa risk 
      was evaluated with logistic regression. RESULTS: One thousand one cases of PCa 
      and 942 controls were analyzed. The prevalence of digoxin use in controls was 
      2.7%, and use was positively correlated with age. In multivariate analysis 
      adjusting for age, race, PSA screening, and family history of PCa, digoxin use 
      was associated with a reduction in the odds ratio of PCa (OR 0.58, 95% CI: 
      0.30-1.10). Among those with >/=3 PSA tests over the preceding 5 years (546 cases, 
      380 controls), digoxin use was associated with a stronger reduction of PCa risk 
      (OR 0.44, 95% CI: 0.20-0.98). CONCLUSION: These data indicate digoxin use may be 
      associated with a reduction in risk of PCa. Given the potential mechanisms by 
      which digoxin may exert an anti-neoplastic effect and other recent studies 
      showing a negative association between digoxin use and PCa, further research is 
      warranted.
CI  - (c) 2013 Wiley Periodicals, Inc.
FAU - Wright, Jonathan L
AU  - Wright JL
AD  - Department of Urology, University of Washington School of Medicine, Seattle, 
      Washington; Division of Public Health Sciences, Fred Hutchinson Cancer Research 
      Center, Seattle, Washington.
FAU - Hansten, Philip D
AU  - Hansten PD
FAU - Stanford, Janet L
AU  - Stanford JL
LA  - eng
GR  - T32 CA009168-30/CA/NCI NIH HHS/United States
GR  - T32 CA009168/CA/NCI NIH HHS/United States
GR  - R01 CA092579/CA/NCI NIH HHS/United States
GR  - R01 CA 092579/CA/NCI NIH HHS/United States
GR  - P50 CA097186/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20130921
PL  - United States
TA  - Prostate
JT  - The Prostate
JID - 8101368
RN  - 73K4184T59 (Digoxin)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Cardiovascular Diseases/*drug therapy/*epidemiology
MH  - Case-Control Studies
MH  - Digoxin/adverse effects/*therapeutic use
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Population Surveillance/*methods
MH  - Prostatic Neoplasms/chemically induced/*drug therapy/*epidemiology
MH  - Risk Factors
PMC - PMC3935420
MID - NIHMS531626
OTO - NOTNLM
OT  - case-control study
OT  - digoxin
OT  - population based
OT  - prostate cancer
OT  - risk
EDAT- 2013/12/10 06:00
MHDA- 2014/02/04 06:00
PMCR- 2015/01/01
CRDT- 2013/12/10 06:00
PHST- 2013/07/09 00:00 [received]
PHST- 2013/08/29 00:00 [accepted]
PHST- 2013/12/10 06:00 [entrez]
PHST- 2013/12/10 06:00 [pubmed]
PHST- 2014/02/04 06:00 [medline]
PHST- 2015/01/01 00:00 [pmc-release]
AID - 10.1002/pros.22733 [doi]
PST - ppublish
SO  - Prostate. 2014 Jan;74(1):97-102. doi: 10.1002/pros.22733. Epub 2013 Sep 21.

PMID- 22266735
OWN - NLM
STAT- MEDLINE
DCOM- 20120626
LR  - 20240509
IS  - 1935-5548 (Electronic)
IS  - 0149-5992 (Print)
IS  - 0149-5992 (Linking)
VI  - 35
IP  - 3
DP  - 2012 Mar
TI  - Screening for gestational diabetes mellitus: are the criteria proposed by the 
      international association of the Diabetes and Pregnancy Study Groups 
      cost-effective?
PG  - 529-35
LID - 10.2337/dc11-1643 [doi]
AB  - OBJECTIVE: The International Association of the Diabetes and Pregnancy Study 
      Groups (IADPSG) recently recommended new criteria for diagnosing gestational 
      diabetes mellitus (GDM). This study was undertaken to determine whether adopting 
      the IADPSG criteria would be cost-effective, compared with the current standard 
      of care. RESEARCH DESIGN AND METHODS: We developed a decision analysis model 
      comparing the cost-utility of three strategies to identify GDM: 1) no screening, 
      2) current screening practice (1-h 50-g glucose challenge test between 24 and 28 
      weeks followed by 3-h 100-g glucose tolerance test when indicated), or 3) 
      screening practice proposed by the IADPSG. Assumptions included that 1) women 
      diagnosed with GDM received additional prenatal monitoring, mitigating the risks 
      of preeclampsia, shoulder dystocia, and birth injury; and 2) GDM women had 
      opportunity for intensive postdelivery counseling and behavior modification to 
      reduce future diabetes risks. The primary outcome measure was the incremental 
      cost-effectiveness ratio (ICER). RESULTS: Our model demonstrates that the IADPSG 
      recommendations are cost-effective only when postdelivery care reduces diabetes 
      incidence. For every 100,000 women screened, 6,178 quality-adjusted life-years 
      (QALYs) are gained, at a cost of $125,633,826. The ICER for the IADPSG strategy 
      compared with the current standard was $20,336 per QALY gained. When postdelivery 
      care was not accomplished, the IADPSG strategy was no longer cost-effective. 
      These results were robust in sensitivity analyses. CONCLUSIONS: The IADPSG 
      recommendation for glucose screening in pregnancy is cost-effective. The model is 
      most sensitive to the likelihood of preventing future diabetes in patients 
      identified with GDM using postdelivery counseling and intervention.
FAU - Werner, Erika F
AU  - Werner EF
AD  - Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, 
      Baltimore, Maryland, USA. ewerner4@jhmi.edu
FAU - Pettker, Christian M
AU  - Pettker CM
FAU - Zuckerwise, Lisa
AU  - Zuckerwise L
FAU - Reel, Michael
AU  - Reel M
FAU - Funai, Edmund F
AU  - Funai EF
FAU - Henderson, Janice
AU  - Henderson J
FAU - Thung, Stephen F
AU  - Thung SF
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20120120
PL  - United States
TA  - Diabetes Care
JT  - Diabetes care
JID - 7805975
SB  - IM
CIN - Diabetes Care. 2012 Mar;35(3):461-2. doi: 10.2337/dc11-2237. PMID: 22355016
MH  - Cost-Benefit Analysis
MH  - Diabetes, Gestational/*diagnosis/*economics
MH  - Female
MH  - Glucose Tolerance Test/*economics
MH  - Humans
MH  - Mass Screening/economics/methods
MH  - Pregnancy
MH  - Quality-Adjusted Life Years
PMC - PMC3322683
EDAT- 2012/01/24 06:00
MHDA- 2012/06/27 06:00
PMCR- 2013/03/01
CRDT- 2012/01/24 06:00
PHST- 2012/01/24 06:00 [entrez]
PHST- 2012/01/24 06:00 [pubmed]
PHST- 2012/06/27 06:00 [medline]
PHST- 2013/03/01 00:00 [pmc-release]
AID - dc11-1643 [pii]
AID - 1643 [pii]
AID - 10.2337/dc11-1643 [doi]
PST - ppublish
SO  - Diabetes Care. 2012 Mar;35(3):529-35. doi: 10.2337/dc11-1643. Epub 2012 Jan 20.

PMID- 22453060
OWN - NLM
STAT- MEDLINE
DCOM- 20121015
LR  - 20211021
IS  - 1757-7241 (Electronic)
IS  - 1757-7241 (Linking)
VI  - 20
DP  - 2012 Mar 27
TI  - Does a 4 diagram manual enable laypersons to operate the Laryngeal Mask Supreme(R)? 
      A pilot study in the manikin.
PG  - 21
LID - 10.1186/1757-7241-20-21 [doi]
AB  - BACKGROUND: Bystander resuscitation plays an important role in lifesaving 
      cardiopulmonary resuscitation (CPR). A significant reduction in the 
      "no-flow-time", quantitatively better chest compressions and an improved quality 
      of ventilation can be demonstrated during CPR using supraglottic airway devices 
      (SADs). Previous studies have demonstrated the ability of inexperienced persons 
      to operate SADs after brief instruction. The aim of this pilot study was to 
      determine whether an instruction manual consisting of four diagrams enables 
      laypersons to operate a Laryngeal Mask Supreme(R) (LMAS) in the manikin. METHODS: 
      An instruction manual of four illustrations with speech bubbles displaying the 
      correct use of the LMAS was designed. Laypersons were handed a bag containing a 
      LMAS, a bag mask valve device (BMV), a syringe prefilled with air and the 
      instruction sheet, and were asked to perform and ventilate the manikin as 
      displayed. Time to ventilation was recorded and degree of success evaluated. 
      RESULTS: A total of 150 laypersons took part. Overall 145 participants (96.7%) 
      inserted the LMAS in the manikin in the right direction. The device was inserted 
      inverted or twisted in 13 (8.7%) attempts. Eight (5.3%) individuals recognized 
      this and corrected the position. Within the first 2 minutes 119 (79.3%) 
      applicants were able to insert the LMAS and provide tidal volumes greater than 
      150 ml (estimated dead space). Time to insertion and first ventilation was 83.2 +/- 
      29 s. No significant difference related to previous BLS training (P = 0.85), 
      technical education (P = 0.07) or gender could be demonstrated (P = 0.25). 
      CONCLUSION: In manikin laypersons could insert LMAS in the correct direction 
      after onsite instruction by a simple manual with a high success rate. This 
      indicates some basic procedural understanding and intellectual transfer in 
      principle. Operating errors (n = 91) were frequently not recognized and corrected 
      (n = 77). Improvements in labeling and the quality of instructional photographs 
      may reduce individual error and may optimize understanding.
FAU - Schalte, Gereon
AU  - Schalte G
AD  - Department of Anesthesiology, University Hospital Aachen, Aachen, Germany. 
      gschaelte@ukaachen.de
FAU - Stoppe, Christian
AU  - Stoppe C
FAU - Rossaint, Rolf
AU  - Rossaint R
FAU - Gilles, Laura
AU  - Gilles L
FAU - Heuser, Maike
AU  - Heuser M
FAU - Rex, Steffen
AU  - Rex S
FAU - Coburn, Mark
AU  - Coburn M
FAU - Zoremba, Norbert
AU  - Zoremba N
FAU - Rieg, Annette
AU  - Rieg A
LA  - eng
PT  - Journal Article
DEP - 20120327
PL  - England
TA  - Scand J Trauma Resusc Emerg Med
JT  - Scandinavian journal of trauma, resuscitation and emergency medicine
JID - 101477511
SB  - IM
MH  - Cardiopulmonary Resuscitation/*education/instrumentation/methods
MH  - Female
MH  - First Aid
MH  - Germany
MH  - Humans
MH  - *Laryngeal Masks
MH  - Male
MH  - *Manikins
MH  - Manuals as Topic
MH  - Pilot Projects
MH  - Program Evaluation
MH  - Resuscitation/*methods
MH  - Volunteers
MH  - Young Adult
PMC - PMC3375204
EDAT- 2012/03/29 06:00
MHDA- 2012/10/16 06:00
PMCR- 2012/03/27
CRDT- 2012/03/29 06:00
PHST- 2011/11/22 00:00 [received]
PHST- 2012/03/27 00:00 [accepted]
PHST- 2012/03/29 06:00 [entrez]
PHST- 2012/03/29 06:00 [pubmed]
PHST- 2012/10/16 06:00 [medline]
PHST- 2012/03/27 00:00 [pmc-release]
AID - 1757-7241-20-21 [pii]
AID - 10.1186/1757-7241-20-21 [doi]
PST - epublish
SO  - Scand J Trauma Resusc Emerg Med. 2012 Mar 27;20:21. doi: 10.1186/1757-7241-20-21.

PMID- 10401824
OWN - NLM
STAT- MEDLINE
DCOM- 19990811
LR  - 20190704
IS  - 0004-0010 (Print)
IS  - 0004-0010 (Linking)
VI  - 134
IP  - 7
DP  - 1999 Jul
TI  - Is laparoscopic reoperation for failed antireflux surgery feasible?
PG  - 733-7
AB  - HYPOTHESIS: Laparoscopic techniques can be used to treat patients whose 
      antireflux surgery has failed. DESIGN: Case series. SETTING: Two academic medical 
      centers. PATIENTS: Forty-six consecutive patients, of whom 21 were male and 25 
      were female (mean age, 55.6 years; range, 15-80 years). Previous antireflux 
      procedures were laparoscopic (21 patients), laparotomy (21 patients), thoracotomy 
      (3 patients), and thoracoscopy (1 patient). MAIN OUTCOME MEASURES: The cause of 
      failure, operative and postoperative morbidity, and the level of follow-up 
      satisfaction were determined for all patients. RESULTS: The causes of failure 
      were hiatal herniation (31 patients [67%]), fundoplication breakdown (20 patients 
      [43%]), fundoplication slippage (9 patients [20%]), tight fundoplication (5 
      patients [11%]), misdiagnosed achalasia (2 patients [4%]), and displaced 
      Angelchik prosthesis (2 patients [4%]). Twenty-two patients (48%) had more than 1 
      cause. Laparoscopic reoperative procedures were Nissen fundoplication (n = 22), 
      Toupet fundoplication (n = 13), paraesophageal hernia repair (n = 4), Dor 
      procedure (n = 2), Angelchik prosthesis removal (n = 2), Heller myotomy (n = 2), 
      and the takedown of a wrap (n = 1). In addition, 18 patients required crural 
      repair and 13 required paraesophageal hernia repair. The mean +/- SEM duration of 
      surgery was 3.5+/-1.1 hours. Operative complications were fundus tear (n = 8), 
      significant bleeding (n = 4), bougie perforation (n = 1), small bowel enterotomy 
      (n = 1), and tension pneumothorax (n = 1). The conversion rate (from laparoscopic 
      to an open procedure) was 20% overall (9 patients) but 0% in the last 10 
      patients. Mortality was 0%. The mean +/- SEM hospital stay was 2.3+/-0.9 days for 
      operations completed laparoscopically. Follow-up was possible in 35 patients 
      (76%) at 17.2+/-11.8 months. The well-being score (1 best; 10, worst) was 
      8.6+/-2.1 before and 2.9+/-2.4 after surgery (P<.001). Thirty-one (89%) of 35 
      patients were satisfied with their decision to have reoperation. CONCLUSIONS: 
      Antireflux surgery failures are most commonly associated with hiatal herniation, 
      followed by the breakdown of the fundoplication. The laparoscopic approach may be 
      used successfully to treat patients with failed antireflux operations. Good 
      results were achieved despite the technical difficulty of the procedures.
FAU - Floch, N R
AU  - Floch NR
AD  - Department of Surgery, Mayo Clinic, Jacksonville, Fla 32224, USA.
FAU - Hinder, R A
AU  - Hinder RA
FAU - Klingler, P J
AU  - Klingler PJ
FAU - Branton, S A
AU  - Branton SA
FAU - Seelig, M H
AU  - Seelig MH
FAU - Bammer, T
AU  - Bammer T
FAU - Filipi, C J
AU  - Filipi CJ
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
PL  - United States
TA  - Arch Surg
JT  - Archives of surgery (Chicago, Ill. : 1960)
JID - 9716528
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Feasibility Studies
MH  - Female
MH  - Follow-Up Studies
MH  - Gastroesophageal Reflux/*surgery
MH  - Humans
MH  - *Laparoscopy/adverse effects
MH  - Male
MH  - Middle Aged
MH  - Postoperative Complications/epidemiology
MH  - Reoperation
MH  - Treatment Failure
EDAT- 1999/07/13 00:00
MHDA- 1999/07/13 00:01
CRDT- 1999/07/13 00:00
PHST- 1999/07/13 00:00 [pubmed]
PHST- 1999/07/13 00:01 [medline]
PHST- 1999/07/13 00:00 [entrez]
AID - 10.1001/archsurg.134.7.733 [doi]
PST - ppublish
SO  - Arch Surg. 1999 Jul;134(7):733-7. doi: 10.1001/archsurg.134.7.733.

PMID- 15208005
OWN - NLM
STAT- MEDLINE
DCOM- 20041012
LR  - 20220321
IS  - 0091-7435 (Print)
IS  - 0091-7435 (Linking)
VI  - 39
IP  - 1
DP  - 2004 Jul
TI  - The Omega-3 Index: a new risk factor for death from coronary heart disease?
PG  - 212-20
AB  - BACKGROUND: Low intakes or blood levels of eicosapentaenoic and docosahexaenoic 
      acids (EPA + DHA) are independently associated with increased risk of death from 
      coronary heart disease (CHD). In randomized secondary prevention trials, fish or 
      fish oil have been demonstrated to reduce total and CHD mortality at intakes of 
      about 1 g/day. Red blood cell (RBC) fatty acid (FA) composition reflects 
      long-term intake of EPA + DHA. We propose that the RBC EPA + DHA (hereafter 
      called the Omega-3 Index) be considered a new risk factor for death from CHD. 
      METHODS: We conducted clinical and laboratory experiments to generate data 
      necessary for the validation of the Omega-3 Index as a CHD risk predictor. The 
      relationship between this putative marker and risk for CHD death, especially 
      sudden cardiac death (SCD), was then evaluated in several published primary and 
      secondary prevention studies. RESULTS: The Omega-3 Index was inversely associated 
      with risk for CHD mortality. An Omega-3 Index of > or = 8% was associated with 
      the greatest cardioprotection, whereas an index of < or = 4% was associated with 
      the least. CONCLUSION: The Omega-3 Index may represent a novel, physiologically 
      relevant, easily modified, independent, and graded risk factor for death from CHD 
      that could have significant clinical utility.
CI  - Copyright 2004 The Institute for Cancer Prevention and Elsevier Inc.
FAU - Harris, William S
AU  - Harris WS
AD  - Lipid and Diabetes Research Center, Mid America Heart Institute of Saint Luke's 
      Hospital, University of Missouri-KC School of Medicine, Kansas City, MO 64111, 
      USA. vharris@saint-lukes.org
FAU - Von Schacky, Clemens
AU  - Von Schacky C
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Prev Med
JT  - Preventive medicine
JID - 0322116
RN  - 0 (Biomarkers)
RN  - 0 (Fatty Acids, Omega-3)
SB  - IM
MH  - Biomarkers
MH  - Coronary Disease/mortality/*prevention & control
MH  - Death, Sudden, Cardiac/etiology/*prevention & control
MH  - Double-Blind Method
MH  - Fatty Acids, Omega-3/administration & dosage/blood/*therapeutic use
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Risk Factors
EDAT- 2004/06/23 05:00
MHDA- 2004/10/13 09:00
CRDT- 2004/06/23 05:00
PHST- 2004/06/23 05:00 [pubmed]
PHST- 2004/10/13 09:00 [medline]
PHST- 2004/06/23 05:00 [entrez]
AID - S0091743504000878 [pii]
AID - 10.1016/j.ypmed.2004.02.030 [doi]
PST - ppublish
SO  - Prev Med. 2004 Jul;39(1):212-20. doi: 10.1016/j.ypmed.2004.02.030.

PMID- 16713745
OWN - NLM
STAT- MEDLINE
DCOM- 20060912
LR  - 20181201
IS  - 1542-3565 (Print)
IS  - 1542-3565 (Linking)
VI  - 4
IP  - 6
DP  - 2006 Jun
TI  - Do cytokine concentrations in pancreatic juice predict the presence of pancreatic 
      diseases?
PG  - 782-9
AB  - BACKGROUND & AIMS: Cytokine concentration in pancreatic juice of patients with 
      pancreatic disease is unknown. Secretin stimulation allows endoscopic collection 
      of pancreatic juice secreted into the duodenum. We aimed to evaluate the cytokine 
      concentrations in pancreatic juice of patients with abdominal pain to 
      discriminate presence from absence of pancreatic disease. METHODS: From January 
      2003-December 2004, consecutive patients with abdominal pain compatible with 
      pancreatic origin were enrolled. Patients underwent upper endoscopy. Intravenous 
      secretin (0.2 mug/kg) was given immediately before scope intubation. Pancreatic 
      juice collected from the duodenum was immediately snap-frozen in liquid nitrogen 
      until assays were performed. Pancreatic juice levels of interleukin-8, 
      interleukin-6, intercellular adhesion molecule 1, and transforming growth 
      factor-beta 1 were measured by modified enzyme-linked immunosorbent assays. The 
      final diagnosis was made by the primary gastroenterologist on the basis of 
      medical history; laboratory, endoscopic, and imaging studies; and clinical 
      follow-up. Fisher exact test and Kruskal-Wallis rank sum test were used for 
      statistical analysis. RESULTS: Of 130 patients screened, 118 met the inclusion 
      criteria. Multivariate analysis revealed that only interleukin-8 was able to 
      discriminate between normal pancreas and chronic pancreatitis (P = .011), 
      pancreatic cancer (P = .044), and the presence of pancreatic diseases (P = .007). 
      Individual cytokine concentrations were not significantly different in chronic 
      pancreatitis compared with pancreatic cancer. CONCLUSIONS: Cytokine levels can be 
      measured in pancreatic juice obtained from the duodenum without direct 
      cannulation of the pancreatic duct. Interleukin-8 concentration in pancreatic 
      juice can be used to discriminate between normal pancreas and patients with 
      pancreatic disease. This is a relatively simple and noninvasive method to aid in 
      the diagnosis of pancreatic diseases.
FAU - Noh, Kyung W
AU  - Noh KW
AD  - Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, 
      USA.
FAU - Pungpapong, Surakit
AU  - Pungpapong S
FAU - Wallace, Michael B
AU  - Wallace MB
FAU - Woodward, Timothy A
AU  - Woodward TA
FAU - Raimondo, Massimo
AU  - Raimondo M
LA  - eng
PT  - Journal Article
DEP - 20060519
PL  - United States
TA  - Clin Gastroenterol Hepatol
JT  - Clinical gastroenterology and hepatology : the official clinical practice journal 
      of the American Gastroenterological Association
JID - 101160775
RN  - 0 (Biomarkers)
RN  - 0 (Cytokines)
RN  - 0 (Interleukin-6)
RN  - 0 (Interleukin-8)
RN  - 0 (Transforming Growth Factor beta)
RN  - 126547-89-5 (Intercellular Adhesion Molecule-1)
RN  - 1393-25-5 (Secretin)
RN  - EC 3.1.1.3 (Lipase)
SB  - IM
MH  - Abdominal Pain/etiology
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Biomarkers/analysis
MH  - Cytokines/*analysis
MH  - Diagnosis, Differential
MH  - Endoscopy, Gastrointestinal
MH  - Female
MH  - Humans
MH  - Intercellular Adhesion Molecule-1/analysis
MH  - Interleukin-6/analysis
MH  - Interleukin-8/analysis
MH  - Lipase/analysis
MH  - Male
MH  - Middle Aged
MH  - Pancreatic Diseases/*diagnosis
MH  - Pancreatic Juice/*chemistry/metabolism
MH  - Pancreatic Neoplasms/diagnosis
MH  - Pancreatitis, Chronic/diagnosis
MH  - Secretin/pharmacology
MH  - Transforming Growth Factor beta/analysis
EDAT- 2006/05/23 09:00
MHDA- 2006/09/13 09:00
CRDT- 2006/05/23 09:00
PHST- 2006/05/23 09:00 [pubmed]
PHST- 2006/09/13 09:00 [medline]
PHST- 2006/05/23 09:00 [entrez]
AID - S1542-3565(06)00329-6 [pii]
AID - 10.1016/j.cgh.2006.03.026 [doi]
PST - ppublish
SO  - Clin Gastroenterol Hepatol. 2006 Jun;4(6):782-9. doi: 10.1016/j.cgh.2006.03.026. 
      Epub 2006 May 19.

PMID- 21864397
OWN - NLM
STAT- MEDLINE
DCOM- 20120320
LR  - 20220419
IS  - 1471-2407 (Electronic)
IS  - 1471-2407 (Linking)
VI  - 11
DP  - 2011 Aug 24
TI  - Factors determining the survival of nasopharyngeal carcinoma with lung metastasis 
      alone: does combined modality treatment benefit?
PG  - 370
LID - 10.1186/1471-2407-11-370 [doi]
AB  - BACKGROUND: Nasopharyngeal carcinoma (NPC) with lung metastasis alone has been 
      reported as a relatively favorable prognostic group, and combined modality 
      treatment might be indicated for selected cases. However, the prognostic factors 
      determining survival of this group and the indication of combined therapy have 
      not been thoroughly studied. METHODS: We retrospectively reviewed 246 patients of 
      NPC with lung metastasis(es) alone presented at diagnosis or as the first failure 
      after primary treatment from 1993 to 2008 in an academic tertiary hospital. 
      Univariate and multivariate survival analyses of post-metastasis survival (PMS) 
      and overall survival (OS) were carried out to determine the prognostic factors. 
      RESULTS: The 3-year, 5-year, and 10-year of PMS and OS for the whole cohort were 
      34.3%, 17.0%, 8.6% and 67.8%, 45.4%, 18.5%, respectively. The median PMS (45.6 
      months vs. 23.7 months) and OS (73.7 months vs. 46.2 months) of patients treated 
      with combined therapy was significantly longer than that of those treated with 
      chemotherapy alone (P < 0.001). Age, disease-free interval (DFI) and treatment 
      modality were evaluated as independent prognostic factors of OS, while only age 
      and treatment modality retain their independent significance in PMS analysis. In 
      stratified survival analysis, compared to chemotherapy alone, combined therapy 
      could benefit the patients with DFI > 1 year, but not those with DFI </= 1 year. 
      CONCLUSIONS: Age </= 45 years, DFI > 1 year, and the combined therapy were good 
      prognostic factors for NPC patients with lung metastasis(es) alone. The 
      combination of local therapy and the basic chemotherapy should be considered for 
      these patients with DFI > 1 year.
FAU - Cao, Xun
AU  - Cao X
AD  - State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-Sen 
      University, Guangzhou, China.
FAU - He, Li-Ru
AU  - He LR
FAU - Xie, Fang-Yun
AU  - Xie FY
FAU - Chen, You-Fang
AU  - Chen YF
FAU - Wen, Zhe-Sheng
AU  - Wen ZS
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20110824
PL  - England
TA  - BMC Cancer
JT  - BMC cancer
JID - 100967800
SB  - IM
MH  - Adult
MH  - Carcinoma
MH  - Chemotherapy, Adjuvant
MH  - Disease-Free Survival
MH  - Female
MH  - Humans
MH  - Lung Neoplasms/*secondary/*therapy
MH  - Male
MH  - Middle Aged
MH  - Nasopharyngeal Carcinoma
MH  - Nasopharyngeal Neoplasms/*pathology/*therapy
MH  - Neoadjuvant Therapy
MH  - Neoplasm Recurrence, Local/pathology
MH  - Prognosis
MH  - Retrospective Studies
MH  - Survival Rate
PMC - PMC3170652
EDAT- 2011/08/26 06:00
MHDA- 2012/03/21 06:00
PMCR- 2011/08/24
CRDT- 2011/08/26 06:00
PHST- 2011/04/12 00:00 [received]
PHST- 2011/08/24 00:00 [accepted]
PHST- 2011/08/26 06:00 [entrez]
PHST- 2011/08/26 06:00 [pubmed]
PHST- 2012/03/21 06:00 [medline]
PHST- 2011/08/24 00:00 [pmc-release]
AID - 1471-2407-11-370 [pii]
AID - 10.1186/1471-2407-11-370 [doi]
PST - epublish
SO  - BMC Cancer. 2011 Aug 24;11:370. doi: 10.1186/1471-2407-11-370.

PMID- 25810292
OWN - NLM
STAT- MEDLINE
DCOM- 20160310
LR  - 20150529
IS  - 1569-9285 (Electronic)
IS  - 1569-9285 (Linking)
VI  - 20
IP  - 6
DP  - 2015 Jun
TI  - Is minimally invasive mitral valve repair with artificial chords reproducible and 
      applicable in routine surgery?
PG  - 707-11
LID - 10.1093/icvts/ivv065 [doi]
AB  - OBJECTIVES: Traditional resectional techniques and chordal transfer are difficult 
      to apply in video-assisted mitral valve repair. Using artificial chords appears 
      easier in this setting. The purpose of this study was to review the effectiveness 
      and reproducibility of neochordal repair as a routine approach to minimally 
      invasive mitral repair, and to assess the stability of neochord implantation 
      using the figure-of-eight suture without pledgets in this setting. METHODS: This 
      is a retrospective review of all patients who underwent minimally invasive 
      video-assisted mitral valve repair from 2008 to 2013. The primary endpoints were 
      recurrent mitral regurgitation and reoperation. RESULTS: A total of 426 
      consecutive patients were included during the study period, with a mean age of 55 
      +/- 18 years. Neochords were used in all patients, and in association with leaflet 
      resection in 47 patients. One patient was not repairable and underwent valve 
      replacement (repair rate, 99.8%). Fifteen patients had Grade I (3.5%) 
      regurgitation, whereas the remainder had none. Patients were fast-tracked, with 
      25% extubated in the operation theatre and the remainder within 6 h. There were 5 
      deaths within 30 days (1.2%). Follow-up ranged 3-60 months, during which all of 
      the patients remained with no or trace mitral regurgitation. No de-insertion or 
      rupture of any neochords was found, and no patients required a reoperation. 
      CONCLUSIONS: Minimally invasive mitral valve repair using neochords provided a 
      high rate of repair, reproducible results in a routine cardiac surgery setting 
      and stable repair during follow-up. This has become our preferred technique for 
      mitral valve surgery.
CI  - (c) The Author 2015. Published by Oxford University Press on behalf of the European 
      Association for Cardio-Thoracic Surgery. All rights reserved.
FAU - Panos, Aristotelis
AU  - Panos A
AD  - Center for Minimally Invasive Cardiac Surgery, Geneva, Switzerland Cardiovascular 
      Surgery, Geneva University Hospitals & School of Medicine, Geneva, Switzerland 
      Clinic for Cardiac Surgery, Hygeia Hospital, Athens, Greece a.panos@bluewin.ch.
FAU - Vlad, Sylvio
AU  - Vlad S
AD  - Clinic for Cardiac Surgery, Hygeia Hospital, Athens, Greece.
FAU - Milas, Fotios
AU  - Milas F
AD  - Clinic for Cardiac Surgery, Hygeia Hospital, Athens, Greece.
FAU - Myers, Patrick O
AU  - Myers PO
AD  - Cardiovascular Surgery, Geneva University Hospitals & School of Medicine, Geneva, 
      Switzerland.
LA  - eng
PT  - Journal Article
DEP - 20150324
PL  - England
TA  - Interact Cardiovasc Thorac Surg
JT  - Interactive cardiovascular and thoracic surgery
JID - 101158399
SB  - IM
MH  - Adult
MH  - Aged
MH  - Chordae Tendineae/physiopathology/*surgery
MH  - Female
MH  - *Heart Valve Prosthesis
MH  - Heart Valve Prosthesis Implantation/adverse 
      effects/*instrumentation/methods/mortality
MH  - Humans
MH  - Kaplan-Meier Estimate
MH  - Male
MH  - Middle Aged
MH  - Minimally Invasive Surgical Procedures
MH  - Mitral Valve/physiopathology/*surgery
MH  - Mitral Valve Insufficiency/diagnosis/mortality/physiopathology/*surgery
MH  - Prosthesis Design
MH  - Recurrence
MH  - Reoperation
MH  - Retrospective Studies
MH  - Risk Factors
MH  - Suture Techniques
MH  - Time Factors
MH  - Treatment Outcome
MH  - Video-Assisted Surgery/adverse effects/*instrumentation/methods/mortality
OTO - NOTNLM
OT  - Minimally invasive cardiac surgery
OT  - Mitral valve repair
OT  - Neochords
OT  - Video-assisted
EDAT- 2015/03/27 06:00
MHDA- 2016/03/11 06:00
CRDT- 2015/03/27 06:00
PHST- 2014/09/19 00:00 [received]
PHST- 2015/02/27 00:00 [accepted]
PHST- 2015/03/27 06:00 [entrez]
PHST- 2015/03/27 06:00 [pubmed]
PHST- 2016/03/11 06:00 [medline]
AID - ivv065 [pii]
AID - 10.1093/icvts/ivv065 [doi]
PST - ppublish
SO  - Interact Cardiovasc Thorac Surg. 2015 Jun;20(6):707-11. doi: 
      10.1093/icvts/ivv065. Epub 2015 Mar 24.

PMID- 11943048
OWN - NLM
STAT- MEDLINE
DCOM- 20020604
LR  - 20220420
IS  - 0002-8614 (Print)
IS  - 0002-8614 (Linking)
VI  - 50
IP  - 3
DP  - 2002 Mar
TI  - Does receipt of hospice care in nursing homes improve the management of pain at 
      the end of life?
PG  - 507-15
AB  - OBJECTIVES: To compare analgesic management of daily pain for dying nursing home 
      residents enrolled and not enrolled in Medicare hospice. DESIGN: Retrospective, 
      comparative cohort study. SETTING: Over 800 nursing homes in Kansas, Maine, 
      Mississippi, New York, and South Dakota. PARTICIPANTS: A subset of residents with 
      daily pain near the end of life taken from a matched cohort of hospice (2,644) 
      and nonhospice (7,929) nursing home residents who had at least two resident 
      assessments (Minimum Data Sets (MDSs)) completed, their last between 1992 and 
      1996, and who died before April 1997. The daily pain subset consisted of 709 
      hospice and 1,326 nonhospice residents. MEASUREMENTS: Detailed drug use data 
      contained on the last MDS before death were used to examine analgesic management 
      of daily pain. Guidelines from the American Medical Directors Association (AMDA) 
      were used to identify analgesics not recommended for use in managing chronic pain 
      in long-term care settings. The study outcome, regular treatment of daily pain, 
      examined whether patients received any analgesic, other than those not 
      recommended by AMDA, at least twice a day for each day of documented daily pain 
      (i.e., 7 days before date of last MDS). RESULTS: Fifteen percent of hospice 
      residents and 23% of nonhospice residents in daily pain received no analgesics 
      (odds ratio (OR) = 0.57, 95% confidence interval (CI) = 0.45-0.74). A lower 
      proportion of hospice residents (21%) than of nonhospice residents (29%) received 
      analgesics not recommended by AMDA (OR = 0.65, 95% CI =0.52-0.80). Overall, 
      acetaminophen (not in combination with other drugs) was used most frequently for 
      nonhospice residents (25% of 1,673 prescriptions), whereas morphine derivatives 
      were used most frequently for hospice residents (30% of 1,058 prescriptions). 
      Fifty-one percent of hospice residents and 33% of nonhospice residents received 
      regular treatment for daily pain. Controlling for clinical confounders, hospice 
      residents were twice as likely as nonhospice residents to receive regular 
      treatment for daily pain (adjusted odds ratio = 2.08, 95% CI = 1.68-2.56). 
      CONCLUSION: Findings suggest that analgesic management of daily pain is better 
      for nursing home residents enrolled in hospice than for those not enrolled in 
      hospice.The prescribing practices portrayed by this study reveal that many dying 
      nursing home residents in daily pain are receiving no analgesic treatment or are 
      receiving analgesic treatment inconsistent with AMDA and other pain management 
      guidelines. Improving the analgesic management of pain in nursing homes is 
      essential if high-quality end-of-life care in nursing homes is to be achieved.
FAU - Miller, Susan C
AU  - Miller SC
AD  - Department of Community Health, Center for Gerontology and Health Care Research, 
      Brown University, Box GH-3, Providence, RI 029191. susan_miller@brown.edu
FAU - Mor, Vincent
AU  - Mor V
FAU - Wu, Ning
AU  - Wu N
FAU - Gozalo, Pedro
AU  - Gozalo P
FAU - Lapane, Kate
AU  - Lapane K
LA  - eng
GR  - AG 11624-06S1/AG/NIA NIH HHS/United States
GR  - CA 76551/CA/NCI NIH HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - J Am Geriatr Soc
JT  - Journal of the American Geriatrics Society
JID - 7503062
RN  - 0 (Analgesics)
SB  - IM
MH  - Aged
MH  - Analgesics/*therapeutic use
MH  - Cohort Studies
MH  - Drug Utilization/statistics & numerical data
MH  - Female
MH  - Homes for the Aged
MH  - *Hospice Care
MH  - Humans
MH  - Male
MH  - Nursing Homes
MH  - Pain/*drug therapy
MH  - Retrospective Studies
OID - KIE: 104384
OTO - KIE
OT  - Death and Euthanasia
OT  - Empirical Approach
OT  - Professional Patient Relationship
GN  - KIE: 42 refs.
GN  - KIE: KIE Bib: terminal care
EDAT- 2002/04/12 10:00
MHDA- 2002/06/05 10:01
CRDT- 2002/04/12 10:00
PHST- 2002/04/12 10:00 [pubmed]
PHST- 2002/06/05 10:01 [medline]
PHST- 2002/04/12 10:00 [entrez]
AID - 50118 [pii]
AID - 10.1046/j.1532-5415.2002.50118.x [doi]
PST - ppublish
SO  - J Am Geriatr Soc. 2002 Mar;50(3):507-15. doi: 10.1046/j.1532-5415.2002.50118.x.

PMID- 23347337
OWN - NLM
STAT- MEDLINE
DCOM- 20140214
LR  - 20220317
IS  - 1445-5994 (Electronic)
IS  - 1444-0903 (Linking)
VI  - 43
IP  - 6
DP  - 2013 Jun
TI  - Is intensive chemotherapy safe for rural cancer patients?
PG  - 643-9
LID - 10.1111/imj.12083 [doi]
AB  - BACKGROUND: To provide equality of cancer care to rural patients, Townsville 
      Cancer Centre administers intensive chemotherapy regimens to rural patients with 
      node-positive breast and metastatic colorectal cancers at the same doses as urban 
      patients. Side-effects were usually managed by rural general practitioners 
      locally. AIM: The aim is to determine the safety of this practice by comparing 
      the profile of serious adverse events and dose intensities between urban and 
      rural patients at the Townsville Cancer Centre. METHOD: A retrospective audit was 
      conducted in patients with metastatic colorectal and node-positive breast cancers 
      during a 24-month period. Fisher's exact test was used for analysis. Rurality was 
      determined as per rural, remote and metropolitan classification. RESULTS: Of the 
      121 patients included, 70 and 51 patients had breast and colon cancers 
      respectively. The urban versus rural patient split among all patients, breast and 
      colorectal cancer subgroups was 68 versus 53, 43 versus 27 and 25 versus 26 
      respectively. A total of 421 cycles was given with dose intensity of >95% for 
      breast cancer in both groups (P > 0.05). Rate of febrile neutropenia was 9.3% 
      versus 7.4% (P = 0.56). For XELOX, rate of diarrhoea was 20% versus 19% (P = 
      0.66) and rate of vomiting was 20% versus 11% (P = 0.11). Only two patients were 
      transferred to Townsville for admission. No toxic death occurred in either group. 
      CONCLUSION: It appears safe to administer intensive chemotherapy regimens at 
      standard doses to rural patients without increased morbidity or mortality. 
      Support for general practitioners through phone or videoconferencing may reduce 
      the safety concerns.
CI  - (c) 2013 The Authors; Internal Medicine Journal (c) 2013 Royal Australasian College 
      of Physicians.
FAU - Pathmanathan, S
AU  - Pathmanathan S
AD  - School of Medicine and Dentistry, James Cook University, Australia.
FAU - Burgher, B
AU  - Burgher B
FAU - Sabesan, S
AU  - Sabesan S
LA  - eng
PT  - Journal Article
PL  - Australia
TA  - Intern Med J
JT  - Internal medicine journal
JID - 101092952
RN  - 0 (Antineoplastic Agents)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Antineoplastic Agents/*administration & dosage/*adverse effects
MH  - Breast Neoplasms/*drug therapy/epidemiology
MH  - Colonic Neoplasms/*drug therapy/epidemiology
MH  - Diarrhea/chemically induced/epidemiology
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Retrospective Studies
MH  - *Rural Population
MH  - Vomiting/chemically induced/epidemiology
EDAT- 2013/01/26 06:00
MHDA- 2014/02/15 06:00
CRDT- 2013/01/26 06:00
PHST- 2012/11/20 00:00 [received]
PHST- 2013/01/16 00:00 [accepted]
PHST- 2013/01/26 06:00 [entrez]
PHST- 2013/01/26 06:00 [pubmed]
PHST- 2014/02/15 06:00 [medline]
AID - 10.1111/imj.12083 [doi]
PST - ppublish
SO  - Intern Med J. 2013 Jun;43(6):643-9. doi: 10.1111/imj.12083.

PMID- 23992109
OWN - NLM
STAT- MEDLINE
DCOM- 20140620
LR  - 20151119
IS  - 1525-6049 (Electronic)
IS  - 0886-022X (Linking)
VI  - 35
IP  - 10
DP  - 2013
TI  - Is the urinary biomarkers assessment a non-invasive approach to tubular lesions 
      of the solitary kidney?
PG  - 1358-64
LID - 10.3109/0886022X.2013.828367 [doi]
AB  - INTRODUCTION: The solitary kidney (SK) is currently debated in the literature, as 
      living kidney donation is extensively used and the diagnosis of congenital SK is 
      frequent. Tubulointerstitial lesions associated with adaptive phenomena may occur 
      early within the SK. AIMS: Analysis of the significance of urinary biomarkers in 
      the assessment of tubulointerstitial lesions of the SK. METHODS: A 
      cross-sectional study of 37 patients with SK included 18 patients-acquired SK 
      (mean age 56.44 +/- 12.20 years, interval from nephrectomy 10.94 +/- 9.37 years), 19 
      patients-congenital SK (mean age 41.52 +/- 10.54 years). Urinary NAG, urinary 
      alpha-1-microglobulin, albuminuria, eGFR (CKD-EPI equation) were measured. 
      RESULTS: In acquired SK, NAG increased in 60.66%, urinary alpha 1-microglobulin 
      in 16.66%, albuminuria in 55.55% of patients. Inverse correlation with eGFR 
      presented NAG (R(2 )= 0.537, p = 0.022), urinary alpha 1-microglobulin 
      (R(2 )= 0.702, p = 0.001), albuminuria (R(2 )= 0.655, p = 0.003). In congenital 
      SK, NAG increased in 52.63%, urinary alpha 1-microglobulin in 5.26%, albuminuria 
      in 47.36% of patients. In this group, urinary biomarkers correlated inversely 
      with eGFR: NAG (R(2 )= 0.743, p < 0.001), urinary alpha 1-microglobulin 
      (R(2 )= 0.701, p = 0.001), albuminuria (R(2 )= 0.821, p < 0.001). Significant 
      correlations were found between the urinary biomarkers in both groups. 
      CONCLUSIONS: Urinary biomarkers allow a non-invasive, sensitive, early assessment 
      of the tubular lesions of the SK. Urinary biomarkers of PT injury parallel renal 
      function decline, thus complementing the estimation of GFR. Monitoring of PT 
      dysfunction is mandatory in patients with SK.
FAU - Gadalean, Florica
AU  - Gadalean F
AD  - Department of Nephrology, County Emergency Hospital, 'Victor Babes' University of 
      Medicine and Pharmacy , Timisoara , Romania and.
FAU - Kaycsa, Adriana
AU  - Kaycsa A
FAU - Gluhovschi, Gheorghe
AU  - Gluhovschi G
FAU - Velciov, Silvia
AU  - Velciov S
FAU - Gluhovschi, Cristina
AU  - Gluhovschi C
FAU - Bob, Flaviu
AU  - Bob F
FAU - Bozdog, Gheorghe
AU  - Bozdog G
FAU - Petrica, Ligia
AU  - Petrica L
LA  - eng
PT  - Journal Article
DEP - 20130902
PL  - England
TA  - Ren Fail
JT  - Renal failure
JID - 8701128
RN  - 0 (Alpha-Globulins)
RN  - 0 (Biomarkers)
RN  - 0 (alpha-1-microglobulin)
RN  - EC 3.2.1.52 (Acetylglucosaminidase)
SB  - IM
MH  - Acetylglucosaminidase/*urine
MH  - Adult
MH  - Aged
MH  - Albuminuria/etiology
MH  - Alpha-Globulins/*urine
MH  - Biomarkers/urine
MH  - Cross-Sectional Studies
MH  - Female
MH  - Glomerular Filtration Rate
MH  - Humans
MH  - Kidney Diseases/*urine
MH  - Male
MH  - Middle Aged
EDAT- 2013/09/03 06:00
MHDA- 2014/06/21 06:00
CRDT- 2013/09/03 06:00
PHST- 2013/09/03 06:00 [entrez]
PHST- 2013/09/03 06:00 [pubmed]
PHST- 2014/06/21 06:00 [medline]
AID - 10.3109/0886022X.2013.828367 [doi]
PST - ppublish
SO  - Ren Fail. 2013;35(10):1358-64. doi: 10.3109/0886022X.2013.828367. Epub 2013 Sep 
      2.

PMID- 10922093
OWN - NLM
STAT- MEDLINE
DCOM- 20000927
LR  - 20220408
IS  - 0016-5107 (Print)
IS  - 0016-5107 (Linking)
VI  - 52
IP  - 2
DP  - 2000 Aug
TI  - Does open access endoscopy close the door to an adequately informed patient?
PG  - 212-7
AB  - BACKGROUND: The use of open access endoscopy is increasing. Its effect on the 
      adequacy of patient informed consent, procedure acceptance and the impact on 
      subsequent communication/transfer of procedure results to the patient have not 
      been evaluated. The aim of our study was to compare the extent of preknowledge of 
      procedures and test explanation, patient medical complexity, information transfer 
      and overall patient satisfaction between a patient group referred for outpatient 
      open access endoscopy versus a patient group from a gastrointestinal (GI) 
      subspecialty clinic. METHODS: Information was obtained from all patients 
      presenting for outpatient upper and lower endoscopy by using a 1-page 
      questionnaire. Patients from the two groups who had an outpatient upper/lower 
      endoscopic procedure were contacted by phone after the procedure to obtain 
      information with a standardized questionnaire. RESULTS: The open access patients 
      reported receiving significantly less information to help them identify the 
      procedure (p < 0.01) and less explanation concerning the nature of the procedure 
      than the group of patients referred from the subspecialty clinic (p < 0.005). 
      There was no difference between the two groups in satisfaction scores for 
      examinations performed under conscious sedation. For flexible sigmoidoscopy 
      without sedation, however, the GI clinic patient group were more satisfied with 
      their procedure. The majority of patients, regardless of access, were more likely 
      to receive endoscopic results from a gastroenterologist than the referring 
      physician. Furthermore, the patients in the GI clinic group who underwent 
      colonoscopy felt significantly better at follow-up. CONCLUSIONS: Patients 
      undergoing open access procedures are less likely to be properly informed about 
      their endoscopic procedure. Our results indicate that with open access endoscopy, 
      a defined mechanism needs to be in place for communication of endoscopic results 
      to the patient.
FAU - Staff, D M
AU  - Staff DM
AD  - Division of Gastroenterology and Hepatology, Medical College of Wisconsin, 
      Milwaukee, Wisconsin, USA.
FAU - Saeian, K
AU  - Saeian K
FAU - Rochling, F
AU  - Rochling F
FAU - Narayanan, S
AU  - Narayanan S
FAU - Kern, M
AU  - Kern M
FAU - Shaker, R
AU  - Shaker R
FAU - Hogan, W J
AU  - Hogan WJ
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Gastrointest Endosc
JT  - Gastrointestinal endoscopy
JID - 0010505
SB  - IM
MH  - Adult
MH  - Aged
MH  - Ambulatory Care
MH  - Endoscopy, Gastrointestinal/*methods/statistics & numerical data
MH  - Female
MH  - Gastrointestinal Diseases/diagnosis
MH  - Health Care Surveys
MH  - *Health Knowledge, Attitudes, Practice
MH  - Health Services Accessibility
MH  - Humans
MH  - *Informed Consent
MH  - Male
MH  - Middle Aged
MH  - Patient Satisfaction
MH  - Probability
MH  - Referral and Consultation/*organization & administration
MH  - Surveys and Questionnaires
MH  - Truth Disclosure
MH  - United States
EDAT- 2000/08/02 11:00
MHDA- 2000/09/30 11:01
CRDT- 2000/08/02 11:00
PHST- 2000/08/02 11:00 [pubmed]
PHST- 2000/09/30 11:01 [medline]
PHST- 2000/08/02 11:00 [entrez]
AID - S0016-5107(00)87927-4 [pii]
AID - 10.1067/mge.2000.107719 [doi]
PST - ppublish
SO  - Gastrointest Endosc. 2000 Aug;52(2):212-7. doi: 10.1067/mge.2000.107719.

PMID- 26601554
OWN - NLM
STAT- MEDLINE
DCOM- 20160105
LR  - 20151125
IS  - 1781-782X (Print)
IS  - 1781-782X (Linking)
VI  - 11
IP  - 3
DP  - 2015
TI  - Do viral infections have a role in benign paroxysmal positional vertigo?
PG  - 211-8
AB  - OBJECTIVES: To investigate the role of viral infection in benign paroxysmal 
      positional vertigo (BPPV). METHODS: In this retrospective study, 483 patients 
      with BPPV were included in the study group. The control group consisted of 461 
      healthy subjects. In both groups, serologic analysis of viral agents (HSV1, HSV2, 
      Herpes zoster, EBV, CMV, adenovirus, influenza, and parainfluenza virus) was 
      performed. RESULTS: With the exception of influenza and parainfluenza, all viral 
      serology values were higher in the BBPV group than the control group. We also 
      observed seasonal variation. The BPPV group exhibited elevated values for HSV1 
      and adenovirus in March and May, for Herpes zoster, adenovirus, and influenza in 
      April, for HSV1 in June, and for HSV1 and CMV in September, compared to the 
      control group. In October, the BPPV group showed increased values for all of the 
      viruses studied, compared to the control group. CONCLUSION: BPPV is associated 
      with positive viral serology, particularly during certain months of the year, 
      mainly in spring and autumn. Viral infection might promote BPPV attacks due to 
      the development of vestibulopathy or induce secondary BPPV via viral 
      infection-related neurolabyrinthitis.
FAU - Hanci, D
AU  - Hanci D
FAU - Ulusoy, S
AU  - Ulusoy S
FAU - Muluk, N B
AU  - Muluk NB
FAU - Cingi, C
AU  - Cingi C
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Belgium
TA  - B-ENT
JT  - B-ENT
JID - 101247842
RN  - 0 (Antibodies, Viral)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Antibodies, Viral/*analysis
MH  - Benign Paroxysmal Positional Vertigo/epidemiology/*etiology
MH  - Child
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Incidence
MH  - Male
MH  - Middle Aged
MH  - Retrospective Studies
MH  - Turkey/epidemiology
MH  - Virus Diseases/*complications/virology
MH  - Viruses/*immunology
MH  - Young Adult
EDAT- 2015/11/26 06:00
MHDA- 2016/01/06 06:00
CRDT- 2015/11/26 06:00
PHST- 2015/11/26 06:00 [entrez]
PHST- 2015/11/26 06:00 [pubmed]
PHST- 2016/01/06 06:00 [medline]
PST - ppublish
SO  - B-ENT. 2015;11(3):211-8.

PMID- 15489384
OWN - NLM
STAT- MEDLINE
DCOM- 20041202
LR  - 20181113
IS  - 0022-3050 (Print)
IS  - 1468-330X (Electronic)
IS  - 0022-3050 (Linking)
VI  - 75
IP  - 11
DP  - 2004 Nov
TI  - Does reducing spasticity translate into functional benefit? An exploratory 
      meta-analysis.
PG  - 1547-51
AB  - BACKGROUND: Spasticity and loss of function in an affected arm are common after 
      stroke. Although botulinum toxin is used to reduce spasticity, its functional 
      benefits are less easily demonstrated. This paper reports an exploratory 
      meta-analysis to investigate the relationship between reduced arm spasticity and 
      improved arm function. METHOD: Individual data from stroke patients in two 
      randomised controlled trials of intra-muscular botulinum toxin were pooled. The 
      Modified Ashworth Scale (elbow, wrist, fingers) was used to calculate a 
      "Composite Spasticity Index". Data from the arm section of the Barthel Activities 
      of Daily Living Index (dressing, grooming, and feeding) and three subjective 
      measures (putting arm through sleeve, cleaning palm, cutting fingernails) were 
      summed to give a "Composite Functional Index". Change scores and the time of 
      maximum change were also calculated. RESULTS: Maximum changes in both composite 
      measures occurred concurrently in 47 patients. In 26 patients the improvement in 
      spasticity preceded the improvement in function with 18 showing the reverse. 
      There was a definite relationship between the maximum change in spasticity and 
      the maximum change in arm function, independent of treatment (rho = -0.2822, p = 
      0.0008, n = 137). There was a clear relationship between the changes in 
      spasticity and in arm function in patients treated with botulinum toxin (Dysport) 
      at 500 or 1000 units (rho = -0.5679, p = 0.0090, n = 22; rho = -0.4430, p = 
      0.0018, n = 47), but not in those treated with placebo or 1500 units. 
      CONCLUSIONS: Using a targeted meta-analytic approach, it is possible to 
      demonstrate that reducing spasticity in the arm is associated with a significant 
      improvement in arm function.
FAU - Francis, H P
AU  - Francis HP
AD  - Ipsen Limited, 190 Bath Road, Slough, SL1 3XE, Berkshire, UK. 
      hilary.francis@ipsen.com
FAU - Wade, D T
AU  - Wade DT
FAU - Turner-Stokes, L
AU  - Turner-Stokes L
FAU - Kingswell, R S
AU  - Kingswell RS
FAU - Dott, C S
AU  - Dott CS
FAU - Coxon, E A
AU  - Coxon EA
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PL  - England
TA  - J Neurol Neurosurg Psychiatry
JT  - Journal of neurology, neurosurgery, and psychiatry
JID - 2985191R
RN  - 0 (Neuromuscular Agents)
RN  - EC 3.4.24.69 (Botulinum Toxins, Type A)
SB  - IM
MH  - Activities of Daily Living/*classification
MH  - Aged
MH  - Arm/innervation
MH  - Botulinum Toxins, Type A/*therapeutic use
MH  - Double-Blind Method
MH  - Female
MH  - Humans
MH  - Injections, Intramuscular
MH  - Male
MH  - Middle Aged
MH  - Motor Activity/drug effects
MH  - Muscle Spasticity/*drug therapy
MH  - Neuromuscular Agents/*therapeutic use
MH  - Randomized Controlled Trials as Topic
MH  - Stroke/*complications
MH  - Stroke Rehabilitation
PMC - PMC1738826
EDAT- 2004/10/19 09:00
MHDA- 2004/12/16 09:00
PMCR- 2007/11/01
CRDT- 2004/10/19 09:00
PHST- 2004/10/19 09:00 [pubmed]
PHST- 2004/12/16 09:00 [medline]
PHST- 2004/10/19 09:00 [entrez]
PHST- 2007/11/01 00:00 [pmc-release]
AID - 75/11/1547 [pii]
AID - 10.1136/jnnp.2003.025551 [doi]
PST - ppublish
SO  - J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1547-51. doi: 
      10.1136/jnnp.2003.025551.

PMID- 27818079
OWN - NLM
STAT- MEDLINE
DCOM- 20170420
LR  - 20170817
IS  - 1531-5053 (Electronic)
IS  - 0278-2391 (Linking)
VI  - 75
IP  - 2
DP  - 2017 Feb
TI  - Is the Retromandibular Transparotid Approach a Reliable Option for the Surgical 
      Treatment of Condylar Fractures?
PG  - 348-356
LID - S0278-2391(16)30945-4 [pii]
LID - 10.1016/j.joms.2016.10.003 [doi]
AB  - PURPOSE: This study evaluated the outcomes and complications of the surgical 
      treatment of condylar fractures by the retromandibular transparotid approach. The 
      authors hypothesized that such an approach would be safe and reliable for the 
      treatment of most condylar fractures. MATERIALS AND METHODS: A retrospective 
      evaluation of patients who underwent surgical reduction of a condylar fracture 
      from January 2012 to December 2014 at the Clinic of Dentistry and Maxillofacial 
      Surgery of the University Hospital of Verona (Verona, Italy) was performed. 
      Inclusion criteria were having undergone surgical treatment of condylar fractures 
      with a retromandibular transparotid approach and the availability of computed 
      tomograms of the preoperative and postoperative facial skeleton with a minimum 
      follow-up of 1 year. Static and dynamic occlusal function, temporomandibular 
      joint health status, presence of neurologic impairments, and esthetic outcomes 
      were evaluated in all patients. RESULTS: The sample was composed of 25 patients. 
      Preinjury occlusion and temporomandibular joint health were restored in most 
      patients. Esthetic outcomes were deemed satisfactory by clinicians and patients. 
      Neither permanent neurologic impairments nor major postoperative complications 
      were observed. CONCLUSIONS: According to the results of the present study, the 
      retromandibular transparotid approach is a viable and safe approach for the 
      surgical treatment of condylar fractures.
CI  - Copyright (c) 2016 American Association of Oral and Maxillofacial Surgeons. 
      Published by Elsevier Inc. All rights reserved.
FAU - D'Agostino, Antonio
AU  - D'Agostino A
AD  - Associate Professor, Unit of Maxillofacial Surgery and Dentistry, University of 
      Verona, Verona, Italy.
FAU - Trevisiol, Lorenzo
AU  - Trevisiol L
AD  - Associate Professor, Unit of Maxillofacial Surgery and Dentistry, University of 
      Verona, Verona, Italy.
FAU - Procacci, Pasquale
AU  - Procacci P
AD  - Assistant Professor, Unit of Maxillofacial Surgery and Dentistry, University of 
      Verona, Verona, Italy.
FAU - Favero, Vittorio
AU  - Favero V
AD  - Clinical Assistant, Unit of Maxillofacial Surgery and Dentistry, University of 
      Verona, Verona, Italy. Electronic address: Vittorio_favero@yahoo.it.
FAU - Odorizzi, Silvia
AU  - Odorizzi S
AD  - Assistant, Unit of Maxillofacial Surgery and Dentistry, University of Verona, 
      Verona, Italy.
FAU - Nocini, Pier Francesco
AU  - Nocini PF
AD  - Professor and Chief, Unit of Maxillofacial Surgery and Dentistry, University of 
      Verona, Verona, Italy.
LA  - eng
PT  - Journal Article
DEP - 20161013
PL  - United States
TA  - J Oral Maxillofac Surg
JT  - Journal of oral and maxillofacial surgery : official journal of the American 
      Association of Oral and Maxillofacial Surgeons
JID - 8206428
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Female
MH  - Humans
MH  - Male
MH  - Mandibular Condyle/diagnostic imaging/*injuries/surgery
MH  - Mandibular Fractures/diagnostic imaging/*surgery
MH  - Middle Aged
MH  - Retrospective Studies
MH  - Tomography, X-Ray Computed
MH  - Young Adult
EDAT- 2016/11/08 06:00
MHDA- 2017/04/21 06:00
CRDT- 2016/11/08 06:00
PHST- 2016/06/28 00:00 [received]
PHST- 2016/08/10 00:00 [revised]
PHST- 2016/10/02 00:00 [accepted]
PHST- 2016/11/08 06:00 [pubmed]
PHST- 2017/04/21 06:00 [medline]
PHST- 2016/11/08 06:00 [entrez]
AID - S0278-2391(16)30945-4 [pii]
AID - 10.1016/j.joms.2016.10.003 [doi]
PST - ppublish
SO  - J Oral Maxillofac Surg. 2017 Feb;75(2):348-356. doi: 10.1016/j.joms.2016.10.003. 
      Epub 2016 Oct 13.

PMID- 24340838
OWN - NLM
STAT- MEDLINE
DCOM- 20140114
LR  - 20220330
IS  - 1565-1088 (Print)
VI  - 15
IP  - 9
DP  - 2013 Sep
TI  - Do ventricular arrhythmias in athletes subside over time?
PG  - 485-8
AB  - BACKGROUND: Sudden death in athletes can occur during sport activities and is 
      presumably related to ventricular arrhythmias. OBJECTIVES: To investigate the 
      long-term follow-up ofathletes with ventricular arrhythmias during an exercise 
      test. METHODS: From a database of 56,462 athletes we identified 192 athletes (35 
      years old who had ventricular arrhythmias during an exercise test. Ninety 
      athletes had > or =3 ventricular premature beats (VPB) (group A) and 102 athletes 
      had ventricular couplets or non-sustained ventricular tachycardia during an 
      exercise test (group B). A control group of 92 athletesfrom without ventricular 
      arrhythmias was randomly seleclted from the database (group C). Of the 192 
      athletes 39 returnied for a repeat exercise test after a mean follow-up period of 
      70 +/- 25 months and they constitute the study population. RESULTS: Twelve 
      athletes from group A, 21 fromgroup B and 6 from group C returned for a repeat 
      exercise test. The athletes reached a significantly lower peak heart rate during 
      their follow-up exercise test (P = 0.001). More athletes were engaged in 
      competitive sports during their initialexercise test than in the follow-up test 
      (P = 0.021). Most of theathletes who had VPB and/orventricular couplets and/or 
      NSVT during their initial exercise test had far fewer ventricular arrhythmias in 
      the follow-up exercise test (P = 0.001). CONCLUSIONS: Athletes engaged in 
      competitive sports are more likely to develop ventricular arrhythmias during 
      exercise. These arrhythmias subside over time when athletes are engaged in 
      non-competitive sports.
FAU - Fuchs, Therese
AU  - Fuchs T
AD  - Arrhythmia Service, Assaf Harofeh Medical Center, Zerifin, affiliated with 
      Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. 
      therese@fuchs.org
FAU - Torjman, Amram
AU  - Torjman A
AD  - College of Management, Rishon Lezion, Israel.
FAU - Galitzkaya, Luba
AU  - Galitzkaya L
AD  - Wingate Institute for Physical Education and Sport, Netanya, Israel.
FAU - Leitman, Marina
AU  - Leitman M
AD  - Arrhythmia Service, Assaf Harofeh Medical Center, Zerifin, affiliated with 
      Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
FAU - Pilz-Burstein, Rutie
AU  - Pilz-Burstein R
AD  - Wingate Institute for Physical Education and Sport, Netanya, Israel.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Israel
TA  - Isr Med Assoc J
JT  - The Israel Medical Association journal : IMAJ
JID - 100930740
SB  - IM
MH  - Adult
MH  - Arrhythmias, Cardiac/*epidemiology
MH  - *Athletes
MH  - Case-Control Studies
MH  - Databases, Factual
MH  - Exercise Test
MH  - Follow-Up Studies
MH  - Heart Rate/physiology
MH  - Humans
MH  - Sports/*physiology
MH  - Tachycardia, Ventricular/*epidemiology
MH  - Time Factors
MH  - Ventricular Premature Complexes/*epidemiology
MH  - Young Adult
EDAT- 2013/12/18 06:00
MHDA- 2014/01/15 06:00
CRDT- 2013/12/18 06:00
PHST- 2013/12/18 06:00 [entrez]
PHST- 2013/12/18 06:00 [pubmed]
PHST- 2014/01/15 06:00 [medline]
PST - ppublish
SO  - Isr Med Assoc J. 2013 Sep;15(9):485-8.

PMID- 16971978
OWN - NLM
STAT- MEDLINE
DCOM- 20061019
LR  - 20190608
IS  - 0828-282X (Print)
IS  - 1916-7075 (Electronic)
IS  - 0828-282X (Linking)
VI  - 22
IP  - 11
DP  - 2006 Sep
TI  - Are complex coronary lesions more frequent in patients with diabetes mellitus?
PG  - 935-7
AB  - BACKGROUND: Coronary atherosclerotic burden is excessive in diabetic patients. 
      Diabetes mellitus (DM) is an independent predictor for both death and myocardial 
      infarction. It is not known whether the prevalence of complex coronary lesions, 
      such as bifurcation and ostial lesions, is different in diabetics from 
      nondiabetics. OBJECTIVE: The aim of present study was to investigate the 
      prevalence of these lesions in patients with DM. METHODS: One thousand fourteen 
      consecutive patients (mean age 61.3+/-10.7 years) were investigated. Coronary 
      angiograms were examined for bifurcation and ostial lesions using a digital 
      quantitative system. Patients were classified as diabetic (n=281) or nondiabetic 
      (n=733). RESULTS: Patient mean age, and rates of hypertension and hyperlipidemia 
      were significantly higher in the diabetic group than in the nondiabetic group 
      (P<0.0001), although smoking was significantly lower (P=0.001). Reasons for 
      coronary angiography and treatment were comparable between the two groups. The 
      prevalence of bifurcation lesions and ostial lesions was significantly greater in 
      the diabetic group than in the nondiabetic group (9.8% versus 4.3% [P=0.001] and 
      38.4% versus 29.2% [P=0.003] in the diabetic group versus the nondiabetic group). 
      The presence of DM and greater age were found to be independent predictors for 
      bifurcation lesions (OR=2.27 [P=0.004] and OR=1.03 [P=0.01], for DM and age, 
      respectively) and ostial lesions (OR=1.40 [P=0.027] and OR=1.02 [P=0.001], for DM 
      and age, respectively) in multivariate analysis. CONCLUSIONS: Complex coronary 
      lesions such as bifurcation and ostial lesions were significantly more common in 
      diabetic patients than in nondiabetic patients. Greater age and the presence of 
      DM were independent predictors for these complex lesions. These results may help 
      to explain the poor prognosis of coronary artery disease among diabetic patients.
FAU - Baris, Nezihi
AU  - Baris N
AD  - Department of Cardiology, Faculty of Medicine, Dokuz Eylul University, Izmir, 
      Turkey. nezihi.baris@deu.edu.tr
FAU - Akdeniz, Bahri
AU  - Akdeniz B
FAU - Uyar, Samet
AU  - Uyar S
FAU - Ozel, Erdem
AU  - Ozel E
FAU - Kirimli, Onder
AU  - Kirimli O
FAU - Badak, Ozer
AU  - Badak O
FAU - Aslan, Ozgur
AU  - Aslan O
FAU - Guneri, Sema
AU  - Guneri S
LA  - eng
PT  - Journal Article
PL  - England
TA  - Can J Cardiol
JT  - The Canadian journal of cardiology
JID - 8510280
SB  - IM
MH  - Coronary Angiography
MH  - Coronary Artery Disease/complications/diagnostic imaging/*epidemiology
MH  - *Diabetes Mellitus
MH  - Female
MH  - Humans
MH  - Hyperlipidemias
MH  - Hypertension
MH  - Male
MH  - Middle Aged
MH  - Prevalence
MH  - Turkey/epidemiology
PMC - PMC2570247
EDAT- 2006/09/15 09:00
MHDA- 2006/10/20 09:00
PMCR- 2007/09/01
CRDT- 2006/09/15 09:00
PHST- 2006/09/15 09:00 [pubmed]
PHST- 2006/10/20 09:00 [medline]
PHST- 2006/09/15 09:00 [entrez]
PHST- 2007/09/01 00:00 [pmc-release]
AID - S0828-282X(06)70312-9 [pii]
AID - cjc220935 [pii]
AID - 10.1016/s0828-282x(06)70312-9 [doi]
PST - ppublish
SO  - Can J Cardiol. 2006 Sep;22(11):935-7. doi: 10.1016/s0828-282x(06)70312-9.

PMID- 21689015
OWN - NLM
STAT- MEDLINE
DCOM- 20111013
LR  - 20130715
IS  - 1557-7708 (Electronic)
IS  - 1075-5535 (Linking)
VI  - 17
IP  - 7
DP  - 2011 Jul
TI  - Can dogs prime autistic children for therapy? Evidence from a single case study.
PG  - 655-9
LID - 10.1089/acm.2010.0436 [doi]
AB  - BACKGROUND AND OBJECTIVES: Canine-assisted therapy has been receiving growing 
      attention as a means of aiding children with autism spectrum disorder (ASD). Yet, 
      only limited studies have been done and a great deal of literature related to 
      this intervention is anecdotal. The present study aims at providing additional 
      quantitative evidence on the potential of dogs to positively modulate the 
      behavior of children with ASD. SETTINGS/LOCATION, SUBJECTS, AND INTERVENTIONS: A 
      12-year-old boy diagnosed with ASD was exposed, at his usual treatment location 
      (the Portuguese Association for Developmental Disorders and Autism at Vila Nova 
      de Gaia, Portugal), to the following treatment conditions: (1) one-to-one 
      structured activities with a therapist assisted by a certified therapy dog, and 
      (2) one-to-one structured activities with the same therapist alone (as a 
      control). To accurately assess differences in the behavior of the participant 
      between these treatment conditions, the therapist followed a strict research 
      protocol. The behavior of the participant was continuously video-recorded during 
      both treatment conditions for further analysis and comparison. Treatment 
      outcomes: In the presence of the dog, the participant exhibited more frequent and 
      longer durations of positive behaviors (such as smiling and positive physical 
      contacting) as well as less frequent and shorter durations of negative behaviors 
      (such as aggressive manifestations). CONCLUSIONS: These findings are in 
      accordance with previous experimental work and provide additional support for the 
      assertion that dogs can prime autistic children for therapy. Ultimately, this 
      study may contribute toward a change for full acceptance of canine-assisted 
      therapy programs within the medical milieu. Additional studies using a similar 
      research protocol on more autistic children will certainly help professionals to 
      work on the most effective methods to individually serve this population through 
      canine-assisted interventions.
FAU - Silva, Karine
AU  - Silva K
AD  - Departamento de Ciencias do Comportamento, Instituto de Ciencias Biomedicas Abel 
      Salazar, Porto, Portugal. karine_silva_24@hotmail.com
FAU - Correia, Rita
AU  - Correia R
FAU - Lima, Mariely
AU  - Lima M
FAU - Magalhaes, Ana
AU  - Magalhaes A
FAU - de Sousa, Liliana
AU  - de Sousa L
LA  - eng
PT  - Case Reports
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20110620
PL  - United States
TA  - J Altern Complement Med
JT  - Journal of alternative and complementary medicine (New York, N.Y.)
JID - 9508124
SB  - IM
MH  - *Animal Assisted Therapy
MH  - Animals
MH  - Autistic Disorder/*therapy
MH  - Behavior Therapy/*methods
MH  - Child
MH  - *Child Behavior
MH  - Dogs
MH  - Humans
MH  - Male
MH  - Portugal
MH  - *Social Behavior
MH  - Treatment Outcome
EDAT- 2011/06/22 06:00
MHDA- 2011/10/14 06:00
CRDT- 2011/06/22 06:00
PHST- 2011/06/22 06:00 [entrez]
PHST- 2011/06/22 06:00 [pubmed]
PHST- 2011/10/14 06:00 [medline]
AID - 10.1089/acm.2010.0436 [doi]
PST - ppublish
SO  - J Altern Complement Med. 2011 Jul;17(7):655-9. doi: 10.1089/acm.2010.0436. Epub 
      2011 Jun 20.

PMID- 12846929
OWN - NLM
STAT- MEDLINE
DCOM- 20090630
LR  - 20181113
IS  - 1477-7525 (Electronic)
IS  - 1477-7525 (Linking)
VI  - 1
DP  - 2003 Jun 9
TI  - Quality of life in lung cancer patients: does socioeconomic status matter?
PG  - 19
AB  - BACKGROUND: As part of a prospective study on quality of life in newly diagnosed 
      lung cancer patients an investigation was carried out to examine whether there 
      were differences among patients' quality of life scores and their socioeconomic 
      status. METHODS: Quality of life was measured at two points in time (baseline and 
      three months after initial treatment) using three standard instruments; the 
      Nottingham Health Profile (NHP), the European Organization for Research and 
      Cancer Treatment Quality of Life Questionnaire (EORTC QLQ-C30) and its lung 
      cancer supplement (QLQ-LC13). Socioeconomic status for each individual patient 
      was derived using Carstairs and Morris Deprivation Category ranging from 1 (least 
      deprived) to 7 (most deprived) on the basis of the postcode sector of their 
      address. RESULTS: In all, 129 lung cancer patients entered into the study. Of 
      these data for 82 patients were complete (at baseline and follow-up). 57% of 
      patients were of lower socioeconomic status and they had more health problems, 
      less functioning, and more symptoms as compared to affluent patients. Of these, 
      physical mobility (P = 0.05), energy (P = 0.01), role functioning (P = 0.04), 
      physical functioning (P = 0.03), and breathlessness (P = 0.02) were significant 
      at baseline. However, at follow-up assessment there was no significant difference 
      between patient groups nor did any consistent pattern emerge. CONCLUSION: At 
      baseline assessment patients of lower socioeconomic status showed lower health 
      related quality of life. Since there was no clear trend at follow-up assessment 
      this suggests that patients from different socioeconomic status responded to 
      treatment similarly. In general, the findings suggest that quality of life is not 
      only the outcome of the disease and its treatment, but is also highly dependent 
      on each patients' socioeconomic characteristics.
FAU - Montazeri, Ali
AU  - Montazeri A
AD  - Iranian Institute for Health Sciences Research, Tehran, Iran. ali@jdcord.jd.ac.ir
FAU - Hole, David J
AU  - Hole DJ
FAU - Milroy, Robert
AU  - Milroy R
FAU - McEwen, James
AU  - McEwen J
FAU - Gillis, Charles R
AU  - Gillis CR
LA  - eng
PT  - Journal Article
DEP - 20030609
PL  - England
TA  - Health Qual Life Outcomes
JT  - Health and quality of life outcomes
JID - 101153626
SB  - IM
MH  - Aged
MH  - Female
MH  - Humans
MH  - Lung Neoplasms/*economics/psychology
MH  - Male
MH  - Middle Aged
MH  - Prospective Studies
MH  - *Quality of Life
MH  - Sickness Impact Profile
MH  - *Social Class
MH  - Statistics, Nonparametric
MH  - Surveys and Questionnaires
PMC - PMC165601
EDAT- 2003/07/09 05:00
MHDA- 2009/07/01 09:00
PMCR- 2003/06/09
CRDT- 2003/07/09 05:00
PHST- 2003/02/18 00:00 [received]
PHST- 2003/06/09 00:00 [accepted]
PHST- 2003/07/09 05:00 [pubmed]
PHST- 2009/07/01 09:00 [medline]
PHST- 2003/07/09 05:00 [entrez]
PHST- 2003/06/09 00:00 [pmc-release]
AID - 1477-7525-1-19 [pii]
AID - 10.1186/1477-7525-1-19 [doi]
PST - epublish
SO  - Health Qual Life Outcomes. 2003 Jun 9;1:19. doi: 10.1186/1477-7525-1-19.

PMID- 22694248
OWN - NLM
STAT- MEDLINE
DCOM- 20130627
LR  - 20130122
IS  - 1365-2931 (Electronic)
IS  - 1364-5706 (Linking)
VI  - 22
IP  - 1
DP  - 2013 Feb
TI  - Is there a model to teach and practice retroperitoneoscopic nephrectomy?
PG  - 33-8
LID - 10.3109/13645706.2012.696544 [doi]
AB  - INTRODUCTION: Although the retroperitoneal approach has been the preferred choice 
      for open urological procedures, retroperitoneoscopy is not the preferred approach 
      for laparoscopy. This study aims to develop a training model for 
      retroperitoneoscopy and to establish an experimental learning curve. MATERIAL AND 
      METHODS: Fifteen piglets were operated on to develop a standard 
      retroperitoneoscopic nephrectomy (RPN) training model. All procedures were 
      performed with three ports. Intraoperative data (side, operative time, blood 
      loss, peritoneal opening) were recorded. Animals were divided into groups A, the 
      first eight, and B, the last seven cases. Data were statistically analyzed. 
      RESULTS: We performed fifteen RPNs. The operative time varied from 15 to 50 
      minutes (median 30 minutes). Blood loss varied from 5 to 100 mL (median 20 mL). 
      We experienced five peritoneal openings; we had two surgical vascular 
      complications managed laparoscopically. There was statistical difference between 
      groups A and B for peritoneal opening (p = 0.025), operative time (p = 0.0037), 
      and blood loss (p = 0.026). DISCUSSION: RPN in a porcine model could simulate the 
      whole procedure, from creating the space to nephrectomy completion. Experimental 
      learning curve was eight cases, after statistical data analysis. CONCLUSION: RPN 
      in a porcine model is feasible and could be very useful for teaching and 
      practicing retroperitoneoscopy.
FAU - Hisano, Marcelo
AU  - Hisano M
AD  - CEPEC Vicky Safra, University of Sao Paulo, Division of Urology , Sao Paulo, SP. 
      marcelohisano@hotmail.com
FAU - Duarte, Ricardo Jordao
AU  - Duarte RJ
FAU - Colombo, Jose Roberto Jr
AU  - Colombo JR Jr
FAU - Srougi, Miguel
AU  - Srougi M
LA  - eng
PT  - Journal Article
DEP - 20120614
PL  - England
TA  - Minim Invasive Ther Allied Technol
JT  - Minimally invasive therapy & allied technologies : MITAT : official journal of 
      the Society for Minimally Invasive Therapy
JID - 9612996
SB  - IM
MH  - Animals
MH  - Blood Loss, Surgical
MH  - Feasibility Studies
MH  - Laparoscopy/*education/methods
MH  - Models, Animal
MH  - Nephrectomy/*education/methods
MH  - Operative Time
MH  - Retroperitoneal Space/*surgery
MH  - Swine
EDAT- 2012/06/15 06:00
MHDA- 2013/06/29 06:00
CRDT- 2012/06/15 06:00
PHST- 2012/06/15 06:00 [entrez]
PHST- 2012/06/15 06:00 [pubmed]
PHST- 2013/06/29 06:00 [medline]
AID - 10.3109/13645706.2012.696544 [doi]
PST - ppublish
SO  - Minim Invasive Ther Allied Technol. 2013 Feb;22(1):33-8. doi: 
      10.3109/13645706.2012.696544. Epub 2012 Jun 14.

PMID- 15488260
OWN - NLM
STAT- MEDLINE
DCOM- 20050223
LR  - 20221207
IS  - 0165-0327 (Print)
IS  - 0165-0327 (Linking)
VI  - 82
IP  - 2
DP  - 2004 Oct 15
TI  - Is the type of remission after a major depressive episode an important risk 
      factor to relapses in a 4-year follow up?
PG  - 291-6
AB  - BACKGROUND: Rates of relapse and predictive relapse factors were studied over 
      more than 4 years in a sample of Spanish outpatients with DSM-III-R criteria for 
      unipolar major depressive episode. METHODS: A final sample of 139 outpatient was 
      followed monthly in a naturalistic study. The Structured Clinical Interview for 
      DSM-III-R was used. Phases of evolution were recorded using the Hamilton 
      Depression Rating Scale, applying the Frank criteria. Survival analysis, 
      Kaplan-Meier product limit and proportional hazards models were used. RESULTS: A 
      higher rate of relapses was observed in the partial remission group (91.4%) 
      compared to the complete remission one (51.3%). The four factors with predictive 
      relapse value were: "partial remission versus complete remission", "the intensity 
      of clinical symptoms", "the age" and "the number of previous depressive 
      episodes". The existence of partial remission was the most powerful predictive 
      factor. LIMITATIONS: The decreasing sample size during the follow-up and the 
      difficulty in warranting the treatment compliance. CONCLUSIONS: At medium term, 
      relapse rates for a major depressive episode are high. Partial remission after a 
      depressive episode seems to be an important predictive factor for relapses in a 
      4-year follow-up. CLINICAL RELEVANCE: Not reaching complete remission is a strong 
      risk factor for relapses in a 4-year follow up study.
FAU - Pintor, Luis
AU  - Pintor L
AD  - Instituto Clinico de Psiquiatria y Psicologia, Hospital Clinico y Provincial de 
      Barcelona, C/Villarroel-170, 08036 Barcelona, Spain. lpintor@clinic.ub.es
FAU - Torres, Xavier
AU  - Torres X
FAU - Navarro, Victor
AU  - Navarro V
FAU - Matrai, Silvia
AU  - Matrai S
FAU - Gasto, Cristobal
AU  - Gasto C
LA  - eng
PT  - Journal Article
PL  - Netherlands
TA  - J Affect Disord
JT  - Journal of affective disorders
JID - 7906073
RN  - 0 (Antidepressive Agents)
RN  - 0 (Serotonin Uptake Inhibitors)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Antidepressive Agents/therapeutic use
MH  - Depressive Disorder, Major/diagnosis/drug therapy/*epidemiology/psychology
MH  - Diagnostic and Statistical Manual of Mental Disorders
MH  - Drug Therapy, Combination
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Personality Inventory
MH  - Prospective Studies
MH  - Recurrence
MH  - Risk Factors
MH  - Selective Serotonin Reuptake Inhibitors/therapeutic use
MH  - Spain
MH  - Survival Analysis
EDAT- 2004/10/19 09:00
MHDA- 2005/02/24 09:00
CRDT- 2004/10/19 09:00
PHST- 2003/05/30 00:00 [received]
PHST- 2003/11/18 00:00 [revised]
PHST- 2003/11/19 00:00 [accepted]
PHST- 2004/10/19 09:00 [pubmed]
PHST- 2005/02/24 09:00 [medline]
PHST- 2004/10/19 09:00 [entrez]
AID - S0165032703003240 [pii]
AID - 10.1016/j.jad.2003.11.008 [doi]
PST - ppublish
SO  - J Affect Disord. 2004 Oct 15;82(2):291-6. doi: 10.1016/j.jad.2003.11.008.

PMID- 23690198
OWN - NLM
STAT- MEDLINE
DCOM- 20130719
LR  - 20130521
IS  - 1128-3602 (Print)
IS  - 1128-3602 (Linking)
VI  - 17
IP  - 9
DP  - 2013 May
TI  - Implementation of epidural analgesia for labor: is the standard of effective 
      analgesia reachable in all women? An audit of two years.
PG  - 1262-8
LID - 4100 [pii]
AB  - BACKGROUND: Social and cultural factors combined with little information may 
      prevent the diffusion of epidural analgesia for pain relief during childbirth. 
      The present study was launched contemporarily to the implementation of analgesia 
      for labor in our Department in order to perform a 2 years audit on its use. The 
      goal is to evaluate the epidural acceptance and penetration into hospital 
      practice by women and care givers and safety and efficacy during childbirth. 
      PATIENTS AND METHODS: This audit cycle measured epidural analgesia performance 
      against 4 standards: (1) Implementation of epidural analgesia for labor to all 
      patients; (2) Acceptance and good satisfaction level reported by patients and 
      caregivers. (3) Effectiveness of labor analgesia; (4) No maternal or fetal side 
      effects. RESULTS: During the audit period epidural analgesia increased from 15.5% 
      of all labors in the first trimester of the study to 51% in the last trimester (p 
      < 0.005). Satisfaction levels reported by patients and care givers were good. A 
      hierarchical clustering analysis identified two clusters based on VAS (Visual 
      Analogue Scale) time course: in 226 patients (cluster 1) VAS decreased from 
      8.5+/-1.4 before to 4.1+/-1.3 after epidural analgesia; in 1002 patients (cluster 2) 
      VAS decreased from 8.12+/-1.7 before (NS vs cluster 1), to 0.76+/-0.79 after (p < 
      0.001 vs before and vs cluster 2 after). No other differences between clusters 
      were observed. CONCLUSIONS: Present audit shows that the process of 
      implementation of labor analgesia was quick, successful and safe, notwithstanding 
      the identification of one cluster of women with suboptimal response to epidural 
      analgesia that need to be further studies, overall pregnant womens'adhesion to 
      labor analgesia was satisfactory.
FAU - Pugliese, P L
AU  - Pugliese PL
AD  - Department of Anaesthesia and Intensive Care, University of Foggia, Foggia, 
      Italy.
FAU - Cinnella, G
AU  - Cinnella G
FAU - Raimondo, P
AU  - Raimondo P
FAU - De Capraris, A
AU  - De Capraris A
FAU - Salatto, P
AU  - Salatto P
FAU - Sforza, D
AU  - Sforza D
FAU - Menga, R
AU  - Menga R
FAU - D'Ambrosio, A
AU  - D'Ambrosio A
FAU - Fede, R N
AU  - Fede RN
FAU - D'Onofrio, C
AU  - D'Onofrio C
FAU - Consoletti, L
AU  - Consoletti L
FAU - Malvasi, A
AU  - Malvasi A
FAU - Brizzi, A
AU  - Brizzi A
FAU - Dambrosio, M
AU  - Dambrosio M
LA  - eng
PT  - Journal Article
PL  - Italy
TA  - Eur Rev Med Pharmacol Sci
JT  - European review for medical and pharmacological sciences
JID - 9717360
SB  - IM
MH  - Adult
MH  - Analgesia, Epidural/*methods/*standards
MH  - Analgesia, Obstetrical/*methods/*standards
MH  - Apgar Score
MH  - Cesarean Section
MH  - Cluster Analysis
MH  - Female
MH  - Hemodynamics/physiology
MH  - Humans
MH  - Infant, Newborn
MH  - Pain Measurement
MH  - Parity
MH  - Patient Safety
MH  - Patient Satisfaction
MH  - Pregnancy
EDAT- 2013/05/22 06:00
MHDA- 2013/07/20 06:00
CRDT- 2013/05/22 06:00
PHST- 2013/05/22 06:00 [entrez]
PHST- 2013/05/22 06:00 [pubmed]
PHST- 2013/07/20 06:00 [medline]
AID - 4100 [pii]
PST - ppublish
SO  - Eur Rev Med Pharmacol Sci. 2013 May;17(9):1262-8.

PMID- 10173769
OWN - NLM
STAT- MEDLINE
DCOM- 19971202
LR  - 20250103
IS  - 0963-8172 (Print)
IS  - 0963-8172 (Linking)
VI  - 6
IP  - 3
DP  - 1997 Sep
TI  - Longer term quality of life and outcome in stroke patients: is the Barthel index 
      alone an adequate measure of outcome?
PG  - 125-30
AB  - OBJECTIVES: To consider whether the Barthel Index alone provides sufficient 
      information about the long term outcome of stroke. DESIGN: Cross sectional follow 
      up study with a structured interview questionnaire and measures of impairment, 
      disability, handicap, and general health. The scales used were the hospital 
      anxiety and depression scale, mini mental state examination, Barthel index, 
      modified Rankin scale, London handicap scale, Frenchay activities index, SF36, 
      Nottingham health profile, life satisfaction index, and the caregiver strain 
      index. SETTING: South east London. SUBJECTS: People, and their identified carers, 
      resident in south east London in 1989-90 when they had their first in a life-time 
      stroke aged under 75 years. INTERVENTIONS: Observational study. MAIN OUTCOME 
      MEASURES: Comparison and correlation of the individual Barthel index scores with 
      the scores on other outcome measures. RESULTS: One hundred and twenty three (42%) 
      people were known to be alive, of whom 106 (86%) were interviewed. The median age 
      was 71 years (range 34-79). The mean interval between the stroke and follow up 
      was 4.9 years. The rank correlation coefficients between the Barthel and the 
      different dimensions of the SF36 ranged from r = 0.217 (with the role emotional 
      dimension) to r = 0.810 (with the physical functioning dimension); with the 
      Nottingham health profile the range was r = -0.189 (with the sleep dimension, NS) 
      to r = -0.840 (with the physical mobility dimension); with the hospital and 
      anxiety scale depression component the coefficient was r = -0.563, with the life 
      satisfaction index r = 0.361, with the London handicap scale r = 0.726 and with 
      the Frenchay activities index r = 0.826. CONCLUSIONS: The place of the Barthel 
      index as the standard outcome measure for populations of stroke patients is still 
      justified for long term follow up, and may be a proxy for different outcome 
      measures intended for the assessment of other domains.
FAU - Wilkinson, P R
AU  - Wilkinson PR
AD  - St Thomas's Hospital, London.
FAU - Wolfe, C D
AU  - Wolfe CD
FAU - Warburton, F G
AU  - Warburton FG
FAU - Rudd, A G
AU  - Rudd AG
FAU - Howard, R S
AU  - Howard RS
FAU - Ross-Russell, R W
AU  - Ross-Russell RW
FAU - Beech, R
AU  - Beech R
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - Qual Health Care
JT  - Quality in health care : QHC
JID - 9209948
MH  - Activities of Daily Living
MH  - Adult
MH  - Aged
MH  - Caregivers/psychology
MH  - Cerebrovascular Disorders/classification/epidemiology/*physiopathology
MH  - Cognition Disorders
MH  - Cohort Studies
MH  - Cross-Sectional Studies
MH  - Persons with Disabilities/*classification
MH  - Humans
MH  - London/epidemiology
MH  - Middle Aged
MH  - Outcome Assessment, Health Care/*methods
MH  - Patient Satisfaction
MH  - *Quality of Life
MH  - Registries
MH  - State Medicine
PMC - PMC1055473
EDAT- 1997/08/05 00:00
MHDA- 1997/08/05 00:01
PMCR- 1997/09/01
CRDT- 1997/08/05 00:00
PHST- 1997/08/05 00:00 [pubmed]
PHST- 1997/08/05 00:01 [medline]
PHST- 1997/08/05 00:00 [entrez]
PHST- 1997/09/01 00:00 [pmc-release]
AID - 10.1136/qshc.6.3.125 [doi]
PST - ppublish
SO  - Qual Health Care. 1997 Sep;6(3):125-30. doi: 10.1136/qshc.6.3.125.

PMID- 12098035
OWN - NLM
STAT- MEDLINE
DCOM- 20030117
LR  - 20061115
IS  - 1432-2218 (Electronic)
IS  - 0930-2794 (Linking)
VI  - 16
IP  - 12
DP  - 2002 Dec
TI  - Does a special interest in laparoscopy affect the treatment of acute 
      cholecystitis?
PG  - 1697-703
AB  - BACKGROUND: We tested the hypothesis that the treatment of patients with acute 
      cholecystitis (AC) would be improved under the care of laparoscopic specialists. 
      METHODS: The records of patients undergoing cholecystectomy for AC from 1 January 
      1996 to 31 December 1998 were reviewed retrospectively. Of 170 patients, 48 were 
      cared for by three laparoscopic specialists (LS group), whereas 122 were treated 
      by nine general surgeons who perform only laparoscopic cholecystectomy (LC) (GS 
      group). The rates of successful LC, complications, and length of hospital stay 
      were compared. Multivariate analysis was used to control for baseline 
      differences. RESULTS: The patients in the GS group were older (median age, 63 vs 
      53 years; p = 0.01). In all, 31 LS patients (65%), as compared with 44 GS 
      patients (36%), had successful laparoscopic treatment (p = 0.001). The operating 
      time was the same (median, 70 min). The proportion of patients with postoperative 
      complications was similar in the two groups (37% in the GS vs 31% in the LS 
      group; p = 0.6). The median postoperative hospital stay (3 vs 5 days; p <0.01) 
      was shorter in the LS group. On logistic regression analysis, significant 
      predictors of a successful laparoscopic operation included LS group (p <0.01) and 
      age (p = 0). Predictors of prolonged length of hospital stay were age (p <0.01) 
      and comorbidity score (p <0.01), with LS group status not a significant factor (p 
      = 0.21). CONCLUSIONS: Patients with AC are more likely to undergo successful LC 
      if cared for by a surgeon with an interest in laparoscopy. However, length of 
      hospital stay is influenced more by patient factors in a multivariate model.
FAU - Feldman, L S
AU  - Feldman LS
AD  - Department of Surgery, McGill University, Montreal, Quebec, Canada. 
      liane.feldman@muhc.mcgill.ca
FAU - Medeiros, L E
AU  - Medeiros LE
FAU - Hanley, J
AU  - Hanley J
FAU - Sigman, H H
AU  - Sigman HH
FAU - Garzon, J
AU  - Garzon J
FAU - Fried, G M
AU  - Fried GM
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20020708
PL  - Germany
TA  - Surg Endosc
JT  - Surgical endoscopy
JID - 8806653
SB  - IM
MH  - Acute Disease
MH  - Adult
MH  - Age Factors
MH  - Aged
MH  - Aged, 80 and over
MH  - Cholecystectomy, Laparoscopic/*methods/statistics & numerical data/trends
MH  - Cholecystitis/complications/*surgery
MH  - Humans
MH  - Intraoperative Complications/epidemiology
MH  - Laparoscopy/*methods/statistics & numerical data/trends
MH  - Length of Stay/statistics & numerical data
MH  - Logistic Models
MH  - Middle Aged
MH  - Multivariate Analysis
MH  - Postoperative Complications/epidemiology
MH  - Predictive Value of Tests
MH  - Retrospective Studies
MH  - Risk Factors
MH  - Time Factors
MH  - Treatment Outcome
MH  - Workload/statistics & numerical data
EDAT- 2002/07/05 10:00
MHDA- 2003/01/18 04:00
CRDT- 2002/07/05 10:00
PHST- 2002/01/17 00:00 [received]
PHST- 2002/05/15 00:00 [accepted]
PHST- 2002/07/05 10:00 [pubmed]
PHST- 2003/01/18 04:00 [medline]
PHST- 2002/07/05 10:00 [entrez]
AID - 10.1007/s00464-002-8514-6 [doi]
PST - ppublish
SO  - Surg Endosc. 2002 Dec;16(12):1697-703. doi: 10.1007/s00464-002-8514-6. Epub 2002 
      Jul 8.

PMID- 23448747
OWN - NLM
STAT- MEDLINE
DCOM- 20130820
LR  - 20131121
IS  - 1538-0688 (Electronic)
IS  - 0190-535X (Linking)
VI  - 40
IP  - 2
DP  - 2013 Mar
TI  - Do older adults with cancer fall more often? A comparative analysis of falls in 
      those with and without cancer.
PG  - E69-78
LID - 10.1188/13.ONF.E69-E78 [doi]
AB  - PURPOSE/OBJECTIVES: To examine whether a history of cancer increased the 
      likelihood of a fall in community-dwelling older adults, and if cancer type, 
      stage, or time since diagnosis increased falls. DESIGN: A longitudinal, 
      retrospective, cohort study. SETTING: A home- and community-based waiver program 
      in Michigan. SAMPLE: 862 older adults aged 65 years or older with cancer compared 
      to 8,617 older adults without cancer using data from the Minimum Data Set-Home 
      Care and Michigan cancer registry. METHODS: Reports of falls were examined for 
      90-180 days. Generalized estimating equations were used to compare differences 
      between the groups. MAIN RESEARCH VARIABLES: Cancer, falls, patient 
      characteristics, comorbidities, medications, pain, weight loss, vision, memory 
      recall, and activities, as well as cancer type, stage, and time since diagnosis. 
      FINDINGS: A fall occurred at a rate of 33% in older adults with cancer compared 
      to 29% without cancer (p < 0.00). Those with a history of cancer were more likely 
      to fall than those without cancer (adjusted odds ratio 1.16; 95% confidence 
      interval [1.02, 1.33]; p = 0.03). No differences in fall rates were determined by 
      cancer type or stage, and the odds of a fall did not increase when adding time 
      since cancer diagnosis. CONCLUSIONS: The fall rate was higher in older adults 
      with cancer than in older adults without cancer. IMPLICATIONS FOR NURSING: Nurses 
      need to assess fall risk and initiate fall prevention measures for older adults 
      at the time of cancer diagnosis. KNOWLEDGE TRANSLATION: When caring for older 
      adults with cancer, nurses should be aware of an increased risk for falls. 
      Healthcare staff also should be aware of an increased risk for falls in that 
      population during cancer treatment. Evidence-based fall prevention measures 
      should be included in care plans for older adult cancer survivors.
FAU - Spoelstra, Sandra L
AU  - Spoelstra SL
AD  - College of Nursing, Michigan State University in East Lansing, MI, USA. 
      sandra.spoelstra@hc.msu
FAU - Given, Barbara A
AU  - Given BA
FAU - Schutte, Debra L
AU  - Schutte DL
FAU - Sikorskii, Alla
AU  - Sikorskii A
FAU - You, Mei
AU  - You M
FAU - Given, Charles W
AU  - Given CW
LA  - eng
GR  - 1F31NR011522-01A1/NR/NINR NIH HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Oncol Nurs Forum
JT  - Oncology nursing forum
JID - 7809033
SB  - IM
MH  - Accidental Falls/*statistics & numerical data
MH  - Aged
MH  - Aged, 80 and over
MH  - *Aging
MH  - Comorbidity
MH  - Female
MH  - Humans
MH  - Longitudinal Studies
MH  - Male
MH  - Michigan/epidemiology
MH  - Neoplasms/*epidemiology/nursing
MH  - Oncology Nursing
MH  - Prevalence
MH  - Registries/statistics & numerical data
MH  - Residence Characteristics/statistics & numerical data
MH  - Retrospective Studies
MH  - Risk Factors
EDAT- 2013/03/02 06:00
MHDA- 2013/08/21 06:00
CRDT- 2013/03/02 06:00
PHST- 2013/03/02 06:00 [entrez]
PHST- 2013/03/02 06:00 [pubmed]
PHST- 2013/08/21 06:00 [medline]
AID - 0312080076535885 [pii]
AID - 10.1188/13.ONF.E69-E78 [doi]
PST - ppublish
SO  - Oncol Nurs Forum. 2013 Mar;40(2):E69-78. doi: 10.1188/13.ONF.E69-E78.

PMID- 24359102
OWN - NLM
STAT- MEDLINE
DCOM- 20150112
LR  - 20220408
IS  - 1365-2133 (Electronic)
IS  - 0007-0963 (Linking)
VI  - 170
IP  - 5
DP  - 2014 May
TI  - Two-year follow-up survey of patients with allergic contact dermatitis from an 
      occupational cohort: is the prognosis dependent on the omnipresence of the 
      allergen?
PG  - 1100-5
LID - 10.1111/bjd.12795 [doi]
AB  - BACKGROUND: Skin diseases are the most frequently recognized occupational 
      diseases in Denmark. The prognosis for occupational contact dermatitis is often 
      poor. OBJECTIVES: To investigate the prognosis, assessed by eczema, job status 
      and skin-related quality of life, among patients allergic to rubber chemicals and 
      latex (ubiquitous allergens) and epoxy (nonubiquitous allergen), 2 years after 
      recognition of occupational allergic contact dermatitis. METHODS: From a cohort 
      of all patients recognized as having occupational dermatitis by the Danish 
      National Board of Industrial Injuries in 2010, 199 patients with relevant rubber 
      allergy (contact allergy to rubber chemicals or contact urticaria from latex) or 
      epoxy allergy were identified. Follow-up consisted of a questionnaire covering 
      current severity of eczema, employment, exposure and quality of life. RESULTS: 
      The response rate was 75%. Clearance of eczema was reported by 11% of patients 
      and 67% reported improvement. Overall 22% of patients with allergy to a 
      nonubiquitous allergen had total clearance of eczema compared with 10% of cases 
      allergic to ubiquitous allergens and 0% of those with contact urticaria 
      (P = 0.116). Improvement was significantly more frequent in those who had changed 
      jobs compared with those who had not (P = 0.01). CONCLUSIONS: At follow-up, 
      patients with contact urticaria had significantly poorer prognosis than those 
      with contact allergy, and there was a trend towards a poorer prognosis for those 
      with contact allergy to rubber chemicals than those with allergy to epoxy. A 
      significant positive association between job change and improvement was found.
CI  - (c) 2013 British Association of Dermatologists.
FAU - Clemmensen, K K B
AU  - Clemmensen KK
AD  - Department of Dermatology, University of Copenhagen, Bispebjerg Hospital, 2400, 
      Copenhagen, Denmark.
FAU - Caroe, T K
AU  - Caroe TK
FAU - Thomsen, S F
AU  - Thomsen SF
FAU - Ebbehoj, N E
AU  - Ebbehoj NE
FAU - Agner, T
AU  - Agner T
LA  - eng
PT  - Journal Article
PL  - England
TA  - Br J Dermatol
JT  - The British journal of dermatology
JID - 0004041
RN  - 0 (Allergens)
SB  - IM
CIN - Br J Dermatol. 2014 May;170(5):1010-1. doi: 10.1111/bjd.13018. PMID: 24841583
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Allergens/*analysis
MH  - Denmark/epidemiology
MH  - Dermatitis, Allergic Contact/*epidemiology
MH  - Dermatitis, Occupational/*epidemiology
MH  - Eczema/epidemiology
MH  - Employment/statistics & numerical data
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Latex Hypersensitivity/epidemiology
MH  - Male
MH  - Middle Aged
MH  - Prognosis
MH  - Quality of Life
MH  - Urticaria/epidemiology
MH  - Young Adult
EDAT- 2013/12/24 06:00
MHDA- 2015/01/13 06:00
CRDT- 2013/12/24 06:00
PHST- 2013/12/16 00:00 [accepted]
PHST- 2013/12/24 06:00 [entrez]
PHST- 2013/12/24 06:00 [pubmed]
PHST- 2015/01/13 06:00 [medline]
AID - 10.1111/bjd.12795 [doi]
PST - ppublish
SO  - Br J Dermatol. 2014 May;170(5):1100-5. doi: 10.1111/bjd.12795.

PMID- 14697414
OWN - NLM
STAT- MEDLINE
DCOM- 20040209
LR  - 20220409
IS  - 0360-3016 (Print)
IS  - 0360-3016 (Linking)
VI  - 58
IP  - 1
DP  - 2004 Jan 1
TI  - Is there a favorable subset of patients with prostate cancer who develop 
      oligometastases?
PG  - 3-10
AB  - OBJECTIVE: To analyze, retrospectively, the patterns and behavior of metastatic 
      lesions in prostate cancer patients treated with external beam radiotherapy and 
      to investigate whether patients with < or =5 lesions had an improved outcome 
      relative to patients with >5 lesions. METHODS AND MATERIALS: The treatment and 
      outcome of 369 eligible patients with Stage T1-T3aN0-NXM0 prostate cancer were 
      analyzed during a minimal 10-year follow-up period. All patients were treated 
      with curative intent to a mean dose of 65 Gy. The full history of any metastatic 
      disease was documented for each subject, including the initial site of 
      involvement, any progression over time, and patient survival. RESULTS: The 
      overall survival rate for the 369 patients was 75% at 5 years and 45% at 10 
      years. The overall survival rate of patients who never developed metastases was 
      90% and 81% at 5 and 10 years, respectively. However, among the 74 patients (20%) 
      who developed metastases, the survival rate at both 5 and 10 years was 
      significantly reduced (p <0.0001). The overall survival rate for patients who 
      developed bone metastases was 58% and 27% at 5 and 10 years, respectively, and 
      patients with bone metastases to the pelvis fared worse compared with those with 
      vertebral metastases. With regard to the metastatic number, patients with < or =5 
      metastatic lesions had superior survival rates relative to those with >5 lesions 
      (73% and 36% at 5 and 10 years vs. 45% and 18% at 5 and 10 years, respectively; p 
      = 0.02). In addition, both the metastasis-free survival rate and the interval 
      measured from the date of the initial diagnosis of prostate cancer to the 
      development of bone metastasis were statistically superior for patients with < or 
      =5 lesions compared with patients with >5 lesions (p = 0.01 and 0.02, 
      respectively). However, the survival rate and the interval from the date of 
      diagnosis of bone metastasis to the time of death for patients in both groups 
      were not significantly different, statistically (p = 0.17 and 0.27, 
      respectively). CONCLUSIONS: Patients with < or =5 metastatic sites had 
      significantly better survival rates than patients with >5 lesions. Because 
      existing sites of metastatic disease may be the primary sites of origin for 
      additional metastases, our findings suggest that early detection and aggressive 
      treatment of patients with a small number of metastatic lesions is worth testing 
      as an approach to improving long-term survival.
FAU - Singh, Deepinder
AU  - Singh D
AD  - Department of Radiation Oncology, University of Rochester Medical Center, 
      Rochester, NY 14642-8647, USA
FAU - Yi, Won Sam
AU  - Yi WS
FAU - Brasacchio, Ralph A
AU  - Brasacchio RA
FAU - Muhs, Ann G
AU  - Muhs AG
FAU - Smudzin, Therese
AU  - Smudzin T
FAU - Williams, Jacqueline P
AU  - Williams JP
FAU - Messing, Edward
AU  - Messing E
FAU - Okunieff, Paul
AU  - Okunieff P
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Int J Radiat Oncol Biol Phys
JT  - International journal of radiation oncology, biology, physics
JID - 7603616
RN  - 0 (Androgen Antagonists)
RN  - 0 (Antineoplastic Agents, Hormonal)
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Androgen Antagonists/therapeutic use
MH  - Antineoplastic Agents, Hormonal/therapeutic use
MH  - Bone Neoplasms/mortality/*secondary
MH  - Brain Neoplasms/mortality/secondary
MH  - Humans
MH  - Liver Neoplasms/mortality/secondary
MH  - Lung Neoplasms/mortality/secondary
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Staging
MH  - Orchiectomy
MH  - Prostatic Neoplasms/mortality/*pathology/radiotherapy
MH  - Retrospective Studies
MH  - Survival Rate
MH  - Treatment Outcome
EDAT- 2003/12/31 05:00
MHDA- 2004/02/11 05:00
CRDT- 2003/12/31 05:00
PHST- 2003/12/31 05:00 [pubmed]
PHST- 2004/02/11 05:00 [medline]
PHST- 2003/12/31 05:00 [entrez]
AID - S0360301603014421 [pii]
AID - 10.1016/s0360-3016(03)01442-1 [doi]
PST - ppublish
SO  - Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):3-10. doi: 
      10.1016/s0360-3016(03)01442-1.

PMID- 15050326
OWN - NLM
STAT- MEDLINE
DCOM- 20040427
LR  - 20061115
IS  - 0360-3016 (Print)
IS  - 0360-3016 (Linking)
VI  - 58
IP  - 5
DP  - 2004 Apr 1
TI  - Does radiotherapy around the time of pregnancy for Hodgkin's disease modify the 
      risk of breast cancer?
PG  - 1474-9
AB  - PURPOSE: To determine whether the risk of secondary breast cancer after 
      radiotherapy (RT) for Hodgkin's disease is greater among women who underwent RT 
      around time of pregnancy. METHODS AND MATERIALS: The records of 382 women treated 
      with RT for Hodgkin's disease were reviewed and divided into those who received 
      RT around the time of pregnancy and those who were not pregnant. Comparisons of 
      the overall incidence, actuarial rates, and latency to breast cancer between the 
      two groups were made. Multivariate Cox regression modeling was performed to 
      determine possible contributing factors. RESULTS: Of the 382 women, 14 developed 
      breast cancer (3.7%). The increase in the overall incidence (16.0% vs. 2.3%, p = 
      0.0001) and the actuarial rate of breast cancer among the women in the pregnant 
      group (p = 0.011) was statistically significant. The women treated around the 
      time of pregnancy had a 10- and 15-year actuarial rate of breast cancer of 6.7% 
      and 32.6%, respectively. The 10-year and 15-year actuarial rate for the 
      nonpregnant women was 0.4% and 1.7%, respectively. The median latency from RT to 
      the diagnosis of breast cancer was 13.1 and 18.9 years for women in the pregnant 
      and nonpregnant groups, respectively. In the multivariate analysis, pregnancy 
      around the time of RT was the only variable associated with an increased risk of 
      breast cancer. The risk was dependent on the length of time from pregnancy to RT, 
      with women receiving RT during pregnancy and within 1 month of pregnancy having 
      an increased risk of breast cancer compared with nonpregnant women and women 
      irradiated later than 1 month after pregnancy (hazard ratio, 22.49; 95% 
      confidence interval, 5.56-90.88; p <0.001). CONCLUSION: The results of this study 
      indicate that the risk of breast cancer after RT is greater with irradiation 
      around the time of pregnancy. This suggests that pregnancy is a time of increased 
      sensitivity of breast tissue to the carcinogenic effects of radiation. Because of 
      the small sample size and limited follow-up, additional studies are recommended 
      to confirm these findings.
FAU - Chen, Jergin
AU  - Chen J
AD  - Department of Radiation Oncology, University of Utah, Salt Lake City, UT 84132, 
      USA.
FAU - Lee, R Jeffrey
AU  - Lee RJ
FAU - Tsodikov, Alex
AU  - Tsodikov A
FAU - Smith, Lynn
AU  - Smith L
FAU - Gaffney, David K
AU  - Gaffney DK
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - Int J Radiat Oncol Biol Phys
JT  - International journal of radiation oncology, biology, physics
JID - 7603616
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Breast Neoplasms/*etiology
MH  - Epidemiologic Methods
MH  - Female
MH  - Hodgkin Disease/*radiotherapy
MH  - Humans
MH  - Neoplasms, Radiation-Induced/*etiology
MH  - Neoplasms, Second Primary/*etiology
MH  - Pregnancy
MH  - Time Factors
EDAT- 2004/03/31 05:00
MHDA- 2004/04/28 05:00
CRDT- 2004/03/31 05:00
PHST- 2003/01/13 00:00 [received]
PHST- 2003/08/15 00:00 [revised]
PHST- 2003/09/03 00:00 [accepted]
PHST- 2004/03/31 05:00 [pubmed]
PHST- 2004/04/28 05:00 [medline]
PHST- 2004/03/31 05:00 [entrez]
AID - S0360301603019448 [pii]
AID - 10.1016/j.ijrobp.2003.09.018 [doi]
PST - ppublish
SO  - Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1474-9. doi: 
      10.1016/j.ijrobp.2003.09.018.

PMID- 27131771
OWN - NLM
STAT- MEDLINE
DCOM- 20170808
LR  - 20170817
IS  - 1874-1754 (Electronic)
IS  - 0167-5273 (Linking)
VI  - 215
DP  - 2016 Jul 15
TI  - Does left atrial appendage (LAA) occlusion device alter the echocardiography and 
      electrocardiogram parameters in patients with atrial fibrillation?
PG  - 494-501
LID - S0167-5273(16)30628-3 [pii]
LID - 10.1016/j.ijcard.2016.03.204 [doi]
AB  - BACKGROUND: The alterations of echocardiography and electrocardiogram (ECG) in 
      patients received left atrial appendage LAA occlusion therapy are still unclear. 
      The present study was to evaluate the influence of LAA occlusion device on 
      echocardiography and ECG changes in patients with atrial fibrillation (AF). 
      METHODS: Seventy-three patients who had undergone Watchman, LAmbre and Lefort 
      were enrolled in this study. Echocardiography and ECG results at pre- and 
      post-operation were collected. Besides, echocardiography was also performed 
      during follow-up visits at 1, 6 and 12months after discharge. RESULTS: After LAA 
      occlusion, a slight and measureable movement of QRS electric axis was observed in 
      most patients. The significant differences were also observed in heart rate (HR) 
      and the mean-mean QT interval between pre- and post-operation for all patients. 
      There existed no significant difference in echocardiographic parameters between 
      before and after device implantation. However, a larger left atrial (LA) diameter 
      was detected by echocardiography during follow-up visit at 6months when compared 
      with pre-operation parameters. Similarly, aortic root diameter (ARD) was also 
      larger during follow-up at 12months than the baseline dimension in pre-operation. 
      CONCLUSIONS: LAA occlusion device resulted in a slightly movement in QRS axis, 
      reduced HR and increased the mean-mean QT interval duration. In addition, LA 
      diameter and ARD seemed to be larger after device implantation.
CI  - Copyright (c) 2016 Elsevier Ireland Ltd. All rights reserved.
FAU - Jie, Qiqiang
AU  - Jie Q
AD  - Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University 
      School of Medicine, 301 Yanchang Road, Shanghai 200072, China.
FAU - Wang, Dongzhi
AU  - Wang D
AD  - Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University 
      School of Medicine, 301 Yanchang Road, Shanghai 200072, China.
FAU - Liu, Baoxin
AU  - Liu B
AD  - Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University 
      School of Medicine, 301 Yanchang Road, Shanghai 200072, China.
FAU - Zhao, Dongdong
AU  - Zhao D
AD  - Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University 
      School of Medicine, 301 Yanchang Road, Shanghai 200072, China.
FAU - Li, Yong
AU  - Li Y
AD  - Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University 
      School of Medicine, 301 Yanchang Road, Shanghai 200072, China.
FAU - Luo, Jiachen
AU  - Luo J
AD  - Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University 
      School of Medicine, 301 Yanchang Road, Shanghai 200072, China.
FAU - Dai, Liming
AU  - Dai L
AD  - Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University 
      School of Medicine, 301 Yanchang Road, Shanghai 200072, China.
FAU - Li, Shuang
AU  - Li S
AD  - Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University 
      School of Medicine, 301 Yanchang Road, Shanghai 200072, China.
FAU - Xu, Yawei
AU  - Xu Y
AD  - Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University 
      School of Medicine, 301 Yanchang Road, Shanghai 200072, China.
FAU - Wei, Yidong
AU  - Wei Y
AD  - Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University 
      School of Medicine, 301 Yanchang Road, Shanghai 200072, China. Electronic 
      address: ywei@tongji.edu.cn.
LA  - eng
PT  - Journal Article
DEP - 20160409
PL  - Netherlands
TA  - Int J Cardiol
JT  - International journal of cardiology
JID - 8200291
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Atrial Appendage/*surgery
MH  - Atrial Fibrillation/*diagnostic imaging
MH  - Cardiac Catheterization/methods
MH  - Cardiac Surgical Procedures/*instrumentation
MH  - Echocardiography
MH  - Electrocardiography
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Prostheses and Implants
MH  - Treatment Outcome
OTO - NOTNLM
OT  - Atrial fibrillation
OT  - Echocardiography
OT  - Electrocardiogram
OT  - Left atrial appendage occlusion
EDAT- 2016/05/02 06:00
MHDA- 2017/08/09 06:00
CRDT- 2016/05/02 06:00
PHST- 2016/03/21 00:00 [received]
PHST- 2016/03/26 00:00 [accepted]
PHST- 2016/05/02 06:00 [entrez]
PHST- 2016/05/02 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - S0167-5273(16)30628-3 [pii]
AID - 10.1016/j.ijcard.2016.03.204 [doi]
PST - ppublish
SO  - Int J Cardiol. 2016 Jul 15;215:494-501. doi: 10.1016/j.ijcard.2016.03.204. Epub 
      2016 Apr 9.

PMID- 26923375
OWN - NLM
STAT- MEDLINE
DCOM- 20170105
LR  - 20220310
IS  - 0975-0711 (Electronic)
IS  - 0254-8860 (Linking)
VI  - 35
IP  - 1
DP  - 2016 Jan
TI  - Is non-invasive diagnosis of esophageal varices in patients with compensated 
      hepatic cirrhosis possible by duplex Doppler ultrasonography?
PG  - 60-6
LID - 10.1007/s12664-016-0630-7 [doi]
AB  - BACKGROUND AND AIM: Esophageal varices are present in 30% to 40% of patients in 
      compensated cirrhosis (Child-Pugh class A) and in 60% to 85% of patients in 
      decompensated cirrhosis (Child-Pugh classes B and C). It is important to identify 
      patients with compensated cirrhosis at risk for esophageal varix development. We 
      evaluated the accuracy of a duplex Doppler ultrasonographic index for predicting 
      the presence or absence of esophageal varices in patients with compensated 
      hepatic cirrhosis (Child-Pugh class A) by using endoscopy as the reference 
      standard. METHODS: Fifty-six enrolled patients underwent duplex Doppler 
      ultrasonography followed by screening endoscopy. Mean portal vein velocity (PVV), 
      splenic index (SI), splenoportal index (SPI), hepatic and splenic arterial 
      resistive, and pulsatility indices (hepatic artery resistive index [HARI], 
      hepatic artery pulsatility index [HAPI], splenic artery resistive index [SARI], 
      splenic artery pulsatility index [SAPI]) were recorded. Univariate logistic 
      regression analysis was followed by receiver operating characteristic (ROC) curve 
      construction for the indices that were significant. RESULTS: The indices HARI, 
      HAPI, SARI, SAPI were not helpful (p > 0.05). Mean PVV, SI, and SPI were all 
      predictive of the presence of esophageal varices (p < 0.05) and SPI was found to 
      be the most accurate parameter. Of the various cut-off levels of SPI evaluated, a 
      cut-off value of SPI at 5.0, offered the highest diagnostic accuracy (88%). For 
      the 28 patients with SPI <5.0, the absence of esophageal varices in 27 of them 
      could be correctly diagnosed using only SPI without invasive screening endoscopy, 
      with high negative predictive value (96%) and sensitivity (96%). Of the remaining 
      28 patients with SPI >/=5.0, presence of esophageal varices could be similarly 
      correctly diagnosed in 22 of them by using SPI without screening endoscopy, with 
      high positive predictive value (79%) and specificity (82%). CONCLUSION: The SPI 
      was accurate in predicting the presence or absence of esophageal varices in 
      patients with compensated cirrhosis.
FAU - Chakrabarti, Ritwik
AU  - Chakrabarti R
AD  - Military Hospital Tiruvananthapuram, Pangode, Tiruvananthapuram, 695 006, India.
FAU - Sen, Debraj
AU  - Sen D
AD  - Indian Field Hospital Level II, UN Mission in South Sudan (UNMISS), C/O 56 APO, 
      Malakal, Sudan. sendebraj@gmail.com.
FAU - Khanna, Vikram
AU  - Khanna V
AD  - 92 Base Hospital, c/o 56 APO, Srinagar, India.
LA  - eng
PT  - Journal Article
DEP - 20160229
PL  - India
TA  - Indian J Gastroenterol
JT  - Indian journal of gastroenterology : official journal of the Indian Society of 
      Gastroenterology
JID - 8409436
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - *Endosonography
MH  - Esophageal and Gastric Varices/*diagnostic imaging/epidemiology/etiology
MH  - Female
MH  - Humans
MH  - Liver Cirrhosis/*complications
MH  - Male
MH  - Middle Aged
MH  - Prevalence
MH  - Regression Analysis
MH  - Sensitivity and Specificity
MH  - Sex Distribution
MH  - *Ultrasonography, Doppler, Duplex
OTO - NOTNLM
OT  - Compensated cirrhosis
OT  - Duplex Doppler ultrasonography
OT  - Esophageal varices
OT  - Splenoportal index
EDAT- 2016/03/01 06:00
MHDA- 2017/01/06 06:00
CRDT- 2016/03/01 06:00
PHST- 2015/11/10 00:00 [received]
PHST- 2016/01/28 00:00 [accepted]
PHST- 2016/03/01 06:00 [entrez]
PHST- 2016/03/01 06:00 [pubmed]
PHST- 2017/01/06 06:00 [medline]
AID - 10.1007/s12664-016-0630-7 [pii]
AID - 10.1007/s12664-016-0630-7 [doi]
PST - ppublish
SO  - Indian J Gastroenterol. 2016 Jan;35(1):60-6. doi: 10.1007/s12664-016-0630-7. Epub 
      2016 Feb 29.

PMID- 15841770
OWN - NLM
STAT- MEDLINE
DCOM- 20050527
LR  - 20061115
IS  - 0803-5253 (Print)
IS  - 0803-5253 (Linking)
VI  - 93
IP  - 12
DP  - 2004 Dec
TI  - Do inhaled steroids differ from cromones in terms of hospital admission rates for 
      asthma in children?
PG  - 1612-8
AB  - AIM: The aim of the present study was to investigate the characteristics of 
      hospital admissions in two child populations receiving different types of drugs 
      as their regular medication for steady-state asthma. METHODS: Annual data on 
      children aged under 16 y treated for asthma, including consumption of regular 
      medication for asthma, numbers of hospital periods, lengths of hospitalizations 
      and annual proportions of readmissions, were collected using patient-specific 
      medical records from 1995 to 1999. In the Kuopio province, on average, 
      35.6-36.7/1000 children were on maintenance for asthma, of which 23% were 
      receiving cromones, 51% were taking inhaled steroids and 26% were treated with 
      cromones plus intermittent steroids. In the Oulu province, the respective 
      prevalence was 32.7-34.9/1000, and the respective proportions were 5%, 93% and 
      2%. RESULTS: Total and first admissions, as well as hospital days were clearly 
      less in the Oulu province. In the children aged > or = 6y, the average annual 
      total admissions were 0.3/1000 (Oulu) vs 1.2/1000 (Kuopio) (p < 0.001). 
      Similarly, the first admissions were 0.2/1000 vs 1.0/1000 (p < 0.001), 
      proportions of readmissions 6.3% vs 19.3% (p < 0.05), and numbers of hospital 
      days 0.7/1000 vs 3.8/1000 (p < 0.001). The differences were in the same 
      direction, though less prominent, also among children 2-5 y of age. CONCLUSION: 
      Our results suggest that inhaled steroids are better than cromones in preventing 
      admissions for asthma when two provinces with different practices for maintenance 
      medication of steady-state asthma were compared.
FAU - Korhonen, K
AU  - Korhonen K
AD  - Department of Paediatrics, Kuopio University Hospital, Kuopio, Finland. 
      kaj.korhonen@uku.fi
FAU - Dunder, T
AU  - Dunder T
FAU - Klaukka, T
AU  - Klaukka T
FAU - Reijonen, T M
AU  - Reijonen TM
FAU - Issakoff, K
AU  - Issakoff K
FAU - Kiviharju, M
AU  - Kiviharju M
FAU - Linna, O
AU  - Linna O
FAU - Remes, K
AU  - Remes K
FAU - Korppi, M
AU  - Korppi M
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Norway
TA  - Acta Paediatr
JT  - Acta paediatrica (Oslo, Norway : 1992)
JID - 9205968
RN  - 0 (Anti-Inflammatory Agents)
RN  - 0 (Chromones)
SB  - IM
MH  - Administration, Inhalation
MH  - Adolescent
MH  - Anti-Inflammatory Agents/administration & dosage/*therapeutic use
MH  - Asthma/*drug therapy/epidemiology/*rehabilitation
MH  - Child
MH  - Child, Preschool
MH  - Chromones/administration & dosage/*therapeutic use
MH  - Female
MH  - Hospitalization/statistics & numerical data
MH  - Humans
MH  - Length of Stay
MH  - Male
MH  - Patient Admission/statistics & numerical data
MH  - Prevalence
MH  - Retrospective Studies
EDAT- 2005/04/22 09:00
MHDA- 2005/05/28 09:00
CRDT- 2005/04/22 09:00
PHST- 2005/04/22 09:00 [pubmed]
PHST- 2005/05/28 09:00 [medline]
PHST- 2005/04/22 09:00 [entrez]
PST - ppublish
SO  - Acta Paediatr. 2004 Dec;93(12):1612-8.

PMID- 25503376
OWN - NLM
STAT- MEDLINE
DCOM- 20150805
LR  - 20181113
IS  - 1643-3750 (Electronic)
IS  - 1234-1010 (Print)
IS  - 1234-1010 (Linking)
VI  - 20
DP  - 2014 Dec 13
TI  - Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? 
      A retrospective case review.
PG  - 2651-7
LID - 10.12659/MSM.892230 [doi]
AB  - BACKGROUND: Obstructive sleep apnea (OSA) is tightly linked to increased 
      cardiovascular disease. Surgery is an important method to treat OSA, but its 
      effect on serum lipid levels in OSA patients is unknown. We aimed to evaluate the 
      effect of upper airway surgery on lipid profiles. MATERIAL AND METHODS: We 
      performed a retrospective review of 113 adult patients with OSA who underwent 
      surgery (nasal or uvulopalatopharyngoplasty [UPPP]) at a major, urban, academic 
      hospital in Beijing from 2012 to 2013 who had preoperative and postoperative 
      serum lipid profiles. RESULTS: Serum TC (4.86+/-0.74 to 4.69+/-0.71) and LP(a) 
      (median 18.50 to 10.90) all decreased significantly post-operatively (P<0.01, 
      0.01, respectively), with no changes in serum HDL, LDL, or TG (P>0.05, all). For 
      UPPP patients (n=51), serum TC, HDL and LP(a) improved (P=0.01, 0.01,<0.01, 
      respectively). For nasal patients (n=62), only the serum LP(a) decreased 
      (P<0.01). In patients with normal serum lipids at baseline, only serum LP(a) 
      decreased (P<0.01). In contrast, in patients with isolated hypertriglyceridemia, 
      the serum HDL, TG and LP(a) showed significant improvements (P=0.02, 0.03, <0.01, 
      respectively). In patients with isolated hypercholesterolemia, the serum LP(a) 
      decreased significantly (P=0.01), with a similar trend for serum TC (P=0.06). In 
      patients with mixed hyperlipidemia, the serum TC and LDL also decreased (P=0.02, 
      0.03, respectively). CONCLUSIONS: Surgery may improve blood lipid levels in 
      patients with OSA, especially in patients with preoperative dyslipidemia, 
      potentially yielding a major benefit in metabolism and cardiovascular sequelae. 
      Prospective studies should examine this potential metabolic effect of airway 
      surgery for OSA.
FAU - Li, Li
AU  - Li L
AD  - Department of Otolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, 
      Capital Medical University, Beijing, China (mainland).
FAU - Zhan, Xiaojun
AU  - Zhan X
AD  - Department of Otolaryngology Head and Neck Surgery, Beijing Anzhen Hospital, 
      Capital Medical University, Beijing, China (mainland).
FAU - Wang, Ningyu
AU  - Wang N
AD  - Department of Otolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, 
      Capital Medical University, Beijing, China (mainland).
FAU - Pinto, Jayant Marian
AU  - Pinto JM
AD  - Section of Otolaryngology Head and Neck Surgery, Department of Surgery, 
      University of Chicago, Chicago, IL, USA.
FAU - Ge, Xiaohui
AU  - Ge X
AD  - Department of Otolaryngology Head and Neck Surgery, Beijing Anzhen Hospital, 
      Capital Medical University, Beijing, China (mainland).
FAU - Wang, Chunyan
AU  - Wang C
AD  - Department of Otolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, 
      Capital Medical University, Beijing, China (mainland).
FAU - Tian, Jun
AU  - Tian J
AD  - Department of Otolaryngology Head and Neck Surgery, Beijing Anzhen Hospital, 
      Capital Medical University, Beijing, China (mainland).
FAU - Wei, Yongxiang
AU  - Wei Y
AD  - Department of Otolaryngology Head and Neck Surgery, Beijing Anzhen Hospital, 
      Capital Medical University, Beijing, China (mainland).
LA  - eng
GR  - K23 AG036762/AG/NIA NIH HHS/United States
GR  - UL1 TR000430/TR/NCATS NIH HHS/United States
GR  - AG036762/AG/NIA NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20141213
PL  - United States
TA  - Med Sci Monit
JT  - Medical science monitor : international medical journal of experimental and 
      clinical research
JID - 9609063
RN  - 0 (Lipids)
SB  - IM
MH  - Adult
MH  - Demography
MH  - Female
MH  - Humans
MH  - Lipids/*blood
MH  - Male
MH  - Polysomnography
MH  - Respiratory System/*surgery
MH  - Retrospective Studies
MH  - Sleep Apnea, Obstructive/*blood
PMC - PMC4271797
EDAT- 2014/12/17 06:00
MHDA- 2015/08/06 06:00
PMCR- 2014/12/13
CRDT- 2014/12/16 06:00
PHST- 2014/12/16 06:00 [entrez]
PHST- 2014/12/17 06:00 [pubmed]
PHST- 2015/08/06 06:00 [medline]
PHST- 2014/12/13 00:00 [pmc-release]
AID - 892230 [pii]
AID - 10.12659/MSM.892230 [doi]
PST - epublish
SO  - Med Sci Monit. 2014 Dec 13;20:2651-7. doi: 10.12659/MSM.892230.

PMID- 19394934
OWN - NLM
STAT- MEDLINE
DCOM- 20100709
LR  - 20181201
IS  - 1879-0267 (Electronic)
IS  - 0020-1383 (Linking)
VI  - 40
IP  - 7
DP  - 2009 Jul
TI  - Israeli hospital preparedness for terrorism-related multiple casualty incidents: 
      can the surge capacity and injury severity distribution be better predicted?
PG  - 727-31
LID - 10.1016/j.injury.2008.11.010 [doi]
AB  - BACKGROUND: The incidence of large-scale urban attacks on civilian populations 
      has significantly increased across the globe over the past decade. These 
      incidents often result in Hospital Multiple Casualty Incidents (HMCI), which are 
      very challenging to hospital teams. 15 years ago the Emergency and Disaster 
      Medicine Division in the Israeli Ministry of Health defined a key of 20 percent 
      of each hospital's bed capacity as its readiness for multiple casualties. Half of 
      those casualties are expected to require immediate medical treatment. This study 
      was performed to evaluate the efficacy of the current readiness guidelines based 
      on the epidemiology of encountered HMCIs. METHODS: A retrospective study of HMCIs 
      was recorded in the Israeli Defense Force (IDF) home front command and the 
      Israeli National Trauma Registry (ITR) between November 2000 and June 2003. An 
      HMCI is defined by the Emergency and Disaster Medicine Division in the Israeli 
      Ministry of Health as >or=10 casualties or >or=4 suffering from injuries with an 
      ISS>or=16 arriving to a single hospital. RESULTS: The study includes a total of 
      32 attacks, resulting in 62 HMCIs and 1292 casualties. The mean number of 
      arriving casualties to a single hospital was 20.8+/-13.3 (range 4-56, median 
      16.5). In 95% of the HMCIs the casualty load was <or=52. Based on severity scores 
      and ED discharges 1022 (79.2%) casualties did not necessitate immediate medical 
      treatment. CONCLUSION: Hospital preparedness can be better defined by a fixed 
      number of casualties rather than a percentile of its bed capacity. Only 20% of 
      the arriving casualties will require immediate medical treatment. Implementation 
      of this concept may improve the utilisation of national emergency health 
      resources both in the preparation phase and on real time.
FAU - Kosashvili, Yona
AU  - Kosashvili Y
AD  - Orthopedic Department, Assaf Harofeh Medical Center, Zerrifin, Israel; Israeli 
      Defense Force, Medical Corps, Trauma Division, Tel Hashomer, Israel. 
      yonasofi@gmail.com
FAU - Aharonson-Daniel, L
AU  - Aharonson-Daniel L
FAU - Peleg, Kobi
AU  - Peleg K
FAU - Horowitz, Ariel
AU  - Horowitz A
FAU - Laor, Danny
AU  - Laor D
FAU - Blumenfeld, Amir
AU  - Blumenfeld A
LA  - eng
PT  - Journal Article
DEP - 20090423
PL  - Netherlands
TA  - Injury
JT  - Injury
JID - 0226040
SB  - IM
EIN - Injury. 2010 Jul;41(7):1076. Daniel, Limor A [corrected to Aharonson-Daniel, L]
MH  - Disaster Planning/*organization & administration
MH  - Emergency Service, Hospital/organization & administration/*statistics & numerical 
      data
MH  - Health Resources/statistics & numerical data
MH  - Hospitalization/statistics & numerical data
MH  - Humans
MH  - Israel/epidemiology
MH  - *Mass Casualty Incidents
MH  - Registries
MH  - Retrospective Studies
MH  - Risk Assessment
MH  - Risk Management
MH  - Surge Capacity/organization & administration/*statistics & numerical data
MH  - Terrorism
MH  - Trauma Severity Indices
MH  - Wounds and Injuries/*epidemiology/therapy
EDAT- 2009/04/28 09:00
MHDA- 2010/07/10 06:00
CRDT- 2009/04/28 09:00
PHST- 2008/07/07 00:00 [received]
PHST- 2008/09/01 00:00 [revised]
PHST- 2008/11/11 00:00 [accepted]
PHST- 2009/04/28 09:00 [entrez]
PHST- 2009/04/28 09:00 [pubmed]
PHST- 2010/07/10 06:00 [medline]
AID - S0020-1383(08)00525-1 [pii]
AID - 10.1016/j.injury.2008.11.010 [doi]
PST - ppublish
SO  - Injury. 2009 Jul;40(7):727-31. doi: 10.1016/j.injury.2008.11.010. Epub 2009 Apr 
      23.

PMID- 22188074
OWN - NLM
STAT- MEDLINE
DCOM- 20120213
LR  - 20111222
IS  - 1532-5415 (Electronic)
IS  - 0002-8614 (Linking)
VI  - 59
IP  - 12
DP  - 2011 Dec
TI  - Do instrumental activities of daily living predict dementia at 1- and 2-year 
      follow-up? Findings from the Development of Screening guidelines and diagnostic 
      Criteria for Predementia Alzheimer's disease study.
PG  - 2273-81
LID - 10.1111/j.1532-5415.2011.03732.x [doi]
AB  - OBJECTIVES: To investigate whether problems in instrumental activities of daily 
      living (IADL) can add to conventionally used clinical measurements in helping to 
      predict a diagnosis of dementia at 1- and 2-year follow-up. DESIGN: Multicenter 
      prospective cohort study. SETTING: Memory clinics in Europe. PARTICIPANTS: 
      Individuals aged 55 and older without dementia. MEASUREMENTS: IADLs were measured 
      using pooled activities from five informant-based questionnaires. Structural 
      equation modeling (SEM) was used to investigate the relation between IADLs and 
      dementia. Age, sex, education, depression, and cognitive measures (Mini-Mental 
      State Examination and verbal memory) were included in the model. RESULTS: Five 
      hundred thirty-one participants had baseline and 1-year follow-up assessments; 69 
      (13.0%) of these had developed dementia at 1-year follow-up. At 2-year follow-up, 
      481 participants were seen, of whom 100 (20.8%) had developed dementia. 
      Participants with IADL disabilities at baseline had a higher conversion rate 
      (24.4%) than participants without IADL disabilities (16.7%) (chi-square = 4.28, 
      degrees of freedom = 1, P = .04). SEM showed that IADL disability could help 
      predict dementia in addition to the measured variables at 1-year follow-up (odds 
      ratio (OR) = 2.20, 95% confidence interval (CI) = 1.51-3.13) and 2-year follow-up 
      (OR = 2.11, 95% CI = 1.33-3.33). CONCLUSION: IADL disability is a useful addition 
      to the diagnostic process in a memory clinic setting, indicating who is at higher 
      risk of developing dementia at 1- and 2-year follow-up.
CI  - (c) 2011, Copyright the Authors Journal compilation (c) 2011, The American Geriatrics 
      Society.
FAU - Sikkes, Sietske A M
AU  - Sikkes SA
AD  - Department of Epidemiology and Biostatistics, VU University Medical Center, 
      Amsterdam, the Netherlands. s.sikkes@vumc.nl
FAU - Visser, Pieter Jelle
AU  - Visser PJ
FAU - Knol, Dirk L
AU  - Knol DL
FAU - de Lange-de Klerk, Elly S M
AU  - de Lange-de Klerk ES
FAU - Tsolaki, Magda
AU  - Tsolaki M
FAU - Frisoni, Giovani B
AU  - Frisoni GB
FAU - Nobili, Flavio
AU  - Nobili F
FAU - Spiru, Luiza
AU  - Spiru L
FAU - Rigaud, Anne Sophie
AU  - Rigaud AS
FAU - Frolich, Lutz
AU  - Frolich L
FAU - Rikkert, Marcel Olde
AU  - Rikkert MO
FAU - Soininen, Hilkka
AU  - Soininen H
FAU - Touchon, Jacques
AU  - Touchon J
FAU - Wilcock, Gordon
AU  - Wilcock G
FAU - Boada, Merce
AU  - Boada M
FAU - Hampel, Harald
AU  - Hampel H
FAU - Bullock, Roger
AU  - Bullock R
FAU - Vellas, Bruno
AU  - Vellas B
FAU - Pijnenburg, Yolande A L
AU  - Pijnenburg YA
FAU - Scheltens, Philip
AU  - Scheltens P
FAU - Verhey, Frans R
AU  - Verhey FR
FAU - Uitdehaag, Bernard M J
AU  - Uitdehaag BM
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - J Am Geriatr Soc
JT  - Journal of the American Geriatrics Society
JID - 7503062
SB  - IM
MH  - *Activities of Daily Living
MH  - Aged
MH  - Dementia/*diagnosis
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Male
MH  - Prognosis
MH  - Prospective Studies
MH  - Time Factors
EDAT- 2011/12/23 06:00
MHDA- 2012/02/14 06:00
CRDT- 2011/12/23 06:00
PHST- 2011/12/23 06:00 [entrez]
PHST- 2011/12/23 06:00 [pubmed]
PHST- 2012/02/14 06:00 [medline]
AID - 10.1111/j.1532-5415.2011.03732.x [doi]
PST - ppublish
SO  - J Am Geriatr Soc. 2011 Dec;59(12):2273-81. doi: 10.1111/j.1532-5415.2011.03732.x.

PMID- 21394762
OWN - NLM
STAT- MEDLINE
DCOM- 20120111
LR  - 20211020
IS  - 1520-6777 (Electronic)
IS  - 0733-2467 (Print)
IS  - 0733-2467 (Linking)
VI  - 30
IP  - 7
DP  - 2011 Sep
TI  - Is pelvic pain associated with defecatory symptoms in women with pelvic organ 
      prolapse?
PG  - 1305-8
LID - 10.1002/nau.21059 [doi]
AB  - OBJECTIVE: To investigate the significance of pelvic pain and its association 
      with defecatory symptoms in women with pelvic organ prolapse (POP). STUDY DESIGN: 
      This is a cross sectional study of 248 women with stage II POP or greater. Women 
      were stratified into "pain" and "no-pain" groups based on their response to a 
      question on the Pelvic Floor Distress Inventory short form. Associations between 
      patient demographics, exam findings and responses to validated questionnaires 
      were evaluated. RESULTS: In women with POP, defecatory symptoms are significantly 
      more common in women with pelvic pain including straining with bowel movement (OR 
      2.4, 95% CI 1.3, 4.6), sense of incomplete emptying (OR 4.4, 95% CI 2.3, 8.2), 
      pain with bowel movement (OR 5.3, 95% CI 1.2, 23.0) and splinting with bowel 
      movement (OR 3.8, 95% CI 2.0, 7.5). CONCLUSION: In women with POP, the symptom of 
      pelvic pain is associated with the presence of defecatory symptoms.
CI  - Copyright (c) 2011 Wiley-Liss, Inc.
FAU - Asfaw, Tirsit S
AU  - Asfaw TS
AD  - Division of Urogynecology and Reconstructive Pelvic Surgery, Department of 
      Obstetrics and Gynecology, University of Pennsylvania, School of Medicine, 
      Philadelphia, Pennsylvania 19104, USA. Tirsit@yahoo.com
FAU - Saks, Emily K
AU  - Saks EK
FAU - Northington, Gina M
AU  - Northington GM
FAU - Arya, Lily A
AU  - Arya LA
LA  - eng
GR  - T32 HD007440/HD/NICHD NIH HHS/United States
GR  - R01 DK077699/DK/NIDDK NIH HHS/United States
GR  - R01 DK077699-03S1/DK/NIDDK NIH HHS/United States
GR  - DK077699-S2 ARRA/DK/NIDDK NIH HHS/United States
GR  - DK077699-S1/DK/NIDDK NIH HHS/United States
GR  - DK077699/DK/NIDDK NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20110310
PL  - United States
TA  - Neurourol Urodyn
JT  - Neurourology and urodynamics
JID - 8303326
SB  - IM
MH  - Adult
MH  - Aged
MH  - Cross-Sectional Studies
MH  - *Defecation
MH  - Female
MH  - Humans
MH  - Logistic Models
MH  - Middle Aged
MH  - Odds Ratio
MH  - Pain Measurement
MH  - Pelvic Organ Prolapse/*complications/diagnosis/physiopathology
MH  - Pelvic Pain/diagnosis/*etiology/physiopathology
MH  - Philadelphia
MH  - Risk Assessment
MH  - Risk Factors
MH  - Severity of Illness Index
MH  - Surveys and Questionnaires
PMC - PMC3129364
MID - NIHMS257203
EDAT- 2011/03/12 06:00
MHDA- 2012/01/12 06:00
PMCR- 2012/09/01
CRDT- 2011/03/12 06:00
PHST- 2010/04/26 00:00 [received]
PHST- 2010/12/03 00:00 [accepted]
PHST- 2011/03/12 06:00 [entrez]
PHST- 2011/03/12 06:00 [pubmed]
PHST- 2012/01/12 06:00 [medline]
PHST- 2012/09/01 00:00 [pmc-release]
AID - 10.1002/nau.21059 [doi]
PST - ppublish
SO  - Neurourol Urodyn. 2011 Sep;30(7):1305-8. doi: 10.1002/nau.21059. Epub 2011 Mar 
      10.

PMID- 9582182
OWN - NLM
STAT- MEDLINE
DCOM- 19980702
LR  - 20191102
IS  - 0885-9701 (Print)
IS  - 0885-9701 (Linking)
VI  - 13
IP  - 3
DP  - 1998 Jun
TI  - Does the SCL 90-R obsessive-compulsive dimension identify cognitive impairments?
PG  - 94-101
AB  - OBJECTIVE: To investigate the relevance of the Symptom Checklist 90-R 
      Obsessive-Compulsive subscale to cognition in individuals with brain tumor. 
      DESIGN: A prospective study of patients assessed with a neuropsychological test 
      battery. SETTING: A university medical center. PATIENTS: Nineteen adults with 
      biopsy-confirmed diagnoses of malignant brain tumors were assessed prior to 
      aggressive chemotherapy. MAIN OUTCOME MEASURES: Included in the assessment were 
      the Mattis Dementia Rating Scale, California Verbal Learning Test, Trail Making 
      Test B, Symptom Checklist 90-R, Mood Assessment Scale, Beck Anxiety Inventory, 
      and Chronic Illness Problem Inventory. RESULTS: The SCL 90-R Obsessive-Compulsive 
      subscale was not related to objective measures of attention, verbal memory, or 
      age. It was related significantly to symptoms of depression (r = .81, P < .005), 
      anxiety (r = .66, P < .005), and subjective complaints of memory problems (r = 
      .75, P < .005). Multivariate analyses indicated that reported symptoms of 
      depression contributed 66% of the variance in predicting SCL 90-R 
      Obsessive-Compulsive Scores, whereas symptoms of anxiety contributed an 
      additional 6% (P < .0001). CONCLUSIONS: Our data suggest that the SCL 90-R is 
      best viewed as an indicator of unidimensional emotional distress and somatic 
      effects of structural brain injury.
FAU - Kaplan, C P
AU  - Kaplan CP
AD  - Department of Physical Medicine and Rehabilitation, Medical University of South 
      Carolina, Charleston, SC 29425, USA.
FAU - Miner, M E
AU  - Miner ME
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
PL  - United States
TA  - J Head Trauma Rehabil
JT  - The Journal of head trauma rehabilitation
JID - 8702552
SB  - IM
MH  - Adult
MH  - Aged
MH  - Brain Neoplasms/*complications
MH  - Cognition Disorders/*diagnosis/etiology
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Multivariate Analysis
MH  - *Neuropsychological Tests
MH  - Obsessive-Compulsive Disorder/*diagnosis/etiology
MH  - *Personality Assessment
MH  - Predictive Value of Tests
MH  - Prospective Studies
MH  - Sensitivity and Specificity
EDAT- 1998/06/12 00:00
MHDA- 1998/06/12 00:01
CRDT- 1998/06/12 00:00
PHST- 1998/06/12 00:00 [pubmed]
PHST- 1998/06/12 00:01 [medline]
PHST- 1998/06/12 00:00 [entrez]
AID - 10.1097/00001199-199806000-00009 [doi]
PST - ppublish
SO  - J Head Trauma Rehabil. 1998 Jun;13(3):94-101. doi: 
      10.1097/00001199-199806000-00009.

PMID- 28056802
OWN - NLM
STAT- MEDLINE
DCOM- 20171010
LR  - 20181113
IS  - 1471-2261 (Electronic)
IS  - 1471-2261 (Linking)
VI  - 17
IP  - 1
DP  - 2017 Jan 5
TI  - Is non-HDL-cholesterol a better predictor of long-term outcome in patients after 
      acute myocardial infarction compared to LDL-cholesterol? : a retrospective study.
PG  - 10
LID - 10.1186/s12872-016-0450-9 [doi]
LID - 10
AB  - BACKGROUND: It has recently been shown that non-high density lipoprotein 
      cholesterol (non-HDL-C) may be a better predictor of cardiovascular risk than low 
      density lipoprotein cholesterol (LDL-C). Based on known ethic differences in 
      lipid parameters and cardiovascular risk prediction, we sought to study the 
      predictability of attaining non-HDL-C target and long-term major adverse 
      cardiovascular event (MACE) in Thai patients after acute myocardial infarction 
      (AMI) compared to attaining LDL-C target. METHODS: We retrospectively obtained 
      the data of all patients who were admitted at Maharaj Nakorn Chiang Mai hospital 
      due to AMI during 2006-2013. The mean non-HDL-C and LDL-C during long-term 
      follow-up were used to predict MACE at each time point. The patients were 
      classified as target attainment if non-HDL-C <100 mg/dl and/or LDL-C <70 mg/dl. 
      The MACE was defined as combination of all-cause death, nonfatal coronary event 
      and nonfatal stroke. RESULTS: During mean follow-up of 2.6 +/- 1.6 years among 868 
      patients after AMI, 34.4% achieved non-HDL-C target, 23.7% achieved LDL-C target 
      and 21.2% experienced MACEs. LDL-C and non-HDL-C were directly compared in Cox 
      regression model. Compared with non-HDL-C <100 mg/dl, patients with non-HDL-C of 
      >130 mg/dl had higher incidence of MACEs (HR 3.15, 95% CI 1.46-6.80, P = 0.003). 
      Surprisingly, LDL-C >100 mg/dl was associated with reduced risk of MACE as 
      compared to LDL <70 mg/dl (HR 0.42, 95% CI 0.18-0.98, p = 0.046) after direct 
      pairwise comparison with non-HDL-C level. CONCLUSIONS: Non-attaining non-HDL-C 
      goal predicted MACE at long-term follow-up after AMI whereas non-attaining LDL-C 
      goal was not associated with the higher risk. Therefore, non-HDL-C may be a more 
      suitable target of dyslipidemia treatment than LDL-C in patients after AMI.
FAU - Wongcharoen, Wanwarang
AU  - Wongcharoen W
AD  - Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, 
      Chiang Mai, Thailand.
FAU - Sutthiwutthichai, Satjatham
AU  - Sutthiwutthichai S
AD  - Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, 
      Chiang Mai, Thailand.
FAU - Gunaparn, Siriluck
AU  - Gunaparn S
AD  - Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, 
      Chiang Mai, Thailand.
FAU - Phrommintikul, Arintaya
AU  - Phrommintikul A
AD  - Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, 
      Chiang Mai, Thailand. arintaya.p@cmu.ac.th.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20170105
PL  - England
TA  - BMC Cardiovasc Disord
JT  - BMC cardiovascular disorders
JID - 100968539
RN  - 0 (Biomarkers)
RN  - 0 (Cardiovascular Agents)
RN  - 0 (Cholesterol, LDL)
RN  - 0 (Hypolipidemic Agents)
RN  - 97C5T2UQ7J (Cholesterol)
SB  - IM
MH  - Aged
MH  - Biomarkers/blood
MH  - Cardiovascular Agents/therapeutic use
MH  - Chi-Square Distribution
MH  - Cholesterol/*blood
MH  - Cholesterol, LDL/*blood
MH  - Dyslipidemias/blood/diagnosis/*drug therapy/epidemiology
MH  - Female
MH  - Humans
MH  - Hypolipidemic Agents/*therapeutic use
MH  - Incidence
MH  - Male
MH  - Middle Aged
MH  - Multivariate Analysis
MH  - Non-ST Elevated Myocardial Infarction/blood/diagnosis/epidemiology/*therapy
MH  - Percutaneous Coronary Intervention
MH  - Proportional Hazards Models
MH  - Retrospective Studies
MH  - Risk Factors
MH  - ST Elevation Myocardial Infarction/blood/diagnosis/*epidemiology
MH  - Secondary Prevention/*methods
MH  - Thailand/epidemiology
MH  - Thrombolytic Therapy
MH  - Time Factors
MH  - Treatment Outcome
PMC - PMC5217612
OTO - NOTNLM
OT  - Acute myocardial infarction
OT  - LDL-cholesterol
OT  - Major adverse cardiovascular events
OT  - Non-HDL-cholesterol
EDAT- 2017/01/07 06:00
MHDA- 2017/10/11 06:00
PMCR- 2017/01/05
CRDT- 2017/01/07 06:00
PHST- 2016/05/06 00:00 [received]
PHST- 2016/12/17 00:00 [accepted]
PHST- 2017/01/07 06:00 [entrez]
PHST- 2017/01/07 06:00 [pubmed]
PHST- 2017/10/11 06:00 [medline]
PHST- 2017/01/05 00:00 [pmc-release]
AID - 10.1186/s12872-016-0450-9 [pii]
AID - 450 [pii]
AID - 10.1186/s12872-016-0450-9 [doi]
PST - epublish
SO  - BMC Cardiovasc Disord. 2017 Jan 5;17(1):10. doi: 10.1186/s12872-016-0450-9.

PMID- 18182265
OWN - NLM
STAT- MEDLINE
DCOM- 20090707
LR  - 20090413
IS  - 1872-7727 (Electronic)
IS  - 0720-048X (Linking)
VI  - 70
IP  - 1
DP  - 2009 Apr
TI  - Body diffusion-weighted MR imaging of uterine endometrial cancer: is it helpful 
      in the detection of cancer in nonenhanced MR imaging?
PG  - 122-7
LID - 10.1016/j.ejrad.2007.11.042 [doi]
AB  - OBJECTIVE: In this study, the authors discussed the feasibility and value of 
      diffusion-weighted (DW) MR imaging in the detection of uterine endometrial cancer 
      in addition to conventional nonenhanced MR images. METHODS AND MATERIALS: DW 
      images of endometrial cancer in 23 patients were examined by using a 1.5-T MR 
      scanner. This study investigated whether or not DW images offer additional 
      incremental value to conventional nonenhanced MR imaging in comparison with 
      histopathological results. Moreover, the apparent diffusion coefficient (ADC) 
      values were measured in the regions of interest within the endometrial cancer and 
      compared with those of normal endometrium and myometrium in 31 volunteers, 
      leiomyoma in 14 patients and adenomyosis in 10 patients. The Wilcoxon rank sum 
      test was used, with a p<0.05 considered statistically significant. RESULTS: In 19 
      of 23 patients, endometrial cancers were detected only on T2-weighted images. In 
      the remaining 4 patients, of whom two had coexisting leiomyoma, no cancer was 
      detected on T2-weighted images. This corresponds to an 83% detection sensitivity 
      for the carcinomas. When DW images and fused DW images/T2-weighted images were 
      used in addition to the T2-weighted images, cancers were identified in 3 of the 
      remaining 4 patients in addition to the 19 patients (overall detection 
      sensitivity of 96%). The mean ADC value of endometrial cancer (n=22) was 
      (0.97+/-0.19)x10(-3)mm(2)/s, which was significantly lower than those of the 
      normal endometrium, myometrium, leiomyoma and adenomyosis (p<0.05). CONCLUSION: 
      DW imaging can be helpful in the detection of uterine endometrial cancer in 
      nonenhanced MR imaging.
FAU - Inada, Yuki
AU  - Inada Y
AD  - Department of Radiology, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki 
      City, Osaka 569-8686, Japan. rad068@poh.osaka-med.ac.jp
FAU - Matsuki, Mitsuru
AU  - Matsuki M
FAU - Nakai, Go
AU  - Nakai G
FAU - Tatsugami, Fuminari
AU  - Tatsugami F
FAU - Tanikake, Masato
AU  - Tanikake M
FAU - Narabayashi, Isamu
AU  - Narabayashi I
FAU - Yamada, Takashi
AU  - Yamada T
FAU - Tsuji, Motomu
AU  - Tsuji M
LA  - eng
PT  - Journal Article
DEP - 20080107
PL  - Ireland
TA  - Eur J Radiol
JT  - European journal of radiology
JID - 8106411
RN  - 0 (Contrast Media)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Contrast Media
MH  - Diffusion Magnetic Resonance Imaging/*methods
MH  - Endometrial Neoplasms/*diagnosis
MH  - Female
MH  - Humans
MH  - Image Enhancement/*methods
MH  - Middle Aged
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - Subtraction Technique
MH  - Whole Body Imaging/*methods
EDAT- 2008/01/10 09:00
MHDA- 2009/07/08 09:00
CRDT- 2008/01/10 09:00
PHST- 2007/03/28 00:00 [received]
PHST- 2007/11/28 00:00 [revised]
PHST- 2007/11/28 00:00 [accepted]
PHST- 2008/01/10 09:00 [pubmed]
PHST- 2009/07/08 09:00 [medline]
PHST- 2008/01/10 09:00 [entrez]
AID - S0720-048X(07)00601-8 [pii]
AID - 10.1016/j.ejrad.2007.11.042 [doi]
PST - ppublish
SO  - Eur J Radiol. 2009 Apr;70(1):122-7. doi: 10.1016/j.ejrad.2007.11.042. Epub 2008 
      Jan 7.

PMID- 9142039
OWN - NLM
STAT- MEDLINE
DCOM- 19970605
LR  - 20190706
IS  - 0090-3493 (Print)
IS  - 0090-3493 (Linking)
VI  - 25
IP  - 4
DP  - 1997 Apr
TI  - Does pediatric housestaff experience influence tests ordered for infants in the 
      neonatal intensive care unit?
PG  - 704-9
AB  - OBJECTIVE: To assess the relationship between the experience of pediatric 
      housestaff and tests ordered on infants in the neonatal intensive care unit 
      (ICU). DESIGN: Prospective, cohort study over one full academic year. SETTING: 
      One academic Level III neonatal intensive care nursery. PATIENTS: Data were 
      collected prospectively on all 785 infants admitted to the neonatal ICU from July 
      1993 to June 1994. These infants were cared for by 14 different categorical 
      pediatric housestaff. MEASUREMENTS AND MAIN RESULTS: Our neonatal ICU has either 
      a resident or an intern on-call by himself/herself at night, affording us a 
      natural setting to compare intern vs. resident test ordering. The outcomes of 
      interest were number of arterial blood gases, radiographs, and electrolytes 
      ordered per infant by the on-call pediatric houseofficer, as tabulated the 
      morning after the call night. Control variables included the severity-of-illness 
      of the individual infant (using the Neonatal Therapeutic Intervention Scoring 
      System), the workload of the houseofficer (number of patients, number of 
      admissions), and supervision (rounding frequency and on-call attending). 
      Controlling for the severity-of-illness of the infant, the workload on the call 
      night, and supervision with multiple linear regression, we found that interns 
      ordered significantly (p = .02) greater numbers of arterial blood gases per 
      infant than residents, amounting to some 0.33 blood gases per infant per call 
      night (3.22 vs. 2.89 arterial blood gases per infant per night). This increase of 
      0.33 blood gases per infant amounts to interns ordering $169 more arterial blood 
      gases per call night at our institution. There was no difference between interns 
      and residents in ordering radiographs or electrolytes. CONCLUSION: Interns order 
      significantly more arterial blood gases per infant than junior and senior 
      residents on-call in the neonatal ICU. Additional study is required to see if the 
      experience of housestaff is associated with a broader array of neonatal outcomes, 
      such as morbidity and mortality.
FAU - Griffith, C H 3rd
AU  - Griffith CH 3rd
AD  - Department of Internal Medicine, University of Kentucky Medical Center, 
      Lexington, USA.
FAU - Wilson, J F
AU  - Wilson JF
FAU - Desai, N S
AU  - Desai NS
FAU - Rich, E C
AU  - Rich EC
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Crit Care Med
JT  - Critical care medicine
JID - 0355501
SB  - IM
MH  - Blood Gas Analysis/statistics & numerical data
MH  - Clinical Competence
MH  - Diagnostic Tests, Routine/*statistics & numerical data
MH  - Hospitals, University
MH  - Humans
MH  - Infant, Newborn
MH  - Intensive Care Units, Neonatal/*standards
MH  - Internship and Residency/*standards
MH  - Kentucky
MH  - *Pediatrics/education/standards
MH  - Practice Patterns, Physicians'/*statistics & numerical data
MH  - Prospective Studies
MH  - Severity of Illness Index
MH  - Workload
EDAT- 1997/04/01 00:00
MHDA- 2001/03/28 10:01
CRDT- 1997/04/01 00:00
PHST- 1997/04/01 00:00 [pubmed]
PHST- 2001/03/28 10:01 [medline]
PHST- 1997/04/01 00:00 [entrez]
AID - 10.1097/00003246-199704000-00024 [doi]
PST - ppublish
SO  - Crit Care Med. 1997 Apr;25(4):704-9. doi: 10.1097/00003246-199704000-00024.

PMID- 20084845
OWN - NLM
STAT- MEDLINE
DCOM- 20100224
LR  - 20100120
IS  - 1081-1206 (Print)
IS  - 1081-1206 (Linking)
VI  - 103
IP  - 6
DP  - 2009 Dec
TI  - Biomolecular identification of allergenic pollen: a new perspective for 
      aerobiological monitoring?
PG  - 508-14
LID - 10.1016/S1081-1206(10)60268-2 [doi]
AB  - BACKGROUND: Accurate and updated information on airborne pollen in specific areas 
      can help allergic patients. Current monitoring systems are based on a morphologic 
      identification approach, a time-consuming method that may represent a limiting 
      factor for sampling network enhancement. OBJECTIVE: To verify the feasibility of 
      developing a real-time polymerase chain reaction (PCR) approach, an alternative 
      to optical analysis, as a rapid, accurate, and automated tool for the detection 
      and quantification of airborne allergenic pollen taxa. METHODS: The traditional 
      cetyl trimethyl ammonium bromide-based method was modified for DNA isolation from 
      pollen. Taxon-specific DNA sequences were identified via bioinformatics or 
      literature searches and were PCR amplified from the matching allergenic taxa; 
      based on the sequences of PCR products, complementary or degenerate TaqMan probes 
      were developed. The accuracy of the quantitative real-time PCR assay was tested 
      on 3 plant species. RESULTS: The setup of a modified DNA extraction protocol 
      allowed us to achieve good-quality pollen DNA. Taxon-specific nuclear gene 
      fragments were identified and sequenced. Designed primer pairs and probes 
      identified selected pollen taxa, mostly at the required classification level. 
      Pollen was properly identified even when collected on routine aerobiological 
      tape. Preliminary quantification assays on pollen grains were successfully 
      performed on test species and in mixes. CONCLUSIONS: The real-time PCR approach 
      revealed promising results in pollen identification and quantification, even when 
      analyzing pollen mixes. Future perspectives could concern the development of 
      multiplex real-time PCR for the simultaneous detection of different taxa in the 
      same reaction tube and the application of high-throughput molecular methods.
FAU - Longhi, Sara
AU  - Longhi S
AD  - IASMA Research and Innovation Centre, Fondazione Edmund Mach, Trento, Italy.
FAU - Cristofori, Antonella
AU  - Cristofori A
FAU - Gatto, Pamela
AU  - Gatto P
FAU - Cristofolini, Fabiana
AU  - Cristofolini F
FAU - Grando, Maria Stella
AU  - Grando MS
FAU - Gottardini, Elena
AU  - Gottardini E
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Ann Allergy Asthma Immunol
JT  - Annals of allergy, asthma & immunology : official publication of the American 
      College of Allergy, Asthma, & Immunology
JID - 9503580
RN  - 0 (Antigens, Plant)
RN  - 0 (DNA Primers)
RN  - 0 (DNA Probes)
RN  - 0 (DNA, Plant)
RN  - 0 (Plant Proteins)
SB  - IM
MH  - *Antigens, Plant
MH  - Computational Biology
MH  - DNA Primers/genetics
MH  - DNA Probes/genetics
MH  - DNA, Plant/analysis/genetics/isolation & purification
MH  - Environmental Monitoring/*methods
MH  - Italy
MH  - *Molecular Probe Techniques
MH  - Plant Leaves/chemistry/genetics
MH  - Plant Proteins/genetics
MH  - Pollen/chemistry/classification/*genetics/immunology
MH  - Polymerase Chain Reaction
EDAT- 2010/01/21 06:00
MHDA- 2010/02/25 06:00
CRDT- 2010/01/21 06:00
PHST- 2010/01/21 06:00 [entrez]
PHST- 2010/01/21 06:00 [pubmed]
PHST- 2010/02/25 06:00 [medline]
AID - S1081-1206(10)60268-2 [pii]
AID - 10.1016/S1081-1206(10)60268-2 [doi]
PST - ppublish
SO  - Ann Allergy Asthma Immunol. 2009 Dec;103(6):508-14. doi: 
      10.1016/S1081-1206(10)60268-2.

PMID- 24298614
OWN - NLM
STAT- MEDLINE
DCOM- 20140116
LR  - 20181023
IS  - 0172-6390 (Print)
IS  - 0172-6390 (Linking)
VI  - 60
IP  - 125
DP  - 2013 Jul-Aug
TI  - Is the 7th TNM edition suitable for biological predictor in early gastric cancer?
PG  - 1225-30
LID - 10.5754/hge11579 [doi]
AB  - BACKGROUND/AIMS: The clinical and prognostic value of the previous node 
      classification of TNM staging in early gastric cancer (EGC) has been less 
      definitive. The aim was to assess the suitability of the revised node staging for 
      prediction of clinical behavior of EGC. METHODOLOGY: Between 2005 and 2008, 1,845 
      patients were diagnosed with EGC and underwent surgery at Severance Hospitals. 
      Clinicopathological characteristics were analyzed with comparisons between sixth 
      and seventh TNM staging. RESULTS: When comparing IB with IIA upstaged based on 
      seventh staging, poor differentiation, signet ring cell, diffuse, 
      undifferentiated types, perineural invasion (PNI), larger size and younger age, 
      were more significantly associated with IIA. Clinicopathological factors were 
      compared between N0/N1 and N2/N3 based on both staging. In mucosal cancer, 
      younger age, diffuse and undifferentiated types were more significantly 
      associated with N2/N3 based on seventh staging. In submucosal cancer, larger 
      size, poor differentiation, signet ring cell, diffuse, undifferentiated types, 
      PNI and deeper submucosal invasion, were more significantly associated with N2/N3 
      based on seventh staging. CONCLUSIONS: Upstaging in EGC based on the revised TNM 
      staging reflects more aggressive biological behavior of cancer. The new TNM 
      staging system may be informative in prediction of biological behavior of EGC as 
      well as prognosis and survival.
FAU - Jung, Da Hyun
AU  - Jung DH
FAU - Kim, Jie-Hyun
AU  - Kim JH
FAU - Lee, Yong Chan
AU  - Lee YC
FAU - Huh, Cheal Wung
AU  - Huh CW
FAU - Youn, Young Hoon
AU  - Youn YH
FAU - Park, Hyojin
AU  - Park H
FAU - Lee, Sang In
AU  - Lee SI
FAU - Choi, Seung Ho
AU  - Choi SH
FAU - Noh, Sung Hoon
AU  - Noh SH
LA  - eng
PT  - Journal Article
PL  - Greece
TA  - Hepatogastroenterology
JT  - Hepato-gastroenterology
JID - 8007849
SB  - IM
MH  - Adult
MH  - Aged
MH  - Female
MH  - Gastric Mucosa/pathology
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Invasiveness
MH  - Neoplasm Staging
MH  - Stomach Neoplasms/*pathology
EDAT- 2013/12/04 06:00
MHDA- 2014/01/17 06:00
CRDT- 2013/12/04 06:00
PHST- 2013/12/04 06:00 [entrez]
PHST- 2013/12/04 06:00 [pubmed]
PHST- 2014/01/17 06:00 [medline]
AID - 10.5754/hge11579 [doi]
PST - ppublish
SO  - Hepatogastroenterology. 2013 Jul-Aug;60(125):1225-30. doi: 10.5754/hge11579.

PMID- 12145243
OWN - NLM
STAT- MEDLINE
DCOM- 20030113
LR  - 20221207
IS  - 0149-5992 (Print)
IS  - 0149-5992 (Linking)
VI  - 25
IP  - 8
DP  - 2002 Aug
TI  - Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes 
      associated with improved outcomes?: U.K. prospective diabetes study 61.
PG  - 1410-7
AB  - OBJECTIVE: Type 2 diabetes may be present for several years before diagnosis, by 
      which time many patients have already developed diabetic complications. Earlier 
      detection and treatment may reduce this burden, but evidence to support this 
      approach is lacking. RESEARCH DESIGN AND METHODS: Glycemic control and clinical 
      and surrogate outcomes were compared for 5,088 of 5,102 U.K. Diabetes Prospective 
      Study participants according to whether they had low (<140 mg/dl [<7.8 mmol/l]), 
      intermediate (140 to <180 mg/dl [7.8 to <10.0 mmol/l]), or high (> or =180 mg/dl 
      [> or =10 mmol/l]) fasting plasma glucose (FPG) levels at diagnosis. Individuals 
      who presented with and without diabetic symptoms were also compared. RESULTS: 
      Fewer people with FPG in the lowest category had retinopathy, abnormal 
      biothesiometer measurements, or reported erectile dysfunction. The rate of 
      increase in FPG and HbA(1c) during the study was identical in all three groups, 
      although absolute differences persisted. Individuals in the low FPG group had a 
      significantly reduced risk for each predefined clinical outcome except stroke, 
      whereas those in the intermediate group had significantly reduced risk for each 
      outcome except stroke and myocardial infarction. The low and intermediate FPG 
      groups had a significantly reduced risk for progression of retinopathy, reduction 
      in vibration sensory threshold, or development of microalbuminuria. CONCLUSIONS: 
      People presenting with type 2 diabetes with lower initial glycemia who may be 
      earlier in the course of their disease had fewer adverse clinical outcomes 
      despite similar glycemic progression. Since most such people are asymptomatic at 
      diagnosis, active case detection programs would be required to identify them.
FAU - Colagiuri, Stephen
AU  - Colagiuri S
AD  - Diabetes Center, Prince of Wales Hospital, Randwick, Australia. Diabetes Trials 
      Unit, Oxford Center for Diabetes, Endocrinology and Metabolism, University of 
      Oxford, Oxford, UK.
FAU - Cull, Carole A
AU  - Cull CA
FAU - Holman, Rury R
AU  - Holman RR
CN  - UKPDS Group
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Diabetes Care
JT  - Diabetes care
JID - 7805975
RN  - 0 (Blood Glucose)
RN  - 0 (Glycated Hemoglobin A)
SB  - IM
MH  - Aged
MH  - *Blood Glucose
MH  - Diabetes Mellitus, Type 2/*blood/*diagnosis/therapy
MH  - Diabetic Retinopathy/blood/diagnosis/therapy
MH  - Disease-Free Survival
MH  - Fasting
MH  - Female
MH  - Glycated Hemoglobin/analysis
MH  - Humans
MH  - Hyperglycemia/blood/diagnosis/therapy
MH  - Male
MH  - Middle Aged
MH  - Predictive Value of Tests
MH  - Prospective Studies
MH  - Treatment Outcome
EDAT- 2002/07/30 10:00
MHDA- 2003/01/14 04:00
CRDT- 2002/07/30 10:00
PHST- 2002/07/30 10:00 [pubmed]
PHST- 2003/01/14 04:00 [medline]
PHST- 2002/07/30 10:00 [entrez]
AID - 10.2337/diacare.25.8.1410 [doi]
PST - ppublish
SO  - Diabetes Care. 2002 Aug;25(8):1410-7. doi: 10.2337/diacare.25.8.1410.

PMID- 21952349
OWN - NLM
STAT- MEDLINE
DCOM- 20120220
LR  - 20161125
IS  - 1421-9751 (Electronic)
IS  - 0008-6312 (Linking)
VI  - 119
IP  - 3
DP  - 2011
TI  - Remote ischemic postconditioning: does it protect against ischemic damage in 
      percutaneous coronary revascularization? justification and design of a randomized 
      placebo-controlled clinical trial.
PG  - 164-9
LID - 10.1159/000331432 [doi]
AB  - OBJECTIVE: Myocardial damage that is associated with percutaneous coronary 
      intervention (PCI) partially affects the results of the procedure, and is related 
      to medium-term cardiovascular death. Remote postischemic conditioning might 
      reduce the myocardial lesions that are associated with PCI, but perhaps less so 
      in diabetics. The aim of this study was to evaluate the protective effect of 
      remote postischemic conditioning in patients undergoing elective PCI for stable 
      angina or non-ST elevation acute coronary syndrome with troponin <1 ng/ml at the 
      time of randomization. METHODS: This randomized single-blinded single-center 
      clinical trial involved 320 patients undergoing elective PCI who were randomized 
      to either receive three 5-min cycles of ischemia by inflation of a cuff on the 
      non-dominant arm to 200 mm Hg (remote postischemic conditioning) or to placebo 
      (uninflated cuff). The primary outcome variable was the maximum increase in 
      troponin in the first 24 h. The secondary outcome variable was readmission due to 
      heart failure or cardiovascular mortality after 1 year of follow-up. In addition, 
      a diabetic population was studied. CONCLUSIONS: This clinical trial evaluated the 
      possible reduction in intervention-related myocardial damage that was 
      attributable to remote postischemic conditioning.
CI  - Copyright (c) 2011 S. Karger AG, Basel.
FAU - Jimenez-Navarro, M F
AU  - Jimenez-Navarro MF
AD  - Servicio de Cardiologia, Hospital Clinico Universitario Virgen de la Victoria, 
      Malaga, Spain. fernandocarrascochinchilla@gmail.com
FAU - Carrasco-Chinchilla, F
AU  - Carrasco-Chinchilla F
FAU - Munoz-Garcia, A J
AU  - Munoz-Garcia AJ
FAU - Dominguez-Franco, A
AU  - Dominguez-Franco A
FAU - Caballero-Borrego, J
AU  - Caballero-Borrego J
FAU - Alonso-Briales, J H
AU  - Alonso-Briales JH
FAU - Hernandez-Garcia, J M
AU  - Hernandez-Garcia JM
FAU - de Teresa-Galvan, E
AU  - de Teresa-Galvan E
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20110927
PL  - Switzerland
TA  - Cardiology
JT  - Cardiology
JID - 1266406
SB  - IM
MH  - Analysis of Variance
MH  - Angioplasty, Balloon, Coronary/*adverse effects/methods
MH  - Confidence Intervals
MH  - Coronary Angiography/methods
MH  - Elective Surgical Procedures
MH  - Female
MH  - Humans
MH  - Ischemic Postconditioning/*methods
MH  - Kaplan-Meier Estimate
MH  - Logistic Models
MH  - Male
MH  - Middle Aged
MH  - Multivariate Analysis
MH  - Myocardial Infarction/diagnostic imaging/mortality/*therapy
MH  - Myocardial Ischemia/*prevention & control
MH  - Patient Selection
MH  - Prognosis
MH  - Prospective Studies
MH  - Reference Values
MH  - Risk Assessment
MH  - Severity of Illness Index
MH  - Single-Blind Method
MH  - Survival Analysis
MH  - Treatment Outcome
EDAT- 2011/09/29 06:00
MHDA- 2012/02/22 06:00
CRDT- 2011/09/29 06:00
PHST- 2011/02/25 00:00 [received]
PHST- 2011/07/19 00:00 [accepted]
PHST- 2011/09/29 06:00 [entrez]
PHST- 2011/09/29 06:00 [pubmed]
PHST- 2012/02/22 06:00 [medline]
AID - 000331432 [pii]
AID - 10.1159/000331432 [doi]
PST - ppublish
SO  - Cardiology. 2011;119(3):164-9. doi: 10.1159/000331432. Epub 2011 Sep 27.

PMID- 27592038
OWN - NLM
STAT- MEDLINE
DCOM- 20171113
LR  - 20190416
IS  - 1532-2769 (Electronic)
IS  - 1356-689X (Linking)
VI  - 26
DP  - 2016 Dec
TI  - Does multi-modal cervical physical therapy improve tinnitus in patients with 
      cervicogenic somatic tinnitus?
PG  - 125-131
LID - S1356-689X(16)30700-7 [pii]
LID - 10.1016/j.math.2016.08.005 [doi]
AB  - BACKGROUND: Tinnitus can be related to many different aetiologies such as hearing 
      loss or a noise trauma, but it can also be related to the somatosensory system of 
      the cervical spine, called cervicogenic somatic tinnitus (CST). Case studies 
      suggest a positive effect of cervical spine treatment on tinnitus complaints in 
      patients with CST, but no experimental studies are available. OBJECTIVE: To 
      investigate the effect of a multimodal cervical physical therapy treatment on 
      tinnitus complaints in patients with CST. DESIGN: Randomized controlled trial. 
      PATIENTS: Patients with a combination of severe subjective tinnitus (Tinnitus 
      Functional Index (TFI): 25-90 points) and neck complaints (Neck Bournemouth 
      Questionnaire (NBQ) > 14 points). INTERVENTION: All patients received cervical 
      physical therapy for 6 weeks (12 sessions). Patients were randomized in an 
      immediate-start therapy group (n = 19) and a 6-week delayed-start therapy group 
      (n = 19). MEASUREMENTS: TFI and NBQ-scores were documented at baseline, after the 
      wait-and-see period in the delayed-start group, after treatment and after 6 weeks 
      follow-up. The Global Perceived Effect (GPE) was documented at all measuring 
      moments, except at baseline. RESULTS: In all patients (n = 38) TFI and NBQ-scores 
      decreased significantly after treatment (p = 0.04 and p < 0.001). NBQ-scores 
      remained significantly lower after follow-up (p = 0.001). Immediately after 
      treatment, 53% (n = 38) experienced substantial improvement of tinnitus. This 
      effect was maintained in 24% of patients after follow-up at six weeks. 
      CONCLUSION: Cervical physical therapy can have a positive effect on subjective 
      tinnitus complaints in patients with a combination of tinnitus and neck 
      complaints. Larger studies, using more responsive outcome measures, are however 
      necessary to prove this effect. TRIAL REGISTRATION: NCT02016313.
CI  - Copyright (c) 2016 Elsevier Ltd. All rights reserved.
FAU - Michiels, S
AU  - Michiels S
AD  - Department of Rehabilitation Sciences and Physiotherapy, Faculty of Medicine and 
      Health Sciences, University of Antwerp, Antwerp, Belgium; Department of 
      Otorhinolaryngology, Antwerp University Hospital, Edegem, Belgium. Electronic 
      address: sarah.michiels@uantwerpen.be.
FAU - Van de Heyning, P
AU  - Van de Heyning P
AD  - Department of Otorhinolaryngology, Antwerp University Hospital, Edegem, Belgium; 
      Multidisciplinary Motor Centre Antwerp, University of Antwerp, Antwerp, Belgium; 
      Department of Translational Neurosciences, Faculty of Medicine and Health 
      Sciences, University of Antwerp, Antwerp, Belgium.
FAU - Truijen, S
AU  - Truijen S
AD  - Department of Rehabilitation Sciences and Physiotherapy, Faculty of Medicine and 
      Health Sciences, University of Antwerp, Antwerp, Belgium; Multidisciplinary Motor 
      Centre Antwerp, University of Antwerp, Antwerp, Belgium.
FAU - Hallemans, A
AU  - Hallemans A
AD  - Department of Rehabilitation Sciences and Physiotherapy, Faculty of Medicine and 
      Health Sciences, University of Antwerp, Antwerp, Belgium; Multidisciplinary Motor 
      Centre Antwerp, University of Antwerp, Antwerp, Belgium; Laboratory of Functional 
      Morphology, Faculty of Science, University of Antwerp, Antwerp, Belgium.
FAU - De Hertogh, W
AU  - De Hertogh W
AD  - Department of Rehabilitation Sciences and Physiotherapy, Faculty of Medicine and 
      Health Sciences, University of Antwerp, Antwerp, Belgium.
LA  - eng
SI  - ClinicalTrials.gov/NCT02016313
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20160826
PL  - Scotland
TA  - Man Ther
JT  - Manual therapy
JID - 9610924
SB  - IM
CIN - J Am Osteopath Assoc. 2017 Oct 1;117(10):666-667. doi: 10.7556/jaoa.2017.126. 
      PMID: 28973185
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Cervical Vertebrae/*physiopathology
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Neck Pain/*physiopathology/*therapy
MH  - *Physical Therapy Modalities
MH  - Somatosensory Disorders/*diagnosis/*therapy
MH  - Tinnitus/*therapy
MH  - Treatment Outcome
OTO - NOTNLM
OT  - Cervical spine
OT  - Physical therapy
OT  - Somatic tinnitus
OT  - Treatment
EDAT- 2016/10/31 06:00
MHDA- 2017/11/14 06:00
CRDT- 2016/09/05 06:00
PHST- 2016/04/13 00:00 [received]
PHST- 2016/08/17 00:00 [revised]
PHST- 2016/08/21 00:00 [accepted]
PHST- 2016/10/31 06:00 [pubmed]
PHST- 2017/11/14 06:00 [medline]
PHST- 2016/09/05 06:00 [entrez]
AID - S1356-689X(16)30700-7 [pii]
AID - 10.1016/j.math.2016.08.005 [doi]
PST - ppublish
SO  - Man Ther. 2016 Dec;26:125-131. doi: 10.1016/j.math.2016.08.005. Epub 2016 Aug 26.

PMID- 25481573
OWN - NLM
STAT- MEDLINE
DCOM- 20160929
LR  - 20250103
IS  - 1873-5134 (Electronic)
IS  - 0738-3991 (Linking)
VI  - 98
IP  - 3
DP  - 2015 Mar
TI  - Processing fluency effects: can the content and presentation of participant 
      information sheets influence recruitment and participation for an antenatal 
      intervention?
PG  - 391-4
LID - S0738-3991(14)00478-9 [pii]
LID - 10.1016/j.pec.2014.11.005 [doi]
AB  - OBJECTIVE: To assess the extent to which the title and font of participant 
      information sheets (PISs) can influence pregnant women's and trainee midwives' 
      perceptions of an antenatal intervention. METHODS: Pregnant women (n=35) and 
      trainee midwives (n=36) were randomly presented with one of four PISs where the 
      title and font of the PIS had been manipulated to create four experimental 
      conditions (i.e., Double Fluent; Double Awkward; Fluent Title-Awkward Font; 
      Awkward Title-Fluent Font). After reading the PIS, participants rated their 
      perceptions of the intervention (i.e., Attractiveness, Complexity, Expected Risk, 
      Required Effort) using five-point Likert scales. RESULTS: A 4x2 factorial 
      multivariate analysis of variance revealed that pregnant women rated the Double 
      Awkward condition as significantly more complex than the Double Fluent (p=.024) 
      and Awkward Title-Fluent Font (p=.021) conditions. CONCLUSION: Font influenced 
      pregnant women's ratings of intervention complexity. PRACTICE IMPLICATIONS: 
      Results have implications for ethical recruitment, and in turn, the optimisation 
      of corresponding interventions.
CI  - Copyright (c) 2014 Elsevier Ireland Ltd. All rights reserved.
FAU - Manley, Andrew J
AU  - Manley AJ
AD  - Research Institute for Sport, Physical Activity & Leisure, Leeds Beckett 
      University, Leeds, UK. Electronic address: A.J.Manley@leedsbeckett.ac.uk.
FAU - Lavender, Tina
AU  - Lavender T
AD  - The School of Nursing, Midwifery and Social Work, The University of Manchester, 
      Manchester, UK.
FAU - Smith, Debbie M
AU  - Smith DM
AD  - The School of Psychological Sciences, The University of Manchester, Manchester, 
      UK.
LA  - eng
PT  - Journal Article
DEP - 20141120
PL  - Ireland
TA  - Patient Educ Couns
JT  - Patient education and counseling
JID - 8406280
MH  - Adult
MH  - Female
MH  - Humans
MH  - Midwifery
MH  - Multivariate Analysis
MH  - *Pamphlets
MH  - *Patient Selection
MH  - Pregnancy
MH  - Pregnant People/*psychology
MH  - Prenatal Care/methods
MH  - *Reading
OTO - NOTNLM
OT  - Cognitive processes
OT  - Intervention studies
OT  - Judgement
OT  - Participant recruitment
OT  - Professional standards
OT  - Research Ethics
EDAT- 2014/12/08 06:00
MHDA- 2016/09/30 06:00
CRDT- 2014/12/08 06:00
PHST- 2014/06/12 00:00 [received]
PHST- 2014/10/19 00:00 [revised]
PHST- 2014/11/11 00:00 [accepted]
PHST- 2014/12/08 06:00 [entrez]
PHST- 2014/12/08 06:00 [pubmed]
PHST- 2016/09/30 06:00 [medline]
AID - S0738-3991(14)00478-9 [pii]
AID - 10.1016/j.pec.2014.11.005 [doi]
PST - ppublish
SO  - Patient Educ Couns. 2015 Mar;98(3):391-4. doi: 10.1016/j.pec.2014.11.005. Epub 
      2014 Nov 20.

PMID- 20306735
OWN - NLM
STAT- MEDLINE
DCOM- 20100406
LR  - 20181201
IS  - 0189-160X (Print)
IS  - 0189-160X (Linking)
VI  - 28
IP  - 3
DP  - 2009 May
TI  - Fulfilling human resources development goal in West Africa: can the training of 
      ophthalmologist diplomates be improved?
PG  - 177-81
AB  - OBJECTIVE: To ascertain the perspectives of Trainee Ophthalmologist Diplomats 
      (TOD) on the Ophthalmic Diploma Training (ODT) in West Africa with a view to 
      improving the programme. METHODS: A survey of set 2005 TOD on ODT was carried out 
      in Ghana, 2006. RESULTS: The trainees included 10 (83.35%) males and two (16.7%) 
      females whose ages ranged between thirty-two and fifty-one years. The sponsors of 
      the trainees included Sight Savers International, five (41.7%); Christian Blind 
      Mission International, three (25.0%); Eye Foundation, Lagos, Nigeria two (16.7%); 
      Ministry of Defence Nigeria, one (8.3%); and Health Authority Ghana, one (8.3%). 
      Nine trainees (75.0%) felt the programme was well structured, training allowances 
      were adequate eight (66.7%) and inadequate four (33.3%). Eleven (91.7%) trainees 
      would work wherever they were posted; ten (83.3%) trainees had sense of 
      fulfillment and three (25%) would like to proceed for residency training. All 
      trainees were at least good in chalazion surgery and treatment of common medical 
      eye conditions. Majority were at least good in eye surgery like cataract, eleven 
      (91.7%); trabeculectomy nine (75.0%); pterygium 10 (83.3%); eyelid, eight 
      (66.7%); destructive 11 (91.6%) and refraction 9 (75.0%). Some trainees' 
      perceived problems included inadequate sponsorship (33.3%), short duration of the 
      course four (33.3%) and poor accommodation facility two (16.7%). However, 
      trainees' suggested increase in training posts, four (33.3); training allowance 
      three (25.0%); and incentives for trainers/training hospitals two (16.7%). 
      CONCLUSION: The ODT programme ensures ophthalmic manpower for secondary eye care 
      level despite challenges. The stakeholders should look into problems facing the 
      programme in order to improve it.
FAU - Ayanniyi, A A
AU  - Ayanniyi AA
AD  - Department of Ophthalmology, University of Ilorin Teaching Hospital, Ilorin, 
      Kwara State, Nigeria. ayanniyikabir2003@yahoo.com
FAU - Taoheed, A A
AU  - Taoheed AA
LA  - eng
PT  - Journal Article
PL  - Nigeria
TA  - West Afr J Med
JT  - West African journal of medicine
JID - 8301891
SB  - IM
MH  - Clinical Competence
MH  - Education, Medical, Continuing/*methods
MH  - Female
MH  - Ghana
MH  - Health Workforce/*trends
MH  - Humans
MH  - Male
MH  - Medical Staff, Hospital/education
MH  - Nigeria
MH  - Ophthalmology/*education
MH  - Staff Development/*methods/organization & administration
MH  - Surveys and Questionnaires
EDAT- 2010/03/24 06:00
MHDA- 2010/04/07 06:00
CRDT- 2010/03/24 06:00
PHST- 2010/03/24 06:00 [entrez]
PHST- 2010/03/24 06:00 [pubmed]
PHST- 2010/04/07 06:00 [medline]
PST - ppublish
SO  - West Afr J Med. 2009 May;28(3):177-81.

PMID- 26864326
OWN - NLM
STAT- MEDLINE
DCOM- 20170206
LR  - 20170206
IS  - 1472-0213 (Electronic)
IS  - 1472-0205 (Linking)
VI  - 34
IP  - 1
DP  - 2017 Jan
TI  - Predicting admission at triage: are nurses better than a simple objective score?
PG  - 2-7
LID - 10.1136/emermed-2014-204455 [doi]
AB  - AIM: We compared two methods of predicting hospital admission from ED triage: 
      probabilities estimated by triage nurses and probabilities calculated by the 
      Glasgow Admission Prediction Score (GAPS). METHODS: In this single-centre 
      prospective study, triage nurses estimated the probability of admission using a 
      100 mm visual analogue scale (VAS), and GAPS was generated automatically from 
      triage data. We compared calibration using rank sum tests, discrimination using 
      area under receiver operating characteristic curves (AUC) and accuracy with 
      McNemar's test. RESULTS: Of 1829 attendances, 745 (40.7%) were admitted, not 
      significantly different from GAPS' prediction of 750 (41.0%, p=0.678). In 
      contrast, the nurses' mean VAS predicted 865 admissions (47.3%), overestimating 
      by 6.6% (p<0.0001). GAPS discriminated between admission and discharge as well as 
      nurses, its AUC 0.876 compared with 0.875 for VAS (p=0.93). As a binary 
      predictor, its accuracy was 80.6%, again comparable with VAS (79.0%), p=0.18. In 
      the minority of attendances, when nurses felt at least 95% certain of the 
      outcome, VAS' accuracy was excellent, at 92.4%. However, in the remaining 
      majority, GAPS significantly outperformed VAS on calibration (+1.2% vs +9.2%, 
      p<0.0001), discrimination (AUC 0.810 vs 0.759, p=0.001) and accuracy (75.1% vs 
      68.9%, p=0.0009). When we used GAPS, but 'over-ruled' it when clinical certainty 
      was >/=95%, this significantly outperformed either method, with AUC 0.891 
      (0.877-0.907) and accuracy 82.5% (80.7%-84.2%). CONCLUSIONS: GAPS, a simple 
      clinical score, is a better predictor of admission than triage nurses, unless the 
      nurse is sure about the outcome, in which case their clinical judgement should be 
      respected.
CI  - Published by the BMJ Publishing Group Limited. For permission to use (where not 
      already granted under a licence) please go to 
      http://www.bmj.com/company/products-services/rights-and-licensing/.
FAU - Cameron, Allan
AU  - Cameron A
AD  - Acute Medicine Unit, Glasgow Royal Infirmary, Glasgow, UK.
FAU - Ireland, Alastair J
AU  - Ireland AJ
AD  - Emergency Department, Glasgow Royal Infirmary, Glasgow, UK.
FAU - McKay, Gerard A
AU  - McKay GA
AD  - Acute Medicine Unit, Glasgow Royal Infirmary, Glasgow, UK.
FAU - Stark, Adam
AU  - Stark A
AD  - Medical School, University of Glasgow, Glasgow, UK.
FAU - Lowe, David J
AU  - Lowe DJ
AUID- ORCID: 0000-0003-4866-2049
AD  - Emergency Department, Glasgow Royal Infirmary, Glasgow, UK.
AD  - Academic Unit of Anaesthesia, Pain and Critical Care Medicine, School of 
      Medicine, University of Glasgow, Glasgow, UK.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Observational Study
DEP - 20160210
PL  - England
TA  - Emerg Med J
JT  - Emergency medicine journal : EMJ
JID - 100963089
SB  - IM
MH  - Adult
MH  - Female
MH  - Humans
MH  - Male
MH  - *Nursing Assessment
MH  - *Patient Admission
MH  - Predictive Value of Tests
MH  - Probability
MH  - Prospective Studies
MH  - Severity of Illness Index
MH  - *Triage
OTO - NOTNLM
OT  - clinical assessment
OT  - efficiency
OT  - management, emergency department management
OT  - nursing, emergency departments
OT  - triage
EDAT- 2016/02/13 06:00
MHDA- 2017/02/07 06:00
CRDT- 2016/02/12 06:00
PHST- 2014/10/26 00:00 [received]
PHST- 2016/01/13 00:00 [revised]
PHST- 2016/01/19 00:00 [accepted]
PHST- 2016/02/13 06:00 [pubmed]
PHST- 2017/02/07 06:00 [medline]
PHST- 2016/02/12 06:00 [entrez]
AID - emermed-2014-204455 [pii]
AID - 10.1136/emermed-2014-204455 [doi]
PST - ppublish
SO  - Emerg Med J. 2017 Jan;34(1):2-7. doi: 10.1136/emermed-2014-204455. Epub 2016 Feb 
      10.

PMID- 21123461
OWN - NLM
STAT- MEDLINE
DCOM- 20110225
LR  - 20230318
IS  - 1938-3207 (Electronic)
IS  - 0002-9165 (Linking)
VI  - 93
IP  - 2
DP  - 2011 Feb
TI  - Are adult body circumferences associated with height? Relevance to normative 
      ranges and circumferential indexes.
PG  - 302-7
LID - 10.3945/ajcn.110.005132 [doi]
AB  - BACKGROUND: Weight scales as height squared, which is an observation that forms 
      the basis of body mass index (weight/height(2)). If, and how, circumferences, 
      including waist circumference (WC) and hip circumference (HC), scale to height 
      remains unclear, but this is an important consideration when developing normative 
      ranges or applying WC/height and HC/height as risk indexes. OBJECTIVE: The study 
      aim was to examine the scaling of weight, WC, and HC to height in NHANES 
      (National Health and Nutrition Examination Survey) III participants. DESIGN: 
      Subjects were adult non-Hispanic white, non-Hispanic black, and Mexican American 
      men (n = 7422) and nonpregnant women (n = 7999) who had complete demographic and 
      anthropometric data. In addition to height, allometric models were developed for 
      each measure that controlled for age, race, and self-reported health status. 
      RESULTS: After adjustment for age and race, weight scaled to height in men and 
      women with mean (+/-SEE) powers of 2.29 +/- 0.11 and 1.80 +/- 0.07, respectively (both 
      P < 0.001). Although univariate circumference-height models were weak or 
      nonsignificant, when adjusted for age and race WC and HC scaled to height with 
      powers of 0.76 +/- 0.08 and 0.45 +/- 0.05, respectively, in men and 0.80 +/- 0.05 and 
      0.53 +/- 0.04, respectively, in women (all P < 0.001). Age- and race-adjusted 
      incremental increases in circumferences ranged from 0.2 to 0.5 cm per centimeter 
      increase in height. Both WC/height and HC/height scaled negatively to height in 
      men and women, and WC/HC scaled negatively to height in women only (all P < 
      0.001). Health status-adjusted models were similar. CONCLUSIONS: Circumferences 
      and related ratios scale significantly to height, notably after adjustment for 
      age and race, across subjects who are representative of the US population. These 
      observations have implications for the clinical and epidemiologic use of these 
      anthropometric measures and indexes.
FAU - Heymsfield, Steven B
AU  - Heymsfield SB
AD  - Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA. 
      steven.heymsfield@pbrc.edu
FAU - Heo, Moonseong
AU  - Heo M
FAU - Pietrobelli, Angelo
AU  - Pietrobelli A
LA  - eng
PT  - Journal Article
DEP - 20101201
PL  - United States
TA  - Am J Clin Nutr
JT  - The American journal of clinical nutrition
JID - 0376027
SB  - IM
MH  - Adult
MH  - Anthropometry
MH  - *Body Height
MH  - Body Weight
MH  - Female
MH  - Hip/*anatomy & histology
MH  - Humans
MH  - Male
MH  - Nutrition Surveys
MH  - Obesity/*diagnosis
MH  - Reference Values
MH  - *Waist Circumference
EDAT- 2010/12/03 06:00
MHDA- 2011/02/26 06:00
CRDT- 2010/12/03 06:00
PHST- 2010/12/03 06:00 [entrez]
PHST- 2010/12/03 06:00 [pubmed]
PHST- 2011/02/26 06:00 [medline]
AID - S0002-9165(23)02067-1 [pii]
AID - 10.3945/ajcn.110.005132 [doi]
PST - ppublish
SO  - Am J Clin Nutr. 2011 Feb;93(2):302-7. doi: 10.3945/ajcn.110.005132. Epub 2010 Dec 
      1.

PMID- 12963175
OWN - NLM
STAT- MEDLINE
DCOM- 20031117
LR  - 20190628
IS  - 0003-4975 (Print)
IS  - 0003-4975 (Linking)
VI  - 76
IP  - 3
DP  - 2003 Sep
TI  - Can progression of valvar aortic stenosis be predicted accurately?
PG  - 676-80; discussion 680
AB  - BACKGROUND: It was the aim of the present study to elaborate criteria for the 
      assessment of rapid hemodynamic progression of valvar aortic stenosis. These 
      criteria are of special importance when cardiac surgery is indicated for other 
      reasons but the established criteria for aortic valve replacement are not yet 
      fulfilled. Such aspects of therapeutic planing were mostly disregarded in the 
      past so that patients had to undergo cardiac reoperation within a few years. 
      METHODS: Hemodynamic, echocardiographic, and clinical data of 169 men and 88 
      women with aortic stenosis, aged 55.2 +/- 15.7 years at their first and 63.4 +/- 
      15.6 years at their second cardiac catheterization, were analyzed. RESULTS: The 
      progression rate of aortic valve obstruction was found to be dependent on the 
      degree of valvar calcification ([VC] scoring 0 to III) and to be exponentially 
      correlated with the aortic valve opening area (AVA) at initial catheterization. 
      Neither age nor sex of the patient nor etiology of the valvar obstruction 
      significantly influence the progression of aortic stenosis. If AVA decreases 
      below 0.75 cm(2) with a present degree of VC = 0, or AVA of 0.8 with VC of I, AVA 
      of 0.9 with VC of II, or AVA of 1.0 with VC of III, it is probable that aortic 
      stenosis will have to be operated upon in the following years. CONCLUSIONS: The 
      present data indicate that for clinical purposes and planning of valvar surgery 
      the progression of asymptomatic aortic stenosis can be sufficiently predicted by 
      the present aortic valve opening area and the degree of valvar calcification.
FAU - Piper, Cornelia
AU  - Piper C
AD  - Department of Cardiology, Heart Center North Rhine-Westphalia, Ruhr University of 
      Bochum, Bad Oeynhausen, Germany. cpiper@hdz-nrw.de
FAU - Bergemann, Rito
AU  - Bergemann R
FAU - Schulte, Hagen D
AU  - Schulte HD
FAU - Koerfer, Reiner
AU  - Koerfer R
FAU - Horstkotte, Dieter
AU  - Horstkotte D
LA  - eng
PT  - Journal Article
PL  - Netherlands
TA  - Ann Thorac Surg
JT  - The Annals of thoracic surgery
JID - 15030100R
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Aortic Valve Stenosis/*diagnosis
MH  - Child
MH  - Disease Progression
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Predictive Value of Tests
MH  - Reproducibility of Results
EDAT- 2003/09/10 05:00
MHDA- 2003/12/03 05:00
CRDT- 2003/09/10 05:00
PHST- 2003/09/10 05:00 [pubmed]
PHST- 2003/12/03 05:00 [medline]
PHST- 2003/09/10 05:00 [entrez]
AID - S0003497503005666 [pii]
AID - 10.1016/s0003-4975(03)00566-6 [doi]
PST - ppublish
SO  - Ann Thorac Surg. 2003 Sep;76(3):676-80; discussion 680. doi: 
      10.1016/s0003-4975(03)00566-6.

PMID- 10548670
OWN - NLM
STAT- MEDLINE
DCOM- 19991123
LR  - 20220310
IS  - 0039-2499 (Print)
IS  - 0039-2499 (Linking)
VI  - 30
IP  - 11
DP  - 1999 Nov
TI  - Does the National Institutes of Health Stroke Scale favor left hemisphere 
      strokes? NINDS t-PA Stroke Study Group.
PG  - 2355-9
AB  - BACKGROUND AND PURPOSE: The National Institutes of Health Stroke Scale (NIHSS) is 
      a valid, reproducible scale that measures neurological deficit. Of 42 possible 
      points, 7 points are directly related to measurement of language compared with 
      only 2 points related to neglect. METHODS: We examined the placebo arm of the 
      NINDS t-PA stroke trial to test the hypothesis that the total volume of cerebral 
      infarction in patients with right hemisphere strokes would be greater than the 
      volume of cerebral infarction in patients with left hemisphere strokes who have 
      similar NIHSS scores. The volume of stroke was determined by computerized image 
      analysis of CT films and CT images stored on computer tape and optical disks. 
      Cube-root transformation of lesion volume was performed for each CT. Transformed 
      lesion volume was analyzed in a logistic regression model to predict volume of 
      stroke by NIHSS score for each hemisphere. Spearman rank correlation was used to 
      determine the relation between the NIHSS score and lesion volume. RESULTS: The 
      volume for right hemisphere stroke was statistically greater than the volume for 
      left hemisphere strokes, adjusting for the baseline NIHSS (P<0. 001). For each 
      5-point category of the NIHSS score <20, the median volume of right hemisphere 
      strokes was approximately double the median volume of left hemisphere strokes. 
      For example, for patients with a left hemisphere stroke and a 24-hour NIHSS score 
      of 16 to 20, the median volume of cerebral infarction was 48 mL (interquartile 
      range 14 to 111 mL) as compared with 133 mL (interquartile range 81 to 208 mL) 
      for patients with a right hemisphere stroke (P<0.001). The median volume of a 
      right hemisphere stroke was roughly equal to the median volume of a left 
      hemisphere stroke in the next highest 5-point category of the NIHSS. The Spearman 
      rank correlation between the 24-hour NIHSS score and 3-month lesion volume was 
      0.72 for patients with left hemisphere stroke and 0.71 for patients with right 
      hemisphere stroke. CONCLUSIONS: For a given NIHSS score, the median volume of 
      right hemisphere strokes is consistently larger than the median volume of left 
      hemisphere strokes. The clinical implications of our finding need further 
      exploration.
FAU - Woo, D
AU  - Woo D
AD  - Department of Neurology, University of Cincinnati, Cincinnati, Ohio 45220, USA. 
      daniel.woo@uc.edu
FAU - Broderick, J P
AU  - Broderick JP
FAU - Kothari, R U
AU  - Kothari RU
FAU - Lu, M
AU  - Lu M
FAU - Brott, T
AU  - Brott T
FAU - Lyden, P D
AU  - Lyden PD
FAU - Marler, J R
AU  - Marler JR
FAU - Grotta, J C
AU  - Grotta JC
LA  - eng
GR  - N-01-NS-02382/NS/NINDS NIH HHS/United States
GR  - N01-NS-02374/NS/NINDS NIH HHS/United States
GR  - N01-NS-02377/NS/NINDS NIH HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - Stroke
JT  - Stroke
JID - 0235266
RN  - 0 (Fibrinolytic Agents)
RN  - 0 (Placebos)
RN  - EC 3.4.21.68 (Tissue Plasminogen Activator)
SB  - IM
MH  - Brain/diagnostic imaging/physiopathology
MH  - Cerebral Infarction/classification/diagnostic imaging/physiopathology
MH  - Compact Disks
MH  - Fibrinolytic Agents/therapeutic use
MH  - Follow-Up Studies
MH  - Humans
MH  - Image Processing, Computer-Assisted/methods
MH  - Language
MH  - Logistic Models
MH  - *National Institutes of Health (U.S.)
MH  - Neurologic Examination
MH  - Placebos
MH  - Stroke/*classification/diagnostic imaging/drug therapy/physiopathology
MH  - Thrombolytic Therapy
MH  - Tissue Plasminogen Activator/therapeutic use
MH  - Tomography, X-Ray Computed
MH  - United States
EDAT- 1999/11/05 00:00
MHDA- 1999/11/05 00:01
CRDT- 1999/11/05 00:00
PHST- 1999/11/05 00:00 [pubmed]
PHST- 1999/11/05 00:01 [medline]
PHST- 1999/11/05 00:00 [entrez]
AID - 10.1161/01.str.30.11.2355 [doi]
PST - ppublish
SO  - Stroke. 1999 Nov;30(11):2355-9. doi: 10.1161/01.str.30.11.2355.

PMID- 21848798
OWN - NLM
STAT- MEDLINE
DCOM- 20111223
LR  - 20181201
IS  - 1365-2036 (Electronic)
IS  - 0269-2813 (Linking)
VI  - 34
IP  - 7
DP  - 2011 Oct
TI  - MiraLAX vs. Golytely: is there a significant difference in the adenoma detection 
      rate?
PG  - 775-82
LID - 10.1111/j.1365-2036.2011.04795.x [doi]
AB  - BACKGROUND: In recent clinical trials (RCT) of bowel preparation, Golytely was 
      more efficacious than MiraLAX. We hypothesised that there is a difference in 
      adenoma detection between Golytely and MiraLAX. AIMS: To compare the adenoma 
      detection rate (ADR) between these bowel preparations, and to identify 
      independent predictors of bowel preparation quality and adenoma detection. 
      METHODS: This was a post hoc analysis of an RCT that assessed efficacy and 
      patient tolerability of Golytely vs. MiraLAX/Gatorade in average risk screening 
      colonoscopy patients. Bowel preparation quality was measured with the Boston 
      Bowel Preparation Scale (BBPS). An excellent/good equivalent BBPS score was 
      defined as >/= 7. Polyp pathology review was performed. ADR was defined as the 
      proportion of colonoscopies with an adenoma. Univariate and multivariate analyses 
      were conducted. RESULTS: One hundred and ninety patients were prospectively 
      enrolled (87 MiraLAX, 103 Golytely). Golytely had a higher rate of a BBPS score >/= 
      7 (82.5% vs. MiraLAX 67.8%, P=0.02). The ADR in the Golytely cohort was 26.2% 
      (27/103), and was 16.1% (14/87) for MiraLAX (P = 0.091). On multivariate 
      analyses, Golytely was 2.13 x more likely to be associated with a BBPS >/= 7 (95% 
      CI 1.05-4.32, P = 0.04) and 2.28 x more likely to be associated with adenoma 
      detection (95% CI 1.05-4.98, P = 0.04) than MiraLAX. CONCLUSIONS: Golytely was 
      more efficacious than MiraLAX in bowel cleansing, and was independently 
      associated with both bowel prep quality (BBPS >/= 7) and higher adenoma detection. 
      Golytely should be used as first line for bowel prep for colonoscopy. Studies 
      with larger populations are needed to confirm these results.
CI  - (c) 2011 Blackwell Publishing Ltd.
FAU - Enestvedt, B K
AU  - Enestvedt BK
AD  - Division of Gastroenterology and Hepatology, Oregon Health & Science University, 
      Portland, OR, USA. brintha.enestvedt@uphs.upenn.edu
FAU - Brian Fennerty, M
AU  - Brian Fennerty M
FAU - Zaman, A
AU  - Zaman A
FAU - Eisen, G M
AU  - Eisen GM
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20110817
PL  - England
TA  - Aliment Pharmacol Ther
JT  - Alimentary pharmacology & therapeutics
JID - 8707234
RN  - 0 (Electrolytes)
RN  - 0 (Golytely)
RN  - 0 (Solvents)
RN  - 3WJQ0SDW1A (Polyethylene Glycols)
SB  - IM
MH  - Adenoma/*diagnosis
MH  - Age Factors
MH  - Aged
MH  - Colonoscopy/*methods
MH  - Colorectal Neoplasms/*diagnosis
MH  - *Electrolytes
MH  - Female
MH  - Humans
MH  - Male
MH  - Mass Screening/methods
MH  - Middle Aged
MH  - Multivariate Analysis
MH  - *Polyethylene Glycols
MH  - Preoperative Care/methods
MH  - Randomized Controlled Trials as Topic
MH  - Retrospective Studies
MH  - *Solvents
EDAT- 2011/08/19 06:00
MHDA- 2011/12/24 06:00
CRDT- 2011/08/19 06:00
PHST- 2011/08/19 06:00 [entrez]
PHST- 2011/08/19 06:00 [pubmed]
PHST- 2011/12/24 06:00 [medline]
AID - 10.1111/j.1365-2036.2011.04795.x [doi]
PST - ppublish
SO  - Aliment Pharmacol Ther. 2011 Oct;34(7):775-82. doi: 
      10.1111/j.1365-2036.2011.04795.x. Epub 2011 Aug 17.

PMID- 25675614
OWN - NLM
STAT- MEDLINE
DCOM- 20150310
LR  - 20150213
IS  - 0028-7571 (Print)
IS  - 0028-7571 (Linking)
VI  - 80
IP  - 6
DP  - 2014 Nov
TI  - Can gingival crevicular blood be relied upon for assessment of blood glucose 
      level?
PG  - 38-42
AB  - Diabetes mellitus (DM) is undiagnosed in approximately half of the patients 
      actually suffering from the disease. In addition, the prevalence of DM is more 
      than twice as high as in patients with periodontitis when compared to 
      periodontally healthy subjects. Thus, a high number of patients with 
      periodontitis may have undiagnosed DM. The purpose of the present study was to 
      evaluate whether blood oozing from a gingival crevice during routine periodontal 
      examination can be used for determining glucose levels. MATERIALS AND METHODS: 
      Observational cross-sectional studies were carried out in 75 patients (43 males 
      and 32 females) with chronic periodontitis who were divided into two groups: 
      Group I and Group II, respectively. Blood oozing from the gingival crevices of 
      anterior teeth following periodontal probing was collected with the stick of 
      glucose self-monitoring device, and the blood glucose levels were measured. At 
      the same time, finger-prick blood was taken for glucometric analysis and 
      subsequent readings were recorded. RESULTS: The patient's blood glucose values 
      ranged from 74 to 256 mg/dl. The comparison between gingival crevicular blood and 
      finger-prick blood showed a very strong correlation, with a t value of 3.97 (at P 
      value = 0.001). CONCLUSIONS: The data from this study has shown that GCB 
      collected during diagnostic periodontal examination can be an excellent source of 
      blood for glucometric analysis.
FAU - Dwivedi, Shivani
AU  - Dwivedi S
FAU - Verma, Sharmila J
AU  - Verma SJ
FAU - Shah, Monali
AU  - Shah M
FAU - Jain, Kapil
AU  - Jain K
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Observational Study
PL  - United States
TA  - N Y State Dent J
JT  - The New York state dental journal
JID - 0414634
RN  - 0 (Blood Glucose)
SB  - IM
MH  - Blood Glucose/*analysis
MH  - Blood Glucose Self-Monitoring/instrumentation
MH  - Capillaries
MH  - Chronic Periodontitis/*blood
MH  - Cross-Sectional Studies
MH  - Diabetes Mellitus/blood
MH  - Feasibility Studies
MH  - Female
MH  - Fingers/blood supply
MH  - Gingival Crevicular Fluid/*chemistry
MH  - Gingival Hemorrhage/blood
MH  - Humans
MH  - Male
MH  - Reproducibility of Results
EDAT- 2015/02/14 06:00
MHDA- 2015/03/11 06:00
CRDT- 2015/02/14 06:00
PHST- 2015/02/14 06:00 [entrez]
PHST- 2015/02/14 06:00 [pubmed]
PHST- 2015/03/11 06:00 [medline]
PST - ppublish
SO  - N Y State Dent J. 2014 Nov;80(6):38-42.

PMID- 25986020
OWN - NLM
STAT- MEDLINE
DCOM- 20150820
LR  - 20220311
IS  - 1098-4275 (Electronic)
IS  - 0031-4005 (Linking)
VI  - 135
IP  - 6
DP  - 2015 Jun
TI  - Is zero central line-associated bloodstream infection rate sustainable? A 5-year 
      perspective.
PG  - e1485-93
LID - 10.1542/peds.2014-2523 [doi]
AB  - BACKGROUND AND OBJECTIVE: Adoption and implementation of evidence-based measures 
      for catheter care leads to reductions in central line-associated bloodstream 
      infection (CLABSI) rates in the NICU. The purpose of this study is to evaluate 
      whether this rate reduction is sustainable for at least 1 year and to identify 
      key determinants of this sustainability at the NICU of the Floating Hospital for 
      Children at Tufts Medical Center. METHODS: We reviewed the incidence of CLABSIs 
      in the NICU temporally to the implementation of new practice policies and 
      procedures, from July 2008 to December 2013. RESULTS: Adoption of standardized 
      care practices, including bundles and checklists, was associated with a 
      significant reduction of the CLABSI rate to zero for >370 consecutive days in our 
      NICU in 2012. Overall, our CLABSI rates decreased from 4.1 per 1000 line days in 
      2009 (13 infections; 3163 line days) to 0.94 in 2013 (2 infections; 2115 line 
      days), which represents a 77% reduction over a 5-year period. In the first 
      quarter of 2013, there was a brief increase in CLABSI rate to 3.3 per 1000 line 
      days; after a series of interventions, the CLABSI rate was maintained at zero for 
      >600 days. Ongoing training, surveillance, and vigilance with catheter insertion 
      and maintenance practices and improved documentation were identified as key 
      drivers for success. CONCLUSIONS: High-quality training, strict compliance with 
      evidence-based guidelines, and thorough documentation is associated with 
      significant reductions in CLABSIs. Mindful organizing may lead to a better 
      understanding of what goes into a unit's ability to handle peak demands and 
      sustain extraordinary performance in the long-term.
CI  - Copyright (c) 2015 by the American Academy of Pediatrics.
FAU - Erdei, Carmina
AU  - Erdei C
AD  - Division of Neonatology, Department of Pediatrics (Neonatology), Floating 
      Hospital for Children at Tufts Medical Center, Boston, Massachusetts; 
      carmina.erdei@gmail.com.
FAU - McAvoy, Linda L
AU  - McAvoy LL
AD  - Division of Neonatology, Department of Pediatrics (Neonatology), Floating 
      Hospital for Children at Tufts Medical Center, Boston, Massachusetts;
FAU - Gupta, Munish
AU  - Gupta M
AD  - Department of Pediatrics (Neonatology), Beth Israel Deaconess Medical Center, 
      Boston, Massachusetts; and.
FAU - Pereira, Sunita
AU  - Pereira S
AD  - Division of Neonatology, Department of Pediatrics (Neonatology), Floating 
      Hospital for Children at Tufts Medical Center, Boston, Massachusetts;
FAU - McGowan, Elisabeth C
AU  - McGowan EC
AD  - Department of Pediatrics (Neonatology), Women and Infants' Hospital, Providence, 
      Rhode Island.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150518
PL  - United States
TA  - Pediatrics
JT  - Pediatrics
JID - 0376422
SB  - IM
MH  - Bacteremia/epidemiology/*etiology/*prevention & control
MH  - Catheter-Related Infections/epidemiology/*etiology/*prevention & control
MH  - Catheterization, Central Venous/*adverse effects
MH  - Guideline Adherence
MH  - Humans
MH  - Infant, Newborn
MH  - Time Factors
EDAT- 2015/05/20 06:00
MHDA- 2015/08/21 06:00
CRDT- 2015/05/20 06:00
PHST- 2015/01/26 00:00 [accepted]
PHST- 2015/05/20 06:00 [entrez]
PHST- 2015/05/20 06:00 [pubmed]
PHST- 2015/08/21 06:00 [medline]
AID - peds.2014-2523 [pii]
AID - 10.1542/peds.2014-2523 [doi]
PST - ppublish
SO  - Pediatrics. 2015 Jun;135(6):e1485-93. doi: 10.1542/peds.2014-2523. Epub 2015 May 
      18.

PMID- 18472368
OWN - NLM
STAT- MEDLINE
DCOM- 20081231
LR  - 20220408
IS  - 1879-355X (Electronic)
IS  - 0360-3016 (Print)
IS  - 0360-3016 (Linking)
VI  - 72
IP  - 5
DP  - 2008 Dec 1
TI  - Does treatment duration affect outcome after radiotherapy for prostate cancer?
PG  - 1402-7
LID - 10.1016/j.ijrobp.2008.03.011 [doi]
AB  - PURPOSE: The protraction of external beam radiotherapy (RT) time is detrimental 
      in several disease sites. In prostate cancer, the overall treatment time can be 
      considerable, as can the potential for treatment breaks. We evaluated the effect 
      of elapsed treatment time on outcome after RT for prostate cancer. METHODS AND 
      MATERIALS: Between April 1989 and November 2004, 1,796 men with prostate cancer 
      were treated with RT alone. The nontreatment day ratio (NTDR) was defined as the 
      number of nontreatment days divided by the total elapsed days of RT. This ratio 
      was used to account for the relationship between treatment duration and total RT 
      dose. Men were stratified into low risk (n = 789), intermediate risk (n = 798), 
      and high risk (n = 209) using a single-factor model. RESULTS: The 10-year freedom 
      from biochemical failure (FFBF) rate was 68% for a NTDR <33% vs. 58% for NTDR 
      >/=33% (p = 0.02; BF was defined as a prostate-specific antigen nadir + 2 ng/mL). 
      In the low-risk group, the 10-year FFBF rate was 82% for NTDR <33% vs. 57% for 
      NTDR >/=33% (p = 0.0019). The NTDR was independently predictive for FFBF (p = 
      0.03), in addition to T stage (p = 0.005) and initial prostate-specific antigen 
      level (p < 0.0001) on multivariate analysis, including Gleason score and 
      radiation dose. The NTDR was not a significant predictor of FFBF when examined in 
      the intermediate-risk group, high-risk group, or all risk groups combined. 
      CONCLUSIONS: A proportionally longer treatment duration was identified as an 
      adverse factor in low-risk patients. Treatment breaks resulting in a NTDR of 
      >/=33% (e.g., four or more breaks during a 40-fraction treatment, 5 d/wk) should 
      be avoided.
FAU - D'Ambrosio, David J
AU  - D'Ambrosio DJ
AD  - Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
FAU - Li, Tianyu
AU  - Li T
FAU - Horwitz, Eric M
AU  - Horwitz EM
FAU - Chen, David Y T
AU  - Chen DY
FAU - Pollack, Alan
AU  - Pollack A
FAU - Buyyounouski, Mark K
AU  - Buyyounouski MK
LA  - eng
GR  - CA101984-01/CA/NCI NIH HHS/United States
GR  - CA-006927/CA/NCI NIH HHS/United States
GR  - R01 CA101984-05/CA/NCI NIH HHS/United States
GR  - R01 CA101984/CA/NCI NIH HHS/United States
GR  - P30 CA006927/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20080509
PL  - United States
TA  - Int J Radiat Oncol Biol Phys
JT  - International journal of radiation oncology, biology, physics
JID - 7603616
SB  - IM
CIN - Nat Rev Clin Oncol. 2009 Jun;6(6):312-3. doi: 10.1038/nrclinonc.2009.71. PMID: 
      19483737
MH  - Humans
MH  - Male
MH  - Neoplasm Staging
MH  - Physical Examination
MH  - Prostatic Neoplasms/pathology/*radiotherapy
MH  - Radiotherapy/*methods
MH  - Radiotherapy, Conformal/*methods
MH  - Retrospective Studies
MH  - Risk Assessment
MH  - Treatment Outcome
PMC - PMC2763099
MID - NIHMS150052
COIS- Conflict of interest: A. Pollack received a departmental Varian research grant; 
      all other authors have no conflicts of interest.
EDAT- 2008/05/13 09:00
MHDA- 2009/01/01 09:00
PMCR- 2009/10/17
CRDT- 2008/05/13 09:00
PHST- 2007/11/08 00:00 [received]
PHST- 2008/03/11 00:00 [revised]
PHST- 2008/03/12 00:00 [accepted]
PHST- 2008/05/13 09:00 [pubmed]
PHST- 2009/01/01 09:00 [medline]
PHST- 2008/05/13 09:00 [entrez]
PHST- 2009/10/17 00:00 [pmc-release]
AID - S0360-3016(08)00486-0 [pii]
AID - 10.1016/j.ijrobp.2008.03.011 [doi]
PST - ppublish
SO  - Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1402-7. doi: 
      10.1016/j.ijrobp.2008.03.011. Epub 2008 May 9.

PMID- 26578404
OWN - NLM
STAT- MEDLINE
DCOM- 20170109
LR  - 20170110
IS  - 1873-6513 (Electronic)
IS  - 0885-3924 (Linking)
VI  - 51
IP  - 3
DP  - 2016 Mar
TI  - Patient-Controlled Therapy of Breathlessness in Palliative Care: A New 
      Therapeutic Concept for Opioid Administration?
PG  - 581-8
LID - S0885-3924(15)00579-5 [pii]
LID - 10.1016/j.jpainsymman.2015.10.015 [doi]
AB  - CONTEXT: Breathlessness is one of the most distressing symptoms experienced by 
      patients with advanced cancer and noncancer diagnoses alike. Often, severity of 
      breathlessness increases quickly, calling for rapid symptom control. Oral, 
      buccal, and parenteral routes of provider-controlled drug administration have 
      been described. It is unclear whether patient-controlled therapy (PCT) systems 
      would be an additional treatment option. OBJECTIVES: To investigate whether 
      intravenous opioid PCT can be an effective therapeutic method to reduce 
      breathlessness in patients with advanced disease. Secondary aims were to study 
      the feasibility and acceptance of opioid PCT in patients with refractory 
      breathlessness. METHODS: This was a pilot observational study with 18 inpatients 
      with advanced disease and refractory breathlessness receiving opioid PCT. 
      Breathlessness was measured on a self-reported numeric rating scale. Richmond 
      Agitation Sedation Scale scores, Palliative Performance Scale scores, vital 
      signs, and a self-developed patient satisfaction questionnaire were used for 
      measuring secondary outcomes. Descriptive and interference analyses (Friedman 
      test) and post hoc analyses (Wilcoxon tests and Bonferroni corrections) were 
      performed. RESULTS: Eighteen of 815 patients (advanced cancer; median 
      age = 57.5 years [range 36-81]; 77.8% female) received breathlessness symptom 
      control with opioid PCT; daily morphine equivalent dose at Day 1 was 
      median = 20.3 mg (5.0-49.6 mg); Day 2: 13.0 mg (1.0-78.5 mg); Day 3: 16.0 mg 
      (8.3-47.0 mg). Numeric rating scale of current breathlessness decreased 
      (baseline: median = 5 [range 1-10]; Day 1: median = 4 [range 0-8], P < 0.01; Day 
      2: median = 4 [range 0-5], P < 0.01). Physiological parameters were stable over 
      time. On Day 3, 12/12 patients confirmed that this mode of application provided 
      relief of breathlessness. CONCLUSION: Opioid PCT is a feasible and acceptable 
      therapeutic method to reduce refractory breathlessness in palliative care 
      patients.
CI  - Copyright (c) 2016 American Academy of Hospice and Palliative Medicine. Published 
      by Elsevier Inc. All rights reserved.
FAU - Schmitz, Andrea
AU  - Schmitz A
AD  - Interdisciplinary Center for Palliative Medicine, Medical Faculty, 
      Heinrich-Heine-University Dusseldorf, Dusseldorf, Germany; Department of 
      Anesthesiology, Medical Faculty, Heinrich-Heine-University Dusseldorf, 
      Dusseldorf, Germany.
FAU - Schulz, Christian
AU  - Schulz C
AD  - Interdisciplinary Center for Palliative Medicine, Medical Faculty, 
      Heinrich-Heine-University Dusseldorf, Dusseldorf, Germany. Electronic address: 
      christian.schulz@med.uni-duesseldorf.de.
FAU - Friebel, Uta
AU  - Friebel U
AD  - Department of Anesthesiology, Medical Faculty, Heinrich-Heine-University 
      Dusseldorf, Dusseldorf, Germany.
FAU - Hohlfeld, Thomas
AU  - Hohlfeld T
AD  - Institute of Pharmacology and Clinical Pharmacology, Medical Faculty, 
      Heinrich-Heine-University Dusseldorf, Dusseldorf, Germany.
FAU - Bausewein, Claudia
AU  - Bausewein C
AD  - Department for Palliative Medicine, Munich University Hospital, 
      Ludwig-Maximilians-University, Munich, Germany.
LA  - eng
PT  - Journal Article
PT  - Observational Study
DEP - 20151111
PL  - United States
TA  - J Pain Symptom Manage
JT  - Journal of pain and symptom management
JID - 8605836
RN  - 0 (Analgesics, Opioid)
SB  - IM
MH  - Administration, Intravenous
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Analgesia, Patient-Controlled/*methods
MH  - Analgesics, Opioid/*administration & dosage
MH  - Dyspnea/*drug therapy/etiology/physiopathology/psychology
MH  - Feasibility Studies
MH  - Female
MH  - Humans
MH  - Longitudinal Studies
MH  - Male
MH  - Middle Aged
MH  - Neoplasms/complications/drug therapy/physiopathology/psychology
MH  - Palliative Care/*methods
MH  - Patient Satisfaction
MH  - Prospective Studies
MH  - Self Report
MH  - Severity of Illness Index
OTO - NOTNLM
OT  - Breathlessness
OT  - dyspnea
OT  - opioid
OT  - palliative care
OT  - patient-controlled therapy
OT  - therapy
EDAT- 2015/11/19 06:00
MHDA- 2017/01/10 06:00
CRDT- 2015/11/19 06:00
PHST- 2015/07/24 00:00 [received]
PHST- 2015/10/28 00:00 [revised]
PHST- 2015/11/03 00:00 [accepted]
PHST- 2015/11/19 06:00 [entrez]
PHST- 2015/11/19 06:00 [pubmed]
PHST- 2017/01/10 06:00 [medline]
AID - S0885-3924(15)00579-5 [pii]
AID - 10.1016/j.jpainsymman.2015.10.015 [doi]
PST - ppublish
SO  - J Pain Symptom Manage. 2016 Mar;51(3):581-8. doi: 
      10.1016/j.jpainsymman.2015.10.015. Epub 2015 Nov 11.

PMID- 14872327
OWN - NLM
STAT- MEDLINE
DCOM- 20040504
LR  - 20181113
IS  - 0932-433X (Print)
IS  - 0932-433X (Linking)
VI  - 18
IP  - 1
DP  - 2004 Feb
TI  - [Is pain a clinically relevant problem in general adult psychiatry? A clinical 
      epidemiological cross-sectional study in patients with psychiatric disorders].
PG  - 28-37
AB  - OBJECTIVE: To study the prevalence of pain and risk factors for pain in 
      psychiatric patients in a psychiatric hospital. METHODS: Using a questionnaire we 
      investigated in a cross-sectional study the prevalence of pain, duration of pain, 
      impairment and unfitness for work due to pain in 106 patients primarily diagnosed 
      with a psychiatric disorder in the field of general adult psychiatry. Potential 
      risk factors were explored. RESULTS: The point prevalence of pain was about 50%, 
      the 6-month prevalence 75.5% and the 12-month prevalence 76.5%. The patients' 
      most frequent complaints were low back pain, headache and shoulder and neck pain. 
      Patients with affective disorders most frequently had pain complaints, followed 
      by those with neurotic, stress-related and somatoform disorders and those with 
      psychotic disorders such as schizophrenia, schizotypic and delusional disorders. 
      Almost 10% of all patients reported pain continuing at least 3 months in the past 
      year. Impairment and unfitness for work were related to specific psychiatric 
      diagnosis. Statistically significant risk factors for pain were depression 
      (OR=6.05) and the number of past admissions to psychiatric hospitals (OR=3.609). 
      CONCLUSION: We found evidence that pain can be a significant clinical problem in 
      psychiatric patients which seems to be underestimated in psychiatry. The 
      investigated patients in general adult psychiatry are characterized by specific 
      risk factors different from clinical subpopulations of other disciplines.
FAU - Baune MPH, B T
AU  - Baune MPH BT
AD  - Department of Psychiatry, Springfield University Hospital, London, UK. 
      B.Baune@uni-bielefeld.de
FAU - Aljeesh, Y
AU  - Aljeesh Y
LA  - ger
PT  - English Abstract
PT  - Journal Article
TT  - Sind Schmerzen ein klinisch relevantes Problem in der Allgemeinpsychiatrie? Eine 
      klinisch-epidemiologische Querschnittstudie bei Patienten mit psychischen 
      Storungen.
PL  - Germany
TA  - Schmerz
JT  - Schmerz (Berlin, Germany)
JID - 8906258
SB  - IM
MH  - Adult
MH  - Cross-Sectional Studies
MH  - Germany/epidemiology
MH  - Hospitals, Psychiatric
MH  - Humans
MH  - Incidence
MH  - Mental Disorders/*physiopathology/psychology
MH  - Pain/epidemiology/physiopathology/*psychology
MH  - Pain Measurement/methods
MH  - Prevalence
MH  - *Psychiatry
MH  - Surveys and Questionnaires
EDAT- 2004/02/12 05:00
MHDA- 2004/05/05 05:00
CRDT- 2004/02/12 05:00
PHST- 2004/02/12 05:00 [pubmed]
PHST- 2004/05/05 05:00 [medline]
PHST- 2004/02/12 05:00 [entrez]
AID - 10.1007/s00482-003-0262-6 [doi]
PST - ppublish
SO  - Schmerz. 2004 Feb;18(1):28-37. doi: 10.1007/s00482-003-0262-6.

PMID- 23412195
OWN - NLM
STAT- MEDLINE
DCOM- 20140325
LR  - 20220408
IS  - 1432-1068 (Electronic)
IS  - 1633-8065 (Linking)
VI  - 23
IP  - 6
DP  - 2013 Aug
TI  - Should displaced midshaft clavicular fractures be treated surgically? A 
      meta-analysis based on current evidence.
PG  - 621-9
LID - 10.1007/s00590-012-1063-3 [doi]
AB  - PURPOSE: This study was designed to compare clinical effectiveness of operative 
      with nonoperative treatment for displaced midshaft clavicular fractures (DMCF). 
      METHODS: We systematically searched electronic databases (MEDILINE, EMBASE, 
      CLINICAL, OVID, BIOSIS and Cochrane registry of controlled clinical trials) to 
      identify randomized controlled trials (RCTs) in which operative treatment was 
      compared with nonoperative treatment for DMCF from 1980 to 2012. The methodologic 
      quality of trials was assessed. Data from chosen studies were pooled with using 
      of fixed-effects and random-effects models with mean differences and risk ratios 
      for continuous and dichotomous variables, respectively. RESULTS: Four RCTs with a 
      total of 321 patients were screened for the present study. Results showed that 
      the operative treatment was superior to the nonoperative treatment regarding the 
      rate of nonunion [95 % confidence interval (CI) (0.05, 0.43), P = 0.0004], 
      malunion [95 % CI (0.06, 0.34), P < 0.00001] and overall complication [95 % CI 
      (0.43-0.76), P = 0.0001]. Subgroup analyses of complications revealed that 
      significant differences were existed in the incidence of neurologic symptoms 
      [95 % CI (0.20, 0.74), P = 0.004] and dissatisfaction with appearance [95 % CI 
      (0.19, 0.65), P = 0.001]. Lack of consistent and standardized assessment data, 
      insufficiency analysis that carried out showed improved functional outcomes 
      (P < 0.05) in operative treatment. CONCLUSIONS: The available evidence suggests 
      that the operative treatment for DMCF is associated with a lower rate of 
      nonunion, malunion and complication than nonoperative treatment. This study 
      supports traditional primary operative treatment for DMCF in active adults.
FAU - Xu, Chang-peng
AU  - Xu CP
AD  - Orthopaedics and Trauma, NanFang Hospital, Southern Medical University, No. 1838 
      Guangzhou Da Dao Bei, Guangzhou, Guangdong Province 510515, China.
FAU - Li, Xue
AU  - Li X
FAU - Cui, Zhuang
AU  - Cui Z
FAU - Diao, Xi-cai
AU  - Diao XC
FAU - Yu, Bin
AU  - Yu B
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
DEP - 20120815
PL  - France
TA  - Eur J Orthop Surg Traumatol
JT  - European journal of orthopaedic surgery & traumatology : orthopedie traumatologie
JID - 9518037
SB  - IM
MH  - Clavicle/*injuries
MH  - Databases, Factual
MH  - Fracture Fixation, Internal/*methods
MH  - Fractures, Bone/*surgery
MH  - Humans
MH  - Postoperative Complications
MH  - Randomized Controlled Trials as Topic
MH  - Recovery of Function
MH  - Treatment Outcome
EDAT- 2013/02/16 06:00
MHDA- 2014/03/26 06:00
CRDT- 2013/02/16 06:00
PHST- 2012/07/07 00:00 [received]
PHST- 2012/07/28 00:00 [accepted]
PHST- 2013/02/16 06:00 [entrez]
PHST- 2013/02/16 06:00 [pubmed]
PHST- 2014/03/26 06:00 [medline]
AID - 10.1007/s00590-012-1063-3 [doi]
PST - ppublish
SO  - Eur J Orthop Surg Traumatol. 2013 Aug;23(6):621-9. doi: 
      10.1007/s00590-012-1063-3. Epub 2012 Aug 15.

PMID- 24139705
OWN - NLM
STAT- MEDLINE
DCOM- 20141112
LR  - 20221207
IS  - 1878-1780 (Electronic)
IS  - 1262-3636 (Linking)
VI  - 40
IP  - 1
DP  - 2014 Feb
TI  - Telemedicine and type 1 diabetes: is technology per se sufficient to improve 
      glycaemic control?
PG  - 61-66
LID - S1262-3636(13)00159-6 [pii]
LID - 10.1016/j.diabet.2013.09.001 [doi]
AB  - AIM: In the TELEDIAB-1 study, the Diabeo system (a smartphone coupled to a 
      website) improved HbA1c by 0.9% vs controls in patients with chronic, poorly 
      controlled type 1 diabetes. The system provided two main functions: automated 
      advice on the insulin doses required; and remote monitoring by teleconsultation. 
      The question is: how much did each function contribute to the improvement in 
      HbA1c? METHODS: Each patient received a smartphone with an insulin dose advisor 
      (IDA) and with (G3 group) or without (G2 group) the 
      telemonitoring/teleconsultation function. Patients were classified as "high 
      users" if the proportion of "informed" meals using the IDA exceeded 67% (median) 
      and as "low users" if not. Also analyzed was the respective impact of the IDA 
      function and teleconsultations on the final HbA1c levels. RESULTS: Among the high 
      users, the proportion of informed meals remained stable from baseline to the end 
      of the study 6months later (from 78.1+/-21.5% to 73.8+/-25.1%; P=0.107), but 
      decreased in the low users (from 36.6+/-29.4% to 26.7+/-28.4%; P=0.005). As expected, 
      HbA1c improved in high users from 8.7% [range: 8.3-9.2%] to 8.2% [range: 
      7.8-8.7%] in patients with (n=26) vs without (n=30) the benefit of 
      telemonitoring/teleconsultation (-0.49+/-0.60% vs -0.52+/-0.73%, respectively; 
      P=0.879). However, although HbA1c also improved in low users from 9.0% [8.5-10.1] 
      to 8.5% [7.9-9.6], those receiving support via teleconsultation tended to show 
      greater improvement than the others (-0.93+/-0.97 vs -0.46+/-1.05, respectively; 
      P=0.084). CONCLUSION: The Diabeo system improved glycaemic control in both high 
      and low users who avidly used the IDA function, while the greatest improvement 
      was seen in the low users who had the motivational support of teleconsultations.
CI  - Copyright (c) 2013 Elsevier Masson SAS. All rights reserved.
FAU - Franc, S
AU  - Franc S
AD  - Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France; Centre 
      d'Etudes et de Recherches pour l'Intensification du Traitement du Diabete 
      (CERITD), Corbeil-Essonnes, France. Electronic address: 
      sylvia.franc@ch-sud-francilien.fr.
FAU - Borot, S
AU  - Borot S
AD  - Department of Endocrinology-Metabolism and Diabetology-Nutrition, Jean-Minjoz 
      Hospital, Besancon, France.
FAU - Ronsin, O
AU  - Ronsin O
AD  - Department of Diabetes, Sainte-Marguerite University Hospital, Marseille, France.
FAU - Quesada, J-L
AU  - Quesada JL
AD  - Department of Biostatistics, CIC-Inserm, University Hospital, Grenoble, France.
FAU - Dardari, D
AU  - Dardari D
AD  - Centre d'Etudes et de Recherches pour l'Intensification du Traitement du Diabete 
      (CERITD), Corbeil-Essonnes, France.
FAU - Fagour, C
AU  - Fagour C
AD  - Department of Endocrinology, University Hospital Pessac, Pessac, France.
FAU - Renard, E
AU  - Renard E
AD  - Department of Endocrinology, University Hospital, Montpellier, France.
FAU - Leguerrier, A-M
AU  - Leguerrier AM
AD  - Department of Endocrinology, University Hospital, Rennes, France.
FAU - Vigeral, C
AU  - Vigeral C
AD  - Department of Diabetes, Hotel-Dieu University Hospital, Paris, France.
FAU - Moreau, F
AU  - Moreau F
AD  - Department of Endocrinology, University Hospital, Strasbourg, France.
FAU - Winiszewski, P
AU  - Winiszewski P
AD  - Department of Endocrinology, Belfort Hospital, Belfort, France.
FAU - Vambergue, A
AU  - Vambergue A
AD  - Clinique Marc Linquette, Department of Endocrinology and Diabetology, Lille, 
      France.
FAU - Mosnier-Pudar, H
AU  - Mosnier-Pudar H
AD  - Department of Diabetes, Cochin Hospital, Paris, France.
FAU - Kessler, L
AU  - Kessler L
AD  - Department of Endocrinology, University Hospital, Strasbourg, France.
FAU - Reffet, S
AU  - Reffet S
AD  - Department of Endocrinology, Edouard-Herriot Hospital, Lyon, France.
FAU - Guerci, B
AU  - Guerci B
AD  - Diabetology, Nutrition, Metabolic disorders, Brabois Hospital and Center of 
      Clinical Investigation ILCV, University Hospital, Nancy, France.
FAU - Millot, L
AU  - Millot L
AD  - Department of Endocrinology, Bellevue Hospital, Saint-Etienne, France.
FAU - Halimi, S
AU  - Halimi S
AD  - Department of Endocrinology, Diabetology, Nutrition University Hospital, 
      Grenoble, France; University J Fourier 1, Grenoble, France.
FAU - Thivolet, C
AU  - Thivolet C
AD  - Department of Endocrinology, Edouard-Herriot Hospital, Lyon, France.
FAU - Benhamou, P-Y
AU  - Benhamou PY
AD  - Department of Endocrinology, Diabetology, Nutrition University Hospital, 
      Grenoble, France.
FAU - Penfornis, A
AU  - Penfornis A
AD  - Department of Endocrinology-Metabolism and Diabetology-Nutrition, Jean-Minjoz 
      Hospital, Besancon, France.
FAU - Charpentier, G
AU  - Charpentier G
AD  - Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France; Centre 
      d'Etudes et de Recherches pour l'Intensification du Traitement du Diabete 
      (CERITD), Corbeil-Essonnes, France.
FAU - Hanaire, H
AU  - Hanaire H
AD  - Department of Diabetes, Rangueil University Hospital, Toulouse, France.
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20131016
PL  - France
TA  - Diabetes Metab
JT  - Diabetes & metabolism
JID - 9607599
RN  - 0 (Blood Glucose)
RN  - 0 (Glycated Hemoglobin A)
RN  - 0 (Hypoglycemic Agents)
RN  - 0 (Insulin)
RN  - 0 (hemoglobin A1c protein, human)
SB  - IM
EIN - Diabetes Metab. 2014 Jun;40(3):235
MH  - Adult
MH  - Blood Glucose/*metabolism
MH  - *Cell Phone
MH  - Diabetes Mellitus, Type 1/*drug therapy
MH  - Female
MH  - Glycated Hemoglobin/metabolism
MH  - Humans
MH  - Hypoglycemic Agents/*administration & dosage
MH  - Insulin/*administration & dosage
MH  - Insulin Infusion Systems
MH  - Internet
MH  - Male
MH  - Patient Compliance
MH  - Reminder Systems/*instrumentation
MH  - *Remote Consultation
MH  - Self Care
MH  - Software
MH  - Telemedicine
OTO - NOTNLM
OT  - Decision support software
OT  - Telemedicine
OT  - Telemonitoring
OT  - Type 1 diabetes
EDAT- 2013/10/22 06:00
MHDA- 2014/11/13 06:00
CRDT- 2013/10/22 06:00
PHST- 2013/05/26 00:00 [received]
PHST- 2013/08/15 00:00 [revised]
PHST- 2013/09/02 00:00 [accepted]
PHST- 2013/10/22 06:00 [entrez]
PHST- 2013/10/22 06:00 [pubmed]
PHST- 2014/11/13 06:00 [medline]
AID - S1262-3636(13)00159-6 [pii]
AID - 10.1016/j.diabet.2013.09.001 [doi]
PST - ppublish
SO  - Diabetes Metab. 2014 Feb;40(1):61-66. doi: 10.1016/j.diabet.2013.09.001. Epub 
      2013 Oct 16.

PMID- 23224030
OWN - NLM
STAT- MEDLINE
DCOM- 20140424
LR  - 20221207
IS  - 1436-6215 (Electronic)
IS  - 1436-6207 (Linking)
VI  - 52
IP  - 7
DP  - 2013 Oct
TI  - Do European people with type 1 diabetes consume a high atherogenic diet? 7-year 
      follow-up of the EURODIAB Prospective Complications Study.
PG  - 1701-10
LID - 10.1007/s00394-012-0473-7 [doi]
AB  - BACKGROUND/OBJECTIVES: Individuals with type 1 diabetes have a high risk of 
      developing cardiovascular diseases, and it has been reported that they consume a 
      high atherogenic diet. We examined how nutrient intake and adherence to current 
      European nutritional recommendations evolved in a large cohort of European 
      individuals with type 1 diabetes over a period of 7 years. SUBJECTS/METHODS: We 
      analysed data from the EURODIAB Prospective Complications Study, a European 
      multicentre prospective cohort study. Standardized 3-day dietary records were 
      employed in individuals with type 1 diabetes. One thousand one hundred and two 
      patients (553 men, 549 women, baseline age 33 +/- 10 years, duration 15 +/- 9 years) 
      had complete nutritional data available at baseline and after 7 years. We 
      calculated mean differences in reported nutrients over time and adjusted these 
      for age, gender, HbA1c and BMI with ANOVA models. RESULTS: Compared to baseline, 
      there were minor changes in nutrients. Reported protein (-0.35% energy (en), fat 
      (-1.07% en), saturated fat (-0.25% en) and cholesterol (-7.42 mg/1000 kcal) 
      intakes were lower, whereas carbohydrate (+1.23% en) and fibre (+0.46 g/1000 
      kcal) intakes were higher at the 7-year follow-up. European recommendations for 
      adequate nutrient intakes were followed in individuals with type 1 diabetes for 
      protein (76% at baseline and 78% at follow-up), moderately for fat (34, 40%), 
      carbohydrate (34, 41%) and cholesterol (39, 47%), but poorly for fibre (1.4, 
      2.4%) and saturated fat (11, 13%). CONCLUSION: European individuals with type 1 
      diabetes consume a high atherogenic diet as few patients met recommendations for 
      dietary fibre and saturated fat. This study showed minor changes in dietary 
      nutrients and energy intakes over a period of 7 years. Nutrition education needs 
      particular focus on strategies to increase dietary fibre and reduce saturated fat 
      to exploit their potential benefit.
FAU - Soedamah-Muthu, Sabita S
AU  - Soedamah-Muthu SS
AD  - Division of Human Nutrition, Wageningen University, 6700 EV, PO Box 8129, 
      Wageningen, The Netherlands, sabita.soedamah-muthu@wur.nl.
FAU - Chaturvedi, Nish
AU  - Chaturvedi N
FAU - Fuller, John H
AU  - Fuller JH
FAU - Toeller, Monika
AU  - Toeller M
CN  - EURODIAB Prospective Complications Study Group
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20121207
PL  - Germany
TA  - Eur J Nutr
JT  - European journal of nutrition
JID - 100888704
RN  - 0 (Cholesterol, Dietary)
RN  - 0 (Dietary Carbohydrates)
RN  - 0 (Dietary Fiber)
RN  - 0 (Dietary Proteins)
RN  - 0 (Insulin)
RN  - 97C5T2UQ7J (Cholesterol)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Body Mass Index
MH  - Body Weight
MH  - Cardiovascular Diseases/complications/*epidemiology
MH  - Cholesterol/blood
MH  - Cholesterol, Dietary/administration & dosage
MH  - Diabetes Mellitus, Type 1/complications/*epidemiology
MH  - Diet Records
MH  - *Diet, Atherogenic
MH  - Dietary Carbohydrates/administration & dosage
MH  - Dietary Fiber/administration & dosage
MH  - Dietary Proteins/administration & dosage
MH  - Energy Intake
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Insulin/administration & dosage
MH  - Male
MH  - Middle Aged
MH  - Motor Activity
MH  - Nutrition Assessment
MH  - Nutritional Status
MH  - Prospective Studies
MH  - Recommended Dietary Allowances
MH  - White People
MH  - Young Adult
FIR - Karamanos, B
IR  - Karamanos B
FIR - Kofinis, A
IR  - Kofinis A
FIR - Petrou, K
IR  - Petrou K
FIR - Giorgino, F
IR  - Giorgino F
FIR - Picca, G
IR  - Picca G
FIR - Angarano, A
IR  - Angarano A
FIR - De Pergola, G
IR  - De Pergola G
FIR - Laviola, L
IR  - Laviola L
FIR - Giorgino, R
IR  - Giorgino R
FIR - Ionescu-Tirgoviste, C
IR  - Ionescu-Tirgoviste C
FIR - Coszma, A
IR  - Coszma A
FIR - Guja, C
IR  - Guja C
FIR - Songini, M
IR  - Songini M
FIR - Casu, A
IR  - Casu A
FIR - Pedron, M
IR  - Pedron M
FIR - Pintus, S
IR  - Pintus S
FIR - Fossarello, M
IR  - Fossarello M
FIR - Ferriss, J B
IR  - Ferriss J
FIR - O'Keefe, D
IR  - O'Keefe D
FIR - Grealy, G
IR  - Grealy G
FIR - Toeller, M
IR  - Toeller M
FIR - Arden, C
IR  - Arden C
FIR - Rottiers, R
IR  - Rottiers R
FIR - Tuyttens, C
IR  - Tuyttens C
FIR - Priem, H
IR  - Priem H
FIR - Ebeling, P
IR  - Ebeling P
FIR - Kyllia, M
IR  - Kyllia M
FIR - Koivisto, V A
IR  - Koivisto V
FIR - Idzior-Walus, B
IR  - Idzior-Walus B
FIR - Sieradzki, J
IR  - Sieradzki J
FIR - Cyganek, K
IR  - Cyganek K
FIR - Solnica, B
IR  - Solnica B
FIR - Lemkes, H H P J
IR  - Lemkes H
FIR - Lemkes-Stuffken, J C
IR  - Lemkes-Stuffken J
FIR - Rogado, M C
IR  - Rogado M
FIR - Gardete-Correia, L
IR  - Gardete-Correia L
FIR - Cardoso, M C
IR  - Cardoso M
FIR - Silva, A
IR  - Silva A
FIR - Boavida, J
IR  - Boavida J
FIR - Machado Sa Marques, M
IR  - Machado Sa Marques M
FIR - Michel, G
IR  - Michel G
FIR - Wirion, R
IR  - Wirion R
FIR - Cardillo, S
IR  - Cardillo S
FIR - Pozza, G
IR  - Pozza G
FIR - Mangili, R
IR  - Mangili R
FIR - Asnaghi, V
IR  - Asnaghi V
FIR - Standl, E
IR  - Standl E
FIR - Schaffler, B
IR  - Schaffler B
FIR - Brand, H
IR  - Brand H
FIR - Soussan, D Ben
IR  - Soussan D
FIR - Verier, O
IR  - Verier O
FIR - Fallas, P
IR  - Fallas P
FIR - Fallas, M C
IR  - Fallas M
FIR - Fuller, J H
IR  - Fuller J
FIR - Holloway, J
IR  - Holloway J
FIR - Asbury, L
IR  - Asbury L
FIR - Betteridge, D J
IR  - Betteridge D
FIR - Cathelineau, G
IR  - Cathelineau G
FIR - Bouallouche, A
IR  - Bouallouche A
FIR - Cathelineau, B Villatte
IR  - Cathelineau B
FIR - Santeusanio, F
IR  - Santeusanio F
FIR - Rosi, G
IR  - Rosi G
FIR - D'Alessandro, V
IR  - D'Alessandro V
FIR - Cagini, C
IR  - Cagini C
FIR - Bottini, P
IR  - Bottini P
FIR - Reboldi, G P
IR  - Reboldi G
FIR - Navalesi, R
IR  - Navalesi R
FIR - Penno, G
IR  - Penno G
FIR - Bandinelli, S
IR  - Bandinelli S
FIR - Miccoli, R
IR  - Miccoli R
FIR - Nannipieri, M
IR  - Nannipieri M
FIR - Ghirlanda, G
IR  - Ghirlanda G
FIR - Saponara, C
IR  - Saponara C
FIR - Cotroneo, P
IR  - Cotroneo P
FIR - Manto, A
IR  - Manto A
FIR - Ward, J D
IR  - Ward J
FIR - Tesfaye, S
IR  - Tesfaye S
FIR - Eaton, S
IR  - Eaton S
FIR - Mody, C
IR  - Mody C
FIR - Borra, M
IR  - Borra M
FIR - Perin, P Cavallo
IR  - Perin PC
FIR - Giunti, S
IR  - Giunti S
FIR - Grassi, G
IR  - Grassi G
FIR - Pagano, G F
IR  - Pagano G
FIR - Porta, M
IR  - Porta M
FIR - Sivieri, R
IR  - Sivieri R
FIR - Vitelli, F
IR  - Vitelli F
FIR - Veglio, M
IR  - Veglio M
FIR - Papazoglou, N
IR  - Papazoglou N
FIR - Manes, G
IR  - Manes G
FIR - Muggeo, M
IR  - Muggeo M
FIR - Iagulli, M
IR  - Iagulli M
FIR - Cacciatori, V
IR  - Cacciatori V
FIR - Cattedra, V
IR  - Cattedra V
FIR - Irsigler, K
IR  - Irsigler K
FIR - Abrahamian, H
IR  - Abrahamian H
FIR - Walford, S
IR  - Walford S
FIR - Sinclair, J
IR  - Sinclair J
FIR - Hughes, S
IR  - Hughes S
FIR - McLelland, V
IR  - McLelland V
FIR - Ward, J
IR  - Ward J
FIR - Roglic, G
IR  - Roglic G
FIR - Metelko, Z
IR  - Metelko Z
FIR - Pepeonik, Z R
IR  - Pepeonik Z
FIR - Fuller, J H
IR  - Fuller J
FIR - Karamanos, B
IR  - Karamanos B
FIR - Chaturvedi, N
IR  - Chaturvedi N
FIR - Toeller, M
IR  - Toeller M
FIR - Pozza, G
IR  - Pozza G
FIR - Ferriss, B
IR  - Ferriss B
FIR - Porta, M
IR  - Porta M
FIR - Rottiers, R
IR  - Rottiers R
FIR - Michel, G
IR  - Michel G
FIR - Fuller, J H
IR  - Fuller J
FIR - Chaturvedi, N
IR  - Chaturvedi N
FIR - Holloway, J
IR  - Holloway J
FIR - Webb, D
IR  - Webb D
FIR - Asbury, L
IR  - Asbury L
FIR - Viberti, G C
IR  - Viberti GC
FIR - Swaminathan, R
IR  - Swaminathan R
FIR - Lumb, P
IR  - Lumb P
FIR - Collins, A
IR  - Collins A
FIR - Sankaralingham, S
IR  - Sankaralingham S
FIR - Crook, M A
IR  - Crook MA
FIR - Aldington, S
IR  - Aldington S
FIR - Mortemore, T
IR  - Mortemore T
FIR - Lipinski, H
IR  - Lipinski H
FIR - Toeller, M
IR  - Toeller M
FIR - Scherbaum, W A
IR  - Scherbaum WA
FIR - Gries, F A
IR  - Gries FA
EDAT- 2012/12/12 06:00
MHDA- 2014/04/25 06:00
CRDT- 2012/12/11 06:00
PHST- 2012/06/21 00:00 [received]
PHST- 2012/11/22 00:00 [accepted]
PHST- 2012/12/11 06:00 [entrez]
PHST- 2012/12/12 06:00 [pubmed]
PHST- 2014/04/25 06:00 [medline]
AID - 10.1007/s00394-012-0473-7 [doi]
PST - ppublish
SO  - Eur J Nutr. 2013 Oct;52(7):1701-10. doi: 10.1007/s00394-012-0473-7. Epub 2012 Dec 
      7.

PMID- 24013712
OWN - NLM
STAT- MEDLINE
DCOM- 20140730
LR  - 20211021
IS  - 1435-2451 (Electronic)
IS  - 1435-2443 (Linking)
VI  - 398
IP  - 8
DP  - 2013 Dec
TI  - Preoperative platelet count in esophageal squamous cell carcinoma: is it a 
      prognostic factor?
PG  - 1115-22
LID - 10.1007/s00423-013-1111-4 [doi]
AB  - PURPOSE: Platelet count is inversely related to prognosis in many cancers; 
      however, its role in esophageal cancer is still controversial. The purpose of 
      this study was to determine the prognostic value of preoperative platelet count 
      in esophageal squamous cell carcinoma (ESCC). METHODS: From January 2006 to 
      December 2008, a retrospective analysis of 425 consecutive patients with ESCC was 
      conducted. A receiver operating characteristic (ROC) curve for survival 
      prediction was plotted to verify the optimum cutoff point for preoperative 
      platelet count. Univariate and multivariate analyses were performed to evaluate 
      the prognostic parameters. RESULTS: A ROC curve for survival prediction was 
      plotted to verify the optimum cutoff point for platelet count, which was 205 (x 
      10(9)/L). Patients with platelet count </= 205 had a significantly better 5-year 
      survival than patients with a platelet count >205 (60.7 vs. 31.6 %, P < 0.001). 
      The 5-year survival of patients either with platelet count </= 205 or >205 were 
      similar (68.6 vs. 58.8 %, P = 0.085) when the nodes were negative. However, the 
      5-year survival of patients with platelet count </= 205 was better than that of 
      patients with a platelet count >205 when the nodes were involved (32.0 vs. 12.7 
      %, P = 0.004). Multivariate analysis showed that platelet count (P = 0.013), T 
      grade (P = 0.017), and N staging (P < 0.001) were independent prognostic factors. 
      CONCLUSIONS: Preoperative platelet count is a predictive factor for long-term 
      survival in ESCC, especially in nodal-positive patients. We conclude that 205 
      (x10(9)/L) may be the optimum cutoff point for platelet count in predicting 
      survival in ESCC patients.
FAU - Feng, Ji Feng
AU  - Feng JF
AD  - Department of Thoracic Surgery, Zhejiang Cancer Hospital, No.38 Guangji Road, 
      Banshan Bridge, Hangzhou, 310022, China, Jifzhejiang@gmail.com.
FAU - Huang, Ying
AU  - Huang Y
FAU - Lu, Wei Shan
AU  - Lu WS
FAU - Chen, Qi Xun
AU  - Chen QX
LA  - eng
PT  - Journal Article
DEP - 20130908
PL  - Germany
TA  - Langenbecks Arch Surg
JT  - Langenbeck's archives of surgery
JID - 9808285
SB  - IM
MH  - Carcinoma, Squamous Cell/*blood/*pathology
MH  - Esophageal Neoplasms/*blood/*pathology
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Staging
MH  - *Platelet Count
MH  - Prognosis
MH  - Retrospective Studies
MH  - Sensitivity and Specificity
MH  - Survival Rate
EDAT- 2013/09/10 06:00
MHDA- 2014/07/31 06:00
CRDT- 2013/09/10 06:00
PHST- 2013/01/22 00:00 [received]
PHST- 2013/08/26 00:00 [accepted]
PHST- 2013/09/10 06:00 [entrez]
PHST- 2013/09/10 06:00 [pubmed]
PHST- 2014/07/31 06:00 [medline]
AID - 10.1007/s00423-013-1111-4 [doi]
PST - ppublish
SO  - Langenbecks Arch Surg. 2013 Dec;398(8):1115-22. doi: 10.1007/s00423-013-1111-4. 
      Epub 2013 Sep 8.

PMID- 15943725
OWN - NLM
STAT- MEDLINE
DCOM- 20051013
LR  - 20161124
IS  - 1445-1433 (Print)
IS  - 1445-1433 (Linking)
VI  - 75
IP  - 6
DP  - 2005 Jun
TI  - Should serum pancreatic lipase replace serum amylase as a biomarker of acute 
      pancreatitis?
PG  - 399-404
AB  - BACKGROUND: Serum pancreatic lipase may improve the diagnosis of pancreatitis 
      compared to serum amylase. Both enzymes have been measured simultaneously at our 
      hospital allowing for a comparison of their diagnostic accuracy. METHODS: 
      Seventeen thousand five hundred and thirty-one measurements of either serum 
      amylase and or serum pancreatic lipase were made on 10 931 patients treated at a 
      metropolitan teaching hospital between January 2001 and May 2003. Of these, 8937 
      were initially treated in the Emergency Department. These results were collected 
      in a database, which was linked by the patients' medical record number to the 
      radiology and medical records. Patients with either an elevated lipase value or a 
      discharge diagnosis of acute pancreatitis had their radiological diagnosis 
      reviewed along with their biochemistry and histology record. The diagnosis of 
      acute pancreatitis was made if there was radiological evidence of peripancreatic 
      inflammation. RESULTS: One thousand eight hundred and twenty-five patients had 
      either elevated serum amylase and or serum pancreatic lipase. The medical records 
      coded for pancreatitis in a further 55 whose enzymes were not elevated. Three 
      hundred and twenty of these had radiological evidence of acute pancreatitis. 
      Receiver operator characteristic analysis of the initial sample from patients 
      received in the Emergency Department showed improved diagnostic accuracy for 
      serum pancreatic lipase (area under the curve (AUC) 0.948) compared with serum 
      amylase (AUC, 0.906, P < 0.05). A clinically useful cut-off point would be at the 
      diagnostic threshold; 208 U/L (normal <190 U/L) for serum pancreatic lipase and 
      114 U/L (normal 27-100 U/L) for serum amylase where the sensitivity was 90.3 cf., 
      76.8% and the specificity was 93 cf., 92.6%. 18.8% of the acute pancreatitis 
      patients did not have elevated serum amylase while only 2.9% did not have 
      elevated serum pancreatic lipase on the first emergency department measurement. 
      CONCLUSION: It is concluded that serum pancreatic lipase is a more accurate 
      biomarker of acute pancreatitis than serum amylase.
FAU - Smith, Ross C
AU  - Smith RC
AD  - Sydney University Department of Surgery, Royal North Shore Hospital, Sydney New 
      South Wales, Australia. rsmith@med.usyd.edu.au
FAU - Southwell-Keely, James
AU  - Southwell-Keely J
FAU - Chesher, Douglas
AU  - Chesher D
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - Australia
TA  - ANZ J Surg
JT  - ANZ journal of surgery
JID - 101086634
RN  - 0 (Biomarkers)
RN  - EC 3.1.1.3 (Lipase)
RN  - EC 3.2.1.- (Amylases)
SB  - IM
MH  - Acute Disease
MH  - Amylases/*blood
MH  - Biomarkers/*blood
MH  - Humans
MH  - Lipase/*blood
MH  - Pancreas/enzymology
MH  - Pancreatitis/*diagnosis/diagnostic imaging
MH  - Radiography
MH  - Sensitivity and Specificity
MH  - Time Factors
EDAT- 2005/06/10 09:00
MHDA- 2005/10/14 09:00
CRDT- 2005/06/10 09:00
PHST- 2005/06/10 09:00 [pubmed]
PHST- 2005/10/14 09:00 [medline]
PHST- 2005/06/10 09:00 [entrez]
AID - ANS3391 [pii]
AID - 10.1111/j.1445-2197.2005.03391.x [doi]
PST - ppublish
SO  - ANZ J Surg. 2005 Jun;75(6):399-404. doi: 10.1111/j.1445-2197.2005.03391.x.

PMID- 27456836
OWN - NLM
STAT- MEDLINE
DCOM- 20171012
LR  - 20221207
IS  - 1935-5548 (Electronic)
IS  - 0149-5992 (Print)
IS  - 0149-5992 (Linking)
VI  - 39
IP  - 10
DP  - 2016 Oct
TI  - Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes 
      in Autoantibody-Positive TrialNet Subjects?
PG  - 1738-44
LID - 10.2337/dc16-0302 [doi]
AB  - OBJECTIVE: To explore whether electrochemiluminescence (ECL) assays can help 
      improve prediction of time to type 1 diabetes in the TrialNet 
      autoantibody-positive population. RESEARCH DESIGN AND METHODS: TrialNet subjects 
      who were positive for one or more autoantibodies (microinsulin autoantibody, 
      GAD65 autoantibody [GADA], IA-2A, and ZnT8A) with available ECL-insulin 
      autoantibody (IAA) and ECL-GADA data at their initial visit were analyzed; after 
      a median follow-up of 24 months, 177 of these 1,287 subjects developed diabetes. 
      RESULTS: Univariate analyses showed that autoantibodies by radioimmunoassays 
      (RIAs), ECL-IAA, ECL-GADA, age, sex, number of positive autoantibodies, presence 
      of HLA DR3/4-DQ8 genotype, HbA1c, and oral glucose tolerance test (OGTT) 
      measurements were all significantly associated with progression to diabetes. 
      Subjects who were ECL positive had a risk of progression to diabetes within 6 
      years of 58% compared with 5% for the ECL-negative subjects (P < 0.0001). 
      Multivariate Cox proportional hazards models were compared, with the base model 
      including age, sex, OGTT measurements, and number of positive autoantibodies by 
      RIAs. The model with positivity for ECL-GADA and/or ECL-IAA was the best, and 
      factors that remained significantly associated with time to diabetes were area 
      under the curve (AUC) C-peptide, fasting C-peptide, AUC glucose, number of 
      positive autoantibodies by RIAs, and ECL positivity. Adding ECL to the Diabetes 
      Prevention Trial risk score (DPTRS) improved the receiver operating 
      characteristic curves with AUC of 0.83 (P < 0.0001). CONCLUSIONS: ECL assays 
      improved the ability to predict time to diabetes in these autoantibody-positive 
      relatives at risk for developing diabetes. These findings might be helpful in the 
      design and eligibility criteria for prevention trials in the future.
CI  - (c) 2016 by the American Diabetes Association.
FAU - Fouts, Alexandra
AU  - Fouts A
AD  - Barbara Davis Center for Childhood Diabetes, University of Colorado School of 
      Medicine, Aurora, CO.
FAU - Pyle, Laura
AU  - Pyle L
AD  - Department of Pediatrics, University of Colorado Denver, Aurora, CO Department of 
      Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO.
FAU - Yu, Liping
AU  - Yu L
AD  - Barbara Davis Center for Childhood Diabetes, University of Colorado School of 
      Medicine, Aurora, CO.
FAU - Miao, Dongmei
AU  - Miao D
AD  - Barbara Davis Center for Childhood Diabetes, University of Colorado School of 
      Medicine, Aurora, CO.
FAU - Michels, Aaron
AU  - Michels A
AD  - Barbara Davis Center for Childhood Diabetes, University of Colorado School of 
      Medicine, Aurora, CO.
FAU - Krischer, Jeffrey
AU  - Krischer J
AD  - Pediatrics Epidemiology Center, University of South Florida, Tampa, FL.
FAU - Sosenko, Jay
AU  - Sosenko J
AD  - University of Miami School of Medicine, Miami, FL.
FAU - Gottlieb, Peter
AU  - Gottlieb P
AD  - Barbara Davis Center for Childhood Diabetes, University of Colorado School of 
      Medicine, Aurora, CO.
FAU - Steck, Andrea K
AU  - Steck AK
AD  - Barbara Davis Center for Childhood Diabetes, University of Colorado School of 
      Medicine, Aurora, CO andrea.steck@ucdenver.edu.
CN  - Type 1 Diabetes TrialNet Study Group
LA  - eng
GR  - U01 DK085476/DK/NIDDK NIH HHS/United States
GR  - U01 DK061010/DK/NIDDK NIH HHS/United States
GR  - R01 DK032083/DK/NIDDK NIH HHS/United States
GR  - U01 DK085466/DK/NIDDK NIH HHS/United States
GR  - U01 DK103153/DK/NIDDK NIH HHS/United States
GR  - U01 DK061058/DK/NIDDK NIH HHS/United States
GR  - U01 DK085505/DK/NIDDK NIH HHS/United States
GR  - U01 DK085453/DK/NIDDK NIH HHS/United States
GR  - U01 DK106984/DK/NIDDK NIH HHS/United States
GR  - U01 DK085499/DK/NIDDK NIH HHS/United States
GR  - U01 DK085463/DK/NIDDK NIH HHS/United States
GR  - U01 DK103266/DK/NIDDK NIH HHS/United States
GR  - U01 DK107014/DK/NIDDK NIH HHS/United States
GR  - U01 DK061042/DK/NIDDK NIH HHS/United States
GR  - U01 DK061034/DK/NIDDK NIH HHS/United States
GR  - U01 DK085461/DK/NIDDK NIH HHS/United States
GR  - U01 DK085509/DK/NIDDK NIH HHS/United States
GR  - R37 DK032083/DK/NIDDK NIH HHS/United States
GR  - U01 DK103180/DK/NIDDK NIH HHS/United States
GR  - U01 DK085465/DK/NIDDK NIH HHS/United States
GR  - U01 DK085504/DK/NIDDK NIH HHS/United States
PT  - Journal Article
DEP - 20160725
PL  - United States
TA  - Diabetes Care
JT  - Diabetes care
JID - 7805975
RN  - 0 (Autoantibodies)
RN  - 0 (Blood Glucose)
RN  - 0 (C-Peptide)
RN  - 0 (Glycated Hemoglobin A)
RN  - 0 (Insulin Antibodies)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Autoantibodies/*blood
MH  - Blood Glucose/metabolism
MH  - C-Peptide/blood
MH  - Child
MH  - Diabetes Mellitus, Type 1/blood/*diagnosis
MH  - *Disease Progression
MH  - Female
MH  - Glycated Hemoglobin/metabolism
MH  - Humans
MH  - Insulin Antibodies/blood
MH  - Longitudinal Studies
MH  - *Luminescence
MH  - Male
MH  - Proportional Hazards Models
MH  - Prospective Studies
MH  - Risk Factors
MH  - Time Factors
MH  - Young Adult
PMC - PMC5033080
EDAT- 2016/07/28 06:00
MHDA- 2017/10/13 06:00
PMCR- 2017/10/01
CRDT- 2016/07/27 06:00
PHST- 2016/02/12 00:00 [received]
PHST- 2016/06/28 00:00 [accepted]
PHST- 2016/07/27 06:00 [entrez]
PHST- 2016/07/28 06:00 [pubmed]
PHST- 2017/10/13 06:00 [medline]
PHST- 2017/10/01 00:00 [pmc-release]
AID - dc16-0302 [pii]
AID - 0302 [pii]
AID - 10.2337/dc16-0302 [doi]
PST - ppublish
SO  - Diabetes Care. 2016 Oct;39(10):1738-44. doi: 10.2337/dc16-0302. Epub 2016 Jul 25.

PMID- 24671913
OWN - NLM
STAT- MEDLINE
DCOM- 20161213
LR  - 20161230
IS  - 1897-4279 (Electronic)
IS  - 0022-9032 (Linking)
VI  - 72
IP  - 9
DP  - 2014
TI  - Does SYNTAX score predict in-hospital outcomes in patients with ST elevation 
      myocardial infarction undergoing primary percutaneous coronary intervention?
PG  - 806-13
LID - 10.5603/KP.a2014.0064 [doi]
AB  - BACKGROUND: SYNTAX score (SxS) has been demonstrated to predict long-term 
      outcomes in stable patients with coronary artery disease. But its prognostic 
      value for patients with acute coronary syndrome remains unknown. AIM: To evaluate 
      whether SxS could predict in-hospital outcomes for patients admitted with ST 
      elevation myocardial infarction (STEMI) who undergo primary percutaneous coronary 
      intervention (pPCI). METHODS: The study included 538 patients with STEMI who 
      underwent pPCI between January 2010 and December 2012. The patients were divided 
      into two groups: low SxS (< 22) and high SxS (> 22). The SxS of all patients was 
      calculated from aninitial angiogram and TIMI flow grade of infarct related artery 
      was calculated after pPCI. Left ventricular systolic functions of the patients 
      were evaluated with an echocardiogram in the following week. The rates of 
      reinfarction and mortality during hospitalisation were obtained from the medical 
      records of our hospital. RESULTS: The high SxS group had more no-reflow (41% and 
      25.1%, p < 0.001, respectively), lower ejection fraction (38.2 +/- 7.5% and 44.6 +/- 
      8.8%, p < 0.001, respectively), and greater rates of re-infarction (9.5% and 
      7.3%, p = 0.037, respectively) and mortality (0.9% and 0.2%, p = 0.021, 
      respectively) during hospitalisation compared to the low SxS group. On 
      multivariate logistic regression analysis including clinical variables, SxS was 
      an independent predictor of no-reflow (OR 1.081, 95% CI 1.032-1.133, p = 0.001). 
      CONCLUSIONS: SxS is a useful tool that can predict in-hospital outcomes of 
      patients with STEMI undergoing pPCI.
FAU - Ayca, Burak
AU  - Ayca B
AD  - Bagcilar Education and Research Hospital, Turkey. drburakayca@yahoo.com.tr.
FAU - Akin, Fatih
AU  - Akin F
FAU - Celik, Omer
AU  - Celik O
FAU - Cetin, Sukru
AU  - Cetin S
FAU - Sahin, Irfan
AU  - Sahin I
FAU - Gulsen, Kamil
AU  - Gulsen K
FAU - Kalyoncuoglu, Muhsin
AU  - Kalyoncuoglu M
FAU - Katkat, Fahrettin
AU  - Katkat F
FAU - Okuyan, Ertugrul
AU  - Okuyan E
FAU - Dinckal, Mustafa Hakan
AU  - Dinckal MH
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20140327
PL  - Poland
TA  - Kardiol Pol
JT  - Kardiologia polska
JID - 0376352
SB  - IM
MH  - Aged
MH  - Female
MH  - Hospital Mortality
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Myocardial Infarction/*mortality/*surgery
MH  - *Percutaneous Coronary Intervention
MH  - Poland
MH  - Prognosis
MH  - Risk Assessment
MH  - Risk Factors
MH  - Severity of Illness Index
MH  - Treatment Outcome
EDAT- 2014/03/29 06:00
MHDA- 2016/12/15 06:00
CRDT- 2014/03/28 06:00
PHST- 2013/08/14 00:00 [received]
PHST- 2014/02/20 00:00 [accepted]
PHST- 2014/01/20 00:00 [revised]
PHST- 2014/03/28 06:00 [entrez]
PHST- 2014/03/29 06:00 [pubmed]
PHST- 2016/12/15 06:00 [medline]
AID - VM/OJS/KP/8148 [pii]
AID - 10.5603/KP.a2014.0064 [doi]
PST - ppublish
SO  - Kardiol Pol. 2014;72(9):806-13. doi: 10.5603/KP.a2014.0064. Epub 2014 Mar 27.

PMID- 22825590
OWN - NLM
STAT- MEDLINE
DCOM- 20130211
LR  - 20221207
IS  - 1464-3685 (Electronic)
IS  - 0300-5771 (Linking)
VI  - 41
IP  - 4
DP  - 2012 Aug
TI  - Are behavioural risk factors to be blamed for the conversion from optimal blood 
      pressure to hypertensive status in Black South Africans? A 5-year prospective 
      study.
PG  - 1114-23
LID - 10.1093/ije/dys106 [doi]
AB  - BACKGROUND: Longitudinal cohort studies in sub-Saharan Africa are urgently needed 
      to understand cardiovascular disease development. We, therefore, explored health 
      behaviours and conventional risk factors of African individuals with optimal 
      blood pressure (BP) (</= 120/80 mm Hg), and their 5-year prediction for the 
      development of hypertension. METHODS: The Prospective Urban Rural Epidemiology 
      study in the North West Province, South Africa, started in 2005 and included 
      African volunteers (n = 1994; aged > 30 years) from a sample of 6000 randomly 
      selected households in rural and urban areas. RESULTS: At baseline, 48% of the 
      participants were hypertensive (>/= 140/90 mmHg). Those with optimal BP (n = 478) 
      were followed at a success rate of 70% for 5 years (213 normotensive, 68 
      hypertensive, 57 deceased). Africans that became hypertensive smoked more than 
      the normotensive individuals (68.2% vs 49.8%), and they also had a greater waist 
      circumference [ratio of geometric means of 0.94 cm (95% CI: 0.86-0.99)] and 
      greater amount of gamma-glutamyltransferase [0.74 U/l (95% CI: 0.62-0.88)] at 
      baseline. The 5-year change in BP was independently explained by baseline 
      gamma-glutamyltransferase [R(2) = 0.23, beta = 0.13 U/l (95% CI: 0.01-0.19)]. Alcohol 
      intake also predicted central systolic BP and carotid cross-sectional wall area 
      (CSWA) at follow-up. Waist circumference was another predictor of BP changes [beta = 
      0.18 cm (95% CI: 0.05-0.24)] and CSWA. HIV infection was inversely associated 
      with increased BP. CONCLUSIONS: During the 5 years, 24% of Africans with optimal 
      BP developed hypertension. The surge in hypertension in Africa is largely 
      explained by modifiable risk factors. Public health strategies should focus 
      aggressively on lifestyle to prevent a catastrophic burden on the national health 
      system.
FAU - Schutte, Aletta E
AU  - Schutte AE
AD  - Hypertension in Africa Research Team, North-West University, Potchefstroom, South 
      Africa. Alta.Schutte@nwu.ac.za
FAU - Schutte, Rudolph
AU  - Schutte R
FAU - Huisman, Hugo W
AU  - Huisman HW
FAU - van Rooyen, Johannes M
AU  - van Rooyen JM
FAU - Fourie, Carla M T
AU  - Fourie CM
FAU - Malan, Nico T
AU  - Malan NT
FAU - Malan, Leone
AU  - Malan L
FAU - Mels, Catharina M C
AU  - Mels CM
FAU - Smith, Wayne
AU  - Smith W
FAU - Moss, Sarah J
AU  - Moss SJ
FAU - Towers, G Wayne
AU  - Towers GW
FAU - Kruger, H Salome
AU  - Kruger HS
FAU - Wentzel-Viljoen, Edelweiss
AU  - Wentzel-Viljoen E
FAU - Vorster, Hester H
AU  - Vorster HH
FAU - Kruger, Annamarie
AU  - Kruger A
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20120723
PL  - England
TA  - Int J Epidemiol
JT  - International journal of epidemiology
JID - 7802871
RN  - 0 (Biomarkers)
RN  - 0 (Lipids)
RN  - 9007-41-4 (C-Reactive Protein)
RN  - AYI8EX34EU (Creatinine)
RN  - EC 2.3.2.2 (gamma-Glutamyltransferase)
SB  - IM
MH  - Anthropometry
MH  - Biomarkers/blood
MH  - *Black People
MH  - Blood Pressure/*physiology
MH  - C-Reactive Protein/metabolism
MH  - Chi-Square Distribution
MH  - Creatinine/blood
MH  - Female
MH  - *Health Behavior
MH  - Humans
MH  - Hypertension/*epidemiology
MH  - Linear Models
MH  - Lipids/blood
MH  - Male
MH  - Middle Aged
MH  - Predictive Value of Tests
MH  - Prospective Studies
MH  - Risk Factors
MH  - South Africa/epidemiology
MH  - gamma-Glutamyltransferase/blood
EDAT- 2012/07/25 06:00
MHDA- 2013/02/12 06:00
CRDT- 2012/07/25 06:00
PHST- 2012/07/25 06:00 [entrez]
PHST- 2012/07/25 06:00 [pubmed]
PHST- 2013/02/12 06:00 [medline]
AID - dys106 [pii]
AID - 10.1093/ije/dys106 [doi]
PST - ppublish
SO  - Int J Epidemiol. 2012 Aug;41(4):1114-23. doi: 10.1093/ije/dys106. Epub 2012 Jul 
      23.

PMID- 23361217
OWN - NLM
STAT- MEDLINE
DCOM- 20130812
LR  - 20131121
IS  - 1878-7401 (Electronic)
IS  - 0928-7329 (Linking)
VI  - 21
IP  - 1
DP  - 2013
TI  - Does the type of tibial component affect mechanical alignment in unicompartmental 
      knee replacement?
PG  - 81-5
LID - 10.3233/THC-2012-00703 [doi]
AB  - PURPOSE: There are a number of factors responsible for the longevity of 
      unicompartmental knee replacements (UKR). These include the magnitude of 
      postoperative alignment and the type of material used. The effect of component 
      design and material on postoperative alignment, however, has not been explored. 
      MATERIALS AND METHODS: We retrospectively reviewed 89 patients who underwent UKR 
      with robotic guidance. Patients were divided into two groups, according to 
      whether they had received an all-polyethylene inlay component (Inlay group) or a 
      metal-backed onlay component (Onlay group). We explored the magnitude of 
      mechanical alignment correction obtained in both groups. RESULTS: Mean 
      postoperative mechanical alignment was significantly closer to neutral in the 
      Onlay group (mean=2.8 degrees ; 95% CI=2.4 degrees , 3.2 degrees ) compared to the Inlay group 
      (mean=3.9 degrees ; 95% CI=3.4 degrees , 4.4 degrees ) (R2=0.65; P=0.003), adjusting for gender, BMI, 
      age, side and preoperative mechanical alignment (Fig. 2). Further exploration 
      revealed that the thickness of the tibial polyethyelene insert had a significant 
      effect on postoperative alignment when added to the model (R2=0.68; P=0.01). 
      CONCLUSION: Patients who received a metal-backed Onlay tibial component obtained 
      better postoperative mechanical alignment compared to those who received 
      all-polyethylene Inlay prostheses. The thicker overall construct of Onlay 
      prostheses appears to be an important determinant of postoperative alignment. 
      Considering their higher survivorship rates and improved postoperative mechanical 
      alignment, Onlay prostheses should be the first option when performing medial 
      UKR.
FAU - Suero, Eduardo M
AU  - Suero EM
AD  - Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY 
      10021, USA. EduardoSueroMD@gmail.com
FAU - Citak, Mustafa
AU  - Citak M
FAU - Njoku, Innocent U
AU  - Njoku IU
FAU - Pearle, Andrew D
AU  - Pearle AD
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Technol Health Care
JT  - Technology and health care : official journal of the European Society for 
      Engineering and Medicine
JID - 9314590
RN  - 0 (Biocompatible Materials)
RN  - 9002-88-4 (Polyethylene)
SB  - IM
MH  - Arthroplasty, Replacement, Knee/*methods
MH  - Biocompatible Materials
MH  - Biomechanical Phenomena/physiology
MH  - Body Mass Index
MH  - Confidence Intervals
MH  - Female
MH  - Humans
MH  - *Knee Prosthesis
MH  - Male
MH  - Medical Audit
MH  - Middle Aged
MH  - Polyethylene
MH  - Prosthesis Failure
MH  - Retrospective Studies
MH  - *Tibia/anatomy & histology
MH  - United States
EDAT- 2013/01/31 06:00
MHDA- 2013/08/13 06:00
CRDT- 2013/01/31 06:00
PHST- 2013/01/31 06:00 [entrez]
PHST- 2013/01/31 06:00 [pubmed]
PHST- 2013/08/13 06:00 [medline]
AID - T5287313182K7K8R [pii]
AID - 10.3233/THC-2012-00703 [doi]
PST - ppublish
SO  - Technol Health Care. 2013;21(1):81-5. doi: 10.3233/THC-2012-00703.

PMID- 18307476
OWN - NLM
STAT- MEDLINE
DCOM- 20080513
LR  - 20250103
IS  - 0887-378X (Print)
IS  - 1468-0009 (Electronic)
IS  - 0887-378X (Linking)
VI  - 86
IP  - 1
DP  - 2008 Mar
TI  - Upstream solutions: does the supplemental security income program reduce 
      disability in the elderly?
PG  - 5-45
LID - 10.1111/j.1468-0009.2007.00512.x [doi]
AB  - CONTEXT: The robust relationship between socioeconomic factors and health 
      suggests that social and economic policies might substantially affect health, 
      while other evidence suggests that medical care, the main focus of current health 
      policy, may not be the primary determinant of population health. Income support 
      policies are one promising avenue to improve population health. This study 
      examines whether the federal cash transfer program to poor elderly, the 
      Supplemental Security Income (SSI) program, affects old-age disability. METHODS: 
      This study uses the 1990 and 2000 censuses, employing state and year fixed-effect 
      models, to test whether within-state changes in maximum SSI benefits over time 
      lead to changes in disability among people aged sixty-five and older. FINDINGS: 
      Higher benefits are linked to lower disability rates. Among all single elderly 
      individuals, 30 percent have mobility limitations, and an increase of $100 per 
      month in the maximum SSI benefit caused the rate of mobility limitations to fall 
      by 0.46 percentage points. The findings were robust to sensitivity analyses. 
      First, analyses limited to those most likely to receive SSI produced larger 
      effects, but analyses limited to those least likely to receive SSI produced no 
      measurable effect. Second, varying the disability measure did not meaningfully 
      alter the findings. Third, excluding the institutionalized, immigrants, 
      individuals living in states with exceptionally large benefit changes, and 
      individuals living in states with no SSI supplements did not change the 
      substantive conclusions. Fourth, Medicaid did not confound the effects. Finally, 
      these results were robust for married individuals. CONCLUSIONS: Income support 
      policy may be a significant new lever for improving population health, especially 
      that of lower-income persons. Even though the findings are robust, further 
      analyses are needed to confirm their reliability. Future research should examine 
      a variety of different income support policies, as well as whether a broader 
      range of social and economic policies affect health.
FAU - Herd, Pamela
AU  - Herd P
AD  - University of Wisconsin, Madison, WI 53706, USA. pherd@lafollette.wisc.edu
FAU - Schoeni, Robert F
AU  - Schoeni RF
FAU - House, James S
AU  - House JS
LA  - eng
GR  - R03 AG0276611/AG/NIA NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - Milbank Q
JT  - The Milbank quarterly
JID - 8607003
SB  - IM
MH  - Activities of Daily Living
MH  - Aged
MH  - Aged, 80 and over
MH  - Censuses
MH  - *Persons with Disabilities
MH  - Female
MH  - Humans
MH  - Income
MH  - Male
MH  - Medicaid
MH  - Models, Econometric
MH  - Policy Making
MH  - Social Security/*economics
MH  - United States
PMC - PMC2690339
EDAT- 2008/03/01 09:00
MHDA- 2008/05/14 09:00
PMCR- 2009/03/01
CRDT- 2008/03/01 09:00
PHST- 2008/03/01 09:00 [pubmed]
PHST- 2008/05/14 09:00 [medline]
PHST- 2008/03/01 09:00 [entrez]
PHST- 2009/03/01 00:00 [pmc-release]
AID - MILQ512 [pii]
AID - 10.1111/j.1468-0009.2007.00512.x [doi]
PST - ppublish
SO  - Milbank Q. 2008 Mar;86(1):5-45. doi: 10.1111/j.1468-0009.2007.00512.x.

PMID- 22237146
OWN - NLM
STAT- MEDLINE
DCOM- 20130329
LR  - 20220321
IS  - 1537-453X (Electronic)
IS  - 0277-3732 (Linking)
VI  - 36
IP  - 1
DP  - 2013 Feb
TI  - Can serum be used for analyzing the EGFR mutation status in patients with 
      advanced non-small cell lung cancer?
PG  - 57-63
LID - 10.1097/COC.0b013e31823a5217 [doi]
AB  - BACKGROUND: Epidermal growth factor receptor (EGFR) mutations as prognostic or 
      predictive marker in patients with non-small cell lung cancer (NSCLC) have been 
      used widely. However, it may be difficult to get tumor tissue for analyzing the 
      status of EGFR mutation status in large proportion of patients with advanced 
      disease. PATIENTS AND METHODS: We obtained pairs of tumor and serum samples from 
      57 patients with advanced NSCLC, between March 2006 and January 2009. EGFR 
      mutation status from tumor samples was analyzed by genomic polymerase chain 
      reaction and direct sequence and EGFR mutation status from serum samples was 
      determined by the peptide nucleic acid locked nucleic acid polymerase chain 
      reaction clamp. RESULTS: EGFR mutations were detected in the serum samples of 11 
      patients and in the tumor samples of 12 patients. EGFR mutation status in the 
      serum and tumor samples was consistent in 50 of the 57 pairs (87.7%). There was a 
      high correlation between the mutations detected in serum sample and the mutations 
      detected in the matched tumor sample (correlation index 0.62; P<0.001). 
      Twenty-two of 57 patients (38.5%) received EGFR-tyrosine kinase inhibitors as any 
      line therapy. The response for EGFR-tyrosine kinase inhibitors was significantly 
      associated with EGFR mutations in both tumor samples and serum samples (P<0.05). 
      There was no significant differences in overall survival according to the status 
      of EGFR mutations in both serum and tumor samples (P>0.05). CONCLUSIONS: Serum 
      sample might be alternatively used in the difficult time of getting tumor tissue 
      for analyzing the status of EGFR mutation status in patients with advanced NSCLC.
FAU - Kim, Seung Tae
AU  - Kim ST
AD  - Division of Hematology-Oncology, Korea University College of Medicine, Seoul, 
      South Korea.
FAU - Jung, Hae-Yun
AU  - Jung HY
FAU - Sung, Jae Sook
AU  - Sung JS
FAU - Jo, Uk Hyun
AU  - Jo UH
FAU - Tanaka, Tomoaki
AU  - Tanaka T
FAU - Hagiwara, Koichi
AU  - Hagiwara K
FAU - Park, Kyong Hwa
AU  - Park KH
FAU - Shin, Sang Won
AU  - Shin SW
FAU - Kim, Jun Suk
AU  - Kim JS
FAU - Kim, Yeul Hong
AU  - Kim YH
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Am J Clin Oncol
JT  - American journal of clinical oncology
JID - 8207754
RN  - 0 (Biomarkers, Tumor)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Biomarkers, Tumor/*blood/genetics
MH  - Carcinoma, Non-Small-Cell Lung/*blood/*genetics/pathology
MH  - DNA Mutational Analysis/*methods
MH  - Female
MH  - Genes, erbB-1/*genetics
MH  - Humans
MH  - Lung Neoplasms/*blood/*genetics/pathology
MH  - Male
MH  - Middle Aged
MH  - Mutation
MH  - Neoplasm Staging
MH  - Polymerase Chain Reaction
MH  - Sensitivity and Specificity
EDAT- 2012/01/13 06:00
MHDA- 2013/03/30 06:00
CRDT- 2012/01/13 06:00
PHST- 2012/01/13 06:00 [entrez]
PHST- 2012/01/13 06:00 [pubmed]
PHST- 2013/03/30 06:00 [medline]
AID - 10.1097/COC.0b013e31823a5217 [doi]
PST - ppublish
SO  - Am J Clin Oncol. 2013 Feb;36(1):57-63. doi: 10.1097/COC.0b013e31823a5217.

PMID- 25043083
OWN - NLM
STAT- MEDLINE
DCOM- 20150409
LR  - 20220310
IS  - 2542-5641 (Electronic)
IS  - 0366-6999 (Linking)
VI  - 127
IP  - 14
DP  - 2014
TI  - Are failures of anterior cruciate ligament reconstruction associated with steep 
      posterior tibial slopes? A case control study.
PG  - 2649-53
AB  - BACKGROUND: Recently, increasing number of literature has identified the 
      posterior tibial slope (PTS) as one of the risk factors of primary anterior 
      cruciate ligament (ACL) injury. However, few studies concerning the association 
      between failure of ACL reconstruction (ACLR) and PTS have been published. The 
      objective of this study was to explore the association between the failure of 
      ACLR and PTS at a minimum of two years follow-up. METHODS: Two hundred and thirty 
      eight eligible patients from June 2009 to October 2010 were identified from our 
      database. A total of 20 failure cases of ACLR and 20 randomly selected controls 
      were included in this retrospective study. The demographic data and the results 
      of manual maximum side-to-side difference with KT-1000 arthrometer at 30 degrees  of knee 
      flexion and pivot-shift test before the ACLR and at the final follow-up were 
      collected. The medial and lateral PTSs were measured using the magnetic resonance 
      imaging (MRI) scan, based on Hudek's measurement. A comparison of PTS between the 
      two groups was performed. RESULTS: The overall failure rate of the present study 
      was 8.4%. Of the 40 participants, the mean medial PTS was 4.1 degrees  +/- 3.2 degrees  and the 
      mean lateral PTS was 4.6 degrees  +/- 2.6 degrees . The medial PTS of the ACLR failure group was 
      significantly steeper than the control group (3.5 degrees  +/- 2.5 degrees  vs. 6.1 degrees  +/- 2.1 degrees , P = 
      0.000). Similarly, the lateral PTS of the ACLR failure group was significantly 
      steeper than the control group (2.9 degrees  +/- 2.1 degrees  vs. 5.5 degrees  +/- 3.0 degrees , P = 0.006). For 
      medial PTS >/= 5 degrees , the odds ratio of ACLR failure was 6.8 (P = 0.007); for lateral 
      PTS >/=5 degrees , the odds ratio of ACLR failure was 10.8 (P = 0.000). CONCLUSION: Both 
      medial and lateral PTS were significantly steeper in failures of ACLR than the 
      control group. Medial or lateral PTS >/=5 degrees  was a new risk factor of ACLR failure.
FAU - Li, Yue
AU  - Li Y
AD  - Sports Medicine Service, Beijing Jishuitan Hospital, Beijing 100035, China.
FAU - Hong, Lei
AU  - Hong L
AD  - Sports Medicine Service, Beijing Jishuitan Hospital, Beijing 100035, China.
FAU - Feng, Hua
AU  - Feng H
AD  - Sports Medicine Service, Beijing Jishuitan Hospital, Beijing 100035, China. 
      Email: fenghua20080617@126.com.
FAU - Wang, Qianqian
AU  - Wang Q
AD  - Sports Medicine Service, Beijing Jishuitan Hospital, Beijing 100035, China.
FAU - Zhang, Hui
AU  - Zhang H
AD  - Sports Medicine Service, Beijing Jishuitan Hospital, Beijing 100035, China.
FAU - Song, Guanyang
AU  - Song G
AD  - Sports Medicine Service, Beijing Jishuitan Hospital, Beijing 100035, China.
LA  - eng
PT  - Journal Article
PL  - China
TA  - Chin Med J (Engl)
JT  - Chinese medical journal
JID - 7513795
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Anterior Cruciate Ligament/*surgery
MH  - Anterior Cruciate Ligament Injuries
MH  - Anterior Cruciate Ligament Reconstruction/*statistics & numerical data
MH  - Case-Control Studies
MH  - Female
MH  - Humans
MH  - Male
MH  - Retrospective Studies
MH  - Tibia/injuries/surgery
MH  - Young Adult
EDAT- 2014/07/22 06:00
MHDA- 2015/04/10 06:00
CRDT- 2014/07/22 06:00
PHST- 2014/07/22 06:00 [entrez]
PHST- 2014/07/22 06:00 [pubmed]
PHST- 2015/04/10 06:00 [medline]
PST - ppublish
SO  - Chin Med J (Engl). 2014;127(14):2649-53.

PMID- 26561905
OWN - NLM
STAT- MEDLINE
DCOM- 20160314
LR  - 20220317
IS  - 1326-5377 (Electronic)
IS  - 0025-729X (Linking)
VI  - 203
IP  - 10
DP  - 2015 Nov 16
TI  - Do teleoncology models of care enable safe delivery of chemotherapy in rural 
      towns?
PG  - 406-6.e6
AB  - OBJECTIVES: To compare the dose intensity and toxicity profiles for patients 
      undergoing chemotherapy at the Townsville Cancer Centre (TCC), a tertiary cancer 
      centre in northern Queensland, with those for patients treated in Mount Isa, 
      supervised by the same medical oncologists via teleoncology. DESIGN: A 
      quasi-experimental design comparing two patient groups. SETTING: TCC and Mount 
      Isa Hospital, which both operate under the auspices of the Townsville 
      Teleoncology Network (TTN). PARTICIPANTS: Eligible patients who received 
      chemotherapy at TCC or Mt Isa Hospital between 1 May 2007 and 30 April 2012. 
      INTERVENTION: Teleoncology model for managing cancer patients in rural towns. 
      MAIN OUTCOME MEASURES: Dose intensity (doses, number of cycles and lines of 
      treatment) and toxicity rates (rate of serious side effects, hospital admissions 
      and mortality). RESULTS: Over 5 years, 89 patients received a total of 626 cycles 
      of various chemotherapy regimens in Mount Isa. During the same period, 117 
      patients who received a total of 799 cycles of chemotherapy at TCC were eligible 
      for inclusion in the comparison group. There were no significant differences 
      between the Mount Isa and TCC patients in most demographic characteristics, mean 
      numbers of treatment cycles, dose intensities, proportions of side effects, and 
      hospital admissions. There were no toxicity-related deaths in either group. 
      CONCLUSION: It appears safe to administer chemotherapy in rural towns under the 
      supervision of medical oncologists from larger centres via teleoncology, provided 
      that rural health care resources and governance arrangements are adequate.
FAU - Chan, Bryan A
AU  - Chan BA
AD  - Townsville Cancer Centre, Townsville, QLD Sabe.sabesan@health.qld.gov.au.
FAU - Larkins, Sarah L
AU  - Larkins SL
AD  - Anton Breinl Research Centre for Health Systems Strengthening, James Cook 
      University, Townsville, QLD.
FAU - Evans, Rebecca
AU  - Evans R
AD  - Anton Breinl Research Centre for Health Systems Strengthening, James Cook 
      University, Townsville, QLD.
FAU - Watt, Kerrianne
AU  - Watt K
AD  - James Cook University, Townsville, QLD.
FAU - Sabesan, Sabe
AU  - Sabesan S
AD  - Townsville Cancer Centre, Townsville, QLD.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - Australia
TA  - Med J Aust
JT  - The Medical journal of Australia
JID - 0400714
RN  - 0 (Antineoplastic Agents)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Antineoplastic Agents/administration & dosage/*adverse effects
MH  - Female
MH  - Humans
MH  - Male
MH  - Medical Oncology/methods
MH  - Middle Aged
MH  - *Models, Organizational
MH  - Neoplasms/epidemiology/*therapy
MH  - Oncology Service, Hospital/*organization & administration
MH  - Queensland
MH  - Retrospective Studies
MH  - Rural Health Services/*organization & administration
MH  - Rural Population/statistics & numerical data
MH  - Telemedicine/*organization & administration
MH  - Young Adult
EDAT- 2015/11/13 06:00
MHDA- 2016/03/15 06:00
CRDT- 2015/11/13 06:00
PHST- 2015/02/15 00:00 [received]
PHST- 2015/09/07 00:00 [accepted]
PHST- 2015/11/13 06:00 [entrez]
PHST- 2015/11/13 06:00 [pubmed]
PHST- 2016/03/15 06:00 [medline]
AID - 10.5694/mja15.00190 [pii]
AID - 10.5694/mja15.00190 [doi]
PST - ppublish
SO  - Med J Aust. 2015 Nov 16;203(10):406-6.e6. doi: 10.5694/mja15.00190.

PMID- 23517744
OWN - NLM
STAT- MEDLINE
DCOM- 20131211
LR  - 20130812
IS  - 1527-3792 (Electronic)
IS  - 0022-5347 (Linking)
VI  - 190
IP  - 3
DP  - 2013 Sep
TI  - Is solitary kidney really more resistant to ischemia? An experimental canine 
      study.
PG  - 1110-5
LID - S0022-5347(13)03689-6 [pii]
LID - 10.1016/j.juro.2013.03.042 [doi]
AB  - PURPOSE: To our knowledge there are no evidence-based medicine data to date to 
      critically judge the vulnerability of a solitary kidney to warm ischemia compared 
      to paired kidneys. MATERIALS AND METHODS: Ten dogs were exposed to open right 
      nephrectomy to create a solitary kidney model (group 1). Ten dogs with both 
      kidneys were considered group 2. All dogs underwent warm ischemia by open 
      occlusion of the left renal artery for 90 minutes. Dogs were sacrificed at 
      different intervals (3 days to 4 weeks). All dogs were reevaluated by renogram 
      before sacrifice and histopathology of the investigated kidney. The 
      proinflammatory markers CD95 and tumor necrosis factor-alpha were assessed using 
      real-time polymerase chain reaction. RESULTS: In group 1 clearance decreased by 
      20% at 1 week but basal function was regained starting at week 2. In group 2 
      clearance decreased more than 90% up to week 2. Recovery started at week 3 and by 
      4 weeks there was a 23% clearance reduction. Histopathological examination in 
      group 1 revealed significant tubular necrosis (60%) at 3 days with regeneration 
      starting at 1 week. In group 2 there was more pronounced tubular necrosis (90%) 
      with regeneration starting at 2 weeks. The expression of proinflammatory markers 
      was up-regulated in each group with higher, more sustained expression in group 2. 
      CONCLUSIONS: Solitary kidney in a canine model is more resistant to ischemia than 
      paired kidneys based on radiological, pathological and genetic evidence.
CI  - Copyright (c) 2013 American Urological Association Education and Research, Inc. 
      Published by Elsevier Inc. All rights reserved.
FAU - Osman, Yasser
AU  - Osman Y
AD  - Urology and Nephrology Center, Mansoura University, Mansoura, Egypt. 
      y_osman99@yahoo.com
FAU - Hamed, Sahar M
AU  - Hamed SM
FAU - Moustafa, Fatma E
AU  - Moustafa FE
FAU - Barakat, Nashwa M
AU  - Barakat NM
FAU - Abd Elhameed, Mohamed
AU  - Abd Elhameed M
FAU - Mosbah, Ahmed
AU  - Mosbah A
FAU - Mansour, Sahar
AU  - Mansour S
FAU - Gaballah, Mohamed A
AU  - Gaballah MA
FAU - Shaaban, Atallah
AU  - Shaaban A
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20130319
PL  - United States
TA  - J Urol
JT  - The Journal of urology
JID - 0376374
SB  - IM
MH  - Animals
MH  - Biopsy, Needle
MH  - Disease Models, Animal
MH  - Dogs
MH  - Glomerular Filtration Rate
MH  - Immunohistochemistry
MH  - Ischemia/pathology/*physiopathology
MH  - Kidney/*abnormalities/*blood supply
MH  - *Nephrectomy
MH  - Random Allocation
MH  - Reference Values
MH  - Warm Ischemia
OTO - NOTNLM
OT  - GFR
OT  - ISOM
OT  - MAG-3
OT  - OSOM
OT  - PCR
OT  - TNF-alpha
OT  - WI
OT  - abnormalities
OT  - dogs
OT  - glomerular filtration rate
OT  - high power fields
OT  - hpf
OT  - kidney
OT  - mercaptoacetyltriglycine
OT  - outer medulla inner strip
OT  - outer medulla outer strip
OT  - polymerase chain reaction
OT  - recovery of function
OT  - tumor necrosis factor-alpha
OT  - warm ischemia
EDAT- 2013/03/23 06:00
MHDA- 2013/12/16 06:00
CRDT- 2013/03/23 06:00
PHST- 2013/03/12 00:00 [accepted]
PHST- 2013/03/23 06:00 [entrez]
PHST- 2013/03/23 06:00 [pubmed]
PHST- 2013/12/16 06:00 [medline]
AID - S0022-5347(13)03689-6 [pii]
AID - 10.1016/j.juro.2013.03.042 [doi]
PST - ppublish
SO  - J Urol. 2013 Sep;190(3):1110-5. doi: 10.1016/j.juro.2013.03.042. Epub 2013 Mar 
      19.

PMID- 27136599
OWN - NLM
STAT- MEDLINE
DCOM- 20170714
LR  - 20191210
IS  - 1463-1318 (Electronic)
IS  - 1462-8910 (Linking)
VI  - 18
IP  - 12
DP  - 2016 Dec
TI  - Is it safe to perform rectal anastomosis in gynaecological debulking surgery 
      without a diverting stoma?
PG  - 1142-1146
LID - 10.1111/codi.13364 [doi]
AB  - AIM: Colorectal resection is frequently performed during cytoreductive surgery 
      for gynaecological malignancy. The aim of this study was to assess the safety of 
      colorectal anastomosis, and especially low rectal anastomosis, in the absence of 
      a protective stoma in patients with gynaecological cancer and peritoneal 
      metastasis. METHOD: Patient data were retrospectively collected from a database 
      for gynaecological cancer procedures carried out between January 2013 and July 
      2015. All patients who underwent a colorectal resection during cytoreduction were 
      included in the study. The primary outcome was anastomotic leakage in the 
      presence or absence of a diverting stoma. Secondary outcome parameters were 
      complications and reoperations. RESULTS: In the period of study, 43 major 
      colorectal procedures were performed on 37 women. The most common colorectal 
      procedure was low rectal resection (n = 22; 59%) followed by anterior rectal 
      resection (n = 7; 19%) and sigmoid resection (n = 4; 11%). Five (14%) patients 
      underwent Hartmann's procedure. In three (8%) patients, a diverting loop 
      ileostomy was created. CONCLUSION: Low rectal resection during debulking 
      procedures for gynaecological cancers with peritoneal carcinomatosis can safely 
      be performed by an experienced surgeon without a diverting stoma.
CI  - Colorectal Disease (c) 2016 The Association of Coloproctology of Great Britain and 
      Ireland.
FAU - Reinisch, A
AU  - Reinisch A
AD  - Department of General and Visceral Surgery, University Hospital Frankfurt, 
      Frankfurt, Germany.
FAU - El-Balat, A
AU  - El-Balat A
AD  - Department of Gynecology and Gynecological Oncology, University Hospital 
      Frankfurt, Frankfurt, Germany.
FAU - Becker, S
AU  - Becker S
AD  - Department of Gynecology and Gynecological Oncology, University Hospital 
      Frankfurt, Frankfurt, Germany.
FAU - Bechstein, W O
AU  - Bechstein WO
AD  - Department of General and Visceral Surgery, University Hospital Frankfurt, 
      Frankfurt, Germany.
FAU - Habbe, N
AU  - Habbe N
AD  - Department of General and Visceral Surgery, University Hospital Frankfurt, 
      Frankfurt, Germany.
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
PL  - England
TA  - Colorectal Dis
JT  - Colorectal disease : the official journal of the Association of Coloproctology of 
      Great Britain and Ireland
JID - 100883611
SB  - IM
MH  - Adult
MH  - Aged
MH  - Anastomosis, Surgical/adverse effects/methods
MH  - Anastomotic Leak/etiology
MH  - Cytoreduction Surgical Procedures/adverse effects/*methods
MH  - Female
MH  - Genital Neoplasms, Female/*surgery
MH  - Gynecologic Surgical Procedures/adverse effects/*methods
MH  - Humans
MH  - Middle Aged
MH  - Rectum/*surgery
MH  - Retrospective Studies
MH  - *Surgical Stomas
OTO - NOTNLM
OT  - Leakage
OT  - anastomosis
OT  - colorectal resection
OT  - gynaecological cancer
EDAT- 2016/05/03 06:00
MHDA- 2017/07/15 06:00
CRDT- 2016/05/03 06:00
PHST- 2015/12/01 00:00 [received]
PHST- 2016/02/18 00:00 [accepted]
PHST- 2016/05/03 06:00 [pubmed]
PHST- 2017/07/15 06:00 [medline]
PHST- 2016/05/03 06:00 [entrez]
AID - 10.1111/codi.13364 [doi]
PST - ppublish
SO  - Colorectal Dis. 2016 Dec;18(12):1142-1146. doi: 10.1111/codi.13364.

PMID- 10749257
OWN - NLM
STAT- MEDLINE
DCOM- 20000428
LR  - 20080215
IS  - 0361-803X (Print)
IS  - 0361-803X (Linking)
VI  - 174
IP  - 4
DP  - 2000 Apr
TI  - Has the mammography quality standards act affected the mammography quality in 
      North Carolina?
PG  - 1089-91
AB  - OBJECTIVE: The United States Food and Drug Administration implemented federal 
      regulations governing mammography under the Mammography Quality Standards Act 
      (MQSA) of 1992. During 1995, its first year in implementation, we examined the 
      impact of the MQSA on the quality of mammography in North Carolina. MATERIALS AND 
      METHODS: All mammography facilities were inspected during 1993-1994, and again in 
      1995. Both inspections evaluated mean glandular radiation dose, phantom image 
      evaluation, darkroom fog, and developer temperature. Two mammography health 
      specialists employed by the North Carolina Division of Radiation Protection 
      performed all inspections and collected and codified data. RESULTS: The 
      percentage of facilities that met quality standards increased from the first 
      inspection to the second inspection. Phantom scores passing rate was 31.6% versus 
      78.2%; darkroom fog passing rate was 74.3% versus 88.5%; and temperature 
      difference passing rate was 62.4% versus 86.9%. CONCLUSION: In 1995, the first 
      year that the MQSA was in effect, there was a significant improvement in the 
      quality of mammography in North Carolina. This improvement probably resulted from 
      facilities' compliance with federal regulations.
FAU - Pisano, E D
AU  - Pisano ED
AD  - Department of Radiology, University of North Carolina, Chapel Hill 27599-7510, 
      USA.
FAU - Schell, M
AU  - Schell M
FAU - Rollins, J
AU  - Rollins J
FAU - Burns, C B
AU  - Burns CB
FAU - Hall, B
AU  - Hall B
FAU - Lin, Y
AU  - Lin Y
FAU - Braeuning, M P
AU  - Braeuning MP
FAU - Burke, E
AU  - Burke E
FAU - Holliday, J
AU  - Holliday J
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - AJR Am J Roentgenol
JT  - AJR. American journal of roentgenology
JID - 7708173
SB  - IM
MH  - Mammography/*standards
MH  - North Carolina
MH  - United States
MH  - United States Food and Drug Administration/standards
EDAT- 2000/04/05 09:00
MHDA- 2000/05/08 09:00
CRDT- 2000/04/05 09:00
PHST- 2000/04/05 09:00 [pubmed]
PHST- 2000/05/08 09:00 [medline]
PHST- 2000/04/05 09:00 [entrez]
AID - 10.2214/ajr.174.4.1741089 [doi]
PST - ppublish
SO  - AJR Am J Roentgenol. 2000 Apr;174(4):1089-91. doi: 10.2214/ajr.174.4.1741089.

PMID- 17598882
OWN - NLM
STAT- MEDLINE
DCOM- 20070914
LR  - 20181113
IS  - 1465-542X (Electronic)
IS  - 1465-5411 (Print)
IS  - 1465-5411 (Linking)
VI  - 9
IP  - 3
DP  - 2007
TI  - Is breast cancer prognosis inherited?
PG  - R39
AB  - INTRODUCTION: A genetic component is well established in the etiology of breast 
      cancer. It is not well known, however, whether genetic traits also influence 
      prognostic features of the malignant phenotype. METHODS: We carried out a 
      population-based cohort study in Sweden based on the nationwide Multi-Generation 
      Register. Among all women with breast cancer diagnosed from 1961 to 2001, 2,787 
      mother-daughter pairs and 831 sister pairs with breast cancer were identified; we 
      achieved complete follow-up and classified 5-year breast cancer-specific 
      prognosis among proband (mother or oldest sister) into tertiles as poor, 
      intermediary, or good. We used Kaplan-Meier estimates of survival proportions and 
      Cox models to calculate relative risks of dying from breast cancer within 5 years 
      depending on the proband's outcome. RESULTS: The 5-year survival proportion among 
      daughters whose mothers died within 5 years was 87% compared to 91% if the mother 
      was alive (p = 0.03). Among sisters, the corresponding proportions were 70% and 
      88%, respectively (p = 0.001). After adjustment for potential confounders, 
      daughters and sisters of a proband with poor prognosis had a 60% higher 5-year 
      breast cancer mortality compared to those of a proband with good prognosis 
      (hazard ratio [HR], 1.6; 95% confidence interval [CI], 1.2 to 2.2; p for trend 
      0.002). This association was slightly stronger among sisters (HR, 1.8; 95% CI, 
      1.0 to 3.4) than among daughters (HR, 1.6; 95% CI, 1.1 to 2.3). CONCLUSION: 
      Breast cancer prognosis of a woman predicts the survival in her first-degree 
      relatives with breast cancer. Our novel findings suggest that breast cancer 
      prognosis might be inherited.
FAU - Hartman, Mikael
AU  - Hartman M
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 
      Stockholm, Sweden. mikael.hartman@ki.se
FAU - Lindstrom, Linda
AU  - Lindstrom L
FAU - Dickman, Paul W
AU  - Dickman PW
FAU - Adami, Hans-Olov
AU  - Adami HO
FAU - Hall, Per
AU  - Hall P
FAU - Czene, Kamila
AU  - Czene K
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - Breast Cancer Res
JT  - Breast cancer research : BCR
JID - 100927353
SB  - IM
MH  - Adult
MH  - Aged
MH  - Breast Neoplasms/*epidemiology/*genetics/mortality/physiopathology
MH  - Cause of Death
MH  - Cohort Studies
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Middle Aged
MH  - Nuclear Family
MH  - Prognosis
MH  - Registries
MH  - Survival Analysis
MH  - Survivors
MH  - Sweden/epidemiology
MH  - Time Factors
PMC - PMC1929105
EDAT- 2007/06/30 09:00
MHDA- 2007/09/15 09:00
PMCR- 2007/06/28
CRDT- 2007/06/30 09:00
PHST- 2007/02/06 00:00 [received]
PHST- 2007/04/25 00:00 [revised]
PHST- 2007/06/28 00:00 [accepted]
PHST- 2007/06/30 09:00 [pubmed]
PHST- 2007/09/15 09:00 [medline]
PHST- 2007/06/30 09:00 [entrez]
PHST- 2007/06/28 00:00 [pmc-release]
AID - bcr1737 [pii]
AID - 10.1186/bcr1737 [doi]
PST - ppublish
SO  - Breast Cancer Res. 2007;9(3):R39. doi: 10.1186/bcr1737.

PMID- 15223779
OWN - NLM
STAT- MEDLINE
DCOM- 20040727
LR  - 20211203
IS  - 0146-0404 (Print)
IS  - 0146-0404 (Linking)
VI  - 45
IP  - 7
DP  - 2004 Jul
TI  - c-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target?
PG  - 2075-82
AB  - PURPOSE: This study was conducted to investigate the expression and functional 
      impact of the proto-oncogene c-kit in uveal melanoma. METHODS: Based on 
      immunohistochemical (IHC) study of paraffin-embedded specimens from 134 uveal 
      melanomas and Western blot analysis on eight fresh-frozen samples the expression 
      of c-kit in uveal melanoma was studied. Furthermore, the phosphorylation of c-kit 
      and the impact of the tyrosine kinase inhibitor STI571 was examined in the three 
      uveal melanoma cell lines OCM-1, OCM-3, and 92-1. RESULTS: Eighty-four of 134 
      paraffin-embedded samples and six of eight fresh-frozen samples expressed c-kit. 
      c-Kit was strongly expressed and tyrosine phosphorylated in cultured uveal 
      melanoma cells compared with cutaneous melanoma cells. Moreover, in contrast to 
      cutaneous melanoma cell lines c-kit maintained a high phosphorylation level in 
      serum-depleted uveal melanoma cells. No activation-related mutations in exon 11 
      of the KIT gene were found. On the contrary, expression of the stem cell growth 
      factor (c-kit ligand) was detected in all three uveal melanoma cell lines, 
      suggesting the presence of autocrine (paracrine) stimulation pathways. Treatment 
      of uveal melanoma cell lines with STI571, which blocks c-kit autophosphorylation, 
      resulted in cell death. The IC(50) of the inhibitory effects on c-kit 
      phosphorylation and cell proliferation was of equal size and less than 2.5 
      microM. CONCLUSIONS: The results confirm that c-kit is vastly expressed in uveal 
      melanoma, suggest that the c-kit molecular pathway may be important in uveal 
      melanoma growth, and point to its use as a target for therapy with STI571.
FAU - All-Ericsson, Charlotta
AU  - All-Ericsson C
AD  - St. Erik's Eye Hospital, Stockholm, Sweden.
FAU - Girnita, Leonard
AU  - Girnita L
FAU - Muller-Brunotte, Anja
AU  - Muller-Brunotte A
FAU - Brodin, Bertha
AU  - Brodin B
FAU - Seregard, Stefan
AU  - Seregard S
FAU - Ostman, Arne
AU  - Ostman A
FAU - Larsson, Olle
AU  - Larsson O
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Invest Ophthalmol Vis Sci
JT  - Investigative ophthalmology & visual science
JID - 7703701
RN  - 0 (Benzamides)
RN  - 0 (MAS1 protein, human)
RN  - 0 (Piperazines)
RN  - 0 (Proto-Oncogene Mas)
RN  - 0 (Pyrimidines)
RN  - 0 (RNA, Messenger)
RN  - 42HK56048U (Tyrosine)
RN  - 8A1O1M485B (Imatinib Mesylate)
RN  - EC 2.7.10.1 (Proto-Oncogene Proteins c-kit)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Benzamides
MH  - Blotting, Western
MH  - Cell Division
MH  - Female
MH  - Humans
MH  - Imatinib Mesylate
MH  - Immunoenzyme Techniques
MH  - Male
MH  - Melanoma/*metabolism/*pathology
MH  - Middle Aged
MH  - Paraffin Embedding
MH  - Phosphorylation/drug effects
MH  - Piperazines
MH  - Polymerase Chain Reaction
MH  - Proto-Oncogene Mas
MH  - Proto-Oncogene Proteins c-kit/genetics/*metabolism
MH  - Pyrimidines/pharmacology
MH  - RNA, Messenger/metabolism
MH  - Skin Neoplasms/metabolism/pathology
MH  - Tumor Cells, Cultured
MH  - Tyrosine/metabolism
MH  - Uveal Neoplasms/*metabolism/*pathology
EDAT- 2004/06/30 05:00
MHDA- 2004/07/28 05:00
CRDT- 2004/06/30 05:00
PHST- 2004/06/30 05:00 [pubmed]
PHST- 2004/07/28 05:00 [medline]
PHST- 2004/06/30 05:00 [entrez]
AID - 10.1167/iovs.03-1196 [doi]
PST - ppublish
SO  - Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2075-82. doi: 10.1167/iovs.03-1196.

PMID- 16776337
OWN - NLM
STAT- MEDLINE
DCOM- 20060718
LR  - 20220317
IS  - 0022-3085 (Print)
IS  - 0022-3085 (Linking)
VI  - 104
IP  - 6
DP  - 2006 Jun
TI  - Pituitary apoplexy: do histological features influence the clinical presentation 
      and outcome?
PG  - 931-7
AB  - OBJECT: A retrospective analysis of a contemporary series of patients with 
      pituitary apoplexy was performed to ascertain whether the histopathological 
      features influence the clinical presentation or the outcome. METHODS: A 
      retrospective analysis was performed in 59 patients treated for pituitary 
      apoplexy at the University of Virginia Health System, Charlottesville, Virginia, 
      or Groote Schuur Hospital, University of Cape Town, South Africa. The patients 
      were divided into two groups according to the histological features of their 
      disease: one group with infarction alone, comprising 22 patients; and the other 
      with hemorrhagic infarction and/or frank hemorrhage, comprising 37 patients. The 
      presenting symptoms, clinical features, endocrinological status, and outcome were 
      compared between the two groups. CONCLUSIONS: The patients who presented with 
      histological features of pituitary tumor infarction alone had less severe 
      clinical features on presentation, a longer course prior to presentation, and a 
      better outcome than those presenting with hemorrhagic infarction or frank 
      hemorrhage. The endocrine replacement requirements were similar in both groups.
FAU - Semple, Patrick L
AU  - Semple PL
AD  - Division of Neurosurgery, Department of Pathology, Groote Schuur Hospital, 
      University of Cape Town, South Africa.
FAU - De Villiers, Jacques C
AU  - De Villiers JC
FAU - Bowen, Robert M
AU  - Bowen RM
FAU - Lopes, M Beatriz S
AU  - Lopes MB
FAU - Laws, Edward R Jr
AU  - Laws ER Jr
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Neurosurg
JT  - Journal of neurosurgery
JID - 0253357
SB  - IM
MH  - Adenoma/blood supply/pathology/surgery
MH  - Female
MH  - Follow-Up Studies
MH  - Hemorrhage/*complications
MH  - Humans
MH  - Infarction/*complications
MH  - Male
MH  - Middle Aged
MH  - Pituitary Apoplexy/*etiology/*pathology/surgery
MH  - Pituitary Gland/*blood supply/*pathology
MH  - Pituitary Neoplasms/blood supply/pathology/surgery
MH  - Retrospective Studies
MH  - Treatment Outcome
EDAT- 2006/06/17 09:00
MHDA- 2006/07/19 09:00
CRDT- 2006/06/17 09:00
PHST- 2006/06/17 09:00 [pubmed]
PHST- 2006/07/19 09:00 [medline]
PHST- 2006/06/17 09:00 [entrez]
AID - 10.3171/jns.2006.104.6.931 [doi]
PST - ppublish
SO  - J Neurosurg. 2006 Jun;104(6):931-7. doi: 10.3171/jns.2006.104.6.931.

PMID- 23916653
OWN - NLM
STAT- MEDLINE
DCOM- 20140627
LR  - 20131111
IS  - 1873-5126 (Electronic)
IS  - 1353-8020 (Linking)
VI  - 19
IP  - 11
DP  - 2013 Nov
TI  - Orthostatic myoclonus: an underrecognized cause of unsteadiness?
PG  - 1013-7
LID - S1353-8020(13)00256-3 [pii]
LID - 10.1016/j.parkreldis.2013.07.004 [doi]
AB  - BACKGROUND AND PURPOSE: Recently, orthostatic myoclonus (OM) has been suggested 
      as a cause of gait impairment and unsteadiness in neurodegenerative diseases. The 
      aim of this study was to investigate the frequency of orthostatic myoclonus, its 
      clinical characteristics and the underlying associated neurological disorders. 
      METHODS: A retrospective analysis of clinical data and electromyogram surface 
      recordings from subjects with unexplained unsteadiness/gait impairment was 
      performed. Diagnosis of OM was made when a pattern of non-rhythmic bursts was 
      observed (duration range 20-100 ms; bursts per second </=16). RESULTS: Among 93 
      subjects studied, OM was the most frequent disorder (n = 16; 17.2%), followed by 
      orthostatic tremor (13.9%) and low frequency tremors during orthostatism (12.9%). 
      All patients with OM complained about unsteadiness during orthostatism and/or 
      during gait. Leg jerking was only observed by visual inspection during 
      orthostatism in four subjects and two also presented falls. Eleven out of 16 
      patients (68.7%) with OM had an associated neurodegenerative disease, such as 
      multiple system atrophy (n = 3) Parkinson's disease (n = 2), Alzheimer's disease 
      (n = 2), mild cognitive impairment (n = 2) and normal pressure hydrocephalus (n = 
      2). Although four subjects showed improvement of orthostatic myoclonus with 
      antimyoclonic treatment, the follow-up was not systematic enough to evaluate 
      their therapeutic effect on OM. CONCLUSIONS: Orthostatic myoclonus is often 
      underdiagnosed and can be considered a possible cause of unsteadiness in subjects 
      with neurodegenerative diseases. Electromyography surface recording is thereby an 
      aid for investigating unsteadiness of unknown origin.
CI  - Copyright (c) 2013 Elsevier Ltd. All rights reserved.
FAU - Gasca-Salas, Carmen
AU  - Gasca-Salas C
AD  - Department of Neurology, Clinica Universidad de Navarra, University of Navarra 
      School of Medicine, Pamplona, Spain; CIBERNED, Centro de Investigacion Biomedica 
      en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Spain.
FAU - Arcocha, Juan
AU  - Arcocha J
FAU - Artieda, Julio
AU  - Artieda J
FAU - Pastor, Pau
AU  - Pastor P
LA  - eng
PT  - Journal Article
PT  - Observational Study
DEP - 20130802
PL  - England
TA  - Parkinsonism Relat Disord
JT  - Parkinsonism & related disorders
JID - 9513583
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Dizziness/*diagnosis/epidemiology/physiopathology
MH  - Electromyography/methods
MH  - Female
MH  - Follow-Up Studies
MH  - Gait Disorders, Neurologic/*diagnosis/epidemiology/physiopathology
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Myoclonus/*diagnosis/epidemiology/physiopathology
MH  - Neurodegenerative Diseases/*diagnosis/epidemiology/physiopathology
MH  - Retrospective Studies
OTO - NOTNLM
OT  - Myoclonus
OT  - Orthostatism
OT  - Surface EMG
OT  - Unsteadiness
EDAT- 2013/08/07 06:00
MHDA- 2014/06/28 06:00
CRDT- 2013/08/07 06:00
PHST- 2013/01/10 00:00 [received]
PHST- 2013/04/25 00:00 [revised]
PHST- 2013/07/04 00:00 [accepted]
PHST- 2013/08/07 06:00 [entrez]
PHST- 2013/08/07 06:00 [pubmed]
PHST- 2014/06/28 06:00 [medline]
AID - S1353-8020(13)00256-3 [pii]
AID - 10.1016/j.parkreldis.2013.07.004 [doi]
PST - ppublish
SO  - Parkinsonism Relat Disord. 2013 Nov;19(11):1013-7. doi: 
      10.1016/j.parkreldis.2013.07.004. Epub 2013 Aug 2.

PMID- 10201555
OWN - NLM
STAT- MEDLINE
DCOM- 19990607
LR  - 20061115
IS  - 1350-6277 (Print)
IS  - 1350-6277 (Linking)
VI  - 5
IP  - 3
DP  - 1998 Jun
TI  - Is low serum chloride level a risk factor for cardiovascular mortality?
PG  - 177-84
AB  - BACKGROUND: Serum chloride level is routinely assayed in clinical laboratories in 
      the management of patients with kidney disorders and with metabolic diseases. It 
      is a biological parameter that is easily, precisely and relatively cheaply 
      measured. The epidemiological features of serum chloride levels have not been 
      studied before. METHODS: For the random sample of men and women from the Belgian 
      Interuniversity Research on Nutrition and Health aged 25-74 years, free of 
      symptomatic coronary heart disease at baseline, serum chloride concentrations 
      were measured, among those of other electrolytes. The cohort was followed up for 
      10 years with respect to subsequent cause-specific mortality. RESULTS: The 
      results are based on observations of 4793 men and 4313 women. According to Cox 
      regression analysis serum chloride level was one of the strongest predictors of 
      total, cardiovascular disease (CVD) and non-CVD mortalities independently of age, 
      body mass index, sex, smoking, systolic blood pressure, levels of total and 
      high-density lipoprotein cholesterol, uric acid, serum creatinine and serum total 
      proteins and intake of diuretics. This relation was proved to be independent of 
      levels of other serum electrolytes and similar for men and women. The estimated 
      adjusted risk ratio for CVD death for subjects with a serum chloride level < or 
      =100 mmol/l compared with those with levels above that limit was 1.65 (95% 
      confidence interval 1.06-2.57) for men and 2.16 (95% confidence interval 
      1.11-4.22) for women. The study of adjusted risk ratios for four groups of 
      subjects defined on the basis of their baseline serum chloride levels revealed a 
      decreasing log-linear 'dose-response' relation to total and cardiovascular 
      mortalities. CONCLUSION: This s the first report from a population-based study to 
      indicate that there is an association between serum chloride level and the 
      incidence of total, CVD and non-CVD mortalities. The risk ratio for CVD mortality 
      associated with a low serum chloride level was comparable to or higher than those 
      observed for well-established CVD risk factors.
FAU - De Bacquer, D
AU  - De Bacquer D
AD  - Department of Public Health, University of Gent, Belgium. 
      dirk.debacquer@rug.ac.be
FAU - De Backer, G
AU  - De Backer G
FAU - De Buyzere, M
AU  - De Buyzere M
FAU - Kornitzer, M
AU  - Kornitzer M
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - J Cardiovasc Risk
JT  - Journal of cardiovascular risk
JID - 9436980
RN  - 0 (Chlorides)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Cardiovascular Diseases/*mortality/physiopathology
MH  - Chlorides/*blood
MH  - Cohort Studies
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Regression Analysis
MH  - Risk Factors
EDAT- 1999/04/14 00:00
MHDA- 1999/04/14 00:01
CRDT- 1999/04/14 00:00
PHST- 1999/04/14 00:00 [pubmed]
PHST- 1999/04/14 00:01 [medline]
PHST- 1999/04/14 00:00 [entrez]
PST - ppublish
SO  - J Cardiovasc Risk. 1998 Jun;5(3):177-84.

PMID- 24751724
OWN - NLM
STAT- MEDLINE
DCOM- 20150120
LR  - 20220129
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 9
IP  - 4
DP  - 2014
TI  - Does ethnicity affect where people with cancer die? A population-based 10 year 
      study.
PG  - e95052
LID - 10.1371/journal.pone.0095052 [doi]
LID - e95052
AB  - BACKGROUND: Ageing is a growing issue for people from UK black, Asian and 
      minority ethnic (BAME) groups. The health experiences of these groups are 
      recognised as a 'tracer' to measure success in end of life patient-preferred 
      outcomes that includes place of death (PoD). AIM: To examine patterns in PoD 
      among BAME groups who died of cancer. MATERIAL AND METHODS: Mortality data for 
      93,375 cancer deaths of those aged >/=65 years in London from 2001-2010 were 
      obtained from the UK Office for National Statistics (ONS). Decedent's country of 
      birth was used as a proxy for ethnicity. Linear regression examined trends in 
      place of death across the eight ethnic groups and Poisson regression examined the 
      association between country of birth and place of death. RESULTS: 76% decedents 
      were born in the UK, followed by Ireland (5.9%), Europe(5.4%) and 
      Caribbean(4.3%). Most deaths(52.5%) occurred in hospital, followed by 
      home(18.7%). During the study period, deaths in hospital declined with an 
      increase in home deaths; trend for time analysis for those born in 
      UK(0.50%/yr[0.36-0.64%]p<0.001), Europe (1.00%/yr[0.64-1.30%]p<0.001), 
      Asia(1.09%/yr[0.94-1.20%]p<0.001) and Caribbean(1.03%/yr[0.72-1.30%]p<0.001). 
      However, time consistent gaps across the geographical groups remained. Following 
      adjustment hospital deaths were more likely for those born in Asia(Proportion 
      ratio(PR)1.12[95%CI1.08-1.15]p<0.001) and Africa(PR 1.11[95%CI1.07-1.16]p<0.001). 
      Hospice deaths were less likely for those born in Asia(PR 0.73 [0.68-0.80] 
      p<0.001), Africa (PR 0.83[95%CI0.74-0.93]p<0.001), and 'other' geographical 
      regions (PR0.90[95% 0.82-0.98]p<0.001). Home deaths were less likely for those 
      born in the Caribbean(PR0.91[95%CI 0.85-0.98]p<0.001). CONCLUSIONS: Location of 
      death varies by country of birth. BAME groups are more likely to die in a 
      hospital and less likely to die at home or in a hospice. Further investigation is 
      needed to determine whether these differences result from patient-centred 
      preferences, or other environment or service-related factors. This knowledge will 
      enable strategies to be developed to improve access to relevant palliative care 
      and related services, where necessary.
FAU - Koffman, Jonathan
AU  - Koffman J
AD  - King's College London, Cicely Saunders Institute, Department of Palliative Care, 
      Policy and Rehabilitation, London, United Kingdom.
FAU - Ho, Yuen King
AU  - Ho YK
AD  - King's College London, Cicely Saunders Institute, Department of Palliative Care, 
      Policy and Rehabilitation, London, United Kingdom.
FAU - Davies, Joanna
AU  - Davies J
AD  - King's College London, Cicely Saunders Institute, Department of Palliative Care, 
      Policy and Rehabilitation, London, United Kingdom.
FAU - Gao, Wei
AU  - Gao W
AD  - King's College London, Cicely Saunders Institute, Department of Palliative Care, 
      Policy and Rehabilitation, London, United Kingdom.
FAU - Higginson, Irene J
AU  - Higginson IJ
AD  - King's College London, Cicely Saunders Institute, Department of Palliative Care, 
      Policy and Rehabilitation, London, United Kingdom.
LA  - eng
GR  - 09/2000/58/DH_/Department of Health/United Kingdom
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20140421
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - Demography
MH  - Ethnicity/*statistics & numerical data
MH  - Female
MH  - Hospice Care/statistics & numerical data
MH  - Humans
MH  - London
MH  - Male
MH  - Neoplasms/*ethnology/*mortality
MH  - Parturition
MH  - Regression Analysis
MH  - Terminal Care/*statistics & numerical data
PMC - PMC3994011
COIS- Competing Interests: The authors have declared that no competing interests exist.
EDAT- 2014/04/23 06:00
MHDA- 2015/01/21 06:00
PMCR- 2014/04/21
CRDT- 2014/04/23 06:00
PHST- 2013/08/21 00:00 [received]
PHST- 2014/03/22 00:00 [accepted]
PHST- 2014/04/23 06:00 [entrez]
PHST- 2014/04/23 06:00 [pubmed]
PHST- 2015/01/21 06:00 [medline]
PHST- 2014/04/21 00:00 [pmc-release]
AID - PONE-D-13-36782 [pii]
AID - 10.1371/journal.pone.0095052 [doi]
PST - epublish
SO  - PLoS One. 2014 Apr 21;9(4):e95052. doi: 10.1371/journal.pone.0095052. eCollection 
      2014.

PMID- 8910148
OWN - NLM
STAT- MEDLINE
DCOM- 19970213
LR  - 20041117
IS  - 1053-0770 (Print)
IS  - 1053-0770 (Linking)
VI  - 10
IP  - 6
DP  - 1996 Oct
TI  - Transesophageal echocardiographic assessment of left ventricular function in 
      brain-dead patients: are marginally acceptable hearts suitable for 
      transplantation?
PG  - 708-12
AB  - BACKGROUND: The brain-dead donor supply has become one of the criteria limiting 
      the performance of heart transplantation. Conventional screening criteria are too 
      limiting and exclude suitable heart donors. Echocardiography is now widely 
      available and is a reliable tool to assess left ventricular dysfunction in 
      brain-dead donors. Yet few data are available on the degree of left ventricular 
      dysfunction where a transplantation is possible. METHODS: Fifty-five potential 
      brain-dead heart donors (age 38 +/- 11 years) were prospectively evaluated by 
      transesophageal echocardiography (TEE) before harvesting. Fractional area change 
      (FAC) was used to assess left ventricular function in potential brain-dead 
      donors. Transplanted hearts were evaluated on the fifth postoperative day. The 
      transplantation was considered a success if the recipient was alive, not 
      retransplanted, without an assistance device or an epinephrine infusion of more 
      than 1 mg/h and showed an ejection fraction above 40%. RESULTS: Of the 55 
      potential heart donors, 20 exhibited an FAC of less than 50%. Forty hearts were 
      harvested, 36 of which were successfully transplanted. Nine patients had an FAC 
      below 50% (group H2) and 27 had an FAC over 50% (group H1). Four patients died: 2 
      from hemorrhage (FAC > 50% in donors); 1 from right and one from left ventricular 
      dysfunction (FAC < 50% in donors). The FAC increased significantly from 51 +/- 
      15% to 57 +/- 11% in 18 hearts that underwent TEE in donors and afterwards in 
      recipients. Overall actuarial survival was 86.2% versus 64.6% at 1 and 2 years in 
      group H1 and group H2, respectively (p = NS). CONCLUSIONS: TEE is useful to 
      assess left ventricular function in potential brain-dead donors. An FAC less than 
      50% is present in 36% of potential heart donors. Because left ventricular 
      dysfunction is often reversible shortly after transplantation, an FAC below 50% 
      may not necessarily preclude the use of hearts for transplantation.
FAU - Vedrinne, J M
AU  - Vedrinne JM
AD  - Intensive Care Unit, Edouard Herriot Hospital, Lyon, France.
FAU - Vedrinne, C
AU  - Vedrinne C
FAU - Coronel, B
AU  - Coronel B
FAU - Mercatello, A
AU  - Mercatello A
FAU - Estanove, S
AU  - Estanove S
FAU - Moskovtchenko, J F
AU  - Moskovtchenko JF
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Cardiothorac Vasc Anesth
JT  - Journal of cardiothoracic and vascular anesthesia
JID - 9110208
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Brain Death/*physiopathology
MH  - *Echocardiography, Transesophageal
MH  - Female
MH  - *Heart Transplantation
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Prospective Studies
MH  - Tissue Donors
MH  - *Ventricular Function, Left
EDAT- 1996/10/01 00:00
MHDA- 1996/10/01 00:01
CRDT- 1996/10/01 00:00
PHST- 1996/10/01 00:00 [pubmed]
PHST- 1996/10/01 00:01 [medline]
PHST- 1996/10/01 00:00 [entrez]
AID - S1053-0770(96)80194-7 [pii]
AID - 10.1016/S1053-0770(96)80194-7 [doi]
PST - ppublish
SO  - J Cardiothorac Vasc Anesth. 1996 Oct;10(6):708-12. doi: 
      10.1016/S1053-0770(96)80194-7.

PMID- 18065862
OWN - NLM
STAT- MEDLINE
DCOM- 20080124
LR  - 20191110
IS  - 0035-1040 (Print)
IS  - 0035-1040 (Linking)
VI  - 93
IP  - 6
DP  - 2007 Oct
TI  - [Can the postoperative pain level be predicted preoperatively?].
PG  - 541-5
AB  - PURPOSE OF THE STUDY: We searched for factors present preoperatively which could 
      be used to predict the intensity of postoperative pain. MATERIAL AND METHODS: We 
      undertook a prospective study among all patients aged over 18 years who underwent 
      shoulder surgery from January to September 2004 in our unit. The study included 
      86 patients for which the following data were noted preoperatively: past history 
      of pain, intensity and duration of prior pain, triggering factors, localization, 
      psychological context. The intensity of the postoperative pain was measured on a 
      visual analog scale (VAS); measurements were noted up to 24 hours postop then at 
      one month. Data processing was performed with Statview5.5. RESULTS: Significant 
      postoperative pain was correlated with a prior history of surgical pain, with 
      duration of prior pain, with intensity of preoperative pain, and with depression. 
      DISCUSSION: Significant sustained preoperative pain can favor memory of pain 
      leading to postoperative sensitivization of nociception neurons. Intense 
      postoperative pain can favor the development of refractory chronic pain. 
      CONCLUSION: Significant postoperative pain can be expected in the following 
      situations: pain after prior surgery, presence of chronic pain sustained for more 
      than six months, intense preoperative pain, state of depression.
FAU - Dambreville, A
AU  - Dambreville A
AD  - Service de chirurgie orthopedique et chirurgie du sport, Hopital de l'Archet 2, 
      CHU de Nice, 151, route de Saint-Antoine-de-Ginestiere, 06202 Nice. 
      alain.dambreville@wanadoo.fr
FAU - Blay, M
AU  - Blay M
FAU - Carles, M
AU  - Carles M
FAU - Hovorka, I
AU  - Hovorka I
FAU - Boileau, P
AU  - Boileau P
LA  - fre
PT  - English Abstract
PT  - Journal Article
TT  - Peut-on prevoir, avant l'intervention, l'intensite de la douleur postoperatoire?
PL  - France
TA  - Rev Chir Orthop Reparatrice Appar Mot
JT  - Revue de chirurgie orthopedique et reparatrice de l'appareil moteur
JID - 1272427
RN  - 0 (Analgesics, Non-Narcotic)
RN  - 0 (Narcotics)
RN  - 362O9ITL9D (Acetaminophen)
RN  - 76I7G6D29C (Morphine)
SB  - IM
MH  - Acetaminophen/therapeutic use
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Analgesia, Patient-Controlled
MH  - Analgesics, Non-Narcotic/therapeutic use
MH  - Anxiety/psychology
MH  - Depression/psychology
MH  - Female
MH  - Follow-Up Studies
MH  - Forecasting
MH  - Humans
MH  - Life Change Events
MH  - Male
MH  - Medical History Taking
MH  - Middle Aged
MH  - Morphine/therapeutic use
MH  - Narcotics/therapeutic use
MH  - Pain Measurement/methods
MH  - Pain, Postoperative/classification/*etiology/psychology
MH  - Prospective Studies
MH  - Shoulder Joint/surgery
EDAT- 2007/12/11 09:00
MHDA- 2008/01/25 09:00
CRDT- 2007/12/11 09:00
PHST- 2007/12/11 09:00 [pubmed]
PHST- 2008/01/25 09:00 [medline]
PHST- 2007/12/11 09:00 [entrez]
AID - MDOI-RCO-10-2007-93-6-0035-1040-101019-200520002 [pii]
AID - 10.1016/s0035-1040(07)92675-6 [doi]
PST - ppublish
SO  - Rev Chir Orthop Reparatrice Appar Mot. 2007 Oct;93(6):541-5. doi: 
      10.1016/s0035-1040(07)92675-6.

PMID- 22617083
OWN - NLM
STAT- MEDLINE
DCOM- 20121003
LR  - 20120523
IS  - 1538-1145 (Electronic)
IS  - 1527-4160 (Linking)
VI  - 18
IP  - 3
DP  - 2012 May
TI  - Does age moderate the effect of personality disorder on coping style in 
      psychiatric inpatients?
PG  - 187-98
LID - 10.1097/01.pra.0000415075.20873.0d [doi]
AB  - OBJECTIVE: To examine age-related differences in the relationship between 
      personality and coping strategies in an Australian population of psychiatric 
      inpatients. METHOD: Consenting eligible adults (N=238) from 18-100 years of age 
      consecutively admitted to inpatient psychiatry units were assessed using the SCID 
      I and II, the Coping Orientations to Problems Experienced Scale (COPE), the Brief 
      Psychiatric Rating Scale (BPRS), the Global Assessment of Functioning Scale 
      (GAF), the Social and Occupational Functioning Assessment Scale (SOFAS), the 12 
      Item Short-Form Heath Survey (SF12), the Sarason Social Support Questionnaire, 
      and the NEO Five Factor Inventory (NEO-FFI) (cognitively impaired, and 
      non-English speaking patients were excluded). RESULTS: Older adults reported less 
      symptomatology than younger patients and younger patients described more 
      personality dysfunction than older patients. As assessed by the COPE, older 
      adults reported lower levels of dysfunctional coping strategies than younger 
      adults. Personality traits, social supports, gender, and age predicted coping 
      strategies, while Axis I diagnosis, education, personality disorder, and symptom 
      severity were not significant predictors of coping strategies. CONCLUSION: This 
      study found that influences on coping were multifactorial and moderated by age. 
      These factors have implications for interventions designed to enhance coping 
      strategies.
FAU - Stevenson, Janine
AU  - Stevenson J
AD  - Sydney Medical School-Western and Westmead Hospital, Wentworthville, NSW 2145, 
      Australia. janine.stevenson@sydney.edu.au
FAU - Brodaty, Henry
AU  - Brodaty H
FAU - Boyce, Philip
AU  - Boyce P
FAU - Byth, Karen
AU  - Byth K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Psychiatr Pract
JT  - Journal of psychiatric practice
JID - 100901141
SB  - IM
MH  - *Adaptation, Psychological
MH  - Adolescent
MH  - Adult
MH  - Age Factors
MH  - Aged
MH  - Aged, 80 and over
MH  - Aging/*psychology
MH  - Australia
MH  - Female
MH  - Hospitals, Psychiatric
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Multivariate Analysis
MH  - Personality Disorders/*psychology
MH  - Prospective Studies
MH  - Regression Analysis
MH  - Sex Factors
MH  - Social Support
EDAT- 2012/05/24 06:00
MHDA- 2012/10/04 06:00
CRDT- 2012/05/24 06:00
PHST- 2012/05/24 06:00 [entrez]
PHST- 2012/05/24 06:00 [pubmed]
PHST- 2012/10/04 06:00 [medline]
AID - 00131746-201205000-00005 [pii]
AID - 10.1097/01.pra.0000415075.20873.0d [doi]
PST - ppublish
SO  - J Psychiatr Pract. 2012 May;18(3):187-98. doi: 
      10.1097/01.pra.0000415075.20873.0d.

PMID- 25499207
OWN - NLM
STAT- MEDLINE
DCOM- 20151009
LR  - 20220317
IS  - 1878-1632 (Electronic)
IS  - 1529-9430 (Linking)
VI  - 15
IP  - 4
DP  - 2015 Apr 1
TI  - Is neck pain associated with worse health-related quality of life 6 months later? 
      A population-based cohort study.
PG  - 675-84
LID - S1529-9430(14)01779-3 [pii]
LID - 10.1016/j.spinee.2014.12.009 [doi]
AB  - BACKGROUND CONTEXT: Current evidence suggests that neck pain is negatively 
      associated with health-related quality of life (HRQoL). However, these studies 
      are cross-sectional and do not inform the association between neck pain and 
      future HRQoL. PURPOSE: The purpose of this study was to investigate the 
      association between increasing grades of neck pain severity and HRQoL 6 months 
      later. In addition, this longitudinal study examines the crude association 
      between the course of neck pain and HRQoL. STUDY DESIGN: This is a 
      population-based cohort study. PATIENT SAMPLE: Eleven hundred randomly sampled 
      Saskatchewan adults were included. OUTCOME MEASURES: Outcome measures were the 
      mental component summary (MCS) and physical component summary (PCS) of the 
      Short-Form-36 (SF-36) questionnaire. METHODS: We formed a cohort of 1,100 
      randomly sampled Saskatchewan adults in September 1995. We used the Chronic Pain 
      Questionnaire to measure neck pain and its related disability. The SF-36 
      questionnaire was used to measure physical and mental HRQoL 6 months later. 
      Multivariable linear regression was used to measure the association between 
      graded neck pain and HRQoL while controlling for confounding. Analysis of 
      variance and t tests were used to measure the crude association among four 
      possible courses of neck pain and HRQoL at 6 months. The neck pain trajectories 
      over 6 months were no or mild neck pain, improving neck pain, worsening neck 
      pain, and persistent neck pain. Finally, analysis of variance was used to examine 
      changes in baseline to 6-month PCS and MCS scores among the four neck pain 
      trajectory groups. RESULTS: The 6-month follow-up rate was 74.9%. We found an 
      exposure-response relationship between neck pain and physical HRQoL after 
      adjusting for age, education, arthritis, low back pain, and depressive 
      symptomatology. Compared with participants without neck pain at baseline, those 
      with mild (beta=-1.53, 95% confidence interval [CI]=-2.83, -0.24), intense (beta=-3.60, 
      95% CI=-5.76, -1.44), or disabling (beta=-8.55, 95% CI=-11.68, -5.42) neck pain had 
      worse physical HRQoL 6 months later. We did not find an association between neck 
      pain and mental HRQoL. A worsening course of neck pain and persistent neck pain 
      were associated with worse physical HRQoL. CONCLUSIONS: We found that neck pain 
      was negatively associated with physical but not mental HRQoL. Our analysis 
      suggests that neck pain may be a contributor of future poor physical HRQoL in the 
      population. Raising awareness of the possible future impact of neck pain on 
      physical HRQoL is important for health-care providers and policy makers with 
      respect to the management of neck pain in populations.
CI  - Copyright (c) 2015 Elsevier Inc. All rights reserved.
FAU - Nolet, Paul S
AU  - Nolet PS
AD  - Department of Graduate Education and Research, Canadian Memorial Chiropractic 
      College, 6100 Leslie Street, North York, Ontario, Canada. M2H 3J1. Electronic 
      address: pnolet@rogers.com.
FAU - Cote, Pierre
AU  - Cote P
AD  - Department of Graduate Education and Research, Canadian Memorial Chiropractic 
      College, 6100 Leslie Street, North York, Ontario, Canada. M2H 3J1; Division of 
      Epidemiology, Dalla Lana School of Public Health, University of Toronto, 6th 
      floor, 155 College Street, Toronto, Ontario, Canada. M5T 3M7; Toronto Western 
      Research Institute, University Health Network, Toronto Western Hospital, 399 
      Bathurst Street, Toronto, Ontario, Canada. M5T 2S8.
FAU - Kristman, Vicki L
AU  - Kristman VL
AD  - Division of Epidemiology, Dalla Lana School of Public Health, University of 
      Toronto, 6th floor, 155 College Street, Toronto, Ontario, Canada. M5T 3M7; 
      Department of Health Sciences, Lakehead University, 955 Oliver Road, Thunder Bay, 
      Ontario, Canada. P7B 5E1; Institute for Work & Health, 481 University Avenue, 
      Toronto, Ontario, Canada. M5G 2E9.
FAU - Rezai, Mana
AU  - Rezai M
AD  - Division of Epidemiology, Dalla Lana School of Public Health, University of 
      Toronto, 6th floor, 155 College Street, Toronto, Ontario, Canada. M5T 3M7; 
      Toronto Western Research Institute, University Health Network, Toronto Western 
      Hospital, 399 Bathurst Street, Toronto, Ontario, Canada. M5T 2S8.
FAU - Carroll, Linda J
AU  - Carroll LJ
AD  - Department of Public Health Sciences, The Alberta Centre for Injury Control and 
      Research, School of Public Health, University of Alberta, 8308 114 Street 
      Northwest, Edmonton, AB T6G 2E1.
FAU - Cassidy, J David
AU  - Cassidy JD
AD  - Division of Epidemiology, Dalla Lana School of Public Health, University of 
      Toronto, 6th floor, 155 College Street, Toronto, Ontario, Canada. M5T 3M7; 
      Toronto Western Research Institute, University Health Network, Toronto Western 
      Hospital, 399 Bathurst Street, Toronto, Ontario, Canada. M5T 2S8; Institute for 
      Sport Science and Clinical Biomechanics, Faculty of Health, University of 
      Southern Denmark, Campusvej 55 5230, Odense M, Denmark.
LA  - eng
GR  - Canadian Institutes of Health Research/Canada
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20141211
PL  - United States
TA  - Spine J
JT  - The spine journal : official journal of the North American Spine Society
JID - 101130732
SB  - IM
MH  - Adult
MH  - Aged
MH  - Canada
MH  - Cohort Studies
MH  - Cross-Sectional Studies
MH  - Female
MH  - Humans
MH  - Longitudinal Studies
MH  - Male
MH  - Middle Aged
MH  - Neck Pain/*epidemiology/psychology
MH  - *Quality of Life
MH  - Surveys and Questionnaires
OTO - NOTNLM
OT  - Cohort study
OT  - Disability
OT  - Epidemiology
OT  - Health-related quality of life
OT  - Neck pain
OT  - Risk
EDAT- 2014/12/17 06:00
MHDA- 2015/10/10 06:00
CRDT- 2014/12/16 06:00
PHST- 2012/05/29 00:00 [received]
PHST- 2014/09/18 00:00 [revised]
PHST- 2014/12/03 00:00 [accepted]
PHST- 2014/12/16 06:00 [entrez]
PHST- 2014/12/17 06:00 [pubmed]
PHST- 2015/10/10 06:00 [medline]
AID - S1529-9430(14)01779-3 [pii]
AID - 10.1016/j.spinee.2014.12.009 [doi]
PST - ppublish
SO  - Spine J. 2015 Apr 1;15(4):675-84. doi: 10.1016/j.spinee.2014.12.009. Epub 2014 
      Dec 11.

PMID- 16465002
OWN - NLM
STAT- MEDLINE
DCOM- 20060307
LR  - 20220409
IS  - 0019-6061 (Print)
IS  - 0019-6061 (Linking)
VI  - 43
IP  - 1
DP  - 2006 Jan
TI  - Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide 
      in extremely low birth weight infants in the first week of life?
PG  - 20-5
AB  - OBJECTIVE: To study the correlation and agreement between end-tidal carbon 
      dioxide (EtCO2) and arterial carbon dioxide (PaCO(2)) in ventilated extremely low 
      birth weight (ELBW) infants in the first week of life. METHODS: Retrospective 
      chart review of all ELBW (<1,000 g) infants admitted to a level III NICU from 
      January 2003 to December 2003. Data collected included demographic details and 
      simultaneous EtCO(2) (mainstream capnography) and arterial blood gas values (pH, 
      PaCO(2), PaO(2)). OUTCOME: The correlation coefficient, degree of bias with 95% 
      confidence interval between the EtCO(2) and PaCO(2). RESULTS: There were 754 
      end-tidal and arterial CO(2) pairs from 31 ELBW infants (21 male and 10 female). 
      The overall EtCO(2) values were significantly lower than PaCO(2) value. In only 
      89/754(11.8%) pairs, the EtCO(2) was higher than the PaCO(2). The overall bias 
      was 5.6 +/- 6.9 mmHg (95% C.I. 5.11-6.09). The intraclass correlation coefficient 
      was 0.81. Using EtCO2 ranges of 30 to 50 mmHg, the capnographic method was able 
      to identify 84% of instances where PaCO(2) was between 35 (<35 = hypocarbia) and 
      55 mmHg (>55= hypercapnia). CONCLUSIONS: There is good correlation and agreement 
      between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 
      30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for 
      screening abnormal PaCO(2) values in ELBW infants in first week of life.
FAU - Amuchou Singh, Soraisham
AU  - Amuchou Singh S
AD  - Department of Pediatrics, University of Calgary, Alberta, Canada. 
      amuchou@yahoo.com
FAU - Singhal, Nalini
AU  - Singhal N
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - India
TA  - Indian Pediatr
JT  - Indian pediatrics
JID - 2985062R
RN  - 142M471B3J (Carbon Dioxide)
SB  - IM
MH  - Blood Gas Analysis
MH  - Capnography/*methods
MH  - Carbon Dioxide/blood/*metabolism
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Infant, Newborn
MH  - Infant, Very Low Birth Weight/*blood
MH  - Male
MH  - Respiration, Artificial
MH  - Respiratory Distress Syndrome, Newborn/blood/*diagnosis
MH  - Retrospective Studies
MH  - Risk Assessment
MH  - Sensitivity and Specificity
MH  - Tidal Volume
EDAT- 2006/02/09 09:00
MHDA- 2006/03/08 09:00
CRDT- 2006/02/09 09:00
PHST- 2006/02/09 09:00 [pubmed]
PHST- 2006/03/08 09:00 [medline]
PHST- 2006/02/09 09:00 [entrez]
PST - ppublish
SO  - Indian Pediatr. 2006 Jan;43(1):20-5.

PMID- 25940336
OWN - NLM
STAT- MEDLINE
DCOM- 20160711
LR  - 20220409
IS  - 1528-1132 (Electronic)
IS  - 0009-921X (Print)
IS  - 0009-921X (Linking)
VI  - 474
IP  - 4
DP  - 2016 Apr
TI  - Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery 
      Residency?
PG  - 908-14
LID - 10.1007/s11999-015-4317-7 [doi]
AB  - BACKGROUND: More than 1000 candidates applied for orthopaedic residency positions 
      in 2014, and the competition is intense; approximately one-third of the 
      candidates failed to secure a position in the match. However, the criteria used 
      in the selection process often are subjective and studies have differed in terms 
      of which criteria predict either objective measures or subjective ratings of 
      resident performance by faculty. QUESTIONS/PURPOSES: Do preresidency selection 
      factors serve as predictors of success in residency? Specifically, we asked which 
      preresidency selection factors are associated or correlated with (1) objective 
      measures of resident knowledge and performance; and (2) subjective ratings by 
      faculty. METHODS: Charts of 60 orthopaedic residents from our institution were 
      reviewed. Preresidency selection criteria examined included United States Medical 
      Licensing Examination (USMLE) Step 1 and Step 2 scores, Medical College Admission 
      Test (MCAT) scores, number of clinical clerkship honors, number of letters of 
      recommendation, number of away rotations, Alpha Omega Alpha (AOA) honor medical 
      society membership, fourth-year subinternship at our institution, and number of 
      publications. Resident performance was assessed using objective measures 
      including American Board of Orthopaedic Surgery (ABOS) Part I scores and 
      Orthopaedics In-Training Exam (OITE) scores and subjective ratings by faculty 
      including global evaluation scores and faculty rankings of residents. We tested 
      associations between preresidency criteria and the subsequent objective and 
      subjective metrics using linear correlation analysis and Mann-Whitney tests when 
      appropriate. RESULTS: Objective measures of resident performance namely, ABOS 
      Part I scores, had a moderate linear correlation with the USMLE Step 2 scores (r 
      = 0.55, p < 0.001) and number of clinical honors received in medical school (r = 
      0.45, p < 0.001). OITE scores had a weak linear correlation with the number of 
      clinical honors (r = 0.35, p = 0.009) and USMLE Step 2 scores (r = 0.29, p = 
      0.02). With regards to subjective outcomes, AOA membership was associated with 
      higher scores on the global evaluation (p = 0.005). AOA membership also 
      correlated with higher global evaluation scores (r = 0.60, p = 0.005) with the 
      strongest correlation existing between AOA membership and the "interpersonal and 
      communication skills" subsection of the global evaluations. CONCLUSIONS: We found 
      that USMLE Step 2, number of honors in medical school clerkships, and AOA 
      membership demonstrated the strongest correlations with resident performance. Our 
      goal in analyzing these data was to provide residency programs at large a sense 
      of which criteria may be "high yield" in ranking applicants by analyzing data 
      from within our own pool of residents. Similar studies across a broader scope of 
      programs are warranted to confirm applicability of our findings. The continually 
      emerging complexities of the field of orthopaedic surgery lend increasing 
      importance to future work on the appropriate selection and training of 
      orthopaedic residents.
FAU - Raman, Tina
AU  - Raman T
AD  - Rutgers-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, 
      USA.
FAU - Alrabaa, Rami George
AU  - Alrabaa RG
AD  - Rutgers-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, 
      USA.
FAU - Sood, Amit
AU  - Sood A
AD  - Rutgers-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, 
      USA.
FAU - Maloof, Paul
AU  - Maloof P
AD  - Rutgers-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, 
      USA.
FAU - Benevenia, Joseph
AU  - Benevenia J
AD  - Rutgers-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, 
      USA.
FAU - Berberian, Wayne
AU  - Berberian W
AD  - Rutgers-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, 
      USA. berberws@rutgers.edu.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - United States
TA  - Clin Orthop Relat Res
JT  - Clinical orthopaedics and related research
JID - 0075674
SB  - IM
MH  - Clinical Clerkship
MH  - Clinical Competence
MH  - *College Admission Test
MH  - Committee Membership
MH  - Curriculum
MH  - Education, Medical, Graduate/*methods
MH  - Educational Status
MH  - Female
MH  - Humans
MH  - *Internship and Residency
MH  - Linear Models
MH  - Male
MH  - New Jersey
MH  - Orthopedic Procedures/*education
MH  - *Personnel Selection
MH  - Retrospective Studies
MH  - Societies, Medical
MH  - Teaching/methods
PMC - PMC4773357
EDAT- 2015/05/06 06:00
MHDA- 2016/07/12 06:00
PMCR- 2017/04/01
CRDT- 2015/05/06 06:00
PHST- 2015/05/06 06:00 [entrez]
PHST- 2015/05/06 06:00 [pubmed]
PHST- 2016/07/12 06:00 [medline]
PHST- 2017/04/01 00:00 [pmc-release]
AID - 10.1007/s11999-015-4317-7 [pii]
AID - 4317 [pii]
AID - 10.1007/s11999-015-4317-7 [doi]
PST - ppublish
SO  - Clin Orthop Relat Res. 2016 Apr;474(4):908-14. doi: 10.1007/s11999-015-4317-7.

PMID- 24191126
OWN - NLM
STAT- MEDLINE
DCOM- 20140620
LR  - 20220331
IS  - 1875-8630 (Electronic)
IS  - 0278-0240 (Print)
IS  - 0278-0240 (Linking)
VI  - 35
IP  - 5
DP  - 2013
TI  - Is CA72-4 a useful biomarker in differential diagnosis between ovarian 
      endometrioma and epithelial ovarian cancer?
PG  - 331-5
LID - 10.1155/2013/984641 [doi]
AB  - BACKGROUND: Surgical excision of ovarian endometriomas in patients desiring 
      pregnancy has recently been criticized because of the risk of damage to healthy 
      ovarian tissue and consequent reduction of ovarian reserve. A correct diagnosis 
      in cases not scheduled for surgery is therefore mandatory in order to avoid 
      unexpected ovarian cancer misdiagnosis. Endometriosis is often associated with 
      high levels of CA125. This marker is therefore not useful for discriminating 
      ovarian endometrioma from ovarian malignancy. The aim of this study was to 
      establish if the serum marker CA72-4 could be helpful in the differential 
      diagnosis between ovarian endometriosis and epithelial ovarian cancer. METHODS: 
      Serums CA125 and CA72-4 were measured in 72 patients with ovarian endometriomas 
      and 55 patients with ovarian cancer. RESULTS: High CA125 concentrations were 
      observed in patients with ovarian endometriosis and in those with ovarian cancer. 
      A marked difference in CA72-4 values was observed between women with ovarian 
      cancer (71.0%) and patients with endometriosis (13.8%) (P < 0.0001). CONCLUSIONS: 
      This study suggests that CA72-4 determination can be useful to confirm the benign 
      nature of ovarian endometriomas in women with high CA125 levels.
FAU - Anastasi, Emanuela
AU  - Anastasi E
AD  - Department of Molecular Medicine, "Sapienza" University of Rome, Policlinico 
      Umberto I, Viale Regina Elena 324, 00161 Rome, Italy.
FAU - Manganaro, Lucia
AU  - Manganaro L
FAU - Granato, Teresa
AU  - Granato T
FAU - Benedetti Panici, Pierluigi
AU  - Benedetti Panici P
FAU - Frati, Luigi
AU  - Frati L
FAU - Porpora, Maria Grazia
AU  - Porpora MG
LA  - eng
PT  - Journal Article
DEP - 20130922
PL  - United States
TA  - Dis Markers
JT  - Disease markers
JID - 8604127
RN  - 0 (Antigens, Tumor-Associated, Carbohydrate)
RN  - 0 (CA-125 Antigen)
RN  - 0 (CA-72-4 antigen)
RN  - 0 (MUC16 protein, human)
RN  - 0 (Membrane Proteins)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Antigens, Tumor-Associated, Carbohydrate/*blood
MH  - CA-125 Antigen/blood
MH  - Carcinoma/blood/*diagnosis
MH  - Diagnosis, Differential
MH  - Endometriosis/blood/*diagnosis
MH  - Female
MH  - Humans
MH  - Membrane Proteins/blood
MH  - Middle Aged
MH  - Ovarian Neoplasms/blood/*diagnosis
PMC - PMC3793285
EDAT- 2013/11/06 06:00
MHDA- 2014/06/21 06:00
PMCR- 2013/09/22
CRDT- 2013/11/06 06:00
PHST- 2013/06/26 00:00 [received]
PHST- 2013/09/08 00:00 [accepted]
PHST- 2013/11/06 06:00 [entrez]
PHST- 2013/11/06 06:00 [pubmed]
PHST- 2014/06/21 06:00 [medline]
PHST- 2013/09/22 00:00 [pmc-release]
AID - 10.1155/2013/984641 [doi]
PST - ppublish
SO  - Dis Markers. 2013;35(5):331-5. doi: 10.1155/2013/984641. Epub 2013 Sep 22.

PMID- 8375607
OWN - NLM
STAT- MEDLINE
DCOM- 19931015
LR  - 20061115
IS  - 0742-3225 (Print)
IS  - 0742-3225 (Linking)
VI  - 25
IP  - 7
DP  - 1993 Jul-Aug
TI  - Is the breast best for children with a family history of atopy? The relation 
      between way of feeding and early childhood morbidity.
PG  - 471-5
AB  - BACKGROUND: Previous studies reported that breast-feeding protects children 
      against a variety of diseases, but these studies were generally conducted on 
      "high-risk" or hospitalized children. This paper describes the results of our 
      study on the effects of breast-feeding on rate of illness in normal children with 
      a family history of atopy. METHODS: A historic cohort approach of 794 children 
      with a family history of atopy was used to assess the effects of breast-feeding 
      on illness rates. Family history of atopy was based on allergic diseases in 
      family members as registered by the family physician. Illness data from birth 
      onwards were available from the Continuous Morbidity Registration of the 
      Department of Family Medicine. Information on breast-feeding was collected by 
      postal questionnaire. We then compared rates of illness between children with a 
      family history of atopy who were and who were not breast-fed. RESULTS: 
      Breast-feeding was related to lower levels of childhood illness both in the first 
      and the first three years of life. In the first year of life they had fewer 
      episodes of gastroenteritis, lower respiratory tract infections, and digestive 
      tract disorders. Over the next three years of life they had fewer respiratory 
      tract infections and skin infections. CONCLUSIONS: Our results suggest a 
      protective effect of breast-feeding among children with a family history of atopy 
      that is not confined to the period of breast-feeding but continues during the 
      first three years of life. Breast-feeding should be promoted in children with a 
      family history of atopy.
FAU - van den Bogaard, C
AU  - van den Bogaard C
AD  - Department of Family Medicine, University of Nijmegen, The Netherlands.
FAU - van den Hoogen, H J
AU  - van den Hoogen HJ
FAU - Huygen, F J
AU  - Huygen FJ
FAU - van Weel, C
AU  - van Weel C
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - United States
TA  - Fam Med
JT  - Family medicine
JID - 8306464
SB  - IM
MH  - *Breast Feeding
MH  - Cohort Studies
MH  - Humans
MH  - Hypersensitivity, Immediate/genetics/*prevention & control
MH  - Infant, Newborn
MH  - Morbidity
MH  - Risk Factors
EDAT- 1993/07/01 00:00
MHDA- 1993/07/01 00:01
CRDT- 1993/07/01 00:00
PHST- 1993/07/01 00:00 [pubmed]
PHST- 1993/07/01 00:01 [medline]
PHST- 1993/07/01 00:00 [entrez]
PST - ppublish
SO  - Fam Med. 1993 Jul-Aug;25(7):471-5.

PMID- 26965932
OWN - NLM
STAT- MEDLINE
DCOM- 20161213
LR  - 20161230
IS  - 1876-7605 (Electronic)
IS  - 1936-8798 (Linking)
VI  - 9
IP  - 5
DP  - 2016 Mar 14
TI  - Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients 
      Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the 
      ZEUS Trial.
PG  - 426-36
LID - S1936-8798(15)01751-3 [pii]
LID - 10.1016/j.jcin.2015.11.015 [doi]
AB  - OBJECTIVES: This study sought to investigate the ischemic and bleeding outcomes 
      of patients fulfilling high bleeding risk (HBR) criteria who were randomized to 
      zotarolimus-eluting Endeavor Sprint stent (E-ZES) or bare-metal stent (BMS) 
      implantation followed by an abbreviated dual antiplatelet therapy (DAPT) duration 
      for stable or unstable coronary artery disease. BACKGROUND: DES instead of BMS 
      use remains controversial in HBR patients, in whom long-term DAPT poses safety 
      concerns. METHODS: The ZEUS (Zotarolimus-Eluting Endeavor Sprint Stent in 
      Uncertain DES Candidates) is a multinational, randomized single-blinded trial 
      that randomized among others, in a stratified manner, 828 patients fulfilling 
      pre-defined clinical or biochemical HBR criteria-including advanced age, 
      indication to oral anticoagulants or other pro-hemorrhagic medications, history 
      of bleeding and known anemia-to receive E-ZES or BMS followed by a 
      protocol-mandated 30-day DAPT regimen. The primary endpoint of the study was the 
      12-month major adverse cardiovascular event rate, consisting of death, myocardial 
      infarction, or target vessel revascularization. RESULTS: Compared with patients 
      without, those with 1 or more HBR criteria had worse outcomes, owing to higher 
      ischemic and bleeding risks. Among HBR patients, major adverse cardiovascular 
      events occurred in 22.6% of the E-ZES and 29% of the BMS patients (hazard ratio: 
      0.75; 95% confidence interval: 0.57 to 0.98; p = 0.033), driven by lower 
      myocardial infarction (3.5% vs. 10.4%; p < 0.001) and target vessel 
      revascularization (5.9% vs. 11.4%; p = 0.005) rates in the E-ZES arm. The 
      composite of definite or probable stent thrombosis was significantly reduced in 
      E-ZES recipients, whereas bleeding events did not differ between stent groups. 
      CONCLUSIONS: Among HBR patients with stable or unstable coronary artery disease, 
      E-ZES implantation provides superior efficacy and safety as compared with 
      conventional BMS. (Zotarolimus-Eluting Endeavor Sprint Stent in Uncertain DES 
      Candidates [ZEUS]; NCT01385319).
CI  - Copyright (c) 2016 American College of Cardiology Foundation. Published by Elsevier 
      Inc. All rights reserved.
FAU - Ariotti, Sara
AU  - Ariotti S
AD  - Swiss Cardiovascular Center Bern, Inselspital, Bern University Hospital, 
      Switzerland; Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.
FAU - Adamo, Marianna
AU  - Adamo M
AD  - Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.
FAU - Costa, Francesco
AU  - Costa F
AD  - Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.
FAU - Patialiakas, Athanasios
AU  - Patialiakas A
AD  - Cardiology Department, Crete Naval Hospital, Crete, Greece.
FAU - Briguori, Carlo
AU  - Briguori C
AD  - Clinica Mediterranea, Napoli, Italy.
FAU - Thury, Attila
AU  - Thury A
AD  - Cardiology Center, Szeged, Hungary.
FAU - Colangelo, Salvatore
AU  - Colangelo S
AD  - Interventional Cardiology, San Giovanni Bosco Hospital, Torino, Italy.
FAU - Campo, Gianluca
AU  - Campo G
AD  - Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, 
      Ferrara, Italy.
FAU - Tebaldi, Matteo
AU  - Tebaldi M
AD  - Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, 
      Ferrara, Italy.
FAU - Ungi, Imre
AU  - Ungi I
AD  - Cardiology Center, Szeged, Hungary.
FAU - Tondi, Stefano
AU  - Tondi S
AD  - Azienda Unita Sanitaria Locale di Modena-Ospedale Baggiovara, Italy.
FAU - Roffi, Marco
AU  - Roffi M
AD  - Division of Cardiology, University Hospital, Geneva, Switzerland.
FAU - Menozzi, Alberto
AU  - Menozzi A
AD  - Interventional Cardiology Unit, Azienda Ospedaliero-Universitaria di Parma, 
      Italy.
FAU - de Cesare, Nicoletta
AU  - de Cesare N
AD  - Policlinico S. Marco, Zingonia (Bergamo), Italy.
FAU - Garbo, Roberto
AU  - Garbo R
AD  - Interventional Cardiology, San Giovanni Bosco Hospital, Torino, Italy.
FAU - Meliga, Emanuele
AU  - Meliga E
AD  - Azienda Ospedaliera Ordine Mauriziano, Torino, Italy.
FAU - Testa, Luca
AU  - Testa L
AD  - Interventional Cardiology, Ist. Clinico S. Ambrogio, IRCCS San Donato, Milan, 
      Italy.
FAU - Gabriel, Henrique Mesquita
AU  - Gabriel HM
AD  - Hospital de Santa Cruz, Carnaxide, Lisbon, Portugal.
FAU - Ferlini, Marco
AU  - Ferlini M
AD  - Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
FAU - Vranckx, Pascal
AU  - Vranckx P
AD  - Virga Jesse Ziekenhuis, Hasselt, Belgium.
FAU - Valgimigli, Marco
AU  - Valgimigli M
AD  - Swiss Cardiovascular Center Bern, Inselspital, Bern University Hospital, 
      Switzerland; Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands. Electronic 
      address: marco.valgimigli@insel.ch.
CN  - ZEUS Investigators
LA  - eng
SI  - ClinicalTrials.gov/NCT01385319
PT  - Comparative Study
PT  - Journal Article
PT  - Multicenter Study
PT  - Randomized Controlled Trial
PL  - United States
TA  - JACC Cardiovasc Interv
JT  - JACC. Cardiovascular interventions
JID - 101467004
RN  - 0 (Cardiovascular Agents)
RN  - 0 (Metals)
RN  - 0 (Platelet Aggregation Inhibitors)
RN  - H4GXR80IZE (zotarolimus)
RN  - W36ZG6FT64 (Sirolimus)
SB  - IM
CIN - JACC Cardiovasc Interv. 2016 Mar 14;9(5):437-9. doi: 10.1016/j.jcin.2015.12.277. 
      PMID: 26965933
MH  - Aged
MH  - Aged, 80 and over
MH  - Cardiovascular Agents/administration & dosage
MH  - Coronary Artery Disease/diagnostic imaging/mortality/*therapy
MH  - Drug Therapy, Combination
MH  - Drug-Eluting Stents
MH  - Female
MH  - Hemorrhage/*chemically induced/mortality
MH  - Humans
MH  - Male
MH  - *Metals
MH  - Myocardial Infarction/etiology
MH  - Patient Selection
MH  - Percutaneous Coronary Intervention/adverse effects/*instrumentation/mortality
MH  - Platelet Aggregation Inhibitors/*adverse effects
MH  - Prosthesis Design
MH  - Risk Assessment
MH  - Risk Factors
MH  - Single-Blind Method
MH  - Sirolimus/administration & dosage/analogs & derivatives
MH  - *Stents
MH  - Time Factors
MH  - Treatment Outcome
OTO - NOTNLM
OT  - dual antiplatelet therapy
OT  - high bleeding risk
OT  - zotarolimus-eluting stent(s)
EDAT- 2016/03/12 06:00
MHDA- 2016/12/15 06:00
CRDT- 2016/03/12 06:00
PHST- 2015/05/18 00:00 [received]
PHST- 2015/10/19 00:00 [revised]
PHST- 2015/11/05 00:00 [accepted]
PHST- 2016/03/12 06:00 [entrez]
PHST- 2016/03/12 06:00 [pubmed]
PHST- 2016/12/15 06:00 [medline]
AID - S1936-8798(15)01751-3 [pii]
AID - 10.1016/j.jcin.2015.11.015 [doi]
PST - ppublish
SO  - JACC Cardiovasc Interv. 2016 Mar 14;9(5):426-36. doi: 10.1016/j.jcin.2015.11.015.

PMID- 22012962
OWN - NLM
STAT- MEDLINE
DCOM- 20121023
LR  - 20120606
IS  - 1470-2738 (Electronic)
IS  - 0143-005X (Linking)
VI  - 66
IP  - 7
DP  - 2012 Jul
TI  - Marital status, living arrangement and mortality: does the association vary by 
      gender?
PG  - e22
LID - 10.1136/jech.2010.128397 [doi]
AB  - BACKGROUND: Men appear to benefit more from being married than women with respect 
      to mortality in middle age. However, there is some uncertainty about gender 
      differences in mortality risks in older individuals, widowed, divorced and single 
      individuals and about the impact of living arrangements. METHODS: Longitudinal 
      data with 1990 census records being linked to mortality data up to 2005 were used 
      (Swiss National Cohort). The sample comprised all residents over age 44 years in 
      Switzerland (n=2,440,242). All-cause mortality HRs for marital status and living 
      arrangements were estimated by Cox regression for men and women and different age 
      groups with adjustment for education and socio-professional category. RESULTS: 
      The benefit of being married was stronger for men than for women; however, 
      mortality patterns were similar, with higher mortality in divorced and single 
      individuals compared with widowed individuals (<80 years). After adjustment for 
      living arrangements, the gender difference by marital status disappeared. 
      Stratification by living arrangement revealed that mortality risks were highest 
      for 45-64-year-old divorced (HR 1.72 (95% CI 1.67 to 1.76)) and single men (HR 
      1.67 (95% CI 1.63 to 1.71)) who lived alone. In women of the same age, the 
      highest mortality risk was observed for those who were single and living with a 
      partner (HR 1.70 (95% CI 1.58 to 1.82)). In older age groups, the impact of 
      marital status decreased. CONCLUSIONS: Evaluation of living arrangements is 
      crucial for identifying and explaining gender differences in mortality risks by 
      marital status. The impact of living alone and living with a partner seems to be 
      different in men and women.
FAU - Staehelin, Katharina
AU  - Staehelin K
AD  - Department of Epidemiology and Public Health, Swiss Tropical and Public Health 
      Institute, associated Institute of University of Basel, Switzerland, Socinstrasse 
      57, 4051 Basel, Switzerland. katharina.staehelin@unibas.ch
FAU - Schindler, Christian
AU  - Schindler C
FAU - Spoerri, Adrian
AU  - Spoerri A
FAU - Zemp Stutz, Elisabeth
AU  - Zemp Stutz E
CN  - Swiss National Cohort Study Group
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20111019
PL  - England
TA  - J Epidemiol Community Health
JT  - Journal of epidemiology and community health
JID - 7909766
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Female
MH  - Humans
MH  - Male
MH  - *Marital Status
MH  - Middle Aged
MH  - Mortality/*trends
MH  - Proportional Hazards Models
MH  - *Residence Characteristics
MH  - Switzerland/epidemiology
EDAT- 2011/10/21 06:00
MHDA- 2012/10/24 06:00
CRDT- 2011/10/21 06:00
PHST- 2011/10/21 06:00 [entrez]
PHST- 2011/10/21 06:00 [pubmed]
PHST- 2012/10/24 06:00 [medline]
AID - jech.2010.128397 [pii]
AID - 10.1136/jech.2010.128397 [doi]
PST - ppublish
SO  - J Epidemiol Community Health. 2012 Jul;66(7):e22. doi: 10.1136/jech.2010.128397. 
      Epub 2011 Oct 19.

PMID- 12442934
OWN - NLM
STAT- MEDLINE
DCOM- 20030221
LR  - 20190916
IS  - 0265-0215 (Print)
IS  - 0265-0215 (Linking)
VI  - 19
IP  - 11
DP  - 2002 Nov
TI  - Does ibuprofen increase perioperative blood loss during hip arthroplasty?
PG  - 829-31
AB  - BACKGROUND AND OBJECTIVE: To determine whether prior exposure of non-steroidal 
      anti-inflammatory drugs increases perioperative blood loss associated with major 
      orthopaedic surgery. METHODS: Fifty patients scheduled for total hip replacement 
      were allocated to two groups (double blind, randomized manner). All patients were 
      pretreated for 2 weeks before surgery: Group 1 with placebo drug, Group 2 with 
      ibuprofen. All patients were injected intrathecally with bupivacaine 20mg plus 
      morphine 0.1 mg, in a total volume of 4 mL, to provide surgical anaesthesia. 
      RESULTS: The presence of severe adverse effects caused eight patients in the 
      ibuprofen group and six in the placebo group to terminate their participation in 
      the trial. The perioperative blood loss increased by 45% in the ibuprofen group 
      compared with placebo. The total (+/-SD) blood loss in the ibuprofen group was 
      1161 (+/-472) mL versus 796 (+/-337) mL in the placebo group. CONCLUSIONS: 
      Pretreatment with ibuprofen before elective total hip surgery increases the 
      perioperative blood loss significantly. Early discontinuation of non-selective 
      non-steroidal anti-inflammatory drugs is advised.
FAU - Slappendel, R
AU  - Slappendel R
AD  - St Maartenskliniek, Department of Anaesthesiology, Nijmegen, The Netherlands. 
      r.slappendel@maartenskliniek.nl
FAU - Weber, E W G
AU  - Weber EW
FAU - Benraad, B
AU  - Benraad B
FAU - Dirksen, R
AU  - Dirksen R
FAU - Bugter, M L T
AU  - Bugter ML
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
PT  - Randomized Controlled Trial
PL  - England
TA  - Eur J Anaesthesiol
JT  - European journal of anaesthesiology
JID - 8411711
RN  - 0 (Analgesics, Non-Narcotic)
RN  - 0 (Anti-Inflammatory Agents, Non-Steroidal)
RN  - WK2XYI10QM (Ibuprofen)
SB  - IM
MH  - Analgesics, Non-Narcotic/*adverse effects
MH  - Anesthesia, Spinal
MH  - Anti-Inflammatory Agents, Non-Steroidal/*adverse effects
MH  - *Arthroplasty, Replacement, Hip
MH  - *Blood Loss, Surgical
MH  - Double-Blind Method
MH  - Female
MH  - Humans
MH  - Ibuprofen/*adverse effects
MH  - Male
MH  - Middle Aged
MH  - Postoperative Hemorrhage/*chemically induced
MH  - Preoperative Care
EDAT- 2002/11/22 04:00
MHDA- 2003/02/22 04:00
CRDT- 2002/11/22 04:00
PHST- 2002/11/22 04:00 [pubmed]
PHST- 2003/02/22 04:00 [medline]
PHST- 2002/11/22 04:00 [entrez]
AID - 10.1017/s0265021502001345 [doi]
PST - ppublish
SO  - Eur J Anaesthesiol. 2002 Nov;19(11):829-31. doi: 10.1017/s0265021502001345.

PMID- 19430778
OWN - NLM
STAT- MEDLINE
DCOM- 20091006
LR  - 20211020
IS  - 1432-2161 (Electronic)
IS  - 0364-2348 (Linking)
VI  - 38
IP  - 9
DP  - 2009 Sep
TI  - Can magnetic resonance imaging accurately predict concordant pain provocation 
      during provocative disc injection?
PG  - 877-85
LID - 10.1007/s00256-009-0709-7 [doi]
AB  - OBJECTIVE: To correlate magnetic resonance (MR) image findings with pain response 
      by provocation discography in patients with discogenic low back pain, with an 
      emphasis on the combination analysis of a high intensity zone (HIZ) and disc 
      contour abnormalities. MATERIALS AND METHODS: Sixty-two patients (aged 17-68 
      years) with axial low back pain that was likely to be disc related underwent 
      lumbar discography (178 discs tested). The MR images were evaluated for disc 
      degeneration, disc contour abnormalities, HIZ, and endplate abnormalities. Based 
      on the combination of an HIZ and disc contour abnormalities, four classes were 
      determined: (1) normal or bulging disc without HIZ; (2) normal or bulging disc 
      with HIZ; (3) disc protrusion without HIZ; (4) disc protrusion with HIZ. These MR 
      image findings and a new combined MR classification were analyzed in the base of 
      concordant pain determined by discography. RESULTS: Disc protrusion with HIZ 
      [sensitivity 45.5%; specificity 97.8%; positive predictive value (PPV), 87.0%] 
      correlated significantly with concordant pain provocation (P < 0.01). A normal or 
      bulging disc with HIZ was not associated with reproduction of pain. Disc 
      degeneration (sensitivity 95.4%; specificity 38.8%; PPV 33.9%), disc protrusion 
      (sensitivity 68.2%; specificity 80.6%; PPV 53.6%), and HIZ (sensitivity 56.8%; 
      specificity 83.6%; PPV 53.2%) were not helpful in the identification of a disc 
      with concordant pain. CONCLUSION: The proposed MR classification is useful to 
      predict a disc with concordant pain. Disc protrusion with HIZ on MR imaging 
      predicted positive discography in patients with discogenic low back pain.
FAU - Kang, Chang Ho
AU  - Kang CH
AD  - Department of Radiology, Korea University Anam Hospital, Korea University College 
      of Medicine, 5-ga 126-1, Anam-dong, Sungbuk-gu, Seoul, 136-705, Korea.
FAU - Kim, Yun Hwan
AU  - Kim YH
FAU - Lee, Sang-Heon
AU  - Lee SH
FAU - Derby, Richard
AU  - Derby R
FAU - Kim, Jung Hyuk
AU  - Kim JH
FAU - Chung, Kyoo Byung
AU  - Chung KB
FAU - Sung, Deuk Jae
AU  - Sung DJ
LA  - eng
PT  - Journal Article
DEP - 20090509
PL  - Germany
TA  - Skeletal Radiol
JT  - Skeletal radiology
JID - 7701953
RN  - 0 (Contrast Media)
SB  - IM
EIN - Skeletal Radiol. 2010 Feb;39(2):207
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Contrast Media/administration & dosage
MH  - Female
MH  - Humans
MH  - Injections
MH  - Intervertebral Disc Displacement/*complications/*diagnosis
MH  - Low Back Pain/*diagnosis/*etiology
MH  - Magnetic Resonance Imaging/*methods
MH  - Male
MH  - Middle Aged
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - Young Adult
EDAT- 2009/05/12 09:00
MHDA- 2009/10/07 06:00
CRDT- 2009/05/12 09:00
PHST- 2008/09/15 00:00 [received]
PHST- 2009/04/20 00:00 [accepted]
PHST- 2009/03/19 00:00 [revised]
PHST- 2009/05/12 09:00 [entrez]
PHST- 2009/05/12 09:00 [pubmed]
PHST- 2009/10/07 06:00 [medline]
AID - 10.1007/s00256-009-0709-7 [doi]
PST - ppublish
SO  - Skeletal Radiol. 2009 Sep;38(9):877-85. doi: 10.1007/s00256-009-0709-7. Epub 2009 
      May 9.

PMID- 20605051
OWN - NLM
STAT- MEDLINE
DCOM- 20110201
LR  - 20101018
IS  - 1872-6054 (Electronic)
IS  - 0168-8510 (Linking)
VI  - 98
IP  - 1
DP  - 2010 Nov
TI  - Does case-mix based reimbursement stimulate the development of process-oriented 
      care delivery?
PG  - 74-80
LID - 10.1016/j.healthpol.2010.06.005 [doi]
AB  - OBJECTIVES: Reimbursement based on the total care of a patient during an acute 
      episode of illness is believed to stimulate management and clinicians to reduce 
      quality problems like waiting times and poor coordination of care delivery. 
      Although many studies already show that this kind of case-mix based reimbursement 
      leads to more efficiency, it remains unclear whether care coordination improved 
      as well. This study aims to explore whether case-mix based reimbursement 
      stimulates development of care coordination by the use of care programmes, and a 
      process-oriented way of working. METHODS: Data for this study were gathered 
      during the winter of 2007/2008 in a survey involving all Dutch hospitals. 
      Descriptive and structural equation modelling (SEM) analyses were conducted. 
      RESULTS: SEM reveals that adoption of the case-mix reimbursement within 
      hospitals' budgeting processes stimulates hospitals to establish care programmes 
      by the use of process-oriented performance measures. However, the implementation 
      of care programmes is not (yet) accompanied by a change in focus from function 
      (the delivery of independent care activities) to process (the delivery of care 
      activities as being connected to a chain of interdependent care activities). 
      CONCLUSION: This study demonstrates that hospital management can stimulate the 
      development of care programmes by the adoption of case-mix reimbursement within 
      hospitals' budgeting processes. Future research is recommended to confirm this 
      finding and to determine whether the establishment of care programmes will in 
      time indeed lead to a more process-oriented view of professionals.
CI  - Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.
FAU - Vos, Leti
AU  - Vos L
AD  - NIVEL, Netherlands Institute for Health Services Research, P.O. Box 1568, 3500 BN 
      Utrecht, The Netherlands. l.vos@lumc.nl
FAU - Duckers, Michel L A
AU  - Duckers ML
FAU - Wagner, Cordula
AU  - Wagner C
FAU - van Merode, Godefridus G
AU  - van Merode GG
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Ireland
TA  - Health Policy
JT  - Health policy (Amsterdam, Netherlands)
JID - 8409431
MH  - Budgets
MH  - Delivery of Health Care/*organization & administration
MH  - *Diagnosis-Related Groups
MH  - Economics, Hospital
MH  - Health Care Surveys
MH  - Humans
MH  - Models, Theoretical
MH  - Netherlands
MH  - Patient Care Management/*economics
MH  - Quality of Health Care
MH  - Reimbursement Mechanisms/*organization & administration
EDAT- 2010/07/08 06:00
MHDA- 2011/02/02 06:00
CRDT- 2010/07/08 06:00
PHST- 2009/12/17 00:00 [received]
PHST- 2010/06/01 00:00 [revised]
PHST- 2010/06/06 00:00 [accepted]
PHST- 2010/07/08 06:00 [entrez]
PHST- 2010/07/08 06:00 [pubmed]
PHST- 2011/02/02 06:00 [medline]
AID - S0168-8510(10)00163-6 [pii]
AID - 10.1016/j.healthpol.2010.06.005 [doi]
PST - ppublish
SO  - Health Policy. 2010 Nov;98(1):74-80. doi: 10.1016/j.healthpol.2010.06.005.

PMID- 19108857
OWN - NLM
STAT- MEDLINE
DCOM- 20100427
LR  - 20140930
IS  - 0035-3787 (Print)
IS  - 0035-3787 (Linking)
VI  - 165
IP  - 12
DP  - 2009 Dec
TI  - [Cerebromediastinal tuberculosis in a child with a probable Say-Barber-Miller 
      syndrome: a causative link?].
PG  - 1111-6
LID - 10.1016/j.neurol.2008.08.014 [doi]
AB  - INTRODUCTION: Tuberculosis continues to be a public health problem in emerging 
      countries with a recent evidence of increased incidence of extrapulmonary 
      localization in developed countries probably linked to HIV. To our knowledge the 
      occurrence of cerebro-mediastinal tuberculosis in an immuno-competent child has 
      not been previously described; moreover the child we describe has a probable 
      Say-Barber-Miller syndrome. We discuss a putative causative link between this 
      syndrome and the occurrence of tuberculosis. CASE REPORT: A seven-year-old girl 
      presented to our department with a history of infantile encephalopathy since 
      birth characterized by a facial dysmorphy (evocative of a bird face), 
      microcephaly, and mental retardation, and with recurrent infections. The child 
      had complained of back pain for several months; the parents reported anorexia, 
      loss of weight. Spinal and cerebral MRI showed a mediastinal mass involving the 
      spine and cerebral lesions evocative of tuberculomas. The tuberculin interdermal 
      reaction was positive. Culture of a vertebral biopsy was positive for Koch 
      bacillus. Anti-tuberculosis treatment improved general and local status. An 
      extensive immunological work-up was normal. CONCLUSION: [corrected] This 
      observation is exceptional in many aspects: very early age of onset of 
      extrapulmonary tuberculosis, no immune deficit, association with a rare 
      congenital neurological syndrome. We discuss the possible link between this 
      entity and the occurrence of tuberculosis.
FAU - Kechaou, I
AU  - Kechaou I
AD  - Service de neurologie pediatrique, institut national de neurologie, 1007 La 
      Rabta, Tunis, Tunisie.
FAU - Rouissi, A
AU  - Rouissi A
FAU - Kraoua, I
AU  - Kraoua I
FAU - Regayeg, A
AU  - Regayeg A
FAU - Turki, I
AU  - Turki I
FAU - Ben Hamouda, M
AU  - Ben Hamouda M
FAU - Gouider-Khouja, N
AU  - Gouider-Khouja N
LA  - fre
PT  - Case Reports
PT  - English Abstract
PT  - Journal Article
TT  - Tuberculose cerebromediastinale chez un enfant atteint de syndrome de 
      Say-Barber-Miller probable : un lien de causalite ?
PL  - France
TA  - Rev Neurol (Paris)
JT  - Revue neurologique
JID - 2984779R
SB  - IM
MH  - Anorexia/etiology
MH  - Body Dysmorphic Disorders/pathology
MH  - Child
MH  - Consanguinity
MH  - Diagnosis, Differential
MH  - Face/*abnormalities
MH  - Female
MH  - Humans
MH  - Intellectual Disability/genetics
MH  - Male
MH  - Pedigree
MH  - Syndrome
MH  - Tuberculoma/diagnosis
EDAT- 2008/12/26 09:00
MHDA- 2010/04/28 06:00
CRDT- 2008/12/26 09:00
PHST- 2008/05/16 00:00 [received]
PHST- 2008/07/16 00:00 [revised]
PHST- 2008/08/21 00:00 [accepted]
PHST- 2008/12/26 09:00 [entrez]
PHST- 2008/12/26 09:00 [pubmed]
PHST- 2010/04/28 06:00 [medline]
AID - S0035-3787(08)00596-1 [pii]
AID - 10.1016/j.neurol.2008.08.014 [doi]
PST - ppublish
SO  - Rev Neurol (Paris). 2009 Dec;165(12):1111-6. doi: 10.1016/j.neurol.2008.08.014.

PMID- 24516646
OWN - NLM
STAT- MEDLINE
DCOM- 20150113
LR  - 20211021
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 9
IP  - 2
DP  - 2014
TI  - Is the determination of specific IgE against components using ISAC 112 a 
      reproducible technique?
PG  - e88394
LID - 10.1371/journal.pone.0088394 [doi]
LID - e88394
AB  - BACKGROUND: The ImmunoCAP ISAC 112 is a fluoro-immunoassay that allows detection 
      of specific IgE to 112 molecular components from 51 allergenic sources. We 
      studied the reliability of this technique intra- and inter- assay, as well as 
      inter-batch- and inter-laboratory-assay. METHODS: Twenty samples were studied, 
      nineteen sera from polysensitized allergic patients, and the technique calibrator 
      provided by the manufacturer (CTR02). We measured the sIgE from CTR02 and three 
      patients' sera ten times in the same and in different assays. Furthermore, all 
      samples were tested in two laboratories and with two batches of ISAC kit. To 
      evaluate the accuracy of ISAC 112, we contrasted the determinations of CTR02 
      calibrator with their expected values by T Student test. To analyse the 
      precision, we calculated the coefficient of variation (CV) of the 15 allergens 
      that generate the calibration curve, and to analyse the repeatability and the 
      reproducibility, we calculated the intraclass coefficient correlation (ICC) to 
      each allergen. RESULTS: The results obtained for CTR02 were similar to those 
      expected in 7 of 15 allergens that generate the calibration curve, whereas in 8 
      allergens the results showed significant differences. The mean CV obtained in the 
      CTR02 determinations was of 9.4%, and the variability of sera from patients was 
      of 22.9%. The agreement in the intra- and inter-assay analysis was very good to 
      94 allergens and good to one. In the inter-batch analyse, we obtained a very good 
      agreement to 82 allergens, good to 14, moderate to 5 allergens, poor to one, and 
      bad to 1 allergen. In the inter-laboratory analyse, we obtained a very good 
      agreement to 73 allergens, good to 22, moderate to 6 and poor to two allergens. 
      CONCLUSION: The allergen microarray immunoassay, ISAC 112, is a repeatable and 
      reproducible in vitro diagnostic tool for determination of sIgE beyond the own 
      laboratory.
FAU - Martinez-Aranguren, Ruben
AU  - Martinez-Aranguren R
AD  - Department of Allergology and Clinical Immunology, Clinica Universidad de 
      Navarra, Pamplona, Spain.
FAU - Lizaso, Maria T
AU  - Lizaso MT
AD  - Allergology Service, Complejo Hospitalario de Navarra, Pamplona, Spain.
FAU - Goikoetxea, Maria J
AU  - Goikoetxea MJ
AD  - Department of Allergology and Clinical Immunology, Clinica Universidad de 
      Navarra, Pamplona, Spain.
FAU - Garcia, Blanca E
AU  - Garcia BE
AD  - Allergology Service, Complejo Hospitalario de Navarra, Pamplona, Spain.
FAU - Cabrera-Freitag, Paula
AU  - Cabrera-Freitag P
AD  - Department of Allergology and Clinical Immunology, Clinica Universidad de 
      Navarra, Pamplona, Spain.
FAU - Trellez, Oswaldo
AU  - Trellez O
AD  - Department of Computer Architecture, Universidad de Malaga, Malaga, Spain.
FAU - Sanz, Maria L
AU  - Sanz ML
AD  - Department of Allergology and Clinical Immunology, Clinica Universidad de 
      Navarra, Pamplona, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20140206
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
RN  - 37341-29-0 (Immunoglobulin E)
SB  - IM
MH  - Calibration
MH  - Fluoroimmunoassay/*methods
MH  - Humans
MH  - Immunoglobulin E/*analysis
MH  - Reproducibility of Results
PMC - PMC3916438
COIS- Competing Interests: Thermofisher supplies part of the material (ISAC CRD 112 
      kits) required for this study. This does not alter the authors' adherence to all 
      the PLOS ONE policies on sharing data and materials.
EDAT- 2014/02/12 06:00
MHDA- 2015/01/15 06:00
PMCR- 2014/02/06
CRDT- 2014/02/12 06:00
PHST- 2013/11/06 00:00 [received]
PHST- 2013/12/13 00:00 [accepted]
PHST- 2014/02/12 06:00 [entrez]
PHST- 2014/02/12 06:00 [pubmed]
PHST- 2015/01/15 06:00 [medline]
PHST- 2014/02/06 00:00 [pmc-release]
AID - PONE-D-13-46510 [pii]
AID - 10.1371/journal.pone.0088394 [doi]
PST - epublish
SO  - PLoS One. 2014 Feb 6;9(2):e88394. doi: 10.1371/journal.pone.0088394. eCollection 
      2014.

PMID- 25752725
OWN - NLM
STAT- MEDLINE
DCOM- 20160502
LR  - 20200109
IS  - 1778-3585 (Electronic)
IS  - 0924-9338 (Linking)
VI  - 30
IP  - 5
DP  - 2015 Jul
TI  - Schizophrenia patients with high intelligence: A clinically distinct sub-type of 
      schizophrenia?
PG  - 628-32
LID - S0924-9338(15)00072-3 [pii]
LID - 10.1016/j.eurpsy.2015.02.007 [doi]
AB  - BACKGROUND: Schizophrenia patients are typically found to have low IQ both pre- 
      and post-onset, in comparison to the general population. However, a subgroup of 
      patients displays above average IQ pre-onset. The nature of these patients' 
      illness and its relationship to typical schizophrenia is not well understood. The 
      current study sought to investigate the symptom profile of high-IQ schizophrenia 
      patients. METHODS: We identified 29 schizophrenia patients of exceptionally high 
      pre-morbid intelligence (mean estimated pre-morbid intelligence quotient (IQ) of 
      120), of whom around half also showed minimal decline (less than 10 IQ points) 
      from their estimated pre-morbid IQ. We compared their symptom scores (SAPS, SANS, 
      OPCRIT, MADRS, GAF, SAI-E) with a comparison group of schizophrenia patients of 
      typical IQ using multinomial logistic regression. RESULTS: The patients with very 
      high pre-morbid IQ had significantly lower scores on negative and disorganised 
      symptoms than typical patients (RRR=0.019; 95% CI=0.001, 0.675, P=0.030), and 
      showed better global functioning and insight (RRR=1.082; 95% CI=1.020, 1.148; 
      P=0.009). Those with a minimal post-onset IQ decline also showed higher levels of 
      manic symptoms (RRR=8.213; 95% CI=1.042, 64.750, P=0.046). CONCLUSIONS: These 
      findings provide evidence for the existence of a high-IQ variant of schizophrenia 
      that is associated with markedly fewer negative symptoms than typical 
      schizophrenia, and lends support to the idea of a psychosis spectrum or continuum 
      over boundaried diagnostic categories.
CI  - Copyright (c) 2015 Elsevier Masson SAS. All rights reserved.
FAU - Cernis, E
AU  - Cernis E
AD  - Department of Psychosis Studies, Institute of Psychiatry, King's College London, 
      Box P063, De Crespigny Park, London, United Kingdom, SE5 8AF. Electronic address: 
      Emma.cernis@hmc.ox.ac.uk.
FAU - Vassos, E
AU  - Vassos E
AD  - Department of Psychosis Studies, Institute of Psychiatry, King's College London, 
      Box P063, De Crespigny Park, London, United Kingdom, SE5 8AF.
FAU - Brebion, G
AU  - Brebion G
AD  - Unit of Research and Development, Parc Sanitari Sant Joan de Deu and CIBERSAM, 
      Barcelona, Spain.
FAU - McKenna, P J
AU  - McKenna PJ
AD  - Benito Menni CASM, and CIBERSAM, Barcelona, Spain.
FAU - Murray, R M
AU  - Murray RM
AD  - Department of Psychosis Studies, Institute of Psychiatry, King's College London, 
      Box P063, De Crespigny Park, London, United Kingdom, SE5 8AF.
FAU - David, A S
AU  - David AS
AD  - Department of Psychosis Studies, Institute of Psychiatry, King's College London, 
      Box P063, De Crespigny Park, London, United Kingdom, SE5 8AF.
FAU - MacCabe, J H
AU  - MacCabe JH
AD  - Department of Psychosis Studies, Institute of Psychiatry, King's College London, 
      Box P063, De Crespigny Park, London, United Kingdom, SE5 8AF.
LA  - eng
GR  - Department of Health/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150306
PL  - England
TA  - Eur Psychiatry
JT  - European psychiatry : the journal of the Association of European Psychiatrists
JID - 9111820
SB  - IM
MH  - Adult
MH  - *Cognition
MH  - Female
MH  - Humans
MH  - *Intelligence
MH  - Intelligence Tests
MH  - Male
MH  - Middle Aged
MH  - Neuropsychological Tests
MH  - Schizophrenia/*classification/*physiopathology
MH  - Schizophrenic Psychology
OTO - NOTNLM
OT  - Cognitive function
OT  - IQ
OT  - Psychosis
OT  - Schizophrenia
OT  - Superphrenia
EDAT- 2015/03/11 06:00
MHDA- 2016/05/03 06:00
CRDT- 2015/03/11 06:00
PHST- 2014/11/06 00:00 [received]
PHST- 2015/02/09 00:00 [revised]
PHST- 2015/02/11 00:00 [accepted]
PHST- 2015/03/11 06:00 [entrez]
PHST- 2015/03/11 06:00 [pubmed]
PHST- 2016/05/03 06:00 [medline]
AID - S0924-9338(15)00072-3 [pii]
AID - 10.1016/j.eurpsy.2015.02.007 [doi]
PST - ppublish
SO  - Eur Psychiatry. 2015 Jul;30(5):628-32. doi: 10.1016/j.eurpsy.2015.02.007. Epub 
      2015 Mar 6.

PMID- 20537205
OWN - NLM
STAT- MEDLINE
DCOM- 20110524
LR  - 20121115
IS  - 1748-5460 (Electronic)
IS  - 0022-2151 (Linking)
VI  - 124
IP  - 10
DP  - 2010 Oct
TI  - Is halofantrine ototoxic? Experimental study on guinea pig cochlea model.
PG  - 1061-6
LID - 10.1017/S0022215110001301 [doi]
AB  - INTRODUCTION: Halofantrine is a newly developed antimalarial drug used for the 
      treatment of Plasmodium falciparum malaria. The introduction of this drug has 
      been delayed because of its possible side effects, and due to insufficient 
      studies on adverse reactions in humans. There have been no studies investigating 
      its effect on hearing. METHODS: Thirty guinea pigs were divided into three 
      groups: a control group, a halofantrine therapeutic dose group and a halofantrine 
      double therapeutic dose group. One cochlea specimen from each animal was stained 
      with haematoxylin and eosin and the other with toluidine blue. RESULTS: No 
      changes were detected in the control group. The halofantrine therapeutic dose 
      group showed loss and distortion of inner hair cells and inner phalangeal cells, 
      and loss of spiral ganglia cells. In the halofantrine double therapeutic dose 
      group, the inner and outer hair cells were distorted and there was loss of spiral 
      ganglia cells. CONCLUSION: Halofantrine has mild to moderate pathological effects 
      on cochlea histology, and can be considered an ototoxic drug.
FAU - Iskander, N M
AU  - Iskander NM
AD  - Department of Otolaryngology, Faculty of Medicine, Suez Canal University, 
      Ismailia, Egypt.
FAU - Youssef, T F
AU  - Youssef TF
FAU - Ahmed, M R
AU  - Ahmed MR
FAU - Mohamed, A A K
AU  - Mohamed AA
LA  - eng
PT  - Journal Article
DEP - 20100611
PL  - England
TA  - J Laryngol Otol
JT  - The Journal of laryngology and otology
JID - 8706896
RN  - 0 (Antimalarials)
RN  - 0 (Phenanthrenes)
RN  - Q2OS4303HZ (halofantrine)
SB  - IM
MH  - Animals
MH  - Antimalarials/*toxicity
MH  - Cochlea/*drug effects/pathology
MH  - Dose-Response Relationship, Drug
MH  - Guinea Pigs
MH  - Hair Cells, Auditory, Outer/drug effects
MH  - Phenanthrenes/*toxicity
MH  - Staining and Labeling/methods
EDAT- 2010/06/12 06:00
MHDA- 2011/05/25 06:00
CRDT- 2010/06/12 06:00
PHST- 2010/06/12 06:00 [entrez]
PHST- 2010/06/12 06:00 [pubmed]
PHST- 2011/05/25 06:00 [medline]
AID - S0022215110001301 [pii]
AID - 10.1017/S0022215110001301 [doi]
PST - ppublish
SO  - J Laryngol Otol. 2010 Oct;124(10):1061-6. doi: 10.1017/S0022215110001301. Epub 
      2010 Jun 11.

PMID- 20602784
OWN - NLM
STAT- MEDLINE
DCOM- 20101014
LR  - 20221207
IS  - 1476-072X (Electronic)
IS  - 1476-072X (Linking)
VI  - 9
DP  - 2010 Jul 5
TI  - Identification of racial disparities in breast cancer mortality: does scale 
      matter?
PG  - 35
LID - 10.1186/1476-072X-9-35 [doi]
AB  - BACKGROUND: This paper investigates the impact of geographic scale (census tract, 
      zip code, and county) on the detection of disparities in breast cancer mortality 
      among three ethnic groups in Texas (period 1995-2005). Racial disparities were 
      quantified using both relative (RR) and absolute (RD) statistics that account for 
      the population size and correct for unreliable rates typically observed for 
      minority groups and smaller geographic units. Results were then correlated with 
      socio-economic status measured by the percentage of habitants living below the 
      poverty level. RESULTS: African-American and Hispanic women generally experience 
      higher mortality than White non-Hispanics, and these differences are especially 
      significant in the southeast metropolitan areas and southwest border of Texas. 
      The proportion and location of significant racial disparities however changed 
      depending on the type of statistic (RR versus RD) and the geographic level. The 
      largest proportion of significant results was observed for the RD statistic and 
      census tract data. Geographic regions with significant racial disparities for 
      African-Americans and Hispanics frequently had a poverty rate above 10.00%. 
      CONCLUSIONS: This study investigates both relative and absolute racial 
      disparities in breast cancer mortality between White non-Hispanic and 
      African-American/Hispanic women at the census tract, zip code and county levels. 
      Analysis at the census tract level generally led to a larger proportion of 
      geographical units experiencing significantly higher mortality rates for minority 
      groups, although results varied depending on the use of the relative versus 
      absolute statistics. Additional research is needed before general conclusions can 
      be formulated regarding the choice of optimal geographic regions for the 
      detection of racial disparities.
FAU - Tian, Nancy
AU  - Tian N
AD  - Texas Center for Geographic Information Science, Department of Geography, Texas 
      State University-San Marcos, San Marcos, Texas 78666, USA. jt1277@txstate.edu
FAU - Goovaerts, Pierre
AU  - Goovaerts P
FAU - Zhan, F Benjamin
AU  - Zhan FB
FAU - Wilson, Jeff G
AU  - Wilson JG
LA  - eng
GR  - R44 CA132347-02/CA/NCI NIH HHS/United States
GR  - R43-CA135814-01/CA/NCI NIH HHS/United States
GR  - R44 CA132347/CA/NCI NIH HHS/United States
GR  - R43 CA135814-01/CA/NCI NIH HHS/United States
GR  - R43 CA135814/CA/NCI NIH HHS/United States
GR  - R44-CA132347-02/CA/NCI NIH HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20100705
PL  - England
TA  - Int J Health Geogr
JT  - International journal of health geographics
JID - 101152198
SB  - IM
MH  - Adult
MH  - Black or African American/statistics & numerical data
MH  - Age Distribution
MH  - Aged
MH  - Breast Neoplasms/*ethnology/*mortality
MH  - *Cause of Death
MH  - Censuses
MH  - Confidence Intervals
MH  - Cross-Sectional Studies
MH  - Databases, Factual
MH  - Female
MH  - Health Knowledge, Attitudes, Practice
MH  - *Health Status Disparities
MH  - Hispanic or Latino/statistics & numerical data
MH  - Humans
MH  - Incidence
MH  - Logistic Models
MH  - Middle Aged
MH  - Odds Ratio
MH  - Risk Assessment
MH  - Socioeconomic Factors
MH  - Survival Analysis
MH  - Texas
MH  - White People/statistics & numerical data
PMC - PMC2910022
EDAT- 2010/07/07 06:00
MHDA- 2010/10/15 06:00
PMCR- 2010/07/05
CRDT- 2010/07/07 06:00
PHST- 2010/04/13 00:00 [received]
PHST- 2010/07/05 00:00 [accepted]
PHST- 2010/07/07 06:00 [entrez]
PHST- 2010/07/07 06:00 [pubmed]
PHST- 2010/10/15 06:00 [medline]
PHST- 2010/07/05 00:00 [pmc-release]
AID - 1476-072X-9-35 [pii]
AID - 10.1186/1476-072X-9-35 [doi]
PST - epublish
SO  - Int J Health Geogr. 2010 Jul 5;9:35. doi: 10.1186/1476-072X-9-35.

PMID- 22302761
OWN - NLM
STAT- MEDLINE
DCOM- 20120727
LR  - 20191210
IS  - 1096-9101 (Electronic)
IS  - 0196-8092 (Linking)
VI  - 44
IP  - 2
DP  - 2012 Feb
TI  - Can fractional lasers enhance transdermal absorption of topical lidocaine in an 
      in vivo animal model?
PG  - 168-74
LID - 10.1002/lsm.21130 [doi]
AB  - BACKGROUND AND OBJECTIVE: It has been shown in vitro that pretreatment of skin 
      with fractional lasers enhances transdermal delivery of drugs. The aim of this 
      study is to demonstrate in vivo firstly that laser enhances transdermal drug 
      absorption and secondly that this can be manipulated by altering laser settings. 
      STUDY DESIGN/MATERIALS AND METHODS: Four pigs were used in the IACUC approved 
      animal study. On day 0, 5 g of 4% topical lidocaine was applied under occlusion 
      for 60 minutes to a 400 cm(2) area on the abdomen. Blood was drawn at 0, 60, 90, 
      120, 180, and 240 minutes. On day 7, the Er:YAG laser was used at 500, 250, 50, 
      and 25 microm ablative depth, respectively, over a 400 cm(2) area on the abdomen. 
      Five grams of 4% topical lidocaine was applied immediately with occlusion for 60 
      minutes, and then removed. Blood was drawn at 0, 60, 90, 120, 180, and 240 
      minutes. The serum was extracted and analyzed for lidocaine and its metabolite 
      monoethylglycinexylidide (MEGX). RESULTS: Serum levels of lidocaine and MEGX were 
      undetectable in untreated skin. Following laser treatment both lidocaine and MEGX 
      were detectable. Peak levels of lidocaine were significantly higher (P = 0.0002) 
      at 250 microm (0.62 mg/L), compared to 500 microm (0.45 mg/L), 50 microm (0.48 mg/L), and 25 
      microm (0.3 mg/L). Peak levels of MEGX were significantly higher (P </= 0.0001) at 250 
      microm (0.048 mg/L), compared to 500 microm (0.018 mg/L), 50 microm (0.036 mg/L), and 25 microm 
      (0.0144 mg/L). CONCLUSIONS: This study demonstrates that laser pretreatment 
      significantly increases absorption of topical lidocaine so that it is detectable 
      in the blood and that manipulating laser settings can affect drug absorption. 
      Future work will look at translating this effect into clinical benefit.
CI  - Copyright (c) 2012 Wiley Periodicals, Inc.
FAU - Oni, Georgette
AU  - Oni G
AD  - Plastic Surgery Department, UT Southwestern Medical Center, Dallas, Texas, USA.
FAU - Brown, Spencer A
AU  - Brown SA
FAU - Kenkel, Jeffrey M
AU  - Kenkel JM
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
DEP - 20120202
PL  - United States
TA  - Lasers Surg Med
JT  - Lasers in surgery and medicine
JID - 8007168
RN  - 0 (Anesthetics, Local)
RN  - 98PI200987 (Lidocaine)
RN  - D8Q99HC770 (monoethylglycinexylidide)
SB  - IM
MH  - Administration, Cutaneous
MH  - Anesthetics, Local/*administration & dosage/blood/pharmacokinetics
MH  - Animals
MH  - Drug Delivery Systems/instrumentation/*methods
MH  - *Lasers, Solid-State
MH  - Lidocaine/*administration & dosage/analogs & derivatives/blood/pharmacokinetics
MH  - Skin Absorption/*radiation effects
MH  - Swine
EDAT- 2012/02/04 06:00
MHDA- 2012/07/28 06:00
CRDT- 2012/02/04 06:00
PHST- 2011/09/02 00:00 [accepted]
PHST- 2012/02/04 06:00 [entrez]
PHST- 2012/02/04 06:00 [pubmed]
PHST- 2012/07/28 06:00 [medline]
AID - 10.1002/lsm.21130 [doi]
PST - ppublish
SO  - Lasers Surg Med. 2012 Feb;44(2):168-74. doi: 10.1002/lsm.21130. Epub 2012 Feb 2.

PMID- 18322741
OWN - NLM
STAT- MEDLINE
DCOM- 20090423
LR  - 20211020
IS  - 1432-2218 (Electronic)
IS  - 0930-2794 (Print)
IS  - 0930-2794 (Linking)
VI  - 23
IP  - 1
DP  - 2009 Jan
TI  - Does laparoscopic surgery decrease the risk of atrial fibrillation after foregut 
      surgery?
PG  - 204-8
LID - 10.1007/s00464-008-9800-8 [doi]
AB  - BACKGROUND: Atrial fibrillation, which occurs in 12% of all major foregut 
      surgeries, can prolong hospital stay and increase morbidity. Minimally invasive 
      techniques in foregut surgery have been suggested to cause less tissue trauma. We 
      examined the factors associated with new-onset atrial fibrillation after foregut 
      surgery at our institution. METHODS: We retrospectively examined the records of 
      154 adult patients who underwent major foregut surgery which included 
      esophagectomy, partial or total gastrectomy, redo Heller myotomy, redo or 
      transthoracic fundoplications. Univariate and multivariate logistic regression 
      analysis with standard modeling techniques were performed to determine risk 
      factors for new-onset atrial fibrillation. RESULTS: Of the 154 patients, 14 
      patients developed new-onset atrial fibrillation with a higher mean age of 67.1 
      years (+/-8.8 years) versus 56.4 years (+/-14.1 years) (p = 0.006). Laparoscopic 
      (p = 0.004) and nonthoracic surgeries (p = 0.01) were associated with lower risk 
      of atrial fibrillation. Patients with atrial fibrillation had received more fluid 
      (6.5 +/- 2.8 liters versus 5.3 +/- 2.0 liters) and had longer operations (370 +/- 
      103 min versus 362 +/- 142 min), none of which were statistically significant. 
      The average intensive care length of stay of patients was longer: 7.5 +/- 6.8 
      days versus 4.0 +/- 7.1 days (p = 0.004). Multivariate analysis revealed an 
      association of atrial fibrillation with age (OR 1.08, 95% CI 1.02-1.14, p = 
      0.01), and laparoscopic surgery (OR 0.09, 95% CI 0.01-0.95, p = 0.04) after 
      adjusting for surgery type. CONCLUSIONS: Laparoscopic surgery is associated with 
      lower risk of atrial fibrillation in foregut surgery. Development of atrial 
      fibrillation is associated with increased length of intensive care stay. We 
      recommend a prospective trial to confirm our findings.
FAU - Turaga, Kiran K
AU  - Turaga KK
AD  - Department of Surgery, Creighton University Medical Center, 601 N 30th street, 
      Omaha, NE 68131, USA.
FAU - Shah, Kinjal U
AU  - Shah KU
FAU - Neill, Erin O
AU  - Neill EO
FAU - Mittal, Sumeet K
AU  - Mittal SK
LA  - eng
PT  - Journal Article
DEP - 20080306
PL  - Germany
TA  - Surg Endosc
JT  - Surgical endoscopy
JID - 8806653
SB  - IM
MH  - Adult
MH  - Age Factors
MH  - Aged
MH  - Atrial Fibrillation/diagnosis/*epidemiology/prevention & control
MH  - Cohort Studies
MH  - Digestive System Surgical Procedures/*adverse effects
MH  - Female
MH  - Humans
MH  - *Laparoscopy
MH  - Length of Stay
MH  - Male
MH  - Middle Aged
MH  - Retrospective Studies
MH  - Risk Factors
PMC - PMC7103156
EDAT- 2008/03/07 09:00
MHDA- 2009/04/25 09:00
PMCR- 2020/03/29
CRDT- 2008/03/07 09:00
PHST- 2007/08/09 00:00 [received]
PHST- 2008/01/24 00:00 [accepted]
PHST- 2007/12/19 00:00 [revised]
PHST- 2008/03/07 09:00 [pubmed]
PHST- 2009/04/25 09:00 [medline]
PHST- 2008/03/07 09:00 [entrez]
PHST- 2020/03/29 00:00 [pmc-release]
AID - 399 [pii]
AID - 10.1007/s00464-008-9800-8 [doi]
PST - ppublish
SO  - Surg Endosc. 2009 Jan;23(1):204-8. doi: 10.1007/s00464-008-9800-8. Epub 2008 Mar 
      6.

PMID- 14692023
OWN - NLM
STAT- MEDLINE
DCOM- 20040120
LR  - 20220408
IS  - 0008-543X (Print)
IS  - 0008-543X (Linking)
VI  - 100
IP  - 1
DP  - 2004 Jan 1
TI  - Is breast cancer survival improving?
PG  - 44-52
AB  - BACKGROUND: Despite advances in therapies for breast cancer, improvement in 
      survival for patients with recurrent or metastatic breast cancer has been 
      difficult to establish. The objective of the current study was to determine 
      whether the survival of women with recurrent breast cancer has improved from 1974 
      to 2000. METHODS: The authors analyzed the survival experience of 834 women who 
      developed recurrent breast cancer between November 1974 and December 2000. All 
      patients had been treated previously with adjuvant anthracycline-based protocols. 
      Patients were divided into five consecutive groups based on year of breast cancer 
      recurrence, and survival was compared across the five groups. Because some 
      prognostic variables were divided unevenly divided among the cohorts, a 
      multivariate model was created to determine the association of year of recurrence 
      and survival after accounting for other prognostic factors. RESULTS: In the 
      unadjusted analysis, there was a statistically significant improvement in 
      survival across the five groups, and the more recent cohorts had longer survival 
      (P < 0.001). Other variables that predicted longer survival after breast cancer 
      recurrence included smaller initial tumor size, lower stage of disease, fewer 
      lymph nodes involved, longer disease-free interval, estrogen receptor-positive 
      tumors, and nonvisceral dominant site of disease recurrence. In the multivariate 
      analysis, which adjusted for these prognostic factors, year of recurrence was 
      associated with a trend toward improved survival, with a 1% reduction in risk for 
      each increasing year. CONCLUSIONS: For these cohorts of patients, the authors 
      present data suggesting that the prognosis for patients with recurrent breast 
      cancer improved between 1974 and 2000.
CI  - Copyright 2003 American Cancer Society.
FAU - Giordano, Sharon H
AU  - Giordano SH
AD  - Department of Breast Medical Oncology, The University of Texas M. D. Anderson 
      Cancer Center, Houston, Texas 77030, USA. sgiordan@mdanderson.org
FAU - Buzdar, Aman U
AU  - Buzdar AU
FAU - Smith, Terry L
AU  - Smith TL
FAU - Kau, Shu-Wan
AU  - Kau SW
FAU - Yang, Ying
AU  - Yang Y
FAU - Hortobagyi, Gabriel N
AU  - Hortobagyi GN
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Cancer
JT  - Cancer
JID - 0374236
SB  - IM
MH  - Adult
MH  - Aged
MH  - Breast Neoplasms/*mortality/pathology/therapy
MH  - Cohort Studies
MH  - Female
MH  - Humans
MH  - Middle Aged
MH  - Multivariate Analysis
MH  - Neoplasm Recurrence, Local/*mortality/pathology
MH  - Prognosis
MH  - Retrospective Studies
MH  - Survival Analysis
EDAT- 2003/12/24 05:00
MHDA- 2004/01/21 05:00
CRDT- 2003/12/24 05:00
PHST- 2003/12/24 05:00 [pubmed]
PHST- 2004/01/21 05:00 [medline]
PHST- 2003/12/24 05:00 [entrez]
AID - 10.1002/cncr.11859 [doi]
PST - ppublish
SO  - Cancer. 2004 Jan 1;100(1):44-52. doi: 10.1002/cncr.11859.

PMID- 22348433
OWN - NLM
STAT- MEDLINE
DCOM- 20120601
LR  - 20211021
IS  - 1477-7819 (Electronic)
IS  - 1477-7819 (Linking)
VI  - 10
DP  - 2012 Feb 20
TI  - Does partial expander deflation exacerbate the adverse effects of radiotherapy in 
      two-stage breast reconstruction?
PG  - 44
LID - 10.1186/1477-7819-10-44 [doi]
AB  - BACKGROUND: The optimum protocol for expander volume adjustment with respect to 
      the timing and application of radiotherapy remains controversial. METHODS: 
      Eighteen New Zealand rabbits were divided into three groups. Metallic port 
      integrated anatomic breast expanders of 250 cc were implanted on the back of each 
      animal and controlled expansion was performed. Group I underwent radiotherapy 
      with full expanders while in Group II, expanders were partially deflated 
      immediately prior to radiotherapy. Control group did not receive radiotherapy.The 
      changes in blood flow at different volume adjustments were investigated in Group 
      II by laser Doppler flowmetry. Variations in the histopathologic properties of 
      the irradiated tissues including the skin, capsule and the pocket floor, were 
      compared in the biopsy specimens taken from different locations in each group. 
      RESULTS: A significant increase in skin blood flow was detected in Group II with 
      partial expander deflation. Overall, histopathologic exam revealed aggravated 
      findings of chronic radiodermatitis (epidermal atrophy, dermal inflammation and 
      fibrosis, neovascularisation and vascular changes as well as increased capsule 
      thickness) especially around the lower expander pole, in Group II. CONCLUSIONS: 
      Expander deflation immediately prior to radiotherapy, may augment the adverse 
      effects, especially in the lower expander pole, possibly via enhanced 
      radiosensitization due to a relative increase in the blood flow and tissue 
      oxygenation.
FAU - Celet Ozden, Burcu
AU  - Celet Ozden B
AD  - Istanbul University, Istanbul Faculty of Medicine, Department of Plastic, 
      Reconstructive and Aesthetic Surgery, Istanbul, Turkey. beletzden@yahoo.com
FAU - Guven, Erdem
AU  - Guven E
FAU - Aslay, Isik
AU  - Aslay I
FAU - Kemikler, Gonul
AU  - Kemikler G
FAU - Olgac, Vakur
AU  - Olgac V
FAU - Soluk Tekkesin, Merva
AU  - Soluk Tekkesin M
FAU - Serarslan, Bengul
AU  - Serarslan B
FAU - Tumerdem Ulug, Burcak
AU  - Tumerdem Ulug B
FAU - Bilgin Karabulut, Aylin
AU  - Bilgin Karabulut A
FAU - Arinci, Atilla
AU  - Arinci A
FAU - Emekli, Ufuk
AU  - Emekli U
LA  - eng
PT  - Journal Article
DEP - 20120220
PL  - England
TA  - World J Surg Oncol
JT  - World journal of surgical oncology
JID - 101170544
SB  - IM
MH  - Animals
MH  - *Breast Implants
MH  - Breast Neoplasms/pathology/*radiotherapy/surgery
MH  - Dermatologic Surgical Procedures
MH  - Female
MH  - Magnetic Resonance Imaging
MH  - *Mammaplasty
MH  - Mastectomy/*rehabilitation
MH  - Rabbits
MH  - Radiation Injuries/*etiology
MH  - Radiation Oncology
MH  - Radiotherapy Planning, Computer-Assisted/instrumentation
MH  - Skin/*blood supply/pathology
MH  - Tissue Expansion/*adverse effects
MH  - Tissue Expansion Devices
PMC - PMC3315407
EDAT- 2012/02/22 06:00
MHDA- 2012/06/02 06:00
PMCR- 2012/02/20
CRDT- 2012/02/22 06:00
PHST- 2011/12/04 00:00 [received]
PHST- 2012/02/20 00:00 [accepted]
PHST- 2012/02/22 06:00 [entrez]
PHST- 2012/02/22 06:00 [pubmed]
PHST- 2012/06/02 06:00 [medline]
PHST- 2012/02/20 00:00 [pmc-release]
AID - 1477-7819-10-44 [pii]
AID - 10.1186/1477-7819-10-44 [doi]
PST - epublish
SO  - World J Surg Oncol. 2012 Feb 20;10:44. doi: 10.1186/1477-7819-10-44.

PMID- 26215326
OWN - NLM
STAT- MEDLINE
DCOM- 20160216
LR  - 20151103
IS  - 1097-6868 (Electronic)
IS  - 0002-9378 (Linking)
VI  - 213
IP  - 5
DP  - 2015 Nov
TI  - Does the clinical presentation of a prior preterm birth predict risk in a 
      subsequent pregnancy?
PG  - 686.e1-7
LID - S0002-9378(15)00779-6 [pii]
LID - 10.1016/j.ajog.2015.07.029 [doi]
AB  - OBJECTIVE: The objective of the study was to determine whether risk of recurrent 
      preterm birth differs based on the clinical presentation of a prior spontaneous 
      preterm birth (SPTB): advanced cervical dilatation (ACD), preterm premature 
      rupture of membranes (PPROM), or preterm labor (PTL). STUDY DESIGN: This 
      retrospective cohort study included singleton pregnancies from 2009 to 2014 
      complicated by a history of prior SPTB. Women were categorized based on the 
      clinical presentation of their prior preterm delivery as having ACD, PPROM, or 
      PTL. Risks for sonographic short cervical length and recurrent SPTB were compared 
      between women based on the clinical presentation of their prior preterm birth. 
      Log-linear regression was used to control for confounders. RESULTS: Of 522 
      patients included in this study, 96 (18.4%) had prior ACD, 246 (47.1%) had prior 
      PPROM, and 180 (34.5%) had prior PTL. Recurrent PTB occurred in 55.2% of patients 
      with a history of ACD compared with 27.2% of those with PPROM and 32.2% with PTL 
      (P = .001). The mean gestational age at delivery was significantly lower for 
      those with a history of ACD (34.0 weeks) compared with women with prior PPROM 
      (37.2 weeks) or PTL (37.0 weeks) (P = .001). The lowest mean cervical length 
      prior to 24 weeks was significantly shorter in patients with a history of 
      advanced cervical dilation when compared with the other clinical presentations. 
      CONCLUSION: Patients with a history of ACD are at an increased risk of having 
      recurrent preterm birth and cervical shortening in a subsequent pregnancy 
      compared with women with prior preterm birth associated PPROM or PTL.
CI  - Copyright (c) 2015 Elsevier Inc. All rights reserved.
FAU - Drassinower, Daphnie
AU  - Drassinower D
AD  - Department of Obstetrics and Gynecology, Columbia University Medical Center, New 
      York, NY. Electronic address: daphniedrassinower@yahoo.com.
FAU - Obican, Sarah G
AU  - Obican SG
AD  - Department of Obstetrics and Gynecology, Columbia University Medical Center, New 
      York, NY.
FAU - Siddiq, Zainab
AU  - Siddiq Z
AD  - Department of Obstetrics and Gynecology, Columbia University Medical Center, New 
      York, NY.
FAU - Heller, Danielle
AU  - Heller D
AD  - Department of Obstetrics and Gynecology, Columbia University Medical Center, New 
      York, NY.
FAU - Gyamfi-Bannerman, Cynthia
AU  - Gyamfi-Bannerman C
AD  - Department of Obstetrics and Gynecology, Columbia University Medical Center, New 
      York, NY.
FAU - Friedman, Alexander M
AU  - Friedman AM
AD  - Department of Obstetrics and Gynecology, Columbia University Medical Center, New 
      York, NY.
LA  - eng
PT  - Journal Article
DEP - 20150726
PL  - United States
TA  - Am J Obstet Gynecol
JT  - American journal of obstetrics and gynecology
JID - 0370476
SB  - IM
MH  - Adult
MH  - Female
MH  - Fetal Membranes, Premature Rupture/*epidemiology
MH  - Gestational Age
MH  - Humans
MH  - *Labor Stage, First
MH  - Pregnancy
MH  - *Pregnancy Outcome
MH  - Premature Birth/*epidemiology
MH  - Recurrence
MH  - Retrospective Studies
MH  - Risk Assessment
OTO - NOTNLM
OT  - advanced cervical dilation
OT  - recurrence risk
OT  - recurrent preterm birth
EDAT- 2015/07/29 06:00
MHDA- 2016/02/18 06:00
CRDT- 2015/07/29 06:00
PHST- 2015/04/22 00:00 [received]
PHST- 2015/06/15 00:00 [revised]
PHST- 2015/07/18 00:00 [accepted]
PHST- 2015/07/29 06:00 [entrez]
PHST- 2015/07/29 06:00 [pubmed]
PHST- 2016/02/18 06:00 [medline]
AID - S0002-9378(15)00779-6 [pii]
AID - 10.1016/j.ajog.2015.07.029 [doi]
PST - ppublish
SO  - Am J Obstet Gynecol. 2015 Nov;213(5):686.e1-7. doi: 10.1016/j.ajog.2015.07.029. 
      Epub 2015 Jul 26.

PMID- 23539689
OWN - NLM
STAT- MEDLINE
DCOM- 20140109
LR  - 20130509
IS  - 1938-2707 (Electronic)
IS  - 0009-9228 (Linking)
VI  - 52
IP  - 6
DP  - 2013 Jun
TI  - Cold preparation use in young children after FDA warnings: do concerns still 
      exist?
PG  - 534-9
LID - 10.1177/0009922813482761 [doi]
AB  - OBJECTIVE: To characterize the use and delivery of cough and cold medicines in 
      children younger than 6 presenting to an inner-city pediatric emergency 
      department (PED) following 2007 FDA warnings. METHODS: A cross-sectional 
      observational study was performed using a convenience sampling of PED patients 
      during the fall of 2010. Caregivers were presented with 6 commonly used cough 
      medicine preparations and were asked to demonstrate if and how they would 
      administer these to their children. RESULTS: In all, 65 patients and their 
      caregivers consented and participated in the study. During the demonstration, 82% 
      (53/65) stated that they would treat with cough or cold medicines, and 72% 
      (38/53) incorrectly dosed the medication they desired to give. CONCLUSIONS: 
      Despite current recommendations, cough and cold medicines are still used in 
      children younger than 6 years of age. A significant portion of caregivers report 
      that they are still unaware of public warnings, potential side effects, and 
      interactions with other medications.
FAU - Lazarus, Sarah Gard
AU  - Lazarus SG
AD  - Department of Pediatrics, Emory University, Atlanta, GA 30329, USA. 
      sagard@emory.edu
FAU - Lanski, Steven L
AU  - Lanski SL
FAU - Smith, Ashley S
AU  - Smith AS
FAU - Simon, Harold K
AU  - Simon HK
LA  - eng
PT  - Journal Article
DEP - 20130328
PL  - United States
TA  - Clin Pediatr (Phila)
JT  - Clinical pediatrics
JID - 0372606
RN  - 0 (Antitussive Agents)
RN  - 0 (Nasal Decongestants)
RN  - 0 (Nonprescription Drugs)
SB  - IM
CIN - Clin Pediatr (Phila). 2013 Nov;52(11):1083-4. doi: 10.1177/0009922813497427. 
      PMID: 23899582
MH  - Antitussive Agents/*adverse effects/therapeutic use
MH  - Caregivers/*psychology
MH  - Child
MH  - Child, Preschool
MH  - Common Cold/*drug therapy
MH  - Cough/*drug therapy
MH  - Cross-Sectional Studies
MH  - Drug Packaging
MH  - Female
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Male
MH  - Nasal Decongestants/*adverse effects/therapeutic use
MH  - Nonprescription Drugs/*adverse effects/therapeutic use
MH  - United States
MH  - United States Food and Drug Administration
OTO - NOTNLM
OT  - cough
OT  - emergency medicine
OT  - over-the-counter (OTC)
OT  - parenting education
EDAT- 2013/03/30 06:00
MHDA- 2014/01/10 06:00
CRDT- 2013/03/30 06:00
PHST- 2013/03/30 06:00 [entrez]
PHST- 2013/03/30 06:00 [pubmed]
PHST- 2014/01/10 06:00 [medline]
AID - 0009922813482761 [pii]
AID - 10.1177/0009922813482761 [doi]
PST - ppublish
SO  - Clin Pediatr (Phila). 2013 Jun;52(6):534-9. doi: 10.1177/0009922813482761. Epub 
      2013 Mar 28.

PMID- 9363244
OWN - NLM
STAT- MEDLINE
DCOM- 19971205
LR  - 20170404
IS  - 1354-4195 (Print)
IS  - 1354-4195 (Linking)
VI  - 1
IP  - 2
DP  - 1995 Jun
TI  - Does occupational nuclear power plant radiation affect conception and pregnancy?
PG  - 130-3
AB  - OBJECTIVES: To determine the effect of occupational exposure in a nuclear power 
      plant in Griefswald, Germany on male and female fecundity. METHODS: The frequency 
      of men and women exposed to ionizing radiation through work in a nuclear power 
      plant among 270 infertile couples was retrospectively compared to a control 
      fertile population using a pair-matched analysis. The total cumulative equivalent 
      radiation dose was determined. In addition, the spermiograms of the male partners 
      in both groups were compared and correlated to the degree of exposure. RESULTS: 
      No differences were noted in the frequency of nuclear power plant exposure 
      between sterile and fertile groups. There was a higher rate of anomalous 
      spermiograms in nuclear power plant workers. However, abnormalities were 
      temporary. No correlation was found between the cumulative equivalent radiation 
      dose and abnormal spermiograms. CONCLUSION: The data suggest that occupational 
      exposure due to ionizing radiation should be investigated as a possible cause for 
      involuntary temporary sterility and as a risk factor for early pregnancy 
      disorders.
FAU - Straube, E
AU  - Straube E
AD  - Institute of Occupational Medicine, Ernst-Moritz-Arndt-University, Greifswald, 
      Germany.
FAU - Straube, W
AU  - Straube W
FAU - Romer, T
AU  - Romer T
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Early Pregnancy
JT  - Early pregnancy : biology and medicine : the official journal of the Society for 
      the Investigation of Early Pregnancy
JID - 9508879
SB  - IM
MH  - Female
MH  - Humans
MH  - Infertility/*etiology
MH  - Male
MH  - *Occupational Exposure
MH  - *Power Plants
MH  - Pregnancy
MH  - Radiation Dosage
MH  - Retrospective Studies
MH  - Sperm Count
MH  - Spermatozoa/abnormalities/physiology
EDAT- 1995/06/01 00:00
MHDA- 1997/11/18 00:01
CRDT- 1995/06/01 00:00
PHST- 1995/06/01 00:00 [pubmed]
PHST- 1997/11/18 00:01 [medline]
PHST- 1995/06/01 00:00 [entrez]
PST - ppublish
SO  - Early Pregnancy. 1995 Jun;1(2):130-3.

PMID- 24507422
OWN - NLM
STAT- MEDLINE
DCOM- 20141022
LR  - 20161125
IS  - 1878-4046 (Electronic)
IS  - 1076-6332 (Linking)
VI  - 21
IP  - 3
DP  - 2014 Mar
TI  - Can shape analysis differentiate free-floating internal carotid artery thrombus 
      from atherosclerotic plaque in patients evaluated with CTA for stroke or 
      transient ischemic attack?
PG  - 345-54
LID - S1076-6332(13)00544-8 [pii]
LID - 10.1016/j.acra.2013.11.011 [doi]
AB  - RATIONALE AND OBJECTIVES: Patients presenting with transient ischemic attack or 
      stroke may have symptom-related lesions on acute computed tomography angiography 
      (CTA) such as free-floating intraluminal thrombus (FFT). It is difficult to 
      distinguish FFT from carotid plaque, but the distinction is critical as 
      management differs. By contouring the shape of these vascular lesions ("virtual 
      endarterectomy"), advanced morphometric analysis can be performed. The objective 
      of our study is to determine whether quantitative shape analysis can accurately 
      differentiate FFT from atherosclerotic plaque. MATERIALS AND METHODS: We 
      collected 23 consecutive cases of suspected carotid FFT seen on CTA (13 men, 65 +/- 
      10 years; 10 women, 65.5 +/- 8.8 years). True-positive FFT cases (FFT+) were 
      defined as filling defects resolving with anticoagulant therapy versus 
      false-positives (FFT-), which remained unchanged. Lesion volumes were extracted 
      from CTA images and quantitative shape descriptors were computed. The five most 
      discriminative features were used to construct receiver operator characteristic 
      (ROC) curves and to generate three machine-learning classifiers. Average 
      classification accuracy was determined by cross-validation. RESULTS: Follow-up 
      imaging confirmed sixteen FFT+ and seven FFT- cases. Five shape descriptors 
      delineated FFT+ from FFT- cases. The logistic regression model produced from 
      combining all five shape features demonstrated a sensitivity of 87.5% and a 
      specificity of 71.4% with an area under the ROC curve = 0.85 +/- 0.09. Average 
      accuracy for each classifier ranged from 65.2%-76.4%. CONCLUSIONS: We identified 
      five quantitative shape descriptors of carotid FFT. This shape "signature" shows 
      potential for supplementing conventional lesion characterization in cases of 
      suspected FFT.
CI  - Copyright (c) 2014 AUR. Published by Elsevier Inc. All rights reserved.
FAU - Thornhill, Rebecca E
AU  - Thornhill RE
AD  - Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada; 
      Department of Medical Imaging, The Ottawa Hospital, 1053 Carling Ave, Ottawa, 
      Ontario K1Y 4E9, Canada; Clinical Epidemiology Program/Methods Centre, Ottawa 
      Hospital Research Institute, Ottawa, Ontario, Canada. Electronic address: 
      rthornhi@gmail.com.
FAU - Lum, Cheemun
AU  - Lum C
AD  - Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada; 
      Department of Medical Imaging, The Ottawa Hospital, 1053 Carling Ave, Ottawa, 
      Ontario K1Y 4E9, Canada; Clinical Epidemiology Program/Methods Centre, Ottawa 
      Hospital Research Institute, Ottawa, Ontario, Canada.
FAU - Jaberi, Arash
AU  - Jaberi A
AD  - Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada; 
      Department of Medical Imaging, The Ottawa Hospital, 1053 Carling Ave, Ottawa, 
      Ontario K1Y 4E9, Canada.
FAU - Stefanski, Pawel
AU  - Stefanski P
AD  - Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada; 
      Department of Medical Imaging, The Ottawa Hospital, 1053 Carling Ave, Ottawa, 
      Ontario K1Y 4E9, Canada.
FAU - Torres, Carlos H
AU  - Torres CH
AD  - Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada; 
      Department of Medical Imaging, The Ottawa Hospital, 1053 Carling Ave, Ottawa, 
      Ontario K1Y 4E9, Canada; Clinical Epidemiology Program/Methods Centre, Ottawa 
      Hospital Research Institute, Ottawa, Ontario, Canada.
FAU - Momoli, Franco
AU  - Momoli F
AD  - Clinical Epidemiology Program/Methods Centre, Ottawa Hospital Research Institute, 
      Ottawa, Ontario, Canada; Children's Hospital of Eastern Ontario Research 
      Institute, Ottawa, Ontario, Canada.
FAU - Petrcich, William
AU  - Petrcich W
AD  - Clinical Epidemiology Program/Methods Centre, Ottawa Hospital Research Institute, 
      Ottawa, Ontario, Canada.
FAU - Dowlatshahi, Dar
AU  - Dowlatshahi D
AD  - Clinical Epidemiology Program/Methods Centre, Ottawa Hospital Research Institute, 
      Ottawa, Ontario, Canada; Division of Neurology, Department of Medicine, 
      University of Ottawa, Ottawa, Ontario, Canada.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - United States
TA  - Acad Radiol
JT  - Academic radiology
JID - 9440159
SB  - IM
MH  - Aged
MH  - Carotid Artery Thrombosis/complications/*diagnostic imaging
MH  - Carotid Stenosis/complications/*diagnostic imaging
MH  - Cerebral Angiography/methods
MH  - Diagnosis, Differential
MH  - Female
MH  - Humans
MH  - Ischemic Attack, Transient/*diagnostic imaging/etiology
MH  - Male
MH  - Pattern Recognition, Automated/*methods
MH  - Radiographic Image Interpretation, Computer-Assisted/*methods
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - Stroke/*diagnostic imaging/etiology
MH  - Tomography, X-Ray Computed/methods
OTO - NOTNLM
OT  - CT angiography
OT  - computer aided diagnosis
OT  - free-floating thrombus
OT  - image postprocessing
OT  - stroke
EDAT- 2014/02/11 06:00
MHDA- 2014/10/23 06:00
CRDT- 2014/02/11 06:00
PHST- 2013/08/12 00:00 [received]
PHST- 2013/10/22 00:00 [revised]
PHST- 2013/11/08 00:00 [accepted]
PHST- 2014/02/11 06:00 [entrez]
PHST- 2014/02/11 06:00 [pubmed]
PHST- 2014/10/23 06:00 [medline]
AID - S1076-6332(13)00544-8 [pii]
AID - 10.1016/j.acra.2013.11.011 [doi]
PST - ppublish
SO  - Acad Radiol. 2014 Mar;21(3):345-54. doi: 10.1016/j.acra.2013.11.011.

PMID- 22350859
OWN - NLM
STAT- MEDLINE
DCOM- 20120911
LR  - 20240322
IS  - 1573-7225 (Electronic)
IS  - 0957-5243 (Print)
IS  - 0957-5243 (Linking)
VI  - 23 Suppl 1
IP  - 0 1
DP  - 2012 Mar
TI  - Can pictorial warning labels on cigarette packages address smoking-related health 
      disparities? Field experiments in Mexico to assess pictorial warning label 
      content.
PG  - 69-80
LID - 10.1007/s10552-012-9899-8 [doi]
AB  - OBJECTIVE: The objective of this study was to determine the most effective 
      content of pictorial health warning labels (HWLs) and whether educational 
      attainment moderates these effects. METHODS: Field experiments were conducted 
      with 529 adult smokers and 530 young adults (258 nonsmokers; 271 smokers). 
      Participants reported responses to different pictorial HWLs printed on cigarette 
      packages. One experiment involved manipulating textual form (testimonial 
      narrative vs. didactic) and the other involved manipulating image type (diseased 
      organs vs. human suffering). RESULTS: Tests of mean ratings and rankings 
      indicated that pictorial HWLs with didactic textual forms had equivalent or 
      significantly higher credibility, relevance, and impact than pictorial HWLs with 
      testimonial forms. Results from mixed-effects models confirmed these results. 
      However, responses differed by participant educational attainment: didactic forms 
      were consistently rated higher than testimonials among participants with higher 
      education, whereas the difference between didactic and testimonial narrative 
      forms was weaker or not statistically significant among participants with lower 
      education. In the second experiment, with textual content held constant, greater 
      credibility, relevance, and impact was found for graphic imagery of diseased 
      organs than imagery of human suffering. CONCLUSIONS: Pictorial HWLs with didactic 
      textual forms seem to work better than those with testimonial narratives. Future 
      research should determine which pictorial HWL content has the greatest real-world 
      impact among consumers from disadvantaged groups, including assessment of how HWL 
      content should change to maintain its impact as tobacco control environments 
      strengthen and consumer awareness of smoking-related risks increases.
FAU - Thrasher, James F
AU  - Thrasher JF
AD  - Department of Health Promotion, Education and Behavior, Arnold School of Public 
      Health, University of South Carolina, 800 Sumter Street, Columbia, SC 29208, USA. 
      thrasher@mailbox.sc.edu
FAU - Arillo-Santillan, Edna
AU  - Arillo-Santillan E
FAU - Villalobos, Victor
AU  - Villalobos V
FAU - Perez-Hernandez, Rosaura
AU  - Perez-Hernandez R
FAU - Hammond, David
AU  - Hammond D
FAU - Carter, Jarvis
AU  - Carter J
FAU - Sebrie, Ernesto
AU  - Sebrie E
FAU - Sansores, Raul
AU  - Sansores R
FAU - Regalado-Pineda, Justino
AU  - Regalado-Pineda J
LA  - eng
GR  - P01 CA138389/CA/NCI NIH HHS/United States
GR  - P01 CA138389-03/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20120215
PL  - Netherlands
TA  - Cancer Causes Control
JT  - Cancer causes & control : CCC
JID - 9100846
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Educational Status
MH  - Female
MH  - *Healthcare Disparities
MH  - Humans
MH  - Male
MH  - Mexico
MH  - Middle Aged
MH  - Product Labeling/*methods
MH  - Smoking/*adverse effects/psychology
MH  - *Smoking Prevention
MH  - Young Adult
PMC - PMC3339765
MID - NIHMS365078
EDAT- 2012/02/22 06:00
MHDA- 2012/09/12 06:00
PMCR- 2013/03/01
CRDT- 2012/02/22 06:00
PHST- 2011/07/11 00:00 [received]
PHST- 2012/01/21 00:00 [accepted]
PHST- 2012/02/22 06:00 [entrez]
PHST- 2012/02/22 06:00 [pubmed]
PHST- 2012/09/12 06:00 [medline]
PHST- 2013/03/01 00:00 [pmc-release]
AID - 10.1007/s10552-012-9899-8 [doi]
PST - ppublish
SO  - Cancer Causes Control. 2012 Mar;23 Suppl 1(0 1):69-80. doi: 
      10.1007/s10552-012-9899-8. Epub 2012 Feb 15.

PMID- 19640728
OWN - NLM
STAT- MEDLINE
DCOM- 20110111
LR  - 20191210
IS  - 1873-734X (Electronic)
IS  - 1010-7940 (Linking)
VI  - 37
IP  - 1
DP  - 2010 Jan
TI  - Surgical treatment of prosthetic valve endocarditis in patients with double 
      prostheses: is single-valve replacement safe?
PG  - 159-62
LID - 10.1016/j.ejcts.2009.06.019 [doi]
AB  - OBJECTIVE: Bias against operating on patients with prosthetic valve endocarditis 
      (PVE) who have multiple prostheses may preclude the use of life-saving valve 
      replacement. We investigated the accuracy of the preoperative diagnosis of PVE in 
      patients with both mitral and aortic prosthesis and the safety of single-valve 
      replacement when only one valve seemed infected. METHODS: Patients with a 
      diagnosis of active PVE who had mitral and aortic prosthesis in place were 
      assessed. We looked at the methods for diagnosis, causative agents, indication 
      for valve replacement, operative findings and outcome. RESULTS: Twenty patients, 
      who had both mitral and aortic prostheses and a diagnosis of PVE, were assessed. 
      Streptococci and staphylococci caused 70% of cases. By means of echocardiography, 
      the valves involved were: mitral (11 patients), aortic (six patients), and in 
      three cases both prosthetic valves seemed infected. Surgery was undertaken in 17 
      patients (85%). The positive predictive value of transesophageal echocardiogram 
      (TEE) for the preoperative diagnosis of the site of infection was 100%. In 13 
      patients, only the prosthetic valve that seemed infected was replaced. Four of 
      these patients died within a week after the procedure. Nine patients survived the 
      surgical procedure, completed a course of antimicrobial therapy and were followed 
      up for 15.78 months (95% CI: 12.83-18.72). All were considered cured and relapses 
      were not observed. CONCLUSIONS: TEE allowed a diagnosis of site involvement that 
      did correlate with the anatomic diagnosis obtained during the operation. This 
      fact contributed to the management of patients and was of great help in guiding 
      the surgical intervention. Echo-oriented single-valve replacement may be a safe 
      strategy for patients with PVE and double prostheses.
CI  - Copyright 2009 European Association for Cardio-Thoracic Surgery. Published by 
      Elsevier B.V. All rights reserved.
FAU - Guerrero, Manuel L Fernandez
AU  - Guerrero ML
AD  - Division of Infectious Diseases, Fundacion Jimenez Diaz, Universidad Autonoma de 
      Madrid, Madrid, Spain. mlfernandez@fjd.es
FAU - Alonso, Julio
AU  - Alonso J
FAU - Rey, Manuel
AU  - Rey M
FAU - Martinell, Jorge
AU  - Martinell J
FAU - Gorgolas, Miguel
AU  - Gorgolas M
FAU - Artiz, Victor
AU  - Artiz V
FAU - Fraile, Julian
AU  - Fraile J
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
DEP - 20090728
PL  - Germany
TA  - Eur J Cardiothorac Surg
JT  - European journal of cardio-thoracic surgery : official journal of the European 
      Association for Cardio-thoracic Surgery
JID - 8804069
SB  - IM
MH  - Aged
MH  - Aortic Valve/diagnostic imaging/microbiology/*surgery
MH  - Echocardiography, Transesophageal
MH  - Endocarditis, Bacterial/diagnostic imaging/microbiology/*surgery
MH  - Female
MH  - Heart Valve Prosthesis/*adverse effects
MH  - Heart Valve Prosthesis Implantation/adverse effects/*methods
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Mitral Valve/diagnostic imaging/microbiology/*surgery
MH  - Prosthesis-Related Infections/diagnostic imaging/microbiology/*surgery
MH  - Retrospective Studies
MH  - Treatment Outcome
EDAT- 2009/07/31 09:00
MHDA- 2011/01/12 06:00
CRDT- 2009/07/31 09:00
PHST- 2009/03/04 00:00 [received]
PHST- 2009/06/08 00:00 [revised]
PHST- 2009/06/12 00:00 [accepted]
PHST- 2009/07/31 09:00 [entrez]
PHST- 2009/07/31 09:00 [pubmed]
PHST- 2011/01/12 06:00 [medline]
AID - S1010-7940(09)00604-6 [pii]
AID - 10.1016/j.ejcts.2009.06.019 [doi]
PST - ppublish
SO  - Eur J Cardiothorac Surg. 2010 Jan;37(1):159-62. doi: 10.1016/j.ejcts.2009.06.019. 
      Epub 2009 Jul 28.

PMID- 23806388
OWN - NLM
STAT- MEDLINE
DCOM- 20130916
LR  - 20211021
IS  - 1527-9995 (Electronic)
IS  - 0090-4295 (Print)
IS  - 0090-4295 (Linking)
VI  - 82
IP  - 1
DP  - 2013 Jul
TI  - Do nomograms designed to predict biochemical recurrence (BCR) do a better job of 
      predicting more clinically relevant prostate cancer outcomes than BCR? A report 
      from the SEARCH database group.
PG  - 53-8
LID - S0090-4295(13)00172-6 [pii]
LID - 10.1016/j.urology.2012.10.090 [doi]
AB  - OBJECTIVE: To examine the ability of various postoperative nomograms to predict 
      prostate cancer-specific mortality (PCSM) and to validate that they could predict 
      aggressive biochemical recurrence (BCR). Prostate-specific antigen (PSA), grade, 
      and stage are the classic triad used to predict BCR after radical prostatectomy 
      (RP). Multiple nomograms use these to predict risk of BCR. A previous study 
      showed that several nomograms could predict aggressive BCR (prostate-specific 
      antigen doubling time [PSADT] <9 months) more accurately than BCR. However, it 
      remains unknown if they can predict more definitive endpoints, such as PCSM. 
      METHODS: We performed Cox analyses to examine the ability of 4 postoperative 
      nomograms, the Duke Prostate Center (DPC) nomogram, the Kattan postoperative 
      nomogram, the Johns Hopkins Hospital (JHH) nomogram, and the joint Center for 
      Prostate Disease Research(CPDR)/Cancer of the Prostate Strategic Urologic 
      Research Endeavor (CaPSURE) nomogram to predict BCR and PCSM among 1778 men in 
      the Shared Equal Access Regional Cancer Hospital (SEARCH) database who underwent 
      RP between 1990 and 2009. We also compared their ability to predict BCR and 
      aggressive BCR in a subset of men. We calculated the c-index for each nomogram to 
      determine its predictive accuracy for estimating actual outcomes. RESULTS: We 
      found that each nomogram could predict aggressive BCR and PCSM in a statistically 
      significant manner and that they all predicted PCSM more accurately than they 
      predicted BCR (ie, with higher c-index values). CONCLUSION: Currently available 
      nomograms used to predict BCR accurately predict PCSM and other more clinically 
      relevant endpoints. Moreover, not only do they significantly predict PCSM, but do 
      so with generally greater accuracy than BCR.
CI  - Published by Elsevier Inc.
FAU - Teeter, Anna E
AU  - Teeter AE
AD  - Department of Surgery, Duke University Medical Center, Durham, NC, USA.
FAU - Presti, Joseph C Jr
AU  - Presti JC Jr
FAU - Aronson, William J
AU  - Aronson WJ
FAU - Terris, Martha K
AU  - Terris MK
FAU - Kane, Christopher J
AU  - Kane CJ
FAU - Amling, Christopher L
AU  - Amling CL
FAU - Freedland, Stephen J
AU  - Freedland SJ
LA  - eng
GR  - K24 CA160653/CA/NCI NIH HHS/United States
GR  - P50 CA092131/CA/NCI NIH HHS/United States
GR  - UL1 RR024128/RR/NCRR NIH HHS/United States
GR  - UL1RR024128/RR/NCRR NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - Urology
JT  - Urology
JID - 0366151
RN  - EC 3.4.21.77 (Prostate-Specific Antigen)
SB  - IM
CIN - Urology. 2013 Jul;82(1):58-9; discussion 59. doi: 10.1016/j.urology.2012.10.093. 
      PMID: 23806389
MH  - Aged
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Grading
MH  - Neoplasm Recurrence, Local/*blood
MH  - Neoplasm Staging
MH  - *Nomograms
MH  - Predictive Value of Tests
MH  - Proportional Hazards Models
MH  - Prostate-Specific Antigen/blood
MH  - Prostatectomy
MH  - Prostatic Neoplasms/*blood/mortality/*pathology
MH  - Time Factors
PMC - PMC3774016
MID - NIHMS461448
EDAT- 2013/06/29 06:00
MHDA- 2013/09/17 06:00
PMCR- 2014/07/01
CRDT- 2013/06/29 06:00
PHST- 2012/09/12 00:00 [received]
PHST- 2012/10/11 00:00 [revised]
PHST- 2012/10/15 00:00 [accepted]
PHST- 2013/06/29 06:00 [entrez]
PHST- 2013/06/29 06:00 [pubmed]
PHST- 2013/09/17 06:00 [medline]
PHST- 2014/07/01 00:00 [pmc-release]
AID - S0090-4295(13)00172-6 [pii]
AID - 10.1016/j.urology.2012.10.090 [doi]
PST - ppublish
SO  - Urology. 2013 Jul;82(1):53-8. doi: 10.1016/j.urology.2012.10.090.

PMID- 9920954
OWN - NLM
STAT- MEDLINE
DCOM- 19990202
LR  - 20191210
IS  - 0028-4793 (Print)
IS  - 0028-4793 (Linking)
VI  - 340
IP  - 4
DP  - 1999 Jan 28
TI  - Do "America's Best Hospitals" perform better for acute myocardial infarction?
PG  - 286-92
AB  - BACKGROUND: "America's Best Hospitals," an influential list published annually by 
      U.S. News and World Report, assesses the quality of hospitals. It is not known 
      whether patients admitted to hospitals ranked at the top in cardiology have lower 
      short-term mortality from acute myocardial infarction than those admitted to 
      other hospitals or whether differences in mortality are explained by differential 
      use of recommended therapies. METHODS: Using data from the Cooperative 
      Cardiovascular Project on 149,177 elderly Medicare beneficiaries with acute 
      myocardial infarction in 1994 or 1995, we examined the care and outcomes of 
      patients admitted to three types of hospitals: those ranked high in cardiology 
      (top-ranked hospitals); hospitals not in the top rank that had on-site facilities 
      for cardiac catheterization, coronary angioplasty, and bypass surgery (similarly 
      equipped hospitals); and the remaining hospitals (non-similarly equipped 
      hospitals). We compared 30-day mortality; the rates of use of aspirin, 
      beta-blockers, and reperfusion; and the relation of differences in rates of 
      therapy to short-term mortality. RESULTS: Admission to a top-ranked hospital was 
      associated with lower adjusted 30-day mortality (odds ratio, 0.87; 95 percent 
      confidence interval, 0.76 to 1.00; P=0.05 for top-ranked hospitals vs. the 
      others). Among patients without contraindications to therapy, top-ranked 
      hospitals had significantly higher rates of use of aspirin (96.2 percent, as 
      compared with 88.6 percent for similarly equipped hospitals and 83.4 percent for 
      non-similarly equipped hospitals; P<0.01) and beta-blockers (75.0 percent vs. 
      61.8 percent and 58.7 percent, P<0.01), but lower rates of reperfusion therapy 
      (61.0 percent vs. 70.7 percent and 65.6 percent, P=0.03). The survival advantage 
      associated with admission to top-ranked hospitals was less strong after we 
      adjusted for factors including the use of aspirin and beta-blockers (odds ratio, 
      0.94; 95 percent confidence interval, 0.82 to 1.08; P=0.38). CONCLUSIONS: 
      Admission to a hospital ranked high on the list of "America's Best Hospitals" was 
      associated with lower 30-day mortality among elderly patients with acute 
      myocardial infarction. A substantial portion of the survival advantage may be 
      associated with these hospitals' higher rates of use of aspirin and beta-blocker 
      therapy.
FAU - Chen, J
AU  - Chen J
AD  - Department of Medicine, Yale University School of Medicine, New Haven, CT 
      06520-8025, USA.
FAU - Radford, M J
AU  - Radford MJ
FAU - Wang, Y
AU  - Wang Y
FAU - Marciniak, T A
AU  - Marciniak TA
FAU - Krumholz, H M
AU  - Krumholz HM
LA  - eng
GR  - 500-96-P549/PHS HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Adrenergic beta-Antagonists)
RN  - R16CO5Y76E (Aspirin)
SB  - IM
CIN - N Engl J Med. 1999 Jan 28;340(4):309-10. doi: 10.1056/NEJM199901283400410. PMID: 
      9920957
CIN - N Engl J Med. 1999 Jun 24;340(25):2006-7; author reply 2007. doi: 
      10.1056/nejm199906243402518. PMID: 10383285
MH  - Adrenergic beta-Antagonists/therapeutic use
MH  - Aged
MH  - Angioplasty, Balloon, Coronary/statistics & numerical data
MH  - Aspirin/therapeutic use
MH  - Female
MH  - Health Care Surveys
MH  - Hospitals/*standards/statistics & numerical data
MH  - Humans
MH  - Logistic Models
MH  - Male
MH  - Medicare/economics/statistics & numerical data
MH  - Multivariate Analysis
MH  - Myocardial Infarction/classification/mortality/*therapy
MH  - *Outcome and Process Assessment, Health Care
MH  - *Quality of Health Care
MH  - Severity of Illness Index
MH  - Thrombolytic Therapy/statistics & numerical data
MH  - United States/epidemiology
EDAT- 1999/01/28 00:00
MHDA- 1999/01/28 00:01
CRDT- 1999/01/28 00:00
PHST- 1999/01/28 00:00 [pubmed]
PHST- 1999/01/28 00:01 [medline]
PHST- 1999/01/28 00:00 [entrez]
AID - 10.1056/NEJM199901283400407 [doi]
PST - ppublish
SO  - N Engl J Med. 1999 Jan 28;340(4):286-92. doi: 10.1056/NEJM199901283400407.

PMID- 8916748
OWN - NLM
STAT- MEDLINE
DCOM- 19961218
LR  - 20220318
IS  - 0959-8138 (Print)
IS  - 1468-5833 (Electronic)
IS  - 0959-8138 (Linking)
VI  - 313
IP  - 7066
DP  - 1996 Nov 9
TI  - Do socioeconomic differences in mortality persist after retirement? 25 year 
      follow up of civil servants from the first Whitehall study.
PG  - 1177-80
AB  - OBJECTIVE: To assess the risk of death associated with work based and non-work 
      based measures of socioeconomic status before and after retirement age. DESIGN: 
      Follow up study of mortality in relation to employment grade and car ownership 
      over 25 years. SETTING: The first Whitehall study. SUBJECTS: 18,133 male civil 
      servants aged 40-69 years who attended a screening examination between 1967 and 
      1970. MAIN OUTCOME MEASURE: Death. RESULTS: Grade of employment was a strong 
      predictor of mortality before retirement. For men dying at ages 40-64 the lowest 
      employment grade had 3.12 times the mortality of the highest grade (95% 
      confidence interval 2.4 to 4.1). After retirement the ability of grade to predict 
      mortality declined (rate ratio 1.86; 1.6 to 2.2). A non-work based measure of 
      socioeconomic status (car ownership) predicted mortality less well than 
      employment grade before retirement but its ability to predict mortality declined 
      less after retirement. Using a relative index of inequality that was sensitive to 
      the distribution among socioeconomic groups showed employment grade and car 
      ownership to have independent associations with mortality that were of equal 
      magnitude after retirement. The absolute difference in death rates between the 
      lowest and highest employment grades increased with age from 12.9 per 1000 person 
      years at ages 40-64 to 38.3 per 1000 at ages 70-89. CONCLUSIONS: Socioeconomic 
      differences in mortality persist beyond retirement age and in magnitude increase 
      with age. Social differentials in mortality based on an occupational status 
      measure seem to decrease to a greater degree after retirement than those based on 
      a non-work measure. This suggests that alongside other socioeconomic factors work 
      itself may play an important part in generating social inequalities in health in 
      men of working age.
FAU - Marmot, M G
AU  - Marmot MG
AD  - Department of Epidemiology and Public Health, University College, London Medical 
      School.
FAU - Shipley, M J
AU  - Shipley MJ
LA  - eng
GR  - G8802774/MRC_/Medical Research Council/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
SB  - IM
CIN - BMJ. 1997 Apr 12;314(7087):1130. doi: 10.1136/bmj.314.7087.1130. PMID: 9133913
MH  - Adult
MH  - Age Factors
MH  - Aged
MH  - Cause of Death
MH  - England/epidemiology
MH  - Follow-Up Studies
MH  - *Government
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Mortality
MH  - Retirement/*statistics & numerical data
MH  - Social Class
MH  - *Socioeconomic Factors
MH  - Survival Rate
PMC - PMC2352486
EDAT- 1996/11/09 00:00
MHDA- 1996/11/09 00:01
PMCR- 1996/11/09
CRDT- 1996/11/09 00:00
PHST- 1996/11/09 00:00 [pubmed]
PHST- 1996/11/09 00:01 [medline]
PHST- 1996/11/09 00:00 [entrez]
PHST- 1996/11/09 00:00 [pmc-release]
AID - 10.1136/bmj.313.7066.1177 [doi]
PST - ppublish
SO  - BMJ. 1996 Nov 9;313(7066):1177-80. doi: 10.1136/bmj.313.7066.1177.

PMID- 11970923
OWN - NLM
STAT- MEDLINE
DCOM- 20020524
LR  - 20190501
IS  - 1468-2044 (Electronic)
IS  - 0003-9888 (Print)
IS  - 0003-9888 (Linking)
VI  - 86
IP  - 5
DP  - 2002 May
TI  - Convulsions and retinal haemorrhage: should we look further?
PG  - 334-5
AB  - BACKGROUND AND AIMS: The prevalence of retinal haemorrhages after convulsions is 
      not well established. As these haemorrhages are considered characteristic of 
      child abuse, we investigated their occurrence after convulsive episodes to see 
      whether the finding of haemorrhage should prompt further investigation. METHODS: 
      Prospective study of 153 children (aged 2 months to 2 years), seen in the 
      emergency department after a convulsive episode. After a thorough history and 
      physical examination, a retinal examination was performed by an ophthalmologist. 
      If findings were positive, further investigation was undertaken to rule out 
      systemic disorder or child abuse. RESULTS: One child was found with unilateral 
      retinal haemorrhages following an episode of a simple febrile convulsion. A 
      thorough investigation uncovered no other reason for this finding. CONCLUSION: 
      Retinal haemorrhages following a convulsive episode are rare. Such a finding 
      should trigger an extensive search for other reasons, including child abuse.
FAU - Mei-Zahav, M
AU  - Mei-Zahav M
AD  - Division of Paediatric Emergency Medicine, Department of Paediatrics, Sapir 
      Medical Center, Kfar Saba, Sackler School of Medicine, Tel Aviv University, 
      Israel. meir.mei-zahav@sickkids.ca
FAU - Uziel, Y
AU  - Uziel Y
FAU - Raz, J
AU  - Raz J
FAU - Ginot, N
AU  - Ginot N
FAU - Wolach, B
AU  - Wolach B
FAU - Fainmesser, P
AU  - Fainmesser P
LA  - eng
PT  - Journal Article
PL  - England
TA  - Arch Dis Child
JT  - Archives of disease in childhood
JID - 0372434
SB  - IM
MH  - Child Abuse/*diagnosis
MH  - Child, Preschool
MH  - Diagnosis, Differential
MH  - Female
MH  - Humans
MH  - Infant
MH  - Male
MH  - Ophthalmoscopy
MH  - Physical Examination
MH  - Prospective Studies
MH  - Referral and Consultation
MH  - Retinal Hemorrhage/*etiology
MH  - Seizures/*complications
PMC - PMC1751108
EDAT- 2002/04/24 10:00
MHDA- 2002/05/25 10:01
PMCR- 2005/05/01
CRDT- 2002/04/24 10:00
PHST- 2002/04/24 10:00 [pubmed]
PHST- 2002/05/25 10:01 [medline]
PHST- 2002/04/24 10:00 [entrez]
PHST- 2005/05/01 00:00 [pmc-release]
AID - 10.1136/adc.86.5.334 [doi]
PST - ppublish
SO  - Arch Dis Child. 2002 May;86(5):334-5. doi: 10.1136/adc.86.5.334.

PMID- 19302863
OWN - NLM
STAT- MEDLINE
DCOM- 20090715
LR  - 20121115
IS  - 1531-5037 (Electronic)
IS  - 0022-3468 (Linking)
VI  - 44
IP  - 3
DP  - 2009 Mar
TI  - Is the use of cyanoacrylate in intestinal anastomosis a good and reliable 
      alternative?
PG  - 581-6
LID - 10.1016/j.jpedsurg.2008.08.033 [doi]
AB  - PURPOSE: The present study aims to compare strength, healing, and operation time 
      of experimental intestinal anastomoses performed by polyglactin 910 (Vicryl; 
      Ethicon, Edinburgh, United Kingdom) sutures with ethyl-2-cyanoacrylate glue 
      (Pattex; Henkel, Dusseldorf, Germany). MATERIAL AND METHODS: Ninety-six 
      Sprague-Dawley rats were divided into 2 (groups E and L). Each group was further 
      subdivided into 6 subgroups (EA1, EA2, EA3, EB1, EB2, EB3, LA1, LA2, LA3, LB1, 
      LB2, LB3), each containing 8 rats. Intestinal anastomosis was performed by 
      polyglactin 910 sutures in A subgroups and with ethyl-2-cyanoacrylate in B 
      subgroups. The anastomosis was end to end in A1 and B1, side to side in A2 and 
      B2, and end to side in A3 and B3. Time for anastomosis performance (AT) was 
      recorded. In group E, bursting pressures and hydroxyproline levels were 
      determined on the second postoperative day, whereas in group L, the same 
      measurements were made on the sixth postoperative day. One-way analysis of 
      variance was used for analyses of variance in the groups. Quantitative data were 
      analyzed with Student's t test. P value was considered significant at less than 
      .05. RESULTS: There was no significant difference between bursting pressures of 
      subgroup pairs on both postoperative days 2 and 6. Hydroxyproline levels and AT 
      were significantly better in B subgroups. CONCLUSION: Better healing, shorter AT, 
      and equal strength were achieved with ethyl-2-cyanoacrylate compared with 
      polyglactin 910 sutures in intestinal anastomosis in the experimental setting.
FAU - Elemen, Levent
AU  - Elemen L
AD  - Department of Pediatric Surgery, Medical Faculty, Kocaeli University, Kocaeli, 
      Turkey.
FAU - Sarimurat, Nuvit
AU  - Sarimurat N
FAU - Ayik, Bekir
AU  - Ayik B
FAU - Aydin, Seval
AU  - Aydin S
FAU - Uzun, Hafize
AU  - Uzun H
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Pediatr Surg
JT  - Journal of pediatric surgery
JID - 0052631
RN  - 0 (Adhesives)
RN  - 0 (Cyanoacrylates)
RN  - 2G95FOH7SF (ethyl 2-cyanoacrylate)
RN  - 34346-01-5 (Polyglactin 910)
SB  - IM
MH  - Adhesives/*therapeutic use
MH  - Anastomosis, Surgical
MH  - Animals
MH  - Cyanoacrylates/*therapeutic use
MH  - Intestines/*surgery
MH  - Polyglactin 910/*therapeutic use
MH  - Rats
MH  - Rats, Sprague-Dawley
MH  - Tensile Strength
MH  - Wound Healing
EDAT- 2009/03/24 09:00
MHDA- 2009/07/16 09:00
CRDT- 2009/03/24 09:00
PHST- 2008/08/26 00:00 [received]
PHST- 2008/08/27 00:00 [accepted]
PHST- 2009/03/24 09:00 [entrez]
PHST- 2009/03/24 09:00 [pubmed]
PHST- 2009/07/16 09:00 [medline]
AID - S0022-3468(08)00729-X [pii]
AID - 10.1016/j.jpedsurg.2008.08.033 [doi]
PST - ppublish
SO  - J Pediatr Surg. 2009 Mar;44(3):581-6. doi: 10.1016/j.jpedsurg.2008.08.033.

PMID- 22532370
OWN - NLM
STAT- MEDLINE
DCOM- 20121024
LR  - 20161125
IS  - 1097-0096 (Electronic)
IS  - 0091-2751 (Linking)
VI  - 40
IP  - 6
DP  - 2012 Jul-Aug
TI  - Are increased carotid artery pulsatility and resistance indexes early signs of 
      vascular abnormalities in young obese males?
PG  - 335-40
LID - 10.1002/jcu.21927 [doi]
AB  - PURPOSE: To provide insight into the factors by which obesity in itself may 
      directly lead to early arterial damage, we aimed to determine early sonographic 
      markers of obesity-related vascular dysfunction in young obese males. METHODS: 
      Thirty-five young obese males and 23 age-matched healthy male volunteers were 
      recruited into the study. Common carotid artery pulsatility index and resistance 
      index were calculated from blood flow velocities curves obtained by pulsed 
      Doppler ultrasonography. RESULTS: The mean pulsatility index, resistance index, 
      body mass index, waist circumference, systolic and diastolic blood pressure, 
      homeostasis model assessment for insulin resistance, plasma fasting glucose, 
      insulin, C-peptide, triglycerides, low-density lipoprotein cholesterol, and 
      high-sensitivity C-reactive protein were statistically higher in obese subjects 
      than in healthy controls. CONCLUSIONS: Our results suggest that depressed vessel 
      compliance and increased vascular resistance are features of young, obese, 
      normotensive subjects independently of and in addition to cardiovascular risk 
      factors. As changes in arterial wall properties may be incipient in young obese 
      subjects, future studies will be required to demonstrate whether early 
      intervention such as diet and exercise in this population can improve vascular 
      functions.
CI  - Copyright (c) 2012 Wiley Periodicals, Inc.
FAU - Ozari, H Onur
AU  - Ozari HO
AD  - Division of Internal Medicine, GATA Haydarpasa Training Hospital, Tibbiye Caddesi 
      TR-34668 Uskudar-Istanbul, Turkey.
FAU - Oktenli, Cagatay
AU  - Oktenli C
FAU - Celik, Serkan
AU  - Celik S
FAU - Tangi, Fatih
AU  - Tangi F
FAU - Ipcioglu, Osman
AU  - Ipcioglu O
FAU - Terekeci, Hakan M
AU  - Terekeci HM
FAU - Top, Cihan
AU  - Top C
FAU - Uzun, Mehmet
AU  - Uzun M
FAU - Sanisoglu, Yavuz S
AU  - Sanisoglu YS
FAU - Nalbant, Selim
AU  - Nalbant S
LA  - eng
PT  - Journal Article
DEP - 20120425
PL  - United States
TA  - J Clin Ultrasound
JT  - Journal of clinical ultrasound : JCU
JID - 0401663
RN  - 0 (Blood Glucose)
RN  - 0 (C-Peptide)
RN  - 0 (Insulin)
RN  - 0 (Lipoproteins, LDL)
RN  - 0 (Triglycerides)
RN  - 9007-41-4 (C-Reactive Protein)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Blood Flow Velocity
MH  - Blood Glucose/analysis
MH  - Blood Pressure
MH  - Body Mass Index
MH  - C-Peptide/blood
MH  - C-Reactive Protein/metabolism
MH  - Carotid Arteries/*diagnostic imaging/*physiopathology
MH  - Case-Control Studies
MH  - Humans
MH  - Insulin/blood
MH  - Insulin Resistance
MH  - Lipoproteins, LDL/blood
MH  - Male
MH  - Obesity/*complications
MH  - Pulsatile Flow
MH  - Statistics, Nonparametric
MH  - Triglycerides/blood
MH  - *Ultrasonography, Doppler, Pulsed
MH  - Vascular Resistance
MH  - Waist Circumference
EDAT- 2012/04/26 06:00
MHDA- 2012/10/25 06:00
CRDT- 2012/04/26 06:00
PHST- 2011/01/24 00:00 [received]
PHST- 2012/03/19 00:00 [accepted]
PHST- 2012/04/26 06:00 [entrez]
PHST- 2012/04/26 06:00 [pubmed]
PHST- 2012/10/25 06:00 [medline]
AID - 10.1002/jcu.21927 [doi]
PST - ppublish
SO  - J Clin Ultrasound. 2012 Jul-Aug;40(6):335-40. doi: 10.1002/jcu.21927. Epub 2012 
      Apr 25.

PMID- 18179827
OWN - NLM
STAT- MEDLINE
DCOM- 20080610
LR  - 20181201
IS  - 0165-5876 (Print)
IS  - 0165-5876 (Linking)
VI  - 72
IP  - 3
DP  - 2008 Mar
TI  - Does topical ropivacaine reduce the post-tonsillectomy morbidity in pediatric 
      patients?
PG  - 361-5
LID - 10.1016/j.ijporl.2007.11.011 [doi]
AB  - OBJECTIVES: To determine whether post-operative administration of topical 
      ropivacaine hydrochloride decreases morbidity following adenotonsillectomy. STUDY 
      DESIGN: Prospective, randomized, double-blind clinical trial. SETTING: University 
      referral center; ENT Department. PARTICIPANTS: Fourty one children, aged 4-16 
      years, undergoing tonsillectomy. METHODS: Patients received 1.0% ropivacaine 
      hydrochloride soaked swabs packed in their tonsillar fossae while the control 
      group received saline-soaked swabs. Mc Grath's face scale was used to compare the 
      two groups in respect of pain control. Chi-square and two-tailed unpaired 
      Student's t-tests or Mann-Whitney-U-tests were used to compare the two 
      independent groups. As 10 we made 11 comparison between groups, for Bonferroni 
      correction, p<0.005 was accepted as statistically significant. RESULTS: Only 
      first hour there was no significant pain-relieving effect seen in the ropivacaine 
      group (p>0.05). The other hours and days there were statistically significance 
      between the two groups (p<0.001). Also, the other post-operative parameters such 
      as nausea, fever, vomiting, odor, bleeding, otalgia and trismus were not 
      statistically different between the two groups. There were no complications 
      associated with ropivacaine hydrochloride. No patients in this study suffered 
      systemic side effects related to the use of this medication. CONCLUSION: Locally 
      1.0% ropivacaine administration significantly relieves the pain of pediatric 
      tonsillectomy and, it is a safe and effective method. High concentrations of 
      ropivaciane may produce clinically significant pain relief. It is more effective 
      to reduce of post-operative analgesic requirement after first hour.
FAU - Oghan, Fatih
AU  - Oghan F
AD  - University of Dumlupinar, Training and Research Hospital, Department of 
      Otorhinolaryngology and Head and Neck Surgery, Kutahya, Turkey. 
      fatihoghan@hotmail.com
FAU - Harputluoglu, Ugur
AU  - Harputluoglu U
FAU - Guclu, Ender
AU  - Guclu E
FAU - Kocaman, Buket
AU  - Kocaman B
FAU - Ozturk, Ozcan
AU  - Ozturk O
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20080107
PL  - Ireland
TA  - Int J Pediatr Otorhinolaryngol
JT  - International journal of pediatric otorhinolaryngology
JID - 8003603
RN  - 0 (Amides)
RN  - 0 (Anesthetics, Local)
RN  - 7IO5LYA57N (Ropivacaine)
SB  - IM
MH  - Administration, Topical
MH  - Adolescent
MH  - Amides/administration & dosage/*therapeutic use
MH  - Anesthetics, Local/administration & dosage/*therapeutic use
MH  - Child
MH  - Child, Preschool
MH  - Double-Blind Method
MH  - Female
MH  - Humans
MH  - Male
MH  - Pain Measurement
MH  - Pain, Postoperative/diagnosis/*drug therapy
MH  - Prospective Studies
MH  - Ropivacaine
MH  - Time Factors
MH  - *Tonsillectomy
EDAT- 2008/01/09 09:00
MHDA- 2008/06/11 09:00
CRDT- 2008/01/09 09:00
PHST- 2007/08/20 00:00 [received]
PHST- 2007/11/24 00:00 [revised]
PHST- 2007/11/25 00:00 [accepted]
PHST- 2008/01/09 09:00 [pubmed]
PHST- 2008/06/11 09:00 [medline]
PHST- 2008/01/09 09:00 [entrez]
AID - S0165-5876(07)00571-X [pii]
AID - 10.1016/j.ijporl.2007.11.011 [doi]
PST - ppublish
SO  - Int J Pediatr Otorhinolaryngol. 2008 Mar;72(3):361-5. doi: 
      10.1016/j.ijporl.2007.11.011. Epub 2008 Jan 7.

PMID- 18399830
OWN - NLM
STAT- MEDLINE
DCOM- 20080522
LR  - 20220316
IS  - 1464-410X (Electronic)
IS  - 1464-4096 (Linking)
VI  - 101
IP  - 9
DP  - 2008 May
TI  - Is robotically assisted laparoscopic radical prostatectomy less invasive than 
      retropubic radical prostatectomy? Results from a prospective, unrandomized, 
      comparative study.
PG  - 1145-9
LID - 10.1111/j.1464-410X.2008.07513.x [doi]
AB  - OBJECTIVES: To evaluate whether robotically assisted laparoscopic prostatectomy 
      (RALP) is less invasive than radical retropubic prostatectomy (RRP), as 
      experimental studies suggest that the acute phase reaction is proportional to 
      surgery-induced tissue damage. PATIENTS AND METHODS: Between May and November 
      2006, all patients undergoing RRP or RALP in our department were prospectively 
      assessed. Blood samples were collected 24 h before (T0), during surgery (T1), at 
      the end of anaesthesia (T2), and 12 (T3) and 24 h after surgery (T4), and assayed 
      for interleukin(IL)-6 and IL-1 alpha, C-reactive protein (CRP), and lactate. The 
      Mann-Whitney U-, Student's t- and Friedman tests were used to compare continuous 
      variables, and the Pearson chi-square and Fisher test for categorical variables, 
      with a two-sided P < 0.05 considered to indicate significance. RESULTS: In all, 
      35 and 26 patients were assessed for RALP and RRP, respectively; the median 
      (interquartile range) age was 62 (56-68) and 68.5 (59.2-71.2) years, respectively 
      (P < 0.009). Baseline levels (T0) of IL-1, IL-6, CRP and lactate were comparable 
      in both arms. IL-6, CRP and lactates levels increased during both kinds of 
      surgery. The mean IL-6 and CPR values were higher for RRP at T1 (P = 0.01 and 
      0.001), T2 (P = 0.001 and <0.001), T3 (P = 0.002 and <0.001) and T4 (P < 0.001 
      and 0.02), respectively. Lactate was higher for RRP at T2 (P = 0.001), T3 (P = 
      0.001) and T4 (P = 0.004), although remaining within the normal ranges. IL-1 
      alpha did not change at the different sample times. CONCLUSIONS: This study 
      showed for the first time that RALP induces lower tissue trauma than RRP.
FAU - Fracalanza, Simonetta
AU  - Fracalanza S
AD  - Department of Oncological and Surgical Sciences, Urology Clinic, University of 
      Padua, Italy.
FAU - Ficarra, Vincenzo
AU  - Ficarra V
FAU - Cavalleri, Stefano
AU  - Cavalleri S
FAU - Galfano, Antonio
AU  - Galfano A
FAU - Novara, Giacomo
AU  - Novara G
FAU - Mangano, Angelo
AU  - Mangano A
FAU - Plebani, Mario
AU  - Plebani M
FAU - Artibani, Walter
AU  - Artibani W
LA  - eng
PT  - Comparative Study
PT  - Evaluation Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - BJU Int
JT  - BJU international
JID - 100886721
RN  - 0 (Interleukin-1alpha)
RN  - 0 (Interleukin-6)
RN  - 33X04XA5AT (Lactic Acid)
RN  - 9007-41-4 (C-Reactive Protein)
SB  - IM
MH  - Acute-Phase Reaction/*prevention & control
MH  - Aged
MH  - C-Reactive Protein/analysis
MH  - Humans
MH  - Interleukin-1alpha/blood
MH  - Interleukin-6/blood
MH  - Lactic Acid/blood
MH  - *Laparoscopy
MH  - Male
MH  - Middle Aged
MH  - Postoperative Complications/*prevention & control
MH  - Prospective Studies
MH  - Prostatectomy/adverse effects/*methods
MH  - Prostatic Neoplasms/blood/*surgery
MH  - *Robotics
MH  - Statistics, Nonparametric
MH  - Treatment Outcome
EDAT- 2008/04/11 09:00
MHDA- 2008/05/23 09:00
CRDT- 2008/04/11 09:00
PHST- 2008/04/11 09:00 [pubmed]
PHST- 2008/05/23 09:00 [medline]
PHST- 2008/04/11 09:00 [entrez]
AID - BJU7513 [pii]
AID - 10.1111/j.1464-410X.2008.07513.x [doi]
PST - ppublish
SO  - BJU Int. 2008 May;101(9):1145-9. doi: 10.1111/j.1464-410X.2008.07513.x.

PMID- 12595848
OWN - NLM
STAT- MEDLINE
DCOM- 20030318
LR  - 20220318
IS  - 1097-6744 (Electronic)
IS  - 0002-8703 (Linking)
VI  - 145
IP  - 2
DP  - 2003 Feb
TI  - Is specialty care associated with improved survival of patients with congestive 
      heart failure?
PG  - 300-9
AB  - BACKGROUND: Implementation of the complex treatment strategies that have been 
      shown to improve survival of patients with congestive heart failure (CHF) may 
      require certain expertise. We wanted to examine the association between pattern 
      of outpatient care and survival of patients with CHF. METHODS: In a retrospective 
      cohort study conducted with national Veterans Health Administration (VHA) 
      databases, we examined the association between the pattern of outpatient care and 
      survival in 11,661 patients discharged from VA hospitals between October 1, 1991, 
      and September 30, 1992, with the primary diagnosis of CHF (cohort 1). Patients 
      were divided into 4 groups, on the basis of their pattern of outpatient care over 
      a 12-month period after discharge: 1) general medicine clinic visits only 
      (GM-only); 2) cardiology clinic visits only (CARD-only); 3) general medicine and 
      cardiology (MIXED) clinic visits; and 4) neither general medicine nor cardiology 
      clinic visits (no-GM/CARD). We used the Cox proportional hazards model to 
      evaluate 1-year survival, controlling for clinical and demographic factors. 
      Consistency of our results was examined by performing identical analysis on a 
      cohort of patients discharged from VHA hospitals between October 1, 1994, and 
      September 30, 1995 (cohort 2, n = 10,141). RESULTS: The overall 1-year mortality 
      rate was 23% in the primary cohort. The unadjusted mortality rate was highest for 
      patients in the no-GM/CARD follow up (29%) and lowest for patients in the MIXED 
      group (19%). By use of the MIXED group as reference and adjusting for important 
      clinical and demographic factors, the risk of death (risk ratio [95% CI]) was 
      1.12 (0.94-1.34) in the CARD-only group, 1.26 (1.15-1.38) in the GM-only group, 
      and 1.48 (1.28-1.72) in the no-GM/CARD group. Cohort-2 results were consistent 
      with cohort 1 for most covariates, and significant survival differences were 
      again found between GM-only and the MIXED group (1.25 [1.14-1.37]). CONCLUSIONS: 
      We found an improved survival associated with cardiologist care and a mixture of 
      general practitioner and cardiologist care compared with general practitioner 
      care. The pattern of outpatient care may therefore be important for the survival 
      of patients with CHF.
FAU - Indridason, Olafur S
AU  - Indridason OS
AD  - Department of Medicine, Division of Nephrology, Duke University Medical Center, 
      Durham, NC, USA.
FAU - Coffman, Cynthia J
AU  - Coffman CJ
FAU - Oddone, Eugene Z
AU  - Oddone EZ
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - United States
TA  - Am Heart J
JT  - American heart journal
JID - 0370465
SB  - IM
CIN - Am Heart J. 2003 Feb;145(2):209-13. doi: 10.1067/mhj.2003.55. PMID: 12595835
MH  - Aged
MH  - Cardiology/*standards/statistics & numerical data
MH  - Clinical Competence
MH  - Cohort Studies
MH  - Databases, Factual
MH  - Family Practice/*standards/statistics & numerical data
MH  - Health Services Accessibility/statistics & numerical data
MH  - Heart Failure/*mortality/*therapy
MH  - Hospitals, Veterans/standards
MH  - Humans
MH  - Male
MH  - Outcome Assessment, Health Care
MH  - Outpatient Clinics, Hospital/*standards
MH  - Patient Discharge
MH  - Prognosis
MH  - Proportional Hazards Models
MH  - Survival Rate
MH  - United States/epidemiology
EDAT- 2003/02/22 04:00
MHDA- 2003/03/19 04:00
CRDT- 2003/02/22 04:00
PHST- 2003/02/22 04:00 [pubmed]
PHST- 2003/03/19 04:00 [medline]
PHST- 2003/02/22 04:00 [entrez]
AID - S0002870302947630 [pii]
AID - 10.1067/mhj.2003.54 [doi]
PST - ppublish
SO  - Am Heart J. 2003 Feb;145(2):300-9. doi: 10.1067/mhj.2003.54.

PMID- 18158048
OWN - NLM
STAT- MEDLINE
DCOM- 20080108
LR  - 20220318
IS  - 1527-9995 (Electronic)
IS  - 0090-4295 (Linking)
VI  - 70
IP  - 6
DP  - 2007 Dec
TI  - Histologic evaluation of the testicular remnant associated with the vanishing 
      testes syndrome: is surgical management necessary?
PG  - 1204-6
AB  - OBJECTIVES: There is controversy surrounding the optimal management of the 
      testicular remnant associated with the vanishing testes syndrome. Some urologists 
      advocate the need for surgical exploration, whereas others believe this is 
      unnecessary. These differing opinions are based on the variable reports of viable 
      germ cell elements found within the testicular remnants. To better understand the 
      pathology associated with this syndrome and the need for surgical management, we 
      reviewed our experience regarding the incidence of viable germ cell elements 
      within the testicular remnant. METHODS: An institutional review board-approved, 
      retrospective review was performed of all consecutive patients undergoing 
      exploration for a nonpalpable testis at Eastern Virginia Medical School and 
      Geisinger Medical Center between 1994 and 2006. Patients who were found to have 
      spermatic vessels and a vas deferens exiting a closed internal inguinal ring were 
      included in this analysis. RESULTS: Fifty-six patients underwent removal of the 
      testicular remnant. Patient age ranged from 11 to 216 months. In 8 of the 
      specimens (14%), we identified viable germ cell elements. In an additional 4 
      patients (7%), we identified seminiferous tubules without germ cell elements. 
      CONCLUSIONS: In our review, we identified that a significant number of testicular 
      remnants associated with the vanishing testes syndrome can harbor viable germ 
      cell elements or seminiferous tubules. The exact fate of these residual elements 
      remains unknown; however, there may exist the potential for malignant 
      transformation. Given the potential for malignant degeneration, we believe that 
      these remnants should be removed.
FAU - Storm, Douglas
AU  - Storm D
AD  - Geisinger Medical Center, Danville, Pennsylvania 17822, USA. 
      dwstorm@geisinger.edu
FAU - Redden, Timothy
AU  - Redden T
FAU - Aguiar, Maria
AU  - Aguiar M
FAU - Wilkerson, Myra
AU  - Wilkerson M
FAU - Jordan, Gerald
AU  - Jordan G
FAU - Sumfest, Joel
AU  - Sumfest J
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Urology
JT  - Urology
JID - 0366151
SB  - IM
MH  - Child, Preschool
MH  - Cryptorchidism/*pathology/surgery
MH  - Germ Cells/pathology
MH  - Humans
MH  - Infant
MH  - Male
MH  - Seminiferous Tubules/pathology
MH  - Testis/*abnormalities/pathology/surgery
EDAT- 2007/12/26 09:00
MHDA- 2008/01/09 09:00
CRDT- 2007/12/26 09:00
PHST- 2007/03/09 00:00 [received]
PHST- 2007/06/28 00:00 [revised]
PHST- 2007/08/10 00:00 [accepted]
PHST- 2007/12/26 09:00 [pubmed]
PHST- 2008/01/09 09:00 [medline]
PHST- 2007/12/26 09:00 [entrez]
AID - S0090-4295(07)02002-X [pii]
AID - 10.1016/j.urology.2007.08.020 [doi]
PST - ppublish
SO  - Urology. 2007 Dec;70(6):1204-6. doi: 10.1016/j.urology.2007.08.020.

PMID- 23848044
OWN - NLM
STAT- MEDLINE
DCOM- 20140429
LR  - 20191112
IS  - 0350-199X (Print)
IS  - 0350-199X (Linking)
VI  - 67
IP  - 3
DP  - 2013
TI  - Does oxybutynin hydrochloride cause arrhythmia in children with bladder 
      dysfunction?
PG  - 202-4
AB  - AIM: Pediatric surgeons frequently encounter children presenting with voiding 
      dysfunction symptoms, including urgency, frequency, and incontinence. 
      Antimuscarinic agents Oxybutynin) are the main drugs used to treat patients with 
      overactive bladder (OAB) syndrome, defined as urgency, with or without urgency 
      incontinence, usually with increased daytime frequency and nocturia. Increased QT 
      dispersion is known to be the cause of ventricular arrhythmia in various systemic 
      diseases and leads to increased mortality and morbidity. METHOD: This study 
      represents a subset of a complete data set, considering only those children aged 
      admitted to the Pediatric Surgery and Pediatric Nephrology Clinics during the 
      period January 2011 to July 2012. RESULT: In this study, we have determined that 
      the QT interval changes significantly depending on the use of oxybutynin. The QT 
      changes increased cardiac arrhythmia in children. CONCLUSION: For this reason, 
      children using such drugs should be closely monitored for cardiac arrhythmia.
FAU - Ciftci, Ilihan
AU  - Ciftci I
AD  - Department of Pediatric Surgery, University of Selcuk, Selcuklu Medical Faculty, 
      Konya, Turkey. driciftci@yahoo.com
FAU - Arslan, Derya
AU  - Arslan D
FAU - Peru, Harun
AU  - Peru H
FAU - Cimen, Derya
AU  - Cimen D
FAU - Oran, Bulent
AU  - Oran B
FAU - Gunduz, Metin
AU  - Gunduz M
LA  - eng
PT  - Journal Article
PL  - Bosnia and Herzegovina
TA  - Med Arch
JT  - Medical archives (Sarajevo, Bosnia and Herzegovina)
JID - 101635337
RN  - 0 (Mandelic Acids)
RN  - 0 (Muscarinic Antagonists)
RN  - K9P6MC7092 (oxybutynin)
SB  - IM
MH  - Adolescent
MH  - Arrhythmias, Cardiac/*chemically induced/physiopathology
MH  - Child
MH  - Child, Preschool
MH  - Electrocardiography/*drug effects
MH  - Female
MH  - Humans
MH  - Male
MH  - Mandelic Acids/*adverse effects/therapeutic use
MH  - Muscarinic Antagonists/adverse effects/therapeutic use
MH  - Retrospective Studies
MH  - Urinary Bladder, Overactive/*drug therapy
EDAT- 2013/07/16 06:00
MHDA- 2014/04/30 06:00
CRDT- 2013/07/16 06:00
PHST- 2013/07/16 06:00 [entrez]
PHST- 2013/07/16 06:00 [pubmed]
PHST- 2014/04/30 06:00 [medline]
AID - 10.5455/medarh.2013.67.202-204 [doi]
PST - ppublish
SO  - Med Arch. 2013;67(3):202-4. doi: 10.5455/medarh.2013.67.202-204.

PMID- 11481172
OWN - NLM
STAT- MEDLINE
DCOM- 20010830
LR  - 20071114
IS  - 0002-953X (Print)
IS  - 0002-953X (Linking)
VI  - 158
IP  - 8
DP  - 2001 Aug
TI  - Does the manic/mixed episode distinction in bipolar disorder patients run true 
      over time?
PG  - 1324-6
AB  - OBJECTIVE: The authors sought to determine whether the manic/mixed episode 
      distinction in patients with bipolar disorder runs true over time. METHOD: Over 
      an 11-year period, the observed distribution of manic and mixed episodes 
      (N=1,224) for patients with three or more entries in the management information 
      system of a community mental health center (N=241) was compared to the expected 
      distribution determined by averaging 1,000 randomly generated simulations. 
      RESULTS: Episodes were consistent (all manic or all mixed) in significantly more 
      patients than would be expected by chance. CONCLUSIONS: These data suggest a 
      pattern of diagnostic stability over time for manic and mixed episodes in 
      patients with bipolar disorder. Careful prospective studies of this issue are 
      needed.
FAU - Woods, S W
AU  - Woods SW
AD  - Department of Psychiatry, Treatment Research Program, Connecticut Mental Health 
      Center, Yale University School of Medicine, 34 Park St., New Haven, CT 06519, 
      USA. scott.woods@yale.edu
FAU - Money, R
AU  - Money R
FAU - Baker, C B
AU  - Baker CB
LA  - eng
GR  - MH-54446/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - Am J Psychiatry
JT  - The American journal of psychiatry
JID - 0370512
SB  - IM
MH  - Bipolar Disorder/*diagnosis/psychology
MH  - Community Mental Health Centers
MH  - Computer Simulation
MH  - Depressive Disorder/diagnosis/psychology
MH  - Humans
MH  - Management Information Systems/statistics & numerical data
MH  - Probability
MH  - Random Allocation
MH  - Retrospective Studies
MH  - Statistical Distributions
EDAT- 2001/08/02 10:00
MHDA- 2001/08/31 10:01
CRDT- 2001/08/02 10:00
PHST- 2001/08/02 10:00 [pubmed]
PHST- 2001/08/31 10:01 [medline]
PHST- 2001/08/02 10:00 [entrez]
AID - 10.1176/appi.ajp.158.8.1324 [doi]
PST - ppublish
SO  - Am J Psychiatry. 2001 Aug;158(8):1324-6. doi: 10.1176/appi.ajp.158.8.1324.

PMID- 28247485
OWN - NLM
STAT- MEDLINE
DCOM- 20170623
LR  - 20210109
IS  - 1600-0412 (Electronic)
IS  - 0001-6349 (Print)
IS  - 0001-6349 (Linking)
VI  - 96
IP  - 5
DP  - 2017 May
TI  - Is the first urinary albumin/creatinine ratio (ACR) in women with suspected 
      preeclampsia a prognostic factor for maternal and neonatal adverse outcome? A 
      retrospective cohort study.
PG  - 580-588
LID - 10.1111/aogs.13123 [doi]
AB  - INTRODUCTION: The aim of this study was to determine the prognostic value of the 
      first urinary albumin/creatinine ratio (ACR) for adverse maternal and neonatal 
      outcomes and how it relates to other prognostic factors. MATERIAL AND METHODS: We 
      performed a retrospective cohort study from December 2009 to February 2012 with 
      analysis of demographic, clinical and biochemical data from two obstetric day 
      assessment units in hospitals in Southeast Scotland. We included 717 pregnant 
      women, with singleton pregnancies after 20 weeks' gestation, referred for 
      evaluation of suspected preeclampsia and having their first ACR performed. The 
      ability of ACR to predict future outcomes was assessed in both univariable and 
      multivariable logistic regression models. The latter assessed its prognostic 
      value independent of (adjusting for) existing prognostic factors. Primary outcome 
      measures were maternal and neonatal composite adverse outcomes, and a secondary 
      outcome was gestation at delivery. RESULTS: In all, 204 women (28.5%) experienced 
      a composite adverse maternal outcome and 146 women (20.4%) experienced a 
      composite adverse neonatal outcome. Multivariate analysis of log-transformed ACR 
      demonstrated that a 1-unit increase in log ACR is associated with an increased 
      odds of adverse maternal [odds ratio 1.60, 95% confidence interval (CI) 
      1.45-1.80] and adverse neonatal (odds ratio 1.15, 95% CI 1.02-1.29) composite 
      outcomes, and with reduced gestational age at delivery (coefficient: -0.46, 95% 
      CI -0.54 to -0.38). CONCLUSIONS: ACR is an independent prognostic factor for 
      maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be 
      useful to inform risk predictions within a prognostic model.
CI  - (c) 2017 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by 
      John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics 
      and Gynecology (NFOG).
FAU - Elia, Eleni G
AU  - Elia EG
AD  - Public Health, Epidemiology and Biostatistics, School of Health and Population 
      Sciences, College of Medical and Dental Sciences, University of Birmingham, 
      Birmingham, UK.
FAU - Robb, Amy O
AU  - Robb AO
AD  - The Simpson Centre for Reproductive Health, Royal Infirmary of Edinburgh, 
      Edinburgh, UK.
FAU - Hemming, Karla
AU  - Hemming K
AD  - Public Health, Epidemiology and Biostatistics, School of Health and Population 
      Sciences, College of Medical and Dental Sciences, University of Birmingham, 
      Birmingham, UK.
FAU - Price, Malcolm J
AU  - Price MJ
AD  - Public Health, Epidemiology and Biostatistics, School of Health and Population 
      Sciences, College of Medical and Dental Sciences, University of Birmingham, 
      Birmingham, UK.
FAU - Riley, Richard D
AU  - Riley RD
AD  - Primary Care and Health Sciences, Keele University, Newcastle, UK.
FAU - French-Constant, Anna
AU  - French-Constant A
AD  - The Simpson Centre for Reproductive Health, Royal Infirmary of Edinburgh, 
      Edinburgh, UK.
FAU - Denison, Fiona C
AU  - Denison FC
AD  - Tommy's Centre for Maternal and Fetal Health, MRC Centre for Reproductive Health, 
      University of Edinburgh Queen's Medical Research Institute, Edinburgh, UK.
FAU - Kilby, Mark D
AU  - Kilby MD
AD  - Birmingham Centre for Women's & Newborn's Health, Institute of Metabolism and 
      Systems Research, College of Medical & Dental Sciences, University of Birmingham, 
      Birmingham, UK.
FAU - Morris, Rachel K
AU  - Morris RK
AD  - Birmingham Centre for Women's & Newborn's Health, Institute of Metabolism and 
      Systems Research, College of Medical & Dental Sciences, University of Birmingham, 
      Birmingham, UK.
FAU - Stock, Sarah J
AU  - Stock SJ
AUID- ORCID: 0000-0003-4308-856X
AD  - Tommy's Centre for Maternal and Fetal Health, MRC Centre for Reproductive Health, 
      University of Edinburgh Queen's Medical Research Institute, Edinburgh, UK.
AD  - School of Women's and Infant's Health, University of Western Australia, The 
      University of Western Australia at King Edward Memorial Hospital, Crawley, WA, 
      Australia.
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
DEP - 20170324
PL  - United States
TA  - Acta Obstet Gynecol Scand
JT  - Acta obstetricia et gynecologica Scandinavica
JID - 0370343
RN  - AYI8EX34EU (Creatinine)
SB  - IM
MH  - Adult
MH  - Albuminuria/diagnosis/urine
MH  - Cohort Studies
MH  - Creatinine/*urine
MH  - Female
MH  - Humans
MH  - Infant, Newborn
MH  - Pre-Eclampsia/*diagnosis/urine
MH  - Predictive Value of Tests
MH  - Pregnancy
MH  - Pregnancy Outcome
MH  - *Prenatal Diagnosis
MH  - Prognosis
MH  - Proteinuria/*diagnosis/urine
MH  - Retrospective Studies
MH  - Scotland
PMC - PMC5413808
OTO - NOTNLM
OT  - ACR
OT  - Preeclampsia
OT  - adverse events
OT  - albumin to creatinine ratio
OT  - cohort study
OT  - prognosis
OT  - risk factors
EDAT- 2017/03/02 06:00
MHDA- 2017/06/24 06:00
PMCR- 2017/05/03
CRDT- 2017/03/02 06:00
PHST- 2016/10/04 00:00 [received]
PHST- 2017/02/08 00:00 [accepted]
PHST- 2017/03/02 06:00 [pubmed]
PHST- 2017/06/24 06:00 [medline]
PHST- 2017/03/02 06:00 [entrez]
PHST- 2017/05/03 00:00 [pmc-release]
AID - AOGS13123 [pii]
AID - 10.1111/aogs.13123 [doi]
PST - ppublish
SO  - Acta Obstet Gynecol Scand. 2017 May;96(5):580-588. doi: 10.1111/aogs.13123. Epub 
      2017 Mar 24.

PMID- 24977765
OWN - NLM
STAT- MEDLINE
DCOM- 20140905
LR  - 20140701
IS  - 2163-0763 (Electronic)
IS  - 2163-0755 (Linking)
VI  - 77
IP  - 1
DP  - 2014 Jul
TI  - Are pediatric concussion patients compliant with discharge instructions?
PG  - 117-22; discussion 122
LID - 10.1097/TA.0000000000000275 [doi]
AB  - BACKGROUND: Concussions are commonly diagnosed in pediatric patients presenting 
      to the emergency department (ED). The primary objective of this study was to 
      evaluate compliance with ED discharge instructions for concussion management. 
      METHODS: A prospective cohort study was conducted from November 2011 to November 
      2012 in a pediatric ED at a regional Level 1 trauma center, serving 35,000 
      pediatric patients per year. Subjects were aged 8 years to 17 years and were 
      discharged from the ED with a diagnosis of concussion. Exclusion criteria 
      included recent (past 3 months) diagnosis of head injury, hospital admission, 
      intracranial injury, skull fracture, suspected nonaccidental trauma, or 
      preexisting neurologic condition. Subjects were administered a baseline survey in 
      the ED and were given standardized discharge instructions for concussion by the 
      treating physician. Telephone follow-up surveys were conducted at 2 weeks and 4 
      weeks after ED visit. RESULTS: A total of 150 patients were enrolled. The 
      majority (67%) of concussions were sports related. Among sports-related 
      concussions, soccer (30%), football (11%), lacrosse (8%), and basketball (8%) 
      injuries were most common. More than one third (39%) reported return to play 
      (RTP) on the day of the injury. Physician follow-up was equivalent for sport and 
      nonsport concussions (2 weeks, 58%; 4 weeks, 64%). Sports-related concussion 
      patients were more likely to follow up with a trainer (2 weeks, 25% vs. 10%, p = 
      0.06; 4 weeks, 29% vs. 8%, p < 0.01). Of the patients who did RTP or normal 
      activities at 2 weeks (44%), more than one third (35%) were symptomatic, and most 
      (58%) did not receive medical clearance. Of the patients who had returned to 
      activities at 4 weeks (64%), less than one quarter (23%) were symptomatic, and 
      most (54%) received medical clearance. CONCLUSION: Pediatric patients discharged 
      from the ED are mostly compliant with concussion instructions. However, a 
      significant number of patients RTP on the day of injury, while experiencing 
      symptoms or without medical clearance. LEVEL OF EVIDENCE: Care management, level 
      IV. Epidemiologic study, level III.
FAU - Hwang, Vivian
AU  - Hwang V
AD  - From the Department of Emergency Medicine, Inova Fairfax Hospital, Falls Church, 
      Virginia.
FAU - Trickey, Amber W
AU  - Trickey AW
FAU - Lormel, Christy
AU  - Lormel C
FAU - Bradford, Anna N
AU  - Bradford AN
FAU - Griffen, Margaret M
AU  - Griffen MM
FAU - Lawrence, Cheryl P
AU  - Lawrence CP
FAU - Sturek, Charles
AU  - Sturek C
FAU - Stacey, Elizabeth
AU  - Stacey E
FAU - Howell, John M
AU  - Howell JM
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Trauma Acute Care Surg
JT  - The journal of trauma and acute care surgery
JID - 101570622
SB  - IM
MH  - Adolescent
MH  - Athletic Injuries/*therapy
MH  - Basketball/injuries
MH  - Brain Concussion/*therapy
MH  - Child
MH  - Emergency Service, Hospital
MH  - Female
MH  - Humans
MH  - Male
MH  - *Patient Compliance
MH  - *Patient Discharge Summaries
MH  - Prospective Studies
MH  - Racquet Sports/injuries
MH  - Soccer/injuries
EDAT- 2014/07/01 06:00
MHDA- 2014/09/06 06:00
CRDT- 2014/07/01 06:00
PHST- 2014/07/01 06:00 [entrez]
PHST- 2014/07/01 06:00 [pubmed]
PHST- 2014/09/06 06:00 [medline]
AID - 01586154-201407000-00019 [pii]
AID - 10.1097/TA.0000000000000275 [doi]
PST - ppublish
SO  - J Trauma Acute Care Surg. 2014 Jul;77(1):117-22; discussion 122. doi: 
      10.1097/TA.0000000000000275.

PMID- 14551704
OWN - NLM
STAT- MEDLINE
DCOM- 20040206
LR  - 20151119
IS  - 0723-5003 (Print)
IS  - 0723-5003 (Linking)
VI  - 98
IP  - 9
DP  - 2003 Sep 15
TI  - [Can communication with terminally ill patients be taught? Evaluation of a course 
      model].
PG  - 477-83
AB  - BACKGROUND AND PURPOSE: Communication with terminally ill patients is a main 
      responsibility of physicians. However, many physicians feel insufficiently 
      prepared for this task. Models of courses resulting in improvements of 
      communicative skills of participants have been published mainly in the 
      Anglo-American literature. This study describes the realization of a 2-day course 
      model based on the experiences of the first three courses of this kind in 
      Rhineland-Palatinate, and analyzes changes of participants' communication 
      behavior. METHODS: After each seminary, an evaluation form concerning 
      participants' satisfaction with the course was filled in. Furthermore, all course 
      participants received a questionnaire at the beginning and at the end of the 
      course, as well as 3 months afterwards. The participants were asked to assess 
      their own sense of security in seven different communication settings on a visual 
      analog scale, and to specify perceived changes in their communication behavior 3 
      months after the course. RESULTS: The first three courses were attended by 31 
      participants. Course evaluation revealed high satisfaction scores with methods as 
      well as with clarity and relevance of the contents. Self-assessment of 
      participants showed a growing sense of security in different communication 
      settings. Important increases could be demonstrated for communicating a diagnosis 
      of cancer with good or less good prognosis, recurrence of cancer or a far 
      progressive cancer disease without curative approach. 3 months after the course, 
      participants described multiple changes indicating increased sensibility and 
      professionalism in communication behavior. CONCLUSION: The realized communication 
      skills courses resulted in relevant changes in communication behaviour and 
      self-confidence of participants. Communication with terminally ill patients can 
      be taught.
FAU - Weber, Martin
AU  - Weber M
AD  - III. Medizinische Klinik der Universitatskliniken Mainz und Tumorzentrum 
      Rheinland-Pfalz, Mainz. drweber@hospiz-mainz.de
FAU - Bohler, Eva
AU  - Bohler E
FAU - Kohler, Elisabeth
AU  - Kohler E
LA  - ger
PT  - Comparative Study
PT  - English Abstract
PT  - Journal Article
TT  - Kann Kommunikation mit unheilbar kranken Patienten gelehrt werden?Evaluation 
      eines Kursmodells.
PL  - Germany
TA  - Med Klin (Munich)
JT  - Medizinische Klinik (Munich, Germany : 1983)
JID - 8303501
SB  - IM
MH  - *Communication
MH  - Curriculum
MH  - Humans
MH  - *Medical Oncology/education
MH  - *Physician-Patient Relations
MH  - Surveys and Questionnaires
MH  - *Terminally Ill
EDAT- 2003/10/11 05:00
MHDA- 2004/02/10 05:00
CRDT- 2003/10/11 05:00
PHST- 2003/04/28 00:00 [received]
PHST- 2003/07/02 00:00 [accepted]
PHST- 2003/10/11 05:00 [pubmed]
PHST- 2004/02/10 05:00 [medline]
PHST- 2003/10/11 05:00 [entrez]
AID - 10.1007/s00063-003-1289-2 [doi]
PST - ppublish
SO  - Med Klin (Munich). 2003 Sep 15;98(9):477-83. doi: 10.1007/s00063-003-1289-2.

PMID- 12632437
OWN - NLM
STAT- MEDLINE
DCOM- 20030325
LR  - 20161124
IS  - 0004-3591 (Print)
IS  - 0004-3591 (Linking)
VI  - 48
IP  - 3
DP  - 2003 Mar
TI  - Are environmental factors important in primary systemic vasculitis? A 
      case-control study.
PG  - 814-23
AB  - OBJECTIVE: To investigate the association between primary systemic vasculitis 
      (PSV) and environmental risk factors. METHODS: Seventy-five PSV cases and 273 
      controls (220 nonvasculitis, 19 secondary vasculitis, and 34 asthma controls) 
      were interviewed using a structured questionnaire. Factors investigated were 
      social class, occupational and residential history, smoking, pets, allergies, 
      vaccinations, medications, hepatitis, tuberculosis, and farm exposure in the year 
      before symptom onset (index year). The Standard Occupational Classification 2000 
      and job-exposure matrices were used to assess occupational silica, solvent, and 
      metal exposure. Stepwise multiple logistic regression was used to calculate the 
      odds ratio (OR) and 95% confidence interval (95% CI) adjusted for potential 
      confounders. Total PSV, subgroups (47 Wegener's granulomatosis [WG], 12 
      microscopic polyangiitis, 16 Churg-Strauss syndrome [CSS]), and antineutrophil 
      cytoplasmic antibody (ANCA)-positive cases were compared with control groups. 
      RESULTS: Farming in the index year was significantly associated with PSV (OR 2.3 
      [95% CI 1.2-4.6]), with WG (2.7 [1.2-5.8]), with MPA (6.3 [1.9-21.6]), and with 
      perinuclear ANCA (pANCA) (4.3 [1.5-12.7]). Farming during working lifetime was 
      associated with PSV (2.2 [1.2-3.8]) and with WG (2.7 [1.3-5.7]). Significant 
      associations were found for high occupational silica exposure in the index year 
      (with PSV 3.0 [1.0-8.4], with CSS 5.6 [1.3-23.5], and with ANCA 4.9 [1.3-18.6]), 
      high occupational solvent exposure in the index year (with PSV 3.4 [0.9-12.5], 
      with WG 4.8 [1.2-19.8], and with classic ANCA [cANCA] 3.9 [1.6-9.5]), high 
      occupational solvent exposure during working lifetime (with PSV 2.7 [1.1-6.6], 
      with WG 3.4 [1.3-8.9], and with cANCA 3.3 [1.0-10.8]), drug allergy (with PSV 3.6 
      [1.8-7.0], with WG 4.0 [1.8-8.7], and with cANCA 4.7 [1.9-11.7]), and allergy 
      overall (with PSV 2.2 [1.2-3.9], with WG 2.7 [1.4-5.7]). No other significant 
      associations were found. CONCLUSION: A significant association between farming 
      and PSV has been identified for the first time. Results also support previously 
      reported associations with silica, solvents, and allergy.
FAU - Lane, Suzanne E
AU  - Lane SE
AD  - Norfolk and Norwich University Hospital, Norwich, UK. LANE@suzanne-e.fsnet.co.uk
FAU - Watts, Richard A
AU  - Watts RA
FAU - Bentham, Graham
AU  - Bentham G
FAU - Innes, Nicholas J
AU  - Innes NJ
FAU - Scott, David G I
AU  - Scott DG
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Arthritis Rheum
JT  - Arthritis and rheumatism
JID - 0370605
RN  - 0 (Hazardous Substances)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Agriculture
MH  - Case-Control Studies
MH  - Female
MH  - Hazardous Substances/*adverse effects
MH  - Hospitals, University
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Occupational Exposure/*adverse effects
MH  - Risk Factors
MH  - Surveys and Questionnaires
MH  - United Kingdom/epidemiology
MH  - Vasculitis/epidemiology/*etiology
EDAT- 2003/03/13 04:00
MHDA- 2003/03/26 05:00
CRDT- 2003/03/13 04:00
PHST- 2003/03/13 04:00 [pubmed]
PHST- 2003/03/26 05:00 [medline]
PHST- 2003/03/13 04:00 [entrez]
AID - 10.1002/art.10830 [doi]
PST - ppublish
SO  - Arthritis Rheum. 2003 Mar;48(3):814-23. doi: 10.1002/art.10830.

PMID- 20850631
OWN - NLM
STAT- MEDLINE
DCOM- 20110203
LR  - 20161125
IS  - 1531-5037 (Electronic)
IS  - 0022-3468 (Linking)
VI  - 45
IP  - 9
DP  - 2010 Sep
TI  - Diagnosis and follow-up in constipated children: should we use ultrasound?
PG  - 1849-55
LID - 10.1016/j.jpedsurg.2010.05.006 [doi]
AB  - PURPOSE: We investigated the efficacy of ultrasound in determining megarectum and 
      fecal load and the response to treatment in constipation and tried to specify 
      objective criteria in this study. METHODS: A total of 66 cases were queried and 
      divided into 2 groups as constipated (n = 35; mean age, 6.8 +/- 2.9 years) and 
      control (n = 31; mean age, 8.4 +/- 3.8 years) according to Rome III criteria. After 
      the clinical evaluation, pelvic ultrasonography (US) was performed by 2 separate 
      radiologists. The bladder capacity and the transverse rectal diameter were 
      measured with a full bladder. Then the rectal diameter and rectal anterior wall 
      thickness were measured, and the presence of fecal load in the rectum and sigmoid 
      colon was recorded with an empty bladder. The examination and ultrasound were 
      repeated after treatment for a month in these patients. RESULTS: Comparison of 
      the US measurements of the 2 radiologists performing the US tests did not show 
      any interobserver difference (r = 0.981; P < .001). We therefore believe our 
      results are objective and reproducible. We found a positive correlation between 
      the rectal diameters and the age, height, weight, and bladder capacity. The 
      posturination mean rectal diameter was thicker in the constipated group (3.02 +/- 
      1.04 cm) than in the control group (1.98 +/- 0.64 cm) (P < .001). The cutoff point 
      of rectal diameter for a diagnosis of constipation was determined as 2.44 cm (71% 
      sensitive; 76% specific; area under curve, 0.825; P < .001). The rectal anterior 
      wall thickness and fecal load were higher in the constipated patients (P < .001). 
      There was a significant decrease in the constipation score and fecal load after 
      treatment for a month (P < .001), but the rectal diameter had not reached normal 
      limits yet despite the decrease (2.71 +/- 0.77 cm) (P > .05). CONCLUSION: The use 
      of US helps in making a correct diagnosis and in the follow-up with objective 
      criteria and also convinces the patient and the family that the treatment needs 
      to be continued.
CI  - Copyright (c) 2010 Elsevier Inc. All rights reserved.
FAU - Karaman, Ayse
AU  - Karaman A
AD  - Department of Pediatric Surgery, Dr Sami Ulus Children's Hospital, 06080 Ankara, 
      Turkey. ayseuk@gmail.com
FAU - Ramadan, Selma Uysal
AU  - Ramadan SU
FAU - Karaman, Ibrahim
AU  - Karaman I
FAU - Gokharman, Dilek
AU  - Gokharman D
FAU - Erdogan, Derya
AU  - Erdogan D
FAU - Kacar, Mahmut
AU  - Kacar M
FAU - Cavusoglu, Yusuf Hakan
AU  - Cavusoglu YH
FAU - Kosar, Ugur
AU  - Kosar U
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Pediatr Surg
JT  - Journal of pediatric surgery
JID - 0052631
SB  - IM
MH  - Child
MH  - Child, Preschool
MH  - Constipation/*diagnostic imaging/therapy
MH  - Feces
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Male
MH  - Prospective Studies
MH  - Rectum/*diagnostic imaging
MH  - Ultrasonography
EDAT- 2010/09/21 06:00
MHDA- 2011/02/04 06:00
CRDT- 2010/09/21 06:00
PHST- 2009/12/07 00:00 [received]
PHST- 2010/04/19 00:00 [revised]
PHST- 2010/05/04 00:00 [accepted]
PHST- 2010/09/21 06:00 [entrez]
PHST- 2010/09/21 06:00 [pubmed]
PHST- 2011/02/04 06:00 [medline]
AID - S0022-3468(10)00413-6 [pii]
AID - 10.1016/j.jpedsurg.2010.05.006 [doi]
PST - ppublish
SO  - J Pediatr Surg. 2010 Sep;45(9):1849-55. doi: 10.1016/j.jpedsurg.2010.05.006.

PMID- 17565137
OWN - NLM
STAT- MEDLINE
DCOM- 20071228
LR  - 20240322
IS  - 1468-3318 (Electronic)
IS  - 0964-4563 (Print)
IS  - 0964-4563 (Linking)
VI  - 16
IP  - 3
DP  - 2007 Jun
TI  - Out of the smokescreen II: will an advertisement targeting the tobacco industry 
      affect young people's perception of smoking in movies and their intention to 
      smoke?
PG  - 177-81
AB  - OBJECTIVE: To evaluate the effect of an antismoking advertisement on young 
      people's perceptions of smoking in movies and their intention to smoke. 
      SUBJECTS/SETTING: 3091 cinema patrons aged 12-24 years in three Australian 
      states; 18.6% of the sample (n = 575) were current smokers. DESIGN/INTERVENTION: 
      Quasi-experimental study of patrons, surveyed after having viewed a movie. The 
      control group was surveyed in week 1, and the intervention group in weeks 2 and 
      3. Before seeing the movie in weeks 2 and 3, a 30 s antismoking advertisement was 
      shown, shot in the style of a movie trailer that warned patrons not to be sucked 
      in by the smoking in the movie they were about to see. OUTCOMES: Attitude of 
      current smokers and non-smokers to smoking in the movies; intention of current 
      smokers and non-smokers to smoke in 12 months. RESULTS: Among non-smokers, 47.8% 
      of the intervention subjects thought that the smoking in the viewed movie was not 
      OK compared with 43.8% of the control subjects (p = 0.04). However, there was no 
      significant difference among smokers in the intervention (16.5%) and control 
      (14.5%) groups (p = 0.4). A higher percentage of smokers in the intervention 
      group indicated that they were likely to be smoking in 12 months time (38.6%) 
      than smokers in the control group (25.6%; p<0.001). For non-smokers, there was no 
      significant difference in smoking intentions between groups, with 1.2% of 
      intervention subjects and 1.6% of controls saying that they would probably be 
      smoking in 12 months time (p = 0.54). CONCLUSIONS: This real-world study suggests 
      that placing an antismoking advertisement before movies containing smoking scenes 
      can help to immunise non-smokers against the influences of film stars' smoking. 
      Caution must be exercised in the type of advertisement screened as some types of 
      advertising may reinforce smokers' intentions to smoke.
FAU - Edwards, Christine
AU  - Edwards C
AD  - Central Coast Health Promotion Unit, Northern Sydney Central Coast Health, PO Box 
      361, Gosford, NSW 2250, Australia. cedwards@nsccahs.health.nsw.gov.au
FAU - Oakes, Wendy
AU  - Oakes W
FAU - Bull, Diane
AU  - Bull D
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - Tob Control
JT  - Tobacco control
JID - 9209612
SB  - IM
MH  - Adolescent
MH  - *Advertising
MH  - *Attitude to Health
MH  - Female
MH  - Humans
MH  - Male
MH  - *Motion Pictures
MH  - Smoking/adverse effects/*psychology
MH  - Smoking Prevention
PMC - PMC2598498
COIS- Competing interests: None declared.
EDAT- 2007/06/15 09:00
MHDA- 2007/12/29 09:00
PMCR- 2010/01/01
CRDT- 2007/06/15 09:00
PHST- 2007/06/15 09:00 [pubmed]
PHST- 2007/12/29 09:00 [medline]
PHST- 2007/06/15 09:00 [entrez]
PHST- 2010/01/01 00:00 [pmc-release]
AID - 16/3/177 [pii]
AID - tc17194 [pii]
AID - 10.1136/tc.2006.017194 [doi]
PST - ppublish
SO  - Tob Control. 2007 Jun;16(3):177-81. doi: 10.1136/tc.2006.017194.

PMID- 9616411
OWN - NLM
STAT- MEDLINE
DCOM- 19980625
LR  - 20190503
IS  - 0143-005X (Print)
IS  - 1470-2738 (Electronic)
IS  - 0143-005X (Linking)
VI  - 52
IP  - 4
DP  - 1998 Apr
TI  - Do general practitioner hospitals reduce the utilisation of general hospital 
      beds? Evidence from Finnmark county in north Norway.
PG  - 243-6
AB  - STUDY OBJECTIVE: To assess whether populations with access to general 
      practitioner hospitals (GP hospitals) utilise general hospitals less than 
      populations without such access. DESIGN: Observational study comparing the total 
      rates of admissions and of occupied bed days in general hospitals between 
      populations with and without access to GP hospitals. Comparisons were also made 
      separately for diagnoses commonly encountered in GP hospitals. SETTING: Two 
      general hospitals serving the population of Finnmark county in north Norway. 
      PATIENTS: 35,435 admissions based on five years' routine recordings from the two 
      hospitals. MAIN RESULTS: The total rate of admission to general hospitals was 
      lower in peripheral municipalities with a GP hospital than in central 
      municipalities without this kind of institution, 26% and 28% lower for men and 
      women respectively. The corresponding differences were 38% and 52%, when analysed 
      for occupied bed days. The differences were most pronounced for patients with 
      respiratory diseases, cardiac failure, and cancer who are primarily or 
      intermediately treated or cared for in GP hospitals, and for patients with stroke 
      and fractures, who are regularly transferred from general hospitals to GP 
      hospitals for longer term follow up care. CONCLUSION: GP hospitals seem to reduce 
      the utilisation of general hospitals with respect to admissions as well as 
      occupied bed days.
FAU - Aaraas, I
AU  - Aaraas I
AD  - Institute of Community Medicine, University of Tromso, Norway.
FAU - Forde, O H
AU  - Forde OH
FAU - Kristiansen, I S
AU  - Kristiansen IS
FAU - Melbye, H
AU  - Melbye H
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - J Epidemiol Community Health
JT  - Journal of epidemiology and community health
JID - 7909766
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Bed Occupancy/*statistics & numerical data
MH  - Child
MH  - Child, Preschool
MH  - Female
MH  - Health Services Accessibility
MH  - Hospitals, County/*statistics & numerical data
MH  - Hospitals, General/*statistics & numerical data
MH  - Hospitals, Group Practice/*statistics & numerical data
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Length of Stay/statistics & numerical data
MH  - Male
MH  - Middle Aged
MH  - Norway
MH  - Patient Admission/statistics & numerical data
MH  - Retrospective Studies
PMC - PMC1756694
EDAT- 1998/06/09 00:00
MHDA- 1998/06/09 00:01
PMCR- 2001/04/01
CRDT- 1998/06/09 00:00
PHST- 1998/06/09 00:00 [pubmed]
PHST- 1998/06/09 00:01 [medline]
PHST- 1998/06/09 00:00 [entrez]
PHST- 2001/04/01 00:00 [pmc-release]
AID - 10.1136/jech.52.4.243 [doi]
PST - ppublish
SO  - J Epidemiol Community Health. 1998 Apr;52(4):243-6. doi: 10.1136/jech.52.4.243.

PMID- 22720085
OWN - NLM
STAT- MEDLINE
DCOM- 20121213
LR  - 20211021
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 7
IP  - 6
DP  - 2012
TI  - Does insulin resistance drive the association between hyperglycemia and 
      cardiovascular risk?
PG  - e39260
LID - 10.1371/journal.pone.0039260 [doi]
LID - e39260
AB  - BACKGROUND: Several studies have shown associations between hyperglycemia and 
      risk of cardiovascular disease (CVD) and mortality, yet glucose-lowering 
      treatment does little to mitigate this risk. We examined whether associations 
      between hyperglycemia and CVD risk were explained by underlying insulin 
      resistance. METHODS: In 60 middle-aged individuals without diabetes we studied 
      the associations of fasting plasma glucose, 2-hour post oral glucose tolerance 
      test plasma glucose, insulin sensitivity as well as body fat percentage with CVD 
      risk. Insulin sensitivity was measured as the glucose infusion rate during a 
      euglycemic hyperinsulinemic clamp, body fat percentage was measured by dual X-ray 
      absorptiometry, and CVD risk was estimated using the Framingham risk score. 
      Associations of fasting plasma glucose, 2-hour plasma glucose, insulin 
      sensitivity and body fat percentage with the Framingham risk score were assessed 
      in linear regression models. RESULTS: Both fasting and 2-hour plasma glucose 
      levels were associated with higher Framingham risk score (fasting glucose: r(2) = 
      0.21; 2-hour glucose: r(2) = 0.24; P<0.001 for both), and insulin sensitivity 
      with lower Framingham risk score (r(2) = 0.36; P<0.001). However, adjustment for 
      insulin sensitivity and 2-hour glucose made the effect of fasting glucose 
      non-significant (P = 0.060). Likewise, when adjusting for insulin sensitivity and 
      fasting glucose, the association between 2-hour glucose and Framingham risk score 
      disappeared (P = 0.143). In contrast, insulin sensitivity was still associated 
      with Framingham risk score after adjusting for glucose levels (P<0.001). Body fat 
      was not associated with Framingham risk score when taking insulin sensitivity 
      into account (P = 0.550). CONCLUSION: The association between plasma glucose 
      levels and CVD risk is mainly explained by insulin resistance, which raises the 
      question of whether glucose lowering per se without changes in the processes that 
      underlie hyperglycemia should be the sole clinical paradigm in the treatment of 
      type 2 diabetes or its prevention.
FAU - Faerch, Kristine
AU  - Faerch K
AD  - Steno Diabetes Center, Gentofte, Denmark. krif@steno.dk
FAU - Bergman, Bryan
AU  - Bergman B
FAU - Perreault, Leigh
AU  - Perreault L
LA  - eng
GR  - DK064811/DK/NIDDK NIH HHS/United States
GR  - RR00036/RR/NCRR NIH HHS/United States
GR  - F32 DK059739/DK/NIDDK NIH HHS/United States
GR  - DK059739/DK/NIDDK NIH HHS/United States
GR  - K23 DK064811/DK/NIDDK NIH HHS/United States
GR  - M01 RR000036/RR/NCRR NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20120615
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
RN  - 0 (Blood Glucose)
SB  - IM
MH  - Adult
MH  - Blood Glucose/analysis
MH  - Cardiovascular Diseases/*complications
MH  - Female
MH  - Humans
MH  - Hyperglycemia/*complications
MH  - *Insulin Resistance
MH  - Male
MH  - Middle Aged
MH  - Risk Factors
PMC - PMC3376119
COIS- Competing Interests: The authors have read the journal's policy and have the 
      following conflicts: KF is employed by Steno Diabetes Center A/S, a research 
      hospital working in the Danish National Health Service and which is owned by Novo 
      Nordisk A/S. Steno Diabetes Center A/S receives part of its core funding from 
      unrestricted grants from the Novo Nordisk Foundation and Novo Nordisk A/S. K.F. 
      owns shares in Novo Nordisk A/S. No other potential conflicts of interest 
      relevant to this article were reported. This does not alter the authors' 
      adherence to all the PLoS ONE policies on sharing data and materials.
EDAT- 2012/06/22 06:00
MHDA- 2012/12/14 06:00
PMCR- 2012/06/15
CRDT- 2012/06/22 06:00
PHST- 2012/03/16 00:00 [received]
PHST- 2012/05/22 00:00 [accepted]
PHST- 2012/06/22 06:00 [entrez]
PHST- 2012/06/22 06:00 [pubmed]
PHST- 2012/12/14 06:00 [medline]
PHST- 2012/06/15 00:00 [pmc-release]
AID - PONE-D-12-07716 [pii]
AID - 10.1371/journal.pone.0039260 [doi]
PST - ppublish
SO  - PLoS One. 2012;7(6):e39260. doi: 10.1371/journal.pone.0039260. Epub 2012 Jun 15.

PMID- 21074975
OWN - NLM
STAT- MEDLINE
DCOM- 20110426
LR  - 20160526
IS  - 1573-2509 (Electronic)
IS  - 0920-9964 (Linking)
VI  - 125
IP  - 1
DP  - 2011 Jan
TI  - Ultra high risk (UHR) for psychosis criteria: are there different levels of risk 
      for transition to psychosis?
PG  - 62-8
LID - 10.1016/j.schres.2010.10.017 [doi]
AB  - INTRODUCTION: The ultra high risk (UHR) for psychosis criteria have been 
      validated in a number of studies. However, it is not known whether particular UHR 
      criteria (Attenuated Psychotic Symptoms (APS), Brief Limited Intermittent 
      Psychotic Symptoms (BLIPS) or Trait vulnerability criteria), or combination of 
      criteria, is associated with a higher risk of transition to psychosis. The 
      current study investigated this issue over a 6-month follow-up period. We 
      hypothesised that the risk of transition would increase in the following order: 
      Trait alone<APS alone < APS+Trait<BLIPS. METHOD: Data on UHR intake criteria and 
      transition to psychosis status at 6 months were analysed for UHR patients seen at 
      the PACE clinic, Orygen Youth Health between January 2000 and November 2008. 
      RESULTS: A total of 928 new referrals were accepted into the PACE clinic over 
      this period of whom 817 (88%) had baseline information available for analysis. 
      The percentage of subjects who presented with APS, Trait and BLIPS were 83%, 27% 
      and 4%, respectively. When the two intermediate groups (APS alone and APS+Trait) 
      were combined, there was evidence that the risk of transition increased in the 
      order of Trait alone<APS<BLIPS (p=0.024, adjusted analysis). CONCLUSIONS: Our 
      data suggest that UHR intake criteria predict transition over 6 months in the 
      order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest 
      risk of transition over the short term is consistent with the "early" versus 
      "late" prodrome model. It also indicates that particular clinical attention may 
      need to be paid to BLIPS patients, especially early in the course of treatment.
CI  - Copyright (c) 2010 Elsevier B.V. All rights reserved.
FAU - Nelson, B
AU  - Nelson B
AD  - Orygen Youth Health Research Centre, Centre for Youth Mental Health, University 
      of Melbourne, Melbourne, Victoria, Australia. nelsonb@unimelb.edu.au
FAU - Yuen, K
AU  - Yuen K
FAU - Yung, A R
AU  - Yung AR
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20101112
PL  - Netherlands
TA  - Schizophr Res
JT  - Schizophrenia research
JID - 8804207
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Male
MH  - Neuropsychological Tests
MH  - Psychiatric Status Rating Scales
MH  - Psychotic Disorders/*diagnosis/*etiology
MH  - Regression Analysis
MH  - Retrospective Studies
MH  - Risk Factors
MH  - Severity of Illness Index
MH  - Time Factors
MH  - Young Adult
EDAT- 2010/11/16 06:00
MHDA- 2011/04/27 06:00
CRDT- 2010/11/16 06:00
PHST- 2010/06/07 00:00 [received]
PHST- 2010/10/13 00:00 [revised]
PHST- 2010/10/14 00:00 [accepted]
PHST- 2010/11/16 06:00 [entrez]
PHST- 2010/11/16 06:00 [pubmed]
PHST- 2011/04/27 06:00 [medline]
AID - S0920-9964(10)01592-6 [pii]
AID - 10.1016/j.schres.2010.10.017 [doi]
PST - ppublish
SO  - Schizophr Res. 2011 Jan;125(1):62-8. doi: 10.1016/j.schres.2010.10.017. Epub 2010 
      Nov 12.

PMID- 25604390
OWN - NLM
STAT- MEDLINE
DCOM- 20150812
LR  - 20201209
IS  - 1432-2323 (Electronic)
IS  - 0364-2313 (Linking)
VI  - 39
IP  - 4
DP  - 2015 Apr
TI  - Aberrant loss of dickkopf-3 in gastric cancer: can it predict lymph node 
      metastasis preoperatively?
PG  - 1018-25
LID - 10.1007/s00268-014-2886-3 [doi]
AB  - BACKGROUND: Dickkopf-3 (DKK3) may act as a tumor suppressor as it is 
      down-regulated in various types of cancer. This study assessed the DKK3 protein 
      expression in gastric cancer and its potential value as a prognostic marker. 
      METHODS: DKK3 expression was evaluated by immunohistochemistry in 158 gastric 
      cancer samples from patients who underwent gastrectomy from 2002 to 2008. 
      Clinicopathological parameters and survival data were analyzed. RESULTS: Loss of 
      DKK3 expression was found in 64 of 158 (40.5%) samples, and it was associated 
      with advanced T stage (p < 0.001), lymph node metastasis (p < 0.001), UICC TNM 
      stage (p < 0.001), tumor location (p = 0.029), lymphovascular invasion (p = 
      0.035), and perineural invasion (p = 0.032). Patients without DKK3 expression in 
      tumor cells had a significantly worse disease-free and overall survival than 
      those with DKK3 expression (p < 0.001, and p = 0.001, respectively). TNM stage (p 
      = 0.028 and p < 0.001, respectively) and residual tumor (p < 0.001 and p = 0.003, 
      respectively) were independent predictors of disease-free and overall survival. 
      Based on the preoperative clinical stage assessed by computed tomography (CT), 
      loss of DKK3 expression was predominantly associated with worse prognosis in 
      patients with clinically node-negative advanced gastric cancer (AGC). The 
      combination of DKK3 expression status and CT increased the accuracy of CT staging 
      for predicting lymph node involvement from 71.5 to 80.0% in AGC patients. 
      CONCLUSION: Loss of DKK3 protein expression was significantly associated with 
      poor survival in patients with gastric cancer and was strongly correlated with 
      the TNM stage. DKK3 might be a potential biomarker of lymph node involvement that 
      can improve the predictive power of CT.
FAU - Park, Joong-Min
AU  - Park JM
AD  - Department of Surgery, Chung-Ang University College of Medicine, Seoul, Korea, 
      jmpark@cau.ac.kr.
FAU - Kim, Mi Kyung
AU  - Kim MK
FAU - Chi, Kyong-Choun
AU  - Chi KC
FAU - Kim, Jae Hyung
AU  - Kim JH
FAU - Lee, Sang-Hoon
AU  - Lee SH
FAU - Lee, Eun-Ju
AU  - Lee EJ
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - World J Surg
JT  - World journal of surgery
JID - 7704052
RN  - 0 (Adaptor Proteins, Signal Transducing)
RN  - 0 (Chemokines)
RN  - 0 (DKK3 protein, human)
RN  - 0 (Intercellular Signaling Peptides and Proteins)
SB  - IM
MH  - Adaptor Proteins, Signal Transducing
MH  - Adenocarcinoma/*metabolism/*secondary/surgery
MH  - Aged
MH  - Chemokines
MH  - Disease-Free Survival
MH  - Female
MH  - Gastrectomy
MH  - Humans
MH  - Immunohistochemistry
MH  - Intercellular Signaling Peptides and Proteins/*metabolism
MH  - Lymphatic Metastasis
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Invasiveness
MH  - Neoplasm Staging
MH  - Neoplasm, Residual
MH  - Preoperative Period
MH  - Retrospective Studies
MH  - Stomach Neoplasms/*metabolism/*pathology/surgery
MH  - Survival Rate
MH  - *Tomography, X-Ray Computed
EDAT- 2015/01/22 06:00
MHDA- 2015/08/13 06:00
CRDT- 2015/01/22 06:00
PHST- 2015/01/22 06:00 [entrez]
PHST- 2015/01/22 06:00 [pubmed]
PHST- 2015/08/13 06:00 [medline]
AID - 10.1007/s00268-014-2886-3 [doi]
PST - ppublish
SO  - World J Surg. 2015 Apr;39(4):1018-25. doi: 10.1007/s00268-014-2886-3.

PMID- 14968373
OWN - NLM
STAT- MEDLINE
DCOM- 20040707
LR  - 20181113
IS  - 0256-7040 (Print)
IS  - 0256-7040 (Linking)
VI  - 20
IP  - 3
DP  - 2004 Mar
TI  - Can CT predict the level of CSF block in tuberculous hydrocephalus?
PG  - 183-7
AB  - INTRODUCTION: Treatment of obstructive hydrocephalus in children with tuberculous 
      meningitis (TBM) depends on the level of the cerebrospinal fluid (CSF) block. 
      Air-encephalography is regarded as the gold standard for differentiating 
      communicating and non-communicating hydrocephalus. Since air-encephalography 
      involves a lumbar puncture, it carries the risk of cerebral herniation. AIM. The 
      aim of this study was to determine whether communicating and non-communicating 
      hydrocephalus in TBM can be differentiated by means of cranial computerised 
      tomography (CT). METHODS: A number of CT indices were measured in 50 children 
      with communicating and 34 children with non-communicating hydrocephalus according 
      to air-encephalographic findings. RESULTS: The only CT finding that correlated 
      with the type of hydrocephalus was the shape of the third ventricle. 
      Significantly more children with non-communicating hydrocephalus had a rounded 
      third ventricle than those with communicating hydrocephalus. CONCLUSION: CT is 
      therefore not useful in determining the level of CSF block in TBM. 
      Air-encephalography remains the most reliable way of determining the level of CSF 
      obstruction.
FAU - Bruwer, G E
AU  - Bruwer GE
AD  - Department of Paediatrics and Child Health, Faculty of Health Sciences, Tygerberg 
      Hospital, PO Box 19063, 7505, Tygerberg, South Africa.
FAU - Van der Westhuizen, S
AU  - Van der Westhuizen S
FAU - Lombard, C J
AU  - Lombard CJ
FAU - Schoeman, J F
AU  - Schoeman JF
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20040213
PL  - Germany
TA  - Childs Nerv Syst
JT  - Child's nervous system : ChNS : official journal of the International Society for 
      Pediatric Neurosurgery
JID - 8503227
SB  - IM
MH  - Cerebrospinal Fluid/*physiology
MH  - Child, Preschool
MH  - Diagnosis, Differential
MH  - Female
MH  - Humans
MH  - Hydrocephalus/*diagnostic imaging
MH  - Infant
MH  - Male
MH  - Pneumoencephalography
MH  - *Radiographic Image Interpretation, Computer-Assisted
MH  - Retrospective Studies
MH  - Sensitivity and Specificity
MH  - Third Ventricle/diagnostic imaging
MH  - *Tomography, X-Ray Computed
MH  - Tuberculosis, Meningeal/*diagnostic imaging
EDAT- 2004/02/18 05:00
MHDA- 2004/07/09 05:00
CRDT- 2004/02/18 05:00
PHST- 2003/10/03 00:00 [received]
PHST- 2004/02/18 05:00 [pubmed]
PHST- 2004/07/09 05:00 [medline]
PHST- 2004/02/18 05:00 [entrez]
AID - 10.1007/s00381-003-0887-x [doi]
PST - ppublish
SO  - Childs Nerv Syst. 2004 Mar;20(3):183-7. doi: 10.1007/s00381-003-0887-x. Epub 2004 
      Feb 13.

PMID- 10135926
OWN - NLM
STAT- MEDLINE
DCOM- 19941010
LR  - 20061115
IS  - 1067-991X (Print)
IS  - 1067-991X (Linking)
VI  - 13
IP  - 8
DP  - 1994 Aug
TI  - Is oral endotracheal intubation efficacy impaired in the helicopter environment?
PG  - 319-21
AB  - INTRODUCTION: Patients transported by helicopter often require advanced airway 
      management. The purpose of this study was to determine whether or not the 
      in-flight environment of air medical transport in a BO-105 helicopter impairs the 
      ability of flight nurses to perform oral endotracheal intubation. SETTING: The 
      study was conducted in an MBB BO-105 helicopter. METHODS: Flight nurses performed 
      three manikin intubations in each of the two study environments: on an emergency 
      department stretcher and in-flight in the BO-105 helicopter. RESULTS: The mean 
      time required for in-flight intubation (25.9 +/- 10.9 seconds) was significantly 
      longer than the corresponding time (13.2 +/- 2.8 seconds) required for intubation 
      in the control setting (ANOVA, F = 38.7, p < .001). All intubations performed in 
      the control setting were placed correctly in the trachea; there were two (6.7%) 
      esophageal intubations in the in-flight setting. The difference in appropriate 
      endotracheal intubation between the two settings was not significant (chi 2 = 
      0.3; p > 0.05). CONCLUSION: Oral endotracheal intubation in the in-flight setting 
      of the BO-105 helicopter takes approximately twice as long as intubation in a 
      ground setting. The results support pre-flight intubation of patients who appear 
      likely to require urgent intubation during air medical transport in the BO-105 
      helicopter.
FAU - Stone, C K
AU  - Stone CK
AD  - University of Kentucky Medical Center, Lexington 40536.
FAU - Thomas, S H
AU  - Thomas SH
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - United States
TA  - Air Med J
JT  - Air medical journal
JID - 9312325
MH  - Air Ambulances/*standards
MH  - Analysis of Variance
MH  - Data Collection
MH  - Emergency Nursing/standards
MH  - Humans
MH  - Intubation, Intratracheal/*standards/statistics & numerical data
MH  - North Carolina
MH  - Time and Motion Studies
MH  - Transportation of Patients/*standards/statistics & numerical data
MH  - *Treatment Outcome
EDAT- 1994/07/07 00:00
MHDA- 1994/07/07 00:01
CRDT- 1994/07/07 00:00
PHST- 1994/07/07 00:00 [pubmed]
PHST- 1994/07/07 00:01 [medline]
PHST- 1994/07/07 00:00 [entrez]
AID - S1067-991X(05)80337-2 [pii]
AID - 10.1016/S1067-991X(05)80337-2 [doi]
PST - ppublish
SO  - Air Med J. 1994 Aug;13(8):319-21. doi: 10.1016/S1067-991X(05)80337-2.

PMID- 19419587
OWN - NLM
STAT- MEDLINE
DCOM- 20090625
LR  - 20220317
IS  - 1749-8090 (Electronic)
IS  - 1749-8090 (Linking)
VI  - 4
DP  - 2009 May 7
TI  - Sternal plating for primary and secondary sternal closure; can it improve sternal 
      stability?
PG  - 19
LID - 10.1186/1749-8090-4-19 [doi]
AB  - BACKGROUND: Sternal instability with mediastinitis is a very serious complication 
      after median sternotomy. Biomechanical studies have suggested superiority of 
      rigid plate fixation over wire cerclage for sternal fixation. This study tests 
      the hypothesis that sternal closure stability can be improved by adding plate 
      fixation in a human cadaver model. METHODS: Midline sternotomy was performed in 
      18 human cadavers. Four sternal closure techniques were tested: (1) approximation 
      with six interrupted steel wires; (2) approximation with six interrupted cables; 
      (3) closure 1 (wires) or 2 (cables) reinforced with a transverse sternal plate at 
      the sixth rib; (4) Closure using 4 sternal plates alone. Intrathoracic pressure 
      was increased in all techniques while sternal separation was measured by three 
      pairs of sonomicrometry crystals fixed at the upper, middle and lower parts of 
      the sternum until 2.0 mm separation was detected. Differences in displacement 
      pressures were analyzed using repeated measures ANOVA and Regression 
      Coefficients. RESULTS: Intrathoracic pressure required to cause 2.0 mm separation 
      increased significantly from 183.3 +/- 123.9 to 301.4 +/- 204.5 in wires/cables 
      alone vs. wires/cables plus one plate respectively, and to 355.0 +/- 210.4 in the 
      4 plates group (p < 0.05). Regression Coefficients (95% CI) were 120 (47-194) and 
      142 (66-219) respectively for the plate groups. CONCLUSION: Transverse sternal 
      plating with 1 or 4 plates significantly improves sternal stability closure in 
      human cadaver model. Adding a single sternal plate to primary closure improves 
      the strength of sternal closure with traditional wiring potentially reducing the 
      risk of sternal dehiscence and could be considered in high risk patients.
FAU - Fawzy, Hosam
AU  - Fawzy H
AD  - Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Terrence 
      Donnelly Heart Center, Keenan Research Center in the Li Ka Shing Knowledge 
      Institute of St Michael's Hospital, University of Toronto, Ontario, Canada. 
      hosamfawzy@hotmail.com
FAU - Alhodaib, Nasser
AU  - Alhodaib N
FAU - Mazer, C David
AU  - Mazer CD
FAU - Harrington, Alana
AU  - Harrington A
FAU - Latter, David
AU  - Latter D
FAU - Bonneau, Daniel
AU  - Bonneau D
FAU - Errett, Lee
AU  - Errett L
FAU - Mahoney, James
AU  - Mahoney J
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20090507
PL  - England
TA  - J Cardiothorac Surg
JT  - Journal of cardiothoracic surgery
JID - 101265113
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Analysis of Variance
MH  - Bone Plates
MH  - Bone Wires
MH  - Cadaver
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Orthopedic Procedures/*methods
MH  - Regression Analysis
MH  - Sternum/*surgery
MH  - Suture Techniques
MH  - Thoracotomy/methods
PMC - PMC2684105
EDAT- 2009/05/08 09:00
MHDA- 2009/06/26 09:00
PMCR- 2009/05/07
CRDT- 2009/05/08 09:00
PHST- 2009/04/09 00:00 [received]
PHST- 2009/05/07 00:00 [accepted]
PHST- 2009/05/08 09:00 [entrez]
PHST- 2009/05/08 09:00 [pubmed]
PHST- 2009/06/26 09:00 [medline]
PHST- 2009/05/07 00:00 [pmc-release]
AID - 1749-8090-4-19 [pii]
AID - 10.1186/1749-8090-4-19 [doi]
PST - epublish
SO  - J Cardiothorac Surg. 2009 May 7;4:19. doi: 10.1186/1749-8090-4-19.

PMID- 23379759
OWN - NLM
STAT- MEDLINE
DCOM- 20140123
LR  - 20130516
IS  - 1651-2251 (Electronic)
IS  - 0001-6489 (Linking)
VI  - 133
IP  - 6
DP  - 2013 Jun
TI  - Can early second-look tympanoplasty reduce the rate of conversion to modified 
      radical mastoidectomy?
PG  - 590-3
LID - 10.3109/00016489.2012.762116 [doi]
AB  - CONCLUSIONS: Combined approach tympanoplasty (CAT) allows for successful 
      treatment of cholesteatoma with rates of recurrent and residual disease 
      comparable to open mastoid surgery. Early timing of second-look procedures allows 
      easier removal of any recurrent or residual disease, which reduces the conversion 
      rate to open mastoidectomy. OBJECTIVES: The aims of the study were to report the 
      rates of recurrent and residual cholesteatoma following primary CAT surgery and 
      to report the rate of conversion to a modified radical mastoidectomy. METHODS: 
      This was a retrospective review of a single surgeon series between 2006 and 2012. 
      RESULTS: In total 132 second-look operations were undertaken, with a mean 
      interval between primary surgery and second-look procedures of 6 months. The rate 
      of cholesteatoma at second-look surgery was 19.7%, which was split into residual 
      disease (10.6%) and recurrent disease (9.09%). New tympanic membrane defects with 
      cholesteatoma were considered as recurrent disease. Residual disease was defined 
      as cholesteatoma present behind an intact tympanic membrane. The majority of 
      recurrent and residual disease was easily removed at second look (73.1%). Only 
      four cases were converted to a modified radical mastoidectomy (3%) and three 
      cases required a third-look procedure.
FAU - Stew, Benjamin T
AU  - Stew BT
AD  - Department of Otolaryngology - Head and Neck Surgery, Royal Glamorgan Hospital, 
      Llantrisant, UK. stewb@doctors.org.uk
FAU - Fishpool, Samuel J C
AU  - Fishpool SJ
FAU - Clarke, Jonathan D
AU  - Clarke JD
FAU - Johnson, Peter M
AU  - Johnson PM
LA  - eng
PT  - Journal Article
DEP - 20130205
PL  - England
TA  - Acta Otolaryngol
JT  - Acta oto-laryngologica
JID - 0370354
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Child
MH  - Child, Preschool
MH  - Cholesteatoma, Middle Ear/diagnosis/*surgery
MH  - Humans
MH  - Middle Aged
MH  - Recurrence
MH  - Retrospective Studies
MH  - Second-Look Surgery
MH  - Treatment Outcome
MH  - *Tympanoplasty
MH  - Young Adult
EDAT- 2013/02/06 06:00
MHDA- 2014/01/24 06:00
CRDT- 2013/02/06 06:00
PHST- 2013/02/06 06:00 [entrez]
PHST- 2013/02/06 06:00 [pubmed]
PHST- 2014/01/24 06:00 [medline]
AID - 10.3109/00016489.2012.762116 [doi]
PST - ppublish
SO  - Acta Otolaryngol. 2013 Jun;133(6):590-3. doi: 10.3109/00016489.2012.762116. Epub 
      2013 Feb 5.

PMID- 19923859
OWN - NLM
STAT- MEDLINE
DCOM- 20100420
LR  - 20191210
IS  - 1423-0216 (Electronic)
IS  - 1021-7401 (Linking)
VI  - 17
IP  - 2
DP  - 2010
TI  - Can T-cell deficiency affect spatial learning ability following toluene exposure?
PG  - 132-4
LID - 10.1159/000258697 [doi]
AB  - OBJECTIVE: The present studywas designed to investigate the possible role of T 
      cells in spatial learning ability in mouse after toluene exposure. METHOD: 
      Eight-week-old male wild-type (WT) and nude mice of BALB/c strain were exposed to 
      toluene (0, 9 and 90 ppm) in a nose-only exposure chamber for 30 min per day for 
      3 consecutive days and then once per week for 4 weeks. Twenty-four hours after 
      the completion of exposure, we examined the spatial learning ability in each 
      mouse using the Morris water maze apparatus. RESULTS: In the acquisition phase, a 
      longer escape latency was observed in nude mice exposed to 90 ppm toluene on days 
      3 and 4 when compared with corresponding WT mice. However, the effect of toluene 
      on the escape latency was not significant in nude mice. In the probe trial, WT 
      mice exposed to 90 ppm toluene showed poor retention memory compared with the 
      control group. In the reversal phase, we did not find any significant difference 
      between groups. CONCLUSION: These results indicate that T-cell deficiency may 
      affect spatial learning performance following toluene exposure.
CI  - Copyright 2009 S. Karger AG, Basel.
FAU - Win-Shwe, Tin-Tin
AU  - Win-Shwe TT
AD  - Research Center for Environmental Risk, National Institute for Environmental 
      Studies, Tsukuba, Japan. tin.tin.win.shwe @ nies.go.jp
FAU - Nakajima, Daisuke
AU  - Nakajima D
FAU - Fujimaki, Hidekazu
AU  - Fujimaki H
LA  - eng
PT  - Journal Article
DEP - 20091117
PL  - Switzerland
TA  - Neuroimmunomodulation
JT  - Neuroimmunomodulation
JID - 9422763
RN  - 0 (Neurotoxins)
RN  - 0 (Solvents)
RN  - 3FPU23BG52 (Toluene)
SB  - IM
MH  - Animals
MH  - Astrocytes/immunology/metabolism
MH  - Disease Models, Animal
MH  - Immune Tolerance/drug effects/immunology
MH  - Immunity, Cellular/drug effects/immunology
MH  - Immunity, Innate/drug effects/immunology
MH  - Learning Disabilities/*chemically induced/immunology/physiopathology
MH  - Male
MH  - Maze Learning/drug effects
MH  - Memory Disorders/*chemically induced/immunology/physiopathology
MH  - Mice
MH  - Mice, Inbred BALB C
MH  - Microglia/immunology/metabolism
MH  - Neuroimmunomodulation/*drug effects/immunology
MH  - Neurotoxins/toxicity
MH  - Solvents/toxicity
MH  - T-Lymphocytes/*drug effects/immunology
MH  - Toluene/*toxicity
EDAT- 2009/11/20 06:00
MHDA- 2010/04/21 06:00
CRDT- 2009/11/20 06:00
PHST- 2009/05/08 00:00 [received]
PHST- 2009/07/31 00:00 [accepted]
PHST- 2009/11/20 06:00 [entrez]
PHST- 2009/11/20 06:00 [pubmed]
PHST- 2010/04/21 06:00 [medline]
AID - 000258697 [pii]
AID - 10.1159/000258697 [doi]
PST - ppublish
SO  - Neuroimmunomodulation. 2010;17(2):132-4. doi: 10.1159/000258697. Epub 2009 Nov 
      17.

PMID- 22656647
OWN - NLM
STAT- MEDLINE
DCOM- 20121018
LR  - 20211021
IS  - 1471-2458 (Electronic)
IS  - 1471-2458 (Linking)
VI  - 12
DP  - 2012 Jun 1
TI  - Are acceptance rates of a national preventive home visit programme for older 
      people socially imbalanced?: a cross sectional study in Denmark.
PG  - 396
LID - 10.1186/1471-2458-12-396 [doi]
AB  - BACKGROUND: Preventive home visits are offered to community dwelling older people 
      in Denmark aimed at maintaining their functional ability for as long as possible, 
      but only two thirds of older people accept the offer from the municipalities. The 
      purpose of this study is to investigate 1) whether socioeconomic status was 
      associated with acceptance of preventive home visits among older people and 2) 
      whether municipality invitational procedures for the preventive home visits 
      modified the association. METHODS: The study population included 1,023 community 
      dwelling 80-year-old individuals from the Danish intervention study on preventive 
      home visits. Information on preventive home visit acceptance rates was obtained 
      from questionnaires. Socioeconomic status was measured by financial assets 
      obtained from national registry data, and invitational procedures were identified 
      through the municipalities. Logistic regression analyses were used, adjusted by 
      gender. RESULTS: Older persons with high financial assets accepted preventive 
      home visits more frequently than persons with low assets (adjusted OR = 1.5 
      (CI95%: 1.1-2.0)). However, the association was attenuated when adjusted by the 
      invitational procedures. The odds ratio for accepting preventive home visits was 
      larger among persons with low financial assets invited by a letter with a 
      proposed date than among persons with high financial assets invited by other 
      procedures, though these estimates had wide confidence intervals. CONCLUSION: 
      High socioeconomic status was associated with a higher acceptance rate of 
      preventive home visits, but the association was attenuated by invitational 
      procedures. The results indicate that the social inequality in acceptance of 
      publicly offered preventive services might decrease if municipalities adopt more 
      proactive invitational procedures.
FAU - Yamada, Yukari
AU  - Yamada Y
AD  - Section of Social Medicine, Department of Public Health, University of 
      Copenhagen, Copenhagen, Denmark. yukari.yamada@upol.cz
FAU - Ekmann, Anette
AU  - Ekmann A
FAU - Nilsson, Charlotte Juul
AU  - Nilsson CJ
FAU - Vass, Mikkel
AU  - Vass M
FAU - Avlund, Kirsten
AU  - Avlund K
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20120601
PL  - England
TA  - BMC Public Health
JT  - BMC public health
JID - 100968562
SB  - IM
MH  - Aged, 80 and over
MH  - Cross-Sectional Studies
MH  - Denmark
MH  - Female
MH  - Financing, Personal/economics/statistics & numerical data
MH  - Geriatric Assessment
MH  - *Health Services for the Aged/economics
MH  - Healthcare Disparities/economics
MH  - Home Care Services/economics/statistics & numerical data
MH  - House Calls/*statistics & numerical data
MH  - Humans
MH  - Logistic Models
MH  - Male
MH  - Patient Acceptance of Health Care/*psychology/statistics & numerical data
MH  - Physicians, Family/education/standards
MH  - Prevalence
MH  - Preventive Health Services/economics/*methods
MH  - *Program Evaluation
MH  - Residence Characteristics
MH  - Sex Distribution
MH  - Social Class
MH  - Surveys and Questionnaires
PMC - PMC3403897
EDAT- 2012/06/05 06:00
MHDA- 2012/10/19 06:00
PMCR- 2012/06/01
CRDT- 2012/06/05 06:00
PHST- 2012/02/08 00:00 [received]
PHST- 2012/06/01 00:00 [accepted]
PHST- 2012/06/05 06:00 [entrez]
PHST- 2012/06/05 06:00 [pubmed]
PHST- 2012/10/19 06:00 [medline]
PHST- 2012/06/01 00:00 [pmc-release]
AID - 1471-2458-12-396 [pii]
AID - 10.1186/1471-2458-12-396 [doi]
PST - epublish
SO  - BMC Public Health. 2012 Jun 1;12:396. doi: 10.1186/1471-2458-12-396.

PMID- 12163782
OWN - NLM
STAT- MEDLINE
DCOM- 20020913
LR  - 20201208
IS  - 0090-3493 (Print)
IS  - 0090-3493 (Linking)
VI  - 30
IP  - 8
DP  - 2002 Aug
TI  - Increased neutrophil migratory activity after major trauma: a factor in the 
      etiology of acute respiratory distress syndrome?
PG  - 1717-21
AB  - OBJECTIVE: Neutrophil infiltration of the lung is characteristic of early 
      posttraumatic acute respiratory distress syndrome (ARDS). This study examines the 
      ability of neutrophils isolated (over the first 24 hrs) from the peripheral blood 
      of patients admitted after major trauma to migrate in response to interleukin-8. 
      Interleukin-8 is elevated in the lung within 2 hrs of major trauma in patients 
      who later develop ARDS, and thus it plays a central role in the recruitment of 
      neutrophils to the lung and their subsequent activation. We hypothesized that 
      enhanced interleukin-8-mediated neutrophil migratory activity in the early 
      postinjury phase, before the development of ARDS, may be a crucial factor in the 
      etiology of ARDS. DESIGN: Prospective observational study. SETTING: University 
      Hospital Wales, the Royal Gwent Hospital, and East Glamorgan General Hospital. 
      Laboratory work was conducted at the Institute of Nephrology. PATIENTS: Adult 
      blunt trauma victims with Injury Severity Score > or = 18. MEASUREMENTS AND MAIN 
      RESULTS: Neutrophils were isolated from citrated blood from 17 adult blunt major 
      trauma patients at admission (0 hrs) and 8 and 24 hrs later. Identical samples 
      were obtained from normal laboratory volunteers (n = 9). The neutrophil count in 
      each specimen was measured, and the number of neutrophils migrating across porous 
      tissue culture inserts in response to defined concentrations of interleukin-8 (0, 
      10, 30, and 100 ng/mL) was quantitated by peroxidase assay. Neutrophil counts in 
      the whole blood specimens obtained from those later developing ARDS were elevated 
      significantly at admission and declined rapidly throughout the next 24 hrs. 
      Significantly greater numbers of trauma patients' neutrophils migrated to 
      concentrations of interleukin-8 (30 and 100 ng/mL) at each time point when 
      compared with normal volunteers (Mann-Whitney U test, p <.05). Neutrophils 
      isolated from major trauma patients exhibited an enhanced migratory response to 
      high concentrations of interleukin-8 throughout the first 24 hrs of admission, in 
      contrast to the normal physiologic attenuation of migration seen in neutrophils 
      isolated from normal laboratory volunteers. CONCLUSIONS: These data indicate that 
      major blunt trauma enhances the migratory capacity of circulating neutrophils. 
      This is manifest within 2 hrs of admission and may be attributable to alteration 
      in interleukin-8 receptor expression, affinity, or downstream signaling. In 
      patients who later develop ARDS, initially elevated circulating neutrophil counts 
      decrease rapidly, over the same time course. Early enhanced neutrophil migratory 
      activity coupled with elevated pulmonary concentrations of interleukin-8 may be 
      central to the establishment of the neutrophil infiltration that is 
      characteristic of ARDS.
FAU - Pallister, Ian
AU  - Pallister I
AD  - Department of Trauma & Orthopaedics, Division of Surgery, University of Wales 
      College of Medicine, Heath Park, Cardiff, Wales.
FAU - Dent, Colin
AU  - Dent C
FAU - Topley, Nicholas
AU  - Topley N
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Crit Care Med
JT  - Critical care medicine
JID - 0355501
RN  - 0 (Interleukin-8)
SB  - IM
MH  - Acute Disease
MH  - Adult
MH  - Cell Movement/*physiology
MH  - Humans
MH  - Interleukin-8/metabolism
MH  - Leukocyte Count
MH  - Neutrophil Infiltration/*physiology
MH  - Neutrophils
MH  - Prospective Studies
MH  - Respiratory Distress Syndrome/epidemiology/etiology/metabolism
MH  - Risk Factors
MH  - Time Factors
MH  - Trauma Severity Indices
MH  - Wales/epidemiology
MH  - Wounds, Nonpenetrating/*complications/epidemiology/*metabolism
EDAT- 2002/08/07 10:00
MHDA- 2002/09/14 10:01
CRDT- 2002/08/07 10:00
PHST- 2002/08/07 10:00 [pubmed]
PHST- 2002/09/14 10:01 [medline]
PHST- 2002/08/07 10:00 [entrez]
AID - 10.1097/00003246-200208000-00007 [doi]
PST - ppublish
SO  - Crit Care Med. 2002 Aug;30(8):1717-21. doi: 10.1097/00003246-200208000-00007.

PMID- 21658267
OWN - NLM
STAT- MEDLINE
DCOM- 20111201
LR  - 20220317
IS  - 1471-2458 (Electronic)
IS  - 1471-2458 (Linking)
VI  - 11
DP  - 2011 Jun 9
TI  - Do improvements in outreach, clinical, and family and community-based services 
      predict improvements in child survival? An analysis of serial cross-sectional 
      national surveys.
PG  - 456
LID - 10.1186/1471-2458-11-456 [doi]
AB  - BACKGROUND: There are three main service delivery channels: clinical services, 
      outreach, and family and community. To determine which delivery channels are 
      associated with the greatest reductions in under-5 mortality rates (U5MR), we 
      used data from sequential population-based surveys to examine the correlation 
      between changes in coverage of clinical, outreach, and family and community 
      services and in U5MR for 27 high-burden countries. METHODS: Household survey data 
      were abstracted from serial surveys in 27 countries. Average annual changes (AAC) 
      between the most recent and penultimate survey were calculated for under-five 
      mortality rates and for 22 variables in the domains of clinical, outreach, and 
      family- and community-based services. For all 27 countries and a subset of 19 
      African countries, we conducted principal component analysis to reduce the 
      variables into a few components in each domain and applied linear regression to 
      assess the correlation between changes in the principal components and changes in 
      under-five mortality rates after controlling for multiple potential confounding 
      factors. RESULTS: AAC in under 5-mortality varied from 6.6% in Nepal to -0.9% in 
      Kenya, with six of the 19 African countries all experiencing less than a 1% 
      decline in mortality. The strongest correlation with reductions in U5MR was 
      observed for access to clinical services (all countries: p = 0.02, r(2) = 0.58; 19 
      African countries p < 0.001, r(2) = 0.67). For outreach activities, AAC U5MR was 
      significantly correlated with antenatal care and family planning services, while 
      AAC in immunization services showed no association. In the family- and community 
      services domain, improvements in breastfeeding were associated with significant 
      changes in mortality in the 30 countries but not in the African subset; while in 
      the African countries, nutritional status improvements were associated with a 
      significant decline in mortality. CONCLUSIONS: Our findings support the 
      importance of increasing access to clinical services, certain outreach services 
      and breastfeeding and, in Africa, of improving nutritional status. Integrated 
      programs that emphasize these services may lead to substantial mortality 
      declines.
FAU - Binkin, Nancy
AU  - Binkin N
AD  - Health Section, Programme Division, UNICEF, 3 UN Plaza, New York, NY, USA. 
      nancy.binkin3@gmail.com
FAU - Chopra, Mickey
AU  - Chopra M
FAU - Simen-Kapeu, Aline
AU  - Simen-Kapeu A
FAU - Westhof, Dirk
AU  - Westhof D
LA  - eng
PT  - Journal Article
DEP - 20110609
PL  - England
TA  - BMC Public Health
JT  - BMC public health
JID - 100968562
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Africa/epidemiology
MH  - Asia/epidemiology
MH  - Caribbean Region/epidemiology
MH  - Child Health Services/statistics & numerical data
MH  - Child Mortality/*trends
MH  - Child, Preschool
MH  - Community Health Services/*statistics & numerical data
MH  - *Community-Institutional Relations
MH  - Cross-Sectional Studies
MH  - *Family
MH  - Female
MH  - Forecasting
MH  - Humans
MH  - Infant
MH  - Latin America/epidemiology
MH  - Male
MH  - Middle Aged
MH  - Middle East/epidemiology
MH  - *Survival
MH  - Young Adult
PMC - PMC3141447
EDAT- 2011/06/11 06:00
MHDA- 2011/12/13 00:00
PMCR- 2011/06/09
CRDT- 2011/06/11 06:00
PHST- 2010/10/12 00:00 [received]
PHST- 2011/06/09 00:00 [accepted]
PHST- 2011/06/11 06:00 [entrez]
PHST- 2011/06/11 06:00 [pubmed]
PHST- 2011/12/13 00:00 [medline]
PHST- 2011/06/09 00:00 [pmc-release]
AID - 1471-2458-11-456 [pii]
AID - 10.1186/1471-2458-11-456 [doi]
PST - epublish
SO  - BMC Public Health. 2011 Jun 9;11:456. doi: 10.1186/1471-2458-11-456.

PMID- 9199905
OWN - NLM
STAT- MEDLINE
DCOM- 19970813
LR  - 20190722
IS  - 0016-5107 (Print)
IS  - 0016-5107 (Linking)
VI  - 45
IP  - 6
DP  - 1997 Jun
TI  - Vertical lines in distal esophageal mucosa (VLEM): a true endoscopic 
      manifestation of esophagitis in children?
PG  - 485-9
AB  - BACKGROUND: We observed an endoscopic abnormally in a group of children with 
      histological esophagitis. We termed this finding "vertical lines in esophageal 
      mucosa" (VLEM). We examined the relationship between the presence of VLEM and 
      significant histologic changes in esophageal mucosal biopsies. METHODS: Between 
      January 1, 1992, and August 31, 1994, the senior author (JFF) performed 255 
      esophageal biopsies. The procedure reports, available endoscopic photographs, and 
      histology reports were reviewed to establish the endoscopic and histologic 
      appearance of the esophageal mucosa. Intraepithelial cells were counted in a 
      blind review of 42 randomly selected biopsies. RESULTS: The esophageal mucosa had 
      a normal appearance on 160 endoscopic studies (Group 1) and VLEM were the only 
      mucosal abnormalities in 41 endoscopies (Group 2). Histology was normal in 92 of 
      160 biopsies (57.5%) from Group 1, and 1 of 41 biopsies (2.4%) from Group 2. Most 
      patients in Group 2 had eosinophilic esophagitis (34 of 41, 83%, specificity 
      0.85, sensitivity 0.5, p > 0.001) which was of moderate to severe intensity (31 
      of 34, 91.2%, specificity 0.88, sensitivity 0.73, p < 0.001). CONCLUSIONS: 
      Histology usually demonstrated moderate to severe inflammation when VLEM were 
      present. VLEM may be a highly specific endoscopic feature of esophagitis in 
      children.
FAU - Gupta, S K
AU  - Gupta SK
AD  - Division of Gastroenterology/Hepatology, James Whitcomb Riley Hospital for 
      Children, Indiana University, School of Medicine, Indianapolis 46202-5225, USA.
FAU - Fitzgerald, J F
AU  - Fitzgerald JF
FAU - Chong, S K
AU  - Chong SK
FAU - Croffie, J M
AU  - Croffie JM
FAU - Collins, M H
AU  - Collins MH
LA  - eng
PT  - Clinical Trial
PT  - Comparative Study
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Gastrointest Endosc
JT  - Gastrointestinal endoscopy
JID - 0010505
SB  - IM
MH  - Adolescent
MH  - Biopsy
MH  - Cell Count
MH  - Child
MH  - Child, Preschool
MH  - *Endosonography
MH  - Esophagitis/*diagnostic imaging/pathology
MH  - Esophagoscopy/methods
MH  - Female
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Intestinal Mucosa/*diagnostic imaging/pathology
MH  - Male
MH  - Observer Variation
MH  - Random Allocation
MH  - Retrospective Studies
MH  - Sensitivity and Specificity
EDAT- 1997/06/01 00:00
MHDA- 1997/06/01 00:01
CRDT- 1997/06/01 00:00
PHST- 1997/06/01 00:00 [pubmed]
PHST- 1997/06/01 00:01 [medline]
PHST- 1997/06/01 00:00 [entrez]
AID - S0016-5107(97)70178-0 [pii]
AID - 10.1016/s0016-5107(97)70178-0 [doi]
PST - ppublish
SO  - Gastrointest Endosc. 1997 Jun;45(6):485-9. doi: 10.1016/s0016-5107(97)70178-0.

PMID- 23375036
OWN - NLM
STAT- MEDLINE
DCOM- 20130805
LR  - 20191210
IS  - 2352-4146 (Electronic)
IS  - 1995-7645 (Linking)
VI  - 6
IP  - 3
DP  - 2013 Mar
TI  - An HIV1/2 point of care test on sputum for screening TB/HIV co-infection in 
      Central India - Will it work?
PG  - 216-9
LID - S1995-7645(13)60026-7 [pii]
LID - 10.1016/S1995-7645(13)60026-7 [doi]
AB  - OBJECTIVE: To determine whether the OraQuick(R) HIV-1/2 Assay (OraSure 
      Technologies, Inc., Bethlehem, PA, USA) in sputum is a valid tool for HIV 
      surveillance among TB patients. METHODS: A cross sectional study was carried out 
      on sputa of patients diagnosed with tuberculosis. Sputa were tested for 
      antibodies to HIV using OraQuick(R) HIV-1/2 Assay (OraSure Technologies, Inc., 
      Bethlehem, PA, USA). The results were compared with results of serum ELISA. 
      RESULTS: Compared to serum ELISA, the OraQuick(R) HIV-1/2 Assay in sputum specimens 
      reported 90% sensitivity (9/10) and 100% specificity (307/307), with a positive 
      predictive value of 100% (95%CI: 66.37%-100.00%) and a negative predictive value 
      of 99.68% (95%CI: 98.20%-99.99%). CONCLUSIONS: This testing method may provide a 
      useful strategy for conducting HIV surveillance in possible co-infected TB 
      patients at peripheral centres. Since there is no investment on infrastructure, 
      it may be possible for paramedical health professionals to carry out the test, 
      particularly in areas with low HIV endemicity.
CI  - Copyright (c) 2013 Hainan Medical College. Published by Elsevier B.V. All rights 
      reserved.
FAU - Desikan, Prabha
AU  - Desikan P
AD  - Department of Microbiology, Bhopal Memorial Hospital and Research Centre, Bhopal, 
      India. prabhadesikan@yahoo.com
FAU - De, Sajal
AU  - De S
FAU - Pai, Nitika Pant
AU  - Pai NP
FAU - Mishra, Pradyumna K
AU  - Mishra PK
FAU - Kumar, Kaushal
AU  - Kumar K
FAU - Panwalkar, Nikita
AU  - Panwalkar N
FAU - Verma, Mayanka
AU  - Verma M
FAU - Hasan, Zia Ul
AU  - Hasan ZU
FAU - Maudar, Kewal K
AU  - Maudar KK
LA  - eng
PT  - Journal Article
PT  - Validation Study
PL  - India
TA  - Asian Pac J Trop Med
JT  - Asian Pacific journal of tropical medicine
JID - 101533720
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Cross-Sectional Studies
MH  - Enzyme-Linked Immunosorbent Assay
MH  - Female
MH  - HIV Infections/blood/complications/*diagnosis
MH  - HIV-1/*isolation & purification
MH  - HIV-2/*isolation & purification
MH  - Humans
MH  - India
MH  - Male
MH  - Mass Screening/*methods
MH  - Middle Aged
MH  - Point-of-Care Systems
MH  - Sensitivity and Specificity
MH  - Sputum/*chemistry
MH  - Tuberculosis, Pulmonary/blood/complications
MH  - Young Adult
EDAT- 2013/02/05 06:00
MHDA- 2013/08/06 06:00
CRDT- 2013/02/05 06:00
PHST- 2012/10/15 00:00 [received]
PHST- 2012/12/27 00:00 [revised]
PHST- 2013/01/28 00:00 [accepted]
PHST- 2013/02/05 06:00 [entrez]
PHST- 2013/02/05 06:00 [pubmed]
PHST- 2013/08/06 06:00 [medline]
AID - S1995-7645(13)60026-7 [pii]
AID - 10.1016/S1995-7645(13)60026-7 [doi]
PST - ppublish
SO  - Asian Pac J Trop Med. 2013 Mar;6(3):216-9. doi: 10.1016/S1995-7645(13)60026-7.

PMID- 24495711
OWN - NLM
STAT- MEDLINE
DCOM- 20150204
LR  - 20140319
IS  - 1873-4758 (Electronic)
IS  - 0955-3959 (Linking)
VI  - 25
IP  - 2
DP  - 2014 Mar
TI  - Is crime associated with over-the-counter pharmacy syringe sales? Findings from 
      Los Angeles, California.
PG  - 244-50
LID - S0955-3959(14)00002-4 [pii]
LID - 10.1016/j.drugpo.2013.12.015 [doi]
AB  - BACKGROUND: More than 50,000 new HIV infections occur annually in the United 
      States. Injection drug users represent twelve percent of incident HIV infections 
      each year. Pharmacy sales of over-the-counter (OTC) syringes have helped prevent 
      HIV transmission among injection drug users in many states throughout the United 
      States. However, concerns exist among some law enforcement officials, 
      policymakers, pharmacists, and community members about potential links between 
      OTC syringe sales and crime. METHODS: We used a geographic information system and 
      novel spatial and longitudinal analyses to determine whether implementation of 
      pharmacy-based OTC syringe sales were associated with reported crime between 
      January 2006 and December 2008 in Los Angeles Police Department Reporting 
      Districts. We assessed reported crime pre- and post-OTC syringe sales initiation 
      as well as longitudinal associations between crime and OTC syringe-selling 
      pharmacies. RESULTS: By December 2008, 9.3% (94/1010) of Los Angeles Police 
      Department Reporting Districts had at least one OTC syringe-selling pharmacy. 
      Overall reported crime counts and reported crime rates decreased between 2006 and 
      2008 in all 1010 Reporting Districts. Using generalized estimating equations and 
      adjusting for potential confounders, reported crime rates were negatively 
      associated with OTC syringe sales (adjusted rate ratio: 0.89; 95% confidence 
      interval: 0.81, 0.99). CONCLUSION: Our findings demonstrate that OTC pharmacy 
      syringe sales were not associated with increases in reported crime in local 
      communities in Los Angeles during 2006-2008.
CI  - Copyright (c) 2014 Elsevier B.V. All rights reserved.
FAU - Stopka, Thomas J
AU  - Stopka TJ
AD  - Department of Public Health and Community Medicine, Tufts University School of 
      Medicine, United States. Electronic address: thomas.stopka@tufts.edu.
FAU - Geraghty, Estella M
AU  - Geraghty EM
AD  - Graduate Group in Epidemiology, Department of Public Health Sciences, University 
      of California, Davis, United States; Department of Internal Medicine, University 
      of California, Davis, Sacramento, CA, United States.
FAU - Azari, Rahman
AU  - Azari R
AD  - Graduate Group in Epidemiology, Department of Public Health Sciences, University 
      of California, Davis, United States.
FAU - Gold, Ellen B
AU  - Gold EB
AD  - Graduate Group in Epidemiology, Department of Public Health Sciences, University 
      of California, Davis, United States.
FAU - DeRiemer, Kathryn
AU  - DeRiemer K
AD  - Graduate Group in Epidemiology, Department of Public Health Sciences, University 
      of California, Davis, United States.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20140108
PL  - Netherlands
TA  - Int J Drug Policy
JT  - The International journal on drug policy
JID - 9014759
SB  - IM
MH  - Commerce/*statistics & numerical data
MH  - Crime/*statistics & numerical data
MH  - Drug Users
MH  - Geographic Information Systems
MH  - Los Angeles
MH  - Models, Statistical
MH  - Pharmacies/*statistics & numerical data
MH  - *Syringes
OTO - NOTNLM
OT  - Crime
OT  - GIS
OT  - Longitudinal analysis
OT  - Pharmacies
OT  - Syringe distribution
EDAT- 2014/02/06 06:00
MHDA- 2015/02/05 06:00
CRDT- 2014/02/06 06:00
PHST- 2013/04/18 00:00 [received]
PHST- 2013/12/21 00:00 [revised]
PHST- 2013/12/30 00:00 [accepted]
PHST- 2014/02/06 06:00 [entrez]
PHST- 2014/02/06 06:00 [pubmed]
PHST- 2015/02/05 06:00 [medline]
AID - S0955-3959(14)00002-4 [pii]
AID - 10.1016/j.drugpo.2013.12.015 [doi]
PST - ppublish
SO  - Int J Drug Policy. 2014 Mar;25(2):244-50. doi: 10.1016/j.drugpo.2013.12.015. Epub 
      2014 Jan 8.

PMID- 26820719
OWN - NLM
STAT- MEDLINE
DCOM- 20170118
LR  - 20181202
IS  - 1437-7772 (Electronic)
IS  - 1341-9625 (Linking)
VI  - 21
IP  - 4
DP  - 2016 Aug
TI  - Colorectal cancer in young patients: is it a distinct clinical entity?
PG  - 684-695
LID - 10.1007/s10147-015-0935-z [doi]
AB  - BACKGROUND: The incidence of colorectal cancer in young patients is increasing. 
      It remains unclear if the disease has unique features in this age group. METHODS: 
      This was a single-center, retrospective cohort study which included patients 
      diagnosed with colorectal cancer at age </=40 years in 1997-2013 matched 1:2 by 
      year of diagnosis with consecutive colorectal cancer patients diagnosed at age 
      >50 years during the same period. Patients aged 41-50 years were not included in 
      the study, to accentuate potential age-related differences. Clinicopathological 
      characteristics, treatment, and outcome were compared between groups. RESULTS: 
      The cohort included 330 patients, followed for a median time of 65.9 months 
      (range 4.7-211). Several significant differences were noted. The younger group 
      had a different ethnic composition. They had higher rates of family history of 
      colorectal cancer (p = 0.003), hereditary colorectal cancer syndromes 
      (p < 0.0001), and inflammatory bowel disease (p = 0.007), and a lower rate of 
      polyps (p < 0.0001). They were more likely to present with stage III or IV 
      disease (p = 0.001), angiolymphatic invasion, signet cell ring adenocarcinoma, 
      and rectal tumors (p = 0.02). Younger patients more frequently received 
      treatment. Young patients had a worse estimated 5-year disease-free survival rate 
      (57.6  vs. 70 %, p = 0.039), but this did not retain significance when analyzed 
      by stage (p = 0.092). Estimated 5-year overall survival rates were 59.1 and 
      62.1 % in the younger and the control group, respectively (p = 0.565). 
      CONCLUSIONS: Colorectal cancer among young patients may constitute a distinct 
      clinical entity. Further research is needed to validate our findings and define 
      the optimal approach in this population.
FAU - Goldvaser, Hadar
AU  - Goldvaser H
AD  - Davidoff Cancer Center, Rabin Medical Center, Institute of Oncology, Beilinson 
      Hospital, 39 Jabotinski St., Petach Tikva, 49100, Israel.
FAU - Purim, Ofer
AU  - Purim O
AD  - Davidoff Cancer Center, Rabin Medical Center, Institute of Oncology, Beilinson 
      Hospital, 39 Jabotinski St., Petach Tikva, 49100, Israel.
AD  - Sackler Faculty of Medicine, Tel Aviv University, P.O Box 39040, Tel Aviv, 
      Israel.
FAU - Kundel, Yulia
AU  - Kundel Y
AD  - Davidoff Cancer Center, Rabin Medical Center, Institute of Oncology, Beilinson 
      Hospital, 39 Jabotinski St., Petach Tikva, 49100, Israel.
AD  - Sackler Faculty of Medicine, Tel Aviv University, P.O Box 39040, Tel Aviv, 
      Israel.
FAU - Shepshelovich, Daniel
AU  - Shepshelovich D
AD  - Department of Medicine A, Rabin Medical Center, Beilinson Hospital, 39 Jabotinski 
      St., Petach Tikva, Israel.
AD  - Sackler Faculty of Medicine, Tel Aviv University, P.O Box 39040, Tel Aviv, 
      Israel.
FAU - Shochat, Tzippy
AU  - Shochat T
AD  - Statistical Consulting Unit, Rabin Medical Center, Beilinson Hospital, 39 
      Jabotinski St., Petach Tikva, Israel.
FAU - Shemesh-Bar, Lital
AU  - Shemesh-Bar L
AD  - Maccabi Health Services, 33 Peres St., Rishon Lezion, Israel.
FAU - Sulkes, Aaron
AU  - Sulkes A
AD  - Davidoff Cancer Center, Rabin Medical Center, Institute of Oncology, Beilinson 
      Hospital, 39 Jabotinski St., Petach Tikva, 49100, Israel.
AD  - Sackler Faculty of Medicine, Tel Aviv University, P.O Box 39040, Tel Aviv, 
      Israel.
FAU - Brenner, Baruch
AU  - Brenner B
AD  - Davidoff Cancer Center, Rabin Medical Center, Institute of Oncology, Beilinson 
      Hospital, 39 Jabotinski St., Petach Tikva, 49100, Israel. brennerb@clalit.org.il.
AD  - Sackler Faculty of Medicine, Tel Aviv University, P.O Box 39040, Tel Aviv, 
      Israel. brennerb@clalit.org.il.
LA  - eng
PT  - Journal Article
DEP - 20160128
PL  - Japan
TA  - Int J Clin Oncol
JT  - International journal of clinical oncology
JID - 9616295
SB  - IM
MH  - Adenomatous Polyposis Coli/*epidemiology
MH  - Adult
MH  - *Age Factors
MH  - Aged
MH  - Aged, 80 and over
MH  - Carcinoma, Signet Ring Cell/*pathology
MH  - Colonic Polyps/*epidemiology
MH  - Colorectal Neoplasms/*ethnology/genetics/*pathology
MH  - Disease-Free Survival
MH  - Female
MH  - Humans
MH  - Inflammatory Bowel Diseases/*epidemiology
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Invasiveness
MH  - Neoplasm Staging
MH  - Rectal Neoplasms/epidemiology/pathology
MH  - Retrospective Studies
MH  - Survival Rate
MH  - Young Adult
OTO - NOTNLM
OT  - Age
OT  - Carcinoma
OT  - Colon
OT  - Rectum
OT  - Young
EDAT- 2016/01/29 06:00
MHDA- 2017/01/19 06:00
CRDT- 2016/01/29 06:00
PHST- 2015/07/19 00:00 [received]
PHST- 2015/11/26 00:00 [accepted]
PHST- 2016/01/29 06:00 [entrez]
PHST- 2016/01/29 06:00 [pubmed]
PHST- 2017/01/19 06:00 [medline]
AID - 10.1007/s10147-015-0935-z [pii]
AID - 10.1007/s10147-015-0935-z [doi]
PST - ppublish
SO  - Int J Clin Oncol. 2016 Aug;21(4):684-695. doi: 10.1007/s10147-015-0935-z. Epub 
      2016 Jan 28.

PMID- 26516021
OWN - NLM
STAT- MEDLINE
DCOM- 20170110
LR  - 20220318
IS  - 1365-2753 (Electronic)
IS  - 1356-1294 (Linking)
VI  - 21
IP  - 6
DP  - 2015 Dec
TI  - Does evidence-based practice improve patient outcomes? An analysis of a natural 
      experiment in a Spanish hospital.
PG  - 1059-65
LID - 10.1111/jep.12460 [doi]
AB  - RATIONALE, AIMS AND OBJECTIVES: Evidence-based practice (EBP) is widely promoted, 
      but does EBP produce better patient outcomes? We report a natural experiment when 
      part of the internal medicine service in a hospital was reorganized in 2003 to 
      form an EBP unit, the rest of the service remaining unchanged. The units attended 
      similar patients until 2012 permitting comparisons of outcomes and activity. 
      METHODS: We used routinely collected statistics (2004-11) to compare the two 
      different methods of practice and test whether patients being seen by the EBP 
      unit differed from standard practice (SP) patients. Data were available by doctor 
      and year. To check for differences between the EBP and SP doctors prior to 
      reorganization, we used statistics from 2000 to 2003. We looked for changes in 
      patient outcomes or activity following reorganization and whether the EBP unit 
      was achieving significantly different results from SP. Data across the periods 
      were combined and tested using Mann-Whitney test. RESULTS: No statistically 
      significant differences in outcomes were detected between the EBP and the SP 
      doctors prior to reorganization. Following the unit's establishment, the 
      mortality of patients being treated by EBP doctors compared with their previous 
      performance dropped from 7.4% to 6.3% (P < 0.02) and length of stay from 9.15 to 
      6.01 days (P = 0.002). No statistically significant improvements were seen in SP 
      physicians' performance. No differences in the proportion of patients admitted or 
      their complexity between the services were detected. Despite this, EBP patients 
      had a clinically significantly lower risk of death 6.27% versus 7.75% (P < 0.001) 
      and a shorter length of stay 6.01 versus 8.46 days (P < 0.001) than SP patients. 
      Readmission rates were similar: 14.4% (EBP); 14.5% (SP). EBP doctors attended 
      twice as many patients/doctor as SP doctors. CONCLUSION: The EBP unit was 
      associated with better patient outcomes and more efficient performance than 
      achieved by the same physicians previously or by SP concurrently.
CI  - (c) 2015 John Wiley & Sons, Ltd.
FAU - Emparanza, Jose I
AU  - Emparanza JI
AD  - Unidad de Epidemiologia Clinica, CASPe, CIBER-ESP, Biodonostia, Hospital 
      Universitario Donostia, Donostia/San Sebastian, Gipuzkoa, Spain.
FAU - Cabello, Juan B
AU  - Cabello JB
AD  - Hospital General Universitario de Alicante, Alicante, Spain.
FAU - Burls, Amanda J E
AU  - Burls AJ
AD  - School of Health Sciences, City University London, London, UK.
LA  - eng
PT  - Journal Article
DEP - 20151029
PL  - England
TA  - J Eval Clin Pract
JT  - Journal of evaluation in clinical practice
JID - 9609066
SB  - IM
MH  - Evidence-Based Medicine/*statistics & numerical data
MH  - Hospital Administration/*statistics & numerical data
MH  - Hospital Bed Capacity
MH  - Humans
MH  - Internal Medicine/*statistics & numerical data
MH  - Length of Stay
MH  - Patient Readmission
MH  - Practice Patterns, Physicians'/statistics & numerical data
MH  - Spain
MH  - Treatment Outcome
OTO - NOTNLM
OT  - #EBPimpact
OT  - evidence-based health care
OT  - evidence-based medicine
OT  - evidence-based practice
OT  - natural experiment
OT  - service evaluation
OT  - service reorganization
EDAT- 2015/10/31 06:00
MHDA- 2017/01/11 06:00
CRDT- 2015/10/31 06:00
PHST- 2015/08/28 00:00 [accepted]
PHST- 2015/10/31 06:00 [entrez]
PHST- 2015/10/31 06:00 [pubmed]
PHST- 2017/01/11 06:00 [medline]
AID - 10.1111/jep.12460 [doi]
PST - ppublish
SO  - J Eval Clin Pract. 2015 Dec;21(6):1059-65. doi: 10.1111/jep.12460. Epub 2015 Oct 
      29.

PMID- 20064872
OWN - NLM
STAT- MEDLINE
DCOM- 20110311
LR  - 20220408
IS  - 1462-0332 (Electronic)
IS  - 1462-0324 (Linking)
VI  - 49
IP  - 4
DP  - 2010 Apr
TI  - Can the prognosis of polymyalgia rheumatica be predicted at disease onset? 
      Results from a 5-year prospective study.
PG  - 716-22
LID - 10.1093/rheumatology/kep395 [doi]
AB  - OBJECTIVE: To identify the features of PMR that may predict the duration of 
      steroid therapy, the occurrence of relapses and the late development of GCA. 
      METHODS: Prospective cohort study of 176 patients with PMR, followed up for 5 
      years. Baseline factors associated with the duration of steroids therapy were 
      identified using Cox regression. Predictors of relapse and the late development 
      of GCA were identified using binary logistic regression. RESULTS: A total of 176 
      patients with PMR were included, of whom 124 stopped steroids within 5 years. The 
      probability of stopping steroids within 5 years was independently reduced by an 
      elevated plasma viscosity (PV) [hazard ratio (HR) = 0.49; 95% CI 0.29, 0.82 for a 
      PV > or = 2.00 mPa s compared with a PV < or = 1.80 mPa s; overall P = 0.024] and 
      by starting treatment at >15 mg prednisolone (HR = 0.63; 95% CI 0.41, 0.97; P = 
      0.036). Either of these independently reduced the chances of stopping steroids 
      within a given time interval between 27 and 51%. No significant predictors of 
      relapse were identified. Predictors of late GCA on univariable analysis were 
      female sex [odds ratio (OR) = 8.16; 95% CI 1.06, 63.13; P = 0.044], HLA-DRB1*0101 
      or -*0401 alleles (OR = 4.95; 95% CI 1.05, 23.34; P = 0.043), PV > or = 2.00 mPa 
      s compared with PV < or = 1.80 mPa s (OR = 10.64; 95% CI 1.28, 88.38; P = 0.029) 
      and initial prednisolone dose >15 mg (OR = 4.53; 95% CI 1.61, 12.79; P = 0.004). 
      CONCLUSION: A higher PV in PMR increases the risk of prolonged steroid therapy 
      and late GCA. Female sex and particular HLA alleles may increase the risk of late 
      GCA. Starting patients on >15 mg prednisolone is associated with a prolonged 
      steroid duration.
FAU - Mackie, Sarah L
AU  - Mackie SL
AD  - NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular 
      Medicine, University of Leeds, Leeds, UK.
FAU - Hensor, Elizabeth M A
AU  - Hensor EM
FAU - Haugeberg, Glenn
AU  - Haugeberg G
FAU - Bhakta, Bipin
AU  - Bhakta B
FAU - Pease, Colin T
AU  - Pease CT
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20100111
PL  - England
TA  - Rheumatology (Oxford)
JT  - Rheumatology (Oxford, England)
JID - 100883501
RN  - 0 (Anti-Inflammatory Agents)
RN  - 0 (HLA Antigens)
RN  - 0 (Steroids)
RN  - 9PHQ9Y1OLM (Prednisolone)
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Anti-Inflammatory Agents/*therapeutic use
MH  - Female
MH  - Follow-Up Studies
MH  - Giant Cell Arteritis/*drug therapy/genetics/immunology
MH  - HLA Antigens/genetics
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Polymyalgia Rheumatica/*drug therapy/genetics/immunology
MH  - Predictive Value of Tests
MH  - Prednisolone/*therapeutic use
MH  - Prognosis
MH  - Prospective Studies
MH  - Regression Analysis
MH  - Steroids/*therapeutic use
EDAT- 2010/01/13 06:00
MHDA- 2011/03/12 06:00
CRDT- 2010/01/13 06:00
PHST- 2010/01/13 06:00 [entrez]
PHST- 2010/01/13 06:00 [pubmed]
PHST- 2011/03/12 06:00 [medline]
AID - kep395 [pii]
AID - 10.1093/rheumatology/kep395 [doi]
PST - ppublish
SO  - Rheumatology (Oxford). 2010 Apr;49(4):716-22. doi: 10.1093/rheumatology/kep395. 
      Epub 2010 Jan 11.

PMID- 15708048
OWN - NLM
STAT- MEDLINE
DCOM- 20051005
LR  - 20151119
IS  - 1527-9995 (Electronic)
IS  - 0090-4295 (Linking)
VI  - 65
IP  - 2
DP  - 2005 Feb
TI  - Does prior benign prostate biopsy predict outcome for patients treated with 
      radical perineal prostatectomy?
PG  - 332-6
AB  - OBJECTIVES: To determine the effect of prior benign prostate biopsies on the 
      surgical and clinical outcomes of patients treated with radical perineal 
      prostatectomy for prostate cancer. METHODS: A total of 1369 patients with 
      clinically localized prostate cancer underwent radical prostatectomy by a single 
      surgeon between 1991 and 2001. A subset of 203 patients (14.9%), who had 
      undergone at least one prior benign prostate biopsy for a rising 
      prostate-specific antigen and/or abnormal digital rectal examination, constituted 
      our study population. A total of 1115 patients with no prior biopsy represented 
      our control group. After prostatectomy, patients were evaluated at 6-month 
      intervals for biochemical evidence of recurrence, defined as a prostate-specific 
      antigen level of 0.5 ng/mL or greater. RESULTS: Patients with a prior benign 
      biopsy had more favorable pathologic features with more organ-confined (74% 
      versus 64%; P <0.001) and less margin-positive (9.8% versus 18%) disease. Only 24 
      patients (12%) in the study group (versus 20% in control group; P = 0.01) had 
      eventual evidence of biochemical failure. Kaplan-Meier analyses suggested that 
      patients with prior benign biopsies have improved biochemical disease-free 
      survival, especially for those with more aggressive disease (Gleason sum 7 or 
      greater; P <0.01). Overall, patients in the study group had lower probability 
      (odds ratio 0.57, P <0.001) of biochemical failure compared with those in the 
      control group. CONCLUSIONS: A prior benign prostate biopsy may be independently 
      associated with more favorable surgical and biochemical outcomes after 
      prostatectomy. Additional studies are needed to confirm these findings.
FAU - Raj, Ganesh V
AU  - Raj GV
AD  - Division of Urology, Duke University Medical Center, Durham, North Carolina 
      27710, USA.
FAU - Brashears, James H
AU  - Brashears JH
FAU - Anand, Ankur
AU  - Anand A
FAU - Paulson, David F
AU  - Paulson DF
FAU - Polascik, Thomas J
AU  - Polascik TJ
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Urology
JT  - Urology
JID - 0366151
RN  - 0 (Biomarkers, Tumor)
RN  - 0 (Neoplasm Proteins)
RN  - EC 3.4.21.77 (Prostate-Specific Antigen)
SB  - IM
MH  - Adenocarcinoma/pathology/secondary/*surgery
MH  - Aged
MH  - Biomarkers, Tumor/blood
MH  - *Biopsy
MH  - Cohort Studies
MH  - Disease-Free Survival
MH  - Follow-Up Studies
MH  - Humans
MH  - Life Tables
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Proteins/blood
MH  - Proportional Hazards Models
MH  - Prostate/*pathology
MH  - Prostate-Specific Antigen/blood
MH  - Prostatectomy/*methods
MH  - Prostatic Neoplasms/pathology/*surgery
MH  - Treatment Outcome
EDAT- 2005/02/15 09:00
MHDA- 2005/10/06 09:00
CRDT- 2005/02/15 09:00
PHST- 2004/07/07 00:00 [received]
PHST- 2004/09/16 00:00 [accepted]
PHST- 2005/02/15 09:00 [pubmed]
PHST- 2005/10/06 09:00 [medline]
PHST- 2005/02/15 09:00 [entrez]
AID - S0090-4295(04)01093-3 [pii]
AID - 10.1016/j.urology.2004.09.027 [doi]
PST - ppublish
SO  - Urology. 2005 Feb;65(2):332-6. doi: 10.1016/j.urology.2004.09.027.

PMID- 29112560
OWN - NLM
STAT- MEDLINE
DCOM- 20171113
LR  - 20171113
IS  - 1530-0358 (Electronic)
IS  - 0012-3706 (Linking)
VI  - 60
IP  - 12
DP  - 2017 Dec
TI  - Is the Distance Worth It? Patients With Rectal Cancer Traveling to High-Volume 
      Centers Experience Improved Outcomes.
PG  - 1250-1259
LID - 10.1097/DCR.0000000000000924 [doi]
AB  - BACKGROUND: It is unclear whether traveling long distances to high-volume centers 
      would compensate for travel burden among patients undergoing rectal cancer 
      resection. OBJECTIVE: The purpose of this study was to determine whether 
      operative volume outweighs the advantages of being treated locally by comparing 
      the outcomes of patients with rectal cancer treated at local, low-volume centers 
      versus far, high-volume centers. DESIGN: This was a population-based study. 
      SETTINGS: The National Cancer Database was queried for patients with rectal 
      cancer. PATIENTS: Patients with stage II or III rectal cancer who underwent 
      surgical resection between 2006 and 2012 were included. MAIN OUTCOME MEASURES: 
      The outcomes of interest were margins, lymph node yield, receipt of neoadjuvant 
      chemoradiation, adjuvant chemotherapy, readmission within 30 days, 30-day and 
      90-day mortality, and 5-year overall survival. RESULTS: A total of 18,605 
      patients met inclusion criteria; 2067 patients were in the 
      long-distance/high-volume group and 1362 in the short-distance/low-volume group. 
      The median travel distance was 62.6 miles for the long-distance/high-volume group 
      and 2.3 miles for the short-distance/low-volume group. Patients who were younger, 
      white, privately insured, and stage III were more likely to have traveled to a 
      high-volume center. When controlled for patient factors, stage, and hospital 
      factors, patients in the short-distance/low-volume group had lower odds of a 
      lymph node yield >/=12 (OR = 0.51) and neoadjuvant chemoradiation (OR = 0.67) and 
      higher 30-day (OR = 3.38) and 90-day mortality (OR = 2.07) compared with those in 
      the long-distance/high-volume group. The short-distance/low-volume group had a 
      34% high risk of overall mortality at 5 years compared with the 
      long-distance/high-volume group. LIMITATIONS: We lacked data regarding patient 
      and physician decision making and surgeon-specific factors. CONCLUSIONS: Our 
      results indicate that when controlled for patient, tumor, and hospital factors, 
      patients who traveled a long distance to a high-volume center had improved lymph 
      node yield, neoadjuvant chemoradiation receipt, and 30- and 90-day mortality 
      compared with those who traveled a short distance to a low-volume center. They 
      also had improved 5-year survival. See Video Abstract at 
      http://links.lww.com/DCR/A446.
FAU - Xu, Zhaomin
AU  - Xu Z
AD  - 1 Department of Surgery, University of Rochester Medical Center, Rochester, New 
      York 2 Division of Epidemiology, Department of Public Health Sciences, University 
      of Rochester Medical Center, Rochester, New York.
FAU - Becerra, Adan Z
AU  - Becerra AZ
FAU - Justiniano, Carla F
AU  - Justiniano CF
FAU - Boodry, Courtney I
AU  - Boodry CI
FAU - Aquina, Christopher T
AU  - Aquina CT
FAU - Swanger, Alex A
AU  - Swanger AA
FAU - Temple, Larissa K
AU  - Temple LK
FAU - Fleming, Fergal J
AU  - Fleming FJ
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Dis Colon Rectum
JT  - Diseases of the colon and rectum
JID - 0372764
SB  - IM
MH  - Adenocarcinoma/mortality/*surgery
MH  - Adenocarcinoma, Mucinous/mortality/*surgery
MH  - Aged
MH  - Chemoradiotherapy
MH  - Chemotherapy, Adjuvant
MH  - Female
MH  - *Health Services Accessibility
MH  - Hospitals, High-Volume
MH  - Humans
MH  - Lymph Node Excision
MH  - Male
MH  - Margins of Excision
MH  - Middle Aged
MH  - Neoplasm Staging
MH  - Patient Readmission/statistics & numerical data
MH  - Rectal Neoplasms/mortality/pathology/*surgery
MH  - Risk Factors
MH  - Survival Rate
MH  - *Travel
MH  - Treatment Outcome
MH  - United States
EDAT- 2017/11/08 06:00
MHDA- 2017/11/14 06:00
CRDT- 2017/11/08 06:00
PHST- 2017/11/08 06:00 [entrez]
PHST- 2017/11/08 06:00 [pubmed]
PHST- 2017/11/14 06:00 [medline]
AID - 00003453-201712000-00007 [pii]
AID - 10.1097/DCR.0000000000000924 [doi]
PST - ppublish
SO  - Dis Colon Rectum. 2017 Dec;60(12):1250-1259. doi: 10.1097/DCR.0000000000000924.

PMID- 23949294
OWN - NLM
STAT- MEDLINE
DCOM- 20140310
LR  - 20181023
IS  - 1972-2680 (Electronic)
IS  - 1972-2680 (Linking)
VI  - 7
IP  - 8
DP  - 2013 Aug 15
TI  - Treatment as prevention in resource-limited settings: is it feasible to maintain 
      HIV viral load suppression over time?
PG  - 593-9
LID - 10.3855/jidc.2926 [doi]
AB  - INTRODUCTION: Recently, there has been increasing interest in the role of 
      "treatment as prevention" (TasP). Some of the questions regarding TasP strategies 
      arise from the perceived difficulties in achieving and maintaining viral load 
      (VL) suppression over time and the risk of emergence of viral resistance that 
      could compromise future treatment options. This study was conducted to assess 
      these questions in a resource-limited setting. METHODOLOGY: We performed a 
      retrospective observational study of HIV-infected patients diagnosed in the 
      pre-HAART era on follow-up at a private center from Buenos Aires, Argentina. 
      Socio-demographic, clinical, and laboratory data were extracted from clinical 
      charts. Analyses were performed to test for potential associations of selected 
      variables with current virologic failure or use of third-line drugs. RESULTS: Of 
      619 patients on follow-up, 82 (13.2%) were diagnosed in the pre-HAART era. At the 
      time of our study, 79 (96.3%) patients were on HAART, with a median duration of 
      14 years (IQR 12-15) of therapy, and exposure to mono or dual nucleoside reverse 
      transcriptase inhibitors regimens in 47.8% of cases. Sixty-nine patients (87.3%) 
      had undetectable VL, 37 (46.8%) never presented virologic failure, and 19 (24.1%) 
      experienced only one failure. Thirteen patients (16.5%) were receiving third-line 
      ART regimens, with an average of 2.7-fold more virologic failures than those on 
      first- or second-line regimens (p = 0.007). CONCLUSIONS: Maintaining viral load 
      suppression over time in resource-limited-settings is feasible.
FAU - Socias, Maria Eugenia
AU  - Socias ME
AD  - Sanatorio Otamendi, Buenos Aires, Argentina. eugenia.socias@gmail.com
FAU - Rotryng, Flavio
AU  - Rotryng F
FAU - Lapadula, Pablo
AU  - Lapadula P
FAU - Medrano, Maira
AU  - Medrano M
FAU - Paz, Daniela
AU  - Paz D
FAU - Stern, Liliana
AU  - Stern L
FAU - Lambierto, Alberto
AU  - Lambierto A
FAU - Pryluka, Daniel
AU  - Pryluka D
LA  - eng
PT  - Journal Article
DEP - 20130815
PL  - Italy
TA  - J Infect Dev Ctries
JT  - Journal of infection in developing countries
JID - 101305410
RN  - 0 (Anti-HIV Agents)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Anti-HIV Agents/*administration & dosage/pharmacology
MH  - Argentina
MH  - Chemoprevention/*methods
MH  - Cohort Studies
MH  - Developing Countries
MH  - Drug Resistance, Viral
MH  - Female
MH  - HIV/drug effects/*isolation & purification
MH  - HIV Infections/*drug therapy/*prevention & control/virology
MH  - Humans
MH  - Male
MH  - Retrospective Studies
MH  - Treatment Failure
MH  - *Viral Load
MH  - Young Adult
EDAT- 2013/08/21 06:00
MHDA- 2014/03/13 06:00
CRDT- 2013/08/17 06:00
PHST- 2012/08/15 00:00 [received]
PHST- 2012/10/23 00:00 [accepted]
PHST- 2012/10/22 00:00 [revised]
PHST- 2013/08/17 06:00 [entrez]
PHST- 2013/08/21 06:00 [pubmed]
PHST- 2014/03/13 06:00 [medline]
AID - 10.3855/jidc.2926 [doi]
PST - epublish
SO  - J Infect Dev Ctries. 2013 Aug 15;7(8):593-9. doi: 10.3855/jidc.2926.

PMID- 10877371
OWN - NLM
STAT- MEDLINE
DCOM- 20000926
LR  - 20191104
IS  - 1057-0829 (Print)
IS  - 1057-0829 (Linking)
VI  - 9
IP  - 3
DP  - 2000 Jun
TI  - Does head positioning influence anterior chamber depth in pseudoexfoliation 
      syndrome?
PG  - 214-8
AB  - PURPOSE: Phacodonesis can occur in pseudoexfoliation syndrome because of impaired 
      zonular support. This study investigates whether the increased mobility of the 
      lens influences anterior chamber depth in patients with pseudoexfoliation while 
      assuming a prone position. METHODS: Central anterior chamber depth was measured 
      in 39 patients with clinically apparent unilateral pseudoexfoliation and elevated 
      intraocular pressure. Patients were placed in a face-up position for 5 minutes, 
      at which time anterior chamber depth and axial length were measured by A scan, 
      and intraocular pressure was measured by Tonopen (Oculab, La Jolla, CA) in both 
      eyes. The measurements were repeated on both eyes after 5 minutes in a face-down 
      position. RESULTS: No significant differences in intraocular pressure or axial 
      length between the prone and supine positions were found in either eye. Anterior 
      chamber depth in eyes with pseudoexfoliation decreased from a mean of 3.08 mm in 
      the supine position to a mean of 2.95 mm in the prone position, whereas mean 
      anterior chamber depth in the fellow eyes decreased from 3.01 mm to 2.97 mm. The 
      decrease in anterior chamber depth when facing down in the eyes with 
      pseudoexfoliation was significantly greater than in the fellow eyes. CONCLUSIONS: 
      In patients with clinically apparent unilateral pseudoexfoliation, the lens seems 
      to be more mobile in the affected eye. This results in a shallower anterior 
      chamber when the head is placed in a prone position. Whether this fact might 
      potentially lead to transient pupillary block when engaging in activities such as 
      facing down while reading warrants further study.
FAU - Lanzl, I M
AU  - Lanzl IM
AD  - Augenklinik und -Poliklinik der Technischen Universitat Munchen am Klinikum 
      rechts der Isar, Germany.
FAU - Merte, R L
AU  - Merte RL
FAU - Graham, A D
AU  - Graham AD
LA  - eng
GR  - EY 03176/EY/NEI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - J Glaucoma
JT  - Journal of glaucoma
JID - 9300903
SB  - IM
MH  - Anterior Chamber/diagnostic imaging/*physiopathology
MH  - Exfoliation Syndrome/*physiopathology
MH  - Head Movements/*physiology
MH  - Humans
MH  - Intraocular Pressure
MH  - Lens, Crystalline/*physiopathology
MH  - *Posture
MH  - Prone Position
MH  - Ultrasonography
EDAT- 2000/07/06 11:00
MHDA- 2000/09/30 11:01
CRDT- 2000/07/06 11:00
PHST- 2000/07/06 11:00 [pubmed]
PHST- 2000/09/30 11:01 [medline]
PHST- 2000/07/06 11:00 [entrez]
AID - 10.1097/00061198-200006000-00003 [doi]
PST - ppublish
SO  - J Glaucoma. 2000 Jun;9(3):214-8. doi: 10.1097/00061198-200006000-00003.

PMID- 23870157
OWN - NLM
STAT- MEDLINE
DCOM- 20140627
LR  - 20140505
IS  - 1097-685X (Electronic)
IS  - 0022-5223 (Linking)
VI  - 147
IP  - 5
DP  - 2014 May
TI  - Are intraoperative precursor events associated with postoperative major adverse 
      events?
PG  - 1499-504
LID - S0022-5223(13)00581-3 [pii]
LID - 10.1016/j.jtcvs.2013.05.018 [doi]
AB  - OBJECTIVES: Precursor events are undesirable events that can lead to a subsequent 
      adverse event and have been associated with postoperative mortality. The purpose 
      of the present study was to determine whether precursor events are associated 
      with a composite endpoint of major adverse cardiac events (MACE) (death, acute 
      renal failure, stroke, infection) in a low- to medium-risk coronary artery bypass 
      grafting, valve, and valve plus coronary artery bypass grafting population. These 
      events might be targets for strategies aimed at quality improvement. METHODS: The 
      present study was a retrospective cohort design performed at the Queen Elizabeth 
      Health Science Centre. Low- to medium-risk patients who had experienced 
      postoperative MACE were matched 1:1 with patients who had not experienced 
      postoperative MACE. The operative notes, for both groups, were scored by 5 
      surgeons to determine the frequency of 4 precursor events: bleeding, difficulty 
      weaning from cardiopulmonary bypass, repair or regrafting, and incomplete 
      revascularization or repair. A univariate comparison of >/=1 precursor events in 
      the matched groups was performed. RESULTS: A total of 311 MACE patients (98.4%) 
      were matched. The primary outcome occurred more frequently in the MACE group than 
      in the non-MACE group (33% vs 24%; P = .015). The incidence of the individual 
      events of bleeding and difficulty weaning from cardiopulmonary bypass was 
      significantly higher in the MACE group. Those patients with a precursor event in 
      the absence of MACE also appeared to have a greater prevalence of other important 
      postoperative outcomes. CONCLUSIONS: Patients undergoing cardiac surgery who are 
      exposed to intraoperative precursor events were more likely to experience a 
      postoperative MACE. Quality improvement techniques aimed at mitigating the 
      consequences of precursor events might improve the surgical outcomes for cardiac 
      surgical patients.
CI  - Crown Copyright (c) 2014. Published by Mosby, Inc. All rights reserved.
FAU - Herman, Christine R
AU  - Herman CR
AD  - Division of Cardiac Surgery, Dallhousie University, Halifax, Nova Scotia, Canada; 
      Department of Community Health and Epidemiology, Dallhousie University, Halifax, 
      Nova Scotia, Canada. Electronic address: cherman@dal.ca.
FAU - Legare, Jean-Francois
AU  - Legare JF
AD  - Division of Cardiac Surgery, Dallhousie University, Halifax, Nova Scotia, Canada.
FAU - Levy, Adrian
AU  - Levy A
AD  - Department of Community Health and Epidemiology, Dallhousie University, Halifax, 
      Nova Scotia, Canada.
FAU - Buth, Karen J
AU  - Buth KJ
AD  - Division of Cardiac Surgery, Dallhousie University, Halifax, Nova Scotia, Canada.
FAU - Baskett, Roger
AU  - Baskett R
AD  - Division of Cardiac Surgery, Dallhousie University, Halifax, Nova Scotia, Canada.
LA  - eng
PT  - Journal Article
DEP - 20130716
PL  - United States
TA  - J Thorac Cardiovasc Surg
JT  - The Journal of thoracic and cardiovascular surgery
JID - 0376343
SB  - IM
MH  - Aged
MH  - Blood Loss, Surgical/mortality
MH  - Cardiopulmonary Bypass
MH  - Coronary Artery Bypass/*adverse effects/mortality
MH  - Female
MH  - Heart Valve Prosthesis Implantation/*adverse effects/mortality
MH  - Humans
MH  - Incidence
MH  - Male
MH  - Middle Aged
MH  - Nova Scotia/epidemiology
MH  - Postoperative Complications/*epidemiology/mortality/surgery
MH  - Prevalence
MH  - Quality Improvement
MH  - Quality Indicators, Health Care
MH  - Registries
MH  - Reoperation
MH  - Retrospective Studies
MH  - Risk Factors
MH  - Time Factors
MH  - Treatment Outcome
EDAT- 2013/07/23 06:00
MHDA- 2014/06/28 06:00
CRDT- 2013/07/23 06:00
PHST- 2012/10/12 00:00 [received]
PHST- 2013/01/21 00:00 [revised]
PHST- 2013/05/30 00:00 [accepted]
PHST- 2013/07/23 06:00 [entrez]
PHST- 2013/07/23 06:00 [pubmed]
PHST- 2014/06/28 06:00 [medline]
AID - S0022-5223(13)00581-3 [pii]
AID - 10.1016/j.jtcvs.2013.05.018 [doi]
PST - ppublish
SO  - J Thorac Cardiovasc Surg. 2014 May;147(5):1499-504. doi: 
      10.1016/j.jtcvs.2013.05.018. Epub 2013 Jul 16.

PMID- 18540901
OWN - NLM
STAT- MEDLINE
DCOM- 20090116
LR  - 20080910
IS  - 0803-5253 (Print)
IS  - 0803-5253 (Linking)
VI  - 97
IP  - 10
DP  - 2008 Oct
TI  - Transient tachypnea of the newborn (TTN): a role for polymorphisms in the 
      beta-adrenergic receptor (ADRB) encoding genes?
PG  - 1346-50
LID - 10.1111/j.1651-2227.2008.00888.x [doi]
AB  - AIM: Transient tachypnea of the newborn (TTN) is a common cause of early 
      respiratory distress in the neonatal period of term infants. Delayed resorption 
      of foetal lung fluid after birth is considered as the main pathophysiological 
      factor. As resorption of foetal lung fluid is a catecholamine dependent process, 
      we aimed at investigating, whether beta1- and beta2-adrenoreceptor (ADRB1, ADRB2) 
      polymorphisms, known to alter catecholamine activity, are operative in TTN. 
      METHODS: DNA was collected for genotyping from 73 term newborns suffering from 
      TTN and 55 healthy controls from a Caucasian cohort. RESULTS: TTN infants were 
      more likely to be male (70% vs. 49%; p < 0.05), had a lower mean birthweight 
      (3120 +/- 450 vs. 3396 +/- 504 g; p < 0.001) and gestational age (GA) (38.4 +/- 
      1.2 vs. 39.4 +/- 1.3 weeks; p < 0.001) and were more often delivered by caesarean 
      section (CS) (71% vs. 26%; p < 0.001). The beta1Ser49Gly polymorphism differed 
      significantly between cases and controls. Multivariate analysis provided 
      beta1Gly49 homozygotes with higher risk for TTN (OR 18.5; 95%CI 1.5-229; p = 
      0.023) than beta1Ser49 allele carrier. Further analysis showed significant 
      association of T-47C, A46G, C79G and C491T (TACC) haplotype in ADRB2 gene with 
      TTN (p = 0.048). CONCLUSION: We conclude that beta1Gly49 homozygosity and TACC 
      haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose 
      to TTN.
FAU - Aslan, Ece
AU  - Aslan E
AD  - Center of Pediatrics and Neonatology, Children's University Hospital of Saarland, 
      Homburg/Saar, Germany.
FAU - Tutdibi, Erol
AU  - Tutdibi E
FAU - Martens, Swantje
AU  - Martens S
FAU - Han, Yihua
AU  - Han Y
FAU - Monz, Dominik
AU  - Monz D
FAU - Gortner, Ludwig
AU  - Gortner L
LA  - eng
PT  - Journal Article
DEP - 20080605
PL  - Norway
TA  - Acta Paediatr
JT  - Acta paediatrica (Oslo, Norway : 1992)
JID - 9205968
RN  - 0 (Receptors, Adrenergic, beta)
RN  - 9007-49-2 (DNA)
SB  - IM
CIN - Acta Paediatr. 2008 Oct;97(10):1324-6. doi: 10.1111/j.1651-2227.2008.00954.x. 
      PMID: 18673362
MH  - Apgar Score
MH  - Case-Control Studies
MH  - DNA/analysis
MH  - Female
MH  - Genotype
MH  - Gestational Age
MH  - Haplotypes
MH  - Humans
MH  - Infant, Newborn
MH  - Male
MH  - *Polymorphism, Single Nucleotide
MH  - Receptors, Adrenergic, beta/drug effects/*genetics
MH  - Respiration Disorders/complications/*genetics/physiopathology
MH  - Time Factors
EDAT- 2008/06/11 09:00
MHDA- 2009/01/17 09:00
CRDT- 2008/06/11 09:00
PHST- 2008/06/11 09:00 [pubmed]
PHST- 2009/01/17 09:00 [medline]
PHST- 2008/06/11 09:00 [entrez]
AID - APA888 [pii]
AID - 10.1111/j.1651-2227.2008.00888.x [doi]
PST - ppublish
SO  - Acta Paediatr. 2008 Oct;97(10):1346-50. doi: 10.1111/j.1651-2227.2008.00888.x. 
      Epub 2008 Jun 5.

PMID- 21420186
OWN - NLM
STAT- MEDLINE
DCOM- 20130611
LR  - 20161125
IS  - 1874-1754 (Electronic)
IS  - 0167-5273 (Linking)
VI  - 159
IP  - 3
DP  - 2012 Sep 6
TI  - Could ADMA levels in young adults born preterm predict an early endothelial 
      dysfunction?
PG  - 217-9
LID - 10.1016/j.ijcard.2011.02.069 [doi]
AB  - BACKGROUND: Sporadic data present in literature report how preterm birth and low 
      birth weight are risk factors for the development of cardiovascular diseases in 
      later life. High levels of asymmetric dimethylarginine (ADMA), a strong inhibitor 
      of nitric oxide synthesis, are associated with the future development of adverse 
      cardiovascular events and cardiac death. AIMS: 1) to verify the presence of a 
      statistically significant difference between ADMA levels in young adults born 
      preterm at extremely low birth weight (<1000 g; ex-ELBW) and those of a control 
      group of healthy adults born at term (C) and 2) to seek correlations between ADMA 
      levels in ex-ELBW and anthropometric and clinical parameters (gender, 
      chronological age, gestational age, birth weight, and duration of stay in 
      Neonatal Intensive Care Unit). METHODS: Thirty-two ex-ELBW subjects (11 males [M] 
      and 21 females [F], aged 17-29years, mean age 22.2 +/- 2.3 years) were compared 
      with 25 C (7 M and 18F). ADMA levels were assessed by high-performance liquid 
      chromatography with highly sensitive laser fluorescent detection. RESULTS: ADMA 
      levels were reduced in ex-ELBW subjects compared to C (0.606+0.095 vs 0.562+0.101 
      mumol/L, p<0.05), and significantly correlated inversely with gestational age 
      (r=-0.61, p<0.00001) and birth weight (r=-0.57, p<0.0002). CONCLUSIONS: Our 
      findings reveal a significant decrease in ADMA levels of ex-ELBW subjects 
      compared to C, underlining a probable correlation with preterm birth and low 
      birth weight. Taken together, these results may underlie the onset of early 
      circulatory dysfunction predictive of increased cardiovascular risk.
CI  - Copyright (c) 2011 Elsevier Ireland Ltd. All rights reserved.
FAU - Bassareo, P P
AU  - Bassareo PP
AD  - Department of Cardiovascular and Neurological Sciences, University of Cagliari, 
      Cagliari, Italy. piercard@inwind.it
FAU - Puddu, M
AU  - Puddu M
FAU - Flore, G
AU  - Flore G
FAU - Deidda, M
AU  - Deidda M
FAU - Manconi, E
AU  - Manconi E
FAU - Melis, A
AU  - Melis A
FAU - Fanos, V
AU  - Fanos V
FAU - Mercuro, G
AU  - Mercuro G
LA  - eng
PT  - Journal Article
DEP - 20110321
PL  - Netherlands
TA  - Int J Cardiol
JT  - International journal of cardiology
JID - 8200291
RN  - 63CV1GEK3Y (N,N-dimethylarginine)
RN  - 94ZLA3W45F (Arginine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Arginine/*analogs & derivatives/blood
MH  - Early Diagnosis
MH  - Endothelium, Vascular/*metabolism/*physiopathology
MH  - Female
MH  - Gestational Age
MH  - Humans
MH  - Infant, Extremely Low Birth Weight/blood
MH  - Infant, Low Birth Weight/*blood
MH  - Infant, Newborn
MH  - Male
MH  - Predictive Value of Tests
MH  - Premature Birth/blood/epidemiology
MH  - Vascular Diseases/blood/*diagnosis/epidemiology
MH  - Young Adult
EDAT- 2011/03/23 06:00
MHDA- 2013/06/12 06:00
CRDT- 2011/03/23 06:00
PHST- 2010/12/21 00:00 [received]
PHST- 2011/02/11 00:00 [revised]
PHST- 2011/02/25 00:00 [accepted]
PHST- 2011/03/23 06:00 [entrez]
PHST- 2011/03/23 06:00 [pubmed]
PHST- 2013/06/12 06:00 [medline]
AID - S0167-5273(11)00247-6 [pii]
AID - 10.1016/j.ijcard.2011.02.069 [doi]
PST - ppublish
SO  - Int J Cardiol. 2012 Sep 6;159(3):217-9. doi: 10.1016/j.ijcard.2011.02.069. Epub 
      2011 Mar 21.

PMID- 12484580
OWN - NLM
STAT- MEDLINE
DCOM- 20030124
LR  - 20151119
IS  - 0035-8843 (Print)
IS  - 1478-7083 (Electronic)
IS  - 0035-8843 (Linking)
VI  - 84
IP  - 6
DP  - 2002 Nov
TI  - Informed consent for total hip arthroplasty: does a written information sheet 
      improve recall by patients?
PG  - 404-8
AB  - OBJECTIVE: To ascertain whether a written information sheet is acceptable to 
      patients and improves recall of the consent interview. DESIGN: Prospective 
      randomised controlled study using questionnaires, comparing a group of patients 
      given information in a written sheet with appropriate explanation to a group 
      given verbal information alone. SETTING: A specialist orthopaedic surgery unit. 
      PATIENTS: The test group was 126 patients undergoing revision or primary total 
      hip arthroplasty; 65 patients were given information verbally, 61 patients were 
      given written information. OUTCOME MEASURE: Patients' recall of information 
      given, tested with a questionnaire completed on admission (mean of 18 days 
      later). RESULTS: The patients receiving written information scored significantly 
      higher (48% correct answers) than the patients receiving verbal information (38% 
      correct answers). CONCLUSIONS: Written information sheets contribute to the 
      process of informed consent. As patients' recall of information is generally 
      poor, the sheets may also be useful medicolegally, as a permanent record of what 
      was discussed.
FAU - Langdon, I J
AU  - Langdon IJ
AD  - University Department of Orthopaedic Surgery, Avon Orthopaedic Centre, Southmead 
      Hospital, Bristol, UK. Ilana.Langdon@ruh-bath.swest.nhs.uk
FAU - Hardin, R
AU  - Hardin R
FAU - Learmonth, I D
AU  - Learmonth ID
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
PT  - Randomized Controlled Trial
PL  - England
TA  - Ann R Coll Surg Engl
JT  - Annals of the Royal College of Surgeons of England
JID - 7506860
SB  - IM
MH  - *Arthroplasty, Replacement, Hip
MH  - Female
MH  - Humans
MH  - Informed Consent/ethics/*legislation & jurisprudence
MH  - Male
MH  - *Mental Recall
MH  - Patient Education as Topic/*methods
MH  - Professional-Patient Relations
MH  - Prospective Studies
MH  - Surveys and Questionnaires
PMC - PMC2504187
EDAT- 2002/12/18 04:00
MHDA- 2003/01/25 04:00
PMCR- 2003/11/01
CRDT- 2002/12/18 04:00
PHST- 2002/12/18 04:00 [pubmed]
PHST- 2003/01/25 04:00 [medline]
PHST- 2002/12/18 04:00 [entrez]
PHST- 2003/11/01 00:00 [pmc-release]
AID - 10.1308/003588402760978201 [doi]
PST - ppublish
SO  - Ann R Coll Surg Engl. 2002 Nov;84(6):404-8. doi: 10.1308/003588402760978201.

PMID- 23321509
OWN - NLM
STAT- MEDLINE
DCOM- 20130307
LR  - 20211021
IS  - 1532-1827 (Electronic)
IS  - 0007-0920 (Print)
IS  - 0007-0920 (Linking)
VI  - 108
IP  - 1
DP  - 2013 Jan 15
TI  - Quaternary cytoreductive surgery in ovarian cancer: does surgical effort still 
      matter?
PG  - 32-8
LID - 10.1038/bjc.2012.544 [doi]
AB  - BACKGROUND: To evaluate surgical outcome and survival benefit after quaternary 
      cytoreduction (QC) in epithelial ovarian cancer (EOC) relapse. METHODS: We 
      systematically evaluated all consecutive patients undergoing QC in our 
      institution over a 12-year period (October 2000-January 2012). All relevant 
      surgical and clinical outcome parameters were systematically assessed. RESULTS: 
      Forty-nine EOC patients (median age: 57; range: 28-76) underwent QC; in a median 
      of 16 months (range:2-142) after previous chemotherapy. The majority of the 
      patients had an initial FIGO stage III (67.3%), peritoneal carcinomatosis (77.6%) 
      and no ascites (67.3%). At QC, patients presented following tumour pattern: lower 
      abdomen 85.7%; middle abdomen 79.6% and upper abdomen 42.9%. Median duration of 
      surgery was 292 min (range: a total macroscopic tumour clearance could be 
      achieved. Rates of major operative morbidity and 30-day mortality were 28.6% and 
      2%, respectively.Mean follow-up from QC was 18.41 months (95% confidence interval 
      (CI):12.64-24.18) and mean overall survival (OS) 23.05 months (95% CI: 
      15.5-30.6). Mean OS for patients without vs any tumour residuals was 43 months 
      (95% CI: 26.4-59.5) vs 13.4 months (95% CI: 7.42-19.4); P=0.001. Mean OS for 
      patients who received postoperative chemotherapy (n=18; 36.7%) vs those who did 
      not was 40.5 months (95% CI: 27.4-53.6) vs 12.03 months (95% CI: 5.9-18.18); 
      P<0.001.Multivariate analysis indentified multifocal tumour dissemination to be 
      of predictive significance for incomplete tumour resection, higher operative 
      morbidity and lower survival, while systemic chemotherapy subsequent to QC had a 
      protective significant impact on OS. No prognostic impact had ascites, platinum 
      resistance, high grading and advanced age. CONCLUSION: Even in this highly 
      advanced setting of the third EOC relapse, maximal therapeutic effort combining 
      optimal surgery and chemotherapy appear to significantly prolong survival in a 
      selected patients 'group'.
FAU - Fotopoulou, C
AU  - Fotopoulou C
AD  - Department of Gynecology, Charite University Medical Center Berlin, 13353 Berlin, 
      Germany. chfotopoulou@gmail.com
FAU - Savvatis, K
AU  - Savvatis K
FAU - Kosian, P
AU  - Kosian P
FAU - Braicu, I E
AU  - Braicu IE
FAU - Papanikolaou, G
AU  - Papanikolaou G
FAU - Pietzner, K
AU  - Pietzner K
FAU - Schmidt, S-C
AU  - Schmidt SC
FAU - Sehouli, J
AU  - Sehouli J
LA  - eng
PT  - Journal Article
PL  - England
TA  - Br J Cancer
JT  - British journal of cancer
JID - 0370635
SB  - IM
MH  - Adult
MH  - Aged
MH  - Carcinoma, Ovarian Epithelial
MH  - Chemotherapy, Adjuvant
MH  - Female
MH  - Humans
MH  - Middle Aged
MH  - Neoplasm Invasiveness
MH  - Neoplasms, Glandular and Epithelial/drug therapy/mortality/pathology/*surgery
MH  - Ovarian Neoplasms/drug therapy/mortality/pathology/*surgery
MH  - Prognosis
MH  - Recurrence
MH  - Survival Rate
MH  - Treatment Outcome
PMC - PMC3553531
COIS- The authors declare no conflict of interest.
EDAT- 2013/01/17 06:00
MHDA- 2013/03/08 06:00
PMCR- 2014/01/15
CRDT- 2013/01/17 06:00
PHST- 2013/01/17 06:00 [entrez]
PHST- 2013/01/17 06:00 [pubmed]
PHST- 2013/03/08 06:00 [medline]
PHST- 2014/01/15 00:00 [pmc-release]
AID - bjc2012544 [pii]
AID - 10.1038/bjc.2012.544 [doi]
PST - ppublish
SO  - Br J Cancer. 2013 Jan 15;108(1):32-8. doi: 10.1038/bjc.2012.544.

PMID- 26907557
OWN - NLM
STAT- MEDLINE
DCOM- 20170420
LR  - 20170817
IS  - 1531-5053 (Electronic)
IS  - 0278-2391 (Linking)
VI  - 74
IP  - 7
DP  - 2016 Jul
TI  - Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and 
      Reduce Complications?
PG  - 1336-42
LID - S0278-2391(16)00131-2 [pii]
LID - 10.1016/j.joms.2016.01.039 [doi]
AB  - PURPOSE: This clinical study investigated whether the vascular-guided multilayer 
      preauricular approach (VMPA) to the temporomandibular joint (TMJ) could improve 
      access and decrease complications. PATIENTS AND METHODS: This retrospective 
      evaluation consisted of a consecutive series of patients who underwent TMJ 
      surgeries through the VMPA from January through December 2013. Patients with a 
      history of TMJ surgery were excluded. Clinical data, including operating times, 
      subjective complaints of incision scars, functional conditions of the 
      auriculotemporal nerve and facial nerve, and other complications, were recorded 
      and analyzed. All patients in this study were followed for at least 6 months. 
      RESULTS: All patients (606 joints) had successful TMJ surgeries through the VMPA. 
      All incisions healed favorably with an uneventful recovery. No patient developed 
      permanent weakness of the facial nerve or other severe complications. CONCLUSION: 
      The VMPA can provide direct access and favorable visibility to the TMJ region and 
      yield good esthetic and functional results. The VMPA can be considered the 
      approach of choice for common TMJ surgeries.
CI  - Copyright (c) 2016 American Association of Oral and Maxillofacial Surgeons. 
      Published by Elsevier Inc. All rights reserved.
FAU - Qiu, Ya-Ting
AU  - Qiu YT
AD  - Surgeon, Department of Oral and Maxillofacial Surgery, Shanghai Ninth People's 
      Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
FAU - Yang, Chi
AU  - Yang C
AD  - Professor and Director, Department of Oral and Maxillofacial Surgery, Shanghai 
      Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, 
      Shanghai, China. Electronic address: yangchi63@hotmail.com.
FAU - Chen, Min-Jie
AU  - Chen MJ
AD  - Surgeon, Department of Oral and Maxillofacial Surgery, Shanghai Ninth People's 
      Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
FAU - Qiu, Wei-Liu
AU  - Qiu WL
AD  - Former Professor and Director, Department of Oral and Maxillofacial Surgery, 
      Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of 
      Medicine, Shanghai, China.
LA  - eng
PT  - Journal Article
DEP - 20160129
PL  - United States
TA  - J Oral Maxillofac Surg
JT  - Journal of oral and maxillofacial surgery : official journal of the American 
      Association of Oral and Maxillofacial Surgeons
JID - 8206428
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Child
MH  - Child, Preschool
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Oral Surgical Procedures
MH  - Postoperative Complications/*prevention & control
MH  - Retrospective Studies
MH  - Temporomandibular Joint Disorders/*surgery
MH  - Treatment Outcome
EDAT- 2016/02/26 06:00
MHDA- 2017/04/21 06:00
CRDT- 2016/02/25 06:00
PHST- 2015/09/30 00:00 [received]
PHST- 2016/01/12 00:00 [revised]
PHST- 2016/01/14 00:00 [accepted]
PHST- 2016/02/25 06:00 [entrez]
PHST- 2016/02/26 06:00 [pubmed]
PHST- 2017/04/21 06:00 [medline]
AID - S0278-2391(16)00131-2 [pii]
AID - 10.1016/j.joms.2016.01.039 [doi]
PST - ppublish
SO  - J Oral Maxillofac Surg. 2016 Jul;74(7):1336-42. doi: 10.1016/j.joms.2016.01.039. 
      Epub 2016 Jan 29.

PMID- 22644412
OWN - NLM
STAT- MEDLINE
DCOM- 20130107
LR  - 20211021
IS  - 1867-108X (Electronic)
IS  - 1867-1071 (Linking)
VI  - 30
IP  - 7
DP  - 2012 Aug
TI  - Hepatic arterial embolization for unresectable hepatocellular carcinomas: do 
      technical factors affect prognosis?
PG  - 560-6
LID - 10.1007/s11604-012-0088-1 [doi]
AB  - PURPOSE: To evaluate retrospectively whether technical factors of hepatic 
      arterial embolization affect the prognosis of patients with hepatocellular 
      carcinoma (HCC). MATERIALS AND METHODS: Inclusion criteria of this study were the 
      following: (1) patients received embolization as the initial treatment during 
      2003-2004, (2) Child A or B liver profile, (3) five or fewer HCCs with maximum 
      diameter of 7 cm or smaller, and (4) no extrahepatic metastasis. Patient data 
      were gathered from 43 centers. Prognostic factors were evaluated using univariate 
      and multivariate analyses. RESULTS: Eight hundred fifteen patients were enrolled. 
      The 1-, 3-, 5-, and 7-year overall survival rates were 92.0 % (95 % CI 
      90.1-93.9), 62.9 % (95 % CI 59.3-66.6), 39.0 % (95 % CI 35.1-43.0), and 26.7 % 
      (95 % CI 22.6-30.8) in all patients. Univariate analysis showed a Child-Pugh 
      class-A, alpha-fetoprotein level lower than 100 ng/ml, tumor size of 3 cm or 
      smaller, tumor number of 3 or fewer, one-lobe tumor distribution, nodular tumor 
      type, within the Milan criteria, stage I or II, no portal venous invasion, use of 
      iodized oil, and selective embolization were significantly better prognostic 
      factors. In the multivariate Cox model, the benefit to survival of selective 
      embolization remained significant (hazard ratio 0.68; 95 % CI 0.48-0.97; p = 
      0.033). CONCLUSION: Selective embolization contributes to survival in patients 
      with HCCs.
FAU - Yamakado, Koichiro
AU  - Yamakado K
AD  - Department of Interventional Radiology, Mie University School of Medicine, 2-174 
      Edobashi, Tsu 514-8507, Japan. yama@clin.medic.mie-u.ac.jp
FAU - Miyayama, Shiro
AU  - Miyayama S
FAU - Hirota, Shozo
AU  - Hirota S
FAU - Mizunuma, Kimiyoshi
AU  - Mizunuma K
FAU - Nakamura, Kenji
AU  - Nakamura K
FAU - Inaba, Yoshitaka
AU  - Inaba Y
FAU - Maeda, Akihiro
AU  - Maeda A
FAU - Matsuo, Kunihiro
AU  - Matsuo K
FAU - Nishida, Norifumi
AU  - Nishida N
FAU - Aramaki, Takeshi
AU  - Aramaki T
FAU - Anai, Hiroshi
AU  - Anai H
FAU - Koura, Shinichi
AU  - Koura S
FAU - Oikawa, Shigeo
AU  - Oikawa S
FAU - Watanabe, Ken
AU  - Watanabe K
FAU - Yasumoto, Taku
AU  - Yasumoto T
FAU - Furuichi, Kinya
AU  - Furuichi K
FAU - Yamaguchi, Masato
AU  - Yamaguchi M
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20120530
PL  - Japan
TA  - Jpn J Radiol
JT  - Japanese journal of radiology
JID - 101490689
RN  - 0 (alpha-Fetoproteins)
RN  - 8001-40-9 (Iodized Oil)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Carcinoma, Hepatocellular/*therapy
MH  - Chemoembolization, Therapeutic/*methods
MH  - Disease Progression
MH  - Female
MH  - Hepatic Artery
MH  - Humans
MH  - Iodized Oil/administration & dosage
MH  - Liver Neoplasms/*therapy
MH  - Male
MH  - Middle Aged
MH  - Prognosis
MH  - Proportional Hazards Models
MH  - Retrospective Studies
MH  - Survival Rate
MH  - alpha-Fetoproteins/analysis
EDAT- 2012/05/31 06:00
MHDA- 2013/01/08 06:00
CRDT- 2012/05/31 06:00
PHST- 2012/04/04 00:00 [received]
PHST- 2012/05/10 00:00 [accepted]
PHST- 2012/05/31 06:00 [entrez]
PHST- 2012/05/31 06:00 [pubmed]
PHST- 2013/01/08 06:00 [medline]
AID - 10.1007/s11604-012-0088-1 [doi]
PST - ppublish
SO  - Jpn J Radiol. 2012 Aug;30(7):560-6. doi: 10.1007/s11604-012-0088-1. Epub 2012 May 
      30.

PMID- 25521278
OWN - NLM
STAT- MEDLINE
DCOM- 20150720
LR  - 20240610
IS  - 1930-739X (Electronic)
IS  - 1930-7381 (Print)
IS  - 1930-7381 (Linking)
VI  - 23
IP  - 2
DP  - 2015 Feb
TI  - Is plate clearing a risk factor for obesity? A cross-sectional study of 
      self-reported data in US adults.
PG  - 301-4
LID - 10.1002/oby.20976 [doi]
AB  - OBJECTIVES: Identifying eating behaviors which contribute to excess weight gain 
      will inform obesity prevention strategies. A tendency to clear one's plate when 
      eating may be a risk factor for obesity in an environment where food is 
      plentiful. Whether plate clearing is associated with increased body weight in a 
      cohort of US participants was examined. METHODS: Nine hundred and ninety-three US 
      adults (60% male, 80% American European, mean age=31 years) completed self-report 
      measures of habitual plate clearing together with behavioral and demographic 
      characteristics known to be associated with obesity. RESULTS: Plate clearing 
      tendencies were positively associated with BMI and remained so after accounting 
      for a large number of other demographic and behavioral predictors of BMI in 
      analyses (beta=0.18, 95% CIs=0.07, 0.29, P<0.001); an increased tendency to plate 
      clear was associated with a significantly higher body weight. CONCLUSIONS: The 
      tendency to clear one's plate when eating is associated with increased body 
      weight and may constitute a risk factor for weight gain.
CI  - (c) 2014 The Obesity Society.
FAU - Robinson, Eric
AU  - Robinson E
AD  - Psychological Sciences, University of Liverpool, Liverpool, UK.
FAU - Aveyard, Paul
AU  - Aveyard P
FAU - Jebb, Susan A
AU  - Jebb SA
LA  - eng
GR  - WT_/Wellcome Trust/United Kingdom
GR  - 090207/Z/09/Z/WT_/Wellcome Trust/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20141217
PL  - United States
TA  - Obesity (Silver Spring)
JT  - Obesity (Silver Spring, Md.)
JID - 101264860
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Body Mass Index
MH  - Body Weight/physiology
MH  - Cross-Sectional Studies
MH  - Feeding Behavior/*physiology
MH  - Female
MH  - *Health Surveys
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Obesity/*epidemiology/*physiopathology
MH  - Risk Factors
MH  - *Self Report
MH  - Surveys and Questionnaires
MH  - United States/epidemiology
MH  - Weight Gain/physiology
MH  - Young Adult
PMC - PMC4719168
MID - EMS66650
OID - NLM: EMS66650
EDAT- 2014/12/19 06:00
MHDA- 2015/07/21 06:00
PMCR- 2016/01/20
CRDT- 2014/12/19 06:00
PHST- 2014/09/08 00:00 [received]
PHST- 2014/10/28 00:00 [accepted]
PHST- 2014/12/19 06:00 [entrez]
PHST- 2014/12/19 06:00 [pubmed]
PHST- 2015/07/21 06:00 [medline]
PHST- 2016/01/20 00:00 [pmc-release]
AID - 10.1002/oby.20976 [doi]
PST - ppublish
SO  - Obesity (Silver Spring). 2015 Feb;23(2):301-4. doi: 10.1002/oby.20976. Epub 2014 
      Dec 17.

PMID- 21845457
OWN - NLM
STAT- MEDLINE
DCOM- 20120110
LR  - 20211020
IS  - 1432-2323 (Electronic)
IS  - 0364-2313 (Linking)
VI  - 35
IP  - 10
DP  - 2011 Oct
TI  - Outcomes of severely injured adult trauma patients in an Australian health 
      service: does trauma center level make a difference?
PG  - 2332-40
LID - 10.1007/s00268-011-1217-1 [doi]
AB  - BACKGROUND: Trauma centers are designated to provide systematized 
      multidisciplinary care to injured patients. Effective trauma systems reduce 
      patient mortality by facilitating the treatment of injured patients at 
      appropriately resourced hospitals. Several U.S. studies report reduced mortality 
      among patients admitted directly to a level I trauma center compared with those 
      admitted to hospitals with less resources. It has yet to be shown whether there 
      is an outcome benefit associated with the "level of hospital" initially treating 
      severely injured trauma patients in Australia. This study was designed to 
      determine whether the level of trauma center providing treatment impacts 
      mortality and/or hospital length of stay. METHODS: Outcomes were evaluated for 
      severely injured trauma patients with an Injury Severity Score (ISS) > 15 using 
      NSW Institute of Trauma and Injury Management data from 2002-2007 for our 
      regional health service. To assess the association between trauma centers and 
      binary outcomes, a logistic regression model was used. To assess the association 
      between trauma centers and continuous outcomes, a multivariable linear regression 
      model was used. Sex, age, and ISS were included as covariates in all models. 
      RESULTS: There were 1,986 trauma presentations during the 6-year period. Patients 
      presenting to a level III trauma center had a significantly higher risk of death 
      than those presenting to the level I center, regardless of age, sex, ISS, or 
      prehospital time. Peer review of deaths at the level III center identified 
      problems in care delivery in 15 cases associated with technical errors, delay in 
      decision making, or errors of judgement. CONCLUSION: Severely injured patients 
      treated at a level III center had a higher mortality rate than those treated at a 
      level I center. Most problems identified occurred in the emergency department and 
      were related to delays in care provision. This research highlights the importance 
      of efficient prehospital, in-hospital, and regional trauma systems, performance 
      monitoring, peer review, and adherence to protocols and guidelines.
FAU - Curtis, Kate
AU  - Curtis K
AD  - Trauma Department, St George Hospital, Gray Street, Kogarah, NSW, Australia. 
      Kate.Curtis@sesiahs.health.nsw.gov.au
FAU - Chong, Shanley
AU  - Chong S
FAU - Mitchell, Rebecca
AU  - Mitchell R
FAU - Newcombe, Mark
AU  - Newcombe M
FAU - Black, Deborah
AU  - Black D
FAU - Langcake, Mary
AU  - Langcake M
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - World J Surg
JT  - World journal of surgery
JID - 7704052
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Australia
MH  - Female
MH  - Humans
MH  - Injury Severity Score
MH  - Male
MH  - Middle Aged
MH  - Trauma Centers/*classification
MH  - Treatment Outcome
MH  - Wounds and Injuries/mortality/*therapy
MH  - Young Adult
EDAT- 2011/08/17 06:00
MHDA- 2012/01/11 06:00
CRDT- 2011/08/17 06:00
PHST- 2011/08/17 06:00 [entrez]
PHST- 2011/08/17 06:00 [pubmed]
PHST- 2012/01/11 06:00 [medline]
AID - 10.1007/s00268-011-1217-1 [doi]
PST - ppublish
SO  - World J Surg. 2011 Oct;35(10):2332-40. doi: 10.1007/s00268-011-1217-1.

PMID- 18565233
OWN - NLM
STAT- MEDLINE
DCOM- 20080728
LR  - 20211020
IS  - 1475-2840 (Electronic)
IS  - 1475-2840 (Linking)
VI  - 7
DP  - 2008 Jun 19
TI  - Does the lipid-lowering peroxisome proliferator-activated receptors ligand 
      bezafibrate prevent colon cancer in patients with coronary artery disease?
PG  - 18
LID - 10.1186/1475-2840-7-18 [doi]
AB  - BACKGROUND: Epidemiologic studies have suggested that hypertriglyceridemia and 
      insulin resistance are related to the development of colon cancer. Nuclear 
      peroxisome proliferator-activated receptors (PPAR), which play a central role in 
      lipid and glucose metabolism, had been hypothesized as being involved in colon 
      cancerogenesis. In animal studies the lipid-lowering PPAR ligand bezafibrate 
      suppressed colonic tumors. However, the effect of bezafibrate on colon cancer 
      development in humans is unknown. Therefore, we proposed to investigate a 
      possible preventive effect of bezafibrate on the development of colon cancer in 
      patients with coronary artery disease during a 6-year follow-up. METHODS: Our 
      population included 3011 patients without any cancer diagnosis who were enrolled 
      in the randomized, double blind Bezafibrate Infarction Prevention (BIP) Study. 
      The patients received either 400 mg of bezafibrate retard (1506 patients) or 
      placebo (1505 patients) once a day. Cancer incidence data were obtained by 
      matching a subject's identification numbers with the National Cancer Registry. 
      Each matched record was checked for correct identification. RESULTS: Development 
      of new cancer (all types) was recorded in 177 patients: in 79 (5.25%) patients 
      from the bezafibrate group vs. 98 (6.51%) from the placebo group. Development of 
      colon cancer was recorded in 25 patients: in 8 (0.53%) patients from the 
      bezafibrate group vs. 17 (1.13%) from the placebo group, (Fisher's exact test: 
      one side p = 0.05; two side p = 0.07). A difference in the incidence of cancer 
      was only detectable after a 4 year lag and progressively increased with continued 
      follow-up. On multivariable analysis the colon cancer risk in patients who 
      received bezafibrate tended to be lower with a hazard ratio of 0.47 and 95% 
      confidence interval 0.2-1.1. CONCLUSION: Our data, derived from patients with 
      coronary artery disease, support the hypothesis regarding a possible preventive 
      effect of bezafibrate on the development of colon cancer.
FAU - Tenenbaum, Alexander
AU  - Tenenbaum A
AD  - Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel-Hashomer, 
      affiliated with Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, 
      Israel. altenen@post.tau.ac.il
FAU - Boyko, Valentina
AU  - Boyko V
FAU - Fisman, Enrique Z
AU  - Fisman EZ
FAU - Goldenberg, Ilan
AU  - Goldenberg I
FAU - Adler, Yehuda
AU  - Adler Y
FAU - Feinberg, Micha S
AU  - Feinberg MS
FAU - Motro, Michael
AU  - Motro M
FAU - Tanne, David
AU  - Tanne D
FAU - Shemesh, Joseph
AU  - Shemesh J
FAU - Schwammenthal, Ehud
AU  - Schwammenthal E
FAU - Behar, Solomon
AU  - Behar S
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20080619
PL  - England
TA  - Cardiovasc Diabetol
JT  - Cardiovascular diabetology
JID - 101147637
RN  - 0 (Hypolipidemic Agents)
RN  - 0 (Ligands)
RN  - 0 (Peroxisome Proliferator-Activated Receptors)
RN  - Y9449Q51XH (Bezafibrate)
SB  - IM
MH  - Aged
MH  - Bezafibrate/*therapeutic use
MH  - Colonic Neoplasms/*prevention & control
MH  - Coronary Artery Disease/*prevention & control
MH  - Dose-Response Relationship, Drug
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Hypolipidemic Agents/*therapeutic use
MH  - Incidence
MH  - Kaplan-Meier Estimate
MH  - Ligands
MH  - Longitudinal Studies
MH  - Male
MH  - Middle Aged
MH  - Multivariate Analysis
MH  - Peroxisome Proliferator-Activated Receptors/*antagonists & inhibitors
MH  - Randomized Controlled Trials as Topic
PMC - PMC2440374
EDAT- 2008/06/21 09:00
MHDA- 2008/07/29 09:00
PMCR- 2008/06/19
CRDT- 2008/06/21 09:00
PHST- 2008/06/07 00:00 [received]
PHST- 2008/06/19 00:00 [accepted]
PHST- 2008/06/21 09:00 [pubmed]
PHST- 2008/07/29 09:00 [medline]
PHST- 2008/06/21 09:00 [entrez]
PHST- 2008/06/19 00:00 [pmc-release]
AID - 1475-2840-7-18 [pii]
AID - 10.1186/1475-2840-7-18 [doi]
PST - epublish
SO  - Cardiovasc Diabetol. 2008 Jun 19;7:18. doi: 10.1186/1475-2840-7-18.

PMID- 17894828
OWN - NLM
STAT- MEDLINE
DCOM- 20080416
LR  - 20221207
IS  - 0742-3071 (Print)
IS  - 0742-3071 (Linking)
VI  - 24
IP  - 12
DP  - 2007 Dec
TI  - Serum angiotensin-converting enzyme and frequency of severe hypoglycaemia in Type 
      1 diabetes: does a relationship exist?
PG  - 1449-54
AB  - AIMS: An association has been described between elevated serum 
      angiotensin-converting enzyme (ACE) and an increased risk of severe hypoglycaemia 
      (SH). To ascertain whether this reported association could be replicated in a 
      different country, it was re-examined in 300 individuals with Type 1 diabetes. 
      METHODS: People with Type 1 diabetes, none of whom was taking renin-angiotensin 
      system blocking drugs, were recruited. Participants recorded the frequency with 
      which they had experienced SH. Glycated haemoglobin (HbA(1c)) and serum ACE were 
      measured. The difference in the incidence of SH between different quartiles of 
      ACE activity and the relationship between serum ACE and SH were examined using 
      non-parametric statistical tests and a negative binomial model. RESULTS: Data 
      were obtained from 300 patients [158 male; HbA(1c) median (range) 8.2% 
      (5.2-12.8%), median age 36 years (16-88); duration of diabetes 14.5 years 
      (2-49)]. The incidence of SH was 0.93 episodes per patient year. The mean 
      incidence of SH in the top and bottom quartiles of ACE activity was 0.5 and 1.7 
      episodes per patient year, respectively, but this difference was not 
      statistically significant (P = 0.075). Spearman's test showed a very weak, 
      although statistically significant, association between serum ACE level and SH 
      incidence (r = 0.115, P = 0.047). The binomial model also showed a statistically 
      significant (P = 0.002), but clinically weak, relationship between serum ACE and 
      SH. CONCLUSIONS: The present survey showed a weak relationship between serum ACE 
      and the frequency of SH, the clinical relevance of which is unclear. This limits 
      the proposed role for serum ACE as an index of risk for SH.
FAU - Zammitt, N N
AU  - Zammitt NN
AD  - Department of Diabetes, Royal Infirmary of Edinburgh, Edinburgh, UK.
FAU - Geddes, J
AU  - Geddes J
FAU - Warren, R E
AU  - Warren RE
FAU - Marioni, R
AU  - Marioni R
FAU - Ashby, J P
AU  - Ashby JP
FAU - Frier, B M
AU  - Frier BM
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20070926
PL  - England
TA  - Diabet Med
JT  - Diabetic medicine : a journal of the British Diabetic Association
JID - 8500858
RN  - 0 (Glycated Hemoglobin A)
RN  - EC 3.4.15.1 (Peptidyl-Dipeptidase A)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Chromatography, High Pressure Liquid
MH  - Diabetes Mellitus, Type 1/*blood
MH  - Female
MH  - Glycated Hemoglobin/*analysis
MH  - Humans
MH  - Hypoglycemia/*enzymology
MH  - Incidence
MH  - Male
MH  - Middle Aged
MH  - Peptidyl-Dipeptidase A/*blood
MH  - Spectrophotometry
EDAT- 2007/09/27 09:00
MHDA- 2008/04/17 09:00
CRDT- 2007/09/27 09:00
PHST- 2007/09/27 09:00 [pubmed]
PHST- 2008/04/17 09:00 [medline]
PHST- 2007/09/27 09:00 [entrez]
AID - DME2263 [pii]
AID - 10.1111/j.1464-5491.2007.02263.x [doi]
PST - ppublish
SO  - Diabet Med. 2007 Dec;24(12):1449-54. doi: 10.1111/j.1464-5491.2007.02263.x. Epub 
      2007 Sep 26.

PMID- 10490564
OWN - NLM
STAT- MEDLINE
DCOM- 19991105
LR  - 20190503
IS  - 1468-201X (Electronic)
IS  - 1355-6037 (Print)
IS  - 1355-6037 (Linking)
VI  - 82
IP  - 4
DP  - 1999 Oct
TI  - Hypotension in patients with coronary disease: can profound hypotensive events 
      cause myocardial ischaemic events?
PG  - 477-81
AB  - OBJECTIVE: To determine whether anginal episodes might be related to extremes of 
      hypotension in patients with ischaemic heart disease taking drugs to treat angina 
      and heart failure. DESIGN AND SETTING: Observational study of patients with 
      ischaemic heart disease attending an urban tertiary referral cardiology centre. 
      INTERVENTIONS AND OUTCOME MEASURES: A selected patient population was enrolled, 
      having: angina on one or more hypotensive cardiovascular medications; hypotension 
      on clinic or ambulatory measurement; and a resting ECG suitable for ambulatory 
      monitoring. Patients had echocardiography, ambulatory blood pressure monitoring, 
      and Holter monitoring. Hypotension induced ischaemic (HII) events were defined as 
      episodes of ST segment ischaemia occurring at least one minute after an 
      ambulatory blood pressure measurement (systolic/diastolic) below 100/65 mm Hg 
      during the day, or 90/50 mm Hg at night. RESULTS: 25 suitable patients were 
      enrolled, and 107 hypotensive events were documented. 40 ST events occurred in 14 
      patients, of which a quarter were symptomatic. Fourteen HII events occurred in 
      eight patients, with 13 of the 14 preceded by a fall in diastolic pressure 
      (median diastolic pressure 57.5 mm Hg, interquartile range 11, maximum 72 mm Hg, 
      minimum 45 mm Hg), and six preceded by a fall in systolic pressure (chi(2) = 
      11.9, p < 0.001). ST events were significantly associated with preceding 
      hypotensive events (chi(2) = 40.2, p < 0.0001). Patients with HII events were 
      more frequently taking multiple hypotensive drug regimens (8/8 v 9/17, chi(2) = 
      5.54, p = 0.022). CONCLUSIONS: In patients with ischaemic heart disease and 
      hypotension, symptomatic and silent ischaemia occurred in a temporally causal 
      relation with hypotension, particularly for diastolic pressures, suggesting that 
      patients with coronary disease may be susceptible to ischaemic events incurred as 
      a result of low blood pressure caused by excessive hypotensive drug treatment.
FAU - Owens, P
AU  - Owens P
AD  - Blood Pressure Unit, Beaumont Hospital, Dublin, Ireland. 
      patrick.e.owens@man.ac.uk
FAU - O'Brien, E
AU  - O'Brien E
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - Heart
JT  - Heart (British Cardiac Society)
JID - 9602087
RN  - 0 (Adrenergic beta-Antagonists)
RN  - 0 (Antihypertensive Agents)
RN  - 50VV3VW0TI (Atenolol)
RN  - A6D97U294I (Sotalol)
RN  - DRB57K47QC (Celiprolol)
RN  - GEB06NHM23 (Metoprolol)
SB  - IM
MH  - Adrenergic beta-Antagonists/*adverse effects/therapeutic use
MH  - Aged
MH  - Antihypertensive Agents/*adverse effects/therapeutic use
MH  - Atenolol/adverse effects/therapeutic use
MH  - Blood Pressure Monitoring, Ambulatory
MH  - Celiprolol/adverse effects/therapeutic use
MH  - Chi-Square Distribution
MH  - Coronary Disease/complications/drug therapy
MH  - Diastole
MH  - Drug Therapy, Combination
MH  - Echocardiography
MH  - Electrocardiography, Ambulatory
MH  - Female
MH  - Humans
MH  - Hypotension/*chemically induced/complications
MH  - Iatrogenic Disease
MH  - Male
MH  - Metoprolol/adverse effects/therapeutic use
MH  - Middle Aged
MH  - Myocardial Ischemia/*chemically induced
MH  - Sotalol/adverse effects/therapeutic use
PMC - PMC1760270
EDAT- 1999/09/22 00:00
MHDA- 1999/09/22 00:01
PMCR- 2002/10/01
CRDT- 1999/09/22 00:00
PHST- 1999/09/22 00:00 [pubmed]
PHST- 1999/09/22 00:01 [medline]
PHST- 1999/09/22 00:00 [entrez]
PHST- 2002/10/01 00:00 [pmc-release]
AID - 10.1136/hrt.82.4.477 [doi]
PST - ppublish
SO  - Heart. 1999 Oct;82(4):477-81. doi: 10.1136/hrt.82.4.477.

PMID- 7860319
OWN - NLM
STAT- MEDLINE
DCOM- 19950323
LR  - 20191210
IS  - 0017-9124 (Print)
IS  - 0017-9124 (Linking)
VI  - 29
IP  - 6
DP  - 1995 Feb
TI  - Measuring hospital mortality rates: are 30-day data enough? Ischemic Heart 
      Disease Patient Outcomes Research Team.
PG  - 679-95
AB  - OBJECTIVE: We compare 30-day and 180-day postadmission hospital mortality rates 
      for all Medicare patients and those in three categories of cardiac care: coronary 
      artery bypass graft surgery, acute myocardial infarction, and congestive heart 
      failure. DATA SOURCES/COLLECTION: Health Care Financing Administration (HCFA) 
      hospital mortality data for FY 1989. STUDY DESIGN: Using hospital level public 
      use files of actual and predicted mortality at 30 and 180 days, we constructed 
      residual mortality measures for each hospital. We ranked hospitals and used 
      receiver operating characteristic (ROC) curves to compare 0-30, 31-180, and 
      0-180-day postadmission mortality. PRINCIPAL FINDINGS: For the admissions we 
      studied, we found a broad range of hospital performance when we ranked hospitals 
      using the 30-day data; some hospitals had much lower than predicted 30-day 
      mortality rates, while others had much higher than predicted mortality rates. 
      Data from the time period 31-180 days postadmission yield results that 
      corroborate the 0-30 day postadmission data. Moreover, we found evidence that 
      hospital performance on one condition is related to performance on the other 
      conditions, but that the correlation is much weaker in the 31-180-day interval 
      than in the 0-30-day period. Using ROC curves, we found that the 30-day data 
      discriminated the top and bottom fifths of the 180-day data extremely well, 
      especially for AMI outcomes. CONCLUSIONS: Using data on cumulative hospital 
      mortality from 180 days postadmission does not yield a different perspective from 
      using data from 30 days postadmission for the conditions we studied.
FAU - Garnick, D W
AU  - Garnick DW
AD  - Institute for Health Policy, Heller School, Brandeis University, Waltham, MA 
      02254-9110.
FAU - DeLong, E R
AU  - DeLong ER
FAU - Luft, H S
AU  - Luft HS
LA  - eng
GR  - HS06503/HS/AHRQ HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - Health Serv Res
JT  - Health services research
JID - 0053006
SB  - IM
MH  - Cardiology Service, Hospital/*standards/statistics & numerical data
MH  - Centers for Medicare and Medicaid Services, U.S.
MH  - Coronary Artery Bypass/mortality/statistics & numerical data
MH  - Forecasting
MH  - Heart Failure/mortality
MH  - Hospital Mortality/*trends
MH  - Humans
MH  - Medicare/statistics & numerical data
MH  - Myocardial Infarction/mortality
MH  - Patient Admission/statistics & numerical data
MH  - ROC Curve
MH  - Survival Rate
MH  - Time Factors
MH  - United States/epidemiology
PMC - PMC1070038
EDAT- 1995/02/01 00:00
MHDA- 1995/02/01 00:01
PMCR- 1995/02/01
CRDT- 1995/02/01 00:00
PHST- 1995/02/01 00:00 [pubmed]
PHST- 1995/02/01 00:01 [medline]
PHST- 1995/02/01 00:00 [entrez]
PHST- 1995/02/01 00:00 [pmc-release]
PST - ppublish
SO  - Health Serv Res. 1995 Feb;29(6):679-95.

PMID- 18568239
OWN - NLM
STAT- MEDLINE
DCOM- 20090716
LR  - 20220629
IS  - 1807-5932 (Print)
IS  - 1980-5322 (Electronic)
IS  - 1807-5932 (Linking)
VI  - 63
IP  - 3
DP  - 2008 Jun
TI  - Is the ability to perform transurethral resection of the prostate influenced by 
      the surgeon's previous experience?
PG  - 315-20
AB  - PURPOSE: To evaluate the influence of the urologist's experience on the surgical 
      results and complications of transurethral resection of the prostate (TURP). 
      PATIENTS AND METHODS: Sixty-seven patients undergoing transurethral resection of 
      the prostate without the use of a video camera were randomly allocated into three 
      groups according to the urologist's experience: a urologist having done 25 
      transurethral resections of the prostate (Group I - 24 patients); a urologist 
      having done 50 transurethral resections of the prostate (Group II - 24 patients); 
      a senior urologist with vast transurethral resection of the prostate experience 
      (Group III - 19 patients). The following were recorded: the weight of resected 
      tissue, the duration of the resection procedure, the volume of irrigation used, 
      the amount of irrigation absorbed and the hemoglobin and sodium levels in the 
      serum during the procedure. RESULTS: There were no differences between the groups 
      in the amount of irrigation fluid used per operation, the amount of irrigation 
      fluid absorbed or hematocrit and hemoglobin variation during the procedure. The 
      weight of resected tissue per minute was approximately four times higher in group 
      III than in groups I and II. The mean absorbed irrigation fluid was similar 
      between the groups, with no statistical difference between them (p=0.24). Four 
      patients (6%) presented with TUR syndrome, without a significant difference 
      between the groups. CONCLUSION: The senior urologist was capable of resecting 
      four times more tissue per time unit than the more inexperienced surgeons. 
      Therefore, a surgeon's experience may be important to reduce the risk of 
      secondary TURP due to recurring adenomas or adenomas that were incompletely 
      resected. However, the incidence of complications was the same between the three 
      groups.
FAU - Cury, Jose
AU  - Cury J
AD  - Department of Urology, Hospital das Clinicas, Faculdade de Medicina, Universidade 
      de Sao Paulo, Sao Paulo, SP, Brazil.
FAU - Coelho, Rafael Ferreira
AU  - Coelho RF
FAU - Bruschini, Homero
AU  - Bruschini H
FAU - Srougi, Miguel
AU  - Srougi M
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
PL  - United States
TA  - Clinics (Sao Paulo)
JT  - Clinics (Sao Paulo, Brazil)
JID - 101244734
RN  - 0 (Anti-Infective Agents, Local)
RN  - 0 (Indicators and Reagents)
RN  - 3K9958V90M (Ethanol)
RN  - 506T60A25R (Sorbitol)
SB  - IM
MH  - Aged
MH  - Anti-Infective Agents, Local
MH  - *Clinical Competence
MH  - Ethanol
MH  - Humans
MH  - Hyponatremia/etiology
MH  - Indicators and Reagents/pharmacokinetics
MH  - Male
MH  - Middle Aged
MH  - Organ Size
MH  - Prospective Studies
MH  - Prostate/pathology/surgery
MH  - *Quality of Health Care
MH  - Sorbitol/pharmacokinetics
MH  - Statistics, Nonparametric
MH  - Syndrome
MH  - Time Factors
MH  - Transurethral Resection of Prostate/adverse effects/*standards
MH  - Urology/*standards
PMC - PMC2664229
EDAT- 2008/06/24 09:00
MHDA- 2009/07/17 09:00
PMCR- 2008/06/01
CRDT- 2008/06/24 09:00
PHST- 2008/01/12 00:00 [received]
PHST- 2008/02/18 00:00 [accepted]
PHST- 2008/06/24 09:00 [pubmed]
PHST- 2009/07/17 09:00 [medline]
PHST- 2008/06/24 09:00 [entrez]
PHST- 2008/06/01 00:00 [pmc-release]
AID - S1807-5932(22)02791-0 [pii]
AID - cln63_3p0315 [pii]
AID - 10.1590/s1807-59322008000300005 [doi]
PST - ppublish
SO  - Clinics (Sao Paulo). 2008 Jun;63(3):315-20. doi: 10.1590/s1807-59322008000300005.

PMID- 9488747
OWN - NLM
STAT- MEDLINE
DCOM- 19980311
LR  - 20190831
IS  - 0929-693X (Print)
IS  - 0929-693X (Linking)
VI  - 4
IP  - 11
DP  - 1997 Nov
TI  - [Syncope during bathing in infants, a pediatric form of water-induced 
      urticaria?].
PG  - 1111-5
AB  - BACKGROUND: Apparent life-threatening events in infants are a difficult and 
      frequent problem in pediatric practice. The prognosis is uncertain because of 
      risk of sudden infant death syndrome. CASE REPORTS: Eight infants aged 2 to 15 
      months were admitted during a period of 6 years; they suffered from similar 
      maladies in the bath: on immersion, they became pale, hypotonic, still and 
      unreactive; recovery took a few seconds after withdrawal from the bath and 
      stimulation. Two diagnoses were initially considered: seizure or gastroesophageal 
      reflux but this was doubtful. The hypothesis of an equivalent of aquagenic 
      urticaria was then considered; as for patients with this disease, each infant's 
      family contained members suffering from dermographism, maladies or eruption after 
      exposure to water or sun. All six infants had dermographism. We found an increase 
      in blood histamine levels after a trial bath in the two infants tested. The 
      evolution of these "aquagenic maladies" was favourable after a few weeks without 
      baths. After a 2-7 year follow-up, three out of seven infants continue to suffer 
      from troubles associated with sun or water. CONCLUSION: "Aquagenic maladies" 
      could be a pediatric form of the aquagenic urticaria.
FAU - Mouterde, O
AU  - Mouterde O
AD  - Centre de reference regional de recherche et prevention de la mort subite du 
      nourrisson, hopital Charles-Nicolle, Rouen, France.
FAU - Mallet, E
AU  - Mallet E
FAU - Spriet, J
AU  - Spriet J
LA  - fre
PT  - English Abstract
PT  - Journal Article
TT  - Malaises au bain chez le nourrisson, une forme pediatrique de l'urticaire 
      aquagenique?
PL  - France
TA  - Arch Pediatr
JT  - Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
JID - 9421356
RN  - 059QF0KO0R (Water)
RN  - 820484N8I3 (Histamine)
SB  - IM
MH  - *Baths
MH  - Histamine/blood
MH  - Humans
MH  - Infant
MH  - Syncope/blood/*etiology
MH  - Urticaria/blood/*etiology
MH  - Water
EDAT- 1998/03/07 03:14
MHDA- 2000/05/05 09:00
CRDT- 1998/03/07 03:14
PHST- 1998/03/07 03:14 [pubmed]
PHST- 2000/05/05 09:00 [medline]
PHST- 1998/03/07 03:14 [entrez]
AID - S0929693X97889804 [pii]
AID - 10.1016/s0929-693x(97)88980-4 [doi]
PST - ppublish
SO  - Arch Pediatr. 1997 Nov;4(11):1111-5. doi: 10.1016/s0929-693x(97)88980-4.

PMID- 20354380
OWN - NLM
STAT- MEDLINE
DCOM- 20100525
LR  - 20151119
IS  - 1938-808X (Electronic)
IS  - 1040-2446 (Linking)
VI  - 85
IP  - 4
DP  - 2010 Apr
TI  - Do women residents delay childbearing due to perceived career threats?
PG  - 640-6
LID - 10.1097/ACM.0b013e3181d2cb5b [doi]
AB  - PURPOSE: To assess gender differences among residents regarding their plans to 
      have children during residency and determine the most influential reasons for 
      these differences. METHOD: Using the Health Belief Model as a framework, the 
      authors created an instrument to survey 424 residents from 11 residency programs 
      at three academic medical institutions about their intentions to have children 
      during residency. The authors developed a scale to assess the perceived career 
      threats of having children during residency, evaluated its psychometric 
      properties, and calculated the effect of the mediators. RESULTS: The response 
      rate was 77% (328/424). Forty-one percent of men versus 27% of women planned to 
      have children during residency (P = .01). The instrument measured four career 
      threats-extended training, loss of fellowship positions, pregnancy complications, 
      and interference with career plans-on a five-point Likert scale. The scale had a 
      Cronbach alpha of 0.84 and an eigenvalue of 2.2. Compared with men, women had 
      higher scores for each item and a higher mean score (2.9 versus 2.1, P = .001), 
      signifying greater belief in the potential of pregnancy to threaten careers. 
      After adjusting for age, institution, postgraduate year, and knowledge of 
      parental leave policies, women were less likely to plan to have children during 
      residency (odds ratio 0.46 [95% confidence interval 0.25-0.84]). In mediation 
      analysis, threats to career explained 67% of the gender variance. CONCLUSIONS: 
      Women residents intentionally postpone pregnancy because of perceived threats to 
      their careers. Medical educators should be aware of these findings when 
      counseling female trainees.
FAU - Willett, Lisa L
AU  - Willett LL
AD  - Internal Medicine Residency Program, Division of General Internal Medicine, 
      University of Alabama at Birmingham, Birmingham, Alabama 35291-0012, USA. 
      lwillett@uab.edu
FAU - Wellons, Melissa F
AU  - Wellons MF
FAU - Hartig, Jason R
AU  - Hartig JR
FAU - Roenigk, Lindsey
AU  - Roenigk L
FAU - Panda, Mukta
AU  - Panda M
FAU - Dearinger, Angela T
AU  - Dearinger AT
FAU - Allison, Jeroan
AU  - Allison J
FAU - Houston, Thomas K
AU  - Houston TK
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Multicenter Study
PL  - United States
TA  - Acad Med
JT  - Academic medicine : journal of the Association of American Medical Colleges
JID - 8904605
SB  - IM
MH  - Adult
MH  - *Career Mobility
MH  - Cross-Sectional Studies
MH  - Female
MH  - Humans
MH  - *Internship and Residency
MH  - Male
MH  - Physicians, Women/*psychology
MH  - Pregnancy
MH  - Psychometrics/methods
MH  - Reproductive Behavior/*psychology
MH  - Sex Factors
MH  - Surveys and Questionnaires
MH  - United States
EDAT- 2010/04/01 06:00
MHDA- 2010/05/26 06:00
CRDT- 2010/04/01 06:00
PHST- 2010/04/01 06:00 [entrez]
PHST- 2010/04/01 06:00 [pubmed]
PHST- 2010/05/26 06:00 [medline]
AID - 00001888-201004000-00024 [pii]
AID - 10.1097/ACM.0b013e3181d2cb5b [doi]
PST - ppublish
SO  - Acad Med. 2010 Apr;85(4):640-6. doi: 10.1097/ACM.0b013e3181d2cb5b.

PMID- 24245816
OWN - NLM
STAT- MEDLINE
DCOM- 20150421
LR  - 20220321
IS  - 1945-7103 (Electronic)
IS  - 0003-3219 (Print)
IS  - 0003-3219 (Linking)
VI  - 84
IP  - 3
DP  - 2014 May
TI  - Is trabecular bone related to primary stability of miniscrews?
PG  - 500-7
LID - 10.2319/052513-39.1 [doi]
AB  - OBJECTIVE: To compare the primary stability of miniscrews inserted into bone 
      blocks of different bone mineral densities (BMDs) with and without cortical bone, 
      and investigate whether some trabecular properties could influence primary 
      stability. MATERIALS AND METHODS: Fifty-two bone blocks were extracted from fresh 
      bovine pelvic bone. Four groups were created based on bone type (iliac or pubic 
      region) and presence or absence of cortical bone. Specimens were micro-computed 
      tomography imaged to evaluate trabecular thickness, trabecular number, trabecular 
      separation, bone volume density (BV/TV), BMD, and cortical thickness. Miniscrews 
      1.4 mm in diameter and 6 mm long were inserted into the bone blocks, and primary 
      stability was evaluated by insertion torque (IT), mini-implant mobility (PTV), 
      and pull-out strength (PS). RESULTS: Intergroup comparison showed lower levels of 
      primary stability when the BMD of trabecular bone was lower and in the absence of 
      cortical bone (P</=.05). The Pearson correlation test showed correlation between 
      trabecular number, trabecular thickness, BV/TV, trabecular BMD, total BMD, and 
      IT, PTV, and PS. There was correlation between cortical thickness and IT and PS 
      (P</=.05). CONCLUSION: Cancellous bone plays an important role in primary stability 
      of mini-implants in the presence or absence of cortical bone.
FAU - Marquezan, Mariana
AU  - Marquezan M
AD  - a  PhD Student, Department of Pedodontics and Orthodontics, Universidade Federal 
      do Rio de Janeiro, Rio de Janeiro, Brazil.
FAU - Lima, Inaya
AU  - Lima I
FAU - Lopes, Ricardo Tadeu
AU  - Lopes RT
FAU - Sant'Anna, Eduardo Franzotti
AU  - Sant'Anna EF
FAU - de Souza, Margareth Maria Gomes
AU  - de Souza MM
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20131118
PL  - United States
TA  - Angle Orthod
JT  - The Angle orthodontist
JID - 0370550
RN  - 91D9GV0Z28 (Durapatite)
SB  - IM
MH  - Anatomy, Cross-Sectional/methods
MH  - Animals
MH  - Bone Density/physiology
MH  - *Bone Screws
MH  - Bone and Bones/*anatomy & histology/surgery
MH  - Cattle
MH  - Dental Stress Analysis/instrumentation
MH  - Durapatite/chemistry
MH  - Ilium/surgery
MH  - Image Processing, Computer-Assisted/methods
MH  - Imaging, Three-Dimensional/methods
MH  - Miniaturization
MH  - Orthodontic Anchorage Procedures/instrumentation
MH  - *Orthodontic Appliances
MH  - Pubic Bone/surgery
MH  - Stress, Mechanical
MH  - Torque
MH  - X-Ray Microtomography/methods
PMC - PMC8667495
EDAT- 2013/11/20 06:00
MHDA- 2015/04/22 06:00
PMCR- 2014/05/01
CRDT- 2013/11/20 06:00
PHST- 2013/11/20 06:00 [entrez]
PHST- 2013/11/20 06:00 [pubmed]
PHST- 2015/04/22 06:00 [medline]
PHST- 2014/05/01 00:00 [pmc-release]
AID - 052513-395R-052513-39.1-angl-84_3_500 [pii]
AID - 10.2319/052513-39.1 [doi]
PST - ppublish
SO  - Angle Orthod. 2014 May;84(3):500-7. doi: 10.2319/052513-39.1. Epub 2013 Nov 18.

PMID- 11481599
OWN - NLM
STAT- MEDLINE
DCOM- 20011004
LR  - 20220310
IS  - 0883-9441 (Print)
IS  - 0883-9441 (Linking)
VI  - 16
IP  - 2
DP  - 2001 Jun
TI  - Acute respiratory distress syndrome in children with malignancy--can we predict 
      outcome?
PG  - 54-8
AB  - PURPOSE: The purpose of this study was to delineate early respiratory predictors 
      of mortality in children with hemato-oncology malignancy who developed acute 
      respiratory distress syndrome (ARDS). MATERIALS AND METHODS: We conducted a 
      retrospective chart review of children with malignant and ARDS who needed 
      mechanical ventilation and were admitted to a pediatric intensive care unit from 
      January 1987 to January 1997. RESULTS: Seventeen children with ARDS and 
      malignancy aged 10.5 +/- 5.1 years were identified. Six of the 17 children 
      (35.3%) survived. Sepsis syndrome was present in 70.6% of all the children. Peak 
      inspiratory pressure, positive end-expiratory pressure (PEEP), and ventilation 
      index values could distinguish outcome by day 3. A significant relationship 
      between respiratory data and outcome related to efficiency of oxygenation, as 
      determined by PaO(2)/FIO(2) and P(A-a)O(2), was present from day 8 after onset of 
      mechanical ventilation. CONCLUSIONS: Peak inspiratory pressure, PEEP, and 
      ventilation index values could distinguish survivors from nonsurvivors by day 3. 
      This may assist in early application of supportive nonconventional therapies in 
      children with malignancy and ARDS.
CI  - Copyright 2001 by W.B. Saunders Company
FAU - Ben-Abraham, R
AU  - Ben-Abraham R
AD  - Department of Anesthesia and Critical Care Medicine, Tel-Aviv Sourasky Medical 
      Center, Tel-Aviv, Israel.
FAU - Weinbroum, A A
AU  - Weinbroum AA
FAU - Augerten, A
AU  - Augerten A
FAU - Toren, A
AU  - Toren A
FAU - Harel, R
AU  - Harel R
FAU - Vardi, A
AU  - Vardi A
FAU - Barzilay, Z
AU  - Barzilay Z
FAU - Paret, G
AU  - Paret G
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Crit Care
JT  - Journal of critical care
JID - 8610642
SB  - IM
MH  - Adult
MH  - Analysis of Variance
MH  - Child
MH  - Child, Preschool
MH  - Female
MH  - Humans
MH  - Leukemia/*complications
MH  - Lymphoma/*complications
MH  - Male
MH  - Positive-Pressure Respiration
MH  - Prognosis
MH  - Respiratory Distress Syndrome/etiology/*mortality/physiopathology
MH  - Retrospective Studies
EDAT- 2001/08/02 10:00
MHDA- 2001/10/05 10:01
CRDT- 2001/08/02 10:00
PHST- 2001/08/02 10:00 [pubmed]
PHST- 2001/10/05 10:01 [medline]
PHST- 2001/08/02 10:00 [entrez]
AID - S0883-9441(01)70022-6 [pii]
AID - 10.1053/jcrc.2001.25232 [doi]
PST - ppublish
SO  - J Crit Care. 2001 Jun;16(2):54-8. doi: 10.1053/jcrc.2001.25232.

PMID- 27217036
OWN - NLM
STAT- MEDLINE
DCOM- 20170328
LR  - 20181113
IS  - 1941-6636 (Electronic)
VI  - 47
IP  - 4
DP  - 2016 Dec
TI  - Neoadjuvant Imatinib in Locally Advanced Gastrointestinal stromal Tumours, Will 
      Kit Mutation Analysis Be a Pathfinder?
PG  - 381-388
AB  - INTRODUCTION: Longer duration of neoadjuvant (NA) imatinib (IM) used for locally 
      advanced (LA) gastrointestinal stromal tumours (GIST) is not based on biology of 
      the tumour reflected by kit mutation analysis. MATERIAL AND METHODS: LA or 
      locally recurrent (LR) GIST treated with NA IM from May 2008 to March 2015 from a 
      prospective database were included in the analysis. Archived formalin-fixed 
      paraffin-embedded tissues (FFPE) were used for testing KIT exons 9, 11, 13 and 17 
      by PCR. RESULTS: One hundred twenty-five patients with LA or LR GIST were treated 
      with NA IM. Forty-five patients (36 %) had undergone c-kit mutation testing. Exon 
      11 was seen in 25 patients (55.5 %), 3 with exon 9 (6.7 %) and 2 with exon 13 
      (4.4 %). Twelve were wild type (26.6 %) and  3 (6.7 %) were declared 
      uninterpretable. Response rate (RR) for the exon 11 mutants was higher than the 
      non-exon 11 mutant group (84 vs. 40 %, p = 0.01). Disease stabilization rate 
      (DSR) rates were also higher in the exon 11 subgroup than non-exon 11 group (92 
      vs. 75 %). Eighty-four per cent exon 11 and 75 % non-exon 11 mutants were 
      surgical candidates. Patients undergoing surgery had significantly improved event 
      free survival (EFS) (p < 0.001) compared to patients not undergoing surgery, with 
      the same trend seen in OS (p = 0.021). Patients with a SD on response to NA IM 
      had a lower EFS (p = 0.076) and OS compared to patients achieving CR/PR. There 
      were no differences between the various exon variants in terms of outcomes and 
      responses CONCLUSION: Upfront evaluation of kit mutation status may help us in 
      delineating separate treatment strategies for potentially biologically different 
      tumours and assessing the correct timing of surgery for this subset of GIST.
FAU - Ramaswamy, Anant
AU  - Ramaswamy A
AD  - Department of Medical Oncology, TMH, Mumbai, 400012, India.
FAU - Ostwal, Vikas
AU  - Ostwal V
AD  - Department of Medical Oncology, TMH, Mumbai, 400012, India. 
      dr.vikas.ostwal@gmail.com.
FAU - Shetty, Omshree
AU  - Shetty O
AD  - Department of Pathology, TMH, Mumbai, 400012, India.
FAU - Sahu, Arvind
AU  - Sahu A
AD  - Department of Medical Oncology, TMH, Mumbai, 400012, India.
FAU - Paul, Davinder
AU  - Paul D
AD  - Department of Medical Oncology, TMH, Mumbai, 400012, India.
FAU - Pai, Trupti
AU  - Pai T
AD  - Department of Pathology, TMH, Mumbai, 400012, India.
FAU - Gurav, Mamta
AU  - Gurav M
AD  - Department of Pathology, TMH, Mumbai, 400012, India.
FAU - Shetty, Nitin
AU  - Shetty N
AD  - Department of Interventional Radiology, TMH, Mumbai, 400012, India.
FAU - Shrikhande, Shailesh
AU  - Shrikhande S
AD  - Department of Surgical Oncology, TMH, Mumbai, 400012, India.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Gastrointest Cancer
JT  - Journal of gastrointestinal cancer
JID - 101479627
RN  - 0 (Antineoplastic Agents)
RN  - 8A1O1M485B (Imatinib Mesylate)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Antineoplastic Agents/administration & dosage/*therapeutic use
MH  - Female
MH  - Gastrointestinal Stromal Tumors/*drug therapy/pathology
MH  - Humans
MH  - Imatinib Mesylate/administration & dosage/*therapeutic use
MH  - Male
MH  - Middle Aged
MH  - Mutation
MH  - Neoadjuvant Therapy/*methods
MH  - Young Adult
OTO - NOTNLM
OT  - Gist
OT  - KIT mutation analysis
OT  - Locally advanced
OT  - Neoadjuvant imatinib
EDAT- 2016/05/25 06:00
MHDA- 2017/03/30 06:00
CRDT- 2016/05/25 06:00
PHST- 2016/05/25 06:00 [pubmed]
PHST- 2017/03/30 06:00 [medline]
PHST- 2016/05/25 06:00 [entrez]
AID - 10.1007/s12029-016-9835-3 [pii]
AID - 10.1007/s12029-016-9835-3 [doi]
PST - ppublish
SO  - J Gastrointest Cancer. 2016 Dec;47(4):381-388. doi: 10.1007/s12029-016-9835-3.

PMID- 23283159
OWN - NLM
STAT- MEDLINE
DCOM- 20130304
LR  - 20220330
IS  - 1879-1972 (Electronic)
IS  - 1054-139X (Print)
IS  - 1054-139X (Linking)
VI  - 51
IP  - 6 Suppl
DP  - 2012 Dec
TI  - Is obesity a risk factor for wheezing among adolescents? A prospective study in 
      southern Brazil.
PG  - S38-45
LID - S1054-139X(12)00360-6 [pii]
LID - 10.1016/j.jadohealth.2012.08.016 [doi]
AB  - PURPOSE: To investigate the effect of obesity at the start of adolescence on the 
      prevalence, incidence and maintenance of chest wheezing among individuals aged 
      11-15 years in a birth cohort in a developing country. METHODS: The seventh 
      follow-up of the 1993 Pelotas birth cohort occurred in 2004 (individuals aged 
      10-11 years). Between January and August 2008, the eighth follow-up of the cohort 
      was conducted. All the individuals of the original cohort who were alive (who 
      were then adolescents aged between 14 and 15 years) were targets for the study. 
      The International Study of Asthma and Allergies in Childhood (ISAAC) 
      questionnaire was used to define wheezing. In addition to the body mass index 
      (BMI), used to define obesity by the World Health Organization (WHO) criteria, we 
      assessed skinfold thickness. RESULTS: From the original cohort, 4,349 individuals 
      were located (85.7% follow-up rate). The prevalence of chest wheezing at 11 and 
      15 years were 13.5% (95% CI: 12.5%-14.5%) and 12.1% (95% CI: 11.1%-13.1%), 
      respectively. The prevalence of wheezing at both times was 4.5% (95% CI: 
      3.9%-5.1%) and the incidence of wheezing was 7.5% (95% CI: 6.7%-8.3%). 
      Independent of the effect of various confounding variables, the prevalence of 
      wheezing at 15 years was 50% greater among obese individuals than among eutrophic 
      individuals at 11 years (RR 1.53; 95% CI: 1.14-2.05). The greater the skinfold 
      tertile at 11 years, the higher the prevalence of wheezing at 15 years was (p = 
      .011). Weight status and skinfolds did not present any association with incident 
      wheezing. After controlling for confounding factors, the risk of persistent 
      wheezing among obese individuals at 11 years was 1.82 (95% CI: 1.30-2.54). 
      CONCLUSIONS: Since obesity at the start of adolescence is associated with asthma 
      symptom persistence, prevention and treatment of obesity may reduce avoidable 
      healthcare costs and disease burden.
CI  - Copyright (c) 2012 Society for Adolescent Health and Medicine. Published by 
      Elsevier Inc. All rights reserved.
FAU - Noal, Ricardo B
AU  - Noal RB
AD  - Epidemiology Postgraduate Program, Federal University of Pelotas, Pelotas, 
      Brazil. ricardonoal@gmail.com
FAU - Menezes, Ana M B
AU  - Menezes AM
FAU - Macedo, Silvia E C
AU  - Macedo SE
FAU - Dumith, Samuel C
AU  - Dumith SC
FAU - Perez-Padilla, Rogelio
AU  - Perez-Padilla R
FAU - Araujo, Cora L P
AU  - Araujo CL
FAU - Hallal, Pedro C
AU  - Hallal PC
LA  - eng
GR  - Wellcome Trust/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20121110
PL  - United States
TA  - J Adolesc Health
JT  - The Journal of adolescent health : official publication of the Society for 
      Adolescent Medicine
JID - 9102136
SB  - IM
MH  - Adolescent
MH  - Asthma/*epidemiology
MH  - Brazil/epidemiology
MH  - Child
MH  - Cohort Studies
MH  - Confounding Factors, Epidemiologic
MH  - Female
MH  - Humans
MH  - Incidence
MH  - Male
MH  - Obesity/*epidemiology
MH  - Prevalence
MH  - *Respiratory Sounds
MH  - Risk Factors
PMC - PMC3500686
EDAT- 2013/01/11 06:00
MHDA- 2013/03/05 06:00
PMCR- 2012/12/01
CRDT- 2013/01/04 06:00
PHST- 2012/01/23 00:00 [received]
PHST- 2012/08/29 00:00 [revised]
PHST- 2012/08/30 00:00 [accepted]
PHST- 2013/01/04 06:00 [entrez]
PHST- 2013/01/11 06:00 [pubmed]
PHST- 2013/03/05 06:00 [medline]
PHST- 2012/12/01 00:00 [pmc-release]
AID - S1054-139X(12)00360-6 [pii]
AID - 10.1016/j.jadohealth.2012.08.016 [doi]
PST - ppublish
SO  - J Adolesc Health. 2012 Dec;51(6 Suppl):S38-45. doi: 
      10.1016/j.jadohealth.2012.08.016. Epub 2012 Nov 10.

PMID- 19593710
OWN - NLM
STAT- MEDLINE
DCOM- 20090917
LR  - 20090713
IS  - 1538-957X (Electronic)
IS  - 1538-9588 (Linking)
VI  - 10
IP  - 4
DP  - 2009 Aug
TI  - Could ESC (Electronic Stability Control) change the way we drive?
PG  - 340-7
LID - 10.1080/15389580903043446 [doi]
AB  - OBJECTIVE: ESC (Electronic Stability Control) is a crash avoidance technology 
      that reduces the likelihood of collisions involving loss of control. Although 
      past and emerging research indicates that ESC is effective in reducing collision 
      rates and saving lives, and its inclusion in all vehicle platforms is encouraged, 
      drivers may demonstrate behavioral adaptation or an overreliance on ESC that 
      could offset or reduce its overall effectiveness. The main objective of the 
      present study was to determine whether behavioral adaptation to ESC is likely to 
      occur upon the widespread introduction of ESC into the Canadian vehicle fleet. 
      Secondary objectives were to confirm the results of a previous ESC public survey 
      and to generate a baseline measure for the future assessment of planned and 
      ongoing ESC promotional activities in Canada. METHODS: Two separate telephone 
      surveys evaluated drivers' perceptions and awareness of ESC. The first surveyed 
      500 randomly selected owners/drivers of passenger vehicles. The second surveyed 
      1017 owners/drivers of 2006-2008 ESC-equipped passenger vehicles from the 
      provinces of Quebec and British Columbia, Canada. RESULTS: Though ESC drivers 
      were much more likely than drivers of other vehicles to be aware of ESC (77% vs. 
      39%) and that their own vehicle was equipped with it (63% vs. 8%), 23 percent had 
      never heard of it. Ninety percent of drivers who knew that their vehicle was 
      equipped with ESC believed that ESC had made it safer to drive and reported being 
      confident that ESC would work in an emergency. Twenty-three percent of ESC owners 
      who knew their vehicle had ESC reported noticing long-lasting changes in their 
      driving behavior since they began driving the vehicle. CONCLUSIONS: Collectively, 
      results suggest that behavioral adaptation to ESC is likely in certain drivers; 
      however, its proven effectiveness in reducing the likelihood of being involved in 
      a serious crash probably outweighs any potential increases in unsafe driving. To 
      fully benefit from ESC, vehicle manufacturers are encouraged to market 
      ESC-equipped vehicles in a realistic, safe manner. Driver training and safety 
      organizations are also encouraged to provide balanced educational information 
      about ESC to their members.
FAU - Rudin-Brown, Christina M
AU  - Rudin-Brown CM
AD  - Ergonomics and Crash Avoidance Division, Standards and Research Branch, Road 
      Safety and Motor Vehicle Regulation Directorate, Transport Canada, Ontario, 
      Canada. missy.rudinbrown@muarc.monash.edu.au
FAU - Jenkins, Richard W
AU  - Jenkins RW
FAU - Whitehead, Tanya
AU  - Whitehead T
FAU - Burns, Peter C
AU  - Burns PC
LA  - eng
PT  - Journal Article
PL  - England
TA  - Traffic Inj Prev
JT  - Traffic injury prevention
JID - 101144385
SB  - IM
MH  - Accidents, Traffic/prevention & control
MH  - Adolescent
MH  - Age Factors
MH  - Automobile Driving/*psychology/statistics & numerical data
MH  - *Automobiles/statistics & numerical data
MH  - Awareness
MH  - Behavior
MH  - Canada
MH  - Data Collection
MH  - Educational Status
MH  - Female
MH  - Humans
MH  - Interviews as Topic
MH  - Logistic Models
MH  - Male
MH  - *Protective Devices
MH  - Public Opinion
MH  - Risk-Taking
MH  - Sex Factors
EDAT- 2009/07/14 09:00
MHDA- 2009/09/18 06:00
CRDT- 2009/07/14 09:00
PHST- 2009/07/14 09:00 [entrez]
PHST- 2009/07/14 09:00 [pubmed]
PHST- 2009/09/18 06:00 [medline]
AID - 913060830 [pii]
AID - 10.1080/15389580903043446 [doi]
PST - ppublish
SO  - Traffic Inj Prev. 2009 Aug;10(4):340-7. doi: 10.1080/15389580903043446.

PMID- 18693227
OWN - NLM
STAT- MEDLINE
DCOM- 20080912
LR  - 20220408
IS  - 1079-5006 (Print)
IS  - 1079-5006 (Linking)
VI  - 63
IP  - 7
DP  - 2008 Jul
TI  - Does a geriatric oncology consultation modify the cancer treatment plan for 
      elderly patients?
PG  - 724-30
AB  - BACKGROUND: This study was performed to describe the treatment plan modifications 
      after a geriatric oncology clinic. Assessment of health and functional status and 
      cancer assessment was performed in older cancer patients referred to a cancer 
      center. PATIENTS AND METHODS: Between June 2004 and May 2005, 105 patients 70 
      years old or older referred to a geriatric oncology consultation at the Institut 
      Curie cancer center were included. Functional status, nutritional status, mood, 
      mobility, comorbidity, medication, social support, and place of residence were 
      assessed. Oncology data and treatment decisions were recorded before and after 
      this consultation. Data were analyzed for a possible correlation between one 
      domain of the assessment and modification of the treatment plan. RESULTS: Patient 
      characteristics included a median age of 79 years and a predominance of women 
      with breast cancer. About one half of patients had an independent functional 
      status. Nearly 15% presented severe undernourishment. Depression was suspected in 
      53.1% of cases. One third of these patients had >2 chronic diseases, and 74% of 
      patients took > or =3 medications. Of the 93 patients with an initial treatment 
      decision, the treatment plan was modified for 38.7% of cases after this 
      assessment. Only body mass index and the absence of depressive symptoms were 
      associated with a modification of the treatment plan. CONCLUSION: The geriatric 
      oncology consultation led to a modification of the cancer treatment plan in more 
      than one third of cases. Further studies are needed to determine whether these 
      modifications improve the outcome of these older patients.
FAU - Girre, Veronique
AU  - Girre V
AD  - Institut Curie, Departement d'Oncologie Medicale, Paris, France. 
      veronique.girre@curie.net
FAU - Falcou, Marie-Christine
AU  - Falcou MC
FAU - Gisselbrecht, Mathilde
AU  - Gisselbrecht M
FAU - Gridel, Genevieve
AU  - Gridel G
FAU - Mosseri, Veronique
AU  - Mosseri V
FAU - Bouleuc, Carole
AU  - Bouleuc C
FAU - Poinsot, Rollon
AU  - Poinsot R
FAU - Vedrine, Lionel
AU  - Vedrine L
FAU - Ollivier, Liliane
AU  - Ollivier L
FAU - Garabige, Valerie
AU  - Garabige V
FAU - Pierga, Jean-Yves
AU  - Pierga JY
FAU - Dieras, Veronique
AU  - Dieras V
FAU - Mignot, Laurent
AU  - Mignot L
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Gerontol A Biol Sci Med Sci
JT  - The journals of gerontology. Series A, Biological sciences and medical sciences
JID - 9502837
SB  - IM
MH  - Activities of Daily Living
MH  - Affect
MH  - Aged
MH  - Aged, 80 and over
MH  - Cancer Care Facilities
MH  - Female
MH  - *Geriatric Assessment
MH  - Humans
MH  - Male
MH  - *Medical Oncology
MH  - Neoplasms/*therapy
MH  - *Referral and Consultation
EDAT- 2008/08/12 09:00
MHDA- 2008/09/16 09:00
CRDT- 2008/08/12 09:00
PHST- 2008/08/12 09:00 [pubmed]
PHST- 2008/09/16 09:00 [medline]
PHST- 2008/08/12 09:00 [entrez]
AID - 63/7/724 [pii]
AID - 10.1093/gerona/63.7.724 [doi]
PST - ppublish
SO  - J Gerontol A Biol Sci Med Sci. 2008 Jul;63(7):724-30. doi: 
      10.1093/gerona/63.7.724.

PMID- 21346501
OWN - NLM
STAT- MEDLINE
DCOM- 20110628
LR  - 20110331
IS  - 1938-808X (Electronic)
IS  - 1040-2446 (Linking)
VI  - 86
IP  - 4
DP  - 2011 Apr
TI  - Can students' scores on preclerkship clinical performance examinations predict 
      that they will fail a senior clinical performance examination?
PG  - 516-20
LID - 10.1097/ACM.0b013e31820de435 [doi]
AB  - PURPOSE: This study was designed to determine whether preclerkship performance 
      examinations could accurately identify medical students at risk for failing a 
      senior clinical performance examination (CPE). METHOD: This study used a 
      retrospective case-control, multiyear design, with contingency table analyses, to 
      examine the performance of 412 students in the classes of 2005 to 2010 at a 
      midwestern medical school. During their second year, these students took four 
      CPEs that each used three standardized patient (SP) cases, for a total of 12 
      cases. The authors correlated each student's average year 2 case score with the 
      student's average case score on a senior (year 4) CPE. Contingency table analysis 
      was carried out using performance on the year 2 CPEs and passing/failing the 
      senior CPE. Similar analyses using each student's United States Medical Licensing 
      Examination (USMLE) Step 1 scores were also performed. Sensitivity, specificity, 
      odds ratio, and relative risk were calculated for two year 2 performance 
      standards. RESULTS: Students' low performances relative to their class on the 
      year 2 CPEs were a strong predictor that they would fail the senior CPE. Their 
      USMLE Step 1 scores also correlated with their performance on the senior CPE, 
      although the predictive values for these scores were considerably weaker. 
      CONCLUSIONS: Under the conditions of this study, preclerkship (year 2) CPEs 
      strongly predicted medical students at risk for failing a senior CPE. This 
      finding opens the opportunity for remediation of deficits prior to or during 
      clerkships.
CI  - (c) by the Association of American Medical Colleges.
FAU - Klamen, Debra L
AU  - Klamen DL
AD  - Southern Illinois University School of Medicine, Springfield, Illinois 62794, 
      USA. dklamen@siumed.edu
FAU - Borgia, Peter T
AU  - Borgia PT
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Acad Med
JT  - Academic medicine : journal of the Association of American Medical Colleges
JID - 8904605
SB  - IM
MH  - Case-Control Studies
MH  - Chi-Square Distribution
MH  - *Clinical Clerkship
MH  - Clinical Competence
MH  - Education, Medical, Undergraduate/*standards
MH  - *Educational Measurement
MH  - *Educational Status
MH  - Humans
MH  - Illinois
MH  - Licensure
MH  - Patient Simulation
MH  - Predictive Value of Tests
MH  - Retrospective Studies
MH  - Risk Factors
MH  - Sensitivity and Specificity
MH  - United States
EDAT- 2011/02/25 06:00
MHDA- 2011/06/29 06:00
CRDT- 2011/02/25 06:00
PHST- 2011/02/25 06:00 [entrez]
PHST- 2011/02/25 06:00 [pubmed]
PHST- 2011/06/29 06:00 [medline]
AID - 10.1097/ACM.0b013e31820de435 [doi]
PST - ppublish
SO  - Acad Med. 2011 Apr;86(4):516-20. doi: 10.1097/ACM.0b013e31820de435.

PMID- 17910536
OWN - NLM
STAT- MEDLINE
DCOM- 20080206
LR  - 20250103
IS  - 0964-2633 (Print)
IS  - 0964-2633 (Linking)
VI  - 51
IP  - Pt 11
DP  - 2007 Nov
TI  - Adults with mild intellectual disabilities: can their reading comprehension 
      ability be improved?
PG  - 835-49
AB  - BACKGROUND: Adults with a mild intellectual disability (ID) often show poor 
      decoding and reading comprehension skills. The goal of this study was to 
      investigate the effects of teaching text comprehension strategies to these 
      adults. Specific research goals were to determine (1) the effects of two 
      instruction conditions, i.e. strategy instruction to individuals and strategy 
      instruction in small groups in a reciprocal teaching context; (2) intervention 
      programme effects on specific strategy tests (so-called direct effects), and 
      possible differences between strategies; (3) (long-term) transfer effects of the 
      programme on general reading comprehension ability; and (4) the regression of 
      general text comprehension by the variables of technical reading, IQ, reading 
      comprehension of sentences (RCS), and pretest and posttest scores on the 
      strategies taught. METHODS: In total, 38 adults (age range 20-72 years; mean age 
      of 36 years) with ID participated in the study. IQs ranged from 45 to 69 with a 
      mean IQ of 58. The intervention programme involved 15 weekly lessons of 1 h each, 
      taught during 3 months. Blocks of lessons included each of Brown and Palincsar's 
      strategies of summarizing, questioning, clarifying and predicting, as 
      participants read and studied narrative and expository texts. RESULTS: Results 
      indicated no significant difference between group and individual instruction 
      conditions. Second, direct programme effects - as determined by posttest-pretest 
      contrasts for strategy tests - were substantial, except for the questioning 
      strategy. Third, even more substantial was the transfer effect to general text 
      comprehension. Moreover, the results on this test were well maintained at a 
      follow-up test. Finally, the variance of general reading comprehension ability 
      was best explained by the test of RCS, and only moderately by the strategies 
      trained. CONCLUSION: The presently used intervention programme provides a good 
      starting point for adults with ID to become better readers.
FAU - van den Bos, K P
AU  - van den Bos KP
AD  - Department of Special Education, University of Groningen, Groningen, The 
      Netherlands. k.p. van.den.bos@rug.nl
FAU - Nakken, H
AU  - Nakken H
FAU - Nicolay, P G
AU  - Nicolay PG
FAU - van Houten, E J
AU  - van Houten EJ
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Multicenter Study
PT  - Randomized Controlled Trial
PL  - England
TA  - J Intellect Disabil Res
JT  - Journal of intellectual disability research : JIDR
JID - 9206090
SB  - IM
MH  - Adult
MH  - Aged
MH  - *Comprehension
MH  - *Education of Persons with Intellectual Disabilities
MH  - Female
MH  - Follow-Up Studies
MH  - Group Processes
MH  - Humans
MH  - *Intelligence
MH  - Male
MH  - Middle Aged
MH  - Netherlands
MH  - *Reading
MH  - Transfer, Psychology
EDAT- 2007/10/04 09:00
MHDA- 2008/02/07 09:00
CRDT- 2007/10/04 09:00
PHST- 2007/10/04 09:00 [pubmed]
PHST- 2008/02/07 09:00 [medline]
PHST- 2007/10/04 09:00 [entrez]
AID - JIR921 [pii]
AID - 10.1111/j.1365-2788.2006.00921.x [doi]
PST - ppublish
SO  - J Intellect Disabil Res. 2007 Nov;51(Pt 11):835-49. doi: 
      10.1111/j.1365-2788.2006.00921.x.

PMID- 26304701
OWN - NLM
STAT- MEDLINE
DCOM- 20171030
LR  - 20180222
IS  - 1873-1953 (Electronic)
IS  - 1474-5151 (Linking)
VI  - 15
IP  - 6
DP  - 2016 Oct
TI  - Can nurse-led preoperative education reduce anxiety and postoperative 
      complications of patients undergoing cardiac surgery?
PG  - 447-58
LID - 10.1177/1474515115602678 [doi]
AB  - BACKGROUND: The effect of preoperative education on anxiety and postoperative 
      outcomes of cardiac surgery patients remains unclear. AIM: The aim of the study 
      was to estimate the effectiveness of a nurse-led preoperative education on 
      anxiety and postoperative outcomes. METHODS: A randomised controlled study was 
      designed. All the patients who were admitted for elective cardiac surgery in a 
      general hospital in Athens with knowledge of the Greek language were eligible to 
      take part in the study. Patients in the intervention group received preoperative 
      education by specially trained nurses. The control group received the standard 
      information by the ward personnel. Measurements of anxiety were conducted on 
      admission-A, before surgery-B and before discharge-C by the state-trait anxiety 
      inventory. RESULTS: The sample consisted of 395 patients (intervention group: 
      205, control group: 190). The state anxiety on the day before surgery decreased 
      only in the intervention group (34.0 (8.4) versus 36.9 (10.7); P=0.001). The mean 
      decrease in state score during the follow-up period was greater in the 
      intervention group (P=0.001). No significant difference was found in the length 
      of stay or readmission. Lower proportions of chest infection were found in the 
      intervention group (10 (5.3) versus 1 (0.5); P=0.004). Multivariate linear 
      regression revealed that education and score in trait anxiety scale on admission 
      are independent predictors of a reduction in state anxiety. CONCLUSION: 
      Preoperative education delivered by nurses reduced anxiety and postoperative 
      complications of patients undergoing cardiac surgery, but it was not effective in 
      reducing readmissions or length of stay.
CI  - (c) The European Society of Cardiology 2015.
FAU - Kalogianni, Antonia
AU  - Kalogianni A
AD  - Faculty of Nursing, Technological Educational Institute of Athens, Greece 
      antonia_cal@teiath.gr.
FAU - Almpani, Panagiota
AU  - Almpani P
AD  - Faculty of Nursing, Technological Educational Institute of Athens, Greece.
FAU - Vastardis, Leonidas
AU  - Vastardis L
AD  - Intensive Care Unit of Department of Cardiac Surgery, 'Evangelismos' General 
      Hospital, Athens, Greece.
FAU - Baltopoulos, George
AU  - Baltopoulos G
AD  - Faculty of Nursing, National and Kapodistrian University of Athens, Greece.
FAU - Charitos, Christos
AU  - Charitos C
AD  - Cardiothoracic Surgery Department, 'Evangelismos', General Hospital of Athens, 
      Greece.
FAU - Brokalaki, Hero
AU  - Brokalaki H
AD  - Faculty of Nursing, National and Kapodistrian University of Athens, Greece.
LA  - eng
PT  - Journal Article
DEP - 20150824
PL  - England
TA  - Eur J Cardiovasc Nurs
JT  - European journal of cardiovascular nursing
JID - 101128793
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Anxiety Disorders/*etiology/*prevention & control
MH  - Cardiac Surgical Procedures/*adverse effects/*nursing
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Nurse-Patient Relations
MH  - *Patient Education as Topic
MH  - Postoperative Complications/*etiology/*prevention & control
MH  - Preoperative Care
MH  - Preoperative Period
OTO - NOTNLM
OT  - Preoperative patients' education
OT  - anxiety
OT  - cardiac surgery
OT  - length of stay
OT  - postoperative complications
EDAT- 2015/08/26 06:00
MHDA- 2017/10/31 06:00
CRDT- 2015/08/26 06:00
PHST- 2015/01/27 00:00 [received]
PHST- 2015/07/25 00:00 [accepted]
PHST- 2015/08/26 06:00 [entrez]
PHST- 2015/08/26 06:00 [pubmed]
PHST- 2017/10/31 06:00 [medline]
AID - 1474515115602678 [pii]
AID - 10.1177/1474515115602678 [doi]
PST - ppublish
SO  - Eur J Cardiovasc Nurs. 2016 Oct;15(6):447-58. doi: 10.1177/1474515115602678. Epub 
      2015 Aug 24.

PMID- 18616781
OWN - NLM
STAT- MEDLINE
DCOM- 20081222
LR  - 20131121
IS  - 1365-2133 (Electronic)
IS  - 0007-0963 (Linking)
VI  - 159
IP  - 3
DP  - 2008 Sep
TI  - Is there a relationship between homocysteine and vitiligo? A pilot study.
PG  - 720-4
LID - 10.1111/j.1365-2133.2008.08712.x [doi]
AB  - BACKGROUND: Pigmentary dilution is observed in patients with homocystinuria. 
      Therefore, it is possible that an increase of local homocysteine (Hcy) interferes 
      with normal melanogenesis and plays a role in the pathogenesis of vitiligo. 
      Vitamin B12 and folic acid, levels of which are decreased in vitiligo, are 
      important cofactors in the metabolism of Hcy. Consequently, a nutritional 
      deficiency in either of these two vitamins will result in an increase in 
      homocysteine in the circulation, a finding that we expect to find in vitiligo. 
      OBJECTIVE: To determine the level of Hcy in the blood of patients with vitiligo 
      as a first step in revealing if it has any relationship with the pathogenesis of 
      vitiligo and consequently if this will have an impact on the treatment of 
      vitiligo. METHODS: Twenty-six patients of both sexes with vitiligo (age range 
      20-50 years, mean 31.4 +/- 8.09) and 26 age-matched healthy controls were 
      included in the study. After excluding factors that may affect serum Hcy levels, 
      blood samples from patients and controls were obtained for homocysteine 
      determination by enzyme immunoassay. RESULTS: The mean serum level of Hcy was 
      significantly higher in patients with vitiligo than in controls (21.61 +/- 13.28 
      vs. 13.1 +/- 4.88 micromol L(-1); P < 0.001). The Hcy level was significantly 
      higher in male patients than in female patients (28.67 +/- 15.95 vs. 15.56 +/- 
      6.2 micromol L(-1); P < 0.001) and in male controls compared with female controls 
      (15.07 +/- 4.61 vs. 12.05 +/- 4.82 micromol L(-1); P < 0.001). The homocysteine 
      level was related to the activity of vitiligo and was significantly higher in 
      patients with progressive disease than in controls (25.4 +/- 14.99 vs. 13.1 +/- 
      4.88 micromol L(-1); P < 0.001). No significant difference in Hcy levels was 
      found between either untreated vitiligo patients (22.77 +/- 13.36 micromol L(-1)) 
      or patients receiving ultraviolet therapy (20.45 +/- 13.73 micromol L(-1)) and 
      the total patient group (21.62 +/- 13.28 micromol L(-1)). CONCLUSION: An elevated 
      homocysteine level may be a precipitating factor for vitiligo in predisposed 
      individuals. In view of the biological role of vitamin B(12) and folic acid in 
      Hcy metabolism, we present our recommendations regarding the investigation and 
      treatment of this common disease.
FAU - Shaker, O G
AU  - Shaker OG
AD  - Department of Medical Biochemistry, Faculty of Medicine, Cairo University, Cairo 
      0123, Egypt. olfatshaker@yahoo.com
FAU - El-Tahlawi, S M R
AU  - El-Tahlawi SM
LA  - eng
PT  - Journal Article
DEP - 20080704
PL  - England
TA  - Br J Dermatol
JT  - The British journal of dermatology
JID - 0004041
RN  - 0LVT1QZ0BA (Homocysteine)
SB  - IM
MH  - Adult
MH  - Age Factors
MH  - Case-Control Studies
MH  - Female
MH  - Homocysteine/*blood
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Sex Factors
MH  - Skin/pathology
MH  - Vitiligo/*blood/pathology
EDAT- 2008/07/12 09:00
MHDA- 2008/12/23 09:00
CRDT- 2008/07/12 09:00
PHST- 2008/07/12 09:00 [pubmed]
PHST- 2008/12/23 09:00 [medline]
PHST- 2008/07/12 09:00 [entrez]
AID - BJD8712 [pii]
AID - 10.1111/j.1365-2133.2008.08712.x [doi]
PST - ppublish
SO  - Br J Dermatol. 2008 Sep;159(3):720-4. doi: 10.1111/j.1365-2133.2008.08712.x. Epub 
      2008 Jul 4.

PMID- 9483814
OWN - NLM
STAT- MEDLINE
DCOM- 19980406
LR  - 20141120
IS  - 0044-4197 (Print)
IS  - 0044-4197 (Linking)
VI  - 119
IP  - 12
DP  - 1997
TI  - [Does para-cervical block offer additional advantages in abortion induction with 
      gemeprost in the 2nd trimester?].
PG  - 621-4
AB  - Uterus-specific synthetic Prostaglandin analogues (gemeprost, sulproston etc.) 
      have been widely employed for termination of pregnancy in the second trimester. 
      Since paracervical anaesthesia may be useful during this procedure, we 
      investigated in this prospective randomised study its impact on the clinical 
      course of abortion and pain especially in the late first and second stage of 
      labour. PATIENTS AND METHODS: 20 women scheduled for elective abortion (fetal 
      reasons) between the 16th and 23rd week of gestation were to be given 1 mg 
      gemeprost vaginally every 6 hours. They were allocated at random: 10 women 
      received only Pethidin intravenously and Butylscopolamine rectally, another 10 
      women were additionally treated by paracervical anaesthesia (2 x 10 ml 0.5% 
      Bupivacain solution) at a cervical dilatation of 2-3 cm. RESULTS: A median of 3 
      gemeprost applications were administered in both groups. In the group without 
      paracervical anaesthesia the median induction to abortion interval was 20 hours 
      (range: 8-44 hours), 13 hours (range: 8-36 hours, NS) resulting for the 
      paracervical anaesthesia group. The intervals from the last application of 
      prostaglandin until abortion and from 3 cm cervical dilatation to abortion were 
      slightly, but not significantly shorter in the paracervical anaesthesia group. 
      The requirement of Butylscopolamine was higher in the latter group (p < 0.05). 
      The requirement of Pethidin and the intensity of pain (measured by pain scale 
      according to Huskisson) especially in the late first stage of labour were not 
      statistically different between both groups. Side effects of paracervical 
      anaesthesia did not occur. CONCLUSION: Paracervical anaesthesia is a method for 
      analgesia during second trimester abortion with a low rate of side effects. It 
      can shorten the duration of last period of second trimester abortion in some 
      cases but has no impact on the perception of pain nor requirement of analgesics 
      and so with only limited benefit in second trimester abortion with vaginal 
      gemeprost.
FAU - Winkler, M
AU  - Winkler M
AD  - Frauenklinik, Universitatsklinikum der Rheinisch-Westfalischen Technischen 
      Hochschule (RWTH) Aachen.
FAU - Wolters, S
AU  - Wolters S
FAU - Funk, A
AU  - Funk A
FAU - Rath, W
AU  - Rath W
LA  - ger
PT  - Clinical Trial
PT  - Comparative Study
PT  - English Abstract
PT  - Journal Article
PT  - Randomized Controlled Trial
TT  - Bietet die Parazervikalblockade zusatzliche Vorteile bei der Abortinduktion mit 
      Gemeprost im II. Trimenon?
PL  - Germany
TA  - Zentralbl Gynakol
JT  - Zentralblatt fur Gynakologie
JID - 21820100R
RN  - 0 (Abortifacient Agents, Nonsteroidal)
RN  - 45KZB1FOLS (gemeprost)
RN  - F5TD010360 (Alprostadil)
RN  - Y8335394RO (Bupivacaine)
SB  - IM
MH  - Abortifacient Agents, Nonsteroidal/*administration & dosage
MH  - *Abortion, Eugenic
MH  - Adolescent
MH  - Adult
MH  - Alprostadil/administration & dosage/*analogs & derivatives
MH  - *Anesthesia, Local
MH  - *Anesthesia, Obstetrical
MH  - *Bupivacaine
MH  - Cervix Uteri/drug effects
MH  - Female
MH  - Humans
MH  - Pain Measurement
MH  - Pregnancy
MH  - Pregnancy Trimester, Second
MH  - Prospective Studies
EDAT- 1997/01/01 00:00
MHDA- 1998/03/04 00:01
CRDT- 1997/01/01 00:00
PHST- 1997/01/01 00:00 [pubmed]
PHST- 1998/03/04 00:01 [medline]
PHST- 1997/01/01 00:00 [entrez]
PST - ppublish
SO  - Zentralbl Gynakol. 1997;119(12):621-4.

PMID- 12848629
OWN - NLM
STAT- MEDLINE
DCOM- 20031009
LR  - 20190901
IS  - 0269-2813 (Print)
IS  - 0269-2813 (Linking)
VI  - 18
IP  - 1
DP  - 2003 Jul 1
TI  - Is a 9-month treatment sufficient in tuberculous enterocolitis? A prospective, 
      randomized, single-centre study.
PG  - 85-91
AB  - BACKGROUND: Tuberculosis has increased in parallel with the acquired 
      immunodeficiency syndrome epidemic and the use of immunosuppressive therapy, and 
      the growing incidence of extra-pulmonary tuberculosis, especially with intestinal 
      involvement, reflects this trend. However, the duration of anti-tuberculous 
      therapy has not been clarified in intestinal tuberculosis. AIM: To compare the 
      efficacy of different treatment durations in tuberculous enterocolitis in terms 
      of response and recurrence rates. METHODS: Forty patients with tuberculous 
      enterocolitis were randomized prospectively: 22 patients into a 9-month and 18 
      into a 15-month group. Diagnosis was made either by colonoscopic findings of 
      discrete ulcers and histopathological findings of caseating granuloma and/or 
      acid-fast bacilli, or by clinical improvement after therapeutic trial. Patients 
      were followed up with colonoscopy every other month until complete response or 
      treatment completion, and then every 6 months for 1 year and annually. Complete 
      response was defined as a resolution of symptoms and active tuberculosis by 
      colonoscopy. RESULTS: Complete response was obtained in all patients in both 
      groups. Two patients in the 9-month group and one in the 15-month group underwent 
      operation due to intestinal obstruction and perianal fistula, respectively. No 
      recurrence of active intestinal tuberculosis occurred during the follow-up period 
      in either group. CONCLUSIONS: Tuberculous enterocolitis can be managed by 9-month 
      chemotherapy without disease recurrence. Further investigations are needed in 
      immunocompromised patients.
FAU - Kim, S G
AU  - Kim SG
AD  - Department of Internal Medicine, Liver Research Institute, Seoul National 
      University College of Medicine and Clinical Research Institute, Seoul National 
      University Hospital, Seoul, South Korea.
FAU - Kim, J S
AU  - Kim JS
FAU - Jung, H C
AU  - Jung HC
FAU - Song, I S
AU  - Song IS
LA  - eng
PT  - Clinical Trial
PT  - Comparative Study
PT  - Journal Article
PT  - Randomized Controlled Trial
PL  - England
TA  - Aliment Pharmacol Ther
JT  - Alimentary pharmacology & therapeutics
JID - 8707234
RN  - 0 (Antitubercular Agents)
SB  - IM
MH  - Adult
MH  - Antitubercular Agents/*therapeutic use
MH  - Colonoscopy/methods
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Male
MH  - Prospective Studies
MH  - Recurrence
MH  - Treatment Outcome
MH  - Tuberculosis, Gastrointestinal/diagnosis/*drug therapy
EDAT- 2003/07/10 05:00
MHDA- 2003/10/10 05:00
CRDT- 2003/07/10 05:00
PHST- 2003/07/10 05:00 [pubmed]
PHST- 2003/10/10 05:00 [medline]
PHST- 2003/07/10 05:00 [entrez]
AID - 1599 [pii]
AID - 10.1046/j.1365-2036.2003.01599.x [doi]
PST - ppublish
SO  - Aliment Pharmacol Ther. 2003 Jul 1;18(1):85-91. doi: 
      10.1046/j.1365-2036.2003.01599.x.

PMID- 25280365
OWN - NLM
STAT- MEDLINE
DCOM- 20151120
LR  - 20161020
IS  - 1939-165X (Electronic)
IS  - 0275-6382 (Linking)
VI  - 43
IP  - 4
DP  - 2014 Dec
TI  - Reporting and interpreting red blood cell morphology: is there discordance 
      between clinical pathologists and clinicians?
PG  - 487-95
LID - 10.1111/vcp.12202 [doi]
AB  - BACKGROUND: Clinical pathologists (CPs) report RBC morphologic (RBC-M) changes to 
      assist clinicians in prioritizing differential diagnoses. However, reporting is 
      subjective, semiquantitative, and potentially biased. Reporting decisions vary 
      among CPs, and reports may not be interpreted by clinicians as intended. 
      OBJECTIVES: The aims of this study were to survey clinicians and CPs about RBC-M 
      terms and their clinical value, and identify areas of agreement and discordance. 
      METHODS: Online surveys were distributed to small animal clinicians via the 
      Veterinary Information Network and to CPs via the ASVCP listserv. A quiz assessed 
      understanding of RBC-M terms among respondent groups. Descriptive statistics were 
      used to analyze responses to survey questions, and quiz scores were compared 
      among groups. RESULTS: Analyzable responses were obtained from 1662 clinicians 
      and 82 CPs. Both clinicians and CPs considered some terms, e.g., agglutination, 
      useful, whereas only CPs considered other terms, e.g., ghost cells, useful. All 
      groups interpreted certain terms, e.g., Heinz bodies, correctly, whereas some 
      clinicians misinterpreted others, e.g., eccentrocytes. Responses revealed that 
      CPs often do not report RBC-M they consider insignificant, when present in low 
      numbers. Twenty-eight percent of clinicians think CPs review all blood smears 
      while only 19% of CPs report reviewing all smears. CONCLUSIONS: Important 
      differences about the clinical relevance of certain RBC-M terms exist between 
      clinicians and CPs. Inclusion of interpretive comments on CBC reports is the 
      clearest way to ensure that RBC-M changes are interpreted as intended by the CP. 
      Reporting practices should be examined critically to improve communication, 
      transparency, and ultimately medical decisions.
CI  - (c) 2014 American Society for Veterinary Clinical Pathology.
FAU - Newman, Ashleigh W
AU  - Newman AW
AD  - Department of Population Medicine and Diagnostic Sciences, Cornell University 
      College of Veterinary Medicine, Ithaca, NY, USA.
FAU - Rishniw, Mark
AU  - Rishniw M
FAU - Behling-Kelly, Erica
AU  - Behling-Kelly E
LA  - eng
PT  - Journal Article
DEP - 20141003
PL  - United States
TA  - Vet Clin Pathol
JT  - Veterinary clinical pathology
JID - 9880575
SB  - IM
MH  - Animal Diseases/blood/diagnosis
MH  - Animals
MH  - Diagnosis, Differential
MH  - Erythrocytes/*pathology
MH  - Pathology, Veterinary/methods/*standards/statistics & numerical data
MH  - Surveys and Questionnaires
MH  - Veterinarians/*standards/statistics & numerical data
OTO - NOTNLM
OT  - Blood smear
OT  - CBC
OT  - hematology
OT  - hemogram
EDAT- 2014/10/04 06:00
MHDA- 2015/12/15 06:00
CRDT- 2014/10/04 06:00
PHST- 2014/10/04 06:00 [entrez]
PHST- 2014/10/04 06:00 [pubmed]
PHST- 2015/12/15 06:00 [medline]
AID - 10.1111/vcp.12202 [doi]
PST - ppublish
SO  - Vet Clin Pathol. 2014 Dec;43(4):487-95. doi: 10.1111/vcp.12202. Epub 2014 Oct 3.

PMID- 25311479
OWN - NLM
STAT- MEDLINE
DCOM- 20151123
LR  - 20150114
IS  - 1470-2738 (Electronic)
IS  - 0143-005X (Linking)
VI  - 69
IP  - 2
DP  - 2015 Feb
TI  - The inverse equity hypothesis: does it apply to coverage of cancer screening in 
      middle-income countries?
PG  - 149-55
LID - 10.1136/jech-2014-204355 [doi]
AB  - BACKGROUND: It is uncertain whether the inverse equity hypothesis-the idea that 
      new health interventions are initially primarily accessed by the rich, but that 
      inequalities narrow with diffusion to the poor-holds true for cancer screening in 
      low and middle income countries (LMICs).This study examines the relationship 
      between overall coverage and economic inequalities in coverage of cancer 
      screening in four middle-income countries. METHODS: Secondary analyses of 
      cross-sectional data from the WHO study on Global Ageing and Adult Health in 
      China, Mexico, Russia and South Africa (2007-2010). Three regression-based 
      methods were used to measure economic inequalities: (1) Adjusted OR; (2) Relative 
      Index of Inequality (RII); and (3) Slope Index of Inequality. RESULTS: Coverage 
      for breast cancer screening was 10.5% in South Africa, 19.3% in China, 33.8% in 
      Russia and 43% in Mexico, and coverage for cervical cancer screening was 24% in 
      South Africa, 27.2% in China, 63.7% in Mexico and 81.5% in Russia. Economic 
      inequalities in screening participation were substantially lower or non-existent 
      in countries with higher aggregate coverage, for both breast cancer screening 
      (RII: 14.57 in South Africa, 4.90 in China, 2.01 in Mexico, 1.04 in Russia) and 
      cervical cancer screening (RII: 3.60 in China, 2.47 in South Africa, 1.39 in 
      Mexico, 1.12 in Russia). CONCLUSIONS: Economic inequalities in breast and 
      cervical cancer screening are low in LMICs with high screening coverage. These 
      findings are consistent with the inverse equity hypothesis and indicate that high 
      levels of equity in cancer screening are feasible even in countries with high 
      income inequality.
CI  - Published by the BMJ Publishing Group Limited. For permission to use (where not 
      already granted under a licence) please go to 
      http://group.bmj.com/group/rights-licensing/permissions.
FAU - Lee, John Tayu
AU  - Lee JT
AD  - Department of Primary Care and Public Health, School of Public Health, Imperial 
      College London, London, UK.
FAU - Huang, Zhilian
AU  - Huang Z
AD  - Department of Primary Care and Public Health, School of Public Health, Imperial 
      College London, London, UK.
FAU - Basu, Sanjay
AU  - Basu S
AD  - Prevention Research Center, Stanford University, Palo Alto, California, USA.
FAU - Millett, Christopher
AU  - Millett C
AD  - Department of Primary Care and Public Health, School of Public Health, Imperial 
      College London, London, UK.
LA  - eng
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20141013
PL  - England
TA  - J Epidemiol Community Health
JT  - Journal of epidemiology and community health
JID - 7909766
SB  - IM
MH  - Adult
MH  - Aged
MH  - Breast Neoplasms/*diagnosis
MH  - China
MH  - Cross-Cultural Comparison
MH  - Cross-Sectional Studies
MH  - Developing Countries/*economics/statistics & numerical data
MH  - Early Detection of Cancer/*economics/statistics & numerical data
MH  - Female
MH  - Health Services Accessibility/*economics/statistics & numerical data
MH  - Humans
MH  - Mexico
MH  - Middle Aged
MH  - Regression Analysis
MH  - Russia
MH  - *Social Class
MH  - South Africa
MH  - Uterine Cervical Neoplasms/*diagnosis
OTO - NOTNLM
OT  - ACCESS TO HLTH CARE
OT  - AGEING
OT  - CANCER: BREAST
OT  - CANCER: CERVIX
OT  - Health inequalities
EDAT- 2014/10/15 06:00
MHDA- 2015/12/15 06:00
CRDT- 2014/10/15 06:00
PHST- 2014/10/15 06:00 [entrez]
PHST- 2014/10/15 06:00 [pubmed]
PHST- 2015/12/15 06:00 [medline]
AID - jech-2014-204355 [pii]
AID - 10.1136/jech-2014-204355 [doi]
PST - ppublish
SO  - J Epidemiol Community Health. 2015 Feb;69(2):149-55. doi: 
      10.1136/jech-2014-204355. Epub 2014 Oct 13.

PMID- 16046584
OWN - NLM
STAT- MEDLINE
DCOM- 20051102
LR  - 20171116
IS  - 0021-972X (Print)
IS  - 0021-972X (Linking)
VI  - 90
IP  - 10
DP  - 2005 Oct
TI  - Menopausal hormone therapy and irregular endometrial bleeding: a potential role 
      for uterine natural killer cells?
PG  - 5528-35
AB  - CONTEXT: Irregular bleeding affects many users of combined menopausal hormone 
      therapy (HT) and commonly leads to invasive and expensive investigations to 
      exclude underlying malignancy. In most cases no abnormality is found. OBJECTIVE: 
      The main objective of this study was to explore the role of uterine natural 
      killer (uNK) cells and their regulatory cytokine IL-15 in irregular bleeding in 
      HT users. DESIGN: This was a prospective observational study conducted between 
      2002 and 2004. SETTING: The study was conducted in a tertiary referral menopause 
      clinic at King Edward Memorial Hospital, Western Australia. PATIENTS: Patients 
      included 117 postmenopausal women taking combined HT. INTERVENTIONS: Outpatient 
      endometrial biopsies were taken during and outside bleeding episodes. MAIN 
      OUTCOME MEASURES: The relationship between endometrial uNK cells (CD56+) and 
      bleeding patterns was measured. We also addressed the impact of HT exposure on 
      uNK cell populations, the relationship between endometrial IL-15 expression and 
      uNK cell populations, and killer Ig like receptor genotype in subjects with 
      irregular bleeding. RESULTS: Endometrial CD56+ uNK cells were significantly 
      increased in biopsies obtained during bleeding episodes (P < 0.001), compared 
      with HT users with no bleeding. The highest level of IL-15 expression was also 
      seen in biopsies taken during bleeding. No clear relationship between killer Ig 
      like receptor genotype and bleeding on HT was observed. CONCLUSIONS: Little is 
      known about the mechanisms underlying irregular bleeding in HT users. This is the 
      first report of uNK cells and their association with regulating cytokines in 
      postmenopausal endometrium and demonstrates a possible mechanism by which HT may 
      induce irregular bleeding.
FAU - Hickey, M
AU  - Hickey M
AD  - School of Women's and Infants' Health, Royal Perth Hospital, Perth 6008, Western 
      Australia, Australia. mhickey@obsgyn.uwa.edu.au
FAU - Crewe, J
AU  - Crewe J
FAU - Goodridge, J P
AU  - Goodridge JP
FAU - Witt, C S
AU  - Witt CS
FAU - Fraser, I S
AU  - Fraser IS
FAU - Doherty, D
AU  - Doherty D
FAU - Christiansen, F T
AU  - Christiansen FT
FAU - Salamonsen, L A
AU  - Salamonsen LA
LA  - eng
PT  - Case Reports
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20050726
PL  - United States
TA  - J Clin Endocrinol Metab
JT  - The Journal of clinical endocrinology and metabolism
JID - 0375362
RN  - 0 (CD56 Antigen)
RN  - 0 (Estrogens, Conjugated (USP))
RN  - 0 (Interleukin-15)
RN  - 0 (Receptors, Immunologic)
RN  - 4TI98Z838E (Estradiol)
SB  - IM
MH  - CD56 Antigen/immunology
MH  - Endometrium/*pathology
MH  - Estradiol/adverse effects/therapeutic use
MH  - Estrogen Replacement Therapy/*adverse effects
MH  - Estrogens, Conjugated (USP)/adverse effects/therapeutic use
MH  - Female
MH  - Genotype
MH  - Hemorrhage/*physiopathology
MH  - Humans
MH  - Immunohistochemistry
MH  - Interleukin-15/metabolism
MH  - Killer Cells, Natural/*physiology
MH  - Lymphocyte Count
MH  - Menopause/*drug effects
MH  - Middle Aged
MH  - Receptors, Immunologic/genetics
MH  - Uterus/cytology/*physiopathology
EDAT- 2005/07/28 09:00
MHDA- 2005/11/03 09:00
CRDT- 2005/07/28 09:00
PHST- 2005/07/28 09:00 [pubmed]
PHST- 2005/11/03 09:00 [medline]
PHST- 2005/07/28 09:00 [entrez]
AID - jc.2005-0688 [pii]
AID - 10.1210/jc.2005-0688 [doi]
PST - ppublish
SO  - J Clin Endocrinol Metab. 2005 Oct;90(10):5528-35. doi: 10.1210/jc.2005-0688. Epub 
      2005 Jul 26.

PMID- 26418441
OWN - NLM
STAT- MEDLINE
DCOM- 20160930
LR  - 20151209
IS  - 1445-5994 (Electronic)
IS  - 1444-0903 (Linking)
VI  - 45
IP  - 12
DP  - 2015 Dec
TI  - Can we ease the financial burden of colonoscopy? Using real-time endoscopic 
      assessment of polyp histology to predict surveillance intervals.
PG  - 1293-9
LID - 10.1111/imj.12917 [doi]
AB  - BACKGROUND: Polyps identified at colonoscopy are predominantly diminutive (<5 mm) 
      with a small risk (>1%) of high-grade dysplasia or carcinoma; however, the cost 
      of histological assessment is substantial. AIM: The aim of this study was to 
      determine whether prediction of colonoscopy surveillance intervals based on 
      real-time endoscopic assessment of polyp histology is accurate and cost 
      effective. METHODS: A prospective cohort study was conducted across a tertiary 
      care and private community hospital. Ninety-four patients underwent colonoscopy 
      and polypectomy of diminutive (</=5 mm) polyps from October 2012 to July 2013, 
      yielding a total of 159 polyps. Polyps were examined and classified according to 
      the Sano-Emura classification system. The endoscopic assessment (optical 
      diagnosis) of polyp histology was used to predict appropriate colonoscopy 
      surveillance intervals. The main outcome measure was the accuracy of optical 
      diagnosis of diminutive colonic polyps against the gold standard of histological 
      assessment. RESULTS: Optical diagnosis was correct in 105/108 (97.2%) adenomas. 
      This yielded a sensitivity, specificity and positive and negative predictive 
      values (with 95%CI) of 97.2% (92.1-99.4%), 78.4% (64.7-88.7%), 90.5% (83.7-95.2%) 
      and 93% (80.9-98.5%) respectively. Ninety-two (98%) patients were correctly 
      triaged to their repeat surveillance colonoscopy. Based on these findings, a cut 
      and discard approach would have resulted in a saving of $319.77 per patient. 
      CONCLUSION: Endoscopists within a tertiary care setting can accurately predict 
      diminutive polyp histology and confer an appropriate surveillance interval with 
      an associated financial benefit to the healthcare system. However, limitations to 
      its application in the community setting exist, which may improve with further 
      training and high-definition colonoscopes.
CI  - (c) 2015 Royal Australasian College of Physicians.
FAU - Chandran, S
AU  - Chandran S
AD  - Departments of Gastroenterology, Austin Health, Melbourne, Australia.
FAU - Parker, F
AU  - Parker F
AD  - Anaesthetics, Austin Health, Melbourne, Australia.
FAU - Lontos, S
AU  - Lontos S
AD  - Departments of Gastroenterology, Austin Health, Melbourne, Australia.
AD  - Department of Gastroenterology, Warringal Private Hospital, Melbourne, Australia.
FAU - Vaughan, R
AU  - Vaughan R
AD  - Departments of Gastroenterology, Austin Health, Melbourne, Australia.
AD  - Department of Gastroenterology, Warringal Private Hospital, Melbourne, Australia.
FAU - Efthymiou, M
AU  - Efthymiou M
AD  - Departments of Gastroenterology, Austin Health, Melbourne, Australia.
LA  - eng
PT  - Journal Article
PL  - Australia
TA  - Intern Med J
JT  - Internal medicine journal
JID - 101092952
SB  - IM
MH  - Adenomatous Polyps/*diagnosis/*economics/epidemiology/pathology
MH  - Adult
MH  - Aged
MH  - Australia/epidemiology
MH  - Colonic Neoplasms/*diagnosis/*economics/epidemiology/pathology
MH  - Colonoscopy/*economics
MH  - Cost-Benefit Analysis
MH  - Early Detection of Cancer/*economics/instrumentation
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Predictive Value of Tests
MH  - Prospective Studies
MH  - Sensitivity and Specificity
OTO - NOTNLM
OT  - colonic neoplasm
OT  - colonoscopy
OT  - cost-benefit analysis
OT  - histology
OT  - polyps
EDAT- 2015/09/30 06:00
MHDA- 2016/10/01 06:00
CRDT- 2015/09/30 06:00
PHST- 2015/01/10 00:00 [received]
PHST- 2015/09/15 00:00 [revised]
PHST- 2015/09/18 00:00 [accepted]
PHST- 2015/09/30 06:00 [entrez]
PHST- 2015/09/30 06:00 [pubmed]
PHST- 2016/10/01 06:00 [medline]
AID - 10.1111/imj.12917 [doi]
PST - ppublish
SO  - Intern Med J. 2015 Dec;45(12):1293-9. doi: 10.1111/imj.12917.

PMID- 22683044
OWN - NLM
STAT- MEDLINE
DCOM- 20140515
LR  - 20161021
IS  - 1578-6749 (Electronic)
IS  - 0210-5691 (Linking)
VI  - 37
IP  - 4
DP  - 2013 May
TI  - [Does open access publishing increase the impact of scientific articles? An 
      empirical study in the field of intensive care medicine].
PG  - 232-40
LID - S0210-5691(12)00154-4 [pii]
LID - 10.1016/j.medin.2012.04.002 [doi]
AB  - OBJECTIVE: Some studies suggest that open access articles are more often cited 
      than non-open access articles. However, the relationship between open access and 
      citations count in a discipline such as intensive care medicine has not been 
      studied to date. The present article analyzes the effect of open access 
      publishing of scientific articles in intensive care medicine journals in terms of 
      citations count. METHODS: We evaluated a total of 161 articles (76% being 
      non-open access articles) published in Intensive Care Medicine in the year 2008. 
      Citation data were compared between the two groups up until April 30, 2011. 
      Potentially confounding variables for citation counts were adjusted for in a 
      linear multiple regression model. RESULTS: The median number (interquartile 
      range) of citations of non-open access articles was 8 (4-12) versus 9 (6-18) in 
      the case of open access articles (p=0.084). In the highest citation range (>8), 
      the citation count was 13 (10-16) and 18 (13-21) (p=0.008), respectively. The 
      mean follow-up was 37.5 +/- 3 months in both groups. In the 30-35 months after 
      publication, the average number (mean +/- standard deviation) of citations per 
      article per month of non-open access articles was 0.28 +/- 0.6 versus 0.38 +/- 0.7 in 
      the case of open access articles (p=0.043). Independent factors for citation 
      advantage were the Hirsch index of the first signing author (beta=0.207; p=0.015) 
      and open access status (beta=3.618; p=0.006). CONCLUSIONS: Open access publishing 
      and the Hirsch index of the first signing author increase the impact of 
      scientific articles. The open access advantage is greater for the more highly 
      cited articles, and appears in the 30-35 months after publication.
CI  - Copyright (c) 2012 Elsevier Espana, S.L. and SEMICYUC. All rights reserved.
FAU - Riera, M
AU  - Riera M
AD  - Servicio de Medicina Intensiva, Hospital Universitario Son Espases, Palma de 
      Mallorca, Espana. rierasagrera@gmail.com
FAU - Aibar, E
AU  - Aibar E
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  -  inverted question markFavorece la publicacion en abierto el impacto de los articulos cientificos? Un 
      estudio empirico en el ambito de la medicina intensiva.
DEP - 20120607
PL  - Spain
TA  - Med Intensiva
JT  - Medicina intensiva
JID - 9207689
SB  - IM
MH  - *Access to Information
MH  - *Critical Care
MH  - *Journal Impact Factor
MH  - Periodicals as Topic/*statistics & numerical data
MH  - Publishing/*statistics & numerical data
EDAT- 2012/06/12 06:00
MHDA- 2014/05/16 06:00
CRDT- 2012/06/12 06:00
PHST- 2012/02/11 00:00 [received]
PHST- 2012/03/25 00:00 [revised]
PHST- 2012/04/04 00:00 [accepted]
PHST- 2012/06/12 06:00 [entrez]
PHST- 2012/06/12 06:00 [pubmed]
PHST- 2014/05/16 06:00 [medline]
AID - S0210-5691(12)00154-4 [pii]
AID - 10.1016/j.medin.2012.04.002 [doi]
PST - ppublish
SO  - Med Intensiva. 2013 May;37(4):232-40. doi: 10.1016/j.medin.2012.04.002. Epub 2012 
      Jun 7.

PMID- 26200172
OWN - NLM
STAT- MEDLINE
DCOM- 20160523
LR  - 20181202
IS  - 2326-3660 (Electronic)
IS  - 0091-3847 (Linking)
VI  - 43
IP  - 3
DP  - 2015 Jul
TI  - Can biofeedback training of psychophysiological responses enhance athletes' sport 
      performance? A practitioner's perspective.
PG  - 287-99
LID - 10.1080/00913847.2015.1069169 [doi]
AB  - BACKGROUND: In recent years, biofeedback has become increasingly popular for its 
      proven success in peak performance training - the psychophysiological preparation 
      of athletes for high-stakes sport competitions, such as the Olympic games. The 
      aim of this research was to test whether an 8-week period of exposure to 
      biofeedback training could improve the psychophysiological control over 
      competitive anxiety and enhance athletic performance in participating subjects. 
      METHODS: Participants of this study were highly competent athletes, each training 
      in different sport disciplines. The experimental group consisted of 18 athletes 
      (4 women, 14 men), whereas the Control group had 21 athletes (4 women, 17 men). 
      All athletes were between 16 and 34 years old. The biofeedback device, Nexus 10, 
      was used to detect and measure the psychophysiological responses of athletes. 
      Athletes from both groups (control and experimental) were subjected to stress 
      tests at the beginning of the study and once again at its conclusion. In between, 
      the experimental group received training in biofeedback techniques. We then 
      calculated the overall percentage of athletes in the experimental group compared 
      with those in the control group who were able to control respiration, skin 
      conductance, heart rate, blood flow amplitude, heart rate variability, and heart 
      respiration coherence. One year following completion of the initial study, we 
      questioned athletes from the experimental group, to determine whether they 
      continued to use these skills and if they could detect any subsequent enhancement 
      in their athletic performance. RESULTS: We demonstrated that a greater number of 
      participants in the experimental group were able to successfully control their 
      psychophysiological parameters, in comparison to their peers in the control 
      group. Significant results (p < 0.05) were noted in regulation of GSR following 
      short stress test conditions (p = 0.037), in regulation of HR after exposure to 
      STROOP stressor (p = 0.037), in regulation of GSR following the Math and GSR 
      stressors (p = 0.033, p = 0.409) and in achieving HR - breathing coherence 
      following the math stressor (p = 0.042). CONCLUSION: One year following 
      completion of the training program, all participants from the experimental group 
      indicated that they were still using the biofeedback - psycho-regulation skills. 
      Furthermore, these participants uniformly reported believing that these skills 
      had enhanced their athletic performance and general well-being.
FAU - Pusenjak, Nika
AU  - Pusenjak N
AD  - a 1 Research Group Larus Inventa, Ljubljana University Incubator , Vojkova 63, 
      Ljubljana, Slovenia.
FAU - Grad, Anton
AU  - Grad A
FAU - Tusak, Matej
AU  - Tusak M
FAU - Leskovsek, Matevz
AU  - Leskovsek M
FAU - Schwarzlin, Romina
AU  - Schwarzlin R
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150722
PL  - England
TA  - Phys Sportsmed
JT  - The Physician and sportsmedicine
JID - 0427461
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Anxiety/prevention & control
MH  - Athletic Performance/*physiology/*psychology
MH  - *Biofeedback, Psychology
MH  - Competitive Behavior/*physiology
MH  - Exercise Test
MH  - Female
MH  - Galvanic Skin Response
MH  - Heart Rate/physiology
MH  - Humans
MH  - Male
MH  - Respiration
MH  - Young Adult
OTO - NOTNLM
OT  - Biofeedback training
OT  - CSAI-2
OT  - SAS
OT  - athletes
OT  - competition
OT  - pre-competitive anxiety
OT  - stress tests
EDAT- 2015/07/23 06:00
MHDA- 2016/05/24 06:00
CRDT- 2015/07/23 06:00
PHST- 2015/07/23 06:00 [entrez]
PHST- 2015/07/23 06:00 [pubmed]
PHST- 2016/05/24 06:00 [medline]
AID - 10.1080/00913847.2015.1069169 [doi]
PST - ppublish
SO  - Phys Sportsmed. 2015 Jul;43(3):287-99. doi: 10.1080/00913847.2015.1069169. Epub 
      2015 Jul 22.

PMID- 20121683
OWN - NLM
STAT- MEDLINE
DCOM- 20100610
LR  - 20220311
IS  - 0025-729X (Print)
IS  - 0025-729X (Linking)
VI  - 192
IP  - 3
DP  - 2010 Feb 1
TI  - Are patients willing participants in the new wave of community-based medical 
      education in regional and rural Australia?
PG  - 150-3
AB  - OBJECTIVE: Community-based medical education is growing to meet the increased 
      demand for quality clinical education in expanded settings, and its 
      sustainability relies on patient participation. This study investigated patients' 
      views on being used as an educational resource for teaching medical students. 
      DESIGN: Questionnaire-based survey. SETTING AND PARTICIPANTS: Patients attending 
      six rural and 11 regional general practices in New South Wales over 18 teaching 
      sessions in November 2008, who consented to student involvement in their 
      consultation. MAIN OUTCOME MEASURES: Patient perceptions, expectations and 
      acceptance of medical student involvement in consultations, assessed by surveys 
      before and after their consultations. RESULTS: 118 of 122 patients consented to 
      medical student involvement; of these, 117 (99%) completed a survey before the 
      consultation, and 100 (85%) after the consultation. Patients were overwhelmingly 
      positive about their doctor and practice being involved in student teaching and 
      felt they themselves played an important role. Pre-consultation, patients 
      expressed reluctance to allow students to conduct some or all aspects of the 
      consultation independently. However, after the consultation, they reported they 
      would have accepted higher levels of involvement than actually occurred. 
      CONCLUSIONS: Patients in regional and rural settings were willing partners in 
      developing skills of junior medical students, who had greater involvement in 
      patient consultations than previously reported for urban students. Our study 
      extends the findings from urban general practice that patients are underutilised 
      partners in community-based medical training. The support of patients from 
      regional and rural settings could facilitate the expansion of primary care-based 
      medical education in these areas of workforce need.
FAU - Hudson, J Nicky
AU  - Hudson JN
AD  - Graduate School of Medicine, University of Wollongong, Wollongong, NSW. 
      nickyh@uow.edu.au
FAU - Weston, Kathryn M
AU  - Weston KM
FAU - Farmer, Elizabeth E
AU  - Farmer EE
FAU - Ivers, Rowena G
AU  - Ivers RG
FAU - Pearson, Russell W
AU  - Pearson RW
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Australia
TA  - Med J Aust
JT  - The Medical journal of Australia
JID - 0400714
SB  - IM
CIN - Fam Med. 2010 Apr;42(4):288. PMID: 20373173
CIN - Med J Aust. 2010 Jun 21;192(12):727-8. doi: 10.5694/j.1326-5377.2010.tb03724.x. 
      PMID: 20565362
MH  - *Community Health Services
MH  - Education, Medical, Graduate/*organization & administration
MH  - Family Practice/*education
MH  - Health Care Surveys
MH  - Humans
MH  - New South Wales
MH  - *Patient Satisfaction
MH  - Physician-Patient Relations
MH  - *Problem-Based Learning
MH  - *Rural Health Services
EDAT- 2010/02/04 06:00
MHDA- 2010/06/11 06:00
CRDT- 2010/02/04 06:00
PHST- 2009/04/07 00:00 [received]
PHST- 2009/09/14 00:00 [accepted]
PHST- 2010/02/04 06:00 [entrez]
PHST- 2010/02/04 06:00 [pubmed]
PHST- 2010/06/11 06:00 [medline]
AID - hud10406_fm [pii]
AID - 10.5694/j.1326-5377.2010.tb03454.x [doi]
PST - ppublish
SO  - Med J Aust. 2010 Feb 1;192(3):150-3. doi: 10.5694/j.1326-5377.2010.tb03454.x.

PMID- 18222909
OWN - NLM
STAT- MEDLINE
DCOM- 20080317
LR  - 20211020
IS  - 1095-8290 (Electronic)
IS  - 0305-7364 (Print)
IS  - 0305-7364 (Linking)
VI  - 101
IP  - 4
DP  - 2008 Mar
TI  - Are pectins involved in cold acclimation and de-acclimation of winter oil-seed 
      rape plants?
PG  - 521-30
LID - 10.1093/aob/mcm329 [doi]
AB  - BACKGROUND AND AIMS: The hypothesis was tested that pectin content and 
      methylation degree participate in regulation of cell wall mechanical properties 
      and in this way may affect tissue growth and freezing resistance over the course 
      of plant cold acclimation and de-acclimation. METHODS: Experiments were carried 
      on the leaves of two double-haploid lines of winter oil-seed rape (Brassica napus 
      subsp. oleifera), differing in winter survival and resistance to blackleg fungus 
      (Leptosphaeria maculans). KEY RESULTS: Plant acclimation in the cold (2 degrees 
      C) brought about retardation of leaf expansion, concomitant with development of 
      freezing resistance. These effects were associated with the increases in leaf 
      tensile stiffness, cell wall and pectin contents, pectin methylesterase (EC 
      3.1.1.11) activity and the low-methylated pectin content, independently of the 
      genotype studied. However, the cold-induced modifications in the cell wall 
      properties were more pronounced in the leaves of the more pathogen-resistant 
      genotype. De-acclimation promoted leaf expansion and reversed most of the 
      cold-induced effects, with the exception of pectin methylesterase activity. 
      CONCLUSIONS: The results show that the temperature-dependent modifications in 
      pectin content and their methyl esterification degree correlate with changes in 
      tensile strength of a leaf tissue, and in this way affect leaf expansion ability 
      and its resistance to freezing and to fungus pathogens.
FAU - Solecka, Danuta
AU  - Solecka D
AD  - Department of Plant Molecular Biology, Institute of Experimental Plant Biology, 
      University of Warsaw, Miecznikowa 1, 02-096 Warsaw, Poland.
FAU - Zebrowski, Jacek
AU  - Zebrowski J
FAU - Kacperska, Alina
AU  - Kacperska A
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20080125
PL  - England
TA  - Ann Bot
JT  - Annals of botany
JID - 0372347
RN  - 89NA02M4RX (Pectins)
RN  - EC 3.1.1.- (Carboxylic Ester Hydrolases)
RN  - EC 3.1.1.11 (pectinesterase)
SB  - IM
MH  - Acclimatization/*physiology
MH  - Ascomycota/physiology
MH  - Biomechanical Phenomena
MH  - Brassica napus/*metabolism/microbiology/physiology
MH  - Carboxylic Ester Hydrolases/metabolism
MH  - Cell Enlargement
MH  - Cell Wall/*physiology
MH  - Esterification
MH  - Freezing
MH  - Genotype
MH  - Pectins/*metabolism
MH  - Plant Diseases
MH  - Plant Leaves/growth & development/*metabolism/physiology
PMC - PMC2710196
EDAT- 2008/01/29 09:00
MHDA- 2008/03/18 09:00
PMCR- 2009/03/01
CRDT- 2008/01/29 09:00
PHST- 2008/01/29 09:00 [pubmed]
PHST- 2008/03/18 09:00 [medline]
PHST- 2008/01/29 09:00 [entrez]
PHST- 2009/03/01 00:00 [pmc-release]
AID - mcm329 [pii]
AID - 10.1093/aob/mcm329 [doi]
PST - ppublish
SO  - Ann Bot. 2008 Mar;101(4):521-30. doi: 10.1093/aob/mcm329. Epub 2008 Jan 25.

PMID- 12221908
OWN - NLM
STAT- MEDLINE
DCOM- 20021021
LR  - 20151119
IS  - 0300-9041 (Print)
IS  - 0300-9041 (Linking)
VI  - 70
DP  - 2002 Jul
TI  - [The HELPP syndrome--evidence of a possible systemic inflammatory response in 
      pre-eclampsia?].
PG  - 328-37
AB  - INTRODUCTION: The principal causes of morbidity and mortality during pregnancy in 
      Mexico, are preeclampsia/eclampsia, obstetric hemorrhage and puerperium 
      complications; this is, 62% of maternal deaths in last years. HELLP syndrome was 
      observed between 5 to 25% of the mortality in pregnancies of 36 weeks or less. 
      OBJECTIVE: To analyze patients with HELLP syndrome in ICU's (Intensive Care Unit) 
      of a Gynecology and Obstetric Hospital, related to the abnormal hematological, 
      hepatic and renal results with the obstetric case history and the clinical 
      complications. MATERIALS AND METHODS: A transversal study in patients with HELLP 
      syndrome during 1998 and 1999 were carry out. CASE DEFINITION: Peripheral blood 
      with Microangiopathic hemolysis, elevated liver enzymes: AST, ALT over 40 UI/L, 
      even when were LDH lower than 600 UI/L. It was evaluated the hepatic and renal 
      function, platelets count, microangiopathic hemolysis, arterial pressure, 
      seizures, icteric skin color, blindness, visual disturbances, nausea, vomiting 
      and upper quadrant right abdominal pain. In newborn we analyzed gestational age, 
      sex, weight and APGAR. We studied for an association between maternal and 
      biochemical variables with Correlation Pearson Test, and dependence between 
      variables with lineal regression model. RESULTS: 2878 patients with hypertensives 
      disorders in pregnancy (11.64%). The 1.15% (n = 33) had HELLP syndrome with 
      specific maternal mortality of 0.4 per 10,000 live birth, perinatal mortality of 
      1.62 per 10,000 live birth; and renal damage in 84.5%. Coefficient beta was 
      higher between number of pregnancies to platelets count (-0.33) and creatinine 
      clearance (-0.401). CONCLUSION: We found an important renal damage, low 
      platelets, elevated liver enzymes in women with two or more pregnancies. Then we 
      propose there are similarities between HELLP syndrome and Systemic Inflammatory 
      Response Syndrome (SIRS) because they could have the same pathophysiology.
FAU - Balderas-Pena, Luz Ma Adriana
AU  - Balderas-Pena LM
AD  - Unidad de Investigacion Medica en Epidemiologia Clinica.
FAU - Canales-Munoz, Jose Luis
AU  - Canales-Munoz JL
FAU - Angulo-Vazquez, Jose
AU  - Angulo-Vazquez J
FAU - Anaya-Prado, Roberto
AU  - Anaya-Prado R
FAU - Gonzalez Ojeda, Alejandro
AU  - Gonzalez Ojeda A
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Sindrome HELLP ?evidencias de una posible respuesta inflamatoria sistemica en la 
      preeclampsia?
PL  - Mexico
TA  - Ginecol Obstet Mex
JT  - Ginecologia y obstetricia de Mexico
JID - 0376552
SB  - IM
MH  - Abortion, Induced
MH  - Adult
MH  - Anemia, Hemolytic/blood/*epidemiology/physiopathology
MH  - Cesarean Section
MH  - Comorbidity
MH  - Critical Care
MH  - Cross-Sectional Studies
MH  - Disease Susceptibility
MH  - Female
MH  - Humans
MH  - Hypertension/complications
MH  - Infant Mortality
MH  - Infant, Newborn
MH  - Infant, Newborn, Diseases/epidemiology
MH  - Kidney Function Tests
MH  - Liver Diseases/blood/*epidemiology/physiopathology
MH  - Liver Function Tests
MH  - Male
MH  - Maternal Age
MH  - Maternal Mortality
MH  - Mexico/epidemiology
MH  - Parity
MH  - Pre-Eclampsia/blood/*epidemiology/physiopathology
MH  - Pregnancy
MH  - Pregnancy Complications/blood/*epidemiology/physiopathology
MH  - Socioeconomic Factors
MH  - Systemic Inflammatory Response Syndrome/blood/*epidemiology/physiopathology
MH  - Thrombocytopenia/blood/*epidemiology/physiopathology
EDAT- 2002/09/12 10:00
MHDA- 2002/10/22 04:00
CRDT- 2002/09/12 10:00
PHST- 2002/09/12 10:00 [pubmed]
PHST- 2002/10/22 04:00 [medline]
PHST- 2002/09/12 10:00 [entrez]
PST - ppublish
SO  - Ginecol Obstet Mex. 2002 Jul;70:328-37.

PMID- 24014276
OWN - NLM
STAT- MEDLINE
DCOM- 20140624
LR  - 20211021
IS  - 1720-8319 (Electronic)
IS  - 1594-0667 (Print)
IS  - 1594-0667 (Linking)
VI  - 25
IP  - 5
DP  - 2013 Oct
TI  - Optimism and survival: does an optimistic outlook predict better survival at 
      advanced ages? A twelve-year follow-up of Danish nonagenarians.
PG  - 517-25
LID - 10.1007/s40520-013-0122-x [doi]
AB  - BACKGROUND AND AIMS: Studies examining predictors of survival among the 
      oldest-old have primarily focused on objective measures, such as physical 
      function and health status. Only a few studies have examined the effect of 
      personality traits on survival, such as optimism. The aim of this study was to 
      examine whether an optimistic outlook predicts survival among the oldest-old. 
      METHODS: The Danish 1905 Cohort Survey is a nationwide, longitudinal survey 
      comprising all individuals born in Denmark in 1905. At baseline in 1998, a total 
      of 2,262 persons aged 92 or 93 agreed to participate in the intake survey. The 
      baseline in-person interview consisted of a comprehensive questionnaire including 
      physical functioning and health, and a question about whether the respondent had 
      an optimistic, neutral or pessimistic outlook on his or her own future. RESULTS: 
      During the follow-up period of 12 years (1998-2010) there were 2,239 deaths (99 
      %) in the 1905 Cohort Survey. Univariable analyses revealed that optimistic women 
      and men were at lower risk of death compared to their neutral counterparts [HR 
      0.82, 95 % CI (0.73-0.93) and 0.81, 95 % CI (0.66-0.99), respectively]. When 
      confounding factors such as baseline physical and cognitive functioning and 
      disease were taken into account the association between optimism and survival 
      weakened in both sexes, but the general pattern persisted. Optimistic women were 
      still at lower risk of death compared to neutral women [HR 0.85, 95 % CI 
      (0.74-0.97)]. The risk of death was also decreased for optimistic men compared to 
      their neutral counterparts, but the effect was non-significant [HR 0.91, 95 % CI 
      (0.73-1.13)]. CONCLUSION: An optimistic outlook appears to be a significant 
      predictor of survival among the oldest-old women. It may also be a significant 
      predictor for men but the sample size is small.
FAU - Engberg, Henriette
AU  - Engberg H
AD  - Department of Epidemiology, The Danish Aging Research Center, Institute of Public 
      Health, University of Southern Denmark, Odense, Denmark, engbergh@gmail.com.
FAU - Jeune, Bernard
AU  - Jeune B
FAU - Andersen-Ranberg, Karen
AU  - Andersen-Ranberg K
FAU - Martinussen, Torben
AU  - Martinussen T
FAU - Vaupel, James W
AU  - Vaupel JW
FAU - Christensen, Kaare
AU  - Christensen K
LA  - eng
GR  - P01 AG008761/AG/NIA NIH HHS/United States
GR  - P01AG08761/AG/NIA NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20130907
PL  - Germany
TA  - Aging Clin Exp Res
JT  - Aging clinical and experimental research
JID - 101132995
SB  - IM
MH  - Aged
MH  - Denmark
MH  - Female
MH  - Follow-Up Studies
MH  - *Health Status
MH  - Humans
MH  - Longitudinal Studies
MH  - Male
MH  - *Survival
PMC - PMC3844795
MID - NIHMS525872
COIS- Conflict of interest The authors declare that they have no conflict of interest 
      regarding the paper.
EDAT- 2013/09/10 06:00
MHDA- 2014/06/25 06:00
PMCR- 2013/12/02
CRDT- 2013/09/10 06:00
PHST- 2012/11/14 00:00 [received]
PHST- 2013/03/12 00:00 [accepted]
PHST- 2013/09/10 06:00 [entrez]
PHST- 2013/09/10 06:00 [pubmed]
PHST- 2014/06/25 06:00 [medline]
PHST- 2013/12/02 00:00 [pmc-release]
AID - 10.1007/s40520-013-0122-x [doi]
PST - ppublish
SO  - Aging Clin Exp Res. 2013 Oct;25(5):517-25. doi: 10.1007/s40520-013-0122-x. Epub 
      2013 Sep 7.

PMID- 24270957
OWN - NLM
STAT- MEDLINE
DCOM- 20140930
LR  - 20220629
IS  - 1980-5322 (Electronic)
IS  - 1807-5932 (Print)
IS  - 1807-5932 (Linking)
VI  - 68
IP  - 11
DP  - 2013 Nov
TI  - Is combined therapy more effective than growth hormone or hyperbaric oxygen alone 
      in the healing of left ischemic and non-ischemic colonic anastomoses?
PG  - 1440-5
LID - 10.6061/clinics/2013(11)10 [doi]
AB  - OBJECTIVE: Our aim was to investigate the effects of growth hormone (GH), 
      hyperbaric oxygen and combined therapy on normal and ischemic colonic anastomoses 
      in rats. METHODS: Eighty male Wistar rats were divided into eight groups 
      (n = 10). In the first four groups, non-ischemic colonic anastomosis was 
      performed, whereas in the remaining four groups, ischemic colonic anastomosis was 
      performed. In groups 5, 6, 7, and 8, colonic ischemia was established by ligating 
      2 cm of the mesocolon on either side of the anastomosis. The control groups (1 
      and 5) received no treatment. Hyperbaric oxygen therapy was initiated immediately 
      after surgery and continued for 4 days in groups 3 and 4. Groups 2 and 6 received 
      recombinant human growth hormone, whereas groups 4 and 8 received GH and 
      hyperbaric oxygen treatment. Relaparotomy was performed on postoperative day 4, 
      and a perianastomotic colon segment 2 cm in length was excised for the detection 
      of biochemical and mechanical parameters of anastomotic healing and 
      histopathological evaluation. RESULTS: Combined treatment with hyperbaric oxygen 
      and GH increased the mean bursting pressure values in all of the groups, and a 
      statistically significant increase was noted in the ischemic groups compared to 
      the controls (p<0.05). This improvement was more evident in the ischemic and 
      normal groups treated with combined therapy. In addition, a histopathological 
      evaluation of anastomotic neovascularization and collagen deposition showed 
      significant differences among the groups. CONCLUSIONS: Combined treatment with 
      recombinant human growth hormone and hyperbaric oxygen resulted in a favorable 
      therapeutic effect on the healing of ischemic colonic anastomoses.
FAU - Adas, Mine
AU  - Adas M
AD  - Department of Endocrinology, Okmeydani Education and Research Hospital, Istanbul, 
      Turkey.
FAU - Kemik, Ozgur
AU  - Kemik O
FAU - Adas, Gokhan
AU  - Adas G
FAU - Arikan, Soykan
AU  - Arikan S
FAU - Kuntsal, Leyla
AU  - Kuntsal L
FAU - Kapran, Yersu
AU  - Kapran Y
FAU - Toklu, Akin Savas
AU  - Toklu AS
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - United States
TA  - Clinics (Sao Paulo)
JT  - Clinics (Sao Paulo, Brazil)
JID - 101244734
RN  - 12629-01-5 (Human Growth Hormone)
RN  - 9007-34-5 (Collagen)
SB  - IM
MH  - Anastomosis, Surgical
MH  - Animals
MH  - Collagen/analysis
MH  - Colon/blood supply/pathology/*surgery
MH  - Combined Modality Therapy
MH  - Disease Models, Animal
MH  - Human Growth Hormone/*therapeutic use
MH  - Hyperbaric Oxygenation/*methods
MH  - Ischemia/*therapy
MH  - Male
MH  - Necrosis
MH  - Neovascularization, Physiologic
MH  - Pressure
MH  - Rats
MH  - Rats, Wistar
MH  - Reproducibility of Results
MH  - Treatment Outcome
MH  - Wound Healing/*drug effects
PMC - PMC3812562
COIS- No potential conflict of interest was reported.
EDAT- 2013/11/26 06:00
MHDA- 2014/10/01 06:00
PMCR- 2013/11/01
CRDT- 2013/11/26 06:00
PHST- 2013/02/17 00:00 [received]
PHST- 2013/05/27 00:00 [accepted]
PHST- 2013/11/26 06:00 [entrez]
PHST- 2013/11/26 06:00 [pubmed]
PHST- 2014/10/01 06:00 [medline]
PHST- 2013/11/01 00:00 [pmc-release]
AID - S1807-5932(22)02056-7 [pii]
AID - cln_68p1440 [pii]
AID - 10.6061/clinics/2013(11)10 [doi]
PST - ppublish
SO  - Clinics (Sao Paulo). 2013 Nov;68(11):1440-5. doi: 10.6061/clinics/2013(11)10.

PMID- 18507507
OWN - NLM
STAT- MEDLINE
DCOM- 20080918
LR  - 20230823
IS  - 1083-4087 (Print)
IS  - 1944-706X (Electronic)
IS  - 1083-4087 (Linking)
VI  - 14
IP  - 4 Suppl
DP  - 2008 May
TI  - The promise of specialty pharmaceuticals: are they worth the price?
PG  - S3-6
LID - 10.18553/jmcp.2008.14.S4-A.3
AB  - BACKGROUND: Specialty pharmaceuticals have evolved beyond their status as niche 
      drugs designed to treat rare conditions and are now poised to become the standard 
      of care in a wide variety of common chronic illnesses. Due in part to the cost of 
      these therapies, payers are increasingly demanding evidence of their value. 
      Determining the value of these medications is hampered by a lack of robust 
      pharmacoeconomic data. OBJECTIVE: To outline emerging strategies and case study 
      examples for the medical and pharmacy benefits management of specialty 
      pharmaceuticals. SUMMARY: The promise of specialty pharmaceuticals: increased 
      life expectancy, improved quality of life, enhanced workplace productivity, 
      decreased burden of disease, and reduced health care spending comes at a 
      significant cost. These agents require special handling, administration, patient 
      education, clinical support, and risk mitigation. Additionally, specialty drugs 
      require distribution systems that ensure appropriate patient selection and data 
      collection. With the specialty pharmaceutical pipeline overflowing with new 
      medicines and an aging population increasingly relying on these novel treatments 
      to treat common diseases, the challenge of managing the costs associated with 
      these agents can be daunting. Aided by sophisticated pharmacoeconomic models to 
      assess value, the cost impacts of these specialty drugs can be appropriately 
      controlled. CONCLUSION: Current evidence suggests that when used in targeted 
      patient populations, specialty pharmaceuticals may represent a good health care 
      value.
FAU - Sullivan, Sean D
AU  - Sullivan SD
AD  - Pharmaceutical Outcomes Research and Policy Program, University of Washington, 
      Seattle, WA 98195-7630, USA. sdsull@u.washington.edu
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Manag Care Pharm
JT  - Journal of managed care pharmacy : JMCP
JID - 9605854
RN  - 0 (Pharmaceutical Preparations)
SB  - IM
MH  - Chronic Disease
MH  - *Drug Costs
MH  - Humans
MH  - Managed Care Programs/*economics
MH  - Pharmaceutical Preparations/*economics
MH  - Rare Diseases/drug therapy
MH  - United States
PMC - PMC10438149
EDAT- 2008/06/25 09:00
MHDA- 2008/09/19 09:00
PMCR- 2008/05/01
CRDT- 2008/06/25 09:00
PHST- 2008/06/25 09:00 [pubmed]
PHST- 2008/09/19 09:00 [medline]
PHST- 2008/06/25 09:00 [entrez]
PHST- 2008/05/01 00:00 [pmc-release]
AID - 2008(14)4: 3-6 [pii]
AID - 10.18553/jmcp.2008.14.s4-a.3 [doi]
PST - ppublish
SO  - J Manag Care Pharm. 2008 May;14(4 Suppl):S3-6. doi: 10.18553/jmcp.2008.14.s4-a.3.

PMID- 16772913
OWN - NLM
STAT- MEDLINE
DCOM- 20060628
LR  - 20150624
IS  - 1529-4242 (Electronic)
IS  - 0032-1052 (Linking)
VI  - 117
IP  - 7
DP  - 2006 Jun
TI  - A comparison of 500 prefilled textured saline breast implants versus 500 standard 
      textured saline breast implants: is there a difference in deflation rates?
PG  - 2175-8; discussion 2179-81
AB  - BACKGROUND: This study provides the first large-volume (1000 implant) comparison 
      of the deflation rates of Poly Implant Prosthesis prefilled textured saline 
      breast implants versus a control group of Mentor Siltex textured saline implants. 
      METHODS: A consecutive series of 500 Poly Implant Prosthesis prefilled textured 
      saline breast implants was compared with a consecutive series of 500 Mentor 
      Siltex breast implants. Each breast implant was evaluated for a 4-year period, 
      and the annual deflation rate (number of deflations during a given year divided 
      by the total number of implants) and cumulative deflation rate (cumulative total 
      of deflations through a given year divided by the total number of implants) were 
      recorded. Statistical significance was calculated using the Fisher's exact test 
      at year 1 and the chi-square analysis at years 2 through 4. RESULTS: The 
      cumulative deflation rates of the Poly Implant Prosthesis implants was as 
      follows: year 1, 1.2 percent; year 2, 5.6 percent; year 3, 11.4 percent; and year 
      4, 15.4 percent. The cumulative deflation rates of the Mentor implants was: year 
      1, 0.2 percent; year 2, 0.6 percent; year 3, 1.6 percent; and year 4, 4.4 
      percent. At year 1, the difference between deflation rates was not statistically 
      significant (Fisher's exact test, p > 0.05). However, at year 2 (chi-square, 
      13.29; p < 0.001), year 3 (chi-square, 37.91; p < 0.001), and year 4 (chi-square, 
      32.69; p < 0.001), the difference was statistically significant. CONCLUSIONS: 
      There was a statistically significant difference between the overall deflation 
      rates of Poly Implant Prosthesis prefilled textured saline breast implants and 
      Mentor Siltex breast implants at year 2, year 3, and year 4. After 4 years, the 
      15.56 percent cumulative deflation rate of Poly Implant Prosthesis implants was 
      over 3.5 times higher than the 4.31 percent deflation rate of the Mentor Siltex 
      implants. There may be several factors contributing to the higher deflation rate 
      seen in Poly Implant Prosthesis implants, including possible in vitro deflation 
      before implantation and silicone shell curing technique. Nevertheless, this 
      statistically significant deflation difference must be taken into account when 
      balancing the risks and benefits of Poly Implant Prosthesis breast implants.
FAU - Stevens, W Grant
AU  - Stevens WG
AD  - Marina Plastic Surgery Associates, Marina del Rey, CA, USA. drstevens@hotmail.com
FAU - Hirsch, Elliot M
AU  - Hirsch EM
FAU - Stoker, David A
AU  - Stoker DA
FAU - Cohen, Robert
AU  - Cohen R
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - United States
TA  - Plast Reconstr Surg
JT  - Plastic and reconstructive surgery
JID - 1306050
SB  - IM
MH  - Breast Implantation/*instrumentation
MH  - *Breast Implants
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Postoperative Complications
MH  - *Prosthesis Failure
EDAT- 2006/06/15 09:00
MHDA- 2006/06/29 09:00
CRDT- 2006/06/15 09:00
PHST- 2006/06/15 09:00 [pubmed]
PHST- 2006/06/29 09:00 [medline]
PHST- 2006/06/15 09:00 [entrez]
AID - 00006534-200606000-00011 [pii]
AID - 10.1097/01.prs.0000218199.28082.9d [doi]
PST - ppublish
SO  - Plast Reconstr Surg. 2006 Jun;117(7):2175-8; discussion 2179-81. doi: 
      10.1097/01.prs.0000218199.28082.9d.

PMID- 12172698
OWN - NLM
STAT- MEDLINE
DCOM- 20030107
LR  - 20151119
IS  - 0033-3158 (Print)
IS  - 0033-3158 (Linking)
VI  - 162
IP  - 4
DP  - 2002 Aug
TI  - Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency?
PG  - 433-7
AB  - RATIONALE: Associations between several psychopathological alterations and 
      lowered beta-endorphin(beta E) plasma levels have already been stated in former 
      studies. However, whereas single measures during static conditions generally 
      failed in linking beta E levels with psychopathology, dynamic changes of beta E 
      in particular have been shown to be associated with spells of anxiety and 
      depression. During alcohol withdrawal, a decreased secretion of beta E with a 
      delayed normalization has been reported, but up to now only few data became 
      available regarding the interaction of plasma beta E and psychopathological 
      parameters. OBJECTIVES: The aim of our study was to test the hypothesis whether 
      beta E during acute alcohol withdrawal is associated with anxiety, depression, 
      and craving. METHODS: We observed self-rated anxiety, depression, and craving 
      during alcohol withdrawal and assessed beta E levels (RIA) in a consecutive 
      sample of 60 alcoholics on day 1 and day 14 after onset of withdrawal, and in 30 
      healthy volunteers. To control for mutual interactions of beta E and the 
      pituitary-adrenocortical hormone secretion, plasma corticotropin (ACTH) and 
      cortisol were also determined. RESULTS: In accordance with prior studies, beta E 
      was significantly lowered on day 1 and day 14 of alcohol withdrawal relative to 
      controls. Plasma levels of ACTH correlated significantly with beta E in 
      alcoholics at both time points and in controls, without differing significantly 
      between the groups. Self-rated anxiety, depression, and alcohol craving decreased 
      significantly between day 1 and day 14. Levels of beta E were inversely 
      correlated with anxiety day 1 (r=-0.58) and day 14 (r=-0.71). Partial correlation 
      coefficients controlling for ACTH plasma levels revealed that this correlation 
      was largely independent from ACTH. In addition, a significant inverse 
      relationship was found between beta E and craving on day 14 (r=-0.28). No 
      association appeared between beta E and depression. CONCLUSIONS: Our results give 
      first evidence that lowered beta E during alcohol withdrawal may contribute to 
      anxiety as a common disturbance during this state.
FAU - Kiefer, Falk
AU  - Kiefer F
AD  - Department of Psychiatry, University Hospital Hamburg-Eppendorf, Martinistrasse 
      52, 20251 Hamburg, Germany. kiefer@psyunihh.de
FAU - Horntrich, Mirko
AU  - Horntrich M
FAU - Jahn, Holger
AU  - Jahn H
FAU - Wiedemann, Klaus
AU  - Wiedemann K
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20020625
PL  - Germany
TA  - Psychopharmacology (Berl)
JT  - Psychopharmacology
JID - 7608025
RN  - 60617-12-1 (beta-Endorphin)
RN  - 9002-60-2 (Adrenocorticotropic Hormone)
RN  - WI4X0X7BPJ (Hydrocortisone)
SB  - IM
CIN - Psychopharmacology (Berl). 2003 Jan;165(2):202-3. doi: 10.1007/s00213-002-1308-7. 
      PMID: 12428151
MH  - Adrenocorticotropic Hormone/blood
MH  - Adult
MH  - Alcohol Drinking/adverse effects/blood
MH  - Alcoholism/*blood/complications
MH  - Anxiety/*blood/etiology
MH  - Depression/blood/etiology
MH  - Disruptive, Impulse Control, and Conduct Disorders/blood/psychology
MH  - Female
MH  - Humans
MH  - Hydrocortisone/blood
MH  - Male
MH  - Middle Aged
MH  - Substance Withdrawal Syndrome/*blood/etiology/psychology
MH  - Time Factors
MH  - beta-Endorphin/blood/*deficiency
EDAT- 2002/08/13 10:00
MHDA- 2003/01/08 04:00
CRDT- 2002/08/13 10:00
PHST- 2002/02/05 00:00 [received]
PHST- 2002/04/08 00:00 [accepted]
PHST- 2002/08/13 10:00 [pubmed]
PHST- 2003/01/08 04:00 [medline]
PHST- 2002/08/13 10:00 [entrez]
AID - 10.1007/s00213-002-1118-y [doi]
PST - ppublish
SO  - Psychopharmacology (Berl). 2002 Aug;162(4):433-7. doi: 10.1007/s00213-002-1118-y. 
      Epub 2002 Jun 25.

PMID- 26460153
OWN - NLM
STAT- MEDLINE
DCOM- 20170609
LR  - 20170609
IS  - 1447-0594 (Electronic)
IS  - 1447-0594 (Linking)
VI  - 16
IP  - 10
DP  - 2016 Oct
TI  - Cardiac reoperations in octogenarians: Do they really benefit?
PG  - 1138-1144
LID - 10.1111/ggi.12609 [doi]
AB  - AIM: According to the demographic development of our society, the numbers of 
      octogenarians referred to cardiac surgery are continuously growing. Although the 
      benefit of first-time cardiac procedures for these patients is well documented, 
      the fate of octogenarians after redo-procedures, with special regard to long-term 
      survival, functional status and quality of life, is poorly investigated. METHODS: 
      We retrospectively identified 84 consecutive patients aged >/=80 years, who 
      underwent a cardiac reoperation at the department for Cardiothoracic Surgery in 
      the Heart & Vessel Center Bad Bevensen between January 2007 and 2013. Demographic 
      profiles as well as operative data were analyzed, and the patients were 
      prospectively followed. Patient's functional status and quality of life were 
      assessed with the Barthel Index, New York Heart Association class and the short 
      form-12 questionnaire. RESULTS: The mean age of the study group (61 men, 23 
      women) was 81.9 +/- 1.9 years. Most redo-procedures were carried out after primary 
      coronary artery bypass grafting (65%), primary aortic valve replacement (21%) and 
      primary mitral valve replacement (6%). The most frequent actual surgical 
      procedures were combined coronary artery bypass grafting and aortic valve 
      replacement (26%), isolated coronary artery bypass grafting (19%), and isolated 
      aortic valve replacement (19%). The mean length of hospital stay was 17 +/- 15 
      days. In-hospital mortality counted for 32.1%. During follow up (29 +/- 20 months) 
      a further 19.0% of the patients died. The Barthel Index of the survivors was 
      89 +/- 17 and their mean New York Heart Association class was 2 +/- 1. A total of 93% 
      of the patients were living at home. Summary scores of physical and mental health 
      of the short form-12 questionnaire equalled those of an age- and sex-matched 
      normative population. CONCLUSIONS: Despite high perioperative mortality, results 
      document a sustainable recovery of the survivors offering the prospect of a 
      highly independent and satisfying life. Therefore, advanced age alone should not 
      be a contraindication for redo cardiac interventions. Geriatr Gerontol Int 2016; 
      16: 1138-1144.
CI  - (c) 2015 Japan Geriatrics Society.
FAU - Deschka, Heinz
AU  - Deschka H
AD  - Department of Cardiothoracic Surgery, Division of Cardiac Surgery, University 
      Hospital Munster, Munster, Germany. deschkaheinz@hotmail.com.
FAU - Machner, Matthias
AU  - Machner M
AD  - Department for Cardiothoracic Surgery, Heart & Vessel Center Bad Bevensen, Bad 
      Bevensen, Germany.
FAU - Welp, Henryk
AU  - Welp H
AD  - Department of Cardiothoracic Surgery, Division of Cardiac Surgery, University 
      Hospital Munster, Munster, Germany.
FAU - Dell'Aquila, Angelo Maria
AU  - Dell'Aquila AM
AD  - Department of Cardiothoracic Surgery, Division of Cardiac Surgery, University 
      Hospital Munster, Munster, Germany.
FAU - Erler, Stefan
AU  - Erler S
AD  - Department for Cardiothoracic Surgery, Heart & Vessel Center Bad Bevensen, Bad 
      Bevensen, Germany.
FAU - Wimmer-Greinecker, Gerhard
AU  - Wimmer-Greinecker G
AD  - Department for Cardiothoracic Surgery, Heart & Vessel Center Bad Bevensen, Bad 
      Bevensen, Germany.
LA  - eng
PT  - Journal Article
DEP - 20151013
PL  - Japan
TA  - Geriatr Gerontol Int
JT  - Geriatrics & gerontology international
JID - 101135738
SB  - IM
MH  - Age Factors
MH  - Aged, 80 and over
MH  - Cardiovascular Surgical Procedures/*adverse effects/methods
MH  - Cause of Death
MH  - Cohort Studies
MH  - Female
MH  - Frail Elderly
MH  - Geriatric Assessment
MH  - Hospital Mortality/trends
MH  - Humans
MH  - Kaplan-Meier Estimate
MH  - Male
MH  - Prognosis
MH  - *Quality of Life
MH  - Reoperation/methods/*mortality
MH  - Retrospective Studies
MH  - Risk Assessment
MH  - Sex Factors
MH  - Survival Analysis
MH  - Treatment Outcome
OTO - NOTNLM
OT  - functional status
OT  - octogenarians
OT  - operative outcomes
OT  - quality of life
OT  - redo-cardiac surgery
EDAT- 2016/10/21 06:00
MHDA- 2017/06/10 06:00
CRDT- 2015/10/14 06:00
PHST- 2015/07/20 00:00 [accepted]
PHST- 2016/10/21 06:00 [pubmed]
PHST- 2017/06/10 06:00 [medline]
PHST- 2015/10/14 06:00 [entrez]
AID - 10.1111/ggi.12609 [doi]
PST - ppublish
SO  - Geriatr Gerontol Int. 2016 Oct;16(10):1138-1144. doi: 10.1111/ggi.12609. Epub 
      2015 Oct 13.

PMID- 12419743
OWN - NLM
STAT- MEDLINE
DCOM- 20030320
LR  - 20200203
IS  - 0923-7534 (Print)
IS  - 0923-7534 (Linking)
VI  - 13
IP  - 11
DP  - 2002 Nov
TI  - Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic 
      breast cancer patients as effective as combination chemotherapy? No difference in 
      survival but higher quality of life were found in a multicenter randomized trial.
PG  - 1717-29
AB  - BACKGROUND: To determine whether patients with high-risk metastatic breast cancer 
      draw benefit from combination chemotherapy as first-line treatment. PATIENTS AND 
      METHODS: A total of 260 women with measurable metastatic breast cancer fulfilling 
      high-risk criteria, previously untreated with chemotherapy for their metastatic 
      disease, were randomized to receive either mitoxantrone 12 mg/m(2) or the 
      combination of fluorouracil 500 mg/m(2), epirubicin 50 mg/m(2) and 
      cyclophosphamide 500 mg/m(2) (FEC) every 3 weeks. Treatment was continued until 
      complete remission plus two cycles, or until disease progression. In the case of 
      partial remission or stable disease, treatment was stopped after 12 cycles. 
      Second-line treatment was vindesine, mitomycin and prednisolone. Gain from 
      treatment was estimated using a modified Brunner's score composed of time to 
      progression, patients' rating of the treatment benefit, alopecia, vomiting and 
      performance status. RESULTS: After recruitment from 1992 to 1997 and observation 
      from 1997 to 1999, the final evaluation showed that single-agent treatment with 
      mitoxantrone does not differ significantly from combination treatment with FEC in 
      terms of response, objective remission rate, remission duration, time to 
      response, time to best response, time to progression or overall survival. There 
      was, however, a significant difference in gain from treatment using a modified 
      Brunner's score favoring the single-agent treatment arm. There was no evidence 
      that any subgroup would fare better with combination treatment. CONCLUSIONS: No 
      significant difference was detected between the treatment with mitoxantrone as a 
      single agent and the combination of low-dose FEC in terms of response or 
      survival; therefore, the imperative of the necessity of first-line combination 
      chemotherapy for patients with high-risk metastatic breast cancer may be 
      questioned. Since toxicity and quality of life score favored the single-agent 
      mitoxantrone treatment arm, this treatment may be offered to patients preferring 
      quality of life to a potential small prolongation of survival.
FAU - Heidemann, E
AU  - Heidemann E
AD  - Department of Hematology and Medical Oncology, Deaconess Hospital, Oncological 
      Center of Stuttgart, Germany. heidemann@diak-stuttgart.de
FAU - Stoeger, H
AU  - Stoeger H
FAU - Souchon, R
AU  - Souchon R
FAU - Hirschmann, W-D
AU  - Hirschmann WD
FAU - Bodenstein, H
AU  - Bodenstein H
FAU - Oberhoff, C
AU  - Oberhoff C
FAU - Fischer, J T
AU  - Fischer JT
FAU - Schulze, M
AU  - Schulze M
FAU - Clemens, M
AU  - Clemens M
FAU - Andreesen, R
AU  - Andreesen R
FAU - Mahlke, M
AU  - Mahlke M
FAU - Konig, M
AU  - Konig M
FAU - Scharl, A
AU  - Scharl A
FAU - Fehnle, K
AU  - Fehnle K
FAU - Kaufmann, M
AU  - Kaufmann M
LA  - eng
PT  - Clinical Trial
PT  - Comparative Study
PT  - Journal Article
PT  - Multicenter Study
PT  - Randomized Controlled Trial
PL  - England
TA  - Ann Oncol
JT  - Annals of oncology : official journal of the European Society for Medical 
      Oncology
JID - 9007735
RN  - 3Z8479ZZ5X (Epirubicin)
RN  - 8N3DW7272P (Cyclophosphamide)
RN  - BZ114NVM5P (Mitoxantrone)
RN  - U3P01618RT (Fluorouracil)
RN  - FEC protocol
SB  - IM
MH  - Adult
MH  - Aged
MH  - Antineoplastic Combined Chemotherapy Protocols/administration & 
      dosage/therapeutic use
MH  - Biopsy, Needle
MH  - Bone Neoplasms/drug therapy/*secondary
MH  - Breast Neoplasms/*drug therapy/*mortality/pathology
MH  - Cyclophosphamide/administration & dosage
MH  - Disease-Free Survival
MH  - Epirubicin/administration & dosage
MH  - Female
MH  - Fluorouracil/administration & dosage
MH  - Germany
MH  - Humans
MH  - Liver Neoplasms/drug therapy/*secondary
MH  - Logistic Models
MH  - Lung Neoplasms/drug therapy/*secondary
MH  - Middle Aged
MH  - Mitoxantrone/*administration & dosage
MH  - Neoplasm Staging
MH  - Probability
MH  - Proportional Hazards Models
MH  - *Quality of Life
MH  - Risk Assessment
MH  - Sensitivity and Specificity
MH  - Statistics, Nonparametric
MH  - Survival Analysis
MH  - Treatment Outcome
EDAT- 2002/11/07 04:00
MHDA- 2003/03/21 04:00
CRDT- 2002/11/07 04:00
PHST- 2002/11/07 04:00 [pubmed]
PHST- 2003/03/21 04:00 [medline]
PHST- 2002/11/07 04:00 [entrez]
AID - S0923-7534(19)63738-5 [pii]
AID - 10.1093/annonc/mdf306 [doi]
PST - ppublish
SO  - Ann Oncol. 2002 Nov;13(11):1717-29. doi: 10.1093/annonc/mdf306.

PMID- 25725704
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20171211
IS  - 0156-5788 (Print)
IS  - 0156-5788 (Linking)
VI  - 39
IP  - 4
DP  - 2015 Sep
TI  - Can clinical supervision sustain our workforce in the current healthcare 
      landscape? Findings from a Queensland study of allied health professionals.
PG  - 476-482
LID - 10.1071/AH14183 [doi]
AB  - OBJECTIVE: Clinical supervision is widely recognised as a mechanism for providing 
      professional support, professional development and clinical governance for 
      healthcare workers. There have been limited studies about the effectiveness of 
      clinical supervision for allied health and minimal studies conducted within the 
      Australian health context. The aim of the present study was to identify whether 
      clinical supervision was perceived to be effective by allied health professionals 
      and to identify components that contributed to effectiveness. Participants 
      completed an anonymous online questionnaire, administered through the health 
      service's intranet. METHODS: A cross-sectional study was conducted with community 
      allied health workers (n = 82) 8 months after implementation of structured 
      clinical supervision. Demographic data (age, gender), work-related history 
      (profession employment level, years of experience), and supervision practice 
      (number and length of supervision sessions) were collected through an online 
      survey. The outcome measure, clinical supervision effectiveness, was 
      operationalised using the Manchester Clinical Supervision Scale-26 (MCSS-26). 
      Data were analysed with Pearson correlation (r) and independent sample t-tests 
      (t) with significance set at 0.05 (ie the probability of significant difference 
      set at P < 0.05). RESULTS: The length of the supervision sessions (r(s) >/= 0.44), 
      the number of sessions (r(s) >/= 0.35) and the total period supervision had been 
      received (r(s) >/= 0.42) were all significantly positively correlated with the 
      MCSS-26 domains of clinical supervision effectiveness. Three individual 
      variables, namely 'receiving clinical supervision', 'having some choice in the 
      allocation of clinical supervisor' and 'having a completed clinical supervision 
      agreement', were also significantly associated with higher total MCSS-26 scores 
      (P(s) < 0.014). CONCLUSION: The results of the study demonstrate that when 
      clinical supervision uses best practice principles, it can provide professional 
      support for allied health workers, even during times of rapid organisational 
      change.
FAU - Saxby, Christine
AU  - Saxby C
AD  - School of Social Work and Human Services, The University of Queensland, Qld 4072, 
      Australia. Email.
FAU - Wilson, Jill
AU  - Wilson J
AD  - School of Social Work and Human Services, The University of Queensland, Qld 4072, 
      Australia. Email.
FAU - Newcombe, Peter
AU  - Newcombe P
AD  - School of Psychology, The University of Queensland, Qld 4072, Australia. Email.
LA  - eng
PT  - Journal Article
PL  - Australia
TA  - Aust Health Rev
JT  - Australian health review : a publication of the Australian Hospital Association
JID - 8214381
MH  - Adult
MH  - Allied Health Personnel/*organization & administration/supply & distribution
MH  - Female
MH  - Humans
MH  - Male
MH  - Personnel Administration, Hospital/*standards
MH  - Queensland
MH  - Surveys and Questionnaires
EDAT- 2015/03/03 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/03/02 06:00
PHST- 2014/10/09 00:00 [received]
PHST- 2015/01/09 00:00 [accepted]
PHST- 2015/03/02 06:00 [entrez]
PHST- 2015/03/03 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - AH14183 [pii]
AID - 10.1071/AH14183 [doi]
PST - ppublish
SO  - Aust Health Rev. 2015 Sep;39(4):476-482. doi: 10.1071/AH14183.

PMID- 25669733
OWN - NLM
STAT- MEDLINE
DCOM- 20150529
LR  - 20161125
IS  - 1527-9995 (Electronic)
IS  - 0090-4295 (Linking)
VI  - 85
IP  - 4
DP  - 2015 Apr
TI  - Can distal ureteral diameter predict reflux resolution after endoscopic 
      injection?
PG  - 896-9
LID - S0090-4295(14)01397-1 [pii]
LID - 10.1016/j.urology.2014.12.021 [doi]
AB  - OBJECTIVE: To test the predictive value of distal ureteral diameter (UD) on 
      reflux resolution after endoscopic injection in children with primary 
      vesicoureteral reflux (VUR). MATERIALS AND METHODS: This was a retrospective 
      review of patients diagnosed with primary VUR between 2009 and 2012 who were 
      managed by endoscopic injection. Seventy preoperative and postoperative voiding 
      cystourethrograms were reviewed. The largest UD within the false pelvis was 
      measured. The UD was divided by the L1-L3 vertebral body distance to get the UD 
      ratio (UDR). One radiologist interpreted the findings of voiding 
      cystourethrography in all patients. Clinical outcome was defined as reflux 
      resolution. RESULTS: Seventy patients were enrolled in this series (17 boys and 
      53 girls). Mean age was 5.9 years (1.2-13 years). Grade III presented in 37 
      patients (53%), and 33 patients (47%) were of grade IV. Mean distal UD was 5.5 mm 
      (2.5-13 mm). Mean UDR was 37.8% (18%-70%). Macroplastique injection was performed 
      in all. Subureteric injection was performed in 60 patients (86%), whereas 
      intraureteric injection was performed in 10 patients. No postoperative 
      complications were detected. The effect of grade, UD, and UDR on success after 
      endoscopic injection was tested. UD and UDR were significant predictors of reflux 
      resolution on logistic regression analysis (P <.007 and .001, respectively). 
      CONCLUSION: UDR provides an objective measurement of VUR and appears as a 
      predictive tool of success after endoscopic injection.
CI  - Copyright (c) 2015 Elsevier Inc. All rights reserved.
FAU - Helmy, Tamer
AU  - Helmy T
AD  - Pediatric Urology Department, Urology and Nephrology Center, Mansoura University, 
      Mansoura, Egypt. Electronic address: drthelmy@yahoo.com.
FAU - Sharaf, Doaa
AU  - Sharaf D
AD  - Pediatric Urology Department, Urology and Nephrology Center, Mansoura University, 
      Mansoura, Egypt.
FAU - AbdelHalim, Ahmed
AU  - AbdelHalim A
AD  - Pediatric Urology Department, Urology and Nephrology Center, Mansoura University, 
      Mansoura, Egypt.
FAU - Hafez, Ashraf
AU  - Hafez A
AD  - Pediatric Urology Department, Urology and Nephrology Center, Mansoura University, 
      Mansoura, Egypt.
FAU - Dawaba, Mohammed
AU  - Dawaba M
AD  - Pediatric Urology Department, Urology and Nephrology Center, Mansoura University, 
      Mansoura, Egypt.
LA  - eng
PT  - Journal Article
DEP - 20150207
PL  - United States
TA  - Urology
JT  - Urology
JID - 0366151
RN  - 0 (Dimethylpolysiloxanes)
RN  - 0 (Urological Agents)
RN  - 63148-62-9 (baysilon)
SB  - IM
MH  - Adolescent
MH  - Child
MH  - Child, Preschool
MH  - Dimethylpolysiloxanes/*administration & dosage
MH  - Female
MH  - Humans
MH  - Infant
MH  - Lumbar Vertebrae/anatomy & histology/diagnostic imaging
MH  - Male
MH  - Predictive Value of Tests
MH  - Radiography
MH  - Retrospective Studies
MH  - Ureter/*anatomy & histology/diagnostic imaging
MH  - Ureteroscopy
MH  - Urological Agents/*administration & dosage
MH  - Vesico-Ureteral Reflux/diagnostic imaging/*drug therapy
EDAT- 2015/02/12 06:00
MHDA- 2015/05/30 06:00
CRDT- 2015/02/12 06:00
PHST- 2014/10/18 00:00 [received]
PHST- 2014/12/08 00:00 [revised]
PHST- 2014/12/16 00:00 [accepted]
PHST- 2015/02/12 06:00 [entrez]
PHST- 2015/02/12 06:00 [pubmed]
PHST- 2015/05/30 06:00 [medline]
AID - S0090-4295(14)01397-1 [pii]
AID - 10.1016/j.urology.2014.12.021 [doi]
PST - ppublish
SO  - Urology. 2015 Apr;85(4):896-9. doi: 10.1016/j.urology.2014.12.021. Epub 2015 Feb 
      7.

PMID- 24614789
OWN - NLM
STAT- MEDLINE
DCOM- 20140918
LR  - 20220408
IS  - 0390-5616 (Print)
IS  - 0390-5616 (Linking)
VI  - 58
IP  - 1
DP  - 2014 Mar
TI  - Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine 
      surgery effective?
PG  - 23-7
AB  - AIM: This study is a retrospective consecutive case series analysis of 198 
      patients who underwent spine surgery between 2009 and 2010. The aim of this paper 
      was to assess the efficacy and safeness of bed rest and lumbar drainage in 
      treating postoperative CSF fistula. Postoperative cerebrospinal fluid (CSF) 
      fistula is a well-known complication in spine surgery which lead to a significant 
      change in length of hospitalization and possible postoperative complications. 
      Management of CSF leaks has changed little over the past 20 years with no golden 
      standard advocated from literature. METHODS: Postoperative CSF fistulas were 
      described in 16 of 198 patients (8%) who underwent spine surgery between 2009 and 
      2010. The choice of the therapeutic strategy was based on the clinical condition 
      of the patients, taking into account the possibility to maintain the prone 
      position continuously and the risk of morbidity due to prolonged bed rest. Six 
      patients were treated conservatively (position prone for three weeks), ten 
      patients were treated by positioning an external CSF lumbar drainage for ten 
      days. The mean follow-up period was ten months. RESULTS: All patients healed 
      their wound properly and no adverse events were recorded. Patients treated 
      conservatively were cured in a mean period of 30 days, while patients treated 
      with CSF drainage were cured in a mean period of 10 days. CONCLUSION: Lumbar 
      drainage seems to be effective and safe both in preventing CSF fistula in cases 
      of large dural tears and debilitated/irradiated patients and in treating CSF 
      leaks.
FAU - Barbanti Brodano, G
AU  - Barbanti Brodano G
AD  - Department of Oncologic and Degenerative Spine Surgery Rizzoli Orthopedic 
      Institute, Bologna, Italy2 Department of Neurosurgery BellariaMaggiore Hospital, 
      Bologna, Italy3 Orthopedics and Traumatology Division Reggio Emilia Hospital, 
      Reggio Emilia, Italy - giovanni@barbantibrodano.com.
FAU - Serchi, E
AU  - Serchi E
FAU - Babbi, L
AU  - Babbi L
FAU - Terzi, S
AU  - Terzi S
FAU - Corghi, A
AU  - Corghi A
FAU - Gasbarrini, A
AU  - Gasbarrini A
FAU - Bandiera, S
AU  - Bandiera S
FAU - Griffoni, C
AU  - Griffoni C
FAU - Colangeli, S
AU  - Colangeli S
FAU - Ghermandi, R
AU  - Ghermandi R
FAU - Boriani, S
AU  - Boriani S
LA  - eng
PT  - Journal Article
PL  - Italy
TA  - J Neurosurg Sci
JT  - Journal of neurosurgical sciences
JID - 0432557
SB  - IM
MH  - Cerebrospinal Fluid Rhinorrhea/*surgery
MH  - Drainage/adverse effects
MH  - Dura Mater/surgery
MH  - Female
MH  - Fistula/*cerebrospinal fluid/*surgery
MH  - Humans
MH  - Male
MH  - Postoperative Complications/prevention & control/*surgery
MH  - Retrospective Studies
MH  - Treatment Outcome
EDAT- 2014/03/13 06:00
MHDA- 2014/09/19 06:00
CRDT- 2014/03/12 06:00
PHST- 2014/03/12 06:00 [entrez]
PHST- 2014/03/13 06:00 [pubmed]
PHST- 2014/09/19 06:00 [medline]
AID - R38Y2014N01A0023 [pii]
PST - ppublish
SO  - J Neurosurg Sci. 2014 Mar;58(1):23-7.

PMID- 24996865
OWN - NLM
STAT- MEDLINE
DCOM- 20160602
LR  - 20211021
IS  - 1433-7347 (Electronic)
IS  - 0942-2056 (Linking)
VI  - 23
IP  - 11
DP  - 2015 Nov
TI  - Assessing joint line positions by means of the contralateral knee: a new approach 
      for planning knee revision surgery?
PG  - 3244-50
LID - 10.1007/s00167-014-3157-4 [doi]
AB  - PURPOSE: Reconstructing the natural joint line in knee revision surgery improves 
      clinical and functional outcome but may be challenging when both cartilage and 
      bone were removed during previous operations. Assessing joint lines (JLs) by 
      means of bony landmarks is inadvisable because of large variations in human 
      anatomy. Because of the inherent symmetry of the human body, we hypothesised that 
      JLs may be directly assessed by measuring the distances from the bony landmarks 
      to the JL of the contralateral knee by means of radiographic images. METHODS: 
      Using scaled weight-bearing radiographs in anteroposterior view of both knees, 
      two independent observers measured the distances from the fibular head, the 
      medial and lateral epicondyle, and the adductor tubercle to the JL. A two-sided p 
      value of </=0.05 was considered statistically significant. RESULTS: Two hundred 
      knees of 100 patients (50 men and 50 women) were examined. For the fibular head, 
      the mean difference between the treated and the control knee was 0.0 mm with 
      narrow confidence limits ranging from -1.1 to 1.1. CONCLUSION: As a new 
      assessment method, we have suggested to assess the JL by means of radiographs of 
      the contralateral knee. The most precise parameter was found to be the distance 
      between the fibular head and the JL. The level of arthritis, age, gender, 
      visibility of the landmarks, and misalignment did not influence measurement 
      accuracy. This parameter is the first tibia-related landmark for assessing the 
      JL, which advantageously corresponds to the tibia-first technique in revision 
      surgery. LEVEL OF EVIDENCE: Diagnostic Study, Level II.
FAU - Maderbacher, Gunther
AU  - Maderbacher G
AD  - Department of Orthopaedic Surgery, University of Regensburg, Regensburg, Germany. 
      Guenther.Maderbacher@klinik.uni-regensburg.de.
FAU - Keshmiri, Armin
AU  - Keshmiri A
AD  - Department of Orthopaedic Surgery, University of Regensburg, Regensburg, Germany.
FAU - Zeman, Florian
AU  - Zeman F
AD  - Center of Clinical Studies, University of Regensburg, Regensburg, Germany.
FAU - Grifka, Joachim
AU  - Grifka J
AD  - Department of Orthopaedic Surgery, University of Regensburg, Regensburg, Germany.
FAU - Baier, Clemens
AU  - Baier C
AD  - Department of Orthopaedic Surgery, University of Regensburg, Regensburg, Germany.
LA  - eng
PT  - Journal Article
DEP - 20140705
PL  - Germany
TA  - Knee Surg Sports Traumatol Arthrosc
JT  - Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA
JID - 9314730
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Anatomic Landmarks
MH  - Arthroplasty, Replacement, Knee/*methods
MH  - Female
MH  - Humans
MH  - Knee Joint/*diagnostic imaging/surgery
MH  - Male
MH  - Middle Aged
MH  - *Preoperative Care
MH  - Radiography
MH  - Reoperation
MH  - Weight-Bearing
OTO - NOTNLM
OT  - Contralateral knee
OT  - Fibular head
OT  - Joint line
OT  - Knee revision surgery
EDAT- 2014/07/06 06:00
MHDA- 2016/06/03 06:00
CRDT- 2014/07/06 06:00
PHST- 2014/03/27 00:00 [received]
PHST- 2014/06/20 00:00 [accepted]
PHST- 2014/07/06 06:00 [entrez]
PHST- 2014/07/06 06:00 [pubmed]
PHST- 2016/06/03 06:00 [medline]
AID - 10.1007/s00167-014-3157-4 [pii]
AID - 10.1007/s00167-014-3157-4 [doi]
PST - ppublish
SO  - Knee Surg Sports Traumatol Arthrosc. 2015 Nov;23(11):3244-50. doi: 
      10.1007/s00167-014-3157-4. Epub 2014 Jul 5.

PMID- 18928979
OWN - NLM
STAT- MEDLINE
DCOM- 20081113
LR  - 20081020
IS  - 1097-6868 (Electronic)
IS  - 0002-9378 (Linking)
VI  - 199
IP  - 4
DP  - 2008 Oct
TI  - Can myometrial electrical activity identify patients in preterm labor?
PG  - 378.e1-6
LID - 10.1016/j.ajog.2008.08.003 [doi]
AB  - OBJECTIVE: The objective of the study was to determine whether myometrial 
      electrical activity can differentiate false from true preterm labor. STUDY 
      DESIGN: Electrical uterine myography (EUM) was measured prospectively on 87 
      women, gestational age less than 35 weeks. The period between contractions, power 
      of contraction peaks and movement of center of electrical activity (RMS), was 
      used to develop an index score (1-5) for prediction of preterm delivery (PTD) 
      within 14 days of the test. The score was compared with fetal fibronectin (fFN) 
      and cervical length (CL). RESULTS: Patients delivering within 14 days from 
      testing showed a higher index and mean RMS (P = .000). No patients with EUM index 
      scores of 1-2 delivered in this time frame. Combining EUM with CL or fFN 
      increased predictability. Logistic regression revealed that history of PTD and 
      EUM index had 4- to 5-fold increased risk for PTD. Gestational age at testing, 
      body mass index, fFN, and CL were nonsignificant contributors to PTD risk. 
      CONCLUSION: Measuring myometrial electrical activity may enhance identification 
      of patients in true premature labor.
FAU - Most, Orli
AU  - Most O
AD  - Department of Obstetrics and Gynecology, New York University Medical Center, New 
      York, NY, USA.
FAU - Langer, Oded
AU  - Langer O
FAU - Kerner, Ram
AU  - Kerner R
FAU - David, Gal Ben
AU  - David GB
FAU - Calderon, Ilan
AU  - Calderon I
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - United States
TA  - Am J Obstet Gynecol
JT  - American journal of obstetrics and gynecology
JID - 0370476
RN  - 0 (Fibronectins)
SB  - IM
MH  - Adult
MH  - Body Mass Index
MH  - Electromyography/methods
MH  - Female
MH  - Fetus/metabolism
MH  - Fibronectins/analysis
MH  - Humans
MH  - Logistic Models
MH  - Myometrium/*physiopathology
MH  - Obstetric Labor, Premature/*diagnosis/*physiopathology
MH  - Pregnancy
MH  - Prospective Studies
MH  - Sensitivity and Specificity
MH  - Uterine Contraction/*physiology
EDAT- 2008/10/22 09:00
MHDA- 2008/11/14 09:00
CRDT- 2008/10/22 09:00
PHST- 2008/02/26 00:00 [received]
PHST- 2008/07/10 00:00 [revised]
PHST- 2008/08/01 00:00 [accepted]
PHST- 2008/10/22 09:00 [pubmed]
PHST- 2008/11/14 09:00 [medline]
PHST- 2008/10/22 09:00 [entrez]
AID - S0002-9378(08)00911-3 [pii]
AID - 10.1016/j.ajog.2008.08.003 [doi]
PST - ppublish
SO  - Am J Obstet Gynecol. 2008 Oct;199(4):378.e1-6. doi: 10.1016/j.ajog.2008.08.003.

PMID- 25699562
OWN - NLM
STAT- MEDLINE
DCOM- 20160202
LR  - 20240610
IS  - 1097-9891 (Electronic)
IS  - 0095-2990 (Print)
IS  - 0095-2990 (Linking)
VI  - 41
IP  - 3
DP  - 2015 May
TI  - Does the Transmissible Liability Index (TLI) assessed in late childhood predict 
      suicidal symptoms at young adulthood?
PG  - 264-8
LID - 10.3109/00952990.2015.1011744 [doi]
AB  - OBJECTIVE: Our previous work demonstrated that the Transmissible Liability Index 
      (TLI), an instrument designed as an index of liability for substance use disorder 
      (SUD), is associated with risk of substance use disorder. This longitudinal study 
      assessed whether TLI measured in 10-12-year-olds (late childhood) predicts 
      suicidal behavior from age 12-14 (preadolescence) to age 25 (young adulthood). We 
      hypothesized that TLI would predict number and severity of suicide attempts. 
      METHODS: Subjects were sons of men who had lifetime history of SUD (n = 250), 
      called the High Average Risk (HAR) group, and sons of men with no lifetime 
      history of a SUD (n = 250), called the Low Average Risk (LAR) group. The TLI was 
      delineated at baseline (age 10-12), and age-specific versions were administered 
      at 12-14, 16, 19, 22, and 25 years of age. RESULTS: TLI was significantly 
      associated with number and severity of lifetime suicide attempts. CONCLUSIONS: 
      These findings confirm the hypothesis that TLI assessed at late childhood is a 
      predictor of frequency and severity of suicidal behavior from preadolescence to 
      young adulthood.
FAU - Cornelius, Jack R
AU  - Cornelius JR
AD  - Center for Education and Drug Abuse Research (CEDAR), University of Pittsburgh , 
      Pittsburgh, PA , USA.
FAU - Kirisci, Levent
AU  - Kirisci L
FAU - Reynolds, Maureen
AU  - Reynolds M
FAU - Vanyukov, Michael
AU  - Vanyukov M
FAU - Tarter, Ralph
AU  - Tarter R
LA  - eng
GR  - UL1 TR000005/TR/NCATS NIH HHS/United States
GR  - K24 AA15320/AA/NIAAA NIH HHS/United States
GR  - K05 DA031248/DA/NIDA NIH HHS/United States
GR  - R01 AA015173/AA/NIAAA NIH HHS/United States
GR  - R21 AA022123/AA/NIAAA NIH HHS/United States
GR  - K02 AA000291/AA/NIAAA NIH HHS/United States
GR  - R01 DA019142/DA/NIDA NIH HHS/United States
GR  - R01 AA14357/AA/NIAAA NIH HHS/United States
GR  - K02 AA018195/AA/NIAAA NIH HHS/United States
GR  - R21 AA022863/AA/NIAAA NIH HHS/United States
GR  - P50 DA005605/DA/NIDA NIH HHS/United States
GR  - R01 AA013370/AA/NIAAA NIH HHS/United States
GR  - R01 DA14635/DA/NIDA NIH HHS/United States
GR  - R01 AA013397/AA/NIAAA NIH HHS/United States
GR  - R01 AA13397/AA/NIAAA NIH HHS/United States
GR  - K24 AA015320/AA/NIAAA NIH HHS/United States
GR  - K02 DA017822/DA/NIDA NIH HHS/United States
GR  - R01 DA014635/DA/NIDA NIH HHS/United States
GR  - R01 AA014357/AA/NIAAA NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20150220
PL  - England
TA  - Am J Drug Alcohol Abuse
JT  - The American journal of drug and alcohol abuse
JID - 7502510
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Child
MH  - Humans
MH  - Longitudinal Studies
MH  - Male
MH  - Risk Factors
MH  - *Suicidal Ideation
MH  - Suicide, Attempted/*psychology
MH  - Young Adult
PMC - PMC4435565
MID - NIHMS690829
OTO - NOTNLM
OT  - Transmissible Liability Index (TLI)
OT  - suicide
OT  - young adults
EDAT- 2015/02/24 06:00
MHDA- 2016/02/03 06:00
PMCR- 2015/05/18
CRDT- 2015/02/21 06:00
PHST- 2015/02/21 06:00 [entrez]
PHST- 2015/02/24 06:00 [pubmed]
PHST- 2016/02/03 06:00 [medline]
PHST- 2015/05/18 00:00 [pmc-release]
AID - 10.3109/00952990.2015.1011744 [doi]
PST - ppublish
SO  - Am J Drug Alcohol Abuse. 2015 May;41(3):264-8. doi: 
      10.3109/00952990.2015.1011744. Epub 2015 Feb 20.

PMID- 24577079
OWN - NLM
STAT- MEDLINE
DCOM- 20150511
LR  - 20211021
IS  - 1423-0003 (Electronic)
IS  - 0304-324X (Print)
IS  - 0304-324X (Linking)
VI  - 60
IP  - 4
DP  - 2014
TI  - Does strategy training reduce age-related deficits in working memory?
PG  - 346-56
LID - 10.1159/000356699 [doi]
AB  - BACKGROUND: Older adults typically perform worse on measures of working memory 
      (WM) than do young adults; however, age-related differences in WM performance 
      might be reduced if older adults use effective encoding strategies. OBJECTIVE: 
      The purpose of the current experiment was to evaluate WM performance after 
      training individuals to use effective encoding strategies. METHODS: Participants 
      in the training group (older adults: n = 39; young adults: n = 41) were taught 
      about various verbal encoding strategies and their differential effectiveness and 
      were trained to use interactive imagery and sentence generation on a 
      list-learning task. Participants in the control group (older: n = 37; young: n = 
      38) completed an equally engaging filler task. All participants completed a pre- 
      and post-training reading span task, which included self-reported strategy use, 
      as well as two transfer tasks that differed in the affordance to use the trained 
      strategies - a paired-associate recall task and the self-ordered pointing task. 
      RESULTS: Both young and older adults were able to use the target strategies on 
      the WM task and showed gains in WM performance after training. The age-related WM 
      deficit was not greatly affected, however, and the training gains did not 
      transfer to the other cognitive tasks. In fact, participants attempted to adapt 
      the trained strategies for a paired-associate recall task, but the increased 
      strategy use did not benefit their performance. CONCLUSIONS: Strategy training 
      can boost WM performance, and its benefits appear to arise from strategy-specific 
      effects and not from domain-general gains in cognitive ability.
CI  - (c) 2014 S. Karger AG, Basel
FAU - Bailey, Heather R
AU  - Bailey HR
AD  - Department of Psychology, Washington University in St. Louis, St. Louis, Mo., 
      USA.
FAU - Dunlosky, John
AU  - Dunlosky J
FAU - Hertzog, Christopher
AU  - Hertzog C
LA  - eng
GR  - F32 AG039162/AG/NIA NIH HHS/United States
GR  - R37 AG013148/AG/NIA NIH HHS/United States
GR  - R37 AG13148/AG/NIA NIH HHS/United States
GR  - F32AG039162/AG/NIA NIH HHS/United States
PT  - Evaluation Study
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20140227
PL  - Switzerland
TA  - Gerontology
JT  - Gerontology
JID - 7601655
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aging/*psychology
MH  - Cognition
MH  - Female
MH  - Humans
MH  - Learning
MH  - Male
MH  - *Memory, Short-Term
MH  - Mental Recall
MH  - Middle Aged
MH  - Reading
MH  - Task Performance and Analysis
MH  - Transfer, Psychology
MH  - Young Adult
PMC - PMC4074452
MID - NIHMS536283
EDAT- 2014/03/01 06:00
MHDA- 2015/05/12 06:00
PMCR- 2015/02/27
CRDT- 2014/03/01 06:00
PHST- 2013/06/29 00:00 [received]
PHST- 2013/10/07 00:00 [accepted]
PHST- 2014/03/01 06:00 [entrez]
PHST- 2014/03/01 06:00 [pubmed]
PHST- 2015/05/12 06:00 [medline]
PHST- 2015/02/27 00:00 [pmc-release]
AID - 000356699 [pii]
AID - 10.1159/000356699 [doi]
PST - ppublish
SO  - Gerontology. 2014;60(4):346-56. doi: 10.1159/000356699. Epub 2014 Feb 27.

PMID- 24669960
OWN - NLM
STAT- MEDLINE
DCOM- 20141209
LR  - 20211021
IS  - 1471-2377 (Electronic)
IS  - 1471-2377 (Linking)
VI  - 14
DP  - 2014 Mar 26
TI  - Does the sex of acute stroke patients influence the effectiveness of rt-PA?
PG  - 60
LID - 10.1186/1471-2377-14-60 [doi]
AB  - BACKGROUND: Women have been reported to show more frequent recanalization and 
      better recovery after intravenous (IV) recombinant tissue plasminogen activator 
      (rt-PA) treatment for acute stroke compared with men. To investigate this we 
      studied a series of stroke patients receiving IV rt-PA and undergoing acute 
      transcranial doppler (TCD) examination. METHODS: Acute stroke patients received 
      IV rt-PA and had acute TCD examination within 4 hours of symptom onset at 4 major 
      stroke centers. TCD findings were interpreted using the Thrombolysis in Brain 
      Ischemia (TIBI) flow grading system. The recanalization rates, and poor 3-month 
      outcomes (modified Rankin scale >2) of men and women were compared using the 
      chi-square test. Multiple regression analysis was used to assess sex as a 
      predictor of recanalization and poor 3-month outcome after controlling for age, 
      baseline NIH Stroke Scale (NIHSS), time to treatment, hypertension, and blood 
      glucose. RESULTS: 369 patients had TCD examinations before or during IV rt-PA 
      treatment. The 199 (53.9%) men and 170 (46.1%) women had mean ages of 67 +/- 13 and 
      70 +/- 14 years, respectively. The sexes did not differ significantly in baseline 
      stroke severity, time to TCD examination, or time to thrombolysis. Of the men, 68 
      (34.2%) had complete recanalization, 58 (29.1%) had partial recanalization, and 
      73 (36.6%) had no recanalization. Of the women, 53 (31.2%) had complete 
      recanalization, 46 (27%) had partial recanalization, and 71 (41.8%) had no 
      recanalization (p = 0.6). Multiple regression analyses showed no difference 
      between the sexes in recanalization rate, time to recanalization, or clinical 
      outcome at 3 months. CONCLUSIONS: In our study; sex is not a significant 
      predictor of recanalization rate, time to recanalization or 3-month outcome in 
      stroke patients following IV rt-PA. TRIAL REGISTRATION: Data from CLOTBUST trial 
      Clinicaltrials.gov Identifier: NCT01240356.
FAU - Al-hussain, Fawaz
AU  - Al-hussain F
AD  - Department of Medicine, King Saud University, Riyadh, Saudi Arabia. 
      faalhussain@ksu.edu.sa.
FAU - Hussain, Muhammad S
AU  - Hussain MS
FAU - Molina, Carlos
AU  - Molina C
FAU - Uchino, Ken
AU  - Uchino K
FAU - Shuaib, Ashfaq
AU  - Shuaib A
FAU - Demchuk, Andrew M
AU  - Demchuk AM
FAU - Alexandrov, Andrei V
AU  - Alexandrov AV
FAU - Saqqur, Maher
AU  - Saqqur M
CN  - CLOTBUST Investigators
LA  - eng
SI  - ClinicalTrials.gov/NCT01240356
PT  - Clinical Trial
PT  - Journal Article
DEP - 20140326
PL  - England
TA  - BMC Neurol
JT  - BMC neurology
JID - 100968555
RN  - 0 (Fibrinolytic Agents)
RN  - 0 (Recombinant Proteins)
RN  - EC 3.4.21.68 (Tissue Plasminogen Activator)
SB  - IM
MH  - Aged
MH  - Female
MH  - Fibrinolytic Agents/*therapeutic use
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Recombinant Proteins/therapeutic use
MH  - Sex Factors
MH  - Stroke/*drug therapy
MH  - Tissue Plasminogen Activator/*therapeutic use
MH  - Ultrasonography, Doppler, Transcranial
PMC - PMC3994292
EDAT- 2014/03/29 06:00
MHDA- 2014/12/15 06:00
PMCR- 2014/03/26
CRDT- 2014/03/28 06:00
PHST- 2013/03/05 00:00 [received]
PHST- 2014/02/26 00:00 [accepted]
PHST- 2014/03/28 06:00 [entrez]
PHST- 2014/03/29 06:00 [pubmed]
PHST- 2014/12/15 06:00 [medline]
PHST- 2014/03/26 00:00 [pmc-release]
AID - 1471-2377-14-60 [pii]
AID - 10.1186/1471-2377-14-60 [doi]
PST - epublish
SO  - BMC Neurol. 2014 Mar 26;14:60. doi: 10.1186/1471-2377-14-60.

PMID- 15502995
OWN - NLM
STAT- MEDLINE
DCOM- 20050401
LR  - 20181113
IS  - 0031-6970 (Print)
IS  - 0031-6970 (Linking)
VI  - 60
IP  - 9
DP  - 2004 Nov
TI  - Does the early adopter of drugs exist? A population-based study of general 
      practitioners' prescribing of new drugs.
PG  - 667-72
AB  - OBJECTIVE: To analyse associations between indicators for adoption of new drugs 
      and to test the hypothesis that physicians' early adoption of new drugs is a 
      personal trait independent of drug groups. METHODS: In a population-based cohort 
      study using register data, we analysed the prescribing of new drugs by Danish 
      general practitioners. Angiotensin-II antagonists, triptans, selective 
      cyclo-oxygenase-2 antagonists and esomeprazol were used in the assessment. As 
      indicators of new drug uptake, we used adoption time, cumulative incidence, 
      preference proportion, incidence rate and prescription cost and volume. For each 
      measure, we ranked the general practices. Ranks were pair-wise plotted, and 
      Pearson's correlation coefficient ( r) was calculated. Next, we analysed the 
      correlation between ranks across different drug classes. RESULTS: For all 
      indicators, the general practitioners' adoption of one group of drugs was poorly 
      associated with adoption of others ( r</=0.49), indicating that early adoption of 
      one type of drugs is not associated with early adoption of another. For all drug 
      groups, adoption time adjusted for practice size was only weakly associated with 
      other indicators ( r: -0.56 to -0.27). Indicators, based on cost and volume of 
      drugs, were highly correlated ( r: 0.96-0.99), and the others correlated 
      reasonably well ( r: 0.51-0.91). CONCLUSIONS: Within drug groups, indicators of 
      drug adoption, except for adoption time, correlate reasonably well. However, the 
      theory that physicians' early adoption of new drugs is a personal trait 
      independent of the type of drug could not be confirmed. The notion of the 
      early-drug-adopting general practitioner may be mistaken.
FAU - Dybdahl, Torben
AU  - Dybdahl T
AD  - Research Unit of General Practice, Institute of Public Health, University of 
      Southern Denmark, Winslowparken 19, 3rd, 5000, Odense C, Denmark. 
      tdybdahl@health.sdu.dk
FAU - Andersen, Morten
AU  - Andersen M
FAU - Sondergaard, Jens
AU  - Sondergaard J
FAU - Kragstrup, Jakob
AU  - Kragstrup J
FAU - Kristiansen, Ivar Sonbo
AU  - Kristiansen IS
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20041021
PL  - Germany
TA  - Eur J Clin Pharmacol
JT  - European journal of clinical pharmacology
JID - 1256165
SB  - IM
EIN - Eur J Clin Pharmacol. 2005 Mar;61(1):75
MH  - Cohort Studies
MH  - Databases, Factual/*statistics & numerical data
MH  - Decision Making
MH  - Denmark
MH  - *Drug Therapy
MH  - Drug Utilization/economics/statistics & numerical data
MH  - Family Practice/*statistics & numerical data
MH  - Humans
MH  - Physicians, Family/*statistics & numerical data
MH  - Practice Patterns, Physicians'/*statistics & numerical data
MH  - Time Factors
EDAT- 2004/10/27 09:00
MHDA- 2005/04/02 09:00
CRDT- 2004/10/27 09:00
PHST- 2004/02/27 00:00 [received]
PHST- 2004/06/08 00:00 [accepted]
PHST- 2004/10/27 09:00 [pubmed]
PHST- 2005/04/02 09:00 [medline]
PHST- 2004/10/27 09:00 [entrez]
AID - 10.1007/s00228-004-0797-1 [doi]
PST - ppublish
SO  - Eur J Clin Pharmacol. 2004 Nov;60(9):667-72. doi: 10.1007/s00228-004-0797-1. Epub 
      2004 Oct 21.

PMID- 21214884
OWN - NLM
STAT- MEDLINE
DCOM- 20110714
LR  - 20110407
IS  - 1651-2227 (Electronic)
IS  - 0803-5253 (Linking)
VI  - 100
IP  - 5
DP  - 2011 May
TI  - Can 'high-risk' human papillomaviruses (HPVs) be detected in human breast milk?
PG  - 705-7
LID - 10.1111/j.1651-2227.2010.02129.x [doi]
AB  - AIM: Human papillomavirus (HPV) transmission via nonsexual modes in childhood has 
      been proposed by several researchers. The aim of our study was to determine the 
      presence of 'high-risk' HPV DNA in human breast milk. METHODS: Using polymerase 
      chain reaction techniques, we evaluated the presence of HPV infection in human 
      breast milk collected from 21 HPV-positive and 11 HPV-negative mothers. RESULTS: 
      Of the 32 studied human milk specimens, no 'high-risk' HPV 16, 18, 31, 33, 35, 
      39, 45, 51, 52, 56, 58 or 58 DNA was detected. CONCLUSION: This preliminary 
      case-control study indicates the absence of mucosal 'high-risk' HPV types in 
      human breast milk.
CI  - (c) 2011 The Author(s)/Acta Paediatrica (c) 2011 Foundation Acta Paediatrica.
FAU - Mammas, Ioannis N
AU  - Mammas IN
AD  - Department of Paediatrics, 'Penteli' Children's Hospital, Athens, Greece. 
      mammasjo@googlemail.com
FAU - Zaravinos, Apostolos
AU  - Zaravinos A
FAU - Sourvinos, George
AU  - Sourvinos G
FAU - Myriokefalitakis, Nikolaos
AU  - Myriokefalitakis N
FAU - Theodoridou, Maria
AU  - Theodoridou M
FAU - Spandidos, Demetrios A
AU  - Spandidos DA
LA  - eng
PT  - Journal Article
DEP - 20110114
PL  - Norway
TA  - Acta Paediatr
JT  - Acta paediatrica (Oslo, Norway : 1992)
JID - 9205968
RN  - 0 (DNA, Viral)
SB  - IM
MH  - Adult
MH  - Alphapapillomavirus/*genetics
MH  - Case-Control Studies
MH  - DNA, Viral/*isolation & purification
MH  - Female
MH  - Humans
MH  - Infant
MH  - Infectious Disease Transmission, Vertical
MH  - Milk, Human/*virology
MH  - Papillomavirus Infections/transmission
MH  - Polymerase Chain Reaction
MH  - Risk Assessment
MH  - Young Adult
EDAT- 2011/01/11 06:00
MHDA- 2011/07/16 06:00
CRDT- 2011/01/11 06:00
PHST- 2011/01/11 06:00 [entrez]
PHST- 2011/01/11 06:00 [pubmed]
PHST- 2011/07/16 06:00 [medline]
AID - 10.1111/j.1651-2227.2010.02129.x [doi]
PST - ppublish
SO  - Acta Paediatr. 2011 May;100(5):705-7. doi: 10.1111/j.1651-2227.2010.02129.x. Epub 
      2011 Jan 14.

PMID- 24476003
OWN - NLM
STAT- MEDLINE
DCOM- 20150330
LR  - 20190116
IS  - 1521-0553 (Electronic)
IS  - 0894-1939 (Linking)
VI  - 27
IP  - 4
DP  - 2014 Aug
TI  - Is nasogastric decompression useful in prevention of leaks after laparoscopic 
      sleeve gastrectomy? A randomized trial.
PG  - 234-9
LID - 10.3109/08941939.2013.875606 [doi]
AB  - INTRODUCTION: Although its excellent results, laparoscopic sleeve gastrectomy 
      (LSG) presents major complications ranging from 0% to 29%. Among them, the staple 
      line leak presents an incidence varying from 0% to 7%. Many trials debated about 
      different solutions in order to reduce leaks' incidence. No author has 
      investigated the role of gastric decompression in the prevention of this 
      complication. Aim of our work is to evaluate if this procedure can play a role in 
      avoiding the occurrence of staple line leaks after LSG. MATERIALS AND METHODS: 
      Between January 2008 and November 2012, 145 patients were prospectively and 
      randomly included in the study. Seventy patients composed the group A, whose 
      operations were completed with placement of nasogastric tube; the other 75 
      patients were included in the group B, in which no nasogastric tube was placed. 
      RESULTS: No statistical differences were observed between group A and group B 
      regarding gender distribution, age, weight, and BMI. No intraoperative 
      complications and no conversion occurred in both groups. Intraoperative blood 
      loss (50.1 +/- 42.3 vs. 52.5 +/- 37.6 ml, respectively) and operative time (65.4 +/- 
      25.5 vs. 62.6 +/- 27.8 min, respectively) were comparable between the two groups 
      (p: NS). One staple line leak (1.4%) occurred on 6th postoperative day in group A 
      patients. No leak was observed in group B patients. Postoperative hospital stay 
      was significantly longer in group A vs. group B patients (7.6 +/- 3.4 vs. 6.2 +/- 3.1 
      days, respectively, p: 0.04). CONCLUSIONS: Routine placement of nasogastric tube 
      in patients operated of LSG seems not useful in reducing leaks' incidence.
FAU - Rossetti, Gianluca
AU  - Rossetti G
AD  - Digestive Surgery Unit, Second University of Naples , via Pansini 5, Naples , 
      Italy .
FAU - Fei, Landino
AU  - Fei L
FAU - Docimo, Ludovico
AU  - Docimo L
FAU - Del Genio, Gianmattia
AU  - Del Genio G
FAU - Micanti, Fausta
AU  - Micanti F
FAU - Belfiore, Annamaria
AU  - Belfiore A
FAU - Brusciano, Luigi
AU  - Brusciano L
FAU - Moccia, Francesco
AU  - Moccia F
FAU - Cimmino, Marco
AU  - Cimmino M
FAU - Marra, Teresa
AU  - Marra T
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20140129
PL  - United States
TA  - J Invest Surg
JT  - Journal of investigative surgery : the official journal of the Academy of 
      Surgical Research
JID - 8809255
SB  - IM
MH  - Adult
MH  - *Bariatric Surgery
MH  - Female
MH  - *Gastrectomy
MH  - Humans
MH  - *Intubation, Gastrointestinal
MH  - Male
MH  - Middle Aged
MH  - Obesity, Morbid/surgery
MH  - Postoperative Complications/*prevention & control
MH  - Prospective Studies
MH  - Young Adult
OTO - NOTNLM
OT  - Bariatric surgery
OT  - laparoscopy
OT  - nasogastric tube
OT  - sleeve gastrectomy
OT  - staple line leak
EDAT- 2014/01/31 06:00
MHDA- 2015/03/31 06:00
CRDT- 2014/01/31 06:00
PHST- 2014/01/31 06:00 [entrez]
PHST- 2014/01/31 06:00 [pubmed]
PHST- 2015/03/31 06:00 [medline]
AID - 10.3109/08941939.2013.875606 [doi]
PST - ppublish
SO  - J Invest Surg. 2014 Aug;27(4):234-9. doi: 10.3109/08941939.2013.875606. Epub 2014 
      Jan 29.

PMID- 22758782
OWN - NLM
STAT- MEDLINE
DCOM- 20121212
LR  - 20211021
IS  - 1526-4637 (Electronic)
IS  - 1526-2375 (Print)
IS  - 1526-2375 (Linking)
VI  - 13
IP  - 7
DP  - 2012 Jul
TI  - Regional anesthesia as compared with general anesthesia for surgery in geriatric 
      patients with hip fracture: does it decrease morbidity, mortality, and health 
      care costs? Results of a single-centered study.
PG  - 948-56
LID - 10.1111/j.1526-4637.2012.01402.x [doi]
AB  - INTRODUCTION: Hip fracture in geriatric patients has a substantial economic 
      impact and represents a major cause of morbidity and mortality in this 
      population. At our institution, a regional anesthesia program was instituted for 
      patients undergoing surgery for hip fracture. This retrospective cohort review 
      examines the effects of regional anesthesia (from mainly after July 2007) vs 
      general anesthesia (mainly prior to July 2007) on morbidity, mortality and 
      hospitalization costs. METHODS: This retrospective cohort study involved data 
      collection from electronic and paper charts of 308 patients who underwent surgery 
      for hip fracture from September 2006 to December 2008. Data on postoperative 
      morbidity, in-patient mortality, and cost of hospitalization (as estimated from 
      data on hospital charges) were collected and analyzed. Seventy-three patients 
      received regional anesthesia and 235 patients received general anesthesia. During 
      July 2007, approximately halfway through the study period, a regional anesthesia 
      and analgesia program was introduced. RESULTS: The average cost of 
      hospitalization in patients who received surgery for hip fracture was no 
      different between patients who receive regional or general anesthesia ($16,789 + 
      631 vs $16,815 + 643, respectively, P = 0.9557). Delay in surgery and intensive 
      care unit (ICU) admission resulted in significantly higher hospitalization costs. 
      Age, male gender, African American race and ICU admission were associated with 
      increased in-hospital mortality. In-hospital mortality and rates of readmission 
      are not statistically different between the two anesthesia groups. CONCLUSIONS: 
      There is no difference in postoperative morbidity, rates of rehospitalization, 
      in-patient mortality or hospitalization costs in geriatric patients undergoing 
      regional or general anesthesia for repair of hip fracture. Delay in surgery 
      beyond 3 days and ICU admission both increase cost of hospitalization.
CI  - Wiley Periodicals, Inc.
FAU - Le-Wendling, Linda
AU  - Le-Wendling L
AD  - Department of Anesthesiology Anesthesiology, University of Florida College of 
      Medicine, Gainesville, FL, USA.
FAU - Bihorac, Azra
AU  - Bihorac A
FAU - Baslanti, Tezcan Ozrazgat
AU  - Baslanti TO
FAU - Lucas, Stephen
AU  - Lucas S
FAU - Sadasivan, Kalia
AU  - Sadasivan K
FAU - Wendling, Adam
AU  - Wendling A
FAU - Heyman, H James
AU  - Heyman HJ
FAU - Boezaart, Andre
AU  - Boezaart A
LA  - eng
GR  - K23 GM087709/GM/NIGMS NIH HHS/United States
GR  - K23GM087709/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20120703
PL  - England
TA  - Pain Med
JT  - Pain medicine (Malden, Mass.)
JID - 100894201
SB  - IM
MH  - Aged
MH  - Anesthesia, Conduction/*economics/statistics & numerical data
MH  - Anesthesia, General/*economics
MH  - Arthroplasty, Replacement, Hip/*economics/*mortality
MH  - Female
MH  - Florida/epidemiology
MH  - Health Care Costs/*statistics & numerical data
MH  - *Hip Fractures/economics/mortality/surgery
MH  - Humans
MH  - Male
MH  - Prevalence
MH  - Survival Analysis
MH  - Survival Rate
MH  - Treatment Outcome
PMC - PMC3730262
MID - NIHMS474053
EDAT- 2012/07/05 06:00
MHDA- 2012/12/13 06:00
PMCR- 2013/08/01
CRDT- 2012/07/05 06:00
PHST- 2012/07/05 06:00 [entrez]
PHST- 2012/07/05 06:00 [pubmed]
PHST- 2012/12/13 06:00 [medline]
PHST- 2013/08/01 00:00 [pmc-release]
AID - 10.1111/j.1526-4637.2012.01402.x [doi]
PST - ppublish
SO  - Pain Med. 2012 Jul;13(7):948-56. doi: 10.1111/j.1526-4637.2012.01402.x. Epub 2012 
      Jul 3.

PMID- 14627582
OWN - NLM
STAT- MEDLINE
DCOM- 20040120
LR  - 20191210
IS  - 0361-803X (Print)
IS  - 0361-803X (Linking)
VI  - 181
IP  - 6
DP  - 2003 Dec
TI  - Double reading of barium enemas: is it necessary?
PG  - 1607-10
AB  - OBJECTIVE: The purpose of our study was to determine the effectiveness, clinical 
      impact, and feasibility of double reading barium enemas. MATERIALS AND METHODS: 
      Independent double readings of 1,003 consecutive barium enemas (822 double- and 
      181 single-contrast examinations) were prospectively performed. From this pool of 
      1,003 examinations, 994 were included in our study. Examinations showing at least 
      one polyp or carcinoma 5 mm or larger were considered to have positive results. 
      For combined readings, results were considered positive if either of the two 
      interpreters reported finding a polyp or carcinoma. A McNemar test was used to 
      compare the first reader's results with the combined results of the first and 
      second readers. Results were retrospectively correlated with endoscopic or 
      surgical results in 360 patients, and agreement between first and combined 
      readings and endoscopic results was determined. RESULTS: Adding a second reader 
      increased the number of positive results on examinations from 249 to 315 (p < 
      0.0001) and resulted in potential alteration of clinical treatment in 98 patients 
      (9.9%). Sensitivity of the first and combined readings for detection of all 
      lesions was identical, 76.3% (95% CI, 65.4-87.1%). Specificity decreased from 
      91.0% (95% CI, 87.9-94.3%) for the first reading to 86.4% (95% CI, 82.2-90.0%) 
      for the combined reading. The overall measurement of agreement decreased from a 
      kappa value of 61.8 (95% CI, 51.2-72.4%) for the first reading to 52.9 (95% CI, 
      42.2-63.6%) for the combined reading. The second reading required an average of 
      3.3 min. Sensitivity for the detection of adenocarcinomas was 100%. CONCLUSION: 
      Although feasible, double reading of barium enemas does not improve sensitivity 
      for detection of polyps and produces a higher false-positive rate.
FAU - Canon, Cheri L
AU  - Canon CL
AD  - Department of Radiology, University of Alabama at Birmingham, Birmingham, AL 
      35249, USA. ccanon@uabmc.edu
FAU - Smith, J Kevin
AU  - Smith JK
FAU - Morgan, Desiree E
AU  - Morgan DE
FAU - Jones, Brian C
AU  - Jones BC
FAU - Fell, Sean C
AU  - Fell SC
FAU - Kenney, Philip J
AU  - Kenney PJ
FAU - Ferrante, Dino
AU  - Ferrante D
FAU - Lockhart, Mark E
AU  - Lockhart ME
FAU - Westfall, Andrew O
AU  - Westfall AO
FAU - Koehler, Robert E
AU  - Koehler RE
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
PL  - United States
TA  - AJR Am J Roentgenol
JT  - AJR. American journal of roentgenology
JID - 7708173
RN  - 0 (Contrast Media)
RN  - 25BB7EKE2E (Barium Sulfate)
SB  - IM
MH  - Adult
MH  - *Barium Sulfate
MH  - Colonic Polyps/*diagnostic imaging
MH  - Colorectal Neoplasms/*diagnostic imaging
MH  - *Contrast Media
MH  - Enema/*methods
MH  - False Positive Reactions
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Observer Variation
MH  - Prospective Studies
MH  - Radiography
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
EDAT- 2003/11/25 05:00
MHDA- 2004/01/21 05:00
CRDT- 2003/11/25 05:00
PHST- 2003/11/25 05:00 [pubmed]
PHST- 2004/01/21 05:00 [medline]
PHST- 2003/11/25 05:00 [entrez]
AID - 10.2214/ajr.181.6.1811607 [doi]
PST - ppublish
SO  - AJR Am J Roentgenol. 2003 Dec;181(6):1607-10. doi: 10.2214/ajr.181.6.1811607.

PMID- 24666444
OWN - NLM
STAT- MEDLINE
DCOM- 20140520
LR  - 20220321
IS  - 1488-2310 (Electronic)
IS  - 0008-428X (Print)
IS  - 0008-428X (Linking)
VI  - 57
IP  - 2
DP  - 2014 Apr
TI  - Is there any evidence of a "July effect" in patients undergoing major cancer 
      surgery?
PG  - 82-8
AB  - BACKGROUND: The "July effect" refers to the phenomenon of adverse impacts on 
      patient care arising from the changeover in medical staff that takes place during 
      this month at academic medical centres in North America. There has been some 
      evidence supporting the presence of the July effect, including data from surgical 
      specialties. Uniformity of care, regardless of time of year, is required for 
      patients undergoing major cancer surgery. We therefore sought to perform a 
      population-level assessment for the presence of a July effect in this field. 
      METHODS: We used the Nationwide Inpatient Sample to abstract data on patients 
      undergoing 1 of 8 major cancer surgeries at academic medical centres between Jan. 
      1, 1999, and Dec. 30, 2009. The primary outcomes examined were postoperative 
      complications and in-hospital mortality. Univariate analyses and subsequently 
      multivariate analyses, controlling for patient and hospital characteristics, were 
      performed to identify whether the time of surgery was an independent predictor of 
      outcome after major cancer surgery. RESULTS: On univariate analysis, the overall 
      postoperative complication rate, as well as genitourinary and hematologic 
      complications specifically, was higher in July than the rest of the year. 
      However, on multivariate analysis, only hematologic complications were 
      significantly higher in July, with no difference in overall postoperative 
      complication rate or in-hospital mortality for all 8 surgeries considered 
      separately or together. CONCLUSION: On the whole, the data confirm an absence of 
      a July effect in patients undergoing major cancer surgery.
FAU - Ravi, Praful
AU  - Ravi P
AD  - The Center for Outcomes Research and Analytics, Vattikuti Urology Institute, 
      Detroit, Mich.
FAU - Trinh, Vincent Q
AU  - Trinh VQ
AD  - The Cancer Prognostics and Health Outcomes Unit, University of Montreal Health 
      Center, University of Montreal, Montreal, Que.
FAU - Sun, Maxine
AU  - Sun M
AD  - The Cancer Prognostics and Health Outcomes Unit, University of Montreal Health 
      Center, University of Montreal, Montreal, Que.
FAU - Sammon, Jesse
AU  - Sammon J
AD  - The Center for Outcomes Research and Analytics, Vattikuti Urology Institute, 
      Detroit, Mich.
FAU - Sukumar, Shyam
AU  - Sukumar S
AD  - The Center for Outcomes Research and Analytics, Vattikuti Urology Institute, 
      Detroit, Mich.
FAU - Gervais, Mai-Kim
AU  - Gervais MK
AD  - The Department of Surgery, Division of General Surgery, University of Montreal, 
      Montreal, Que.
FAU - Shariat, Shahrokh F
AU  - Shariat SF
AD  - The Department of Urology, Weill Medical College of Cornell University, New York, 
      NY.
FAU - Kim, Simon P
AU  - Kim SP
AD  - The Department of Urology, Mayo Clinic, Rochester, Minn.
FAU - Kowalczyk, Keith J
AU  - Kowalczyk KJ
AD  - The Department of Urology, Georgetown University Hospital, Washington, DC.
FAU - Hu, Jim C
AU  - Hu JC
AD  - The Department of Urology, David Geffen School of Medicine, University of 
      California, Los Angeles, Calif.
FAU - Menon, Mani
AU  - Menon M
AD  - The Center for Outcomes Research and Analytics, Vattikuti Urology Institute, 
      Detroit, Mich.
FAU - Karakiewicz, Pierre I
AU  - Karakiewicz PI
AD  - The Cancer Prognostics and Health Outcomes Unit, University of Montreal Health 
      Center, University of Montreal, Montreal, Que.
FAU - Trinh, Quoc-Dien
AU  - Trinh QD
AD  - The Center for Outcomes Research and Analytics, Vattikuti Urology Institute, 
      Detroit, Mich. and the Cancer Prognostics and Health Outcomes Unit, University of 
      Montreal Health Center, University of Montreal, Montreal, Que.
LA  - eng
PT  - Journal Article
PL  - Canada
TA  - Can J Surg
JT  - Canadian journal of surgery. Journal canadien de chirurgie
JID - 0372715
SB  - IM
MH  - Adult
MH  - Aged
MH  - Female
MH  - *Hospital Mortality
MH  - Hospitalization/*statistics & numerical data
MH  - *Hospitals, Teaching
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Neoplasms/mortality/*surgery
MH  - North America
MH  - *Periodicity
MH  - Personnel Staffing and Scheduling
MH  - *Postoperative Complications
MH  - Retrospective Studies
MH  - Risk Factors
PMC - PMC3968195
EDAT- 2014/03/29 06:00
MHDA- 2014/05/21 06:00
PMCR- 2014/04/01
CRDT- 2014/03/27 06:00
PHST- 2014/03/27 06:00 [entrez]
PHST- 2014/03/29 06:00 [pubmed]
PHST- 2014/05/21 06:00 [medline]
PHST- 2014/04/01 00:00 [pmc-release]
AID - 10.1503/cjs.002713 [pii]
AID - 0570082 [pii]
AID - 10.1503/cjs.002713 [doi]
PST - ppublish
SO  - Can J Surg. 2014 Apr;57(2):82-8. doi: 10.1503/cjs.002713.

PMID- 18496363
OWN - NLM
STAT- MEDLINE
DCOM- 20080617
LR  - 20211020
IS  - 1530-0293 (Electronic)
IS  - 0090-3493 (Linking)
VI  - 36
IP  - 6
DP  - 2008 Jun
TI  - Characterization of the gender dimorphism after injury and hemorrhagic shock: are 
      hormonal differences responsible?
PG  - 1838-45
LID - 10.1097/CCM.0b013e3181760c14 [doi]
AB  - OBJECTIVE: To characterize the gender dimorphism after injury with specific 
      reference to the reproductive age of the women (young, <48 yrs of age, vs. old, 
      >52 yrs of age) in a cohort of severely injured trauma patients for which 
      significant variation in postinjury care is minimized. DESIGN: Secondary data 
      analysis of an ongoing prospective multicenter cohort study. SETTING: Academic, 
      level I trauma and intensive care unit centers. PATIENTS: Blunt-injured adults 
      with hemorrhagic shock. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: 
      Separate Cox proportional hazard regression models were formulated based on all 
      patients to evaluate the effects of gender on mortality, multiple organ failure, 
      and nosocomial infection, after controlling for all important confounders. These 
      models were then used to characterize the effect of gender in young and old age 
      groups. Overall mortality, multiple organ failure, and nosocomial infection rates 
      for the entire cohort (n = 1,036) were 20%, 40%, and 45%, respectively. Mean 
      Injury Severity Score was 32 +/- 14 (mean +/- SD). Men (n = 680) and women (n = 
      356) were clinically similar except that men required higher crystalloid volumes, 
      more often had a history of alcoholism and liver disease, and had greater 
      ventilatory and intensive care unit requirements. Female gender was independently 
      associated with a 43% and 23% lower risk of multiple organ failure and nosocomial 
      infection, respectively. Gender remained an independent risk factor in young and 
      old subgroup analysis, with the protection afforded by female gender remaining 
      unchanged. CONCLUSIONS: The independent protective effect of female gender on 
      multiple organ failure and nosocomial infection rates remains significant in both 
      premenopausal and postmenopausal women when compared with similarly aged men. 
      This is contrary to previous experimental studies and the known physiologic sex 
      hormone changes that occur after menopause in women. These results suggest that 
      factors other than sex hormones may be responsible for gender-based differences 
      after injury.
FAU - Sperry, Jason L
AU  - Sperry JL
AD  - Division of Trauma and General Surgery, University of Pittsburgh Medical Center, 
      Pittsburgh, PA, USA. sperryjl@upmc.edu
FAU - Nathens, Avery B
AU  - Nathens AB
FAU - Frankel, Heidi L
AU  - Frankel HL
FAU - Vanek, Sue L
AU  - Vanek SL
FAU - Moore, Ernest E
AU  - Moore EE
FAU - Maier, Ronald V
AU  - Maier RV
FAU - Minei, Joseph P
AU  - Minei JP
CN  - Inflammation and the Host Response to Injury Investigators
LA  - eng
GR  - P50 GM021700/GM/NIGMS NIH HHS/United States
GR  - U54 GM062119-1/GM/NIGMS NIH HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - Crit Care Med
JT  - Critical care medicine
JID - 0355501
RN  - 0 (Estrogens)
SB  - IM
CIN - Crit Care Med. 2008 Jun;36(6):1976. doi: 10.1097/CCM.0b013e318176ae01. PMID: 
      18520662
MH  - Abbreviated Injury Scale
MH  - Adult
MH  - Age Factors
MH  - Cause of Death
MH  - Cohort Studies
MH  - Cross Infection/mortality/physiopathology
MH  - Estrogens/*blood
MH  - Female
MH  - Glasgow Coma Scale
MH  - Hospital Mortality
MH  - Humans
MH  - Injury Severity Score
MH  - Male
MH  - Menopause/physiology
MH  - Middle Aged
MH  - Multiple Organ Failure/mortality/physiopathology
MH  - Multiple Trauma/*mortality/physiopathology
MH  - Proportional Hazards Models
MH  - Prospective Studies
MH  - Regression Analysis
MH  - Sex Factors
MH  - Shock, Hemorrhagic/*mortality/physiopathology
MH  - Survival Analysis
MH  - Wounds, Nonpenetrating/*mortality/physiopathology
EDAT- 2008/05/23 09:00
MHDA- 2008/06/18 09:00
CRDT- 2008/05/23 09:00
PHST- 2008/05/23 09:00 [pubmed]
PHST- 2008/06/18 09:00 [medline]
PHST- 2008/05/23 09:00 [entrez]
AID - 10.1097/CCM.0b013e3181760c14 [doi]
PST - ppublish
SO  - Crit Care Med. 2008 Jun;36(6):1838-45. doi: 10.1097/CCM.0b013e3181760c14.

PMID- 12040336
OWN - NLM
STAT- MEDLINE
DCOM- 20020610
LR  - 20241219
IS  - 1097-6744 (Electronic)
IS  - 0002-8703 (Linking)
VI  - 143
IP  - 5
DP  - 2002 May
TI  - Cardiogenic shock complicating acute myocardial infarction in elderly patients: 
      does admission to a tertiary center improve survival?
PG  - 768-76
AB  - BACKGROUND: The role of early revascularization among patients with acute 
      myocardial infarction complicated by cardiogenic shock remains controversial. 
      Angioplasty registries, while suggesting a benefit, are subject to selection 
      bias, and clinical trials have been underpowered to detect early benefits. If an 
      invasive strategy is beneficial in this population, patients admitted to 
      hospitals with onsite coronary revascularization might be expected to have a 
      better prognosis. We sought to determine whether access to cardiovascular 
      resources at the admitting hospital influenced the prognosis of patients with 
      acute myocardial infarction complicated by cardiogenic shock. METHODS: By use of 
      the Cooperative Cardiovascular Project database (a retrospective medical record 
      review of Medicare patients discharged with acute myocardial infarction), we 
      identified patients aged > or =65 years whose myocardial infarction was 
      complicated by cardiogenic shock. RESULTS: Of the 601 patients with cardiogenic 
      shock, 287 (47.8%) were admitted to hospitals without revascularization services 
      and 314 (52.2%) were admitted to hospitals with coronary angioplasty and coronary 
      artery bypass surgery facilities. Clinical characteristics were similar across 
      the subgroups. Patients admitted to hospitals with revascularization services 
      were more likely to undergo coronary revascularization during the index 
      hospitalization and during the first month after acute myocardial infarction. 
      After adjustment for demographic, clinical, hospital, and treatment strategies, 
      the presence of onsite revascularization services was not associated with a 
      significantly lower 30-day (odds ratio 0.83, 95% CI 0.47, 1.45) or 1-year 
      mortality (odds ratio 0.91, 95% CI 0.49, 1.72). CONCLUSIONS: In a community-based 
      cohort, patients with acute myocardial infarction complicated by cardiogenic 
      shock did not have significantly different adjusted 30-day and 1-year mortality, 
      irrespective of the revascularization capabilities of the admitting hospital.
FAU - Berger, Alan K
AU  - Berger AK
AD  - Section of Cardiovascular Medicine, Department of Medicine, Yale University 
      School of Medicine, and Yale-New Haven Hospital Center for Outcomes Research and 
      Evaluation, New Haven, CT 06520-8025, USA.
FAU - Radford, Martha J
AU  - Radford MJ
FAU - Krumholz, Harlan M
AU  - Krumholz HM
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - Am Heart J
JT  - American heart journal
JID - 0370465
SB  - IM
MH  - Aged
MH  - Angioplasty, Balloon, Coronary/statistics & numerical data
MH  - Cohort Studies
MH  - Coronary Artery Bypass/statistics & numerical data
MH  - *Coronary Care Units
MH  - Databases, Factual
MH  - Female
MH  - *Hospitalization
MH  - Humans
MH  - Male
MH  - Myocardial Infarction/*complications/mortality/therapy
MH  - Myocardial Revascularization/mortality/*statistics & numerical data
MH  - Odds Ratio
MH  - Prognosis
MH  - Shock, Cardiogenic/*complications/mortality/therapy
EDAT- 2002/06/01 10:00
MHDA- 2002/06/11 10:01
CRDT- 2002/06/01 10:00
PHST- 2002/06/01 10:00 [pubmed]
PHST- 2002/06/11 10:01 [medline]
PHST- 2002/06/01 10:00 [entrez]
AID - S0002870302597143 [pii]
AID - 10.1067/mhj.2002.122289 [doi]
PST - ppublish
SO  - Am Heart J. 2002 May;143(5):768-76. doi: 10.1067/mhj.2002.122289.

PMID- 14631523
OWN - NLM
STAT- MEDLINE
DCOM- 20040209
LR  - 20220309
IS  - 0256-7040 (Print)
IS  - 0256-7040 (Linking)
VI  - 19
IP  - 10-11
DP  - 2003 Nov
TI  - Sub-classification of low-grade cerebellar astrocytoma: is it clinically 
      meaningful?
PG  - 729-35
AB  - OBJECTIVES: The objectives were to identify prognostic factors for the survival 
      of children with cerebellar astrocytoma, and to evaluate the reproducibility and 
      prognostic value of histological sub-classification and grading. METHODS: 
      Children aged 0-14 years treated in Denmark for a cerebellar astrocytoma in the 
      period 1960-1984 were included and followed until January 2001 or until their 
      death. The histological specimens from each patient were reviewed for revised 
      grading and classification according to three different classification schemes: 
      the WHO, the Kernohan and the Daumas-Duport grading systems. RESULTS: The overall 
      survival rate was 81% after a follow-up time of 15-40 years. The significant 
      positive prognostic factors for survival were "surgically gross-total removal" of 
      the tumour at surgery and location of the tumour in the cerebellum proper as 
      opposed to location in the fourth ventricle. No difference in survival time was 
      demonstrated when we compared pilocytic astrocytoma and fibrillary astrocytoma. 
      Moreover, we found that the Kernohan and the WHO classification systems had no 
      predictive value and that the Daumas-Duport system is unsuitable as a prognostic 
      tool for low-grade posterior fossa astrocytomas. CONCLUSION: Discordant 
      observations due to interobserver variability make histological 
      sub-classification of low-grade cerebellar astrocytomas in children insufficient 
      for predicting prognosis and biological behaviour. Similar survival rates in a 
      population of paediatric low-grade cerebellar astrocytomas of grades I and II 
      indicate that tumour grade has no prognostic significance within this group of 
      patients. "Surgically gross-total removal", especially if the tumour is located 
      in the fourth ventricle is of the highest importance for long-term survival. 
      Histological sub-classification of the tumours has no predictive value.
FAU - Bernhardtsen, Tine
AU  - Bernhardtsen T
AD  - University Clinic of Neurosurgery, Rigshospitalet, H:S, 2100 Copenhagen, Denmark. 
      tineb@dadlnet.dk
FAU - Laursen, Henning
AU  - Laursen H
FAU - Bojsen-Moller, Marie
AU  - Bojsen-Moller M
FAU - Gjerris, Flemming
AU  - Gjerris F
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20030930
PL  - Germany
TA  - Childs Nerv Syst
JT  - Child's nervous system : ChNS : official journal of the International Society for 
      Pediatric Neurosurgery
JID - 8503227
RN  - 0 (alpha-Crystallin B Chain)
SB  - IM
MH  - Adolescent
MH  - Astrocytoma/*classification/metabolism/*mortality
MH  - Cerebellar Neoplasms/*classification/metabolism/*mortality
MH  - Child
MH  - Child, Preschool
MH  - Female
MH  - Follow-Up Studies
MH  - Histological Techniques/methods
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Male
MH  - Neurologic Examination
MH  - Predictive Value of Tests
MH  - Prognosis
MH  - Retrospective Studies
MH  - Survival Rate
MH  - Time Factors
MH  - World Health Organization
MH  - alpha-Crystallin B Chain/metabolism
EDAT- 2003/11/25 05:00
MHDA- 2004/02/11 05:00
CRDT- 2003/11/25 05:00
PHST- 2003/06/19 00:00 [received]
PHST- 2003/11/25 05:00 [pubmed]
PHST- 2004/02/11 05:00 [medline]
PHST- 2003/11/25 05:00 [entrez]
AID - 10.1007/s00381-003-0825-y [doi]
PST - ppublish
SO  - Childs Nerv Syst. 2003 Nov;19(10-11):729-35. doi: 10.1007/s00381-003-0825-y. Epub 
      2003 Sep 30.

PMID- 21823940
OWN - NLM
STAT- MEDLINE
DCOM- 20111201
LR  - 20181201
IS  - 1538-957X (Electronic)
IS  - 1538-9588 (Linking)
VI  - 12
IP  - 4
DP  - 2011 Aug
TI  - Department of Transportation vs self-reported data on motor vehicle collisions 
      and driving convictions for stroke survivors: do they agree?
PG  - 327-32
LID - 10.1080/15389588.2011.581716 [doi]
AB  - OBJECTIVE: Research on stroke survivors' driving safety has typically used either 
      self-reports or government records, but the extent to which the 2 may differ is 
      not known. We compared government records and self-reports of motor vehicle 
      collisions and driving convictions in a sample of stroke survivors. METHODS: The 
      56 participants were originally recruited for a prospective study on driving and 
      community re-integration post-stroke; the study population consisted of 
      moderately impaired stroke survivors without severe communication disorders who 
      had been referred for a driving assessment. The driving records of the 56 
      participants for the 5 years before study entry and the 1-year study period were 
      acquired with written consent from the Ministry of Transportation of Ontario 
      (MTO), Canada. Self-reports of collisions and convictions were acquired via a 
      semistructured interview and then compared with the MTO records. RESULTS: 
      Forty-three participants completed the study. For 7 (13.5%) the MTO records did 
      not match the self-reports regarding collision involvement, and for 9 (17.3%) the 
      MTO records did not match self-reports regarding driving convictions. The kappa 
      coefficient for the correlation between MTO records and self-reports was 0.52 for 
      collisions and 0.47 for convictions (both in the moderate range of agreement). 
      When both sources of data were consulted, up to 56 percent more accidents and up 
      to 46 percent more convictions were identified in the study population in the 5 
      years before study entry compared to when either source was used alone. 
      CONCLUSION: In our population of stroke survivors, self-reports of motor vehicle 
      collisions and driving convictions differed from government records. In future 
      studies, the use of both government and self-reported data would ensure a more 
      accurate picture of driving safety post-stroke.
FAU - Finestone, Hillel M
AU  - Finestone HM
AD  - Elisabeth Bruyere Hospital, Bruyere Continuing Care, Ottawa, Ontario, Canada. 
      hfinestone@bruyere.org
FAU - Guo, Meiqi
AU  - Guo M
FAU - O'Hara, Paddi
AU  - O'Hara P
FAU - Greene-Finestone, Linda
AU  - Greene-Finestone L
FAU - Marshall, Shawn C
AU  - Marshall SC
FAU - Hunt, Lynn
AU  - Hunt L
FAU - Jessup, Anita
AU  - Jessup A
FAU - Biggs, Jennifer
AU  - Biggs J
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - Traffic Inj Prev
JT  - Traffic injury prevention
JID - 101144385
SB  - IM
MH  - Accidents, Traffic/*statistics & numerical data
MH  - Aged
MH  - Automobile Driving/legislation & jurisprudence/psychology/*statistics & numerical 
      data
MH  - Female
MH  - *Government Agencies
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Ontario
MH  - Prospective Studies
MH  - *Records
MH  - Reproducibility of Results
MH  - Safety
MH  - *Self Report
MH  - Stroke/*epidemiology/psychology
MH  - Survivors/psychology/*statistics & numerical data
EDAT- 2011/08/10 06:00
MHDA- 2011/12/13 00:00
CRDT- 2011/08/10 06:00
PHST- 2011/08/10 06:00 [entrez]
PHST- 2011/08/10 06:00 [pubmed]
PHST- 2011/12/13 00:00 [medline]
AID - 10.1080/15389588.2011.581716 [doi]
PST - ppublish
SO  - Traffic Inj Prev. 2011 Aug;12(4):327-32. doi: 10.1080/15389588.2011.581716.

PMID- 17971187
OWN - NLM
STAT- MEDLINE
DCOM- 20080221
LR  - 20151119
IS  - 0803-5253 (Print)
IS  - 0803-5253 (Linking)
VI  - 96
IP  - 12
DP  - 2007 Dec
TI  - Cholesterol screening in school children: is family history reliable to choose 
      the ones to screen?
PG  - 1794-8
AB  - AIM: Hyperlipidemia is a major factor accompanying atherosclerosis. As the basis 
      of atherosclerotic heart disease begins at early childhood, we aim to find out 
      which children should be tested for hypercholesterolemia, what the high 
      cholesterol level in children is and what cautions should be taken to avoid 
      atherosclerosis. METHODS: The study was carried on 2096 school children (1043 
      male, 1053 female) in Ankara. Their mean age was 9.03 years. Demographic 
      properties of the study group and their families were determined and the serum 
      lipid levels of the subjects were obtained. The relation between these 
      demographic properties and lipid levels were investigated. RESULTS: In 135 of the 
      subjects' serum cholesterol level was >or=200 mg/dL and in 83 subjects serum 
      LDL-cholesterol level was >or=130 mg/dL. Despite 64.4% of the subjects reported a 
      family history of hyperlipidemia, no relations between family history and serum 
      lipid levels were found. CONCLUSION: We suggest that regardless of family 
      history, all children over 5 years should be screened for hyperlipidemia. 
      Education about hyperlipidemia and precautions for its complications should be 
      given to both children and families. The best and easiest way to reach children 
      is to screen them at schools. School is also a good place for education of 
      children about hyperlipidemia and risk factors.
FAU - Derinoz, Oksan
AU  - Derinoz O
AD  - Pediatrics Department, Gazi University Hospital, Ankara, Turkey. 
      oderinoz@gazi.edu.tr
FAU - Tumer, Leyla
AU  - Tumer L
FAU - Hasanoglu, Alev
AU  - Hasanoglu A
FAU - Pasaoglu, Hatice
AU  - Pasaoglu H
FAU - Aksakal, F Nur
AU  - Aksakal FN
FAU - Ceyhan, Mustafa Nuri
AU  - Ceyhan MN
LA  - eng
PT  - Journal Article
DEP - 20071030
PL  - Norway
TA  - Acta Paediatr
JT  - Acta paediatrica (Oslo, Norway : 1992)
JID - 9205968
RN  - 0 (Lipoproteins)
SB  - IM
MH  - Adolescent
MH  - Atherosclerosis/prevention & control
MH  - Body Mass Index
MH  - Child
MH  - Child, Preschool
MH  - Family
MH  - Female
MH  - Humans
MH  - Hyperlipidemias/*diagnosis/epidemiology
MH  - Lipoproteins/*blood
MH  - Male
MH  - Mass Screening/*methods
MH  - Medical History Taking
MH  - Risk Factors
MH  - Socioeconomic Factors
MH  - Surveys and Questionnaires
MH  - Turkey/epidemiology
EDAT- 2007/11/01 09:00
MHDA- 2008/02/22 09:00
CRDT- 2007/11/01 09:00
PHST- 2007/11/01 09:00 [pubmed]
PHST- 2008/02/22 09:00 [medline]
PHST- 2007/11/01 09:00 [entrez]
AID - APA554 [pii]
AID - 10.1111/j.1651-2227.2007.00554.x [doi]
PST - ppublish
SO  - Acta Paediatr. 2007 Dec;96(12):1794-8. doi: 10.1111/j.1651-2227.2007.00554.x. 
      Epub 2007 Oct 30.

PMID- 27642458
OWN - NLM
STAT- MEDLINE
DCOM- 20170322
LR  - 20220129
IS  - 1937-8688 (Electronic)
VI  - 24
DP  - 2016
TI  - Did the call for boycott by the Catholic bishops affect the polio vaccination 
      coverage in Kenya in 2015? A cross-sectional study.
PG  - 120
LID - 10.11604/pamj.2016.24.120.8986 [doi]
LID - 120
AB  - INTRODUCTION: Polio eradication is now feasible after removal of Nigeria from the 
      list of endemic countries and global reduction of cases of wild polio virus in 
      2015 by more than 80%. However, all countries must remain focused to achieve 
      eradication. In August 2015, the Catholic bishops in Kenya called for boycott of 
      a polio vaccination campaign citing safety concerns with the polio vaccine. We 
      conducted a survey to establish if the coverage was affected by the boycott. 
      METHODS: A cross sectional survey was conducted in all the 32 counties that 
      participated in the campaign. A total of 90,157 children and 37,732 
      parents/guardians were sampled to determine the vaccination coverage and reasons 
      for missed vaccination. RESULTS: The national vaccination coverage was 93% 
      compared to 94% in the November 2014 campaign. The proportion of 
      parents/guardians that belonged to Catholic Church was 31% compared to 7% of the 
      children who were missed. Reasons for missed vaccination included house not being 
      visited (44%), children not being at home at time of visit (38%), refusal by 
      parents (12%), children being as leep (1%), and various other reasons (5%). 
      Compared to the November 2014 campaign, the proportion of children who were not 
      vaccinated due to parent's refusal significantly increased from 6% to 12% in 
      August 2015. CONCLUSION: The call for boycott did not affect the campaign 
      significantly. However, if the call for boycott is repeated in future it could 
      have some significant negative implication to polio eradication. It is therefore 
      important to ensure that any vaccine safety issues are addressed accordingly.
FAU - Njeru, Ian
AU  - Njeru I
AD  - Ministry of Health, Nairobi, Kenya.
FAU - Ajack, Yusuf
AU  - Ajack Y
AD  - Ministry of Health, Nairobi, Kenya.
FAU - Muitherero, Charles
AU  - Muitherero C
AD  - World Health Organization, Nairobi, Kenya.
FAU - Onyango, Dickens
AU  - Onyango D
AD  - Ministry of Health, Nairobi, Kenya.
FAU - Musyoka, Johnny
AU  - Musyoka J
AD  - Ministry of Health, Nairobi, Kenya.
FAU - Onuekusi, Iheoma
AU  - Onuekusi I
AD  - World Health Organization, Nairobi, Kenya.
FAU - Kioko, Jackson
AU  - Kioko J
AD  - Ministry of Health, Nairobi, Kenya.
FAU - Muraguri, Nicholas
AU  - Muraguri N
AD  - Ministry of Health, Nairobi, Kenya.
FAU - Davis, Robert
AU  - Davis R
AD  - American Red Cross, Nairobi, Kenya.
LA  - eng
GR  - 001/WHO_/World Health Organization/International
PT  - Journal Article
DEP - 20160607
PL  - Uganda
TA  - Pan Afr Med J
JT  - The Pan African medical journal
JID - 101517926
RN  - 0 (Poliovirus Vaccines)
SB  - IM
MH  - Catholicism
MH  - Child
MH  - Cross-Sectional Studies
MH  - Humans
MH  - *Immunization Programs
MH  - Kenya/epidemiology
MH  - Poliomyelitis/epidemiology/*prevention & control
MH  - Poliovirus Vaccines/*administration & dosage/adverse effects
MH  - *Religion and Medicine
MH  - Treatment Refusal/statistics & numerical data
PMC - PMC5012825
OTO - NOTNLM
OT  - Catholic bishops
OT  - Polio vaccine
OT  - boycott
OT  - vaccination
OT  - vaccine safety
EDAT- 2016/09/20 06:00
MHDA- 2017/03/23 06:00
PMCR- 2016/06/07
CRDT- 2016/09/20 06:00
PHST- 2016/01/30 00:00 [received]
PHST- 2016/04/07 00:00 [accepted]
PHST- 2016/09/20 06:00 [entrez]
PHST- 2016/09/20 06:00 [pubmed]
PHST- 2017/03/23 06:00 [medline]
PHST- 2016/06/07 00:00 [pmc-release]
AID - PAMJ-24-120 [pii]
AID - 10.11604/pamj.2016.24.120.8986 [doi]
PST - epublish
SO  - Pan Afr Med J. 2016 Jun 7;24:120. doi: 10.11604/pamj.2016.24.120.8986. 
      eCollection 2016.

PMID- 12970636
OWN - NLM
STAT- MEDLINE
DCOM- 20031007
LR  - 20181130
IS  - 0022-3476 (Print)
IS  - 0022-3476 (Linking)
VI  - 143
IP  - 2
DP  - 2003 Aug
TI  - Does early discharge with nurse home visits affect adequacy of newborn metabolic 
      screening?
PG  - 213-8
AB  - OBJECTIVE: To examine the impact of early discharge on newborn metabolic 
      screening. STUDY DESIGN: Metabolic screening results were obtained from the 
      Alabama State Lab for all infants born at our hospital between 8/1/97, and 
      1/31/99, and were matched with an existing database of early discharge infants. 
      An early newborn discharge was defined as a discharge between 24 and 47 hours of 
      age. Metabolic screening tests included phenylketonuria (PKU), hypothyroidism, 
      and congenital adrenal hyperplasia (CAH). Early discharge and traditional stay 
      infants were compared to determine the percentage of newborns screened and the 
      timing of the first adequate specimen. RESULTS: The state laboratory received 
      specimens from 3860 infants; 1324 were on early discharge newborns and 2536 
      infants in the traditional stay group. At least one filter paper test (PKU, 
      hypothyroidism, and CAH) was collected on 99.2% of early discharge infants and 
      96.0% of traditional stay infants (P<.0001). Early discharge infants had a higher 
      rate of initial filter paper specimens being inadequate (22.9%) compared with 
      traditional stay infants (14.3%, P<.0001) but had a higher rate of repeat 
      specimens when the initial specimen was inadequate (85.0% early discharge vs 
      75.3% traditional stay, P=.002). The early discharge group was more likely to 
      have an adequate specimen within the first 9 days of life (1001, 98.8% early 
      discharge vs 2016, 96.7% traditional stay, P=.0005). CONCLUSIONS: In this well 
      established early discharge program with nurse home visits, newborn metabolic 
      screening is not compromised by early discharge.
FAU - Wall, Terry C
AU  - Wall TC
AD  - Department of Pediatrics, Division of General Pediatrics, University of Alabama 
      at Birmingham, 1616 6th Avenue South, Suite 201, Birmingham, AL 35233, USA. 
      twall@peds.uab.edu
FAU - Brumfield, Cynthia G
AU  - Brumfield CG
FAU - Cliver, Suzanne P
AU  - Cliver SP
FAU - Hou, Jinrong
AU  - Hou J
FAU - Ashworth, Carolyn S
AU  - Ashworth CS
FAU - Norris, M Jean
AU  - Norris MJ
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - United States
TA  - J Pediatr
JT  - The Journal of pediatrics
JID - 0375410
SB  - IM
MH  - Alabama
MH  - Female
MH  - Humans
MH  - Infant, Newborn
MH  - Male
MH  - Medical Indigency
MH  - Metabolic Diseases/*diagnosis
MH  - Metabolism, Inborn Errors/diagnosis
MH  - Neonatal Screening/*statistics & numerical data
MH  - Nursing Homes/statistics & numerical data
MH  - *Patient Discharge
MH  - Prospective Studies
EDAT- 2003/09/13 05:00
MHDA- 2003/10/08 05:00
CRDT- 2003/09/13 05:00
PHST- 2003/09/13 05:00 [pubmed]
PHST- 2003/10/08 05:00 [medline]
PHST- 2003/09/13 05:00 [entrez]
AID - S0022-3476(03)00247-6 [pii]
AID - 10.1067/S0022-3476(03)00247-6 [doi]
PST - ppublish
SO  - J Pediatr. 2003 Aug;143(2):213-8. doi: 10.1067/S0022-3476(03)00247-6.

PMID- 11138995
OWN - NLM
STAT- MEDLINE
DCOM- 20010412
LR  - 20190831
IS  - 0033-3174 (Print)
IS  - 0033-3174 (Linking)
VI  - 62
IP  - 6
DP  - 2000 Nov-Dec
TI  - Is alexithymia a risk factor for unexplained physical symptoms in general medical 
      outpatients?
PG  - 768-78
AB  - OBJECTIVE: Alexithymia is presumed to play an important predisposing role in the 
      pathogenesis of medically unexplained physical symptoms. However, no research on 
      alexithymia has been done among general medical outpatients who present with 
      medically unexplained physical symptoms as their main problem and in which 
      anxiety and depression have been considered as possible confounding factors. This 
      study investigated whether patients with medically unexplained physical symptoms 
      are more alexithymic than those with explained symptoms and whether, in patients 
      with unexplained symptoms, alexithymia is associated with subjective health 
      experience and use of medical services. METHODS: We conducted a cross-sectional 
      study among patients attending an internal medicine outpatient clinic. All 
      patients were given a standardized interview and completed a number of 
      questionnaires. RESULTS: After complete physical examinations, 169 of 321 
      patients had unexplained physical symptoms according to two independent raters. 
      Patients with medically unexplained symptoms more often had a mental disorder, 
      but overall they were not more alexithymic. In patients with unexplained physical 
      symptoms, alexithymia was not associated with subjective health experience or use 
      of medical services. However, patients with both unexplained symptoms and a 
      mental disorder who also denied any possible connection between emotional 
      problems and their physical symptoms did have more alexithymic traits. 
      CONCLUSIONS: In the majority of patients with medically unexplained physical 
      symptoms, alexithymia does not play a role of clinical significance. Patients 
      with unexplained physical symptoms are heterogeneous with respect to psychiatric 
      syndrome pathology and probably also with respect to personality pathology.
FAU - Kooiman, C G
AU  - Kooiman CG
AD  - Department of Psychiatry, Leiden University Medical Center, The Netherlands. 
      cgkooiman@lumc.nl
FAU - Bolk, J H
AU  - Bolk JH
FAU - Brand, R
AU  - Brand R
FAU - Trijsburg, R W
AU  - Trijsburg RW
FAU - Rooijmans, H G
AU  - Rooijmans HG
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Psychosom Med
JT  - Psychosomatic medicine
JID - 0376505
SB  - IM
MH  - Adult
MH  - Affective Symptoms/*psychology
MH  - Ambulatory Care
MH  - Anxiety/psychology
MH  - Depression/psychology
MH  - Dissociative Disorders/psychology
MH  - Female
MH  - Humans
MH  - Internal Medicine
MH  - Male
MH  - Middle Aged
MH  - Netherlands
MH  - Patient Acceptance of Health Care/*psychology
MH  - Risk Factors
MH  - *Sick Role
MH  - Somatoform Disorders/*psychology
EDAT- 2001/01/04 11:00
MHDA- 2001/04/17 10:01
CRDT- 2001/01/04 11:00
PHST- 2001/01/04 11:00 [pubmed]
PHST- 2001/04/17 10:01 [medline]
PHST- 2001/01/04 11:00 [entrez]
AID - 10.1097/00006842-200011000-00005 [doi]
PST - ppublish
SO  - Psychosom Med. 2000 Nov-Dec;62(6):768-78. doi: 10.1097/00006842-200011000-00005.

PMID- 15388567
OWN - NLM
STAT- MEDLINE
DCOM- 20050316
LR  - 20081120
IS  - 1473-0480 (Electronic)
IS  - 0306-3674 (Print)
IS  - 0306-3674 (Linking)
VI  - 38
IP  - 5
DP  - 2004 Oct
TI  - Are sports medicine journals relevant and applicable to practitioners and 
      athletes?
PG  - E23
AB  - OBJECTIVE: To examine the evidence base of sports medicine research and assess 
      how relevant and applicable it is to everyday practice. METHODS: Original 
      research articles, short reports, and case reports published in four major sport 
      and exercise medicine journals were studied and classified according to the main 
      topic of study and type of subjects used. RESULTS: The most common topic was 
      sports science, and very few studies related to the treatment of injuries and 
      medical conditions. The majority of published articles used healthy subjects 
      sampled from the sedentary population, and few studies have been carried out on 
      injured participants. CONCLUSIONS: There is a dearth of studies addressing 
      diagnostic and treatment interventions in the sports medicine literature. The 
      evidence base for sports medicine must continue to increase in terms of volume 
      and quality.
FAU - Bleakley, C
AU  - Bleakley C
AD  - University of Ulster, Jordanstown, Northern Ireland, UK.
FAU - MacAuley, D
AU  - MacAuley D
FAU - McDonough, S
AU  - McDonough S
LA  - eng
PT  - Journal Article
PL  - England
TA  - Br J Sports Med
JT  - British journal of sports medicine
JID - 0432520
SB  - IM
MH  - Health Personnel
MH  - Humans
MH  - *Periodicals as Topic
MH  - Research
MH  - *Sports
MH  - *Sports Medicine
PMC - PMC1724949
EDAT- 2004/09/25 05:00
MHDA- 2005/03/17 09:00
PMCR- 2007/10/01
CRDT- 2004/09/25 05:00
PHST- 2004/09/25 05:00 [pubmed]
PHST- 2005/03/17 09:00 [medline]
PHST- 2004/09/25 05:00 [entrez]
PHST- 2007/10/01 00:00 [pmc-release]
AID - 38/5/e23 [pii]
AID - 10.1136/bjsm.2003.010553 [doi]
PST - ppublish
SO  - Br J Sports Med. 2004 Oct;38(5):E23. doi: 10.1136/bjsm.2003.010553.

PMID- 19142546
OWN - NLM
STAT- MEDLINE
DCOM- 20090825
LR  - 20220629
IS  - 1980-5322 (Electronic)
IS  - 1807-5932 (Print)
IS  - 1807-5932 (Linking)
VI  - 64
IP  - 1
DP  - 2009
TI  - Does quantitative left ventricular regional wall motion change after fibrous 
      tissue resection in endomyocardial fibrosis?
PG  - 17-22
AB  - OBJECTIVES: We compared left ventricular regional wall motion, the global left 
      ventricular ejection fraction, and the New York Heart Association functional 
      class pre- and postoperatively. INTRODUCTION: Endomyocardial fibrosis is 
      characterized by fibrous tissue deposition in the endomyocardium of the apex 
      and/or inflow tract of one or both ventricles. Although left ventricular global 
      systolic function is preserved, patients exhibit wall motion abnormalities in the 
      apical and inferoapical regions. Fibrous tissue resection in New York Heart 
      Association FC III and IV endomyocardial fibrosis patients has been shown to 
      decrease morbidity and mortality. METHODS: We prospectively studied 30 patients 
      (20 female, 30+/-10 years) before and 5+/-8 months after surgery. The left 
      ventricular ejection fraction was determined using the area-length method. 
      Regional left ventricular motion was measured by the centerline method. Five left 
      ventricular segments were analyzed pre- and postoperatively. Abnormality was 
      expressed in units of standard deviation from the mean motion in a normal 
      reference population. RESULTS: Left ventricular wall motion in the five regions 
      did not differ between pre- and postoperative measurements. Additionally, the 
      left ventricular ejection fraction did not change after surgery (0.45+/-0.13% x 
      0.43+/-0.12% pre- and postoperatively, respectively). The New York Heart 
      Association functional class improved to class I in 40% and class II in 43% of 
      patients postoperatively (p<0.05). CONCLUSIONS: Although endomyocardial fibrosis 
      patients have improved clinical symptoms after surgery, the global left 
      ventricular ejection fraction and regional wall motion in these patients do not 
      change. This finding suggests that other explanations, such as improvements in 
      diastolic function, may be operational.
FAU - Salemi, Vera Maria Cury
AU  - Salemi VM
AD  - Cardiomyopathy Unit, Heart Institute (InCor), Hospital das Clinicas, Faculdade de 
      Medicina, Universidade de Sao Paulo, SP, Brazil. verasalemi@uol.com.br
FAU - Fernandes, Fabio
AU  - Fernandes F
FAU - Sirvente, Raquel
AU  - Sirvente R
FAU - Nastari, Luciano
AU  - Nastari L
FAU - Rosa, Leonardo Vieira
AU  - Rosa LV
FAU - Ferreira, Cristiano A
AU  - Ferreira CA
FAU - Pena, Jose Luiz Barros
AU  - Pena JL
FAU - Picard, Michael H
AU  - Picard MH
FAU - Mady, Charles
AU  - Mady C
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - United States
TA  - Clinics (Sao Paulo)
JT  - Clinics (Sao Paulo, Brazil)
JID - 101244734
SB  - IM
MH  - Adult
MH  - Diastole/physiology
MH  - Endomyocardial Fibrosis/complications/*physiopathology/surgery
MH  - Female
MH  - Heart Ventricles/physiopathology
MH  - Humans
MH  - Male
MH  - Postoperative Complications/*physiopathology
MH  - Prospective Studies
MH  - Severity of Illness Index
MH  - Statistics, Nonparametric
MH  - Stroke Volume/physiology
MH  - Ventricular Dysfunction, Left/etiology/*physiopathology
PMC - PMC2671969
EDAT- 2009/01/15 09:00
MHDA- 2009/08/26 09:00
PMCR- 2009/01/01
CRDT- 2009/01/15 09:00
PHST- 2008/07/03 00:00 [received]
PHST- 2008/09/15 00:00 [accepted]
PHST- 2009/01/15 09:00 [entrez]
PHST- 2009/01/15 09:00 [pubmed]
PHST- 2009/08/26 09:00 [medline]
PHST- 2009/01/01 00:00 [pmc-release]
AID - S1807-5932(22)02700-4 [pii]
AID - cln64_1p0017 [pii]
AID - 10.1590/s1807-59322009000100004 [doi]
PST - ppublish
SO  - Clinics (Sao Paulo). 2009;64(1):17-22. doi: 10.1590/s1807-59322009000100004.

PMID- 8921484
OWN - NLM
STAT- MEDLINE
DCOM- 19970207
LR  - 20241205
IS  - 0300-5771 (Print)
IS  - 0300-5771 (Linking)
VI  - 25
IP  - 5
DP  - 1996 Oct
TI  - Does gestational age misclassification explain the difference in birthweights for 
      Australian aborigines and whites?
PG  - 980-8
AB  - BACKGROUND: After 34 weeks gestation, summary measures of location for 
      birthweight (e.g means and centiles) increase more slowly for Australian 
      Aborigines than for whites. A similar pattern has been observed for blacks in the 
      US. This study tests whether the reported pattern is due to differential 
      misclassification of gestational age. METHODS: Simulation was used to measure the 
      potential effect of differential misclassification of gestational age. Reported 
      gestational age data were obtained from Queensland Perinatal Data Collection 
      (QPDC). Estimates of the true distributions of gestational age were obtained by 
      assuming various (plausible) types of misclassification and applying these to the 
      reported distributions. Previous studies and data from the QPDC were used to help 
      specify the birthweight distributions used in the simulations. RESULTS: At full 
      term, the parameters of the birthweight distributions were robust to gestational 
      age misclassification. At preterm, the 10th centiles were robust to 
      misclassification. In contrast, the 90th centiles were sensitive to even minor 
      misclassification. Extreme types of misclassification were required to remove the 
      divergence in median birthweights for Aborigines and whites. CONCLUSIONS: 
      Gestational age misclassification is an unlikely explanation for the reported 
      divergence in average birth-weights for Aborigines and whites. The results might 
      help with the interpretation of other between-population comparisons.
FAU - Coory, M
AU  - Coory M
AD  - Centre for Clinical Epidemiology and Biostatistics, Faculty of Medicine and 
      Health Science, University of Newcastle, Royal Newcastle Hospital, Newcastle, New 
      South Wales, Australia.
LA  - eng
PT  - Journal Article
PL  - England
TA  - Int J Epidemiol
JT  - International journal of epidemiology
JID - 7802871
SB  - IM
MH  - Adult
MH  - Australia/epidemiology
MH  - *Birth Weight
MH  - Classification/*methods
MH  - Computer Simulation
MH  - Female
MH  - *Gestational Age
MH  - Humans
MH  - Male
MH  - Pregnancy
MH  - *White People
EDAT- 1996/10/01 00:00
MHDA- 1996/10/01 00:01
CRDT- 1996/10/01 00:00
PHST- 1996/10/01 00:00 [pubmed]
PHST- 1996/10/01 00:01 [medline]
PHST- 1996/10/01 00:00 [entrez]
AID - 10.1093/ije/25.5.980 [doi]
PST - ppublish
SO  - Int J Epidemiol. 1996 Oct;25(5):980-8. doi: 10.1093/ije/25.5.980.

PMID- 26209118
OWN - NLM
STAT- MEDLINE
DCOM- 20160912
LR  - 20181113
IS  - 1432-1998 (Electronic)
IS  - 0301-0449 (Linking)
VI  - 45
IP  - 13
DP  - 2015 Dec
TI  - Utility of unenhanced fat-suppressed T1-weighted MRI in children with sickle cell 
      disease -- can it differentiate bone infarcts from acute osteomyelitis?
PG  - 1981-7
LID - 10.1007/s00247-015-3423-8 [doi]
AB  - BACKGROUND: Children with sickle cell disease (SCD) are at risk of bone infarcts 
      and acute osteomyelitis. The clinical differentiation between a bone infarct and 
      acute osteomyelitis is a diagnostic challenge. Unenhanced T1-W fat-saturated MR 
      images have been proposed as a potential tool to differentiate bone infarcts from 
      osteomyelitis. OBJECTIVE: To evaluate the reliability of unenhanced T1-W 
      fat-saturated MRI for differentiation between bone infarcts and acute 
      osteomyelitis in children with SCD. MATERIALS AND METHODS: We retrospectively 
      reviewed the records of 31 children (20 boys, 11 girls; mean age 10.6 years, 
      range 1.1-17.9 years) with SCD and acute bone pain who underwent MR imaging 
      including unenhanced T1-W fat-saturated images from 2005 to 2010. Complete 
      clinical charts were reviewed by a pediatric hematologist with training in 
      infectious diseases to determine a clinical standard to define the presence or 
      absence of osteomyelitis. A pediatric radiologist reviewed all MR imaging and was 
      blinded to clinical information. Based on the signal intensity in T1-W 
      fat-saturated images, the children were further classified as positive for 
      osteomyelitis (low bone marrow signal intensity) or positive for bone infarct 
      (high bone marrow signal intensity). RESULTS: Based on the clinical standard, 5 
      children were classified as positive for osteomyelitis and 26 children as 
      positive for bone infarct (negative for osteomyelitis). The bone marrow signal 
      intensity on T1-W fat-saturated imaging was not significant for the 
      differentiation between bone infarct and osteomyelitis (P = 0.56). None of the 
      additional evaluated imaging parameters on unenhanced MRI proved reliable in 
      differentiating these diagnoses. CONCLUSION: The bone marrow signal intensity on 
      unenhanced T1-W fat-saturated MR images is not a reliable criterion to 
      differentiate bone infarcts from osteomyelitis in children.
FAU - Delgado, Jorge
AU  - Delgado J
AD  - Department of Radiology, The Children's Hospital of Philadelphia, 34th Street & 
      Civic Center Boulevard, Philadelphia, PA, 19104, USA. 
      jorge.delgado.londono@gmail.com.
FAU - Bedoya, Maria A
AU  - Bedoya MA
AD  - Department of Radiology, The Children's Hospital of Philadelphia, 34th Street & 
      Civic Center Boulevard, Philadelphia, PA, 19104, USA.
FAU - Green, Abby M
AU  - Green AM
AD  - Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, 
      USA.
FAU - Jaramillo, Diego
AU  - Jaramillo D
AD  - Department of Radiology, The Children's Hospital of Philadelphia, 34th Street & 
      Civic Center Boulevard, Philadelphia, PA, 19104, USA.
AD  - The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, 
      PA, USA.
FAU - Ho-Fung, Victor
AU  - Ho-Fung V
AD  - Department of Radiology, The Children's Hospital of Philadelphia, 34th Street & 
      Civic Center Boulevard, Philadelphia, PA, 19104, USA.
AD  - The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, 
      PA, USA.
LA  - eng
PT  - Journal Article
DEP - 20150725
PL  - Germany
TA  - Pediatr Radiol
JT  - Pediatric radiology
JID - 0365332
SB  - IM
MH  - Acute Disease
MH  - Adolescent
MH  - Anemia, Sickle Cell/*pathology
MH  - Bone and Bones/*blood supply
MH  - Child
MH  - Child, Preschool
MH  - Diagnosis, Differential
MH  - Female
MH  - Humans
MH  - Infant
MH  - Magnetic Resonance Imaging/*methods
MH  - Male
MH  - Osteomyelitis/*diagnosis
MH  - Retrospective Studies
OTO - NOTNLM
OT  - Bone infarction
OT  - Children
OT  - Magnetic resonance imaging
OT  - Osteomyelitis
OT  - Sickle cell disease
EDAT- 2015/07/26 06:00
MHDA- 2016/09/13 06:00
CRDT- 2015/07/26 06:00
PHST- 2015/01/13 00:00 [received]
PHST- 2015/06/19 00:00 [accepted]
PHST- 2015/05/14 00:00 [revised]
PHST- 2015/07/26 06:00 [entrez]
PHST- 2015/07/26 06:00 [pubmed]
PHST- 2016/09/13 06:00 [medline]
AID - 10.1007/s00247-015-3423-8 [pii]
AID - 10.1007/s00247-015-3423-8 [doi]
PST - ppublish
SO  - Pediatr Radiol. 2015 Dec;45(13):1981-7. doi: 10.1007/s00247-015-3423-8. Epub 2015 
      Jul 25.

PMID- 22668852
OWN - NLM
STAT- MEDLINE
DCOM- 20121211
LR  - 20240610
IS  - 1941-2452 (Electronic)
IS  - 0884-5336 (Print)
IS  - 0884-5336 (Linking)
VI  - 27
IP  - 4
DP  - 2012 Aug
TI  - Do African American women require fewer calories to maintain weight?: Results 
      from a controlled feeding trial.
PG  - 561-7
LID - 10.1177/0884533612445072 [doi]
AB  - BACKGROUND: The high prevalence of obesity in African American (AA) women may 
      result, in part, from a lower resting metabolic rate (RMR) than non-AA women. If 
      true, AA women should require fewer calories than non-AA women to maintain 
      weight. Our objective was to determine in the setting of a controlled feeding 
      study, if AA women required fewer calories than non-AA women to maintain weight. 
      MATERIALS AND METHODS: This analysis includes 206 women (73% AA), aged 22-75 
      years, who participated in the Dietary Approaches to Stop Hypertension (DASH) 
      trial-a multicenter, randomized, controlled, feeding study comparing the effects 
      of 3 dietary patterns on blood pressure in individuals with prehypertension or 
      stage 1 hypertension. After a 3-week run-in, participants were randomized to 1 of 
      3 dietary patterns for 8 weeks. Calorie intake was adjusted during feeding to 
      maintain stable weight. The primary outcome of this analysis was average daily 
      calorie (kcal) intake during feeding. RESULTS: AA women had higher baseline 
      weight and body mass index than non-AA women (78.4 vs 72.4 kg, P < .01; 29.0 vs 
      27.6 kg/m(2), P < .05, respectively). During intervention feeding, mean (SD) kcal 
      was 2168 (293) in AA women and 2073 (284) in non-AA women. Mean intake was 94.7 
      kcal higher in AA women than in non-AA women (P < .05). After adjustment for 
      potential confounders, there was no difference in caloric intake between AA and 
      non-AA women (Delta = -2.8 kcal, P = .95). CONCLUSION: These results do not support 
      the view that AA women are at greater risk for obesity because they require fewer 
      calories to maintain weight.
FAU - Brewer, Laprincess C
AU  - Brewer LC
AD  - Department of Internal Medicine, Johns Hopkins Bayview Medical Center, Johns 
      Hopkins School of Medicine, Baltimore, MD, USA.
FAU - Miller, Edgar R
AU  - Miller ER
FAU - Appel, Lawrence J
AU  - Appel LJ
FAU - Anderson, Cheryl A M
AU  - Anderson CA
LA  - eng
GR  - K01 HL092595/HL/NHLBI NIH HHS/United States
GR  - TL1 RR025007/RR/NCRR NIH HHS/United States
GR  - 5TL1RR-025007/RR/NCRR NIH HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Multicenter Study
PT  - Randomized Controlled Trial
PT  - Research Support, N.I.H., Extramural
DEP - 20120605
PL  - United States
TA  - Nutr Clin Pract
JT  - Nutrition in clinical practice : official publication of the American Society for 
      Parenteral and Enteral Nutrition
JID - 8606733
SB  - IM
MH  - Adult
MH  - *Black or African American
MH  - Aged
MH  - Basal Metabolism
MH  - Blood Pressure
MH  - Body Composition
MH  - Body Mass Index
MH  - *Body Weight
MH  - Diet
MH  - *Energy Intake
MH  - Female
MH  - Humans
MH  - Hypertension/diet therapy/physiopathology
MH  - Middle Aged
MH  - Obesity/physiopathology
MH  - Young Adult
PMC - PMC5533074
MID - NIHMS879100
EDAT- 2012/06/07 06:00
MHDA- 2012/12/12 06:00
PMCR- 2017/07/28
CRDT- 2012/06/07 06:00
PHST- 2012/06/07 06:00 [entrez]
PHST- 2012/06/07 06:00 [pubmed]
PHST- 2012/12/12 06:00 [medline]
PHST- 2017/07/28 00:00 [pmc-release]
AID - 0884533612445072 [pii]
AID - 10.1177/0884533612445072 [doi]
PST - ppublish
SO  - Nutr Clin Pract. 2012 Aug;27(4):561-7. doi: 10.1177/0884533612445072. Epub 2012 
      Jun 5.

PMID- 18019905
OWN - NLM
STAT- MEDLINE
DCOM- 20071220
LR  - 20071119
IS  - 1710-2774 (Print)
IS  - 1710-2774 (Linking)
VI  - 10
IP  - 4
DP  - 2007
TI  - The use of audit to identify maternal mortality in different settings: is it just 
      a difference between the rich and the poor?
PG  - 133-8
AB  - OBJECTIVE: To illustrate how maternal mortality audit identifies different causes 
      of and contributing factors to maternal deaths in different settings in low- and 
      high-income countries and how this can lead to local solutions in reducing 
      maternal deaths. DESIGN: Descriptive study of maternal mortality from different 
      settings and review of data on the history of reducing maternal mortality in what 
      are now high-income countries. SETTINGS: Kalabo district in Zambia, Farafenni 
      division in The Gambia, Onandjokwe district in Namibia, and the Netherlands. 
      POPULATION: Population of rural areas in Zambia and The Gambia, peri-urban 
      population in Namibia and nationwide data from The Netherlands. METHODS: Data 
      from facility-based maternal mortality audits from three African hospitals and 
      data from the latest confidential enquiry in The Netherlands. MAIN OUTCOME 
      MEASURES: Maternal mortality ratio (MMR), causes (direct and indirect) and 
      characteristics. RESULTS: MMR ranged from 10 per 100,000 (the Netherlands) to 
      1540 per 100,000 (The Gambia). Differences in causes of deaths were characterized 
      by HIV/AIDS in Namibia, sepsis and HIV/AIDS in Zambia, (pre-)eclampsia in the 
      Netherlands and obstructed labour in The Gambia. CONCLUSION: Differences in 
      maternal mortality are more than just differences between the rich and poor. 
      Acknowledging the magnitude of maternal mortality and harnessing a strong 
      political will to tackle the issues are important factors. However, there is no 
      single, general solution to reduce maternal mortality, and identification of 
      problems needs to be promoted through audit, both national and local.
FAU - van Dillen, Jeroen
AU  - van Dillen J
AD  - Netherlands Maternal Mortality Committee, Netherlands.
FAU - Stekelenburg, Jelle
AU  - Stekelenburg J
FAU - Schutte, Joke
AU  - Schutte J
FAU - Walraven, Gijs
AU  - Walraven G
FAU - van Roosmalen, Jos
AU  - van Roosmalen J
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - Canada
TA  - Healthc Q
JT  - Healthcare quarterly (Toronto, Ont.)
JID - 101208192
MH  - Africa
MH  - Cause of Death
MH  - Female
MH  - Hospital Mortality
MH  - Humans
MH  - *Maternal Mortality
MH  - *Medical Audit
MH  - Netherlands
EDAT- 2007/11/21 09:00
MHDA- 2007/12/21 09:00
CRDT- 2007/11/21 09:00
PHST- 2007/11/21 09:00 [pubmed]
PHST- 2007/12/21 09:00 [medline]
PHST- 2007/11/21 09:00 [entrez]
PST - ppublish
SO  - Healthc Q. 2007;10(4):133-8.

PMID- 18378554
OWN - NLM
STAT- MEDLINE
DCOM- 20080806
LR  - 20080401
IS  - 1545-7214 (Electronic)
IS  - 1064-7481 (Linking)
VI  - 16
IP  - 4
DP  - 2008 Apr
TI  - Are wandering and physically nonaggressive agitation equivalent?
PG  - 293-9
LID - 10.1097/JGP.0b013e3181629943 [doi]
AB  - OBJECTIVE: The authors examined equivalence of wandering and physically 
      nonaggressive agitation (PNA) as concepts. DESIGN: A cross-sectional 
      correlational design was used. SETTING: Participants were recruited from 22 
      nursing homes and 6 assisted living facilities in two states. PARTICIPANTS: 
      Ambulatory residents meeting DSM-IV criteria for dementia (N = 181) were studied. 
      MEASUREMENTS: Video-tapes for up to twelve 20-minute observations per participant 
      were coded for wandering using an empirically derived taxonomy of ambulation 
      patterns. Separate raters coded the same tapes for six PNA behaviors on the 
      agitation behavior mapping instrument. RESULTS: Most participants (73.5%) 
      wandered; all showed PNA behaviors. Factor analyses yielded an one-factor 
      solution for wandering (explained variance = 43.66%) and a two-factor solution 
      for PNA (explained variance = 53.45%). Overall wandering correlated significantly 
      with PNA Factor 1 (df =179, r = 0.68, p <0.001) and Factor 2, but at a lower 
      value (df = 179, r = 0.26, p <0.01). CONCLUSION: Findings depict wandering and 
      PNA as overlapping, but nonequivalent phenomena. Evidence supporting construct 
      validity of wandering was more robust than that for PNA. Results have 
      implications for accuracy in scientific and clinical detection and labeling of 
      wandering and agitation.
FAU - Algase, Donna L
AU  - Algase DL
AD  - University of Michigan School of Nursing, Ann Arbor, MI 48109-0482, USA. 
      dalgase@umich.edu
FAU - Antonakos, Cathy
AU  - Antonakos C
FAU - Yao, Lan
AU  - Yao L
FAU - Beattie, Elizabeth R A
AU  - Beattie ER
FAU - Hong, Gwi-Ryung Son
AU  - Hong GR
FAU - Beel-Bates, Cynthia A
AU  - Beel-Bates CA
LA  - eng
GR  - R01 NR04569/NR/NINR NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PL  - England
TA  - Am J Geriatr Psychiatry
JT  - The American journal of geriatric psychiatry : official journal of the American 
      Association for Geriatric Psychiatry
JID - 9309609
SB  - IM
MH  - Aged
MH  - Assisted Living Facilities
MH  - Cross-Sectional Studies
MH  - Homes for the Aged
MH  - Humans
MH  - Motor Activity/*physiology
MH  - Nursing Homes
MH  - Patient Selection
MH  - Psychomotor Agitation/classification/*physiopathology
MH  - Videotape Recording
MH  - *Walking
EDAT- 2008/04/02 09:00
MHDA- 2008/08/07 09:00
CRDT- 2008/04/02 09:00
PHST- 2008/04/02 09:00 [pubmed]
PHST- 2008/08/07 09:00 [medline]
PHST- 2008/04/02 09:00 [entrez]
AID - 16/4/293 [pii]
AID - 10.1097/JGP.0b013e3181629943 [doi]
PST - ppublish
SO  - Am J Geriatr Psychiatry. 2008 Apr;16(4):293-9. doi: 10.1097/JGP.0b013e3181629943.

PMID- 24073931
OWN - NLM
STAT- MEDLINE
DCOM- 20140425
LR  - 20211021
IS  - 2047-783X (Electronic)
IS  - 0949-2321 (Print)
IS  - 0949-2321 (Linking)
VI  - 18
IP  - 1
DP  - 2013 Sep 28
TI  - Is the covering of the resection margin after distal pancreatectomy advantageous?
PG  - 33
LID - 10.1186/2047-783X-18-33 [doi]
AB  - BACKGROUND: In recent years, many advances in pancreatic surgery have been 
      achieved. Nevertheless, the rate of pancreatic fistula following pancreatic tail 
      resection does not differ between various techniques, still reaching up to 30% in 
      prospective multicentric studies. Taking into account contradictory results 
      concerning the usefulness of covering resection margins after distal 
      pancreatectomy, we sought to perform a systematic, retrospective analysis of 
      patients that underwent distal pancreatectomy at our center. METHODS: We 
      retrospectively analysed the data of 74 patients that underwent distal 
      pancreatectomy between 2001 and 2011 at the community hospital in Neuss. 
      Demographic factors, indications, postoperative complications, surgical or 
      interventional revisions, and length of hospital stay were registered to compare 
      the outcome of patients undergoing distal pancreatectomy with coverage of the 
      resection margins vs. patients undergoing distal pancreatectomy without coverage 
      of the resection margins. Differences between groups were calculated using 
      Fisher's exact and Mann-Whitney U test. RESULTS: Main indications for pancreatic 
      surgery were insulinoma (n=18, 24%), ductal adenocarcinoma (n=9, 12%), 
      non-single-insulinoma-pancreatogenic-hypoglycemia-syndrome (NSIPHS) (n=8, 11%), 
      and pancreatic cysts with pancreatitis (n=8, 11%). In 39 of 74 (53%) patients no 
      postoperative complications were noted. In detail we found that 23/42 (55%) 
      patients with coverage vs. 16/32 (50%) without coverage of the resection margins 
      had no postoperative complications. The most common complications were pancreatic 
      fistulas in eleven patients (15%), and postoperative bleeding in nine patients 
      (12%). Pancreatic fistulas occurred in patients without coverage of the resection 
      margins in 7/32 (22%) vs. 4/42 (1011%) with coverage are of the resection 
      margins, yet without reaching statistical significance. Postoperative bleeding 
      ensued with equal frequency in both groups (12% with coverage versus 13% without 
      coverage of the resection margins). The reoperation rate was 8%. The hospital 
      stay for patients without coverage was 13 days (5-60) vs. 17 days (8-60) for 
      patients with coverage. CONCLUSIONS: The results show no significant difference 
      in the fistula rate after covering of the resection margin after distal 
      pancreatectomy, which contributes to the picture of an unsolved problem.
FAU - Akca, Aycan
AU  - Akca A
AD  - Department of Visceral and Endocrine Surgery, Lukaskrankenhaus Neuss, 
      Preussenstr, 84, Neuss, 41464, Germany. aakca@lukasneuss.de.
FAU - Goretzki, Peter E
AU  - Goretzki PE
FAU - Wirowski, Denis
AU  - Wirowski D
FAU - Renter, Marc A
AU  - Renter MA
FAU - Bolke, Edwin
AU  - Bolke E
FAU - Matuschek, Christiane
AU  - Matuschek C
FAU - Gerber, Peter Arne
AU  - Gerber PA
FAU - Lammers, Bernhard J
AU  - Lammers BJ
LA  - eng
PT  - Journal Article
DEP - 20130928
PL  - England
TA  - Eur J Med Res
JT  - European journal of medical research
JID - 9517857
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Child
MH  - Demography
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Pancreas/*pathology/*surgery
MH  - *Pancreatectomy/adverse effects
MH  - Pancreatic Fistula/etiology
MH  - Perioperative Care
MH  - Postoperative Complications/etiology
MH  - Young Adult
PMC - PMC3849835
EDAT- 2013/10/01 06:00
MHDA- 2014/04/26 06:00
PMCR- 2013/09/28
CRDT- 2013/10/01 06:00
PHST- 2012/11/21 00:00 [received]
PHST- 2013/08/28 00:00 [accepted]
PHST- 2013/10/01 06:00 [entrez]
PHST- 2013/10/01 06:00 [pubmed]
PHST- 2014/04/26 06:00 [medline]
PHST- 2013/09/28 00:00 [pmc-release]
AID - 2047-783X-18-33 [pii]
AID - 10.1186/2047-783X-18-33 [doi]
PST - epublish
SO  - Eur J Med Res. 2013 Sep 28;18(1):33. doi: 10.1186/2047-783X-18-33.

PMID- 7547656
OWN - NLM
STAT- MEDLINE
DCOM- 19951113
LR  - 20131121
IS  - 0146-521X (Print)
IS  - 0146-521X (Linking)
VI  - 20
IP  - 3
DP  - 1995 May-Jun
TI  - Does continuous intravenous infusion of low-concentration epinephrine impair 
      uterine blood flow in pregnant ewes?
PG  - 206-11
AB  - BACKGROUND AND OBJECTIVES: Bolus intravenous injection of epinephrine can 
      decrease uterine blood flow. This study examined the effects of intravenous 
      infusion of epinephrine on uterine blood flow in the gravid ewe. METHODS: 
      Maternal and fetal vascular catheters and a maternal electromagnetic uterine 
      artery flow probe were implanted in 10 near-term gravid ewes. After recovery, 
      saline, 0.125% bupivacaine, 0.125% bupivacaine with 1:200,000 epinephrine, 0.125% 
      bupivacaine with 1:400,000 epinephrine, and 0.125% bupivacaine with 1:800,000 
      epinephrine were infused into the maternal superior vena cava. Drugs were infused 
      at 10 mL/h for 30 minutes and then at 20 mL/h for an additional 30 minutes. 
      Animals also received an intravenous bolus of epinephrine 15 micrograms. 
      Throughout all infusions, maternal heart rate, systemic and pulmonary blood 
      pressures, uterine blood flow, cardiac output, and acid-base balance were 
      measured, as well as fetal heart rate, blood pressure, and acid-base balance. 
      RESULTS: Epinephrine 15 micrograms decreased uterine blood flow to 68 +/- 14% of 
      baseline (mean +/- SD). Infusion of all solutions had no effect on any measured 
      hemodynamic variable. CONCLUSIONS: In gravid ewes, intravenous infusion of < or = 
      1.67 micrograms/min epinephrine altered neither maternal hemodynamics nor uterine 
      blood flow. To the extent that sheep data can be extrapolated to humans, these 
      results suggest that continuous intravenous infusion of epinephrine in local 
      anesthetic solutions is safe if the epidural catheter should enter a blood vessel 
      during the infusion.
FAU - Norris, M C
AU  - Norris MC
AD  - Department of Anesthesiology, Jefferson Medical College, Thomas Jefferson 
      University, Philadelphia, Pennsylvania, USA.
FAU - Grieco, W
AU  - Grieco W
FAU - Arkoosh, V A
AU  - Arkoosh VA
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Reg Anesth
JT  - Regional anesthesia
JID - 7707549
RN  - YKH834O4BH (Epinephrine)
SB  - IM
MH  - Anesthesia, Obstetrical/methods
MH  - Animals
MH  - Dose-Response Relationship, Drug
MH  - Epinephrine/*pharmacology
MH  - Female
MH  - Fetus/drug effects
MH  - Hemodynamics/drug effects
MH  - Infusions, Intravenous
MH  - Pregnancy
MH  - Pregnancy, Animal/blood/drug effects/*physiology
MH  - Sheep
MH  - Uterus/*blood supply/drug effects
EDAT- 1995/05/01 00:00
MHDA- 1995/05/01 00:01
CRDT- 1995/05/01 00:00
PHST- 1995/05/01 00:00 [pubmed]
PHST- 1995/05/01 00:01 [medline]
PHST- 1995/05/01 00:00 [entrez]
PST - ppublish
SO  - Reg Anesth. 1995 May-Jun;20(3):206-11.

PMID- 28359277
OWN - NLM
STAT- MEDLINE
DCOM- 20170905
LR  - 20190110
IS  - 1472-6963 (Electronic)
IS  - 1472-6963 (Linking)
VI  - 17
IP  - 1
DP  - 2017 Mar 31
TI  - Do healthier lifestyles lead to less utilization of healthcare resources?
PG  - 243
LID - 10.1186/s12913-017-2185-4 [doi]
LID - 243
AB  - BACKGROUND: Governments are urged to determine methods to control the use of 
      medical resources and curb the rise of healthcare costs. The question is, do 
      health behaviors have an impact on the use of medical resources? This study aims 
      to identify and understand the difference in the number of outpatient visits and 
      health examinations based on various health behaviors and to determine whether 
      patients seek medical care for illness from the same physicians. METHODS: This 
      study used the dataset derived from the Department of Budget, Accounting and 
      Statistics of Kaohsiung, Taiwan in 2005. Persons older than 15 years were 
      surveyed using an on-site questionnaire. A total of 2911 persons were enrolled in 
      this study. Independent t-tests, chi-square tests, one-way ANOVA, multiple linear 
      regression and binominal logistic regression were used in the data analysis. 
      RESULTS: The regression model for the frequency of doctor visits, health 
      examinations, and whether the same physician is sought for medical care has 
      demonstrated significant correlations with gender, age and education-level 
      variables. Four health behaviors (i.e., exercise habits, dietary habits, regular 
      blood pressure measurement, drinking habits) exhibited a significant correlation 
      with healthcare utilization (P <0.05). CONCLUSIONS: Healthy lifestyles lead to an 
      increase in the utilization of preventive health services. However, there is not 
      much significantly reducing the number of outpatient visits in people with health 
      behaviors. Specifically, people with regular exercise habits and who take their 
      blood pressure measurement regularly have an increased number of outpatient 
      visits. It is suggested that more available and accessible health consultation 
      services be provided to inculcate in the general public the importance of 
      maintaining a healthy lifestyle.
FAU - Lee, I-Chen
AU  - Lee IC
AD  - Department of Healthcare Administration and Medical Informatics, Kaohsiung 
      Medical University, 100, Shih-Chuan 1st Road, Kaohsiung, 807, Taiwan.
FAU - Chang, Chao-Sung
AU  - Chang CS
AD  - Department of Hematology-Oncology, E-Da Cancer Hospital; School of Medicine for 
      International Students, I-Shou University, No.21, Yi-Da Road, Jiao-Su Village, 
      Yan-Chao District, Kaohsiung City, 824, Taiwan.
FAU - Du, Pey-Lan
AU  - Du PL
AD  - Department of Sport and Leisure, National Quemoy University, No.1, Daxue Rd., 
      Jinning Township, Kinmen County, Kinmen, 892, Taiwan. peylandu@nqu.edu.tw.
LA  - eng
PT  - Journal Article
DEP - 20170331
PL  - England
TA  - BMC Health Serv Res
JT  - BMC health services research
JID - 101088677
SB  - IM
MH  - Adult
MH  - Aged
MH  - Alcohol Drinking/economics/epidemiology
MH  - Exercise/physiology
MH  - Female
MH  - *Health Behavior
MH  - Health Care Costs
MH  - Health Services Accessibility/economics/statistics & numerical data
MH  - *Healthy Lifestyle
MH  - Humans
MH  - Logistic Models
MH  - Male
MH  - Middle Aged
MH  - Patient Acceptance of Health Care/*statistics & numerical data
MH  - Preventive Health Services/economics/*statistics & numerical data
MH  - Surveys and Questionnaires
MH  - Taiwan/epidemiology
PMC - PMC5374670
OTO - NOTNLM
OT  - Healthy lifestyle
OT  - Preventive health services
OT  - Utilization of healthcare resources
EDAT- 2017/04/01 06:00
MHDA- 2017/09/07 06:00
PMCR- 2017/03/31
CRDT- 2017/04/01 06:00
PHST- 2015/12/29 00:00 [received]
PHST- 2017/03/23 00:00 [accepted]
PHST- 2017/04/01 06:00 [entrez]
PHST- 2017/04/01 06:00 [pubmed]
PHST- 2017/09/07 06:00 [medline]
PHST- 2017/03/31 00:00 [pmc-release]
AID - 10.1186/s12913-017-2185-4 [pii]
AID - 2185 [pii]
AID - 10.1186/s12913-017-2185-4 [doi]
PST - epublish
SO  - BMC Health Serv Res. 2017 Mar 31;17(1):243. doi: 10.1186/s12913-017-2185-4.

PMID- 18667100
OWN - NLM
STAT- MEDLINE
DCOM- 20090611
LR  - 20211020
IS  - 0033-2917 (Print)
IS  - 1469-8978 (Electronic)
IS  - 0033-2917 (Linking)
VI  - 39
IP  - 5
DP  - 2009 May
TI  - Do risk factors for suicidal behavior differ by affective disorder polarity?
PG  - 763-71
LID - 10.1017/S0033291708004078 [doi]
AB  - BACKGROUND: Suicide is a leading cause of death and has been strongly associated 
      with affective disorders. The influence of affective disorder polarity on 
      subsequent suicide attempts or completions and any differential effect of suicide 
      risk factors by polarity were assessed in a prospective cohort. METHOD: 
      Participants with major affective disorders in the National Institute of Mental 
      Health (NIMH) Collaborative Depression Study (CDS) were followed prospectively 
      for up to 25 years. A total of 909 participants meeting prospective diagnostic 
      criteria for major depressive and bipolar disorders were followed through 4204 
      mood cycles. Suicidal behavior was defined as suicide attempts or completions. 
      Mixed-effects, grouped-time survival analysis assessed risk of suicidal behavior 
      and differential effects of risk factors for suicidal behavior by polarity. In 
      addition to polarity, the main effects of age, gender, hopelessness, married 
      status, prior suicide attempts and active substance abuse were modeled, with mood 
      cycle as the unit of analysis. RESULTS: After controlling for age of onset, there 
      were no differences in prior suicide attempts by polarity although bipolar 
      participants had more prior severe attempts. During follow-up, 40 cycles ended in 
      suicide and 384 cycles contained at least one suicide attempt. Age, hopelessness 
      and active substance abuse but not polarity predicted suicidal behavior. The 
      effects of risk factors did not differ by polarity. CONCLUSIONS: Bipolarity does 
      not independently influence risk of suicidal behavior or alter the influence of 
      well-established suicide risk factors within affective disorders. Suicide risk 
      assessment strategies may continue to appraise these common risk factors without 
      regard to mood polarity.
FAU - Fiedorowicz, J G
AU  - Fiedorowicz JG
AD  - Department of Psychiatry, Roy J. and Lucille A. Carver College of Medicine, 
      University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA. 
      jess-fiedorowicz@uiowa.edu
FAU - Leon, A C
AU  - Leon AC
FAU - Keller, M B
AU  - Keller MB
FAU - Solomon, D A
AU  - Solomon DA
FAU - Rice, J P
AU  - Rice JP
FAU - Coryell, W H
AU  - Coryell WH
LA  - eng
GR  - L30 MH075180/MH/NIMH NIH HHS/United States
GR  - R01 MH023864/MH/NIMH NIH HHS/United States
GR  - R01 MH025430/MH/NIMH NIH HHS/United States
GR  - 5R01MH029957-30/MH/NIMH NIH HHS/United States
GR  - R01 MH025416/MH/NIMH NIH HHS/United States
GR  - 5R01MH023864-35/MH/NIMH NIH HHS/United States
GR  - 5R01MH025430-33/MH/NIMH NIH HHS/United States
GR  - R01 MH025478/MH/NIMH NIH HHS/United States
GR  - R01 MH025416-33/MH/NIMH NIH HHS/United States
GR  - L30 MH075180-02/MH/NIMH NIH HHS/United States
GR  - 5R01MH025416-33/MH/NIMH NIH HHS/United States
GR  - R01 MH029957/MH/NIMH NIH HHS/United States
GR  - 5R01MH025478-33/MH/NIMH NIH HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20080730
PL  - England
TA  - Psychol Med
JT  - Psychological medicine
JID - 1254142
SB  - IM
MH  - Adult
MH  - Bipolar Disorder/*mortality
MH  - Cohort Studies
MH  - Comorbidity
MH  - Cost of Illness
MH  - Depressive Disorder, Major/*mortality/psychology
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Personality Inventory/statistics & numerical data
MH  - Prospective Studies
MH  - Psychometrics
MH  - Risk Factors
MH  - Socioeconomic Factors
MH  - Substance-Related Disorders/mortality/psychology
MH  - Suicide/psychology/*statistics & numerical data
MH  - Suicide, Attempted/psychology/*statistics & numerical data
MH  - Survival Analysis
MH  - United States
MH  - Young Adult
PMC - PMC2775816
MID - NIHMS155968
COIS- Declaration of Interest Dr. Fiedorowicz is supported by L30 MH075180-02, the 
      Nellie Ball Trust Research Fund, and a NARSAD Young Investigator Award. He has 
      further received support for participating in a colleague's 
      investigator-initiated study with Eli Lilly. Dr. Leon has served as a consultant 
      to the National Institute of Mental Health and Food and Drug Administration and 
      as a member of Data and Safety Monitoring Boards for Pfizer, Organon, and 
      Dainippon Sumitomo Pharma America. Dr. Keller has served as a consultant or 
      received honoraria from Collegium, Cypress Bioscience, Cyberonics, Eli Lilly, 
      Forest Laboratories, Janssen, Organon, Otsuka, Pfizer, Pharmastar, Sepracor, Vela 
      Pharmaceuticals, Wyeth Pharmaceuticals. He has received grants from Eli Lilly, 
      Pfizer, and Wyeth Pharmaceuticals. He has served on advisory boards for Abbott 
      Laboratories, Bristol-Myers Squibb, Cyberonics, Cypress Bioscience, Eli Lilly, 
      Forest Laboratories, GlaxoSmithKline, Janssen, Novartis, Organon, Pfizer, 
      Sepracor, and Wyeth Pharmaceuticals. Dr. Solomon has served as an investigator 
      for research funded by Jansenn Pharmaceutica, as a consultant to Solvay 
      Pharmaceuticals, Shire, and Novartis, and has served on the lecture bureaus of 
      AstraZeneca, Pfizer, GlaxoSmithKline, and Shire. Dr. Rice is listed as an 
      inventor on a patent (US 20070258898) held by Perlegen Sciences, Inc., covering 
      the use of certain single nucleotide polymorphisms in determining the diagnosis, 
      prognosis, and treatment of addiction. All other authors declare that they have 
      no conflicts of interest.
EDAT- 2008/08/01 09:00
MHDA- 2009/06/12 09:00
PMCR- 2009/11/11
CRDT- 2008/08/01 09:00
PHST- 2008/08/01 09:00 [pubmed]
PHST- 2009/06/12 09:00 [medline]
PHST- 2008/08/01 09:00 [entrez]
PHST- 2009/11/11 00:00 [pmc-release]
AID - S0033291708004078 [pii]
AID - 10.1017/S0033291708004078 [doi]
PST - ppublish
SO  - Psychol Med. 2009 May;39(5):763-71. doi: 10.1017/S0033291708004078. Epub 2008 Jul 
      30.

PMID- 10781708
OWN - NLM
STAT- MEDLINE
DCOM- 20000719
LR  - 20191103
IS  - 0300-2977 (Print)
IS  - 0300-2977 (Linking)
VI  - 56
IP  - 5
DP  - 2000 May
TI  - Thrombosis prophylaxis in hospitalised medical patients: does prophylaxis in all 
      patients make sense?
PG  - 171-6
AB  - BACKGROUND: Most studies on thrombosis prophylaxis focus on postoperative venous 
      thrombosis. In medical wards thrombosis prophylaxis is generally restricted to 
      patients who are immobilised. Our primary aim was to investigate the incidence of 
      venous thrombosis in a general internal ward, to assess whether more rigorous 
      prophylaxis would be feasible. METHODS: We investigated the incidence of venous 
      thrombosis in patients hospitalised from 1992 to 1996 and related our findings to 
      literature reports. RESULTS: The incidence of symptomatic venous thrombosis in 
      internal patients during hospitalisation was 39/6332 (0.6%). Among these 39 
      patients, 24 had a malignancy, whereas 876 out of all 6332 patients had a known 
      malignancy. So, the incidence in this group with cancer was 2.7% compared with 
      0.3% (15/5456) in the non-cancer group (relative risk for venous thrombosis due 
      to malignancy was 10.0 (95%C.I. 5.3-18.9). CONCLUSION: The incidence of venous 
      thrombosis during hospitalisation in a department of general internal medicine is 
      low and does not justify prophylaxis in all internal patients. Cancer is a strong 
      risk factor for hospital-acquired thrombosis in the medical ward. Further studies 
      may answer the question as to whether thrombosis prophylaxis in this subgroup is 
      feasible.
FAU - Schuurman, B
AU  - Schuurman B
AD  - University Medical Centre St. Radboud, Geert Grooteplein 8, 6500 HB, Nijmegen, 
      The Netherlands. miba@xs4all.nl
FAU - den Heijer, M
AU  - den Heijer M
FAU - Nijs, A M
AU  - Nijs AM
LA  - eng
PT  - Journal Article
PL  - Netherlands
TA  - Neth J Med
JT  - The Netherlands journal of medicine
JID - 0356133
RN  - 0 (Enoxaparin)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Enoxaparin/*therapeutic use
MH  - Female
MH  - Humans
MH  - Incidence
MH  - Male
MH  - Neoplasms/complications
MH  - Postoperative Care/methods
MH  - Postoperative Complications/epidemiology/*prevention & control
MH  - Retrospective Studies
MH  - Risk Factors
MH  - Venous Thrombosis/epidemiology/etiology/*prevention & control
EDAT- 2000/04/27 09:00
MHDA- 2000/07/25 11:00
CRDT- 2000/04/27 09:00
PHST- 2000/04/27 09:00 [pubmed]
PHST- 2000/07/25 11:00 [medline]
PHST- 2000/04/27 09:00 [entrez]
AID - S0300297700000115 [pii]
AID - 10.1016/s0300-2977(00)00011-5 [doi]
PST - ppublish
SO  - Neth J Med. 2000 May;56(5):171-6. doi: 10.1016/s0300-2977(00)00011-5.

PMID- 22522271
OWN - NLM
STAT- MEDLINE
DCOM- 20120606
LR  - 20131121
IS  - 1175-8716 (Electronic)
IS  - 0028-8446 (Linking)
VI  - 125
IP  - 1353
DP  - 2012 Apr 20
TI  - Is late-night salivary cortisol a better screening test for possible cortisol 
      excess than standard screening tests in obese patients with Type 2 diabetes?
PG  - 47-58
AB  - AIM: To compare the performance, in terms of specificity for cortisol excess, of 
      late-night salivary cortisol with 24-hour urine-free cortisol (24hr UFC) and 
      overnight 1mg dexamethasone suppression test (1mg DST) in a group of obese T2DM 
      patients. METHODS: Forty obese patients with T2DM without clinical features of 
      Cushing's syndrome were recruited. Plasma, urinary and salivary cortisol were 
      measured directly by an enzyme-linked immunosorbent assay using monoclonal 
      antibodies. The specificities of the three tests using various cutoffs were 
      calculated and compared, employing the assumption that none of the patients had 
      hypercortisolism. RESULTS: The patients had a mean age and BMI of 56 years (range 
      31-75) and 37 kg/m(2) (31-56) respectively. All 40 provided late-night salivary 
      cortisol samples. Thirty-eight patients completed all three tests. Two patients 
      only completed two screening tests. The specificities of late-night salivary 
      cortisol (cutoff 10 nmol/L), 24hr UFC (400 nmol) and 1mg DST (50 nmol/L) were 70% 
      (95% CI 53-83%), 90% (76-97%) and 72% (55-85%) respectively. The specificity of 
      late-night salivary cortisol was significantly less than 24 hr UFC (P=0.039) but 
      not 1mg DST (P>0.99). CONCLUSION: Late-night salivary cortisol has a poor 
      specificity for cortisol excess in obese patients with T2DM with 24 hr UFC 
      showing significantly better specificity in our population.
FAU - Ellis, Elna
AU  - Ellis E
AD  - Christchurch Hospital, Christchurch, New Zealand.
FAU - Chin, Paul K L
AU  - Chin PK
FAU - Hunt, Penelope J
AU  - Hunt PJ
FAU - Lunt, Helen
AU  - Lunt H
FAU - Lewis, John G
AU  - Lewis JG
FAU - Soule, Steven G
AU  - Soule SG
LA  - eng
PT  - Clinical Trial
PT  - Comparative Study
PT  - Journal Article
DEP - 20120420
PL  - New Zealand
TA  - N Z Med J
JT  - The New Zealand medical journal
JID - 0401067
RN  - WI4X0X7BPJ (Hydrocortisone)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Cushing Syndrome/*diagnosis/metabolism
MH  - Diabetes Mellitus, Type 2/*complications
MH  - Female
MH  - Humans
MH  - Hydrocortisone/*analysis/blood/urine
MH  - Male
MH  - Middle Aged
MH  - Obesity/*complications
MH  - Saliva/*chemistry
MH  - Time Factors
MH  - Urinalysis
EDAT- 2012/04/24 06:00
MHDA- 2012/06/07 06:00
CRDT- 2012/04/24 06:00
PHST- 2012/04/24 06:00 [entrez]
PHST- 2012/04/24 06:00 [pubmed]
PHST- 2012/06/07 06:00 [medline]
PST - epublish
SO  - N Z Med J. 2012 Apr 20;125(1353):47-58.

PMID- 11955750
OWN - NLM
STAT- MEDLINE
DCOM- 20020513
LR  - 20190708
IS  - 0360-3016 (Print)
IS  - 0360-3016 (Linking)
VI  - 52
IP  - 5
DP  - 2002 Apr 1
TI  - Does escalation of the apical dose change treatment outcome in beta-radiation of 
      posterior choroidal melanomas with 106Ru plaques?
PG  - 1360-6
AB  - PURPOSE: To show the results of treating posterior uveal melanomas with 106Ru 
      plaque beta-ray radiotherapy and to review and discuss the literature concerning 
      the optimal apical dose prescription (100 vs. 160 Gy). METHODS AND MATERIALS: 
      Forty-eight patients with uveal melanomas (median height 3.85 mm + 1 mm sclera) 
      were treated with ruthenium plaques. The median apical dose was 120 Gy, the 
      median scleral dose 546 Gy. RESULTS: After 5.8 years of follow-up, the overall 
      5-year survival rate was 90%, the disease specific 5-year survival rate was 92% 
      (3 patients alive with metastasis). Six percent received a second ruthenium 
      application, 10% of the eyes had to be enucleated. Local control was achieved in 
      90% of the patients with conservative therapy alone. Central or paracentral 
      tumors showed 50% of the pretherapeutic vision after 4 years, and 80% of the 
      vision was preserved in those with peripheral tumors. The main side effects were 
      mostly an uncomplicated retinopathy (30%); macular degeneration or scarring led 
      to poor central vision in 30% of cases. CONCLUSION: Brachytherapy with ruthenium 
      applicators is an effective therapy for small- and medium-size posterior uveal 
      melanomas. Our results are comparable to other series. The treatment outcome does 
      not seem to be capable of improvement by increasing the apical dose. An 
      internationally accepted model for defining the dosage in brachytherapy is 
      needed.
FAU - Hermann, Robert Michael
AU  - Hermann RM
AD  - Department of Radiotherapy and Radiooncology, University of Goettingen, 
      Goettingen, Germany. ro.hermann@t-online.de
FAU - Pradier, Olivier
AU  - Pradier O
FAU - Lauritzen, Katharina
AU  - Lauritzen K
FAU - Ott, Marcel
AU  - Ott M
FAU - Schmidberger, Heinz
AU  - Schmidberger H
FAU - Hess, Clemens F
AU  - Hess CF
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Int J Radiat Oncol Biol Phys
JT  - International journal of radiation oncology, biology, physics
JID - 7603616
RN  - 0 (Ruthenium Radioisotopes)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Choroid Neoplasms/mortality/*radiotherapy
MH  - Female
MH  - Humans
MH  - Male
MH  - Melanoma/mortality/*radiotherapy
MH  - Middle Aged
MH  - Radiotherapy Dosage
MH  - Ruthenium Radioisotopes/adverse effects/*therapeutic use
MH  - Survival Rate
MH  - Visual Acuity
EDAT- 2002/04/17 10:00
MHDA- 2002/05/15 10:01
CRDT- 2002/04/17 10:00
PHST- 2002/04/17 10:00 [pubmed]
PHST- 2002/05/15 10:01 [medline]
PHST- 2002/04/17 10:00 [entrez]
AID - S0360301601027638 [pii]
AID - 10.1016/s0360-3016(01)02763-8 [doi]
PST - ppublish
SO  - Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1360-6. doi: 
      10.1016/s0360-3016(01)02763-8.

PMID- 26126304
OWN - NLM
STAT- MEDLINE
DCOM- 20150716
LR  - 20161125
IS  - 0024-7758 (Print)
IS  - 0024-7758 (Linking)
VI  - 60
IP  - 5-6
DP  - 2015 May-Jun
TI  - Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro 
      Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to 
      Oral Contraceptive Pill?
PG  - 199-204
AB  - OBJECTIVE: To compare in vitro fertilization (IVF) outcomes in low responders 
      stimulated with microdose leuprolide protocol (ML) following pretreatment with 
      either oral contraceptive pill (OCP) or luteal estradiol (E2) + GnRH antagonist 
      (E2 + antag) for follicular synchronization prior to controlled ovarian 
      hyperstimulation (COH). STUDY DESIGN: This was a retrospective study of 130 
      women, who were poor responders, undergoing IVF with either OCP/ML or E2+ 
      antag/ML protocols. The main outcome measures were ongoing pregnancy rates, 
      number of oocytes retrieved, and cancellation rate. RESULTS: Both groups were 
      similar in baseline characteristics. There were no significant differences in 
      gonadotropin requirement, cancellation rate, and number of embryos transferred. 
      Ongoing pregnancy rates (40% vs. 15%) were significantly higher in the OCP/ML 
      group. Trends toward greater number of oocytes retrieved (7.7 +/- 3.4 vs. 5.9 +/- 
      4.2) and improved implantation rates (20% vs. 12%) were also noted, but these did 
      not reach statistical significance. CONCLUSION: E2+antag pretreatment does not 
      appear to improve IVF outcomes in ML protocol when compared to the standard OCP 
      in poor responders. Randomized trials with adequate power to study the optimal 
      method of steroid pretreatments appear justified.
FAU - Elassar, Alyaa
AU  - Elassar A
FAU - Nulsen, John
AU  - Nulsen J
FAU - Engmann, Lawrence
AU  - Engmann L
FAU - Benadiva, Claudio
AU  - Benadiva C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Reprod Med
JT  - The Journal of reproductive medicine
JID - 0173343
RN  - 0 (Contraceptives, Oral, Hormonal)
RN  - 0 (Estrogens)
RN  - 0 (Fertility Agents, Female)
RN  - 0 (Hormone Antagonists)
RN  - 33515-09-2 (Gonadotropin-Releasing Hormone)
RN  - 4TI98Z838E (Estradiol)
RN  - EFY6W0M8TG (Leuprolide)
RN  - IX503L9WN0 (ganirelix)
SB  - IM
MH  - Adult
MH  - Contraceptives, Oral, Hormonal/therapeutic use
MH  - Estradiol/*therapeutic use
MH  - Estrogens/*therapeutic use
MH  - Female
MH  - Fertility Agents, Female/therapeutic use
MH  - *Fertilization in Vitro
MH  - Gonadotropin-Releasing Hormone/*analogs & derivatives/therapeutic use
MH  - Hormone Antagonists/*therapeutic use
MH  - Humans
MH  - Leuprolide/therapeutic use
MH  - Oocyte Retrieval
MH  - Pregnancy
MH  - Pregnancy Rate
MH  - *Premedication
MH  - Retrospective Studies
EDAT- 2015/07/02 06:00
MHDA- 2015/07/17 06:00
CRDT- 2015/07/02 06:00
PHST- 2015/07/02 06:00 [entrez]
PHST- 2015/07/02 06:00 [pubmed]
PHST- 2015/07/17 06:00 [medline]
PST - ppublish
SO  - J Reprod Med. 2015 May-Jun;60(5-6):199-204.

PMID- 27338535
OWN - NLM
STAT- MEDLINE
DCOM- 20170621
LR  - 20191210
IS  - 1095-8673 (Electronic)
IS  - 0022-4804 (Linking)
VI  - 203
IP  - 1
DP  - 2016 Jun 1
TI  - Do risk calculators accurately predict surgical site occurrences?
PG  - 56-63
LID - S0022-4804(16)00134-7 [pii]
LID - 10.1016/j.jss.2016.03.040 [doi]
AB  - INTRODUCTION: Current risk assessment models for surgical site occurrence (SSO) 
      and surgical site infection (SSI) after open ventral hernia repair (VHR) have 
      limited external validation. Our aim was to determine (1) whether existing models 
      stratify patients into groups by risk and (2) which model best predicts the rate 
      of SSO and SSI. METHODS: Patients who underwent open VHR and were followed for at 
      least 1 mo were included. Using two data sets-a retrospective multicenter 
      database (Ventral Hernia Outcomes Collaborative) and a single-center prospective 
      database (Prospective)-each patient was assigned a predicted risk with each of 
      the following models: Ventral Hernia Risk Score (VHRS), Ventral Hernia Working 
      Group (VHWG), Centers for Disease Control and Prevention Wound Class, and Hernia 
      Wound Risk Assessment Tool (HW-RAT). Patients in the Prospective database were 
      also assigned a predicted risk from the American College of Surgeons National 
      Surgical Quality Improvement Program (ACS-NSQIP). Areas under the receiver 
      operating characteristic curve (area under the curve [AUC]) were compared to 
      assess the predictive accuracy of the models for SSO and SSI. Pearson's 
      chi-square was used to determine which models were able to risk-stratify patients 
      into groups with significantly differing rates of actual SSO and SSI. RESULTS: 
      The Ventral Hernia Outcomes Collaborative database (n = 795) had an overall SSO 
      and SSI rate of 23% and 17%, respectively. The AUCs were low for SSO (0.56, 0.54, 
      0.52, and 0.60) and SSI (0.55, 0.53, 0.50, and 0.58). The VHRS (P = 0.01) and 
      HW-RAT (P < 0.01) significantly stratified patients into tiers for SSO, whereas 
      the VHWG (P < 0.05) and HW-RAT (P < 0.05) stratified for SSI. In the Prospective 
      database (n = 88), 14% and 8% developed an SSO and SSI, respectively. The AUCs 
      were low for SSO (0.63, 0.54, 0.50, 0.57, and 0.69) and modest for SSI (0.81, 
      0.64, 0.55, 0.62, and 0.73). The ACS-NSQIP (P < 0.01) stratified for SSO, whereas 
      the VHRS (P < 0.01) and ACS-NSQIP (P < 0.05) stratified for SSI. In both 
      databases, VHRS, VHWG, and Centers for Disease Control and Prevention 
      overestimated risk of SSO and SSI, whereas HW-RAT and ACS-NSQIP underestimated 
      risk for all groups. CONCLUSIONS: All five existing predictive models have 
      limited ability to risk-stratify patients and accurately assess risk of SSO. 
      However, both the VHRS and ACS-NSQIP demonstrate modest success in identifying 
      patients at risk for SSI. Continued model refinement is needed to improve the two 
      highest performing models (VHRS and ACS-NSQIP) along with investigation to 
      determine whether modifications to perioperative management based on risk 
      stratification can improve outcomes.
CI  - Copyright (c) 2016 Elsevier Inc. All rights reserved.
CN  - Ventral Hernia Outcome Collaborative
FAU - Mitchell, Thomas O
AU  - Mitchell TO
AD  - Department of Surgery, University of Texas Health Science Center at Houston, 
      Houston, Texas.
FAU - Holihan, Julie L
AU  - Holihan JL
AD  - Department of Surgery, University of Texas Health Science Center at Houston, 
      Houston, Texas. Electronic address: Julie.L.Holihan@uth.tmc.edu.
FAU - Askenasy, Erik P
AU  - Askenasy EP
AD  - Department of Surgery, Baylor College of Medicine, Houston, Texas.
FAU - Greenberg, Jacob A
AU  - Greenberg JA
AD  - Department of Surgery, University of Wisconsin, Madison, Wisconsin.
FAU - Keith, Jerrod N
AU  - Keith JN
AD  - Department of Surgery, University of Iowa, Iowa City, Iowa.
FAU - Martindale, Robert G
AU  - Martindale RG
AD  - Department of Surgery, Oregon Health and Science University, Portland, Oregon.
FAU - Roth, John Scott
AU  - Roth JS
AD  - Department of Surgery, University of Kentucky, Lexington, Kentucky.
FAU - Liang, Mike K
AU  - Liang MK
AD  - Department of Surgery, University of Texas Health Science Center at Houston, 
      Houston, Texas.
LA  - eng
GR  - UL1 TR000371/TR/NCATS NIH HHS/United States
GR  - KL2 TR000370/TR/NCATS NIH HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Multicenter Study
PT  - Validation Study
DEP - 20160326
PL  - United States
TA  - J Surg Res
JT  - The Journal of surgical research
JID - 0376340
SB  - IM
MH  - Adult
MH  - Aged
MH  - Databases, Factual
MH  - *Decision Support Techniques
MH  - Female
MH  - Follow-Up Studies
MH  - *Herniorrhaphy
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Prognosis
MH  - ROC Curve
MH  - Retrospective Studies
MH  - Risk Assessment
MH  - Risk Factors
MH  - Surgical Wound Infection/*diagnosis/etiology
OTO - NOTNLM
OT  - NSQIP
OT  - Risk calculator
OT  - Surgical risk
OT  - Surgical site infection
OT  - Surgical site occurrence
OT  - Ventral hernia
EDAT- 2016/06/25 06:00
MHDA- 2017/06/22 06:00
CRDT- 2016/06/25 06:00
PHST- 2015/11/17 00:00 [received]
PHST- 2016/03/10 00:00 [revised]
PHST- 2016/03/18 00:00 [accepted]
PHST- 2016/06/25 06:00 [entrez]
PHST- 2016/06/25 06:00 [pubmed]
PHST- 2017/06/22 06:00 [medline]
AID - S0022-4804(16)00134-7 [pii]
AID - 10.1016/j.jss.2016.03.040 [doi]
PST - ppublish
SO  - J Surg Res. 2016 Jun 1;203(1):56-63. doi: 10.1016/j.jss.2016.03.040. Epub 2016 
      Mar 26.

PMID- 24799031
OWN - NLM
STAT- MEDLINE
DCOM- 20141204
LR  - 20181202
IS  - 1873-4499 (Electronic)
IS  - 0899-7071 (Linking)
VI  - 38
IP  - 4
DP  - 2014 Jul-Aug
TI  - Is diffusion-weighted imaging a significant indicator of the development of 
      vascularization in hypovascular hepatocellular lesions?
PG  - 458-463
LID - S0899-7071(14)00082-5 [pii]
LID - 10.1016/j.clinimag.2014.03.013 [doi]
AB  - OBJECTIVE: The objective was to evaluate the efficacy of diffusion-weighted 
      imaging (DWI) in predicting the development of vascularization in hypovascular 
      hepatocellular lesions (HHLs). MATERIALS AND METHODS: Forty-two HHLs that were 
      diagnosed by computed tomographic (CT) arteriography were evaluated 
      retrospectively. The lesion on DWI was classified as isointense, hypointense, or 
      hyperintense. Follow-up studies that included intravenous dynamic CT or magnetic 
      resonance imaging were performed. RESULTS: The 730-day cumulative developments of 
      vascularization in hypointense, isointense, and hyperintense lesions were 17%, 
      30%, and 40%, respectively. The differences among these developments were not 
      statistically significant. CONCLUSION: The signal intensity on DWI showed no 
      significant difference in the development of vascularization.
CI  - Copyright (c) 2014 Elsevier Inc. All rights reserved.
FAU - Takara, Kenichi
AU  - Takara K
AD  - Department of Radiology, Tokyo Medical University.
FAU - Saito, Kazuhiro
AU  - Saito K
AD  - Department of Radiology, Tokyo Medical University. Electronic address: 
      saito-k@tokyo-med.ac.jp.
FAU - Saguchi, Toru
AU  - Saguchi T
AD  - Department of Radiology, Tokyo Medical University.
FAU - Sugimoto, Katsutoshi
AU  - Sugimoto K
AD  - Department of Gastroenterology and Hepatology, Tokyo Medical University.
FAU - Taira, Junichi
AU  - Taira J
AD  - Department of Gastroenterology and Hepatology, Tokyo Medical University.
FAU - Imai, Yasuharu
AU  - Imai Y
AD  - Department of Gastroenterology and Hepatology, Tokyo Medical University.
FAU - Moriyasu, Fuminori
AU  - Moriyasu F
AD  - Department of Gastroenterology and Hepatology, Tokyo Medical University.
FAU - Akata, Soichi
AU  - Akata S
AD  - Department of Radiology, Tokyo Medical University.
FAU - Tokuuye, Koichi
AU  - Tokuuye K
AD  - Department of Radiology, Tokyo Medical University.
LA  - eng
PT  - Journal Article
DEP - 20140330
PL  - United States
TA  - Clin Imaging
JT  - Clinical imaging
JID - 8911831
RN  - 0 (Contrast Media)
RN  - K2I13DR72L (Gadolinium DTPA)
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Carcinoma, Hepatocellular/*diagnostic imaging/pathology
MH  - Contrast Media
MH  - *Diffusion Magnetic Resonance Imaging
MH  - Female
MH  - Gadolinium DTPA
MH  - Hepatitis B, Chronic/diagnosis
MH  - Hepatitis C, Chronic/diagnosis
MH  - Humans
MH  - Liver Diseases, Alcoholic/diagnosis
MH  - Liver Neoplasms/*diagnostic imaging/pathology
MH  - Male
MH  - Middle Aged
MH  - Neovascularization, Pathologic/*diagnostic imaging
MH  - Non-alcoholic Fatty Liver Disease/diagnosis
MH  - Reproducibility of Results
MH  - Retrospective Studies
MH  - *Tomography, X-Ray Computed
OTO - NOTNLM
OT  - Development of vascularization
OT  - Diffusion-weighted imaging
OT  - Gd-EOB-DTPA
OT  - Hepatocellular carcinoma
OT  - Hypovascular hepatocellular nodule
EDAT- 2014/05/07 06:00
MHDA- 2014/12/15 06:00
CRDT- 2014/05/07 06:00
PHST- 2013/11/04 00:00 [received]
PHST- 2014/03/16 00:00 [revised]
PHST- 2014/03/24 00:00 [accepted]
PHST- 2014/05/07 06:00 [entrez]
PHST- 2014/05/07 06:00 [pubmed]
PHST- 2014/12/15 06:00 [medline]
AID - S0899-7071(14)00082-5 [pii]
AID - 10.1016/j.clinimag.2014.03.013 [doi]
PST - ppublish
SO  - Clin Imaging. 2014 Jul-Aug;38(4):458-463. doi: 10.1016/j.clinimag.2014.03.013. 
      Epub 2014 Mar 30.

PMID- 18319270
OWN - NLM
STAT- MEDLINE
DCOM- 20080606
LR  - 20080422
IS  - 1460-2350 (Electronic)
IS  - 0268-1161 (Linking)
VI  - 23
IP  - 5
DP  - 2008 May
TI  - Does confined placental mosaicism account for adverse perinatal outcomes in IVF 
      pregnancies?
PG  - 1107-12
LID - 10.1093/humrep/den062 [doi]
AB  - BACKGROUND: IVF singletons have poorer perinatal outcomes than singletons from 
      spontaneous conceptions. This may be due to the influence of ovarian stimulation 
      on the chromosomal constitution of the embryos which could be translated into 
      localized chromosomal anomalies in the placenta. The aim of this study was to 
      compare the incidence of confined placental mosaicism (CPM) in IVF/ICSI 
      pregnancies and spontaneous conceptions. METHODS: We conducted a multi-centre 
      retrospective analysis of karyotype results obtained by chorionic villus sampling 
      (CVS), performed due to advanced maternal age (>or=36 years at 18 weeks of 
      gestation), in the Netherlands between 1995 and 2005. RESULTS: From a total of 
      322 246 pregnancies, 20 885 CVS results were analysed: 235 in the IVF/ICSI group 
      and 20 650 in the control group. The mean age of women in both groups was 38.4 
      years (mean difference -0.08, 95% CI -0.35 to 0.18). Data relating to the fetal 
      karyotype were missing in 143 cases in the control group. When taking into 
      account missing data, the incidence of CPM was lower in the IVF-ICSI group than 
      in the control group, 1.3% versus 2.2% (odds ratio 0.59, 95% CI 0.19-1.85), 
      whereas the incidence of fetal chromosomal anomalies was increased 4.3% versus 
      2.4% (odds ratio 1.81, 95% CI 0.95-3.42). Neither differences were statistically 
      significant. CONCLUSIONS: The incidence of CPM is not increased in IVF/ICSI 
      pregnancies compared with spontaneous conceptions. CPM probably does not account 
      for the adverse perinatal outcomes following IVF/ICSI.
FAU - Jacod, B C
AU  - Jacod BC
AD  - Department of Reproductive Medicine and Gynaecology, University Medical Centre, 
      Utrecht, The Netherlands. b.c.jacod@students.uu.nl
FAU - Lichtenbelt, K D
AU  - Lichtenbelt KD
FAU - Schuring-Blom, G H
AU  - Schuring-Blom GH
FAU - Laven, J S E
AU  - Laven JS
FAU - van Opstal, D
AU  - van Opstal D
FAU - Eijkemans, M J C
AU  - Eijkemans MJ
FAU - Macklon, N S
AU  - Macklon NS
CN  - IVF-CPM Study Group
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20080303
PL  - England
TA  - Hum Reprod
JT  - Human reproduction (Oxford, England)
JID - 8701199
SB  - IM
MH  - Adult
MH  - Chorionic Villi Sampling
MH  - Female
MH  - *Fertilization in Vitro
MH  - Fetus/cytology
MH  - Humans
MH  - Karyotyping
MH  - *Mosaicism
MH  - Ovulation Induction/adverse effects
MH  - Placenta/*cytology
MH  - Pregnancy
MH  - Pregnancy Outcome/*genetics
MH  - Retrospective Studies
MH  - *Sperm Injections, Intracytoplasmic
FIR - Bots, R S G M
IR  - Bots RS
FIR - Cohlen, B J
IR  - Cohlen BJ
FIR - van Dop, P
IR  - van Dop P
FIR - Faas, B H V
IR  - Faas BH
FIR - Goddijn, M
IR  - Goddijn M
FIR - Hoffer, M J V
IR  - Hoffer MJ
FIR - van Inzen, W G
IR  - van Inzen WG
FIR - Knegt, A C
IR  - Knegt AC
FIR - Kremer, J A M
IR  - Kremer JA
FIR - Land, J A
IR  - Land JA
FIR - Macville, M V E
IR  - Macville MV
FIR - Muntjewerff, N
IR  - Muntjewerff N
FIR - Nieuwint, A W M
IR  - Nieuwint AW
FIR - Schats, R
IR  - Schats R
FIR - Sikkema-Raddatz, B
IR  - Sikkema-Raddatz B
FIR - Verburg, H J
IR  - Verburg HJ
EDAT- 2008/03/06 09:00
MHDA- 2008/06/07 09:00
CRDT- 2008/03/06 09:00
PHST- 2008/03/06 09:00 [pubmed]
PHST- 2008/06/07 09:00 [medline]
PHST- 2008/03/06 09:00 [entrez]
AID - den062 [pii]
AID - 10.1093/humrep/den062 [doi]
PST - ppublish
SO  - Hum Reprod. 2008 May;23(5):1107-12. doi: 10.1093/humrep/den062. Epub 2008 Mar 3.

PMID- 21789019
OWN - NLM
STAT- MEDLINE
DCOM- 20110825
LR  - 20221007
IS  - 0300-8916 (Print)
IS  - 0300-8916 (Linking)
VI  - 97
IP  - 3
DP  - 2011 May-Jun
TI  - Do elderly cancer patients have different care needs compared with younger ones?
PG  - 374-9
AB  - AIMS AND BACKGROUND: The increasingly older population confronts oncologists with 
      an imposing challenge: older cancer patients have specific healthcare needs both 
      independent of and associated with the diagnosis of cancer. The aim of the 
      present study is to examine whether elderly versus younger cancer patients have 
      different needs with respect to attendance, treatment and information. METHODS 
      AND STUDY DESIGN: This is an observational and cross-sectional study. Cancer 
      patients aged 35 to 82 years were consecutively interviewed. The group was 
      divided into two subgroups aged </=65 and >/=66 years old. The Needs Evaluation 
      Questionnaire (NEQ) was used to assess patients' needs and demographic variables 
      were collected. Data analysis was carried out by means of cross-tabulation 
      analyses and the chi-square test. RESULTS: The requests most frequently expressed 
      by the older group concerned financial-insurance information (73.9%), the need to 
      talk to people with the same illness (71.7%), the need to receive more 
      comprehensible information from doctors and nurses (71.7%), and the need for a 
      better dialogue with clinicians (69.6%). Few significant differences between the 
      two age subgroups were found, with the exception of issues such as the need for 
      intimacy and support. CONCLUSIONS: Elderly patients have informational and 
      relational needs similar to those of younger patients. In fact, most of the whole 
      sample flagged up the need for higher levels of satisfaction especially 
      concerning a better dialogue with health staff, along with a new factor: the need 
      to talk to people with the same illness.
FAU - Romito, Francesca
AU  - Romito F
AD  - Experimental Unit of Psychological Oncology, Department of Critical Area and 
      Surgery, National Cancer Institute Giovanni Paolo II, Bari, Italy. 
      francescaromito@yahoo.com
FAU - Corvasce, Chiara
AU  - Corvasce C
FAU - Montanaro, Rosanna
AU  - Montanaro R
FAU - Mattioli, Vittorio
AU  - Mattioli V
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Tumori
JT  - Tumori
JID - 0111356
SB  - IM
CIN - Tumori. 2012 May-Jun;98(3):393. doi: 10.1177/030089161209800318. PMID: 22825517
MH  - Adult
MH  - Age Factors
MH  - Aged
MH  - Aged, 80 and over
MH  - Chi-Square Distribution
MH  - Cross-Sectional Studies
MH  - Female
MH  - *Health Services Needs and Demand
MH  - Humans
MH  - *Insurance Coverage
MH  - Insurance, Health
MH  - Male
MH  - Middle Aged
MH  - *Neoplasms
MH  - *Patient Satisfaction
MH  - *Professional-Patient Relations
MH  - Surveys and Questionnaires
EDAT- 2011/07/27 06:00
MHDA- 2011/08/27 06:00
CRDT- 2011/07/27 06:00
PHST- 2011/07/27 06:00 [entrez]
PHST- 2011/07/27 06:00 [pubmed]
PHST- 2011/08/27 06:00 [medline]
AID - 10.1177/030089161109700320 [doi]
PST - ppublish
SO  - Tumori. 2011 May-Jun;97(3):374-9. doi: 10.1177/030089161109700320.

PMID- 11567820
OWN - NLM
STAT- MEDLINE
DCOM- 20011011
LR  - 20220410
IS  - 0360-3016 (Print)
IS  - 0360-3016 (Linking)
VI  - 51
IP  - 2
DP  - 2001 Oct 1
TI  - Does increased nerve length within the treatment volume improve trigeminal 
      neuralgia radiosurgery? A prospective double-blind, randomized study.
PG  - 449-54
AB  - PURPOSE: To test the hypothesis that increasing the nerve length within the 
      treatment volume for trigeminal neuralgia radiosurgery would improve pain relief. 
      METHODS AND MATERIALS: Eighty-seven patients with typical trigeminal neuralgia 
      were randomized to undergo retrogasserian gamma knife radiosurgery (75 Gy maximal 
      dose with 4-mm diameter collimators) using either one (n = 44) or two (n = 43) 
      isocenters. The median follow-up was 26 months (range 1-36). RESULTS: Pain relief 
      was complete in 57 patients (45 without medication and 12 with low-dose 
      medication), partial in 15, and minimal in another 15 patients. The actuarial 
      rate of obtaining complete pain relief (with or without medication) was 67.7% +/- 
      5.1%. The pain relief was identical for one- and two-isocenter radiosurgery. Pain 
      relapsed in 30 of 72 responding patients. Facial numbness and mild and severe 
      paresthesias developed in 8, 5, and 1 two-isocenter patients vs. 3, 4, and 0 
      one-isocenter patients, respectively (p = 0.23). Improved pain relief correlated 
      with younger age (p = 0.025) and fewer prior procedures (p = 0.039) and 
      complications (numbness or paresthesias) correlated with the nerve length 
      irradiated (p = 0.018). CONCLUSIONS: Increasing the treatment volume to include a 
      longer nerve length for trigeminal neuralgia radiosurgery does not significantly 
      improve pain relief but may increase complications.
FAU - Flickinger, J C
AU  - Flickinger JC
AD  - Department of Radiation Oncology, University of Pittsburgh School of Medicine, 
      Pittsburgh, PA, USA. jflickin@msx.upmc.edu
FAU - Pollock, B E
AU  - Pollock BE
FAU - Kondziolka, D
AU  - Kondziolka D
FAU - Phuong, L K
AU  - Phuong LK
FAU - Foote, R L
AU  - Foote RL
FAU - Stafford, S L
AU  - Stafford SL
FAU - Lunsford, L D
AU  - Lunsford LD
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
PT  - Multicenter Study
PT  - Randomized Controlled Trial
PL  - United States
TA  - Int J Radiat Oncol Biol Phys
JT  - International journal of radiation oncology, biology, physics
JID - 7603616
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Analysis of Variance
MH  - Double-Blind Method
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Magnetic Resonance Imaging
MH  - Male
MH  - Middle Aged
MH  - Prospective Studies
MH  - Radiosurgery/*methods
MH  - Trigeminal Nerve/pathology/*surgery
MH  - Trigeminal Neuralgia/pathology/*surgery
EDAT- 2001/09/25 10:00
MHDA- 2001/10/12 10:01
CRDT- 2001/09/25 10:00
PHST- 2001/09/25 10:00 [pubmed]
PHST- 2001/10/12 10:01 [medline]
PHST- 2001/09/25 10:00 [entrez]
AID - S0360-3016(01)01606-6 [pii]
AID - 10.1016/s0360-3016(01)01606-6 [doi]
PST - ppublish
SO  - Int J Radiat Oncol Biol Phys. 2001 Oct 1;51(2):449-54. doi: 
      10.1016/s0360-3016(01)01606-6.

PMID- 10966943
OWN - NLM
STAT- MEDLINE
DCOM- 20001010
LR  - 20190501
IS  - 0007-1161 (Print)
IS  - 1468-2079 (Electronic)
IS  - 0007-1161 (Linking)
VI  - 84
IP  - 9
DP  - 2000 Sep
TI  - Amblyopia: is visual loss permanent?
PG  - 952-6
AB  - AIM: To ascertain whether recovery of visual function in amblyopic eyes is likely 
      to occur when the fellow eye is lost as a result of age related macular 
      degeneration. METHODS: The records of 465 patients with an established diagnosis 
      of age related macular degeneration who had attended a specialist macular clinic 
      between 1990 and 1998 were scrutinised. A full clinical examination and 
      standardised refraction had been carried out in 189 of these cases on a minimum 
      of two occasions. Cases were looked for where an improvement of one or more lines 
      of either distance or near acuity was recorded in the eye unaffected by macular 
      disease. In each one of these cases the improvement in visual acuity could not be 
      attributed to treatment of other existing pathology. RESULTS: 12 such cases were 
      detected. In nine of these the eye showing improvement of acuity had a history of 
      amblyopia. The mean improvement in distance and near acuity in amblyopic eyes by 
      12 months was 3.3 and 1.9 lines logMAR respectively. The improvement in acuity 
      generally occurred between 1 and 12 months from baseline and remained stable over 
      the period of follow up. CONCLUSIONS: Older people with a history of amblyopia 
      who develop visual loss in the previously normal eye can experience recovery of 
      visual function in the amblyopic eye over a period of time. This recovery in 
      visual function occurs in the wake of visual loss in the fellow eye and the 
      improvement appears to be sustained.
FAU - El Mallah, M K
AU  - El Mallah MK
AD  - Ophthalmology and Vision Science, Queen's University, Royal Victoria Hospital, 
      Belfast BT 12 6BA.
FAU - Chakravarthy, U
AU  - Chakravarthy U
FAU - Hart, P M
AU  - Hart PM
LA  - eng
PT  - Journal Article
PL  - England
TA  - Br J Ophthalmol
JT  - The British journal of ophthalmology
JID - 0421041
SB  - IM
CIN - Br J Ophthalmol. 2000 Sep;84(9):944-5. doi: 10.1136/bjo.84.9.944. PMID: 10966940
MH  - Amblyopia/*physiopathology/rehabilitation
MH  - Distance Perception/physiology
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Macular Degeneration/*physiopathology/rehabilitation
MH  - Male
MH  - Neuronal Plasticity/physiology
MH  - Retrospective Studies
MH  - Visual Acuity/*physiology
PMC - PMC1723664
EDAT- 2000/09/01 11:00
MHDA- 2000/10/14 11:01
PMCR- 2003/09/01
CRDT- 2000/09/01 11:00
PHST- 2000/09/01 11:00 [pubmed]
PHST- 2000/10/14 11:01 [medline]
PHST- 2000/09/01 11:00 [entrez]
PHST- 2003/09/01 00:00 [pmc-release]
AID - 10.1136/bjo.84.9.952 [doi]
PST - ppublish
SO  - Br J Ophthalmol. 2000 Sep;84(9):952-6. doi: 10.1136/bjo.84.9.952.

PMID- 8199520
OWN - NLM
STAT- MEDLINE
DCOM- 19940701
LR  - 20181130
IS  - 0008-350X (Print)
IS  - 1715-5258 (Electronic)
IS  - 0008-350X (Linking)
VI  - 40
DP  - 1994 Apr
TI  - Are physicians meeting the needs of family caregivers of the frail elderly?
PG  - 679-85
AB  - OBJECTIVE: To explore expressed needs, both formal and informal, of family 
      caregivers of frail elderly. To evaluate roles of physicians. DESIGN: 
      Questionnaire survey of members of the Montreal Jewish community providing care 
      for frail elderly family members. SETTING: Jewish community of Montreal. 
      PARTICIPANTS: Volunteer caregivers who were caring for a family member or friend 
      60 years or older, who had greatest responsibility for providing physical or 
      emotional support to an elderly person, who saw themselves as caregivers, and who 
      could speak English or French were studied. Of 118 volunteers, 32 were excluded 
      because they withdrew for personal reasons or because they did not meet study 
      criteria. MAIN OUTCOME MEASURES: Demographic variables, functional status of the 
      care receiver, use of home care services, and needs assessment to identify 
      additional services. RESULTS: An average of 75.4% respondents did not use formal 
      support services. Just under half of caregivers were dissatisfied with the 
      attention they received from the health care system, and more than one third 
      expressed feelings of stress, depression, guilt, and isolation. CONCLUSIONS: 
      Hypotheses for this discontent are presented. Physicians may be uninterested in 
      helping caregivers; even if they were receptive to counseling caregivers, they 
      could be poorly remunerated for the types of counseling sessions that are usual 
      for caregivers; and being a professional caregiver to family caregivers is 
      demanding in itself.
FAU - Brotman, S L
AU  - Brotman SL
AD  - McGill University School of Social Work Consortium for Ethnicity and Stategic 
      Social Planning.
FAU - Yaffe, M J
AU  - Yaffe MJ
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Canada
TA  - Can Fam Physician
JT  - Canadian family physician Medecin de famille canadien
JID - 0120300
SB  - IM
EIN - Can Fam Physician 1994 Jun;40:1093
CIN - Can Fam Physician. 1994 Sep;40:1509. PMID: 7920040
MH  - Activities of Daily Living
MH  - Adult
MH  - Aged
MH  - Attitude to Health
MH  - *Caregivers/psychology
MH  - Counseling
MH  - *Family/psychology
MH  - Female
MH  - *Frail Elderly
MH  - Geriatric Assessment
MH  - Health Services Accessibility
MH  - *Health Services Needs and Demand
MH  - Health Services Research
MH  - Home Care Services/statistics & numerical data
MH  - Humans
MH  - Jews
MH  - Male
MH  - Middle Aged
MH  - Patient Satisfaction
MH  - *Physician's Role
MH  - Quebec
MH  - Surveys and Questionnaires
PMC - PMC2380098
EDAT- 1994/04/01 00:00
MHDA- 1994/04/01 00:01
PMCR- 1994/04/01
CRDT- 1994/04/01 00:00
PHST- 1994/04/01 00:00 [pubmed]
PHST- 1994/04/01 00:01 [medline]
PHST- 1994/04/01 00:00 [entrez]
PHST- 1994/04/01 00:00 [pmc-release]
PST - ppublish
SO  - Can Fam Physician. 1994 Apr;40:679-85.

PMID- 21889895
OWN - NLM
STAT- MEDLINE
DCOM- 20120224
LR  - 20181201
IS  - 1878-4046 (Electronic)
IS  - 1076-6332 (Linking)
VI  - 18
IP  - 11
DP  - 2011 Nov
TI  - Will CT ordering practices change if we educate residents about the potential 
      effects of radiation exposure? Experience at a large academic medical center.
PG  - 1447-52
LID - 10.1016/j.acra.2011.07.006 [doi]
AB  - RATIONALE AND OBJECTIVES: The aim of this study was to determine if educating 
      residents about the potential effects of radiation exposure from computed 
      tomographic (CT) imaging alters ordering patterns. This study also explored 
      whether referring physicians are interested in radiation education and was an 
      initial effort to address their CT ordering behavior. MATERIALS AND METHODS: Two 
      to four months after a radiologist's lecture on the potential effects of 
      radiation exposure related to CT scans, urology and orthopedic residents were 
      surveyed regarding the number and types of CT scans they ordered, the use of 
      alternative imaging modalities, and whether they used the lecture information to 
      educate patients. RESULTS: Twenty-one resident lecture attendants completed the 
      survey. The number of CT scans ordered after the lecture stayed constant for 90% 
      (19 of 21) and decreased for 10% (two of 21). The types of CT scans ordered 
      changed after the lecture for 14% (three of 21). Thirty-three percent (seven of 
      21) reported increases in alternative imaging after the lecture, including 24% 
      (five of 21) reporting increases in magnetic resonance imaging and 19% (four of 
      21) reporting increases in ultrasound. Patients directed questions about 
      radiation exposure to 57% (12 of 21); 38% (eight of 21) used the lecture 
      information to educate patients. Referring physicians were interested in the 
      topic, and afterward, other physician groups requested radiation education 
      lectures. CONCLUSIONS: Most clinicians did not change their CT scan ordering 
      after receiving education about radiation from a radiologist. Radiation education 
      allowed clinicians to discuss CT benefits and risks with their patients and to 
      choose appropriate CT protocols. Referring physician groups are interested in 
      this topic, and radiologists should be encouraged to give radiation lectures to 
      them.
CI  - Copyright (c) 2011 AUR. Published by Elsevier Inc. All rights reserved.
FAU - Horowitz, Jeanne M
AU  - Horowitz JM
AD  - Department of Radiology, Feinberg School of Medicine, Northwestern University, 
      Chicago, IL 60611, USA. jhorowitz77@gmail.com
FAU - Yaghmai, Vahid
AU  - Yaghmai V
FAU - Miller, Frank H
AU  - Miller FH
FAU - Russell, Eric J
AU  - Russell EJ
LA  - eng
PT  - Journal Article
DEP - 20110901
PL  - United States
TA  - Acad Radiol
JT  - Academic radiology
JID - 9440159
SB  - IM
MH  - Academic Medical Centers
MH  - Education, Medical, Graduate/*methods
MH  - Humans
MH  - Internship and Residency
MH  - Patient Education as Topic
MH  - Practice Patterns, Physicians'/*statistics & numerical data
MH  - *Radiation Dosage
MH  - *Radiation Protection
MH  - Radiology/*education
MH  - Risk
MH  - Tomography, X-Ray Computed/*statistics & numerical data
EDAT- 2011/09/06 06:00
MHDA- 2012/03/01 06:00
CRDT- 2011/09/06 06:00
PHST- 2011/03/29 00:00 [received]
PHST- 2011/07/12 00:00 [revised]
PHST- 2011/07/18 00:00 [accepted]
PHST- 2011/09/06 06:00 [entrez]
PHST- 2011/09/06 06:00 [pubmed]
PHST- 2012/03/01 06:00 [medline]
AID - S1076-6332(11)00349-7 [pii]
AID - 10.1016/j.acra.2011.07.006 [doi]
PST - ppublish
SO  - Acad Radiol. 2011 Nov;18(11):1447-52. doi: 10.1016/j.acra.2011.07.006. Epub 2011 
      Sep 1.

PMID- 26113007
OWN - NLM
STAT- MEDLINE
DCOM- 20161213
LR  - 20211203
IS  - 1472-6831 (Electronic)
IS  - 1472-6831 (Linking)
VI  - 15
DP  - 2015 Jun 26
TI  - Is arch form influenced by sagittal molar relationship or Bolton tooth-size 
      discrepancy?
PG  - 70
LID - 10.1186/s12903-015-0062-2 [doi]
LID - 70
AB  - BACKGROUND: Orthodontic patients show high prevalence of tooth-size discrepancy. 
      This study investigates the possible association between arch form, clinically 
      significant tooth-size discrepancy, and sagittal molar relationship. METHODS: 
      Pretreatment orthodontic casts of 230 Saudi patients were classified into one of 
      three arch form types (tapered, ovoid, and square) using digitally scanned images 
      of the mandibular arches. Bolton ratio was calculated, sagittal molar 
      relationship was defined according to Angle classification, and correlations were 
      analyzed using ANOVA, chi-square, and t-tests. RESULTS: No single arch form was 
      significantly more common than the others. Furthermore, no association was 
      observed between the presence of significant Bolton discrepancy and the sagittal 
      molar relationship or arch form. Overall Bolton discrepancy is significantly more 
      prevalent in males. CONCLUSIONS: Arch form in a Saudi patient group is 
      independent of gender, sagittal molar relationship, and Bolton discrepancy.
FAU - Aldrees, Abdullah M
AU  - Aldrees AM
AD  - Department of Pediatric Dentistry and Orthodontics, College of Dentistry, King 
      Saud University, P.O. Box 60169-38, Riyadh, 11545, Saudi Arabia. 
      amaldrees@ksu.edu.sa.
FAU - Al-Shujaa, Abdulmajeed M
AU  - Al-Shujaa AM
AD  - Resident, Department of Dentistry, King Fahad Medical City, Riyadh, Saudi Arabia. 
      o_ams_o@hotmail.com.
FAU - Alqahtani, Mohammad A
AU  - Alqahtani MA
AD  - Resident, Advanced Education in General Dentistry Program, School of Dental 
      Medicine, State University of New York at Buffalo, Buffalo, NY, USA. 
      malqahta@buffalo.edu.
FAU - Aljhani, Ali S
AU  - Aljhani AS
AD  - Division of Orthodontics, College of Dentistry, King Saud bin Abdulaziz 
      University For Health Sciences, Consultant Orthodontist, National Guard Health 
      Affairs, Riyadh, Saudi Arabia. aljhani.a@gmail.com.
LA  - eng
PT  - Journal Article
DEP - 20150626
PL  - England
TA  - BMC Oral Health
JT  - BMC oral health
JID - 101088684
SB  - IM
MH  - Adolescent
MH  - Child
MH  - Computer-Aided Design
MH  - Dental Arch/*pathology
MH  - Female
MH  - Humans
MH  - Image Processing, Computer-Assisted/methods
MH  - Male
MH  - Malocclusion, Angle Class I/pathology
MH  - Malocclusion, Angle Class II/pathology
MH  - Malocclusion, Angle Class III/pathology
MH  - Mandible/*pathology
MH  - Models, Dental
MH  - Molar/*pathology
MH  - Odontometry/*methods
MH  - Optical Imaging/methods
MH  - Saudi Arabia
MH  - Tooth/*pathology
MH  - Tooth Crown/pathology
MH  - Young Adult
PMC - PMC4482311
EDAT- 2015/06/27 06:00
MHDA- 2016/12/15 06:00
PMCR- 2015/06/26
CRDT- 2015/06/27 06:00
PHST- 2014/11/01 00:00 [received]
PHST- 2015/06/17 00:00 [accepted]
PHST- 2015/06/27 06:00 [entrez]
PHST- 2015/06/27 06:00 [pubmed]
PHST- 2016/12/15 06:00 [medline]
PHST- 2015/06/26 00:00 [pmc-release]
AID - 10.1186/s12903-015-0062-2 [pii]
AID - 62 [pii]
AID - 10.1186/s12903-015-0062-2 [doi]
PST - epublish
SO  - BMC Oral Health. 2015 Jun 26;15:70. doi: 10.1186/s12903-015-0062-2.

PMID- 17208539
OWN - NLM
STAT- MEDLINE
DCOM- 20070205
LR  - 20070108
IS  - 1531-5037 (Electronic)
IS  - 0022-3468 (Linking)
VI  - 42
IP  - 1
DP  - 2007 Jan
TI  - Are the long-term results of the transanal pull-through equal to those of the 
      transabdominal pull-through? A comparison of the 2 approaches for Hirschsprung 
      disease.
PG  - 41-7; discussion 47
AB  - PURPOSE: The transanal endorectal pull-through (TERPT) is becoming the most 
      popular procedure in the treatment of Hirschsprung disease (HD), but 
      overstretching of the anal sphincters remains a critical issue that may impact 
      the continence. This study examined the long-term outcome of TERPT versus 
      conventional transabdominal (ABD) pull-through for HD. METHODS: Records of 41 
      patients more than 3 years old who underwent a pull-through for HD (TERPT, n = 
      20; ABD, n = 21) were reviewed, and their families were thoroughly interviewed 
      and scored via a 15-item post-pull-through long-term outcome questionnaire. 
      Patients were operated on between the years 1995 and 2003. During this time, our 
      group transitioned from the ABD to the TERPT technique. Total scoring ranged from 
      0 to 40: 0 to 10, excellent; 11 to 20 good; 21 to 30 fair; 31 to 40 poor. A 
      2-tailed Student t test, analysis of covariance, as well as logistic and linear 
      regression were used to analyze the collected data with confidence interval 
      higher than 95%. RESULTS: Overall scores were similar. However, continence score 
      was significantly better in the ABD group, and the stool pattern score was better 
      in the TERPT group. A significant difference in age at interview between the 2 
      groups was noted; we therefore reanalyzed the data controlling for age, and this 
      showed that age did not significantly affect the long-term scoring outcome 
      between groups. CONCLUSION: Our long-term study showed significantly better 
      (2-fold) results regarding the continence score for the abdominal approach 
      compared with the transanal pull-through. The stool pattern and enterocolitis 
      scores were somewhat better for the TERPT group. These findings raise an 
      important issue about the current surgical management of HD; however, more cases 
      will need to be studied before a definitive conclusion can be drawn.
FAU - El-Sawaf, Mohamed I
AU  - El-Sawaf MI
AD  - Section of Pediatric Surgery, The C.S. Mott's Children's Hospital, University of 
      Michigan, Ann Arbor, MI 48109-0245, USA.
FAU - Drongowski, Robert A
AU  - Drongowski RA
FAU - Chamberlain, Jennifer N
AU  - Chamberlain JN
FAU - Coran, Arnold G
AU  - Coran AG
FAU - Teitelbaum, Daniel H
AU  - Teitelbaum DH
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - United States
TA  - J Pediatr Surg
JT  - Journal of pediatric surgery
JID - 0052631
SB  - IM
MH  - Child
MH  - Child, Preschool
MH  - Colectomy/*methods
MH  - Female
MH  - Hirschsprung Disease/*surgery
MH  - Humans
MH  - Male
MH  - Treatment Outcome
EDAT- 2007/01/09 09:00
MHDA- 2007/02/06 09:00
CRDT- 2007/01/09 09:00
PHST- 2007/01/09 09:00 [pubmed]
PHST- 2007/02/06 09:00 [medline]
PHST- 2007/01/09 09:00 [entrez]
AID - S0022-3468(06)00651-8 [pii]
AID - 10.1016/j.jpedsurg.2006.09.007 [doi]
PST - ppublish
SO  - J Pediatr Surg. 2007 Jan;42(1):41-7; discussion 47. doi: 
      10.1016/j.jpedsurg.2006.09.007.

PMID- 20538207
OWN - NLM
STAT- MEDLINE
DCOM- 20101029
LR  - 20100611
IS  - 1166-7087 (Print)
IS  - 1166-7087 (Linking)
VI  - 20
IP  - 6
DP  - 2010 Jun
TI  - [Should temperature be monitorized during kidney allograft preservation?].
PG  - 430-4
LID - 10.1016/j.purol.2009.11.004 [doi]
AB  - GOAL: It is generally considered that kidney grafts should be preserved at 4 
      degrees C during cold storage. However, actual temperature conditions are not 
      known. We decided to study the temperature levels during preservation with the 
      Biotainer storage can and Vitalpack transport pack. MATERIAL: Temperature was 
      monitored using the Thermobouton probe during preservation of pig kidneys, in the 
      same conditions used with human grafts. The probe recorded the temperature level 
      every 10 minutes during four days. We compared the results found with the new 
      storage can with results obtained in the same conditions with the storage can 
      formerly used by our team. We also studied the best position of the probe for 
      temperature monitoring and the influence of the amount of ice within the 
      transport pack on the temperature level. We then monitored the temperature during 
      the conservation of actual human kidney grafts harvested at our institution from 
      August 2007 to May 2008. RESULTS: The temperature levels were the same regardless 
      of the position of the probe within the transport pack. The lowest temperature 
      was maintained during 15 hours, and the temperature level stayed below 5 degrees 
      C for 57 hours with the new storage can. The former storage can maintained the 
      lowest temperature level for 80 minutes, and temperature reached 5 degrees C 
      after 10 hours 40 minutes. Temperature levels were similar when 2 or 4 kg of 
      crushed ice were used. We observed similar results when monitoring the 
      conservation of human grafts. CONCLUSION: The new storage can affords more stable 
      temperature levels when compared to the formerly used can. Since temperature is 
      stable during conservation, continuous monitoring in everyday practice does not 
      seem warranted.
CI  - Copyright 2009 Elsevier Masson SAS. All rights reserved.
FAU - Billault, C
AU  - Billault C
AD  - Service d'urologie et de transplantation renale et pancreatique, hopital de La 
      Pitie-Salpetriere, 47-83, boulevard de l'Hopital, 75651 Paris cedex 13, France. 
      clairebillault@orange.fr
FAU - Rolland, E
AU  - Rolland E
FAU - Vaessen, C
AU  - Vaessen C
FAU - Van Glabeke, E
AU  - Van Glabeke E
FAU - Gouezo, R
AU  - Gouezo R
FAU - Richard, F
AU  - Richard F
FAU - Barrou, B
AU  - Barrou B
LA  - fre
PT  - English Abstract
PT  - Journal Article
TT  - Faut-il monitorer la temperature pendant la phase de preservation en 
      transplantation renale ?
DEP - 20091230
PL  - France
TA  - Prog Urol
JT  - Progres en urologie : journal de l'Association francaise d'urologie et de la 
      Societe francaise d'urologie
JID - 9307844
SB  - IM
MH  - Animals
MH  - *Body Temperature
MH  - Cold Temperature
MH  - Humans
MH  - *Kidney Transplantation
MH  - Organ Preservation/*methods
MH  - Swine
EDAT- 2010/06/12 06:00
MHDA- 2010/10/30 06:00
CRDT- 2010/06/12 06:00
PHST- 2008/06/25 00:00 [received]
PHST- 2009/10/28 00:00 [revised]
PHST- 2009/11/27 00:00 [accepted]
PHST- 2010/06/12 06:00 [entrez]
PHST- 2010/06/12 06:00 [pubmed]
PHST- 2010/10/30 06:00 [medline]
AID - S1166-7087(09)00470-9 [pii]
AID - 10.1016/j.purol.2009.11.004 [doi]
PST - ppublish
SO  - Prog Urol. 2010 Jun;20(6):430-4. doi: 10.1016/j.purol.2009.11.004. Epub 2009 Dec 
      30.

PMID- 9603166
OWN - NLM
STAT- MEDLINE
DCOM- 19980619
LR  - 20190713
IS  - 0041-1337 (Print)
IS  - 0041-1337 (Linking)
VI  - 65
IP  - 9
DP  - 1998 May 15
TI  - Should all human immunodeficiency virus-infected patients with end-stage renal 
      disease be excluded from transplantation? The views of U.S. transplant centers.
PG  - 1187-91
AB  - BACKGROUND: Human immunodeficiency virus (HIV)-infected patients have generally 
      been excluded from transplantation. Recent advances in the management and 
      prognosis of these patients suggest that this policy should be reevaluated. 
      METHODS: To explore the current views of U.S. transplant centers toward 
      transplanting asymptomatic HIV-infected patients with end-stage renal disease, a 
      written survey was mailed to the directors of transplantation at all 248 renal 
      transplant centers in the United States. RESULTS: All 148 responding centers said 
      they require HIV testing of prospective kidney recipients, and 84% of these 
      centers would not transplant an individual who refuses HIV testing. The vast 
      majority of responding centers would not transplant a kidney from a cadaveric 
      (88%) or a living donor (91%) into an asymptomatic HIV-infected patient who is 
      otherwise a good candidate for transplantation. Among the few centers that would 
      consider transplanting an HIV-infected patient, not a single center had performed 
      such a transplant in the year prior to the survey. Most centers fear that 
      transplantation in the face of HIV infection would be harmful to the individual, 
      and some believe that it would be a waste of precious organs. CONCLUSIONS: The 
      great majority of U.S. renal transplant centers will not transplant kidneys to 
      HIV-infected patients with end-stage renal disease, even if their infection is 
      asymptomatic. However, advances in the management of HIV infection and a review 
      of relevant ethical issues suggest that this approach should be reconsidered.
FAU - Spital, A
AU  - Spital A
AD  - University of Rochester School of Medicine, New York, USA. aspital@rghnet.edu
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Transplantation
JT  - Transplantation
JID - 0132144
SB  - IM
MH  - HIV Infections/*complications/physiopathology
MH  - Health Care Rationing
MH  - Humans
MH  - Kidney Failure, Chronic/*complications/*surgery
MH  - *Kidney Transplantation
MH  - Middle Aged
MH  - Patient Selection
MH  - Postoperative Complications
MH  - Surveys and Questionnaires
OID - KIE: 112092
OID - NRCBL: VF 9.5.6
OTO - KIE
OT  - Empirical Approach
OT  - Health Care and Public Health
GN  - KIE: 36 refs.
GN  - KIE: KIE Bib: AIDS; organ and tissue transplantation; resource 
      allocation/biomedical technologies; selection for treatment
EDAT- 1998/05/29 00:00
MHDA- 1998/05/29 00:01
CRDT- 1998/05/29 00:00
PHST- 1998/05/29 00:00 [pubmed]
PHST- 1998/05/29 00:01 [medline]
PHST- 1998/05/29 00:00 [entrez]
AID - 10.1097/00007890-199805150-00008 [doi]
PST - ppublish
SO  - Transplantation. 1998 May 15;65(9):1187-91. doi: 
      10.1097/00007890-199805150-00008.

PMID- 21194998
OWN - NLM
STAT- MEDLINE
DCOM- 20111028
LR  - 20141120
IS  - 1532-2149 (Electronic)
IS  - 1090-3801 (Linking)
VI  - 15
IP  - 6
DP  - 2011 Jul
TI  - Does minimal access major surgery in the newborn hurt less? An evaluation of 
      cumulative opioid doses.
PG  - 615-20
LID - 10.1016/j.ejpain.2010.11.010 [doi]
AB  - BACKGROUND: Minimal access surgery (MAS) in adults is associated with less 
      postoperative pain in comparison to conventional 'open' surgery. It is not known 
      whether this holds true for neonates as well. Less pain would imply that opioid 
      consumption can be reduced, which has a beneficial effect on morbidity. AIM: To 
      evaluate potential differences in' opioid consumption between neonates undergoing 
      thoracoscopic minimal access surgery or conventional surgery of esophageal 
      atresia (EA) and congenital diaphragmatic hernia (CDH). METHODS: In this 
      retrospective cohort study we included two controls for each MAS patient, matched 
      on diagnosis, sex and age at surgery. Opioid dose titration was based on 
      validated pain scores (VAS and COMFORT behaviour), applied by protocol. 
      Cumulative opioid doses at 12, 24, 48 h and 7 days postoperatively were compared 
      between groups with the Mann-Whitney test. RESULTS: The study group consisted of 
      24 MAS patients (14 EA; 10 CDH). These were matched to 48 control patients (28 
      EA; 20 CDH). At none of the time points cumulative opioid (median in mg/kg (IQR)) 
      doses significantly differed between MAS patients and controls, both with CDH and 
      EA. For example at 24 h postoperative for CDH patients cumulative opioid doses 
      were [0.84(0.61-1.83) MAS vs. 1.06(0.60-1.36) p=1.0] controls, For EA patients at 
      24 h the cumulative opioid doses were [0.48(0.30-0.75) MAS vs. 0.49(0.35-0.79) 
      p=0.83] controls. This held true for the postoperative pain scores as well. 
      CONCLUSIONS: Minimal access surgery for the repair of esophageal atresia or 
      congenital diaphragmatic hernia is not associated with less cumulative opioid 
      doses.
CI  - Copyright (c) 2010. Published by Elsevier Ltd.
FAU - Ceelie, I
AU  - Ceelie I
AD  - Department of Pediatric Surgery, Erasmus MC, Sophia Children's Hospital, 
      Rotterdam, The Netherlands.
FAU - van Dijk, M
AU  - van Dijk M
FAU - Bax, N M A
AU  - Bax NM
FAU - de Wildt, S N
AU  - de Wildt SN
FAU - Tibboel, D
AU  - Tibboel D
LA  - eng
PT  - Journal Article
DEP - 20101230
PL  - England
TA  - Eur J Pain
JT  - European journal of pain (London, England)
JID - 9801774
RN  - 0 (Analgesics, Opioid)
RN  - 76I7G6D29C (Morphine)
RN  - UF599785JZ (Fentanyl)
SB  - IM
MH  - Analgesics, Opioid/*administration & dosage
MH  - Esophageal Atresia/surgery
MH  - Female
MH  - Fentanyl/*administration & dosage
MH  - Hernia, Diaphragmatic/surgery
MH  - Hernias, Diaphragmatic, Congenital
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Male
MH  - Minimally Invasive Surgical Procedures/*adverse effects
MH  - Morphine/*administration & dosage
MH  - Pain Measurement/*drug effects
MH  - Pain, Postoperative/*drug therapy
MH  - Retrospective Studies
EDAT- 2011/01/05 06:00
MHDA- 2011/10/29 06:00
CRDT- 2011/01/04 06:00
PHST- 2010/05/02 00:00 [received]
PHST- 2010/11/07 00:00 [revised]
PHST- 2010/11/24 00:00 [accepted]
PHST- 2011/01/04 06:00 [entrez]
PHST- 2011/01/05 06:00 [pubmed]
PHST- 2011/10/29 06:00 [medline]
AID - S1090-3801(10)00280-6 [pii]
AID - 10.1016/j.ejpain.2010.11.010 [doi]
PST - ppublish
SO  - Eur J Pain. 2011 Jul;15(6):615-20. doi: 10.1016/j.ejpain.2010.11.010. Epub 2010 
      Dec 30.

PMID- 21252642
OWN - NLM
STAT- MEDLINE
DCOM- 20111219
LR  - 20220309
IS  - 1538-9804 (Electronic)
IS  - 0162-220X (Linking)
VI  - 34
IP  - 5
DP  - 2011 Sep-Oct
TI  - Does increased patient awareness improve accrual into cancer-related clinical 
      trials?
PG  - E13-9
LID - 10.1097/NCC.0b013e31820254db [doi]
AB  - BACKGROUND: Oncology literature cites that only 2% to 4% of patients participate 
      in research. Up to 85% of patients are unaware that clinical trials research is 
      being conducted at their treatment facility or that they might be eligible to 
      participate. OBJECTIVES: It was hypothesized that patients' satisfaction with 
      information regarding clinical trials would improve after targeted educational 
      interventions, and accruals to clinical trials would increase in the year 
      following those interventions. METHODS: All new patients referred to the cancer 
      center over a 4-month period were mailed a baseline survey to assess their 
      knowledge of clinical research. Subsequently, educational interventions were 
      provided, including an orientation session highlighting clinical trials, a 
      pamphlet, and a reference to a clinical trials Web site. A postintervention 
      survey was sent to the responders of the initial survey 3 months after the 
      initial mailing. RESULTS: Patient satisfaction with information significantly 
      increased after the interventions. There was no increase in subsequent enrollment 
      in clinical trials. Patients who indicated an inclination to participate in 
      clinical trials tended to have greater satisfaction with the information they 
      received. CONCLUSIONS: A set of educational interventions designed for cancer 
      patients significantly improved their satisfaction with information on clinical 
      research, but did not improve clinical trial enrollment of these participants as 
      of 1 year after the study. IMPLICATIONS FOR PRACTICE: The development of 
      educational interventions may be justified, but such interventions may require 
      prolonged implementation to establish benefit. Information relating to research 
      may be most effectively delivered by patients' primary cancer care providers.
FAU - Stiles, Carla R
AU  - Stiles CR
AD  - Tom Baker Cancer Centre, Alberta Health Services Cancer Care, Calgary, Canada. 
      carla.stiles@albertahealthservices.ca
FAU - Johnson, Laureen
AU  - Johnson L
FAU - Whyte, Darlene
AU  - Whyte D
FAU - Nergaard, Tevi Helland
AU  - Nergaard TH
FAU - Gardner, Jane
AU  - Gardner J
FAU - Wu, Jackson
AU  - Wu J
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Cancer Nurs
JT  - Cancer nursing
JID - 7805358
SB  - IM
MH  - *Clinical Trials as Topic
MH  - Cross-Sectional Studies
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Neoplasms/*therapy
MH  - Patient Education as Topic/*methods
MH  - *Patient Participation
MH  - Patient Satisfaction
MH  - Physician-Patient Relations
MH  - Prospective Studies
EDAT- 2011/01/22 06:00
MHDA- 2011/12/20 06:00
CRDT- 2011/01/22 06:00
PHST- 2011/01/22 06:00 [entrez]
PHST- 2011/01/22 06:00 [pubmed]
PHST- 2011/12/20 06:00 [medline]
AID - 10.1097/NCC.0b013e31820254db [doi]
PST - ppublish
SO  - Cancer Nurs. 2011 Sep-Oct;34(5):E13-9. doi: 10.1097/NCC.0b013e31820254db.

PMID- 16678696
OWN - NLM
STAT- MEDLINE
DCOM- 20060530
LR  - 20121003
IS  - 0741-5214 (Print)
IS  - 0741-5214 (Linking)
VI  - 43
IP  - 5
DP  - 2006 May
TI  - Continuity of care experience of residents in an academic vascular department: 
      are trainees learning complete surgical care?
PG  - 999-1003
AB  - BACKGROUND: It is widely accepted that exemplary surgical care involves a 
      surgeon's involvement in the preoperative, perioperative, and postoperative 
      periods. In an era of ever-expanding therapeutic modalities available to the 
      vascular surgeon, it is important that trainees gain experience in preoperative 
      decision-making and how this affects a patient's operative and postoperative 
      course. The purpose of this study was to define the current experience of 
      residents on a vascular surgery service regarding the continuity of care they are 
      able to provide for patients and the factors affecting this experience. METHODS: 
      This prospective cohort study was approved by the Institutional Review Board and 
      conducted at the University of British Columbia during January 2005. All patients 
      who underwent a vascular procedure at either of the two teaching hospitals were 
      included. In addition to type of case (emergent, outpatient, inpatient), resident 
      demographic data and involvement in each patient's care (preoperative assessment, 
      postoperative daily assessment, and follow-up clinic assessment) were recorded. 
      Categoric data were analyzed with the chi2 test. RESULTS: The study included 159 
      cases, of which 65% were elective same-day admission patients, 20% were elective 
      previously admitted patients; and 15% were emergent. The overall rate of 
      preoperative assessment was 67%, involvement in the decision to operate, 17%; 
      postoperative assessment on the ward, 79%; and patient follow-up in clinic, 3%. 
      The rate of complete in-hospital continuity of care (assessing patient pre-op and 
      post-op) was 57%. Emergent cases were associated with a significantly higher rate 
      of preoperative assessment (92% vs 63%, P < .05). For elective cases admitted 
      before the day of surgery compared with same-day admission patients, the rates of 
      preoperative assessment (78% vs 58%, P < .05) and involvement in the decision to 
      operate (16% vs 4%, P < .05) were significantly higher. CONCLUSIONS: The 
      continuity-of-care experiences of vascular trainees are suboptimal. This is 
      especially true for postoperative clinic assessment. Same-day admission surgery 
      accounted for most of the cases and was associated with the poorest continuity of 
      care. To provide complete surgical training in an era of changing therapeutic 
      modalities and same-day admission surgery, vascular programs must be creative in 
      structuring training to include adequate ambulatory experience.
FAU - Gagnon, Joel
AU  - Gagnon J
AD  - Department of Surgery, Division Vascular Surgery, University of British Columbia, 
      Vancouver, British Columbia, Canada.
FAU - Melck, Adrienne
AU  - Melck A
FAU - Kamal, Dhafer
AU  - Kamal D
FAU - Al-Assiri, Mohammed
AU  - Al-Assiri M
FAU - Chen, Jerry
AU  - Chen J
FAU - Sidhu, Ravi S
AU  - Sidhu RS
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - United States
TA  - J Vasc Surg
JT  - Journal of vascular surgery
JID - 8407742
SB  - IM
MH  - Ambulatory Surgical Procedures/education
MH  - British Columbia
MH  - Cohort Studies
MH  - *Continuity of Patient Care
MH  - Curriculum/trends
MH  - Decision Making
MH  - Emergencies
MH  - Forecasting
MH  - Hospitals, Teaching
MH  - Humans
MH  - *Internship and Residency
MH  - Postoperative Care/*education
MH  - Preoperative Care/*education
MH  - Prospective Studies
MH  - *Surgery Department, Hospital
MH  - Vascular Surgical Procedures/*education
EDAT- 2006/05/09 09:00
MHDA- 2006/05/31 09:00
CRDT- 2006/05/09 09:00
PHST- 2005/11/23 00:00 [received]
PHST- 2006/01/27 00:00 [accepted]
PHST- 2006/05/09 09:00 [pubmed]
PHST- 2006/05/31 09:00 [medline]
PHST- 2006/05/09 09:00 [entrez]
AID - S0741-5214(06)00209-6 [pii]
AID - 10.1016/j.jvs.2006.01.027 [doi]
PST - ppublish
SO  - J Vasc Surg. 2006 May;43(5):999-1003. doi: 10.1016/j.jvs.2006.01.027.

PMID- 20549895
OWN - NLM
STAT- MEDLINE
DCOM- 20100722
LR  - 20101019
IS  - 0023-9852 (Print)
IS  - 0023-9852 (Linking)
VI  - 58
IP  - 2
DP  - 2010 Apr-Jun
TI  - [Health habits and vaccination status of Lebanese residents: are future doctors 
      applying the rules of prevention?].
PG  - 91-6
AB  - BACKGROUND: There has never been a nationally representative survey of medical 
      students' personal health-related practices, although they are inherently of 
      interest and may affect patient-counseling practices. This study evaluated the 
      health practices and the vaccination status of first year residents working at 
      the academic hospital Hotel-Dieu de France. METHODS: The medical files of all 
      medicine and surgery residents in their first year of specialization between the 
      years 2005 and 2008 were reviewed. These residents were required to go through a 
      preventive medical visit at the University Center of Family and Community Health. 
      RESULTS: One hundred and nine residents (109) were included in the study; 68 
      (6239%) were male and 41 (37.61%) were female with a mean age of 26 years. Only 6 
      residents (5.50%) practiced physical activity according to international 
      guidelines (more than three times a week for more than 30 minutes each time). 
      Most residents (n = 76 ; 69.73%) used to skip one or two meals especially 
      breakfast and as a consequence 30 male (44.11%) and 4 female (9.75%) students 
      were overweight, with a statistical difference between the two sexes (Fisher 
      test, p-value = 0.001). Twenty-eight residents (25.69%) were smokers with a male 
      predominance. Fourteen residents of both genders (12.84%) drank alcohol regularly 
      (> 3 times a week) and 71 (65.14%) had a drink occasionally (once a month or 
      less). Only 25 residents (23%) of the cohort had a complete and up-to-date 
      immunization status. The immunization gap was basically against measles, mumps, 
      rubella (MMR) and diphtheria, tetanus, poliomyelitis (dT Polio). Ninety-nine 
      residents (90.83%) had full immunization against hepatitis B with an adequate 
      response in 78 residents (71.56%). CONCLUSION: This study showed that our 
      residents did not always have a healthy lifestyle especially when it comes to 
      physical activity and eating habits. They also lacked an adequate vaccination. 
      Interventions should take place in order to promote healthy life style and to 
      improve their vaccination status.
FAU - Hage, Claudine Nasr
AU  - Hage CN
AD  - Departement de medecine de famille, Universite Saint-Joseph (USJ), Beyrouth, 
      Liban. drnasr@yahoo.com
FAU - Sayegh, Josiane
AU  - Sayegh J
FAU - Rizk, Grace Abi
AU  - Rizk GA
LA  - fre
PT  - English Abstract
PT  - Journal Article
TT  - Comportements a risque et statut vaccinal des residents au Liban: les futurs 
      medecins appliquent-ils les regles de la prevention?
PL  - Lebanon
TA  - J Med Liban
JT  - Le Journal medical libanais. The Lebanese medical journal
JID - 0375352
SB  - IM
MH  - Adult
MH  - Feeding Behavior
MH  - Female
MH  - *Health Behavior
MH  - Humans
MH  - *Internship and Residency
MH  - Lebanon/epidemiology
MH  - Male
MH  - Overweight/epidemiology
MH  - Physicians/*statistics & numerical data
MH  - Smoking/epidemiology
MH  - Vaccination/*statistics & numerical data
EDAT- 2010/06/17 06:00
MHDA- 2010/07/23 06:00
CRDT- 2010/06/17 06:00
PHST- 2010/06/17 06:00 [entrez]
PHST- 2010/06/17 06:00 [pubmed]
PHST- 2010/07/23 06:00 [medline]
PST - ppublish
SO  - J Med Liban. 2010 Apr-Jun;58(2):91-6.

PMID- 16418930
OWN - NLM
STAT- MEDLINE
DCOM- 20060321
LR  - 20091111
IS  - 0023-2165 (Print)
IS  - 0023-2165 (Linking)
VI  - 223
IP  - 1
DP  - 2006 Jan
TI  - [Landolt C and snellen e acuity: differences in strabismus amblyopia?].
PG  - 24-8
AB  - BACKGROUND: Assessment of visual acuity depends on the optotypes used for 
      measurement. The ability to recognize different optotypes differs even if their 
      critical details appear under the same visual angle. Since optotypes are 
      evaluated on individuals with good visual acuity and without eye disorders, 
      differences in the lower visual acuity range cannot be excluded. In this study, 
      visual acuity measured with the Snellen E was compared to the Landolt C acuity. 
      PATIENTS AND METHODS: 100 patients (age 8 - 90 years, median 60.5 years) with 
      various eye disorders, among them 39 with amblyopia due to strabismus, and 13 
      healthy volunteers were tested. Charts with the Snellen E and the Landolt C 
      (Precision Vision) which mimic the ETDRS charts were used to assess visual 
      acuity. Three out of 5 optotypes per line had to be correctly identified, while 
      wrong answers were monitored. In the group of patients, the eyes with the lower 
      visual acuity, and the right eyes of the healthy subjects, were evaluated. 
      RESULTS: Differences between Landolt C acuity (LR) and Snellen E acuity (SE) were 
      small. The mean decimal values for LR and SE were 0.25 and 0.29 in the entire 
      group and 0.14 and 0.16 for the eyes with strabismus amblyopia. The mean 
      difference between LR and SE was 0.55 lines in the entire group and 0.55 lines 
      for the eyes with strabismus amblyopia, with higher values of SE in both groups. 
      The results of the other groups were similar with only small differences between 
      LR and SE. CONCLUSION: Using the charts described, there was only a slight 
      overestimation of visual acuity by the Snellen E compared to the Landolt C, even 
      in strabismus amblyopia. Small differences in the lower visual acuity range have 
      to be considered.
FAU - Becker, R
AU  - Becker R
AD  - Zentrum fur Augenheilkunde der Justus-Liebig-Universitat Giessen. 
      ralph-becker@web.de
FAU - Graf, M
AU  - Graf M
LA  - ger
PT  - Comparative Study
PT  - English Abstract
PT  - Journal Article
TT  - Landolt-Ring- vs. Snellen-E-Visus: Unterschiede bei Schielamblyopie?
PL  - Germany
TA  - Klin Monbl Augenheilkd
JT  - Klinische Monatsblatter fur Augenheilkunde
JID - 0014133
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Amblyopia/*diagnosis
MH  - Cataract/diagnosis
MH  - Child
MH  - Eye Diseases/diagnosis
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Reference Values
MH  - Refractive Errors/diagnosis
MH  - Reproducibility of Results
MH  - Retinal Diseases/diagnosis
MH  - Strabismus/*diagnosis
MH  - Vision Tests/*statistics & numerical data
MH  - *Visual Acuity
EDAT- 2006/01/19 09:00
MHDA- 2006/03/22 09:00
CRDT- 2006/01/19 09:00
PHST- 2006/01/19 09:00 [pubmed]
PHST- 2006/03/22 09:00 [medline]
PHST- 2006/01/19 09:00 [entrez]
AID - 10.1055/s-2005-858613 [doi]
PST - ppublish
SO  - Klin Monbl Augenheilkd. 2006 Jan;223(1):24-8. doi: 10.1055/s-2005-858613.

PMID- 8521557
OWN - NLM
STAT- MEDLINE
DCOM- 19960123
LR  - 20190623
IS  - 0009-7322 (Print)
IS  - 0009-7322 (Linking)
VI  - 92
IP  - 12
DP  - 1995 Dec 15
TI  - The insertion allele of the ACE gene I/D polymorphism. A candidate gene for 
      insulin resistance?
PG  - 3390-3
AB  - BACKGROUND: The insertion/deletion (ID) polymorphism of the 
      angiotensin-converting enzyme (ACE) gene has been associated with increased 
      coronary heart disease (CHD), although the mechanism of this association is not 
      apparent. We tested the hypothesis that the deletion allele of the ACE gene is 
      associated with insulin resistance. METHODS AND RESULTS: We related ACE genotype 
      to components of the insulin-resistance syndrome in 103 non-insulin-dependent 
      diabetic (NIDDM) and 533 nondiabetic white subjects. NIDDM subjects with the DD 
      genotype had significantly lower levels of specific insulin (DD 38.6, ID 57.1, 
      and II 87.4 pmol.L-1 by ANOVA, P = .011). Non-insulin-treated subjects with the 
      DD genotype had increased insulin sensitivity by HOMA % (DD 56.4%, II 29.4%, P = 
      .027) and lower levels of des 31,32 proinsulin (DD 3.3, II 7.6 pmol.L-1, P = 
      .012) compared with II subjects. There were no differences in prevalence of CHD 
      or levels of blood pressure, serum lipids, or plasminogen activator inhibitor-1 
      (PAI-1) activity between the three ACE genotypes. In nondiabetic subjects there 
      were no differences in insulin sensitivity, levels of insulin-like molecules, 
      blood pressure, PAI-1, serum lipids, or CHD prevalence between the three ACE 
      genotypes. CONCLUSIONS: We conclude that increased cardiovascular risk of the DD 
      genotype is not mediated through insulin resistance or abnormalities in 
      fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects 
      with the ACE DD genotype.
FAU - Panahloo, A
AU  - Panahloo A
AD  - Department of Medicine, University College London Medical School, Whittington 
      Hospital, England.
FAU - Andres, C
AU  - Andres C
FAU - Mohamed-Ali, V
AU  - Mohamed-Ali V
FAU - Gould, M M
AU  - Gould MM
FAU - Talmud, P
AU  - Talmud P
FAU - Humphries, S E
AU  - Humphries SE
FAU - Yudkin, J S
AU  - Yudkin JS
LA  - eng
GR  - Wellcome Trust/United Kingdom
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Circulation
JT  - Circulation
JID - 0147763
RN  - 0 (DNA Transposable Elements)
RN  - 0 (Plasminogen Activator Inhibitor 1)
RN  - EC 3.4.15.1 (Peptidyl-Dipeptidase A)
SB  - IM
MH  - Alleles
MH  - Case-Control Studies
MH  - Coronary Disease/genetics
MH  - DNA Transposable Elements
MH  - Diabetes Mellitus, Type 2/*genetics
MH  - Diabetic Angiopathies/genetics
MH  - Female
MH  - Genotype
MH  - Humans
MH  - Insulin Resistance/*genetics
MH  - Male
MH  - Middle Aged
MH  - Peptidyl-Dipeptidase A/*genetics
MH  - Plasminogen Activator Inhibitor 1/metabolism
MH  - Polymerase Chain Reaction
MH  - Polymorphism, Genetic
EDAT- 1995/12/15 00:00
MHDA- 1995/12/15 00:01
CRDT- 1995/12/15 00:00
PHST- 1995/12/15 00:00 [pubmed]
PHST- 1995/12/15 00:01 [medline]
PHST- 1995/12/15 00:00 [entrez]
AID - 10.1161/01.cir.92.12.3390 [doi]
PST - ppublish
SO  - Circulation. 1995 Dec 15;92(12):3390-3. doi: 10.1161/01.cir.92.12.3390.

PMID- 16809243
OWN - NLM
STAT- MEDLINE
DCOM- 20060727
LR  - 20181201
IS  - 0277-0903 (Print)
IS  - 0277-0903 (Linking)
VI  - 43
IP  - 4
DP  - 2006 May
TI  - Is fetal gender associated with emergency department visits for asthma during 
      pregnancy?
PG  - 293-9
AB  - BACKGROUND: To investigate if fetal gender (1) affects the risk of having an 
      emergency department (ED) visit for asthma; and (2) is associated with adverse 
      pregnancy outcomes among women who had at least one visit to the ED for asthma 
      during pregnancy. METHODS: We linked two provincial administrative databases 
      containing records on in-patient deliveries and ED visits. The study sample 
      included women who delivered a live singleton baby between April 2003 and March 
      2004. Pregnant women who made at least one ED visit for asthma were counted as 
      cases and the rest of the women as control subjects. We performed a multivariable 
      analysis using logistic regression to model the risk of having an ED visit for 
      asthma, with fetal gender being one of the predictors. In addition, a series of 
      multivariable logistic regressions were also constructed separately for cases and 
      controls for the following adverse delivery outcomes: low birth weight baby, 
      preterm delivery, and delivery via Caesarian section. RESULTS: Among 109,173 live 
      singleton deliveries, 530 women had visited ED due to asthma during pregnancy. 
      While having an ED visit for asthma was positively associated with teenage 
      pregnancy, low income, and presence of pregnancy-induced hypertension, it was not 
      associated with fetal gender (OR 1.01, 95% CI 0.85-1.19). Fetal gender was not a 
      significant predictor of adverse pregnancy outcomes among women who had an asthma 
      ED visit during pregnancy. CONCLUSION: Fetal gender does not affect the risk of 
      having an ED visit for asthma during pregnancy, and it is not associated with 
      adverse pregnancy outcomes among women who had an asthma-related ED during 
      pregnancy.
FAU - Baibergenova, Akerke
AU  - Baibergenova A
AD  - Department of Clinical Epidemiology and Biostatistics, McMaster University, 
      Hamilton, Ontario, Canada. baibera@mcmaster.ca
FAU - Thabane, Lehana
AU  - Thabane L
FAU - Akhtar-Danesh, Noori
AU  - Akhtar-Danesh N
FAU - Levine, Mitchell
AU  - Levine M
FAU - Gafni, Amiram
AU  - Gafni A
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - England
TA  - J Asthma
JT  - The Journal of asthma : official journal of the Association for the Care of 
      Asthma
JID - 8106454
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Ambulatory Care/*statistics & numerical data
MH  - Asthma/diagnosis/*epidemiology/*therapy
MH  - Case-Control Studies
MH  - Chi-Square Distribution
MH  - Emergency Service, Hospital/*statistics & numerical data
MH  - Female
MH  - Gestational Age
MH  - Humans
MH  - Incidence
MH  - Male
MH  - Maternal Age
MH  - Parity
MH  - Pregnancy
MH  - Pregnancy Complications/diagnosis/*epidemiology/*therapy
MH  - Pregnancy Outcome
MH  - Pregnancy, High-Risk
MH  - Prenatal Care
MH  - Probability
MH  - Registries
MH  - Retrospective Studies
MH  - Risk Assessment
MH  - Sex Determination Analysis
MH  - Sex Distribution
MH  - Sex Factors
EDAT- 2006/07/01 09:00
MHDA- 2006/07/28 09:00
CRDT- 2006/07/01 09:00
PHST- 2006/07/01 09:00 [pubmed]
PHST- 2006/07/28 09:00 [medline]
PHST- 2006/07/01 09:00 [entrez]
AID - V03536605M736820 [pii]
AID - 10.1080/02770900600622984 [doi]
PST - ppublish
SO  - J Asthma. 2006 May;43(4):293-9. doi: 10.1080/02770900600622984.

PMID- 10798511
OWN - NLM
STAT- MEDLINE
DCOM- 20000519
LR  - 20161124
IS  - 0038-4348 (Print)
IS  - 0038-4348 (Linking)
VI  - 93
IP  - 4
DP  - 2000 Apr
TI  - Blunt trauma in intoxicated patients: is computed tomography of the abdomen 
      always necessary?
PG  - 403-5
AB  - BACKGROUND: Physical examination to detect abdominal injuries has been considered 
      unreliable in alcohol-intoxicated trauma patients. Computed tomography (CT) plays 
      the primary role in these abdominal evaluations. METHODS: We reviewed medical 
      records of all blunt trauma patients admitted to our trauma service from January 
      1, 1992, to March 31, 1998. Study patients had a blood alcohol level > or =80 
      mg/dL, Glasgow Coma Scale (GCS) score of 15, and unremarkable abdominal 
      examination. RESULTS: Of 324 patients studied, 317 (98%) had CT scans negative 
      for abdominal injury. Abdominal injuries were identified in 7 patients (2%), with 
      only 2 (0.6%) requiring abdominal exploration. A significant association was 
      found between major chest injury and abdominal injury. CONCLUSION: The incidence 
      of abdominal injury in intoxicated, hemodynamically stable, blunt trauma patients 
      with a normal abdominal examination and normal mentation is low. Physical 
      examination and attention to clinical risk factors allow accurate abdominal 
      evaluation without CT.
FAU - Mavridis, S P
AU  - Mavridis SP
AD  - Department of Surgery, Conemaugh Memorial Medical Center, Johnstown, Penn, USA.
FAU - Firilas, A M
AU  - Firilas AM
LA  - eng
PT  - Journal Article
PL  - United States
TA  - South Med J
JT  - Southern medical journal
JID - 0404522
SB  - IM
MH  - Abdominal Injuries/complications/*diagnostic imaging/epidemiology
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - *Alcoholic Intoxication/complications
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Physical Examination
MH  - Radiography
MH  - Risk Factors
MH  - Trauma Centers
EDAT- 2000/05/08 09:00
MHDA- 2000/06/08 09:00
CRDT- 2000/05/08 09:00
PHST- 2000/05/08 09:00 [pubmed]
PHST- 2000/06/08 09:00 [medline]
PHST- 2000/05/08 09:00 [entrez]
PST - ppublish
SO  - South Med J. 2000 Apr;93(4):403-5.

PMID- 10834864
OWN - NLM
STAT- MEDLINE
DCOM- 20000706
LR  - 20250214
IS  - 0003-4967 (Print)
IS  - 1468-2060 (Electronic)
IS  - 0003-4967 (Linking)
VI  - 59
IP  - 6
DP  - 2000 Jun
TI  - Risk factors for avascular necrosis of bone in patients with systemic lupus 
      erythematosus: is there a role for antiphospholipid antibodies?
PG  - 462-7
AB  - BACKGROUND: Avascular necrosis of bone (AVN) is a well known complication in 
      patients with systemic lupus erythematosus (SLE). OBJECTIVE: To investigate the 
      role of antiphospholipid antibody status (IgM and IgG anticardiolipin antibodies 
      and lupus anticoagulant) with adjustment for corticosteroid use as risk factors 
      for the development of AVN. METHODS: A cohort of 265 patients receiving long term 
      follow up in our SLE clinic from 1978 to 1998 was analysed. Patients with AVN 
      complications were detected and then matched for age, sex, ethnicity, duration of 
      disease, and organ disease with two other patients with SLE. A further 31 
      patients were chosen at random for the analysis. RESULTS: Eleven patients had 
      AVN, giving a point prevalence of 4%. There were no significant differences 
      demonstrable in the presence of individual antiphospholipid antibodies (aPL) or 
      their combination between the group with AVN or the two control groups. 
      CONCLUSION: Incorporating an adjustment for corticosteroid use we were unable to 
      show a link between the presence of aPL and the development of AVN in patients 
      with SLE.
FAU - Mok, M Y
AU  - Mok MY
AD  - Bloomsbury Rheumatology Unit, University College London Medical School, Hong 
      Kong. mymok@netvigator.com
FAU - Farewell, V T
AU  - Farewell VT
FAU - Isenberg, D A
AU  - Isenberg DA
LA  - eng
PT  - Journal Article
PL  - England
TA  - Ann Rheum Dis
JT  - Annals of the rheumatic diseases
JID - 0372355
RN  - 0 (Antibodies, Anticardiolipin)
RN  - 0 (Antibodies, Antiphospholipid)
RN  - 0 (Biomarkers)
RN  - 0 (Immunoglobulin G)
RN  - 0 (Immunoglobulin M)
RN  - 0 (Lupus Coagulation Inhibitor)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Antibodies, Anticardiolipin/blood
MH  - Antibodies, Antiphospholipid/*blood
MH  - Biomarkers/blood
MH  - Case-Control Studies
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Immunoglobulin G/analysis
MH  - Immunoglobulin M/analysis
MH  - Lupus Coagulation Inhibitor/blood
MH  - Lupus Erythematosus, Systemic/*complications/immunology
MH  - Middle Aged
MH  - Osteonecrosis/*etiology/immunology
MH  - Risk Factors
PMC - PMC1753161
EDAT- 2000/06/02 09:00
MHDA- 2000/07/08 11:00
PMCR- 2003/06/01
CRDT- 2000/06/02 09:00
PHST- 2000/06/02 09:00 [pubmed]
PHST- 2000/07/08 11:00 [medline]
PHST- 2000/06/02 09:00 [entrez]
PHST- 2003/06/01 00:00 [pmc-release]
AID - S0003-4967(24)38198-1 [pii]
AID - 10.1136/ard.59.6.462 [doi]
PST - ppublish
SO  - Ann Rheum Dis. 2000 Jun;59(6):462-7. doi: 10.1136/ard.59.6.462.

PMID- 16962519
OWN - NLM
STAT- MEDLINE
DCOM- 20070130
LR  - 20220419
IS  - 1553-4650 (Print)
IS  - 1553-4650 (Linking)
VI  - 13
IP  - 5
DP  - 2006 Sep-Oct
TI  - Volume change of uterine myomas during pregnancy: do myomas really grow?
PG  - 386-90
AB  - STUDY OBJECTIVE: To estimate changes in uterine myoma volume during pregnancy. 
      DESIGN: Review of departmental electronic perinatal database and medical records. 
      Canadian Task Force Classification II-3. SETTING: Obstetrical ultrasound unit in 
      an academic tertiary care center. PATIENTS: One hundred-seven patients diagnosed 
      with uterine myomas during pregnancy and who had two or more obstetrical 
      ultrasounds in different periods of pregnancy. INTERVENTIONS: We analyzed the 
      change in volume of uterine myomas between the first half of pregnancy (up until 
      19 weeks), third quarter (20-30 weeks), and last quarter (31 weeks to term). The 
      volume of largest uterine myoma was calculated using the formula Volume 
      (mm3)=Pi/6x(length mm)x(width mm)x(height mm). MEASUREMENTS AND MAIN RESULTS: The 
      mean age of the population was 31+/-6 years. Between the first and the second 
      study periods, the percentage of uterine myomas that decreased in size was 55.1% 
      (95% CI: 43-66), with a mean decrease in volume of 35%+/-4%; while the percentage 
      of uterine myomas that enlarged was 44.9% (95% CI: 34-56), with a mean increase 
      in volume of 69%+/-11%. Between the second and the third study periods, 75% (95% 
      CI: 56-87) became smaller, with a mean decrease in volume of 30%+/-3%; while 25% 
      (95% CI: 13-43) enlarged, with a mean increase in volume of 102%+/-62%. 
      CONCLUSION: Contrary to common belief, we found that uterine myomas commonly 
      decrease in volume over the course of pregnancy.
FAU - Hammoud, Ahmad O
AU  - Hammoud AO
AD  - Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah 
      84132, USA. ahmad.hammoud@hsc.utah.edu
FAU - Asaad, Radwan
AU  - Asaad R
FAU - Berman, Jay
AU  - Berman J
FAU - Treadwell, Marjorie C
AU  - Treadwell MC
FAU - Blackwell, Sean
AU  - Blackwell S
FAU - Diamond, Michael P
AU  - Diamond MP
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Minim Invasive Gynecol
JT  - Journal of minimally invasive gynecology
JID - 101235322
SB  - IM
MH  - Adult
MH  - Female
MH  - Humans
MH  - Leiomyoma/diagnostic imaging/*pathology
MH  - Longitudinal Studies
MH  - Pregnancy
MH  - Pregnancy Complications, Neoplastic/diagnostic imaging/*pathology
MH  - ROC Curve
MH  - Retrospective Studies
MH  - *Tumor Burden
MH  - Ultrasonography, Prenatal
MH  - Uterine Neoplasms/diagnostic imaging/*pathology
EDAT- 2006/09/12 09:00
MHDA- 2007/01/31 09:00
CRDT- 2006/09/12 09:00
PHST- 2005/12/19 00:00 [received]
PHST- 2006/03/27 00:00 [revised]
PHST- 2006/04/13 00:00 [accepted]
PHST- 2006/09/12 09:00 [pubmed]
PHST- 2007/01/31 09:00 [medline]
PHST- 2006/09/12 09:00 [entrez]
AID - S1553-4650(06)00176-2 [pii]
AID - 10.1016/j.jmig.2006.04.003 [doi]
PST - ppublish
SO  - J Minim Invasive Gynecol. 2006 Sep-Oct;13(5):386-90. doi: 
      10.1016/j.jmig.2006.04.003.

PMID- 19575104
OWN - NLM
STAT- MEDLINE
DCOM- 20100405
LR  - 20220910
IS  - 1808-8694 (Print)
IS  - 1808-8686 (Electronic)
IS  - 1808-8686 (Linking)
VI  - 75
IP  - 2
DP  - 2009 Mar-Apr
TI  - Do foreign bodies migrate through the body towards the heart?
PG  - 195-9
AB  - Fixation of foreign bodies (FB), in the mucosa, can favor its migration, giving 
      origin to the popular saying: 'FB walk to the heart'. AIM: Describe the 
      mechanisms involved in FB migration and how to diagnose them. METHODOLOGY: From a 
      sample of 3,000 foreign bodies, during 40 years, we analyzed four which had 
      extra-lumen migration. We analyzed clinical, radiologic, endoscopic and 
      ultrasound data collected at the medical documentation service. RESULTS: Three 
      clinical histories are presented, describing two fish bones and one piece of fish 
      cartilage. FB shifting was analyzed in all of them. Migration started in the 
      esophagus in two, one going to the aorta and the other to the neck area. In the 
      other two, migration started in the pharynx, and the FB moved towards the 
      prevertebral fascia and the other externalized in the submandibular region. The 
      mechanisms and the risks posed to the patient, by FB migration, and the way to 
      diagnose them are hereby discussed. CONCLUSIONS: The study allows us to determine 
      that FB can move through the body but not towards the heart. The study also 
      serves as a warning sign: in cases of prolonged histories of FB ingestion, 
      imaging studies are mandatory before endoscopic examination.
FAU - Mamede, Rui Celso Martins
AU  - Mamede RC
AD  - Department of Ophthalmology, HCFMRP-USP. rcmmamed@fmrp.usp.br
FAU - Amaral, Fabiana do
AU  - Amaral Fd
FAU - Raimundo, Daniel Garcia
AU  - Raimundo DG
FAU - Freitas, Luiz Carlos Conti de
AU  - Freitas LC
FAU - Ricz, Hilton M A
AU  - Ricz HM
FAU - Mello Filho, Francisco V
AU  - Mello Filho FV
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - Brazil
TA  - Braz J Otorhinolaryngol
JT  - Brazilian journal of otorhinolaryngology
JID - 101207337
SB  - IM
MH  - Adult
MH  - Esophagus/diagnostic imaging
MH  - Female
MH  - Fiber Optic Technology
MH  - Foreign-Body Migration/*diagnosis/diagnostic imaging
MH  - *Heart
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Pharynx/diagnostic imaging
MH  - Tomography, X-Ray Computed
PMC - PMC9450624
EDAT- 2009/07/04 09:00
MHDA- 2010/04/07 06:00
PMCR- 2015/10/19
CRDT- 2009/07/04 09:00
PHST- 2007/10/26 00:00 [received]
PHST- 2008/01/02 00:00 [accepted]
PHST- 2009/07/04 09:00 [entrez]
PHST- 2009/07/04 09:00 [pubmed]
PHST- 2010/04/07 06:00 [medline]
PHST- 2015/10/19 00:00 [pmc-release]
AID - S1808-8694(15)30778-3 [pii]
AID - 10.1016/s1808-8694(15)30778-3 [doi]
PST - ppublish
SO  - Braz J Otorhinolaryngol. 2009 Mar-Apr;75(2):195-9. doi: 
      10.1016/s1808-8694(15)30778-3.

PMID- 24809662
OWN - NLM
STAT- MEDLINE
DCOM- 20150514
LR  - 20211021
IS  - 1433-3023 (Electronic)
IS  - 0937-3462 (Linking)
VI  - 25
IP  - 9
DP  - 2014 Sep
TI  - Does concomitant anterior/apical repair during midurethral sling improve the 
      overactive bladder component of mixed incontinence?
PG  - 1269-75
LID - 10.1007/s00192-014-2400-3 [doi]
AB  - INTRODUCTION AND HYPOTHESIS: Midurethral sling (MUS) can improve overactive 
      bladder (OAB) symptoms. It is unclear if anterior/apical prolapse (AA) repair 
      provides additional benefit. We hypothesized that women with mixed urinary 
      incontinence (MUI) experience greater improvement in the OAB component of their 
      symptoms after concomitant MUS and AA repair compared with MUS alone. METHODS: 
      This is a retrospective cohort study of women with bothersome MUI (defined by 
      objective stress test and validated questionnaire) undergoing MUS alone 
      ("MUS-only") or concomitant MUS and AA repair ("MUS + AA"). Our primary outcome 
      was the Overactive Bladder Questionnaire Symptom Severity (OAB-q SS) change score 
      6 weeks after surgery. RESULTS: Of 151 women, 67 (44 %) underwent MUS-only and 84 
      (56 %) underwent MUS + AA. The MUS-only cohort was younger and had less severe 
      baseline prolapse (p < 0.05 for both). Postoperative complications (predominantly 
      UTI) occurred in 35 (23 %) patients and were similar between cohorts. For all 
      subjects mean OAB-q SS scores significantly improved postoperatively (p < 0.05). 
      Our primary outcome, OAB-q SS change score, showed no significant differences 
      between cohorts (30 +/- 26 MUS-only vs 25 +/- 25 MUS + AA, p = 0.20), indicating 
      similar improvements in OAB symptoms. Multivariate linear regression analysis 
      revealed no difference in OAB-q SS change score between cohorts; however, OAB-q 
      SS change scores were lower for women with a postoperative complication (beta = -19, 
      95 % CI -31 to -6; p < 0.01). CONCLUSIONS: In women with bothersome MUI, 
      concomitant AA repair does not result in additional improvement in OAB symptoms 
      over MUS alone. Patients with postoperative complications exhibit less 
      improvement in OAB symptoms.
FAU - Dieter, Alexis A
AU  - Dieter AA
AD  - Division of Urogynecology & Reconstructive Pelvic Surgery, Department of 
      Obstetrics and Gynecology, Duke University Medical Center, 5324 McFarland Drive 
      Suite 310, Durham, NC, 27707, USA, alexis.dieter@duke.edu.
FAU - Edenfield, Autumn L
AU  - Edenfield AL
FAU - Weidner, Alison C
AU  - Weidner AC
FAU - Levin, Pamela J
AU  - Levin PJ
FAU - Siddiqui, Nazema Y
AU  - Siddiqui NY
LA  - eng
PT  - Journal Article
DEP - 20140509
PL  - England
TA  - Int Urogynecol J
JT  - International urogynecology journal
JID - 101567041
SB  - IM
MH  - Aged
MH  - Female
MH  - *Gynecologic Surgical Procedures
MH  - Humans
MH  - Middle Aged
MH  - Pelvic Organ Prolapse/complications/*surgery
MH  - Retrospective Studies
MH  - Suburethral Slings
MH  - Treatment Outcome
MH  - Urinary Bladder, Overactive/complications/*surgery
MH  - Urinary Incontinence/etiology/*surgery
EDAT- 2014/05/09 06:00
MHDA- 2015/05/15 06:00
CRDT- 2014/05/10 06:00
PHST- 2014/01/21 00:00 [received]
PHST- 2014/04/07 00:00 [accepted]
PHST- 2014/05/10 06:00 [entrez]
PHST- 2014/05/09 06:00 [pubmed]
PHST- 2015/05/15 06:00 [medline]
AID - 10.1007/s00192-014-2400-3 [doi]
PST - ppublish
SO  - Int Urogynecol J. 2014 Sep;25(9):1269-75. doi: 10.1007/s00192-014-2400-3. Epub 
      2014 May 9.

PMID- 20602101
OWN - NLM
STAT- MEDLINE
DCOM- 20110106
LR  - 20220310
IS  - 1432-2323 (Electronic)
IS  - 0364-2313 (Linking)
VI  - 34
IP  - 10
DP  - 2010 Oct
TI  - Is hypoalbuminemia an independent prognostic factor in patients with gastric 
      cancer?
PG  - 2393-8
LID - 10.1007/s00268-010-0641-y [doi]
AB  - BACKGROUND: Studies have indicated that hypoalbuminemia is associated with 
      decreased survival of patients with gastric cancer. However, the prognostic value 
      of albumin may be secondary to an ongoing systemic inflammatory response. The aim 
      of the study was to assess the relation between hypoalbuminemia, the systemic 
      inflammatory response, and survival in patients with gastric cancer. METHODS: 
      Patients diagnosed with gastric carcinoma attending the upper gastrointestinal 
      surgical unit in the Royal Infirmary, Glasgow between April 1997 and December 
      2005 and who had a pretreatment measurement of albumin and C-reactive protein 
      (CRP) were studied. RESULTS: Most of the patients had stage III/IV disease and 
      received palliative treatment. The minimum follow-up was 15 months. During 
      follow-up, 157 (72%) patients died of their cancer. On univariate analysis, stage 
      (p < 0.001), treatment (p < 0.001), albumin level (p < 0.001), and CRP level (p < 
      0.001) were significant predictors of survival. On multivariate analysis, stage 
      (p < 0.001), treatment (p < 0.001), and CRP level (p < 0.001) remained 
      significant predictors of survival. Albumin was no longer an independent 
      predictor of survival. CONCLUSIONS: Low albumin concentrations are associated 
      with poorer survival in patients with gastric cancer. However, the strength of 
      this relation with survival is dependent on the presence of a systemic 
      inflammatory response, as evidenced by an elevated CRP level. Therefore, it 
      appears that the relation between hypoalbuminemia and poor survival is secondary 
      to that of the systemic inflammatory response.
FAU - Crumley, Andrew B C
AU  - Crumley AB
AD  - University Department of Surgery, Royal Infirmary, Glasgow, G31 2ER, UK. 
      abccrumley@doctors.org.uk
FAU - Stuart, Robert C
AU  - Stuart RC
FAU - McKernan, Margaret
AU  - McKernan M
FAU - McMillan, Donald C
AU  - McMillan DC
LA  - eng
PT  - Journal Article
PL  - United States
TA  - World J Surg
JT  - World journal of surgery
JID - 7704052
RN  - 0 (Albumins)
RN  - 9007-41-4 (C-Reactive Protein)
SB  - IM
CIN - World J Surg. 2010 Oct;34(10):2399-400. doi: 10.1007/s00268-010-0703-1. PMID: 
      20602100
MH  - Aged
MH  - Albumins/analysis
MH  - C-Reactive Protein/analysis
MH  - Female
MH  - Humans
MH  - Hypoalbuminemia/blood/*mortality
MH  - Male
MH  - Middle Aged
MH  - Predictive Value of Tests
MH  - Prognosis
MH  - Stomach Neoplasms/*blood/*mortality
MH  - Survival Analysis
MH  - Systemic Inflammatory Response Syndrome/blood/*mortality
EDAT- 2010/07/06 06:00
MHDA- 2011/01/07 06:00
CRDT- 2010/07/06 06:00
PHST- 2010/07/06 06:00 [entrez]
PHST- 2010/07/06 06:00 [pubmed]
PHST- 2011/01/07 06:00 [medline]
AID - 10.1007/s00268-010-0641-y [doi]
PST - ppublish
SO  - World J Surg. 2010 Oct;34(10):2393-8. doi: 10.1007/s00268-010-0641-y.

PMID- 26852225
OWN - NLM
STAT- MEDLINE
DCOM- 20160811
LR  - 20181202
IS  - 1471-244X (Electronic)
IS  - 1471-244X (Linking)
VI  - 16
DP  - 2016 Feb 6
TI  - Is adjustment for reporting heterogeneity necessary in sleep disorders? Results 
      from the Japanese World Health Survey.
PG  - 25
LID - 10.1186/s12888-016-0733-9 [doi]
LID - 25
AB  - BACKGROUND: Anchoring vignettes are brief texts describing a hypothetical 
      character who illustrates a certain fixed level of a trait under evaluation. This 
      research uses vignettes to elucidate factors associated with sleep disorders in 
      adult Japanese before and after adjustment for reporting heterogeneity in 
      self-reports. This study also evaluates the need for adjusting for reporting 
      heterogeneity in the management of sleep and energy related problems in Japan. 
      METHODS: We investigated a dataset of 1002 respondents aged 18 years and over 
      from the Japanese World Health Survey, which collected information through 
      face-to-face interview from 2002 to 2003. The ordered probit model and the 
      Compound Hierarchical Ordered Probit (CHOPIT) model, which incorporated anchoring 
      vignettes, were employed to estimate and compare associations of sleep and energy 
      with socio-demographic and life-style factors before and after adjustment for 
      differences in response category cut-points for each individual. RESULTS: The 
      prevalence of self-reported problems with sleep and energy was 53 %. Without 
      correction of cut-point shifts, age, sex, and the number of comorbidities were 
      significantly associated with a greater severity of sleep-related problems. After 
      correction, age, the number of comorbidities, and regular exercise were 
      significantly associated with a greater severity of sleep-related problems; sex 
      was no longer a significant factor. Compared to the ordered probit model, the 
      CHOPIT model provided two changes with a subtle difference in the magnitude of 
      regression coefficients after correction for reporting heterogeneity. CONCLUSION: 
      Sleep disorders are common in the general adult population of Japan. Correction 
      for reporting heterogeneity using anchoring vignettes is not a necessary tool for 
      proper management of sleep and energy related problems among Japanese adults. 
      Older age, gender differences in communicating sleep-related problems, the 
      presence of multiple morbidities, and regular exercise should be the focus of 
      policies and clinical practice to improve sleep and energy management in Japan.
FAU - Tareque, Md Ismail
AU  - Tareque MI
AD  - Department of Population Science and Human Resource Development, University of 
      Rajshahi, Rajshahi, Bangladesh. tareque_pshd@yahoo.com.
FAU - Ikeda, Nayu
AU  - Ikeda N
AD  - Center for International Collaboration and Partnership, National Institute of 
      Health and Nutrition, National Institutes of Biomedical Innovation, Health and 
      Nutrition, Tokyo, Japan. ikedan@nibiohn.go.jp.
FAU - Koshio, Atsushi
AU  - Koshio A
AD  - The Graduate School of Project Design, Tokyo, Japan. koshio@nms.ac.jp.
FAU - Hasegawa, Toshihiko
AU  - Hasegawa T
AD  - Department of Health Policy and Management, Nippon Medical School, Tokyo, Japan. 
      hasegawatoshihiko@nms.ac.jp.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160206
PL  - England
TA  - BMC Psychiatry
JT  - BMC psychiatry
JID - 100968559
SB  - IM
MH  - Adult
MH  - Aged
MH  - Female
MH  - Health Status Disparities
MH  - Health Surveys
MH  - Humans
MH  - Japan/epidemiology
MH  - Male
MH  - Middle Aged
MH  - Physical Fitness/*psychology
MH  - Prevalence
MH  - Self Report/standards
MH  - *Self-Assessment
MH  - *Sleep Wake Disorders/epidemiology/physiopathology/prevention & 
      control/psychology
MH  - Socioeconomic Factors
PMC - PMC4744451
EDAT- 2016/02/08 06:00
MHDA- 2016/08/12 06:00
PMCR- 2016/02/06
CRDT- 2016/02/08 06:00
PHST- 2015/05/03 00:00 [received]
PHST- 2016/02/02 00:00 [accepted]
PHST- 2016/02/08 06:00 [entrez]
PHST- 2016/02/08 06:00 [pubmed]
PHST- 2016/08/12 06:00 [medline]
PHST- 2016/02/06 00:00 [pmc-release]
AID - 10.1186/s12888-016-0733-9 [pii]
AID - 733 [pii]
AID - 10.1186/s12888-016-0733-9 [doi]
PST - epublish
SO  - BMC Psychiatry. 2016 Feb 6;16:25. doi: 10.1186/s12888-016-0733-9.

PMID- 19398929
OWN - NLM
STAT- MEDLINE
DCOM- 20100618
LR  - 20220409
IS  - 1539-2031 (Electronic)
IS  - 0192-0790 (Linking)
VI  - 43
IP  - 9
DP  - 2009 Oct
TI  - Can the growth rate of a gallbladder polyp predict a neoplastic polyp?
PG  - 865-8
LID - 10.1097/MCG.0b013e31819359aa [doi]
AB  - GOALS: The aim of this study was to evaluate whether the growth rate of a 
      gallbladder (GB) polyp is a predictive indicator for neoplastic polyps. 
      BACKGROUND: Cholecystectomy for GB polyps that are larger than 10 mm is generally 
      recommended because of the high probability of neoplasm. In contrast, a follow-up 
      strategy is preferred for GB polyps smaller than 10 mm. However, there are no 
      treatment guidelines for polyps that grow in size during the follow-up period. 
      STUDY: We retrospectively investigated 145 patients with GB polyps who underwent 
      at least 1 ultrasonographic follow-up examination over an interval greater than 6 
      months, before cholecystectomy at Samsung medical center, South Korea, from 1994 
      to 2007. The growth rate was determined based on the change in size per time 
      interval between 2 ultrasonographic examinations (mm/mo). RESULTS: The median age 
      of the patients was 48 years (range: 25 to 75). One hundred twenty-five 
      non-neoplastic polyps and 20 neoplastic polyps were found. Neoplastic polyps were 
      more frequently found in patients older than 60 years, those with hypertension, a 
      polyp size greater than 10 mm, and a rapid growth rate greater than 0.6 mm/mo. On 
      multivariate analysis, however, the growth rate was not related to the neoplastic 
      nature of a polyp, but older age (>60 y) and large size (>10 mm) were 
      significantly associated with neoplastic polyps. CONCLUSIONS: Patient's age (>60 
      y) and large polyp size (>10 mm) were significant predictive factors for 
      neoplastic GB polyps. GB polyps less than 10 mm in diameter do not require 
      surgical intervention simply because they grow.
FAU - Shin, Su Rin
AU  - Shin SR
AD  - Departments of Medicine, Samsung Medical Center, Sungkyunkwan University School 
      of Medicine, Seoul, Korea.
FAU - Lee, Jong Kyun
AU  - Lee JK
FAU - Lee, Kwang Hyuck
AU  - Lee KH
FAU - Lee, Kyu Taek
AU  - Lee KT
FAU - Rhee, Jong Chul
AU  - Rhee JC
FAU - Jang, Kee-Taek
AU  - Jang KT
FAU - Kim, Seong Hyun
AU  - Kim SH
FAU - Choi, Dong Wook
AU  - Choi DW
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Clin Gastroenterol
JT  - Journal of clinical gastroenterology
JID - 7910017
SB  - IM
MH  - Adult
MH  - Age Factors
MH  - Aged
MH  - Chi-Square Distribution
MH  - Cholecystectomy
MH  - Disease Progression
MH  - Female
MH  - Gallbladder Diseases/*diagnostic imaging/surgery
MH  - Gallbladder Neoplasms/*diagnostic imaging/surgery
MH  - Humans
MH  - Logistic Models
MH  - Male
MH  - Middle Aged
MH  - Odds Ratio
MH  - Polyps/surgery/*ultrastructure
MH  - Precancerous Conditions/*diagnostic imaging/surgery
MH  - Republic of Korea
MH  - Retrospective Studies
MH  - Risk Assessment
MH  - Risk Factors
MH  - Time Factors
MH  - Ultrasonography
EDAT- 2009/04/29 09:00
MHDA- 2010/06/19 06:00
CRDT- 2009/04/29 09:00
PHST- 2009/04/29 09:00 [entrez]
PHST- 2009/04/29 09:00 [pubmed]
PHST- 2010/06/19 06:00 [medline]
AID - 10.1097/MCG.0b013e31819359aa [doi]
PST - ppublish
SO  - J Clin Gastroenterol. 2009 Oct;43(9):865-8. doi: 10.1097/MCG.0b013e31819359aa.

PMID- 25614468
OWN - NLM
STAT- MEDLINE
DCOM- 20170110
LR  - 20181113
IS  - 1436-3305 (Electronic)
IS  - 1436-3291 (Linking)
VI  - 19
IP  - 1
DP  - 2016 Jan
TI  - Preoperative locoregional staging of gastric cancer: is there a place for 
      magnetic resonance imaging? Prospective comparison with EUS and multidetector 
      computed tomography.
PG  - 216-25
LID - 10.1007/s10120-015-0468-1 [doi]
AB  - BACKGROUND: The aim of this study was to prospectively compare the diagnostic 
      performance of magnetic resonance imaging (MRI), multidetector computed 
      tomography (MDCT) and endoscopic ultrasonography (EUS) in the preoperative 
      locoregional staging of gastric cancer. METHODS: This study had Institutional 
      Review Board approval, and informed consent was obtained from all patients. 
      Fifty-two patients with biopsy-proven gastric cancer underwent preoperative 1.5-T 
      MRI, 64-channel MDCT and EUS. All images were analysed blind, and the results 
      were compared with histopathological findings according to the seventh edition of 
      the TNM classification. After the population had been divided on the basis of the 
      local invasion (T1-3 vs T4a-b) and nodal involvement (N0 vs N+), sensitivity, 
      specificity, positive and negative predictive value, and accuracy were calculated 
      and diagnostic performance measures were assessed using the McNemar test. 
      RESULTS: For T staging, EUS showed higher sensitivity (94%) than MDCT and MRI (65 
      and 76%; p = 0.02 and p = 0.08). MDCT and MRI had significantly higher 
      specificity (91 and 89%) than EUS (60%) (p = 0.0009 and p = 0.003). Adding MRI to 
      MDCT or EUS did not result in significant differences for sensitivity. For N 
      staging, EUS showed higher sensitivity (92%) than MRI and MDCT (69 and 73%; p = 
      0.01 and p = 0.02). MDCT showed better specificity (81%) than EUS and MRI (58 and 
      73%; p = 0.03 and p = 0.15). CONCLUSIONS: Our prospective study confirmed the 
      leading role of EUS and MDCT in the staging of gastric cancer and did not prove, 
      at present, the value of the clinical use of MRI.
FAU - Giganti, Francesco
AU  - Giganti F
AD  - Department of Radiology and Centre for Experimental Imaging, San Raffaele 
      Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina 60, 
      20132, Milan, Italy. giganti.fra@gmail.com.
FAU - Orsenigo, Elena
AU  - Orsenigo E
AD  - Department of Surgery, San Raffaele Scientific Institute, Vita-Salute San 
      Raffaele University, Milan, Italy.
FAU - Arcidiacono, Paolo Giorgio
AU  - Arcidiacono PG
AD  - Department of Gastroenterology and Gastrointestinal Endoscopy, San Raffaele 
      Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
FAU - Nicoletti, Roberto
AU  - Nicoletti R
AD  - Department of Radiology and Centre for Experimental Imaging, San Raffaele 
      Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina 60, 
      20132, Milan, Italy.
FAU - Albarello, Luca
AU  - Albarello L
AD  - Pathology Unit, San Raffaele Scientific Institute, Milan, Italy.
FAU - Ambrosi, Alessandro
AU  - Ambrosi A
AD  - Vita-Salute San Raffaele University, Milan, Italy.
FAU - Salerno, Annalaura
AU  - Salerno A
AD  - Department of Radiology and Centre for Experimental Imaging, San Raffaele 
      Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina 60, 
      20132, Milan, Italy.
FAU - Esposito, Antonio
AU  - Esposito A
AD  - Department of Radiology and Centre for Experimental Imaging, San Raffaele 
      Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina 60, 
      20132, Milan, Italy.
FAU - Petrone, Maria Chiara
AU  - Petrone MC
AD  - Department of Gastroenterology and Gastrointestinal Endoscopy, San Raffaele 
      Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
FAU - Chiari, Damiano
AU  - Chiari D
AD  - Department of Surgery, San Raffaele Scientific Institute, Vita-Salute San 
      Raffaele University, Milan, Italy.
FAU - Staudacher, Carlo
AU  - Staudacher C
AD  - Department of Surgery, San Raffaele Scientific Institute, Vita-Salute San 
      Raffaele University, Milan, Italy.
FAU - Del Maschio, Alessandro
AU  - Del Maschio A
AD  - Department of Radiology and Centre for Experimental Imaging, San Raffaele 
      Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina 60, 
      20132, Milan, Italy.
FAU - De Cobelli, Francesco
AU  - De Cobelli F
AD  - Department of Radiology and Centre for Experimental Imaging, San Raffaele 
      Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina 60, 
      20132, Milan, Italy.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20150123
PL  - Japan
TA  - Gastric Cancer
JT  - Gastric cancer : official journal of the International Gastric Cancer Association 
      and the Japanese Gastric Cancer Association
JID - 100886238
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Endosonography/*methods
MH  - Female
MH  - Humans
MH  - Magnetic Resonance Imaging/*methods
MH  - Male
MH  - Middle Aged
MH  - Multidetector Computed Tomography/*methods
MH  - Multimodal Imaging/methods
MH  - Neoplasm Staging
MH  - Preoperative Care
MH  - Prospective Studies
MH  - Sensitivity and Specificity
MH  - Stomach Neoplasms/diagnostic imaging/*pathology/surgery
OTO - NOTNLM
OT  - Endoscopic ultrasonography
OT  - Gastric cancer
OT  - Magnetic resonance imaging
OT  - Multidetector computed tomography
OT  - TNM staging
EDAT- 2015/01/24 06:00
MHDA- 2017/01/11 06:00
CRDT- 2015/01/24 06:00
PHST- 2014/10/08 00:00 [received]
PHST- 2015/01/08 00:00 [accepted]
PHST- 2015/01/24 06:00 [entrez]
PHST- 2015/01/24 06:00 [pubmed]
PHST- 2017/01/11 06:00 [medline]
AID - 10.1007/s10120-015-0468-1 [pii]
AID - 10.1007/s10120-015-0468-1 [doi]
PST - ppublish
SO  - Gastric Cancer. 2016 Jan;19(1):216-25. doi: 10.1007/s10120-015-0468-1. Epub 2015 
      Jan 23.

PMID- 11926574
OWN - NLM
STAT- MEDLINE
DCOM- 20021023
LR  - 20191105
IS  - 1590-8658 (Print)
IS  - 1590-8658 (Linking)
VI  - 34
IP  - 1
DP  - 2002 Jan
TI  - Are hepatitis G virus and TT virus involved in cryptogenic chronic liver disease?
PG  - 53-8
AB  - BACKGROUND: Hepatitis G virus can cause chronic infection in man but the role of 
      this agent in chronic liver disease is poorly understood. Little is known about 
      the relation of another newly discovered agent, the TT virus, with chronic liver 
      disease. AIM: To investigate the rate of infection with hepatitis G virus and TT 
      virus in patients with cryptogenic chronic liver disease. PATIENTS: A total of 23 
      subjects with chronically raised alanine transaminase and a liver biopsy in whom 
      all known causes of liver disease had been excluded, and 40 subjects with 
      hepatitis C virus-related chronic liver disease. METHODS: Evaluation of 
      anti-hepatitis G virus by enzyme immunoassay. Hepatitis G virus-RNA by polymerase 
      chain reaction with primers from the 5' NC and NS5a regions. TT virus-DNA by 
      nested polymerase chain reaction with primers from the ORF1 region. Results. 
      Hepatitis G virus-RNA was detected in 4 out of 23 patients with cryptogenic 
      chronic hepatitis and in 6 out of 40 with hepatitis C virus chronic hepatitis 
      (17.4% vs 15% p=ns). At least one marker of hepatitis G virus infection 
      (hepatitis G virus-RNA and/or anti-hepatitis G virus, mostly mutually exclusive) 
      was present in 6 out of 23 patients with cryptogenic hepatitis and 16 out of 40 
      with hepatitis C virus liver disease (26. 1% vs 40% p=ns). T virus-DNA was 
      present in serum in 3 subjects, 1 with cryptogenic and 2 with hepatitis C 
      virus-related chronic liver disease. Demographic and clinical features, including 
      stage and grade of liver histology, were comparable between hepatitis G 
      virus-infected and uninfected subjects. Severe liver damage [chronic hepatitis 
      with fibrosis or cirrhosis) were significantly more frequent in subjects with 
      hepatitis C virus liver disease. CONCLUSIONS: In Southern Italy, hepatitis G 
      virus infection is widespread among patients with chronic hepatitis, 
      independently of parenteral risk factors. Its frequency in subjects with 
      cryptogenic liver disease parallels that observed in hepatitis C virus chronic 
      liver disease, thus ruling out an aetiologic role of hepatitis G virus. TT virus 
      infection is uncommon in patients with cryptogenic or hepatitis C virus-related 
      liver disease who do not have a history of parenteral exposure.
FAU - Di, Stefano R
AU  - Di SR
AD  - Institute of Internal Medicine, Department of Hygiene and Microbiology, 
      University of Palermo, Italy.
FAU - Ferraro, D
AU  - Ferraro D
FAU - Bonura, C
AU  - Bonura C
FAU - Lo, Pizzolanti G
AU  - Lo PG
FAU - Lacono, O
AU  - Lacono O
FAU - Di Marco, V
AU  - Di Marco V
FAU - Craxi, A
AU  - Craxi A
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Netherlands
TA  - Dig Liver Dis
JT  - Digestive and liver disease : official journal of the Italian Society of 
      Gastroenterology and the Italian Association for the Study of the Liver
JID - 100958385
RN  - EC 2.6.1.2 (Alanine Transaminase)
SB  - IM
MH  - Adult
MH  - Alanine Transaminase/blood
MH  - DNA Virus Infections/*complications
MH  - Female
MH  - Flaviviridae Infections/*complications
MH  - GB virus C/genetics/*isolation & purification
MH  - Hepatitis, Chronic/*virology
MH  - Hepatitis, Viral, Human/*complications
MH  - Humans
MH  - Liver/pathology
MH  - Male
MH  - Middle Aged
MH  - Reverse Transcriptase Polymerase Chain Reaction
MH  - Torque teno virus/genetics/*isolation & purification
EDAT- 2002/04/03 10:00
MHDA- 2002/10/31 04:00
CRDT- 2002/04/03 10:00
PHST- 2002/04/03 10:00 [pubmed]
PHST- 2002/10/31 04:00 [medline]
PHST- 2002/04/03 10:00 [entrez]
AID - S1590-8658(02)80060-3 [pii]
AID - 10.1016/s1590-8658(02)80060-3 [doi]
PST - ppublish
SO  - Dig Liver Dis. 2002 Jan;34(1):53-8. doi: 10.1016/s1590-8658(02)80060-3.

PMID- 10973547
OWN - NLM
STAT- MEDLINE
DCOM- 20001107
LR  - 20190513
IS  - 1010-7940 (Print)
IS  - 1010-7940 (Linking)
VI  - 18
IP  - 3
DP  - 2000 Sep
TI  - Are patients with Werlhof's disease at increased risk for bleeding complications 
      when undergoing cardiac surgery?
PG  - 353-6
AB  - BACKGROUND: It is generally assumed, that patients with Werlhof's disease (WD) 
      are at increased risk for bleeding complications when undergoing cardiac surgery 
      with extracorporeal circulation. Therefore we performed this case control study 
      to estimate the real risk for bleeding complications of these patients. METHODS: 
      Between 05/95 and 07/98, ten patients with WD (eight males, two females) 
      underwent cardiac surgery employing extracorporeal circulation (WD-group). Five 
      of these patients with platelet counts below 80/nl were treated by 
      immunoglobulins preoperatively. Each patient with WD was matched to five patients 
      without WD (no-WD-group) using diagnosis, age, gender, ejection fraction, number 
      of distal anastomosis and body-mass-index as matching criteria. RESULTS: Mean 
      number of platelet counts were significant lower in the WD-group than in the 
      no-WD-group despite a significant increase of platelet counts after 
      immunoglobulin treatment (54/nl-->112/nl, P=0.018). On the day before, directly 
      after and on the first day after surgery they were 141/nl vs. 215/nl (P=0.012), 
      75/nl vs. 147/nl (P=0.001) and 93/nl vs. 136/nl (P=0.009). Accordingly, patients 
      of the WD-group received significantly more platelet concentrates than patients 
      of the no-WD-group (mean number of platelet concentrates: 2.3 versus 0.7, 
      P=0.007). Total drainage loss via the mediastinal chest tubes was almost 
      identical (1197 ml in the no-WD-group and 1140 ml in the WD-group). One patient 
      of each group suffered from a bleeding complication requiring reexploration. 
      Three patients of the no-WD-group (6%) and one patient of the WD-group (10%) 
      expired postoperatively unrelated to WD. CONCLUSIONS: Patients with WD may 
      possibly undergo cardiac surgery without a markedly enhanced risk for bleeding 
      complications despite a more than usual transfusion requirement and significantly 
      lower platelet counts perioperatively.
FAU - Christiansen, S
AU  - Christiansen S
AD  - Klinik und Poliklinik fur Thorax-, Herz- und Gefasschirurgie, Westfalische 
      Wilhelms-Universitat Munster, Albert-Schweitzer-Strasse 33, 48149, Munster, 
      Germany.
FAU - Rotker, J
AU  - Rotker J
FAU - Roeder, N
AU  - Roeder N
FAU - Jahn, U R
AU  - Jahn UR
FAU - Stypmann, J
AU  - Stypmann J
FAU - Scheld, H H
AU  - Scheld HH
FAU - Schmid, C
AU  - Schmid C
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - Germany
TA  - Eur J Cardiothorac Surg
JT  - European journal of cardio-thoracic surgery : official journal of the European 
      Association for Cardio-thoracic Surgery
JID - 8804069
RN  - 0 (Immunoglobulins)
SB  - IM
MH  - Adult
MH  - Aged
MH  - *Blood Loss, Surgical/prevention & control
MH  - Blood Transfusion
MH  - Cardiopulmonary Bypass
MH  - Coronary Artery Bypass/*adverse effects
MH  - Coronary Disease/blood/complications/*surgery
MH  - Female
MH  - Humans
MH  - Immunoglobulins/therapeutic use
MH  - Male
MH  - Middle Aged
MH  - Platelet Count
MH  - *Postoperative Hemorrhage/blood/etiology/prevention & control
MH  - Prognosis
MH  - Purpura, Thrombocytopenic, Idiopathic/blood/*complications/therapy
MH  - Retrospective Studies
MH  - Risk Factors
MH  - Splenectomy
EDAT- 2000/09/06 11:00
MHDA- 2001/02/28 10:01
CRDT- 2000/09/06 11:00
PHST- 2000/09/06 11:00 [pubmed]
PHST- 2001/02/28 10:01 [medline]
PHST- 2000/09/06 11:00 [entrez]
AID - S1010-7940(00)00346-8 [pii]
AID - 10.1016/s1010-7940(00)00346-8 [doi]
PST - ppublish
SO  - Eur J Cardiothorac Surg. 2000 Sep;18(3):353-6. doi: 
      10.1016/s1010-7940(00)00346-8.

PMID- 26471488
OWN - NLM
STAT- MEDLINE
DCOM- 20161110
LR  - 20190221
IS  - 1534-4681 (Electronic)
IS  - 1068-9265 (Linking)
VI  - 23
IP  - 3
DP  - 2016 Mar
TI  - Does Mammographic Density have an Impact on the Margin Re-excision Rate After 
      Breast-Conserving Surgery?
PG  - 782-8
LID - 10.1245/s10434-015-4917-1 [doi]
AB  - BACKGROUND: Limited and conflicting data exist on an association between 
      mammographic density (MD) and re-excision rates after breast-conserving surgery 
      (BCS). Additionally, the correlation of MD with resection of unnecessary margins 
      during initial BCS is unknown. METHODS: All women with a diagnosis of breast 
      cancer from 2003 to 2012 and enrolled in a larger study on MD were evaluated. 
      Operative and pathology reports were reviewed to determine margin resection and 
      involvement. Mammographic density was determined both by breast imaging-reporting 
      and data system (BI-RADS) classification and by an automated software program 
      (Volpara Solutions). Additional margins were deemed unnecessary if the lumpectomy 
      specimen margin was free of invasive tumor [>/=2 mm for ductal carcinoma in situ 
      (DCIS)] or if further re-excision was needed. RESULTS: Of 655 patients, 398 
      (60.8%) had BCS, whereas 226 (34.5%) underwent initial mastectomy. The women with 
      denser breasts (BI-RADS 3 or 4) underwent initial mastectomy more frequently than 
      the women with less dense breasts (40.0 vs. 30.5%, respectively; p = 0.0118). Of 
      the patients with BCS, 166 (41.7%) required separate re-excision. Additional 
      margins were taken during BCS in 192 (48.2%) patients, with 151 (78.6%) proving 
      to be unnecessary. In the bivariable analysis, the patients with denser breasts 
      according to BI-RADS classification and volumetric density showed a trend toward 
      requiring more frequent re-excision, but this association was not seen in the 
      multivariable analysis. The rate of unnecessary margins did not differ by breast 
      density. In the multivariate analysis, the re-excision rates increased with DCIS 
      (p < 0.0003) and decreased with resection of additional margins (p = 0.0043). 
      CONCLUSIONS: Mammographic density is not associated with an increased need for 
      re-excision or resection of unnecessary margins at initial BCS.
FAU - Edwards, Brandy L
AU  - Edwards BL
AD  - Department of Surgery, University of Virginia, Charlottesville, VA, USA.
FAU - Guidry, Christopher A
AU  - Guidry CA
AD  - Department of Surgery, University of Virginia, Charlottesville, VA, USA.
FAU - Larson, Krista N
AU  - Larson KN
AD  - School of Medicine, University of Virginia, Charlottesville, VA, USA.
FAU - Novicoff, Wendy M
AU  - Novicoff WM
AD  - Department of Public Health Sciences, University of Virginia, Charlottesville, 
      VA, USA.
FAU - Harvey, Jennifer A
AU  - Harvey JA
AD  - Department of Radiology and Medical Imaging, University of Virginia, 
      Charlottesville, VA, USA.
FAU - Schroen, Anneke T
AU  - Schroen AT
AD  - Department of Surgery, University of Virginia, Charlottesville, VA, USA. 
      ats2x@virginia.edu.
AD  - Department of Public Health Sciences, University of Virginia, Charlottesville, 
      VA, USA. ats2x@virginia.edu.
LA  - eng
GR  - CA163177/CA/NCI NIH HHS/United States
PT  - Clinical Trial
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20151015
PL  - United States
TA  - Ann Surg Oncol
JT  - Annals of surgical oncology
JID - 9420840
RN  - 0 (Biomarkers, Tumor)
RN  - 0 (Receptors, Estrogen)
RN  - 0 (Receptors, Progesterone)
RN  - EC 2.7.10.1 (ERBB2 protein, human)
RN  - EC 2.7.10.1 (Receptor, ErbB-2)
SB  - IM
MH  - Aged
MH  - Biomarkers, Tumor/metabolism
MH  - Breast Density
MH  - Breast Neoplasms/metabolism/*pathology/surgery
MH  - Carcinoma, Ductal, Breast/metabolism/*pathology/surgery
MH  - Carcinoma, Intraductal, Noninfiltrating/metabolism/*pathology/surgery
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Immunoenzyme Techniques
MH  - Mammary Glands, Human/*abnormalities/pathology
MH  - *Mastectomy, Segmental
MH  - Middle Aged
MH  - Neoplasm Invasiveness
MH  - Neoplasm Staging
MH  - Prognosis
MH  - Receptor, ErbB-2/metabolism
MH  - Receptors, Estrogen/metabolism
MH  - Receptors, Progesterone/metabolism
MH  - Retrospective Studies
EDAT- 2015/10/17 06:00
MHDA- 2016/11/12 06:00
CRDT- 2015/10/17 06:00
PHST- 2015/06/12 00:00 [received]
PHST- 2015/10/17 06:00 [entrez]
PHST- 2015/10/17 06:00 [pubmed]
PHST- 2016/11/12 06:00 [medline]
AID - 10.1245/s10434-015-4917-1 [pii]
AID - 10.1245/s10434-015-4917-1 [doi]
PST - ppublish
SO  - Ann Surg Oncol. 2016 Mar;23(3):782-8. doi: 10.1245/s10434-015-4917-1. Epub 2015 
      Oct 15.

PMID- 19520213
OWN - NLM
STAT- MEDLINE
DCOM- 20090811
LR  - 20220408
IS  - 1365-229X (Electronic)
IS  - 0009-9260 (Linking)
VI  - 64
IP  - 7
DP  - 2009 Jul
TI  - Are UK radiologists satisfied with the training and support received in suspected 
      child abuse?
PG  - 690-8
LID - 10.1016/j.crad.2009.02.012 [doi]
AB  - AIM: To determine current practice and perceptions of the adequacy of training 
      and support received for the reporting of skeletal surveys in suspected physical 
      child abuse. MATERIALS AND METHODS: A list of telephone numbers of UK hospitals 
      with a radiology department was obtained from the Royal College of Radiologists. 
      One hundred hospitals were then randomly selected for inclusion in the survey. An 
      18-item questionnaire was successfully administered to consultant radiologists 
      from 84 departments. RESULTS: Sixty-one percent of departments had a named 
      radiologist to report their skeletal surveys, 16% assigned surveys to a random 
      radiologist, and 23% referred them elsewhere. Only 52% of departments had a 
      dedicated paediatric radiologist, thus in a significant proportion of departments 
      (25%) initial reports on skeletal surveys for physical abuse were provided by 
      non-paediatric radiologists. Fifteen percent did not have ready access to a 
      paediatric radiology opinion. Sixty-one percent thought that the service could be 
      improved. Expert evidence was provided by 5% of respondents. Seventy-three 
      percent would never consider providing expert evidence, even if given adequate 
      radiology and/or legal training. CONCLUSION: The survey shows significant 
      dissatisfaction amongst consultant radiologists with the current service, 
      confirms a low number of paediatric radiologists taking on this work, and 
      suggests the potential to increase numbers of radiology child abuse experts by 
      27% if given improved training and support. Appropriate service and education 
      strategies should be implemented.
FAU - Leung, R S
AU  - Leung RS
AD  - Department of Radiology, Great Ormond Street Hospital for Children, London, UK.
FAU - Nwachuckwu, C
AU  - Nwachuckwu C
FAU - Pervaiz, A
AU  - Pervaiz A
FAU - Wallace, C
AU  - Wallace C
FAU - Landes, C
AU  - Landes C
FAU - Offiah, A C
AU  - Offiah AC
LA  - eng
PT  - Journal Article
DEP - 20090425
PL  - England
TA  - Clin Radiol
JT  - Clinical radiology
JID - 1306016
SB  - IM
MH  - Attitude of Health Personnel
MH  - Bone and Bones/diagnostic imaging/injuries
MH  - Child
MH  - *Child Abuse/diagnosis/psychology
MH  - Clinical Competence
MH  - *Education, Medical, Continuing
MH  - Humans
MH  - Medical Staff, Hospital/*education
MH  - Radiography
MH  - Radiology/*education
MH  - United Kingdom
EDAT- 2009/06/13 09:00
MHDA- 2009/08/12 09:00
CRDT- 2009/06/13 09:00
PHST- 2008/11/21 00:00 [received]
PHST- 2009/02/06 00:00 [revised]
PHST- 2009/02/16 00:00 [accepted]
PHST- 2009/06/13 09:00 [entrez]
PHST- 2009/06/13 09:00 [pubmed]
PHST- 2009/08/12 09:00 [medline]
AID - S0009-9260(09)00103-2 [pii]
AID - 10.1016/j.crad.2009.02.012 [doi]
PST - ppublish
SO  - Clin Radiol. 2009 Jul;64(7):690-8. doi: 10.1016/j.crad.2009.02.012. Epub 2009 Apr 
      25.

PMID- 23677366
OWN - NLM
STAT- MEDLINE
DCOM- 20130708
LR  - 20220409
IS  - 1535-1386 (Electronic)
IS  - 0021-9355 (Linking)
VI  - 95
IP  - 10
DP  - 2013 May 15
TI  - Do oblique views add value in the diagnosis of spondylolysis in adolescents?
PG  - e65
LID - 10.2106/JBJS.L.00824 [doi]
AB  - BACKGROUND: Anteroposterior, lateral, and right and left oblique lumbar spine 
      radiographs are often a standard part of the evaluation of children who are 
      clinically suspected of having spondylolysis. Recent concerns regarding radiation 
      exposure and costs have brought the value of oblique radiographs into question. 
      The purpose of the present study was to determine the diagnostic value of oblique 
      views in the diagnosis of spondylolysis. METHODS: Radiographs of fifty 
      adolescents with L5 spondylolysis without spondylolisthesis and fifty controls 
      were retrospectively reviewed. All controls were confirmed not to have 
      spondylolysis on the basis of computed tomographic scanning, magnetic resonance 
      imaging, or bone scanning. Anteroposterior, lateral, and right and left oblique 
      radiographs of the lumbar spine were arranged into two sets of slides: one 
      showing four views (anteroposterior, lateral, right oblique, and left oblique) 
      and one showing two views (anteroposterior and lateral only). The slides were 
      randomly presented to four pediatric spine surgeons for diagnosis, with four-view 
      slides being presented first, followed by two-view slides. The slides for twenty 
      random patients were later reanalyzed in order to calculate of intra-rater 
      agreement. A power analysis demonstrated that this study was adequately powered. 
      Inter-rater and intra-rater agreement were assessed on the basis of the 
      percentage of overall agreement and intraclass correlation coefficients (ICCs). 
      PCXMC software was used to generate effective radiation doses. Study charges were 
      determined from radiology billing data. RESULTS: There was no significant 
      difference in sensitivity and specificity between four-view and two-view 
      radiographs in the diagnosis of spondylolysis. The sensitivity was 0.59 for 
      two-view studies and 0.53 for four-view studies (p = 0.33). The specificity was 
      0.96 for two-view studies and 0.94 for four-view studies (p = 0.60). Inter-rater 
      agreement, intra-rater agreement, and agreement with gold-standard ICC values 
      were in the moderate range and also demonstrated no significant differences. 
      Percent overall agreement was 78% for four-view studies and 82% for two-view 
      studies. The radiation effective dose was 1.26 mSv for four-view studies and 0.72 
      mSv for two-view studies (difference, 0.54 mSv). The charge for four-view studies 
      was $145 more than that for two-view studies. CONCLUSIONS: There is no difference 
      in sensitivity and specificity between four-view and two-view studies. Although 
      oblique views have long been considered standard practice by some, our data could 
      not identify a diagnostic benefit that might outweigh the additional cost and 
      radiation exposure.
FAU - Beck, Nicholas A
AU  - Beck NA
AD  - Division of Orthopaedic Surgery, The Children's Hospital of Philadelphia, 34th 
      and Civic Center Boulevard, Philadelphia, PA 19104, USA.
FAU - Miller, Robert
AU  - Miller R
FAU - Baldwin, Keith
AU  - Baldwin K
FAU - Zhu, X
AU  - Zhu X
FAU - Spiegel, David
AU  - Spiegel D
FAU - Drummond, Denis
AU  - Drummond D
FAU - Sankar, Wudbhav N
AU  - Sankar WN
FAU - Flynn, John M
AU  - Flynn JM
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
PL  - United States
TA  - J Bone Joint Surg Am
JT  - The Journal of bone and joint surgery. American volume
JID - 0014030
SB  - IM
MH  - Adolescent
MH  - Case-Control Studies
MH  - Cohort Studies
MH  - Hospital Costs
MH  - Humans
MH  - Lumbar Vertebrae/*diagnostic imaging
MH  - Observer Variation
MH  - Philadelphia
MH  - Radiation Dosage
MH  - Radiography
MH  - Retrospective Studies
MH  - Sensitivity and Specificity
MH  - Spondylolysis/*diagnostic imaging/economics
EDAT- 2013/05/17 06:00
MHDA- 2013/07/09 06:00
CRDT- 2013/05/17 06:00
PHST- 2013/05/17 06:00 [entrez]
PHST- 2013/05/17 06:00 [pubmed]
PHST- 2013/07/09 06:00 [medline]
AID - 1684781 [pii]
AID - 10.2106/JBJS.L.00824 [doi]
PST - ppublish
SO  - J Bone Joint Surg Am. 2013 May 15;95(10):e65. doi: 10.2106/JBJS.L.00824.

PMID- 17342562
OWN - NLM
STAT- MEDLINE
DCOM- 20070508
LR  - 20220716
IS  - 1432-2218 (Electronic)
IS  - 0930-2794 (Linking)
VI  - 21
IP  - 5
DP  - 2007 May
TI  - The clinical significance of bile duct sludge: is it different from bile duct 
      stones?
PG  - 769-73
AB  - BACKGROUND: Some patients with suspected common bile duct (CBD) stones are found 
      to have sludge and no stones. Although sludge in the gallbladder is a precursor 
      of gallbladder stones, the significance of bile duct sludge (BDS) is poorly 
      defined. This study aimed to compare BDS with bile duct stones in terms of 
      frequency, associated risk factors, and clinical outcome after endoscopic 
      therapy. METHODS: The study enrolled 228 patients who underwent therapeutic 
      endoscopic retrograde cholangiopancreatography (ERCP) for suspected 
      choledocholithiasis. The patients were divided into two groups: patients with BDS 
      but no stones on ERCP and patients with CBD stones. The presence of risk factors 
      for bile duct stones (age, periampullary diverticulum, ductal dilation or 
      angulation, previous open cholecystectomy) were assessed at ERCP. Follow-up data 
      (36 +/- 19 months) were obtained from medical records and by patient questioning. 
      RESULTS: Bile duct sludge occurred in 14% (31/228) of patients and was more 
      common in females. After endoscopic clearance, CBD stones recurred in 17% 
      (33/197) of the patients with CBD stones, and in 16% (5/31) of the patients with 
      BDS (p = 0.99). Common bile duct dilation was less common in the sludge group. 
      The other known risk factors for recurrent CBD stones (age, previous open 
      cholecystectomy, bile duct angulation, and the presence of a peripampullary 
      diverticulum) were not statistically different between the two groups. 
      CONCLUSIONS: The findings indicate that the clinical significance of symptomatic 
      BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage 
      of choledocholithiasis.
FAU - Keizman, D
AU  - Keizman D
AD  - Department of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, 
      Israel.
FAU - Ish-Shalom, M
AU  - Ish-Shalom M
FAU - Konikoff, F M
AU  - Konikoff FM
LA  - eng
PT  - Journal Article
DEP - 20070307
PL  - Germany
TA  - Surg Endosc
JT  - Surgical endoscopy
JID - 8806653
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Child
MH  - *Cholangiopancreatography, Endoscopic Retrograde
MH  - Choledocholithiasis/*diagnostic imaging/epidemiology/surgery
MH  - Cohort Studies
MH  - Female
MH  - Humans
MH  - Incidence
MH  - Male
MH  - Middle Aged
MH  - Recurrence
MH  - Retrospective Studies
MH  - Risk Factors
MH  - Sex Distribution
MH  - Sphincterotomy, Endoscopic
EDAT- 2007/03/08 09:00
MHDA- 2007/05/09 09:00
CRDT- 2007/03/08 09:00
PHST- 2006/08/22 00:00 [received]
PHST- 2006/08/30 00:00 [accepted]
PHST- 2006/08/22 00:00 [revised]
PHST- 2007/03/08 09:00 [pubmed]
PHST- 2007/05/09 09:00 [medline]
PHST- 2007/03/08 09:00 [entrez]
AID - 10.1007/s00464-006-9153-0 [doi]
PST - ppublish
SO  - Surg Endosc. 2007 May;21(5):769-73. doi: 10.1007/s00464-006-9153-0. Epub 2007 Mar 
      7.

PMID- 16296668
OWN - NLM
STAT- MEDLINE
DCOM- 20051215
LR  - 20240109
IS  - 0002-0729 (Print)
IS  - 0002-0729 (Linking)
VI  - 27
IP  - 2
DP  - 1998 Mar
TI  - Can bedside assessment reliably exclude aspiration following acute stroke?
PG  - 99-106
AB  - OBJECTIVE: To investigate the ability of a bedside swallowing assessment to 
      reliably exclude aspiration following acute stroke. SUBJECTS: Consecutive 
      patients admitted within 24 h of stroke onset to two hospitals. METHODS: A 
      prospective study. Where possible, all patients had their ability to swallow 
      assessed on the day of admission by both a doctor and a speech and language 
      therapist using a standardized proforma. A videofluoroscopy examination was 
      conducted within 3 days of admission. RESULTS: 94 patients underwent 
      videofluoroscopy; 20 (21%) were seen to be aspirating, although this was not 
      detected at the bedside in 10. In 18 (22%) of the patients the speech and 
      language therapist considered the swallow to be unsafe. In the medical 
      assessment, 39 patients (41%) had an unsafe swallow. Bedside assessment by a 
      speech and language therapist gave a sensitivity of 47%, a specificity of 86%, 
      positive predictive value (PPV) of 50% and a negative predictive value (NPV) of 
      85% for the presence of aspiration. Multiple logistic regression was used to 
      identify the optimum elements of the bedside assessments for predicting the 
      presence of aspiration. A weak voluntary cough and any alteration in conscious 
      level gave a sensitivity of 75%, specificity of 72%, PPV of 41% and NPV of 91% 
      for aspiration. CONCLUSION: Bedside assessment of swallowing lacks the necessary 
      sensitivity to be used as a screening instrument in acute stroke, but there are 
      concerns about the use of videofluoroscopy as a gold standard. The relative 
      importance of aspiration and bedside assessment in predicting complications and 
      outcome needs to be studied.
FAU - Smithard, D G
AU  - Smithard DG
AD  - University Department of Geriatric Medicine, Speech and Language Therapy, 
      Withington Hospital, Manchester, UK.
FAU - O'Neill, P A
AU  - O'Neill PA
FAU - Park, C
AU  - Park C
FAU - England, R
AU  - England R
FAU - Renwick, D S
AU  - Renwick DS
FAU - Wyatt, R
AU  - Wyatt R
FAU - Morris, J
AU  - Morris J
FAU - Martin, D F
AU  - Martin DF
CN  - North West Dysphagia Group
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - Age Ageing
JT  - Age and ageing
JID - 0375655
SB  - IM
MH  - Acute Disease
MH  - Aged
MH  - Aged, 80 and over
MH  - Deglutition Disorders/*diagnostic imaging/*etiology
MH  - Female
MH  - Fluoroscopy/methods
MH  - Geriatric Assessment/*methods
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Pneumonia, Aspiration/*diagnostic imaging/*etiology
MH  - Predictive Value of Tests
MH  - Prospective Studies
MH  - Sensitivity and Specificity
MH  - Stroke/*complications
MH  - Videotape Recording
EDAT- 2005/11/22 09:00
MHDA- 2005/12/16 09:00
CRDT- 2005/11/22 09:00
PHST- 2005/11/22 09:00 [pubmed]
PHST- 2005/12/16 09:00 [medline]
PHST- 2005/11/22 09:00 [entrez]
AID - 10.1093/ageing/27.2.99 [doi]
PST - ppublish
SO  - Age Ageing. 1998 Mar;27(2):99-106. doi: 10.1093/ageing/27.2.99.

PMID- 17054994
OWN - NLM
STAT- MEDLINE
DCOM- 20070103
LR  - 20061120
IS  - 0022-4804 (Print)
IS  - 0022-4804 (Linking)
VI  - 136
IP  - 2
DP  - 2006 Dec
TI  - Does frozen section alter surgical management of multinodular thyroid disease?
PG  - 179-81
AB  - BACKGROUND: Frozen section (FS) evaluation during thyroid surgery is often used 
      to guide intraoperative management. We sought to determine the utility of FS in 
      patients undergoing thyroidectomy for multinodular thyroid disease. METHODS: From 
      May 1994 through November 2004, 236 patients with multinodular goiter underwent 
      thyroidectomy at our institution. Patient data were retrospectively analyzed to 
      see if a frozen section was performed during the procedure and whether it changed 
      the patient's outcome. RESULTS: Of the 236 patients, 135 (57%) had 
      intra-operative FS. There were no differences between patients who had FS 
      analysis and those who did not with regard to age, gender, and the incidence of 
      malignancy. Of the patients who had FS, 4/135 (3%) were subsequently diagnosed 
      with thyroid cancer on permanent histology. Three of these FS were misread as 
      benign. Therefore, the sensitivity of FS for the diagnosis of thyroid cancer was 
      only 25%. Importantly, in none of the 135 patients did FS alter the 
      intraoperative management. CONCLUSION: While FS was commonly used in patients 
      undergoing thyroidectomy at our institution, in no patient over the last decade 
      did FS correctly alter the intraoperative management. Given the time required to 
      perform FS and the cost associated with it, we believe that routine FS should not 
      be performed in these patients.
FAU - Olson, Sarah
AU  - Olson S
AD  - Department of Surgery, Section of Endocrine Surgery, University of Wisconsin, 
      Madison, Wisconsin 58792, USA.
FAU - Cheema, Yusra
AU  - Cheema Y
FAU - Harter, Josephine
AU  - Harter J
FAU - Starling, James
AU  - Starling J
FAU - Chen, Herbert
AU  - Chen H
LA  - eng
PT  - Journal Article
DEP - 20061019
PL  - United States
TA  - J Surg Res
JT  - The Journal of surgical research
JID - 0376340
SB  - IM
MH  - Adult
MH  - Aged
MH  - Carcinoma, Papillary/epidemiology/pathology/surgery
MH  - Female
MH  - *Frozen Sections
MH  - Goiter, Nodular/epidemiology/*pathology/*surgery
MH  - Humans
MH  - Incidence
MH  - Intraoperative Care/*methods
MH  - Lymphoma/epidemiology/pathology/surgery
MH  - Male
MH  - Middle Aged
MH  - Retrospective Studies
MH  - Sensitivity and Specificity
MH  - Thyroid Neoplasms/epidemiology/pathology/surgery
MH  - *Thyroidectomy
MH  - Treatment Outcome
EDAT- 2006/10/24 09:00
MHDA- 2007/01/04 09:00
CRDT- 2006/10/24 09:00
PHST- 2006/01/11 00:00 [received]
PHST- 2006/05/24 00:00 [revised]
PHST- 2006/07/17 00:00 [accepted]
PHST- 2006/10/24 09:00 [pubmed]
PHST- 2007/01/04 09:00 [medline]
PHST- 2006/10/24 09:00 [entrez]
AID - S0022-4804(06)00396-9 [pii]
AID - 10.1016/j.jss.2006.07.030 [doi]
PST - ppublish
SO  - J Surg Res. 2006 Dec;136(2):179-81. doi: 10.1016/j.jss.2006.07.030. Epub 2006 Oct 
      19.

PMID- 26556589
OWN - NLM
STAT- MEDLINE
DCOM- 20160714
LR  - 20220409
IS  - 1471-2474 (Electronic)
IS  - 1471-2474 (Linking)
VI  - 16
DP  - 2015 Nov 10
TI  - Does type 1 diabetes mellitus affect Achilles tendon response to a 10 km run? A 
      case control study.
PG  - 345
LID - 10.1186/s12891-015-0803-z [doi]
LID - 345
AB  - BACKGROUND: Achilles tendon structure deteriorates 2-days after maximal loading 
      in elite athletes. The load-response behaviour of tendons may be altered in type 
      1 diabetes mellitus (T1DM) as hyperglycaemia accelerates collagen cross-linking. 
      This study compared Achilles tendon load-response in participants with T1DM and 
      controls. METHODS: Achilles tendon structure was quantified at day-0, day-2 and 
      day-4 after a 10 km run. Ultrasound tissue characterisation (UTC) measures tendon 
      structural integrity by classifying pixels as echo-type I, II, III or IV. 
      Echo-type I has the most aligned collagen fibrils and IV has the least. RESULTS: 
      Participants were 7 individuals with T1DM and 10 controls. All regularly ran 
      distances greater than 5 km and VISA-A scores indicated good tendon function 
      (T1DM = 94 +/- 11, control = 94 +/- 10). There were no diabetic complications and 
      HbA1c was 8.7 +/- 2.6 mmol/mol for T1DM and 5.3 +/- 0.4 mmol/mol for control groups. 
      Baseline tendon structure was similar in T1DM and control groups - UTC echo-types 
      (I-IV) and anterior-posterior thickness were all p > 0.05. No response to load 
      was seen in either T1DM or control group over the 4-days post exercise. 
      CONCLUSION: Active individuals with T1DM do not have a heightened Achilles tendon 
      response to load, which suggests no increased risk of tendon injury. We cannot 
      extrapolate these findings to sedentary individuals with T1DM.
FAU - Wong, Andrea M Y
AU  - Wong AM
AD  - Department of Physiotherapy, Monash University, Frankston, 3199, VIC, Australia. 
      andrea.wong90@gmail.com.
FAU - Docking, Sean I
AU  - Docking SI
AD  - Department of Physiotherapy, Monash University, Frankston, 3199, VIC, Australia. 
      S.Docking@latrobe.edu.au.
AD  - Australian Centre for Research into Injury in Sport and its Prevention (ACRISP), 
      Federation University, Ballarat, Australia. S.Docking@latrobe.edu.au.
AD  - School of Allied Health, La Trobe University, Melbourne, Australia. 
      S.Docking@latrobe.edu.au.
FAU - Cook, Jill L
AU  - Cook JL
AD  - Department of Physiotherapy, Monash University, Frankston, 3199, VIC, Australia. 
      J.Cook@latrobe.edu.au.
AD  - Australian Centre for Research into Injury in Sport and its Prevention (ACRISP), 
      Federation University, Ballarat, Australia. J.Cook@latrobe.edu.au.
AD  - School of Allied Health, La Trobe University, Melbourne, Australia. 
      J.Cook@latrobe.edu.au.
FAU - Gaida, James E
AU  - Gaida JE
AD  - Department of Physiotherapy, Monash University, Frankston, 3199, VIC, Australia. 
      Jamie.Gaida@canberra.edu.au.
AD  - University of Canberra Research Institute for Sport and Exercise (UCRISE), 
      Canberra, Australia. Jamie.Gaida@canberra.edu.au.
AD  - Discipline of Physiotherapy, University of Canberra, Canberra, Australia. 
      Jamie.Gaida@canberra.edu.au.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20151110
PL  - England
TA  - BMC Musculoskelet Disord
JT  - BMC musculoskeletal disorders
JID - 100968565
SB  - IM
MH  - Achilles Tendon/*physiopathology
MH  - Adult
MH  - Case-Control Studies
MH  - Diabetes Mellitus, Type 1/*physiopathology
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Running/*physiology
MH  - Weight-Bearing
PMC - PMC4641391
EDAT- 2015/11/12 06:00
MHDA- 2016/07/15 06:00
PMCR- 2015/11/10
CRDT- 2015/11/12 06:00
PHST- 2015/06/01 00:00 [received]
PHST- 2015/11/03 00:00 [accepted]
PHST- 2015/11/12 06:00 [entrez]
PHST- 2015/11/12 06:00 [pubmed]
PHST- 2016/07/15 06:00 [medline]
PHST- 2015/11/10 00:00 [pmc-release]
AID - 10.1186/s12891-015-0803-z [pii]
AID - 803 [pii]
AID - 10.1186/s12891-015-0803-z [doi]
PST - epublish
SO  - BMC Musculoskelet Disord. 2015 Nov 10;16:345. doi: 10.1186/s12891-015-0803-z.

PMID- 15052394
OWN - NLM
STAT- MEDLINE
DCOM- 20040422
LR  - 20191210
IS  - 0933-7954 (Print)
IS  - 1433-9285 (Electronic)
IS  - 0933-7954 (Linking)
VI  - 39
IP  - 2
DP  - 2004 Feb
TI  - Are higher rates of depression in women accounted for by differential symptom 
      reporting?
PG  - 126-32
AB  - BACKGROUND: The gender difference in prevalence and incidence rates of depression 
      is one of the most consistent findings in psychiatric epidemiology. We sought to 
      examine whether any gender differences in symptom profile might account for this 
      difference in rates. METHOD: This study was a population-based 13-year follow-up 
      survey of community-dwelling adults living in East Baltimore in 1981. Subjects 
      were the continuing participants of the Baltimore Epidemiologic Catchment Area 
      Program. Participants interviewed between 1993 and 1996 with complete data on 
      depressive symptoms and covariates were included (n = 1727). We applied 
      structural equations with a measurement model for dichotomous data (the 
      MIMIC-multiple indicators, multiple causes-model) to compare symptoms between 
      women and men, in relation to the nine symptom groups comprising the diagnostic 
      criteria for major depression, adjusting for several potentially influential 
      characteristics (namely, age, self-reported ethnicity, educational attainment, 
      marital status, and employment). RESULTS: There were no significant gender 
      differences in the self-report of depression symptoms even taking into account 
      the higher level of depressive symptoms of women and the influence of other 
      covariates. For example, women were no more likely to endorse sadness than were 
      men, as evidenced by a direct effect coefficient that was not significantly 
      different from the null [adjusted estimated direct effect of gender on report of 
      sadness = 0.105, 95% confidence interval (-0.113, 0.323)]. CONCLUSIONS: Men and 
      women in this community sample reported similar patterns of depressive symptoms. 
      No evidence that the presentation of depressive symptoms differs by gender was 
      found.
FAU - Bogner, Hillary R
AU  - Bogner HR
AD  - Department of Family Practice & Community Medicine, University of Pennsylvania, 
      3400 Spruce Street/2 Gates Building, Philadelphia, PA 19104, USA. 
      bogner@mail.med.upenn.edu
FAU - Gallo, Joseph J
AU  - Gallo JJ
LA  - eng
GR  - R01 MH047447/MH/NIMH NIH HHS/United States
GR  - R01 MH047447-08/MH/NIMH NIH HHS/United States
GR  - MH47447/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - Germany
TA  - Soc Psychiatry Psychiatr Epidemiol
JT  - Social psychiatry and psychiatric epidemiology
JID - 8804358
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Baltimore/epidemiology
MH  - Catchment Area, Health
MH  - Depressive Disorder, Major/diagnosis/*epidemiology/psychology
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Incidence
MH  - Male
MH  - Middle Aged
MH  - Prevalence
MH  - *Psychometrics
MH  - Risk Factors
MH  - *Self Disclosure
MH  - Sex Factors
MH  - Socioeconomic Factors
MH  - *Women's Health
PMC - PMC2830739
MID - NIHMS177673
EDAT- 2004/03/31 05:00
MHDA- 2004/04/23 05:00
PMCR- 2010/03/02
CRDT- 2004/03/31 05:00
PHST- 2003/09/02 00:00 [accepted]
PHST- 2004/03/31 05:00 [pubmed]
PHST- 2004/04/23 05:00 [medline]
PHST- 2004/03/31 05:00 [entrez]
PHST- 2010/03/02 00:00 [pmc-release]
AID - 10.1007/s00127-004-0714-z [doi]
PST - ppublish
SO  - Soc Psychiatry Psychiatr Epidemiol. 2004 Feb;39(2):126-32. doi: 
      10.1007/s00127-004-0714-z.

PMID- 22513023
OWN - NLM
STAT- MEDLINE
DCOM- 20120605
LR  - 20241127
IS  - 0156-5788 (Print)
IS  - 0156-5788 (Linking)
VI  - 36
IP  - 1
DP  - 2012 Feb
TI  - Do Indigenous Australians age prematurely? The implications of life expectancy 
      and health conditions of older Indigenous people for health and aged care policy.
PG  - 68-74
LID - 10.1071/AH11996 [doi]
AB  - OBJECTIVE: To assess whether Indigenous Australians age prematurely compared with 
      other Australians, as implied by Australian Government aged care policy, which 
      uses age 50 years and over for population-based planning for Indigenous people 
      compared with 70 years for non-indigenous people. METHODS: Cross-sectional 
      analysis of aged care assessment, hospital and health survey data comparing 
      Indigenous and non-indigenous age-specific prevalence of health conditions. 
      Analysis of life tables for Indigenous and non-indigenous populations comparing 
      life expectancy at different ages. RESULTS: At age 63 for women and age 65 for 
      men, Indigenous people had the same life expectancy as non-indigenous people at 
      age 70. There is no consistent pattern of a 20-year lead in age-specific 
      prevalence of age-associated conditions for Indigenous compared with other 
      Australians. There is high prevalence from middle-age onwards of some conditions, 
      particularly diabetes (type unspecified), but there is little or no lead for 
      others. CONCLUSION: The idea that Indigenous people age prematurely is not well 
      supported by this study of a series of discrete conditions. The current focus and 
      type of services provided by the aged care sector may not be the best way to 
      respond to the excessive burden of chronic disease and disability of middle-aged 
      Indigenous people.
FAU - Cotter, Philippa R
AU  - Cotter PR
AD  - The Northern Institute, Charles Darwin University, Darwin, NT 0909, Australia. 
      prcotter@bigpond.net.au
FAU - Condon, John R
AU  - Condon JR
FAU - Barnes, Tony
AU  - Barnes T
FAU - Anderson, Ian P S
AU  - Anderson IP
FAU - Smith, Leonard R
AU  - Smith LR
FAU - Cunningham, Teresa
AU  - Cunningham T
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Australia
TA  - Aust Health Rev
JT  - Australian health review : a publication of the Australian Hospital Association
JID - 8214381
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Australia/epidemiology
MH  - Cross-Sectional Studies
MH  - *Geriatric Assessment
MH  - Geriatric Nursing/*legislation & jurisprudence
MH  - *Health Policy
MH  - *Health Status Indicators
MH  - Humans
MH  - Life Expectancy/*ethnology
MH  - Life Tables
MH  - Middle Aged
EDAT- 2012/04/20 06:00
MHDA- 2012/06/06 06:00
CRDT- 2012/04/20 06:00
PHST- 2011/01/11 00:00 [received]
PHST- 2011/04/27 00:00 [accepted]
PHST- 2012/04/20 06:00 [entrez]
PHST- 2012/04/20 06:00 [pubmed]
PHST- 2012/06/06 06:00 [medline]
AID - AH11996 [pii]
AID - 10.1071/AH11996 [doi]
PST - ppublish
SO  - Aust Health Rev. 2012 Feb;36(1):68-74. doi: 10.1071/AH11996.

PMID- 15919266
OWN - NLM
STAT- MEDLINE
DCOM- 20060808
LR  - 20050527
IS  - 1552-6259 (Electronic)
IS  - 0003-4975 (Linking)
VI  - 79
IP  - 6
DP  - 2005 Jun
TI  - Adjuvant radiation of stage III thymoma: is it necessary?
PG  - 1834-9
AB  - BACKGROUND: The criteria for administration of adjuvant radiation therapy after 
      thymoma resection remains controversial, and it is unclear whether patients with 
      Masaoka stage III thymoma benefit from adjuvant radiation. The goal of this 
      report was to determine whether or not this group benefits from radiation therapy 
      in disease-specific survival and disease-free survival. METHODS: Case records of 
      the Massachusetts General Hospital were retrospectively reviewed from 1972 to 
      2004. One hundred and seventy-nine patients underwent resection for thymoma, of 
      which 45 had stage III disease. RESULTS: Forty-five stage III patients underwent 
      resection and in 36 it was complete. Thirty-eight stage III patients received 
      radiation therapy. Baseline prognostic factors between radiated and nonradiated 
      groups were similar. The addition of adjuvant radiotherapy did not alter local or 
      distant recurrence rates in patients with stage III thymoma. Disease-specific 
      survival at 10 years in stage III patients who did not receive radiation was 75% 
      (95% confidence interval, 32% to 100%) and in patients who did receive radiation 
      therapy it was 79% (95% confidence interval, 64% to 94%) (p = 0.21). The most 
      common site of relapse was the pleura. CONCLUSIONS: Most patients who have stage 
      III thymoma undergo complete resection. Some patients enjoy prolonged 
      disease-free survival without adjuvant radiation after resection of stage III 
      thymoma. Radiation does not seem to prevent pleural recurrences when given after 
      resection of stage III thymomas. The use of routine adjuvant radiation after a 
      complete resection of stage III thymoma needs to be re-addressed. There may be a 
      role for the use of chemotherapy to reduce pleural recurrences.
FAU - Mangi, Abeel A
AU  - Mangi AA
AD  - Department of Surgery, Massachusetts General Hospital, Harvard Medical School, 
      Boston, Massachusetts 02114, USA.
FAU - Wain, John C
AU  - Wain JC
FAU - Donahue, Dean M
AU  - Donahue DM
FAU - Grillo, Hermes C
AU  - Grillo HC
FAU - Mathisen, Douglas J
AU  - Mathisen DJ
FAU - Wright, Cameron D
AU  - Wright CD
LA  - eng
PT  - Journal Article
PL  - Netherlands
TA  - Ann Thorac Surg
JT  - The Annals of thoracic surgery
JID - 15030100R
SB  - IM
CIN - Ann Thorac Surg. 2006 Mar;81(3):1180-1; author reply 1181-2. doi: 
      10.1016/j.athoracsur.2005.07.027. PMID: 16488766
MH  - Adolescent
MH  - Adult
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Recurrence, Local
MH  - Neoplasm Staging
MH  - Radiotherapy, Adjuvant
MH  - Retrospective Studies
MH  - Survival Analysis
MH  - Thymoma/pathology/*radiotherapy/surgery
MH  - Thymus Neoplasms/pathology/*radiotherapy/surgery
EDAT- 2005/05/28 09:00
MHDA- 2006/08/09 09:00
CRDT- 2005/05/28 09:00
PHST- 2004/11/01 00:00 [received]
PHST- 2004/12/28 00:00 [revised]
PHST- 2004/12/28 00:00 [accepted]
PHST- 2005/05/28 09:00 [pubmed]
PHST- 2006/08/09 09:00 [medline]
PHST- 2005/05/28 09:00 [entrez]
AID - S0003-4975(05)00047-0 [pii]
AID - 10.1016/j.athoracsur.2004.12.051 [doi]
PST - ppublish
SO  - Ann Thorac Surg. 2005 Jun;79(6):1834-9. doi: 10.1016/j.athoracsur.2004.12.051.

PMID- 15095519
OWN - NLM
STAT- MEDLINE
DCOM- 20040601
LR  - 20180306
IS  - 0145-7217 (Print)
IS  - 0145-7217 (Linking)
VI  - 30
IP  - 2
DP  - 2004 Mar-Apr
TI  - Are patients with diabetes receiving the same message from dietitians and nurses?
PG  - 293-300
AB  - PURPOSE: The purpose of this study was to determine if registered dietitian (RD) 
      and registered nurse (RN) certified diabetes educators (CDEs) provide similar 
      recommendations regarding carbohydrates and dietary supplements to individuals 
      with diabetes. METHODS: A survey was mailed to CDEs in the southern United 
      States. Participants were asked to indicate their recommendations for use of 
      carbohydrates, fiber, artificial sweeteners, and 12 selected dietary and herbal 
      supplements when counseling individuals with diabetes. RESULTS: The survey sample 
      consisted of 366 CDEs: 207 were RNs and 159 were RDs. No statistically 
      significant differences were found between RNs and RDs in typical carbohydrate 
      recommendations for treatment of diabetes. However, RDs were more likely than RNs 
      to make recommendations for fiber intake or use of the glycemic index. A 
      significant difference also was found in the treatment of hypoglycemia: RNs were 
      more likely than RDs to recommend consuming a carbohydrate source with protein to 
      treat hypoglycemia. CONCLUSIONS: Although some differences existed, RD and RN 
      CDEs are making similar overall recommendations in the treatment of individuals 
      with diabetes.
FAU - Venters, Jennifer Y
AU  - Venters JY
AD  - ARK-LA-MISS Diabetes Management Center, West Monroe, Louisiana
FAU - Hunt, Alice E
AU  - Hunt AE
AD  - College of Applied and Natural Sciences, Louisiana Tech University, Ruston, 
      Louisiana
FAU - Pope, Janet F
AU  - Pope JF
AD  - College of Applied and Natural Sciences, Louisiana Tech University, Ruston, 
      Louisiana
FAU - Molaison, Elaine F
AU  - Molaison EF
AD  - College of Applied and Natural Sciences, Louisiana Tech University, Ruston, 
      Louisiana
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - United States
TA  - Diabetes Educ
JT  - The Diabetes educator
JID - 7701401
RN  - 0 (Dietary Carbohydrates)
RN  - 0 (Dietary Fiber)
RN  - 0 (Dietary Proteins)
RN  - 0 (Sweetening Agents)
MH  - Certification
MH  - Diabetes Mellitus/*diet therapy/metabolism/prevention & control
MH  - Diet, Diabetic/*standards
MH  - Dietary Carbohydrates/administration & dosage
MH  - Dietary Fiber/administration & dosage
MH  - Dietary Proteins/administration & dosage
MH  - Dietetics/education/*standards
MH  - Female
MH  - Guideline Adherence/standards
MH  - Humans
MH  - Male
MH  - Nurse Clinicians/education/*standards
MH  - Nutritional Sciences/education
MH  - Patient Education as Topic/*standards
MH  - Phytotherapy
MH  - Practice Guidelines as Topic
MH  - Self Care/*standards
MH  - Surveys and Questionnaires
MH  - Sweetening Agents/therapeutic use
MH  - United States
EDAT- 2004/04/21 05:00
MHDA- 2004/06/02 05:00
CRDT- 2004/04/21 05:00
PHST- 2004/04/21 05:00 [pubmed]
PHST- 2004/06/02 05:00 [medline]
PHST- 2004/04/21 05:00 [entrez]
AID - 10.1177/014572170403000222 [doi]
PST - ppublish
SO  - Diabetes Educ. 2004 Mar-Apr;30(2):293-300. doi: 10.1177/014572170403000222.

PMID- 12006913
OWN - NLM
STAT- MEDLINE
DCOM- 20020628
LR  - 20191210
IS  - 1350-6277 (Print)
IS  - 1350-6277 (Linking)
VI  - 9
IP  - 2
DP  - 2002 Apr
TI  - Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial 
      infarction in women as in men? The Reykjavik Study.
PG  - 67-76
AB  - BACKGROUND: Studies on coronary risk factors in men and women are mainly based on 
      mortality data and few compare results of both sexes with consistent study design 
      and diagnostic criteria. This study assesses the major risk factors for coronary 
      events in men and women from the Reykjavik Study. DESIGN: Within a prospective, 
      population-based cohort study individuals without history of myocardial 
      infarction were identified and the relative risk of baseline variables was 
      assessed in relation to verified myocardial infarction or coronary death during 
      follow-up. METHODS: Of the 9681 women and 8888 men who attended risk assessment 
      from 1967-1991, with follow-up period of up to 28 years, 706 women and 1700 men 
      suffered a non-fatal myocardial infarction or coronary death. RESULTS: Serum 
      cholesterol was a significant risk factor for both sexes, with hazard ratios (HR) 
      decreasing with age. Systolic blood pressure was a stronger risk factor for women 
      as was ECG-confirmed left ventricular hypertrophy (women HR 2.89, 95% confidence 
      interval [CI] 1.67-5.01; men HR 1.11 [CI 0.86-1.43]). Fasting blood glucose > or 
      =6.7 mmol/L identified significantly higher risk for women (HR 2.65) than men (HR 
      2.08) as did self-reported diabetes. Triglyceride risk was significantly higher 
      for women and decreased significantly with age. Smoking increased risk two- to 
      five-fold, increasing with dose, for women, which was significantly higher than 
      the doubling in risk for men. CONCLUSIONS: This large study of the major risk 
      factors compared between the sexes demonstrates similar relative risk of 
      myocardial infarction associated with cholesterol for both sexes, however, the 
      relative risk is higher in women for many other risk factors such as smoking, 
      diabetes, elevated triglycerides and left ventricular hypertrophy.
FAU - Jonsdottir, Lilja S
AU  - Jonsdottir LS
AD  - Heart Preventive Clinic, Icelandic Heart Association, Holtasmari 1, 201 
      Kopavogur, Iceland, University Hospital, Hringbraut, 101 Reykjavik, Iceland.
FAU - Sigfusson, Nikulas
AU  - Sigfusson N
FAU - Gudnason, Vilmundur
AU  - Gudnason V
FAU - Sigvaldason, Helgi
AU  - Sigvaldason H
FAU - Thorgeirsson, Gudmundur
AU  - Thorgeirsson G
LA  - eng
PT  - Comparative Study
PT  - Evaluation Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - J Cardiovasc Risk
JT  - Journal of cardiovascular risk
JID - 9436980
RN  - 0 (Biomarkers)
RN  - 0 (Blood Glucose)
RN  - 0 (Lipids)
SB  - IM
MH  - Adult
MH  - Age Factors
MH  - Biomarkers/blood
MH  - Blood Glucose/analysis
MH  - Blood Pressure/*physiology
MH  - Cohort Studies
MH  - *Diabetes Complications
MH  - Diabetes Mellitus/epidemiology
MH  - Electrocardiography
MH  - Endpoint Determination
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Hypertrophy, Left Ventricular/complications/epidemiology
MH  - Iceland/epidemiology
MH  - Lipids/*blood
MH  - Male
MH  - Middle Aged
MH  - Multivariate Analysis
MH  - Myocardial Infarction/*etiology/mortality
MH  - Prospective Studies
MH  - Risk Factors
MH  - Sex Factors
MH  - Smoking/*adverse effects/blood/epidemiology
MH  - *Women's Health
EDAT- 2002/05/15 10:00
MHDA- 2002/06/29 10:01
CRDT- 2002/05/15 10:00
PHST- 2002/05/15 10:00 [pubmed]
PHST- 2002/06/29 10:01 [medline]
PHST- 2002/05/15 10:00 [entrez]
PST - ppublish
SO  - J Cardiovasc Risk. 2002 Apr;9(2):67-76.

PMID- 8738894
OWN - NLM
STAT- MEDLINE
DCOM- 19960916
LR  - 20190909
IS  - 0355-3140 (Print)
IS  - 0355-3140 (Linking)
VI  - 22
IP  - 2
DP  - 1996 Apr
TI  - Diabetes mellitus among Swedish art glass workers--an effect of arsenic exposure?
PG  - 146-9
AB  - OBJECTIVES: The purpose of this study was to search for evidence of an 
      association between occupational arsenic exposure and diabetes mellitus, as 
      implied by the relation of this disease to arsenic in drinking water in a recent 
      study from Taiwan. METHODS: A case-referent analysis on death records of 5498 
      individuals in the art glass producing part of southeastern Sweden was performed. 
      Out of all the enrolled subjects, 888 were glass workers. According to 
      occupational title, glassblowers, foundry workers, and unspecified workers were 
      regarded as potentially exposed to arsenic. Persons with a diagnosis of diabetes 
      mellitus either as an underlying or contributing cause of death were considered 
      cases. Referents were decedents without any indication of cancer, cardiovascular 
      disease, or diabetes. RESULTS: A slightly elevated risk [Mantel-Haenszel odds 
      ratio (MH-OR) 1.2, 95% confidence interval (95% CI) 0.82-1.8] was found for 
      diabetes mellitus among the glassworks employees, especially in combination with 
      cardiovascular disease (MH-OR 1.4, 95% CI 0.81-2.3). For the glassblowers, other 
      foundry workers and unspecified glassworkers probably exposed to arsenic, the M-H 
      odds ratio was 1.4 (95% CI 0.92-2.2). Unspecified glass workers, who probably 
      included persons with high exposure, carried the higher risk (MH-OR 1.8, 95% CI 
      1.1-2.8). CONCLUSIONS: The observations from this study provide limited support 
      for the possibility that occupational arsenic exposure could play a role in the 
      development of diabetes mellitus. Many other metallic compounds are also used in 
      art glass production, however, and there is a possibility of confounding.
FAU - Rahman, M
AU  - Rahman M
AD  - Department of Occupational and Environmental Medicine University Hospital, 
      Linkoping, Sweden.
FAU - Wingren, G
AU  - Wingren G
FAU - Axelson, O
AU  - Axelson O
LA  - eng
PT  - Journal Article
PL  - Finland
TA  - Scand J Work Environ Health
JT  - Scandinavian journal of work, environment & health
JID - 7511540
RN  - 0 (Poisons)
RN  - N712M78A8G (Arsenic)
SB  - IM
MH  - Age Distribution
MH  - Aged
MH  - Arsenic/*adverse effects
MH  - Cause of Death
MH  - Diabetes Complications
MH  - Diabetes Mellitus/*chemically induced/mortality
MH  - *Glass
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Occupational Exposure/*adverse effects/statistics & numerical data
MH  - Occupations
MH  - Poisons/*adverse effects
MH  - Retrospective Studies
MH  - Risk Assessment
MH  - Sweden/epidemiology
EDAT- 1996/04/01 00:00
MHDA- 1996/04/01 00:01
CRDT- 1996/04/01 00:00
PHST- 1996/04/01 00:00 [pubmed]
PHST- 1996/04/01 00:01 [medline]
PHST- 1996/04/01 00:00 [entrez]
AID - 123 [pii]
AID - 10.5271/sjweh.123 [doi]
PST - ppublish
SO  - Scand J Work Environ Health. 1996 Apr;22(2):146-9. doi: 10.5271/sjweh.123.

PMID- 21431987
OWN - NLM
STAT- MEDLINE
DCOM- 20120103
LR  - 20161125
IS  - 1534-4681 (Electronic)
IS  - 1068-9265 (Linking)
VI  - 18
IP  - 9
DP  - 2011 Sep
TI  - Preoperative staging of patients with liver metastases of colorectal carcinoma. 
      Does PET/CT really add something to multidetector CT?
PG  - 2654-61
LID - 10.1245/s10434-011-1670-y [doi]
AB  - PURPOSE: This study was designed to determine prospectively whether the 
      systematic use of PET/CT associated with conventional techniques could improve 
      the accuracy of staging in patients with liver metastases of colorectal 
      carcinoma. We also assessed the impact on the therapeutic strategy. METHODS: 
      Between 2006 and 2008, 97 patients who were evaluated for resection of LMCRC were 
      prospectively enrolled. Preoperative workup included multidetector-CT (MDCT) and 
      PET/CT. In 11 patients with liver steatosis or iodinated contrast allergy, MR 
      also was performed. Sixty-eight patients underwent laparotomy. Sensitivity, 
      specificity, positive predictive value (PPV), and negative predictive values for 
      hepatic and extrahepatic staging of MDCT and PET-CT were calculated. RESULTS: In 
      a lesion-by-lesion analysis of the hepatic staging, the sensitivity of MDCT/RM 
      was superior to PET/CT (89.2 vs. 55%, p < 0.001). On the extrahepatic staging, 
      PET/CT was superior to MDCT/MR only for the detection of locoregional recurrence 
      (p = 0.03) and recurrence in uncommon sites (p = 0.016). New findings in PET/CT 
      resulted in a change in therapeutic strategy in 17 patients. However, additional 
      information was correct only in eight cases and wrong in nine patients. 
      CONCLUSIONS: PET/CT has a limited role in hepatic staging of LMCRC. Although 
      PET-CT has higher sensitivity for the detection of extrahepatic disease in some 
      anatomic locations, its results are hampered by its low PPV. PET/CT provided 
      additional useful information in 8% of the cases but also incorrect and 
      potentially harmful data in 9% of the staging. Our findings support a more 
      selective use of PET/CT, basically in patients with high risk of local 
      recurrence.
FAU - Ramos, Emilio
AU  - Ramos E
AD  - Department of General Surgery, Hospital Universitario de Bellvitge, Barcelona, 
      Spain. eramos@bellvitgehospital.cat
FAU - Valls, Carlos
AU  - Valls C
FAU - Martinez, Laura
AU  - Martinez L
FAU - Llado, Laura
AU  - Llado L
FAU - Torras, Jaume
AU  - Torras J
FAU - Ruiz, Sandra
AU  - Ruiz S
FAU - Gamez, Cristina
AU  - Gamez C
FAU - Serrano, Teresa
AU  - Serrano T
FAU - Fabregat, Joan
AU  - Fabregat J
FAU - Rafecas, Antonio
AU  - Rafecas A
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20110324
PL  - United States
TA  - Ann Surg Oncol
JT  - Annals of surgical oncology
JID - 9420840
RN  - 0 (Radiopharmaceuticals)
RN  - 0Z5B2CJX4D (Fluorodeoxyglucose F18)
SB  - IM
MH  - Colorectal Neoplasms/diagnostic imaging/*pathology
MH  - Female
MH  - Fluorodeoxyglucose F18
MH  - Follow-Up Studies
MH  - Humans
MH  - Liver Neoplasms/diagnostic imaging/*secondary
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Recurrence, Local/diagnostic imaging/*pathology
MH  - Neoplasm Staging
MH  - *Positron-Emission Tomography
MH  - Preoperative Care
MH  - Prognosis
MH  - Prospective Studies
MH  - Radiopharmaceuticals
MH  - Sensitivity and Specificity
MH  - Survival Rate
MH  - *Tomography, X-Ray Computed
EDAT- 2011/03/25 06:00
MHDA- 2012/01/04 06:00
CRDT- 2011/03/25 06:00
PHST- 2010/12/09 00:00 [received]
PHST- 2011/03/25 06:00 [entrez]
PHST- 2011/03/25 06:00 [pubmed]
PHST- 2012/01/04 06:00 [medline]
AID - 10.1245/s10434-011-1670-y [doi]
PST - ppublish
SO  - Ann Surg Oncol. 2011 Sep;18(9):2654-61. doi: 10.1245/s10434-011-1670-y. Epub 2011 
      Mar 24.

PMID- 22154448
OWN - NLM
STAT- MEDLINE
DCOM- 20120508
LR  - 20181201
IS  - 1769-6623 (Electronic)
IS  - 0750-7658 (Linking)
VI  - 31
IP  - 1
DP  - 2012 Jan
TI  - [Epidural analgesia for surgical treatment of peritoneal carcinomatosis: a risky 
      technique?].
PG  - 53-9
LID - 10.1016/j.annfar.2011.08.020 [doi]
AB  - BACKGROUND: To study the risks of haemodynamic instability, and the possible 
      occurrence of spinal haematoma, meningitis and epidural abscess when epidural 
      analgesia is performed for cytoreductive surgery and hyperthermic intraperitoneal 
      chemotherapy (HIPEC). METHODS: We retrospectively analyzed the data of 35 
      patients treated by HIPEC with oxaliplatin or cisplatin. An epidural catheter was 
      inserted before induction of general anaesthesia. Postoperatively, a continuous 
      epidural infusion of ropivacain, then a patient-controlled epidural analgesia 
      were started. RESULTS: The epidural catheter was used peroperatively before HIPEC 
      in 12 subjects (34%), and after HIPEC in 23 subjects (66%). The median dose of 
      ropivacain given peroperatively in the epidural catheter was 40 mg (30-75). 
      Norepinephrin was used in two subjects (6%) peroperatively (median infusion rate 
      0.325 mug/kg per minute [0.32-0.33]), and in four subjects (11%) in the 
      postoperative 24 hours. No spinal haematoma, meningitis or epidural abscess were 
      noted. Five subjects (14%) had a thrombopenia or a prothrombin time less than 60% 
      before catheter removal. Two subjects (6%) had a leukopenia before catheter 
      removal. No thrombopenia or blood coagulation disorders were recorded the day of 
      catheter removal. CONCLUSION: In this series of 35 patients, the use of epidural 
      analgesia for HIPEC does not seem to be associated with a worse risk of 
      haemodynamic instability, spinal haematoma, meningitis or epidural abscess. HIPEC 
      with platinum salt is not incompatible with the safety of epidural analgesia, 
      with an optimized fluid management peroperatively and the following of 
      perimedullary anesthesia practice guidelines.
CI  - Copyright (c) 2011 Societe francaise d'anesthesie et de reanimation (Sfar). 
      Published by Elsevier SAS. All rights reserved.
FAU - Desgranges, F-P
AU  - Desgranges FP
AD  - Departement d'anesthesie-reanimation, centre regional de lutte contre le cancer 
      Leon-Berard, Lyon, France. fp_desgranges@yahoo.fr
FAU - Steghens, A
AU  - Steghens A
FAU - Rosay, H
AU  - Rosay H
FAU - Meeus, P
AU  - Meeus P
FAU - Stoian, A
AU  - Stoian A
FAU - Daunizeau, A-L
AU  - Daunizeau AL
FAU - Pouderoux-Martin, S
AU  - Pouderoux-Martin S
FAU - Piriou, V
AU  - Piriou V
LA  - fre
PT  - Journal Article
TT  - Analgesie peridurale pour le traitement chirurgical des carcinoses peritoneales : 
      une pratique a risque ?
DEP - 20111206
PL  - France
TA  - Ann Fr Anesth Reanim
JT  - Annales francaises d'anesthesie et de reanimation
JID - 8213275
RN  - 0 (Antineoplastic Agents)
RN  - 0 (Organoplatinum Compounds)
RN  - 0 (Vasoconstrictor Agents)
RN  - 04ZR38536J (Oxaliplatin)
RN  - Q20Q21Q62J (Cisplatin)
RN  - X4W3ENH1CV (Norepinephrine)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Analgesia, Epidural/adverse effects/*methods
MH  - Analgesia, Patient-Controlled
MH  - Anesthesia, General
MH  - Antineoplastic Agents/administration & dosage/therapeutic use
MH  - Carcinoma/drug therapy/*surgery
MH  - Cisplatin/therapeutic use
MH  - Combined Modality Therapy
MH  - Epidural Abscess/epidemiology/etiology
MH  - Female
MH  - Hematoma, Epidural, Spinal/epidemiology/etiology
MH  - Hemodynamics/physiology
MH  - Humans
MH  - Hyperthermia, Induced
MH  - Male
MH  - Meningitis/epidemiology/etiology
MH  - Middle Aged
MH  - Norepinephrine/therapeutic use
MH  - Organoplatinum Compounds/therapeutic use
MH  - Oxaliplatin
MH  - Peritoneal Neoplasms/drug therapy/*surgery
MH  - Retrospective Studies
MH  - Risk
MH  - Safety
MH  - Thrombocytopenia/etiology
MH  - Vasoconstrictor Agents/therapeutic use
EDAT- 2011/12/14 06:00
MHDA- 2012/05/09 06:00
CRDT- 2011/12/14 06:00
PHST- 2011/02/25 00:00 [received]
PHST- 2011/08/25 00:00 [accepted]
PHST- 2011/12/14 06:00 [entrez]
PHST- 2011/12/14 06:00 [pubmed]
PHST- 2012/05/09 06:00 [medline]
AID - S0750-7658(11)00406-0 [pii]
AID - 10.1016/j.annfar.2011.08.020 [doi]
PST - ppublish
SO  - Ann Fr Anesth Reanim. 2012 Jan;31(1):53-9. doi: 10.1016/j.annfar.2011.08.020. 
      Epub 2011 Dec 6.

PMID- 15053041
OWN - NLM
STAT- MEDLINE
DCOM- 20040525
LR  - 20190607
IS  - 1226-3303 (Print)
IS  - 2005-6648 (Electronic)
IS  - 1226-3303 (Linking)
VI  - 19
IP  - 1
DP  - 2004 Mar
TI  - Do acute changes in heart rate by isoproterenol affect aortic stiffness in 
      patients with hypertension?
PG  - 33-7
AB  - BACKGROUND: Increased aortic stiffness is a independent risk factor of 
      cardiovascular disease in patients with hypertension. Acute changes of the heart 
      rate (HR) have been reported not to affect the aortic stiffness in pacing. 
      However, it is unknown whether acute changes in HR caused by sympathomimetics can 
      affect the aortic stiffness in patients with hypertension. We investigated the 
      effect of acute changes in HR produced by isoproterenol on the aortic stiffness 
      in 17 hypertensive patientss (mean age: 59 +/- 9 years). METHODS: All vasoactive 
      drugs were discontinued at least 3 days before the study. The carotid-to-femoral 
      pulse wave velocity (PWV) was measured by the foot-to-foot method. The pulse 
      waves were recorded at the baseline and at every increase of HR by 5 to 10 bpm 
      with a gradual increase of the dose of isoproterenol. The blood pressures and HR 
      were measured simultaneously. For the analysis, HR, PWV, compliance (C), and 
      compliance index (Ci) were converted as percent changes (delta) from the baseline 
      values. Percent changes of the parameters of the aortic stiffness, i.e., 
      deltaPWV, deltaC, and deltaCi, were grouped by every 10% increase in deltaHR. 
      RESULTS: There was no significant difference among groups in deltaPWV, deltaC and 
      deltaCi (p > 0.05 for each of the group). The regression analysis showed no 
      significant correlation of deltaHR with deltaPWV and deltaC (r = 0.18, 0.13 
      respectively, p > 0.05 for each). deltaCi had a poor correlation with deltaHR (r 
      = 0.22, p < 0.05). However, only 4.6% of deltaCi could be referred to deltaHR (r2 
      = 0.046). CONCLUSION: Aortic stiffness was not affected by acute changes in HR 
      produced by isoproterenol which suggests that it is not necessary to consider 
      acute changes in HR when measuring aortic PWV.
FAU - Rhee, Moo-Yong
AU  - Rhee MY
AD  - Department of Internal Medicine, College of Medicine, Dankook University, 
      Cheonan, Korea. rheemy@dankook.ac.kr
FAU - Kwon, Na-Young
AU  - Kwon NY
FAU - Kim, Jae-Deok
AU  - Kim JD
FAU - Song, Seung-Ho
AU  - Song SH
FAU - Yoon, Young-Won
AU  - Yoon YW
FAU - Lee, Myoung-Yong
AU  - Lee MY
FAU - Kim, Young-Kwon
AU  - Kim YK
LA  - eng
PT  - Journal Article
PL  - Korea (South)
TA  - Korean J Intern Med
JT  - The Korean journal of internal medicine
JID - 8712418
RN  - 0 (Sympathomimetics)
RN  - L628TT009W (Isoproterenol)
SB  - IM
MH  - Aged
MH  - Aorta/*drug effects
MH  - Chest Pain/etiology
MH  - Coronary Disease/complications
MH  - Elasticity/drug effects
MH  - Female
MH  - Heart Rate/*drug effects
MH  - Humans
MH  - Hypertension/complications/*physiopathology
MH  - Isoproterenol/*pharmacology
MH  - Linear Models
MH  - Male
MH  - Middle Aged
MH  - Pulsatile Flow/physiology
MH  - Sympathomimetics/*pharmacology
PMC - PMC4531553
EDAT- 2004/04/01 05:00
MHDA- 2004/05/27 05:00
PMCR- 2004/03/01
CRDT- 2004/04/01 05:00
PHST- 2004/04/01 05:00 [pubmed]
PHST- 2004/05/27 05:00 [medline]
PHST- 2004/04/01 05:00 [entrez]
PHST- 2004/03/01 00:00 [pmc-release]
AID - kjim-19-1-33-6 [pii]
AID - 10.3904/kjim.2004.19.1.33 [doi]
PST - ppublish
SO  - Korean J Intern Med. 2004 Mar;19(1):33-7. doi: 10.3904/kjim.2004.19.1.33.

PMID- 22365295
OWN - NLM
STAT- MEDLINE
DCOM- 20120619
LR  - 20240721
IS  - 1535-7732 (Electronic)
IS  - 1051-0443 (Print)
IS  - 1051-0443 (Linking)
VI  - 23
IP  - 3
DP  - 2012 Mar
TI  - Totally implantable venous access device placement by interventional 
      radiologists: are prophylactic antibiotics necessary?
PG  - 358-62
LID - 10.1016/j.jvir.2011.11.004 [doi]
AB  - PURPOSE: To determine the rate of early infection for totally implantable venous 
      access devices (TIVADs) placed without antibiotic prophylaxis. MATERIAL AND 
      METHODS: A list of patients who underwent TIVAD placement in 2009 was obtained 
      from the patient archiving and communication system (PACS). This list was 
      cross-referenced to all patients who underwent TIVAD removal from January 1, 
      2009, through January 30, 2010, to identify TIVADs that were removed within 30 
      days of placement. Retrospective chart review was performed to record patient 
      demographics, including age, sex, cancer diagnosis, and indication for removal. 
      Concurrent antibiotic therapy, chemotherapy, and laboratory data before and 
      within 30 days of placement were recorded. Central line-associated bloodstream 
      infections (CLABSIs) were identified using U.S. Centers for Disease Control and 
      Prevention (CDC) criteria. RESULTS: There were 1,183 ports placed and 13 removed. 
      CLABSIs occurred in seven (0.6%) patients within 30 days of placement. At the 
      time of TIVAD placement, 81 (7%) patients were receiving antibiotics incidental 
      to the procedure. One patient who received an antibiotic the day of implantation 
      developed a CLABSI. Chemotherapy was administered to 148 (13%) patients on the 
      day of placement. CONCLUSIONS: The rate of early infection without antibiotic 
      prophylaxis before TIVAD placement in the interventional radiology suite is < 1%. 
      Based on these data, use of prophylactic antibiotics for TIVAD placement is not 
      recommended.
CI  - Copyright A(c) 2012 SIR. Published by Elsevier Inc. All rights reserved.
FAU - Covey, Anne M
AU  - Covey AM
AD  - Department of Diagnostic Radiology, Memorial Sloan-Kettering Cancer Center, New 
      York, NY 10021, USA. coveya@mskcc.org
FAU - Toro-Pape, Franz W
AU  - Toro-Pape FW
FAU - Thornton, Raymond H
AU  - Thornton RH
FAU - Son, Crystal
AU  - Son C
FAU - Erinjeri, Joseph
AU  - Erinjeri J
FAU - Sofocleous, Constantinos T
AU  - Sofocleous CT
FAU - Brody, Lynn A
AU  - Brody LA
FAU - Brown, Karen T
AU  - Brown KT
FAU - Sepkowitz, Kent A
AU  - Sepkowitz KA
FAU - Getrajdman, George I
AU  - Getrajdman GI
LA  - eng
GR  - P30 CA008748/CA/NCI NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - J Vasc Interv Radiol
JT  - Journal of vascular and interventional radiology : JVIR
JID - 9203369
SB  - IM
EIN - J Vasc Interv Radiol. 2012 Jun;23(6):852. Septkowitz, Kent A [corrected to 
      Sepkowitz, Kent A]
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - *Antibiotic Prophylaxis
MH  - Catheter-Related Infections/diagnosis/microbiology/*prevention & control
MH  - Catheterization, Central Venous/*adverse effects/instrumentation
MH  - Catheters, Indwelling/*adverse effects
MH  - Device Removal
MH  - Equipment Design
MH  - Female
MH  - Guideline Adherence
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Practice Guidelines as Topic
MH  - *Radiography, Interventional
MH  - Retrospective Studies
MH  - Risk Assessment
MH  - Risk Factors
MH  - Time Factors
MH  - Treatment Outcome
MH  - Young Adult
PMC - PMC6830723
MID - NIHMS460205
EDAT- 2012/03/01 06:00
MHDA- 2012/06/20 06:00
PMCR- 2019/11/05
CRDT- 2012/02/28 06:00
PHST- 2011/09/09 00:00 [received]
PHST- 2011/10/28 00:00 [revised]
PHST- 2011/11/06 00:00 [accepted]
PHST- 2012/02/28 06:00 [entrez]
PHST- 2012/03/01 06:00 [pubmed]
PHST- 2012/06/20 06:00 [medline]
PHST- 2019/11/05 00:00 [pmc-release]
AID - S1051-0443(11)01446-1 [pii]
AID - 10.1016/j.jvir.2011.11.004 [doi]
PST - ppublish
SO  - J Vasc Interv Radiol. 2012 Mar;23(3):358-62. doi: 10.1016/j.jvir.2011.11.004.

PMID- 19546588
OWN - NLM
STAT- MEDLINE
DCOM- 20091021
LR  - 20131121
IS  - 1660-2110 (Electronic)
IS  - 1660-2110 (Linking)
VI  - 112
IP  - 4
DP  - 2009
TI  - Does increasing blood pH stimulate protein synthesis in dialysis patients?
PG  - c276-83
LID - 10.1159/000224795 [doi]
AB  - BACKGROUND: Although the mechanism of muscle wasting in end-stage renal disease 
      is not fully understood, there is increasing evidence that acidosis induces 
      muscle protein degradation and could therefore contribute to the loss of muscle 
      protein stores of patients on hemodialysis, a prototypical state of chronic 
      metabolic acidosis (CMA). Because body protein mass is controlled by the balance 
      between synthesis and degradation, protein loss can occur as result of either 
      increased breakdown, impaired synthesis, or both. Correction of acidosis may 
      therefore help to maintain muscle mass and improve the health of patients with 
      CMA. We evaluated whether alkalizing patients on hemodialysis might have a 
      positive effect on protein synthesis and on nutritional parameters. METHODS: 
      Eight chronic hemodialysis patients were treated daily with oral sodium 
      bicarbonate (NaHCO(3)) supplementation for 10-14 days, yielding a pre-dialytic 
      plasma bicarbonate concentration of 28.6 +/-1.6 mmol/l. The fractional synthesis 
      rates (FSR) of muscle protein and albumin were obtained by the 
      L-[(2)H(5)ring]phenylalanine flooding technique. RESULTS: Oral NaHCO(3 
      )supplementation induced a significant increase in serum bicarbonate (21.5 +/- 
      3.4 vs. 28.6 +/- 1.6 mmol/l; p = 0.018) and blood pH (7.41 vs. 7.46; p = 0.041). 
      The FSR of muscle protein and the FSR of albumin did not change significantly 
      (muscle protein: 2.1 +/- 0.2 vs. 2.0 +/- 0.5% per day, p = 0.39; albumin: 8.3 +/- 
      2.2 vs. 8.6 +/- 2.5% per day, p = 0.31). Plasma concentrations of insulin-like 
      growth factor 1 decreased significantly (33.4 +/- 21.3 vs. 25.4 +/- 12.3 nmol/l; 
      p = 0.028), whereas thyroid-stimulating hormone, free thyroxin and free 
      triiodothyronine did not change significantly and nutritional parameters showed 
      no improvement. CONCLUSION: In contrast to other findings, raising the blood pH 
      of dialysis patients was not associated with a positive effect on albumin and 
      muscle protein synthesis, or nutritional and endocrinal parameters.
CI  - Copyright 2009 S. Karger AG, Basel.
FAU - Ruggieri, Fabio
AU  - Ruggieri F
AD  - Department of Internal Medicine, Kantonsspital, Winterthur, Switzerland. 
      fabio.ruggieri@usz.ch
FAU - Caso, Giuseppe
AU  - Caso G
FAU - Wegmann, Marlene
AU  - Wegmann M
FAU - McNurlan, Margaret A
AU  - McNurlan MA
FAU - Wahl, Christoph
AU  - Wahl C
FAU - Imoberdorf, Reinhard
AU  - Imoberdorf R
FAU - Garlick, Peter J
AU  - Garlick PJ
FAU - Ballmer, Peter E
AU  - Ballmer PE
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20090616
PL  - Switzerland
TA  - Nephron Clin Pract
JT  - Nephron. Clinical practice
JID - 101159763
RN  - 0 (Blood Proteins)
RN  - 8MDF5V39QO (Sodium Bicarbonate)
SB  - IM
MH  - Administration, Oral
MH  - Adult
MH  - Aged
MH  - *Blood Chemical Analysis
MH  - Blood Proteins/*analysis
MH  - Female
MH  - Humans
MH  - Hydrogen-Ion Concentration/*drug effects
MH  - Kidney Failure, Chronic/*blood/*rehabilitation
MH  - Male
MH  - Middle Aged
MH  - Protein Biosynthesis/drug effects
MH  - *Renal Dialysis
MH  - Sodium Bicarbonate/*administration & dosage
EDAT- 2009/06/24 09:00
MHDA- 2009/10/22 06:00
CRDT- 2009/06/24 09:00
PHST- 2008/06/12 00:00 [received]
PHST- 2009/02/03 00:00 [accepted]
PHST- 2009/06/24 09:00 [entrez]
PHST- 2009/06/24 09:00 [pubmed]
PHST- 2009/10/22 06:00 [medline]
AID - 000224795 [pii]
AID - 10.1159/000224795 [doi]
PST - ppublish
SO  - Nephron Clin Pract. 2009;112(4):c276-83. doi: 10.1159/000224795. Epub 2009 Jun 
      16.

PMID- 7482275
OWN - NLM
STAT- MEDLINE
DCOM- 19951214
LR  - 20190913
IS  - 0039-6060 (Print)
IS  - 0039-6060 (Linking)
VI  - 118
IP  - 5
DP  - 1995 Nov
TI  - Necrotizing fasciitis: an indication for hyperbaric oxygenation therapy?
PG  - 873-8
AB  - BACKGROUND: The accepted treatment protocol for necrotizing fasciitis (NF) 
      consists of extensive surgery and wide spectrum antibiotics. Hyperbaric 
      oxygenation (HBO) has been recommended as adjuvant therapy for NF, improving 
      patient mortality and outcome. However, the beneficial effect of HBO for NF 
      remains controversial. METHODS: A retrospective evaluation of treatment outcome 
      in 37 patients treated for NF between 1984 and 1993 was carried out. The 
      mortality rate, morbidity criteria, and risk factors for grave prognosis were 
      compared between a group of 25 patients who received HBO as part of their 
      treatment protocol and a group of the remaining 12 patients treated by surgical 
      excision and antibiotics alone. RESULTS: The two groups were found to be similar 
      with regard to age, gender, the incidence of individual risk factors for ominous 
      prognosis, and the Acute Physiology and Chronic Health Evaluation (APACHE) II 
      score for disease's severity on presentation. The mortality rate among the 
      HBO-treated patients was 36%, as opposed to 25% in the non-HBO group. The mean 
      number of surgical debridements required per patient was significantly higher in 
      the HBO group: 3.3 compared with 1.5 in the non-HBO-treated patients. Although 
      the average length of hospitalization for survivors was shorter for the HBO 
      group, the difference between the groups did not reach statistical significance. 
      CONCLUSIONS: The results of this study cast doubt on the suggested advantage of 
      HBO in reducing patient mortality and morbidity when used as adjuvant therapy for 
      NF.
FAU - Shupak, A
AU  - Shupak A
AD  - Israel Naval Medical Institute, IDF, Haifa, Israel.
FAU - Shoshani, O
AU  - Shoshani O
FAU - Goldenberg, I
AU  - Goldenberg I
FAU - Barzilai, A
AU  - Barzilai A
FAU - Moskuna, R
AU  - Moskuna R
FAU - Bursztein, S
AU  - Bursztein S
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Surgery
JT  - Surgery
JID - 0417347
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Fasciitis, Necrotizing/*therapy
MH  - Female
MH  - Humans
MH  - *Hyperbaric Oxygenation
MH  - Male
MH  - Middle Aged
MH  - Retrospective Studies
EDAT- 1995/11/01 00:00
MHDA- 1995/11/01 00:01
CRDT- 1995/11/01 00:00
PHST- 1995/11/01 00:00 [pubmed]
PHST- 1995/11/01 00:01 [medline]
PHST- 1995/11/01 00:00 [entrez]
AID - S0039-6060(05)80278-8 [pii]
AID - 10.1016/s0039-6060(05)80278-8 [doi]
PST - ppublish
SO  - Surgery. 1995 Nov;118(5):873-8. doi: 10.1016/s0039-6060(05)80278-8.

PMID- 24698298
OWN - NLM
STAT- MEDLINE
DCOM- 20141218
LR  - 20170901
IS  - 1872-7727 (Electronic)
IS  - 0720-048X (Linking)
VI  - 83
IP  - 6
DP  - 2014 Jun
TI  - MR arthrography of the shoulder: do we need local anesthesia?
PG  - 980-983
LID - S0720-048X(14)00144-2 [pii]
LID - 10.1016/j.ejrad.2014.03.008 [doi]
AB  - PURPOSE: To assess pain intensity with and without subcutaneous local anesthesia 
      prior to intraarticular administration of contrast medium for magnetic resonance 
      arthrography (MRa) of the shoulder. MATERIALS AND METHODS: This single-center 
      study was conducted after an IRB waiver of authorization, between January 2010 
      and December 2012. All patients provided written, informed consent for the 
      procedure. Our prospectively populated institutional database was searched, based 
      on our inclusion criteria. There were 249 outpatients (178 men and 71 women; mean 
      age, 44.4 years +/- 14.6; range, 15-79) who underwent MRa and were enrolled in this 
      study. Patients were excluded if they had received surgery of the shoulder before 
      MRa, had undergone repeated MRa of the same shoulder, and/or had undergone MRa of 
      both shoulders on the same day. Patients were randomly assigned into one of three 
      groups. Patients in group A (n=61) received skin infiltration with local 
      anesthesia. Patients in control group B (n=92) and group C (n=96) did not receive 
      local anesthesia. Pain levels were immediately assessed after the injection for 
      MRa using a horizontal visual analog scale (VAS) that ranged from 0 to 10. To 
      compare the pain scores of the three groups for male and female patients, a 
      two-way analysis of variance was used. A p-value equal to or less than 0.05 was 
      considered to indicate a significant result. RESULTS: Patients who received local 
      anesthesia (group A) showed a mean pain level on the VAS of 2.6 +/- 2.3. In 
      patients who did not receive local anesthetics (groups B and C), a mean pain 
      level on the VAS of 2.6 +/- 2.2 and 2.7 +/- 2.4 were detected, respectively. Between 
      the three groups, no statistically significant difference in pain intensity was 
      detected (p=.960). There were significant differences in subjective pain 
      perception between men and women (p=.009). Moreover, the sex difference in all 
      three groups was equal (p=.934). CONCLUSION: Local anesthesia is not required to 
      lower a patient's pain intensity when applying intra-articular contrast media for 
      MR arthrography of the shoulder. This could result in reduced costs and a reduced 
      risk of adverse reactions, without an impact on patient comfort.
CI  - Copyright (c) 2014 Elsevier Ireland Ltd. All rights reserved.
FAU - Spick, Claudio
AU  - Spick C
AD  - Department of Biomedical Imaging and Image-guided Therapy, Medical University of 
      Vienna (AKH), Waehringer-Guertel 18-20, 1090 Vienna, Austria. Electronic address: 
      claudio.spick@meduniwien.ac.at.
FAU - Szolar, Dieter H M
AU  - Szolar DHM
AD  - Diagnostikum Graz-Sudwest, Weblinger Guertel 25, 8054 Graz, Austria.
FAU - Reittner, Pia
AU  - Reittner P
AD  - Diagnostikum Graz-Sudwest, Weblinger Guertel 25, 8054 Graz, Austria.
FAU - Preidler, Klaus W
AU  - Preidler KW
AD  - Diagnostikum Graz-Sudwest, Weblinger Guertel 25, 8054 Graz, Austria.
FAU - Tillich, Manfred
AU  - Tillich M
AD  - Diagnostikum Graz-Sudwest, Weblinger Guertel 25, 8054 Graz, Austria.
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20140324
PL  - Ireland
TA  - Eur J Radiol
JT  - European journal of radiology
JID - 8106411
RN  - 0 (Anesthetics, Local)
RN  - 0 (Contrast Media)
RN  - 0 (Organometallic Compounds)
RN  - 15G12L5X8K (gadobenic acid)
RN  - 6HG8UB2MUY (Meglumine)
RN  - 98PI200987 (Lidocaine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Anesthetics, Local/administration & dosage
MH  - Contrast Media/administration & dosage/adverse effects
MH  - Female
MH  - Humans
MH  - Injections, Intra-Articular/adverse effects
MH  - Lidocaine/*administration & dosage
MH  - Magnetic Resonance Imaging/*adverse effects/*methods
MH  - Male
MH  - Meglumine/administration & dosage/adverse effects/*analogs & derivatives
MH  - Middle Aged
MH  - Organometallic Compounds/*administration & dosage/*adverse effects
MH  - Pain Measurement/drug effects
MH  - Shoulder Pain/*diagnosis/*etiology
MH  - Treatment Outcome
MH  - Young Adult
OTO - NOTNLM
OT  - Arthrography
OT  - Local anesthesia
OT  - MR arthrography
OT  - Pain
OT  - Shoulder
EDAT- 2014/04/05 06:00
MHDA- 2014/12/19 06:00
CRDT- 2014/04/05 06:00
PHST- 2013/10/03 00:00 [received]
PHST- 2013/12/31 00:00 [revised]
PHST- 2014/03/07 00:00 [accepted]
PHST- 2014/04/05 06:00 [entrez]
PHST- 2014/04/05 06:00 [pubmed]
PHST- 2014/12/19 06:00 [medline]
AID - S0720-048X(14)00144-2 [pii]
AID - 10.1016/j.ejrad.2014.03.008 [doi]
PST - ppublish
SO  - Eur J Radiol. 2014 Jun;83(6):980-983. doi: 10.1016/j.ejrad.2014.03.008. Epub 2014 
      Mar 24.

PMID- 18274917
OWN - NLM
STAT- MEDLINE
DCOM- 20080811
LR  - 20080215
IS  - 0001-6489 (Print)
IS  - 0001-6489 (Linking)
VI  - 128
IP  - 3
DP  - 2008 Mar
TI  - Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's 
      disease?
PG  - 304-8
LID - 10.1080/00016480601002096 [doi]
AB  - CONCLUSION: We conclude that not all low-tone sudden deafness (SD) patients 
      suffered from endolymphatic hydrops even if they had vertigo attack at the onset 
      and that electrocochleography (ECochG) was a useful prognostic tool. OBJECTIVES: 
      To investigate whether low-tone SD was a precursor of Meniere's disease and 
      whether patients with low-tone SD suffered from endolymphatic hydrops. PATIENTS 
      AND METHODS: This was a retrospective case review in the university hospital. A 
      total of 184 patients with low-tone SD were divided into two groups with single 
      and recurrent episodes. The progress, follow-up audiograms, and ECochG results of 
      the patients were reviewed and compared with those of patients with high-tone SD 
      and Meniere's disease. RESULTS: In all, 83 of 177 patients with low-tone SD 
      unaccompanied by vertigo had recurrent hearing loss; 15 of the 83 developed 
      vertiginous attacks. The remaining 94 patients had a single episode. Three of the 
      seven patients with low-tone SD accompanied by vertigo had recurrent hearing 
      loss; two of the three were subsequently confirmed to have Meniere's disease. The 
      other four had a single episode. No difference in rate of progress from SD to 
      Meniere's disease was observed among the low-tone and the high-tone SD groups. 
      The average -SP/AP of each group with a single episode is smaller than that of 
      other groups with recurrent episodes and Meniere's disease.
FAU - Junicho, Makiko
AU  - Junicho M
AD  - Department of Otolaryngology, University of Toyama, Toyama, Japan.
FAU - Aso, Shin
AU  - Aso S
FAU - Fujisaka, Michiro
AU  - Fujisaka M
FAU - Watanabe, Yukio
AU  - Watanabe Y
LA  - eng
PT  - Journal Article
PL  - England
TA  - Acta Otolaryngol
JT  - Acta oto-laryngologica
JID - 0370354
SB  - IM
MH  - Audiometry, Evoked Response
MH  - Audiometry, Pure-Tone
MH  - Auditory Threshold/physiology
MH  - Disease Progression
MH  - Endolymphatic Hydrops/*diagnosis
MH  - Female
MH  - Follow-Up Studies
MH  - Hearing Loss, Sudden/*diagnosis
MH  - Humans
MH  - Male
MH  - Meniere Disease/*diagnosis
MH  - *Pitch Discrimination
MH  - Recurrence
MH  - Retrospective Studies
EDAT- 2008/02/16 09:00
MHDA- 2008/08/12 09:00
CRDT- 2008/02/16 09:00
PHST- 2008/02/16 09:00 [pubmed]
PHST- 2008/08/12 09:00 [medline]
PHST- 2008/02/16 09:00 [entrez]
AID - 788682508 [pii]
AID - 10.1080/00016480601002096 [doi]
PST - ppublish
SO  - Acta Otolaryngol. 2008 Mar;128(3):304-8. doi: 10.1080/00016480601002096.

PMID- 21946341
OWN - NLM
STAT- MEDLINE
DCOM- 20130111
LR  - 20161222
IS  - 1556-3871 (Electronic)
IS  - 1547-5271 (Linking)
VI  - 9
IP  - 2
DP  - 2012 Feb
TI  - Is there a relationship between complex fractionated atrial electrograms recorded 
      during atrial fibrillation and sinus rhythm fractionation?
PG  - 181-8
LID - 10.1016/j.hrthm.2011.09.062 [doi]
AB  - BACKGROUND: Ablation of persistent atrial fibrillation (AF) may require 
      adjunctive methods of substrate modification. Both ablation-targeting complex 
      fractionated atrial electrograms (CFAEs) recorded during AF and fractionated 
      electrograms recorded during sinus rhythm (sinus rhythm fractionation [SRF]) have 
      been described. However, the relationship of CFAEs with SRF is unclear. METHODS: 
      Twenty patients (age 62 +/- 9 years, 13 males) with persistent AF and 9 control 
      subjects without organic heart disease or AF (age 36 +/- 6 years, 4 males) 
      underwent detailed CFAE and SRF left atrial electroanatomic maps. The overlap in 
      left atrial regions with CFAEs and SRF was compared in the AF population, and the 
      distribution of SRF was compared among patients with AF and normal controls. 
      Propagation maps were analyzed to identify the activation patterns associated 
      with SR fractionation. RESULTS: SRF (338 +/- 150 points) and CFAE (418 +/- 135 
      points) regions comprised 29% +/- 14% and 25% +/- 15% of the left atrial surface 
      area, respectively. There was no significant correlation between SRF and CFAE 
      maps (r = .2; P = NS). On comparing patients with AF and controls, no significant 
      difference was found in the distribution of SRF between groups (P = .74). Regions 
      of SRF overlapped areas of wave-front collision 75% +/- 13% of the time. 
      CONCLUSIONS: (1) There is little overlap between regions of CFAEs during AF and 
      regions of SRF measured in the time domain or the frequency domain, (2) the 
      majority of SRF appears to occur in regions with wave-front collision, (3) the 
      distribution of SRF is similar in patients with AF and normal controls, 
      suggesting that this may not have an important role in AF maintenance and may not 
      be a suitable ablation target.
CI  - Copyright (c) 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights 
      reserved.
FAU - Saghy, Laszlo
AU  - Saghy L
AD  - Second Department of Medicine, Cardiology Center, University of Szeged, Szeged, 
      Hungary.
FAU - Callans, David J
AU  - Callans DJ
FAU - Garcia, Fermin
AU  - Garcia F
FAU - Lin, David
AU  - Lin D
FAU - Marchlinski, Francis E
AU  - Marchlinski FE
FAU - Riley, Michael
AU  - Riley M
FAU - Dixit, Sanjay
AU  - Dixit S
FAU - Tzou, Wendy S
AU  - Tzou WS
FAU - Haqqani, Harris M
AU  - Haqqani HM
FAU - Pap, Robert
AU  - Pap R
FAU - Kim, Steven
AU  - Kim S
FAU - Gerstenfeld, Edward P
AU  - Gerstenfeld EP
LA  - eng
PT  - Journal Article
DEP - 20110923
PL  - United States
TA  - Heart Rhythm
JT  - Heart rhythm
JID - 101200317
SB  - IM
MH  - Aged
MH  - Arrhythmias, Cardiac/*physiopathology/surgery
MH  - Atrial Fibrillation/*physiopathology/surgery
MH  - Catheter Ablation/*methods
MH  - Electrophysiologic Techniques, Cardiac/*methods
MH  - Female
MH  - Heart Atria/*physiopathology/surgery
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Signal Processing, Computer-Assisted
EDAT- 2011/09/29 06:00
MHDA- 2013/01/12 06:00
CRDT- 2011/09/28 06:00
PHST- 2011/03/06 00:00 [received]
PHST- 2011/09/19 00:00 [accepted]
PHST- 2011/09/28 06:00 [entrez]
PHST- 2011/09/29 06:00 [pubmed]
PHST- 2013/01/12 06:00 [medline]
AID - S1547-5271(11)01129-5 [pii]
AID - 10.1016/j.hrthm.2011.09.062 [doi]
PST - ppublish
SO  - Heart Rhythm. 2012 Feb;9(2):181-8. doi: 10.1016/j.hrthm.2011.09.062. Epub 2011 
      Sep 23.

PMID- 23568387
OWN - NLM
STAT- MEDLINE
DCOM- 20140630
LR  - 20220331
IS  - 1433-7347 (Electronic)
IS  - 0942-2056 (Linking)
VI  - 21
IP  - 11
DP  - 2013 Nov
TI  - Is bicompartmental knee arthroplasty more favourable to knee muscle strength and 
      physical performance compared to total knee arthroplasty?
PG  - 2532-41
LID - 10.1007/s00167-013-2489-9 [doi]
AB  - PURPOSE: Bicompartmental knee arthroplasty features bone and ligament sparing as 
      unicompartmental knee arthroplasty and is presumably better in the recovery of 
      muscle strength and function compared to total knee arthroplasty (TKA) though not 
      previously reported in the literature. The aim of the study was to compare 
      isokinetic knee muscle strength and physical performance in patients who 
      underwent either bicompartmental knee arthroplasty or TKA. METHODS: Each of 24 
      patients (31 knees) was prospectively examined preoperatively, at 6 and 12 months 
      after each surgery. Isokinetic knee extensor and flexor strength as well as 
      position sense were measured using the Biodex system. Timed up and go test, stair 
      climbing test, and the 6-min walk test were used to assess physical performance. 
      The results of each group were also compared with those from the corresponding 
      healthy control, respectively. RESULTS: Demography showed significant difference 
      in the mean age between bicompartment (54.8 +/- 5.6 years) and TKA groups (65.7 +/- 
      6.7 years). Comparing between the two groups, knee extensor and flexor torque, 
      hamstring/Quadriceps ratio, position sense, and physical performance were not 
      significantly different preoperatively, at 6 and 12 months after surgery. In 
      intra-group analysis, muscle strength and position sense at each time point were 
      not different in both groups. In physical performance, both groups resulted in 
      improvement in the 6-min walk test, and only TKA group showed enhancement in 
      stair climbing test. CONCLUSIONS: Although theoretically plausible, 
      bicompartmental knee arthroplasty was not superior in knee muscle strength and 
      physical performance at 1 year compared with total knee arthroplasty.
FAU - Chung, Jun Young
AU  - Chung JY
AD  - Department of Orthopedic Surgery, Ajou University School of Medicine, Suwon, 
      Republic of Korea.
FAU - Min, Byoung-Hyun
AU  - Min BH
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20130409
PL  - Germany
TA  - Knee Surg Sports Traumatol Arthrosc
JT  - Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA
JID - 9314730
SB  - IM
MH  - *Arthroplasty, Replacement, Knee
MH  - Female
MH  - Humans
MH  - Knee Joint/physiopathology/surgery
MH  - Male
MH  - Middle Aged
MH  - Muscle Strength
MH  - Muscle, Skeletal/*physiopathology
MH  - Osteoarthritis, Knee/*physiopathology/*surgery
EDAT- 2013/04/10 06:00
MHDA- 2014/07/01 06:00
CRDT- 2013/04/10 06:00
PHST- 2012/11/11 00:00 [received]
PHST- 2013/03/25 00:00 [accepted]
PHST- 2013/04/10 06:00 [entrez]
PHST- 2013/04/10 06:00 [pubmed]
PHST- 2014/07/01 06:00 [medline]
AID - 10.1007/s00167-013-2489-9 [doi]
PST - ppublish
SO  - Knee Surg Sports Traumatol Arthrosc. 2013 Nov;21(11):2532-41. doi: 
      10.1007/s00167-013-2489-9. Epub 2013 Apr 9.

PMID- 21256734
OWN - NLM
STAT- MEDLINE
DCOM- 20110802
LR  - 20110228
IS  - 1879-0852 (Electronic)
IS  - 0959-8049 (Linking)
VI  - 47
IP  - 5
DP  - 2011 Mar
TI  - Does pain intensity predict a poor opioid response in cancer patients?
PG  - 713-7
LID - 10.1016/j.ejca.2010.12.020 [doi]
AB  - AIM: The aim of this study was to test the hypothesis that initial pain intensity 
      is not a predictive factor of poor opioid response in advanced cancer patients, 
      as suggested by a recent work. METHODS: A secondary analysis of 
      one-hundred-sixty-seven patients referred for treatment of cancer-related pain 
      was conducted. Pain intensity at admission was recorded and patients were divided 
      in three categories of pain intensity: mild, moderate and severe. Patients were 
      offered a treatment with opioid dose titration, according to department policy. 
      Data regarding opioid doses and pain intensity were collected after dose 
      titration was completed. Four levels of opioid response were considered: (a) good 
      pain control, with minimal opioid escalation and without relevant adverse 
      effects; (b) good pain control requiring more aggressive opioid escalation, for 
      example doubling the doses in four days; (c) adequate pain control associated 
      with the occurrence of adverse effects; (d) poor pain control with adverse 
      effects. RESULTS: Seventy-six, forty-four, forty-one and six patients showed a 
      response a, b, c, and d, respectively. No correlation between baseline pain 
      intensity categories and opioid response was found. Patients with response 'b' 
      and 'd' showed higher values of OEImg. CONCLUSION: Baseline pain intensity does 
      not predict the outcome after an appropriate opioid titration. It is likely that 
      non-homogeneous pain treatment would have biased the outcome of a previous work.
CI  - Copyright (c) 2011 Elsevier Ltd. All rights reserved.
FAU - Mercadante, Sebastiano
AU  - Mercadante S
AD  - Pain Relief and Palliative Care Unit, La Maddalena Cancer Center, Italy. 
      terapiadeldolore@lamaddalenanet.it
FAU - Gebbia, Vittorio
AU  - Gebbia V
FAU - David, Fabrizio
AU  - David F
FAU - Aielli, Federica
AU  - Aielli F
FAU - Verna, Lucilla
AU  - Verna L
FAU - Porzio, Giampiero
AU  - Porzio G
FAU - Ferrera, Patrizia
AU  - Ferrera P
FAU - Casuccio, Alessandra
AU  - Casuccio A
FAU - Ficorella, Corrado
AU  - Ficorella C
LA  - eng
PT  - Journal Article
DEP - 20110120
PL  - England
TA  - Eur J Cancer
JT  - European journal of cancer (Oxford, England : 1990)
JID - 9005373
RN  - 0 (Analgesics, Opioid)
SB  - IM
MH  - Aged
MH  - Analgesics, Opioid/*therapeutic use
MH  - Analysis of Variance
MH  - Female
MH  - Humans
MH  - Karnofsky Performance Status
MH  - Male
MH  - Middle Aged
MH  - Neoplasms/*complications
MH  - Pain/etiology/*prevention & control
MH  - Pain Measurement
MH  - Prospective Studies
MH  - Treatment Outcome
EDAT- 2011/01/25 06:00
MHDA- 2011/08/04 06:00
CRDT- 2011/01/25 06:00
PHST- 2010/10/20 00:00 [received]
PHST- 2010/12/11 00:00 [revised]
PHST- 2010/12/15 00:00 [accepted]
PHST- 2011/01/25 06:00 [entrez]
PHST- 2011/01/25 06:00 [pubmed]
PHST- 2011/08/04 06:00 [medline]
AID - S0959-8049(10)01209-8 [pii]
AID - 10.1016/j.ejca.2010.12.020 [doi]
PST - ppublish
SO  - Eur J Cancer. 2011 Mar;47(5):713-7. doi: 10.1016/j.ejca.2010.12.020. Epub 2011 
      Jan 20.

PMID- 22534881
OWN - NLM
STAT- MEDLINE
DCOM- 20121001
LR  - 20211021
IS  - 1437-9813 (Electronic)
IS  - 0179-0358 (Linking)
VI  - 28
IP  - 6
DP  - 2012 Jun
TI  - Does the radiographic transition zone correlate with the level of aganglionosis 
      on the specimen in Hirschsprung's disease?
PG  - 597-601
LID - 10.1007/s00383-012-3094-6 [doi]
AB  - PURPOSE: The correlation between radiographic transition zone on contrast enema 
      in Hirschsprung's disease and the total length of aganglionosis is known to be 
      inaccurate. The aim of our study was to analyse this correlation more precisely 
      to improve preoperative planning of the corrective surgery. METHODS: From 1998 to 
      2009, 79 patients were operated on for Hirschsprung's disease. All available 
      preoperative contrast enemas (n = 61) had been single blind reviewed by the same 
      radiologist who defined the radiographic transition zone when present in 
      vertebral level. Four groups were determined (rectal, rectosigmoid, long segment, 
      and absence of transition zone) and by Kappa coefficient of agreement correlated 
      to the length of aganglionosis in the pathological report. RESULTS: Radiological 
      findings were concordant with the specimen in pathology in 8 cases of 19 in 
      rectal form (42 %), in 20 cases of 35 in rectosigmoid form (57 %), in all 6 cases 
      of long-segment form (100 %), in the 2 cases of total colonic form (100 %) with a 
      global agreement of 58.1 %, kappa = 0.39 CI [0.24; 0.57]. CONCLUSION: Correlation 
      between level of radiographic transition zone on contrast enema and length of 
      aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or 
      ombilical incision is mandatory.
FAU - Muller, Cecile Olivia
AU  - Muller CO
AD  - Department of Pediatric Surgery and Urology, Hopital Robert Debre, 48 Boulevard 
      Serrurier, 75019, Paris, France. cessolivia@gmail.com
FAU - Mignot, Cecile
AU  - Mignot C
FAU - Belarbi, Nadia
AU  - Belarbi N
FAU - Berrebi, Dominique
AU  - Berrebi D
FAU - Bonnard, Arnaud
AU  - Bonnard A
LA  - eng
PT  - Journal Article
DEP - 20120426
PL  - Germany
TA  - Pediatr Surg Int
JT  - Pediatric surgery international
JID - 8609169
SB  - IM
MH  - Female
MH  - Hirschsprung Disease/*diagnostic imaging/*pathology/surgery
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Male
MH  - Radiography
MH  - Retrospective Studies
EDAT- 2012/04/27 06:00
MHDA- 2012/10/02 06:00
CRDT- 2012/04/27 06:00
PHST- 2012/04/11 00:00 [accepted]
PHST- 2012/04/27 06:00 [entrez]
PHST- 2012/04/27 06:00 [pubmed]
PHST- 2012/10/02 06:00 [medline]
AID - 10.1007/s00383-012-3094-6 [doi]
PST - ppublish
SO  - Pediatr Surg Int. 2012 Jun;28(6):597-601. doi: 10.1007/s00383-012-3094-6. Epub 
      2012 Apr 26.

PMID- 8566975
OWN - NLM
STAT- MEDLINE
DCOM- 19960301
LR  - 20190503
IS  - 0266-4348 (Print)
IS  - 0266-4348 (Linking)
VI  - 71
IP  - 6
DP  - 1995 Dec
TI  - Serovar specific immunity to Neisseria gonorrhoeae: does it exist?
PG  - 367-9
AB  - OBJECTIVE: To determine whether the host immune response to gonorrhoea provides 
      limited serovar specific protection from reinfection. SUBJECTS: 508 episodes of 
      gonorrhoea diagnosed at a city centre genitourinary medicine clinic including 22 
      patients with multiple infections over a 4 year period. METHODS: Patients with 
      recurrent gonococcal infection were analysed with respect to the initial and 
      subsequent serovars isolated. RESULTS: No significant difference was seen in the 
      prevalence of serovars isolated following a repeat infection compared with those 
      without repeat infections. The site of the initial infection did not appear to 
      influence the subsequent serovar isolated. CONCLUSION: We found no evidence of 
      serovar specific immunity in our population. It remains possible that populations 
      with a higher prevalence of gonorrhoea and more frequent infections may have a 
      quantitatively greater immune response.
FAU - Ross, J D
AU  - Ross JD
AD  - Department of Genitourinary Medicine, Edinburgh Royal Infirmary.
FAU - Moyes, A
AU  - Moyes A
FAU - Young, H
AU  - Young H
LA  - eng
PT  - Journal Article
PL  - England
TA  - Genitourin Med
JT  - Genitourinary medicine
JID - 8503853
RN  - 0 (Antibodies, Bacterial)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Antibodies, Bacterial/biosynthesis
MH  - Antibody Specificity
MH  - Female
MH  - Gonorrhea/*immunology
MH  - Humans
MH  - Male
MH  - Neisseria gonorrhoeae/classification/*immunology
MH  - Recurrence
MH  - Serotyping
MH  - Sexual Behavior
PMC - PMC1196106
EDAT- 1995/12/01 00:00
MHDA- 1995/12/01 00:01
PMCR- 1995/12/01
CRDT- 1995/12/01 00:00
PHST- 1995/12/01 00:00 [pubmed]
PHST- 1995/12/01 00:01 [medline]
PHST- 1995/12/01 00:00 [entrez]
PHST- 1995/12/01 00:00 [pmc-release]
AID - 10.1136/sti.71.6.367 [doi]
PST - ppublish
SO  - Genitourin Med. 1995 Dec;71(6):367-9. doi: 10.1136/sti.71.6.367.

PMID- 23761381
OWN - NLM
STAT- MEDLINE
DCOM- 20140123
LR  - 20130702
IS  - 1758-1001 (Electronic)
IS  - 0004-5632 (Linking)
VI  - 50
IP  - Pt 4
DP  - 2013 Jul
TI  - Is calibration the cause of variation in liquid chromatography tandem mass 
      spectrometry testosterone measurement?
PG  - 368-70
LID - 10.1177/0004563212474563 [doi]
AB  - BACKGROUND: Testosterone measurement by liquid chromatography tandem mass 
      spectrometry (LC-MS/MS) is well accepted as the preferred technique for the 
      analysis of testosterone. Variation is seen between assays and this may be due to 
      differences in calibration as commercial calibrators for this assay are not 
      readily available. We investigated the effects calibration in routine clinical 
      LC-MS/MS assays. METHODS: All LC-MS/MS users that were registered with the 
      UKNEQAS external quality assurance scheme for testosterone were invited to take 
      part in the study. A set of seven serum samples and serum-based calibrators were 
      sent to all laboratories that expressed an interest. The laboratories were 
      instructed to analyse all samples using there own calibrators and return the 
      results and a method questionnaire for analysis. RESULTS: Fifteen laboratories 
      took part in the study. There was no consensus on supplier of testosterone or 
      matrix for the preparation of calibrators and all were prepared in-house. Also, a 
      wide variety of mass spectrometers, internal standards, chromatography conditions 
      and sample extractions were used. The variation in results did not improve when 
      the results were corrected with a common calibrator. CONCLUSIONS: The variation 
      in results obtained could not be attributed to variations in calibrators. The 
      differences in methodologies between laboratories must be the reason for this 
      variation.
FAU - Owen, L J
AU  - Owen LJ
AD  - The University of Manchester, Manchester Academic Health Science Centre, 
      Manchester, UK. Laura.owen@uhsm.nhs.uk
FAU - MacDonald, P R
AU  - MacDonald PR
FAU - Keevil, B G
AU  - Keevil BG
LA  - eng
PT  - Journal Article
DEP - 20130610
PL  - England
TA  - Ann Clin Biochem
JT  - Annals of clinical biochemistry
JID - 0324055
RN  - 3XMK78S47O (Testosterone)
SB  - IM
MH  - Calibration
MH  - Chromatography, Liquid/methods/standards
MH  - Female
MH  - Humans
MH  - Male
MH  - Tandem Mass Spectrometry/*methods/*standards
MH  - Testosterone/*blood
OTO - NOTNLM
OT  - Mass spectrometry
OT  - analytes
OT  - laboratory methods
OT  - steroid hormones
EDAT- 2013/06/14 06:00
MHDA- 2014/01/24 06:00
CRDT- 2013/06/14 06:00
PHST- 2013/06/14 06:00 [entrez]
PHST- 2013/06/14 06:00 [pubmed]
PHST- 2014/01/24 06:00 [medline]
AID - 0004563212474563 [pii]
AID - 10.1177/0004563212474563 [doi]
PST - ppublish
SO  - Ann Clin Biochem. 2013 Jul;50(Pt 4):368-70. doi: 10.1177/0004563212474563. Epub 
      2013 Jun 10.

PMID- 22668712
OWN - NLM
STAT- MEDLINE
DCOM- 20130424
LR  - 20220408
IS  - 2212-4411 (Electronic)
VI  - 113
IP  - 6
DP  - 2012 Jun
TI  - Internal derangement of the temporomandibular joint: is there still a place for 
      ultrasound?
PG  - 832-40
LID - 10.1016/j.oooo.2011.11.017 [doi]
AB  - OBJECTIVE: The aim of this study was to assess the diagnostic value of articular 
      sounds, standardized clinical examination, and standardized articular ultrasound 
      in the detection of internal derangements of the temporomandibular joint. STUDY 
      DESIGN: Forty patients and 20 asymptomatic volunteers underwent a standardized 
      interview, physical examination, and static and dynamic articular ultrasound. 
      Sensitivity, specificity, and predictive values were calculated using magnetic 
      resonance as the reference test. RESULTS: A total of 120 temporomandibular joints 
      were examined. Based on our findings, the presence of articular sounds and 
      physical signs are often insufficient to detect disk displacement. Imaging by 
      static and dynamic high-resolution ultrasound demonstrates considerably lower 
      sensitivity when compared with magnetic resonance. Some of the technical 
      difficulties resulted from a limited access because of the presence of 
      surrounding bone structures. CONCLUSIONS: The present study does not support the 
      recommendation of ultrasound as a conclusive diagnostic tool for internal 
      derangements of the temporomandibular joint.
CI  - Copyright (c) 2012 Elsevier Inc. All rights reserved.
FAU - Dupuy-Bonafe, Isabelle
AU  - Dupuy-Bonafe I
AD  - Dental Care Center, Montpellier University Hospital, UM 1, Montpellier, France. 
      i-bonafe@chu-montpellier.fr
FAU - Picot, Marie-Christine
AU  - Picot MC
FAU - Maldonado, Igor L
AU  - Maldonado IL
FAU - Lachiche, Virginie
AU  - Lachiche V
FAU - Granier, Isabelle
AU  - Granier I
FAU - Bonafe, Alain
AU  - Bonafe A
LA  - eng
PT  - Comparative Study
PT  - Evaluation Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Oral Surg Oral Med Oral Pathol Oral Radiol
JT  - Oral surgery, oral medicine, oral pathology and oral radiology
JID - 101576782
SB  - IM
MH  - Adult
MH  - Case-Control Studies
MH  - Female
MH  - Humans
MH  - Joint Dislocations/diagnostic imaging/pathology
MH  - Magnetic Resonance Imaging
MH  - Male
MH  - Middle Aged
MH  - Prospective Studies
MH  - Reference Standards
MH  - Sensitivity and Specificity
MH  - Statistics, Nonparametric
MH  - Surveys and Questionnaires
MH  - Temporomandibular Joint Disc/*diagnostic imaging/*pathology
MH  - Temporomandibular Joint Disorders/*diagnostic imaging/pathology
MH  - Ultrasonography/*statistics & numerical data
MH  - Young Adult
EDAT- 2012/06/07 06:00
MHDA- 2013/04/25 06:00
CRDT- 2012/06/07 06:00
PHST- 2011/08/31 00:00 [received]
PHST- 2011/11/16 00:00 [revised]
PHST- 2011/11/20 00:00 [accepted]
PHST- 2012/06/07 06:00 [entrez]
PHST- 2012/06/07 06:00 [pubmed]
PHST- 2013/04/25 06:00 [medline]
AID - S2212-4403(12)00038-7 [pii]
AID - 10.1016/j.oooo.2011.11.017 [doi]
PST - ppublish
SO  - Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Jun;113(6):832-40. doi: 
      10.1016/j.oooo.2011.11.017.

PMID- 22023714
OWN - NLM
STAT- MEDLINE
DCOM- 20120910
LR  - 20220316
IS  - 1365-2702 (Electronic)
IS  - 0962-1067 (Linking)
VI  - 21
IP  - 11-12
DP  - 2012 Jun
TI  - Does delivery mode affect women's postpartum quality of life in rural China?
PG  - 1534-43
LID - 10.1111/j.1365-2702.2011.03941.x [doi]
AB  - AIMS AND OBJECTIVES: To explore the impact of delivery mode on women's postpartum 
      quality of life in rural China and probe factors influencing postnatal quality of 
      life. BACKGROUND: Childbirth significantly affects puerpera's physical, 
      psychological and social domains of quality of life. Under the circumstance of 
      increasing high caesarean section rate in rural China, the impact of delivery 
      mode on postnatal quality of life remains unclear. DESIGN: Cross-sectional study 
      design. METHODS: Women residing in rural areas and in their 0-12 months after 
      childbirth from 30 rural townships participated in a household survey. A 
      structured questionnaire was used to evaluate women's socio-demographic 
      characteristics, previous pregnant experiences, foetal characteristics and use of 
      maternal health services. The scale for rural postnatal quality of life was 
      adopted to assess postnatal quality of life from six dimensions: physical 
      complaints and pain, sleep and energy, sex satisfaction, interpersonal 
      communication, self-evaluated living stress and perceived life satisfaction. 
      RESULTS: The overall caeserean section rate was 70.0% (962/1375), and most of 
      them (59.7%) were selected by maternal request. None of six dimensions and total 
      score of quality of life displayed significant difference between women with 
      normal delivery and cesaerean section. It was found that postnatal home visit 
      related to good postnatal quality of life and lower husband education level, male 
      gender of infant were associated with poor quality of life. CONCLUSIONS: Delivery 
      mode did not affect postpartum quality of life in rural China. Socio-cultural 
      determinants may contribute more in influencing postnatal quality of life. 
      RELEVANCE TO CLINICAL PRACTICE: Null findings in impact of delivery mode on 
      postpartum quality of life may cause more difficulties in maternal 
      decision-making for vaginal delivery in rural China. The importance of postnatal 
      home visit could justify available and quality postnatal care in improving 
      postpartum quality of life. Further research needs to explore the effective 
      prevention programmes, especially attention for parenting boys.
CI  - (c) 2011 Blackwell Publishing Ltd.
FAU - Huang, Kun
AU  - Huang K
AD  - School of Public Health, Anhui Medical University, Hefei City, Anhui Province, 
      China.
FAU - Tao, Fangbiao
AU  - Tao F
FAU - Liu, Liu
AU  - Liu L
FAU - Wu, Xiaoyan
AU  - Wu X
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20111025
PL  - England
TA  - J Clin Nurs
JT  - Journal of clinical nursing
JID - 9207302
MH  - Adult
MH  - China
MH  - *Delivery, Obstetric
MH  - Female
MH  - Humans
MH  - Pilot Projects
MH  - *Postpartum Period
MH  - *Quality of Life
MH  - *Rural Population
MH  - Surveys and Questionnaires
EDAT- 2011/10/26 06:00
MHDA- 2012/09/11 06:00
CRDT- 2011/10/26 06:00
PHST- 2011/10/26 06:00 [entrez]
PHST- 2011/10/26 06:00 [pubmed]
PHST- 2012/09/11 06:00 [medline]
AID - 10.1111/j.1365-2702.2011.03941.x [doi]
PST - ppublish
SO  - J Clin Nurs. 2012 Jun;21(11-12):1534-43. doi: 10.1111/j.1365-2702.2011.03941.x. 
      Epub 2011 Oct 25.

PMID- 22504515
OWN - NLM
STAT- MEDLINE
DCOM- 20120925
LR  - 20151119
IS  - 1938-9116 (Electronic)
IS  - 1538-5744 (Linking)
VI  - 46
IP  - 4
DP  - 2012 May
TI  - Endovenous laser ablation in the treatment of small saphenous varicose veins: 
      does site of access influence early outcomes?
PG  - 310-4
LID - 10.1177/1538574412443316 [doi]
AB  - OBJECTIVE: The study was performed to evaluate the clinical and technical 
      efficacy of endovenous laser ablation (EVLA) of small saphenous varicosities, 
      particularly in relation to the site of endovenous access. METHODS: Totally 59 
      patients with unilateral saphenopopliteal junction incompetence and small 
      saphenous vein reflux underwent EVLA (810 nm, 14 W diode laser) with ambulatory 
      phlebectomies. Small saphenous vein access was gained at the lowest site of 
      truncal reflux. Patients were divided into 2 groups: access gained above mid-calf 
      (AMC, n = 33) and below mid-calf (BMC, n = 26) levels. Outcomes included Venous 
      Clinical Severity Scores (VCSS), Aberdeen Varicose Vein Questionnaire (AVVQ), 
      patient satisfaction, complications, and recurrence rates. RESULTS: Both groups 
      demonstrated significant improvement in VCSS, AVVQ, generic quality of life Short 
      Form 36, and EuroQol scores (P < .05) up to 1 year. No differences were seen 
      between AMC and BMC groups for complications (phlebitis: 2 [6%] and 1 [3.8%], P > 
      .05; paresthesia: 2 [6%] and 5 [19%], P = .223) and recurrence (3 [9%] and 1 
      [3.8%], P = .623), respectively. CONCLUSIONS: The site of access in our study 
      does not appear to influence complications specifically neural injury or 
      recurrence rates.
FAU - Samuel, Nehemiah
AU  - Samuel N
AD  - Academic Vascular Surgical Unit, Hull York Medical School, University of Hull, 
      UK. nehemiah.samuel@hey.nhs.uk
FAU - Wallace, T
AU  - Wallace T
FAU - Carradice, D
AU  - Carradice D
FAU - Shahin, Y
AU  - Shahin Y
FAU - Mazari, F A K
AU  - Mazari FA
FAU - Chetter, I C
AU  - Chetter IC
LA  - eng
PT  - Journal Article
DEP - 20120412
PL  - United States
TA  - Vasc Endovascular Surg
JT  - Vascular and endovascular surgery
JID - 101136421
SB  - IM
MH  - Adult
MH  - Ambulatory Surgical Procedures
MH  - Chi-Square Distribution
MH  - *Endovascular Procedures/adverse effects/instrumentation
MH  - England
MH  - Female
MH  - Humans
MH  - *Laser Therapy/adverse effects/instrumentation
MH  - Lasers, Semiconductor
MH  - Male
MH  - Middle Aged
MH  - Paresthesia/etiology
MH  - Patient Satisfaction
MH  - Peripheral Nerve Injuries/etiology
MH  - Phlebitis/etiology
MH  - Prospective Studies
MH  - Quality of Life
MH  - Recurrence
MH  - Risk Assessment
MH  - Risk Factors
MH  - Saphenous Vein/*surgery
MH  - Severity of Illness Index
MH  - Surveys and Questionnaires
MH  - Time Factors
MH  - Treatment Outcome
MH  - Varicose Veins/diagnosis/*surgery
EDAT- 2012/04/17 06:00
MHDA- 2012/09/26 06:00
CRDT- 2012/04/17 06:00
PHST- 2012/04/17 06:00 [entrez]
PHST- 2012/04/17 06:00 [pubmed]
PHST- 2012/09/26 06:00 [medline]
AID - 1538574412443316 [pii]
AID - 10.1177/1538574412443316 [doi]
PST - ppublish
SO  - Vasc Endovascular Surg. 2012 May;46(4):310-4. doi: 10.1177/1538574412443316. Epub 
      2012 Apr 12.

PMID- 21164063
OWN - NLM
STAT- MEDLINE
DCOM- 20110325
LR  - 20190101
IS  - 1535-2900 (Electronic)
IS  - 1079-2082 (Linking)
VI  - 68
IP  - 1
DP  - 2011 Jan 1
TI  - Is there a role for fondaparinux in perioperative bridging?
PG  - 36-42
LID - 10.2146/ajhp100133 [doi]
AB  - PURPOSE: A possible role for fondaparinux as a bridging agent in the 
      perioperative setting is explored. SUMMARY: Anticoagulation guidelines provide 
      minimal direction on the perioperative use of fondaparinux. Fondaparinux's 
      extended half-life of 17-21 hours complicates its use as a perioperative bridging 
      therapy. The ideal time for discontinuation before surgery is an issue, 
      particularly in surgeries with a high bleeding risk or in which neuraxial 
      anesthesia is used. Guidance for perioperative bridging with fondaparinux must be 
      derived from pharmacokinetic data, surgical prophylaxis trials, case reports, and 
      anesthesia guidelines. Published trials used fondaparinux sodium 2.5 mg daily for 
      venous thromboembolism prophylaxis in surgical patients, and the majority avoided 
      its use before surgery in patients receiving neuraxial anesthesia. Three case 
      reports cited the use of fondaparinux sodium as perioperative bridge therapy; one 
      used a 2.5-mg dose, and the other two used a full treatment dose of 7.5 mg. 
      Furthermore, professional anesthesia guidelines conflict in their recommendations 
      regarding the timing of drug administration with neuraxial catheter use. For 
      these reasons, it may be optimal to avoid fondaparinux use before surgery. In 
      some instances, the use of low-molecular-weight heparin or inpatient use of i.v. 
      unfractionated heparin is not possible, is contraindicated, or has limited 
      efficacy, such as a patient with history of heparin-induced thrombocytopenia or 
      antithrombin III deficiency. Fondaparinux may have a role in bridge therapy for 
      these patients. CONCLUSION: The role of fondaparinux in perioperative bridge 
      therapy has not been established, and there are some important limitations to its 
      use as a routine bridging agent.
FAU - Garwood, Candice L
AU  - Garwood CL
AD  - Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health 
      Sciences, Wayne State University, 259 Mack Avenue, Detroit, MI 48201, USA. 
      cgarwood@wayne.edu
FAU - Gortney, Justine Schuller
AU  - Gortney JS
FAU - Corbett, Tia L
AU  - Corbett TL
LA  - eng
PT  - Journal Article
PL  - England
TA  - Am J Health Syst Pharm
JT  - American journal of health-system pharmacy : AJHP : official journal of the 
      American Society of Health-System Pharmacists
JID - 9503023
RN  - 0 (Anticoagulants)
RN  - 0 (Polysaccharides)
RN  - J177FOW5JL (Fondaparinux)
SB  - IM
MH  - Anticoagulants/administration & dosage/pharmacokinetics/*therapeutic use
MH  - Fondaparinux
MH  - Humans
MH  - Perioperative Care/*methods
MH  - Polysaccharides/administration & dosage/pharmacokinetics/*therapeutic use
MH  - Practice Guidelines as Topic
MH  - Surgical Procedures, Operative
EDAT- 2010/12/18 06:00
MHDA- 2011/03/26 06:00
CRDT- 2010/12/18 06:00
PHST- 2010/12/18 06:00 [entrez]
PHST- 2010/12/18 06:00 [pubmed]
PHST- 2011/03/26 06:00 [medline]
AID - 68/1/36 [pii]
AID - 10.2146/ajhp100133 [doi]
PST - ppublish
SO  - Am J Health Syst Pharm. 2011 Jan 1;68(1):36-42. doi: 10.2146/ajhp100133.

PMID- 18359123
OWN - NLM
STAT- MEDLINE
DCOM- 20080814
LR  - 20151119
IS  - 0168-8510 (Print)
IS  - 0168-8510 (Linking)
VI  - 87
IP  - 1
DP  - 2008 Jul
TI  - Is it better to be big? The reconfiguration of 21st century hospitals: responses 
      to a hospital merger in Sweden.
PG  - 92-9
LID - 10.1016/j.healthpol.2008.02.001 [doi]
AB  - OBJECTIVES: Swedish hospital mergers seem to stem from a conviction among policy 
      makers that bigger hospitals lead to lower average costs and improved clinical 
      outcomes. The effects of mergers in the form of multisited hospitals have not 
      been systematically evaluated. The purpose of this article is to contribute to 
      this area of knowledge by exploring responses to the merger of Blekinge Hospital. 
      METHODS: The evaluation was guided by the philosophy of triangulation. A 
      questionnaire was sent to 597 randomly selected employees, that is 24% of the 
      health care staff. Four hundred ninety-eight employees answered the 
      questionnaire, giving a response rate of 83%. Furthermore, interviews of 
      different groups of stakeholders were conducted. RESULTS: A moderate increase of 
      quality was assessed, which, a low proportion of the employees perceived had 
      decisively or largely to do with the merger. The majority perceives economical 
      incentives as the drivers of change, but, at the same time, only 10% of this 
      group believes this target was reached completely or to a large extent. 
      CONCLUSIONS: The employees believe the merger has neither generated economy of 
      scale advantages nor substantial quality improvement. Instead, it seems more 
      rewarding to promote cross-functional collaboration together with clinical 
      specialisation. Needs for both integration and differentiation could thereby be 
      fulfilled.
FAU - Ahgren, Bengt
AU  - Ahgren B
AD  - Nordic School of Public Health, , SE-402 42 Goteborg, Sweden. bengt.ahgren@nhv.se
LA  - eng
PT  - Historical Article
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20080321
PL  - Ireland
TA  - Health Policy
JT  - Health policy (Amsterdam, Netherlands)
JID - 8409431
MH  - Administrative Personnel/psychology
MH  - *Attitude of Health Personnel
MH  - *Health Facility Merger
MH  - History, 21st Century
MH  - Hospitals, Public/*organization & administration/standards
MH  - Humans
MH  - Interviews as Topic
MH  - Quality Assurance, Health Care
MH  - State Medicine
MH  - Surveys and Questionnaires
MH  - Sweden
EDAT- 2008/03/25 09:00
MHDA- 2008/08/15 09:00
CRDT- 2008/03/25 09:00
PHST- 2007/08/26 00:00 [received]
PHST- 2008/01/24 00:00 [revised]
PHST- 2008/02/02 00:00 [accepted]
PHST- 2008/03/25 09:00 [pubmed]
PHST- 2008/08/15 09:00 [medline]
PHST- 2008/03/25 09:00 [entrez]
AID - S0168-8510(08)00036-5 [pii]
AID - 10.1016/j.healthpol.2008.02.001 [doi]
PST - ppublish
SO  - Health Policy. 2008 Jul;87(1):92-9. doi: 10.1016/j.healthpol.2008.02.001. Epub 
      2008 Mar 21.

PMID- 16827975
OWN - NLM
STAT- MEDLINE
DCOM- 20061219
LR  - 20190917
IS  - 0300-2896 (Print)
IS  - 0300-2896 (Linking)
VI  - 42
IP  - 6
DP  - 2006 Jun
TI  - [Chemotherapy and survival in advanced non-small cell lung carcinoma: is 
      pneumologists' skepticism justified?].
PG  - 273-7
AB  - OBJECTIVE: Few studies have assessed whether the advantage chemotherapy has been 
      shown to have in treating advanced non-small lung carcinoma in clinical trials is 
      transferrable to normal health care activity. This could explain the skepticism 
      of a large number of pneumologists towards this treatment. The objective of our 
      study was to analyze prognostic factors related to survival and to see whether 
      cytostatic treatment was an independent predictor. PATIENTS AND METHODS: Patients 
      enrolled in the study had been diagnosed with non-small cell carcinoma in stages 
      IV or IIIB with pleural or N2-N3 involvement and with a performance status of 2 
      or below according to the Eastern Cooperative Oncology Group (ECOG). Survival was 
      analyzed with regard to the following variables: age, sex, comorbidity, weight 
      loss, laboratory test results, histological type, ECOG score, TNM staging, and 
      treatment. The Student t test, the chi(2) test, the Kaplan-Meier method, the 
      log-rank test, and Cox regression analysis were used in the statistical analysis. 
      RESULTS: We enrolled 190 patients (157 men and 33 women) with a mean (SD) age of 
      61.75 (10.85) years (range, 33-85 years). Of these patients, 144 received 
      cytostatic treatment and 46 palliative treatment. The median survival was 31 
      weeks and was related to absence of weight loss (hazard ratio [HR], 1.73; 95% 
      confidence interval [CI], 1.26-2.39; P=.001), cytostatic treatment (HR, 1.85; 95% 
      CI, 1.25-2.76; P=.002), and ECOG score of 0 to 1 (HR, 2.84; 95% CI, 1.62-5.00; 
      P=.0001). In patients with ECOG scores of 0 to 1, weight loss and treatment were 
      significant prognostic factors. Survival in the ECOG 2 group was 15 weeks for 
      patients undergoing cytostatic treatment and 11 weeks for patients with 
      symptomatic treatment. CONCLUSIONS: In normal clinical practice, chemotherapy 
      significantly prolongs survival in patients with performance status of less than 
      2, more time being gained if there is no associated weight loss. We conclude that 
      the reluctance shown by many pneumologists toward using this treatment is not 
      entirely justified.
FAU - Gullon Blanco, Jose Antonio
AU  - Gullon Blanco JA
AD  - Servicio de Neumologia, Hospital Universitario de Canarias, La Laguna, Santa Cruz 
      de Tenerife, Espana. jose993@separ.es
FAU - Suarez Toste, Isabel
AU  - Suarez Toste I
FAU - Fernandez Alvarez, Ramon
AU  - Fernandez Alvarez R
FAU - Rubinos Cuadrado, Gemma
AU  - Rubinos Cuadrado G
FAU - Medina Gonzalvez, Agustin
AU  - Medina Gonzalvez A
FAU - Galindo Morales, Rosa
AU  - Galindo Morales R
FAU - Gonzalez Martin, Isidro Jesus
AU  - Gonzalez Martin IJ
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Quimioterapia y supervivencia en el carcinoma broncogenico no microcitico en 
      estadios avanzados: 'esta justificado el nihilismo de los neumologos?
PL  - Spain
TA  - Arch Bronconeumol
JT  - Archivos de bronconeumologia
JID - 0354720
SB  - IM
MH  - Aged
MH  - Carcinoma, Non-Small-Cell Lung/*drug therapy/*mortality/pathology
MH  - Disease Progression
MH  - Female
MH  - Humans
MH  - Lung Neoplasms/*drug therapy/*mortality/pathology
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Staging
MH  - Prognosis
MH  - Pulmonary Medicine
MH  - Retrospective Studies
MH  - Survival Analysis
MH  - Survival Rate
EDAT- 2006/07/11 09:00
MHDA- 2006/12/21 09:00
CRDT- 2006/07/11 09:00
PHST- 2006/07/11 09:00 [pubmed]
PHST- 2006/12/21 09:00 [medline]
PHST- 2006/07/11 09:00 [entrez]
AID - 13089538 [pii]
AID - 10.1016/s1579-2129(06)60142-0 [doi]
PST - ppublish
SO  - Arch Bronconeumol. 2006 Jun;42(6):273-7. doi: 10.1016/s1579-2129(06)60142-0.

PMID- 24922528
OWN - NLM
STAT- MEDLINE
DCOM- 20150410
LR  - 20140715
IS  - 1873-6327 (Electronic)
IS  - 0306-4603 (Linking)
VI  - 39
IP  - 10
DP  - 2014 Oct
TI  - The association of puberty and young adolescent alcohol use: do parents have a 
      moderating role?
PG  - 1389-93
LID - S0306-4603(14)00155-5 [pii]
LID - 10.1016/j.addbeh.2014.05.006 [doi]
AB  - PURPOSE: To explore the extent to which parent-adolescent emotional closeness, 
      family conflict, and parental permissiveness moderate the association of puberty 
      and alcohol use in adolescents (aged 10-14). METHODS: Cross-sectional survey of 
      7631 adolescents from 231 Australian schools. Measures included pubertal status, 
      recent (30day) alcohol use, parent-adolescent emotional closeness, family 
      conflict, parental permissiveness of alcohol use and peer alcohol use. The 
      analysis was based on a two-level (individuals nested within schools) logistic 
      regression model, with main effects entered first, and interaction terms added 
      second. RESULTS: The interaction of family factors and pubertal stage did not 
      improve the fit of the model, so a main effect model of family factors and 
      pubertal stage was adopted. There were significant main effects for pubertal 
      stage with boys in middle puberty at increased odds of alcohol use, and girls in 
      advanced puberty at increased odds of alcohol use. CONCLUSIONS: Puberty and 
      family factors were strong predictors of adolescent alcohol use, but family 
      factors did not account for variation in the association of pubertal stage and 
      alcohol use.
CI  - Copyright (c) 2014 Elsevier Ltd. All rights reserved.
FAU - Li, H Karen
AU  - Li HK
AD  - Centre for Youth Substance Abuse Research, The University of Queensland, 
      Brisbane, Australia; School of Psychology, The University of Queensland, 
      Brisbane, Australia. Electronic address: k.li@uq.edu.au.
FAU - Kelly, Adrian B
AU  - Kelly AB
AD  - Centre for Youth Substance Abuse Research, The University of Queensland, 
      Brisbane, Australia.
FAU - Chan, Gary C K
AU  - Chan GC
AD  - Centre for Youth Substance Abuse Research, The University of Queensland, 
      Brisbane, Australia.
FAU - Toumbourou, John W
AU  - Toumbourou JW
AD  - Centre for Adolescent Health, Royal Children's Hospital, Melbourne, Australia; 
      Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, 
      Australia; School of Psychology and Centre for Mental Health and Wellbeing 
      Research, Deakin University, Melbourne, Australia.
FAU - Patton, George C
AU  - Patton GC
AD  - Centre for Adolescent Health, Royal Children's Hospital, Melbourne, Australia; 
      Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, 
      Australia; Department of Paediatrics, University of Melbourne, Melbourne, 
      Australia.
FAU - Williams, Joanne W
AU  - Williams JW
AD  - Centre for Adolescent Health, Royal Children's Hospital, Melbourne, Australia; 
      Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, 
      Australia; Department of Paediatrics, University of Melbourne, Melbourne, 
      Australia.
LA  - eng
GR  - 1P60MD003422/MD/NIMHD NIH HHS/United States
GR  - P30 CA016672/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20140527
PL  - England
TA  - Addict Behav
JT  - Addictive behaviors
JID - 7603486
SB  - IM
MH  - Adolescent
MH  - Alcohol Drinking/*epidemiology
MH  - Australia/epidemiology
MH  - Child
MH  - Cross-Sectional Studies
MH  - *Family Conflict
MH  - Female
MH  - Humans
MH  - Logistic Models
MH  - Male
MH  - Odds Ratio
MH  - *Parent-Child Relations
MH  - Parents
MH  - *Puberty
OTO - NOTNLM
OT  - Adolescent
OT  - Alcohol
OT  - Family relationships
OT  - Parents
OT  - Permissiveness
OT  - Puberty
EDAT- 2014/06/13 06:00
MHDA- 2015/04/11 06:00
CRDT- 2014/06/13 06:00
PHST- 2014/01/29 00:00 [received]
PHST- 2014/05/08 00:00 [revised]
PHST- 2014/05/19 00:00 [accepted]
PHST- 2014/06/13 06:00 [entrez]
PHST- 2014/06/13 06:00 [pubmed]
PHST- 2015/04/11 06:00 [medline]
AID - S0306-4603(14)00155-5 [pii]
AID - 10.1016/j.addbeh.2014.05.006 [doi]
PST - ppublish
SO  - Addict Behav. 2014 Oct;39(10):1389-93. doi: 10.1016/j.addbeh.2014.05.006. Epub 
      2014 May 27.

PMID- 15774570
OWN - NLM
STAT- MEDLINE
DCOM- 20051020
LR  - 20191210
IS  - 1741-3842 (Print)
IS  - 1741-3842 (Linking)
VI  - 27
IP  - 2
DP  - 2005 Jun
TI  - Does increased use of private health care reduce the demand for NHS care? A 
      prospective survey of general practice referrals.
PG  - 182-8
AB  - BACKGROUND: The use of the private sector for health care is increasing, but it 
      is unclear whether this will reduce demand on the NHS. The aim of this study was 
      to examine the relationship between private and NHS outpatient referral rates 
      accounting for their association with deprivation. METHODS: This is a prospective 
      survey of general practitioner referrals to private and NHS consultant-led 
      services between 1 January and 31 December 2001 from 10 general practices in the 
      Trent Focus Collaborative Research Network, United Kingdom. Patient referrals 
      were aggregated to give private and NHS referral rates for each electoral ward in 
      each practice. RESULTS: Of 17,137 referrals, 90.4 percent (15,495) were to the 
      NHS and 9.6 percent (1642) to the private sector. Private referral rates were 
      lower in patients from the most deprived fifth of wards compared with the least 
      deprived fifth (rate ratio 0.25, 95 percent CI 0.15 to 0.41, p < 0.001), whereas 
      NHS referral rates were slightly higher in patients in the most deprived fifth of 
      wards (rate ratio 1.18, 95 percent CI 0.98 to 1.42, p = 0.08) both after age 
      standardisation and adjustment for practice. The NHS referral rate was 
      significantly higher (rate ratio 1.40, 95 percent CI 1.15 to 1.71, p = 0.001) in 
      wards with private referral rates in the top fifth compared with the bottom fifth 
      after adjustment for deprivation and practice. CONCLUSIONS: Increased private 
      health care activity does not reduce the demand for NHS care: NHS and private 
      referral rates were positively associated with each other after adjusting for 
      age, deprivation and practice.
FAU - Mulvaney, Caroline
AU  - Mulvaney C
AD  - Department of Health Sciences, University of Leicester, Leicester LE5 4PW. 
      caroline.mulvaney@nottingham.ac.uk
FAU - Coupland, Carol
AU  - Coupland C
FAU - Wilson, Andrew
AU  - Wilson A
FAU - Hammersley, Vicky
AU  - Hammersley V
FAU - Dyas, Jane
AU  - Dyas J
FAU - Carlisle, Robin
AU  - Carlisle R
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20050317
PL  - England
TA  - J Public Health (Oxf)
JT  - Journal of public health (Oxford, England)
JID - 101188638
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Catchment Area, Health
MH  - Child
MH  - Child, Preschool
MH  - Computer Systems
MH  - Confidence Intervals
MH  - England
MH  - Family Practice/*statistics & numerical data
MH  - Female
MH  - Health Care Surveys/methods
MH  - Health Services Needs and Demand/trends
MH  - Hospitals, Private/*statistics & numerical data
MH  - Hospitals, Public/*statistics & numerical data
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Male
MH  - Medicine/classification/*organization & administration/statistics & numerical 
      data
MH  - Middle Aged
MH  - Odds Ratio
MH  - Practice Patterns, Physicians'/*statistics & numerical data
MH  - Private Practice/*statistics & numerical data
MH  - Referral and Consultation/classification/*statistics & numerical data
MH  - *Specialization
MH  - State Medicine/*statistics & numerical data
MH  - Vulnerable Populations/*statistics & numerical data
EDAT- 2005/03/19 09:00
MHDA- 2005/10/21 09:00
CRDT- 2005/03/19 09:00
PHST- 2005/03/19 09:00 [pubmed]
PHST- 2005/10/21 09:00 [medline]
PHST- 2005/03/19 09:00 [entrez]
AID - fdi013 [pii]
AID - 10.1093/pubmed/fdi013 [doi]
PST - ppublish
SO  - J Public Health (Oxf). 2005 Jun;27(2):182-8. doi: 10.1093/pubmed/fdi013. Epub 
      2005 Mar 17.

PMID- 20736887
OWN - NLM
STAT- MEDLINE
DCOM- 20110204
LR  - 20101026
IS  - 1528-1159 (Electronic)
IS  - 0362-2436 (Linking)
VI  - 35
IP  - 23
DP  - 2010 Nov 1
TI  - Is decompressive surgery effective for spinal cord sarcoidosis accompanied with 
      compressive cervical myelopathy?
PG  - E1290-7
LID - 10.1097/BRS.0b013e3181e6d592 [doi]
AB  - STUDY DESIGN: A retrospective multicenter study of series of 12 patients with 
      spinal cord sarcoidosis who underwent surgery. OBJECTIVE: To evaluate the 
      postoperative outcomes of patients with cervical spinal cord sarcoidosis 
      accompanied with compressive myelopathy and effect of decompressive surgery on 
      the prognosis of sarcoidosis. SUMMARY OF BACKGROUND DATA: Sarcoidosis is a 
      chronic, multisystem noncaseating granulomatous disease. It is difficult to 
      differentiate spinal cord sarcoidosis from cervical compressive myelopathy. There 
      are no studies regarding the coexistence of compressive cervical myelopathy with 
      cervical spinal cord sarcoidosis and the effect of decompressive surgery. 
      METHODS: Nagoya Spine Group database included 1560 cases with cervical myelopathy 
      treated with cervical laminectomy or laminoplasty from 2001 to 2005. A total of 
      12 patients (0.08% of cervical myelopathy) were identified spinal cord 
      sarcoidosis treated with decompressive surgery. As a control subject, 8 patients 
      with spinal cord sarcoidosis without compressive lesion who underwent high-dose 
      steroid therapy without surgery were recruited. RESULTS: In the surgery group, 
      enhancing lesions on magnetic resonance imaging (MRI) were mostly seen at C5-C6, 
      coincident with the maximum compression level in all cases. Postoperative 
      recovery rates in the surgery group at 1 week and 4 weeks were -7.4% and -1.1%, 
      respectively. Only 5 cases had showed clinical improvement, and the condition of 
      these 5 patients had worsened again at averaged 7.4 weeks after surgery. 
      Postoperative oral steroid therapy was initiated at an average of 6.4 weeks and 
      the average initial dose was 54.0 mg in the surgery group, while 51.3 mg in the 
      nonsurgery group. The recovery rate of the Japanese Orthopedic Association score, 
      which increased after steroid therapy, was better in the nonsurgery group (62.5%) 
      than in the surgery group (18.6%) with significant difference (P < 0.01). 
      CONCLUSION: The effect of decompression for spinal cord sarcoidosis with 
      compressive myelopathy was not evident. Early diagnosis for sarcoidosis from 
      other organ and steroid therapy should be needed.
FAU - Sakai, Yoshihito
AU  - Sakai Y
AD  - Department of Orthopaedic Surgery, Nagoya University School of Medicine, Aichi 
      Prefecture, Japan. jsakai@ncgg.go.jp
FAU - Matsuyama, Yukihiro
AU  - Matsuyama Y
FAU - Imagama, Shiro
AU  - Imagama S
FAU - Ito, Zenya
AU  - Ito Z
FAU - Wakao, Norimitsu
AU  - Wakao N
FAU - Ishiguro, Naoki
AU  - Ishiguro N
FAU - Watanabe, Hirohisa
AU  - Watanabe H
FAU - Kato, Fumihiko
AU  - Kato F
FAU - Yukawa, Yasutsugu
AU  - Yukawa Y
FAU - Ito, Keigo
AU  - Ito K
FAU - Suzuki, Kazuhiro
AU  - Suzuki K
FAU - Tsuboi, Akiko
AU  - Tsuboi A
FAU - Kanemura, Tokumi
AU  - Kanemura T
FAU - Yoshida, Go
AU  - Yoshida G
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Spine (Phila Pa 1976)
JT  - Spine
JID - 7610646
RN  - 0 (Adrenal Cortex Hormones)
SB  - IM
MH  - Adrenal Cortex Hormones/therapeutic use
MH  - Aged
MH  - Cervical Vertebrae/*surgery
MH  - Databases, Factual
MH  - Decompression, Surgical
MH  - Female
MH  - Humans
MH  - Magnetic Resonance Imaging
MH  - Male
MH  - Middle Aged
MH  - Sarcoidosis/complications/drug therapy/*surgery
MH  - Spinal Cord Compression/complications/drug therapy/*surgery
MH  - Spinal Cord Diseases/drug therapy/*surgery
MH  - Treatment Outcome
EDAT- 2010/08/26 06:00
MHDA- 2011/02/05 06:00
CRDT- 2010/08/26 06:00
PHST- 2010/08/26 06:00 [entrez]
PHST- 2010/08/26 06:00 [pubmed]
PHST- 2011/02/05 06:00 [medline]
AID - 10.1097/BRS.0b013e3181e6d592 [doi]
PST - ppublish
SO  - Spine (Phila Pa 1976). 2010 Nov 1;35(23):E1290-7. doi: 
      10.1097/BRS.0b013e3181e6d592.

PMID- 11483547
OWN - NLM
STAT- MEDLINE
DCOM- 20010920
LR  - 20190503
IS  - 0093-0415 (Print)
IS  - 0093-0415 (Linking)
VI  - 175
IP  - 2
DP  - 2001 Aug
TI  - Does the aggressive use of polyvalent antivenin for rattlesnake bites result in 
      serious acute side effects?
PG  - 88-91
AB  - OBJECTIVE: To determine the incidence and severity of acute side effects from the 
      use of polyvalent antivenin in victims of rattlesnake bites. DESIGN: We 
      retrospectively reviewed the records of all patients who presented with 
      rattlesnake bites to a university teaching hospital during an 11-year period. 
      From patient medical records, we extracted demographic data, clinical 
      measurements, and outcomes during emergency department evaluation and subsequent 
      hospitalization. Data regarding serum sickness were not collected. OUTCOME 
      MEASURES: Primary outcome variables were the occurrence of immediate 
      hypersensitivity reaction to antivenin, the type of reaction, permanent 
      disability at hospital discharge, and mortality. RESULTS: We identified a total 
      of 73 patients with rattlesnake bites during the study period. Bite envenomation 
      was graded as nonenvenomated, 7 patients (10%); mild, 23 patients (32%); 
      moderate, 32 patients (44%); and severe, 11 patients (15%). We identified 65 
      patients who received antivenin. Antivenin doses ranged from 1 to 30 vials per 
      patient (mean, 12.0 +/- 6.0), for a total of 777 vials. In 43 patients (66%), 10 
      or more vials of antivenin were given. The mean number of vials of antivenin 
      given to each snakebite grade were as follows: mild, 8.4 (+/-4.0); moderate, 11.8 
      (+/-5.7); and severe, 18.7 (+/-6.3). No deaths, amputations, or permanent 
      disability from snakebite occurred in the patients receiving antivenin. Acute 
      side effects of antivenin-occurring within the first 6 hours after 
      administration-were seen in 12 patients (18%; 95% confidence interval, 10%-30%). 
      Acute side effects consisted solely of urticaria in all but 1 patient (2%; 95% 
      confidence interval, 0%-8%). This patient had a history of previous antivenin 
      reaction and required a short course of intravenous epinephrine for blood 
      pressure support. No other complications occurred. CONCLUSION: The administration 
      of polyvalent Crotalidae antivenin is safe. Acute hypersensitivity, when it 
      occurs, consists solely in most cases of urticaria. Serious side effects are 
      uncommon.
FAU - Offerman, S R
AU  - Offerman SR
AD  - Division of Emergency Medicine, Department of Internal Medicine, University of 
      California-Davis Medical Center, 2315 Stockton Blvd, PSSB 2100, Sacramento, CA 
      95817, USA. rxsteeps@aol.com
FAU - Smith, T S
AU  - Smith TS
FAU - Derlet, R W
AU  - Derlet RW
LA  - eng
PT  - Journal Article
PL  - United States
TA  - West J Med
JT  - The Western journal of medicine
JID - 0410504
RN  - 0 (Antivenins)
SB  - IM
CIN - West J Med. 2001 Aug;175(2):91-2. doi: 10.1136/ewjm.175.2.91. PMID: 11483548
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Animals
MH  - Antivenins/*adverse effects
MH  - *Crotalus
MH  - Female
MH  - Humans
MH  - Infant
MH  - Male
MH  - Retrospective Studies
MH  - Snake Bites/*drug therapy
MH  - Urticaria/chemically induced
PMC - PMC1071493
EDAT- 2001/08/03 10:00
MHDA- 2001/09/21 10:01
PMCR- 2001/08/01
CRDT- 2001/08/03 10:00
PHST- 2001/08/03 10:00 [pubmed]
PHST- 2001/09/21 10:01 [medline]
PHST- 2001/08/03 10:00 [entrez]
PHST- 2001/08/01 00:00 [pmc-release]
AID - 1750088 [pii]
AID - 10.1136/ewjm.175.2.88 [doi]
PST - ppublish
SO  - West J Med. 2001 Aug;175(2):88-91. doi: 10.1136/ewjm.175.2.88.

PMID- 9542484
OWN - NLM
STAT- MEDLINE
DCOM- 19980603
LR  - 20140912
IS  - 0256-9574 (Print)
VI  - 88
IP  - 2 Suppl
DP  - 1998 Feb
TI  - Does successful completion of the Perinatal Education Programme result in 
      improved obstetric practice?
PG  - 180-2, 184, 187
AB  - OBJECTIVE: To determine whether successful completion of the Perinatal Education 
      Programme (PEP) improves obstetric practice. METHOD: The three midwife obstetric 
      units (MOUs) in a health district of Mpumalanga were included in the study. Two 
      MOUs enrolled in the PEP and the third did not. A 'before-and-after' study design 
      was used to assess any changes in practice, and to monitor whether any changes 
      occurred in the district during the time of the study; data were also collected 
      at the third MOU. Data were collected by scoring of the obstetric files after the 
      patient had delivered. OUTCOME MEASURES: We ascertained whether the obstetric 
      history, syphilis testing, blood group testing, haemoglobin measurement and 
      uterine growth assessment were performed during antenatal care along with whether 
      appropriate action was taken. For intrapartum care, estimation of fetal weight, 
      the performance of pelvimetry, blood pressure monitoring, urine testing, 
      evaluation of head above pelvis, fetal heart rate monitoring, monitoring of 
      contractions and plotting of cervical dilatation, and whether the appropriate 
      actions were taken, were assessed. RESULTS: Eight of the 13 midwives at the two 
      MOUs completed the PEP and all demonstrated an improvement in knowledge. Case 
      notes of 303 patients from the various clinics were studied. There was no change 
      in the referral patterns of any of the clinics during the study period. The 
      obstetric history was well documented, but in no group was there a satisfactory 
      response to a detected problem; appropriate action was taken in between 0% and 
      12% of cases. Syphilis testing was performed in 56-82% of cases, with no 
      difference between the groups. The haemoglobin level was measured in only 4-15% 
      of patients, with no difference before or after completion of the PEP. Where a 
      problem in uterine growth was detected, an appropriate response occurred in 0-8% 
      of patients and no difference before or after completion of the PEP was 
      ascertained. In all groups, estimation of fetal weight and pelvimetry were seldom 
      performed, the urine and fetal heart rate documentation were moderately well done 
      and the blood pressure monitoring, assessment of head above pelvis, monitoring of 
      contractions and plotting of cervical dilatation were usually performed. No 
      differences before or after the PEP were detected. Where problems were detected, 
      appropriate actions taken during labour improved, but not significantly. 
      CONCLUSION: Completion of the obstetric manual of the PEP improved the knowledge 
      of the midwives but no alteration in practice was detected.
FAU - le Roux, E
AU  - le Roux E
AD  - Department of Obstetrics and Gynaecology, Kalafong Hospital.
FAU - Pattinson, R C
AU  - Pattinson RC
FAU - Tsaku, W
AU  - Tsaku W
FAU - Makin, J D
AU  - Makin JD
LA  - eng
PT  - Journal Article
PL  - South Africa
TA  - S Afr Med J
JT  - South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
JID - 0404520
SB  - IM
MH  - Africa
MH  - Female
MH  - Humans
MH  - Midwifery/*education/standards
MH  - Perinatal Care/*standards
MH  - Pregnancy
MH  - Prenatal Care/*standards
MH  - Rural Population
EDAT- 1998/06/06 00:00
MHDA- 1998/06/06 00:01
CRDT- 1998/06/06 00:00
PHST- 1998/06/06 00:00 [pubmed]
PHST- 1998/06/06 00:01 [medline]
PHST- 1998/06/06 00:00 [entrez]
PST - ppublish
SO  - S Afr Med J. 1998 Feb;88(2 Suppl):180-2, 184, 187.

PMID- 18708308
OWN - NLM
STAT- MEDLINE
DCOM- 20090210
LR  - 20191210
IS  - 1743-9159 (Electronic)
IS  - 1743-9159 (Linking)
VI  - 6
IP  - 5
DP  - 2008 Oct
TI  - Can surgeon familiarization with current evidence lead to a change in practice? A 
      prospective study.
PG  - 378-81
LID - 10.1016/j.ijsu.2008.07.001 [doi]
AB  - BACKGROUND: Despite evidence against its utility, many surgeons continue to 
      employ prophylactic nasogastric decompression in elective colonic resection. This 
      study aimed to establish whether an easy and practical intervention, mailing out 
      a summary of current evidence to surgeons, can change surgeons practice to bring 
      it more in line with current evidence. METHODS: The use of prophylactic 
      nasogastric (NG) decompression in elective colonic resections was documented for 
      the 2 consecutive months of October and November, 2004 at the Royal Alexandra 
      Hospital (RAH). A one page summary of recent evidence concerning this practice 
      was then mailed to all general surgeons at that institution. A similar second 
      review was carried out for the months of January and February, 2005. The two 
      periods were compared with regards to prophylactic NG use. RESULTS: Twenty two 
      patients underwent elective colonic resections during the months of October and 
      November, 2004. Twenty one patients underwent such procedures in January and 
      February, 2005. Seven out of the 22 cases in the first group (the 
      pre-intervention block) received prophylactic NG decompression. Five out of the 
      21 cases in the second group (the post-intervention block) received prophylactic 
      NG decompression. The difference in prophylactic NG use between the two groups 
      was not statistically significant. CONCLUSIONS: This study has shown that mailing 
      out a summary of current evidence to surgeons concerning a certain issue is not 
      sufficient to lead to a change in practice.
FAU - Cadili, Ali
AU  - Cadili A
AD  - Dvorkin Lounge, University of Alberta Hospital, Edmonton, Alberta, Canada. 
      acadili@ualberta.ca
FAU - de Gara, Christopher
AU  - de Gara C
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20080716
PL  - United States
TA  - Int J Surg
JT  - International journal of surgery (London, England)
JID - 101228232
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Alberta
MH  - Attitude of Health Personnel
MH  - Chi-Square Distribution
MH  - Colectomy/*methods
MH  - Elective Surgical Procedures/*methods
MH  - *Evidence-Based Medicine
MH  - Female
MH  - Follow-Up Studies
MH  - Health Care Surveys
MH  - Humans
MH  - Intubation, Gastrointestinal/*methods/statistics & numerical data
MH  - Male
MH  - Middle Aged
MH  - Outcome Assessment, Health Care
MH  - Postoperative Complications/prevention & control
MH  - Practice Patterns, Physicians'
MH  - Probability
MH  - Retrospective Studies
MH  - Risk Assessment
MH  - Statistics, Nonparametric
MH  - Treatment Outcome
EDAT- 2008/08/19 09:00
MHDA- 2009/02/12 09:00
CRDT- 2008/08/19 09:00
PHST- 2008/06/23 00:00 [received]
PHST- 2008/07/08 00:00 [accepted]
PHST- 2008/08/19 09:00 [pubmed]
PHST- 2009/02/12 09:00 [medline]
PHST- 2008/08/19 09:00 [entrez]
AID - S1743-9191(08)00104-0 [pii]
AID - 10.1016/j.ijsu.2008.07.001 [doi]
PST - ppublish
SO  - Int J Surg. 2008 Oct;6(5):378-81. doi: 10.1016/j.ijsu.2008.07.001. Epub 2008 Jul 
      16.

PMID- 18435678
OWN - NLM
STAT- MEDLINE
DCOM- 20090323
LR  - 20090119
IS  - 1423-0410 (Electronic)
IS  - 0042-9007 (Linking)
VI  - 95
IP  - 1
DP  - 2008 Jul
TI  - Kell alloimmunization in pregnancy: associated with fetal thrombocytopenia?
PG  - 66-9
LID - 10.1111/j.1423-0410.2008.01061.x [doi]
AB  - BACKGROUND AND OBJECTIVES: Kell haemolytic disease in pregnancies has been 
      suggested to be associated with decreased fetal platelet counts. The aim of this 
      study was to evaluate the incidence and clinical significance of fetal 
      thrombocytopenia in pregnancies complicated by Kell alloimmunization. MATERIALS 
      AND METHODS: In this retrospective cohort study, fetal platelet counts were 
      performed in 42 pregnancies with severe Kell alloimmunization prior to the first 
      intrauterine blood transfusion. Platelet counts from 318 first intrauterine 
      transfusions in RhD alloimmunized pregnancies were used as controls. RESULTS: 
      Fetal thrombocytopenia (platelet count < 150 x 10(9)/l) was found in 4/42 (10%) 
      in the Kell group and in 84/318 (26%) in the RhD group. None of the fetuses in 
      the Kell alloimmunized pregnancies, including 15 with severe hydrops, had a 
      clinically significant thrombocytopenia defined as a platelet count < 50 x 
      10(9)/l. In the RhD alloimmunized pregnancies, 2/230 (1%) of the non-hydropic 
      fetuses and 7/30 (23%) of the severely hydropic fetuses had a clinically 
      significant thrombocytopenia. CONCLUSION: In contrast to fetuses with severe 
      anaemia and hydrops due to RhD alloimmunization, fetuses with severe anaemia due 
      to Kell alloimmunization are generally not at risk for substantial 
      thrombocytopenia.
FAU - van den Akker, E S A
AU  - van den Akker ES
AD  - Department of Obstetrics, Leiden University Medical Centre, Leiden, The 
      Netherlands. e.s.a.van_den_akker@lumc.nl
FAU - Klumper, F J C M
AU  - Klumper FJ
FAU - Brand, A
AU  - Brand A
FAU - Kanhai, H H H
AU  - Kanhai HH
FAU - Oepkes, D
AU  - Oepkes D
LA  - eng
PT  - Journal Article
DEP - 20080423
PL  - England
TA  - Vox Sang
JT  - Vox sanguinis
JID - 0413606
RN  - 0 (Kell Blood-Group System)
SB  - IM
MH  - *Blood Group Incompatibility
MH  - Cohort Studies
MH  - Edema
MH  - Female
MH  - Fetus/immunology
MH  - Humans
MH  - Incidence
MH  - Kell Blood-Group System/*immunology
MH  - Pregnancy
MH  - Pregnancy Complications, Hematologic/*immunology
MH  - Prospective Studies
MH  - Rh Isoimmunization/immunology
MH  - Thrombocytopenia, Neonatal Alloimmune/*etiology/immunology
EDAT- 2008/04/26 09:00
MHDA- 2009/03/24 09:00
CRDT- 2008/04/26 09:00
PHST- 2008/04/26 09:00 [pubmed]
PHST- 2009/03/24 09:00 [medline]
PHST- 2008/04/26 09:00 [entrez]
AID - VOX1061 [pii]
AID - 10.1111/j.1423-0410.2008.01061.x [doi]
PST - ppublish
SO  - Vox Sang. 2008 Jul;95(1):66-9. doi: 10.1111/j.1423-0410.2008.01061.x. Epub 2008 
      Apr 23.

PMID- 23455575
OWN - NLM
STAT- MEDLINE
DCOM- 20151005
LR  - 20211021
IS  - 1436-3771 (Electronic)
IS  - 1432-6981 (Linking)
VI  - 18
IP  - 1
DP  - 2014 Jan
TI  - Globulomaxillary cysts--do they really exist?
PG  - 239-46
LID - 10.1007/s00784-013-0954-y [doi]
AB  - OBJECTIVES: The so-called "globulomaxillary cyst", described as a fissural cyst, 
      caused by entrapped epithelium between the nasal and maxillary process, is no 
      longer considered for its own entity. Nevertheless, cystic lesions, which 
      correspond to the previous image of globulomaxillary cysts, do still occur in 
      daily practice. This raises the question to which entities pathological processes 
      in this particular region actually belong to. MATERIALS AND METHODS: In a 
      retrospective study, 17 cases (12 men and 5 women, 12-59 years old) of primarily 
      diagnosed globulomaxillary cysts are analysed according to clinical, radiological 
      and histological aspects, catamnestic processed and assigned to a new entity. The 
      results are compared with the international literature and draws conclusions on 
      the diagnostic and therapeutic procedure. RESULTS: Seven lateral periodontal 
      cysts, four radicular cysts, two keratocystic odontogenic tumours, one 
      adenomatoid odontogenic tumour, one periapical granuloma, one residual cyst and 
      one undefined jaw cyst were determined. CONCLUSIONS: According to the results of 
      our study and the data from the international literature, the entity 
      globulomaxillary cyst is no longer justified.
FAU - Dammer, U
AU  - Dammer U
AD  - Department of Oral and Maxillofacial Surgery, University of Regensburg, 
      Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany, 
      ulf.dammer@uk-erlangen.de.
FAU - Driemel, O
AU  - Driemel O
FAU - Mohren, W
AU  - Mohren W
FAU - Giedl, C
AU  - Giedl C
FAU - Reichert, T E
AU  - Reichert TE
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20130228
PL  - Germany
TA  - Clin Oral Investig
JT  - Clinical oral investigations
JID - 9707115
MH  - Adolescent
MH  - Adult
MH  - Child
MH  - Cysts/*diagnosis/pathology
MH  - Female
MH  - Humans
MH  - Male
MH  - Maxillary Diseases/*diagnosis/pathology
MH  - Middle Aged
MH  - Retrospective Studies
MH  - Young Adult
EDAT- 2013/03/05 06:00
MHDA- 2015/10/06 06:00
CRDT- 2013/03/05 06:00
PHST- 2011/05/08 00:00 [received]
PHST- 2013/02/13 00:00 [accepted]
PHST- 2013/03/05 06:00 [entrez]
PHST- 2013/03/05 06:00 [pubmed]
PHST- 2015/10/06 06:00 [medline]
AID - 10.1007/s00784-013-0954-y [doi]
PST - ppublish
SO  - Clin Oral Investig. 2014 Jan;18(1):239-46. doi: 10.1007/s00784-013-0954-y. Epub 
      2013 Feb 28.

PMID- 22537902
OWN - NLM
STAT- MEDLINE
DCOM- 20130718
LR  - 20130204
IS  - 2210-741X (Electronic)
IS  - 2210-7401 (Linking)
VI  - 37
IP  - 1
DP  - 2013 Feb
TI  - Colorectal cancer with synchronous liver metastases: does global management at 
      the same centre improve results?
PG  - 56-63
LID - S2210-7401(12)00043-5 [pii]
LID - 10.1016/j.clinre.2012.02.002 [doi]
AB  - BACKGROUND: Synchronous liver metastases (SLM) occur in 20% of colorectal cancers 
      (CRC). Resection of SLM and CLC can be undertaken at different centres (separate 
      management, SM) or at the same centre (global management, GM). METHODS: 
      Retrospective study of SLM and CRC resections carried out during 01/2000 - 
      12/2006 by SM or GM, using a combined or delayed strategy. RESULTS: Morphologic 
      characteristics and type of CRC and SLM resection were similar for the GM (n = 
      45) or SM (n = 66) groups. In patients with delayed liver resection (62 SM, 17 
      GM), chemotherapy prior to liver surgery was used in 92% and 38% of SM and GM 
      patients (P < 0.0001) and the median delay between procedures was 212 and 182 
      days, respectively (P = 0.04). First step of liver resection was more often 
      performed during colorectal surgery in the GM group (62 vs. 6% for SM, P < 
      0.0001) and the mean number of procedures (CRC+SLM) was lower (1.6 vs. 2.3, P = 
      0.003). Three-month mortality was 3% for GM and 0% for SM (n.s.). Overall 
      survival rates were 67% and 51% for SM and GM at 3 years (n.s.), and 35 and 31% 
      at 5 years (n.s.). Disease-free survival to 5 years was higher in SM patients 
      (14% vs. 11%, P = 0.009). CONCLUSIONS: GM of CRC and SLM was associated with 
      fewer procedures but did not influence overall survival. SM was associated with a 
      longer delay and increased use of chemotherapy between procedures, suggesting 
      that more rigorous selection of SM patients for surgery may explain the higher 
      disease-free survival after SLM resection.
CI  - Copyright (c) 2012. Published by Elsevier Masson SAS.
FAU - Faber, Bernard
AU  - Faber B
AD  - Service de chirurgie hepatobiliaire et digestive, hopital Pontchaillou, centre 
      hospitalier universitaire de Rennes, universite de Rennes-1, 2, rue 
      Henri-Le-Guilloux, 35033 Rennes cedex 9, France. fabernard@ymail.com
FAU - Boucher, Eveline
AU  - Boucher E
FAU - Sulpice, Laurent
AU  - Sulpice L
FAU - Meunier, Bernard
AU  - Meunier B
FAU - Compagnon, Philippe
AU  - Compagnon P
FAU - Boudjema, Karim
AU  - Boudjema K
LA  - eng
PT  - Journal Article
DEP - 20120425
PL  - France
TA  - Clin Res Hepatol Gastroenterol
JT  - Clinics and research in hepatology and gastroenterology
JID - 101553659
SB  - IM
MH  - Colorectal Neoplasms/*pathology/*surgery/therapy
MH  - Combined Modality Therapy
MH  - Female
MH  - Humans
MH  - Liver Neoplasms/*secondary/*surgery/therapy
MH  - Male
MH  - Middle Aged
MH  - Retrospective Studies
MH  - Treatment Outcome
EDAT- 2012/04/28 06:00
MHDA- 2013/07/19 06:00
CRDT- 2012/04/28 06:00
PHST- 2011/11/08 00:00 [received]
PHST- 2012/01/31 00:00 [revised]
PHST- 2012/02/14 00:00 [accepted]
PHST- 2012/04/28 06:00 [entrez]
PHST- 2012/04/28 06:00 [pubmed]
PHST- 2013/07/19 06:00 [medline]
AID - S2210-7401(12)00043-5 [pii]
AID - 10.1016/j.clinre.2012.02.002 [doi]
PST - ppublish
SO  - Clin Res Hepatol Gastroenterol. 2013 Feb;37(1):56-63. doi: 
      10.1016/j.clinre.2012.02.002. Epub 2012 Apr 25.

PMID- 18926458
OWN - NLM
STAT- MEDLINE
DCOM- 20081118
LR  - 20090521
IS  - 1879-1190 (Electronic)
IS  - 1072-7515 (Linking)
VI  - 207
IP  - 4
DP  - 2008 Oct
TI  - Are octogenarians at high risk for carotid endarterectomy?
PG  - 549-53
LID - 10.1016/j.jamcollsurg.2008.05.002 [doi]
AB  - BACKGROUND: Several prospective randomized trials have proved carotid 
      endarterectomy to be safe and effective for both symptomatic and asymptomatic 
      patients younger than 80 years of age. Recently, carotid artery stenting (CAS) 
      has been approved for use in selected high-risk patients. It has been proposed 
      that being an octogenarian places patients in this high-risk category. STUDY 
      DESIGN: All patients between the ages of 80 to 89 years undergoing carotid 
      endarterectomy during a 12-year period were included in the study. Information 
      included indications for carotid endarterectomy, associated risk factors, length 
      of stay, and hospital course. Perioperative morbidity and mortality, including 
      neurologic events and myocardial infarction, were recorded. RESULTS: A total of 
      103 carotid endarterectomies were performed in 95 octogenarians. Procedures were 
      performed on 59 men and 36 women. Indications for operation included symptomatic 
      carotid stenosis in 44 patients (43%) and asymptomatic carotid stenosis in 59 
      (57%). Associated risk factors included diabetes mellitus (17%), hypertension 
      (76%), coronary artery disease (28%), hyperlipidemia (39%), and history of 
      smoking (42%). There were 4 perioperative neurologic complications, which 
      included 1 transient ischemic attack (0.97%), 2 minor strokes (1.94%), and 1 
      major stroke (0.97%). There were no deaths. CONCLUSIONS: Combined end points for 
      adverse events are acceptable in the octogenarian. Carotid endarterectomy remains 
      the gold standard for treatment of extracranial carotid disease in all age 
      groups. Age alone should not place patients in the high-risk category for carotid 
      endarterectomy.
FAU - Bremner, Amy K
AU  - Bremner AK
AD  - Huntington Hospital, Pasadena, CA 91105, USA.
FAU - Katz, Steven G
AU  - Katz SG
LA  - eng
PT  - Journal Article
DEP - 20080630
PL  - United States
TA  - J Am Coll Surg
JT  - Journal of the American College of Surgeons
JID - 9431305
SB  - IM
MH  - Age Factors
MH  - Aged, 80 and over
MH  - Carotid Stenosis/*surgery
MH  - Endarterectomy, Carotid/*statistics & numerical data
MH  - Female
MH  - Humans
MH  - Male
MH  - Morbidity
EDAT- 2008/10/18 09:00
MHDA- 2008/11/19 09:00
CRDT- 2008/10/18 09:00
PHST- 2008/03/10 00:00 [received]
PHST- 2008/05/05 00:00 [revised]
PHST- 2008/05/06 00:00 [accepted]
PHST- 2008/10/18 09:00 [pubmed]
PHST- 2008/11/19 09:00 [medline]
PHST- 2008/10/18 09:00 [entrez]
AID - S1072-7515(08)00487-0 [pii]
AID - 10.1016/j.jamcollsurg.2008.05.002 [doi]
PST - ppublish
SO  - J Am Coll Surg. 2008 Oct;207(4):549-53. doi: 10.1016/j.jamcollsurg.2008.05.002. 
      Epub 2008 Jun 30.

PMID- 12090319
OWN - NLM
STAT- MEDLINE
DCOM- 20030109
LR  - 20190906
IS  - 0301-1623 (Print)
IS  - 0301-1623 (Linking)
VI  - 33
IP  - 1
DP  - 2002
TI  - Is there a need for pelvic CT scan in cases of renal cell carcinoma?
PG  - 13-5
AB  - OBJECTIVES: To determine the necessity of pelvic computed tomography (CT) in 
      patients of renal cell carcinoma (RCC). MATERIALS AND METHODS: We reviewed the 
      records of 400 patients of RCC, who underwent treatment at our institution 
      between January 1988 and February 2001. These patients were evaluated 
      pre-operatively with ultrasonograms (USG) and contrast enhanced CT scan of the 
      abdomen and pelvis. USG or CT scans of these cases were reviewed for presence of 
      pathology in the pelvis, which were classified into 3 categories viz; benign and 
      likely to be insignificant, benign and likely to be significant; and malignant. 
      RESULTS: Of the 400 cases, 114 were stage I, 68 were stage II, 99 were stage III 
      and 119 were stage IV. In all patients, tumour was identified in the kidney on 
      preoperative CT scan. Fourteen patients (3.5%) had an abnormality on pelvic CT. 
      Five (1.25%) had category 1, three (0.75%) had category 2 and six (1.5%) had 
      category 3 abnormality on pelvic CT. However, all these abnormalities in pelvis 
      were detected prior to CT by other investigations (USG or plain x-ray). Of the 
      six cases with malignant findings, two had superficial bladder cancer, one had 
      RCC in a pelvic kidney and three had bone metastases in the pelvis. CONCLUSIONS: 
      Pelvic CT does not offer additional information in the vast majority of cases 
      with RCC and should be performed selectively. Thus the cost of diagnostic imaging 
      in RCC can be reduced.
FAU - Khaitan, Anurag
AU  - Khaitan A
AD  - Department of Urology, All India Institute of Medical Sciences, New Delhi.
FAU - Gupta, Narmada P
AU  - Gupta NP
FAU - Hemal, Ashok K
AU  - Hemal AK
FAU - Dogra, P N
AU  - Dogra PN
FAU - Seth, Amlesh
AU  - Seth A
FAU - Aron, Monish
AU  - Aron M
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - Netherlands
TA  - Int Urol Nephrol
JT  - International urology and nephrology
JID - 0262521
SB  - IM
MH  - Adult
MH  - Aged
MH  - Biopsy, Needle
MH  - Carcinoma, Renal Cell/*diagnostic imaging/pathology/*surgery
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - India
MH  - Kidney Neoplasms/*diagnostic imaging/pathology/*surgery
MH  - Male
MH  - Middle Aged
MH  - Needs Assessment
MH  - Neoplasm Staging
MH  - Nephrectomy
MH  - Pelvis/diagnostic imaging
MH  - Preoperative Care/methods
MH  - Registries
MH  - Retrospective Studies
MH  - Tomography, X-Ray Computed/*statistics & numerical data
MH  - *Unnecessary Procedures
EDAT- 2002/07/02 10:00
MHDA- 2003/01/10 04:00
CRDT- 2002/07/02 10:00
PHST- 2002/07/02 10:00 [pubmed]
PHST- 2003/01/10 04:00 [medline]
PHST- 2002/07/02 10:00 [entrez]
AID - 10.1023/a:1014432331201 [doi]
PST - ppublish
SO  - Int Urol Nephrol. 2002;33(1):13-5. doi: 10.1023/a:1014432331201.

PMID- 12380309
OWN - NLM
STAT- MEDLINE
DCOM- 20021217
LR  - 20081121
IS  - 0004-0614 (Print)
IS  - 0004-0614 (Linking)
VI  - 55
IP  - 7
DP  - 2002 Sep
TI  - [Should circumcision be performed in childhood?].
PG  - 807-11
AB  - OBJECTIVE: To evaluate prepuce development and retractibility in a group of boys. 
      To point out the value of circumcision and prepucial forced dilation during 
      childhood. METHODS: Prepuce development and retractibility were evaluated in 400 
      boys ages between 0-16 year old. RESULTS: In boys under 1 year prepuce 
      retractibility (assessed only in children who did not undergo forced dilation 
      previously) was type I (non retractile) in 71.5% whereas type V (completely 
      retractile) was only 5.5%. In adolescent boys type I prepuce was observed in 1 
      boy only, 1.6%, whereas type V was observed in 82.3%. Furthermore, it was 
      observed that at the time of examination for the study 106 boys who had undergone 
      forced dilation at an earlier age had balano-prepucial adhesions again, which 
      demonstrates that prepuce adheres again to glans penis in many boys after a 
      forced dilation is performed. Only 11 boys were considered in need for 
      circumcision, three of them for prepucial orifice stenosis, which prevented 
      normal micturition, causing a prepucial sac, one case due to a constrictive ring 
      below the prepucial edge that would have prevented ulterior retractability, two 
      cases with repetitive balanopostitis, and five cases secondary to xerosol 
      balanitis, accounting for 2.7% of all examined boys. CONCLUSIONS: Incomplete 
      separation between prepuce and glans penis is normal and common among new-borns, 
      progressing until adolescence to spontaneous separation, at which time it is 
      complete in the majority of boys. Accordingly to the criteria we have sustained 
      for years and present study's findings, circumcision has few indications during 
      childhood, as well as forced prepucial dilation.
FAU - Morales Concepcion, Julio Cesar
AU  - Morales Concepcion JC
AD  - Hospital Pediatrico de Centro Habana, Hospital Pediatrico del Cerro, Ciudad de La 
      Habana, Cuba.
FAU - Cordies Jackson, Emilio
AU  - Cordies Jackson E
FAU - Guerra Rodriguez, Marlen
AU  - Guerra Rodriguez M
FAU - Mora Casaco, Barbarita
AU  - Mora Casaco B
FAU - Morales Aranegui, Aymee
AU  - Morales Aranegui A
FAU - Gonzalez Fernandez, Pedro
AU  - Gonzalez Fernandez P
LA  - spa
PT  - Comparative Study
PT  - English Abstract
PT  - Journal Article
TT  - Debe realizarse circuncision en la infancia?
PL  - Spain
TA  - Arch Esp Urol
JT  - Archivos espanoles de urologia
JID - 0064757
SB  - IM
MH  - Adolescent
MH  - Age Factors
MH  - Child, Preschool
MH  - *Circumcision, Male/adverse effects/psychology
MH  - Dilatation/adverse effects
MH  - Humans
MH  - Infant
MH  - Male
MH  - Penile Diseases/epidemiology
MH  - Penis/growth & development
MH  - Phimosis/epidemiology/*surgery
MH  - Tissue Adhesions/epidemiology
MH  - *Unnecessary Procedures
EDAT- 2002/10/17 04:00
MHDA- 2002/12/18 04:00
CRDT- 2002/10/17 04:00
PHST- 2002/10/17 04:00 [pubmed]
PHST- 2002/12/18 04:00 [medline]
PHST- 2002/10/17 04:00 [entrez]
PST - ppublish
SO  - Arch Esp Urol. 2002 Sep;55(7):807-11.

PMID- 27989969
OWN - NLM
STAT- MEDLINE
DCOM- 20170915
LR  - 20181202
IS  - 1878-8769 (Electronic)
IS  - 1878-8750 (Linking)
VI  - 98
DP  - 2017 Feb
TI  - Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of 
      Ventriculoperitoneal Shunt Infection?
PG  - 171-175
LID - S1878-8750(16)31081-6 [pii]
LID - 10.1016/j.wneu.2016.10.092 [doi]
AB  - BACKGROUND: The relationship between the use of an endoscope during 
      ventriculoperitoneal shunt (VPS) procedures and infection remains poorly defined. 
      In this study, we sought to analyze whether the simultaneous use of an endoscope 
      could in fact increase the infection rate associated with VPS procedures. 
      METHODS: This study included 438 VPS procedures, 49 in which an endoscope was 
      used (11.2%) and 389 in which an endoscope was not used (88.8%). The infection 
      rates in these 2 main groups were calculated and compared. Subsequently, 4 new 
      groups were created, composed of patients with a shunt inserted for the first 
      time (groups 1A and 1B) and patients with a shunt reviewed or inserted for a 
      second time (groups 2A and 2B). Groups 1A and 2A comprised patients in whom an 
      endoscope was used simultaneously with VPS surgery, and groups 1B and 2B 
      comprised patients in whom an endoscope was not used. These groups were compared 
      to determine the infection rate. RESULTS: The overall infection rate was 18.5%, 
      including 22.4% in the groups in which an endoscope was used and 18% in those in 
      which an endoscope was not used (P = 0.449). Groups 1A and 1B and groups 2A and 
      2B were matched for possible intervening risk factors. The infection rate was 
      28.6% in group 1A and 16.2% in group 1B (P = 0.27), and 20% in group 2A and 19.8% 
      in group 2B (P = 0.977). CONCLUSIONS: In the present study, the use of an 
      endoscope during VPS procedures did not increase the risk of surgical infection.
CI  - Copyright (c) 2016 Elsevier Inc. All rights reserved.
FAU - Giannetti, Alexandre Varella
AU  - Giannetti AV
AD  - Department of Surgery, School of Medicine, Federal University of Minas Gerais, 
      Belo Horizonte, Minas Gerais, Brazil; Neurosurgery Service, Hospital das 
      Clinicas, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, 
      Brazil. Electronic address: agjg@terra.com.br.
FAU - Pimenta, Fabiana Guerra
AU  - Pimenta FG
AD  - Infection Control Service, Hospital das Clinicas, Federal University of Minas 
      Gerais, Belo Horizonte, Minas Gerais, Brazil.
FAU - Clemente, Wanessa Trindade
AU  - Clemente WT
AD  - Department of Internal Medicine, School of Medicine, Federal University of Minas 
      Gerais, Belo Horizonte, Minas Gerais, Brazil; Infection Control Service, Hospital 
      das Clinicas, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, 
      Brazil.
LA  - eng
PT  - Journal Article
DEP - 20161027
PL  - United States
TA  - World Neurosurg
JT  - World neurosurgery
JID - 101528275
SB  - IM
CIN - World Neurosurg. 2017 Aug;104:1029-1030. doi: 10.1016/j.wneu.2017.03.083. PMID: 
      28732421
MH  - Aged
MH  - Aged, 80 and over
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Incidence
MH  - Male
MH  - Middle Aged
MH  - Neuroendoscopes/adverse effects/*statistics & numerical data
MH  - Retrospective Studies
MH  - Surgical Wound Infection/*diagnosis/*epidemiology
MH  - *Ventriculoperitoneal Shunt/adverse effects
OTO - NOTNLM
OT  - Hydrocephalus
OT  - Infection
OT  - Neuroendoscopy
OT  - Ventriculoperitoneal shunt
EDAT- 2016/12/19 06:00
MHDA- 2017/09/16 06:00
CRDT- 2016/12/20 06:00
PHST- 2016/06/26 00:00 [received]
PHST- 2016/10/19 00:00 [revised]
PHST- 2016/10/20 00:00 [accepted]
PHST- 2016/12/19 06:00 [pubmed]
PHST- 2017/09/16 06:00 [medline]
PHST- 2016/12/20 06:00 [entrez]
AID - S1878-8750(16)31081-6 [pii]
AID - 10.1016/j.wneu.2016.10.092 [doi]
PST - ppublish
SO  - World Neurosurg. 2017 Feb;98:171-175. doi: 10.1016/j.wneu.2016.10.092. Epub 2016 
      Oct 27.

PMID- 25752912
OWN - NLM
STAT- MEDLINE
DCOM- 20150811
LR  - 20150527
IS  - 1471-0528 (Electronic)
IS  - 1470-0328 (Linking)
VI  - 122
IP  - 7
DP  - 2015 Jun
TI  - Is the probability of prenatal diagnosis or termination of pregnancy different 
      for fetuses with congenital anomalies conceived following assisted reproductive 
      techniques? A population-based evaluation of fetuses with congenital heart 
      defects.
PG  - 924-31
LID - 10.1111/1471-0528.13345 [doi]
AB  - OBJECTIVE: To compare the probability of prenatal diagnosis (PND) and termination 
      of pregnancy for fetal anomaly (TOPFA) between fetuses conceived by assisted 
      reproductive techniques (ART) and spontaneously-conceived fetuses with congenital 
      heart defects (CHD). DESIGN: Population-based observational study. SETTING: Paris 
      and surrounding suburbs. POPULATION: Fetuses with CHD in the Paris registry of 
      congenital malformations and cohort of children with CHD (Epicard). METHODS: 
      Comparison of ART-conceived and spontaneously conceived fetuses taking into 
      account potential confounders (maternal characteristics, multiplicity and year of 
      birth or TOPFA). MAIN OUTCOME MEASURES: Probability and gestational age at PND 
      and TOPFA for ART-conceived versus spontaneously conceived fetuses. RESULTS: The 
      probability of PND (28.1% versus 34.6%, P = 0.077) and TOPFA (36.2% versus 39.2%, 
      P = 0.677) were not statistically different between ART-conceived (n = 171) and 
      spontaneously conceived (n = 4620) fetuses. Estimates were similar after 
      adjustment for potential confounders. Gestational age at PND tended to be earlier 
      for ART fetuses (23.1 versus 24.8 weeks, P = 0.05) but no statistical difference 
      was found after adjustment for confounders. Gestational age at TOPFA was 
      comparable between ART-conceived and spontaneously conceived fetuses. 
      CONCLUSIONS: In our population, ART conception was not significantly associated 
      with the probability of PND or TOPFA for CHD. One implication of our results is 
      that live births may be adequate for assessing the overall risk of CHD related to 
      ART. However, total prevalence, in particular of severe CHD, would not be 
      adequately assessed if TOPFA are not included.
CI  - (c) 2015 Royal College of Obstetricians and Gynaecologists.
FAU - Tararbit, K
AU  - Tararbit K
AD  - Inserm UMR 1153, Equipe de recherche en Epidemiologie Obstetricale, Perinatale et 
      Pediatrique (EPOPe), Centre de Recherche Epidemiologie et Statistique Sorbonne 
      Paris Cite DHU Risques et grossesse, Universite Paris Descartes, Paris, France.
FAU - Lelong, N
AU  - Lelong N
AD  - Inserm UMR 1153, Equipe de recherche en Epidemiologie Obstetricale, Perinatale et 
      Pediatrique (EPOPe), Centre de Recherche Epidemiologie et Statistique Sorbonne 
      Paris Cite DHU Risques et grossesse, Universite Paris Descartes, Paris, France.
FAU - Jouannic, J-M
AU  - Jouannic JM
AD  - Centre Pluridisciplinaire de Diagnostic Prenatal de l'Est Parisien, Pole de 
      perinatalite, Hopital Trousseau, Paris, France.
FAU - Goffinet, F
AU  - Goffinet F
AD  - Inserm UMR 1153, Equipe de recherche en Epidemiologie Obstetricale, Perinatale et 
      Pediatrique (EPOPe), Centre de Recherche Epidemiologie et Statistique Sorbonne 
      Paris Cite DHU Risques et grossesse, Universite Paris Descartes, Paris, France.
AD  - Maternite Port Royal, Hopital Cochin, Hopitaux Paris Centre, Assistance Publique 
      Hopitaux de Paris, Paris, France.
FAU - Khoshnood, B
AU  - Khoshnood B
AD  - Inserm UMR 1153, Equipe de recherche en Epidemiologie Obstetricale, Perinatale et 
      Pediatrique (EPOPe), Centre de Recherche Epidemiologie et Statistique Sorbonne 
      Paris Cite DHU Risques et grossesse, Universite Paris Descartes, Paris, France.
CN  - EPICARD Study Group
LA  - eng
PT  - Journal Article
PT  - Observational Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20150306
PL  - England
TA  - BJOG
JT  - BJOG : an international journal of obstetrics and gynaecology
JID - 100935741
SB  - IM
MH  - Abortion, Induced/*statistics & numerical data
MH  - Adult
MH  - Female
MH  - Fetal Diseases/diagnosis/*epidemiology
MH  - Gestational Age
MH  - Heart Defects, Congenital/diagnosis/*epidemiology
MH  - Humans
MH  - Pregnancy
MH  - Prenatal Diagnosis/*statistics & numerical data
MH  - Reproductive Techniques, Assisted/adverse effects/*statistics & numerical data
MH  - Risk Factors
MH  - Young Adult
OTO - NOTNLM
OT  - Assisted
OT  - congenital
OT  - epidemiology/population-based
OT  - heart defects
OT  - prenatal diagnosis
OT  - reproductive techniques
OT  - termination of pregnancy for fetal anomaly
FIR - Goffinet, Francois
IR  - Goffinet F
FIR - Khoshnood, Babak
IR  - Khoshnood B
FIR - Bonnet, Damien
IR  - Bonnet D
FIR - Calderon, Johanna
IR  - Calderon J
FIR - Candilis, Drina
IR  - Candilis D
FIR - Delezoide, Anne-Lise
IR  - Delezoide AL
FIR - De Vigan, Catherine
IR  - De Vigan C
FIR - Goffinet, Francois
IR  - Goffinet F
FIR - Houyel, Lucile
IR  - Houyel L
FIR - Jouannic, Jean-Marie
IR  - Jouannic JM
FIR - Khoshnood, Babak
IR  - Khoshnood B
FIR - Lelong, Nathalie
IR  - Lelong N
FIR - Magnier, Suzel
IR  - Magnier S
FIR - Magny, Jean-Francois
IR  - Magny JF
FIR - Rambaud, Caroline
IR  - Rambaud C
FIR - Salomon, Dominique
IR  - Salomon D
FIR - Vodovar, Veronique
IR  - Vodovar V
FIR - Goffinet, Francois
IR  - Goffinet F
FIR - Khoshnood, Babak
IR  - Khoshnood B
FIR - Lelong, Nathalie
IR  - Lelong N
FIR - Thieulin, Anne-Claire
IR  - Thieulin AC
FIR - Andrieu, Thibaut
IR  - Andrieu T
FIR - Vodovar, Veronique
IR  - Vodovar V
FIR - Chausson, Maggy
IR  - Chausson M
FIR - Brinis, Anissa
IR  - Brinis A
FIR - Faure, Laure
IR  - Faure L
FIR - Delattre, Maryline
IR  - Delattre M
FIR - Treluyer, Jean-Marc
IR  - Treluyer JM
FIR - Breart, Gerard
IR  - Breart G
FIR - Cabrol, Dominique
IR  - Cabrol D
FIR - Serraf, Alain
IR  - Serraf A
FIR - Sidi, Daniel
IR  - Sidi D
FIR - Voyer, Marcel
IR  - Voyer M
EDAT- 2015/03/11 06:00
MHDA- 2015/08/12 06:00
CRDT- 2015/03/11 06:00
PHST- 2015/01/16 00:00 [accepted]
PHST- 2015/03/11 06:00 [entrez]
PHST- 2015/03/11 06:00 [pubmed]
PHST- 2015/08/12 06:00 [medline]
AID - 10.1111/1471-0528.13345 [doi]
PST - ppublish
SO  - BJOG. 2015 Jun;122(7):924-31. doi: 10.1111/1471-0528.13345. Epub 2015 Mar 6.

PMID- 26536001
OWN - NLM
STAT- MEDLINE
DCOM- 20170516
LR  - 20180924
IS  - 1423-0194 (Electronic)
IS  - 0028-3835 (Linking)
VI  - 103
IP  - 5
DP  - 2016
TI  - Is There an Additional Value of Using Somatostatin Receptor Subtype 2a 
      Immunohistochemistry Compared to Somatostatin Receptor Scintigraphy Uptake in 
      Predicting Gastroenteropancreatic Neuroendocrine Tumor Response?
PG  - 560-6
LID - 10.1159/000441604 [doi]
AB  - BACKGROUND AND AIMS: It is unknown whether tumoral somatostatin receptor subtype 
      2a (sst2a) immunohistochemistry (IHC) has additional value compared to 
      somatostatin receptor scintigraphy (SRS) uptake using OctreoScan(R) in predicting 
      response to peptide receptor radiotherapy using 177Lu-octreotate (PRRT) in 
      patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The aims 
      of this study were: (1) to establish the percentage of sst2a immunopositivity in 
      GEP-NET samples of PRRT-treated patients, (2) to determine the relationship 
      between best GEP-NET response using RECIST 1.0 criteria 1 year after PRRT and 
      tumoral sst2a IHC, and (3) to compare characteristics of patients with sst2a 
      IHC-negative and -positive tumors. METHODS: All 73 consecutive patients were 
      selected for PRRT based on a positive SRS. Radiological response was scored 
      according to RECIST 1.0 criteria. sst2a status was detected on tumor samples by 
      IHC. RESULTS: In total, 93% of GEP-NET samples showed sst2a IHC positivity. No 
      statistically significant relationship was observed between in vitro sst2a 
      expression and in vivo best GEP-NET response 1 year after PRRT (p = 0.47). Sex, 
      primary tumor site, disease stage, ENETS TNM classification, Ki-67 index, highest 
      serum chromogranin-A level, and highest neuron-specific enolase level were not 
      significantly different between patients with negative and positive sst2a tumoral 
      IHC with the exception of age at diagnosis (p = 0.007). CONCLUSIONS: sst2a IHC of 
      tumor samples has no additional value compared to SRS uptake using OctreoScan(R) in 
      predicting tumor response after PRRT.
CI  - (c) 2015 S. Karger AG, Basel.
FAU - van Adrichem, Roxanne C S
AU  - van Adrichem RC
FAU - Kamp, Kimberly
AU  - Kamp K
FAU - van Deurzen, Carolien H M
AU  - van Deurzen CH
FAU - Biermann, Katharina
AU  - Biermann K
FAU - Feelders, Richard A
AU  - Feelders RA
FAU - Franssen, Gaston J H
AU  - Franssen GJ
FAU - Kwekkeboom, Dik J
AU  - Kwekkeboom DJ
FAU - Hofland, Leo J
AU  - Hofland LJ
FAU - de Herder, Wouter W
AU  - de Herder WW
LA  - eng
PT  - Journal Article
DEP - 20151105
PL  - Switzerland
TA  - Neuroendocrinology
JT  - Neuroendocrinology
JID - 0035665
RN  - 0 (177Lu-octreotate)
RN  - 0 (Antineoplastic Agents)
RN  - 0 (Receptors, Somatostatin)
RN  - 0 (SSTR2 protein, human)
RN  - RWM8CCW8GP (Octreotide)
RN  - Gastro-enteropancreatic neuroendocrine tumor
SB  - IM
MH  - Adult
MH  - Aged
MH  - Antineoplastic Agents/*therapeutic use
MH  - Female
MH  - Gene Expression Regulation, Neoplastic/drug effects
MH  - Humans
MH  - Immunohistochemistry
MH  - *Intestinal Neoplasms/diagnostic imaging/drug therapy/metabolism
MH  - Male
MH  - Middle Aged
MH  - *Neuroendocrine Tumors/diagnostic imaging/drug therapy/metabolism
MH  - Octreotide/*analogs & derivatives/therapeutic use
MH  - *Pancreatic Neoplasms/diagnostic imaging/drug therapy/metabolism
MH  - *Radionuclide Imaging
MH  - Receptors, Somatostatin/*metabolism
MH  - *Stomach Neoplasms/diagnostic imaging/drug therapy/metabolism
MH  - *Treatment Outcome
EDAT- 2015/11/05 06:00
MHDA- 2017/05/17 06:00
CRDT- 2015/11/05 06:00
PHST- 2015/06/02 00:00 [received]
PHST- 2015/10/08 00:00 [accepted]
PHST- 2015/11/05 06:00 [entrez]
PHST- 2015/11/05 06:00 [pubmed]
PHST- 2017/05/17 06:00 [medline]
AID - 000441604 [pii]
AID - 10.1159/000441604 [doi]
PST - ppublish
SO  - Neuroendocrinology. 2016;103(5):560-6. doi: 10.1159/000441604. Epub 2015 Nov 5.

PMID- 21849531
OWN - NLM
STAT- MEDLINE
DCOM- 20111118
LR  - 20111006
IS  - 1945-7197 (Electronic)
IS  - 0021-972X (Linking)
VI  - 96
IP  - 10
DP  - 2011 Oct
TI  - Does growth hormone replacement therapy reduce mortality in adults with growth 
      hormone deficiency? Data from the Dutch National Registry of Growth Hormone 
      Treatment in adults.
PG  - 3151-9
LID - 10.1210/jc.2011-1215 [doi]
AB  - CONTEXT: Adults with GH deficiency (GHD) have a decreased life expectancy. The 
      effect of GH treatment on mortality remains to be established. OBJECTIVE: This 
      nationwide cohort study investigates the effect of GH treatment on all-cause and 
      cause-specific mortality and analyzes patient characteristics influencing 
      mortality in GHD adults. DESIGN, SETTING, AND PATIENTS: Patients in the Dutch 
      National Registry of Growth Hormone Treatment in Adults were retrospectively 
      monitored (1985-2009) and subdivided into treatment (n = 2229), primary 
      (untreated, n = 109), and secondary control (partly treated, n = 356) groups. 
      MAIN OUTCOME MEASURES: Standardized mortality ratios (SMR) were calculated for 
      all-cause, malignancy, and cardiovascular disease (CVD) mortality. Expected 
      mortality was obtained from cause, sex, calendar year, and age-specific death 
      rates from national death and population counts. RESULTS: In the treatment group, 
      95 patients died compared to 74.6 expected [SMR 1.27 (95% confidence interval, 
      1.04-1.56)]. Mortality was higher in women than in men. After exclusion of 
      high-risk patients, the SMR for CVD mortality remained increased in women. 
      Mortality due to malignancies was not elevated. In the control groups mortality 
      was not different from the background population. Univariate analyses 
      demonstrated sex, GHD onset, age, and underlying diagnosis as influencing 
      factors. CONCLUSIONS: GHD men receiving GH treatment have a mortality rate not 
      different from the background population. In women, after exclusion of high-risk 
      patients, mortality was not different from the background population except for 
      CVD. Mortality due to malignancies was not elevated in adults receiving GH 
      treatment. Next to gender, the heterogeneous etiology is of influence on 
      mortality in GHD adults with GH treatment.
FAU - van Bunderen, Christa C
AU  - van Bunderen CC
AD  - Department of Internal Medicine, Section Endocrinology, VU University Medical 
      Center, 1081 HV Amsterdam, The Netherlands. c.vanbunderen@vumc.nl
FAU - van Nieuwpoort, I Caroline
AU  - van Nieuwpoort IC
FAU - Arwert, Lucia I
AU  - Arwert LI
FAU - Heymans, Martijn W
AU  - Heymans MW
FAU - Franken, Anton A M
AU  - Franken AA
FAU - Koppeschaar, Hans P F
AU  - Koppeschaar HP
FAU - van der Lely, Aart J
AU  - van der Lely AJ
FAU - Drent, Madeleine L
AU  - Drent ML
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20110817
PL  - United States
TA  - J Clin Endocrinol Metab
JT  - The Journal of clinical endocrinology and metabolism
JID - 0375362
RN  - 0 (Recombinant Proteins)
RN  - 9002-72-6 (Growth Hormone)
SB  - IM
MH  - Adult
MH  - Cardiovascular Diseases/mortality
MH  - Cause of Death
MH  - Cerebrovascular Disorders/mortality
MH  - Female
MH  - Growth Hormone/*deficiency/*therapeutic use
MH  - *Hormone Replacement Therapy
MH  - Humans
MH  - Life Expectancy
MH  - Male
MH  - Middle Aged
MH  - Mortality
MH  - Neoplasms/mortality
MH  - Netherlands/epidemiology
MH  - Recombinant Proteins/therapeutic use
MH  - Registries
MH  - Risk Factors
EDAT- 2011/08/19 06:00
MHDA- 2011/12/13 00:00
CRDT- 2011/08/19 06:00
PHST- 2011/08/19 06:00 [entrez]
PHST- 2011/08/19 06:00 [pubmed]
PHST- 2011/12/13 00:00 [medline]
AID - jc.2011-1215 [pii]
AID - 10.1210/jc.2011-1215 [doi]
PST - ppublish
SO  - J Clin Endocrinol Metab. 2011 Oct;96(10):3151-9. doi: 10.1210/jc.2011-1215. Epub 
      2011 Aug 17.

PMID- 16872243
OWN - NLM
STAT- MEDLINE
DCOM- 20061207
LR  - 20181113
IS  - 0114-5916 (Print)
IS  - 0114-5916 (Linking)
VI  - 29
IP  - 8
DP  - 2006
TI  - Can decisional algorithms replace global introspection in the individual 
      causality assessment of spontaneously reported ADRs?
PG  - 697-702
AB  - AIM: The usefulness of algorithms for assessing the causality of suspected 
      adverse drug reactions (ADRs) has yet to be established and, since the validation 
      of causality algorithms depends upon their sensitivity and specificity, our study 
      was carried out to evaluate these measures. METHOD: In this study, an expert 
      panel assessed causality of adverse reports by using the WHO global introspection 
      (GI) method. The same reports were independently assessed using 15 published 
      algorithms. The causality assessment level 'possible' was considered the lower 
      limit for a report to be considered to be drug related. For a given algorithm, 
      sensitivity was determined by the proportion of reports simultaneously classified 
      as drug related by the algorithm and the GI method. Specificity was measured as 
      the proportion of reports simultaneously considered non-drug related. The 
      analysis was performed for the total sample and within serious or unexpected 
      events. RESULTS: Five hundred adverse reports were studied. Algorithms presented 
      high rates of sensitivity (average of 93%, positive predictive value of 89%) and 
      low rates of specificity (average of 7%, negative predictive value of 31%). 
      CONCLUSION: Decisional algorithms are sensitive methods for the detection of 
      ADRs, but they present poor specificity. A reference method was not identified. 
      Algorithms do not replace GI and are not definite alternatives in the individual 
      causality assessment of suspected ADRs.
FAU - Macedo, Ana F
AU  - Macedo AF
AD  - Administracao Regional de Saude do Centro, Nucleo de Farmacovigilancia do Centro, 
      Faculdade de Medicina, Faculdade de Farmacia, Universidade de Coimbra, Coimbra, 
      Portugal. filipa@fcsaude.ubi.pt
FAU - Marques, Francisco B
AU  - Marques FB
FAU - Ribeiro, Carlos F
AU  - Ribeiro CF
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - New Zealand
TA  - Drug Saf
JT  - Drug safety
JID - 9002928
SB  - IM
MH  - *Adverse Drug Reaction Reporting Systems
MH  - *Algorithms
MH  - *Decision Support Techniques
MH  - *Drug-Related Side Effects and Adverse Reactions
MH  - Evaluation Studies as Topic
MH  - Gastrointestinal Diseases/chemically induced
MH  - Humans
MH  - Reproducibility of Results
MH  - Risk Factors
MH  - Skin Diseases/chemically induced
MH  - World Health Organization
EDAT- 2006/07/29 09:00
MHDA- 2006/12/09 09:00
CRDT- 2006/07/29 09:00
PHST- 2006/07/29 09:00 [pubmed]
PHST- 2006/12/09 09:00 [medline]
PHST- 2006/07/29 09:00 [entrez]
AID - 2986 [pii]
AID - 10.2165/00002018-200629080-00006 [doi]
PST - ppublish
SO  - Drug Saf. 2006;29(8):697-702. doi: 10.2165/00002018-200629080-00006.

PMID- 23571528
OWN - NLM
STAT- MEDLINE
DCOM- 20140512
LR  - 20211021
IS  - 1530-0374 (Electronic)
IS  - 1072-3714 (Print)
IS  - 1072-3714 (Linking)
VI  - 20
IP  - 11
DP  - 2013 Nov
TI  - Sternal skin conductance: a reasonable surrogate for hot flash measurement?
PG  - 1164-8
LID - 10.1097/GME.0b013e31828cec53 [doi]
AB  - OBJECTIVE: This study aims to examine the accuracy of a new sternal skin 
      conductance (SSC) device in measuring hot flashes and to assess the acceptability 
      of the device by women. METHODS: Three small descriptive pilot studies were 
      performed using two sequential prototypes of the SSC device developed by an 
      engineering device company in the Midwest. The devices were worn either in a 
      monitored setting for 24 hours or in an ambulatory setting for 5 weeks. During 
      the study period, women recorded hot flashes in a prospective hot flash diary and 
      answered questions about the acceptability of wearing the SSC device. RESULTS: 
      The first prototype was not able to collect any analyzable skin conductance data 
      owing to various malfunction issues, including poor conductance and battery 
      failure. However, 16 women wore the device for 5 weeks and reported that wearing 
      the device was acceptable, although 31% stated that it interfered with daily 
      activities. Hot flash data from the second prototype revealed a 24% concordance 
      rate between self-reported and device-recorded hot flashes. CONCLUSIONS: Findings 
      from these studies support discordance between device-recorded and self-reported 
      hot flashes. In addition, the studies reveal further limitations of SSC 
      monitoring, including difficulties with data collection and lack of consistency 
      in interpretation. Based on these results and other recent trials identifying 
      issues with SSC methodology, it is time to find a better physiologic surrogate 
      measure for hot flashes.
FAU - Pachman, Deirdre R
AU  - Pachman DR
AD  - From the 1Department of Oncology and 2Cancer Center Statistics, Mayo Clinic, 
      Rochester, MN.
FAU - Loprinzi, Charles L
AU  - Loprinzi CL
FAU - Novotny, Paul J
AU  - Novotny PJ
FAU - Satele, Daniel V
AU  - Satele DV
FAU - Linquist, Breanna M
AU  - Linquist BM
FAU - Wolf, Sherry
AU  - Wolf S
FAU - Barton, Debra L
AU  - Barton DL
LA  - eng
GR  - CA 124477/CA/NCI NIH HHS/United States
GR  - K05 CA124477/CA/NCI NIH HHS/United States
GR  - R43 EB006013/EB/NIBIB NIH HHS/United States
GR  - R43 EB 06013/EB/NIBIB NIH HHS/United States
GR  - P30 CA015083/CA/NCI NIH HHS/United States
GR  - R43 AT004075/AT/NCCIH NIH HHS/United States
GR  - UL1 TR000135/TR/NCATS NIH HHS/United States
PT  - Historical Article
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - Menopause
JT  - Menopause (New York, N.Y.)
JID - 9433353
SB  - IM
MH  - Female
MH  - Galvanic Skin Response/*physiology
MH  - History, Ancient
MH  - Hot Flashes/*diagnosis
MH  - Humans
MH  - *Menopause
MH  - Middle Aged
MH  - Monitoring, Ambulatory/*instrumentation/methods
MH  - Monitoring, Physiologic/*instrumentation/methods
MH  - Pilot Projects
MH  - Prospective Studies
MH  - Self Report
MH  - Skin/blood supply
MH  - Skin Temperature
MH  - *Sternum
MH  - Women's Health
PMC - PMC3724754
MID - NIHMS456956
EDAT- 2013/04/11 06:00
MHDA- 2014/05/13 06:00
PMCR- 2014/11/01
CRDT- 2013/04/11 06:00
PHST- 2013/04/11 06:00 [entrez]
PHST- 2013/04/11 06:00 [pubmed]
PHST- 2014/05/13 06:00 [medline]
PHST- 2014/11/01 00:00 [pmc-release]
AID - 10.1097/GME.0b013e31828cec53 [doi]
PST - ppublish
SO  - Menopause. 2013 Nov;20(11):1164-8. doi: 10.1097/GME.0b013e31828cec53.

PMID- 19481382
OWN - NLM
STAT- MEDLINE
DCOM- 20091105
LR  - 20151119
IS  - 1873-4111 (Electronic)
IS  - 0378-5122 (Linking)
VI  - 63
IP  - 4
DP  - 2009 Aug 20
TI  - Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the 
      screening of partial androgenic deficiency of aging men?
PG  - 365-8
LID - 10.1016/j.maturitas.2009.04.004 [doi]
AB  - BACKGROUND: Androgen serum levels significantly decrease in older men, causing 
      quality of life impairment and increasing the risk of chronic disease. This 
      disorder is defined as PADAM (Partial Androgen Deficiency of Aging Men). 
      OBJECTIVE: To evaluate a PADAM screening tool and determine the prevalence of 
      this disorder in healthy adult men. METHODS: This was a cross-sectional study in 
      which 96 men aged 40 or more of the South Metropolitan Region of Santiago de 
      Chile were surveyed with the Androgen Deficiency of Aging Men (ADAM) 
      questionnaire of the Saint Louis University and sampled for the serum 
      determination of total testosterone, sexual hormone binding globulin (SHBG) and 
      albumin. Also free and bioavailable testosterone were calculated. PADAM was 
      considered present if items 1 or 7 or any 3 other questions of the ADAM 
      questionnaire were positive. An available testosterone of <198.4 ng/dL was used 
      as a gold standard for the diagnosis of PADAM. RESULTS: A total of 78 men (81.3%) 
      were identified as possible PADAM according to the ADAM questionnaire. Total 
      testosterone levels fell from 503.6+/-180.1 ng/dL in men aged 40 to 54 years to 
      382.1+/-247.3 in those >70 years; however this was not statistically significant 
      (ANOVA, p=0.06). In the same age groups, SHBG significantly increased 
      (31.0+/-15.0 to 47.5+/-15.0 nmol/L, p<0.001) whereas free and available 
      testosterone significantly decreased (10.6+/-3.2 to 6.4+/-3.6 ng/dL and 
      266.6+/-81.2 to 152.2+/-97.6 ng/dL, respectively, p<0.0001). Overall (n=96), 
      available testosterone confirmed PADAM diagnosis in 27 cases (28.1%). The ADAM 
      tool rendered a 83.3% sensitivity and 19.7% specificity in the detection of 
      PADAM. Item 1 (decreased sexual desire) was a better predictor of hypogonadism 
      than the complete questionnaire (63.3% sensitivity and 66.7% specificity). 
      CONCLUSION: In this series, in accordance to available testosterone, the 
      prevalence of PADAM was determined to be high, in which the ADAM questionnaire 
      rendered a low diagnostic efficiency. PADAM diagnosis could be clinically 
      suspected when symptoms of sexual dysfunction are present.
FAU - Blumel, Juan E
AU  - Blumel JE
AD  - Facultad Medicina, Universidad de Chile, Santiago de Chile, Chile.
FAU - Chedraui, Peter
AU  - Chedraui P
FAU - Gili, Sebastian A
AU  - Gili SA
FAU - Navarro, Alejandra
AU  - Navarro A
FAU - Valenzuela, Karen
AU  - Valenzuela K
FAU - Vallejo, Soledad
AU  - Vallejo S
LA  - eng
PT  - Journal Article
DEP - 20090528
PL  - Ireland
TA  - Maturitas
JT  - Maturitas
JID - 7807333
RN  - 0 (Androgens)
RN  - 0 (Serum Albumin)
RN  - 0 (Sex Hormone-Binding Globulin)
RN  - 3XMK78S47O (Testosterone)
SB  - IM
MH  - Adult
MH  - Age Factors
MH  - Aged
MH  - Aged, 80 and over
MH  - Androgens/*deficiency
MH  - Andropause/*physiology
MH  - Cross-Sectional Studies
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Serum Albumin/metabolism
MH  - Sex Hormone-Binding Globulin/metabolism
MH  - Statistics, Nonparametric
MH  - Surveys and Questionnaires
MH  - Testosterone/blood
EDAT- 2009/06/02 09:00
MHDA- 2009/11/06 06:00
CRDT- 2009/06/02 09:00
PHST- 2009/03/24 00:00 [received]
PHST- 2009/04/13 00:00 [revised]
PHST- 2009/04/25 00:00 [accepted]
PHST- 2009/06/02 09:00 [entrez]
PHST- 2009/06/02 09:00 [pubmed]
PHST- 2009/11/06 06:00 [medline]
AID - S0378-5122(09)00129-7 [pii]
AID - 10.1016/j.maturitas.2009.04.004 [doi]
PST - ppublish
SO  - Maturitas. 2009 Aug 20;63(4):365-8. doi: 10.1016/j.maturitas.2009.04.004. Epub 
      2009 May 28.

PMID- 23621776
OWN - NLM
STAT- MEDLINE
DCOM- 20130926
LR  - 20231106
IS  - 1931-843X (Electronic)
IS  - 1540-9996 (Print)
IS  - 1540-9996 (Linking)
VI  - 22
IP  - 6
DP  - 2013 Jun
TI  - Does a history of unintended pregnancy lessen the likelihood of desire for 
      sterilization reversal?
PG  - 501-6
LID - 10.1089/jwh.2012.3885 [doi]
AB  - BACKGROUND: Unintended pregnancy has been significantly associated with 
      subsequent female sterilization. Whether women who are sterilized after 
      experiencing an unintended pregnancy are less likely to express desire for 
      sterilization reversal is unknown. METHODS: This study used national, 
      cross-sectional data collected by the 2006-2010 National Survey of Family Growth. 
      The study sample included women ages 15-44 who were surgically sterile from a 
      tubal sterilization at the time of interview. Multivariable logistic regression 
      was used to examine the relationship between a history of unintended pregnancy 
      and desire for sterilization reversal while controlling for potential 
      confounders. RESULTS: In this nationally representative sample of 1,418 women who 
      were sterile from a tubal sterilization, 78% had a history of at least one 
      unintended pregnancy and 28% expressed a desire to have their sterilization 
      reversed. In unadjusted analysis, having a prior unintended pregnancy was 
      associated with higher odds of expressing desire for sterilization reversal (odds 
      ratio [OR]: 1.80; 95% confidence interval [CI]: 1.15-2.79). In adjusted analysis 
      controlling for sociodemographic factors, unintended pregnancy was no longer 
      significantly associated with desire for reversal (OR: 1.46; 95% CI: 0.91-2.34). 
      CONCLUSION: Among women who had undergone tubal sterilization, a prior history of 
      unintended pregnancy did not decrease desire for sterilization reversal.
FAU - Grady, Cynthia D
AU  - Grady CD
AD  - University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
FAU - Schwarz, Eleanor Bimla
AU  - Schwarz EB
FAU - Emeremni, Chetachi A
AU  - Emeremni CA
FAU - Yabes, Jonathan
AU  - Yabes J
FAU - Akers, Aletha
AU  - Akers A
FAU - Zite, Nikki
AU  - Zite N
FAU - Borrero, Sonya
AU  - Borrero S
LA  - eng
GR  - UL1 TR000005/TR/NCATS NIH HHS/United States
GR  - 2KL2 RR024154-06/RR/NCRR NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20130427
PL  - United States
TA  - J Womens Health (Larchmt)
JT  - Journal of women's health (2002)
JID - 101159262
SB  - IM
MH  - *Adolescent
MH  - Adult
MH  - Cross-Sectional Studies
MH  - Female
MH  - Humans
MH  - Motivation
MH  - Pregnancy
MH  - Pregnancy, Unplanned/*psychology
MH  - Sterilization Reversal/*psychology/statistics & numerical data
MH  - Sterilization, Tubal/psychology/*statistics & numerical data
MH  - United States/epidemiology
MH  - Young Adult
PMC - PMC3678583
EDAT- 2013/04/30 06:00
MHDA- 2013/09/27 06:00
PMCR- 2014/06/01
CRDT- 2013/04/30 06:00
PHST- 2013/04/30 06:00 [entrez]
PHST- 2013/04/30 06:00 [pubmed]
PHST- 2013/09/27 06:00 [medline]
PHST- 2014/06/01 00:00 [pmc-release]
AID - 10.1089/jwh.2012.3885 [pii]
AID - 10.1089/jwh.2012.3885 [doi]
PST - ppublish
SO  - J Womens Health (Larchmt). 2013 Jun;22(6):501-6. doi: 10.1089/jwh.2012.3885. Epub 
      2013 Apr 27.

PMID- 22227642
OWN - NLM
STAT- MEDLINE
DCOM- 20130215
LR  - 20211021
IS  - 1435-702X (Electronic)
IS  - 0721-832X (Linking)
VI  - 250
IP  - 11
DP  - 2012 Nov
TI  - Can we measure mesopic pupil size with the cobalt blue light slit-lamp 
      biomicroscopy method?
PG  - 1637-47
LID - 10.1007/s00417-011-1909-0 [doi]
AB  - BACKGROUND: The aim of this work is to assess a previously described slit-lamp 
      biomicroscopy-based method (SLBM) for measuring pupil diameter and compare it to 
      Colvard infrared pupillometry (CIP). METHODS: Two examiners performed three 
      repeated measurements with each instrument in 40 healthy eyes. We determined the 
      agreement of SLBM and CIP, intraobserver and interobserver repeatabilities, and 
      interobserver concordance (kappa) and SLBM ability for detecting pupil sizes over 
      6.0 mm. RESULTS: The mean (+/-standard deviation [SD]) pupil diameter was 5.81 +/- 
      0.70 mm with SLBM and 6.26 +/- 0.68 mm with CIP (p = 0.01) averaging both 
      examiner's results. Mean differences between the SLBM and CIP were -0.60 mm and 
      -0.30 mm for each examiner using the average of the three readings (p = 0.02), 
      and they were very similar using the first reading. Intraobserver 
      reproducibility: the width of the 95% LoA ranged from 1.79 to 2.30 mm. The ICCs 
      were 0.97 and 0.92 for SLBM, and 0.96 and 0.90 for CIP. Interobserver 
      reproducibility: the width of the LoA ranged from 1.82 to 2.09 mm. Kappa 
      statistics were 0.39 and 0.49 for the first and mean SLBM readings, respectively, 
      and 0.45 for both the first and mean CIP readings. Sensitivity and specificity of 
      SLBM for detection of pupils larger than 6 mm ranged from 55.56% to 73.68% and 
      from 76.19% to 95.45%, respectively. The best trade-off between sensitivity and 
      specificity ranged from 5.4 mm to 6.2 mm. CONCLUSIONS: Although the SLBM is quite 
      repeatable, it underestimates mesopic pupil size and shows a too wide range of 
      agreement with CIP. SLBM shows low sensitivity in detecting pupils larger than 
      6 mm, which may be misleading when planning anterior segment surgery. Previous 
      grading-consensus training strategies may increase interrater reproducibility, 
      and compensation for the systematic underestimation could improve accuracy of the 
      SLBM.
FAU - Maldonado, Miguel J
AU  - Maldonado MJ
AD  - IOBA-Eye Institute, University of Valladolid, Paseo Belen, 17, 47011, Valladolid, 
      Spain. maldonado@ioba.med.uva.es
FAU - Lopez-Miguel, Alberto
AU  - Lopez-Miguel A
FAU - Pinero, David P
AU  - Pinero DP
FAU - Juberias, Jose R
AU  - Juberias JR
FAU - Nieto, Juan C
AU  - Nieto JC
FAU - Alio, Jorge L
AU  - Alio JL
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20120108
PL  - Germany
TA  - Graefes Arch Clin Exp Ophthalmol
JT  - Graefe's archive for clinical and experimental ophthalmology = Albrecht von 
      Graefes Archiv fur klinische und experimentelle Ophthalmologie
JID - 8205248
SB  - IM
MH  - Adult
MH  - Dark Adaptation
MH  - Diagnostic Techniques, Ophthalmological/*instrumentation
MH  - Female
MH  - Humans
MH  - Iris/*anatomy & histology
MH  - Light
MH  - Male
MH  - Mesopic Vision/*physiology
MH  - Microscopy
MH  - Middle Aged
MH  - Observer Variation
MH  - Organ Size
MH  - Prospective Studies
MH  - Pupil/*physiology
MH  - ROC Curve
MH  - Sensitivity and Specificity
MH  - Young Adult
EDAT- 2012/01/10 06:00
MHDA- 2013/02/16 06:00
CRDT- 2012/01/10 06:00
PHST- 2011/09/08 00:00 [received]
PHST- 2011/12/13 00:00 [accepted]
PHST- 2011/11/22 00:00 [revised]
PHST- 2012/01/10 06:00 [entrez]
PHST- 2012/01/10 06:00 [pubmed]
PHST- 2013/02/16 06:00 [medline]
AID - 10.1007/s00417-011-1909-0 [doi]
PST - ppublish
SO  - Graefes Arch Clin Exp Ophthalmol. 2012 Nov;250(11):1637-47. doi: 
      10.1007/s00417-011-1909-0. Epub 2012 Jan 8.

PMID- 23025584
OWN - NLM
STAT- MEDLINE
DCOM- 20131111
LR  - 20220318
IS  - 1530-0277 (Electronic)
IS  - 0145-6008 (Linking)
VI  - 37
IP  - 3
DP  - 2013 Mar
TI  - Does stress increase imitation of drinking behavior? An experimental study in a 
      (semi-)naturalistic context.
PG  - 477-83
LID - 10.1111/j.1530-0277.2012.01942.x [doi]
AB  - BACKGROUND: That alcohol consumption is strongly influenced by the drinking 
      behavior of social company has been demonstrated in observational research. 
      However, not everyone is equally vulnerable to other people's drinking, and it is 
      important to unravel which factors underlie these individual differences. This 
      study focuses on the role of psychosocial stress in attempting to explain 
      individual differences in the propensity to imitate alcohol consumption. METHODS: 
      With a 2 (confederate's drinking condition: alcohol vs. soda) x 2 (participant's 
      stress condition: stress vs. no stress) experimental design, we tested whether 
      the tendency to imitate other people's drinking was related to participants' 
      induced stress levels. The young male adults (N = 106) were randomly assigned to 
      each of the conditions. In each session, directly after the stress or no-stress 
      period, confederates and participants entered a bar laboratory where we observed 
      their drinking behavior. Prior to entering the session, confederates were 
      instructed to drink alcohol or soda. RESULTS: Participants in both stress and 
      no-stress conditions consumed substantially more alcohol when confederates drank 
      alcohol than when they drank soda. There was no difference in alcohol consumed 
      between stress and no-stress conditions. No moderating effect of stress on the 
      tendency to drink along with peers was found. CONCLUSIONS: Generally, it appears 
      that among young male adults, imitation of alcohol consumption is a robust 
      phenomenon not dependent on individual stress levels.
CI  - Copyright (c) 2012 by the Research Society on Alcoholism.
FAU - Larsen, Helle
AU  - Larsen H
AD  - Behavioural Science Institute, Radboud University Nijmegen, Nijmegen, The 
      Netherlands. H.Larsen@uva.nl
FAU - Engels, Rutger C M E
AU  - Engels RC
FAU - Granic, Isabela
AU  - Granic I
FAU - Huizink, Anja C
AU  - Huizink AC
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20121001
PL  - England
TA  - Alcohol Clin Exp Res
JT  - Alcoholism, clinical and experimental research
JID - 7707242
RN  - 3K9958V90M (Ethanol)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Alcohol Drinking/epidemiology/*psychology
MH  - Ethanol/*administration & dosage
MH  - Humans
MH  - *Imitative Behavior
MH  - Male
MH  - *Social Behavior
MH  - Stress, Psychological/epidemiology/*psychology
MH  - Young Adult
EDAT- 2012/10/03 06:00
MHDA- 2013/11/12 06:00
CRDT- 2012/10/03 06:00
PHST- 2012/02/06 00:00 [received]
PHST- 2012/07/11 00:00 [accepted]
PHST- 2012/10/03 06:00 [entrez]
PHST- 2012/10/03 06:00 [pubmed]
PHST- 2013/11/12 06:00 [medline]
AID - 10.1111/j.1530-0277.2012.01942.x [doi]
PST - ppublish
SO  - Alcohol Clin Exp Res. 2013 Mar;37(3):477-83. doi: 
      10.1111/j.1530-0277.2012.01942.x. Epub 2012 Oct 1.

PMID- 11862129
OWN - NLM
STAT- MEDLINE
DCOM- 20020425
LR  - 20190910
IS  - 0749-5161 (Print)
IS  - 0749-5161 (Linking)
VI  - 18
IP  - 1
DP  - 2002 Feb
TI  - Do clinical variables predict pathologic radiographs in the first episode of 
      wheezing?
PG  - 8-11
AB  - OBJECTIVE: To determine if clinical variables assessed in relation to Albuterol 
      aerosol treatments accurately identify children with pathologic radiographs 
      during their initial episode of bronchospasm. METHODS: A prospective convenience 
      sample of children with a first episode of wheezing. Data collected included 
      demographics, baseline and post-treatment clinical score and physical 
      examination, number of aerosols, requirement for supplemental oxygen, and 
      disposition. Chest radiographs were obtained and interpreted, and patients were 
      divided into 2 groups based on a pathologic versus nonpathologic radiograph 
      interpretation. Chi2 testing was performed for categoric variables, and the 
      student t test was performed for continuous variables. A discriminant analysis 
      was used to develop a model. RESULTS: Pathologic radiographs were identified in 
      61 patients (9%). Between groups, a significant difference was noted for 
      pretreatment oxygen saturation only. Clinical score, respiratory rate, and 
      presence of rales both pretreatment and posttreatment were not significantly 
      different between groups. The discriminant analysis correctly predicted 90% of 
      nonpathologic radiographs but only 15% of pathologic radiographs. CONCLUSIONS: 
      Clinical variables, either isolated or as components of a model, could not 
      identify all children with pathologic radiographs.
FAU - Walsh-Kelly, Christine M
AU  - Walsh-Kelly CM
AD  - Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, 
      USA. walshkel@mcw.edu
FAU - Hennes, Halim M
AU  - Hennes HM
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Pediatr Emerg Care
JT  - Pediatric emergency care
JID - 8507560
RN  - 0 (Bronchodilator Agents)
RN  - QF8SVZ843E (Albuterol)
SB  - IM
MH  - Adolescent
MH  - Albuterol/pharmacology
MH  - Bronchodilator Agents/pharmacology
MH  - Child
MH  - Child, Preschool
MH  - Discriminant Analysis
MH  - Female
MH  - Humans
MH  - Infant
MH  - Male
MH  - Multivariate Analysis
MH  - *Physical Examination
MH  - Prospective Studies
MH  - Radiography
MH  - Respiratory Sounds/*diagnosis/drug effects
MH  - Respiratory Tract Diseases/*diagnosis/diagnostic imaging/drug therapy
MH  - Sensitivity and Specificity
MH  - Statistics, Nonparametric
EDAT- 2002/02/28 10:00
MHDA- 2002/04/26 10:01
CRDT- 2002/02/28 10:00
PHST- 2002/02/28 10:00 [pubmed]
PHST- 2002/04/26 10:01 [medline]
PHST- 2002/02/28 10:00 [entrez]
AID - 10.1097/00006565-200202000-00003 [doi]
PST - ppublish
SO  - Pediatr Emerg Care. 2002 Feb;18(1):8-11. doi: 10.1097/00006565-200202000-00003.

PMID- 22236315
OWN - NLM
STAT- MEDLINE
DCOM- 20120529
LR  - 20220317
IS  - 1748-0361 (Electronic)
IS  - 0890-765X (Print)
IS  - 0890-765X (Linking)
VI  - 28
IP  - 1
DP  - 2012 Jan
TI  - Is distance to provider a barrier to care for medicaid patients with breast, 
      colorectal, or lung cancer?
PG  - 54-62
LID - 10.1111/j.1748-0361.2011.00371.x [doi]
AB  - PURPOSE: Distance to provider might be an important barrier to timely diagnosis 
      and treatment for cancer patients who qualify for Medicaid coverage. Whether 
      driving time or driving distance is a better indicator of travel burden is also 
      of interest. METHODS: Driving distances and times from patient residence to 
      primary care provider were calculated for 3,917 breast, colorectal (CRC) and lung 
      cancer Medicaid patients in Washington State from 1997 to 2003 using 
      MapQuest.com. We fitted regression models of stage at diagnosis and 
      time-to-treatment (number of days between diagnosis and surgery) to test the 
      hypothesis that travel burden is associated with timely diagnosis and treatment 
      of cancer. FINDINGS: Later stage at diagnosis for breast cancer Medicaid patients 
      is associated with travel burden (OR = 1.488 per 100 driving miles, P= .037 and 
      OR = 1.270 per driving hour, P= .016). Time-to-treatment after diagnosis of CRC 
      is also associated with travel burden (14.57 days per 100 driving miles, P= .002 
      and 5.86 days per driving hour, P= .018). CONCLUSIONS: Although travel burden is 
      associated with timely diagnosis and treatment for some types of cancer, we did 
      not find evidence that driving time was, in general, better at predicting 
      timeliness of cancer diagnosis and treatment than driving distance. More 
      intensive efforts at early detection of breast cancer and early treatment of CRC 
      for Medicaid patients who live in remote areas may be needed.
CI  - (c) 2011 National Rural Health Association.
FAU - Scoggins, John F
AU  - Scoggins JF
AD  - Research and Economic Assessment in Cancer and Healthcare (REACH) Group, Fred 
      Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
FAU - Fedorenko, Catherine R
AU  - Fedorenko CR
FAU - Donahue, Sara M A
AU  - Donahue SM
FAU - Buchwald, Dedra
AU  - Buchwald D
FAU - Blough, David K
AU  - Blough DK
FAU - Ramsey, Scott D
AU  - Ramsey SD
LA  - eng
GR  - U01 CA114642-05/CA/NCI NIH HHS/United States
GR  - R25 CA092408/CA/NCI NIH HHS/United States
GR  - U01 CA114642/CA/NCI NIH HHS/United States
GR  - U48 DP000050/DP/NCCDPHP CDC HHS/United States
GR  - R25 CA 92408/CA/NCI NIH HHS/United States
GR  - 1U01CA114642/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, U.S. Gov't, P.H.S.
DEP - 20110331
PL  - England
TA  - J Rural Health
JT  - The Journal of rural health : official journal of the American Rural Health 
      Association and the National Rural Health Care Association
JID - 8508122
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Breast Neoplasms/diagnosis/*therapy
MH  - Colorectal Neoplasms/diagnosis/*therapy
MH  - Female
MH  - Health Personnel
MH  - Health Services Accessibility/*statistics & numerical data
MH  - Humans
MH  - Lung Neoplasms/diagnosis/*therapy
MH  - Male
MH  - Medicaid/*statistics & numerical data
MH  - Middle Aged
MH  - Neoplasm Staging
MH  - United States
MH  - Washington
MH  - Young Adult
PMC - PMC3257469
MID - NIHMS278115
EDAT- 2012/01/13 06:00
MHDA- 2012/05/30 06:00
PMCR- 2013/01/01
CRDT- 2012/01/13 06:00
PHST- 2012/01/13 06:00 [entrez]
PHST- 2012/01/13 06:00 [pubmed]
PHST- 2012/05/30 06:00 [medline]
PHST- 2013/01/01 00:00 [pmc-release]
AID - 10.1111/j.1748-0361.2011.00371.x [doi]
PST - ppublish
SO  - J Rural Health. 2012 Jan;28(1):54-62. doi: 10.1111/j.1748-0361.2011.00371.x. Epub 
      2011 Mar 31.

PMID- 21361755
OWN - NLM
STAT- MEDLINE
DCOM- 20120117
LR  - 20161125
IS  - 1092-0684 (Electronic)
IS  - 1092-0684 (Linking)
VI  - 30
IP  - 3
DP  - 2011 Mar
TI  - Laminoplasty outcomes: is there a difference between patients with degenerative 
      stenosis and those with ossification of the posterior longitudinal ligament?
PG  - E9
LID - 10.3171/2011.1.FOCUS10279 [doi]
AB  - OBJECT: Two common causes of cervical myelopathy include degenerative stenosis 
      and ossification of the posterior longitudinal ligament (OPLL). It has been 
      postulated that patients with OPLL have more complications and worse outcomes 
      than those with degenerative stenosis. The authors sought to compare the surgical 
      results of laminoplasty in the treatment of cervical stenosis with myelopathy due 
      to either degenerative changes or segmental OPLL. METHODS: The authors conducted 
      a retrospective review of 40 instrumented laminoplasty cases performed at a 
      single institution over a 4-year period to treat cervical myelopathy without 
      kyphosis. Twelve of these patients had degenerative cervical stenotic myelopathy 
      ([CSM]; degenerative group), and the remaining 28 had segmental OPLL (OPLL 
      group). The 2 groups had statistically similar demographic characteristics and 
      number of treated levels (mean 3.9 surgically treated levels; p > 0.05). The 
      authors collected perioperative and follow-up data, including radiographic 
      results. RESULTS: The overall clinical follow-up rate was 88%, and the mean 
      clinical follow-up duration was 16.4 months. The mean radiographic follow-up rate 
      was 83%, and the mean length of radiographic follow-up was 9.3 months. There were 
      no significant differences in the estimated blood loss (EBL) or length of 
      hospital stay (LOS) between the groups (p > 0.05). The mean EBL and LOS for the 
      degenerative group were 206 ml and 3.7 days, respectively. The mean EBL and LOS 
      for the OPLL group were 155 ml and 4 days, respectively. There was a 
      statistically significant improvement of more than one grade in the Nurick score 
      for both groups following surgery (p < 0.05). The Nurick score improvement was 
      not statistically different between the groups (p > 0.05). The visual analog 
      scale (VAS) neck pain scores were similar between groups pre- and postoperatively 
      (p > 0.05). The complication rates were not statistically different between 
      groups either (p > 0.05). Radiographically, both groups lost extension range of 
      motion (ROM) following laminoplasty, but this change was not statistically 
      significant (p > 0.05). CONCLUSIONS: Patients with CSM due to either degenerative 
      disease or segmental OPLL have similar perioperative results and neurological 
      outcomes with laminoplasty. The VAS neck pain scores did not improve 
      significantly with laminoplasty for either group. Laminoplasty may limit 
      extension ROM.
FAU - Meyer, Scott A
AU  - Meyer SA
AD  - Department of Neurological Surgery, University of California-San Francisco, CA, 
      USA.
FAU - Wu, Jau-Ching
AU  - Wu JC
FAU - Mummaneni, Praveen V
AU  - Mummaneni PV
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - United States
TA  - Neurosurg Focus
JT  - Neurosurgical focus
JID - 100896471
SB  - IM
MH  - Cervical Vertebrae/diagnostic imaging/*surgery
MH  - Constriction, Pathologic
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Laminectomy/methods/*trends
MH  - Longitudinal Ligaments/diagnostic imaging/surgery
MH  - Male
MH  - Middle Aged
MH  - Neurodegenerative Diseases/diagnostic imaging/surgery
MH  - Ossification of Posterior Longitudinal Ligament/diagnostic imaging/*surgery
MH  - Radiography
MH  - Retrospective Studies
MH  - Spinal Cord Diseases/diagnostic imaging/*surgery
MH  - Treatment Outcome
EDAT- 2011/03/03 06:00
MHDA- 2012/01/18 06:00
CRDT- 2011/03/03 06:00
PHST- 2011/03/03 06:00 [entrez]
PHST- 2011/03/03 06:00 [pubmed]
PHST- 2012/01/18 06:00 [medline]
AID - 10.3171/2011.1.FOCUS10279 [doi]
PST - ppublish
SO  - Neurosurg Focus. 2011 Mar;30(3):E9. doi: 10.3171/2011.1.FOCUS10279.

PMID- 18719011
OWN - NLM
STAT- MEDLINE
DCOM- 20080902
LR  - 20211020
IS  - 1756-1833 (Electronic)
IS  - 0959-8138 (Print)
IS  - 0959-8138 (Linking)
VI  - 337
DP  - 2008 Aug 21
TI  - Do overweight children necessarily make overweight adults? Repeated cross 
      sectional annual nationwide survey of Japanese girls and women over nearly six 
      decades.
PG  - a802
LID - 337/aug21_1/a802 [pii]
LID - 10.1136/bmj.a802 [doi]
LID - a802
AB  - OBJECTIVE: To compare growth curves of body mass index from children to 
      adolescents, and then to young adults, in Japanese girls and women in birth 
      cohorts born from 1930 to 1999. DESIGN: Retrospective repeated cross sectional 
      annual nationwide surveys (national nutrition survey, Japan) carried out from 
      1948 to 2005. SETTING: Japan. PARTICIPANTS: 76,635 females from 1 to 25 years of 
      age. MAIN OUTCOME MEASURE: Body mass index. RESULTS: Generally, body mass index 
      decreased in preschool children (2-5 years), increased in children (6-12 years) 
      and adolescents (13-18 years), and slightly decreased in young adults (19-25 
      years) in these Japanese females. However, the curves differed among birth 
      cohorts. More recent cohorts were more overweight as children but thinner as 
      young women. The increments in body mass index in early childhood were larger in 
      more recent cohorts than in older cohorts. However, the increments in body mass 
      index in adolescents were smaller and the decrease in body mass index in young 
      adults started earlier, with lower peak values in more recent cohorts than in 
      older cohorts. The decrements in body mass index in young adults were similar in 
      all birth cohorts. CONCLUSIONS: An overweight birth cohort in childhood does not 
      necessarily continue to be overweight in young adulthood. Not only secular trends 
      in body mass index at fixed ages but also growth curves for wide age ranges by 
      birth cohorts should be considered to study obesity and thinness. Growth curves 
      by birth cohorts were produced by a repeated cross sectional annual survey over 
      nearly six decades.
FAU - Funatogawa, Ikuko
AU  - Funatogawa I
AD  - Department of Hygiene and Public Health, Teikyo University School of Medicine, 
      Tokyo 173-8605, Japan. ifunatogawa-tky@umin.ac.jp
FAU - Funatogawa, Takashi
AU  - Funatogawa T
FAU - Yano, Eiji
AU  - Yano E
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20080821
PL  - England
TA  - BMJ
JT  - BMJ (Clinical research ed.)
JID - 8900488
SB  - IM
CIN - BMJ. 2008 Aug 21;337:a669. doi: 10.1136/bmj.a669. PMID: 18719009
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Body Mass Index
MH  - Child
MH  - Child, Preschool
MH  - Cross-Sectional Studies
MH  - Female
MH  - Growth/*physiology
MH  - Humans
MH  - Infant
MH  - Japan/epidemiology
MH  - Middle Aged
MH  - Overweight/*epidemiology/physiopathology
MH  - Prevalence
MH  - Thinness/epidemiology/physiopathology
PMC - PMC2518696
COIS- Competing interests: None declared.
EDAT- 2008/08/23 09:00
MHDA- 2008/09/03 09:00
PMCR- 2008/08/21
CRDT- 2008/08/23 09:00
PHST- 2008/08/23 09:00 [pubmed]
PHST- 2008/09/03 09:00 [medline]
PHST- 2008/08/23 09:00 [entrez]
PHST- 2008/08/21 00:00 [pmc-release]
AID - 337/aug21_1/a802 [pii]
AID - funi545483 [pii]
AID - 10.1136/bmj.a802 [doi]
PST - epublish
SO  - BMJ. 2008 Aug 21;337:a802. doi: 10.1136/bmj.a802.

PMID- 11438275
OWN - NLM
STAT- MEDLINE
DCOM- 20010726
LR  - 20190627
IS  - 0002-9610 (Print)
IS  - 0002-9610 (Linking)
VI  - 181
IP  - 4
DP  - 2001 Apr
TI  - Does patient position during liver surgery influence the risk of venous air 
      embolism?
PG  - 366-7
AB  - BACKGROUND: It is generally believed that positioning of the patient in a 
      head-down tilt (Trendelenberg position) decreases the likelihood of a venous air 
      embolism during liver resection. METHODS: The physiological effect of variation 
      in horizontal attitude on central and hepatic venous pressure was measured in 10 
      patients during liver surgery. Hemodynamic indices were recorded with the 
      operating table in the horizontal, 20 degrees head-up and 20 degrees head-down 
      positions. RESULTS: There was no demonstrable pressure gradient between the 
      hepatic and central venous levels in any of the positions. The absolute pressures 
      did, however, vary in a predictable way, being highest in the head-down and 
      lowest during head-up tilt. However, on no occasion was a negative intraluminal 
      pressure recorded. CONCLUSION: The effect on venous pressures caused by the 
      change in patient positioning alone during liver surgery does not affect the risk 
      of venous air embolism.
FAU - Moulton, C A
AU  - Moulton CA
AD  - Department of Surgery, Prince of Wales Hospital, Chinese University of Hong Kong, 
      Sha Tin, New Territories, Hong Kong, China.
FAU - Chui, A K
AU  - Chui AK
FAU - Mann, D
AU  - Mann D
FAU - Lai, P B
AU  - Lai PB
FAU - Chui, P T
AU  - Chui PT
FAU - Lau, W Y
AU  - Lau WY
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Am J Surg
JT  - American journal of surgery
JID - 0370473
SB  - IM
MH  - Adult
MH  - Aged
MH  - Central Venous Pressure
MH  - Embolism, Air/etiology/physiopathology/*prevention & control
MH  - Female
MH  - Head-Down Tilt/physiology
MH  - Hepatectomy/adverse effects/*methods
MH  - Hepatic Veins/physiopathology
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Posture/*physiology
MH  - Risk Factors
MH  - Vena Cava, Inferior/physiopathology
MH  - Venous Pressure
EDAT- 2001/07/05 10:00
MHDA- 2001/07/28 10:01
CRDT- 2001/07/05 10:00
PHST- 2001/07/05 10:00 [pubmed]
PHST- 2001/07/28 10:01 [medline]
PHST- 2001/07/05 10:00 [entrez]
AID - S0002-9610(01)00570-0 [pii]
AID - 10.1016/s0002-9610(01)00570-0 [doi]
PST - ppublish
SO  - Am J Surg. 2001 Apr;181(4):366-7. doi: 10.1016/s0002-9610(01)00570-0.

PMID- 16778275
OWN - NLM
STAT- MEDLINE
DCOM- 20060801
LR  - 20161124
IS  - 0012-3692 (Print)
IS  - 0012-3692 (Linking)
VI  - 129
IP  - 6
DP  - 2006 Jun
TI  - Is routine chest radiography after transbronchial biopsy necessary?: A 
      prospective study of 350 cases.
PG  - 1561-4
AB  - BACKGROUND AND STUDY OBJECTIVE: Pneumothorax following flexible bronchoscopy (FB) 
      with transbronchial biopsy (TBB) occurs in 1 to 6% of cases. Routine chest 
      radiography (CXR) following TBB is therefore requested by most pulmonologists in 
      an attempt to detect complications, particularly pneumothorax. The objective of 
      this study was to determine if routine CXR after bronchoscopy and TBB is 
      necessary. PATIENTS AND METHOD: The study group included 350 consecutive patients 
      who underwent FB with TBB at our institution between December 2001 and January 
      2004. Routine CXR was performed up to 2 h after the procedure in all cases. 
      Additionally, the following information was recorded in all patients: sex, age, 
      immune status, indication for bronchoscopy, total number of biopsies done, 
      segment sampled, pulse oxygen saturation, and development of symptoms suggestive 
      of pneumothorax. RESULTS: Pneumothorax was diagnosed radiologically in 10 
      patients (2.9%). Seven patients had symptoms strongly suggestive of pneumothorax 
      prior to CXR, including four patients with large (> 10%) pneumothorax. The other 
      three patients were asymptomatic, with only minimal pneumothorax (</= 10%), which 
      resolved completely 24 to 48 h later. CONCLUSIONS: We conclude that routine CXR 
      after bronchoscopy with TBB is necessary only in patients with symptoms 
      suggestive of pneumothorax. In asymptomatic patients, pneumothorax is rare and 
      usually small, so routine CXR is not necessary in this category of patients.
FAU - Izbicki, Gabriel
AU  - Izbicki G
AD  - Pulmonary Institute, Shaare Zedek Medical Center, Jerusalem 91031, Israel. 
      izbicki@szmc.org.il
FAU - Shitrit, David
AU  - Shitrit D
FAU - Yarmolovsky, Alex
AU  - Yarmolovsky A
FAU - Bendayan, Danielle
AU  - Bendayan D
FAU - Miller, Galit
AU  - Miller G
FAU - Fink, Gershon
AU  - Fink G
FAU - Mazar, Asher
AU  - Mazar A
FAU - Kramer, Mordechai R
AU  - Kramer MR
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Chest
JT  - Chest
JID - 0231335
SB  - IM
MH  - Adult
MH  - Aged
MH  - Biopsy/adverse effects
MH  - Bronchi/*pathology
MH  - Bronchoscopy/*adverse effects
MH  - *Diagnostic Tests, Routine
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Lung Diseases/*pathology
MH  - Male
MH  - Middle Aged
MH  - Needs Assessment
MH  - Pneumothorax/*diagnostic imaging/etiology
MH  - Prospective Studies
MH  - *Radiography, Thoracic
EDAT- 2006/06/17 09:00
MHDA- 2006/08/02 09:00
CRDT- 2006/06/17 09:00
PHST- 2006/06/17 09:00 [pubmed]
PHST- 2006/08/02 09:00 [medline]
PHST- 2006/06/17 09:00 [entrez]
AID - S0012-3692(15)50760-5 [pii]
AID - 10.1378/chest.129.6.1561 [doi]
PST - ppublish
SO  - Chest. 2006 Jun;129(6):1561-4. doi: 10.1378/chest.129.6.1561.

PMID- 17051586
OWN - NLM
STAT- MEDLINE
DCOM- 20061207
LR  - 20131121
IS  - 1542-0752 (Print)
IS  - 1542-0752 (Linking)
VI  - 76
IP  - 10
DP  - 2006 Oct
TI  - Can folic acid protect against congenital heart defects in Down syndrome?
PG  - 714-7
AB  - BACKGROUND: Several studies have suggested a protective effect of folic acid (FA) 
      on congenital heart anomalies. Down syndrome (DS) infants are known to have a 
      high frequency of heart anomalies. Not all children with DS suffer from heart 
      anomalies, which raises the question whether maternal factors might affect the 
      risk of these anomalies. Our objectives were to investigate whether 
      first-trimester FA use protects against heart anomalies among DS children. 
      METHODS: Women with liveborn DS children participating in the Slone Epidemiology 
      Center Birth Defects Study between 1976 and 1997 were included. We performed 
      case-control analyses using DS, with heart anomalies as cases and DS, without 
      heart anomalies as controls. Subanalyses were performed for defects that have 
      been associated with FA in non-DS populations (conotruncal, ventricular septal 
      [VSD]) and for those that are associated with DS (ostium secundum type atrial 
      septal defects [ASD] and endocardial cushion defects [ECD]). Exposure was defined 
      as the use of any FA-containing product for an average of at least 4 days per 
      week during the first 12 weeks of pregnancy, whereas no exposure was defined as 
      no use of FA in these 12 weeks. RESULTS: Of the 223 cases, 110 (49%) were exposed 
      versus 84 (46%) of the 184 controls. After adjustment for possible confounders, 
      no protective effect of FA was found on heart anomalies overall (OR 0.95, 95% CI: 
      0.61-1.47) nor separately for conotruncal defects, VSDs, ASDs, or ECDs. 
      CONCLUSIONS: Our study does not show a protective effect of FA on heart anomalies 
      among infants with DS.
CI  - (c) 2006 Wiley-Liss, Inc.
FAU - Meijer, Willemijn M
AU  - Meijer WM
AD  - Slone Epidemiology Center, Boston University, Boston, Massachusetts 02215-1201, 
      USA.
FAU - Werler, Martha M
AU  - Werler MM
FAU - Louik, Carol
AU  - Louik C
FAU - Hernandez-Diaz, Sonia
AU  - Hernandez-Diaz S
FAU - de Jong-van den Berg, Lolkje T W
AU  - de Jong-van den Berg LT
FAU - Mitchell, Allen A
AU  - Mitchell AA
LA  - eng
GR  - HD27697/HD/NICHD NIH HHS/United States
GR  - HL50763/HL/NHLBI NIH HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - Birth Defects Res A Clin Mol Teratol
JT  - Birth defects research. Part A, Clinical and molecular teratology
JID - 101155107
RN  - 935E97BOY8 (Folic Acid)
SB  - IM
MH  - Dietary Supplements
MH  - Down Syndrome/complications/epidemiology/*prevention & control
MH  - Female
MH  - *Folic Acid
MH  - *Food, Fortified
MH  - Heart Defects, Congenital/epidemiology/*prevention & control
MH  - Humans
MH  - Infant, Newborn
MH  - Male
MH  - Pregnancy
MH  - Pregnancy Trimester, First
MH  - Retrospective Studies
EDAT- 2006/10/20 09:00
MHDA- 2006/12/09 09:00
CRDT- 2006/10/20 09:00
PHST- 2006/10/20 09:00 [pubmed]
PHST- 2006/12/09 09:00 [medline]
PHST- 2006/10/20 09:00 [entrez]
AID - 10.1002/bdra.20312 [doi]
PST - ppublish
SO  - Birth Defects Res A Clin Mol Teratol. 2006 Oct;76(10):714-7. doi: 
      10.1002/bdra.20312.

PMID- 24061619
OWN - NLM
STAT- MEDLINE
DCOM- 20141009
LR  - 20211021
IS  - 1432-2218 (Electronic)
IS  - 0930-2794 (Linking)
VI  - 28
IP  - 1
DP  - 2014 Jan
TI  - Location and number of sutures placed for hiatal hernia repair during 
      laparoscopic adjustable gastric banding: does it matter?
PG  - 58-64
LID - 10.1007/s00464-013-3161-7 [doi]
AB  - BACKGROUND: It has been demonstrated that hiatal hernia repair (HHR) during 
      laparoscopic adjustable gastric banding (LAGB) decreases the rate of reoperation. 
      However, the technical aspects (location and number of sutures) are not 
      standardized. It is unknown whether such technical details are associated with 
      differing rates of reoperation for band-related problems. METHODS: A 
      retrospective analysis was performed from a single institution, including 2,301 
      patients undergoing LAGB with HHR from July 1, 2007 to December 31, 2011. 
      Independent variables were number and location of sutures. Data collected 
      included demographics, operating room (OR) time, length of stay (LOS), follow-up 
      time, postoperative BMI/%EWL, and rates of readmission/reoperation. Statistical 
      analyses included ANOVA and Chi squared tests. Kaplan-Meier, log-rank, and Cox 
      regression tests were used for follow-up data and reoperation rates, in order to 
      account for differential length of follow-up and confounding variables. RESULTS: 
      There was no difference in length of follow-up among all groups. The majority of 
      patients had one suture (range 1-6; 55 %). Patients with fewer sutures had 
      shorter OR time (1 suture 45 min vs. 4+ sutures 56 min, p < 0.0001). LOS, 30-day 
      readmission, band-related reoperation, and postop BMI/%EWL were not statistically 
      significant. Anterior suture placement (vs. posterior vs. both) was most common 
      (61 %). OR time was shorter in those with anterior suture (41 min vs. posterior 
      56 min vs. both 59 min, p < 0.0001). Patients with posterior suture had a longer 
      LOS (84 % 1 day vs. anterior 74 % 1 day vs. both 74 % 1 day, p < 0.0001). There 
      was no difference in 30-day readmission, band-related reoperation, and 
      postoperative BMI/%EWL. CONCLUSIONS: Patients with fewer or anterior sutures have 
      shorter OR times. However, 30-day readmission, band-related reoperation, and 
      postoperative weight loss were unaffected by number or location of suture. The 
      technical aspects of HHR did not appear to be associated with readmission or 
      reoperation, and therefore a standardized approach may not be necessary.
FAU - Obeid, Nabeel R
AU  - Obeid NR
AD  - Department of Surgery, New York University Medical Center, 530 First Ave., Suite 
      10S, New York, NY, 10016, USA, nabeel.obeid@nyumc.org.
FAU - Deese-Laurent, Spencer
AU  - Deese-Laurent S
FAU - Schwack, Bradley F
AU  - Schwack BF
FAU - Youn, Heekoung
AU  - Youn H
FAU - Kurian, Marina S
AU  - Kurian MS
FAU - Ren-Fielding, Christine
AU  - Ren-Fielding C
FAU - Fielding, George A
AU  - Fielding GA
LA  - eng
PT  - Journal Article
DEP - 20130906
PL  - Germany
TA  - Surg Endosc
JT  - Surgical endoscopy
JID - 8806653
SB  - IM
MH  - Adult
MH  - Aged
MH  - Analysis of Variance
MH  - Female
MH  - Follow-Up Studies
MH  - Gastroplasty/*methods
MH  - Hernia, Hiatal/complications/*surgery
MH  - Herniorrhaphy/*methods
MH  - Humans
MH  - Laparoscopy/*methods
MH  - Length of Stay
MH  - Male
MH  - Middle Aged
MH  - Obesity, Morbid/complications/*surgery
MH  - Postoperative Period
MH  - Reoperation
MH  - Retrospective Studies
MH  - *Suture Techniques
MH  - Sutures
EDAT- 2013/09/26 06:00
MHDA- 2014/10/10 06:00
CRDT- 2013/09/25 06:00
PHST- 2013/04/17 00:00 [received]
PHST- 2013/07/31 00:00 [accepted]
PHST- 2013/09/25 06:00 [entrez]
PHST- 2013/09/26 06:00 [pubmed]
PHST- 2014/10/10 06:00 [medline]
AID - 10.1007/s00464-013-3161-7 [doi]
PST - ppublish
SO  - Surg Endosc. 2014 Jan;28(1):58-64. doi: 10.1007/s00464-013-3161-7. Epub 2013 Sep 
      6.

PMID- 22233470
OWN - NLM
STAT- MEDLINE
DCOM- 20120410
LR  - 20240321
IS  - 1471-2458 (Electronic)
IS  - 1471-2458 (Linking)
VI  - 12
DP  - 2012 Jan 10
TI  - Does the distribution of health care benefits in Kenya meet the principles of 
      universal coverage?
PG  - 20
LID - 10.1186/1471-2458-12-20 [doi]
AB  - BACKGROUND: The 58th World Health Assembly called for all health systems to move 
      towards universal coverage where everyone has access to key promotive, 
      preventive, curative and rehabilitative health interventions at an affordable 
      cost. Universal coverage involves ensuring that health care benefits are 
      distributed on the basis of need for care and not on ability to pay. The 
      distribution of health care benefits is therefore an important policy question, 
      which health systems should address. The aim of this study is to assess the 
      distribution of health care benefits in the Kenyan health system, compare changes 
      over two time periods and demonstrate the extent to which the distribution meets 
      the principles of universal coverage. METHODS: Two nationally representative 
      cross-sectional households surveys conducted in 2003 and 2007 were the main 
      sources of data. A comprehensive analysis of the entire health system is 
      conducted including the public sector, private-not-for-profit and 
      private-for-profit sectors. Standard benefit incidence analysis techniques were 
      applied and adopted to allow application to private sector services. RESULTS: The 
      three sectors recorded similar levels of pro-rich distribution in 2003, but in 
      2007, the private-not-for-profit sector was pro-poor, public sector benefits 
      showed an equal distribution, while the private-for-profit sector remained 
      pro-rich. Larger pro-rich disparities were recorded for inpatient compared to 
      outpatient benefits at the hospital level, but primary health care services were 
      pro-poor. Benefits were distributed on the basis of ability to pay and not on 
      need for care. CONCLUSIONS: The principles of universal coverage require that all 
      should benefit from health care according to need. The Kenyan health sector is 
      clearly inequitable and benefits are not distributed on the basis of need. 
      Deliberate efforts should be directed to restructuring the Kenyan health system 
      to address access barriers and ensure that all Kenyans benefit from health care 
      when they need it.
FAU - Chuma, Jane
AU  - Chuma J
AD  - Kenya Medical Research Institute -Wellcome Trust Research Programme, Kilifi, 
      Kenya. Jchuma@kilifi.kemri-wellcome.org
FAU - Maina, Thomas
AU  - Maina T
FAU - Ataguba, John
AU  - Ataguba J
LA  - eng
GR  - 092654/Wellcome Trust/United Kingdom
GR  - 084516/WT_/Wellcome Trust/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20120110
PL  - England
TA  - BMC Public Health
JT  - BMC public health
JID - 100968562
SB  - IM
MH  - Cross-Sectional Studies
MH  - Female
MH  - Health Policy
MH  - Health Services Needs and Demand
MH  - Healthcare Disparities/economics/*statistics & numerical data
MH  - Hospitals, Proprietary/statistics & numerical data
MH  - Hospitals, Public/statistics & numerical data
MH  - Hospitals, Voluntary/statistics & numerical data
MH  - Humans
MH  - Insurance Benefits/*statistics & numerical data
MH  - Insurance, Health/*statistics & numerical data
MH  - Kenya
MH  - Male
MH  - Socioeconomic Factors
MH  - Universal Health Insurance/organization & administration/standards/*statistics & 
      numerical data
PMC - PMC3280172
EDAT- 2012/01/12 06:00
MHDA- 2012/04/11 06:00
PMCR- 2012/01/10
CRDT- 2012/01/12 06:00
PHST- 2011/08/16 00:00 [received]
PHST- 2012/01/10 00:00 [accepted]
PHST- 2012/01/12 06:00 [entrez]
PHST- 2012/01/12 06:00 [pubmed]
PHST- 2012/04/11 06:00 [medline]
PHST- 2012/01/10 00:00 [pmc-release]
AID - 1471-2458-12-20 [pii]
AID - 10.1186/1471-2458-12-20 [doi]
PST - epublish
SO  - BMC Public Health. 2012 Jan 10;12:20. doi: 10.1186/1471-2458-12-20.

PMID- 23497210
OWN - NLM
STAT- MEDLINE
DCOM- 20130705
LR  - 20240408
IS  - 1471-2393 (Electronic)
IS  - 1471-2393 (Linking)
VI  - 13
DP  - 2013 Mar 12
TI  - Are women with major depression in pregnancy identifiable in population health 
      data?
PG  - 63
LID - 10.1186/1471-2393-13-63 [doi]
AB  - BACKGROUND: Although record linkage of routinely collected health datasets is a 
      valuable research resource, most datasets are established for administrative 
      purposes and not for health outcomes research. In order for meaningful results to 
      be extrapolated to specific populations, the limitations of the data and linkage 
      methodology need to be investigated and clarified. It is the objective of this 
      study to investigate the differences in ascertainment which may arise between a 
      hospital admission dataset and a dispensing claims dataset, using major 
      depression in pregnancy as an example. The safe use of antidepressants in 
      pregnancy is an ongoing issue for clinicians with around 10% of pregnant women 
      suffer from depression. As the birth admission will be the first admission to 
      hospital during their pregnancy for most women, their use of antidepressants, or 
      their depressive condition, may not be revealed to the attending hospital 
      clinicians. This may result in adverse outcomes for the mother and infant. 
      METHODS: Population-based de-identified data were provided from the Western 
      Australian Data Linkage System linking the administrative health records of women 
      with a delivery to related records from the Midwives' Notification System, the 
      Hospital Morbidity Data System and the national Pharmaceutical Benefits Scheme 
      dataset. The women with depression during their pregnancy were ascertained in two 
      ways: women with dispensing records relating to dispensed antidepressant 
      medicines with an WHO ATC code to the 3rd level, pharmacological subgroup, 'N06A 
      Antidepressants'; and, women with any hospital admission during pregnancy, 
      including the birth admission, if a comorbidity was recorded relating to 
      depression. RESULTS: From 2002 to 2005, there were 96698 births in WA. At least 
      one antidepressant was dispensed to 4485 (4.6%) pregnant women. There were 3010 
      (3.1%) women with a comorbidity related to depression recorded on their delivery 
      admission, or other admission to hospital during pregnancy. There were a total of 
      7495 pregnancies identified by either set of records. Using data linkage, we 
      determined that these records represented 6596 individual pregnancies. Only 899 
      pregnancies were found in both groups (13.6% of all cases). 80% of women 
      dispensed an antidepressant did not have depression recorded as a comorbidity on 
      their hospital records. A simple capture-recapture calculation suggests the 
      prevalence of depression in this population of pregnant women to be around 16%. 
      CONCLUSION: No single data source is likely to provide a complete health profile 
      for an individual. For women with depression in pregnancy and dispensed 
      antidepressants, the hospital admission data do not adequately capture all cases.
FAU - Colvin, Lyn
AU  - Colvin L
AD  - Telethon Institute for Child Health Research, Centre for Child Health Research, 
      The University of Western Australia, Perth, Australia. lync@ichr.uwa.edu.au
FAU - Slack-Smith, Linda
AU  - Slack-Smith L
FAU - Stanley, Fiona J
AU  - Stanley FJ
FAU - Bower, Carol
AU  - Bower C
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20130312
PL  - England
TA  - BMC Pregnancy Childbirth
JT  - BMC pregnancy and childbirth
JID - 100967799
RN  - 0 (Antidepressive Agents)
SB  - IM
MH  - Adult
MH  - Antidepressive Agents/*therapeutic use
MH  - Australia
MH  - Databases, Factual
MH  - Depressive Disorder, Major/*drug therapy
MH  - Female
MH  - Hospital Records/*statistics & numerical data
MH  - Humans
MH  - Longitudinal Studies
MH  - Medical Record Linkage/*methods
MH  - Medical Records Systems, Computerized/*statistics & numerical data
MH  - Pregnancy
MH  - Pregnancy Complications/*drug therapy
MH  - Prevalence
PMC - PMC3602106
EDAT- 2013/03/19 06:00
MHDA- 2013/07/06 06:00
PMCR- 2013/03/12
CRDT- 2013/03/19 06:00
PHST- 2012/11/08 00:00 [received]
PHST- 2013/03/07 00:00 [accepted]
PHST- 2013/03/19 06:00 [entrez]
PHST- 2013/03/19 06:00 [pubmed]
PHST- 2013/07/06 06:00 [medline]
PHST- 2013/03/12 00:00 [pmc-release]
AID - 1471-2393-13-63 [pii]
AID - 10.1186/1471-2393-13-63 [doi]
PST - epublish
SO  - BMC Pregnancy Childbirth. 2013 Mar 12;13:63. doi: 10.1186/1471-2393-13-63.

PMID- 25488308
OWN - NLM
STAT- MEDLINE
DCOM- 20150329
LR  - 20150112
IS  - 1531-5053 (Electronic)
IS  - 0278-2391 (Linking)
VI  - 73
IP  - 2
DP  - 2015 Feb
TI  - Can bone thickness and inter-radicular space affect miniscrew placement in 
      posterior mandibular sites?
PG  - 333-9
LID - S0278-2391(14)01326-3 [pii]
LID - 10.1016/j.joms.2014.08.015 [doi]
AB  - PURPOSE: The proper angle of miniscrew insertion is important for cortical 
      anchorage, patient safety, and biomechanical control. The purposes of this study 
      are to report the alveolar process thickness and inter-radicular space in the 
      posterior region of the mandible, to assess the impact of different miniscrew 
      insertion angle protocols, and to identify differences between the genders or 
      types of malocclusion. MATERIALS AND METHODS: In this retrospective study, 100 
      individuals were selected for orthodontic treatment at a radiology clinic. 
      Cone-beam computed tomography data were imported into 3-dimensional software. The 
      predictor variable was the location in the mandible and insertion angle. The 
      demographic variables collected included age, gender, and malocclusion (Angle 
      Classes I and II). The primary outcome variables were bone thickness and 
      inter-radicular space. The inter-radicular spaces were evaluated 5 mm from the 
      cement-enamel junction. The bone thicknesses were taken at 45 degrees , 60 degrees , and 90 degrees  in 
      relation to the alveolar ridge, simulating a miniscrew insertion. These factors 
      were evaluated for sexual dimorphism and malocclusion (Angle Classes I and II). 
      Sexual dimorphism and malocclusion were evaluated with t tests. To compare the 
      inter-radicular space and the thickness of bone between areas, an analysis of 
      variance for repeated measures was used. RESULTS: The sample was composed of 100 
      patients with a mean age of 17.4 +/- 6.74 years. There were 61 female and 39 male 
      patients and 60 Class I and 40 Class II molar relationships. The inter-radicular 
      space ranged from 2.46 to 3.31 mm, and alveolar bone thickness ranged from 8.01 
      to 13.77 mm. The thickness tended to decrease with the increase in insertion 
      angle from 45 degrees  to 90 degrees . No significant differences between the genders or types of 
      malocclusion were found. CONCLUSIONS: The results of this study suggest that the 
      safest areas for the placement of miniscrews are between the first and second 
      premolars and between the first and second molars, regardless of the angle of 
      insertion.
CI  - Copyright (c) 2015 American Association of Oral and Maxillofacial Surgeons. 
      Published by Elsevier Inc. All rights reserved.
FAU - Sabec, Ricardo da Costa
AU  - Sabec Rda C
AD  - Former Graduate Student, Department of Orthodontics, University of North Parana 
      (UNOPAR), Londrina, Brazil.
FAU - Fernandes, Thais Maria Freire
AU  - Fernandes TM
AD  - Professor, Department of Orthodontics, University of North Parana (UNOPAR), 
      Londrina, Brazil. Electronic address: thaismaria@hotmail.com.
FAU - de Lima Navarro, Ricardo
AU  - de Lima Navarro R
AD  - Postgraduate Researcher, Department of Dentistry, Area of Oral and Maxillofacial 
      Surgery, State University of Maringa, Maringa, Brazil.
FAU - Oltramari-Navarro, Paula Vanessa Pedron
AU  - Oltramari-Navarro PV
AD  - Professor, Department of Orthodontics, University of North Parana (UNOPAR), 
      Londrina, Brazil.
FAU - Conti, Ana Claudia de Castro Ferreira
AU  - Conti AC
AD  - Professor, Department of Orthodontics, University of North Parana (UNOPAR), 
      Londrina, Brazil.
FAU - de Almeida, Marcio Rodrigues
AU  - de Almeida MR
AD  - Professor, Department of Orthodontics, University of North Parana (UNOPAR), 
      Londrina, Brazil.
FAU - Poleti, Marcelo Lupion
AU  - Poleti ML
AD  - Professor, Department of Orthodontics, University of North Parana (UNOPAR), 
      Londrina, Brazil.
LA  - eng
PT  - Journal Article
DEP - 20140813
PL  - United States
TA  - J Oral Maxillofac Surg
JT  - Journal of oral and maxillofacial surgery : official journal of the American 
      Association of Oral and Maxillofacial Surgeons
JID - 8206428
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - *Bone Screws
MH  - Child
MH  - Cone-Beam Computed Tomography
MH  - Humans
MH  - Mandible/*anatomy & histology
MH  - *Orthodontics
MH  - Retrospective Studies
MH  - Young Adult
EDAT- 2014/12/10 06:00
MHDA- 2015/03/31 06:00
CRDT- 2014/12/10 06:00
PHST- 2014/05/28 00:00 [received]
PHST- 2014/08/06 00:00 [revised]
PHST- 2014/08/06 00:00 [accepted]
PHST- 2014/12/10 06:00 [entrez]
PHST- 2014/12/10 06:00 [pubmed]
PHST- 2015/03/31 06:00 [medline]
AID - S0278-2391(14)01326-3 [pii]
AID - 10.1016/j.joms.2014.08.015 [doi]
PST - ppublish
SO  - J Oral Maxillofac Surg. 2015 Feb;73(2):333-9. doi: 10.1016/j.joms.2014.08.015. 
      Epub 2014 Aug 13.

PMID- 22382608
OWN - NLM
STAT- MEDLINE
DCOM- 20120920
LR  - 20220317
IS  - 1864-6433 (Electronic)
IS  - 0914-7187 (Linking)
VI  - 26
IP  - 4
DP  - 2012 May
TI  - SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is 
      there any correlation with Parkinson's disease?
PG  - 337-44
LID - 10.1007/s12149-012-0577-4 [doi]
AB  - OBJECTIVES: The differential diagnosis between essential tremor (ET) and 
      Parkinson's disease (PD) may be, in some cases, very difficult on clinical 
      grounds alone. In addition, it is accepted that a small percentage of ET patients 
      presenting symptoms and signs of possible PD may progress finally to a typical 
      pattern of parkinsonism. Ioflupane, 
      N-u-fluoropropyl-2a-carbomethoxy-3a-(4-iodophenyl) nortropane, also called 
      FP-CIT, labelled with (123)I (commercially known as DaTSCAN) has been proven to 
      be useful in the differential diagnosis between PD and ET and to confirm 
      dopaminergic degeneration in patients with parkinsonism. The aim of this study is 
      to identify dopaminergic degeneration in patients with PD and distinguish them 
      from others with ET using semi-quantitative SPECT (123)I-Ioflupane (DaTSCAN) data 
      in comparison with normal volunteers (NV), in addition with the respective ones 
      of patients referred as suffering from ET, as well as, of patients with a PD 
      diagnosis at an initial stage with a unilateral presentation of motor signs. 
      METHODS: Twenty-eight patients suffering from ET (10 males plus 18 females) and 
      28 NV (12 males and 16 females) were enroled in this study. In addition, 33 
      patients (11 males and 22 females) with an established diagnosis of PD with 
      unilateral limb involvement (12 left hemi-body and 21 right hemi-body) were 
      included for comparison with ET. We used DaTSCAN to obtain SPECT images and 
      measure the radiopharmaceutical uptake in the striatum (S), as well as the 
      caudate nucleus (CN) and putamen (P) in all individuals. RESULTS: Qualitative 
      (Visual) interpretation of the SPECT data did not find any difference in the 
      uptake of the radiopharmaceutical at the level of the S, CN and P between NV and 
      ET patients. Reduced accumulation of the radiopharmaceutical uptake was found in 
      the P of all PD patients. Semiquantitative analysis revealed significant 
      differences between NV and ET patients in the striatum, reduced in the latter. 
      There was also a significant reduction in the tracer accumulation in the left 
      putamen of patients with right hemi-parkinsonism compared to ET and NV. Patients 
      with left hemi-parkinsonism, demonstrated reduced radioligand uptake in the right 
      putamen in comparison with ET and NV. Clinical follow-up of 20 patients with ET 
      at (so many months afterwards) revealed no significant change in clinical 
      presentation, particularly no signs of PD. Follow-up DaTSCAN performed in 10 of 
      them (so many months afterwards) was negative in all but one. This one had an 
      equivocal baseline study which deteriorated 12 months later. CONCLUSIONS: Our 
      results do not support the hypothesis of a link between essential tremor and 
      Parkinson's disease. However, it appears that ET patients have a small degree of 
      striatal dopaminergic degeneration. If this is due to alterations in the 
      nigrostriatl pathway or of other origin it is not clear. Follow-up studies of 
      essential tremor patients are warranted to assess progression of disease and to 
      understand better the possible cause for striatal dopaminergic degeneration.
FAU - Gerasimou, G
AU  - Gerasimou G
AD  - 2nd Laboratory of Nuclear Medicine, AHEPA University Hospital, Thessasloniki, 
      Greece. george_gerasimou@yahoo.gr
FAU - Costa, D C
AU  - Costa DC
FAU - Papanastasiou, E
AU  - Papanastasiou E
FAU - Bostanjiopoulou, S
AU  - Bostanjiopoulou S
FAU - Arnaoutoglou, M
AU  - Arnaoutoglou M
FAU - Moralidis, E
AU  - Moralidis E
FAU - Aggelopoulou, T
AU  - Aggelopoulou T
FAU - Gotzamani-Psarrakou, A
AU  - Gotzamani-Psarrakou A
LA  - eng
PT  - Journal Article
DEP - 20120303
PL  - Japan
TA  - Ann Nucl Med
JT  - Annals of nuclear medicine
JID - 8913398
RN  - 0 (Nortropanes)
RN  - VF232WE742 (ioflupane)
RN  - VTD58H1Z2X (Dopamine)
SB  - IM
MH  - Case-Control Studies
MH  - Diagnosis, Differential
MH  - Dopamine/metabolism
MH  - Essential Tremor/*diagnostic imaging/metabolism/physiopathology
MH  - Female
MH  - Humans
MH  - Male
MH  - Motor Activity
MH  - *Nortropanes
MH  - Parkinson Disease/*diagnostic imaging/metabolism/physiopathology
MH  - *Tomography, Emission-Computed, Single-Photon
EDAT- 2012/03/03 06:00
MHDA- 2012/09/21 06:00
CRDT- 2012/03/03 06:00
PHST- 2011/05/16 00:00 [received]
PHST- 2012/01/24 00:00 [accepted]
PHST- 2012/03/03 06:00 [entrez]
PHST- 2012/03/03 06:00 [pubmed]
PHST- 2012/09/21 06:00 [medline]
AID - 10.1007/s12149-012-0577-4 [doi]
PST - ppublish
SO  - Ann Nucl Med. 2012 May;26(4):337-44. doi: 10.1007/s12149-012-0577-4. Epub 2012 
      Mar 3.

PMID- 19237087
OWN - NLM
STAT- MEDLINE
DCOM- 20090529
LR  - 20191210
IS  - 1879-0828 (Electronic)
IS  - 0953-6205 (Linking)
VI  - 20
IP  - 1
DP  - 2009 Jan
TI  - Are many colorectal cancers due to missed adenomas?
PG  - 20-3
LID - 10.1016/j.ejim.2008.03.013 [doi]
AB  - BACKGROUND: An unknown number of colorectal cancers could be due to missed 
      adenomas during previous endoscopy. Data in the literature are sparse. A large 
      cross-sectional study was done in a prospective database of all patients 
      diagnosed with colorectal cancer. METHODS: All consecutive endoscopies over a 
      period of 15 years, in which colorectal cancer was diagnosed were included. All 
      patients who underwent more than one endoscopy and in whom ultimately cancer was 
      diagnosed were studied separately. RESULTS: Colorectal cancer was diagnosed in 
      835 patients. Twenty-five patients underwent a previous endoscopy without a 
      cancer diagnosis. These 25 patients were divided into three groups according to 
      the time between the endoscopy in which the cancer was detected and the previous 
      endoscopy. Five out of these 25 patients underwent regular surveillance. Only 11 
      patients had no argument for regular follow-up. Assuming that these cancers 
      developed from an adenoma than only 11 out of 835 (1.3%) cancers were missed in 
      the adenoma phase. There was no difference in the size of the tumour between the 
      three groups of patients. CONCLUSION: In normal daily practice, only a small 
      number of clinically important adenomas are missed. The problem of missed 
      adenomas probably is being exaggerated.
FAU - Loffeld, R J L F
AU  - Loffeld RJ
AD  - Department of Internal Medicine, Zaans Medical Centre, PO BOX 210, 1500 EE 
      Zaandam, The Netherlands. loffeld.r@zaansmc.nl
LA  - eng
PT  - Journal Article
PT  - Validation Study
DEP - 20080425
PL  - Netherlands
TA  - Eur J Intern Med
JT  - European journal of internal medicine
JID - 9003220
SB  - IM
MH  - Adenoma/*diagnosis
MH  - Adenomatous Polyps/diagnosis
MH  - Aged
MH  - Aged, 80 and over
MH  - Cecal Neoplasms/diagnosis
MH  - Colonic Diseases/diagnosis
MH  - Colonoscopy/*standards/*statistics & numerical data
MH  - Colorectal Neoplasms/*diagnosis
MH  - Cross-Sectional Studies
MH  - Databases, Factual
MH  - False Negative Reactions
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
EDAT- 2009/02/25 09:00
MHDA- 2009/05/30 09:00
CRDT- 2009/02/25 09:00
PHST- 2007/11/28 00:00 [received]
PHST- 2008/01/27 00:00 [revised]
PHST- 2008/03/09 00:00 [accepted]
PHST- 2009/02/25 09:00 [entrez]
PHST- 2009/02/25 09:00 [pubmed]
PHST- 2009/05/30 09:00 [medline]
AID - S0953-6205(08)00108-8 [pii]
AID - 10.1016/j.ejim.2008.03.013 [doi]
PST - ppublish
SO  - Eur J Intern Med. 2009 Jan;20(1):20-3. doi: 10.1016/j.ejim.2008.03.013. Epub 2008 
      Apr 25.

PMID- 10381996
OWN - NLM
STAT- MEDLINE
DCOM- 19990715
LR  - 20190717
IS  - 0196-0644 (Print)
IS  - 0196-0644 (Linking)
VI  - 34
IP  - 1
DP  - 1999 Jul
TI  - Clinician assessment for acute chest syndrome in febrile patients with sickle 
      cell disease: is it accurate enough?
PG  - 64-9
AB  - STUDY OBJECTIVE: To determine whether the use of empiric chest radiography (CXR) 
      is of significant value in detecting clinically unsuspected acute chest syndrome 
      (ACS) in febrile patients with sickle cell disease (SCD). METHODS: Patients with 
      SCD presenting to the emergency department and hematology clinic with temperature 
      greater than or equal to 38 degrees C were prospectively evaluated using a 
      physician-completed questionnaire. The questionnaire included inquiries into the 
      patient's physical signs and symptoms and the physician's clinical impression for 
      the presence of ACS. The questionnaire was completed before obtaining CXR results 
      in all patients. RESULTS: Seventy-three patients with SCD with 96 febrile events 
      were evaluated over a 1-year period. Twenty-four percent (23/96) of the patients 
      had CXR evidence of ACS. On the basis of the questionnaire data, 61% (14/23) of 
      ACS cases were not clinically suspected by the evaluating physician before 
      obtaining CXR. Comparing the patients with and without ACS revealed that, with 
      the exception of splinting (4/23 [17%] versus 0/73 [0%]), no symptom or physical 
      examination finding helped to identify which patients had ACS. Fifty-seven 
      percent of patients with ACS had completely normal findings on physical 
      examination. The presentation of patients with clinically detected versus 
      clinically unsuspected ACS also did not differ significantly. Length of 
      hospitalization, oxygen use, and need for transfusion were the same in both the 
      unsuspected and detected ACS groups. Overall physician sensitivity for predicting 
      ACS was only 39%, and diagnostic accuracy did not improve significantly with 
      increasing levels of pediatric training. CONCLUSION: ACS is common in patients 
      with SCD who present with fever and was grossly underestimated by evaluating 
      physicians. History and physical examination appear to be of little value in 
      defining which febrile patients require CXR. In view of the mortality and 
      morbidity associated with ACS, empiric CXR should be considered when evaluating a 
      febrile patient with SCD.
FAU - Morris, C
AU  - Morris C
AD  - Departments of Emergency Medicine and Hematology/Oncology, Children's Hospital 
      Oakland, Oakland, CA, USA. lstyles@lanminds.com
FAU - Vichinsky, E
AU  - Vichinsky E
FAU - Styles, L
AU  - Styles L
LA  - eng
GR  - HL-20985/HL/NHLBI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - Ann Emerg Med
JT  - Annals of emergency medicine
JID - 8002646
SB  - IM
MH  - Acute Disease
MH  - Adolescent
MH  - Anemia, Sickle Cell/*complications
MH  - Blood Transfusion
MH  - Child
MH  - Child, Preschool
MH  - Diagnosis, Differential
MH  - Emergency Treatment/*methods
MH  - Female
MH  - Fever/*etiology
MH  - Humans
MH  - Infant
MH  - Length of Stay/statistics & numerical data
MH  - Male
MH  - Oxygen Inhalation Therapy
MH  - Physical Examination
MH  - Pneumonia/*diagnostic imaging/*etiology/therapy
MH  - Prospective Studies
MH  - Radiography
MH  - Reproducibility of Results
MH  - Single-Blind Method
MH  - Surveys and Questionnaires
MH  - Syndrome
EDAT- 1999/06/26 00:00
MHDA- 1999/06/26 00:01
CRDT- 1999/06/26 00:00
PHST- 1999/06/26 00:00 [pubmed]
PHST- 1999/06/26 00:01 [medline]
PHST- 1999/06/26 00:00 [entrez]
AID - S019606449900219X [pii]
AID - 10.1016/s0196-0644(99)70273-8 [doi]
PST - ppublish
SO  - Ann Emerg Med. 1999 Jul;34(1):64-9. doi: 10.1016/s0196-0644(99)70273-8.

PMID- 9100537
OWN - NLM
STAT- MEDLINE
DCOM- 19970429
LR  - 20190620
IS  - 0008-543X (Print)
IS  - 0008-543X (Linking)
VI  - 81
IP  - 1
DP  - 1997 Feb 25
TI  - Can nonproliferative breast disease and proliferative breast disease without 
      atypia be distinguished by fine-needle aspiration cytology?
PG  - 22-8
AB  - BACKGROUND: Cytologic criteria reported to be helpful in the distinction of 
      proliferative breast disease without atypia (PBD) from nonproliferative breast 
      disease (NPBD) have not been rigorously tested. METHODS: Fifty-one air-dried, 
      Diff-Quik-stained fine-needle aspirates (FNA) of palpable breast lesions with 
      biopsy-proven diagnoses of NPBD (34 cases) or PBD (17 cases) were reviewed. The 
      smears were evaluated for the cellularity, size, and architectural arrangement of 
      the epithelial groups; the presence of single epithelial cells and myoepithelial 
      cells; and nuclear characteristics. RESULTS: The only cytologic feature found to 
      be significantly different between PBD and NPBD was a swirling pattern of 
      epithelial cells. A swirling pattern was noted in 13 of 17 PBD cases (76%) and 12 
      of 34 NPBD cases (35%) (P = 0.008). CONCLUSIONS: Because there is significant 
      overlap in cytologic features between NPBD and PBD, the distinction between the 
      two entities is difficult in cytologic sampling.
FAU - Frost, A R
AU  - Frost AR
AD  - Department of Pathology, George Washington University Medical Center, Washington, 
      DC., USA.
FAU - Aksu, A
AU  - Aksu A
FAU - Kurstin, R
AU  - Kurstin R
FAU - Sidawy, M K
AU  - Sidawy MK
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Cancer
JT  - Cancer
JID - 0374236
SB  - IM
MH  - *Biopsy, Needle
MH  - Breast Diseases/*pathology
MH  - Diagnosis, Differential
MH  - Female
MH  - Humans
MH  - Precancerous Conditions/*pathology
MH  - Predictive Value of Tests
EDAT- 1997/02/25 00:00
MHDA- 2000/06/20 09:00
CRDT- 1997/02/25 00:00
PHST- 1997/02/25 00:00 [pubmed]
PHST- 2000/06/20 09:00 [medline]
PHST- 1997/02/25 00:00 [entrez]
AID - 10.1002/(SICI)1097-0142(19970225)81:1<22::AID-CNCR6>3.0.CO;2-I [pii]
AID - 10.1002/(sici)1097-0142(19970225)81:1<22::aid-cncr6>3.0.co;2-i [doi]
PST - ppublish
SO  - Cancer. 1997 Feb 25;81(1):22-8. doi: 
      10.1002/(sici)1097-0142(19970225)81:1<22::aid-cncr6>3.0.co;2-i.

PMID- 23422012
OWN - NLM
STAT- MEDLINE
DCOM- 20130624
LR  - 20211021
IS  - 1756-0500 (Electronic)
IS  - 1756-0500 (Linking)
VI  - 6
DP  - 2013 Feb 19
TI  - Is vancomycin MIC creep a worldwide phenomenon? Assessment of S. aureus 
      vancomycin MIC in a tertiary university hospital.
PG  - 65
LID - 10.1186/1756-0500-6-65 [doi]
AB  - BACKGROUND: Vancomycin is the primary treatment for infections caused by 
      methicilin-resistant Staphylococcus aureus (MRSA). The association of vancomycin 
      treatment failures with increased vancomycin minimum inhibitory concentration 
      (MIC) is a well-recognized problem. A number of single-centre studies have 
      identified progressive increases in glycopeptide MICs for S. aureus strains over 
      recent years - a phenomenon known as vancomycin MIC creep. It is unknown if this 
      is a worldwide phenomenon or if it is localized to specific centers. METHODS: The 
      aim of this study was to evaluate the trend of vancomycin MIC for isolates of 
      MRSA over a 3-year period in a tertiary university hospital in Portugal. MRSA 
      isolates from samples of patients admitted from January 2007 to December 2009 
      were assessed. Etest method was used to determine the respective vancomycin MIC. 
      Only one isolate per patient was included in the final analysis. RESULTS: A total 
      of 93 MRSA isolates were studied. The vancomycin MICs were 0.75, 1, 1.5 and 2 
      mg/L for 1 (1.1%), 19 (20.4%), 38 (40.9%), 35 (37.6%) isolates, respectively. 
      During the 3 year period, we observed a significant fluctuation in the rate of 
      MRSA with a vancomycin MIC > 1 mg/L (2007: 86.2%; 2008: 93.3%; 2009: 58.8%, 
      p = 0.002). No MRSA isolate presented a MIC > 2 mg/L. CONCLUSIONS: We were unable 
      to find in our institution data compatible to the presence of vancomycin MIC 
      creep during the study period. This phenomenon seems not to be generalized; as a 
      result each institution should systematically monitor MRSA vancomycin MIC over 
      time.
FAU - Joana, Silvestre
AU  - Joana S
AD  - Polyvalent Intensive Care Unit, Sao Francisco Xavier Hospital, CHLO, Lisbon, 
      Portugal. joanapsilvestre@gmail.com
FAU - Pedro, Povoa
AU  - Pedro P
FAU - Elsa, Goncalves
AU  - Elsa G
FAU - Filomena, Martins
AU  - Filomena M
LA  - eng
PT  - Journal Article
DEP - 20130219
PL  - England
TA  - BMC Res Notes
JT  - BMC research notes
JID - 101462768
RN  - 0 (Anti-Bacterial Agents)
RN  - 6Q205EH1VU (Vancomycin)
SB  - IM
MH  - Anti-Bacterial Agents/*pharmacology
MH  - *Hospitals, University
MH  - Humans
MH  - *Microbial Sensitivity Tests
MH  - Staphylococcus aureus/*drug effects
MH  - Vancomycin/*pharmacology
PMC - PMC3585458
EDAT- 2013/02/21 06:00
MHDA- 2013/06/26 06:00
PMCR- 2013/02/19
CRDT- 2013/02/21 06:00
PHST- 2012/11/22 00:00 [received]
PHST- 2013/02/07 00:00 [accepted]
PHST- 2013/02/21 06:00 [entrez]
PHST- 2013/02/21 06:00 [pubmed]
PHST- 2013/06/26 06:00 [medline]
PHST- 2013/02/19 00:00 [pmc-release]
AID - 1756-0500-6-65 [pii]
AID - 10.1186/1756-0500-6-65 [doi]
PST - epublish
SO  - BMC Res Notes. 2013 Feb 19;6:65. doi: 10.1186/1756-0500-6-65.

PMID- 22876568
OWN - NLM
STAT- MEDLINE
DCOM- 20120904
LR  - 20220309
IS  - 0334-018X (Print)
IS  - 0334-018X (Linking)
VI  - 25
IP  - 5-6
DP  - 2012
TI  - Is vitamin D deficiency a feature of pediatric celiac disease?
PG  - 607-10
AB  - BACKGROUND: Celiac disease (CD) is an autoimmune enteropathy characterized by 
      villus atrophy and malabsorption of essential nutrients. Vitamin D deficiency has 
      been described in autoimmune diseases, but its status in prepubertal children 
      with CD has not been adequately studied. OBJECTIVE: To determine the vitamin D 
      status of prepubertal children with CD. STUDY DESIGN: A retrospective study of 
      prepubertal children aged 3-12 years with CD (n=24) who were compared to 
      prepubertal, non-CD children of the same age (n=50). Children were included in 
      the study if they had a diagnosis of CD by intestinal biopsy, and were not on a 
      gluten-free diet (GFD). Patients were excluded if they had diseases of calcium or 
      vitamin D metabolism, or were receiving calcium or vitamin D supplementation or 
      had other autoimmune diseases. All subjects had their serum 25-hydroxyvitamin D 
      [25(OH)D] level measured. RESULTS: There was no difference in 25(OH)D level 
      between the CD and non-CD children (27.58 +/- 9.91 versus 26.20 +/- 10.45, p = 
      0.59). However, when the patients were subdivided into obese and non-obese 
      groups, the non-obese CD patients had a significantly higher 25(OH)D level than 
      the obese normal children (28.39 +/- 10.26 versus 21.58 +/- 5.67, p = 0.009). In 
      contrast, there was no difference in 25(OH)D level between non-obese CD patients 
      and non-obese normal children (28.39 +/- 10.26 versus 30.64 +/-12.08, p = 0.52). 
      The season of 25(OH)D measurement was not a significant confounder (p =0.7). 
      CONCLUSIONS: Our data showed no difference in 25(OH) D levels between normal 
      children and those with CD when adjusted for body mass index.
FAU - Villanueva, Jeffrey
AU  - Villanueva J
AD  - University of Massachusetts Medical School, Worcester, 01655, USA.
FAU - Maranda, Louise
AU  - Maranda L
FAU - Nwosu, Benjamin Udoka
AU  - Nwosu BU
LA  - eng
GR  - DK32520/DK/NIDDK NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - Germany
TA  - J Pediatr Endocrinol Metab
JT  - Journal of pediatric endocrinology & metabolism : JPEM
JID - 9508900
RN  - 1406-16-2 (Vitamin D)
RN  - A288AR3C9H (25-hydroxyvitamin D)
SB  - IM
MH  - Biopsy
MH  - Celiac Disease/*complications/pathology
MH  - Child
MH  - Child, Preschool
MH  - Female
MH  - Humans
MH  - Intestinal Absorption/physiology
MH  - Intestinal Mucosa/*pathology
MH  - Male
MH  - Retrospective Studies
MH  - Vitamin D/analogs & derivatives/blood
MH  - Vitamin D Deficiency/blood/*etiology/pathology
EDAT- 2012/08/11 06:00
MHDA- 2012/09/05 06:00
CRDT- 2012/08/11 06:00
PHST- 2012/08/11 06:00 [entrez]
PHST- 2012/08/11 06:00 [pubmed]
PHST- 2012/09/05 06:00 [medline]
AID - 10.1515/jpem-2012-0048 [doi]
PST - ppublish
SO  - J Pediatr Endocrinol Metab. 2012;25(5-6):607-10. doi: 10.1515/jpem-2012-0048.

PMID- 17445978
OWN - NLM
STAT- MEDLINE
DCOM- 20080226
LR  - 20220311
IS  - 0302-2838 (Print)
IS  - 0302-2838 (Linking)
VI  - 52
IP  - 4
DP  - 2007 Oct
TI  - Is renal warm ischemia over 30 minutes during laparoscopic partial nephrectomy 
      possible? One-year results of a prospective study.
PG  - 1170-8
AB  - OBJECTIVE: To evaluate renal damage and impairment of renal function 1 yr after 
      laparoscopic partial nephrectomy (LPN) with warm ischemia >30 min. METHODS: From 
      July 2004 to June 2005, 18 patients underwent LPN with warm ischemia time >30 
      min. Kidney damage markers (daily proteinuria and tubular enzymes) and renal 
      function (serum creatinine, cystatin C, and creatinine clearances) were assessed 
      on postoperative days 1 and 5 and at 12 mo. Glomerular filtration rate (GFR) was 
      evaluated before surgery and at 3 mo. Renal scintigraphy was performed before the 
      procedure, at 5 d and at 3 and 12 mo postoperatively. Statistical analysis was 
      performed using the Student t test and logistic regression analysis. RESULTS: In 
      terms of kidney damage and renal function markers, the statistical analysis 
      demonstrated that at 1 yr there was complete return to the normal range and no 
      statistical difference between the values at the various time points. The GFR was 
      not significantly different before and 3 mo after surgery. In terms of 
      scintigraphy of the operated kidney, the values were 48.35+/-3.82% (40-50%) 
      before the procedure, 36.88+/-8.42 (16-50%) on postoperative day 5 (p=0.0001), 
      40.56+/-8.96 (20-50%) at 3 mo (p=0.003), and 42.8+/-7.2% (20-50%) 1 yr after 
      surgery (p=0.001). CONCLUSION: Our results demonstrate that kidney damage occurs 
      during LPN when warm ischemia is >30 min. This damage is only partially 
      reversible and efforts should be made to keep warm ischemia within 30 min.
FAU - Porpiglia, Francesco
AU  - Porpiglia F
AD  - Department of Urology, University of Turin, San Luigi Hospital, Orbassano Torino, 
      Italy. porpiglia@libero.it
FAU - Renard, Julien
AU  - Renard J
FAU - Billia, Michele
AU  - Billia M
FAU - Musso, Francesca
AU  - Musso F
FAU - Volpe, Alessandro
AU  - Volpe A
FAU - Burruni, Rodolfo
AU  - Burruni R
FAU - Terrone, Carlo
AU  - Terrone C
FAU - Colla, Loredana
AU  - Colla L
FAU - Piccoli, Giorgina
AU  - Piccoli G
FAU - Podio, Valerio
AU  - Podio V
FAU - Scarpa, Roberto Mario
AU  - Scarpa RM
LA  - eng
PT  - Journal Article
DEP - 20070411
PL  - Switzerland
TA  - Eur Urol
JT  - European urology
JID - 7512719
SB  - IM
CIN - Eur Urol. 2007 Oct;52(4):961-3. doi: 10.1016/j.eururo.2007.04.051. PMID: 17499424
MH  - Humans
MH  - Ischemia/*complications
MH  - Kidney/*pathology
MH  - Laparoscopy/*methods
MH  - Nephrectomy/*methods
MH  - Prospective Studies
EDAT- 2007/04/21 09:00
MHDA- 2008/02/27 09:00
CRDT- 2007/04/21 09:00
PHST- 2007/01/30 00:00 [received]
PHST- 2007/04/05 00:00 [accepted]
PHST- 2007/04/21 09:00 [pubmed]
PHST- 2008/02/27 09:00 [medline]
PHST- 2007/04/21 09:00 [entrez]
AID - S0302-2838(07)00552-0 [pii]
AID - 10.1016/j.eururo.2007.04.024 [doi]
PST - ppublish
SO  - Eur Urol. 2007 Oct;52(4):1170-8. doi: 10.1016/j.eururo.2007.04.024. Epub 2007 Apr 
      11.

PMID- 20608141
OWN - NLM
STAT- MEDLINE
DCOM- 20100813
LR  - 20161020
IS  - 1124-3562 (Print)
IS  - 1124-3562 (Linking)
VI  - 81
IP  - 4
DP  - 2009 Dec
TI  - PSA repeatedly fluctuating levels are reassuring enough to avoid biopsy?
PG  - 203-8
AB  - INTRODUCTION: Prostate-specific antigen (PSA) levels can show wide fluctuations 
      when repeatedly measured. Here we investigatewd if: (a) biopsy timing influences 
      the prostate cancer (PC) detection rate in patients with fluctuating PSA 
      (flu-PSA) in comparison with patients with steadily increasing PSA (si-PSA); (b) 
      PSA slope estimated in patients with flu-PSA predicts a different risk of cancer 
      detection; (c) flu-PSA and si-PSA patients develop PC in topographically 
      different sites; (d) the behaviour of pre-operative PSA is an expression of a 
      disease with defferent characteristics to the following radical prostatectomy. 
      METHODS: The study involved 211 patients who underwent at least a second biopsy 
      after a first negative prostate biopsy. PSA Slope, PSA velocity (PSAV) and PSA 
      doubling time (PSADT) were estimated. Flu-PSA level was defined as a PSA series 
      with at least one PSA value lower than the one immediately preceding it. RESULTS: 
      82 patients had flu-PSA levels and 129 si-PSA levels. There were no significant 
      differences between the two groups in terms of cancer detection, clinical or 
      pathological stage, but the si-PSA group with cancer had a higher Gleason score. 
      No difference was found for PSA Slope between flu-PSA patients with cancer and 
      those without. CONCLUSIONS: Our study demonstrates no difference in PC detection 
      rate at repeat biopsy between patients with flu or si-PSA levels. PSA Slope, PSAV 
      and PSADT were not found helpful tools in cancer detection.
FAU - Taverna, Gianluigi
AU  - Taverna G
AD  - Department of Urology Service, Istituto Clinico Humanitas IRCCS, Rozzano, Milan, 
      Italy. gianluigi.taverna@humanitas.it
FAU - Grizzi, Fabio
AU  - Grizzi F
FAU - Minuti, Francesco
AU  - Minuti F
FAU - Seveso, Mauro
AU  - Seveso M
FAU - Piccinelli, Alessandro
AU  - Piccinelli A
FAU - Giusti, Guido
AU  - Giusti G
FAU - Benetti, Alessio
AU  - Benetti A
FAU - Maugeri, Orazio
AU  - Maugeri O
FAU - Pasini, Luisa
AU  - Pasini L
FAU - Zandegiacomo, Silvia
AU  - Zandegiacomo S
FAU - Colombo, Piergiuseppe
AU  - Colombo P
FAU - Di Biccari, Sonia
AU  - Di Biccari S
FAU - Graziotti, Pierpaolo
AU  - Graziotti P
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - Italy
TA  - Arch Ital Urol Androl
JT  - Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa 
      italiana di ecografia urologica e nefrologica
JID - 9308247
RN  - 0 (Biomarkers, Tumor)
RN  - EC 3.4.21.77 (Prostate-Specific Antigen)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Biomarkers, Tumor/*blood
MH  - *Biopsy
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Predictive Value of Tests
MH  - Prostate-Specific Antigen/*blood
MH  - Prostatic Neoplasms/*diagnosis/immunology/pathology
MH  - Reproducibility of Results
EDAT- 2010/07/09 06:00
MHDA- 2010/08/14 06:00
CRDT- 2010/07/09 06:00
PHST- 2010/07/09 06:00 [entrez]
PHST- 2010/07/09 06:00 [pubmed]
PHST- 2010/08/14 06:00 [medline]
PST - ppublish
SO  - Arch Ital Urol Androl. 2009 Dec;81(4):203-8.

PMID- 23177368
OWN - NLM
STAT- MEDLINE
DCOM- 20130530
LR  - 20191210
IS  - 1532-3080 (Electronic)
IS  - 0960-9776 (Linking)
VI  - 22
IP  - 1
DP  - 2013 Feb
TI  - Does immediate breast reconstruction compromise the delivery of adjuvant 
      chemotherapy?
PG  - 64-9
LID - S0960-9776(12)00209-3 [pii]
LID - 10.1016/j.breast.2012.10.008 [doi]
AB  - BACKGROUND: Immediate breast reconstruction (IBR) provides psychological benefit 
      to many early breast cancer patients however concerns persist regarding its 
      potential impact on chemotherapy delivery. We investigated the association 
      between IBR, complications and adjuvant chemotherapy delivery. METHOD: 
      Retrospective analysis of patients in an academic breast service, who underwent 
      mastectomy, with or without reconstruction, and received adjuvant chemotherapy. 
      RESULTS: Comparisons were made between 107 patients who received IBR and 113 who 
      received mastectomy alone. Those receiving IBR were on average younger, with 
      lower body mass index (BMI) and better prognoses. Overall complication rates were 
      comparable (mastectomy alone: 45.1% versus IBR: 35.5%, p = 0.2). There was more 
      return to surgery in the IBR group with 11.5% of tissue expanders requiring 
      removal, whilst more seromas occurred in the mastectomy group. There was no 
      significant difference in the median time to chemotherapy. CONCLUSION: We found 
      no evidence that IBR compromised the delivery of adjuvant chemotherapy, although 
      there was a significant incidence of implant infection.
CI  - Copyright (c) 2012 Elsevier Ltd. All rights reserved.
FAU - Chang, Rachel Jui-Chi
AU  - Chang RJ
AD  - Department of Surgery, The University of Melbourne, Australia. 
      rachelchang2010@gmail.com
FAU - Kirkpatrick, Katharine
AU  - Kirkpatrick K
FAU - De Boer, Richard H
AU  - De Boer RH
FAU - Bruce Mann, G
AU  - Bruce Mann G
LA  - eng
PT  - Comparative Study
PT  - Evaluation Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20121122
PL  - Netherlands
TA  - Breast
JT  - Breast (Edinburgh, Scotland)
JID - 9213011
RN  - 0 (Antineoplastic Agents)
RN  - 0 (Taxoids)
RN  - 80168379AG (Doxorubicin)
RN  - 8N3DW7272P (Cyclophosphamide)
RN  - Q20Q21Q62J (Cisplatin)
RN  - U3P01618RT (Fluorouracil)
RN  - YL5FZ2Y5U1 (Methotrexate)
RN  - AC protocol
RN  - CMF protocol
RN  - TAC protocol
SB  - IM
MH  - Adult
MH  - Aged
MH  - Antineoplastic Agents/*administration & dosage
MH  - Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
MH  - Breast Neoplasms/*drug therapy/surgery
MH  - Chemotherapy, Adjuvant
MH  - Cisplatin/therapeutic use
MH  - Cyclophosphamide/therapeutic use
MH  - Doxorubicin/therapeutic use
MH  - Female
MH  - Fluorouracil/therapeutic use
MH  - Humans
MH  - Incidence
MH  - Kaplan-Meier Estimate
MH  - Logistic Models
MH  - Mammaplasty/*methods
MH  - *Mastectomy
MH  - Methotrexate/therapeutic use
MH  - Middle Aged
MH  - Multivariate Analysis
MH  - Postoperative Complications/epidemiology/etiology/prevention & control
MH  - Retrospective Studies
MH  - Taxoids/therapeutic use
MH  - Time Factors
MH  - Treatment Outcome
EDAT- 2012/11/28 06:00
MHDA- 2013/06/01 06:00
CRDT- 2012/11/27 06:00
PHST- 2012/03/24 00:00 [received]
PHST- 2012/06/20 00:00 [revised]
PHST- 2012/10/13 00:00 [accepted]
PHST- 2012/11/27 06:00 [entrez]
PHST- 2012/11/28 06:00 [pubmed]
PHST- 2013/06/01 06:00 [medline]
AID - S0960-9776(12)00209-3 [pii]
AID - 10.1016/j.breast.2012.10.008 [doi]
PST - ppublish
SO  - Breast. 2013 Feb;22(1):64-9. doi: 10.1016/j.breast.2012.10.008. Epub 2012 Nov 22.

PMID- 8847047
OWN - NLM
STAT- MEDLINE
DCOM- 19961024
LR  - 20061115
IS  - 0172-6390 (Print)
IS  - 0172-6390 (Linking)
VI  - 42
IP  - 6
DP  - 1995 Nov-Dec
TI  - Prognosis of well differentiated small hepatocellular carcinoma--is well 
      differentiated hepatocellular carcinoma clinically early cancer?
PG  - 923-30
AB  - BACKGROUND/AIMS: The purpose of this study is to examine whether or not well 
      differentiated (w-d) hepatocellular carcinoma (HCC) is indeed clinically early 
      cancer. MATERIALS AND METHODS: Seventy six patients with solitary small HCCs up 
      to 3 cm in diameter, who underwent hepatectomy, were observed for at least 2 
      years for possible recurrence. These patients were divided into two groups: 10 
      patients with w-d HCCs (Edmondson and Steiner's grade I) and 66 patients with 
      less differentiated (l-d) HCCs (Edmondson and Steiner's grade I-II, II-III, and 
      III). RESULTS: The histological analysis revealed that w-d HCCs had lower 
      incidences of fibrous capsule formation (P<0.01), when compared to l-d HCCs. 
      There were no significant differences in the incidence of intrahepatic 
      metastasis, or portal vein invasion. In a resected specimen of w-d HCC, barium 
      sulfate and gelatin were injected into portal vein and a transparent specimen was 
      made. The transparent specimen showed that the portal vein in the tumor seemed to 
      be intact. Microscopically, cancer cell infiltration into the fibrous frame of 
      the portal tract was present. There were no significant differences in the 
      disease free survival between the two groups. An analysis of tumor volume 
      doubling time in recurrent foci suggested that minute cancerous foci had been 
      present at the time of operation. CONCLUSIONS: W-d HCCs were clinically 
      demonstrated not to be early cancer, because there was no significant difference 
      in disease free survival between the patients with w-d and l-d HCCs.
FAU - Shirabe, K
AU  - Shirabe K
AD  - Second Department of Surgery, Faculty of Medicine, Kyushu University, Fukuoka, 
      Japan.
FAU - Matsumata, T
AU  - Matsumata T
FAU - Adachi, E
AU  - Adachi E
FAU - Maeda, T
AU  - Maeda T
FAU - Shimada, M
AU  - Shimada M
FAU - Taketomi, A
AU  - Taketomi A
FAU - Sugimachi, K
AU  - Sugimachi K
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - Greece
TA  - Hepatogastroenterology
JT  - Hepato-gastroenterology
JID - 8007849
SB  - IM
MH  - Carcinoma, Hepatocellular/*epidemiology/*pathology/surgery
MH  - Case-Control Studies
MH  - Disease-Free Survival
MH  - Female
MH  - Follow-Up Studies
MH  - Hepatectomy
MH  - Humans
MH  - Incidence
MH  - Liver/*pathology
MH  - Liver Neoplasms/*epidemiology/*pathology/surgery
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Invasiveness
MH  - Neoplasm Recurrence, Local/epidemiology
MH  - Portal Vein/pathology
MH  - Prognosis
MH  - Time Factors
EDAT- 1995/11/01 00:00
MHDA- 1995/11/01 00:01
CRDT- 1995/11/01 00:00
PHST- 1995/11/01 00:00 [pubmed]
PHST- 1995/11/01 00:01 [medline]
PHST- 1995/11/01 00:00 [entrez]
PST - ppublish
SO  - Hepatogastroenterology. 1995 Nov-Dec;42(6):923-30.

PMID- 22011946
OWN - NLM
STAT- MEDLINE
DCOM- 20120416
LR  - 20211020
IS  - 1432-2218 (Electronic)
IS  - 0930-2794 (Linking)
VI  - 26
IP  - 3
DP  - 2012 Mar
TI  - Does a preoperative medically supervised weight loss program improve bariatric 
      surgery outcomes? A pilot randomized study.
PG  - 853-61
LID - 10.1007/s00464-011-1966-9 [doi]
AB  - BACKGROUND: Many insurance payors mandate that bariatric surgery candidates 
      undergo a medically supervised weight management (MSWM) program as a prerequisite 
      for surgery. However, there is little evidence to support this requirement. We 
      evaluated in a randomized controlled trial the hypothesis that participation in a 
      MSWM program does not predict outcomes after laparoscopic adjustable gastric 
      banding (LAGB) in a publicly insured population. METHODS: This pilot randomized 
      trial was conducted in a large academic urban public hospital. Patients who met 
      NIH consensus criteria for bariatric surgery and whose insurance did not require 
      a mandatory 6-month MSWM program were randomized to a MSWM program with monthly 
      visits over 6 months (individual or group) or usual care for 6 months and then 
      followed for bariatric surgery outcomes postoperatively. Demographics, weight, 
      and patient behavior scores, including patient adherence, eating behavior, 
      patient activation, and physical activity, were collected at baseline and at 6 
      months (immediately preoperatively and postoperatively). RESULTS: A total of 55 
      patients were enrolled in the study with complete follow-up on 23 patients. 
      Participants randomized to a MSWM program attended an average of 2 sessions 
      preoperatively. The majority of participants were female and non-Caucasian, mean 
      age was 46 years, average income was less than $20,000/year, and most had 
      Medicaid as their primary insurer, consistent with the demographics of the 
      hospital's bariatric surgery program. Data analysis included both 
      intention-to-treat and completers' analyses. No significant differences in weight 
      loss and most patient behaviors were found between the two groups 
      postoperatively, suggesting that participation in a MSWM program did not improve 
      weight loss outcomes for LAGB. Participation in a MSWM program did appear to have 
      a positive effect on physical activity postoperatively. CONCLUSION: MSWM does not 
      appear to confer additional benefit as compared to the standard preoperative 
      bariatric surgery protocol in terms of weight loss and most behavioral outcomes 
      after LAGB in our patient population.
FAU - Parikh, Manish
AU  - Parikh M
AD  - Bellevue Center for Obesity and Weight Management, Bellevue Hospital Center, 
      Department of Surgery, New York University School of Medicine, New Bellevue 15 
      South 7, 550 First Avenue, New York, NY 10016, USA. manish.parikh@nyumc.org
FAU - Dasari, Meena
AU  - Dasari M
FAU - McMacken, Michelle
AU  - McMacken M
FAU - Ren, Christine
AU  - Ren C
FAU - Fielding, George
AU  - Fielding G
FAU - Ogedegbe, Gbenga
AU  - Ogedegbe G
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20111020
PL  - Germany
TA  - Surg Endosc
JT  - Surgical endoscopy
JID - 8806653
SB  - IM
MH  - Adult
MH  - Body Mass Index
MH  - Exercise/physiology
MH  - Feeding Behavior/physiology
MH  - Female
MH  - Gastroplasty/*methods
MH  - Health Behavior
MH  - Humans
MH  - Laparoscopy/*methods
MH  - Male
MH  - Medication Adherence
MH  - Middle Aged
MH  - Obesity, Morbid/*therapy
MH  - Pilot Projects
MH  - Preoperative Care/*methods
MH  - Treatment Outcome
MH  - Weight Reduction Programs/*methods
EDAT- 2011/10/21 06:00
MHDA- 2012/04/17 06:00
CRDT- 2011/10/21 06:00
PHST- 2011/07/07 00:00 [received]
PHST- 2011/09/11 00:00 [accepted]
PHST- 2011/10/21 06:00 [entrez]
PHST- 2011/10/21 06:00 [pubmed]
PHST- 2012/04/17 06:00 [medline]
AID - 10.1007/s00464-011-1966-9 [doi]
PST - ppublish
SO  - Surg Endosc. 2012 Mar;26(3):853-61. doi: 10.1007/s00464-011-1966-9. Epub 2011 Oct 
      20.

PMID- 27394685
OWN - NLM
STAT- MEDLINE
DCOM- 20170508
LR  - 20211204
IS  - 1432-1068 (Electronic)
IS  - 1633-8065 (Linking)
VI  - 26
IP  - 6
DP  - 2016 Aug
TI  - Bony defects in chronic anterior posttraumatic dislocation of the shoulder: Is 
      there a correlation between humeral and glenoidal lesions?
PG  - 581-6
LID - 10.1007/s00590-016-1815-6 [doi]
AB  - BACKGROUND: The prevalence of combined humeral and glenoid defects varies between 
      79 and 84 % in case of chronic posttraumatic anterior shoulder instability. The 
      main goal of this study was to evaluate the relationship between humeral and 
      glenoid defects based on quantitative radiological criteria. METHODS: A 
      retrospective study was performed between 2000 and 2011 including patients who 
      underwent primary surgical shoulder stabilization for chronic posttraumatic 
      anterior shoulder instability, with bone defects in both the glenoid and humerus 
      and a healthy contralateral shoulder. The following measurements were taken: D/R 
      ratio (Hill-Sachs lesion depth/humeral head radius) on an AP X-ray in internal 
      rotation and the D1/D2 ratio [diameter of the involved glenoid articular surfaces 
      (D1)/the healthy one (D2)] on a comparative Bernageau glenoid profile view. 
      Measurements were taken by two observers. Correlations were determined by the 
      Spearman correlation coefficients (r), Bland and Altman diagrams, and intra-class 
      correlation coefficients (ICC). A sample size calculation was done. RESULTS: 
      Thirty patients were included, 25 men/5 women, mean age 29.8 +/- 11.2 years. The 
      mean D/R was 23 +/- 12 % for observer 1 and 23 +/- 10 % for observer 2. The mean 
      D1/D2 was 95 +/- 4 % for observer 1 and 94 +/- 6 % for observer 2. No significant 
      correlation was found between humeral and glenoid bone defects by observer 1 
      (r = 0.23, p = 0.22) or observer 2 (r = 0.05, p = 0.78). Agreement of the 
      observers for the D/R ratio was excellent (ICC = 0.89 +/- 0.04, p < 0.00001) and 
      good for the D1/D2 ratio (ICC = 0.54 +/- 0.14, p = 0.006). CONCLUSION: Humeral and 
      glenoid bone defects were not correlated. Inter-observer reliability was 
      excellent for the D/R ratio and good for the D1/D2 ratio. LEVEL OF EVIDENCE: 
      Nonconsecutive Patients, Diagnostic Study, Level III.
FAU - Ciais, Gregoire
AU  - Ciais G
AUID- ORCID: 0000-0002-9591-9831
AD  - Hopitaux universitaires Paris Ile-de-France Ouest, AP-HP, 92100, 
      Boulogne-Billancourt, France. gregoire.ciais@gmail.com.
AD  - Ambroise Pare Hospital, 9, Avenue Charles De Gaulle, 92104, Boulogne-Billancourt, 
      France. gregoire.ciais@gmail.com.
FAU - Klouche, Shahnaz
AU  - Klouche S
AD  - Hopitaux universitaires Paris Ile-de-France Ouest, AP-HP, 92100, 
      Boulogne-Billancourt, France.
FAU - Fournier, Alexandre
AU  - Fournier A
AD  - Hopitaux universitaires Paris Ile-de-France Ouest, AP-HP, 92100, 
      Boulogne-Billancourt, France.
FAU - Rousseau, Benoit
AU  - Rousseau B
AD  - Hopitaux universitaires Paris Ile-de-France Ouest, AP-HP, 92100, 
      Boulogne-Billancourt, France.
FAU - Bauer, Thomas
AU  - Bauer T
AD  - Hopitaux universitaires Paris Ile-de-France Ouest, AP-HP, 92100, 
      Boulogne-Billancourt, France.
FAU - Hardy, Philippe
AU  - Hardy P
AD  - Hopitaux universitaires Paris Ile-de-France Ouest, AP-HP, 92100, 
      Boulogne-Billancourt, France.
AD  - Universite de Versailles Saint-Quentin-en-Yvelines, 78035, Versailles, France.
LA  - eng
PT  - Journal Article
DEP - 20160709
PL  - France
TA  - Eur J Orthop Surg Traumatol
JT  - European journal of orthopaedic surgery & traumatology : orthopedie traumatologie
JID - 9518037
SB  - IM
MH  - Adult
MH  - *Arthrodesis/adverse effects/methods
MH  - Female
MH  - France/epidemiology
MH  - Humans
MH  - *Humerus/diagnostic imaging/pathology
MH  - Joint Instability/diagnosis/etiology
MH  - Male
MH  - Outcome and Process Assessment, Health Care
MH  - Prevalence
MH  - Radiography/methods
MH  - Retrospective Studies
MH  - *Scapula/diagnostic imaging/pathology
MH  - *Shoulder Dislocation/diagnosis/epidemiology/etiology/physiopathology
MH  - Shoulder Injuries
MH  - *Shoulder Joint/physiopathology/surgery
MH  - Statistics as Topic
OTO - NOTNLM
OT  - Bernageau profile view
OT  - Bipolar bone defects
OT  - D/R ratio
OT  - Glenoid defects
OT  - Hill-Sachs lesions
OT  - Instability
OT  - Shoulder
OT  - X-ray
EDAT- 2016/07/11 06:00
MHDA- 2017/05/10 06:00
CRDT- 2016/07/11 06:00
PHST- 2016/04/25 00:00 [received]
PHST- 2016/06/27 00:00 [accepted]
PHST- 2016/07/11 06:00 [entrez]
PHST- 2016/07/11 06:00 [pubmed]
PHST- 2017/05/10 06:00 [medline]
AID - 10.1007/s00590-016-1815-6 [pii]
AID - 10.1007/s00590-016-1815-6 [doi]
PST - ppublish
SO  - Eur J Orthop Surg Traumatol. 2016 Aug;26(6):581-6. doi: 
      10.1007/s00590-016-1815-6. Epub 2016 Jul 9.

PMID- 23794696
OWN - NLM
STAT- MEDLINE
DCOM- 20140220
LR  - 20211021
IS  - 1465-3133 (Electronic)
IS  - 1465-3125 (Print)
IS  - 1465-3125 (Linking)
VI  - 40
IP  - 2
DP  - 2013 Jun
TI  - Does the bracket-ligature combination affect the amount of orthodontic space 
      closure over three months? A randomized controlled trial.
PG  - 155-62
LID - 10.1179/1465313313Y.0000000044 [doi]
AB  - OBJECTIVE: To investigate the effect of bracket-ligature combination on the 
      amount of orthodontic space closure over three months. DESIGN: Randomized 
      clinical trial with three parallel groups. SETTING: A hospital orthodontic 
      department (Chesterfield Royal Hospital, UK). PARTICIPANTS: Forty-five patients 
      requiring upper first premolar extractions. METHODS: Informed consent was 
      obtained and participants were randomly allocated into one of three groups: (1) 
      conventional pre-adjusted edgewise brackets and elastomeric ligatures; (2) 
      conventional pre-adjusted edgewise brackets and Super Slick((R)) low friction 
      elastomeric ligatures; (3) Damon 3MX((R)) passive self-ligating brackets. Space 
      closure was undertaken on 0.019x0.025-inch stainless steel archwires with 
      nickel-titanium coil springs. Participants were recalled at four weekly 
      intervals. Upper alginate impressions were taken at each visit (maximum three). 
      The primary outcome measure was the mean amount of space closure in a 3-month 
      period. RESULTS: A one-way ANOVA was undertaken [dependent variable: mean space 
      closure (mm); independent variable: group allocation]. The amount of space 
      closure was very similar between the three groups (1 mm per 28 days); however, 
      there was a wide variation in the rate of space closure between individuals. The 
      differences in the amount of space closure over three months between the three 
      groups was very small and non-significant (P = 0.718). CONCLUSION: The hypothesis 
      that reducing friction by modifying the bracket/ligature interface increases the 
      rate of space closure was not supported. The major determinant of orthodontic 
      tooth movement is probably the individual patient response.
FAU - Wong, Henry
AU  - Wong H
AD  - School of Clinical Dentistry, University of Sheffield, Sheffield, UK.
FAU - Collins, Jill
AU  - Collins J
FAU - Tinsley, David
AU  - Tinsley D
FAU - Sandler, Jonathan
AU  - Sandler J
FAU - Benson, Philip
AU  - Benson P
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Randomized Controlled Trial
PL  - England
TA  - J Orthod
JT  - Journal of orthodontics
JID - 100957268
RN  - 0 (Copper NiTi)
RN  - 0 (Dental Alloys)
RN  - 0 (Elastomers)
RN  - 12035-60-8 (titanium nickelide)
RN  - 12597-68-1 (Stainless Steel)
RN  - 789U1901C5 (Copper)
RN  - 7OV03QG267 (Nickel)
RN  - D1JT611TNE (Titanium)
SB  - IM
MH  - Adolescent
MH  - Bicuspid/surgery
MH  - Child
MH  - Copper/chemistry
MH  - Dental Alloys/chemistry
MH  - *Elastomers/chemistry
MH  - Female
MH  - Follow-Up Studies
MH  - Friction
MH  - Humans
MH  - Male
MH  - Maxilla
MH  - Nickel/chemistry
MH  - Orthodontic Appliance Design
MH  - *Orthodontic Appliances
MH  - *Orthodontic Brackets
MH  - Orthodontic Space Closure/instrumentation/*methods
MH  - Orthodontic Wires
MH  - Stainless Steel/chemistry
MH  - Time Factors
MH  - Titanium/chemistry
MH  - Tooth Extraction
PMC - PMC4161195
OTO - NOTNLM
OT  - Randomized controlled trial
OT  - friction
OT  - orthodontic
OT  - self-ligating
OT  - treatment mechanics
EDAT- 2013/06/26 06:00
MHDA- 2014/02/22 06:00
CRDT- 2013/06/25 06:00
PHST- 2013/06/25 06:00 [entrez]
PHST- 2013/06/26 06:00 [pubmed]
PHST- 2014/02/22 06:00 [medline]
AID - 40/2/155 [pii]
AID - 11302 [pii]
AID - 10.1179/1465313313Y.0000000044 [doi]
PST - ppublish
SO  - J Orthod. 2013 Jun;40(2):155-62. doi: 10.1179/1465313313Y.0000000044.

PMID- 23076787
OWN - NLM
STAT- MEDLINE
DCOM- 20130318
LR  - 20220311
IS  - 1468-3318 (Electronic)
IS  - 0964-4563 (Print)
IS  - 0964-4563 (Linking)
VI  - 21
IP  - 6
DP  - 2012 Nov
TI  - Can increases in the cigarette tax rate be linked to cigarette retail prices? 
      Solving mysteries related to the cigarette pricing mechanism in China.
PG  - 560-2
LID - 10.1136/tobaccocontrol-2011-050027 [doi]
AB  - OBJECTIVE: To explain China's cigarette pricing mechanism and the role of the 
      Chinese State Tobacco Monopoly Administration (STMA) on cigarette pricing and 
      taxation. METHODS: Published government tobacco tax documentation and statistics 
      published by the Chinese STMA are used to analyse the interrelations among 
      industry profits, taxes and retail price of cigarettes in China. RESULTS: The 
      2009 excise tax increase on cigarettes in China has not translated into higher 
      retail prices because the Chinese STMA used its policy authority to ensure that 
      retail cigarette prices did not change. The government tax increase is being 
      collected at both the producer and wholesale levels. As a result, the 2009 excise 
      tax increase in China has resulted in higher tax revenue for the government and 
      lower profits for the tobacco industry, with no increase in the retail price of 
      cigarettes for consumers. CONCLUSIONS: Numerous studies have found that taxation 
      is one of the most effective policy instruments for tobacco control. However, 
      these findings come from countries that have market economies where market forces 
      determine prices and influence how cigarette taxes are passed to the consumers in 
      retail prices. China's tobacco industry is not a market economy; therefore, 
      non-market forces and the current Chinese tobacco monopoly system determine 
      cigarette prices. The result is that tax increases do not necessarily get passed 
      on to the retail price.
FAU - Gao, Song
AU  - Gao S
AD  - School of Public Finance and Public Policy, Central University of Finance and 
      Economics, Beijing 100081, China. song.gao@gmail.com
FAU - Zheng, Rong
AU  - Zheng R
FAU - Hu, Teh-wei
AU  - Hu TW
LA  - eng
GR  - R01 TW005938/TW/FIC NIH HHS/United States
GR  - R01 TW009295/TW/FIC NIH HHS/United States
GR  - R01-TW05938/TW/FIC NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20111007
PL  - England
TA  - Tob Control
JT  - Tobacco control
JID - 9209612
SB  - IM
MH  - China
MH  - Commerce/economics/*legislation & jurisprudence
MH  - Government Regulation
MH  - Humans
MH  - Taxes/economics/*legislation & jurisprudence
MH  - Tobacco Industry/economics/*legislation & jurisprudence
MH  - Tobacco Products/*economics
PMC - PMC3704211
MID - NIHMS478545
EDAT- 2012/10/19 06:00
MHDA- 2013/03/19 06:00
PMCR- 2013/07/08
CRDT- 2012/10/19 06:00
PHST- 2012/10/19 06:00 [entrez]
PHST- 2012/10/19 06:00 [pubmed]
PHST- 2013/03/19 06:00 [medline]
PHST- 2013/07/08 00:00 [pmc-release]
AID - tobaccocontrol-2011-050027 [pii]
AID - 10.1136/tobaccocontrol-2011-050027 [doi]
PST - ppublish
SO  - Tob Control. 2012 Nov;21(6):560-2. doi: 10.1136/tobaccocontrol-2011-050027. Epub 
      2011 Oct 7.

PMID- 19854401
OWN - NLM
STAT- MEDLINE
DCOM- 20091110
LR  - 20220410
IS  - 1879-1190 (Electronic)
IS  - 1072-7515 (Linking)
VI  - 209
IP  - 5
DP  - 2009 Nov
TI  - Attaining negative margins in breast-conservation operations: is there a 
      consensus among breast surgeons?
PG  - 608-13
LID - 10.1016/j.jamcollsurg.2009.07.026 [doi]
AB  - BACKGROUND: The purpose of this survey was to ascertain the most common surgical 
      practices for attaining negative (tumor-free) surgical margins in patients 
      desiring breast-conservation treatment for breast cancer to see if a consensus 
      exists for optimal treatment of patients. STUDY DESIGN: We sent a survey to 1,000 
      surgeons interested in the treatment of breast cancer. Three hundred eighty-one 
      surgeons responded to this survey and 351 were used for the analysis (response 
      rate of 38%). RESULTS: Answers showed a large variety in clinical practices among 
      breast surgeons across the country. There was little intraoperative margin 
      analysis; only 48% of surgeons examine the margins grossly with a pathologist and 
      even fewer used frozen sections or imprint cytology. Decisions to reexcise 
      specific margins varied greatly. For example, 57% of surgeons would never 
      reexcise for a positive deep margin, but 53% would always reexcise for a positive 
      anterior margin. Most importantly, there was a large range in answers about 
      acceptable margins with ductal carcinoma in situ and invasive carcinoma. Fifteen 
      percent of surgeons would accept any negative margin, 28% would accept a 1-mm 
      negative margin, 50% would accept a 2-mm negative margin, 12% would accept a 5-mm 
      negative margin, and 3% would accept a 10-mm negative margin. CONCLUSIONS: 
      Results of this survey highlight the wide variety of practice patterns in the US 
      for handling surgical margins in breast-conservation treatment. This issue 
      remains controversial, with no prevailing standard of care. Consequently, 
      additional study is needed in the modern era of multimodality treatment to 
      examine the minimal amount of surgical treatment necessary, in conjunction with 
      chemotherapy and radiation, to attain adequate local control rates in 
      breast-conservation treatment.
FAU - Blair, Sarah L
AU  - Blair SL
AD  - University of California San Diego, Moores Cancer Center, 3855 Health Sciences Dr 
      #0987, La Jolla, CA 92093-0987, USA. slblair@ucsd.edu
FAU - Thompson, Kari
AU  - Thompson K
FAU - Rococco, Joseph
AU  - Rococco J
FAU - Malcarne, Vanessa
AU  - Malcarne V
FAU - Beitsch, Peter D
AU  - Beitsch PD
FAU - Ollila, David W
AU  - Ollila DW
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20090911
PL  - United States
TA  - J Am Coll Surg
JT  - Journal of the American College of Surgeons
JID - 9431305
SB  - IM
CIN - J Am Coll Surg. 2010 Jun;210(6):1012. doi: 10.1016/j.jamcollsurg.2010.01.023. 
      PMID: 20510813
CIN - J Am Coll Surg. 2010 Jun;210(6):1015-6. doi: 10.1016/j.jamcollsurg.2010.01.022. 
      PMID: 20510817
MH  - Adult
MH  - Aged
MH  - Breast Neoplasms/diagnostic imaging/*pathology/*surgery
MH  - Carcinoma, Intraductal, Noninfiltrating/pathology/surgery
MH  - Female
MH  - Frozen Sections
MH  - Health Care Surveys
MH  - Humans
MH  - Intraoperative Period
MH  - Lymphatic Metastasis
MH  - Male
MH  - Mastectomy, Segmental/*standards
MH  - Middle Aged
MH  - Practice Patterns, Physicians'/*statistics & numerical data
MH  - Radiography
MH  - Surveys and Questionnaires
MH  - United States
EDAT- 2009/10/27 06:00
MHDA- 2009/11/11 06:00
CRDT- 2009/10/27 06:00
PHST- 2009/05/22 00:00 [received]
PHST- 2009/07/24 00:00 [revised]
PHST- 2009/07/27 00:00 [accepted]
PHST- 2009/10/27 06:00 [entrez]
PHST- 2009/10/27 06:00 [pubmed]
PHST- 2009/11/11 06:00 [medline]
AID - S1072-7515(09)01206-X [pii]
AID - 10.1016/j.jamcollsurg.2009.07.026 [doi]
PST - ppublish
SO  - J Am Coll Surg. 2009 Nov;209(5):608-13. doi: 10.1016/j.jamcollsurg.2009.07.026. 
      Epub 2009 Sep 11.

PMID- 14652839
OWN - NLM
STAT- MEDLINE
DCOM- 20040122
LR  - 20041117
IS  - 1078-5884 (Print)
IS  - 1078-5884 (Linking)
VI  - 27
IP  - 1
DP  - 2004 Jan
TI  - Does the sequence of clamp application during open abdominal aortic aneurysm 
      surgery influence distal embolisation?
PG  - 61-4
AB  - BACKGROUND: Embolisation of atherosclerotic debris during abdominal aortic 
      aneurysm (AAA) repair is responsible for significant peri-operative morbidity. 
      Reports have suggested that preferential clamping of the distal vessel(s) before 
      the proximal aorta may decrease the number of emboli passing distally and hence 
      reduce complications. METHODS: Forty patients undergoing AAA repair were 
      randomised to have either first clamping of the proximal aorta or the iliac 
      vessels. Emboli passing through the Superficial Femoral Arteries were detected 
      with a Transcranial Doppler ultrasound system. RESULTS: There was no difference 
      between the two groups in the number of emboli detected (p=0.49) and no 
      significant correlation between number of emboli and dissection time (r=0.0008). 
      However, there was a significantly higher number of emboli in the patient 
      sub-group that were current smokers (p=0.034). CONCLUSIONS: There appears to be 
      no difference in the numbers of emboli detected when the first vascular clamp is 
      applied to the proximal aorta or iliacs.
FAU - Webster, S E
AU  - Webster SE
AD  - Department of Vascular Surgery, Leicester Royal Infirmary, UK.
FAU - Smith, J
AU  - Smith J
FAU - Thompson, M M
AU  - Thompson MM
FAU - Bell, P R F
AU  - Bell PR
FAU - Naylor, A R
AU  - Naylor AR
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
PT  - Randomized Controlled Trial
PL  - England
TA  - Eur J Vasc Endovasc Surg
JT  - European journal of vascular and endovascular surgery : the official journal of 
      the European Society for Vascular Surgery
JID - 9512728
SB  - IM
MH  - Aged
MH  - Aortic Aneurysm, Abdominal/*surgery
MH  - Embolism/*etiology
MH  - Female
MH  - Humans
MH  - *Ligation
MH  - Male
MH  - Middle Aged
MH  - Surgical Instruments
MH  - Vascular Surgical Procedures/adverse effects/*methods
EDAT- 2003/12/04 05:00
MHDA- 2004/01/24 05:00
CRDT- 2003/12/04 05:00
PHST- 2003/12/04 05:00 [pubmed]
PHST- 2004/01/24 05:00 [medline]
PHST- 2003/12/04 05:00 [entrez]
AID - S1078588403004696 [pii]
AID - 10.1016/j.ejvs.2003.09.010 [doi]
PST - ppublish
SO  - Eur J Vasc Endovasc Surg. 2004 Jan;27(1):61-4. doi: 10.1016/j.ejvs.2003.09.010.

PMID- 7664228
OWN - NLM
STAT- MEDLINE
DCOM- 19951012
LR  - 20181113
IS  - 0820-3946 (Print)
IS  - 1488-2329 (Electronic)
IS  - 0820-3946 (Linking)
VI  - 153
IP  - 6
DP  - 1995 Sep 15
TI  - Discharging patients earlier from Winnipeg hospitals: does it adversely affect 
      quality of care?
PG  - 745-51
AB  - OBJECTIVE: To determine whether decreasing lengths of stay over time for selected 
      diagnostic categories were associated with increased hospital readmission rates 
      and mean number of physician visits after discharge. DESIGN: Retrospective 
      descriptive study. SETTING: The seven large (125 beds or more) acute care 
      hospitals in Winnipeg. PATIENTS: Manitoba residents admitted to any one of the 
      seven hospitals because acute myocardial infarction (AMI), bronchitis or asthma, 
      transurethral prostatectomy (TURP) and uterine or adnexal procedures for 
      nonmalignant disease during the fiscal years 1989-90 to 1992-93. Patients from 
      out of province, those who died in hospital, those with excessively long stays 
      (more than 60 days) and those who were transferred to or from another institution 
      were excluded. OUTCOME MEASURES: Length of hospital stay, and rate of readmission 
      within 30 days after discharge for all four categories and mean number of 
      physician visits within 30 days after discharge for two categories (AMI and 
      bronchitis or asthma. RESULTS: The length of stay decreased significantly over 
      the 4 years for all of the four categories, the smallest change being observed 
      for patients with AMI (11.1%) and the largest for those with bronchitis or asthma 
      (22.0%). The readmission rates for AMI, bronchitis or asthma, and TURP showed no 
      consistent change over the 4 years. The readmission rate for uterine or adnexal 
      procedures increased significantly between the first and second year (chi 2 = 
      4.28, p = 0.04) but then remained constant over the next 3 years. The mean number 
      of physician visits increased slightly for AMI in the first year (1.92 to 2.01) 
      and then remained virtually the same. It decreased slightly for bronchitis or 
      asthma over the 4 years. There was no significant correlation between length of 
      stay and readmission rates for individual hospitals in 1992-93 in any of the four 
      categories. Also, no correlation was observed between length of stay and mean 
      number of physician visits for individual hospitals in 1992-93 in the categories 
      AMI and bronchitis or asthma. CONCLUSIONS: Improving hospital efficiency by 
      shortening length of stay does not appear to result in increased rates of 
      readmission or numbers of physician visits within 30 days after discharge from 
      hospital. Research is needed to identify optimal lengths of stay and expected 
      readmission rates.
FAU - Harrison, M L
AU  - Harrison ML
AD  - Department of Community Health Sciences, Faculty of Medicine, University of 
      Manitoba, Winnipeg.
FAU - Graff, L A
AU  - Graff LA
FAU - Roos, N P
AU  - Roos NP
FAU - Brownell, M D
AU  - Brownell MD
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Canada
TA  - CMAJ
JT  - CMAJ : Canadian Medical Association journal = journal de l'Association medicale 
      canadienne
JID - 9711805
SB  - IM
CIN - CMAJ. 1996 Feb 1;154(3):299-300. PMID: 8564892
MH  - Diagnosis-Related Groups
MH  - Humans
MH  - Length of Stay/*trends
MH  - Manitoba
MH  - Office Visits/statistics & numerical data/*trends
MH  - Patient Readmission/statistics & numerical data/*trends
MH  - Quality of Health Care/trends
MH  - Retrospective Studies
PMC - PMC1487263
EDAT- 1995/09/15 00:00
MHDA- 1995/09/15 00:01
PMCR- 1995/09/15
CRDT- 1995/09/15 00:00
PHST- 1995/09/15 00:00 [pubmed]
PHST- 1995/09/15 00:01 [medline]
PHST- 1995/09/15 00:00 [entrez]
PHST- 1995/09/15 00:00 [pmc-release]
PST - ppublish
SO  - CMAJ. 1995 Sep 15;153(6):745-51.

PMID- 17062234
OWN - NLM
STAT- MEDLINE
DCOM- 20061114
LR  - 20071115
IS  - 1552-6259 (Electronic)
IS  - 0003-4975 (Linking)
VI  - 82
IP  - 5
DP  - 2006 Nov
TI  - Surgical management of the atherosclerotic ascending aorta: is endoaortic balloon 
      occlusion safe?
PG  - 1709-14
AB  - BACKGROUND: Occlusion of the atherosclerotic ascending aorta by an endoaortic 
      inflatable balloon has been proposed as an alternative to conventional 
      cross-clamping to prevent injury to the vessel and distal embolization of debris. 
      The safety and the effectiveness of endoaortic occlusion have not been documented 
      in this setting. METHODS: Endoaortic occlusion was employed in 52 of 2,172 
      consecutive patients. Surgeon's choice was based on preoperative identification 
      of aortic calcifications or intraoperative epiaortic ultrasonographic scanning. 
      Deaths and strokes were analyzed casewise and in aggregate. RESULTS: In 10 
      patients (19.2%), the endoaortic balloon had to be replaced by the ordinary 
      cross-clamp because of incomplete occlusion (n = 5), hindered exposure (n = 2), 
      or balloon rupture (n = 3). In-hospital death occurred in 13 patients (25%), and 
      stroke on awakening from anesthesia in 2 (3.8%). The death rate of patients 
      treated by endoaortic occlusion was significantly higher compared with all other 
      patients (4.2%, p < 0.0001) and with the expected estimate by European System for 
      Cardiac Operative Risk Evaluation (10.5%, p = 0.05). By multivariable analysis, 
      use of endoaortic occlusion was independently associated with in-hospital death 
      (odds ratio = 5.609, 95% confidence interval: 2.684 to 11.719). Although the 
      stroke rate was higher in the endoaortic occlusion group compared with all other 
      patients, the difference was only possibly significant (3.8% versus 0.8%, p = 
      0.067). CONCLUSIONS: In this series, the endoaortic occlusion was frequently 
      ineffective, and was associated with a significantly higher risk of in-hospital 
      death and a numerically higher risk of stroke.
FAU - Zingone, Bartolo
AU  - Zingone B
AD  - Division of Cardiac Surgery, Ospedali Riuniti, Trieste, Italy. 
      bartolo.zingone@aots.sanita.fvg.it
FAU - Gatti, Giuseppe
AU  - Gatti G
FAU - Rauber, Elisabetta
AU  - Rauber E
FAU - Pappalardo, Aniello
AU  - Pappalardo A
FAU - Benussi, Bernardo
AU  - Benussi B
FAU - Dreas, Lorella
AU  - Dreas L
LA  - eng
PT  - Journal Article
PL  - Netherlands
TA  - Ann Thorac Surg
JT  - The Annals of thoracic surgery
JID - 15030100R
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Aorta/surgery
MH  - Aortic Diseases/*surgery
MH  - Atherosclerosis/*surgery
MH  - Balloon Occlusion/*adverse effects/mortality
MH  - Constriction
MH  - Coronary Artery Bypass/*methods/mortality
MH  - Female
MH  - Hospital Mortality
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Retrospective Studies
MH  - Stroke/etiology
MH  - Treatment Outcome
EDAT- 2006/10/26 09:00
MHDA- 2006/11/15 09:00
CRDT- 2006/10/26 09:00
PHST- 2006/02/20 00:00 [received]
PHST- 2006/05/22 00:00 [revised]
PHST- 2006/05/25 00:00 [accepted]
PHST- 2006/10/26 09:00 [pubmed]
PHST- 2006/11/15 09:00 [medline]
PHST- 2006/10/26 09:00 [entrez]
AID - S0003-4975(06)01124-6 [pii]
AID - 10.1016/j.athoracsur.2006.05.113 [doi]
PST - ppublish
SO  - Ann Thorac Surg. 2006 Nov;82(5):1709-14. doi: 10.1016/j.athoracsur.2006.05.113.

PMID- 24449622
OWN - NLM
STAT- MEDLINE
DCOM- 20151019
LR  - 20161125
IS  - 1308-0032 (Electronic)
IS  - 1302-8723 (Linking)
VI  - 14
IP  - 2
DP  - 2014 Mar
TI  - Is there a relationship between serum paraoxonase level and epicardial fat tissue 
      thickness?
PG  - 115-20
LID - 10.5152/akd.2014.4742 [doi]
AB  - OBJECTIVE: This study aimed to show the relationship between serum paraoxonase 1 
      level and the epicardial fat tissue thickness. METHODS: Two hundred and seven 
      patients without any atherosclerotic disease history were included in this 
      cross-sectional observational study. Correlation analysis was performed to 
      determine the correlation between epicardial fat tissue thickness, which was 
      measured by echocardiography and serum paraoxonase 1 level. Also correlation 
      analysis was performed to show correlation between patients' clinical and 
      laboratory findings and the level of serum paraoxonase 1 (PON 1) and the 
      epicardial fat tissue thickness. Pearson and Spearman test were used for 
      correlation analysis. RESULTS: No linear correlation between epicardial fat 
      tissue thickness and serum PON 1 found (correlation coefficient: -0.127, 
      p=0.069). When epicardial fat tissue thickness were grouped as 7 mm and over, and 
      below, and 5 mm and over, and below, serum PON 1 level were significantly lower 
      in >/=7 mm group (PON1 : 168.9 U/L) than <7 mm group (PON 1: 253.9 U/L) (p<0.001). 
      Also hypertension prevalence was increased in >/=7 mm group (p=0.001). Serum 
      triglyceride was found to be higher in >/=7 mm group (p=0.014), body mass index was 
      found higher in >/=5 mm group (p=0.006). CONCLUSION: Serum PON 1 level is not 
      correlated with the epicardial fat tissue thickness. But PON 1 level is lower in 
      patients with epicardial fat tissue thickness 7 mm and over. Therefore, increased 
      atherosclerosis progression can be found among patients with 7 mm and higher 
      epicardial fat tissue thickness.
FAU - Ertem, Ahmet Goktug
AU  - Ertem AG
AD  - Clinic of Cardiology, Ankara Penal Instution Campus State Hospital; 
      Ankara-Turkey. agertem@hotmail.com.
FAU - Erayman, Ali
AU  - Erayman A
FAU - Efe, Tolga Han
AU  - Efe TH
FAU - Duran Karaduman, Bilge
AU  - Duran Karaduman B
FAU - Aydin, Halil Ibrahim
AU  - Aydin HI
FAU - Bilge, Mehmet
AU  - Bilge M
LA  - eng
PT  - Journal Article
PT  - Observational Study
DEP - 20140114
PL  - Turkey
TA  - Anadolu Kardiyol Derg
JT  - Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology
JID - 101095069
RN  - EC 3.1.8.1 (Aryldialkylphosphatase)
SB  - IM
MH  - Adipose Tissue/*diagnostic imaging
MH  - Aryldialkylphosphatase/*blood
MH  - Coronary Artery Disease/blood/*diagnostic imaging
MH  - Cross-Sectional Studies
MH  - Echocardiography
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Pericardium/*diagnostic imaging
EDAT- 2014/01/23 06:00
MHDA- 2015/10/20 06:00
CRDT- 2014/01/23 06:00
PHST- 2014/01/23 06:00 [entrez]
PHST- 2014/01/23 06:00 [pubmed]
PHST- 2015/10/20 06:00 [medline]
AID - 10.5152/akd.2014.4742 [doi]
PST - ppublish
SO  - Anadolu Kardiyol Derg. 2014 Mar;14(2):115-20. doi: 10.5152/akd.2014.4742. Epub 
      2014 Jan 14.

PMID- 12070552
OWN - NLM
STAT- MEDLINE
DCOM- 20020830
LR  - 20080623
IS  - 0379-5284 (Print)
IS  - 0379-5284 (Linking)
VI  - 23
IP  - 6
DP  - 2002 Jun
TI  - Do antibiotics decrease post-tonsillectomy morbidity?
PG  - 705-7
AB  - OBJECTIVE: A tonsillectomy audit was carried out and compared with other studies, 
      to emphasize the role of antibiotics. METHODS: This study was carried out at 
      North West Armed Forces Hospital, Tabuk, Kingdom of Saudi Arabia, during the year 
      January 1999 through to December 1999. This is a retrospective study of patients 
      who had tonsillectomy with or with adenoidectomy, the topics audited included 
      indication for surgery, grade of surgeon, method of surgery, length of hospital 
      stay, complications and the use of postoperative antibiotics. RESULTS: A total of 
      185 patients underwent tonsillectomy with or without adenoidectomy. The patients 
      age ranged between 2 years to 53 years and the majority were children. In our 
      audit we found no difference with regard to grade of surgeons, method of 
      hemostasis in the outcome of surgery. Moreover, postoperative antibiotics had no 
      role in pain control, postoperative fever, secondary hemorrhage or reduction in 
      hospital stay. The administration of analgesics on the basis of, as required, had 
      poor pain control. CONCLUSION: Post tonsillectomy antibiotics did not prove to 
      have a role in minimizing postoperative morbidity. Moreover, analgesics given on 
      the basis of as required had a limited value.
FAU - Al-Kindy, Sami A
AU  - Al-Kindy SA
AD  - Department of Ear, Nose and Throat, North West Armed Forces Hospital, Tabuk, 
      Kingdom of Saudi Arabia. sami_kindy@yahoo.com
LA  - eng
PT  - Journal Article
PL  - Saudi Arabia
TA  - Saudi Med J
JT  - Saudi medical journal
JID - 7909441
RN  - 0 (Anti-Bacterial Agents)
RN  - 0 (Anti-Inflammatory Agents, Non-Steroidal)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Anti-Bacterial Agents/*therapeutic use
MH  - Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
MH  - Child
MH  - Child, Preschool
MH  - Female
MH  - Humans
MH  - Male
MH  - Medical Audit
MH  - Middle Aged
MH  - *Postoperative Care
MH  - Postoperative Complications/*prevention & control
MH  - Retrospective Studies
MH  - *Tonsillectomy
EDAT- 2002/06/19 10:00
MHDA- 2002/08/31 10:01
CRDT- 2002/06/19 10:00
PHST- 2002/06/19 10:00 [pubmed]
PHST- 2002/08/31 10:01 [medline]
PHST- 2002/06/19 10:00 [entrez]
PST - ppublish
SO  - Saudi Med J. 2002 Jun;23(6):705-7.

PMID- 19836806
OWN - NLM
STAT- MEDLINE
DCOM- 20091130
LR  - 20211028
IS  - 1527-3792 (Electronic)
IS  - 0022-5347 (Print)
IS  - 0022-5347 (Linking)
VI  - 182
IP  - 6
DP  - 2009 Dec
TI  - Should prostate specific antigen be adjusted for body mass index? Data from the 
      Baltimore Longitudinal Study of Aging.
PG  - 2646-51
LID - 10.1016/j.juro.2009.08.041 [doi]
AB  - PURPOSE: Obesity may be associated with lower prostate specific antigen through 
      hemodilution. We examined the relationship between body mass index and prostate 
      specific antigen by age in men without prostate cancer in a longitudinal aging 
      study to determine whether prostate specific antigen must be adjusted for body 
      mass index. MATERIALS AND METHODS: The study population included 994 men (4,937 
      observations) without prostate cancer in the Baltimore Longitudinal Study of 
      Aging. Mixed effects models were used to examine the relationship between 
      prostate specific antigen and body mass index in kg/m(2) by age. Separate models 
      were explored in men with prostate cancer censored at diagnosis, for percent body 
      fat measurements, for weight changes with time and adjusting for initial prostate 
      size in 483 men (2,523 observations) with pelvic magnetic resonance imaging 
      measurements. RESULTS: In men without prostate cancer body mass index was not 
      significantly associated with prostate specific antigen after adjusting for age 
      (p = 0.06). A 10-point body mass index increase was associated with a prostate 
      specific antigen difference of -0.03 ng/ml (95% CI -0.40-0.49). Results were 
      similar when men with prostate cancer were included, when percent body fat was 
      substituted for body mass index, and after adjusting for prostate volume. 
      Longitudinal weight changes also had no significant association with prostate 
      specific antigen. CONCLUSIONS: Consistent with prior studies, we found an inverse 
      relationship between obesity and serum prostate specific antigen. However, the 
      magnitude of the difference was small. Thus, adjusting prostate specific antigen 
      for body mass index does not appear warranted.
FAU - Loeb, Stacy
AU  - Loeb S
AD  - The James Buchanan Brady Urological Institute, The Johns Hopkins Medical 
      Institutions, Baltimore, Maryland, USA. stacyloeb@gmail.com
FAU - Carter, H Ballentine
AU  - Carter HB
FAU - Schaeffer, Edward M
AU  - Schaeffer EM
FAU - Ferrucci, Luigi
AU  - Ferrucci L
FAU - Kettermann, Anna
AU  - Kettermann A
FAU - Metter, E Jeffrey
AU  - Metter EJ
LA  - eng
GR  - ZIA AG000633-21/ImNIH/Intramural NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Intramural
PL  - United States
TA  - J Urol
JT  - The Journal of urology
JID - 0376374
RN  - EC 3.4.21.77 (Prostate-Specific Antigen)
SB  - IM
CIN - J Urol. 2009 Dec;182(6):2651-2. doi: 10.1016/j.juro.2009.08.189. PMID: 19836785
CIN - J Urol. 2009 Dec;182(6):2651. doi: 10.1016/j.juro.2009.08.188. PMID: 19836803
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - *Body Mass Index
MH  - Humans
MH  - Longitudinal Studies
MH  - Male
MH  - Middle Aged
MH  - Prostate-Specific Antigen/*blood
MH  - Young Adult
PMC - PMC4197054
MID - NIHMS286018
EDAT- 2009/10/20 06:00
MHDA- 2009/12/16 06:00
PMCR- 2014/10/14
CRDT- 2009/10/20 06:00
PHST- 2009/04/04 00:00 [received]
PHST- 2009/10/20 06:00 [entrez]
PHST- 2009/10/20 06:00 [pubmed]
PHST- 2009/12/16 06:00 [medline]
PHST- 2014/10/14 00:00 [pmc-release]
AID - S0022-5347(09)02063-1 [pii]
AID - 10.1016/j.juro.2009.08.041 [doi]
PST - ppublish
SO  - J Urol. 2009 Dec;182(6):2646-51. doi: 10.1016/j.juro.2009.08.041.

PMID- 19913785
OWN - NLM
STAT- MEDLINE
DCOM- 20100427
LR  - 20220330
IS  - 1097-6779 (Electronic)
IS  - 0016-5107 (Linking)
VI  - 71
IP  - 1
DP  - 2010 Jan
TI  - Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic 
      clearance of the common bile duct in patients with choledocholithiasis-induced 
      cholangitis? A prospective, randomized trial.
PG  - 105-10
LID - 10.1016/j.gie.2009.08.009 [doi]
AB  - BACKGROUND: Little is known about whether a routinely inserted endoscopic 
      nasobiliary drainage (ENBD) tube improves the clinical course in patients with 
      choledocholithiasis-induced acute cholangitis after clearance of 
      choledocholithiasis. OBJECTIVE: The aim of this study was to investigate the need 
      for ENBD on the clinical outcomes of patients with acute cholangitis undergoing 
      endoscopic clearance of common bile duct (CBD) stones. DESIGN: Prospective, 
      randomized study. SETTING: Tertiary referral center. PATIENTS: A total of 104 
      patients with choledocholithiasis-induced acute cholangitis who underwent primary 
      endoscopic treatment were compared according to insertion of an ENBD tube (51 in 
      the ENBD group and 53 in the no-ENBD group). INTERVENTION: Insertion of an ENBD 
      tube after clearance of CBD stones. MAIN OUTCOME MEASUREMENTS: Recurrence of 
      cholangitis and length of hospital stay after clearance of CBD stones. RESULTS: 
      Baseline clinical characteristics were similar between both groups. There were no 
      significant differences in the recurrence rate of cholangitis at 24 weeks (3.9% 
      for the ENBD group vs 3.8% for the no-ENBD group at 24 weeks; P = .99) and length 
      of hospital stay (7.9 days [standard error = 1.2] for the ENBD group vs 7.9 days 
      [standard error = 0.7] for the no-ENBD group; P = .98). However, procedure time 
      was longer (26.2 [SE = 1.8] minutes vs 22.7 [SE = 1.0] minutes, respectively; P = 
      .01) and the discomfort score was higher (4.9 [SE = 0.4] vs 2.8 [SE = 0.3], 
      respectively; P = .02) in the ENBD group than in the no-ENBD group. LIMITATIONS: 
      Single-center study. CONCLUSIONS: A routinely inserted ENBD tube did not improve 
      the clinical course, despite patients having to endure increased procedure time 
      and discomfort, and the insertion would therefore be unnecessary.
CI  - 2010 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. 
      All rights reserved.
FAU - Lee, Jun Kyu
AU  - Lee JK
AD  - Department of Internal Medicine, Dongguk University International Hospital, 
      Dongguk University College of Medicine, Goyang, Gyeonggi-do, Korea. 
      gidoctor@snubh.org
FAU - Lee, Sang Hyub
AU  - Lee SH
FAU - Kang, Bong Kyun
AU  - Kang BK
FAU - Kim, Jae Hak
AU  - Kim JH
FAU - Koh, Moon-Soo
AU  - Koh MS
FAU - Yang, Chang-Hun
AU  - Yang CH
FAU - Lee, Jin Ho
AU  - Lee JH
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20091114
PL  - United States
TA  - Gastrointest Endosc
JT  - Gastrointestinal endoscopy
JID - 0010505
SB  - IM
MH  - Acute Disease
MH  - Cholangiopancreatography, Endoscopic Retrograde
MH  - Cholangitis/*therapy
MH  - Choledocholithiasis/complications/*therapy
MH  - Drainage/*methods
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Prospective Studies
EDAT- 2009/11/17 06:00
MHDA- 2010/04/28 06:00
CRDT- 2009/11/17 06:00
PHST- 2009/04/07 00:00 [received]
PHST- 2009/08/07 00:00 [accepted]
PHST- 2009/11/17 06:00 [entrez]
PHST- 2009/11/17 06:00 [pubmed]
PHST- 2010/04/28 06:00 [medline]
AID - S0016-5107(09)02335-9 [pii]
AID - 10.1016/j.gie.2009.08.009 [doi]
PST - ppublish
SO  - Gastrointest Endosc. 2010 Jan;71(1):105-10. doi: 10.1016/j.gie.2009.08.009. Epub 
      2009 Nov 14.

PMID- 24739448
OWN - NLM
STAT- MEDLINE
DCOM- 20141216
LR  - 20220321
IS  - 1525-5069 (Electronic)
IS  - 1525-5050 (Linking)
VI  - 34
DP  - 2014 May
TI  - Have antiepileptic drug prescription claims changed following the FDA suicidality 
      warning? An evaluation in a state Medicaid program.
PG  - 109-15
LID - S1525-5050(14)00098-5 [pii]
LID - 10.1016/j.yebeh.2014.03.017 [doi]
AB  - OBJECTIVE: In January 2008, the Food and Drug Administration (FDA) communicated 
      concerns and, in May 2009, issued a warning about an increased risk of 
      suicidality for all antiepileptic drugs (AEDs). This research evaluated the 
      association between the FDA suicidality communications and the AED prescription 
      claims among members with epilepsy and/or psychiatric disorder. METHODS: A 
      longitudinal interrupted time-series design was utilized to evaluate Oklahoma 
      Medicaid claims data from January 2006 through December 2009. The study included 
      9289 continuously eligible members with prevalent diagnoses of epilepsy and/or 
      psychiatric disorder and at least one AED prescription claim. Trends, expressed 
      as monthly changes in the log odds of AED prescription claims, were compared 
      across three time periods: before (January 2006 to January 2008), during 
      (February 2008 to May 2009), and after (June 2009 to December 2009) the FDA 
      warning. RESULTS: Before the FDA warning period, a significant upward trend of 
      AED prescription claims of 0.01% per month (99% CI: 0.008% to 0.013%, p<0.0001) 
      was estimated. In comparison to the prewarning period, no significant change in 
      trend was detected during (-20.0%, 99% CI: -70.0% to 30.0%, p=0.34) or after 
      (80.0%, 99% CI: -20.0% to 200.0%, p=0.03) the FDA warning period. After 
      stratification, no diagnostic group (i.e., epilepsy alone, epilepsy and comorbid 
      psychiatric disorder, and psychiatric disorder alone) experienced a significant 
      change in trend during the entire study period (p>0.01). CONCLUSIONS: During the 
      time period considered, the FDA AED-related suicidality warning does not appear 
      to have significantly affected prescription claims of AED medications for the 
      study population.
CI  - Copyright (c) 2014 Elsevier Inc. All rights reserved.
FAU - Mittal, Manish
AU  - Mittal M
AD  - Health Economics and Outcomes Research, AbbVie, North Chicago, IL, USA. 
      Electronic address: manish.mittal@abbvie.com.
FAU - Harrison, Donald L
AU  - Harrison DL
AD  - Department of Pharmacy, Clinical and Administrative Sciences, The University of 
      Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: 
      donald-harrison@ouhsc.edu.
FAU - Miller, Michael J
AU  - Miller MJ
AD  - Department of Pharmacy, Clinical and Administrative Sciences, The University of 
      Oklahoma Health Sciences Center, Tulsa, OK, USA. Electronic address: 
      michael-miller@ouhsc.edu.
FAU - Farmer, Kevin C
AU  - Farmer KC
AD  - Department of Pharmacy, Clinical and Administrative Sciences, The University of 
      Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: 
      kevin-farmer@ouhsc.edu.
FAU - Thompson, David M
AU  - Thompson DM
AD  - Department of Biostatistics and Epidemiology, The University of Oklahoma Health 
      Sciences Center, Oklahoma City, OK, USA. Electronic address: 
      dave-thompson@ouhsc.edu.
FAU - Ng, Yu-Tze
AU  - Ng YT
AD  - Department of Neurology, The University of Oklahoma Health Sciences Center, 
      Oklahoma City, OK, USA. Electronic address: Y-Ng@ouhsc.edu.
LA  - eng
PT  - Journal Article
DEP - 20140414
PL  - United States
TA  - Epilepsy Behav
JT  - Epilepsy & behavior : E&B
JID - 100892858
RN  - 0 (Anticonvulsants)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Anticonvulsants/*adverse effects/therapeutic use
MH  - Child
MH  - Child, Preschool
MH  - *Drug Prescriptions
MH  - Epilepsy/*drug therapy/psychology
MH  - Humans
MH  - Infant
MH  - Interrupted Time Series Analysis
MH  - Medicaid
MH  - Middle Aged
MH  - Suicide/*psychology
MH  - United States
MH  - United States Food and Drug Administration
MH  - Young Adult
OTO - NOTNLM
OT  - Antiepileptic drugs
OT  - Epilepsy
OT  - FDA alert
OT  - Psychiatric disorder
OT  - Suicidality
EDAT- 2014/04/18 06:00
MHDA- 2014/12/17 06:00
CRDT- 2014/04/18 06:00
PHST- 2014/03/09 00:00 [received]
PHST- 2014/03/18 00:00 [revised]
PHST- 2014/03/21 00:00 [accepted]
PHST- 2014/04/18 06:00 [entrez]
PHST- 2014/04/18 06:00 [pubmed]
PHST- 2014/12/17 06:00 [medline]
AID - S1525-5050(14)00098-5 [pii]
AID - 10.1016/j.yebeh.2014.03.017 [doi]
PST - ppublish
SO  - Epilepsy Behav. 2014 May;34:109-15. doi: 10.1016/j.yebeh.2014.03.017. Epub 2014 
      Apr 14.

PMID- 24625433
OWN - NLM
STAT- MEDLINE
DCOM- 20140915
LR  - 20140903
IS  - 1468-2052 (Electronic)
IS  - 1359-2998 (Linking)
VI  - 99
IP  - 4
DP  - 2014 Jul
TI  - Are high flow nasal cannulae noisier than bubble CPAP for preterm infants?
PG  - F291-5
AB  - BACKGROUND: Noise exposure in the neonatal intensive care unit is believed to be 
      a risk factor for hearing loss in preterm neonates. Continuous positive airway 
      pressure (CPAP) devices exceed recommended noise levels. High flow nasal cannulae 
      (HFNC) are an increasingly popular alternative to CPAP for treating preterm 
      infants, but there are no in vivo studies assessing noise production by HFNC. 
      OBJECTIVE: To study whether HFNC are noisier than bubble CPAP (BCPAP) for preterm 
      infants. METHODS: An observational study of preterm infants receiving HFNC or 
      BCPAP. Noise levels within the external auditory meatus (EAM) were measured using 
      a microphone probe tube connected to a calibrated digital dosimeter. Noise was 
      measured across a range of frequencies and reported as decibels A-weighted (dBA). 
      RESULTS: A total of 21 HFNC and 13 BCPAP noise measurements were performed in 21 
      infants. HFNC gas flows were 2-5 L/min, and BCPAP gas flows were 6-10 L/min with 
      set pressures of 5-7 cm of water. There was no evidence of a difference in 
      average noise levels measured at the EAM: mean difference (95% CI) of -1.6 (-4.0 
      to 0.9) dBA for HFNC compared to BCPAP. At low frequency (500 Hz), HFNC was mean 
      (95% CI) 3.0 (0.3 to 5.7) dBA quieter than BCPAP. Noise increased with increasing 
      BCPAP gas flow (p=0.007), but not with increasing set pressure. There was a trend 
      to noise increasing with increasing HFNC gas flows. CONCLUSIONS: At the gas flows 
      studied, HFNC are not noisier than BCPAP for preterm infants.
FAU - Roberts, C T
AU  - Roberts CT
FAU - Dawson, J A
AU  - Dawson JA
FAU - Alquoka, E
AU  - Alquoka E
FAU - Carew, P J
AU  - Carew PJ
FAU - Donath, S M
AU  - Donath SM
FAU - Davis, P G
AU  - Davis PG
FAU - Manley, B J
AU  - Manley BJ
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Observational Study
DEP - 20140313
PL  - England
TA  - Arch Dis Child Fetal Neonatal Ed
JT  - Archives of disease in childhood. Fetal and neonatal edition
JID - 9501297
SB  - IM
MH  - Catheters
MH  - Continuous Positive Airway Pressure/adverse effects/instrumentation/methods
MH  - Environmental Monitoring/methods
MH  - Humans
MH  - Infant, Newborn
MH  - Infant, Premature
MH  - Infant, Premature, Diseases/*therapy
MH  - Intensive Care Units, Neonatal
MH  - Nasal Cavity
MH  - Noise/*adverse effects
MH  - Noninvasive Ventilation/adverse effects/*instrumentation/methods
MH  - Terminology as Topic
EDAT- 2014/03/15 06:00
MHDA- 2014/09/16 06:00
CRDT- 2014/03/15 06:00
PHST- 2014/03/15 06:00 [entrez]
PHST- 2014/03/15 06:00 [pubmed]
PHST- 2014/09/16 06:00 [medline]
AID - archdischild-2013-305033 [pii]
AID - 10.1136/archdischild-2013-305033 [doi]
PST - ppublish
SO  - Arch Dis Child Fetal Neonatal Ed. 2014 Jul;99(4):F291-5. doi: 
      10.1136/archdischild-2013-305033. Epub 2014 Mar 13.

PMID- 16403186
OWN - NLM
STAT- MEDLINE
DCOM- 20060302
LR  - 20071114
IS  - 1398-5647 (Print)
IS  - 1398-5647 (Linking)
VI  - 7
IP  - 6
DP  - 2005 Dec
TI  - Are the arginine vasopressin V1a receptor microsatellites related to 
      hypersexuality in children with a prepubertal and early adolescent bipolar 
      disorder phenotype?
PG  - 610-6
AB  - OBJECTIVE: To examine family-based transmission of the number of 5' flanking 
      arginine vasopressin V1a receptor (AVPR1A) microsatellites, which include 
      [(GATA)(14)] and complex [(CT)(4)-TT-(CT)(8)-(GT)(24)] repeats, in probands with 
      a prepubertal and early adolescent bipolar disorder phenotype (PEA-BP). 
      Preferential transmission of the number of AVPR1A microsatellite repeats to 
      hypersexual and uninhibited people-seeking probands was hypothesized, based on 
      reports from preclinical work in the literature. METHODS: Probands were 83 
      participants in an ongoing controlled study of PEA-BP. The PEA-BP phenotype was 
      defined by DSM-IV mania with at least one of the cardinal symptoms of mania 
      (elation and/or grandiosity) to avoid diagnosing mania only by symptoms that 
      overlapped with those for attention-deficit hyperactivity disorder (ADHD). 
      Comprehensive assessment of the probands included separate Washington University 
      in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia 
      (WASH-U-KSADS) interviews of parents about their children and of children about 
      themselves. Hypersexuality and uninhibited people-seeking were assessed from the 
      corresponding WASH-U-KSADS items. Microsatellite genotyping of the AVPR1A repeats 
      was conducted using fluorescently labeled primers and detected by laser-induced 
      fluorescence. Alleles were determined with the assistance of semi-automated 
      allele-calling software. There were 32 complete, biological trios (28 informative 
      families) for the GATA repeat and 34 complete, biological trios (30 informative 
      families) for the complex repeat. Data were analyzed using case-control and 
      family-based association methods. RESULTS: Preferential transmission of AVPR1A 
      GATA or complex repeats was not significant for hypersexuality or uninhibited 
      people-seeking, using the transmission disequilibrium test. Similarly, 
      case-control analyses found no significant associations between hypersexuality or 
      uninhibited people-seeking and the number of AVPR1A GATA or complex repeats. For 
      p < 0.05, there was about 80% power to detect odds ratios of 5.0 and 4.0 (in the 
      family-based analyses) and 3.5 and 2.6 (in the case-control analyses), for allele 
      frequencies of 0.1 and 0.5, respectively. CONCLUSION: Preferential transmission 
      of AVPR1A to hypersexual or uninhibited people-seeking probands was not 
      supported.
FAU - Geller, Barbara
AU  - Geller B
AD  - Washington University School of Medicine, St. Louis, MO 63110, USA. 
      gellerb@medicine.wustl.edu
FAU - Tillman, Rebecca
AU  - Tillman R
FAU - Badner, Judith A
AU  - Badner JA
FAU - Cook, Edwin H Jr
AU  - Cook EH Jr
LA  - eng
GR  - K02 MH-01389/MH/NIMH NIH HHS/United States
GR  - R01 MH-53063/MH/NIMH NIH HHS/United States
GR  - R01 MH-57451/MH/NIMH NIH HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - Denmark
TA  - Bipolar Disord
JT  - Bipolar disorders
JID - 100883596
RN  - 0 (Receptors, Vasopressin)
RN  - 0 (vasotocin receptor)
SB  - IM
MH  - Adolescent
MH  - Alleles
MH  - Bipolar Disorder/complications/*genetics
MH  - Case-Control Studies
MH  - Child
MH  - Female
MH  - Humans
MH  - Linkage Disequilibrium
MH  - Male
MH  - Microsatellite Repeats/*genetics
MH  - *Phenotype
MH  - Psychiatric Status Rating Scales
MH  - Receptors, Vasopressin/*genetics
MH  - Sexual Dysfunctions, Psychological/etiology/*genetics
EDAT- 2006/01/13 09:00
MHDA- 2006/03/03 09:00
CRDT- 2006/01/13 09:00
PHST- 2006/01/13 09:00 [pubmed]
PHST- 2006/03/03 09:00 [medline]
PHST- 2006/01/13 09:00 [entrez]
AID - BDI259 [pii]
AID - 10.1111/j.1399-5618.2005.00259.x [doi]
PST - ppublish
SO  - Bipolar Disord. 2005 Dec;7(6):610-6. doi: 10.1111/j.1399-5618.2005.00259.x.

PMID- 10375486
OWN - NLM
STAT- MEDLINE
DCOM- 19990709
LR  - 20061115
IS  - 1078-5884 (Print)
IS  - 1078-5884 (Linking)
VI  - 17
IP  - 6
DP  - 1999 Jun
TI  - Are variations in the use of carotid endarterectomy explained by population Need? 
      A study of health service utilisation in two English health regions.
PG  - 501-6
AB  - OBJECTIVES: to describe variation in utilisation of carotid endarterectomy (CEA) 
      within two English health regions and explore relationships between use, need and 
      proximity to services. DESIGN: consecutive case series of operations. Comparison 
      at a population level with district stroke mortality, hospital admissions and 
      material deprivation. MAIN OUTCOME MEASURES: standardised utilisation rates for 
      CEA and measures of inter-district variability. Spearman's rank correlation 
      coefficients for associations between variables. RESULTS: variation in 
      utilisation rates was considerable (14-fold difference across district 
      populations). More individuals had bilateral surgery in the Yorkshire region than 
      in the Northern (11.7% vs. 5.5%, p=0.002). There was no association between 
      utilisation rates for CEA and district stroke mortality (r=-0.06, 95% CI -0.41 to 
      0.30) or admission rates for stroke (r=0.17, 95% CI -0.2 to 0.49). There was a 
      strong relationship between residence in districts where services were located 
      and higher utilisation. Rates of CEA were lowest in the regions' most affluent 
      wards. CONCLUSION: use of CEA varies widely, depending on area of residence. 
      Variation is not a consequence of differences in need, but reflects clinical 
      practice and supply of services. There is evidence to suggest unmet need for CEA.
CI  - Copyright 1999 W.B. Saunders Company Ltd.
FAU - Oliver, S E
AU  - Oliver SE
AD  - Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies 
      Road, Bristol, BS8 2PR, U.K.
FAU - Thomson, R G
AU  - Thomson RG
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - England
TA  - Eur J Vasc Endovasc Surg
JT  - European journal of vascular and endovascular surgery : the official journal of 
      the European Society for Vascular Surgery
JID - 9512728
SB  - IM
MH  - Aged
MH  - Cerebrovascular Disorders/*mortality/prevention & control
MH  - Endarterectomy, Carotid/*statistics & numerical data
MH  - England/epidemiology
MH  - Female
MH  - *Health Services Accessibility
MH  - *Health Services Needs and Demand
MH  - Hospitalization/statistics & numerical data
MH  - Humans
MH  - Male
MH  - Middle Aged
EDAT- 1999/06/22 00:00
MHDA- 1999/06/22 00:01
CRDT- 1999/06/22 00:00
PHST- 1999/06/22 00:00 [pubmed]
PHST- 1999/06/22 00:01 [medline]
PHST- 1999/06/22 00:00 [entrez]
AID - S1078-5884(99)90792-X [pii]
AID - 10.1053/ejvs.1999.0792 [doi]
PST - ppublish
SO  - Eur J Vasc Endovasc Surg. 1999 Jun;17(6):501-6. doi: 10.1053/ejvs.1999.0792.

PMID- 17032327
OWN - NLM
STAT- MEDLINE
DCOM- 20070116
LR  - 20191210
IS  - 1462-8910 (Print)
IS  - 1462-8910 (Linking)
VI  - 8
IP  - 9
DP  - 2006 Nov
TI  - Do supervised colorectal trainees differ from consultants in terms of quality of 
      TME surgery?
PG  - 790-4
AB  - OBJECTIVE: The quality of surgical excision is held to be a major determinant of 
      outcome following surgery for rectal cancer. Macroscopic examination of the 
      excised mesorectum allows for reproducible assessment of the quality of surgery. 
      We aimed to determine whether quality of excision undertaken by colorectal 
      trainees under supervision was comparable with that performed by consultants, as 
      measured using mesorectal grades. METHOD: A total of 130 consecutive patients 
      undergoing potentially curative resection for primary adenocarcinoma of the 
      rectum in our centre from 2001 to 2003 were included in the study. The 
      pathologists graded the excised mesorectum according to staged classification 
      proposed by Quirke. The outcome (quality of mesorectal excision and secondary 
      outcomes including local recurrence and overall recurrence) of operations 
      performed by consultants was compared with that of trainees. Statistical 
      significance was tested using Pearson chi(2) test. RESULTS: Eighty-nine 
      operations were performed by consultants and 41 by senior colorectal trainees 
      with consultant supervision. Forty-four patients (49%) had good mesorectum when 
      operated by consultants in comparison with 17 (41.5%) by the trainees. There was 
      no statistically significant difference (P = 0.717) between the two groups in 
      terms of quality of mesorectum excised after potentially curative resection. 
      Furthermore, there were seven local recurrences in patients operated by 
      consultants (7.8%) when compared with four in the trainee group (9.5%) and once 
      again there was no statistical significance between the two groups (P = 0.719). 
      CONCLUSION: We conclude that the quality of rectal cancer excision, as defined by 
      mesorectal grades, achieved by supervised colorectal trainees is comparable with 
      that achieved by consultants.
FAU - Maslekar, S
AU  - Maslekar S
AD  - Academic Surgical Unit, University of Hull, Castle Hill Hospital, Cottingham, 
      East Yorkshire, UK.
FAU - Sharma, A
AU  - Sharma A
FAU - Macdonald, A
AU  - Macdonald A
FAU - Gunn, J
AU  - Gunn J
FAU - Monson, J R T
AU  - Monson JR
FAU - Hartley, J E
AU  - Hartley JE
LA  - eng
PT  - Comparative Study
PT  - Evaluation Study
PT  - Journal Article
PL  - England
TA  - Colorectal Dis
JT  - Colorectal disease : the official journal of the Association of Coloproctology of 
      Great Britain and Ireland
JID - 100883611
SB  - IM
MH  - Aged
MH  - *Clinical Competence
MH  - Digestive System Surgical Procedures/methods/*standards
MH  - Female
MH  - Humans
MH  - *Internship and Residency
MH  - Male
MH  - Neoplasm Recurrence, Local
MH  - *Quality of Health Care
MH  - Rectal Neoplasms/*surgery
MH  - Rectum/anatomy & histology
MH  - Retrospective Studies
MH  - Treatment Outcome
MH  - United Kingdom
EDAT- 2006/10/13 09:00
MHDA- 2007/01/17 09:00
CRDT- 2006/10/13 09:00
PHST- 2006/10/13 09:00 [pubmed]
PHST- 2007/01/17 09:00 [medline]
PHST- 2006/10/13 09:00 [entrez]
AID - CDI1127 [pii]
AID - 10.1111/j.1463-1318.2006.01127.x [doi]
PST - ppublish
SO  - Colorectal Dis. 2006 Nov;8(9):790-4. doi: 10.1111/j.1463-1318.2006.01127.x.

PMID- 27643961
OWN - NLM
STAT- MEDLINE
DCOM- 20171030
LR  - 20190318
IS  - 1573-2517 (Electronic)
IS  - 0165-0327 (Linking)
VI  - 206
DP  - 2016 Dec
TI  - Major depression and alcohol use disorder in adolescence: Does comorbidity lead 
      to poorer outcomes of depression?
PG  - 287-293
LID - S0165-0327(16)30998-3 [pii]
LID - 10.1016/j.jad.2016.09.004 [doi]
AB  - BACKGROUND: Comorbid major depression (MD) and alcohol use disorder (AUD), 
      particularly in adolescents, have been shown to be associated with poorer 
      subsequent MD outcomes. METHODS: Longitudinal data were used to model 
      associations between a four-level classification of MD/AUD during the period 
      15-18 years (neither; MD-only; AUD-only; comorbid MD/AUD) and MD over the period 
      18-35 years. These associations were then adjusted for confounding by a series of 
      factors measured in childhood. RESULTS: The three disorder groups had rates of 
      adult MD during the period 18-35 years that were significantly (p<.05) higher 
      than that of the group with no disorder. Furthermore, those in the comorbid 
      MD/AUD group had significantly (p <.05) higher rates of adult MD than those in 
      the AUD-only group, and marginally (p <.10) higher rates of adult MD than those 
      in the MD-only group. After adjustment for confounding, the difference in rates 
      of adult MD between the MD-only group and the MD/AUD group were no longer 
      statistically significant. The factors that explained the associations were 
      gender, childhood behavior problems, and exposure to physical and sexual abuse. 
      LIMITATIONS: The data were obtained by self-report, and may have been subject to 
      biases. CONCLUSIONS: The results of these analyses suggest that marginally higher 
      rates of depression to age 35 amongst the comorbid MD/AUD group were explained by 
      increased exposure to adverse childhood circumstances amongst members of the 
      comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, 
      rather than a causal factor in subsequent MD.
CI  - Copyright (c) 2016 Elsevier B.V. All rights reserved.
FAU - Boden, Joseph M
AU  - Boden JM
AD  - Christchurch Health and Development Study, Department of Psychological Medicine, 
      University of Otago, Christchurch School of Medicine and Health Sciences, New 
      Zealand. Electronic address: joseph.boden@otago.ac.nz.
FAU - Foulds, James A
AU  - Foulds JA
AD  - Christchurch Health and Development Study, Department of Psychological Medicine, 
      University of Otago, Christchurch School of Medicine and Health Sciences, New 
      Zealand.
LA  - eng
PT  - Journal Article
DEP - 20160913
PL  - Netherlands
TA  - J Affect Disord
JT  - Journal of affective disorders
JID - 7906073
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Alcohol-Related Disorders/*epidemiology
MH  - Comorbidity
MH  - Depressive Disorder, Major/*epidemiology
MH  - Female
MH  - Humans
MH  - Longitudinal Studies
MH  - Male
MH  - Prevalence
MH  - Risk Factors
MH  - Sex Offenses/statistics & numerical data
MH  - Young Adult
OTO - NOTNLM
OT  - *Alcohol use disorders
OT  - *Comorbidity
OT  - *Longitudinal study
OT  - *Major depression
EDAT- 2016/10/25 06:00
MHDA- 2017/10/31 06:00
CRDT- 2016/09/20 06:00
PHST- 2016/06/14 00:00 [received]
PHST- 2016/08/29 00:00 [revised]
PHST- 2016/09/08 00:00 [accepted]
PHST- 2016/10/25 06:00 [pubmed]
PHST- 2017/10/31 06:00 [medline]
PHST- 2016/09/20 06:00 [entrez]
AID - S0165-0327(16)30998-3 [pii]
AID - 10.1016/j.jad.2016.09.004 [doi]
PST - ppublish
SO  - J Affect Disord. 2016 Dec;206:287-293. doi: 10.1016/j.jad.2016.09.004. Epub 2016 
      Sep 13.

PMID- 22042121
OWN - NLM
STAT- MEDLINE
DCOM- 20120712
LR  - 20191027
IS  - 1678-2674 (Electronic)
IS  - 0102-8650 (Linking)
VI  - 26
IP  - 6
DP  - 2011 Dec
TI  - Perioperative care in an animal model for training in abdominal surgery: is it 
      necessary a preoperative fasting?
PG  - 541-8
LID - S0102-86502011000600022 [pii]
AB  - PURPOSE: Demonstrate that the rabbit may be used in the training of surgery, in 
      addition to present its perioperative care. METHODS: Thirty two animals, with age 
      and weight, respectively, from 3 to 5.5 months old and 3000 to 4200 grams, were 
      undergone different periods of pre-operative fasting, exclusive intramuscular 
      anesthesia (ketamine+xylazine), laparotomy with total gastrectomy and total 
      splenectomy. It was dosed the pre-operative (initial) and post-surgical (end) 
      serum blood glucose, in addition to quantify the gastric content after the 
      resection of the part. RESULTS: The anesthetical-surgical procedure presented a 
      mortality rate of 3.125% (1:32) and a morbidity rate of 6.25% (2:32). It was 
      evidenced an initial mean blood glucose = 199.4 mg/dl and the end = 326.1 mg/dl. 
      In spite of extended fasting (minimum of 2 hours for the absolute fasting and 
      maximum of 8.5 hours for liquids, and 20.5 hours for solids) all animals 
      presented at the end of the surgical procedure any gastric content and a blood 
      glucose increase. Those with fasting for liquids and solids when compared to the 
      quantity of solid gastric content, presented a moderate negative degree of 
      correlation. CONCLUSION: The rabbit is a good model to be used in training of 
      surgery, with a low morbi-mortality, able to be anesthetized intramuscularly, 
      with no need of pre-operative fasting and does not present hypoglycemia even with 
      the extended fasting period.
FAU - Alves, Jose Roberto
AU  - Alves JR
AD  - Sciences of Surgery, UNICAMP, Campinas, SP, Brazil. jrobertoa@uol.com.br
FAU - Lopes, Luiz Roberto
AU  - Lopes LR
FAU - Sasasaki, Tania
AU  - Sasasaki T
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Brazil
TA  - Acta Cir Bras
JT  - Acta cirurgica brasileira
JID - 9103983
RN  - 0 (Blood Glucose)
SB  - IM
MH  - Animals
MH  - Blood Glucose/analysis
MH  - Fasting/*blood
MH  - Gastrectomy/*education
MH  - Gastric Emptying
MH  - Laparotomy/*education
MH  - Male
MH  - *Models, Animal
MH  - Perioperative Care/education/methods
MH  - Preoperative Care/education/methods
MH  - Prospective Studies
MH  - *Rabbits
MH  - Splenectomy/*education
EDAT- 2011/11/02 06:00
MHDA- 2012/07/13 06:00
CRDT- 2011/11/02 06:00
PHST- 2011/04/25 00:00 [received]
PHST- 2011/07/21 00:00 [accepted]
PHST- 2011/11/02 06:00 [entrez]
PHST- 2011/11/02 06:00 [pubmed]
PHST- 2012/07/13 06:00 [medline]
AID - S0102-86502011000600022 [pii]
AID - 10.1590/s0102-86502011000600022 [doi]
PST - ppublish
SO  - Acta Cir Bras. 2011 Dec;26(6):541-8. doi: 10.1590/s0102-86502011000600022.

PMID- 17274051
OWN - NLM
STAT- MEDLINE
DCOM- 20071018
LR  - 20070521
IS  - 1043-3074 (Print)
IS  - 1043-3074 (Linking)
VI  - 29
IP  - 6
DP  - 2007 Jun
TI  - Metastatic carcinoma to the cervical nodes from an unknown head and neck primary 
      site: Is there a need for neck dissection?
PG  - 585-90
AB  - BACKGROUND: The aim of the study was to evaluate the outcomes and patterns of 
      failure in patients with metastatic carcinoma to cervical lymph nodes from an 
      unknown head and neck primary origin, who were treated curatively with 
      radiotherapy, with or without neck dissection. METHODS: The study included 61 
      patients referred to the McGill University Hospital Centers from 1987 to 2002. 
      The median age was 57 years, with male to female ratio of 4:1. Distribution of 
      patients by N status was as follows: N1, 16 patients (26%); N2a, 18 (30%); N2b, 
      13 (22%); N2c, 7 (11%); and N3, 7 (11%). Twenty patients underwent neck 
      dissection (11 radical, 9 functional) and 41 patients had biopsy (9 fine-needle 
      aspiration and 32 excisional biopsy). All patients received radiotherapy. The 
      median dose to the involved node(s) was 64 Gy, and 60 Gy to the rest of the neck. 
      Treatment of the neck was bilateral in 50 patients (82%) and ipsilateral in 11 
      (18%). The minimum duration of the follow-up was 12 months, with the median of 32 
      months. RESULTS: The 5- and 8-year overall survival for the whole population was 
      79% and 67%, respectively. There was no statistically significant difference in 
      the 8-year actuarial overall survival (64.8% and 67.6%, respectively, p = .64) 
      and local relapse-free survival (75% vs 74.5%, respectively, p = .57), among 
      patients who had biopsy versus those who had neck dissection. CONCLUSION: In our 
      experience, definitive radiotherapy to the neck and the potential mucosal sites, 
      whether preceded by neck dissection or not, is effective to achieve a good local 
      control rate in the unknown primary cancer of the head and neck. The indication 
      for neck dissection, in particular for early nodal stage, is controversial.
CI  - (c) 2007 Wiley Periodicals, Inc. Head Neck, 2007.
FAU - Aslani, Maryam
AU  - Aslani M
AD  - Department of Radiation Oncology, McGill University, Montreal, Quebec, Canada. 
      aslani_m@yahoo.com
FAU - Sultanem, Khalil
AU  - Sultanem K
FAU - Voung, Te
AU  - Voung T
FAU - Hier, Michael
AU  - Hier M
FAU - Niazi, Tamim
AU  - Niazi T
FAU - Shenouda, George
AU  - Shenouda G
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Head Neck
JT  - Head & neck
JID - 8902541
SB  - IM
MH  - Biopsy, Fine-Needle
MH  - Carcinoma/mortality/*secondary/*therapy
MH  - Female
MH  - Head and Neck Neoplasms/mortality/pathology/*therapy
MH  - Humans
MH  - Lymph Nodes/pathology
MH  - Lymphatic Irradiation
MH  - Lymphatic Metastasis
MH  - Male
MH  - Middle Aged
MH  - *Neck Dissection
MH  - Neoplasms, Unknown Primary/*pathology
MH  - Radiotherapy Dosage
MH  - Survival Analysis
EDAT- 2007/02/03 09:00
MHDA- 2007/10/19 09:00
CRDT- 2007/02/03 09:00
PHST- 2007/02/03 09:00 [pubmed]
PHST- 2007/10/19 09:00 [medline]
PHST- 2007/02/03 09:00 [entrez]
AID - 10.1002/hed.20581 [doi]
PST - ppublish
SO  - Head Neck. 2007 Jun;29(6):585-90. doi: 10.1002/hed.20581.

PMID- 27096199
OWN - NLM
STAT- MEDLINE
DCOM- 20160822
LR  - 20210109
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 11
IP  - 4
DP  - 2016
TI  - Does Viral Co-Infection Influence the Severity of Acute Respiratory Infection in 
      Children?
PG  - e0152481
LID - 10.1371/journal.pone.0152481 [doi]
LID - e0152481
AB  - BACKGROUND: Multiple viruses are often detected in children with respiratory 
      infection but the significance of co-infection in pathogenesis, severity and 
      outcome is unclear. OBJECTIVES: To correlate the presence of viral co-infection 
      with clinical phenotype in children admitted with acute respiratory infections 
      (ARI). METHODS: We collected detailed clinical information on severity for 
      children admitted with ARI as part of a Spanish prospective multicenter study 
      (GENDRES network) between 2011-2013. A nested polymerase chain reaction (PCR) 
      approach was used to detect respiratory viruses in respiratory secretions. 
      Findings were compared to an independent cohort collected in the UK. RESULTS: 204 
      children were recruited in the main cohort and 97 in the replication cohort. The 
      number of detected viruses did not correlate with any markers of severity. 
      However, bacterial superinfection was associated with increased severity (OR: 
      4.356; P-value = 0.005), PICU admission (OR: 3.342; P-value = 0.006), higher 
      clinical score (1.988; P-value = 0.002) respiratory support requirement (OR: 
      7.484; P-value < 0.001) and longer hospital length of stay (OR: 1.468; P-value < 
      0.001). In addition, pneumococcal vaccination was found to be a protective factor 
      in terms of degree of respiratory distress (OR: 2.917; P-value = 0.035), PICU 
      admission (OR: 0.301; P-value = 0.011), lower clinical score (-1.499; P-value = 
      0.021) respiratory support requirement (OR: 0.324; P-value = 0.016) and oxygen 
      necessity (OR: 0.328; P-value = 0.001). All these findings were replicated in the 
      UK cohort. CONCLUSION: The presence of more than one virus in hospitalized 
      children with ARI is very frequent but it does not seem to have a major clinical 
      impact in terms of severity. However bacterial superinfection increases the 
      severity of the disease course. On the contrary, pneumococcal vaccination plays a 
      protective role.
FAU - Cebey-Lopez, Miriam
AU  - Cebey-Lopez M
AD  - Grupo de Investigacion en Genetica, Vacunas, Infecciones y Pediatria, Hospital 
      Clinico Universitario and Universidade de Santiago de Compostela (USC), Galicia, 
      Spain.
AD  - Translational Pediatrics and Infectious Diseases section, Department of 
      Pediatrics, Hospital Clinico Universitario de Santiago, Santiago de Compostela, 
      Galicia, Spain.
FAU - Herberg, Jethro
AU  - Herberg J
AD  - Section of Paediatrics, Division of Infectious Disease, Imperial College of 
      London, South Kensington Campus, London, United Kingdom.
FAU - Pardo-Seco, Jacobo
AU  - Pardo-Seco J
AD  - Grupo de Investigacion en Genetica, Vacunas, Infecciones y Pediatria, Hospital 
      Clinico Universitario and Universidade de Santiago de Compostela (USC), Galicia, 
      Spain.
AD  - Translational Pediatrics and Infectious Diseases section, Department of 
      Pediatrics, Hospital Clinico Universitario de Santiago, Santiago de Compostela, 
      Galicia, Spain.
AD  - Unidade de Xenetica, Departamento de Anatomia Patoloxica e Ciencias Forenses, and 
      Instituto de Ciencias Forenses, Grupo de Medicina Xenomica (GMX), Facultade de 
      Medicina, Universidade de Santiago de Compostela, Galicia, Spain.
FAU - Gomez-Carballa, Alberto
AU  - Gomez-Carballa A
AD  - Grupo de Investigacion en Genetica, Vacunas, Infecciones y Pediatria, Hospital 
      Clinico Universitario and Universidade de Santiago de Compostela (USC), Galicia, 
      Spain.
AD  - Translational Pediatrics and Infectious Diseases section, Department of 
      Pediatrics, Hospital Clinico Universitario de Santiago, Santiago de Compostela, 
      Galicia, Spain.
AD  - Unidade de Xenetica, Departamento de Anatomia Patoloxica e Ciencias Forenses, and 
      Instituto de Ciencias Forenses, Grupo de Medicina Xenomica (GMX), Facultade de 
      Medicina, Universidade de Santiago de Compostela, Galicia, Spain.
FAU - Martinon-Torres, Nazareth
AU  - Martinon-Torres N
AD  - Grupo de Investigacion en Genetica, Vacunas, Infecciones y Pediatria, Hospital 
      Clinico Universitario and Universidade de Santiago de Compostela (USC), Galicia, 
      Spain.
AD  - Translational Pediatrics and Infectious Diseases section, Department of 
      Pediatrics, Hospital Clinico Universitario de Santiago, Santiago de Compostela, 
      Galicia, Spain.
FAU - Salas, Antonio
AU  - Salas A
AD  - Grupo de Investigacion en Genetica, Vacunas, Infecciones y Pediatria, Hospital 
      Clinico Universitario and Universidade de Santiago de Compostela (USC), Galicia, 
      Spain.
AD  - Unidade de Xenetica, Departamento de Anatomia Patoloxica e Ciencias Forenses, and 
      Instituto de Ciencias Forenses, Grupo de Medicina Xenomica (GMX), Facultade de 
      Medicina, Universidade de Santiago de Compostela, Galicia, Spain.
FAU - Martinon-Sanchez, Jose Maria
AU  - Martinon-Sanchez JM
AD  - Grupo de Investigacion en Genetica, Vacunas, Infecciones y Pediatria, Hospital 
      Clinico Universitario and Universidade de Santiago de Compostela (USC), Galicia, 
      Spain.
AD  - Translational Pediatrics and Infectious Diseases section, Department of 
      Pediatrics, Hospital Clinico Universitario de Santiago, Santiago de Compostela, 
      Galicia, Spain.
FAU - Justicia, Antonio
AU  - Justicia A
AD  - Grupo de Investigacion en Genetica, Vacunas, Infecciones y Pediatria, Hospital 
      Clinico Universitario and Universidade de Santiago de Compostela (USC), Galicia, 
      Spain.
AD  - Translational Pediatrics and Infectious Diseases section, Department of 
      Pediatrics, Hospital Clinico Universitario de Santiago, Santiago de Compostela, 
      Galicia, Spain.
FAU - Rivero-Calle, Irene
AU  - Rivero-Calle I
AD  - Grupo de Investigacion en Genetica, Vacunas, Infecciones y Pediatria, Hospital 
      Clinico Universitario and Universidade de Santiago de Compostela (USC), Galicia, 
      Spain.
AD  - Translational Pediatrics and Infectious Diseases section, Department of 
      Pediatrics, Hospital Clinico Universitario de Santiago, Santiago de Compostela, 
      Galicia, Spain.
FAU - Sumner, Edward
AU  - Sumner E
AD  - Micropathology Ltd., University of Warwick Science Park, Coventry, United 
      Kingdom.
FAU - Fink, Colin
AU  - Fink C
AD  - Micropathology Ltd., University of Warwick Science Park, Coventry, United 
      Kingdom.
FAU - Martinon-Torres, Federico
AU  - Martinon-Torres F
AD  - Grupo de Investigacion en Genetica, Vacunas, Infecciones y Pediatria, Hospital 
      Clinico Universitario and Universidade de Santiago de Compostela (USC), Galicia, 
      Spain.
AD  - Translational Pediatrics and Infectious Diseases section, Department of 
      Pediatrics, Hospital Clinico Universitario de Santiago, Santiago de Compostela, 
      Galicia, Spain.
CN  - GENDRES network
LA  - eng
GR  - WT_/Wellcome Trust/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160420
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
RN  - 0 (Pneumococcal Vaccines)
SB  - IM
MH  - Acute Disease
MH  - Adult
MH  - Child, Preschool
MH  - Coinfection/prevention & control/therapy/*virology
MH  - Female
MH  - Hospitalization
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Male
MH  - Middle Aged
MH  - Phenotype
MH  - Pneumococcal Vaccines
MH  - Respiratory Tract Infections/prevention & control/therapy/*virology
PMC - PMC4838299
COIS- Competing Interests: The authors have the following interests. Edward Sumner and 
      Colin Fink are employed by Micropathology Ltd. There are no patents, products in 
      development or marketed products to declare. This does not alter the authors' 
      adherence to all the PLOS ONE policies on sharing data and materials, as detailed 
      online in the guide for authors.
EDAT- 2016/04/21 06:00
MHDA- 2016/08/23 06:00
PMCR- 2016/04/20
CRDT- 2016/04/21 06:00
PHST- 2015/10/06 00:00 [received]
PHST- 2016/03/15 00:00 [accepted]
PHST- 2016/04/21 06:00 [entrez]
PHST- 2016/04/21 06:00 [pubmed]
PHST- 2016/08/23 06:00 [medline]
PHST- 2016/04/20 00:00 [pmc-release]
AID - PONE-D-15-43766 [pii]
AID - 10.1371/journal.pone.0152481 [doi]
PST - epublish
SO  - PLoS One. 2016 Apr 20;11(4):e0152481. doi: 10.1371/journal.pone.0152481. 
      eCollection 2016.

PMID- 7497757
OWN - NLM
STAT- MEDLINE
DCOM- 19960117
LR  - 20190514
IS  - 0012-3692 (Print)
IS  - 0012-3692 (Linking)
VI  - 108
IP  - 6
DP  - 1995 Dec
TI  - Cardiopulmonary bypass temperature does not affect postoperative euthyroid sick 
      syndrome?
PG  - 1541-5
AB  - STUDY OBJECTIVE: To determine if temperature during cardiopulmonary bypass (CPB) 
      has an effect on perioperative and postoperative thyroid function. DESIGN: 
      Prospective study comparing thyroid function during and after hypothermic and 
      normothermic CPB. SETTING: Cardiac surgical unit at a university-affiliated 
      hospital. PATIENTS: Twelve patients scheduled to undergo cardiac operations with 
      normothermic (n = 6) or hypothermic (n = 6) CPB. INTERVENTIONS: Blood was 
      analyzed for serum concentration of total thyroxine (TT4), total triiodothyronine 
      (TT3), free T3 (fT3), reverse T3 (rT3), and thyroid stimulating hormone (TSH) 
      preoperatively, 60 min after CPB was initiated, 30 min after discontinuing CPB, 
      and on postoperative days (POD) 1, 3, and 5. MEASUREMENTS AND RESULTS: Patients 
      who underwent either cold (26 degrees +/- 5 degrees C) or warm (35 degrees +/- 1 
      degree C) CPB were comparable with regard to age, body weight, duration of CPB, 
      cross-clamp time, use of inotropes, total heparin dose, and length of hospital 
      stay. Incidence of postoperative myocardial infarction, congestive heart failure, 
      and death were similar. In both groups, TT4 and TT3 were reduced below baseline 
      values beginning with CPB and persisting for up to 5 days after CPB (p < 0.05), 
      free T3 was reduced for up to 3 days after CPB (p < 0.05), mean serum rT3 was 
      elevated on POD 1 and POD 3 (p < 0.05), and TSH remained unchanged. CONCLUSION: 
      The results of this study suggest that normothermic CPB does not prevent the 
      development of the "euthyroid sick syndrome" during and after CPB. Despite these 
      changes in thyroid function, most patients in both groups had a normal 
      postoperative recovery.
FAU - Thrush, D N
AU  - Thrush DN
AD  - Department of Anesthesiology, University of South Florida, College of Medicine, 
      Tampa 33601, USA.
FAU - Austin, D
AU  - Austin D
FAU - Burdash, N
AU  - Burdash N
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Chest
JT  - Chest
JID - 0231335
RN  - 06LU7C9H1V (Triiodothyronine)
RN  - 5817-39-0 (Triiodothyronine, Reverse)
RN  - 9002-71-5 (Thyrotropin)
RN  - Q51BO43MG4 (Thyroxine)
SB  - IM
MH  - *Body Temperature
MH  - Cardiac Surgical Procedures
MH  - *Cardiopulmonary Bypass
MH  - Euthyroid Sick Syndromes/*etiology/prevention & control
MH  - Humans
MH  - Middle Aged
MH  - *Postoperative Complications/prevention & control
MH  - Thyrotropin/blood
MH  - Thyroxine/blood
MH  - Triiodothyronine/blood
MH  - Triiodothyronine, Reverse/blood
EDAT- 1995/12/01 00:00
MHDA- 1995/12/01 00:01
CRDT- 1995/12/01 00:00
PHST- 1995/12/01 00:00 [pubmed]
PHST- 1995/12/01 00:01 [medline]
PHST- 1995/12/01 00:00 [entrez]
AID - S0012-3692(15)45104-9 [pii]
AID - 10.1378/chest.108.6.1541 [doi]
PST - ppublish
SO  - Chest. 1995 Dec;108(6):1541-5. doi: 10.1378/chest.108.6.1541.

PMID- 21459725
OWN - NLM
STAT- MEDLINE
DCOM- 20110805
LR  - 20191112
IS  - 1499-3872 (Print)
VI  - 10
IP  - 2
DP  - 2011 Apr
TI  - Xanthogranulomatous cholecystitis: a premalignant condition?
PG  - 179-84
AB  - BACKGROUND: Xanthogranulomatous cholecystitis (XGC) is an uncommon variant of 
      chronic cholecystitis, characterized by marked thickening of the gallbladder wall 
      and dense local adhesions. It often mimics a gallbladder carcinoma (GBC), and may 
      coexist with GBC, leading to a diagnostic dilemma. Furthermore, the premalignant 
      nature of this entity is not known. This study was undertaken to assess the p53, 
      PCNA and beta-catenin expression in XGC in comparison to GBC and chronic 
      inflammation. METHODS: Sections from paraffin-embedded blocks of surgically 
      resected specimens of GBC (69 cases), XGC (65), chronic cholecystitis (18) and 
      control gallbladder (10) were stained with the monoclonal antibodies to p53 and 
      PCNA, and a polyclonal antibody to beta-catenin. p53 expression was scored as the 
      percentage of nuclei stained. PCNA expression was scored as the product of the 
      percentage of nuclei stained and the intensity of the staining (1-3). A cut-off 
      value of 80 for this score was taken as a positive result. Beta-catenin 
      expression was scored as type of expression-membranous, cytoplasmic or nuclear 
      staining. RESULTS: p53 mutation was positive in 52% of GBC cases and 3% of XGC, 
      but was not expressed in chronic cholecystitis and control gallbladders. p53 
      expression was lower in XGC than in GBC (P<0.0001). PCNA expression was seen in 
      65% of GBC cases and 11% of XGC, but not in chronic cholecystitis and control 
      gallbladders. PCNA expression was higher in GBC than XGC (P=0.0001), but there 
      was no significant difference between the XGC, chronic cholecystitis and control 
      gallbladder groups. Beta-catenin expression was positive in the GBC, XGC, chronic 
      cholecystitis and control gallbladder groups. But the expression pattern in XGC, 
      chronic cholecystitis and control gallbladders was homogenously membranous, 
      whereas in GBC the membranous expression pattern was altered to cytoplasmic and 
      nuclear. CONCLUSION: The expression of p53, PCNA and beta-catenin in XGC was 
      significantly different from GBC and similar to chronic cholecystitis, thus 
      indicating the inflammatory nature of XGC and may not support a premalignant 
      nature of the lesion.
FAU - Ghosh, Mila
AU  - Ghosh M
AD  - Department of Gastrointestinal Surgery, GB Pant Hospital and Maulana Azad Medical 
      College, New Delhi 110002, India.
FAU - Sakhuja, Puja
AU  - Sakhuja P
FAU - Agarwal, Anil K
AU  - Agarwal AK
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Singapore
TA  - Hepatobiliary Pancreat Dis Int
JT  - Hepatobiliary & pancreatic diseases international : HBPD INT
JID - 101151457
RN  - 0 (CTNNB1 protein, human)
RN  - 0 (Proliferating Cell Nuclear Antigen)
RN  - 0 (Tumor Suppressor Protein p53)
RN  - 0 (beta Catenin)
RN  - Xanthogranulomatous cholecystitis
SB  - IM
MH  - Cholecystitis/metabolism/pathology
MH  - Gallbladder Neoplasms/chemistry/*pathology
MH  - Granuloma/metabolism/pathology
MH  - Humans
MH  - Immunohistochemistry
MH  - Precancerous Conditions/chemistry/*pathology
MH  - Proliferating Cell Nuclear Antigen/analysis
MH  - Tumor Suppressor Protein p53/analysis
MH  - Xanthomatosis/metabolism/pathology
MH  - beta Catenin/analysis
EDAT- 2011/04/05 06:00
MHDA- 2011/08/06 06:00
CRDT- 2011/04/05 06:00
PHST- 2011/04/05 06:00 [entrez]
PHST- 2011/04/05 06:00 [pubmed]
PHST- 2011/08/06 06:00 [medline]
AID - 1460 [pii]
AID - 10.1016/s1499-3872(11)60028-3 [doi]
PST - ppublish
SO  - Hepatobiliary Pancreat Dis Int. 2011 Apr;10(2):179-84. doi: 
      10.1016/s1499-3872(11)60028-3.

PMID- 27040842
OWN - NLM
STAT- MEDLINE
DCOM- 20170130
LR  - 20170130
IS  - 1748-5460 (Electronic)
IS  - 0022-2151 (Linking)
VI  - 130
IP  - 6
DP  - 2016 Jun
TI  - Does septoplasty change the dimensions of compensatory hypertrophy of the middle 
      turbinate?
PG  - 554-9
LID - 10.1017/S0022215116001055 [doi]
AB  - OBJECTIVE: To measure the dimensions of compensatory hypertrophy of the middle 
      turbinate in patients with nasal septal deviation, before and after septoplasty. 
      METHODS: The mucosal and bony structures of the middle turbinate and the angle of 
      the septum were measured using radiological analysis before septoplasty and at 
      least one year after septoplasty. All pre- and post-operative measurements of the 
      middle turbinate were compared using the paired sample t-test and Wilcoxon rank 
      sum test. RESULTS: The dimensions of bony and mucosal components of the middle 
      turbinate on concave and convex sides of the septum were not significantly 
      changed by septoplasty. There was a significant negative correlation after 
      septoplasty between the angle of the septum and the middle turbinate total area 
      on the deviated side (p = 0.033). CONCLUSION: The present study findings suggest 
      that compensatory hypertrophy of the middle turbinate is not affected by 
      septoplasty, even after one year.
FAU - Demir, D
AU  - Demir D
AD  - Department of Otorhinolaryngology,Sakarya University Faculty of 
      Medicine,Sakarya,Turkey.
FAU - Asil, K
AU  - Asil K
AD  - Department of Radiology,Sakarya University Faculty of Medicine,Sakarya,Turkey.
FAU - Guven, M
AU  - Guven M
AD  - Department of Otorhinolaryngology,Sakarya University Faculty of 
      Medicine,Sakarya,Turkey.
FAU - Erkorkmaz, U
AU  - Erkorkmaz U
AD  - Department of Biostatistics,Sakarya University Faculty of 
      Medicine,Sakarya,Turkey.
LA  - eng
PT  - Journal Article
DEP - 20160404
PL  - England
TA  - J Laryngol Otol
JT  - The Journal of laryngology and otology
JID - 8706896
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Female
MH  - Humans
MH  - Hypertrophy/diagnostic imaging
MH  - Male
MH  - Middle Aged
MH  - Nasal Mucosa/*diagnostic imaging/pathology
MH  - Nasal Obstruction/*surgery
MH  - Nasal Septum/abnormalities/*surgery
MH  - Nose Deformities, Acquired/*surgery
MH  - Retrospective Studies
MH  - *Rhinoplasty
MH  - Tomography, X-Ray Computed
MH  - Turbinates/*diagnostic imaging/pathology
MH  - Young Adult
OTO - NOTNLM
OT  - Computed Tomography
OT  - Hypertrophy
OT  - Nasal Septum
OT  - Sinusitis
OT  - Turbinates
EDAT- 2016/04/05 06:00
MHDA- 2017/01/31 06:00
CRDT- 2016/04/05 06:00
PHST- 2016/04/05 06:00 [entrez]
PHST- 2016/04/05 06:00 [pubmed]
PHST- 2017/01/31 06:00 [medline]
AID - S0022215116001055 [pii]
AID - 10.1017/S0022215116001055 [doi]
PST - ppublish
SO  - J Laryngol Otol. 2016 Jun;130(6):554-9. doi: 10.1017/S0022215116001055. Epub 2016 
      Apr 4.

PMID- 20187289
OWN - NLM
STAT- MEDLINE
DCOM- 20100506
LR  - 20211020
IS  - 1432-1041 (Electronic)
IS  - 0031-6970 (Linking)
VI  - 66
IP  - 3
DP  - 2010 Mar
TI  - Prescriptions as a proxy for asthma in children: a good choice?
PG  - 307-13
LID - 10.1007/s00228-009-0755-z [doi]
AB  - PURPOSE: Stock et al. (Eur Respir J 25:47-53, 2005) recently estimated asthma 
      prevalence in Germany using claims data on prescriptions and hospital diagnoses 
      and found high prevalence peaks in infants. Our objective was to critically 
      assess and discuss various aspects of identifying children with asthma using 
      prescription data. METHODS: We replicated the selection procedure of Stock et al. 
      using data on 290,919 children aged 0-17 years insured in the Gmunder ErsatzKasse 
      (GEK) in 2005. Asthma prevalence was also estimated in a sample of 17,641 
      children aged 0-17 years participating in the German Health Interview and 
      Examination Survey for Children and Adolescents (KiGGS) from 2003 to 2006. 
      RESULTS: In children aged 0-4 years insured in the GEK, prevalences were found to 
      range from 11.7 to 17.7% for boys and from 7.2 to 11.1% for girls when the 
      criteria of Stock et al. were applied. A steady decline in prevalences was 
      observed in older age groups. Asthma prevalence estimated in the KiGGS data 
      showed a quite different distribution. In the age group 0-4 years, prevalences 
      were found to range from 0 to 2.6% in boys and from 0 to 1.0% in girls; in 
      children >4 years, prevalences were found to increase with increasing age. 
      CONCLUSIONS: When additional validation studies were taken into account, asthma 
      medications were found to be prescribed not only for asthma but also for other 
      respiratory diseases. In addition, not all children with current asthma had 
      prescriptions. We therefore conclude that asthma medications are therefore not a 
      good proxy for the disease.
FAU - Hoffmann, Falk
AU  - Hoffmann F
AD  - Center for Social Policy Research, University of Bremen, Germany. 
      hoffmann@zes.uni-bremen.de
FAU - Glaeske, Gerd
AU  - Glaeske G
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Germany
TA  - Eur J Clin Pharmacol
JT  - European journal of clinical pharmacology
JID - 1256165
RN  - 0 (Anti-Asthmatic Agents)
SB  - IM
MH  - Adolescent
MH  - Age Distribution
MH  - Age Factors
MH  - Anti-Asthmatic Agents/*therapeutic use
MH  - Asthma/diagnosis/*drug therapy/*epidemiology
MH  - Child
MH  - Child, Preschool
MH  - Drug Prescriptions/statistics & numerical data
MH  - Drug Utilization/statistics & numerical data
MH  - Female
MH  - Germany/epidemiology
MH  - Health Care Surveys
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Insurance, Pharmaceutical Services/statistics & numerical data
MH  - Male
MH  - Prevalence
MH  - Reproducibility of Results
MH  - Time Factors
EDAT- 2010/02/27 06:00
MHDA- 2010/05/07 06:00
CRDT- 2010/02/27 06:00
PHST- 2010/02/27 06:00 [entrez]
PHST- 2010/02/27 06:00 [pubmed]
PHST- 2010/05/07 06:00 [medline]
AID - 10.1007/s00228-009-0755-z [doi]
PST - ppublish
SO  - Eur J Clin Pharmacol. 2010 Mar;66(3):307-13. doi: 10.1007/s00228-009-0755-z.

PMID- 21712147
OWN - NLM
STAT- MEDLINE
DCOM- 20120703
LR  - 20130107
IS  - 1934-8150 (Electronic)
IS  - 1551-7411 (Linking)
VI  - 8
IP  - 2
DP  - 2012 Mar-Apr
TI  - Does combining antiretroviral agents in a single dosage form enhance quality of 
      life of HIV/AIDS patients? A cost-utility study.
PG  - 157-65
LID - 10.1016/j.sapharm.2010.12.004 [doi]
AB  - BACKGROUND: Combining various antiretroviral agents into one single dosage form 
      has been a strategy to reduce pill burden and enhance medication adherence among 
      human immunodeficiency virus /AIDS (HIV/AIDS) patients. OBJECTIVES: This is a 
      cost-utility study from a health care system's perspective comparing coformulated 
      fixed dose (FXD) strategy versus multiple free dose combination (FRC) in 
      antiretroviral therapy. METHOD: The Medical Expenditure Panel Survey (MEPS) was 
      used to identify HIV/AIDS patients with >/=2 active antiretroviral medications. 
      Patients on FXD were matched in 1:1 ratio with the FRC group using propensity 
      scores. All medical costs excluding those paid by patients and families were 
      included. Utility was measured using SF-6D scores from the SF-12 questionnaire. 
      Incremental cost-utility ratios (ICURs) were calculated using the mean annual 
      estimates. A cost-effectiveness acceptability curve was determined using a Monte 
      Carlo probabilistic simulation technique. RESULTS: Nine FXD antiretroviral 
      formulations approved by the U.S. Food and Drug Administration by 2005 was 
      included in this study. One hundred seventy HIV/AIDS patients with >/=2 
      antiretroviral agents were identified from the MEPS database, of which 53% (n=92) 
      were on FXD formulation. On matching, 70 patients from FXD had a match from the 
      FRC group. No differences in sociodemographic and health status variables were 
      observed between the matched groups. The mean annual cost was $15,766.15 for FXD 
      patients and $11,875.21 for FRC patients. The mean utility gained by using FXD 
      over FRC was 0.085; however, this difference was not statistically significant. 
      The ICUR for the FXD treatment over FRC treatment was $45,540.49/quality-adjusted 
      life years (QALYs). Probabilistic sensitivity analysis showed FXD to dominate FRC 
      (>50% probability of being cost-effective) above the $40,000 threshold. 
      CONCLUSION: Although the cost-effectiveness of a single-pill strategy was within 
      the acceptable willingness-to-pay threshold, the QALY difference were minimal. 
      Further research is recommended to explore the long-term impact of the strategy.
CI  - Copyright (c) 2012 Elsevier Inc. All rights reserved.
FAU - Ganguli, Arijit
AU  - Ganguli A
AD  - Health Outcomes and Policy Research, Department of Pharmaceutical Sciences, 
      University of Tennessee College of Pharmacy, 847 Monroe Ave., Memphis, TN 38163, 
      USA. arijit.gangs@gmail.com
FAU - Wang, Junling
AU  - Wang J
FAU - Gourley, Dick R
AU  - Gourley DR
LA  - eng
PT  - Journal Article
DEP - 20110628
PL  - United States
TA  - Res Social Adm Pharm
JT  - Research in social & administrative pharmacy : RSAP
JID - 101231974
RN  - 0 (Anti-Retroviral Agents)
RN  - 0 (Drug Combinations)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Anti-Retroviral Agents/administration & dosage/*economics
MH  - Cost-Benefit Analysis
MH  - Drug Combinations
MH  - *Drug Costs
MH  - Female
MH  - HIV Infections/drug therapy/*economics
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Quality of Life
MH  - Quality-Adjusted Life Years
MH  - Young Adult
EDAT- 2011/06/30 06:00
MHDA- 2012/07/04 06:00
CRDT- 2011/06/30 06:00
PHST- 2010/09/02 00:00 [received]
PHST- 2010/12/18 00:00 [revised]
PHST- 2010/12/18 00:00 [accepted]
PHST- 2011/06/30 06:00 [entrez]
PHST- 2011/06/30 06:00 [pubmed]
PHST- 2012/07/04 06:00 [medline]
AID - S1551-7411(10)00171-3 [pii]
AID - 10.1016/j.sapharm.2010.12.004 [doi]
PST - ppublish
SO  - Res Social Adm Pharm. 2012 Mar-Apr;8(2):157-65. doi: 
      10.1016/j.sapharm.2010.12.004. Epub 2011 Jun 28.

PMID- 10456814
OWN - NLM
STAT- MEDLINE
DCOM- 19990930
LR  - 20190814
IS  - 0001-5172 (Print)
IS  - 0001-5172 (Linking)
VI  - 43
IP  - 7
DP  - 1999 Aug
TI  - Does desflurane alter left ventricular function when used to control surgical 
      stimulation during aortic surgery?
PG  - 737-43
AB  - BACKGROUND: Although desflurane is commonly used to control surgically induced 
      hypertension, its effects on left ventricular (LV) function have not been 
      investigated in this clinical situation. The purpose of the present study was to 
      evaluate the LV function response to desflurane, when used to control 
      intraoperative hypertension. METHODS: In 50 patients, scheduled for vascular 
      surgery, anesthesia was induced with sufentanil 0.5 microg/kg, midazolam 0.3 
      mg/kg and atracurium 0.5 mg/kg. After tracheal intubation, anesthesia was 
      maintained with increments of drugs with controlled ventilation (N2O/O2=60/40%) 
      until the start of surgery. A 5 Mhz transesophageal echocardiography (TEE) probe 
      was inserted after intubation. Pulmonary artery catheter and TEE measurements 
      were obtained after induction (to)(control value), at surgical incision (t1) if 
      it was associated with an increase in systolic arterial pressure (SAP) greater 
      than 140 mmHg (hypertension) and after control of hemodynamic parameters by 
      administration of desflurane (return of systolic arterial pressure to within 20% 
      of the control value) (t2) in a fresh gas flow of 31/ min. RESULTS: Sixteen 
      patients developed hypertension at surgical incision. SAP was controlled by 
      desflurane in all 16 patients. Afterload assessed by systemic vascular resistance 
      index (SVRI), end-systolic wall-stress (ESWS) and left-ventricular stroke work 
      index (LVSWI) increased with incision until the hypertension returned to 
      post-induction values with mean end-tidal concentration of 5.1+/-0.7% desflurane. 
      No change in heart rate, cardiac index, mean pulmonary arterial pressure, stroke 
      volume, end-diastolic and end-systolic cross-sectional areas, fractional area 
      change and left ventricular circumferential fiber shortening was noted when 
      desflurane was added to restore blood pressure. CONCLUSION: This study 
      demonstrates that in patients at risk for cardiac morbidity undergoing vascular 
      surgery, desflurane is effective to control intraoperative hypertension without 
      fear of major cardiac depressant effect.
FAU - Eyraud, D
AU  - Eyraud D
AD  - Department of Anesthesiology and Intensive Care, Hopital de la Pitie-Salpetriere, 
      Paris VI University, France.
FAU - Benmalek, F
AU  - Benmalek F
FAU - Teugels, K
AU  - Teugels K
FAU - Bertrand, M
AU  - Bertrand M
FAU - Mouren, S
AU  - Mouren S
FAU - Coriat, P
AU  - Coriat P
LA  - eng
PT  - Journal Article
PL  - England
TA  - Acta Anaesthesiol Scand
JT  - Acta anaesthesiologica Scandinavica
JID - 0370270
RN  - 0 (Anesthetics, Inhalation)
RN  - 0 (Anesthetics, Intravenous)
RN  - 0 (Neuromuscular Nondepolarizing Agents)
RN  - 2GQ1IRY63P (Atracurium)
RN  - AFE2YW0IIZ (Sufentanil)
RN  - CRS35BZ94Q (Desflurane)
RN  - CYS9AKD70P (Isoflurane)
RN  - K50XQU1029 (Nitrous Oxide)
RN  - R60L0SM5BC (Midazolam)
RN  - S88TT14065 (Oxygen)
SB  - IM
MH  - Anesthetics, Inhalation/*administration & dosage
MH  - Anesthetics, Intravenous/administration & dosage
MH  - Aorta/*surgery
MH  - Atracurium/administration & dosage
MH  - Blood Pressure/physiology
MH  - Cardiac Output/drug effects
MH  - Catheterization, Swan-Ganz
MH  - Desflurane
MH  - Diastole
MH  - Echocardiography, Transesophageal
MH  - Female
MH  - Heart Rate/drug effects
MH  - Heart Ventricles/drug effects
MH  - Humans
MH  - Hypertension/*prevention & control
MH  - Intraoperative Complications/*prevention & control
MH  - Intubation, Intratracheal
MH  - Isoflurane/administration & dosage/*analogs & derivatives
MH  - Male
MH  - Midazolam/administration & dosage
MH  - Middle Aged
MH  - Neuromuscular Nondepolarizing Agents/administration & dosage
MH  - Nitrous Oxide/administration & dosage
MH  - Oxygen/administration & dosage
MH  - Stroke Volume/drug effects
MH  - Sufentanil/administration & dosage
MH  - Systole
MH  - Vascular Resistance/drug effects
MH  - Ventricular Function, Left/*drug effects
EDAT- 1999/08/24 00:00
MHDA- 1999/08/24 00:01
CRDT- 1999/08/24 00:00
PHST- 1999/08/24 00:00 [pubmed]
PHST- 1999/08/24 00:01 [medline]
PHST- 1999/08/24 00:00 [entrez]
AID - 10.1034/j.1399-6576.1999.430709.x [doi]
PST - ppublish
SO  - Acta Anaesthesiol Scand. 1999 Aug;43(7):737-43. doi: 
      10.1034/j.1399-6576.1999.430709.x.

PMID- 17192736
OWN - NLM
STAT- MEDLINE
DCOM- 20070313
LR  - 20220331
IS  - 0042-1138 (Print)
IS  - 0042-1138 (Linking)
VI  - 78
IP  - 1
DP  - 2007
TI  - Is fluoroscopy essential for retrieval of lower ureteric stones?
PG  - 70-2
AB  - INTRODUCTION: The aim of this study was to assess the efficacy of ureteroscopy 
      for lower ureteric stones without the use of fluoroscopy. PATIENTS AND METHODS: 
      Between June 2001 and January 2005, a total of 110 patients with a mean age of 
      33.5 years (range 12-65) suffering from of lower ureteral calculi (below the 
      upper margin of the sacroiliac joint) prospectively underwent ureteroscopic 
      removal. Retrograde pyelography was avoided, and no safety guidewire was placed. 
      Whenever required, the ureteric meatus was dilated with a ureteric balloon under 
      direct vision. Double-J stent placement was done with the aid of ureteroscopy. A 
      fluoroscope was kept standby. The patients had a postoperative X-ray of the 
      kidney-ureter-bladder region to document the stone clearance. RESULTS: The mean 
      stone size was 8.7 mm (range 6-15). Complete clearance without the use of 
      fluoroscopy was achieved in 99 patients (94.2%). Fluoroscopy was required in 6 
      patients (4%) for calcified stricture (n = 1), duplex system (n = 1), narrow and 
      tortuous meatus causing difficulty in passing the 5-Fr balloon dilator (n = 3), 
      and confirmation of spontaneous passage of the stone (n = 1). Of the 13 patients 
      who required balloon dilatation it was successfully achieved without fluoroscopy. 
      Double-J stenting was done due to mucosal ulceration (n = 3), polypoid reaction 
      (n = 2), and perforation (n = 1). All these patients had correct placement of the 
      stent, as confirmed by X-ray of the kidney-ureter-bladder region postoperatively. 
      CONCLUSIONS: To uphold the notion for radiation exposure to be as low as 
      reasonably achievable, ureteroscopic stone retrieval can safely be done without 
      the use of fluoroscopy in a significant number of patients.
FAU - Mandhani, A
AU  - Mandhani A
AD  - Department of Urology and Renal Transplantation, Sanjay Gandhi Postgraduate 
      Institute of Medical Sciences, Lucknow, India. mandhani@sgpgi.ac.in
FAU - Chaudhury, H
AU  - Chaudhury H
FAU - Gupta, N
AU  - Gupta N
FAU - Singh, H K
AU  - Singh HK
FAU - Kapoor, R
AU  - Kapoor R
FAU - Kumar, A
AU  - Kumar A
LA  - eng
PT  - Journal Article
PL  - Switzerland
TA  - Urol Int
JT  - Urologia internationalis
JID - 0417373
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Child
MH  - Contraindications
MH  - Fluoroscopy
MH  - Follow-Up Studies
MH  - Humans
MH  - Middle Aged
MH  - Prosthesis Implantation/methods
MH  - Retrospective Studies
MH  - Stents
MH  - Treatment Outcome
MH  - Ureteral Calculi/diagnostic imaging/*surgery
MH  - Ureteroscopy/*methods
EDAT- 2006/12/29 09:00
MHDA- 2007/03/14 09:00
CRDT- 2006/12/29 09:00
PHST- 2006/01/16 00:00 [received]
PHST- 2006/05/15 00:00 [accepted]
PHST- 2006/12/29 09:00 [pubmed]
PHST- 2007/03/14 09:00 [medline]
PHST- 2006/12/29 09:00 [entrez]
AID - 000096938 [pii]
AID - 10.1159/000096938 [doi]
PST - ppublish
SO  - Urol Int. 2007;78(1):70-2. doi: 10.1159/000096938.

PMID- 27757987
OWN - NLM
STAT- MEDLINE
DCOM- 20171005
LR  - 20171005
IS  - 1444-0938 (Electronic)
IS  - 0816-4622 (Linking)
VI  - 100
IP  - 2
DP  - 2017 Mar
TI  - Does the treatment of amblyopia normalise subfoveal choroidal thickness in 
      amblyopic children?
PG  - 184-188
LID - 10.1111/cxo.12483 [doi]
AB  - PURPOSE: Recent studies have found a choroidal thickening in amblyopic eyes and 
      suggested that there might be a relationship between the choroid and amblyopia. 
      The present study aimed to evaluate the effect of a six-month treatment of 
      amblyopia on choroidal thickness in anisometropic hyperopic amblyopic children. 
      METHODS: Thirty-two anisometropic hyperopic children with unilateral amblyopia 
      were included in this prospective study. Subfoveal choroidal thickness was 
      measured as the distance between the retinal pigment epithelium and the 
      chorioscleral edge, by using spectral domain enhanced depth imaging optical 
      coherence tomography. The treatment of amblyopia was performed based on the full 
      correction of the refractive error with eyeglasses, a refractive adaptation phase 
      and occlusion by patching the fellow eye. RESULTS: The mean visual acuity of the 
      amblyopic eyes significantly increased from 0.35 +/- 0.3 to 0.16 +/- 0.2 logMAR after 
      the treatment (p < 0.001). The mean initial choroidal thickness was significantly 
      higher in the amblyopic eyes than in the fellow eyes (p = 0.019). There were no 
      significant differences between the pre- and post-treatment mean choroidal 
      thickness in the amblyopic eyes (p = 0.428) and in the fellow eyes (p = 0.343). 
      The mean choroidal thickness was still higher in the amblyopic eyes than in the 
      fellow eyes after the treatment (p = 0.006). CONCLUSIONS: Although a six-month 
      treatment of amblyopia increased the visual acuity of the anisometropic hyperopic 
      amblyopic eyes, it could not significantly change choroidal thickness. Our 
      results were in accordance with the conventional explanation, which suggests 
      visual cortex and lateral geniculate nucleus abnormalities in the pathophysiology 
      of amblyopia.
CI  - (c) 2016 Optometry Australia.
FAU - Oner, Veysi
AU  - Oner V
AD  - Department of Ophthalmology, Recep Tayyip Erdogan University Medical School, 
      Rize, Turkey.
FAU - Bulut, Asker
AU  - Bulut A
AD  - Department of Ophthalmology, Recep Tayyip Erdogan University Medical School, 
      Rize, Turkey.
LA  - eng
PT  - Journal Article
DEP - 20161018
PL  - United States
TA  - Clin Exp Optom
JT  - Clinical & experimental optometry
JID - 8703442
SB  - IM
MH  - Adolescent
MH  - Amblyopia/pathology/physiopathology/*therapy
MH  - Child
MH  - Child, Preschool
MH  - Choroid/*pathology
MH  - Female
MH  - Humans
MH  - Male
MH  - Visual Acuity
OTO - NOTNLM
OT  - amblyopia
OT  - choroid
OT  - enhanced depth imaging
OT  - optical coherence tomography
EDAT- 2016/10/21 06:00
MHDA- 2017/10/06 06:00
CRDT- 2016/10/21 06:00
PHST- 2016/07/01 00:00 [revised]
PHST- 2016/04/28 00:00 [received]
PHST- 2016/07/16 00:00 [accepted]
PHST- 2016/10/21 06:00 [pubmed]
PHST- 2017/10/06 06:00 [medline]
PHST- 2016/10/21 06:00 [entrez]
AID - 10.1111/cxo.12483 [doi]
PST - ppublish
SO  - Clin Exp Optom. 2017 Mar;100(2):184-188. doi: 10.1111/cxo.12483. Epub 2016 Oct 
      18.

PMID- 12769830
OWN - NLM
STAT- MEDLINE
DCOM- 20040608
LR  - 20220318
IS  - 1471-2407 (Electronic)
IS  - 1471-2407 (Linking)
VI  - 3
DP  - 2003 May 26
TI  - Should tumor depth be included in prognostication of soft tissue sarcoma?
PG  - 17
AB  - BACKGROUND: Most staging systems for soft tissue sarcoma are based on histologic 
      malignancy-grade, tumor size and tumor depth. These factors are generally 
      dichotomized, size at 5 cm. We believe it is unlikely that tumor depth per se 
      should influence a tumor's metastatic capability. Therefore we hypothesized that 
      the unfavourable prognostic importance of depth could be explained by the close 
      association between size and depth, deep-seated tumors on average being larger 
      than the superficial ones. When tumor size is dichotomized, this effect should be 
      most pronounced in the large size (>5 cm) group in which the size span is larger. 
      METHODS: We analyzed the associations between tumor size and depth and the 
      prognostic importance of grade, size and depth in a population-based series of 
      490 adult patients with soft tissue sarcoma of the extremity or trunk wall with 
      complete, 4.5 years minimum, follow-up. RESULTS: Multivariate analysis showed no 
      major prognostic effect of tumor depth when grade and size were taken into 
      account. The mean size of small tumors was the same whether superficial or deep 
      but the mean size of large and deep-seated tumors were one third larger than that 
      of large but superficial tumors. Tumor depth influenced the prognosis in the 
      subset of high-grade and large tumors. In this subset deep-seated tumors had 
      poorer survival rate than superficial tumors, which could be explained by the 
      larger mean size of the deep-seated tumors. CONCLUSION: Most of the prognostic 
      value of tumor depth in soft tissue sarcomas of the extremity or trunk wall can 
      be explained by the association between tumor size and depth.
FAU - Rydholm, Anders
AU  - Rydholm A
AD  - Department of Orthopedics, University Hospital, SE-221 85 Lund, Sweden. 
      Anders.Rydholm@ort.lu.se
FAU - Gustafson, Pelle
AU  - Gustafson P
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20030526
PL  - England
TA  - BMC Cancer
JT  - BMC cancer
JID - 100967800
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Multivariate Analysis
MH  - Neoplasm Staging/methods
MH  - Prognosis
MH  - Sarcoma/*pathology/secondary
PMC - PMC161793
EDAT- 2003/05/29 05:00
MHDA- 2004/06/21 10:00
PMCR- 2003/05/26
CRDT- 2003/05/29 05:00
PHST- 2002/12/10 00:00 [received]
PHST- 2003/05/26 00:00 [accepted]
PHST- 2003/05/29 05:00 [pubmed]
PHST- 2004/06/21 10:00 [medline]
PHST- 2003/05/29 05:00 [entrez]
PHST- 2003/05/26 00:00 [pmc-release]
AID - 1471-2407-3-17 [pii]
AID - 10.1186/1471-2407-3-17 [doi]
PST - epublish
SO  - BMC Cancer. 2003 May 26;3:17. doi: 10.1186/1471-2407-3-17.

PMID- 22251324
OWN - NLM
STAT- MEDLINE
DCOM- 20120531
LR  - 20140730
IS  - 1600-0579 (Electronic)
IS  - 1396-5883 (Linking)
VI  - 16
IP  - 1
DP  - 2012 Feb
TI  - Does performance in selection processes predict performance as a dental student?
PG  - 27-34
LID - 10.1111/j.1600-0579.2011.00706.x [doi]
AB  - OBJECTIVE: This study investigated associations between the performance of dental 
      students in each of the three components of the selection procedure [academic 
      average, Undergraduate Medicine and Health Sciences Admission Test (UMAT) and 
      structured interview], socio-demographic characteristics and their academic 
      success in an undergraduate dental surgery programme. MATERIALS AND METHODS: 
      Longitudinal review of admissions data relating to students entering dental 
      education at the University of Otago, New Zealand, between 2004 and 2009 was 
      compared with academic performance throughout the dental programme. RESULTS AND 
      DISCUSSION: After controlling for variables, pre-admission academic average, UMAT 
      scores and interview performance did not predict performance as a dental student. 
      Class place in second year, however, was a strong predictor of class place in 
      final year. Multivariate analysis demonstrated that the best predictors of higher 
      class placement in the final year were New Zealand European ethnicity and 
      domestic (rather than international) student status. Other socio-demographic 
      characteristics were not associated with performance. These interim findings 
      provide a sound base for the ongoing study. CONCLUSION: The study found important 
      socio-demographic differences in pre-admission test scores, but those scores did 
      not predict performance in the dental programme, whether measured in second year 
      or in final year.
CI  - (c) 2011 John Wiley & Sons A/S.
FAU - Rich, A M
AU  - Rich AM
AD  - Sir John Walsh Research Institute, Faculty of Dentistry, University of Otago, 
      Dunedin, New Zealand. alison.rich@otago.ac.nz
FAU - Ayers, K M S
AU  - Ayers KM
FAU - Thomson, W M
AU  - Thomson WM
FAU - Sinclair, R J
AU  - Sinclair RJ
FAU - Rohan, M J
AU  - Rohan MJ
FAU - Seymour, G J
AU  - Seymour GJ
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20110927
PL  - England
TA  - Eur J Dent Educ
JT  - European journal of dental education : official journal of the Association for 
      Dental Education in Europe
JID - 9712132
MH  - Achievement
MH  - Adult
MH  - Chi-Square Distribution
MH  - *Clinical Competence
MH  - *College Admission Test
MH  - Educational Measurement
MH  - Female
MH  - Humans
MH  - Interviews as Topic
MH  - Longitudinal Studies
MH  - Male
MH  - New Zealand
MH  - Predictive Value of Tests
MH  - *School Admission Criteria
MH  - *Students, Dental
EDAT- 2012/01/19 06:00
MHDA- 2012/06/01 06:00
CRDT- 2012/01/19 06:00
PHST- 2012/01/19 06:00 [entrez]
PHST- 2012/01/19 06:00 [pubmed]
PHST- 2012/06/01 06:00 [medline]
AID - 10.1111/j.1600-0579.2011.00706.x [doi]
PST - ppublish
SO  - Eur J Dent Educ. 2012 Feb;16(1):27-34. doi: 10.1111/j.1600-0579.2011.00706.x. 
      Epub 2011 Sep 27.

PMID- 28196511
OWN - NLM
STAT- MEDLINE
DCOM- 20170228
LR  - 20220330
IS  - 2049-9957 (Electronic)
IS  - 2049-9957 (Linking)
VI  - 6
IP  - 1
DP  - 2017 Feb 15
TI  - Antiretroviral therapy related adverse effects: Can sub-Saharan Africa cope with 
      the new "test and treat" policy of the World Health Organization?
PG  - 24
LID - 10.1186/s40249-017-0240-3 [doi]
LID - 24
AB  - BACKGROUND: Recent studies have shown that early antiretroviral therapy (ART) 
      initiation results in significant HIV transmission reduction. This is the 
      rationale behind the "test and treat" policy of the World Health Organization 
      (WHO). Implementation of this policy will lead to an increased incidence of 
      ART-related adverse effects, especially in sub-Saharan Africa (SSA). Is the 
      region yet ready to cope with such a challenging issue? MAIN BODY: The 
      introduction and widespread use of ART have drastically changed the natural 
      history of HIV/AIDS, but exposure to ART leads to serious medication-related 
      adverse effects mainly explained by mitochondrial toxicities, and the situation 
      will get worse in the near future. Indeed, ART is associated with an increased 
      risk of developing cardiovascular disease, lipodystrophy, prediabetes and overt 
      diabetes, insulin resistance and hyperlactatemia/lactic acidosis. The prevalence 
      of these disorders is already high in SSA, and the situation will be exacerbated 
      by the implementation of the new WHO recommendations. Most SSA countries are 
      characterized by (extreme) poverty, very weak health systems, inadequate and low 
      quality of health services, inaccessibility to existing health facilities, lack 
      of (qualified) health personnel, lack of adequate equipment, inaccessibility and 
      unaffordability of medicines, and heavy workload in a context of a double burden 
      of disease. Additionally, there is dearth of data on the incidence and predictive 
      factors of ART-related adverse effects in SSA, to anticipate on strategies that 
      should be put in place to prevent the occurrence of these conditions or properly 
      estimate the upcoming burden and prepare an adequate response plan. These are 
      required if we are to anticipate and effectively prevent this upcoming burden. 
      CONCLUSION: While SSA would be the first region to experience the huge benefits 
      of implementing the "test and treat" policy of the WHO, the region is not yet 
      prepared to manage the consequential increased burden of ART-related toxic and 
      metabolic complications. Urgent measures should be taken to fill the lacunae if 
      SSA is not to become over-burdened by the consequences of the "test and treat" 
      policy.
FAU - Nansseu, Jobert Richie N
AU  - Nansseu JR
AD  - Department of Public Health, Faculty of Medicine and Biomedical Sciences of the 
      University of Yaounde I, PO Box 1364, Yaounde, Cameroon. 
      jobertrichie_nansseu@yahoo.fr.
AD  - Sickle Cell Disease Unit, Mother and Child Centre of the Chantal Biya Foundation, 
      Yaounde, Cameroon. jobertrichie_nansseu@yahoo.fr.
FAU - Bigna, Jean Joel R
AU  - Bigna JJ
AD  - Department of Epidemiology and Public Health, Centre Pasteur of Cameroon, 
      Yaounde, Cameroon.
AD  - Faculty of Medicine, University of Paris Sud XI, Le Kremlin Bicetre, Paris, 
      France.
LA  - eng
PT  - Journal Article
DEP - 20170215
PL  - England
TA  - Infect Dis Poverty
JT  - Infectious diseases of poverty
JID - 101606645
RN  - 0 (Anti-HIV Agents)
SB  - IM
MH  - Acquired Immunodeficiency Syndrome/drug therapy/virology
MH  - Africa South of the Sahara/epidemiology
MH  - Anti-HIV Agents/*adverse effects/therapeutic use
MH  - Antiretroviral Therapy, Highly Active/*adverse effects
MH  - HIV Infections/diagnosis/*drug therapy/epidemiology/virology
MH  - *Health Policy
MH  - Humans
MH  - Poverty
MH  - Prevalence
MH  - *World Health Organization
PMC - PMC5310075
OTO - NOTNLM
OT  - 90-90-90
OT  - Antiretroviral therapy
OT  - HIV/AIDS
OT  - Sub-Saharan Africa
OT  - Test and treat
EDAT- 2017/02/16 06:00
MHDA- 2017/03/01 06:00
PMCR- 2017/02/15
CRDT- 2017/02/16 06:00
PHST- 2016/09/06 00:00 [received]
PHST- 2017/01/10 00:00 [accepted]
PHST- 2017/02/16 06:00 [entrez]
PHST- 2017/02/16 06:00 [pubmed]
PHST- 2017/03/01 06:00 [medline]
PHST- 2017/02/15 00:00 [pmc-release]
AID - 10.1186/s40249-017-0240-3 [pii]
AID - 240 [pii]
AID - 10.1186/s40249-017-0240-3 [doi]
PST - epublish
SO  - Infect Dis Poverty. 2017 Feb 15;6(1):24. doi: 10.1186/s40249-017-0240-3.

PMID- 18284441
OWN - NLM
STAT- MEDLINE
DCOM- 20080930
LR  - 20220316
IS  - 1742-1241 (Electronic)
IS  - 1368-5031 (Linking)
VI  - 62
IP  - 8
DP  - 2008 Aug
TI  - Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, 
      cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
PG  - 1206-11
LID - 10.1111/j.1742-1241.2007.01675.x [doi]
AB  - AIM: There are more than 350 million people worldwide chronically infected with 
      hepatitis B virus (HBV), who are at high risk for the development of hepatitis, 
      cirrhosis and hepatocellular carcinoma (HCC). Because of the conflicting results 
      about c-kit expression in HCC and the key role played by c-kit in 
      gastrointestinal stromal tumours (GIST) and other solid tumours, the aim of this 
      study was to determine c-kit expression in the course of hepatitis B infection. 
      MATERIALS AND METHODS: Paraffin-embedded tissues in Cukurova University Faculty 
      of Medicine Department of Pathology between January 2002 and February 2006 were 
      searched restrospectively to investigate this issue. We performed 
      immunohistochemistry on biopsies of 125 patients with HBV infection, grouped as: 
      mild, moderate and severe hepatitis, cirrhosis and HCC, 25 patients in each of 
      them, using anti c-kit monoclonal antibody. The severity of parenchymal 
      inflammation and of interface hepatitis was semiquantitatively graded on a 
      haematoxylin and eosin stained paraffin sections. Additionally, 50 more HCC, 
      formed on HBV basis, were studied to determine the prevalence of c-kit 
      overexpression. RESULTS: In cirrhotic liver, lower intensity of staining and 
      rarely c-kit positivity were present. The greatest number of the c-kit positivity 
      and higher intensity of staining was found in the livers of patients with severe 
      hepatitis and HCC. In chronic hepatitis B infection, the staining intensity was 
      parallel with the grade and stage of the disease. In the areas where fibrosis was 
      seen, c-kit positivity was rare or absent. In the HCC specimens, c-kit positivity 
      appeared both inside and around the cancerous nodes. C-kit expression was 
      observed in 62 of 75 HCC tissue specimens (82%) (p < 0.001). CONCLUSIONS: C-kit 
      positivity was observed in the mitotic, proliferating and also dysplastic hepatic 
      cells. These results suggest that c-kit expression may be used as an early 
      diagnostic indicator for HBV induced HCC.
FAU - Kara, B
AU  - Kara B
AD  - Department of Gastroenterology, Faculty of Medicine, Cukurova University, Adana, 
      Turkey. banu97@superonline.com
FAU - Doran, F
AU  - Doran F
FAU - Kara, I O
AU  - Kara IO
FAU - Akkiz, H
AU  - Akkiz H
FAU - Sandikci, M
AU  - Sandikci M
LA  - eng
PT  - Journal Article
DEP - 20080218
PL  - United States
TA  - Int J Clin Pract
JT  - International journal of clinical practice
JID - 9712381
RN  - 0 (Biomarkers, Tumor)
RN  - EC 2.7.10.1 (Proto-Oncogene Proteins c-kit)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Biomarkers, Tumor/*metabolism
MH  - Biopsy/methods
MH  - Carcinoma, Hepatocellular/*diagnosis/etiology
MH  - Early Diagnosis
MH  - Female
MH  - Hepatitis B, Chronic/complications/*pathology
MH  - Hepatocytes/pathology
MH  - Humans
MH  - Immunohistochemistry
MH  - Liver Cirrhosis/complications/*pathology
MH  - Liver Neoplasms/*diagnosis/etiology
MH  - Male
MH  - Middle Aged
MH  - Multivariate Analysis
MH  - Proto-Oncogene Proteins c-kit/*metabolism
MH  - Severity of Illness Index
EDAT- 2008/02/21 09:00
MHDA- 2008/10/01 09:00
CRDT- 2008/02/21 09:00
PHST- 2008/02/21 09:00 [pubmed]
PHST- 2008/10/01 09:00 [medline]
PHST- 2008/02/21 09:00 [entrez]
AID - IJCP1675 [pii]
AID - 10.1111/j.1742-1241.2007.01675.x [doi]
PST - ppublish
SO  - Int J Clin Pract. 2008 Aug;62(8):1206-11. doi: 10.1111/j.1742-1241.2007.01675.x. 
      Epub 2008 Feb 18.

PMID- 18802997
OWN - NLM
STAT- MEDLINE
DCOM- 20081021
LR  - 20220330
IS  - 1572-0241 (Electronic)
IS  - 0002-9270 (Linking)
VI  - 103
IP  - 8
DP  - 2008 Aug
TI  - Can calprotectin predict relapse risk in inflammatory bowel disease?
PG  - 2007-14
AB  - OBJECTIVE: Assessing the clinical course of inflammatory bowel disease (IBD) 
      patients consists of periodical clinical evaluations and laboratory tests. We 
      aimed to assess the role of calprotectin tests in predicting clinical relapse in 
      IBD patients. METHODS: Ninety-seven patients with ulcerative colitis (UC) and 65 
      with Crohn's disease (CD) in clinical remission were prospectively included in 
      the study. A 10-g stool sample was collected for calprotectin assay. The cutoff 
      level was set at 130 mg/kg of feces. Patients were followed up for 1 yr after the 
      test or until relapse. The cumulative proportion of relapses was estimated by the 
      Kaplan-Meier analysis. Statistics for equality of survival distribution were 
      tested using the log-rank test. RESULTS: The calprotectin test was positive in 44 
      UC patients and 26 of them relapsed within a year, while 11 of 53 UC patients 
      with a negative calprotectin test relapsed within the same time frame. Thirty CD 
      patients had a positive calprotectin test and 13 of them relapsed within a year, 
      as did 7 of the 35 with a negative test result. A significant correlation emerged 
      between a positive calprotectin test and the probability of relapse in UC 
      patients (P= 0.000). In CD patients, only cases of colonic CD showed a 
      significant correlation between a positive calprotectin test and the probability 
      of relapse, i.e., 6 colonic CD patients were positive for the calprotectin test 
      and 4 relapsed (P= 0.02). CONCLUSIONS: Measuring calprotectin may help to 
      identify UC and colonic CD patients at higher risk of clinical relapse.
FAU - D'Inca, Renata
AU  - D'Inca R
AD  - Department of Surgical and Gastroenterological Sciences, University of Padua, 
      Padua, Italy.
FAU - Dal Pont, Elisabetta
AU  - Dal Pont E
FAU - Di Leo, Vincenza
AU  - Di Leo V
FAU - Benazzato, Luca
AU  - Benazzato L
FAU - Martinato, Matteo
AU  - Martinato M
FAU - Lamboglia, Francesca
AU  - Lamboglia F
FAU - Oliva, Lydia
AU  - Oliva L
FAU - Sturniolo, Giacomo Carlo
AU  - Sturniolo GC
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
PL  - United States
TA  - Am J Gastroenterol
JT  - The American journal of gastroenterology
JID - 0421030
RN  - 0 (Leukocyte L1 Antigen Complex)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Colitis, Ulcerative/*diagnosis/*metabolism/therapy
MH  - Crohn Disease/*diagnosis/*metabolism/therapy
MH  - Disease-Free Survival
MH  - Feces/chemistry
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Leukocyte L1 Antigen Complex/*metabolism
MH  - Male
MH  - Middle Aged
MH  - Predictive Value of Tests
MH  - Prospective Studies
MH  - ROC Curve
MH  - Recurrence
EDAT- 2008/09/20 09:00
MHDA- 2008/10/22 09:00
CRDT- 2008/09/20 09:00
PHST- 2008/09/20 09:00 [pubmed]
PHST- 2008/10/22 09:00 [medline]
PHST- 2008/09/20 09:00 [entrez]
AID - 10.1111/j.1572-0241.2008.01870.x [doi]
PST - ppublish
SO  - Am J Gastroenterol. 2008 Aug;103(8):2007-14. doi: 
      10.1111/j.1572-0241.2008.01870.x.

PMID- 17621202
OWN - NLM
STAT- MEDLINE
DCOM- 20070808
LR  - 20220310
IS  - 1528-1159 (Electronic)
IS  - 0362-2436 (Linking)
VI  - 32
IP  - 15
DP  - 2007 Jul 1
TI  - Does shaving the incision site increase the infection rate after spinal surgery?
PG  - 1575-7
AB  - STUDY DESIGN: A prospective randomized clinical study. OBJECTIVE: To determine 
      whether shaving the incision site before spinal surgery causes postsurgical 
      infection. SUMMARY OF BACKGROUND DATA: Spine surgeons usually shave the skin of 
      the incision site immediately before surgery is performed. However, evidence from 
      some surgical series suggests that presurgical shaving may increase the 
      postsurgical infection rate. To our knowledge, no previously published studies 
      have addressed this issue. METHODS: A total of 789 patients scheduled to undergo 
      spinal surgery were randomly allocated into 2 groups: those in whom the site of 
      operation was shaved immediately before surgery (shaved group; 371 patients) and 
      the patients in whom presurgical shaving was not performed (unshaved group; 418 
      patients). The mean duration of anesthesia and the infection rates in both groups 
      were recorded and compared. RESULTS: The duration of anesthesia did not differ in 
      the 2 groups (P > 0.05). A postoperative infection developed in 4 patients in the 
      shaved group and in 1 patient in the nonshaved group (P < 0.01). CONCLUSIONS: The 
      shaving of the incision site immediately before spinal surgery may increase the 
      rate of postoperative infection.
FAU - Celik, Suat E
AU  - Celik SE
AD  - Department of Neurosurgery, Beyoglu State Hospital, Istanbul, Turkey. 
      suaterolcelik@yahoo.com
FAU - Kara, Ayhan
AU  - Kara A
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
PL  - United States
TA  - Spine (Phila Pa 1976)
JT  - Spine
JID - 7610646
RN  - 0 (Anti-Bacterial Agents)
SB  - IM
CIN - Spine (Phila Pa 1976). 2008 May 1;33(10):1156; author reply 1156. doi: 
      10.1097/BRS.0b013e31816f6988. PMID: 18449054
MH  - Adult
MH  - Anti-Bacterial Agents/therapeutic use
MH  - Dermatologic Surgical Procedures
MH  - Double-Blind Method
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Neurosurgical Procedures/*adverse effects
MH  - Preoperative Care/*adverse effects/statistics & numerical data
MH  - Prospective Studies
MH  - Skin/microbiology
MH  - Spinal Diseases/*surgery
MH  - Surgical Wound Infection/*epidemiology/prevention & control
EDAT- 2007/07/11 09:00
MHDA- 2007/08/09 09:00
CRDT- 2007/07/11 09:00
PHST- 2007/07/11 09:00 [pubmed]
PHST- 2007/08/09 09:00 [medline]
PHST- 2007/07/11 09:00 [entrez]
AID - 00007632-200707010-00002 [pii]
AID - 10.1097/BRS.0b013e318074c39f [doi]
PST - ppublish
SO  - Spine (Phila Pa 1976). 2007 Jul 1;32(15):1575-7. doi: 
      10.1097/BRS.0b013e318074c39f.

PMID- 11411430
OWN - NLM
STAT- MEDLINE
DCOM- 20011101
LR  - 20190515
IS  - 1058-0468 (Print)
IS  - 1573-7330 (Electronic)
IS  - 1058-0468 (Linking)
VI  - 18
IP  - 3
DP  - 2001 Mar
TI  - Antral follicle assessment as a tool for predicting outcome in IVF--is it a 
      better predictor than age and FSH?
PG  - 151-5
AB  - PURPOSE: The purpose of this study is to determine if baseline antral follicle 
      assessment may serve as additional information in predicting in vitro 
      fertilization outcome. METHODS: Prospective, descriptive preliminary study of in 
      vitro fertilization outcome. From July 1998 to July 1999, 224 patients underwent 
      antral follicle assessment (follicle 2-6 mm in diameter) on baseline of the 
      planned, stimulated in vitro fertilization cycle. The outcomes were analyzed with 
      respect to antral follicle assessment (< or = 6 or > 6), basal cycle day 3 
      follicle stimulated hormone (< or = 10 or > 10 IU/L) and maternal age (< or = 35 
      or > 35 years). RESULTS: The clinical pregnancy rate was significantly higher in 
      the group with baseline antral follicle > 6 compared to that in the group with 
      antral follicle < or = 6 (51% vs. 19%, respectively). Controlling for patient 
      age, and basal follicle stimulated hormone, the pregnancy rate was significantly 
      higher in the group with antral follicle > 6 compared to that in the group with 
      antral follicle < or = 6. The cancellation rate was significantly increased with 
      advancing maternal age, elevated basal follicle stimulated hormone levels, and 
      baseline antral follicle < or = 6. The cancellation rate was significantly higher 
      in the group with antral follicle < or = 6 compared to that in the group with 
      antral follicle > or = 6 (33% vs. 1%, respectively). CONCLUSIONS: In vitro 
      fertilization outcome is strongly correlated with both maternal ages, basal 
      cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral 
      follicle assessment was a better predictor of in vitro fertilization outcome than 
      were age or follicle stimulated hormone. Antral follicle assessment may provide a 
      marker for ovarian age that is distinct from chronological age or hormonal 
      markers.
FAU - Nahum, R
AU  - Nahum R
AD  - The Vincent IVF Unit, Department of Obstetrics and Gynecology, and Department of 
      Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, 
      Massachusetts, USA.
FAU - Shifren, J L
AU  - Shifren JL
FAU - Chang, Y
AU  - Chang Y
FAU - Leykin, L
AU  - Leykin L
FAU - Isaacson, K
AU  - Isaacson K
FAU - Toth, T L
AU  - Toth TL
LA  - eng
PT  - Journal Article
PL  - Netherlands
TA  - J Assist Reprod Genet
JT  - Journal of assisted reproduction and genetics
JID - 9206495
RN  - 9002-68-0 (Follicle Stimulating Hormone)
SB  - IM
MH  - Adult
MH  - Age Factors
MH  - Female
MH  - *Fertilization in Vitro
MH  - Follicle Stimulating Hormone/*blood
MH  - Humans
MH  - Logistic Models
MH  - Male
MH  - Ovarian Follicle/diagnostic imaging/*physiology
MH  - Ovulation Induction
MH  - Pilot Projects
MH  - Predictive Value of Tests
MH  - Pregnancy
MH  - *Pregnancy Outcome
MH  - Prospective Studies
MH  - Ultrasonography
PMC - PMC3455595
EDAT- 2001/06/20 10:00
MHDA- 2001/11/03 10:01
PMCR- 2002/03/01
CRDT- 2001/06/20 10:00
PHST- 2001/06/20 10:00 [pubmed]
PHST- 2001/11/03 10:01 [medline]
PHST- 2001/06/20 10:00 [entrez]
PHST- 2002/03/01 00:00 [pmc-release]
AID - 293755 [pii]
AID - 10.1023/a:1009424407082 [doi]
PST - ppublish
SO  - J Assist Reprod Genet. 2001 Mar;18(3):151-5. doi: 10.1023/a:1009424407082.

PMID- 26708803
OWN - NLM
STAT- MEDLINE
DCOM- 20171019
LR  - 20171019
IS  - 1873-4898 (Electronic)
IS  - 1477-5131 (Linking)
VI  - 12
IP  - 5
DP  - 2016 Oct
TI  - Treatment of contralateral hydrocele in neonatal testicular torsion: Is less 
      more?
PG  - 306.e1-306.e4
LID - S1477-5131(15)00308-3 [pii]
LID - 10.1016/j.jpurol.2015.07.009 [doi]
AB  - OBJECTIVE: Treatment of neonatal testicular torsion has two objectives: salvage 
      of the involved testicle (which is rarely achieved) and preservation of the 
      contralateral gonad. The second goal universally involves contralateral 
      testicular scrotal fixation to prevent the future occurrence of contralateral 
      torsion. However, there is controversy with regards to management of a 
      synchronous contralateral hydrocele. It has been our policy not to address the 
      contralateral hydrocele through an inguinal incision to minimize potential injury 
      to the spermatic cord. Our objective in this study was to determine whether the 
      decision to manage a contralateral hydrocele in cases of neonatal testicular 
      torsion solely through a scrotal approach is safe and effective. PATIENTS AND 
      METHOD: We reviewed all cases of neonatal testicular torsion occurring at our 
      institution between the years 1999 and 2006. Age at presentation, physical 
      examination, ultrasonographic and intraoperative findings were recorded. Patients 
      were followed after initial surgical intervention to determine the likelihood of 
      developing a subsequent hydrocele or hernia. RESULTS: Thirty-seven patients were 
      identified as presenting with neonatal torsion. Age of presentation averaged 3.5 
      days (range 1-14 days). Left-sided pathology was seen more commonly than the 
      right, with a 25:12 distribution. All torsed testicles were nonviable. Twenty-two 
      patients were noted to have a contralateral hydrocele at presentation. All 
      hydroceles were opened through a scrotal approach at the time of contralateral 
      scrotal fixation. No patient underwent an inguinal exploration to examine for a 
      patent process vaginalis. None of the patients who presented with a hydrocele 
      have developed a clinical hydrocele or hernia after an average 7.5 years (range 
      4.3-11.2) follow-up. CONCLUSION: We have demonstrated that approaching a 
      contralateral hydrocele in cases of neonatal testicular torsion solely through a 
      scrotal incision is safe and effective. Inguinal exploration was not performed in 
      our study and our long-term results demonstrate that such an approach would have 
      brought no additional benefit. In avoiding an inguinal approach we did not 
      subject our patients to unnecessary risk of testicular or vasal injury. 
      Contralateral hydrocele is commonly seen in cases of neonatal testicular torsion. 
      In our experience this is a condition of minimal clinical significance and does 
      not warrant formal inguinal exploration for treatment. This conservative 
      management strategy minimizes the potential of contralateral spermatic cord 
      injury in the neonate. The aims of the study were met.
CI  - Copyright (c) 2015 Journal of Pediatric Urology Company. Published by Elsevier Ltd. 
      All rights reserved.
FAU - Kaefer, Martin
AU  - Kaefer M
AD  - Pediatric Urology, Riley Hospital for Children, Indianapolis, IN, USA. Electronic 
      address: mkaefer@iupui.edu.
FAU - Agarwal, Deepak
AU  - Agarwal D
AD  - Pediatric Urology, Riley Hospital for Children, Indianapolis, IN, USA.
FAU - Misseri, Rosalia
AU  - Misseri R
AD  - Pediatric Urology, Riley Hospital for Children, Indianapolis, IN, USA.
FAU - Whittam, Benjamin
AU  - Whittam B
AD  - Pediatric Urology, Riley Hospital for Children, Indianapolis, IN, USA.
FAU - Hubert, Katherine
AU  - Hubert K
AD  - Pediatric Urology, Riley Hospital for Children, Indianapolis, IN, USA.
FAU - Szymanski, Konrad
AU  - Szymanski K
AD  - Pediatric Urology, Riley Hospital for Children, Indianapolis, IN, USA.
FAU - Rink, Richard
AU  - Rink R
AD  - Pediatric Urology, Riley Hospital for Children, Indianapolis, IN, USA.
FAU - Cain, Mark P
AU  - Cain MP
AD  - Pediatric Urology, Riley Hospital for Children, Indianapolis, IN, USA.
LA  - eng
PT  - Journal Article
DEP - 20150905
PL  - England
TA  - J Pediatr Urol
JT  - Journal of pediatric urology
JID - 101233150
SB  - IM
MH  - Humans
MH  - Infant, Newborn
MH  - Male
MH  - Retrospective Studies
MH  - Spermatic Cord Torsion/*complications
MH  - Testicular Hydrocele/*complications/*surgery
MH  - Urologic Surgical Procedures, Male/methods
OTO - NOTNLM
OT  - Bladder injury
OT  - Hydrocele
OT  - Inguinal hernia
OT  - Neonatal
OT  - Spermatic cord injury
OT  - Testicular torsion
EDAT- 2015/12/29 06:00
MHDA- 2017/10/20 06:00
CRDT- 2015/12/29 06:00
PHST- 2015/01/14 00:00 [received]
PHST- 2015/07/18 00:00 [accepted]
PHST- 2015/12/29 06:00 [pubmed]
PHST- 2017/10/20 06:00 [medline]
PHST- 2015/12/29 06:00 [entrez]
AID - S1477-5131(15)00308-3 [pii]
AID - 10.1016/j.jpurol.2015.07.009 [doi]
PST - ppublish
SO  - J Pediatr Urol. 2016 Oct;12(5):306.e1-306.e4. doi: 10.1016/j.jpurol.2015.07.009. 
      Epub 2015 Sep 5.

PMID- 25079920
OWN - NLM
STAT- MEDLINE
DCOM- 20150309
LR  - 20211021
IS  - 2044-6055 (Print)
IS  - 2044-6055 (Electronic)
IS  - 2044-6055 (Linking)
VI  - 4
IP  - 7
DP  - 2014 Jul 30
TI  - Do parents recall and understand children's weight status information after BMI 
      screening? A randomised controlled trial.
PG  - e004481
LID - 10.1136/bmjopen-2013-004481 [doi]
LID - e004481
AB  - OBJECTIVES: As parents of young children are often unaware their child is 
      overweight, screening provides the opportunity to inform parents and provide the 
      impetus for behaviour change. We aimed to determine if parents could recall and 
      understand the information they received about their overweight child after 
      weight screening. DESIGN: Randomised controlled trial of different methods of 
      feedback. SETTING: Participants were recruited through primary and secondary care 
      but appointments took place at a University research clinic. PARTICIPANTS AND 
      INTERVENTION: 1093 children aged 4-8 years were screened. Only overweight 
      children (n=271, 24.7%) are included in this study. Parents of overweight 
      children were randomised to receive feedback regarding their child's weight using 
      best practice care (BPC) or motivational interviewing (MI) at face-to-face 
      interviews typically lasting 20-40 min. 244 (90%) parents participated in a 
      follow-up interview 2 weeks later to assess recall and understanding of 
      information from the feedback session. PRIMARY AND SECONDARY OUTCOME MEASURES: 
      Interviews were audio-taped and transcribed verbatim before coding for amount and 
      accuracy of recall. Scores were calculated for total recall and sub-categories of 
      interest. RESULTS: Overall, 39% of the information was recalled (mean score 6.3 
      from possible score of 16). Parents given feedback via BPC recalled more than 
      those in the MI group (difference in total score 0.48; 95% CI 0.05 to 0.92). 
      Although 94% of parents were able to correctly recall their child's weight 
      status, fewer than 10 parents could accurately describe what the measurements 
      meant. Maternal education (0.81; 0.25 to 1.37) and parental ratings of how useful 
      they found the information (0.19; 0.04 to 0.35) were significant predictors of 
      recall score in multivariate analyses. CONCLUSIONS: While parents remember that 
      their child's body mass index is higher than recommended, they are unable to 
      remember much of the information and advice provided about the result. TRIAL 
      REGISTRATION NUMBER: Australian New Zealand Clinical Trials Registry 
      ACTRN12609000749202.
CI  - Published by the BMJ Publishing Group Limited. For permission to use (where not 
      already granted under a licence) please go to 
      http://group.bmj.com/group/rights-licensing/permissions.
FAU - Dawson, Anna M
AU  - Dawson AM
AD  - Department of Women's and Children's Health, Dunedin School of Medicine, 
      University of Otago, Dunedin, New Zealand.
FAU - Taylor, Rachael W
AU  - Taylor RW
AD  - Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, 
      New Zealand.
FAU - Williams, Sheila M
AU  - Williams SM
AD  - Department of Preventive and Social Medicine, Dunedin School of Medicine, 
      University of Otago, Dunedin, New Zealand.
FAU - Taylor, Barry J
AU  - Taylor BJ
AD  - Department of Women's and Children's Health, Dunedin School of Medicine, 
      University of Otago, Dunedin, New Zealand.
FAU - Brown, Deirdre A
AU  - Brown DA
AD  - School of Psychology, Victoria University of Wellington, Wellington, New Zealand.
LA  - eng
SI  - ANZCTR/ACTRN12609000749202
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20140730
PL  - England
TA  - BMJ Open
JT  - BMJ open
JID - 101552874
SB  - IM
MH  - Adult
MH  - Body Mass Index
MH  - Body Weight
MH  - Child
MH  - Child, Preschool
MH  - Feedback
MH  - Female
MH  - Humans
MH  - Male
MH  - Mass Screening/*methods
MH  - *Mental Recall
MH  - Middle Aged
MH  - Motivational Interviewing
MH  - Parents/*education/psychology
MH  - *Pediatric Obesity/diagnosis/prevention & control
MH  - Research Design
PMC - PMC4120339
OTO - NOTNLM
OT  - BMI screening
OT  - Health information
OT  - Memory
OT  - Overweight
OT  - Parental recall
EDAT- 2014/08/01 06:00
MHDA- 2015/03/10 06:00
PMCR- 2014/07/30
CRDT- 2014/08/01 06:00
PHST- 2014/08/01 06:00 [entrez]
PHST- 2014/08/01 06:00 [pubmed]
PHST- 2015/03/10 06:00 [medline]
PHST- 2014/07/30 00:00 [pmc-release]
AID - bmjopen-2013-004481 [pii]
AID - 10.1136/bmjopen-2013-004481 [doi]
PST - epublish
SO  - BMJ Open. 2014 Jul 30;4(7):e004481. doi: 10.1136/bmjopen-2013-004481.

PMID- 25793749
OWN - NLM
STAT- MEDLINE
DCOM- 20150810
LR  - 20220318
IS  - 1438-8871 (Electronic)
IS  - 1439-4456 (Print)
IS  - 1438-8871 (Linking)
VI  - 17
IP  - 3
DP  - 2015 Mar 19
TI  - Do Web-based and clinic samples of gay men living with HIV differ on 
      self-reported physical and psychological symptoms? A comparative analysis.
PG  - e57
LID - 10.2196/jmir.3800 [doi]
LID - e57
AB  - BACKGROUND: Although the Internet is commonly used to recruit samples in studies 
      of human immunodeficiency virus (HIV)-related risk behaviors, it has not been 
      used to measure patient-reported well-being. As the burden of long-term chronic 
      HIV infection rises, the Internet may offer enormous potential for recruitment to 
      research and interventions. OBJECTIVE: This study aimed to compare two samples of 
      gay men living with HIV, one recruited via the Web and the other recruited in 
      outpatient settings, in terms of self-reported physical and psychological symptom 
      burden. METHODS: The Internet sample was recruited from a UK-wide Web-based 
      survey of gay men with diagnosed HIV. Of these, 154 respondents identified 
      themselves as resident in London and were included in this analysis. The HIV 
      clinic sample was recruited from five HIV outpatient clinics. Of these 
      participants, 400 gay men recruited in London clinics were included in this 
      analysis. RESULTS: The Web-based sample was younger than the clinic sample (37.3 
      years, SD 7.0 vs 40.9 years, SD 8.3), more likely to be in paid employment 
      (72.8%, 99/136 vs 60.1%, 227/378), less likely to be on antiretroviral therapy 
      (ART) (58.4%, 90/154 vs 68.0%, 266/391), and had worse mean psychological symptom 
      burden compared to the clinic sample (mean scores: 1.61, SD 1.09 vs 1.36, SD 
      0.96) but similar physical symptom burden (mean scores: 0.78, SD 0.65 vs 0.70, SD 
      0.74). In multivariable logistic regression, for the physical symptom burden 
      model, adjusted for age, ethnicity, employment status, and ART use, the 
      recruitment setting (ie, Web-based vs clinic) was not significantly associated 
      with high physical symptom score. The only variable that remained significantly 
      associated with high physical symptom score was employment status, with those in 
      employment being less likely to report being in the upper (worst) physical 
      symptom tertile versus the other two tertiles (adjusted OR 0.41, 95% CI 
      0.28-0.62, P<.001). For the psychological symptom burden model, those recruited 
      via the Web were significantly more likely to report being in the upper (worst) 
      tertile (adjusted OR 2.20, 95% CI 1.41-3.44, P=.001). In addition, those in 
      employment were less likely to report being in the upper (worst) psychological 
      symptom tertile compared to those not in employment (adjusted OR 0.32, 95% CI 
      0.21-0.49, P<.001). CONCLUSIONS: Our data have revealed a number of differences. 
      Compared to the clinic sample, the Web-based sample had worse psychological 
      symptom burden, younger average age, higher prevalence of employment, and a lower 
      proportion on ART. For future research, we recommend that Web-based data 
      collection should include the demographic variables that we note differed between 
      samples. In addition, we recognize that each recruitment method may bring 
      inherent sampling bias, with clinic populations differing by geographical 
      location and reflecting those accessing regular medical care, and Web-based 
      sampling recruiting those with greater Internet access and identifying survey 
      materials through specific searches and contact with specific websites.
FAU - Harding, Richard
AU  - Harding R
AUID- ORCID: 0000-0001-9653-8689
AD  - Cicely Saunders Institute, Department of Palliative Care, Policy & 
      Rehabilitation, King's College London, London, United Kingdom. 
      richard.harding@kcl.ac.uk.
FAU - Lampe, Fiona
AU  - Lampe F
AUID- ORCID: 0000-0001-6851-5471
FAU - Molloy, Tim
AU  - Molloy T
FAU - Sherr, Lorraine
AU  - Sherr L
AUID- ORCID: 0000-0002-5902-8011
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150319
PL  - Canada
TA  - J Med Internet Res
JT  - Journal of medical Internet research
JID - 100959882
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Ambulatory Care Facilities
MH  - Cost of Illness
MH  - Data Collection/methods
MH  - Employment
MH  - Ethnicity
MH  - *HIV Infections/complications/psychology
MH  - *Homosexuality, Male
MH  - Humans
MH  - *Internet
MH  - Male
MH  - Middle Aged
MH  - *Patient Selection
MH  - Risk-Taking
MH  - Self Report
MH  - United Kingdom
PMC - PMC4383834
OTO - NOTNLM
OT  - HIV
OT  - Internet
OT  - mental health
OT  - methods
OT  - pain
OT  - recruitment
OT  - sampling
OT  - symptoms
COIS- Conflicts of Interest: None declared.
EDAT- 2015/03/21 06:00
MHDA- 2015/08/11 06:00
PMCR- 2015/03/19
CRDT- 2015/03/21 06:00
PHST- 2014/08/21 00:00 [received]
PHST- 2015/01/21 00:00 [accepted]
PHST- 2014/12/04 00:00 [revised]
PHST- 2015/03/21 06:00 [entrez]
PHST- 2015/03/21 06:00 [pubmed]
PHST- 2015/08/11 06:00 [medline]
PHST- 2015/03/19 00:00 [pmc-release]
AID - v17i3e57 [pii]
AID - 10.2196/jmir.3800 [doi]
PST - epublish
SO  - J Med Internet Res. 2015 Mar 19;17(3):e57. doi: 10.2196/jmir.3800.

PMID- 19103915
OWN - NLM
STAT- MEDLINE
DCOM- 20090427
LR  - 20211020
IS  - 1355-8196 (Print)
IS  - 1355-8196 (Linking)
VI  - 14
IP  - 1
DP  - 2009 Jan
TI  - Are home sampling kits for sexually transmitted infections acceptable among men 
      who have sex with men?
PG  - 35-43
LID - 10.1258/jhsrp.2008.007065 [doi]
AB  - OBJECTIVE: There is an urgent need to increase opportunistic screening for 
      sexually transmitted infections (STIs) in community settings, particularly for 
      those who are at increased risk including men who have sex with men (MSM). The 
      aim of this qualitative study was to explore whether home sampling kits (HSK) for 
      multiple bacterial STIs are potentially acceptable among MSM and to identify any 
      concerns regarding their use. This study was developed as part of a formative 
      evaluation of HSKs. METHODS: Focus groups and one-to-one semi-structured 
      interviews with MSM were conducted. Focus group participants (n = 20) were shown 
      a variety of self-sampling materials and asked to discuss them. Individual 
      interviewees (n = 24) had experience of the self-sampling techniques as part of a 
      pilot clinical study. All data were digitally recorded and transcribed verbatim. 
      Data were analysed using a framework analysis approach. RESULTS: The concept of a 
      HSK was generally viewed as positive, with many benefits identified relating to 
      increased access to testing, enhanced personal comfort and empowerment. Concerns 
      about the accuracy of the test, delays in receiving the results, the possible 
      lack of support and potential negative impact on 'others' were raised. 
      CONCLUSION: The widespread acceptability of using HSKs for the diagnosis of STIs 
      could have important public health impacts in terms of earlier diagnosis of 
      asymptomatic infections and thus a decrease in the rate of onward transmission. 
      In addition, HSKs could potentially optimize the use of genitourinary medicine 
      services and facilitate patient choice.
FAU - Llewellyn, Carrie
AU  - Llewellyn C
AD  - Division of Public Health & Primary Care, Brighton & Sussex Medical School, 
      Brighton. c.d.llewellyn@bsms.ac.uk
FAU - Pollard, Alex
AU  - Pollard A
FAU - Smith, Helen
AU  - Smith H
FAU - Fisher, Martin
AU  - Fisher M
CN  - Home Sampling Kit Study Group
LA  - eng
GR  - G0300706/MRC_/Medical Research Council/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - J Health Serv Res Policy
JT  - Journal of health services research & policy
JID - 9604936
RN  - 0 (Reagent Kits, Diagnostic)
MH  - Adult
MH  - Bisexuality/*psychology
MH  - Feasibility Studies
MH  - Focus Groups
MH  - *Health Knowledge, Attitudes, Practice
MH  - Homosexuality, Male/*psychology
MH  - Humans
MH  - Interviews as Topic
MH  - Male
MH  - Mass Screening/*instrumentation/methods
MH  - Middle Aged
MH  - Patient Acceptance of Health Care/*statistics & numerical data
MH  - Qualitative Research
MH  - Reagent Kits, Diagnostic/*statistics & numerical data
MH  - Risk-Taking
MH  - Sexually Transmitted Diseases/*diagnosis/microbiology
MH  - United Kingdom
MH  - Young Adult
EDAT- 2008/12/24 09:00
MHDA- 2009/04/28 09:00
CRDT- 2008/12/24 09:00
PHST- 2008/12/24 09:00 [entrez]
PHST- 2008/12/24 09:00 [pubmed]
PHST- 2009/04/28 09:00 [medline]
AID - 14/1/35 [pii]
AID - 10.1258/jhsrp.2008.007065 [doi]
PST - ppublish
SO  - J Health Serv Res Policy. 2009 Jan;14(1):35-43. doi: 10.1258/jhsrp.2008.007065.

PMID- 11867487
OWN - NLM
STAT- MEDLINE
DCOM- 20020328
LR  - 20220330
IS  - 0306-3674 (Print)
IS  - 1473-0480 (Electronic)
IS  - 0306-3674 (Linking)
VI  - 36
IP  - 1
DP  - 2002 Feb
TI  - Does rugby headgear prevent concussion? Attitudes of Canadian players and 
      coaches.
PG  - 19-22
AB  - OBJECTIVES: To examine the attitudes of players and coaches to the use of 
      protective headgear, particularly with respect to the prevention of concussion. 
      METHODS: A questionnaire designed to assess attitudes to headgear was 
      administered to 63 players from four different Canadian teams, each representing 
      a different level of play (high school, university, community club, national). In 
      addition, coaches from all four levels were questioned about team policies and 
      their personal opinions about the use of headgear to prevent concussion. RESULTS: 
      Although the players tended to believe that the headgear could prevent concussion 
      (62%), the coaches were less convinced (33%). Despite the players' belief that 
      headgear offers protection against concussion, only a minority reported wearing 
      headgear (27%) and few (24%) felt that its use should be made mandatory. Common 
      reasons for not wearing headgear were "its use is not mandatory", "it is 
      uncomfortable", and "it costs too much". CONCLUSION: Although most players in the 
      study believe that rugby headgear may prevent concussion, only a minority 
      reported wearing it. Coaches tended to be less convinced than the players that 
      rugby headgear can prevent concussion.
FAU - Pettersen, J A
AU  - Pettersen JA
AD  - University of Toronto, Toronto, Canada. 
      Jacqueline.Pettersen@CalgaryHealthRegion.ca
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - Br J Sports Med
JT  - British journal of sports medicine
JID - 0432520
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Athletic Injuries/*prevention & control
MH  - Brain Concussion/prevention & control
MH  - Canada
MH  - Female
MH  - Football/education/*injuries
MH  - Head Protective Devices/*statistics & numerical data
MH  - *Health Knowledge, Attitudes, Practice
MH  - Humans
MH  - Male
MH  - Sports Equipment/*statistics & numerical data
MH  - Surveys and Questionnaires
PMC - PMC1724442
EDAT- 2002/02/28 10:00
MHDA- 2002/03/29 10:01
PMCR- 2005/02/01
CRDT- 2002/02/28 10:00
PHST- 2002/02/28 10:00 [pubmed]
PHST- 2002/03/29 10:01 [medline]
PHST- 2002/02/28 10:00 [entrez]
PHST- 2005/02/01 00:00 [pmc-release]
AID - 10.1136/bjsm.36.1.19 [doi]
PST - ppublish
SO  - Br J Sports Med. 2002 Feb;36(1):19-22. doi: 10.1136/bjsm.36.1.19.

PMID- 12630042
OWN - NLM
STAT- MEDLINE
DCOM- 20030610
LR  - 20041117
IS  - 0172-6390 (Print)
IS  - 0172-6390 (Linking)
VI  - 50
IP  - 49
DP  - 2003 Jan-Feb
TI  - Does body mass index (BMI) influence morbidity and long-term survival in gastric 
      cancer patients after gastrectomy?
PG  - 284-8
AB  - BACKGROUND/AIMS: The long-term survival of patients with gastric cancer is 
      governed by various factors, such as the clinical stage of the cancer, the 
      patient's nutritional state, and the treatment and may be governed by the volume 
      of intraperitoneal adipose tissue. The aim of this study is to clarify the 
      relationship between the degree of the patients' body mass index and their 
      long-term survival. METHODOLOGY: Gastric cancer patients who had undergone a 
      gastrectomy with D2-lymphadenectomy and with resection A and B according to the 
      criteria of the Japanese Research Society for Gastric Cancer Rules were 
      subgrouped into those patients with a body mass index < 0.185 (the lower body 
      mass index group) and those patients with a body mass index > 0.210 (the higher 
      body mass index group). The patient's morbidity and long-term survival rate was 
      retrospectively compared between the 2 groups. RESULTS: A significantly longer 
      mean survival rate was observed for the lower body mass index group in stage 2 
      (1667 vs. 1322 days, P = 0.0240). Also, a significantly longer mean survival rate 
      was observed for the higher BMI group in stage 3a (1431 vs. 943, P = 0.0071). 
      CONCLUSIONS: The body mass index is one of the prognostic factors of stage 2 and 
      stage 3a gastric cancer. However, it does not appear to be useful for determining 
      the prognosis of stage 1a, 1b, 3b, and 4a gastric cancers.
FAU - Moriwaki, Yoshihiro
AU  - Moriwaki Y
AD  - Department of Surgery, Fujisawa Municipal Hospital, Kanagawa, Japan.
FAU - Kunisaki, Chikara
AU  - Kunisaki C
FAU - Kobayashi, Syunsuke
AU  - Kobayashi S
FAU - Harada, Hirofumi
AU  - Harada H
FAU - Imai, Shinsuke
AU  - Imai S
FAU - Kasaoka, Chitaka
AU  - Kasaoka C
LA  - eng
PT  - Journal Article
PL  - Greece
TA  - Hepatogastroenterology
JT  - Hepato-gastroenterology
JID - 8007849
SB  - IM
MH  - Adult
MH  - Aged
MH  - *Body Mass Index
MH  - Female
MH  - Gastrectomy/*adverse effects
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Recurrence, Local/*etiology/*mortality/pathology
MH  - Neoplasm Staging
MH  - *Postoperative Complications
MH  - Prognosis
MH  - Retrospective Studies
MH  - Risk Factors
MH  - Stomach Neoplasms/*mortality/pathology/*surgery
MH  - Survival Rate
MH  - Time Factors
EDAT- 2003/03/13 04:00
MHDA- 2003/06/11 05:00
CRDT- 2003/03/13 04:00
PHST- 2003/03/13 04:00 [pubmed]
PHST- 2003/06/11 05:00 [medline]
PHST- 2003/03/13 04:00 [entrez]
PST - ppublish
SO  - Hepatogastroenterology. 2003 Jan-Feb;50(49):284-8.

PMID- 19468282
OWN - NLM
STAT- MEDLINE
DCOM- 20100201
LR  - 20220409
IS  - 1476-5624 (Electronic)
IS  - 1362-4393 (Linking)
VI  - 47
IP  - 11
DP  - 2009 Nov
TI  - Is determination between complete and incomplete traumatic spinal cord injury 
      clinically relevant? Validation of the ASIA sacral sparing criteria in a 
      prospective cohort of 432 patients.
PG  - 809-16
LID - 10.1038/sc.2009.44 [doi]
AB  - STUDY DESIGN: Prospective multicenter longitudinal cohort study. OBJECTIVE: To 
      validate the prognostic value of the acute phase sacral sparing measurements with 
      regard to chronic phase-independent ambulation in patients with traumatic spinal 
      cord injury (SCI). SETTING: European Multicenter Study of Human Spinal Cord 
      Injury (EM-SCI). METHODS: In 432 patients, acute phase (0-15 days) American 
      Spinal Injury Association (ASIA)/International Spinal Cord Society neurological 
      standard scale (AIS) grades, ASIA sacral sparing measurements, which are S4-5 
      light touch (LT), S4-5 pin prick (PP), anal sensation and voluntary anal 
      contraction; and chronic phase (6 or 12 months) indoor mobility Spinal Cord 
      Independence Measure (SCIM) measurements were analyzed. Calculations of positive 
      and negative predictive values (PPV/NPV) as well as univariate and multivariate 
      logistic regressions were performed in all four sacral sparing criteria. The area 
      under the receiver-operating characteristic curve (AUC) ratios of all regression 
      equations was calculated. RESULTS: To achieve independent ambulation 1-year post 
      injury, a normal S4-5 PP score showed the best PPV (96.5%, P<0.001, 95% 
      confidence interval (95% CI): 87.9-99.6). Best NPV was reported in the S4-5 LT 
      score (91.7%, P<0.001, 95% CI: 81.6-97.2). The use of the combination of only 
      voluntary anal contraction and the S4-5 LT and PP sensory scores (AUC: 0.906, 
      P<0.001, 95% CI: 0.871-0.941) showed significantly better (P<0.001, 95% CI: 
      0.038-0.128) discriminating results in prognosticating 1-year independent 
      ambulation than with the use of currently used distinction between complete and 
      incomplete SCI (AUC: 0.823, P<0.001, 95% CI: 0.781-0.864). CONCLUSIONS: Out of 
      the four sacral sparing criteria, the acute phase anal sensory score measurements 
      do not contribute significantly to the prognosis of independent ambulation. The 
      combination of the acute phase voluntary anal contraction and the S4-5 LT and PP 
      scores, predicts significantly better chronic phase-independent ambulation 
      outcomes than the currently used distinction between complete and incomplete SCI. 
      SPONSORSHIP: This study was granted by 'Acute Zorgregio Oost' and the 
      'Internationale Stiftung fur Forschung in Paraplegie (IFP)'.
FAU - van Middendorp, J J
AU  - van Middendorp JJ
AD  - Spine Unit, Department of Orthopaedics, Radboud University Nijmegen Medical 
      Centre, Orthopaedie, 6500 HB Nijmegen, The Netherlands.
FAU - Hosman, A J F
AU  - Hosman AJ
FAU - Pouw, M H
AU  - Pouw MH
CN  - EM-SCI Study Group
FAU - Van de Meent, H
AU  - Van de Meent H
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, Non-U.S. Gov't
PT  - Validation Study
DEP - 20090526
PL  - England
TA  - Spinal Cord
JT  - Spinal cord
JID - 9609749
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Anal Canal/innervation/physiopathology
MH  - Cohort Studies
MH  - Diagnosis, Differential
MH  - *Disability Evaluation
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Neurologic Examination
MH  - Paralysis/diagnosis/etiology/physiopathology
MH  - Predictive Value of Tests
MH  - Prospective Studies
MH  - Reproducibility of Results
MH  - Sacrum
MH  - *Severity of Illness Index
MH  - Somatosensory Disorders/diagnosis/etiology/physiopathology
MH  - Spinal Cord/pathology/*physiopathology
MH  - Spinal Cord Injuries/*diagnosis/*physiopathology
MH  - Young Adult
EDAT- 2009/05/27 09:00
MHDA- 2010/02/02 06:00
CRDT- 2009/05/27 09:00
PHST- 2009/05/27 09:00 [entrez]
PHST- 2009/05/27 09:00 [pubmed]
PHST- 2010/02/02 06:00 [medline]
AID - sc200944 [pii]
AID - 10.1038/sc.2009.44 [doi]
PST - ppublish
SO  - Spinal Cord. 2009 Nov;47(11):809-16. doi: 10.1038/sc.2009.44. Epub 2009 May 26.

PMID- 16538201
OWN - NLM
STAT- MEDLINE
DCOM- 20100803
LR  - 20191210
IS  - 1643-3750 (Electronic)
IS  - 1234-1010 (Linking)
VI  - 10 Suppl 3
DP  - 2004 Jun
TI  - Does use of hydrophilic guidewires significantly improve technical success rates 
      of peripheral PTA?
PG  - 55-7
AB  - BACKGROUND: To determine whether the use of hydrophilic guidewires has increased 
      the technical success rate of peripheral percutaneous transluminal angioplasty 
      (PTA). MATERIAL/METHODS: We performed 125 procedures and analyzed the technical 
      success rates of PTA using the conventional guidewire first and then if needed, 
      the hydrophilic guidewire for iliac and SFA stenoses or occlusions. Angioplasty 
      was performed on 25 stenosed, 25 occluded iliac arteries and 25 stenosed, 50 
      occluded femoral arteries. The result was defined as technical success when the 
      lesion was crossed by a guidewire and balloon, then it was dilated with 
      restoration of vessel lumen and less than 30% residual stenosis and the rise in 
      ABI values was at least 0.15 after 24 hours. RESULTS: The technical success rate 
      after PTA of stenosed iliac arteries was achieved in 96% (24/25) using 
      conventional wires and 100% using hydrophilic guidewire; in iliac occlusions, the 
      rates were 60% (15/25) and 96%, respectively; in femoral stenosis - 84% (21/25) 
      and 100%; in occlusions in the first group: lesions <10 cm -64% (16/25) and 96%, 
      in the second group: lesions >10 cm -48% (12/25) and 88%. In the iliac group, 
      there was no significant difference in the success of iliac stenosis PTA. 
      However, there were significant changes in the success rates of PTA performed for 
      SFA stenosis and iliac and SFA occlusions. CONCLUSIONS: In summary, we report an 
      overall improvement and high technical success rate for peripherial PTA. The use 
      of hydrophilic guidewires made significant difference to the technical success 
      rate of PTA, especially in occlusion and more complicated lesions.
FAU - Poncyliusz, Wojciech
AU  - Poncyliusz W
AD  - Department of Diagnostic Imaging and Interventional Radiology, Pomeranian Medical 
      University of Szczecin, Poland. wponcyl@poczta.onet.pl
FAU - Falkowski, Aleksander
AU  - Falkowski A
FAU - Walecka, Anna
AU  - Walecka A
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
PL  - United States
TA  - Med Sci Monit
JT  - Medical science monitor : international medical journal of experimental and 
      clinical research
JID - 9609063
SB  - IM
MH  - Angioplasty, Balloon/*instrumentation
MH  - Arterial Occlusive Diseases/therapy
MH  - Constriction, Pathologic
MH  - Femoral Artery
MH  - Humans
MH  - Iliac Artery
MH  - Treatment Outcome
EDAT- 2006/03/16 09:00
MHDA- 2010/08/04 06:00
CRDT- 2006/03/16 09:00
PHST- 2004/03/05 00:00 [received]
PHST- 2004/03/10 00:00 [accepted]
PHST- 2006/03/16 09:00 [pubmed]
PHST- 2010/08/04 06:00 [medline]
PHST- 2006/03/16 09:00 [entrez]
AID - 5268 [pii]
PST - ppublish
SO  - Med Sci Monit. 2004 Jun;10 Suppl 3:55-7.

PMID- 20971618
OWN - NLM
STAT- MEDLINE
DCOM- 20110324
LR  - 20101129
IS  - 1873-569X (Electronic)
IS  - 0923-1811 (Linking)
VI  - 60
IP  - 3
DP  - 2010 Dec
TI  - Are lifetime prevalence of impetigo, molluscum and herpes infection really 
      increased in children having atopic dermatitis?
PG  - 173-8
LID - 10.1016/j.jdermsci.2010.09.003 [doi]
AB  - BACKGROUND: Cutaneous infections such as impetigo contagiosum (IC), molluscum 
      contagiosum (MC) and herpes virus infection (HI) appear to be associated with 
      atopic dermatitis (AD), but there are no reports of concrete epidemiological 
      evidence. OBJECTIVE: We evaluated the association of childhood AD with these 
      infections by conducting a population-based cross-sectional study. METHODS: 
      Enrolled in this study were 1117 children aged 0-6 years old attending nursery 
      schools in Ishigaki City, Okinawa Prefecture, Japan. Physical examination was 
      performed by dermatologists, and a questionnaire was completed on each child's 
      history of allergic diseases including AD, asthma, allergic rhinitis and egg 
      allergy, and that of skin infections including IC, MC and HI, as well as familial 
      history of AD. RESULTS: In 913 children (AD; 132), a history of IC, MC or HI was 
      observed in 45.1%, 19.7%, and 2.5%, respectively. Multiple logistic regression 
      analysis revealed that the odds of having a history of IC were 1.8 times higher 
      in AD children than in non-AD children. Meanwhile, a history of MC was 
      significantly correlated to the male gender, but not to a personal history of AD. 
      As for HI, we found no correlated factors in this study. CONCLUSIONS: The 
      lifetime prevalence of IC was indeed higher in young children with a history of 
      AD.
CI  - Copyright (c) 2010 Japanese Society for Investigative Dermatology. Published by 
      Elsevier Ireland Ltd. All rights reserved.
FAU - Hayashida, Sayaka
AU  - Hayashida S
AD  - Department of Dermatology, Kyushu University, Higashiku, Fukuoka, Japan. 
      nusayaka@dermatol.med.kyushu-u.ac.jp
FAU - Furusho, Norihiro
AU  - Furusho N
FAU - Uchi, Hiroshi
AU  - Uchi H
FAU - Miyazaki, Shougo
AU  - Miyazaki S
FAU - Eiraku, Kunimitsu
AU  - Eiraku K
FAU - Gondo, Chisato
AU  - Gondo C
FAU - Tsuji, Gaku
AU  - Tsuji G
FAU - Hachisuka, Junichi
AU  - Hachisuka J
FAU - Fukagawa, Shuji
AU  - Fukagawa S
FAU - Kido, Makiko
AU  - Kido M
FAU - Nakahara, Takeshi
AU  - Nakahara T
FAU - Moroi, Yoichi
AU  - Moroi Y
FAU - Hayashi, Jun
AU  - Hayashi J
FAU - Hagihara, Akihito
AU  - Hagihara A
FAU - Furue, Masutaka
AU  - Furue M
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20101023
PL  - Netherlands
TA  - J Dermatol Sci
JT  - Journal of dermatological science
JID - 9011485
SB  - IM
MH  - Child
MH  - Child, Preschool
MH  - Cross-Sectional Studies
MH  - Dermatitis, Atopic/*complications
MH  - Female
MH  - Herpesviridae Infections/*complications/*epidemiology
MH  - Humans
MH  - Impetigo/*complications/*epidemiology
MH  - Infant
MH  - Japan/epidemiology
MH  - Male
MH  - Molluscum Contagiosum/*complications/*epidemiology
MH  - Prevalence
MH  - Risk Factors
EDAT- 2010/10/26 06:00
MHDA- 2011/03/25 06:00
CRDT- 2010/10/26 06:00
PHST- 2010/06/17 00:00 [received]
PHST- 2010/08/24 00:00 [revised]
PHST- 2010/09/07 00:00 [accepted]
PHST- 2010/10/26 06:00 [entrez]
PHST- 2010/10/26 06:00 [pubmed]
PHST- 2011/03/25 06:00 [medline]
AID - S0923-1811(10)00292-6 [pii]
AID - 10.1016/j.jdermsci.2010.09.003 [doi]
PST - ppublish
SO  - J Dermatol Sci. 2010 Dec;60(3):173-8. doi: 10.1016/j.jdermsci.2010.09.003. Epub 
      2010 Oct 23.

PMID- 24336869
OWN - NLM
STAT- MEDLINE
DCOM- 20151215
LR  - 20150325
IS  - 1472-0213 (Electronic)
IS  - 1472-0205 (Linking)
VI  - 32
IP  - 4
DP  - 2015 Apr
TI  - Can routinely collected ambulance data about assaults contribute to reduction in 
      community violence?
PG  - 308-13
LID - 10.1136/emermed-2013-203133 [doi]
AB  - BACKGROUND: The 'law of spatiotemporal concentrations of events' introduced major 
      preventative shifts in policing communities. 'Hotspots' are at the forefront of 
      these developments yet somewhat understudied in emergency medicine. Furthermore, 
      little is known about interagency 'data-crossover', despite some developments 
      through the Cardiff Model. Can police-ED interagency data-sharing be used to 
      reduce community-violence using a hotspots methodology? METHODS: 12-month (2012) 
      descriptive study and analysis of spatiotemporal clusters of police and emergency 
      calls for service using hotspots methodology and assessing the degree of incident 
      overlap. 3775 violent crime incidents and 775 assault incidents analysed using 
      spatiotemporal clustering with k-means++ algorithm and Spearman's rho. RESULTS: 
      Spatiotemporal location of calls for services to the police and the ambulance 
      service are equally highly concentrated in a small number of geographical areas, 
      primarily within intra-agency hotspots (33% and 53%, respectively) but across 
      agencies' hotspots as well (25% and 15%, respectively). Datasets are 
      statistically correlated with one another at the 0.57 and 0.34 levels, with 50% 
      overlap when adjusted for the number of hotspots. At least one in every two 
      police hotspots does not have an ambulance hotspot overlapping with it, 
      suggesting half of assault spatiotemporal concentrations are unknown to the 
      police. Data further suggest that more severely injured patients, as estimated by 
      transfer to hospital, tend to be injured in the places with the highest number of 
      police-recorded crimes. CONCLUSIONS: A hotspots approach to sharing data 
      circumvents the problem of disclosing person-identifiable data between different 
      agencies. Practically, at least half of ambulance hotspots are unknown to the 
      police; if causal, it suggests that data sharing leads to both reduced community 
      violence by way of prevention (such as through anticipatory patrols or 
      problem-oriented policing), particularly of more severe assaults, and improved 
      efficiency of resource deployment.
CI  - Published by the BMJ Publishing Group Limited. For permission to use (where not 
      already granted under a licence) please go to 
      http://group.bmj.com/group/rights-licensing/permissions.
FAU - Ariel, Barak
AU  - Ariel B
AD  - Institute of Criminology, University of Cambridge, Cambridge, UK Institute of 
      Criminology, Hebrew University, Jerusalem, Israel.
FAU - Weinborn, Cristobal
AU  - Weinborn C
AD  - Institute of Criminology, University of Cambridge, Cambridge, UK.
FAU - Boyle, Adrian
AU  - Boyle A
AD  - Emergency Department, Addenbrooke's Hospital Cambridge University Hospitals NHS 
      Foundation Trust, Cambridge, Cambridgeshire, UK.
LA  - eng
PT  - Journal Article
DEP - 20131210
PL  - England
TA  - Emerg Med J
JT  - Emergency medicine journal : EMJ
JID - 100963089
SB  - IM
MH  - Algorithms
MH  - *Ambulances
MH  - Cluster Analysis
MH  - Cooperative Behavior
MH  - Data Collection/*methods
MH  - Emergency Service, Hospital/*statistics & numerical data
MH  - England
MH  - Humans
MH  - *Police
MH  - Violence/*prevention & control/statistics & numerical data
MH  - Wounds and Injuries/*prevention & control
OTO - NOTNLM
OT  - effectiveness
OT  - emergency ambulance systems, effectiveness
OT  - emergency department
OT  - methods
OT  - violence
EDAT- 2013/12/18 06:00
MHDA- 2015/12/17 06:00
CRDT- 2013/12/17 06:00
PHST- 2013/12/17 06:00 [entrez]
PHST- 2013/12/18 06:00 [pubmed]
PHST- 2015/12/17 06:00 [medline]
AID - emermed-2013-203133 [pii]
AID - 10.1136/emermed-2013-203133 [doi]
PST - ppublish
SO  - Emerg Med J. 2015 Apr;32(4):308-13. doi: 10.1136/emermed-2013-203133. Epub 2013 
      Dec 10.

PMID- 20197761
OWN - NLM
STAT- MEDLINE
DCOM- 20100506
LR  - 20220331
IS  - 1572-0241 (Electronic)
IS  - 0002-9270 (Print)
IS  - 0002-9270 (Linking)
VI  - 105
IP  - 4
DP  - 2010 Apr
TI  - Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care 
      providers, gastroenterologists, and IBS experts.
PG  - 848-58
LID - 10.1038/ajg.2010.47 [doi]
AB  - OBJECTIVES: Guidelines emphasize that irritable bowel syndrome (IBS) is not a 
      diagnosis of exclusion and encourage clinicians to make a positive diagnosis 
      using the Rome criteria alone. Yet many clinicians are concerned about 
      overlooking alternative diagnoses. We measured beliefs about whether IBS is a 
      diagnosis of exclusion, and measured testing proclivity between IBS experts and 
      community providers. METHODS: We developed a survey to measure decision-making in 
      two standardized patients with Rome III-positive IBS, including IBS with diarrhea 
      (D-IBS) and IBS with constipation (C-IBS). The survey elicited provider knowledge 
      and beliefs about IBS, including testing proclivity and beliefs regarding IBS as 
      a diagnosis of exclusion. We surveyed nurse practitioners, primary care 
      physicians, community gastroenterologists, and IBS experts. RESULTS: Experts were 
      less likely than nonexperts to endorse IBS as a diagnosis of exclusion (8 vs. 
      72%; P<0.0001). In the D-IBS vignette, experts were more likely to make a 
      positive diagnosis of IBS (67 vs. 38%; P<0.001), to perform fewer tests (2.0 vs. 
      4.1; P<0.01), and to expend less money on testing (US$297 vs. $658; P<0.01). 
      Providers who believed IBS is a diagnosis of exclusion ordered 1.6 more tests and 
      consumed $364 more than others (P<0.0001). Experts only rated celiac sprue 
      screening and complete blood count as appropriate in D-IBS; nonexperts rated most 
      tests as appropriate. Parallel results were found in the C-IBS vignette. 
      CONCLUSIONS: Most community providers believe IBS is a diagnosis of exclusion; 
      this belief is associated with increased resource use. Experts comply more 
      closely with guidelines to diagnose IBS with minimal testing. This disconnect 
      suggests that better implementation of guidelines is warranted to minimize 
      variation and improve cost-effectiveness of care.
FAU - Spiegel, Brennan M R
AU  - Spiegel BM
AD  - Department of Gastroenterology, VA Greater Los Angeles Healthcare System, Los 
      Angeles, California 90073, USA. bspiegel@mednet.ulca.edu
FAU - Farid, Mary
AU  - Farid M
FAU - Esrailian, Eric
AU  - Esrailian E
FAU - Talley, Jennifer
AU  - Talley J
FAU - Chang, Lin
AU  - Chang L
LA  - eng
GR  - P50 DK64539/DK/NIDDK NIH HHS/United States
GR  - M01 RR000865/RR/NCRR NIH HHS/United States
GR  - R01 AR46122/AR/NIAMS NIH HHS/United States
GR  - P50 DK064539/DK/NIDDK NIH HHS/United States
GR  - P50 DK064539-019001/DK/NIDDK NIH HHS/United States
GR  - M01-RR00865/RR/NCRR NIH HHS/United States
GR  - R01 AR046122/AR/NIAMS NIH HHS/United States
GR  - R24 AT002681/AT/NCCIH NIH HHS/United States
GR  - R01 AR046122-01/AR/NIAMS NIH HHS/United States
GR  - R24 AT002681-01/AT/NCCIH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20100302
PL  - United States
TA  - Am J Gastroenterol
JT  - The American journal of gastroenterology
JID - 0421030
SB  - IM
CIN - Z Gastroenterol. 2010 Aug;48(8):852-3. doi: 10.1055/s-0029-1245564. PMID: 
      20687023
MH  - Algorithms
MH  - Decision Making
MH  - Diagnosis, Differential
MH  - Female
MH  - Gastroenterology
MH  - Guidelines as Topic
MH  - *Health Knowledge, Attitudes, Practice
MH  - Humans
MH  - Irritable Bowel Syndrome/*diagnosis
MH  - Male
MH  - Middle Aged
MH  - Nurse Practitioners
MH  - Physicians, Family
MH  - Regression Analysis
MH  - Surveys and Questionnaires
PMC - PMC2887205
MID - NIHMS228001
COIS- CONFLICT OF INTEREST Guarantor of the article: Brennan M.R. Spiegel, MD, MSHS. 
      Specific author contributions: Study design, study implementation, data 
      collection, data analysis, data interpretation, paper preparation, and paper 
      approval: Brennan Spiegel; study design, study implementation, data collection, 
      and paper review: Mary Farid; study design, data interpretation, and paper 
      review: Eric Esrailian; study implementation and data collection: Jennifer 
      Talley; study design, data interpretation, paper preparation, and paper approval: 
      Lin Chang. Potential competing interests: Spiegel and Chang have served as 
      advisors to Prometheus Laboratories, and have received grant support from Takeda 
      Sucampo Pharmaceuticals, Rose Pharmaceuticals, and Prometheus Laboratories.
EDAT- 2010/03/04 06:00
MHDA- 2010/05/07 06:00
PMCR- 2010/10/04
CRDT- 2010/03/04 06:00
PHST- 2010/03/04 06:00 [entrez]
PHST- 2010/03/04 06:00 [pubmed]
PHST- 2010/05/07 06:00 [medline]
PHST- 2010/10/04 00:00 [pmc-release]
AID - ajg201047 [pii]
AID - 10.1038/ajg.2010.47 [doi]
PST - ppublish
SO  - Am J Gastroenterol. 2010 Apr;105(4):848-58. doi: 10.1038/ajg.2010.47. Epub 2010 
      Mar 2.

PMID- 16968876
OWN - NLM
STAT- MEDLINE
DCOM- 20070201
LR  - 20220317
IS  - 0923-7534 (Print)
IS  - 0923-7534 (Linking)
VI  - 17
IP  - 11
DP  - 2006 Nov
TI  - Is a patient's self-reported health-related quality of life a prognostic factor 
      for survival in non-small-cell lung cancer patients? A multivariate analysis of 
      prognostic factors of EORTC study 08975.
PG  - 1698-704
AB  - BACKGROUND: The aim of this prognostic factor analysis was to investigate if a 
      patient's self-reported health-related quality of life (HRQOL) provided 
      independent prognostic information for survival in non-small cell lung cancer 
      (NSCLC) patients. PATIENTS AND METHODS: Pretreatment HRQOL was measured in 391 
      advanced NSCLC patients using the EORTC QLQ-C30 and the EORTC Lung Cancer module 
      (QLQ-LC13). The Cox proportional hazards regression model was used for both 
      univariate and multivariate analyses of survival. In addition, a bootstrap 
      validation technique was used to assess the stability of the outcomes. RESULTS: 
      The final multivariate Cox regression model retained four parameters as 
      independent prognostic factors for survival: male gender with a hazard ratio (HR) 
      = 1.32 (95% CI 1.03-1.69; P = 0.03); performance status (0 to 1 versus 2) with HR 
      = 1.63 (95% CI 1.04-2.54; P = 0.032); patient's self-reported score of pain with 
      HR= 1.11 (95% CI 1.07-1.16; P < 0.001) and dysphagia with HR = 1.12 (95% CI 
      1.04-1.21; P = 0.003). A 10-point shift worse in the scale measuring pain and 
      dysphagia translated into an 11% and 12% increased in the likelihood of death 
      respectively. A risk group categorization was also developed. CONCLUSION: The 
      results suggest that patients' self-reported HRQOL provide independent prognostic 
      information for survival. This finding supports the collection of such data in 
      routine clinical practice.
FAU - Efficace, F
AU  - Efficace F
AD  - European Organisation for Research and Treatment of Cancer (EORTC), EORTC Data 
      Center, Brussels, Belgium. f.efficace@fondazioneime.org
FAU - Bottomley, A
AU  - Bottomley A
FAU - Smit, E F
AU  - Smit EF
FAU - Lianes, P
AU  - Lianes P
FAU - Legrand, C
AU  - Legrand C
FAU - Debruyne, C
AU  - Debruyne C
FAU - Schramel, F
AU  - Schramel F
FAU - Smit, H J
AU  - Smit HJ
FAU - Gaafar, R
AU  - Gaafar R
FAU - Biesma, B
AU  - Biesma B
FAU - Manegold, C
AU  - Manegold C
FAU - Coens, C
AU  - Coens C
FAU - Giaccone, G
AU  - Giaccone G
FAU - Van Meerbeeck, J
AU  - Van Meerbeeck J
CN  - EORTC Lung Cancer Group and Quality of Life Unit
LA  - eng
GR  - 5U10 CA11488-35/CA/NCI NIH HHS/United States
GR  - CA11488-31/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, N.I.H., Extramural
DEP - 20060912
PL  - England
TA  - Ann Oncol
JT  - Annals of oncology : official journal of the European Society for Medical 
      Oncology
JID - 9007735
SB  - IM
MH  - Adult
MH  - Aged
MH  - Carcinoma, Non-Small-Cell Lung/*diagnosis
MH  - Europe
MH  - Female
MH  - *Health Status
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Multivariate Analysis
MH  - Prognosis
MH  - *Quality of Life
MH  - Regression Analysis
MH  - Survival Analysis
EDAT- 2006/09/14 09:00
MHDA- 2007/02/03 09:00
CRDT- 2006/09/14 09:00
PHST- 2006/09/14 09:00 [pubmed]
PHST- 2007/02/03 09:00 [medline]
PHST- 2006/09/14 09:00 [entrez]
AID - S0923-7534(19)38070-6 [pii]
AID - 10.1093/annonc/mdl183 [doi]
PST - ppublish
SO  - Ann Oncol. 2006 Nov;17(11):1698-704. doi: 10.1093/annonc/mdl183. Epub 2006 Sep 
      12.

PMID- 26778755
OWN - NLM
STAT- MEDLINE
DCOM- 20161103
LR  - 20220316
IS  - 1873-1449 (Electronic)
IS  - 1538-4721 (Linking)
VI  - 15
IP  - 2
DP  - 2016 Mar-Apr
TI  - Vaginal dose assessment in image-guided brachytherapy for cervical cancer: Can we 
      really rely on dose-point evaluation?
PG  - 169-76
LID - S1538-4721(15)00606-6 [pii]
LID - 10.1016/j.brachy.2015.11.005 [doi]
AB  - PURPOSE: Although dose-volume parameters in image-guided brachytherapy have 
      become a standard, the use of posterior-inferior border of the pubic symphysis 
      (PIBS) points has been recently proposed in the reporting of vaginal doses. The 
      aim was to evaluate their pertinence. METHODS AND MATERIALS: Nineteen patients 
      who received image-guided brachytherapy after concurrent radiochemotherapy were 
      included. Per treatment, CT scans were performed at Days 2 and 3, with reporting 
      of the initial dwell positions and times. Doses delivered to the PIBS points were 
      evaluated on each plan, considering that they were representative of one-third of 
      the treatment. The movements of the applicator according to the PIBS point were 
      analysed. RESULTS: Mean prescribed doses at PIBS -2, PIBS, PIBS +2 were, 
      respectively, 2.23 +/- 1.4, 6.39 +/- 6.6, and 31.85 +/- 36.06 Gy. Significant 
      differences were observed between the 5 patients with vaginal involvement and the 
      remaining 14 at the level of PIBS +2 and PIBS: +47.60 Gy and +7.46 Gy, 
      respectively (p = 0.023 and 0.03). The variations between delivered and 
      prescribed doses at PIBS points were not significant. However, at International 
      commission on radiation units and measurements rectovaginal point, the delivered 
      dose was decreased by 1.43 +/- 2.49 Gy from the planned dose (p = 0.019). The 
      delivered doses at the four points were strongly correlated with the prescribed 
      doses with R(2) ranging from 0.93 to 0.95. The movements of the applicator in 
      regard of the PIBS point assessed with the Digital Imaging and Communications in 
      Medicine coordinates were insignificant. CONCLUSION: The doses evaluated at PIBS 
      points are not impacted by intrafractional movements. PIBS and PIBS +2 dose 
      points allow distinguishing the plans of patients with vaginal infiltration. 
      Further studies are needed to correlate these parameters with vaginal morbidity.
CI  - Copyright (c) 2016 American Brachytherapy Society. Published by Elsevier Inc. All 
      rights reserved.
FAU - Limkin, Elaine Johanna
AU  - Limkin EJ
AD  - Department of Radiation Oncology, Brachytherapy Unit, Gustave Roussy Cancer 
      Campus, Villejuif, France; Department of Radiotherapy, Philippine General 
      Hospital, Manila, Philippines.
FAU - Dumas, Isabelle
AU  - Dumas I
AD  - Department of Medical Physics, Gustave Roussy Cancer Campus, Villejuif, France.
FAU - Rivin Del Campo, Eleonor
AU  - Rivin Del Campo E
AD  - Department of Radiation Oncology, Brachytherapy Unit, Gustave Roussy Cancer 
      Campus, Villejuif, France.
FAU - Chargari, Cyrus
AU  - Chargari C
AD  - Department of Radiation Oncology, Brachytherapy Unit, Gustave Roussy Cancer 
      Campus, Villejuif, France; Laboratory of Molecular Radiotherapy INSERM 1030, 
      Gustave Roussy Cancer Campus, Villejuif, France.
FAU - Maroun, Pierre
AU  - Maroun P
AD  - Department of Radiation Oncology, Brachytherapy Unit, Gustave Roussy Cancer 
      Campus, Villejuif, France.
FAU - Annede, Pierre
AU  - Annede P
AD  - Department of Radiation Oncology, Brachytherapy Unit, Gustave Roussy Cancer 
      Campus, Villejuif, France.
FAU - Petit, Claire
AU  - Petit C
AD  - Department of Radiation Oncology, Brachytherapy Unit, Gustave Roussy Cancer 
      Campus, Villejuif, France.
FAU - Seisen, Thomas
AU  - Seisen T
AD  - Department of Radiation Oncology, Brachytherapy Unit, Gustave Roussy Cancer 
      Campus, Villejuif, France.
FAU - Doyeux, Kaya
AU  - Doyeux K
AD  - Department of Medical Physics, Gustave Roussy Cancer Campus, Villejuif, France.
FAU - Tailleur, Anne
AU  - Tailleur A
AD  - Department of Radiation Oncology, Brachytherapy Unit, Gustave Roussy Cancer 
      Campus, Villejuif, France.
FAU - Martinetti, Florent
AU  - Martinetti F
AD  - Department of Medical Physics, Gustave Roussy Cancer Campus, Villejuif, France.
FAU - Lefkopoulos, Dimitri
AU  - Lefkopoulos D
AD  - Department of Medical Physics, Gustave Roussy Cancer Campus, Villejuif, France; 
      Laboratory of Molecular Radiotherapy INSERM 1030, Gustave Roussy Cancer Campus, 
      Villejuif, France.
FAU - Haie-Meder, Christine
AU  - Haie-Meder C
AD  - Department of Radiation Oncology, Brachytherapy Unit, Gustave Roussy Cancer 
      Campus, Villejuif, France.
FAU - Mazeron, Renaud
AU  - Mazeron R
AD  - Department of Radiation Oncology, Brachytherapy Unit, Gustave Roussy Cancer 
      Campus, Villejuif, France; Laboratory of Molecular Radiotherapy INSERM 1030, 
      Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: 
      renaud.mazeron@gustaveroussy.fr.
LA  - eng
PT  - Journal Article
DEP - 20160105
PL  - United States
TA  - Brachytherapy
JT  - Brachytherapy
JID - 101137600
SB  - IM
MH  - *Brachytherapy
MH  - Chemoradiotherapy
MH  - Female
MH  - Humans
MH  - *Pubic Symphysis/diagnostic imaging
MH  - *Radiation Dosage
MH  - Radiotherapy, Image-Guided
MH  - Tomography, X-Ray Computed
MH  - Uterine Cervical Neoplasms/*radiotherapy
MH  - *Vagina/radiation effects
OTO - NOTNLM
OT  - Cervical cancer
OT  - Doses
OT  - Image-guided adaptive brachytherapy
OT  - Posterior-inferior border of the pubic symphysis (PIBS)
OT  - Vagina
EDAT- 2016/01/19 06:00
MHDA- 2016/11/04 06:00
CRDT- 2016/01/19 06:00
PHST- 2015/09/07 00:00 [received]
PHST- 2015/11/10 00:00 [revised]
PHST- 2015/11/28 00:00 [accepted]
PHST- 2016/01/19 06:00 [entrez]
PHST- 2016/01/19 06:00 [pubmed]
PHST- 2016/11/04 06:00 [medline]
AID - S1538-4721(15)00606-6 [pii]
AID - 10.1016/j.brachy.2015.11.005 [doi]
PST - ppublish
SO  - Brachytherapy. 2016 Mar-Apr;15(2):169-76. doi: 10.1016/j.brachy.2015.11.005. Epub 
      2016 Jan 5.

PMID- 18568290
OWN - NLM
STAT- MEDLINE
DCOM- 20081125
LR  - 20220317
IS  - 1342-1751 (Print)
IS  - 1342-1751 (Linking)
VI  - 12
IP  - 5
DP  - 2008 Oct
TI  - Is there a role for endothelin-1 in the hemodynamic changes during hemodialysis?
PG  - 370-375
LID - 10.1007/s10157-008-0065-2 [doi]
AB  - BACKGROUND: The etiology of hemodialysis (HD)-induced hypotension and 
      hypertension remains speculative. There is mounting evidence that endothelin-1 
      (ET-1) may play a vital role in these hemodynamic changes. We examined the 
      possible role of intradialytic changes of ET-1 in the pathogenesis of hypotension 
      and rebound hypertension during HD. METHODS: The present study included 45 
      patients with end-stage renal disease (ESRD) on regular HD. They were divided 
      according to their hemodynamic status during HD into three groups (group I had 
      stable intradialytic hemodynamics, group II had dialysis-induced hypotension, and 
      group III had rebound hypertension during HD). In addition, 15 healthy volunteers 
      were included as a control group. Pulse and blood pressure were monitored before, 
      during (every half hour), and after HD session. ET-1 level was measured at the 
      beginning, middle, and end of HD. ET-1 was measured in the control group for 
      comparison. RESULTS: Pre-dialysis levels of ET-1 were significantly higher in 
      dialysis patients compared to the controls (P < 0.001); however, they were 
      comparable in the three HD groups. The post-dialysis ET-1 level was not changed 
      significantly in group I compared with predialysis values (14.49 +/- 2.04 vs. 
      14.33 +/- 2.23 pg/ml; P = NS), while the ET-1 concentration decreased 
      significantly in group II and increased in group III in comparison to predialysis 
      values (8.56 +/- 1.44 vs. 11.75 +/- 2.51; 16.39 +/- 3.12 vs. 11.93 +/- 2.11 
      pg/ml, respectively; P < 0.001). CONCLUSION: Altered ET-1 levels may be involved 
      in the pathogenesis of rebound hypertension and hypotension during HD.
FAU - El-Shafey, E M
AU  - El-Shafey EM
AD  - Department of Internal Medicine, Nephrology, Faculty of Medicine, Tanta 
      University, Tanta, Egypt. shafey70@yahoo.com.
FAU - El-Nagar, G F
AU  - El-Nagar GF
AD  - Department of Internal Medicine, Nephrology, Faculty of Medicine, Tanta 
      University, Tanta, Egypt.
FAU - Selim, M F
AU  - Selim MF
AD  - Department of Internal Medicine, Nephrology, Faculty of Medicine, Tanta 
      University, Tanta, Egypt.
FAU - El-Sorogy, H A
AU  - El-Sorogy HA
AD  - Department of Clinical Pathology, Faculty of Medicine, Tanta University, Tanta, 
      Egypt.
FAU - Sabry, A A
AU  - Sabry AA
AD  - Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
LA  - eng
PT  - Journal Article
DEP - 20080621
PL  - Japan
TA  - Clin Exp Nephrol
JT  - Clinical and experimental nephrology
JID - 9709923
RN  - 0 (Endothelin-1)
SB  - IM
MH  - Adult
MH  - Blood Pressure/physiology
MH  - Case-Control Studies
MH  - Egypt
MH  - Endothelin-1/blood/*physiology
MH  - Female
MH  - Heart Rate/physiology
MH  - Humans
MH  - Hypertension/*etiology/*physiopathology
MH  - Hypotension/*etiology/*physiopathology
MH  - Kidney Failure, Chronic/physiopathology/*therapy
MH  - Male
MH  - Middle Aged
MH  - Prospective Studies
MH  - *Renal Dialysis
EDAT- 2008/06/24 09:00
MHDA- 2008/12/17 09:00
CRDT- 2008/06/24 09:00
PHST- 2007/12/05 00:00 [received]
PHST- 2008/05/07 00:00 [accepted]
PHST- 2008/06/24 09:00 [pubmed]
PHST- 2008/12/17 09:00 [medline]
PHST- 2008/06/24 09:00 [entrez]
AID - 10.1007/s10157-008-0065-2 [pii]
AID - 10.1007/s10157-008-0065-2 [doi]
PST - ppublish
SO  - Clin Exp Nephrol. 2008 Oct;12(5):370-375. doi: 10.1007/s10157-008-0065-2. Epub 
      2008 Jun 21.

PMID- 25371231
OWN - NLM
STAT- MEDLINE
DCOM- 20170428
LR  - 20181202
IS  - 1433-7347 (Electronic)
IS  - 0942-2056 (Linking)
VI  - 24
IP  - 5
DP  - 2016 May
TI  - Is vitamin D insufficiency or deficiency related to the development of 
      osteochondritis dissecans?
PG  - 1575-9
LID - 10.1007/s00167-014-3413-7 [doi]
AB  - PURPOSE: The aetiology of osteochondritis dissecans is still unclear. The aim of 
      this prospective pilot study was to analyse whether vitamin D insufficiency, or 
      deficiency, might be a contributing etiological factor in the development of an 
      OCD lesion. METHODS: The serum level of vitamin D3 in 23 consecutive patients (12 
      male and 11 female) suffering from a stage III, or stages III and IV, OCD lesion 
      (mostly stage III) admitted for surgery was measured. RESULTS: The patients' mean 
      age was 31.3 years and most of them already exhibited closed epiphyseal plates. 
      In the majority of patients (18/23), a distinct vitamin D3 deficiency was found, 
      two patients were vitamin D3-insufficient and, in three patients, the vitamin D3 
      level reached the lowest normal value. CONCLUSION: These first data show that a 
      vitamin D3 deficiency rather than an insufficiency may be involved in the 
      development of OCD lesions. Probably, with a vitamin D3 substitution, the 
      development of an advanced OCD stage could be avoided. Further analyses, 
      including morphological analyses regarding a possible osteomalacia, and 
      examination of the PTH and other determinants of the bone metabolism, should be 
      undertaken to either confirm or refute these data. LEVEL OF EVIDENCE: IV.
FAU - Bruns, Juergen
AU  - Bruns J
AD  - Department of Orthopaedic Surgery, Agaplesion Diakonieklinikum, Hohe Weide 17, 
      20259, Hamburg, Germany. Juergen.bruns@d-k-h.de.
FAU - Werner, Mathias
AU  - Werner M
AD  - Department of Pathology, HELIOS Klinikum Emil von Behring, Walterhoferstr. 11, 
      14165, Berlin, Germany.
FAU - Soyka, Matthias
AU  - Soyka M
AD  - "Activion"Medizinisches Versorgungszentrum, Alte Holstenstrasse 2, 21031, 
      Hamburg, Germany.
LA  - eng
PT  - Journal Article
DEP - 20141105
PL  - Germany
TA  - Knee Surg Sports Traumatol Arthrosc
JT  - Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA
JID - 9314730
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Child
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Osteochondritis Dissecans/*etiology/physiopathology
MH  - Pilot Projects
MH  - Prospective Studies
MH  - Vitamin D Deficiency/blood/*complications
MH  - Young Adult
OTO - NOTNLM
OT  - Aetiology
OT  - Deficiency
OT  - Insufficiency
OT  - Osteochondritis dissecans
OT  - Vitamin D
EDAT- 2014/11/06 06:00
MHDA- 2017/04/30 06:00
CRDT- 2014/11/06 06:00
PHST- 2014/01/08 00:00 [received]
PHST- 2014/10/27 00:00 [accepted]
PHST- 2014/11/06 06:00 [entrez]
PHST- 2014/11/06 06:00 [pubmed]
PHST- 2017/04/30 06:00 [medline]
AID - 10.1007/s00167-014-3413-7 [pii]
AID - 10.1007/s00167-014-3413-7 [doi]
PST - ppublish
SO  - Knee Surg Sports Traumatol Arthrosc. 2016 May;24(5):1575-9. doi: 
      10.1007/s00167-014-3413-7. Epub 2014 Nov 5.

PMID- 25394614
OWN - NLM
STAT- MEDLINE
DCOM- 20160921
LR  - 20151127
IS  - 1476-4954 (Electronic)
IS  - 1476-4954 (Linking)
VI  - 29
IP  - 1
DP  - 2016
TI  - Does timing of initial surfactant treatment make a difference in rates of chronic 
      lung disease or mortality in premature infants? An observational regional study.
PG  - 91-8
LID - 10.3109/14767058.2014.987747 [doi]
AB  - OBJECTIVE: To compare two treatment strategies in preterm infants with or at risk 
      of respiratory distress syndrome: early surfactant administration (within one 
      hour of birth) versus late surfactant administration, in a geographically defined 
      population. OUTCOME: The primary outcome was chronic lung disease (CLD) and 
      mortality before/at 36 weeks. Secondary outcomes included: duration of mechanical 
      ventilation and continuous positive airway pressure (CPAP), post-natal steroids 
      for CLD and major neonatal morbidities. SUBJECTS: Premature infants born at 22-32 
      weeks' gestation between January 2006 and December 2009. SETTING: Ten neonatal 
      intensive care units (NICUs) in New South Wales (NSW) and Australian Capital 
      Territory (ACT), Australia. DESIGN: Retrospective analysis of prospectively 
      collected data from the regional NICU database in NSW and ACT. RESULTS: Of the 
      2170 infants who received surfactant, 1182 (54.5%) and 988 (45.5%) received early 
      and late surfactant, respectively. The early surfactant group was less mature 
      (27.1 +/- 2.1 versus 29.4 +/- 2.1 weeks) and had more CLD and mortality (40.2% versus 
      20.0%). The multivariable analysis showed early surfactant to be associated with 
      less duration of ventilation, longer duration of CPAP and longer hospital stay 
      but had little or no impact on CLD/mortality. CONCLUSION: Early surfactant 
      administration is associated with shorter duration of ventilation but does not 
      appear to be significantly protective against CLD/mortality among premature 
      infants. This may support the growing evidence for consideration of CPAP as an 
      alternative to routine intubation and early surfactant administration. Further 
      investigation from large randomized clinical trials is warranted to confirm these 
      results.
FAU - Premnath, Daphne
AU  - Premnath D
AD  - a Department of Internal Medicine .
FAU - Kent, Alison Louise
AU  - Kent AL
AD  - b Department of Neonatology , Canberra Hospital , Garran , ACT , Australia .
AD  - c The Clinical School, Australian National University , Garran , ACT , Australia 
      .
FAU - Bajuk, Barbara
AU  - Bajuk B
AD  - d Neonatal Intensive Care Units' (NICUS) Data Collection, NSW Pregnancy and 
      Newborn Services Network , NSW , Australia , and.
AD  - e School of Public Health, University of Sydney , NSW , Australia.
FAU - Abdel-Latif, Mohamed E
AU  - Abdel-Latif ME
AD  - b Department of Neonatology , Canberra Hospital , Garran , ACT , Australia .
AD  - c The Clinical School, Australian National University , Garran , ACT , Australia 
      .
CN  - NSW and the ACT Neonatal Intensive Care Audit Group
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Multicenter Study
PT  - Observational Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20141208
PL  - England
TA  - J Matern Fetal Neonatal Med
JT  - The journal of maternal-fetal & neonatal medicine : the official journal of the 
      European Association of Perinatal Medicine, the Federation of Asia and Oceania 
      Perinatal Societies, the International Society of Perinatal Obstetricians
JID - 101136916
RN  - 0 (Pulmonary Surfactants)
RN  - Respiratory Distress Syndrome In Premature Infants
SB  - IM
MH  - Australian Capital Territory/epidemiology
MH  - Chronic Disease
MH  - Female
MH  - Humans
MH  - Infant, Newborn
MH  - Male
MH  - New South Wales/epidemiology
MH  - Pulmonary Surfactants/*administration & dosage
MH  - Respiratory Distress Syndrome, Newborn/mortality/*prevention & control
MH  - Treatment Outcome
OTO - NOTNLM
OT  - Chronic lung disease
OT  - low birth weight
OT  - mortality
OT  - premature
OT  - preterm
OT  - surfactant
OT  - survival
EDAT- 2014/11/15 06:00
MHDA- 2016/09/23 06:00
CRDT- 2014/11/15 06:00
PHST- 2014/11/15 06:00 [entrez]
PHST- 2014/11/15 06:00 [pubmed]
PHST- 2016/09/23 06:00 [medline]
AID - 10.3109/14767058.2014.987747 [doi]
PST - ppublish
SO  - J Matern Fetal Neonatal Med. 2016;29(1):91-8. doi: 10.3109/14767058.2014.987747. 
      Epub 2014 Dec 8.

PMID- 11570976
OWN - NLM
STAT- MEDLINE
DCOM- 20021220
LR  - 20191105
IS  - 1471-230X (Electronic)
IS  - 1471-230X (Linking)
VI  - 1
DP  - 2001
TI  - Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine 
      in patient with rheumatoid arthritis.
PG  - 8
AB  - BACKGROUND: Sulfasalazine is a widely used anti-inflammatory agent in the 
      treatment of inflammatory bowel disease and several rheumatological disorders. 
      Although as many as 20% of treated patients may experience reversible, 
      dose-dependent side effects, less frequent but potentially severe, systemic 
      reactions have also been reported. CASE PRESENTATION: A severe systemic reaction 
      to sulfasalazine developed in a 21-year old female with rheumatoid arthritis 
      characterized by eosinophilia, granulomatous enteritis and myelotoxicity, 
      cholestatic hepatitis, and seizures. The clinical course and management of this 
      patient are presented as well as a review of the incidence and outcome of severe 
      systemic reactions to sulfasalazine. CONCLUSIONS: Granulomatous myelotoxicity and 
      enteritis developed in a 21 year old female within 3 weeks of initiating 
      sulfasalazine for rheumatoid arthritis. Following a short course of 
      corticosteroids, the patient had resolution of her cholestatic hepatitis, rash, 
      eosinophilia, and gastrointestinal symptoms with no residual manifestations at 7 
      months follow-up. Although severe reactions to sulfasalazine are rare and 
      unpredictable, practicing physicians should be aware of unusual clinical 
      presentations of toxicity when prescribing sulfasalazine.
FAU - Quallich, L G
AU  - Quallich LG
AD  - Department of Internal Medicine, University of Michigan Medical School, Ann 
      Arbor, Michigan 48109, USA. lquall@umich.edu
FAU - Greenson, J
AU  - Greenson J
FAU - Haftel, H M
AU  - Haftel HM
FAU - Fontana, R J
AU  - Fontana RJ
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20010829
PL  - England
TA  - BMC Gastroenterol
JT  - BMC gastroenterology
JID - 100968547
RN  - 0 (Antirheumatic Agents)
RN  - 3XC8GUZ6CB (Sulfasalazine)
SB  - IM
MH  - Adult
MH  - Antirheumatic Agents/*adverse effects
MH  - Arthritis, Rheumatoid/drug therapy
MH  - Chemical and Drug Induced Liver Injury/diagnosis
MH  - Crohn Disease/chemically induced/diagnosis
MH  - Diagnosis, Differential
MH  - Enteritis/chemically induced/diagnosis
MH  - Eosinophilia/*chemically induced/diagnosis
MH  - Female
MH  - Granuloma/*chemically induced/diagnosis
MH  - Humans
MH  - Seizures/chemically induced
MH  - Sulfasalazine/*adverse effects
PMC - PMC56591
EDAT- 2001/09/26 10:00
MHDA- 2002/12/21 04:00
PMCR- 2001/08/29
CRDT- 2001/09/26 10:00
PHST- 2001/07/30 00:00 [received]
PHST- 2001/08/29 00:00 [accepted]
PHST- 2001/09/26 10:00 [pubmed]
PHST- 2002/12/21 04:00 [medline]
PHST- 2001/09/26 10:00 [entrez]
PHST- 2001/08/29 00:00 [pmc-release]
AID - 1471-230X-1-8 [pii]
AID - 10.1186/1471-230x-1-8 [doi]
PST - ppublish
SO  - BMC Gastroenterol. 2001;1:8. doi: 10.1186/1471-230x-1-8. Epub 2001 Aug 29.

PMID- 16816043
OWN - NLM
STAT- MEDLINE
DCOM- 20061010
LR  - 20181113
IS  - 0306-6800 (Print)
IS  - 1473-4257 (Electronic)
IS  - 0306-6800 (Linking)
VI  - 32
IP  - 7
DP  - 2006 Jul
TI  - Do French lay people and health professionals find it acceptable to breach 
      confidentiality to protect a patient's wife from a sexually transmitted disease?
PG  - 414-9
AB  - OBJECTIVE: To determine under what conditions lay people and health professionals 
      find it acceptable for a physician to breach confidentiality to protect the wife 
      of a patient with a sexually transmitted disease (STD). METHODS: In a study in 
      France, breaching confidentiality in 48 scenarios were accepted by 144 lay 
      people, 10 psychologists and 7 physicians. The scenarios were all possible 
      combinations of five factors: severity of the disease (severe, lethal); time 
      taken to discuss this with (little time, much time); intent to inform the spouse 
      about the disease (none, one of these days, immediately); intent to adopt 
      protective behaviours (no intent, intent); and decision to consult an expert in 
      STDs (yes, no), 2 x 2 x 3 x 2 x 2. The importance and interactions of each factor 
      were determined, at the group level, by performing analyses of variance and 
      constructing graphs. RESULTS: The concept of breaching confidentiality to protect 
      a wife from her husband's STD was favoured much more by lay people and 
      psychologists than by physicians (mean ratings 11.76, 9.28 and 2.90, 
      respectively, on a scale of 0-22). The patient's stated intentions to protect his 
      wife and to inform her of the disease had the greatest impact on acceptability. A 
      cluster analysis showed groups of lay participants who found breaching 
      confidentiality "always acceptable" (n = 14), "depending on the many 
      circumstances" (n = 87), requiring "consultation with an expert" (n = 30) and 
      "never acceptable (n = 13)". CONCLUSIONS: Most people in France are influenced by 
      situational factors when deciding if a physician should breach confidentiality to 
      protect the spouse of a patient infected with STD.
FAU - Guedj, M
AU  - Guedj M
AD  - Latham Med-Ped, 724 Watervliet-Shaker Road, Latham, NY 12110, USA.
FAU - Sastre, M T Munoz
AU  - Sastre MT
FAU - Mullet, E
AU  - Mullet E
FAU - Sorum, P C
AU  - Sorum PC
LA  - eng
PT  - Journal Article
PL  - England
TA  - J Med Ethics
JT  - Journal of medical ethics
JID - 7513619
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - *Attitude of Health Personnel
MH  - *Attitude to Health
MH  - Cluster Analysis
MH  - *Confidentiality
MH  - Female
MH  - France
MH  - Humans
MH  - Intention
MH  - Interpersonal Relations
MH  - Male
MH  - Middle Aged
MH  - Severity of Illness Index
MH  - Sexual Behavior
MH  - Sexually Transmitted Diseases/*psychology/transmission
MH  - *Spouses
MH  - Time Factors
PMC - PMC2564491
EDAT- 2006/07/04 09:00
MHDA- 2006/10/13 09:00
PMCR- 2009/07/01
CRDT- 2006/07/04 09:00
PHST- 2006/07/04 09:00 [pubmed]
PHST- 2006/10/13 09:00 [medline]
PHST- 2006/07/04 09:00 [entrez]
PHST- 2009/07/01 00:00 [pmc-release]
AID - 32/7/414 [pii]
AID - me12195 [pii]
AID - 10.1136/jme.2005.012195 [doi]
PST - ppublish
SO  - J Med Ethics. 2006 Jul;32(7):414-9. doi: 10.1136/jme.2005.012195.

PMID- 12805495
OWN - NLM
STAT- MEDLINE
DCOM- 20030801
LR  - 20220316
IS  - 1524-4628 (Electronic)
IS  - 0039-2499 (Linking)
VI  - 34
IP  - 7
DP  - 2003 Jul
TI  - Can patients be anticoagulated after intracerebral hemorrhage? A decision 
      analysis.
PG  - 1710-6
AB  - BACKGROUND AND PURPOSE: Warfarin increases both the likelihood and the mortality 
      of intracerebral hemorrhage (ICH), particularly in patients with a history of 
      prior ICH. In light of this consideration, should a patient with both a history 
      of ICH and a clear indication for anticoagulation such as nonvalvular atrial 
      fibrillation be anticoagulated? In the absence of data from a clinical trial, we 
      used a decision-analysis model to compare the expected values of 2 treatment 
      strategies-warfarin and no anticoagulation-for such patients. METHODS: We used a 
      Markov state transition decision model stratified by location of hemorrhage 
      (lobar or deep hemispheric). Effectiveness was measured in quality-adjusted life 
      years (QALYs). Data sources included English language literature identified 
      through MEDLINE searches and bibliographies from selected articles, along with 
      empirical data from our own institution. The base case focused on a 69-year-old 
      man with a history of ICH and newly diagnosed nonvalvular atrial fibrillation. 
      RESULTS: For patients with prior lobar ICH, withholding anticoagulation therapy 
      was strongly preferred, improving quality-adjusted life expectancy by 1.9 QALYs. 
      For patients with prior deep hemispheric ICH, withholding anticoagulation 
      resulted in a smaller gain of 0.3 QALYs. In sensitivity analyses for patients 
      with deep ICH, anticoagulation could be preferred if the risk of thromboembolic 
      stroke is particularly high. CONCLUSIONS: Survivors of lobar ICH with atrial 
      fibrillation should not be offered long-term anticoagulation. Similarly, most 
      patients with deep hemispheric ICH and atrial fibrillation should not receive 
      anticoagulant therapy. However, patients with deep hemispheric ICH at 
      particularly high risk for thromboembolic stroke or low risk of ICH recurrence 
      might benefit from long-term anticoagulation.
FAU - Eckman, Mark H
AU  - Eckman MH
AD  - Division of General Internal Medicine and the Center for Clinical Effectiveness, 
      University of Cincinnati, Cincinnati, OH, USA. mark.eckman@uc.edu
FAU - Rosand, Jonathan
AU  - Rosand J
FAU - Knudsen, Katherine A
AU  - Knudsen KA
FAU - Singer, Daniel E
AU  - Singer DE
FAU - Greenberg, Steven M
AU  - Greenberg SM
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20030612
PL  - United States
TA  - Stroke
JT  - Stroke
JID - 0235266
RN  - 0 (Anticoagulants)
RN  - 0 (Fibrinolytic Agents)
RN  - 5Q7ZVV76EI (Warfarin)
RN  - R16CO5Y76E (Aspirin)
SB  - IM
CIN - Stroke. 2003 Nov;34(11):e217-8; author reply e217-8. doi: 
      10.1161/01.STR.0000099071.46210.3A. PMID: 14563956
CIN - Stroke. 2004 Jan;35(1):e5-6; author reply e5-6. doi: 
      10.1161/01.STR.0000107226.46616.86. PMID: 14671234
MH  - Aged
MH  - Anticoagulants/*adverse effects/therapeutic use
MH  - Aspirin/adverse effects/therapeutic use
MH  - Atrial Fibrillation/complications/drug therapy
MH  - Cerebral Hemorrhage/*chemically induced/*prevention & control
MH  - Cohort Studies
MH  - *Decision Support Techniques
MH  - Fibrinolytic Agents/adverse effects/therapeutic use
MH  - Humans
MH  - Intracranial Thrombosis/etiology/prevention & control
MH  - Male
MH  - Markov Chains
MH  - Quality-Adjusted Life Years
MH  - Risk
MH  - Risk Assessment
MH  - Sensitivity and Specificity
MH  - Warfarin/*adverse effects/therapeutic use
EDAT- 2003/06/14 05:00
MHDA- 2003/08/02 05:00
CRDT- 2003/06/14 05:00
PHST- 2003/06/14 05:00 [pubmed]
PHST- 2003/08/02 05:00 [medline]
PHST- 2003/06/14 05:00 [entrez]
AID - 01.STR.0000078311.18928.16 [pii]
AID - 10.1161/01.STR.0000078311.18928.16 [doi]
PST - ppublish
SO  - Stroke. 2003 Jul;34(7):1710-6. doi: 10.1161/01.STR.0000078311.18928.16. Epub 2003 
      Jun 12.

PMID- 25571931
OWN - NLM
STAT- MEDLINE
DCOM- 20151021
LR  - 20181202
IS  - 1421-9786 (Electronic)
IS  - 1015-9770 (Linking)
VI  - 39
IP  - 2
DP  - 2015
TI  - Do elderly patients call 911 when presented with clinical scenarios suggestive of 
      acute stroke? A cross-sectional study.
PG  - 87-93
LID - 10.1159/000369962 [doi]
AB  - BACKGROUND AND PURPOSE: Among patients with acute stroke symptoms, delay in 
      hospital admission is the main obstacle for the use of thrombolytic therapy and 
      other interventions associated with decreased mortality and disability. The 
      primary aim of this study was to assess whether an elderly clinical population 
      correctly endorsed the response to call for emergency services when presented 
      with signs and symptoms of stroke using a standardized questionnaire. METHODS: We 
      performed a cross-sectional study among elderly out-patients (>/=60 years) in 
      Buenos Aires, Argentina randomly recruited from a government funded health 
      clinic. The correct endorsement of intention to call 911 was assessed with the 
      Stroke Action Test and the cut-off point was set at >/=75%. Knowledge of stroke and 
      clinical and socio-demographic indicators were also collected and evaluated as 
      predictors of correct endorsement using logistic regression. RESULTS: Among 367 
      elderly adults, 14% correctly endorsed intention to call 911. Presented with the 
      most typical signs and symptoms, only 65% reported that they would call an 
      ambulance. Amaurosis Fugax was the symptom for which was called the least (15%). 
      On average, the correct response was chosen only 37% of the time. Compared to 
      lower levels of education, higher levels were associated to correctly endorsed 
      intention to call 911 (secondary School adjusted OR 3.53, 95% CI 1.59-7.86 and 
      Tertiary/University adjusted OR 3.04, 95% CI 1.12-8.21). CONCLUSIONS: These 
      results suggest the need to provide interventions that are specifically designed 
      to increase awareness of potential stroke signs and symptoms and appropriate 
      subsequent clinical actions.
CI  - (c) 2015 S. Karger AG, Basel.
FAU - Caruso, Diego
AU  - Caruso D
AD  - Department of Internal Medicine, Hospital Dr. Cesar Milstein associated with 
      University of Buenos Aires, Buenos Aires, Argentina.
FAU - Perez Akly, Manuel
AU  - Perez Akly M
FAU - Costantini, Pablo Daniel
AU  - Costantini PD
FAU - Fridman, Sebastian
AU  - Fridman S
FAU - Esnaola, Maria Martha
AU  - Esnaola MM
LA  - eng
PT  - Journal Article
DEP - 20150108
PL  - Switzerland
TA  - Cerebrovasc Dis
JT  - Cerebrovascular diseases (Basel, Switzerland)
JID - 9100851
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - *Amaurosis Fugax
MH  - Ambulances/statistics & numerical data
MH  - Argentina
MH  - Cross-Sectional Studies
MH  - Educational Status
MH  - Emergency Medical Service Communication Systems/*statistics & numerical data
MH  - Emergency Medical Services/statistics & numerical data
MH  - Female
MH  - Health Education
MH  - *Health Knowledge, Attitudes, Practice
MH  - Humans
MH  - *Intention
MH  - Male
MH  - Middle Aged
MH  - *Stroke
EDAT- 2015/01/13 06:00
MHDA- 2015/10/22 06:00
CRDT- 2015/01/10 06:00
PHST- 2014/08/26 00:00 [received]
PHST- 2014/11/17 00:00 [accepted]
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/10/22 06:00 [medline]
AID - 000369962 [pii]
AID - 10.1159/000369962 [doi]
PST - ppublish
SO  - Cerebrovasc Dis. 2015;39(2):87-93. doi: 10.1159/000369962. Epub 2015 Jan 8.

PMID- 19578820
OWN - NLM
STAT- MEDLINE
DCOM- 20100430
LR  - 20211020
IS  - 1525-1497 (Electronic)
IS  - 0884-8734 (Print)
IS  - 0884-8734 (Linking)
VI  - 24
IP  - 9
DP  - 2009 Sep
TI  - Are opioid dependence and methadone maintenance treatment (MMT) documented in the 
      medical record? A patient safety issue.
PG  - 1007-11
LID - 10.1007/s11606-009-1043-4 [doi]
AB  - BACKGROUND: Opioid-dependent patients often have co-occurring chronic illnesses 
      requiring medications that interact with methadone. Methadone maintenance 
      treatment (MMT) is typically provided separately from medical care. Hence, 
      coordination of medical care and substance use treatment is important to preserve 
      patient safety. OBJECTIVE: To identify potential safety risks among MMT patients 
      engaged in medical care by evaluating the frequency that opioid dependence and 
      MMT documentation are missing in medical records and characterizing potential 
      medication-methadone interactions. METHODS: Among patients from a methadone 
      clinic who received primary care from an affiliated, but separate, medical 
      center, we reviewed electronic medical records for documentation of methadone, 
      opioid dependence, and potential drug-methadone interactions. The proportions of 
      medical records without opioid dependence and methadone documentation were 
      estimated and potential medication-methadone interactions were identified. 
      RESULTS: Among the study subjects (n = 84), opioid dependence documentation was 
      missing from the medical record in 30% (95% CI, 20%-41%) and MMT documentation 
      was missing from either the last primary care note or the last hospital discharge 
      summary in 11% (95% CI, 5%-19%). Sixty-nine percent of the study subjects had at 
      least 1 medication that potentially interacted with methadone; 19% had 3 or more 
      potentially interacting medications. CONCLUSION: Among patients receiving MMT and 
      medical care at different sites, documentation of opioid dependence and MMT in 
      the medical record occurs for the majority, but is missing in a substantial 
      number of patients. Most of these patients are prescribed medications that 
      potentially interact with methadone. This study highlights opportunities for 
      improved coordination between medical care and MMT.
FAU - Walley, Alexander Y
AU  - Walley AY
AD  - Clinical Addiction Research and Education Unit, Section of General Internal 
      Medicine, Boston Medical Center, Boston, MA 02118, USA. awalley@bu.edu
FAU - Farrar, Danielle
AU  - Farrar D
FAU - Cheng, Debbie M
AU  - Cheng DM
FAU - Alford, Daniel P
AU  - Alford DP
FAU - Samet, Jeffrey H
AU  - Samet JH
LA  - eng
GR  - K24 AA015674/AA/NIAAA NIH HHS/United States
GR  - R25 DA013582/DA/NIDA NIH HHS/United States
GR  - R25-DA13582/DA/NIDA NIH HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20090704
PL  - United States
TA  - J Gen Intern Med
JT  - Journal of general internal medicine
JID - 8605834
RN  - UC6VBE7V1Z (Methadone)
SB  - IM
MH  - Adult
MH  - Documentation/*standards
MH  - Drug Interactions
MH  - Female
MH  - Humans
MH  - Male
MH  - Medical Records/*standards
MH  - Medical Records Systems, Computerized/standards
MH  - Methadone/*adverse effects/metabolism/*therapeutic use
MH  - Middle Aged
MH  - Opioid-Related Disorders/*drug therapy/*epidemiology
MH  - Retrospective Studies
MH  - Risk Factors
PMC - PMC2726880
EDAT- 2009/07/07 09:00
MHDA- 2010/05/01 06:00
PMCR- 2010/09/01
CRDT- 2009/07/07 09:00
PHST- 2008/12/12 00:00 [received]
PHST- 2009/06/04 00:00 [accepted]
PHST- 2009/05/11 00:00 [revised]
PHST- 2009/07/07 09:00 [entrez]
PHST- 2009/07/07 09:00 [pubmed]
PHST- 2010/05/01 06:00 [medline]
PHST- 2010/09/01 00:00 [pmc-release]
AID - 1043 [pii]
AID - 10.1007/s11606-009-1043-4 [doi]
PST - ppublish
SO  - J Gen Intern Med. 2009 Sep;24(9):1007-11. doi: 10.1007/s11606-009-1043-4. Epub 
      2009 Jul 4.

PMID- 18243752
OWN - NLM
STAT- MEDLINE
DCOM- 20080715
LR  - 20080408
IS  - 1278-3218 (Print)
IS  - 1278-3218 (Linking)
VI  - 12
IP  - 2
DP  - 2008 Mar
TI  - [Should chest wall irradiation be included after mastectomy and negative node 
      breast cancer?].
PG  - 73-7
LID - 10.1016/j.canrad.2007.12.004 [doi]
AB  - PURPOSE: This study aims to evaluate local failure patterns in node negative 
      breast cancer patients treated with post-mastectomy radiotherapy including 
      internal mammary chain only. PATIENTS AND METHODS: Retrospective analysis of 92 
      internal or central-breast node-negative tumours with mastectomy and external 
      irradiation of the internal mammary chain at the dose of 50 Gy, from 1994 to 
      1998. RESULTS: Local recurrence rate was 5 % (five cases). Recurrence sites were 
      the operative scare and chest wall. Factors associated with increased risk of 
      local failure were age < or = 40 years and tumour size greater than 20mm, without 
      statistical significance. CONCLUSION: Post-mastectomy radiotherapy should be 
      discussed for a sub-group of node-negative patients with predictors factors of 
      local failure such as age < or = 40 years and larger tumour size.
FAU - Ben Ammar, C N
AU  - Ben Ammar CN
AD  - Service de radiotherapie-oncologie, institut Salah-Azaiz, boulevard du 9 avril, 
      1006 Bab-Saadoun, Tunis, Tunisie. chiraz_ammar@yahoo.com
FAU - Kochbati, L
AU  - Kochbati L
FAU - Chraeit, N
AU  - Chraeit N
FAU - Amrouche, A
AU  - Amrouche A
FAU - Gargouri, W
AU  - Gargouri W
FAU - Frikha, H
AU  - Frikha H
FAU - Besbes, M
AU  - Besbes M
FAU - Abdallah, M B
AU  - Abdallah MB
FAU - Maalej, M
AU  - Maalej M
LA  - fre
PT  - English Abstract
PT  - Journal Article
TT  - L'irradiation parietale est-elle justifiee apres mastectomie et curage negatif ?
DEP - 20080220
PL  - France
TA  - Cancer Radiother
JT  - Cancer radiotherapie : journal de la Societe francaise de radiotherapie 
      oncologique
JID - 9711272
SB  - IM
MH  - Adult
MH  - Aged
MH  - Breast Neoplasms/*prevention & control
MH  - Female
MH  - Humans
MH  - *Mastectomy
MH  - Middle Aged
MH  - Neoplasm Recurrence, Local/*prevention & control
MH  - Radiotherapy
MH  - Retrospective Studies
MH  - Thoracic Wall
EDAT- 2008/02/05 09:00
MHDA- 2008/07/17 09:00
CRDT- 2008/02/05 09:00
PHST- 2007/08/29 00:00 [received]
PHST- 2007/11/13 00:00 [revised]
PHST- 2007/12/12 00:00 [accepted]
PHST- 2008/02/05 09:00 [pubmed]
PHST- 2008/07/17 09:00 [medline]
PHST- 2008/02/05 09:00 [entrez]
AID - S1278-3218(07)00336-8 [pii]
AID - 10.1016/j.canrad.2007.12.004 [doi]
PST - ppublish
SO  - Cancer Radiother. 2008 Mar;12(2):73-7. doi: 10.1016/j.canrad.2007.12.004. Epub 
      2008 Feb 20.

PMID- 11458136
OWN - NLM
STAT- MEDLINE
DCOM- 20010809
LR  - 20190822
IS  - 0025-7079 (Print)
IS  - 0025-7079 (Linking)
VI  - 39
IP  - 7
DP  - 2001 Jul
TI  - Does managed care enable more low income persons to identify a usual source of 
      care? Implications for access to care.
PG  - 716-26
AB  - BACKGROUND: By requiring or encouraging enrollees to obtain a usual source of 
      care, managed care programs hope to improve access to care without incurring 
      higher costs. OBJECTIVES: (1) To examine the effects of managed care on the 
      likelihood of low-income persons having a usual source of care and a usual 
      physician, and; (2) To examine the association between usual source of care and 
      access. RESEARCH DESIGN: Cross-sectional survey of households conducted during 
      1996 and 1997. SUBJECTS: A nationally representative sample of 14,271 low-income 
      persons. MEASURES: Usual source of care, usual physician, managed care 
      enrollment, managed care penetration. RESULTS: High managed care penetration in 
      the community is associated with a lower likelihood of having a usual source of 
      care for uninsured persons (54.8% vs. 62.2% in low penetration areas) as well as 
      a lower likelihood of having a usual physician (60% vs. 72.8%). Managed care has 
      only marginal effects on the likelihood of having a usual source of care for 
      privately insured and Medicaid beneficiaries. Having a usual physician 
      substantially reduces unmet medical needs for the insured but less so for the 
      uninsured. CONCLUSIONS: Having a usual physician can be an effective tool in 
      improving access to care for low-income populations, although it is most 
      effective when combined with insurance coverage. However, the effectiveness of 
      managed care in linking more low-income persons to a medical home is uncertain, 
      and may have unintended consequences for uninsured persons.
FAU - Cunningham, P J
AU  - Cunningham PJ
AD  - Center for Studying Health System Change, Washington, DC 20024, USA. 
      pcunningham@hschange.org
FAU - Trude, S
AU  - Trude S
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Med Care
JT  - Medical care
JID - 0230027
SB  - IM
MH  - Adult
MH  - *Continuity of Patient Care
MH  - Cross-Sectional Studies
MH  - Female
MH  - Health Services Accessibility/*economics/statistics & numerical data
MH  - Humans
MH  - Insurance Coverage
MH  - Male
MH  - *Managed Care Programs
MH  - Medically Uninsured
MH  - Multivariate Analysis
MH  - *Poverty
MH  - United States
EDAT- 2001/07/18 10:00
MHDA- 2001/08/10 10:01
CRDT- 2001/07/18 10:00
PHST- 2001/07/18 10:00 [pubmed]
PHST- 2001/08/10 10:01 [medline]
PHST- 2001/07/18 10:00 [entrez]
AID - 10.1097/00005650-200107000-00008 [doi]
PST - ppublish
SO  - Med Care. 2001 Jul;39(7):716-26. doi: 10.1097/00005650-200107000-00008.

PMID- 12790890
OWN - NLM
STAT- MEDLINE
DCOM- 20031006
LR  - 20220311
IS  - 0013-9580 (Print)
IS  - 0013-9580 (Linking)
VI  - 44
IP  - 6
DP  - 2003 Jun
TI  - Is the cell death in mesial temporal sclerosis apoptotic?
PG  - 778-84
AB  - PURPOSE: Mesial temporal sclerosis (MTS) is characterized by neuronal loss in the 
      hippocampus. Studies on experimental models and patients with intractable 
      epilepsy suggest that apoptosis may be involved in neuronal death induced by 
      recurrent seizures. METHODS: We searched evidence for apoptotic cell death in 
      temporal lobes resected from drug-resistant epilepsy patients with MTS by using 
      the terminal deoxynucleotidyl transferase (TdT) and digoxigenin-11-dUTP (TUNEL) 
      method and immunohistochemistry for Bcl-2, Bax, and caspase-cleaved actin 
      fragment, fractin. The temporal lobe specimens were obtained from 15 patients 
      (six women and nine men; mean age, 29 +/- 8 years). RESULTS: Unlike that in 
      normal adult brain, we observed Bcl-2 immunoreactivity in some of the remaining 
      neurons dispersed throughout the hippocampus proper as well as in most of the 
      reactive astroglia. Bax immunopositivity was increased in almost all neurons. 
      Fractin immunostaining, an indicator of caspase activity, was detected in 
      approximately 10% of these neurons. Despite increased Bax expression and 
      activation of caspases, we could not find evidence for DNA fragmentation by TUNEL 
      staining. We also could not detect typical apoptotic changes in nuclear 
      morphology by Hoechst-33258 or hematoxylin counterstaining. CONCLUSIONS: These 
      data suggest that either apoptosis is not involved in cell loss in MTS, or a very 
      slow rate of cell demise may have precluded detecting TUNEL-positive neurons 
      dying through apoptosis. Increased Bax expression and activation of caspases 
      support the latter possibility.
FAU - Uysal, Hilmi
AU  - Uysal H
AD  - Department of Neurology, Sevgi Hospital, Hacettepe University Hospitals, Ankara, 
      Turkey.
FAU - Cevik, Isin Unal
AU  - Cevik IU
FAU - Soylemezoglu, Figen
AU  - Soylemezoglu F
FAU - Elibol, Bulent
AU  - Elibol B
FAU - Ozdemir, Yasemin Gursoy
AU  - Ozdemir YG
FAU - Evrenkaya, Tulay
AU  - Evrenkaya T
FAU - Saygi, Serap
AU  - Saygi S
FAU - Dalkara, Turgay
AU  - Dalkara T
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Epilepsia
JT  - Epilepsia
JID - 2983306R
SB  - IM
CIN - Epilepsia. 2003 Dec;44(12):1607; author reply 1607-8. doi: 
      10.1111/j.0013-9580.2003.t01-3-33003.x. PMID: 14636340
MH  - Actin Cytoskeleton/ultrastructure
MH  - Adult
MH  - Age of Onset
MH  - *Apoptosis
MH  - Astrocytes/cytology/pathology
MH  - Cell Count
MH  - *Cell Death
MH  - DNA Fragmentation
MH  - Epilepsy, Temporal Lobe/diagnosis/metabolism/*pathology
MH  - Female
MH  - Hippocampus/cytology/pathology
MH  - Humans
MH  - Immunohistochemistry
MH  - In Situ Nick-End Labeling/methods
MH  - Male
MH  - Neurons/cytology/pathology
MH  - Sclerosis
MH  - Temporal Lobe/*pathology
EDAT- 2003/06/07 05:00
MHDA- 2003/10/08 05:00
CRDT- 2003/06/07 05:00
PHST- 2003/06/07 05:00 [pubmed]
PHST- 2003/10/08 05:00 [medline]
PHST- 2003/06/07 05:00 [entrez]
AID - 37402 [pii]
AID - 10.1046/j.1528-1157.2003.37402.x [doi]
PST - ppublish
SO  - Epilepsia. 2003 Jun;44(6):778-84. doi: 10.1046/j.1528-1157.2003.37402.x.

PMID- 18714572
OWN - NLM
STAT- MEDLINE
DCOM- 20081203
LR  - 20221207
IS  - 0392-2936 (Print)
IS  - 0392-2936 (Linking)
VI  - 29
IP  - 4
DP  - 2008
TI  - Does vaginal intraepithelial neoplasia have the same evolution as cervical 
      intraepithelial neoplasia?
PG  - 371-3
AB  - BACKGROUND: Vaginal intraepithelial neoplasia is a little known disease which 
      could be related to risk factors different from simple HPV infections. OBJECTIVE: 
      To ascertain wheter vaginal lesions have a natural history similar to cervical 
      lesions. MATERIALS & METHODS: A retrospective study to identify patients with 
      vaginal lesions and synchronous cervical lesions through biopsy. The rate of mild 
      cervical lesions (koilocytosis, warts, CIN I with and without koilocytosis) was 
      compared with the rate of severe cervical lesions (CIN II and III, cervical 
      carcinoma) in patients with mild vaginal lesions (warts and koilocytosis, and 
      low-grade VAIN) and in patients with severe vaginal lesions (high-grade VAIN). 
      Using koilocytosis as a marker, the rate of "active" cervical lesions was 
      compared with the rate of "non active" cervical lesions in patients with "active" 
      versus "non active" vaginal lesions. Finally, the rates of mild and severe 
      cervical lesions were compared among each group of VAIN (low-grade, high-grade, 
      with or without koilocytosis). RESULTS: In patients with mild vaginal lesions, 
      mild cervical lesions were significantly more frequent than severe cervical 
      lesions. In patients with "active" vaginal lesions the rate of "active" cervical 
      lesions was significantly higher than "non active" cervical lesions. The 
      differences in rates of mild cervical lesions and severe cervical lesions among 
      patients with high-grade VAIN and low-grade VAIN (with and without koilocytosis) 
      were not significant. CONCLUSION: These data suggest that CIN and VAIN may have 
      some common features in certain cases, i.e., if an HPV infection is proved.
FAU - Indraccolo, U
AU  - Indraccolo U
AD  - Institute of Obstetrics and Gynecology, Department of Surgical Sciences, 
      University of Foggia, Italy. ugo.indraccolo@libero.it
FAU - Chiocci, L
AU  - Chiocci L
FAU - Baldoni, A
AU  - Baldoni A
LA  - eng
PT  - Journal Article
PL  - Singapore
TA  - Eur J Gynaecol Oncol
JT  - European journal of gynaecological oncology
JID - 8100357
SB  - IM
MH  - Biopsy
MH  - Female
MH  - Humans
MH  - Neoplasms, Multiple Primary/*pathology/virology
MH  - Retrospective Studies
MH  - Uterine Cervical Neoplasms/*pathology/virology
MH  - Vaginal Neoplasms/*pathology
MH  - Uterine Cervical Dysplasia/*pathology/virology
EDAT- 2008/08/22 09:00
MHDA- 2008/12/17 09:00
CRDT- 2008/08/22 09:00
PHST- 2008/08/22 09:00 [pubmed]
PHST- 2008/12/17 09:00 [medline]
PHST- 2008/08/22 09:00 [entrez]
PST - ppublish
SO  - Eur J Gynaecol Oncol. 2008;29(4):371-3.

PMID- 25103647
OWN - NLM
STAT- MEDLINE
DCOM- 20150204
LR  - 20181202
IS  - 1715-3360 (Electronic)
IS  - 0008-4182 (Linking)
VI  - 49
IP  - 4
DP  - 2014 Aug
TI  - Does government assistance improve utilization of eye care services by low-income 
      individuals?
PG  - 320-5
LID - S0008-4182(14)00082-9 [pii]
LID - 10.1016/j.jcjo.2014.03.006 [doi]
AB  - OBJECTIVE: To examine whether government-funded, low-income vision care programs 
      improve use of eye care services by low-income individuals in Canada. DESIGN: 
      Cross-sectional survey. PARTICIPANTS: 27,375 white respondents to the Canadian 
      Community Health Survey (CCHS) Healthy Aging 2008/2009. METHODS: 
      Government-funded, low-income vision care programs were reviewed. The amount of 
      assistance provided was compared with professional fee schedules for 
      general/routine eye examinations and market prices for eyeglasses. The 
      utilization of eye care providers was derived from the CCHS. RESULTS: To receive 
      low-income vision care assistance, individuals must be in receipt of social 
      assistance. Criteria for receiving social assistance are stringent. The Canadian 
      Financial Capability Survey revealed that 7.9% of Canadians aged 45 to 64 years 
      and 5.5% aged >/=65 years received social assistance in 2009. The CCHS found in 
      2008/2009 that 12.5% of citizens aged 45 to 64 years and 13.2% of those aged >/=65 
      years had difficulty paying for basic expenses such as food. In 5 provinces, 
      low-income vision care assistance fully covers a general/routine eye examination. 
      In the remainder, the assistance provided is insufficient for a general/routine 
      eye examination. The assistance for eyeglasses is inadequate in 5 provinces, 
      requiring out-of-pocket copayments. Among middle-aged whites who self-reported 
      not having glaucoma, cataracts, diabetes, or vision problems not corrected by 
      lenses, utilization of eye care providers was 28.1% among those with financial 
      difficulty versus 41.9% among those without (p < 0.05), giving a prevalence ratio 
      0.68 (95% CI 0.57-0.80) adjusted for age, sex and education. CONCLUSIONS: Despite 
      government assistance, low-income individuals use vision care services less often 
      than wealthy individuals.
CI  - Copyright (c) 2014 Canadian Ophthalmological Society. Published by Elsevier Inc. 
      All rights reserved.
FAU - Hong, Chris J
AU  - Hong CJ
AD  - Faculty of Medicine, University of Ottawa, Ottawa.
FAU - Trope, Graham E
AU  - Trope GE
AD  - Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto.
FAU - Buys, Yvonne M
AU  - Buys YM
AD  - Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto.
FAU - Robinson, Barbara E
AU  - Robinson BE
AD  - School of Optometry, University of Waterloo, Waterloo.
FAU - Jin, Ya-Ping
AU  - Jin YP
AD  - Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto; 
      Department of Ophthalmology and Vision Sciences & Dalla Lana School of Public 
      Health, University of Toronto, Toronto, Ont.. Electronic address: 
      yaping.jin@utoronto.ca.
LA  - eng
GR  - SEC117120/Canadian Institutes of Health Research/Canada
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20140719
PL  - England
TA  - Can J Ophthalmol
JT  - Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
JID - 0045312
SB  - IM
MH  - Adult
MH  - Aged
MH  - Canada
MH  - Cross-Sectional Studies
MH  - Female
MH  - Government Programs
MH  - Health Care Surveys
MH  - Health Services/*statistics & numerical data
MH  - Health Services Accessibility/*statistics & numerical data
MH  - Health Services Research
MH  - Humans
MH  - Male
MH  - Medical Assistance/*statistics & numerical data
MH  - Middle Aged
MH  - National Health Programs
MH  - Ophthalmology/*statistics & numerical data
MH  - Optometry/*statistics & numerical data
MH  - Poverty/*statistics & numerical data
MH  - Young Adult
EDAT- 2014/08/12 06:00
MHDA- 2015/02/05 06:00
CRDT- 2014/08/09 06:00
PHST- 2013/09/13 00:00 [received]
PHST- 2014/03/06 00:00 [revised]
PHST- 2014/03/16 00:00 [accepted]
PHST- 2014/08/09 06:00 [entrez]
PHST- 2014/08/12 06:00 [pubmed]
PHST- 2015/02/05 06:00 [medline]
AID - S0008-4182(14)00082-9 [pii]
AID - 10.1016/j.jcjo.2014.03.006 [doi]
PST - ppublish
SO  - Can J Ophthalmol. 2014 Aug;49(4):320-5. doi: 10.1016/j.jcjo.2014.03.006. Epub 
      2014 Jul 19.

PMID- 24995509
OWN - NLM
STAT- MEDLINE
DCOM- 20150721
LR  - 20210514
IS  - 1442-9071 (Electronic)
IS  - 1442-6404 (Linking)
VI  - 43
IP  - 1
DP  - 2015 Jan-Feb
TI  - HIF1A as a major vascular endothelial growth factor regulator: do its 
      polymorphisms have an association with age-related macular degeneration?
PG  - 47-53
LID - 10.1111/ceo.12376 [doi]
AB  - BACKGROUND: To investigate the association between age-related macular 
      degeneration (AMD) and the polymorphisms of HIF1A, a major vascular epithelial 
      growth factor regulator under hypoxic conditions. The associations of AMD and 
      polymorphisms of genes CFH, SKIV2L and MYRIP were also studied. DESIGN: 
      Prospective study. PARTICIPANTS: Eighty-seven AMD patients and 80 healthy 
      subjects admitted to the Department of Ophthalmology at Pamukkale University 
      Hospital, Denizli, Turkey, were included: 45 (52%) had wet type AMD, and 42 (48%) 
      had dry type AMD. METHODS: Polymorphisms rs1061170 (CFH), rs429608 (SKIV2L), 
      rs2679798 (MYRIP) and both rs11549465 and rs11549467 (HIF1A) were investigated in 
      DNA isolated from peripheral blood samples of the cases and controls by 
      dye-termination DNA sequencing. MAIN OUTCOME MEASURES: Genotype distribution of 
      rs1061170 (CFH), rs429608 (SKIV2L), rs2679798 (MYRIP) and both rs11549465 and 
      rs11549467 (HIF1A) in AMD cases and healthy controls; association between 
      genotypes and AMD subtypes. RESULTS: Given the significant difference between the 
      mean age of case and control groups (72.13 +/- 5.77 vs. 62.80 +/- 5.22, respectively) 
      (P = .000), subsequent analyses were adjusted for age. We found that having at 
      least one C allele for polymorphism rs1061170 increases AMD risk independent of 
      age (OR = 2.42, 95% confidence interval [CI], 1.22-4.81). The ancestral T allele 
      for polymorphism rs1061170 has a protective effect for AMD (OR = 0.53, 95% CI, 
      0.34-0.83). No statistically significant difference for distributions of other 
      single nucleotide polymorphisms (SNPs) emerged between patients and healthy 
      subjects. CONCLUSIONS: No associations appeared between HIF1A SNPs and AMD, which 
      were studied here for the first time; however, polymorphism rs1061170 of the CFH 
      gene is associated with AMD in our population.
CI  - (c) 2014 Royal Australian and New Zealand College of Ophthalmologists.
FAU - Okur, Volkan
AU  - Okur V
AD  - Department of Medical Genetics, Medical School of Pamukkale University, Denizli, 
      Turkey.
FAU - Cetin, Ozan
AU  - Cetin O
FAU - Cetin, Ebru
AU  - Cetin E
FAU - Tepeli, Emre
AU  - Tepeli E
FAU - Bulgu, Yunus
AU  - Bulgu Y
FAU - Yildirim, Cem
AU  - Yildirim C
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20140819
PL  - Australia
TA  - Clin Exp Ophthalmol
JT  - Clinical & experimental ophthalmology
JID - 100896531
RN  - 0 (CFH protein, human)
RN  - 0 (HIF1A protein, human)
RN  - 0 (Hypoxia-Inducible Factor 1, alpha Subunit)
RN  - 0 (MYRIP protein, human)
RN  - 0 (VEGFA protein, human)
RN  - 0 (Vascular Endothelial Growth Factor A)
RN  - 0 (Vesicular Transport Proteins)
RN  - 80295-65-4 (Complement Factor H)
RN  - EC 3.6.4.- (DNA Helicases)
RN  - EC 5.99.- (SKIV2L protein, human)
SB  - IM
CIN - Clin Exp Ophthalmol. 2015 Jan-Feb;43(1):1-2. doi: 10.1111/ceo.12493. PMID: 
      25625895
MH  - Aged
MH  - Complement Factor H/genetics
MH  - DNA Helicases/genetics
MH  - Female
MH  - Gene Frequency
MH  - Genotype
MH  - Geographic Atrophy/*genetics
MH  - Humans
MH  - Hypoxia-Inducible Factor 1, alpha Subunit/*genetics
MH  - Male
MH  - Middle Aged
MH  - Polymerase Chain Reaction
MH  - *Polymorphism, Single Nucleotide
MH  - Prospective Studies
MH  - Sequence Analysis, DNA
MH  - Vascular Endothelial Growth Factor A/*metabolism
MH  - Vesicular Transport Proteins/genetics
MH  - Wet Macular Degeneration/*genetics
OTO - NOTNLM
OT  - AMD
OT  - CFH
OT  - HIF1A
OT  - MYRIP
OT  - SKIV2L
EDAT- 2014/07/06 06:00
MHDA- 2015/07/22 06:00
CRDT- 2014/07/05 06:00
PHST- 2013/12/18 00:00 [received]
PHST- 2014/06/13 00:00 [accepted]
PHST- 2014/07/05 06:00 [entrez]
PHST- 2014/07/06 06:00 [pubmed]
PHST- 2015/07/22 06:00 [medline]
AID - 10.1111/ceo.12376 [doi]
PST - ppublish
SO  - Clin Exp Ophthalmol. 2015 Jan-Feb;43(1):47-53. doi: 10.1111/ceo.12376. Epub 2014 
      Aug 19.

PMID- 27044366
OWN - NLM
STAT- MEDLINE
DCOM- 20161005
LR  - 20181113
IS  - 1471-2466 (Electronic)
IS  - 1471-2466 (Linking)
VI  - 16
DP  - 2016 Apr 5
TI  - Detailed analysis of sputum and systemic inflammation in asthma phenotypes: are 
      paucigranulocytic asthmatics really non-inflammatory?
PG  - 46
LID - 10.1186/s12890-016-0208-2 [doi]
LID - 46
AB  - BACKGROUND: The technique of induced sputum has allowed to subdivide asthma 
      patients into inflammatory phenotypes according to their level of granulocyte 
      airway infiltration. There are very few studies which looked at detailed sputum 
      and blood cell counts in a large cohort of asthmatics divided into inflammatory 
      phenotypes. The purpose of this study was to analyze sputum cell counts, blood 
      leukocytes and systemic inflammatory markers in these phenotypes, and investigate 
      how those groups compared with healthy subjects. METHODS: We conducted a 
      retrospective cross-sectional study on 833 asthmatics recruited from the 
      University Asthma Clinic of Liege and compared them with 194 healthy subjects. 
      Asthmatics were classified into inflammatory phenotypes. RESULTS: The total 
      non-squamous cell count per gram of sputum was greater in mixed granulocytic and 
      neutrophilic phenotypes as compared to eosinophilic, paucigranulocytic asthma and 
      healthy subjects (p < 0.005). Sputum eosinophils (in absolute values and 
      percentages) were increased in all asthma phenotypes including paucigranulocytic 
      asthma, compared to healthy subjects (p < 0.005). Eosinophilic asthma showed 
      higher absolute sputum neutrophil and lymphocyte counts than healthy subjects 
      (p < 0.005), while neutrophilic asthmatics had a particularly low number of 
      sputum macrophages and epithelial cells. All asthma phenotypes showed an 
      increased blood leukocyte count compared to healthy subjects (p < 0.005), with 
      paucigranulocytic asthmatics having also increased absolute blood eosinophils 
      compared to healthy subjects (p < 0.005). Neutrophilic asthma had raised CRP and 
      fibrinogen while eosinophilic asthma only showed raised fibrinogen compared to 
      healthy subjects (p < 0.005). CONCLUSIONS: This study demonstrates that a 
      significant eosinophilic inflammation is present across all categories of asthma, 
      and that paucigranulocytic asthma may be seen as a low grade inflammatory 
      disease.
FAU - Demarche, Sophie
AU  - Demarche S
AD  - Department of Respiratory Medicine, CHU Liege, Sart-Tilman B35, 4000, Liege, 
      Belgium. sophie.demarche@ulg.ac.be.
AD  - GIGA I3 Research Group, University of Liege, Liege, Belgium. 
      sophie.demarche@ulg.ac.be.
AD  - Department of Clinical and Hospital Pharmacy, University of Liege, Liege, 
      Belgium. sophie.demarche@ulg.ac.be.
FAU - Schleich, Florence
AU  - Schleich F
AD  - Department of Respiratory Medicine, CHU Liege, Sart-Tilman B35, 4000, Liege, 
      Belgium.
AD  - GIGA I3 Research Group, University of Liege, Liege, Belgium.
FAU - Henket, Monique
AU  - Henket M
AD  - Department of Respiratory Medicine, CHU Liege, Sart-Tilman B35, 4000, Liege, 
      Belgium.
AD  - GIGA I3 Research Group, University of Liege, Liege, Belgium.
FAU - Paulus, Virginie
AU  - Paulus V
AD  - Department of Respiratory Medicine, CHU Liege, Sart-Tilman B35, 4000, Liege, 
      Belgium.
AD  - GIGA I3 Research Group, University of Liege, Liege, Belgium.
FAU - Van Hees, Thierry
AU  - Van Hees T
AD  - Department of Clinical and Hospital Pharmacy, University of Liege, Liege, 
      Belgium.
FAU - Louis, Renaud
AU  - Louis R
AD  - Department of Respiratory Medicine, CHU Liege, Sart-Tilman B35, 4000, Liege, 
      Belgium.
AD  - GIGA I3 Research Group, University of Liege, Liege, Belgium.
LA  - eng
PT  - Journal Article
DEP - 20160405
PL  - England
TA  - BMC Pulm Med
JT  - BMC pulmonary medicine
JID - 100968563
RN  - 9001-32-5 (Fibrinogen)
RN  - 9007-41-4 (C-Reactive Protein)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Asthma/*immunology
MH  - C-Reactive Protein/*immunology
MH  - Case-Control Studies
MH  - Cross-Sectional Studies
MH  - Eosinophils/cytology/*immunology
MH  - Female
MH  - Fibrinogen/*immunology
MH  - Granulocytes/cytology/immunology
MH  - Humans
MH  - Inflammation
MH  - Leukocyte Count
MH  - Lymphocyte Count
MH  - Macrophages/cytology/*immunology
MH  - Male
MH  - Middle Aged
MH  - Neutrophils/cytology/*immunology
MH  - Phenotype
MH  - Retrospective Studies
MH  - Sputum/*cytology
PMC - PMC4820945
OTO - NOTNLM
OT  - Asthma
OT  - Blood leukocyte count
OT  - CRP
OT  - Fibrinogen
OT  - Healthy subjects
OT  - Phenotypes
OT  - Sputum cytology
EDAT- 2016/04/06 06:00
MHDA- 2016/10/07 06:00
PMCR- 2016/04/05
CRDT- 2016/04/06 06:00
PHST- 2015/11/10 00:00 [received]
PHST- 2016/03/18 00:00 [accepted]
PHST- 2016/04/06 06:00 [entrez]
PHST- 2016/04/06 06:00 [pubmed]
PHST- 2016/10/07 06:00 [medline]
PHST- 2016/04/05 00:00 [pmc-release]
AID - 10.1186/s12890-016-0208-2 [pii]
AID - 208 [pii]
AID - 10.1186/s12890-016-0208-2 [doi]
PST - epublish
SO  - BMC Pulm Med. 2016 Apr 5;16:46. doi: 10.1186/s12890-016-0208-2.

PMID- 26606599
OWN - NLM
STAT- MEDLINE
DCOM- 20161227
LR  - 20181202
IS  - 1531-2291 (Electronic)
IS  - 0890-5339 (Linking)
VI  - 30
IP  - 4
DP  - 2016 Apr
TI  - Do Surrogates of Injury Severity Influence the Occurrence of Heterotopic 
      Ossification in Fractures of the Acetabulum?
PG  - 213-6
LID - 10.1097/BOT.0000000000000490 [doi]
AB  - OBJECTIVES: To determine the relationship between injury severity surrogates and 
      other patient factors with the development and severity of heterotopic 
      ossification (HO) following open reduction internal fixation of acetabular 
      fractures treated with a posterior approach. DESIGN: Retrospective review. 
      SETTING: Academic level 1 trauma center. PARTICIPANTS: Two hundred forty-one 
      patients who were treated through a posterior approach with a minimum of 6-month 
      radiographic follow-up were identified from an acetabular fracture database. 
      INTERVENTION: None. MAIN OUTCOME MEASURES: The occurrence and severity (Brooker 
      Grade III/IV) of HO 6 months postsurgery. RESULTS: Length of stay (LOS) in the 
      intensive care unit (ICU), non-ICU LOS >10 days, and HO prophylaxis with external 
      radiation beam therapy (XRT) were significantly associated with the development 
      of HO in a multivariate model [ICU LOS: 1-2 days, odds ratio (OR) = 4.33, 95% 
      confidence interval (CI): 1.03-18.25; 3-6 days, OR = 4.1, 95% CI, 1.27-13.27; >6 
      days, OR = 11.7, 95% CI, 3.24-42.22; non-ICU LOS >10 days (vs. 0-6 days): OR = 
      7.6, 95% CI, 2.6-22.25; XRT HO prophylaxis: OR = 0.29, 95% CI, 0.10-0.85]. Other 
      variables evaluated in multivariate modeling not significantly associated with 
      development and severity of HO included age, gender, mechanism of injury, injury 
      severity score, presence of neurologic injury, Letournel fracture type, 
      occurrence of hip dislocation, interval from injury to surgery, operative time, 
      and estimated blood loss. CONCLUSIONS: Surrogates of injury severity, including 
      days in the ICU and non-ICU hospital LOS >10 days, were associated with the 
      development of HO in our cohort of acetabular fracture patients. Prophylaxis with 
      XRT was significantly protective against the development of HO, and the ability 
      to provide prophylaxis is very likely related to the severity of injury. LEVEL OF 
      EVIDENCE: Prognostic Level II. See Instructions for Authors for a complete 
      description of levels of evidence.
FAU - d'Heurle, Albert
AU  - d'Heurle A
AD  - Division of Orthopaedic Trauma, Department of Orthopaedic Surgery, University of 
      Cincinnati, Cincinnati, OH.
FAU - Archdeacon, Michael T
AU  - Archdeacon MT
FAU - Hiratzka, Shannon
AU  - Hiratzka S
FAU - Casstevens, Christopher
AU  - Casstevens C
FAU - Finnan, Ryan
AU  - Finnan R
FAU - McCoy, Brett
AU  - McCoy B
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - J Orthop Trauma
JT  - Journal of orthopaedic trauma
JID - 8807705
SB  - IM
MH  - Acetabulum/*injuries/surgery
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Causality
MH  - Comorbidity
MH  - Female
MH  - Fracture Fixation, Internal/statistics & numerical data
MH  - Fractures, Bone/diagnosis/*epidemiology/*surgery
MH  - Humans
MH  - Incidence
MH  - Length of Stay/statistics & numerical data
MH  - Middle Aged
MH  - Ohio/epidemiology
MH  - Open Fracture Reduction/statistics & numerical data
MH  - Ossification, Heterotopic/*diagnosis/*epidemiology
MH  - Prognosis
MH  - Reproducibility of Results
MH  - Retrospective Studies
MH  - Risk Factors
MH  - Sensitivity and Specificity
MH  - *Trauma Severity Indices
EDAT- 2015/11/26 06:00
MHDA- 2016/12/28 06:00
CRDT- 2015/11/26 06:00
PHST- 2015/11/26 06:00 [entrez]
PHST- 2015/11/26 06:00 [pubmed]
PHST- 2016/12/28 06:00 [medline]
AID - 10.1097/BOT.0000000000000490 [doi]
PST - ppublish
SO  - J Orthop Trauma. 2016 Apr;30(4):213-6. doi: 10.1097/BOT.0000000000000490.

PMID- 17076091
OWN - NLM
STAT- MEDLINE
DCOM- 20061128
LR  - 20170214
IS  - 0003-4894 (Print)
IS  - 0003-4894 (Linking)
VI  - 115
IP  - 10
DP  - 2006 Oct
TI  - Does obstructive sleep apnea affect aerobic fitness?
PG  - 715-20
AB  - OBJECTIVES: We sought to determine whether patients with obstructive sleep apnea 
      (OSA) had an objective change in aerobic fitness during cycle ergometry compared 
      to a normal population. The most accurate test of aerobic fitness is measurement 
      of maximum oxygen consumption (VO2max) with cycle ergometry. METHODS: We 
      performed a retrospective cohort analysis (247 patients with OSA) of VO2max from 
      annual cycle ergometry tests compared to a large control group (normative data 
      from 1.4 million US Air Force tests) in a tertiary care setting. RESULTS: 
      Overall, individuals with OSA had increased VO2max when compared to the 
      normalized US Air Force data (p < .001). Patients with an apnea-hypopnea index of 
      greater than 20 demonstrated a decreased VO2max as compared to normalized values 
      (p < .001). No differences in VO2max were observed after either medical or 
      surgical therapy for OSA. CONCLUSIONS: Overall, in a US Air Force population, OSA 
      does not predict a decrease in aerobic fitness as measured by cycle ergometry. 
      However, patients with an apnea-hypopnea index of greater than 20 have a 
      statistically significant decrease in aerobic fitness compared to the normal 
      population. This study demonstrates the effects of OSA on aerobic fitness. 
      Further correlation of fitness testing results with OSA severity and treatment is 
      needed.
FAU - Guillermo, Louis Q
AU  - Guillermo LQ
AD  - Department of Otolaryngology-Head and Neck Surgery, Wilford Hall United States 
      Air Force Medical Center, San Antonio, Texas, USA.
FAU - Gal, Thomas J
AU  - Gal TJ
FAU - Mair, Eric A
AU  - Mair EA
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Ann Otol Rhinol Laryngol
JT  - The Annals of otology, rhinology, and laryngology
JID - 0407300
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Cohort Studies
MH  - Continuous Positive Airway Pressure
MH  - Exercise Test
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Military Personnel
MH  - Oxygen Consumption/*physiology
MH  - Physical Fitness/*physiology
MH  - Retrospective Studies
MH  - Sleep Apnea, Obstructive/*physiopathology/therapy
MH  - United States
EDAT- 2006/11/02 09:00
MHDA- 2006/12/09 09:00
CRDT- 2006/11/02 09:00
PHST- 2006/11/02 09:00 [pubmed]
PHST- 2006/12/09 09:00 [medline]
PHST- 2006/11/02 09:00 [entrez]
AID - 10.1177/000348940611501001 [doi]
PST - ppublish
SO  - Ann Otol Rhinol Laryngol. 2006 Oct;115(10):715-20. doi: 
      10.1177/000348940611501001.

PMID- 26037986
OWN - NLM
STAT- MEDLINE
DCOM- 20160513
LR  - 20220317
IS  - 1863-9941 (Electronic)
IS  - 1863-9933 (Linking)
VI  - 41
IP  - 4
DP  - 2015 Aug
TI  - 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of 
      concern and need for improvement?
PG  - 369-74
LID - 10.1007/s00068-014-0450-3 [doi]
AB  - AIMS: Emergency surgery is associated with poorer outcomes and higher mortality 
      with recent studies suggesting the 30-day mortality to be 14-15%. The aim of this 
      study was to analyse the 30-day mortality, age-related 30-day mortality and 
      1-year mortality following emergency laparotomy. We hope this will encourage 
      prospective data collection, improvement of care and initiate strategies to 
      establish best practice in this area. METHODS: This was a retrospective study of 
      patients who underwent emergency laparotomy from June 2010 to May 2012. The 
      primary end point of the study was 30-day mortality, age-related 30-day mortality 
      and 1-year all-cause mortality. RESULTS: 477 laparotomies were performed in 446 
      patients. 57% were aged <70 and 43% aged >70 years. 30-day mortality was 12, 4% 
      in those aged <70 years and 22% in those >70 years (p < 0.001). 1-year mortality 
      was 25, 15% in those aged under 70 years and 38% in those aged >70 years (p < 
      0.001). CONCLUSIONS: Emergency laparotomy carries a high rate of mortality, 
      especially in those over the age of 70 years, and more needs to be done to 
      improve outcomes, particularly in this group. This could involve increasing acute 
      surgical care manpower, early recognition of patients requiring emergency 
      surgery, development of clear management protocols for such patients or perhaps 
      even considering centralisation of emergency surgical services to specialist 
      centres with multidisciplinary teams involving emergency surgeons and care of the 
      elderly physicians in hospital and related community outreach services for 
      post-discharge care.
FAU - Watt, D G
AU  - Watt DG
AD  - Department of General Surgery, Ninewells Hospital and Medical School, Dundee, DD1 
      9SY, UK, davidwatt1@nhs.net.
FAU - Wilson, M S J
AU  - Wilson MS
FAU - Shapter, O C
AU  - Shapter OC
FAU - Patil, Pradeep
AU  - Patil P
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20140923
PL  - Germany
TA  - Eur J Trauma Emerg Surg
JT  - European journal of trauma and emergency surgery : official publication of the 
      European Trauma Society
JID - 101313350
SB  - IM
MH  - Adult
MH  - Age Factors
MH  - Aged
MH  - Aged, 80 and over
MH  - *Cause of Death
MH  - Cohort Studies
MH  - Emergency Treatment/methods/*mortality
MH  - Female
MH  - *General Surgery
MH  - Humans
MH  - Incidence
MH  - Laparotomy/methods/*mortality
MH  - Male
MH  - Middle Aged
MH  - Needs Assessment
MH  - Retrospective Studies
MH  - Risk Assessment
MH  - Time Factors
MH  - United Kingdom
EDAT- 2015/06/04 06:00
MHDA- 2016/05/14 06:00
CRDT- 2015/06/04 06:00
PHST- 2014/03/02 00:00 [received]
PHST- 2014/09/08 00:00 [accepted]
PHST- 2015/06/04 06:00 [entrez]
PHST- 2015/06/04 06:00 [pubmed]
PHST- 2016/05/14 06:00 [medline]
AID - 10.1007/s00068-014-0450-3 [doi]
PST - ppublish
SO  - Eur J Trauma Emerg Surg. 2015 Aug;41(4):369-74. doi: 10.1007/s00068-014-0450-3. 
      Epub 2014 Sep 23.

PMID- 22491528
OWN - NLM
STAT- MEDLINE
DCOM- 20120926
LR  - 20191210
IS  - 2044-5423 (Electronic)
IS  - 2044-5415 (Linking)
VI  - 21
IP  - 6
DP  - 2012 Jun
TI  - Combining process indicators to evaluate quality of care for surgical patients 
      with colorectal cancer: are scores consistent with short-term outcome?
PG  - 481-9
LID - 10.1136/bmjqs-2011-000439 [doi]
AB  - OBJECTIVE: To determine if composite measures based on process indicators are 
      consistent with short-term outcome indicators in surgical colorectal cancer care. 
      DESIGN: Longitudinal analysis of consistency between composite measures based on 
      process indicators and outcome indicators for 85 Dutch hospitals. SETTING: The 
      Dutch Surgical Colorectal Audit database, the Netherlands. PARTICIPANTS: 4732 
      elective patients with colon carcinoma and 2239 with rectum carcinoma treated in 
      85 hospitals were included in the analyses. MAIN OUTCOME MEASURES: All available 
      process indicators were aggregated into five different composite measures. The 
      association of the different composite measures with risk-adjusted postoperative 
      mortality and morbidity was analysed at the patient and hospital level. RESULTS: 
      At the patient level, only one of the composite measures was negatively 
      associated with morbidity for rectum carcinoma. At the hospital level, a strong 
      negative association was found between composite measures and hospital mortality 
      and morbidity rates for rectum carcinoma (p<0.05), and hospital morbidity rates 
      for colon carcinoma. CONCLUSIONS: For individual patients, a high score on the 
      composite measures based on process indicators is not associated with better 
      short-term outcome. However, at the hospital level, a good score on the composite 
      measures based on process indicators was consistent with more favourable 
      risk-adjusted short-term outcome rates.
FAU - Kolfschoten, N E
AU  - Kolfschoten NE
AD  - Department of Surgery, Leiden University Medical Center, PO Box 9600, Leiden 2300 
      RC, The Netherlands.
FAU - Gooiker, G A
AU  - Gooiker GA
FAU - Bastiaannet, E
AU  - Bastiaannet E
FAU - van Leersum, N J
AU  - van Leersum NJ
FAU - van de Velde, C J H
AU  - van de Velde CJ
FAU - Eddes, E H
AU  - Eddes EH
FAU - Marang-van de Mheen, P J
AU  - Marang-van de Mheen PJ
FAU - Kievit, J
AU  - Kievit J
FAU - van der Harst, E
AU  - van der Harst E
FAU - Wiggers, T
AU  - Wiggers T
FAU - Wouters, M W J M
AU  - Wouters MW
FAU - Tollenaar, R A E M
AU  - Tollenaar RA
CN  - Dutch Surgical Colorectal Audit group
LA  - eng
PT  - Journal Article
DEP - 20120404
PL  - England
TA  - BMJ Qual Saf
JT  - BMJ quality & safety
JID - 101546984
MH  - Colorectal Neoplasms/*surgery
MH  - Databases, Factual
MH  - Female
MH  - Hospitals, Public
MH  - Humans
MH  - Longitudinal Studies
MH  - Male
MH  - Netherlands
MH  - *Outcome Assessment, Health Care
MH  - Quality Assurance, Health Care/*methods
MH  - *Quality Indicators, Health Care
MH  - Surgical Procedures, Operative/*standards
FIR - Bemelman, W A
IR  - Bemelman WA
FIR - Busch, O R C
IR  - Busch OR
FIR - van Dam, R M
IR  - van Dam RM
FIR - Jansen-Landheer, M L E A
IR  - Jansen-Landheer ML
FIR - Karsten, Th M
IR  - Karsten TM
FIR - van Krieken, J H J M
IR  - van Krieken JH
FIR - Kuijpers, W G T
IR  - Kuijpers WG
FIR - Lemmens, V E
IR  - Lemmens VE
FIR - Manusama, E R
IR  - Manusama ER
FIR - Meijerink, J H J
IR  - Meijerink JH
FIR - Rutten, H J T
IR  - Rutten HJ
EDAT- 2012/04/12 06:00
MHDA- 2012/09/27 06:00
CRDT- 2012/04/12 06:00
PHST- 2012/04/12 06:00 [entrez]
PHST- 2012/04/12 06:00 [pubmed]
PHST- 2012/09/27 06:00 [medline]
AID - bmjqs-2011-000439 [pii]
AID - 10.1136/bmjqs-2011-000439 [doi]
PST - ppublish
SO  - BMJ Qual Saf. 2012 Jun;21(6):481-9. doi: 10.1136/bmjqs-2011-000439. Epub 2012 Apr 
      4.

PMID- 24591144
OWN - NLM
STAT- MEDLINE
DCOM- 20141020
LR  - 20140826
IS  - 1531-4995 (Electronic)
IS  - 0023-852X (Linking)
VI  - 124
IP  - 9
DP  - 2014 Sep
TI  - Are the elderly with oropharyngeal carcinoma undertreated?
PG  - 2057-63
LID - 10.1002/lary.24660 [doi]
AB  - OBJECTIVES/HYPOTHESIS: To determine if elderly patients with oropharyngeal 
      squamous cell carcinoma (OPSCC) are receiving less treatment and to evaluate the 
      benefit of aggressive therapy in this population. STUDY DESIGN: Retrospective 
      analysis of a large population database. METHODS: Patients in the Surveillance, 
      Epidemiology, and End Results database with OPSCC diagnosed from 2004 to 2009 
      were included. The patients were categorized into age groups 45 to 54, 55 to 64, 
      65 to 74, 75 to 84, and 85 years and older, then further categorized by treatment 
      status. Kaplan-Meier analysis of disease-specific survival (DSS) for late-stage 
      (III and IV) OPSCC was performed for all age and treatment categories, followed 
      by a multivariate cox regression of treatment status, tumor site, race, stage, 
      and sex per age group. RESULTS: A total of 14,909 patients with OPSCC were 
      identified. In our demographic data, we observed a significant increase in the 
      number of patients who did not receive treatment (surgery, radiation, or combined 
      therapy) after age 55. Kaplan-Meier analysis showed that age groups 65 to 74 and 
      75 to 84 had substantial benefits in DSS with surgery, radiation, or combined 
      therapy. Multivariable analysis did not demonstrate any statistically significant 
      difference in the hazard ratios for combined treatment among age groups 45 to 54, 
      55 to 64, 65 to 74, and 75 to 84. CONCLUSIONS: Proportionally fewer elderly 
      patients with OPSCC are being treated than younger individuals. These patients 
      can have significant benefits from aggressive treatments despite their older age 
      as shown by our survival analysis. We recommend the use of objective measures to 
      assess patient fitness to reduce the potential for undertreatment in the elderly 
      population.
CI  - (c) 2014 The American Laryngological, Rhinological and Otological Society, Inc.
FAU - Camilon, P Ryan
AU  - Camilon PR
AD  - Department of Otolaryngology-Head and Neck Surgery, Medical University of South 
      Carolina, Charleston, South Carolina, U.S.A.
FAU - Stokes, William A
AU  - Stokes WA
FAU - Nguyen, Shaun A
AU  - Nguyen SA
FAU - Lentsch, Eric J
AU  - Lentsch EJ
LA  - eng
PT  - Journal Article
DEP - 20140507
PL  - United States
TA  - Laryngoscope
JT  - The Laryngoscope
JID - 8607378
SB  - IM
MH  - Age Factors
MH  - Aged
MH  - Aged, 80 and over
MH  - Carcinoma, Squamous Cell/*therapy
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Oropharyngeal Neoplasms/*therapy
MH  - Retrospective Studies
MH  - Vulnerable Populations/*statistics & numerical data
OTO - NOTNLM
OT  - Oropharyngeal cancer
OT  - elderly
OT  - survival analysis
OT  - undertreatment
EDAT- 2014/03/05 06:00
MHDA- 2014/10/21 06:00
CRDT- 2014/03/05 06:00
PHST- 2013/09/12 00:00 [received]
PHST- 2014/02/21 00:00 [revised]
PHST- 2014/02/27 00:00 [accepted]
PHST- 2014/03/05 06:00 [entrez]
PHST- 2014/03/05 06:00 [pubmed]
PHST- 2014/10/21 06:00 [medline]
AID - 10.1002/lary.24660 [doi]
PST - ppublish
SO  - Laryngoscope. 2014 Sep;124(9):2057-63. doi: 10.1002/lary.24660. Epub 2014 May 7.

PMID- 19351635
OWN - NLM
STAT- MEDLINE
DCOM- 20091102
LR  - 20090408
IS  - 1469-0756 (Electronic)
IS  - 0032-5473 (Linking)
VI  - 85
IP  - 1001
DP  - 2009 Mar
TI  - Do older patients receive adequate stroke care? An experience of a neurovascular 
      clinic.
PG  - 115-8
LID - 10.1136/pgmj.2008.070607 [doi]
AB  - BACKGROUND: National guidelines and government directives have adopted policies 
      for urgent assessment of patients with a transient ischaemic attack or minor 
      stroke not admitted to hospital. The risk of recurrent stroke increases 
      substantially with age, as does the potential benefit of secondary prevention. In 
      order to develop effective strategies for older patients, it is important to 
      identify how stroke care is currently provided for this patient group. METHODS: 
      Between 2004 and 2006, older patients (>75 years) referred to a neurovascular 
      clinic were compared with younger patients (< or =75 years). Sociodemographic 
      details, clinical features, resource use and secondary prevention in a 
      neurovascular clinic were collected. RESULTS: Of 379 patients referred to the 
      clinic, 129 (34%) were given a non-stroke diagnosis. Of the remaining 250 
      patients, 149 (60%) were < or =75 years. Median time from symptom onset to clinic 
      appointment was similar for the two groups (24 (IQR 15-42) vs 24 (IQR 14-43) 
      days; p = 0.58). Older patients were more likely to be in atrial fibrillation 
      (10.1% vs 22.8%, p<0.001) and have lacunar stroke (34.7% vs 22.1%; p = 0.04). CT 
      rates were similar in the two groups (27.8% vs 80.0%, p = 0.75). Scans were 
      performed more quickly in younger patients (p<0.01). MRI scan rates were higher 
      in younger patients (26% vs 4%, p<0.01), as was carotid Doppler imaging (92% vs 
      77%, p<0.01). There were no differences in prescribed secondary preventive 
      treatments. Older patients experienced less delay for carotid endarterectomy (49 
      vs 90 days, p<0.01). Younger patients were more likely to be given advice on 
      weight reduction (30.2% vs 12.9%, p<0.01) and diet (46.3% vs 31.7%, p = 0.02) 
      than older patients. CONCLUSIONS: Older patients were less likely to receive 
      diagnostic investigations and lifestyle modification advice than younger 
      patients. Guidelines need to be adopted to ensure prompt evidence-based stroke 
      care in the outpatient setting.
FAU - Kee, Y-Y K
AU  - Kee YY
AD  - St Helier Stroke Service, Epsom and St Helier University Hospitals NHS Trust, 
      Carshalton, Surrey, UK. karenkee@doctors.org.uk
FAU - Brooks, W
AU  - Brooks W
FAU - Bhalla, A
AU  - Bhalla A
LA  - eng
PT  - Journal Article
PL  - England
TA  - Postgrad Med J
JT  - Postgraduate medical journal
JID - 0234135
SB  - IM
MH  - Age Factors
MH  - Aged
MH  - Aged, 80 and over
MH  - Delivery of Health Care/*standards
MH  - Emergency Service, Hospital/*standards
MH  - England
MH  - Female
MH  - Health Services for the Aged/*standards
MH  - Humans
MH  - Magnetic Resonance Angiography
MH  - Male
MH  - Quality of Health Care
MH  - Risk Assessment
MH  - Stroke/*therapy
MH  - Waiting Lists
EDAT- 2009/04/09 09:00
MHDA- 2009/11/03 06:00
CRDT- 2009/04/09 09:00
PHST- 2009/04/09 09:00 [entrez]
PHST- 2009/04/09 09:00 [pubmed]
PHST- 2009/11/03 06:00 [medline]
AID - 85/1001/115 [pii]
AID - 10.1136/pgmj.2008.070607 [doi]
PST - ppublish
SO  - Postgrad Med J. 2009 Mar;85(1001):115-8. doi: 10.1136/pgmj.2008.070607.

PMID- 20337202
OWN - NLM
STAT- MEDLINE
DCOM- 20100527
LR  - 20100326
IS  - 0024-7758 (Print)
IS  - 0024-7758 (Linking)
VI  - 55
IP  - 1-2
DP  - 2010 Jan-Feb
TI  - Continuation of pregnancy after antenatal corticosteroid administration: 
      opportunity for rescue?
PG  - 14-8
AB  - OBJECTIVE: To determine the duration of continuing pregnancy after antenatal 
      corticosteroid (AC) administration and to evaluate the potential opportunity for 
      rescue AC. STUDY DESIGN: Retrospective analysis of women at 24-32 weeks' 
      gestation who received AC at one institution. RESULTS: Six hundred ninety-two 
      women received AC. Two hundred forty-seven (35.7%) delivered at > or = 34 weeks' 
      gestation. Three hundred twenty-one (46.4%) delivered within 1 week of AC; 92 of 
      those women (13.3%) delivered within 24 hours. Only 124 (17.9%) remained pregnant 
      1 week after AC and delivered at < 34 weeks. The latter were compared to women 
      delivering > 2 week after AC but > or = 34 weeks. More likely to deliver at < 34 
      weeks were those women who received AC for premature preterm rupture of membranes 
      (OR 3.83, 95% CI 2.06-7.17), twins (OR 2.90, 95% CI 1.42-5.95) or before 28 weeks 
      (OR 2.21, 95% CI 1.38-3.52). CONCLUSION: Rescue AC may apply to only 18% of 
      cases, and we identified subsets of more likely candidates.
FAU - Davidson, Christina
AU  - Davidson C
AD  - Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, 
      Baylor College of Medicine, 1709 Dryden Road, Suite 1100, Houston, TX 77030, USA. 
      cmdavids@bcm.edu
FAU - Monga, Manju
AU  - Monga M
FAU - Ellison, Dayna
AU  - Ellison D
FAU - Vidaeff, Alex
AU  - Vidaeff A
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Reprod Med
JT  - The Journal of reproductive medicine
JID - 0173343
RN  - 0 (Adrenal Cortex Hormones)
SB  - IM
MH  - Adrenal Cortex Hormones/*administration & dosage
MH  - Adult
MH  - Drug Administration Schedule
MH  - Feasibility Studies
MH  - Female
MH  - Fetal Membranes, Premature Rupture/*drug therapy
MH  - Gestational Age
MH  - Humans
MH  - Obstetric Labor, Premature/*drug therapy
MH  - Pregnancy
MH  - Prenatal Care
MH  - Retrospective Studies
MH  - Treatment Outcome
MH  - Young Adult
EDAT- 2010/03/27 06:00
MHDA- 2010/05/28 06:00
CRDT- 2010/03/27 06:00
PHST- 2010/03/27 06:00 [entrez]
PHST- 2010/03/27 06:00 [pubmed]
PHST- 2010/05/28 06:00 [medline]
PST - ppublish
SO  - J Reprod Med. 2010 Jan-Feb;55(1-2):14-8.

PMID- 23149821
OWN - NLM
STAT- MEDLINE
DCOM- 20130627
LR  - 20211021
IS  - 1619-7089 (Electronic)
IS  - 1619-7070 (Linking)
VI  - 40
IP  - 2
DP  - 2013 Jan
TI  - Should HIV-infected patients be screened for silent myocardial ischaemia using 
      gated myocardial perfusion SPECT?
PG  - 271-9
LID - 10.1007/s00259-012-2262-1 [doi]
AB  - PURPOSE: A higher prevalence of cardiovascular risk factors (CRFs) in 
      HIV-infected patients, together with chronic infection and treatments, has 
      resulted in an increased risk of silent myocardial ischaemia (SMI). The objective 
      of this study was to evaluate whether myocardial SPECT should be used for 
      screening HIV-infected patients with no clinical symptoms of coronary artery 
      disease. METHODS: The prevalence of SMI detected by myocardial SPECT was 
      determined in 94 HIV-infected patients with a normal clinical cardiovascular 
      examination in relation to anthropomorphic parameters, CRFs, inflammatory and HIV 
      infection status, and treatment. RESULTS: Coronary artery disease was detected in 
      nine patients (eight with ischaemia, one with myocardial infarction), 
      corresponding to 9.6 % positivity. All but two of the scintigraphic diagnoses of 
      ischaemia were confirmed by coronarography. Univariate analysis revealed that the 
      overall number of CRFs and the combination of gender and age were associated with 
      a diagnosis of SMI (p < 0.05). According to multivariate analysis, the only 
      independent parameter significantly associated with the scintigraphic diagnosis 
      of SMI was the combination of gender and age (p = 0.01). All the positive 
      myocardial SPECT scans were in men older than 52 years with at least two other 
      CRFs. In this subpopulation of 47 patients, the prevalence of SMI detected by 
      myocardial SPECT reached 19.2 %. CONCLUSION: In male HIV-infected patients older 
      than 52 years and with at least two other CRFs, screening for SMI using 
      myocardial SPECT was about four times more likely to be positive than in the 
      general population. This may motivate physicians to advise these patients to 
      undergo more systematic screening for SMI using this technique.
FAU - Mariano-Goulart, Denis
AU  - Mariano-Goulart D
AD  - Department of Nuclear Medicine, Montpellier University Hospital, Montpellier, 
      France. d-mariano_goulart@chu-montpellier.fr
FAU - Jacquet, Jean-Marc
AU  - Jacquet JM
FAU - Molinari, Nicolas
AU  - Molinari N
FAU - Bourdon, Aurelie
AU  - Bourdon A
FAU - Benkiran, Meriem
AU  - Benkiran M
FAU - Sainmont, Melanie
AU  - Sainmont M
FAU - Cornillet, Luc
AU  - Cornillet L
FAU - Macia, Jean-Christophe
AU  - Macia JC
FAU - Reynes, Jacques
AU  - Reynes J
FAU - Ben Bouallegue, Faycal
AU  - Ben Bouallegue F
LA  - eng
PT  - Journal Article
DEP - 20121114
PL  - Germany
TA  - Eur J Nucl Med Mol Imaging
JT  - European journal of nuclear medicine and molecular imaging
JID - 101140988
RN  - 0 (Anti-Retroviral Agents)
SB  - IM
MH  - Aged
MH  - Algorithms
MH  - Anthropometry/methods
MH  - Anti-Retroviral Agents/pharmacology
MH  - Female
MH  - HIV Infections/complications/*diagnosis/pathology
MH  - Humans
MH  - Inflammation
MH  - Male
MH  - Middle Aged
MH  - Myocardial Ischemia/complications/diagnosis/*pathology
MH  - Odds Ratio
MH  - Perfusion
MH  - Prevalence
MH  - Radionuclide Imaging/methods
MH  - Risk Factors
MH  - Tomography, Emission-Computed, Single-Photon/*methods
EDAT- 2012/11/15 06:00
MHDA- 2013/06/29 06:00
CRDT- 2012/11/15 06:00
PHST- 2012/06/05 00:00 [received]
PHST- 2012/09/21 00:00 [accepted]
PHST- 2012/11/15 06:00 [entrez]
PHST- 2012/11/15 06:00 [pubmed]
PHST- 2013/06/29 06:00 [medline]
AID - 10.1007/s00259-012-2262-1 [doi]
PST - ppublish
SO  - Eur J Nucl Med Mol Imaging. 2013 Jan;40(2):271-9. doi: 10.1007/s00259-012-2262-1. 
      Epub 2012 Nov 14.

PMID- 18235194
OWN - NLM
STAT- MEDLINE
DCOM- 20080327
LR  - 20151119
IS  - 1421-9972 (Electronic)
IS  - 1021-7762 (Linking)
VI  - 60
IP  - 2
DP  - 2008
TI  - Is a specialised training of phonological awareness indicated in every preschool 
      child?
PG  - 73-9
LID - 10.1159/000114648 [doi]
AB  - OBJECTIVE AND METHODS: In a prospective study 218 preschool children were 
      enrolled (stratified in 2 training programs, one specialized for phonologic 
      awareness in order to prevent dyslexia, the other consisting in training of 
      general perception) during the last year of kindergarten. After finishing the 
      first grade 131 children were compared in their reading and writing abilities. 
      RESULTS: In the whole group only a slight difference was found between both 
      training modalities concerning their writing abilities. However, children with a 
      history of hearing loss, actual hearing loss or pathologic middle ear findings 
      profited most from the specialized training program compared to the control in 
      their reading abilities. CONCLUSION: A specialized training program to improve 
      phonologic awareness as a basis for reading and writing in every kindergarten and 
      preschool child seems to be unnecessary. However, children with temporary hearing 
      deficits benefit from such a program. For all other children general perception 
      training may be sufficient.
CI  - Copyright 2008 S. Karger AG, Basel.
FAU - Keilmann, Annerose
AU  - Keilmann A
AD  - Division of Communication Disorders, Department of ORL, Mainz Medical School, 
      Mainz, Germany. keilmann@kommunikation.klinik.uni-mainz.de
FAU - Wintermeyer, Monika
AU  - Wintermeyer M
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20080131
PL  - Switzerland
TA  - Folia Phoniatr Logop
JT  - Folia phoniatrica et logopaedica : official organ of the International 
      Association of Logopedics and Phoniatrics (IALP)
JID - 9422792
SB  - IM
MH  - Child Language
MH  - Child, Preschool/*education
MH  - Correction of Hearing Impairment
MH  - Curriculum/standards
MH  - Dyslexia/epidemiology/etiology/*prevention & control
MH  - Education, Special
MH  - Female
MH  - Germany
MH  - Hearing Disorders/epidemiology
MH  - Humans
MH  - Language Development Disorders/epidemiology/rehabilitation
MH  - Linguistics/*education
MH  - Male
MH  - Multilingualism
MH  - Pattern Recognition, Physiological
MH  - Perception
MH  - Phonetics
MH  - Prospective Studies
MH  - Reading
MH  - Speech Disorders/epidemiology/rehabilitation
MH  - Vision Disorders/epidemiology/rehabilitation
MH  - Writing
EDAT- 2008/02/01 09:00
MHDA- 2008/03/28 09:00
CRDT- 2008/02/01 09:00
PHST- 2008/02/01 09:00 [pubmed]
PHST- 2008/03/28 09:00 [medline]
PHST- 2008/02/01 09:00 [entrez]
AID - 000114648 [pii]
AID - 10.1159/000114648 [doi]
PST - ppublish
SO  - Folia Phoniatr Logop. 2008;60(2):73-9. doi: 10.1159/000114648. Epub 2008 Jan 31.

PMID- 16392897
OWN - NLM
STAT- MEDLINE
DCOM- 20060328
LR  - 20191122
IS  - 1084-8592 (Print)
IS  - 1084-8592 (Linking)
VI  - 9
IP  - 4
DP  - 2005
TI  - BCRABL transcript detection by quantitative real-time PCR : are correlated 
      results possible from homebrew assays?
PG  - 187-93
AB  - BACKGROUND: Quantitative real-time PCR has become the predominant molecular 
      technique to monitor BCRABL levels in response to treatment in Ph(+) leukemia 
      patients. However, without some form of standardized methodology between 
      laboratories, the correlation of results is difficult. METHODS: Using 
      TaqMan-based assays, parallel quantitative real-time PCR analysis was performed 
      on 70 clinical specimens at Vanderbilt University Medical Center and Virginia 
      Commonwealth University. While the same positive control cell line (K562) and 
      quality control gene (BCR) were used, the RNA isolation technique, cDNA 
      synthesis, BCR control cell line, and PCR primer and probe sequences were 
      different. RESULTS: The detection of BCRABL-positive results spanned a dynamic 
      range from 10(0) to 10(5)/100,000 cells. Forty-three samples were negative at 
      both facilities. A Spearman rank correlation analysis was performed for the 22 
      BCRABL-positive paired results. The correlation coefficient, r(s), was 0.9435 (p 
      < 0.00001), suggesting a strong correlation of the results. One discordant result 
      was obtained for consecutive samples from one patient with a low BCRABL copy 
      number as a result of a minimal RNA yield at one laboratory. CONCLUSIONS: These 
      results suggest that quantitative real-time PCR assays for BCRABL detection can 
      be comparable between laboratories despite significant differences in 
      methodologies if the same positive control cell line and quality control gene are 
      used. It is imperative that some level of assay standardization be adopted 
      between laboratories, not only for patients who are monitored at different 
      facilities, but also for larger investigative studies in which hematologic, 
      cytogenetic and molecular responses are to be compared.
FAU - Fossey, Sallyanne C
AU  - Fossey SC
AD  - Molecular Genetics Laboratory, Department of Pathology, Vanderbilt University 
      Medical Center, Nashville, Tennessee, USA.
FAU - Ferreira-Gonzalez, Andrea
AU  - Ferreira-Gonzalez A
FAU - Garrett, Carleton T
AU  - Garrett CT
FAU - Dumur, Catherine I
AU  - Dumur CI
FAU - Vnencak-Jones, Cindy L
AU  - Vnencak-Jones CL
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Mol Diagn
JT  - Molecular diagnosis : a journal devoted to the understanding of human disease 
      through the clinical application of molecular biology
JID - 9614965
RN  - 0 (Antineoplastic Agents)
RN  - 0 (Benzamides)
RN  - 0 (Piperazines)
RN  - 0 (Pyrimidines)
RN  - 0 (RNA, Messenger)
RN  - 0 (RNA, Neoplasm)
RN  - 8A1O1M485B (Imatinib Mesylate)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Antineoplastic Agents/therapeutic use
MH  - Benzamides
MH  - Bone Marrow/metabolism/pathology
MH  - Bone Marrow Transplantation
MH  - *Genes, abl
MH  - Humans
MH  - Imatinib Mesylate
MH  - K562 Cells
MH  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics/pathology/therapy
MH  - Leukemia, Myeloid/*genetics/pathology/therapy
MH  - Middle Aged
MH  - Molecular Diagnostic Techniques
MH  - Piperazines/therapeutic use
MH  - Polymerase Chain Reaction
MH  - Precursor Cell Lymphoblastic Leukemia-Lymphoma/*genetics/pathology/therapy
MH  - Pyrimidines/therapeutic use
MH  - RNA, Messenger/analysis
MH  - RNA, Neoplasm/*analysis
MH  - Sensitivity and Specificity
EDAT- 2006/01/06 09:00
MHDA- 2006/03/29 09:00
CRDT- 2006/01/06 09:00
PHST- 2006/01/06 09:00 [pubmed]
PHST- 2006/03/29 09:00 [medline]
PHST- 2006/01/06 09:00 [entrez]
AID - 944 [pii]
AID - 10.1007/BF03260090 [doi]
PST - ppublish
SO  - Mol Diagn. 2005;9(4):187-93. doi: 10.1007/BF03260090.

PMID- 17940352
OWN - NLM
STAT- MEDLINE
DCOM- 20071108
LR  - 20191210
IS  - 1423-0399 (Electronic)
IS  - 0042-1138 (Linking)
VI  - 79
IP  - 3
DP  - 2007
TI  - Does HER2 immunoreactivity provide prognostic information in locally advanced 
      urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?
PG  - 210-6
AB  - INTRODUCTION: To evaluate the impact of HER2 immunoreactivity on clinical outcome 
      in locally advanced urothelial carcinoma patients who received surgery alone, or 
      methotrexate, vinblastine, epirubicin, and cisplatin (M-VEC) as adjuvant 
      chemotherapy. MATERIALS AND METHODS: We studied 114 formalin-fixed 
      paraffin-embedded specimens obtained from locally advanced urothelial carcinoma 
      patients receiving surgery alone or adjuvant M-VEC. The authors evaluated HER2 
      immunoreactivity using immunohistochemical staining and explored the influence of 
      pathological parameters and HER2 immunoreactivity on progression-free survival 
      (PFS) and disease-specific overall survival (OS) using univariate and 
      multivariate Cox's analyses. RESULTS: Urothelial carcinoma of the bladder had a 
      significantly higher frequency of HER2 immunoreactivity than that of the upper 
      urinary tract (60.7 vs. 20.7%, p < 0.0001). Overall, nodal status was a strong 
      and independent prognostic indicator for clinical outcome. The HER2 
      immunoreactivity was significantly associated with PFS (p = 0.02) and 
      disease-specific OS (p = 0.005) in advanced urothelial carcinoma patients. As for 
      patients with adjuvant M-VEC, HER2 immunoreactivity was a significant prognostic 
      factor for PFS (p = 0.03) and disease-specific OS (p = 0.02) using univariate 
      analysis, but not multivariate analysis, and not for patients receiving watchful 
      waiting. CONCLUSIONS: HER2 immunoreactivity might have a limited prognostic value 
      for advanced urothelial carcinoma patients with adjuvant M-VEC.
CI  - Copyright 2007 S. Karger AG, Basel.
FAU - Tsai, Yuh-Shyan
AU  - Tsai YS
AD  - Institute of Clinical Medicine, Department of Urology, College of Medicine, 
      National Cheng Kung University, Tainan, Taiwan.
FAU - Tzai, Tzong-Shin
AU  - Tzai TS
FAU - Chow, Nan-Hua
AU  - Chow NH
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Switzerland
TA  - Urol Int
JT  - Urologia internationalis
JID - 0417373
RN  - 3Z8479ZZ5X (Epirubicin)
RN  - 5V9KLZ54CY (Vinblastine)
RN  - EC 2.7.10.1 (ERBB2 protein, human)
RN  - EC 2.7.10.1 (Receptor, ErbB-2)
RN  - Q20Q21Q62J (Cisplatin)
RN  - YL5FZ2Y5U1 (Methotrexate)
RN  - M-VEC protocol
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
MH  - Carcinoma/chemistry/*drug therapy/pathology/surgery
MH  - Chemotherapy, Adjuvant
MH  - Cisplatin/administration & dosage
MH  - Disease-Free Survival
MH  - Epirubicin/administration & dosage
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - *Immunohistochemistry
MH  - Lymphatic Metastasis
MH  - Male
MH  - Methotrexate/administration & dosage
MH  - Middle Aged
MH  - Proportional Hazards Models
MH  - Receptor, ErbB-2/*analysis
MH  - Time Factors
MH  - Treatment Outcome
MH  - Urinary Bladder Neoplasms/chemistry/*drug therapy/pathology/surgery
MH  - Urothelium/*chemistry/pathology
MH  - Vinblastine/administration & dosage
EDAT- 2007/10/18 09:00
MHDA- 2007/11/09 09:00
CRDT- 2007/10/18 09:00
PHST- 2006/05/22 00:00 [received]
PHST- 2006/09/26 00:00 [accepted]
PHST- 2007/10/18 09:00 [pubmed]
PHST- 2007/11/09 09:00 [medline]
PHST- 2007/10/18 09:00 [entrez]
AID - 000107952 [pii]
AID - 10.1159/000107952 [doi]
PST - ppublish
SO  - Urol Int. 2007;79(3):210-6. doi: 10.1159/000107952.

PMID- 27615402
OWN - NLM
STAT- MEDLINE
DCOM- 20171024
LR  - 20220321
IS  - 1879-0046 (Electronic)
IS  - 0376-8716 (Linking)
VI  - 168
DP  - 2016 Nov 1
TI  - Does the familial transmission of drinking patterns persist into young adulthood? 
      A 10-year follow up.
PG  - 45-51
LID - S0376-8716(16)30872-9 [pii]
LID - 10.1016/j.drugalcdep.2016.08.630 [doi]
AB  - BACKGROUND: Parental drinking has been shown to be associated with offspring 
      drinking. However, the relationship appears to be more complex than often assumed 
      and few studies have tracked it over longer time periods. AIMS: To explore the 
      long-term (10-year) transmission of familial drinking during adolescence to 
      offspring drinking patterns in young adulthood. DESIGN: Swedish longitudinal 
      study, assessing the relationship between familial drinking in 2000 and offspring 
      drinking in 2010 using simultaneous quantile regression analysis (n=744). DATA: 
      Data on familial drinking was gathered from the Swedish level-of-living surveys 
      (LNU) and from partner LNU in 2000 while data on offspring drinking in young 
      adulthood was gathered from LNU 2010. Drinking among offspring, parents and 
      potential stepparents was measured through identical quantity-frequency indices 
      referring to the past 12 months in 2010 and 2000 respectively. RESULTS: Young 
      adults whose families were abstainers in 2000 drank substantially less across 
      quintiles in 2010 than offspring of non-abstaining families. The difference, 
      however, was not statistically significant between quintiles of the conditional 
      distribution. Actual drinking levels in drinking families were not at all or 
      weakly associated with drinking in offspring. Supplementary analyses confirmed 
      these patterns. CONCLUSION: The association between familial drinking and 
      offspring drinking in young adulthood exhibits clear non-linear trends. Changes 
      in the lower part of the familial drinking distribution are strongly related to 
      drinking in young adults, but the actual levels of drinking in drinking families 
      appear less important in shaping the drinking patterns of the offspring in young 
      adulthood.
CI  - Copyright (c) 2016 Elsevier Ireland Ltd. All rights reserved.
FAU - Karlsson, Patrik
AU  - Karlsson P
AD  - Department of Social Work, Stockholm University, 106 91 Stockholm, Sweden. 
      Electronic address: patrik.karlsson@socarb.su.se.
FAU - Magnusson, Charlotta
AU  - Magnusson C
AD  - Swedish Institute for Social Research (SOFI), Stockholm University, 106 91 
      Stockholm, Sweden. Electronic address: charlotta.magnusson@sofi.su.se.
FAU - Svensson, Johan
AU  - Svensson J
AD  - Swedish Council for Information on Alcohol and Drugs (CAN), Box 70412, Klara 
      Norra, Kyrkogata 34, 107 25 Stockholm, Sweden; Department of Clinical 
      Neuroscience, Karolinska Institutet, Administration, Tomtebodavagen 18A, 5th 
      floor, 171 77 Stockholm, Sweden. Electronic address: johan.svensson@can.se.
LA  - eng
PT  - Journal Article
DEP - 20160831
PL  - Ireland
TA  - Drug Alcohol Depend
JT  - Drug and alcohol dependence
JID - 7513587
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Alcohol Drinking/*psychology
MH  - Family/*psychology
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Longitudinal Studies
MH  - Male
MH  - Parent-Child Relations
MH  - Parents/*psychology
MH  - Surveys and Questionnaires
MH  - Sweden
MH  - Young Adult
OTO - NOTNLM
OT  - *Alcohol
OT  - *Familial
OT  - *Parental
OT  - *Quantile regression
OT  - *Sweden
OT  - *Transmission
EDAT- 2016/10/30 06:00
MHDA- 2017/10/25 06:00
CRDT- 2016/09/13 06:00
PHST- 2016/04/08 00:00 [received]
PHST- 2016/08/16 00:00 [revised]
PHST- 2016/08/22 00:00 [accepted]
PHST- 2016/10/30 06:00 [pubmed]
PHST- 2017/10/25 06:00 [medline]
PHST- 2016/09/13 06:00 [entrez]
AID - S0376-8716(16)30872-9 [pii]
AID - 10.1016/j.drugalcdep.2016.08.630 [doi]
PST - ppublish
SO  - Drug Alcohol Depend. 2016 Nov 1;168:45-51. doi: 10.1016/j.drugalcdep.2016.08.630. 
      Epub 2016 Aug 31.

PMID- 25779009
OWN - NLM
STAT- MEDLINE
DCOM- 20151221
LR  - 20201209
IS  - 1769-6690 (Electronic)
IS  - 0399-077X (Linking)
VI  - 45
IP  - 3
DP  - 2015 Mar
TI  - Bactericidal activity of 3 cutaneous/mucosal antiseptic solutions in the presence 
      of interfering substances: Improvement of the NF EN 13727 European Standard?
PG  - 89-94
LID - S0399-077X(15)00012-8 [pii]
LID - 10.1016/j.medmal.2015.01.006 [doi]
AB  - OBJECTIVE: There is no standard protocol for the evaluation of antiseptics used 
      for skin and mucous membranes in the presence of interfering substances. Our 
      objective was to suggest trial conditions adapted from the NF EN 13727 standard, 
      for the evaluation of antiseptics used in gynecology and dermatology. METHODS: 
      Three antiseptic solutions were tested in vitro: a chlorhexidine-benzalkonium 
      (CB) combination, a hexamidine-chlorhexidine-chlorocresol (HCC) combination, and 
      povidone iodine (P). The adaptation of trial conditions to the standard involved 
      choosing dilutions, solvent, and interfering substances. The activity of 
      solutions was assessed on the recommended strains at concentrations of 97% (pure 
      solution), 50%, and 10% (diluted solution), and 1%. A logarithmic reduction >/= 5 
      was expected after 60seconds of contact, to meet requirements of bactericidal 
      activity. RESULTS: HCC did not present any bactericidal activity except on P. 
      aeruginosa at a concentration of 97%. P was not bactericidal on E. hirae at any 
      concentration and on S. aureus at 97%. CB had the most homogeneous bactericidal 
      activity with a reduction>5 log on the 4 bacterial strains at concentrations of 
      97%, 50% and 10%. CONCLUSION: Adapting the NF EN 13727 standard allowed assessing 
      the 3 tested solutions: only CB was bactericidal in dirty conditions. This study 
      proved the possibility of validating antiseptic choice in vitro, in current 
      practice conditions, for adjunctive treatment of skin and mucous membranes 
      disorders, primarily of bacterial origin or with a potential of superinfection.
CI  - Copyright (c) 2015 Elsevier Masson SAS. All rights reserved.
FAU - Salvatico, S
AU  - Salvatico S
AD  - Fonderephar, 35, chemin des Maraichers, 31062 Toulouse cedex 9, France.
FAU - Feuillolay, C
AU  - Feuillolay C
AD  - Fonderephar, 35, chemin des Maraichers, 31062 Toulouse cedex 9, France.
FAU - Mas, Y
AU  - Mas Y
AD  - Laboratoire Innotech International, 22, avenue Aristide-Briand, 94110 Arcueil, 
      France.
FAU - Verriere, F
AU  - Verriere F
AD  - Laboratoire Innotech International, 22, avenue Aristide-Briand, 94110 Arcueil, 
      France.
FAU - Roques, C
AU  - Roques C
AD  - Fonderephar, 35, chemin des Maraichers, 31062 Toulouse cedex 9, France; 
      Laboratoire de genie chimique, UMR 5503, UFR pharmacie, universite de Toulouse, 
      35, chemin des Maraichers, 31062 Toulouse cedex 9, France. Electronic address: 
      ch.roques@wanadoo.fr.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150313
PL  - France
TA  - Med Mal Infect
JT  - Medecine et maladies infectieuses
JID - 0311416
RN  - 0 (Anti-Infective Agents, Local)
RN  - 0 (Benzalkonium Compounds)
RN  - 0 (Benzamidines)
RN  - 0 (Cresols)
RN  - 0 (Drug Combinations)
RN  - 0 (Inorganic Chemicals)
RN  - 0 (Solutions)
RN  - 27432CM55Q (Serum Albumin, Bovine)
RN  - 3483C2H13H (hexamidine)
RN  - 36W53O7109 (chlorocresol)
RN  - 85H0HZU99M (Povidone-Iodine)
RN  - MOR84MUD8E (chlorhexidine gluconate)
RN  - R4KO0DY52L (Chlorhexidine)
SB  - IM
MH  - Animals
MH  - Anti-Infective Agents, Local/*pharmacology
MH  - Benzalkonium Compounds/pharmacology
MH  - Benzamidines/pharmacology
MH  - Cattle
MH  - Chlorhexidine/analogs & derivatives/pharmacology
MH  - Cresols/pharmacology
MH  - Dose-Response Relationship, Drug
MH  - Drug Combinations
MH  - Drug Interactions
MH  - Enterococcus/drug effects
MH  - *Erythrocytes
MH  - Escherichia coli/drug effects
MH  - Europe
MH  - Hand Disinfection
MH  - Humans
MH  - Inorganic Chemicals/*pharmacology
MH  - Microbial Sensitivity Tests/*methods/standards
MH  - Mucous Membrane/microbiology
MH  - Osmolar Concentration
MH  - Povidone-Iodine/pharmacology
MH  - Pseudomonas aeruginosa/drug effects
MH  - Serum Albumin, Bovine/*pharmacology
MH  - Skin/microbiology
MH  - Solutions
MH  - Staphylococcus aureus/drug effects
OTO - NOTNLM
OT  - Antisepsie
OT  - Antisepsis
OT  - Benzalkonium
OT  - Chlorhexidine
OT  - Povidone iodine
OT  - Povidone iodee
EDAT- 2015/03/18 06:00
MHDA- 2015/12/22 06:00
CRDT- 2015/03/18 06:00
PHST- 2014/04/24 00:00 [received]
PHST- 2014/10/20 00:00 [revised]
PHST- 2015/01/14 00:00 [accepted]
PHST- 2015/03/18 06:00 [entrez]
PHST- 2015/03/18 06:00 [pubmed]
PHST- 2015/12/22 06:00 [medline]
AID - S0399-077X(15)00012-8 [pii]
AID - 10.1016/j.medmal.2015.01.006 [doi]
PST - ppublish
SO  - Med Mal Infect. 2015 Mar;45(3):89-94. doi: 10.1016/j.medmal.2015.01.006. Epub 
      2015 Mar 13.

PMID- 12407608
OWN - NLM
STAT- MEDLINE
DCOM- 20030103
LR  - 20220310
IS  - 1053-0770 (Print)
IS  - 1053-0770 (Linking)
VI  - 16
IP  - 5
DP  - 2002 Oct
TI  - Does ultrasound imaging before puncture facilitate internal jugular vein 
      cannulation? Prospective randomized comparison with landmark-guided puncture in 
      ventilated patients.
PG  - 572-5
AB  - OBJECTIVE: To investigate whether prepuncture ultrasound evaluation of vascular 
      anatomy facilitates internal jugular vein cannulation compared with 
      landmark-guided puncture. DESIGN: Prospective randomized study. SETTING: Single 
      community hospital. PARTICIPANTS: Adult patients undergoing general anesthesia (n 
      = 240). INTERVENTIONS: The right internal jugular vein was cannulated using 
      either anatomic landmarks or prepuncture ultrasound (3.75/7.5 MHz) guidance. In 
      the landmark group, respiratory jugular venodilation was used as the primary 
      landmark for locating the vein. Results of cannulation and the incidence of 
      complications were compared. MEASUREMENTS AND MAIN RESULTS: Patients were 
      randomly assigned to the ultrasound or landmark group. Respiratory jugular 
      venodilation was identified in 188 patients (78.3%), in whom results of 
      cannulation did not differ between the 2 techniques with respect to the venous 
      access rate (cannulated at the first attempt: 83.5% in the landmark v 85.7% in 
      the ultrasound group), the success rate (cannulated within 3 attempts: 96.9% v 
      95.6%), and the incidence of arterial puncture (1.0% v 3.3%). In the remaining 52 
      respiratory jugular venodilation-unidentified patients, the access rate (30.4% v 
      86.2%, p < 0.001) and the success rate (78.3 v 100%, p < 0.05) were significantly 
      better in the ultrasound group, and no arterial puncture was recorded in the 
      ultrasound group, whereas the incidence was 13.0% in the landmark group. The 
      results were similar regardless of the ultrasound frequency used. CONCLUSION: 
      Prepuncture ultrasound evaluation did not improve the result of right internal 
      jugular vein cannulation compared with the respiratory jugular 
      venodilation-guided approach. When the landmark was not observed, however, the 
      prepuncture ultrasound guidance was helpful in facilitating the cannulation.
CI  - Copyright 2002, Elsevier Science (USA). All rights reserved.
FAU - Hayashi, Hideaki
AU  - Hayashi H
AD  - Department of Anesthesia, Labor and Welfare Organization, Kansai Rosai Hospital, 
      Hyogo, Japan. hide884@mbox.kyoto-inet.or.jp
FAU - Amano, Masaru
AU  - Amano M
LA  - eng
PT  - Clinical Trial
PT  - Comparative Study
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - J Cardiothorac Vasc Anesth
JT  - Journal of cardiothoracic and vascular anesthesia
JID - 9110208
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Catheterization, Central Venous/adverse effects/*methods
MH  - Female
MH  - Humans
MH  - Jugular Veins/*diagnostic imaging
MH  - Male
MH  - Middle Aged
MH  - Prospective Studies
MH  - Punctures
MH  - Ultrasonography
MH  - Vasodilation
MH  - Ventilators, Mechanical
EDAT- 2002/10/31 04:00
MHDA- 2003/01/07 04:00
CRDT- 2002/10/31 04:00
PHST- 2002/10/31 04:00 [pubmed]
PHST- 2003/01/07 04:00 [medline]
PHST- 2002/10/31 04:00 [entrez]
AID - S1053077002000629 [pii]
AID - 10.1053/jcan.2002.126950 [doi]
PST - ppublish
SO  - J Cardiothorac Vasc Anesth. 2002 Oct;16(5):572-5. doi: 10.1053/jcan.2002.126950.

PMID- 14599616
OWN - NLM
STAT- MEDLINE
DCOM- 20031126
LR  - 20190627
IS  - 0002-9610 (Print)
IS  - 0002-9610 (Linking)
VI  - 186
IP  - 5
DP  - 2003 Nov
TI  - Can a practicing surgeon detect early lymphedema reliably?
PG  - 509-13
AB  - BACKGROUND: Lymphedema may be identified by simpler circumference changes as 
      compared with changes in limb volume. METHODS: Ninety breast cancer patients were 
      prospectively enrolled in an academic trial, and seven upper extremity 
      circumferences were measured quarterly for 3 years. A 10% volume increase or 
      greater than 1 cm increase in arm circumference identified lymphedema with 
      verification by a lymphedema specialist. Sensitivity and specificity of several 
      different criteria for detecting lymphedema were compared using the academic 
      trial as the standard. RESULTS: Thirty-nine cases of lymphedema were identified 
      by the academic trial. Using a 10% increase in circumference at two sites as the 
      criterion, half the lymphedema cases were detected (sensitivity 37%). When using 
      a 10% increase in circumference at any site, 74.4% of cases were detected 
      (sensitivity 49%). Detection by a 5% increase in circumference at any site was 
      91% sensitive. CONCLUSIONS: An increase of 5% in circumference measurements 
      identified the most potential lymphedema cases compared with an academic trial.
FAU - Bland, Keiva L
AU  - Bland KL
AD  - Department of Surgery, School of Medicine, Wayne State University, Detroit, MI, 
      USA.
FAU - Perczyk, Rebecca
AU  - Perczyk R
FAU - Du, Wei
AU  - Du W
FAU - Rymal, Christine
AU  - Rymal C
FAU - Koppolu, Prathima
AU  - Koppolu P
FAU - McCrary, Ruthie
AU  - McCrary R
FAU - Carolin, Kathryn A
AU  - Carolin KA
FAU - Kosir, Mary Ann
AU  - Kosir MA
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PL  - United States
TA  - Am J Surg
JT  - American journal of surgery
JID - 0370473
SB  - IM
MH  - Arm/anatomy & histology
MH  - Breast Neoplasms/*radiotherapy/*surgery
MH  - Early Diagnosis
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Lymphedema/*diagnosis
MH  - Middle Aged
MH  - Postoperative Complications/*diagnosis
MH  - Prospective Studies
MH  - Radiotherapy, Adjuvant
MH  - Sensitivity and Specificity
MH  - Time Factors
EDAT- 2003/11/06 05:00
MHDA- 2003/12/03 05:00
CRDT- 2003/11/06 05:00
PHST- 2003/11/06 05:00 [pubmed]
PHST- 2003/12/03 05:00 [medline]
PHST- 2003/11/06 05:00 [entrez]
AID - S000296100300326X [pii]
AID - 10.1016/j.amjsurg.2003.07.003 [doi]
PST - ppublish
SO  - Am J Surg. 2003 Nov;186(5):509-13. doi: 10.1016/j.amjsurg.2003.07.003.

PMID- 10223070
OWN - NLM
STAT- MEDLINE
DCOM- 19990514
LR  - 20220408
IS  - 0008-428X (Print)
IS  - 1488-2310 (Electronic)
IS  - 0008-428X (Linking)
VI  - 42
IP  - 2
DP  - 1999 Apr
TI  - Is perforation of the appendix a risk factor for tubal infertility and ectopic 
      pregnancy? An appraisal of the evidence.
PG  - 101-8
AB  - OBJECTIVE: To critically assess the evidence that appendiceal perforation is a 
      risk factor for subsequent tubal infertility or ectopic pregnancy. DATA SOURCES: 
      Epidemiologic studies investigating the relationship between appendectomy and 
      infertility or ectopic pregnancy were identified by searching the MEDLINE 
      database from 1966 to 1997. Appropriate citations were also extracted from a 
      manual search of the bibliographies of selected papers. STUDY SELECTION: 
      Twenty-three articles were retrieved. Only 4 presented original data including 
      comparisons to a nonexposed control group and they form the basis for this study. 
      DATA EXTRACTION: Because the raw data or specific techniques of data analysis 
      were not always explicitly described, indices of risk for exposure were extracted 
      from the data as presented and were analysed without attempting to convert them 
      to a common measure. DATA SYNTHESIS: Articles were assessed according to the 
      criteria of the Evidence-Based Medicine Working Group for evaluating articles on 
      harm. Review of the literature yielded estimates of the risk of adverse fertility 
      outcomes ranging from 1.6 (95% confidence interval [CI] 1.1 to 2.5) for ectopic 
      pregnancy after an appendectomy to 4.8 (95% CI 1.5 to 14.9) for tubal infertility 
      from perforation of the appendix. Recall bias, and poor adjustment for 
      confounding variables in some reports, weakened the validity of the studies. 
      CONCLUSIONS: The methodologic weaknesses of the studies do not permit acceptance 
      of increased risk of tubal pregnancy or infertility as a consequence of 
      perforation of the appendix, so a causal relationship cannot be supported by the 
      data currently available. Only a well-designed case-control study with unbiased 
      ascertainment of exposure and adjustment for confounding variables will provide a 
      definitive answer.
FAU - Urbach, D R
AU  - Urbach DR
AD  - Maternal, Infant and Reproductive Health Research Unit, University of Toronto, 
      Ont.
FAU - Cohen, M M
AU  - Cohen MM
LA  - eng
PT  - Journal Article
PL  - Canada
TA  - Can J Surg
JT  - Canadian journal of surgery. Journal canadien de chirurgie
JID - 0372715
SB  - IM
MH  - Appendicitis/*complications
MH  - Causality
MH  - Evidence-Based Medicine
MH  - Female
MH  - Humans
MH  - Infertility, Female/*epidemiology
MH  - Intestinal Perforation/*complications
MH  - Pregnancy
MH  - Pregnancy, Ectopic/*epidemiology
MH  - Research Design
MH  - Risk Factors
PMC - PMC3788969
EDAT- 1999/05/01 00:00
MHDA- 1999/05/01 00:01
PMCR- 1999/04/01
CRDT- 1999/05/01 00:00
PHST- 1999/05/01 00:00 [pubmed]
PHST- 1999/05/01 00:01 [medline]
PHST- 1999/05/01 00:00 [entrez]
PHST- 1999/04/01 00:00 [pmc-release]
AID - 0420101 [pii]
PST - ppublish
SO  - Can J Surg. 1999 Apr;42(2):101-8.

PMID- 20736672
OWN - NLM
STAT- MEDLINE
DCOM- 20100928
LR  - 20100825
IS  - 1938-808X (Electronic)
IS  - 1040-2446 (Linking)
VI  - 85
IP  - 9
DP  - 2010 Sep
TI  - Does perspective-taking increase patient satisfaction in medical encounters?
PG  - 1445-52
LID - 10.1097/ACM.0b013e3181eae5ec [doi]
AB  - PURPOSE: To assess whether perspective-taking, which researchers in other fields 
      have shown to induce empathy, improves patient satisfaction in encounters between 
      student-clinicians and standardized patients (SPs). METHOD: In three studies, 
      randomly assigned students (N = 608) received either a perspective-taking 
      instruction or a neutral instruction prior to a clinical skills examination in 
      2006-2007. SP satisfaction was the main outcome in all three studies. Study 1 
      involved 245 third-year medical students from two universities. Studies 2 and 3 
      extended Study 1 to examine generalizability across student and SP 
      subpopulations. Study 2 (105 physician assistant students, one university) 
      explored the effect of perspective-taking on African American SPs' satisfaction. 
      Study 3 (258 third-year medical students, two universities) examined the 
      intervention's effect on students with high and low baseline perspective-taking 
      tendencies. RESULTS: Intervention students outscored controls in patient 
      satisfaction in all studies: Study 1: P = .01, standardized effect size = 0.16; 
      Study 2: P = .001, standardized effect size = 0.31; Study 3: P = .009, 
      standardized effect size = 0.13. In Study 2, perspective-taking improved African 
      American SPs' satisfaction. In Study 3, intervention students with high baseline 
      perspective-taking tendencies outscored controls (P = .0004, standardized effect 
      size = 0.25), whereas those with low perspective-taking tendencies did not (P = 
      .72, standardized effect size = 0.00). CONCLUSIONS: Perspective-taking increased 
      patient satisfaction in all three studies, across medical schools, clinical 
      disciplines, and racially diverse students and SPs. Perspective-taking as a means 
      for improving patient satisfaction deserves further exploration in clinical 
      training and practice.
FAU - Blatt, Benjamin
AU  - Blatt B
AD  - Department of Medicine, CLASS Clinical Skills Center, George Washington 
      University School of Medicine and Health Sciences, Washington, DC, USA. 
      msdbcb@gwumc.edu
FAU - LeLacheur, Susan F
AU  - LeLacheur SF
FAU - Galinsky, Adam D
AU  - Galinsky AD
FAU - Simmens, Samuel J
AU  - Simmens SJ
FAU - Greenberg, Larrie
AU  - Greenberg L
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
PL  - United States
TA  - Acad Med
JT  - Academic medicine : journal of the Association of American Medical Colleges
JID - 8904605
SB  - IM
MH  - Analysis of Variance
MH  - Clinical Competence
MH  - *Communication
MH  - Curriculum
MH  - Education, Medical, Undergraduate/*methods
MH  - Educational Measurement
MH  - Empathy
MH  - Humans
MH  - *Patient Satisfaction
MH  - *Physician-Patient Relations
MH  - Students, Medical/*psychology
EDAT- 2010/08/26 06:00
MHDA- 2010/09/30 06:00
CRDT- 2010/08/26 06:00
PHST- 2010/08/26 06:00 [entrez]
PHST- 2010/08/26 06:00 [pubmed]
PHST- 2010/09/30 06:00 [medline]
AID - 00001888-201009000-00015 [pii]
AID - 10.1097/ACM.0b013e3181eae5ec [doi]
PST - ppublish
SO  - Acad Med. 2010 Sep;85(9):1445-52. doi: 10.1097/ACM.0b013e3181eae5ec.

PMID- 25277731
OWN - NLM
STAT- MEDLINE
DCOM- 20170425
LR  - 20211021
IS  - 1433-044X (Electronic)
IS  - 0177-5537 (Linking)
VI  - 119
IP  - 7
DP  - 2016 Jul
TI  - [Sternal fracture in growing children : A rare and often overlooked fracture? 
      Documentation of four cases].
PG  - 570-4
LID - 10.1007/s00113-014-2650-z [doi]
AB  - BACKGROUND: Sternal fractures in childhood are rare. The aim of the study was to 
      investigate the accident mechanism, the detection of radiological and 
      sonographical criteria and consideration of associated injuries. METHOD: In the 
      period from January 2010 to December 2012 all inpatients and outpatients with 
      sternal fractures were recorded according to the documentation. RESULTS: A total 
      of 4 children aged 5-14 years with a sternal fracture were treated in 2 years, 
      2 children were hospitalized for pain management and 2 remained in outpatient 
      care. CONCLUSION: Isolated sternal fractures in childhood are often due to 
      typical age-related traumatic incidents. Ultrasonography is a useful diagnostic 
      tool for fracture detection and radiography is the method of choice for 
      visualization of the extent of the dislocation.
FAU - Fichtel, I
AU  - Fichtel I
AD  - Klinik fur Unfall-, Wiederherstellungschirurgie und Orthopadie, Krankenhaus 
      Bietigheim, Riedstr. 12, 74123, Bietigheim-Bissingen, Deutschland. 
      inafichtel@t-online.de.
FAU - Fernandez, F F
AU  - Fernandez FF
AD  - Orthopadische Klinik, Klinikum Stuttgart, Olgahospital, Stuttgart, Deutschland.
FAU - Wirth, T
AU  - Wirth T
AD  - Orthopadische Klinik, Klinikum Stuttgart, Olgahospital, Stuttgart, Deutschland.
LA  - ger
PT  - Case Reports
PT  - Journal Article
TT  - Sternumfraktur im Wachstumsalter : Eine seltene oder haufig ubersehene Fraktur? 
      Dokumentation von 4 Fallen.
PL  - Germany
TA  - Unfallchirurg
JT  - Der Unfallchirurg
JID - 8502736
SB  - IM
MH  - Adolescent
MH  - Chest Pain/diagnosis/etiology/*prevention & control
MH  - Child
MH  - Child, Preschool
MH  - Diagnosis, Differential
MH  - Fractures, Bone/complications/*diagnostic imaging/*therapy
MH  - Humans
MH  - Male
MH  - Rare Diseases/complications/diagnosis/therapy
MH  - Sternum/*diagnostic imaging/*injuries
OTO - NOTNLM
OT  - Accident mechanism
OT  - Diagnostic radiology
OT  - Dislocation
OT  - Fracture sonography
OT  - Radiological criteria
EDAT- 2014/10/04 06:00
MHDA- 2017/04/26 06:00
CRDT- 2014/10/04 06:00
PHST- 2014/10/04 06:00 [entrez]
PHST- 2014/10/04 06:00 [pubmed]
PHST- 2017/04/26 06:00 [medline]
AID - 10.1007/s00113-014-2650-z [pii]
AID - 10.1007/s00113-014-2650-z [doi]
PST - ppublish
SO  - Unfallchirurg. 2016 Jul;119(7):570-4. doi: 10.1007/s00113-014-2650-z.

PMID- 17691856
OWN - NLM
STAT- MEDLINE
DCOM- 20071018
LR  - 20070813
IS  - 1445-6354 (Electronic)
IS  - 1445-6354 (Linking)
VI  - 7
IP  - 3
DP  - 2007 Jul-Sep
TI  - Midwives' competence: is it affected by working in a rural location?
PG  - 764
AB  - INTRODUCTION: Rising health care costs and the need to consolidate expertise in 
      tertiary services have led to the centralisation of services. In the UK, the 
      result has been that many rural maternity units have become midwife-led. A key 
      consideration is that midwives have the skills to competently and confidently 
      provide maternity services in rural areas, which may be geographically isolated 
      and where the midwife may only see a small number of pregnant women each year. 
      Our objective was to compare the views of midwives in rural and urban settings, 
      regarding their competence and confidence with respect to 'competencies' 
      identified as being those which all professionals should have in order to provide 
      effective and safe care for low-risk women. METHOD: This was a comparative 
      questionnaire survey involving a stratified sample of remote and rural maternity 
      units and an ad hoc comparison group of three urban maternity units in Scotland. 
      Questionnaires were sent to 82 midwives working in remote and rural areas and 107 
      midwives working in urban hospitals with midwife-led units. RESULTS: The response 
      rate from midwives in rural settings was considerably higher (85%) than from 
      midwives in the urban areas (60%). Although the proportion of midwives who 
      reported that they were competent was broadly similar in the two groups, there 
      were some significant differences regarding specific competencies. Midwives in 
      the rural group were more likely to report competence for breech delivery (p = 
      0.001), while more urban midwives reported competence in skills such as 
      intravenous fluid replacement (p <0.001) and initial and discharge examination of 
      the newborn (p <0.001). Both groups reported facing barriers to continuing 
      professional development; however, more of the rural group had attended an 
      educational event within the last month (p <0.001). Lack of time was a greater 
      barrier for urban midwives (p = 0.02), whereas distance to training was greater 
      for rural midwives (p = 0.009). Lack of motivation or interest was significantly 
      higher in urban units (p = 0.006). CONCLUSION: It is often assumed that midwives 
      in rural areas where there are fewer deliveries, will be less competent and 
      confident in their practice. Our exploratory study suggests that the issue of 
      competence is far more complex and deserves further attention.
FAU - Hundley, Vanora A
AU  - Hundley VA
AD  - NMAHP Research Unit, University of Stirling, Stirling, United Kingdom. 
      vanora.hundley@stir.ac.uk
FAU - Tucker, Janet S
AU  - Tucker JS
FAU - van Teijlingen, Edwin
AU  - van Teijlingen E
FAU - Kiger, Alice
AU  - Kiger A
FAU - Ireland, Jilly C
AU  - Ireland JC
FAU - Harris, Fiona
AU  - Harris F
FAU - Farmer, Jane
AU  - Farmer J
FAU - Caldow, Jan L
AU  - Caldow JL
FAU - Bryers, Helen
AU  - Bryers H
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20070810
PL  - Australia
TA  - Rural Remote Health
JT  - Rural and remote health
JID - 101174860
SB  - IM
MH  - *Attitude of Health Personnel
MH  - Clinical Competence/*statistics & numerical data
MH  - Education, Nursing, Continuing/statistics & numerical data
MH  - Female
MH  - Health Care Surveys
MH  - Humans
MH  - Midwifery/*statistics & numerical data
MH  - Pregnancy
MH  - Rural Health Services/*statistics & numerical data
MH  - Scotland
MH  - Urban Health Services/statistics & numerical data
EDAT- 2007/08/19 09:00
MHDA- 2007/10/19 09:00
CRDT- 2007/08/19 09:00
PHST- 2007/08/19 09:00 [pubmed]
PHST- 2007/10/19 09:00 [medline]
PHST- 2007/08/19 09:00 [entrez]
AID - 764 [pii]
PST - ppublish
SO  - Rural Remote Health. 2007 Jul-Sep;7(3):764. Epub 2007 Aug 10.

PMID- 16735905
OWN - NLM
STAT- MEDLINE
DCOM- 20060623
LR  - 20060602
IS  - 0023-852X (Print)
IS  - 0023-852X (Linking)
VI  - 116
IP  - 6
DP  - 2006 Jun
TI  - Does the severity of obstructive sleep apnea predict patients requiring high 
      continuous positive airway pressure?
PG  - 951-5
AB  - STUDY OBJECTIVES: To investigate polysomnographic and anthropomorphic factors 
      predicting need of high optimal continuous positive airway pressure (CPAP). 
      DESIGN: Retrospective data analysis. PATIENTS: Three hundred fifty-three 
      consecutive obstructive sleep apnea (OSA) patients who had a successful manual 
      CPAP titration in our sleep disorders unit. MEASUREMENTS AND RESULTS: The mean 
      optimal CPAP was 9.5 +/- 2.4 cm H2O. The optimal CPAP pressure increases with an 
      increase in OSA severity from 7.79 +/- 2.2 in the mild, to 8.7 +/- 1.8 in the 
      moderate, and to 10.1 +/- 2.3 cm H2O in the severe OSA group. A high CPAP was 
      defined as the mean + 1 standard deviation (SD; > or =12 cm H2O). The predictor 
      variables included apnea-hypopnea index (AHI), age, sex, body mass index (BMI), 
      Epworth Sleepiness Scale (ESS), and the Multiple Sleep Latency Test (MSLT). High 
      CPAP was required in 2 (6.9%), 6 (5.8%), and 63 (28.6%) patients with mild, 
      moderate, and severe OSA, respectively. On univariate analysis, AHI, BMI, ESS 
      score, and the proportion of males were significantly higher in those needing 
      high CPAP. They also have a lower MSLT mean. On logistic regression, the use of 
      high CPAP was 5.90 times more frequent (95% confidence interval 2.67-13.1) in 
      severe OSA patients after adjustment for the other variables. The area under the 
      receiver operator curve was 72.4%, showing that the model was adequate. 
      CONCLUSIONS: Severe OSA patients are much more likely to need high CPAP levels. 
      However, because of the low positive predictive value (only 28.6%), the clinical 
      value of such information is limited. ESS and MSLT did not increase the 
      predictive value for the need for high CPAP.
FAU - Oksenberg, Arie
AU  - Oksenberg A
AD  - Sleep Disorders Unit, Loewenstein Hospital-Rehabilitation Center, Raanana, 
      Israel. arieo@clalit.org.il
FAU - Arons, Elena
AU  - Arons E
FAU - Froom, Paul
AU  - Froom P
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Laryngoscope
JT  - The Laryngoscope
JID - 8607378
SB  - IM
MH  - Body Mass Index
MH  - *Continuous Positive Airway Pressure
MH  - Female
MH  - Humans
MH  - Logistic Models
MH  - Male
MH  - Middle Aged
MH  - Models, Theoretical
MH  - Polysomnography
MH  - Predictive Value of Tests
MH  - Retrospective Studies
MH  - Severity of Illness Index
MH  - Sex Factors
MH  - Sleep Apnea, Obstructive/diagnosis/physiopathology/*therapy
EDAT- 2006/06/01 09:00
MHDA- 2006/06/24 09:00
CRDT- 2006/06/01 09:00
PHST- 2006/06/01 09:00 [pubmed]
PHST- 2006/06/24 09:00 [medline]
PHST- 2006/06/01 09:00 [entrez]
AID - 10.1097/01.MLG.0000215833.68519.7B [doi]
PST - ppublish
SO  - Laryngoscope. 2006 Jun;116(6):951-5. doi: 10.1097/01.MLG.0000215833.68519.7B.

PMID- 19694846
OWN - NLM
STAT- MEDLINE
DCOM- 20091221
LR  - 20181201
IS  - 1365-2648 (Electronic)
IS  - 0309-2402 (Linking)
VI  - 65
IP  - 9
DP  - 2009 Sep
TI  - Does self-efficacy mediate the relationship between transformational leadership 
      behaviours and healthcare workers' sleep quality? A longitudinal study.
PG  - 1833-43
LID - 10.1111/j.1365-2648.2009.05039.x [doi]
AB  - AIM: This paper is a report of a study conducted to investigate the longitudinal 
      relationship between transformational leadership behaviours and employees' sleep 
      quality, and the mediating effects of self-efficacy. BACKGROUND: Although there 
      is evidence for the influential role of transformational leadership on health 
      outcomes, researchers have used either attitude outcomes (e.g. job satisfaction) 
      or softer health measures, such as general well-being. Specific measures of 
      well-being such as sleep quality have not been used, despite its association with 
      working conditions. METHODS: A longitudinal design was used to collect data from 
      Danish healthcare workers at time 1 in 2005 (n = 447) and 18 months later at time 
      2 in 2007 (n = 274). Structural equation modelling was used to investigate the 
      relationships between transformational leadership, self-efficacy and sleep 
      quality at both time points independently (cross-sectionally) and longitudinally. 
      RESULTS: For all constructs, time 2 measures were influenced by the baseline 
      level. Direct relationships between transformational leadership and sleep quality 
      were found. This relationship was negative cross-sectionally at both time points, 
      but positive between baseline and follow-up. The relationship between leadership 
      and employees' sleep quality was not mediated by employees' self-efficacy. 
      CONCLUSION: Our results indicate that training managers in transformational 
      leadership behaviours may have a positive impact on healthcare workers' health 
      over time. However, more research is needed to examine the mechanisms by which 
      transformational leadership brings about improved sleep quality; self-efficacy 
      was not found to be the explanation.
FAU - Munir, Fehmidah
AU  - Munir F
AD  - Department of Human Sciences, Loughborough University, United Kingdom. 
      f.munir@lboro.ac.uk
FAU - Nielsen, Karina
AU  - Nielsen K
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - J Adv Nurs
JT  - Journal of advanced nursing
JID - 7609811
SB  - IM
MH  - Adult
MH  - Denmark
MH  - Female
MH  - Humans
MH  - Job Satisfaction
MH  - *Leadership
MH  - Longitudinal Studies
MH  - Male
MH  - Models, Theoretical
MH  - Nursing Assistants/psychology
MH  - Nursing Staff, Hospital/*psychology/statistics & numerical data
MH  - *Self Efficacy
MH  - *Sleep
MH  - Sleep Initiation and Maintenance Disorders/*epidemiology/psychology
MH  - Surveys and Questionnaires
EDAT- 2009/08/22 09:00
MHDA- 2009/12/22 06:00
CRDT- 2009/08/22 09:00
PHST- 2009/08/22 09:00 [entrez]
PHST- 2009/08/22 09:00 [pubmed]
PHST- 2009/12/22 06:00 [medline]
AID - JAN5039 [pii]
AID - 10.1111/j.1365-2648.2009.05039.x [doi]
PST - ppublish
SO  - J Adv Nurs. 2009 Sep;65(9):1833-43. doi: 10.1111/j.1365-2648.2009.05039.x.

PMID- 25007420
OWN - NLM
STAT- MEDLINE
DCOM- 20140925
LR  - 20211021
IS  - 0706-7437 (Print)
IS  - 1497-0015 (Electronic)
IS  - 0706-7437 (Linking)
VI  - 59
IP  - 7
DP  - 2014 Jul
TI  - Are there mental health differences between francophone and non-francophone 
      populations in manitoba?
PG  - 366-75
AB  - OBJECTIVE: Francophones may experience poorer health due to social status, 
      cultural differences in lifestyle and attitudes, and language barriers to health 
      care. Our study sought to compare mental health indicators between Francophones 
      and non-Francophones living in the province of Manitoba. METHODS: Two populations 
      were used: one from administrative datasets housed at the Manitoba Centre for 
      Health Policy and the other from representative survey samples. The 
      administrative datasets contained data from physician billings, hospitalizations, 
      prescription drug use, education, and social services use, and surveys included 
      indicators on language variables and on self-rated health. RESULTS: Outside urban 
      areas, Francophones had lower rates of diagnosed substance use disorder (rate 
      ratio [RR] = 0.80; 95% CI 0.68 to 0.95) and of suicide and suicide attempts (RR = 
      0.59; 95% CI 0.43 to 0.79), compared with non-Francophones, but no differences 
      were found between the groups across the province in rates of diagnosed mood 
      disorders, anxiety disorders, dementia, or any mental disorders after adjusting 
      for age, sex, and geographic area. When surveyed, Francophones were less likely 
      than non-Francophones to report that their mental health was excellent, very 
      good, or good (66.9%, compared with 74.2%). CONCLUSIONS: The discrepancy in how 
      Francophones view their mental health and their rates of diagnosed mental 
      disorders may be related to health seeking behaviours in the Francophone 
      population. Community and government agencies should try to improve the mental 
      health of this population through mental health promotion and by addressing 
      language and cultural barriers to health services.
FAU - Chartier, Mariette Jeanne
AU  - Chartier MJ
AD  - Research Scientist, Manitoba Centre for Health Policy, Department of Community 
      Health Sciences, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba; 
      Assistant Professor, Department of Community Health Sciences, Faculty of 
      Medicine, University of Manitoba, Winnipeg, Manitoba.
FAU - Finlayson, Gregory
AU  - Finlayson G
AD  - Research Scientist, Manitoba Centre for Health Policy, Department of Community 
      Health Sciences, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba.
FAU - Prior, Heather
AU  - Prior H
AD  - Data Analyst, Manitoba Centre for Health Policy, Department of Community Health 
      Sciences, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba.
FAU - Mcgowan, Kari-Lynne
AU  - Mcgowan KL
AD  - Research Coordinator, Manitoba Centre for Health Policy, Department of Community 
      Health Sciences, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba.
FAU - Chen, Hui
AU  - Chen H
AD  - Data Analyst, Manitoba Centre for Health Policy, Department of Community Health 
      Sciences, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba.
FAU - Walld, Randy
AU  - Walld R
AD  - Data Analyst, Manitoba Centre for Health Policy, Department of Community Health 
      Sciences, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba.
FAU - De Rocquigny, Janelle
AU  - De Rocquigny J
AD  - Graduate Student, Department of Community Health Sciences, Faculty of Medicine, 
      University of Manitoba, Winnipeg, Manitoba.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Can J Psychiatry
JT  - Canadian journal of psychiatry. Revue canadienne de psychiatrie
JID - 7904187
SB  - IM
MH  - Adult
MH  - *Communication Barriers
MH  - *Cross-Cultural Comparison
MH  - Cross-Sectional Studies
MH  - *Cultural Characteristics
MH  - Female
MH  - Health Surveys
MH  - *Hierarchy, Social
MH  - Humans
MH  - *Language
MH  - *Life Style
MH  - Male
MH  - Manitoba
MH  - Mental Disorders/diagnosis/*epidemiology/psychology
MH  - Middle Aged
MH  - Substance-Related Disorders/diagnosis/epidemiology/psychology
MH  - Suicide/statistics & numerical data
MH  - Suicide, Attempted/statistics & numerical data
PMC - PMC4086314
EDAT- 2014/07/10 06:00
MHDA- 2014/09/26 06:00
PMCR- 2015/01/01
CRDT- 2014/07/10 06:00
PHST- 2013/09/01 00:00 [received]
PHST- 2014/02/01 00:00 [accepted]
PHST- 2014/07/10 06:00 [entrez]
PHST- 2014/07/10 06:00 [pubmed]
PHST- 2014/09/26 06:00 [medline]
PHST- 2015/01/01 00:00 [pmc-release]
AID - cjp-2014-vol59-july-366-375 [pii]
AID - 10.1177/070674371405900704 [doi]
PST - ppublish
SO  - Can J Psychiatry. 2014 Jul;59(7):366-75. doi: 10.1177/070674371405900704.

PMID- 26134053
OWN - NLM
STAT- MEDLINE
DCOM- 20161103
LR  - 20161230
IS  - 1481-8043 (Electronic)
IS  - 1481-8035 (Linking)
VI  - 17
IP  - 4
DP  - 2015 Jul
TI  - Outcome Feedback within Emergency Medicine Training Programs: An Opportunity to 
      Apply the Theory of Deliberate Practice?
PG  - 367-73
LID - 10.1017/cem.2014.47 [doi]
AB  - OBJECTIVES: Outcome feedback is the process of learning patient outcomes after 
      their care within the emergency department. We conducted a national survey of 
      Canadian Royal College emergency medicine (EM) residents and program directors to 
      determine the extent to which active outcome feedback and follow-up occurred. We 
      also compared the perceived educational value of outcome feedback between 
      residents and program directors. METHODS: We distributed surveys to all Royal 
      College-accredited adult and pediatric EM training programs using a modified 
      Dillman method. We analyzed the data using student's t-test for continuous 
      variables and Fisher's exact test for categorical variables. RESULTS: We received 
      210 completed surveys from 260 eligible residents (80.8%) and 21 of 24 program 
      directors (87.5%) (overall 81.3%). Mandatory active outcome feedback was not 
      present in any EM training program for admitted or discharged patients (0/21). 
      Follow-up was performed electively by 89.4% of residents for patients admitted to 
      the hospital, and by 44.2% of residents for patients discharged home. A majority 
      of residents (76.9%) believed that patient follow-up should be mandatory compared 
      to 42.9% of program directors (p=0.002). The perceived educational value of 
      outcome feedback was 5.8/7 for residents and 5.1/7 for program directors 
      (difference 0.7; p=0.002) based on a seven-point Likert scale (1=not important; 
      7=very important). CONCLUSION: While Canadian EM training programs do not mandate 
      follow-up, it is performed electively by the majority of residents surveyed. 
      Residents place a significantly greater educational value on outcome feedback 
      than their program directors, and believe that follow-up should be a mandatory 
      component of EM residencies.
FAU - Dalseg, Timothy R
AU  - Dalseg TR
AD  - *Department of Emergency Medicine,University of Ottawa,ON,Canada.
FAU - Calder, Lisa A
AU  - Calder LA
AD  - daggerClinical Epidemiology Program,Ottawa Hospital Research Institute,ON,Canada.
FAU - Lee, Curtis
AU  - Lee C
AD  -  section signSchool of Medicine & Public Health,University of 
      Newcastle,Callaghan,NSW,Australia.
FAU - Walker, Jaymie
AU  - Walker J
AD  -  paragraph signUniversity of Winnipeg,MB,Canada.
FAU - Frank, Jason R
AU  - Frank JR
AD  - *Department of Emergency Medicine,University of Ottawa,ON,Canada.
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
PL  - England
TA  - CJEM
JT  - CJEM
JID - 100893237
SB  - IM
MH  - Adult
MH  - Canada
MH  - Child
MH  - *Clinical Competence
MH  - *Curriculum
MH  - Emergency Medicine/*education
MH  - Female
MH  - Humans
MH  - Internship and Residency/*methods
MH  - Male
MH  - *Models, Educational
MH  - *Surveys and Questionnaires
OTO - NOTNLM
OT  - Deliberate practice
OT  - Emergency medicine
OT  - Feedback
OT  - Follow-up
OT  - Outcome feedback
EDAT- 2015/07/03 06:00
MHDA- 2016/11/04 06:00
CRDT- 2015/07/03 06:00
PHST- 2015/07/03 06:00 [entrez]
PHST- 2015/07/03 06:00 [pubmed]
PHST- 2016/11/04 06:00 [medline]
AID - S1481803514000475 [pii]
AID - 10.1017/cem.2014.47 [doi]
PST - ppublish
SO  - CJEM. 2015 Jul;17(4):367-73. doi: 10.1017/cem.2014.47.
